Psyllid ID: psy5927

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-
Protein Sequence
MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGPTLPVM
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHccccHHHHHHHHHHccccHHHHHHHHHHccHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEcccEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEccccEEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEccEEccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccHHHcHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHHHHHHHHHHHcccccHHHHHHHcccccccEcHHHHHccHHHHHHcccccccccccccccccccccccccccccccccccccccEEEEEEEEEcccccHHccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEcccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccEcccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccEEEEEcccHcHEEccccccccHcHHcHHHEEccccccEEcccEEEEEcccccHHHHHcccEcEcccHHHHEEEEEEEEccccccccccccHHHHHHHHHHHHccccHHHcccccccccHHHHHHHHHHHHHHHcccHHccccHHHHHHEccccccccccccccEEEEc
Coil and Loop (DISEMBL)
MNFTSRQLFQMEQAILRrespteellskwgaqnHTVLELFKHLYAMRHYQAMLILKpyveskyhtcipegcsdnrtILQEQSSVFSAQNHNVKSARVnfeneagvrqennpgneptrkvsdpltpmnvlggtphipyqeltlatnnwdklnilgkggfgtvYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLnscrhdnilplygicfetgkYCLVyrympngsledrllmkkntpsllwtqrlhiakgtslglqflhsrepplihgdikSANILlnhhmdpvigdfgltqegpiekaTHITLkrvngtrpylpheflVGKRLSTKVDVYGFGIVLFELAtgmrayddtrRSERHLKSLVEKYSEENMydlvdknaqpiELNIAYAFFRigkqstkqnpkerpeMTQVYNMLsgsggespnatgptlpvm
Flexible Loop (DISEMBL)
mnftsrqlfqmEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNfeneagvrqennpgneptrkvsdpLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKklevhrndraVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHitlkrvngtrpYLPHEFLVGKRLSTKVDVYGFGIVLFELatgmrayddtrrseRHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKqstkqnpkerpEMTQVYNmlsgsggespnatgptlpvm
Low Complexity Region (SEG)
MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGPTLPVM
Disordered region (IsUnstruct)
************************LLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTIL************************************************NVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD**********LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIG***************************************
Disordered Region (DISOPRED)
**FTSRQLFQM*Q*******P**ELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKY**********************************************************************HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEV***********QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD*RRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS**************P**
Disordered Region (DISEMBL)
MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQ**********EMTQVYNMLSG****************
Disordered Region (DISPRO)
*NFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQE*********************GGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGPTLPVM
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGPTLPVM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	441	2.2.26 [Sep-21-2011]
Q05652	501	Serine/threonine-protein	yes	N/A	0.902	0.794	0.366	3e-62
Q9NWZ3	460	Interleukin-1 receptor-as	yes	N/A	0.882	0.845	0.330	1e-46
Q62406	710	Interleukin-1 receptor-as	yes	N/A	0.643	0.4	0.358	4e-46
Q2LGB3	718	Interleukin-1 receptor-as	yes	N/A	0.671	0.412	0.345	5e-45
Q8R4K2	459	Interleukin-1 receptor-as	no	N/A	0.852	0.819	0.323	2e-44
Q1RMT8	461	Interleukin-1 receptor-as	no	N/A	0.870	0.832	0.330	4e-44
P51617	712	Interleukin-1 receptor-as	no	N/A	0.639	0.396	0.345	7e-43
Q8W4S5	614	Probable LRR receptor-lik	no	N/A	0.671	0.482	0.342	1e-42
Q9LFS4	638	Protein NSP-INTERACTING K	no	N/A	0.641	0.443	0.370	6e-42
C0LGT1	613	Probable LRR receptor-lik	no	N/A	0.632	0.455	0.357	4e-41

>sp|Q05652|KPEL_DROME Serine/threonine-protein kinase pelle OS=Drosophila melanogaster GN=pll PE=1 SV=1

 Score =  239 bits (610), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 161/439 (36%), Positives = 230/439 (52%), Gaps = 41/439 (9%)

Query: 7   QLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYVESKYHT 65
           Q+ Q+     R  S + E L+ WG Q NHTV  LF     ++ + AM ++K YV    H 
Sbjct: 68  QVEQISSQKQRGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHK 127

Query: 66  CIPEGCSDNRTILQEQSSVFSAQNHN----------------VKSARVNFENEAGVRQEN 109
            IP       TI + +++  S+   N                 +++    E    +    
Sbjct: 128 YIPRSVP---TISELRAAPDSSAKVNNGPPFPSSSGVSNSNNNRTSTTATEEIPSLESLG 184

Query: 110 NPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT 169
           N      ++ ++ L           I Y EL  AT+ W   N LG+GGFG VY+G W++ 
Sbjct: 185 NIHISTVQRAAESLL---------EIDYAELENATDGWSPDNRLGQGGFGDVYRGKWKQL 235

Query: 170 TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR 229
            +A+K +  +R+    + + + Q  QS  ELKYLNS RHDNIL LYG   + GK CLVY+
Sbjct: 236 DVAIKVMN-YRSPNIDQKMVELQ--QSYNELKYLNSIRHDNILALYGYSIKGGKPCLVYQ 292

Query: 230 YMPNGSLEDRLLMKKNT---PSLLWTQRLHIAKGTSLGLQFLH-SREPPLIHGDIKSANI 285
            M  GSLE RL   K     P+L W QR  I+ GT+ G+ FLH +R  PLIHGDIK ANI
Sbjct: 293 LMKGGSLEARLRAHKAQNPLPALTWQQRFSISLGTARGIYFLHTARGTPLIHGDIKPANI 352

Query: 286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGI 345
           LL+  + P IGDFGL +EGP      + + +V GT+ YLP EF   ++LST VDVY FGI
Sbjct: 353 LLDQCLQPKIGDFGLVREGPKSLDAVVEVNKVFGTKIYLPPEFRNFRQLSTGVDVYSFGI 412

Query: 346 VLFELATGMRAYDDTRRSE--RHLKSLVEKYSEENMYDLVDKN-AQPI--ELNIAYAFFR 400
           VL E+ TG +  D    +E  ++L   V++   +N  +L++K+ A P+  EL++      
Sbjct: 413 VLLEVFTGRQVTDRVPENETKKNLLDYVKQQWRQNRMELLEKHLAAPMGKELDMCMCAIE 472

Query: 401 IGKQSTKQNPKERPEMTQV 419
            G   T  +P++RP M  V
Sbjct: 473 AGLHCTALDPQDRPSMNAV 491

Plays an essential role in the Tl receptor signaling pathway that establishes embryonic dorsoventral polarity; the signal directs import of dl into ventral and ventrolateral nuclei, thereby establishing dorsoventral polarity. Tub recruits pll to the plasma membrane and protein-protein interaction activates pll.
Drosophila melanogaster (taxid: 7227)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9NWZ3|IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1

 Score =  187 bits (476), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 139/420 (33%), Positives = 208/420 (49%), Gaps = 31/420 (7%)

Query: 13  QAILRR-ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGC 71
           +A+L+  +SPT ELL  WG  N TV +L   L     +    +L P    K    +P   
Sbjct: 57  EALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLP--- 113

Query: 72  SDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGG 131
           S     +Q++   F  ++  + +   N E        ++P N+ + +VSD  T  +    
Sbjct: 114 SKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENK-SLEVSD--TRFHSFS- 169

Query: 132 TPHIPYQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAV 185
                + EL   TNN+D+       N +G+GGFG VYKG    TT+AVKKL        V
Sbjct: 170 -----FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA-----MV 219

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
           +   +  ++Q  +E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     
Sbjct: 220 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 279

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
           TP L W  R  IA+G + G+ FLH  E   IH DIKSANILL+      I DFGL +   
Sbjct: 280 TPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARAS- 336

Query: 306 IEK-ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
            EK A  +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +
Sbjct: 337 -EKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 394

Query: 365 RHL-KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
             L      +  E+ + D +DK     +     A + +  Q   +   +RP++ +V  +L
Sbjct: 395 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 454

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q62406|IRAK1_MOUSE Interleukin-1 receptor-associated kinase 1 OS=Mus musculus GN=Irak1 PE=1 SV=3

 Score =  186 bits (471), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 117/326 (35%), Positives = 162/326 (49%), Gaps = 42/326 (12%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           P+ E++  T N+ +   +G+GGFG VY+ V   TT AVK+L+   +      L     +Q
Sbjct: 201 PFCEISQGTCNFSEELRIGEGGFGCVYRAVMRNTTYAVKRLKEEAD------LEWTMVKQ 254

Query: 196 S-LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQ 253
           S L E++ L+  RH NI+   G C E+G YCLVY ++PNGSLED+L L  +    L W Q
Sbjct: 255 SFLTEVEQLSRFRHPNIVDFAGYCAESGLYCLVYGFLPNGSLEDQLHLQTQACSPLSWPQ 314

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ------EGPIE 307
           RL I  GT+  +QFLH   P LIHGDIKS+N+LL+  + P +GDFGL +          +
Sbjct: 315 RLDILLGTARAIQFLHQDSPSLIHGDIKSSNVLLDERLMPKLGDFGLARFSRFAGAKASQ 374

Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL 367
            +T      V GT  YLP E++   RL+   D + FG+V+ E   G RA        ++L
Sbjct: 375 SSTVARTSTVRGTLAYLPEEYIKTGRLAVDTDTFSFGVVILETLAGQRAVRTQGAKTKYL 434

Query: 368 KSLVEKYSEENMYDL------------VDKNAQPIELNI----------------AYAFF 399
           K L+E  +EE    L             D  A PI   I                  A  
Sbjct: 435 KDLIEDEAEEAGVTLKSTQPTLWVGVATDAWAAPIAAQIYKKHLDSRPGPCPPQLGLALA 494

Query: 400 RIGKQSTKQNPKERPEMTQVYNMLSG 425
           ++      +  K+RP MTQVY  L G
Sbjct: 495 QLACCCMHRRAKKRPPMTQVYKRLEG 520

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2LGB3|IRAK1_BOVIN Interleukin-1 receptor-associated kinase 1 OS=Bos taurus GN=IRAK1 PE=2 SV=2

 Score =  182 bits (462), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 118/342 (34%), Positives = 170/342 (49%), Gaps = 46/342 (13%)

Query: 122 PLTPMNVLGGTPH----IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLE 177
           P +PM++L G P      P  E+   T+++ +   +G+GGFG VY+ V   T  AVK+L+
Sbjct: 183 PESPMSLLPGAPSSSFCWPLHEICQGTHDFSEELKIGEGGFGCVYRAVMRNTVYAVKRLK 242

Query: 178 VHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSL 236
              +      L     +QS + E++ L+  RH NI+   G C ++G YCLVY ++PNGSL
Sbjct: 243 EEAD------LEWTTVKQSFQTEVQQLSRFRHPNIVDFAGYCAQSGFYCLVYGFLPNGSL 296

Query: 237 EDRLLMKKNT-PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
           EDRL ++    P L W QRL I  GT+  +QFLH   P LIHGD+KS+N+LL+  + P +
Sbjct: 297 EDRLHVQTQAWPPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDVKSSNVLLDERLMPKL 356

Query: 296 GDFGL------TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFE 349
           GDFGL      T   P + ++    + V GT  YLP E++   RL+   D + FG+VL E
Sbjct: 357 GDFGLARLSRFTGANPGQSSSVARTRTVRGTLAYLPEEYVKTGRLAVDTDTFSFGVVLLE 416

Query: 350 LATGMRAYDDTRRSERHLKSLVEKYSEENMYDL--------------------------- 382
              G RA        ++LK LVE+ +EE    L                           
Sbjct: 417 TLAGQRAVRMHGAQPKYLKDLVEEEAEEAGVTLKGTQTAVQGGPAADTWAALVAAQIYKK 476

Query: 383 -VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            +D    P    +  A  ++      +  K RP MTQVY  L
Sbjct: 477 HLDPRPGPCPPQLGLALGQLACCCLHRRAKRRPPMTQVYQTL 518

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8R4K2|IRAK4_MOUSE Interleukin-1 receptor-associated kinase 4 OS=Mus musculus GN=Irak4 PE=1 SV=1

 Score =  180 bits (457), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 136/420 (32%), Positives = 198/420 (47%), Gaps = 44/420 (10%)

Query: 19  ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTIL 78
           +SPT ELL  WG  N TV +L   L  +  +    +L P    +    +P    +  T+ 
Sbjct: 64  KSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLPDAVPQTVKSLPP--REAATVA 121

Query: 79  QEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQ 138
           Q           +V       E+       ++P N   R V    T  +         + 
Sbjct: 122 QTHGPCQEKDRTSVMPMP-KLEHSCEPPDSSSPDN---RSVESSDTRFHSFS------FH 171

Query: 139 ELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ 192
           EL   TNN+D+       N +G+GGFG VYKG    T +AVKKL        VE   +  
Sbjct: 172 ELKSITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTIVAVKKLGA-----MVEISTEEL 226

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
           ++Q  +E+K + +C+H+N++ L G   ++   CLVY YMPNGSL DRL     TP L W 
Sbjct: 227 KQQFDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSCLDGTPPLSWH 286

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R  +A+GT+ G++FLH  E   IH DIKSANILL+      I DFGL +      A  +
Sbjct: 287 TRCKVAQGTANGIRFLH--ENHHIHRDIKSANILLDKDFTAKISDFGLAR-ASARLAQTV 343

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL----- 367
              R+ GT  Y+  E L G+ ++ K D+Y FG+VL EL TG+ A D+ R  +  L     
Sbjct: 344 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLELITGLAAVDENREPQLLLDIKEE 402

Query: 368 ----KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
               +  +E Y++E M D     A P  +    A +    Q   +    RP++ +V  +L
Sbjct: 403 IEDEEKTIEDYTDEKMSD-----ADPASVE---AMYSAASQCLHEKKNRRPDIAKVQQLL 454

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1RMT8|IRAK4_BOVIN Interleukin-1 receptor-associated kinase 4 OS=Bos taurus GN=IRAK4 PE=2 SV=1

 Score =  179 bits (454), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 140/423 (33%), Positives = 200/423 (47%), Gaps = 39/423 (9%)

Query: 19  ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTIL 78
           +SPT ELL  WG  N TV +L   L     +    +L           +P+    N   L
Sbjct: 64  KSPTCELLFDWGTTNCTVGDLVDILVQNEFFAPASLL-----------LPDAVPKNVNTL 112

Query: 79  QEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNV---LGGTP-- 133
             + +V + Q    K   +  ++   V  + NP  E    + D  +P N       T   
Sbjct: 113 PSKVTVVAVQQ---KPKPLCGKDRTSVISDENP--EQNYVLPDSSSPENTSLEFSDTRFH 167

Query: 134 HIPYQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVET 187
              + EL   TNN+D+       N +G+GGFG VYKG     T+AVKKL     D + E 
Sbjct: 168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNRTVAVKKLAAMV-DISTEE 226

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
           L Q    Q  +E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     TP
Sbjct: 227 LKQ----QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 282

Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
            L W  R  IA+G + GL +LH  E   IH DIKSANILL+      I DFGL +    E
Sbjct: 283 PLSWNMRCKIAQGAANGLSYLH--ENHHIHRDIKSANILLDEDFTAKISDFGLARAS--E 338

Query: 308 K-ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
           K A  +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +  
Sbjct: 339 KFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 397

Query: 367 L-KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
           L      +  E+ + D VD+    I+       + +  Q   +   +RP++ +V  +L  
Sbjct: 398 LDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVASQCLHEKKNKRPDIKKVQQLLEE 457

Query: 426 SGG 428
             G
Sbjct: 458 MTG 460

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51617|IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2

 Score =  175 bits (443), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 112/324 (34%), Positives = 159/324 (49%), Gaps = 42/324 (12%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           P  E++  T+N+ +   +G+GGFG VY+ V   T  AVK+L+ + +      L     +Q
Sbjct: 201 PLCEISRGTHNFSEELKIGEGGFGCVYRAVMRNTVYAVKRLKENAD------LEWTAVKQ 254

Query: 196 S-LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQ 253
           S L E++ L+  RH NI+   G C + G YCLVY ++PNGSLEDRL    +  P L W Q
Sbjct: 255 SFLTEVEQLSRFRHPNIVDFAGYCAQNGFYCLVYGFLPNGSLEDRLHCQTQACPPLSWPQ 314

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ------EGPIE 307
           RL I  GT+  +QFLH   P LIHGDIKS+N+LL+  + P +GDFGL +        P +
Sbjct: 315 RLDILLGTARAIQFLHQDSPSLIHGDIKSSNVLLDERLTPKLGDFGLARFSRFAGSSPSQ 374

Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL 367
            +     + V GT  YLP E++   RL+   D + FG+V+ E   G RA        ++L
Sbjct: 375 SSMVARTQTVRGTLAYLPEEYIKTGRLAVDTDTFSFGVVVLETLAGQRAVKTHGARTKYL 434

Query: 368 KSLVEKYSEENMYDL----------------------------VDKNAQPIELNIAYAFF 399
           K LVE+ +EE    L                            +D    P    +     
Sbjct: 435 KDLVEEEAEEAGVALRSTQSTLQAGLAADAWAAPIAMQIYKKHLDPRPGPCPPELGLGLG 494

Query: 400 RIGKQSTKQNPKERPEMTQVYNML 423
           ++      +  K RP MTQVY  L
Sbjct: 495 QLACCCLHRRAKRRPPMTQVYERL 518

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1

 Score =  174 bits (442), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 112/327 (34%), Positives = 177/327 (54%), Gaps = 31/327 (9%)

Query: 112 GNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTT 170
             E  RK+S         G       +E+ LAT+++++ N++G+GGFG VY+G+  +KT 
Sbjct: 262 AGEDDRKIS--------FGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTK 313

Query: 171 IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY 230
           +AVK+L  + +                RE++ ++   H N+L L G C  + +  LVY Y
Sbjct: 314 VAVKRLADYFSPGGEAAFQ--------REIQLISVAVHKNLLRLIGFCTTSSERILVYPY 365

Query: 231 MPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLN 288
           M N S+  RL  +K     L W  R  +A G++ GL++LH    P +IH D+K+ANILL+
Sbjct: 366 MENLSVAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLD 425

Query: 289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLF 348
           ++ +PV+GDFGL +       TH+T  +V GT  ++  E+L   + S K DV+G+GI L 
Sbjct: 426 NNFEPVLGDFGLAKLVDTS-LTHVT-TQVRGTMGHIAPEYLCTGKSSEKTDVFGYGITLL 483

Query: 349 ELATGMRAYDDTRRSER-------HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRI 401
           EL TG RA D +R  E        H+K L+    E+ + D+VD N    +        ++
Sbjct: 484 ELVTGQRAIDFSRLEEEENILLLDHIKKLLR---EQRLRDIVDSNLTTYDSKEVETIVQV 540

Query: 402 GKQSTKQNPKERPEMTQVYNMLSGSGG 428
               T+ +P++RP M++V  ML G+GG
Sbjct: 541 ALLCTQGSPEDRPAMSEVVKMLQGTGG 567

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  172 bits (435), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 115/310 (37%), Positives = 172/310 (55%), Gaps = 27/310 (8%)

Query: 129 LGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVET 187
           LG      ++EL +ATNN+   N+LGKGG+G VYKG+  + T +AVK+L   ++  A+  
Sbjct: 294 LGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRL---KDGGALGG 350

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
             Q Q E  +  L       H N+L LYG C    +  LVY YM NGS+  R+   K  P
Sbjct: 351 EIQFQTEVEMISLAV-----HRNLLRLYGFCITQTEKLLVYPYMSNGSVASRM---KAKP 402

Query: 248 SLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
            L W+ R  IA G + GL +LH + +P +IH D+K+ANILL+ + + V+GDFGL +    
Sbjct: 403 VLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLD- 461

Query: 307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
            + +H+T   V GT  ++  E+L   + S K DV+GFGI+L EL TG RA++  + + + 
Sbjct: 462 HQDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQK 520

Query: 367 ---LKSLVEKYSEENMYDLVD------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMT 417
              L  + + + E+ +  LVD      K+   IEL+      R+    T+  P  RP+M+
Sbjct: 521 GVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELD---EMVRVALLCTQYLPGHRPKMS 577

Query: 418 QVYNMLSGSG 427
           +V  ML G G
Sbjct: 578 EVVRMLEGDG 587

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  169 bits (428), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 114/319 (35%), Positives = 171/319 (53%), Gaps = 40/319 (12%)

Query: 128 VLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKL---EVHRNDR 183
             G      ++EL LAT+N+ + N+LG+GGFG VYKGV  + T +AVK+L   E    D 
Sbjct: 271 AFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDA 330

Query: 184 AVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-M 242
           A +           RE++ ++   H N+L L G C    +  LVY +M N SL  RL  +
Sbjct: 331 AFQ-----------REVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREI 379

Query: 243 KKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           K   P L W  R  IA G + G ++LH    P +IH D+K+AN+LL+   + V+GDFGL 
Sbjct: 380 KAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLA 439

Query: 302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
           +   + + T++T  +V GT  ++  E+L   + S + DV+G+GI+L EL TG RA D +R
Sbjct: 440 KLVDVRR-TNVT-TQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSR 497

Query: 362 RSER-------HLKSLVEKYSEENMYDLVDKN------AQPIELNIAYAFFRIGKQSTKQ 408
             E        H+K L     E+ +  +VDKN       + +E+ I  A        T+ 
Sbjct: 498 LEEEDDVLLLDHVKKL---EREKRLGAIVDKNLDGEYIKEEVEMMIQVALL-----CTQG 549

Query: 409 NPKERPEMTQVYNMLSGSG 427
           +P++RP M++V  ML G G
Sbjct: 550 SPEDRPVMSEVVRMLEGEG 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
328718288	614	PREDICTED: serine/threonine-protein kina	0.947	0.680	0.481	1e-104
242021687	744	conserved hypothetical protein [Pediculu	0.952	0.564	0.433	2e-97
350396247	513	PREDICTED: serine/threonine-protein kina	0.911	0.783	0.409	7e-92
340722244	513	PREDICTED: serine/threonine-protein kina	0.911	0.783	0.412	2e-91
383851607	505	PREDICTED: serine/threonine-protein kina	0.918	0.801	0.424	2e-90
307169659	489	Probable serine/threonine-protein kinase	0.920	0.830	0.407	8e-89
345484035	582	PREDICTED: serine/threonine-protein kina	0.909	0.689	0.440	2e-88
307198795	510	Probable serine/threonine-protein kinase	0.934	0.807	0.404	2e-88
322791257	489	hypothetical protein SINV_00896 [Solenop	0.913	0.824	0.424	1e-87
156541314	480	PREDICTED: serine/threonine-protein kina	0.913	0.839	0.427	2e-87

>gi|328718288|ref|XP_001943030.2| PREDICTED: serine/threonine-protein kinase pelle-like [Acyrthosiphon pisum]

 Score =  386 bits (991), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 206/428 (48%), Positives = 274/428 (64%), Gaps = 10/428 (2%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVE 60
           M   +  +F++ +A +R  S T+ELL+ WG QNHT+LELF  L  M+HY+AM+ILKP+V+
Sbjct: 42  MKIDTATIFKLSKAPMRNHSSTDELLTLWGEQNHTILELFSILNTMQHYRAMIILKPFVD 101

Query: 61  SKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTR--- 117
            KYH  I +G      +++ ++   S  N      ++N +N    R+ NN   E      
Sbjct: 102 HKYHKLINQGAKSFGYLVKSETDD-SLNNEVDNVIKLNTDNNE--RRGNNIEREDLNTLG 158

Query: 118 KVSDPLTPM--NVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKK 175
           K+++  + M  +    TP I Y EL  ATN W+K NILGKGGFG V+KG+W  TT+A+K+
Sbjct: 159 KINEHPSIMFSSAEACTPLITYNELEQATNYWNKENILGKGGFGVVFKGIWRSTTVAIKR 218

Query: 176 LEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGS 235
           LE  +       + + QR+QSLRELKYLNSCRHDNIL LYG      K CLVY+YM NGS
Sbjct: 219 LEAQKGAEQQFNILEAQRQQSLRELKYLNSCRHDNILSLYGFSIGGEKPCLVYQYMINGS 278

Query: 236 LEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
           LEDRL  ++ T  L W  R  IA G++ GLQFLH  + PLIHGDIKSANILL+ + +P I
Sbjct: 279 LEDRLQCRQGTEPLTWNFRFKIATGSARGLQFLHGMDKPLIHGDIKSANILLDQNFEPRI 338

Query: 296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR 355
           GDFGL +EGP+++ TH+ +  V+GTRPYLP EFL GK+ STKVD Y FG+VLFE+ATG R
Sbjct: 339 GDFGLAREGPLQEYTHVKVSHVHGTRPYLPDEFLRGKKFSTKVDTYSFGVVLFEIATGQR 398

Query: 356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE 415
           AYD+  R+ + LK  VE  ++  + D+ D  A P E N+  +   IGK       K+RPE
Sbjct: 399 AYDNL-RNHKFLKDHVEN-NDCPISDMADVKAGPDENNLYASLMTIGKNCVSYKAKDRPE 456

Query: 416 MTQVYNML 423
           M QV   L
Sbjct: 457 MEQVLRKL 464

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242021687|ref|XP_002431275.1| conserved hypothetical protein [Pediculus humanus corporis] gi|212516532|gb|EEB18537.1| conserved hypothetical protein [Pediculus humanus corporis]

 Score =  362 bits (929), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 208/480 (43%), Positives = 275/480 (57%), Gaps = 60/480 (12%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVE 60
           MNF    +  + + ILR  SPT+ELL+KWG QNHT+LELF  L  M+HYQAMLI+KP+V+
Sbjct: 9   MNFDVLTIQTLRREILRGNSPTDELLTKWGHQNHTILELFVLLSKMQHYQAMLIIKPFVD 68

Query: 61  SKYHTCIPEG--------------CSDNRTILQEQSSVFSAQNHNV-------------- 92
            +YH  I EG               +D    L + +S    QN N+              
Sbjct: 69  PEYHKLIYEGEQNLNRLFKIDQNSKNDTTNRLDQNTSQCRPQNENLNVDLAENKIINGQD 128

Query: 93  --KSARVNFENE-----------------AGVRQENN-------PGNEPTRKVSDPLTPM 126
              SA  +F+N                   G   +N        P +   + VS+  +  
Sbjct: 129 PGSSAVNDFKNSRNNAQTALLNRPLSDTPMGSNHQNQIPSKFLKPDSSKDKNVSEISSIA 188

Query: 127 NVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVE 186
             +G  P I ++EL +AT  WD   ILGKGGFGTVYKG W+ T +A+K+ +    D    
Sbjct: 189 ERVGILPFITFKELEIATGGWDPSTILGKGGFGTVYKGTWKNTLVAIKRTKNSETDEN-- 246

Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
             +  Q +Q L ELK LNS RHDNILPLYG   +    CL+Y++MPNGSLEDRLL +  +
Sbjct: 247 --HSIQIQQILGELKMLNSYRHDNILPLYGFSMDGEDPCLIYQFMPNGSLEDRLLCRHGS 304

Query: 247 PSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             L W+QRL+IA GT+ G+QFLH+  E PLIHGDIKSANILL+ + +P IGDFGL +EGP
Sbjct: 305 KPLTWSQRLNIATGTARGIQFLHTIGEKPLIHGDIKSANILLDLNYEPKIGDFGLAREGP 364

Query: 306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER 365
               TH+ + RV+GTRPYLP EFL  K+ STKVD + FGIVLFELATG+RAYD+ +R  +
Sbjct: 365 YNHYTHMKVSRVHGTRPYLPDEFLRHKKFSTKVDTHSFGIVLFELATGLRAYDE-QRHHK 423

Query: 366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
            LK LVE   +  +  L+D+ +   E     +   +GK    + PK+RPEM  V   L+ 
Sbjct: 424 FLKDLVENIPKVQLGTLIDRKSGLDEQQSFLSLIALGKCCVSRKPKDRPEMVVVLQELNA 483

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350396247|ref|XP_003484492.1| PREDICTED: serine/threonine-protein kinase pelle-like [Bombus impatiens]

 Score =  343 bits (881), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 191/466 (40%), Positives = 273/466 (58%), Gaps = 64/466 (13%)

Query: 13  QAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCS 72
           Q++ + ++PT+ELL+ WG  NHT+LELF  L  M+HYQ+M+ LK +VE K+H  +  G  
Sbjct: 56  QSLRKEKNPTDELLTMWGHYNHTILELFVLLSRMQHYQSMVPLKSFVEEKFHKLLYNGEG 115

Query: 73  DNRTILQEQSSVFSAQNHNVKSARVNFEN----------------EAGVRQENNPG-NEP 115
           +   IL ++       N N K  ++  +N                E   ++E++   NEP
Sbjct: 116 NLHRILGKR------LNKNTKDLKIGTQNFNQIAPPEPNLPKIIVEKNTKEESHKILNEP 169

Query: 116 TRKVSDPLTPMN--------------VLG----------------------GTPHIPYQE 139
            + +   + P N               LG                        PH+PY E
Sbjct: 170 MQALHIGVVPSNSNNLLVASLAAANPALGSLQRTPTSGRKDNDAIIFSAEAAIPHVPYNE 229

Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           L++ATN W+  NILG+GGFGTVY+G W+ T +A+KK+E    D   +  +Q Q +QS RE
Sbjct: 230 LSIATNEWNLYNILGRGGFGTVYRGTWKNTAVAIKKIEKRGADS--DESHQLQLQQSFRE 287

Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           +K LNSCRH+NILPLY    +    C+VY+ M NGSLEDRLL+K+ +  L W QR  IAK
Sbjct: 288 IKILNSCRHENILPLYAYSLDGKLPCIVYQLMKNGSLEDRLLLKQKSQPLSWIQRHEIAK 347

Query: 260 GTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           G + GLQ+LH+  E PLIHGDIKSANILL+ +++P IGDFGL +EGP   +  ++  +++
Sbjct: 348 GAACGLQYLHTVGEKPLIHGDIKSANILLDKNLEPRIGDFGLAREGPERDSMEVS--KIH 405

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN 378
           GTRPYLP EFL G++LSTKVD Y +GIVLFELATG+ AYD +R   R LK  ++ + +++
Sbjct: 406 GTRPYLPEEFLHGRKLSTKVDTYSYGIVLFELATGLPAYDKSRLGNRFLKDFIDSWEDKD 465

Query: 379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           +  L+DK A   +  +      +GK  T +  + RPEM  V+  L+
Sbjct: 466 LPLLIDKKAGEKDKQVYNNLMILGKWCTNRMAQNRPEMDYVFKKLN 511

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340722244|ref|XP_003399518.1| PREDICTED: serine/threonine-protein kinase pelle-like [Bombus terrestris]

 Score =  342 bits (878), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 192/466 (41%), Positives = 270/466 (57%), Gaps = 64/466 (13%)

Query: 13  QAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCS 72
           Q++ + ++PT+ELL+ WG  NHT+LELF  L  M+HYQ+M+ LK +VE K+H  +  G  
Sbjct: 56  QSLRKEKNPTDELLTMWGHYNHTILELFVLLSRMQHYQSMVPLKSFVEEKFHKLLYNGEG 115

Query: 73  DNRTILQEQSSVFSAQNHNVKSARVNFEN----------------EAGVRQENNPG-NEP 115
           +   IL ++       N N K  ++  +N                E   R+E++   N P
Sbjct: 116 NLHRILGKR------LNKNTKDLKIGTQNFNQIAPPEPNMPKIIVEKNTREESHKILNRP 169

Query: 116 TRKVSDPLTPMN--------------VLG----------------------GTPHIPYQE 139
            + +   + P N               LG                        PH+PY E
Sbjct: 170 MQALHVGVVPSNSNNLLVASLAAANPALGSLQRTPTSGRKDNDAIIFSAEAAIPHVPYSE 229

Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           L++ATN W+  NILG+GGFGTVY+G W+ T +A+KK+E    D     L Q Q  QS RE
Sbjct: 230 LSIATNEWNLYNILGRGGFGTVYRGTWKNTAVAIKKIEKRGTDSDESHLLQLQ--QSFRE 287

Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           +K LNSCRH+NILPLY    +    C+VY+ M NGSLEDRLL+K+ +  L W QR  IAK
Sbjct: 288 IKILNSCRHENILPLYAYSLDGKLPCIVYQLMKNGSLEDRLLLKQKSQPLSWIQRHEIAK 347

Query: 260 GTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           G + GLQ+LH+  E PLIHGDIKSANILL+ +++P IGDFGL +EGP   +  ++  +++
Sbjct: 348 GAACGLQYLHTVGEKPLIHGDIKSANILLDKNLEPRIGDFGLAREGPERDSMEVS--KIH 405

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN 378
           GTRPYLP EFL G++LSTKVD Y +GIVLFELATG+ AYD +R   R LK  ++ + +++
Sbjct: 406 GTRPYLPEEFLHGRKLSTKVDTYSYGIVLFELATGLPAYDKSRLGNRFLKDFIDNWEDKD 465

Query: 379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           +  L+DK A   +  +      +GK  T +  + RPEM  V+  L+
Sbjct: 466 LPLLIDKKAGEKDKQVYNNLMILGKWCTNRMAQNRPEMDYVFKKLN 511

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383851607|ref|XP_003701323.1| PREDICTED: serine/threonine-protein kinase pelle-like [Megachile rotundata]

 Score =  339 bits (869), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 197/464 (42%), Positives = 264/464 (56%), Gaps = 59/464 (12%)

Query: 13  QAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCS 72
           Q++ + ++PT+ELL+ WG  NHT+LELF  L  M+HYQAML LK YVE KYH  I  G  
Sbjct: 49  QSLRKEKNPTDELLTMWGHHNHTILELFVLLSKMQHYQAMLPLKLYVEEKYHKLISCGEG 108

Query: 73  DNRTILQEQSSVFSAQNHNVKSARVNFE-------NEAGVRQENNPGNEPTRKVSDPLTP 125
           +   IL+ +         ++K    NF        N   +  E N   E  + ++ P+  
Sbjct: 109 NLNRILERR---LQKNTKDLKIGIQNFNQIAPPEPNVPKIIVERNTKEESYKILNKPMQA 165

Query: 126 M----------NVLGGT---------------------------------PHIPYQELTL 142
           M          N+L G+                                 P   Y+ELT+
Sbjct: 166 MHIADTPSNSNNLLVGSVAPAHLLSPLLQHGISNGKRNNEVAAIQAETTLPQASYEELTI 225

Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            TN+WDK  ILG+GGFGTVYKG+W+ T +A+KKLE  R D       Q Q  QSLRE+K 
Sbjct: 226 VTNDWDKGYILGRGGFGTVYKGIWKNTEVAIKKLEKRRTDSNESYAIQLQ--QSLREIKI 283

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           LNS  H+NILPLY    ++   CLVY++M NGSLEDRLL++  T  L W QR  IAKGT+
Sbjct: 284 LNSFPHENILPLYAYSLDSKSPCLVYQFMKNGSLEDRLLLRHKTQPLTWMQRHQIAKGTA 343

Query: 263 LGLQFLH-SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            GLQ+LH   + PLIHGDIKSANILL+   +P IGDFGL +EGP E +  ++  +++GTR
Sbjct: 344 CGLQYLHIIGKKPLIHGDIKSANILLDKSFEPKIGDFGLAREGPEEDSMKVS--KIHGTR 401

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
           PYLP EFL  + LSTKVD Y FGIVLFELATG+ AYD++R  ++ LK  +  + +  +  
Sbjct: 402 PYLPEEFLYKRELSTKVDTYSFGIVLFELATGLSAYDESRVQDKFLKDFINGWEKSQLDL 461

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
           L DK A   +  +      +GK  T  + + RPEM+ V+   +G
Sbjct: 462 LRDKKAGEKDSQVYNNLMILGKWCT-NSVQNRPEMSSVFKKFNG 504

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307169659|gb|EFN62241.1| Probable serine/threonine-protein kinase pelle [Camponotus floridanus]

 Score =  333 bits (855), Expect = 8e-89,   Method: Compositional matrix adjust.
 Identities = 182/447 (40%), Positives = 264/447 (59%), Gaps = 41/447 (9%)

Query: 13  QAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCS 72
           Q++ + ++PT+ELL+ WG  NHT+ ELF  L  M+HYQ+M+ L  +V+ K+H  +  G +
Sbjct: 47  QSLRKEKNPTDELLTLWGHHNHTITELFVLLSKMQHYQSMVPLLNFVDQKFHRLLHSGEA 106

Query: 73  DNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQE-NNPGNEPTRKVSDPLTPMNVLGG 131
           + + I ++Q  + +    ++K    NF   A  +Q  +   N+P +    P    N+L  
Sbjct: 107 NLQNIPRKQ--LINKNTKDLKIGTQNFNQRASPQQSVDKILNQPVQLAISPSNSNNLLVA 164

Query: 132 T---------------------------------PHIPYQELTLATNNWDKLNILGKGGF 158
           +                                 PH  Y EL +ATN W+  NILGKGGF
Sbjct: 165 SPGAAVVFLPSSQNTGSNAKKINESSLPKTETTLPHASYSELAIATNGWNPHNILGKGGF 224

Query: 159 GTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC 218
           GTVY+G W+ T +A+KK+     D     + Q Q  QSL+E+K LNS  H+NILPLY   
Sbjct: 225 GTVYRGTWKNTDVAIKKIRQKGPDSDESYILQLQ--QSLKEIKILNSRAHENILPLYAYS 282

Query: 219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH-SREPPLIH 277
           F     CLVY+ M NGSLEDRLL+++ T  L W QR  IAKG + GLQ+LH   + PLIH
Sbjct: 283 FGGEAPCLVYQLMKNGSLEDRLLLRQKTKPLTWIQRHEIAKGIARGLQYLHIIGDKPLIH 342

Query: 278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK 337
           GDIKSANILL+ + +P IGDFGL +EGP   +  I+  +++GTRPYLP EFL  K+LSTK
Sbjct: 343 GDIKSANILLDKNFEPRIGDFGLAREGPERDSMKIS--KIHGTRPYLPEEFLFDKKLSTK 400

Query: 338 VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA 397
           +D Y +GIVLFE+ATG+RAYDD+R  ++ L+ L++ + +++++ L+DK A   +  +   
Sbjct: 401 IDTYSYGIVLFEMATGLRAYDDSRPEKKFLRDLIDAWEDKDLFLLIDKKAGEKDKQVYKN 460

Query: 398 FFRIGKQSTKQNPKERPEMTQVYNMLS 424
              +GK    +  + RPEM  V+  L+
Sbjct: 461 LISLGKWCANKLAQNRPEMEFVFRKLN 487

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345484035|ref|XP_001601124.2| PREDICTED: serine/threonine-protein kinase pelle-like [Nasonia vitripennis]

 Score =  332 bits (852), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 189/429 (44%), Positives = 260/429 (60%), Gaps = 28/429 (6%)

Query: 16  LRRE-SPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDN 74
           LR+E +PTEELL+ W   NHTVLELF  L  M HYQAML +K +V+SKYHT +  G  + 
Sbjct: 50  LRKERNPTEELLAIWEKHNHTVLELFMLLARMHHYQAMLPIKSFVDSKYHTLLYNGEGNL 109

Query: 75  RTILQE-------QSSVFSAQNHNVK------SARVNFENEAGVRQE--NNP-----GNE 114
           + +L+        +     AQN N         A++ F N    + E  N P      NE
Sbjct: 110 QILLRNGQLRNDTKDHKIGAQNFNQNLKPQEVDAKILFNNSDKDKSEILNRPMQHDQQNE 169

Query: 115 PTRKVSDPLTPMNVLGGT--PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIA 172
                +  L  +  +  T  P IPY EL  ATNNW K ++LGKGGFGTV+KG W+ T +A
Sbjct: 170 ILSNSNHLLASLPAIFSTLLPCIPYNELASATNNWKKEHLLGKGGFGTVFKGFWKNTEVA 229

Query: 173 VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMP 232
           +KK++   +D   +     Q EQS RE+K LNS  H+NILPLY         CLVY+YM 
Sbjct: 230 IKKIKPRGSD--YDESYALQLEQSFREIKILNSSPHENILPLYAYSIGGEAPCLVYQYMK 287

Query: 233 NGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHM 291
           NGSLEDRL +K  +  L W QRL IAKG + GLQ+LH+ R+ PLIHGDIKSANILL+ + 
Sbjct: 288 NGSLEDRLHLKHGSNPLNWIQRLEIAKGIARGLQYLHTIRDKPLIHGDIKSANILLDKNF 347

Query: 292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
           +P IGDFGL +EG  + +  ++  ++ GTRPYLP E++    LSTK+D Y +GIVLFELA
Sbjct: 348 EPKIGDFGLAREGSPDDSLKVS--KIQGTRPYLPEEYIFKGTLSTKIDTYSYGIVLFELA 405

Query: 352 TGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPK 411
           TG+ AYD +R + + LK  V+ + +++++  +DK A    + +      +GK  + +  +
Sbjct: 406 TGLSAYDKSRPTNKKLKEYVDSFQDKDLHLFMDKKAGDKYVEVYKYLLMLGKWCSNKLAQ 465

Query: 412 ERPEMTQVY 420
            RP+M+ VY
Sbjct: 466 HRPKMSAVY 474

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307198795|gb|EFN79582.1| Probable serine/threonine-protein kinase pelle [Harpegnathos saltator]

 Score =  332 bits (852), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 186/460 (40%), Positives = 274/460 (59%), Gaps = 48/460 (10%)

Query: 13  QAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCS 72
           Q + R ++PT+ELL+ WG  NHT+ ELF  L  M+HYQ+M+ L P+V++K+H  +  G  
Sbjct: 49  QNLRREKNPTDELLTLWGHYNHTITELFVLLARMQHYQSMVPLLPFVDAKFHQLLHNGEG 108

Query: 73  DNRTILQEQSS-------VFSAQNHN-VKSARVNFENEAGVRQENNPGNEPTRKVSDPLT 124
           + + +LQ+Q +          AQN N     ++N +  A  +Q     N+P  ++++  +
Sbjct: 109 NLQRMLQKQQANRNTKDLKIGAQNFNECVQPQLNTKIVAEEKQHCKILNQPMAQLANNRS 168

Query: 125 PMNVL------------------------------------GGTPHIPYQELTLATNNWD 148
             N L                                       P + Y EL +ATN W+
Sbjct: 169 DSNNLLVASPAAAAAPAFSPFRQNTGSSDKKMNESPLPKTEATLPRVTYSELGIATNGWN 228

Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVH-RNDRAVETLN-QCQREQSLRELKYLNSC 206
           K NILGKGGFGTVY+G W+ T +A+K++E   RN    E      Q +QSL E+K L+S 
Sbjct: 229 KYNILGKGGFGTVYRGTWKNTDVAIKRIERKGRNSSEREREGYMIQLQQSLIEIKILDSR 288

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H+NILPLY   F+    CLVY+ M NGSLEDRLL+++ T  L W QR  IAKGT+ GLQ
Sbjct: 289 AHENILPLYAYSFDGDAPCLVYQLMRNGSLEDRLLIREKTKPLTWIQRHEIAKGTARGLQ 348

Query: 267 FLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP-IEKATHITLKRVNGTRPYL 324
           +LH+  E PLIHGDIKSANILL+ + +P IGDFGL +EGP  + ++ + + R+NGTRPYL
Sbjct: 349 YLHTIGEKPLIHGDIKSANILLDKNFEPKIGDFGLAREGPESDSSSDMQVSRINGTRPYL 408

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
           P +FL  K+LSTK+D Y +GIVLFE+ATG+RAYDD+R   ++L+  +  + ++++  L+D
Sbjct: 409 PEDFLFDKKLSTKIDTYSYGIVLFEIATGLRAYDDSRPENKYLRDFIFSWQDKDLPLLID 468

Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           K A   +  +      +GK  +++  ++RP+M  V+  L+
Sbjct: 469 KKAGGKDSQVYGNLIVLGKWCSQRYAQDRPKMELVFRKLN 508

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322791257|gb|EFZ15781.1| hypothetical protein SINV_00896 [Solenopsis invicta]

 Score =  329 bits (844), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 189/445 (42%), Positives = 264/445 (59%), Gaps = 42/445 (9%)

Query: 16  LRRE-SPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDN 74
           LR+E +PT+ELL+ WG  NHT+ ELF  L  M+HYQ+M+ L  YV+ K+H  +  G ++ 
Sbjct: 49  LRKERNPTDELLTLWGHYNHTIAELFVLLSKMQHYQSMVPLLRYVDQKFHRLLHNGEANL 108

Query: 75  RTILQEQSSVFSAQNHNVKSARVNFENEAGVRQE-NNPGNEPTRKVS-DPLTPMNVL--- 129
           + + ++Q  + +    ++K    NF   A  +Q  N   N+PT ++   P    N+L   
Sbjct: 109 QNLSRKQ--LVNKNTKDLKIGTQNFNQRALPQQSINKILNQPTAQLGVSPSNSNNLLVVS 166

Query: 130 -GGT----------------------------PHIPYQELTLATNNWDKLNILGKGGFGT 160
            G                              PH  Y EL +AT+ W++ NILGKGGFGT
Sbjct: 167 PGAAAFSPSPQNTGSNEKKINESPLPKTETTLPHASYSELAIATDGWNQHNILGKGGFGT 226

Query: 161 VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE 220
           VY+G+W+ T +A+KK+    +D     + Q Q  QSL+E+K LNS  H+NILPLY   F 
Sbjct: 227 VYRGIWKNTDVAIKKIRQKGSDSDESYILQLQ--QSLKEIKILNSRTHENILPLYAYSFG 284

Query: 221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGD 279
               CLVY+ M NGSLEDRLL+++ T  L W QR  IAKG + GLQ+LH+  E PLIHGD
Sbjct: 285 GEAPCLVYQLMKNGSLEDRLLLRQKTKPLTWMQRHEIAKGIARGLQYLHTIGEKPLIHGD 344

Query: 280 IKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVD 339
           IKSANILL+ + +P IGDFGL +EGP   +  I+  R++GTRPYLP EFL  K+LSTK+D
Sbjct: 345 IKSANILLDKNFEPRIGDFGLAREGPERDSMKIS--RIHGTRPYLPEEFLRDKKLSTKID 402

Query: 340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
            Y +GIVLFE+ATG+RAYDD+R  ++ L  L+E + ++++  L+DK        +     
Sbjct: 403 TYSYGIVLFEMATGLRAYDDSRLEKKLLGDLIEAWKDKDISLLIDKKGGEENKQVYKNLI 462

Query: 400 RIGKQSTKQNPKERPEMTQVYNMLS 424
            IGK       + RPEM  V+  L+
Sbjct: 463 SIGKWCANGLAQNRPEMELVFQTLN 487

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156541314|ref|XP_001599847.1| PREDICTED: serine/threonine-protein kinase pelle [Nasonia vitripennis]

 Score =  329 bits (844), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 186/435 (42%), Positives = 263/435 (60%), Gaps = 32/435 (7%)

Query: 13  QAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCS 72
           Q + + ++PTEELL+ W   NHTVLELF  L  M HYQAML +K +V+SKYHT +  G  
Sbjct: 48  QNLRKEQNPTEELLAIWEKHNHTVLELFMLLARMHHYQAMLPIKSFVDSKYHTLLYNGEG 107

Query: 73  DNRTILQE-------QSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPL-- 123
           + + +L+        +     AQN N K      EN A +   N+  +E ++ ++ P+  
Sbjct: 108 NLQKLLRNGELRKDTKDLKIGAQNFNQKQKCQ--ENAAKILVNNSLKDESSKILNQPMPH 165

Query: 124 -----TPMN---VLGGTP--------HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE 167
                TP N   +L   P         IPY EL  AT+NW + ++LGKGGFGTV+KG+W+
Sbjct: 166 DQQNETPSNSNNLLASLPAIFSTLLPRIPYSELAAATDNWKREHLLGKGGFGTVFKGIWK 225

Query: 168 KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV 227
            T +A+KK+E   +D   +     Q EQS RE+K LNS  H+NILPLY         CLV
Sbjct: 226 NTEVAIKKIEPRGSD--YDESYALQLEQSFREIKILNSLPHENILPLYAYSIGGEAPCLV 283

Query: 228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANIL 286
           Y+ M NGSLEDRL +K  +  L W QR  IAKG + GLQ+LH+  E PLIHGDIKSANIL
Sbjct: 284 YQCMKNGSLEDRLHLKHGSYPLNWIQRREIAKGIARGLQYLHTIHEKPLIHGDIKSANIL 343

Query: 287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIV 346
           L+ + +P IGDFGL +EG  + +  ++  ++ GTRPYLP E++    LSTK+D Y +GIV
Sbjct: 344 LDKNFEPKIGDFGLAREGSSDDSLKVS--KIQGTRPYLPEEYIFKGNLSTKIDTYSYGIV 401

Query: 347 LFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQST 406
           LFELATG+ AYD +R + + LK  V+ + +++++ L DK A    + +      +GK  +
Sbjct: 402 LFELATGLSAYDKSRPTNKKLKEYVDSFEDKDLHLLRDKKAGDKYIEVYKYLLLLGKWCS 461

Query: 407 KQNPKERPEMTQVYN 421
            +  + RP+M+ VY+
Sbjct: 462 NKLAEHRPQMSTVYD 476

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
FB|FBgn0010441	501	pll "pelle" [Drosophila melano	0.902	0.794	0.389	2.6e-63
WB|WBGene00004029	485	pik-1 [Caenorhabditis elegans	0.907	0.824	0.355	3.2e-58
UNIPROTKB|Q9NWZ3	460	IRAK4 "Interleukin-1 receptor-	0.879	0.843	0.342	2.9e-48
UNIPROTKB|F1N593	673	IRAK1 "Interleukin-1 receptor-	0.594	0.389	0.384	2.8e-47
UNIPROTKB|E2QX24	722	IRAK1 "Uncharacterized protein	0.641	0.391	0.382	1e-46
UNIPROTKB|Q2LGB3	718	IRAK1 "Interleukin-1 receptor-	0.594	0.364	0.384	1.3e-46
MGI|MGI:107420	710	Irak1 "interleukin-1 receptor-	0.614	0.381	0.391	1.4e-46
RGD|1305303	461	Irak4 "interleukin-1 receptor-	0.882	0.843	0.329	2.3e-46
RGD|1563841	711	Irak1 "interleukin-1 receptor-	0.682	0.423	0.354	7.3e-46
UNIPROTKB|E2RDL0	460	IRAK4 "Uncharacterized protein	0.879	0.843	0.332	1e-45

FB|FBgn0010441 pll "pelle" [Drosophila melanogaster (taxid:7227)]

 Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
 Identities = 171/439 (38%), Positives = 238/439 (54%)

Query:     7 QLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYVESKYHT 65
             Q+ Q+     R  S + E L+ WG Q NHTV  LF     ++ + AM ++K YV    H 
Sbjct:    68 QVEQISSQKQRGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHK 127

Query:    66 CIPEGCSDNRTILQEQSSVFSAQNHNVKSARVN----FENEAGVRQENNPGNEPTRKVSD 121
              IP       TI    S + +A +    SA+VN    F + +GV   NN  N  +   ++
Sbjct:   128 YIPRSVP---TI----SELRAAPD---SSAKVNNGPPFPSSSGVSNSNN--NRTSTTATE 175

Query:   122 PLTPMNVLGGTP------------HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT 169
              +  +  LG                I Y EL  AT+ W   N LG+GGFG VY+G W++ 
Sbjct:   176 EIPSLESLGNIHISTVQRAAESLLEIDYAELENATDGWSPDNRLGQGGFGDVYRGKWKQL 235

Query:   170 TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR 229
              +A+K +  +R+    + + + Q  QS  ELKYLNS RHDNIL LYG   + GK CLVY+
Sbjct:   236 DVAIKVMN-YRSPNIDQKMVELQ--QSYNELKYLNSIRHDNILALYGYSIKGGKPCLVYQ 292

Query:   230 YMPNGSLEDRLLMKK--NT-PSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANI 285
              M  GSLE RL   K  N  P+L W QR  I+ GT+ G+ FLH+ R  PLIHGDIK ANI
Sbjct:   293 LMKGGSLEARLRAHKAQNPLPALTWQQRFSISLGTARGIYFLHTARGTPLIHGDIKPANI 352

Query:   286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGI 345
             LL+  + P IGDFGL +EGP      + + +V GT+ YLP EF   ++LST VDVY FGI
Sbjct:   353 LLDQCLQPKIGDFGLVREGPKSLDAVVEVNKVFGTKIYLPPEFRNFRQLSTGVDVYSFGI 412

Query:   346 VLFELATGMRAYDDTRRSE--RHLKSLVEKYSEENMYDLVDKN-AQPI--ELNIAYAFFR 400
             VL E+ TG +  D    +E  ++L   V++   +N  +L++K+ A P+  EL++      
Sbjct:   413 VLLEVFTGRQVTDRVPENETKKNLLDYVKQQWRQNRMELLEKHLAAPMGKELDMCMCAIE 472

Query:   401 IGKQSTKQNPKERPEMTQV 419
              G   T  +P++RP M  V
Sbjct:   473 AGLHCTALDPQDRPSMNAV 491

GO:0007352 "zygotic specification of dorsal/ventral axis" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;NAS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS;NAS

GO:0048262 "determination of dorsal/ventral asymmetry" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005737 "cytoplasm" evidence=NAS;IDA

GO:0019732 "antifungal humoral response" evidence=IMP

GO:0019904 "protein domain specific binding" evidence=IPI

GO:0030097 "hemopoiesis" evidence=TAS

GO:0006952 "defense response" evidence=NAS;TAS

GO:0009950 "dorsal/ventral axis specification" evidence=TAS

GO:0009620 "response to fungus" evidence=TAS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0008063 "Toll signaling pathway" evidence=NAS;TAS

GO:0006606 "protein import into nucleus" evidence=NAS

GO:0035172 "hemocyte proliferation" evidence=TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0030162 "regulation of proteolysis" evidence=TAS

WB|WBGene00004029 pik-1 [Caenorhabditis elegans (taxid:6239)]

 Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
 Identities = 150/422 (35%), Positives = 227/422 (53%)

Query:    19 ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTIL 78
             +SP+E LL  W ++ ++   L++     +  + M +++  V  KYH    E    N T  
Sbjct:    60 QSPSELLLRIWSSKGYSTTHLYQLFAKTKLIRLMRMMRSQVHEKYHYL--ENKVTNSTSR 117

Query:    79 QEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQ 138
               +  V    + +    +     E+         ++ +R  +D    + + G  P + Y 
Sbjct:   118 VSKQMVQPPGSQSASRLKKTEIKESSPSPAAAAASQLSRSNTDDTLRVAIEGTLP-VTYC 176

Query:   139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQS 196
             EL  ATN +   N++GKGG+GTVYKG  + T   +AVK+L  H  +   +  ++ +  QS
Sbjct:   177 ELLEATNGFAVSNVIGKGGYGTVYKGELKGTGGIVAVKRL--HSGNDTSQNGSRERLRQS 234

Query:   197 LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             L EL+ L   RHDNILP+Y    E  + CLVY++M NGSLEDRLL +K +  L W QR  
Sbjct:   235 LTELRTLARFRHDNILPIYAYSLEGSEPCLVYQFMSNGSLEDRLLCRKGSVPLTWIQRKE 294

Query:   257 IAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT---H- 311
             I+ G   GL FLHS  + P+IHGDIK+ANILL+ HM+P IGDFGL ++G +E      H 
Sbjct:   295 ISIGAGRGLGFLHSFGKTPIIHGDIKTANILLDKHMEPKIGDFGLCRDGHVEAEAMEKHP 354

Query:   312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL- 370
             +    + GT  YL  EF+  K L+TK+DVY FGIVL E+A+G RAY D+R +   ++   
Sbjct:   355 LIASHIKGTLAYLAPEFITSKILTTKLDVYSFGIVLLEIASGQRAYSDSRETRGLVEYCQ 414

Query:   371 VEK----YSEENMYDL-VDKNAQPI----ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
             V K    + +  + ++ +D+ A P+    E +   A   +G      + K RP M+Q+  
Sbjct:   415 VNKELAAHRKIPVREIFIDRRAPPLVGDEEKSFLDALIEVGLAGANNDRKVRPTMSQIVE 474

Query:   422 ML 423
              L
Sbjct:   475 YL 476

GO:0007165 "signal transduction" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

UNIPROTKB|Q9NWZ3 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Homo sapiens (taxid:9606)]

 Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
 Identities = 144/421 (34%), Positives = 209/421 (49%)

Query:    13 QAILRR-ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGC 71
             +A+L+  +SPT ELL  WG  N TV +L   L     +    +L P    K    +P   
Sbjct:    57 EALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLP--- 113

Query:    72 SDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGG 131
             S     +Q++   F  ++  + +   N E        ++P N+ + +VSD  T  +    
Sbjct:   114 SKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENK-SLEVSD--TRFHSFS- 169

Query:   132 TPHIPYQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAV 185
                  + EL   TNN+D+       N +G+GGFG VYKG    TT+AVKKL     D   
Sbjct:   170 -----FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA-MVDITT 223

Query:   186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
             E L Q Q +Q   E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     
Sbjct:   224 EELKQ-QFDQ---EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 279

Query:   246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             TP L W  R  IA+G + G+ FLH      IH DIKSANILL+      I DFGL +   
Sbjct:   280 TPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARAS- 336

Query:   306 IEK-ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
              EK A  +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +
Sbjct:   337 -EKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 394

Query:   365 RHL--KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
               L  K  +E   E+ + D +DK     +     A + +  Q   +   +RP++ +V  +
Sbjct:   395 LLLDIKEEIED-EEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 453

Query:   423 L 423
             L
Sbjct:   454 L 454

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0007254 "JNK cascade" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0004672 "protein kinase activity" evidence=EXP

GO:0004674 "protein serine/threonine kinase activity" evidence=EXP;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005886 "plasma membrane" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010008 "endosome membrane" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|F1N593 IRAK1 "Interleukin-1 receptor-associated kinase 1" [Bos taurus (taxid:9913)]

 Score = 467 (169.5 bits), Expect = 2.8e-47, Sum P(2) = 2.8e-47
 Identities = 107/278 (38%), Positives = 155/278 (55%)

Query:   111 PGNEPTRKVSDPLTPMNVLGGTPHI----PYQELTLATNNWDKLNILGKGGFGTVYKGVW 166
             P   P+     P +PM++L G P      P  E+   T+++ +   +G+GGFG VY+ V 
Sbjct:   127 PSPAPSSTKPSPESPMSLLPGAPSSSFCWPLHEICQGTHDFSEELKIGEGGFGCVYRAVM 186

Query:   167 EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL 226
               T  AVK+L   + +  +E     Q  Q+  E++ L+  RH NI+   G C ++G YCL
Sbjct:   187 RNTVYAVKRL---KEEADLEWTTVKQSFQT--EVQQLSRFRHPNIVDFAGYCAQSGFYCL 241

Query:   227 VYRYMPNGSLEDRLLMKKNT-PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI 285
             VY ++PNGSLEDRL ++    P L W QRL I  GT+  +QFLH   P LIHGD+KS+N+
Sbjct:   242 VYGFLPNGSLEDRLHVQTQAWPPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDVKSSNV 301

Query:   286 LLNHHMDPVIGDFGL------TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVD 339
             LL+  + P +GDFGL      T   P + ++    + V GT  YLP E++   RL+   D
Sbjct:   302 LLDERLMPKLGDFGLARLSRFTGANPGQSSSVARTRTVRGTLAYLPEEYVKTGRLAVDTD 361

Query:   340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
              + FG+VL E   G RA        ++LK LVE+ +EE
Sbjct:   362 TFSFGVVLLETLAGQRAVRMHGAQPKYLKDLVEEEAEE 399

GO:0070498 "interleukin-1-mediated signaling pathway" evidence=IEA

GO:0051259 "protein oligomerization" evidence=IEA

GO:0051092 "positive regulation of NF-kappaB transcription factor activity" evidence=IEA

GO:0046982 "protein heterodimerization activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042803 "protein homodimerization activity" evidence=IEA

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=IEA

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=IEA

GO:0032494 "response to peptidoglycan" evidence=IEA

GO:0032088 "negative regulation of NF-kappaB transcription factor activity" evidence=IEA

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IEA

GO:0007250 "activation of NF-kappaB-inducing kinase activity" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001959 "regulation of cytokine-mediated signaling pathway" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2QX24 IRAK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 469 (170.2 bits), Expect = 1.0e-46, Sum P(2) = 1.0e-46
 Identities = 116/303 (38%), Positives = 166/303 (54%)

Query:    87 AQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGG---TPHI-PYQELTL 142
             +Q H+   A +   +  G+ Q   P   P+       +P ++L G   +P   P  E++ 
Sbjct:   151 SQTHS--GAELGPVHSPGILQPPPPRPAPSSTKPSAESPASLLQGAHPSPFCWPLSEISQ 208

Query:   143 ATNNW-DKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              T+N+ DKL I G+GGFG VY+ V   T  AVK+L+    D    T+ Q      L E++
Sbjct:   209 GTHNFSDKLKI-GEGGFGCVYRAVMRNTLYAVKRLK-EGADLEWTTVKQ----SFLTEVE 262

Query:   202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS-LLWTQRLHIAKG 260
              L+  RH NI+   G C E+G YCLVY ++PNGSLEDRL  +    + L W QRL+I  G
Sbjct:   263 QLSRFRHPNIVDFAGYCAESGFYCLVYGFLPNGSLEDRLHFQTEACAPLSWPQRLNILLG 322

Query:   261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ------EGPIEKATHITL 314
             T+  +QFLH   P LIHGDIKS+N+LL+  + P +GDFGL +        P + +T    
Sbjct:   323 TARAIQFLHQDSPSLIHGDIKSSNVLLDDRLMPKLGDFGLARLSRFAGANPGQSSTVART 382

Query:   315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
             + V GT  YLP E++   RL+   D + FG+V+ E   G RA        ++LK LVE+ 
Sbjct:   383 RTVRGTLAYLPEEYVKTGRLAVDTDTFSFGVVVLETLAGQRAVRTQGAKTKYLKDLVEEE 442

Query:   375 SEE 377
             +EE
Sbjct:   443 AEE 445

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|Q2LGB3 IRAK1 "Interleukin-1 receptor-associated kinase 1" [Bos taurus (taxid:9913)]

 Score = 467 (169.5 bits), Expect = 1.3e-46, Sum P(2) = 1.3e-46
 Identities = 107/278 (38%), Positives = 155/278 (55%)

Query:   111 PGNEPTRKVSDPLTPMNVLGGTPHI----PYQELTLATNNWDKLNILGKGGFGTVYKGVW 166
             P   P+     P +PM++L G P      P  E+   T+++ +   +G+GGFG VY+ V 
Sbjct:   172 PSPAPSSTKPSPESPMSLLPGAPSSSFCWPLHEICQGTHDFSEELKIGEGGFGCVYRAVM 231

Query:   167 EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL 226
               T  AVK+L   + +  +E     Q  Q+  E++ L+  RH NI+   G C ++G YCL
Sbjct:   232 RNTVYAVKRL---KEEADLEWTTVKQSFQT--EVQQLSRFRHPNIVDFAGYCAQSGFYCL 286

Query:   227 VYRYMPNGSLEDRLLMKKNT-PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI 285
             VY ++PNGSLEDRL ++    P L W QRL I  GT+  +QFLH   P LIHGD+KS+N+
Sbjct:   287 VYGFLPNGSLEDRLHVQTQAWPPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDVKSSNV 346

Query:   286 LLNHHMDPVIGDFGL------TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVD 339
             LL+  + P +GDFGL      T   P + ++    + V GT  YLP E++   RL+   D
Sbjct:   347 LLDERLMPKLGDFGLARLSRFTGANPGQSSSVARTRTVRGTLAYLPEEYVKTGRLAVDTD 406

Query:   340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
              + FG+VL E   G RA        ++LK LVE+ +EE
Sbjct:   407 TFSFGVVLLETLAGQRAVRMHGAQPKYLKDLVEEEAEE 444

GO:0005811 "lipid particle" evidence=ISS

GO:0005634 "nucleus" evidence=IEA

GO:0070498 "interleukin-1-mediated signaling pathway" evidence=IEA

GO:0051259 "protein oligomerization" evidence=IEA

GO:0051092 "positive regulation of NF-kappaB transcription factor activity" evidence=IEA

GO:0046982 "protein heterodimerization activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042803 "protein homodimerization activity" evidence=IEA

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=IEA

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=IEA

GO:0032494 "response to peptidoglycan" evidence=IEA

GO:0032088 "negative regulation of NF-kappaB transcription factor activity" evidence=IEA

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IEA

GO:0007250 "activation of NF-kappaB-inducing kinase activity" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001959 "regulation of cytokine-mediated signaling pathway" evidence=IEA

GO:0045087 "innate immune response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

MGI|MGI:107420 Irak1 "interleukin-1 receptor-associated kinase 1" [Mus musculus (taxid:10090)]

 Score = 458 (166.3 bits), Expect = 1.4e-46, Sum P(2) = 1.4e-46
 Identities = 114/291 (39%), Positives = 163/291 (56%)

Query:   111 PGNEPTRKVSDPLTPMNVLGG---TPHI-PYQELTLATNNWDKLNILGKGGFGTVYKGVW 166
             P + P+   S P +P++ L     +P   P+ E++  T N+ +   +G+GGFG VY+ V 
Sbjct:   172 PSSAPSSTKSSPESPVSGLQRAHPSPFCWPFCEISQGTCNFSEELRIGEGGFGCVYRAVM 231

Query:   167 EKTTIAVKKLEVHRNDRAVETLNQCQREQS-LRELKYLNSCRHDNILPLYGICFETGKYC 225
               TT AVK+L+   +      L     +QS L E++ L+  RH NI+   G C E+G YC
Sbjct:   232 RNTTYAVKRLKEEAD------LEWTMVKQSFLTEVEQLSRFRHPNIVDFAGYCAESGLYC 285

Query:   226 LVYRYMPNGSLEDRLLMKKNTPS-LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN 284
             LVY ++PNGSLED+L ++    S L W QRL I  GT+  +QFLH   P LIHGDIKS+N
Sbjct:   286 LVYGFLPNGSLEDQLHLQTQACSPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDIKSSN 345

Query:   285 ILLNHHMDPVIGDFGLTQEGPIE--KATHI-TLKR---VNGTRPYLPHEFLVGKRLSTKV 338
             +LL+  + P +GDFGL +       KA+   T+ R   V GT  YLP E++   RL+   
Sbjct:   346 VLLDERLMPKLGDFGLARFSRFAGAKASQSSTVARTSTVRGTLAYLPEEYIKTGRLAVDT 405

Query:   339 DVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP 389
             D + FG+V+ E   G RA        ++LK L+E  +EE    L  K+ QP
Sbjct:   406 DTFSFGVVILETLAGQRAVRTQGAKTKYLKDLIEDEAEEAGVTL--KSTQP 454

GO:0000166 "nucleotide binding" evidence=IEA

GO:0001959 "regulation of cytokine-mediated signaling pathway" evidence=ISO

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005811 "lipid particle" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0007165 "signal transduction" evidence=IEA

GO:0007250 "activation of NF-kappaB-inducing kinase activity" evidence=ISO

GO:0007254 "JNK cascade" evidence=ISO

GO:0016020 "membrane" evidence=IDA

GO:0016301 "kinase activity" evidence=ISO

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IDA

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=ISO;IDA

GO:0032088 "negative regulation of NF-kappaB transcription factor activity" evidence=ISO

GO:0032494 "response to peptidoglycan" evidence=IDA

GO:0032496 "response to lipopolysaccharide" evidence=ISO;IDA

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=ISO;IDA

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=IDA

GO:0042803 "protein homodimerization activity" evidence=ISO

GO:0043406 "positive regulation of MAP kinase activity" evidence=IMP

GO:0043507 "positive regulation of JUN kinase activity" evidence=IMP

GO:0045087 "innate immune response" evidence=IEA

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO;IDA

GO:0046982 "protein heterodimerization activity" evidence=ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=ISO

GO:0051092 "positive regulation of NF-kappaB transcription factor activity" evidence=ISO;IDA

GO:0051259 "protein oligomerization" evidence=ISO

GO:0070498 "interleukin-1-mediated signaling pathway" evidence=ISO;IDA

GO:0070555 "response to interleukin-1" evidence=ISO

GO:0090370 "negative regulation of cholesterol efflux" evidence=IMP

RGD|1305303 Irak4 "interleukin-1 receptor-associated kinase 4" [Rattus norvegicus (taxid:10116)]

 Score = 486 (176.1 bits), Expect = 2.3e-46, P = 2.3e-46
 Identities = 139/422 (32%), Positives = 206/422 (48%)

Query:    13 QAILRR-ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQ-AMLILKPYVESKYHTCIPEG 70
             +A+L+  +SPT ELL  WG  N TV +L   L  +  +  A L+L   V    H+  P  
Sbjct:    57 EALLQTGKSPTCELLFDWGTTNCTVGDLVDLLIQIELFAPATLLLPDAVPQAVHSLPPRE 116

Query:    71 CSDNRTILQEQSSVFSAQNHNVKSARVN-FENEAGVRQENNPGNEPTRKVSDPLTPMNVL 129
              +   T+ Q            V  A     E    +   ++PG++   + SD  T  +  
Sbjct:   117 AA---TVAQAHRPCQEKNRTTVTPALAQKLEPSCELPDSSSPGHQSV-EFSD--TRFHSF 170

Query:   130 GGTPHIPYQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR 183
                    + EL   TN++D+       N +G+GGFG VYKG    TT+AVKKL       
Sbjct:   171 S------FYELKSITNDFDERPVSIGGNRMGEGGFGVVYKGCVNNTTVAVKKLGA----- 219

Query:   184 AVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK 243
              VE   +  ++Q  +E+K +  C+H+N++ L G   ++   CLVY YMPNGSL DRL   
Sbjct:   220 MVEISTEELKQQFDQEIKVMAKCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSCL 279

Query:   244 KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE 303
               TP L W  R  IA+G + G++FLH      IH DIKSANILL+      I DFGL + 
Sbjct:   280 DGTPPLSWHMRCKIARGAANGIRFLHENHH--IHRDIKSANILLDQDFTAKISDFGLARA 337

Query:   304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
                + A  +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL EL TG+ A D+ R  
Sbjct:   338 SA-KLAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLELITGLAAVDENREP 395

Query:   364 ERHL--KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
             +  L  K  +E   E+ + D  D+     +     A + +  Q   +    RP++ +V  
Sbjct:   396 QLLLDIKEEIED-KEKTIEDCTDEKMSDADPASVEAMYSVASQCLHEKKNRRPDIAKVQQ 454

Query:   422 ML 423
             +L
Sbjct:   455 LL 456

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA;ISO

GO:0003674 "molecular_function" evidence=ND

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005149 "interleukin-1 receptor binding" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007254 "JNK cascade" evidence=IMP

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IMP

RGD|1563841 Irak1 "interleukin-1 receptor-associated kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 452 (164.2 bits), Expect = 7.3e-46, Sum P(2) = 7.3e-46
 Identities = 113/319 (35%), Positives = 170/319 (53%)

Query:   107 QENNPGNEPTRKVSDPLTPMNVLGGTPHI-PYQELTLATNNWDKLNILGKGGFGTVYKGV 165
             Q + P +        P++ +     +P   P+ E++  T N+ +   +G+GGFG VY+ V
Sbjct:   172 QSSAPSSIKQPSPESPVSGLQRARPSPFCWPFCEISQGTCNFSEELRIGEGGFGCVYRAV 231

Query:   166 WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC 225
                TT AVK+L   + +  +E      ++  L E++ L+  RH NI+   G C E+G YC
Sbjct:   232 MRNTTYAVKRL---KEEADLEWT--VVKQSFLTEVEQLSRFRHPNIVDFAGYCAESGFYC 286

Query:   226 LVYRYMPNGSLEDRLLMKKNTPS-LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN 284
             LVY ++PNGSLED+L ++    S L W QRL I  GT+  +QFLH   P LIHGDIKS+N
Sbjct:   287 LVYGFLPNGSLEDQLHLQTQACSPLSWPQRLDILLGTARAIQFLHQDSPSLIHGDIKSSN 346

Query:   285 ILLNHHMDPVIGDFGLTQ------EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKV 338
             +LL+  + P +GDFGL +        P + +T      V GT  YLP E++   RL+   
Sbjct:   347 VLLDERLMPKLGDFGLARFSRFAGANPSQSSTVARTCTVRGTLAYLPEEYIKTGRLAVDT 406

Query:   339 DVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP-IELNIAYA 397
             D + FG+V+ E   G RA        ++LK L+E  +EE    L  K+ QP + + +A  
Sbjct:   407 DTFSFGVVILETLAGQRAVRTQGAKTKYLKDLIEDEAEEVGVTL--KSTQPTLWMGVATD 464

Query:   398 FFR--IGKQSTKQNPKERP 414
              +   I  Q  K++   RP
Sbjct:   465 AWTAPIAAQIYKKHLDSRP 483

GO:0001959 "regulation of cytokine-mediated signaling pathway" evidence=IEA;ISO

GO:0004672 "protein kinase activity" evidence=ISO;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005149 "interleukin-1 receptor binding" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005811 "lipid particle" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007250 "activation of NF-kappaB-inducing kinase activity" evidence=IEA;ISO

GO:0007254 "JNK cascade" evidence=IMP

GO:0016020 "membrane" evidence=ISO

GO:0016301 "kinase activity" evidence=ISO

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IMP

GO:0031663 "lipopolysaccharide-mediated signaling pathway" evidence=IEA;ISO

GO:0032088 "negative regulation of NF-kappaB transcription factor activity" evidence=IEA;ISO

GO:0032494 "response to peptidoglycan" evidence=IEA;ISO

GO:0032496 "response to lipopolysaccharide" evidence=ISO

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=IEA;ISO

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=IEA;ISO

GO:0042803 "protein homodimerization activity" evidence=IEA;ISO

GO:0043406 "positive regulation of MAP kinase activity" evidence=ISO

GO:0043507 "positive regulation of JUN kinase activity" evidence=ISO

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=ISO

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0046982 "protein heterodimerization activity" evidence=IEA;ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IMP

GO:0051092 "positive regulation of NF-kappaB transcription factor activity" evidence=IEA;ISO

GO:0051259 "protein oligomerization" evidence=IEA;ISO

GO:0070498 "interleukin-1-mediated signaling pathway" evidence=IEA;ISO

GO:0070555 "response to interleukin-1" evidence=ISO

GO:0071222 "cellular response to lipopolysaccharide" evidence=IEP

GO:0071456 "cellular response to hypoxia" evidence=IEP

GO:0090370 "negative regulation of cholesterol efflux" evidence=ISO

UNIPROTKB|E2RDL0 IRAK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
 Identities = 140/421 (33%), Positives = 205/421 (48%)

Query:    13 QAILRR-ESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCIPEGC 71
             +A+L+  +SPT ELL  WG  N TV +L   L     +    +L P    K    +P   
Sbjct:    57 EALLQTGKSPTCELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAIPKTPNTVP--- 113

Query:    72 SDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGG 131
             S+    +Q+Q    + ++        NFE        ++P N  + + SD  T  +    
Sbjct:   114 SEEAVTVQQQQMPLNGKDRTFVLPVQNFEQNYMPPDSSSPENT-SLEGSD--TRFHSFS- 169

Query:   132 TPHIPYQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAV 185
                  + EL   TNN+D+       N +G+GGFG VYKG     T+AVKKL     D + 
Sbjct:   170 -----FYELKNVTNNFDERPISLGGNKMGEGGFGVVYKGYVNNKTVAVKKLAA-MVDIST 223

Query:   186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
             E L Q Q +Q   E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     
Sbjct:   224 EELKQ-QFDQ---EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 279

Query:   246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             TP L W  R  IA+G + G+ FLH      IH DIKSANILL+      + DFGL +   
Sbjct:   280 TPPLSWHMRCKIAQGAANGISFLHENHH--IHRDIKSANILLDEDFTAKVSDFGLARAS- 336

Query:   306 IEK-ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
              EK A  +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +
Sbjct:   337 -EKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 394

Query:   365 RHL--KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
               L  K  +E   E+ + D +D      +       + +  Q   +   +RP++ +V  +
Sbjct:   395 LLLDIKEEIED-EEKTIEDYIDPKMNDTDPTSIETMYSVASQCLHEKKNKRPDIEKVQQL 453

Query:   423 L 423
             L
Sbjct:   454 L 454

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q05652	KPEL_DROME	2, ., 7, ., 1, 1, ., 1	0.3667	0.9024	0.7944	yes	N/A
Q9NWZ3	IRAK4_HUMAN	2, ., 7, ., 1, 1, ., 1	0.3309	0.8820	0.8456	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	441
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-21
cd08307	97	cd08307, Death_Pelle, Death domain of the protein	7e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-06
cd08309	95	cd08309, Death_IRAK, Death domain of Interleukin-1	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.001
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.001
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	0.002
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.003
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.003
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.004
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.004
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (420), Expect = 3e-48
 Identities = 74/283 (26%), Positives = 110/283 (38%), Gaps = 35/283 (12%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++ L  LG G FGTVYK   + T   +AVK L+              + + + RE++ L 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKS-------KKDQTARREIRILR 53

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
              H NI+ L     +     LV  Y   G L D L        L   +   IA     G
Sbjct: 54  RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRG 110

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATHITLKRVNGTRP 322
           L++LHS    +IH D+K  NILL+ +    I DFGL           T        GT  
Sbjct: 111 LEYLHSN--GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-----GTPW 163

Query: 323 YLPHEFLVGKRL-STKVDVYGFGIVLFELATG-MRAYDDTRRSERHLKSLVEKYSEENMY 380
           Y+  E L+G      KVDV+  G++L+EL TG      +    +  L  +         +
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL--IRRILGPPLEF 221

Query: 381 DLVDKNAQPIELN--IAYAFFRIGKQSTKQNPKERPEMTQVYN 421
           D    ++   E    I             ++P +RP   ++  
Sbjct: 222 DEPKWSSGSEEAKDLIKKCL--------NKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (405), Expect = 1e-46
 Identities = 74/220 (33%), Positives = 110/220 (50%), Gaps = 25/220 (11%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG+GGFGTVY    +KT   +A+K ++   +   +E L        LRE++ L    H N
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEEL--------LREIEILKKLNHPN 52

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+ LYG+  +     LV  Y   GSL+D  L+K+N   L   + L I      GL++LHS
Sbjct: 53  IVKLYGVFEDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHS 110

Query: 271 REPPLIHGDIKSANILLNHHMD-PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFL 329
               +IH D+K  NILL+       + DFGL++   +  +    LK + GT  Y+  E L
Sbjct: 111 N--GIIHRDLKPENILLDSDNGKVKLADFGLSK---LLTSDKSLLKTIVGTPAYMAPEVL 165

Query: 330 VGKR-LSTKVDVYGFGIVLFELA------TGMRAYDDTRR 362
           +GK   S K D++  G++L+EL         M   D  +R
Sbjct: 166 LGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKR 205

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (392), Expect = 3e-44
 Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 23/217 (10%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++ L  LG+G FG VY    +KT   +A+K ++  +  +         RE+ LRE+K L 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--------DRERILREIKILK 52

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSL 263
             +H NI+ LY +  +  K  LV  Y   G L D L  +   +            +    
Sbjct: 53  KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILS 108

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTRP 322
            L++LHS+   ++H D+K  NILL+      + DFGL  Q  P EK T        GT  
Sbjct: 109 ALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPE 161

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
           Y+  E L+GK     VD++  G++L+EL TG   +  
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPG 198

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (384), Expect = 5e-43
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 38/284 (13%)

Query: 149 KLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
               LG+G FG VYKG  +      K  +AVK L+   ++         Q E+ LRE + 
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASE--------QQIEEFLREARI 54

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +    H N++ L G+C E     +V  YM  G L   L  +KN P L  +  L  A   +
Sbjct: 55  MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIA 112

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+++L S+    IH D+ + N L+  ++   I DFGL+++   +        ++    P
Sbjct: 113 RGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL----P 166

Query: 323 Y--LPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM 379
              +  E L   + ++K DV+ FG++L+E+ T G + Y                 +EE +
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPG-------------MSNEEVL 213

Query: 380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
             L +    P   N     + +  Q   ++P++RP  +++  +L
Sbjct: 214 EYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  148 bits (375), Expect = 1e-41
 Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 37/284 (13%)

Query: 149 KLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
               LG+G FG VYKG  +      +  +AVK L+   +++ +E          LRE + 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF--------LREARI 54

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +    H NI+ L G+C E     +V  YMP G L D L   +    L  +  L  A   +
Sbjct: 55  MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIA 113

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+++L S+    IH D+ + N L+  ++   I DFGL+++   +    +   ++    P
Sbjct: 114 RGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL----P 167

Query: 323 Y--LPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM 379
              +  E L   + ++K DV+ FG++L+E+ T G   Y                 + E +
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP-------------GMSNAEVL 214

Query: 380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
             L      P   N     +++  Q   ++P++RP  +++  +L
Sbjct: 215 EYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  143 bits (364), Expect = 4e-40
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 51/291 (17%)

Query: 149 KLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
               LG+G FG VYKG         +T +AVK L+   ++         +RE+ L E   
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--------EREEFLEEASI 54

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +    H NI+ L G+C +     +V  YMP G L D L       +L     L +A   +
Sbjct: 55  MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIA 112

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+++L S+    +H D+ + N L+  ++   I DFGL+++           KR  G  P
Sbjct: 113 KGMEYLESK--NFVHRDLAARNCLVTENLVVKISDFGLSRDI---YEDDYYRKRGGGKLP 167

Query: 323 --YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM 379
             ++  E L   + ++K DV+ FG++L+E+ T G + Y                 S E +
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPG--------------MSNEEV 213

Query: 380 YDLVDKNAQ-------PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            +L++   +       P EL      + +  Q    +P++RP  +++   L
Sbjct: 214 LELLEDGYRLPRPENCPDEL------YELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  138 bits (349), Expect = 7e-38
 Identities = 73/295 (24%), Positives = 124/295 (42%), Gaps = 56/295 (18%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSC 206
             LG+G FG VYKG         K  EV     AV+TL +     +R+  L+E + +   
Sbjct: 1   KKLGEGAFGEVYKGKL--KGKDGKTTEV-----AVKTLKEDASEEERKDFLKEARVMKKL 53

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT------PSLLWTQRLHIAKG 260
            H N++ L G+C E     LV  YM  G L D L   +         +L     L  A  
Sbjct: 54  GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
            + G+++L S+    +H D+ + N L+   +   I DFGL+++   +       K+  G 
Sbjct: 114 IAKGMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR---KKTGGK 168

Query: 321 RP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRA---YDDTRRSERHLK 368
            P  ++  E L     ++K DV+ FG++L+E+ T       G+      +  R+  R  K
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK 228

Query: 369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              E   +E +Y+L+                       + +P++RP  +++   L
Sbjct: 229 P--EYCPDE-LYELM-------------------LSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (309), Expect = 3e-32
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 147 WDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++ L  +GKGGFG VYK         +A+K ++   +          ++E+ + E++ L 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-LESKE--------KKEKIINEIQILK 52

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
            C+H NI+  YG   +  +  +V  +   GSL+D  L+K    +L  +Q  ++ K    G
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD--LLKSTNQTLTESQIAYVCKELLKG 110

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L++LHS    +IH DIK+ANILL    +  + DFGL+ +    KA +  +    GT  ++
Sbjct: 111 LEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWM 164

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
             E + GK    K D++  GI   ELA G 
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (292), Expect = 9e-30
 Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 27/213 (12%)

Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           +++ +LG+G  G VYK   + T    A+KK+ V  ++          R+Q LRELK L S
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE--------FRKQLLRELKTLRS 55

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--HIAKGTSL 263
           C    ++  YG  ++ G+  +V  YM  GSL D  L+KK        + +  +IA+    
Sbjct: 56  CESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD--LLKKVGK---IPEPVLAYIARQILK 110

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN---GT 320
           GL +LH  +  +IH DIK +N+L+N   +  I DFG      I K    TL + N   GT
Sbjct: 111 GLDYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFG------ISKVLENTLDQCNTFVGT 163

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             Y+  E + G+  S   D++  G+ L E A G
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALG 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  115 bits (290), Expect = 1e-29
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)

Query: 146 NWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++ +  +GKG FG VY      +     +K++++         +++ +RE +L E+K L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-------MSEKEREDALNEVKIL 53

Query: 204 NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGT 261
               H NI+  Y   FE  GK C+V  Y   G L  ++   KK        Q L      
Sbjct: 54  KKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNG 319
            L L++LHSR+  ++H DIK  NI L  +    +GDFG+++     ++ A  +      G
Sbjct: 113 CLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-----G 165

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM 379
           T  YL  E    K  + K D++  G VL+EL T    ++                  EN+
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-----------------ENL 208

Query: 380 YDLVDK--NAQPIELNIAY--AFFRIGKQSTKQNPKERPEMTQVYNM 422
            +L  K    Q   +   Y      +     +++P+ERP + Q+   
Sbjct: 209 LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  112 bits (283), Expect = 1e-28
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 29/218 (13%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            W +  +LG+G FG+VY  + + T   +AVK +E+  +    E L   +RE  +  L  L
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE--EELEALEREIRI--LSSL 56

Query: 204 NSCRHDNILPLYGICF--ETGKYCLVYRYMPNGSLEDRLLMKKNTP------SLLWTQRL 255
               H NI+  YG     E     +   Y+  GSL    L+KK              Q L
Sbjct: 57  Q---HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS--LLKKFGKLPEPVIRKYTRQIL 111

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
                   GL +LHS    ++H DIK ANIL++      + DFG  +    +  T     
Sbjct: 112 E-------GLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTG 161

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            V GT  ++  E + G+      D++  G  + E+ATG
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (275), Expect = 1e-27
 Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 34/275 (12%)

Query: 150 LNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           LN +GKG FG V+K V   +K   A+K++++ + +R        +RE+++ E + L    
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-------EREEAIDEARVLAKLD 57

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP---SLLWTQRLHIAKGTSLG 264
              I+  Y    + GK  +V  Y  NG L   L M++  P     +W  R  I     LG
Sbjct: 58  SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFIQ--ILLG 113

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L  LHS++  ++H DIKS N+ L+ + +  IGD G+ +   +          + GT  YL
Sbjct: 114 LAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAK---LLSDNTNFANTIVGTPYYL 168

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
             E    K  + K DV+  G+VL+E  TG   +D   +    LK +   +          
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF---------- 218

Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
               P+    +    ++  Q   ++ ++RP+  Q+
Sbjct: 219 ---PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQL 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (279), Expect = 3e-27
 Identities = 78/281 (27%), Positives = 122/281 (43%), Gaps = 18/281 (6%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           ++  L  LG+G FG VY    ++  +A+K L      ++ E       E+ LRE++ L S
Sbjct: 1   SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKE------VERFLREIQILAS 53

Query: 206 CRH-DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             H  NI+ LY    + G   LV  Y+  GSLED L        L  ++ L I       
Sbjct: 54  LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFGL---TQEGPIEKATHITLKRVNGT 320
           L++LHS+   +IH DIK  NILL+       + DFGL     +     +         GT
Sbjct: 114 LEYLHSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 321 RPYLPHEFLVGKRL---STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
             Y+  E L+G  L   S+  D++  GI L+EL TG+  ++  + S       ++   E 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA-TSQTLKIILEL 230

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
               L    +      I+ A   + K+   ++PK R   + 
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (266), Expect = 6e-26
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 40/220 (18%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSL-RELK 201
            N +K+   G+G  G VYK     T   +A+KK+ +           + Q ++ +  E+ 
Sbjct: 22  KNLEKI---GEGASGEVYKATDRATGKEVAIKKMRL-----------RKQNKELIINEIL 67

Query: 202 YLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
            +  C+H NI+  Y   +  G    +V  YM  GSL D  ++ +N   +   Q  ++ + 
Sbjct: 68  IMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCRE 124

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKR 316
              GL++LHS+   +IH DIKS NILL+      + DFG    LT+E           KR
Sbjct: 125 VLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---------KR 173

Query: 317 --VNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             V GT PY +  E +  K    KVD++  GI+  E+A G
Sbjct: 174 NSVVGT-PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 68/226 (30%), Positives = 100/226 (44%), Gaps = 49/226 (21%)

Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQRE----QSLRELK 201
           +K+  +G+G +G VYK   +KT   +A+KK+ +             ++E     ++RE+K
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-----------EKEGFPITAIREIK 50

Query: 202 YLNSCRHDNILPLYGICFE--TGKYCLVYRYMPNGSLED--RLLMKKN---TPSLLWTQR 254
            L   RH NI+ L  I      G   +V+ YM +    D   LL       T S    Q 
Sbjct: 51  LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH----DLTGLLDSPEVKFTES----QI 102

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
               K    GLQ+LHS    ++H DIK +NIL+N+     + DFGL        A   T 
Sbjct: 103 KCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGL--------ARPYTK 152

Query: 315 KRVNG------TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           +          T  Y P E L+G  R   +VD++  G +L EL  G
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (253), Expect = 2e-24
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 33/218 (15%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
            LG+G +G+VYK + ++T   +A+K + V  + + +            +E+  L  C   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-----------KEISILKQCDSP 58

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
            I+  YG  F+     +V  Y   GS+ D  +MK    +L   +   I   T  GL++LH
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRPYLPHE 327
           S +   IH DIK+ NILLN      + DFG++      + T    KR  V GT  ++  E
Sbjct: 117 SNK--KIHRDIKAGNILLNEEGQAKLADFGVSG-----QLTDTMAKRNTVIGTPFWMAPE 169

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
            +     + K D++  GI   E+A G         MRA
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 6e-23
 Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 37/215 (17%)

Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +++G+G FG VYKG+  +T   +A+K++ + +     E L    +E  L  LK L    H
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDL--LKNLK---H 58

Query: 209 DNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTP------SLLWTQRLHIAKGT 261
            NI+   G   ET     ++  Y  NGSL   +  KK  P      ++   Q L      
Sbjct: 59  PNIVKYIG-SIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVL------ 109

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEKATHITLKRVNG 319
             GL +LH  E  +IH DIK+ANIL     D V+   DFG+  +             V G
Sbjct: 110 -QGLAYLH--EQGVIHRDIKAANILTTK--DGVVKLADFGVATKLN---DVSKDDASVVG 161

Query: 320 TRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T PY +  E +     ST  D++  G  + EL TG
Sbjct: 162 T-PYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 69/237 (29%), Positives = 112/237 (47%), Gaps = 33/237 (13%)

Query: 149 KLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+ +LG G FGTVYKGVW       K  +A+K L         E  +    ++ L E   
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--------EETSPKANKEILDEAYV 62

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQRLHIAKG 260
           + S  H +++ L GIC  + +  L+ + MP G L D +   K+      L    + IAKG
Sbjct: 63  MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI-EKATHITLKRVNG 319
            S    +L  +   L+H D+ + N+L+       I DFGL +   + EK  H    +V  
Sbjct: 122 MS----YLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-- 173

Query: 320 TRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK 373
             P  ++  E ++ +  + K DV+ +G+ ++EL T G + Y+     E  +  L+EK
Sbjct: 174 --PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 150 LNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  LGKG +G+VYK   + +    A+K++++        +++Q +RE ++ E++ L S  
Sbjct: 5   LKKLGKGSYGSVYKVKRLSDNQFYALKEVDL-------GSMSQKEREDAVNEIRILASVN 57

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HIAKGTSLGLQ 266
           H NI+       +  K C+V  Y P G L   +  +K    L+  Q +  I      GLQ
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
            LH ++  ++H D+KSANILL  +    IGD G+++            K   GT  Y+  
Sbjct: 118 ALHEQK--ILHRDLKSANILLVANDLVKIGDLGISK-----VLKKNMAKTQIGTPHYMAP 170

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN 386
           E   G+  S K D++  G +L+E+AT    ++     +   K    KY            
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP----------- 219

Query: 387 AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
             PI    +       +   +  PK RP   ++
Sbjct: 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 20/209 (9%)

Query: 148 DKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           + L  LG G  G V K         +AVK   +         +N+  ++Q LREL  L+ 
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVK--TIRL------EINEAIQKQILRELDILHK 55

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQRLHIAKGTSLG 264
           C    I+  YG  +  G   +   YM  GSL+  L  ++   P  +  +   IA     G
Sbjct: 56  CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKG 112

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LH +   +IH D+K +NIL+N      + DFG++ +     A     K   GT  Y+
Sbjct: 113 LTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KTFVGTSSYM 166

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             E + G   S K D++  G+ L ELATG
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 57/226 (25%), Positives = 110/226 (48%), Gaps = 32/226 (14%)

Query: 153 LGKGGFGTVYKG-------VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG VYKG           T++A+K L   + +   +   + ++E  L      + 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTL---KENAEPKVQQEFRQEAELM-----SD 64

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK------------KNTPSLLW-T 252
            +H NI+ L G+C +    C+++ Y+ +G L + L+              +   S L  +
Sbjct: 65  LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
             LHIA   + G+++L S     +H D+ + N L+   +   I DFGL+++        +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAY 357
             K +   R ++P E ++  + +T+ D++ FG+VL+E+ + G++ Y
Sbjct: 183 QSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 149 KLNILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSL----REL 200
            +  LG+G FG V    ++     T   V          AV++LN    EQ      RE+
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQV----------AVKSLNHSGEEQHRSDFEREI 57

Query: 201 KYLNSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
           + L +  H+NI+   G+C + G     L+  Y+P+GSL D L  +++   +   + L  +
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFS 115

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                G+ +L S+    IH D+ + NIL+       I DFGL +  P +K  +    +  
Sbjct: 116 SQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV--KEP 171

Query: 319 GTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           G  P   Y P E L   + S+  DV+ FG+ L+EL T
Sbjct: 172 GESPIFWYAP-ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|176723 cd08307, Death_Pelle, Death domain of the protein kinase Pelle

 Score = 86.6 bits (215), Expect = 7e-21
 Identities = 28/64 (43%), Positives = 42/64 (65%)

Query: 1  MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVE 60
          M +++  +  +++  LR  SPTEELL  WG +NHT+ ELF  LY  + ++AM I+K  V+
Sbjct: 32 MGYSNDDVEGIQRCCLRGRSPTEELLDIWGNKNHTITELFVLLYREKLFRAMRIIKDLVD 91

Query: 61 SKYH 64
           KYH
Sbjct: 92 PKYH 95

Death domain (DD) of the protein kinase Pelle from Drosophila melanogaster and simlar proteins. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and in mediating innate immune responses to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Pelle also functions in photoreceptor axon targeting. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 97

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           I  +EL L          +GKG FG V  G +    +AVK L+                +
Sbjct: 3   INSKELKL-------GATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----------AAQ 45

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
             L E   + + RH N++ L G+  +     +V  YM  GSL D  L  +    +   Q+
Sbjct: 46  AFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD-YLRSRGRAVITLAQQ 104

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           L  A     G+++L  +    +H D+ + N+L++  +   + DFGL +E         + 
Sbjct: 105 LGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSG 159

Query: 315 K-RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           K  V  T P    E L  K+ STK DV+ FGI+L+E+
Sbjct: 160 KLPVKWTAP----EALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.2 bits (225), Expect = 3e-20
 Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 28/213 (13%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  LG+G +G VYK   +KT   +A+KK+   R D   E +       +LRE+  L   
Sbjct: 3   KLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPS----TALREISLLKEL 55

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKGTSLGL 265
           +H NI+ L  +     K  LV+ Y       D +  + K    L       I      GL
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATH--ITLKRVNGTR 321
            + HS    ++H D+K  NIL+N      + DFGL +    P+   TH  +TL       
Sbjct: 112 AYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW------ 163

Query: 322 PYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
            Y   E L+G +  ST VD++  G +  E+ TG
Sbjct: 164 -YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 73/214 (34%), Positives = 106/214 (49%), Gaps = 27/214 (12%)

Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  LGKG FG+V    Y  + + T   +AVKKL+ H     +            RE++ L
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFE--------REIEIL 59

Query: 204 NSCRHDNILPLYGICFETGKYC--LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    LV  Y+P GSL D L  +K+   L   + L  A   
Sbjct: 60  KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQI 117

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L S+    +H D+ + NIL+       IGDFGLT+  P +K  +    R  G  
Sbjct: 118 CKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV--REPGES 173

Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 174 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 9e-20
 Identities = 74/242 (30%), Positives = 110/242 (45%), Gaps = 25/242 (10%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG V   V +K T    A+K L   +  + ++     + E +L E   L+   H 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVL---KKKKIIKR---KEVEHTLTERNILSRINHP 53

Query: 210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            I+ L+   F+T  K  LV  Y P G L    L K+   S     R + A+   L L++L
Sbjct: 54  FIVKLH-YAFQTEEKLYLVLEYAPGGEL-FSHLSKEGRFSEERA-RFYAAE-IVLALEYL 109

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS    +I+ D+K  NILL+      + DFGL +E   E +   T     GT  YL  E 
Sbjct: 110 HSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT---FCGTPEYLAPEV 164

Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE---RHLKSLVE--KYSEENMYDLV 383
           L+GK     VD +  G++L+E+ TG   +    R E   + LK  +   ++      DL+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLI 224

Query: 384 DK 385
             
Sbjct: 225 SG 226

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 46/242 (19%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVE 186
           H+    + L          LG+G FG V+ G         +K  +AVK L+        E
Sbjct: 1   HVQRDTIVL-------KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--------E 45

Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------ 240
           T +   R+   RE + L + +H+NI+  YG+C E     +V+ YM +G L   L      
Sbjct: 46  TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD 105

Query: 241 --LMKKNTPS---LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
              +K        L  +Q L IA   + G+ +L S+    +H D+ + N L+ + +   I
Sbjct: 106 AAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKI 163

Query: 296 GDFGLTQEGPIEKATHIT-LKRVNGTR--P--YLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           GDFG++++       + T   RV G    P  ++P E ++ ++ +T+ DV+ FG+VL+E+
Sbjct: 164 GDFGMSRD------VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Query: 351 AT 352
            T
Sbjct: 218 FT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 66/205 (32%), Positives = 91/205 (44%), Gaps = 24/205 (11%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G FG V+ G W  TT             AV+TL       E  L+E + +   RHD 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKV-----------AVKTLKPGTMSPEAFLQEAQIMKKLRHDK 62

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS-LLWTQRLHIAKGTSLGLQFLH 269
           ++ LY +C E     +V  YM  GSL D L  K      L   Q + +A   + G+ +L 
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHE 327
           SR    IH D+ + NIL+  ++   I DFGL +  E     A       +  T P    E
Sbjct: 121 SRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAP----E 174

Query: 328 FLVGKRLSTKVDVYGFGIVLFELAT 352
                R + K DV+ FGI+L E+ T
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++K   LG+G +  VYK   ++T   +A+KK+++     A + +N      +LRE+K L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF----TALREIKLL 56

Query: 204 NSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLE----DR--LLMKKNTPSLLWTQRLH 256
              +H NI+ L    F       LV+ +M    LE    D+  +L   +  S +      
Sbjct: 57  QELKHPNIIGLLD-VFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM---- 110

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITL 314
               T  GL++LHS    ++H D+K  N+L+       + DFGL +    P  K TH   
Sbjct: 111 ----TLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--- 161

Query: 315 KRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFEL 350
           + V  TR Y   E L G R     VD++  G +  EL
Sbjct: 162 QVV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 54/290 (18%)

Query: 153 LGKGGFGTVYKGVWEKTT-----IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           LG G FG V +G W  +      +AVK L   ++D+  + +     +  L+E   ++S  
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL---KSDKLSDIM-----DDFLKEAAIMHSLD 54

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP-----SLLWTQRLHIAKGTS 262
           H+N++ LYG+   T    +V    P GSL DRL  +K+       S L    + IA    
Sbjct: 55  HENLIRLYGVVL-THPLMMVTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQIAN--- 108

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+++L S+    IH D+ + NILL       IGDFGL +  P  +  ++  + +     
Sbjct: 109 -GMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVE-KY 374
           +   E L  +  S   DV+ FG+ L+E+ T       G+      ++ ++  + L   + 
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225

Query: 375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
             +++Y+++                    Q    NP +RP    +   L 
Sbjct: 226 CPQDIYNVM-------------------LQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 66/224 (29%), Positives = 95/224 (42%), Gaps = 36/224 (16%)

Query: 150 LNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           +  +G G +G VYK     T   +A+K +++   D           E   +E+  L  CR
Sbjct: 8   IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------DFEIIQQEISMLKECR 58

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H NI+  +G      K  +V  Y   GSL+D  + +     L   Q  ++ + T  GL +
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD--IYQVTRGPLSELQIAYVCRETLKGLAY 116

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN--GTRPY-- 323
           LH      IH DIK ANILL    D  + DFG++ +      T    KR +  GT PY  
Sbjct: 117 LHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQ-----LTATIAKRKSFIGT-PYWM 168

Query: 324 LPHEFLVGKRL--STKVDVYGFGIVLFELATG---------MRA 356
            P    V ++     K D++  GI   ELA           MRA
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 151 NILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           + LG G +G VY+GVW+K   T+AVK L+    +  +E       E+ L+E   +   +H
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEV------EEFLKEAAVMKEIKH 61

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            N++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPH 326
             +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    
Sbjct: 121 EKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP---- 174

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
           E L   + S K DV+ FG++L+E+AT GM  Y
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 19/215 (8%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           +L ++G+G +G VY+G    T   +A+K + +   D  V  +   QRE +L  L  L   
Sbjct: 5   RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI---QREVAL--LSQLRQS 59

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           +  NI   YG   +  +  ++  Y   GS+  R LMK    +  +     I +   + L+
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISV--IIREVLVALK 115

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY--L 324
           ++H     +IH DIK+ANIL+ +  +  + DFG+        +   T     GT PY   
Sbjct: 116 YIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GT-PYWMA 169

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
           P     GK   TK D++  GI ++E+ATG   Y D
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 37/216 (17%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
            L  +GKG FG VYK + ++T   +A+K +++   +  +E + Q        E+++L+ C
Sbjct: 5   LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ--------EIQFLSQC 56

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH------IAKG 260
           R   I   YG   +  K  ++  Y   GS  D          LL   +L       I + 
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD----------LLKPGKLDETYIAFILRE 106

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN-- 318
             LGL++LH      IH DIK+ANILL+   D  + DFG++ +      T    KR    
Sbjct: 107 VLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQ-----LTSTMSKRNTFV 159

Query: 319 GTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           GT P+ +  E +       K D++  GI   ELA G
Sbjct: 160 GT-PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 77/276 (27%), Positives = 126/276 (45%), Gaps = 34/276 (12%)

Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +GKG FG VYKGV +  T +AVK            TL    + + L+E + L    H NI
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCR--------STLPPDLKRKFLQEAEILKQYDHPNI 54

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L G+C +     +V   +P GSL   L  KKN   L   + L ++   + G+++L S+
Sbjct: 55  VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK 112

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLT-QEGPIEKATHITLKR--VNGTRPYLPHEF 328
               IH D+ + N L+  +    I DFG++ +E          LK+  +  T P    E 
Sbjct: 113 N--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP----EA 166

Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   R +++ DV+ +GI+L+E  + G   Y     S +  +  +E       Y +     
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGM--SNQQTRERIES-----GYRMPAPQL 219

Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            P E+      +R+  Q    +P+ RP  +++YN L
Sbjct: 220 CPEEI------YRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V++G+W  TT +AVK L+    D           +  L E + +   RH  +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP----------KDFLAEAQIMKKLRHPKL 63

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +C       +V   M  GSL +  L      +L   Q + +A   + G+ +L ++
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLE-YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEFL 329
               IH D+ + N+L+  +    + DFGL +  +  I +A       +  T P    E  
Sbjct: 123 N--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP----EAA 176

Query: 330 VGKRLSTKVDVYGFGIVLFELAT 352
           +  R S K DV+ FGI+L E+ T
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 19/217 (8%)

Query: 146 NWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++K+ ++G+G FG V+  +   ++  + +K++ V +       + + +R  +  E + L
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-------MTKDERLAAQNECQVL 53

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR-LHIAKGTS 262
               H NI+  Y    E     +V  Y P G+L +   ++K   SLL     LH      
Sbjct: 54  KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAE--YIQKRCNSLLDEDTILHFFVQIL 111

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTR 321
           L L  +H++   ++H D+K+ NILL+ H   V IGDFG+++    +   +     V GT 
Sbjct: 112 LALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT----VVGTP 165

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
            Y+  E   GK  + K D++  G VL+ELA+  RA++
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 8e-18
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            NW +  +LG+G FG VY      T   +AVK++    +    ET  +    +   E++ 
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP--ETKKEVNALEC--EIQL 57

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK---KNTPSLLWT-QRLHIA 258
           L + +H+ I+  YG   +     +   YMP GS++D+L        T +  +T Q L   
Sbjct: 58  LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-- 115

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                G+++LHS    ++H DIK ANIL +   +  +GDFG ++      ++   +K V 
Sbjct: 116 -----GVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           GT  ++  E + G+    K DV+  G  + E+ T
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 21/214 (9%)

Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVH-RNDRAVETLNQCQREQSLRELKYLNSCR 207
            ++ LG G  G+V K     T   + K  VH     +V       R+Q LREL+ ++ CR
Sbjct: 9   TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV-------RKQILRELQIMHECR 61

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGL 265
              I+  YG        C+   +M  GSL DR+  K       +L      IA     GL
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILG----KIAVAVVEGL 116

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L++    ++H DIK +NIL+N      + DFG++ E     A         GT  Y+ 
Sbjct: 117 TYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMS 170

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            E + G + + K DV+  GI + ELA G   +  
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 69/226 (30%), Positives = 101/226 (44%), Gaps = 43/226 (19%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVH-RNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG+G FG VYK    KT   +A+KK+ +H   D    T        +LRE+K L   +H 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT--------ALREIKILKKLKHP 67

Query: 210 NILPLYGICFE-----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI----AKG 260
           N++PL  +  E       K   VY   P         M  +   LL    + +     K 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTP--------YMDHDLSGLLENPSVKLTESQIKC 119

Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATH--- 311
             L    G+ +LH     ++H DIK+ANIL+++     I DFGL +  +GP         
Sbjct: 120 YMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 312 ITLKRVNG---TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
              ++      TR Y P E L+G +R +T VD++G G V  E+ T 
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            + W+ +  LG G FG VYK    K T      ++      ++  ++ + E  + E+  L
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQ-HKETGLFAAAKI------IQIESEEELEDFMVEIDIL 56

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           + C+H NI+ LY   F   K  ++  +   G+L+   +M +    L   Q  ++ +    
Sbjct: 57  SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS--IMLELERGLTEPQIRYVCRQMLE 114

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            L FLHS +  +IH D+K+ NILL    D  + DFG++ +         T     GT  +
Sbjct: 115 ALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYW 169

Query: 324 LPHEFLVGKRLST-----KVDVYGFGIVLFELA 351
           +  E +  +         K D++  GI L ELA
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 150 LNILGKGGFGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L+ LG+G  G+V K   + T  I   K      +  ++       +Q LREL+   SC+ 
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-------KQILRELEINKSCKS 58

Query: 209 DNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLL--MKKNTPSLLWTQRLHIAKGTSLG 264
             I+  YG   +  +    +   Y   GSL D +   +KK    +       IA+    G
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LHSR+  +IH DIK +NILL       + DFG++ E     A   T     GT  Y+
Sbjct: 118 LSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYM 170

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             E + GK  S   DV+  G+ L E+A  
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 150 LNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           + ++G G    VY  +       +A+K++++ +   +V+ L         +E++ ++ C 
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL--------RKEVQAMSQCN 57

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA---KGTSLG 264
           H N++  Y       +  LV  Y+  GSL D  +MK + P     + + IA   K    G
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLD--IMKSSYPRGGLDEAI-IATVLKEVLKG 114

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGT 320
           L++LHS     IH DIK+ NILL       I DFG    L   G     T    K   GT
Sbjct: 115 LEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR---TRKVRKTFVGT 169

Query: 321 RPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATG 353
             ++  E +        K D++ FGI   ELATG
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 37/221 (16%)

Query: 153 LGKGGFGTVYKGV-------WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG V+           +K  +AVK L+   +D A        R+   RE + L +
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNA--------RKDFHREAELLTN 63

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLE--------DRLLMKKNTP--SLLWTQRL 255
            +H++I+  YG+C E     +V+ YM +G L         D +LM +      L  +Q L
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           HIA+  + G+ +L S+    +H D+ + N L+  ++   IGDFG++++            
Sbjct: 124 HIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRD-----VYSTDYY 176

Query: 316 RVNGTR----PYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           RV G       ++P E ++ ++ +T+ DV+  G+VL+E+ T
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 71/287 (24%), Positives = 134/287 (46%), Gaps = 46/287 (16%)

Query: 151 NILGKGGFGTVYKGVWEKT-----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
            ++G G FG V +G  +        +A+K L+   +D+        QR   L E   +  
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--------QRLDFLTEASIMGQ 61

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H NI+ L G+  ++    ++  YM NGSL D+ L ++N       Q + + +G + G+
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFL-RENDGKFTVGQLVGMLRGIASGM 119

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG------ 319
           ++L       +H D+ + NIL+N ++   + DFGL++     +AT+ T     G      
Sbjct: 120 KYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT----KGGKIPIR 173

Query: 320 -TRPYLPHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEE 377
            T P    E +  ++ ++  DV+ FGIV++E ++ G R Y D    +  +K++      E
Sbjct: 174 WTAP----EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-IKAV------E 222

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           + Y L      P  ++   A +++     +++  ERP  +Q+ + L 
Sbjct: 223 DGYRL------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)

Query: 147 WDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           W + N +G G FG VY  V       +AVK++ +  ND           ++   E+K L 
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-------IKEIADEMKVLE 54

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             +H N++  YG+     K  +   Y   G+LE+ L   +     +  +          G
Sbjct: 55  LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRVY--TLQLLEG 111

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN---GTR 321
           L +LHS    ++H DIK ANI L+H+    +GDFG   +  ++  T    + V    GT 
Sbjct: 112 LAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTP 167

Query: 322 PYLPHEFLVGKRLSTK---VDVYGFGIVLFELATGMR 355
            Y+  E + G +        D++  G V+ E+ATG R
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.2 bits (195), Expect = 1e-16
 Identities = 71/286 (24%), Positives = 127/286 (44%), Gaps = 47/286 (16%)

Query: 146 NWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++ +  +G+G FG +Y  K   +     +K++++         +   ++E S +E+  L
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-------TKMPVKEKEASKKEVILL 53

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT-----PSLLWTQRLHIA 258
              +H NI+  +    E G+  +V  Y   G L  R+  ++         L W  ++   
Sbjct: 54  AKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI--- 110

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGDFGLTQEGPIEKATHITLKRV 317
              SLGL+ +H R+  ++H DIKS NI L+ + M   +GDFG+ ++  +  +  +    V
Sbjct: 111 ---SLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCV 163

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
            GT  YL  E    +  + K D++  G VL+EL T                 L   +   
Sbjct: 164 -GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-----------------LKHPFEGN 205

Query: 378 NMYDLVDKNAQ----PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           N++ LV K  Q    PI  N +     +  Q  K +P++RP +T +
Sbjct: 206 NLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 8   KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 59

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               +   YG   +  K  ++  Y+  GS  D L         + T    I KG    L 
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKG----LD 115

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS +   IH DIK+AN+LL+   D  + DFG+  +      T I      GT  ++  
Sbjct: 116 YLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQ---LTDTQIKRNTFVGTPFWMAP 170

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +      +K D++  GI   ELA G
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 42/234 (17%)

Query: 153 LGKGGFGTVYK----GVW---EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           +G+G FG V++    G+      T +AVK L   + + + +     QRE +L     +  
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAAL-----MAE 64

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-------------------LMKKNT 246
             H NI+ L G+C      CL++ YM  G L + L                       N 
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
             L  T++L IAK  + G+ +L  R+   +H D+ + N L+  +M   I DFGL++   I
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRN--I 180

Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAY 357
             A +      N   P  ++P E +   R +T+ DV+ +G+VL+E+ + GM+ Y
Sbjct: 181 YSADYYKASE-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 22/216 (10%)

Query: 153 LGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +G G FG V+ G W EK  +A+K +   R     E       E  + E + +    H  +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSE-------EDFIEEAQVMMKLSHPKL 61

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LYG+C E    CLV+ +M +G L D L  ++          L +      G+ +L S 
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS 119

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRPYLPHEFL 329
              +IH D+ + N L+  +    + DFG+T+    ++ T  T  +  V  + P    E  
Sbjct: 120 N--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP----EVF 173

Query: 330 VGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
              + S+K DV+ FG++++E+ + G   Y++   SE
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  G V+K    +T  T+A+KK+       A+  L      Q+LRE+K L +C+H  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV-------ALRRLEGGIPNQALREIKALQACQHPY 60

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L  +      + LV  YMP   L + L  ++        +     +    G+ ++H+
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHA 117

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGL---TQEGPIEKATHITLKRVNGTRPYLPHE 327
               ++H D+K AN+L++      I DFGL     E      +H    +V  TR Y   E
Sbjct: 118 NG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH----QV-ATRWYRAPE 170

Query: 328 FLVGKR-LSTKVDVYGFGIVLFELATG 353
            L G R     VD++  G +  EL  G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 64/244 (26%), Positives = 114/244 (46%), Gaps = 50/244 (20%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGV-------WEKTTIAVKKLEVHRNDRAVE 186
           HI  +++ L    W+    LG+G FG V+           +K  +AVK         A++
Sbjct: 1   HIKRRDIVL---KWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK---------ALK 44

Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
             ++  R+   RE + L   +H +I+  YG+C E     +V+ YM +G L +R L + + 
Sbjct: 45  EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFL-RSHG 102

Query: 247 PS--------------LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD 292
           P               L   Q L IA   + G+ +L S     +H D+ + N L+   + 
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLV 160

Query: 293 PVIGDFGLTQEGPIEKATHITLKRVNGTR----PYLPHEFLVGKRLSTKVDVYGFGIVLF 348
             IGDFG++++  I    +    RV G       ++P E ++ ++ +T+ D++ FG+VL+
Sbjct: 161 VKIGDFGMSRD--IYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215

Query: 349 ELAT 352
           E+ T
Sbjct: 216 EIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 32/220 (14%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETL---NQCQREQSLRELKYLNSCRHD 209
           LG+G FG V+       +    K+ V     AV+ L       R+   RE + L + +H+
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLV-----AVKALKDPTLAARKDFQREAELLTNLQHE 67

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLE--------DRLLMKKNTP-----SLLWTQRLH 256
           +I+  YG+C +     +V+ YM +G L         D +++    P      L  +Q LH
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           IA   + G+ +L S+    +H D+ + N L+  ++   IGDFG++++            R
Sbjct: 128 IASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRD-----VYSTDYYR 180

Query: 317 VNGTR----PYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           V G       ++P E ++ ++ +T+ DV+ FG++L+E+ T
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 70/238 (29%), Positives = 105/238 (44%), Gaps = 44/238 (18%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ 192
           P +P   +TL       L  LG G FG VY+G++        +L+V     AV+TL +  
Sbjct: 1   PEVPRDSITL-------LRALGHGAFGEVYEGLYRGRDGDAVELQV-----AVKTLPESC 48

Query: 193 REQSLRELKYLNSC------RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
            EQ   E  +L          H NI+ L G+ FE     ++   M  G L+  L   +  
Sbjct: 49  SEQD--ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPR 106

Query: 247 ---PSLLWTQRL-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP----VIGDF 298
              PS L  + L   A+  + G ++L       IH DI + N LL     P     I DF
Sbjct: 107 PERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCK-GPGRVAKIADF 163

Query: 299 GLTQEGPIEKATHITLKRVNGTRPYL------PHEFLVGKRLSTKVDVYGFGIVLFEL 350
           G+ ++  I +A++    R  G R  L      P  FL G   ++K DV+ FG++L+E+
Sbjct: 164 GMARD--IYRASYY---RKGG-RAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 31/231 (13%)

Query: 152 ILGKGGFGTVYKGVW--EKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ILG+G FG+V +G    +  +   +AVK +++       +     + E+ L E   +   
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-------DIHTYSEIEEFLSEAACMKDF 58

Query: 207 RHDNILPLYGICFETG------KYCLVYRYMPNGSLEDRLLMKK--NTPSLLWTQRL-HI 257
            H N++ L G+CFE        K  ++  +M +G L   LL  +    P  L  Q L   
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATHITL 314
               +LG+++L +R    IH D+ + N +L   M   + DFGL+++   G   +   I  
Sbjct: 119 MVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE 364
             V     ++  E L  +  ++K DV+ FG+ ++E+AT G   Y      E
Sbjct: 177 MPVK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 25/204 (12%)

Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           L  +GKG FG V  G +    +AVK +   +ND   +          L E   +   RH 
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF--------LAEASVMTQLRHS 59

Query: 210 NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HIAKGTSLGLQF 267
           N++ L G+  E  G   +V  YM  GSL D L  +    S+L    L   +      +++
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK-RVNGTRPYLPH 326
           L +     +H D+ + N+L++      + DFGLT+E     +T  T K  V  T P    
Sbjct: 118 LEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP---- 168

Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL 350
           E L  K+ STK DV+ FGI+L+E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           N ++ L ++G+G +G V K    K T   +A+KK +   +D  V       ++ +LRE+K
Sbjct: 1   NKYEVLGVVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDV-------KKTALREVK 52

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP-----SLLWTQRLH 256
            L   RH+NI+ L       G+  LV+ Y+    LE         P     S +W Q L 
Sbjct: 53  VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-QLLQ 111

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
                   + + HS    +IH DIK  NIL++      + DFG  +      A+ +T   
Sbjct: 112 -------AIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162

Query: 317 VNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
              TR Y   E LVG     K VDV+  G ++ EL  G
Sbjct: 163 A--TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 19/213 (8%)

Query: 149 KLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG VYKG+    K  +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 8   KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 59

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               I   YG   +  K  ++  Y+  GS  D L       + + T    I KG    L 
Sbjct: 60  DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LD 115

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS     IH DIK+AN+LL+   D  + DFG+  +      T I      GT  ++  
Sbjct: 116 YLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQ---LTDTQIKRNTFVGTPFWMAP 170

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
           E +       K D++  GI   ELA G     D
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 8   KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 59

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               +   YG   +  K  ++  Y+  GS  D L        L  TQ   I +    GL 
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 115

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS +   IH DIK+AN+LL+ H +  + DFG+  +      T I      GT  ++  
Sbjct: 116 YLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNTFVGTPFWMAP 170

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +      +K D++  GI   ELA G
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 43/279 (15%)

Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG+G FG V+ G W  TT +A+K L+                E  L+E + +   RHD +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKP----------GTMMPEAFLQEAQIMKKLRHDKL 63

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +PLY +  E   Y +V  +M  GSL D  L + +   L   Q + +A   + G+ ++   
Sbjct: 64  VPLYAVVSEEPIY-IVTEFMGKGSLLD-FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++ANIL+  ++   I DFGL +   IE   +   +       +   E  + 
Sbjct: 122 N--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 332 KRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
            R + K DV+ FGI+L EL T       GM   +   + ER  +    +   E++++L+ 
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM- 236

Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                             K   K++P ERP    + + L
Sbjct: 237 ------------------KLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 24/219 (10%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSC 206
            ++GKG FG VY G    T I     ++H    AV++LN+     + EQ L+E   +   
Sbjct: 1   RVIGKGHFGCVYHG----TLIDSDGQKIHC---AVKSLNRITDLEEVEQFLKEGIIMKDF 53

Query: 207 RHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSL 263
            H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG   
Sbjct: 54  SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG--- 110

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP- 322
            +++L S++   +H D+ + N +L+      + DFGL ++   +K  +          P 
Sbjct: 111 -MEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARD-IYDKEYYSVHNHTGAKLPV 166

Query: 323 -YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            ++  E L  ++ +TK DV+ FG++L+EL T G   Y D
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 43/228 (18%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQS-LRE---LKYLN 204
           I+G+G F TV     EK T    A+K L+  +       L + ++ +    E   L  LN
Sbjct: 8   IIGEGSFSTVVL-AKEKETNKEYAIKILDKRQ-------LIKEKKVKYVKIEKEVLTRLN 59

Query: 205 SCRHDNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTP-SLLWTQRLHIAKGTS 262
              H  I+ LY   F+       V  Y PNG L     ++K        T+    A    
Sbjct: 60  --GHPGIIKLYY-TFQDEENLYFVLEYAPNGELLQ--YIRKYGSLDEKCTR--FYAAEIL 112

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG---------LTQEGPIEKATHIT 313
           L L++LHS+   +IH D+K  NILL+  M   I DFG           +    +     +
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 314 LKRVNGTRP--------YLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               N  R         Y+  E L  K      D++  G +++++ TG
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 20/217 (9%)

Query: 153 LGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETL----NQCQREQSLRELKYLN 204
           LG+G FG V+    +G+ E       + +      AV+ L     +  R   L+E+K ++
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSL---------EDRLLMKKNTPSLLWTQRL 255
             ++ NI+ L G+C      C++  YM NG L         E       N PS+     L
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           ++A   + G+++L S     +H D+ + N L+ +H    I DFG+++         I  +
Sbjct: 133 YMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            V   R       L+GK  +T  DV+ FG+ L+E+ T
Sbjct: 191 AVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 16/213 (7%)

Query: 147 WDKLNILGKGGFGTVYKG-VWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLRELKYLN 204
           W K  +LGKG +GTVY G   +   IAVK++E+  ++  A E     + E+   E+  L 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEK----EYEKLQEEVDLLK 57

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
           S +H NI+   G C +     +   ++P GS+   L      P  ++ +     K    G
Sbjct: 58  SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDG 114

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT----LKRVNGT 320
           + +LH     ++H DIK  N++L  +    + DFG  +        H T    LK ++GT
Sbjct: 115 VAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-HGTHSNMLKSMHGT 171

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             ++  E +       K D++  G  +FE+ATG
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 66/283 (23%), Positives = 133/283 (46%), Gaps = 35/283 (12%)

Query: 149 KLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           K  ++G G FG V++G+ +     +  +A+K L+    ++        QR+  L E   +
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--------QRQDFLSEASIM 60

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L G+  +     ++  YM NG+L D+ L + +       Q + + +G + 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYL-RDHDGEFSSYQLVGMLRGIAA 118

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP- 322
           G+++L   +   +H D+ + NIL+N +++  + DFGL++   +E     T     G  P 
Sbjct: 119 GMKYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSR--VLEDDPEGTYTTSGGKIPI 174

Query: 323 -YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY 380
            +   E +  ++ ++  DV+ FGIV++E+ + G R Y D    E  +K++ + +      
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFR----- 228

Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                   P  ++   A +++  Q  +Q+   RP    + N+L
Sbjct: 229 -------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 36/223 (16%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           Q+LTL         I+G+G FG V +G +    +AVK ++     +A            L
Sbjct: 6   QKLTLGE-------IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAF-----------L 47

Query: 198 RELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK----NTPSLLWTQ 253
            E   +    H N++ L G+    G Y +V   M  G+L + L  +     +   LL   
Sbjct: 48  EETAVMTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            L +A+G    +++L S++  L+H D+ + NIL++      + DFGL + G        +
Sbjct: 107 -LDVAEG----MEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGS--MGVDNS 157

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
              V  T P    E L  K+ S+K DV+ +G++L+E+ +  RA
Sbjct: 158 KLPVKWTAP----EALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 74/292 (25%), Positives = 129/292 (44%), Gaps = 51/292 (17%)

Query: 153 LGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG+G FG+V +G   +      +AVK +++    R+       + E  L E   +    H
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS-------EMEDFLSEAVCMKEFDH 59

Query: 209 DNILPLYGICFETGKY------CLVYRYMPNGSLEDRLLMKK--NTPSLLWTQRL-HIAK 259
            N++ L G+C +T +        ++  +M +G L   LL  +  + P  L TQ L     
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATHITLKR 316
             + G+++L S+    IH D+ + N +LN +M+  + DFGL+++   G   +   I    
Sbjct: 120 DIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS 375
           V     ++  E L  +  +TK DV+ FG+ ++E+AT G   Y     SE           
Sbjct: 178 VK----WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----------- 222

Query: 376 EENMYDLV---DKNAQPIE-LNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +YD +   ++  QP + L+  Y+           NPK+RP    +   L
Sbjct: 223 ---IYDYLRQGNRLKQPPDCLDGLYSLM---SSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)

Query: 146 NWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKY 202
            W K   LG G F + Y  + V   T +AVK++   RN  +     Q +  ++LR E++ 
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS----EQEEVVEALRKEIRL 56

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK----KNTPSLLWTQRLHIA 258
           +    H +I+ + G   E   + L   +M  GS+   LL K    K    + +T++L   
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVS-HLLSKYGAFKEAVIINYTEQL--- 112

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIGDFGLTQEGPIEKATHIT-- 313
                GL +LH  +  +IH D+K AN+L++     +   I DFG         A   T  
Sbjct: 113 ---LRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLR--IADFG----AAARLAAKGTGA 161

Query: 314 ---LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                ++ GT  ++  E L G++     DV+  G V+ E+AT 
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 34/219 (15%)

Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           W K  +LG G FG+VY+G+   +    AVK++ +  +    +T  +  ++   +E+  L+
Sbjct: 2   WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG---QTGQEAVKQLE-QEIALLS 57

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-----NTPSLLWTQRLHIAK 259
             +H NI+   G   E     +    +P GSL    L+KK          L+T+++    
Sbjct: 58  KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAK--LLKKYGSFPEPVIRLYTRQI---- 111

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT----LK 315
              LGL++LH R    +H DIK ANIL++ +    + DFG+        A  +      K
Sbjct: 112 --LLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGM--------AKQVVEFSFAK 159

Query: 316 RVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATG 353
              G+  ++  E +  +       D++  G  + E+ATG
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 22/210 (10%)

Query: 149 KLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +G+G +G VYK         +A+KK+        +   ++   + +LRE+K L   
Sbjct: 3   KLGKIGEGTYGVVYKARDKLTGEIVAIKKI-------KLRFESEGIPKTALREIKLLKEL 55

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L  +    G   LV+ +M     +   L+K     L  +           GL 
Sbjct: 56  NHPNIIKLLDVFRHKGDLYLVFEFMDTDLYK---LIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITLKRVNGTRPYL 324
           F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +     TR Y 
Sbjct: 113 FCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYR 165

Query: 325 PHEFLVGKRL-STKVDVYGFGIVLFELATG 353
             E L+G +  ST VD++  G +  EL + 
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 150 LNILGKGGFGTV----YKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           L +LG+G FG V    YK   E   I A+KK ++   D  VE+L  C++    R  +  N
Sbjct: 4   LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE-VESL-MCEK----RIFETAN 57

Query: 205 SCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           S RH  ++ L+  CF+T  + C V  Y   G L    +M  +T      + +  A    L
Sbjct: 58  SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL----MMHIHTDVFSEPRAVFYAACVVL 112

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GLQ+LH  +  +++ D+K  N+LL+      I DFGL +EG        T     GT  +
Sbjct: 113 GLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF---CGTPEF 167

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           L  E L     +  VD +G G++++E+  G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 27/212 (12%)

Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           KL  LG G  G V K +   + + + +  +H        +    R Q +RELK L+ C  
Sbjct: 5   KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE------IKPAIRNQIIRELKVLHECNS 58

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HIAKGTS 262
             I+  YG  +  G+  +   +M  GSL+   ++KK         R+       I+    
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLD--QVLKK-------AGRIPENILGKISIAVL 109

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            GL +L   +  ++H D+K +NIL+N   +  + DFG++ +     A         GTR 
Sbjct: 110 RGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRS 163

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           Y+  E L G   + + D++  G+ L E+A G 
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 34/220 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQRE----QSLR 198
            ++KLN + +G +G VY+   +K T   +A+KKL++ +           ++E     SLR
Sbjct: 6   EYEKLNRIEEGTYGVVYRAR-DKKTGEIVALKKLKMEK-----------EKEGFPITSLR 53

Query: 199 ELKYLNSCRHDNILPLYGICFETG--KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
           E+  L   +H NI+ +  +   +   K  +V  Y+ +   + + LM+      L ++   
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH---DLKSLMETMKQPFLQSEVKC 110

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITL 314
           +      G+  LH     ++H D+K++N+LLN+     I DFGL +E   P++  T + +
Sbjct: 111 LMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168

Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                T  Y   E L+G K  ST +D++  G +  EL T 
Sbjct: 169 -----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 33/244 (13%)

Query: 142 LATNNWDKLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 55

Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR- 254
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+     +    
Sbjct: 56  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114

Query: 255 -LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 115 CVQIAK----GMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 169 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 222

Query: 370 LVEK 373
           ++EK
Sbjct: 223 ILEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 67/282 (23%), Positives = 126/282 (44%), Gaps = 32/282 (11%)

Query: 146 NWDKLNILGKGGFG--TVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++  + +LGKG FG  T+Y+   + + +  K++ + R       L++ +R  +L E+  L
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-------LSEKERRDALNEIVIL 53

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA--KGT 261
           +  +H NI+  Y    +     +   Y   G+L D+++ +K     L+ + + +      
Sbjct: 54  SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQI 110

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              + ++H     ++H DIK+ NI L       +GDFG+++    E +   T   V GT 
Sbjct: 111 VSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---VVGTP 165

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
            Y+  E   G + + K D++  G VL+EL T  R +D T         LV K        
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVK-------- 212

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           +V  N  P+    +     +     +Q+P++RP   +V +  
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 76/296 (25%), Positives = 121/296 (40%), Gaps = 61/296 (20%)

Query: 152 ILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            LG+G FG V K    +       TT+AVK L+        E  +  +    L E   L 
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK--------ENASSSELRDLLSEFNLLK 58

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQR--------- 254
              H +++ LYG C + G   L+  Y   GSL   L   +K  PS L +           
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 255 -----------LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE 303
                      +  A   S G+Q+L   E  L+H D+ + N+L+       I DFGL+++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 304 GPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDT 360
              E +    +KR  G  P  ++  E L     +T+ DV+ FG++L+E+ T G   Y   
Sbjct: 177 VYEEDS---YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233

Query: 361 RRSERHLKSLVEKYSEENMYDLVDKNAQPIEL--NIAYAFFRIGKQSTKQNPKERP 414
                         + E +++L+ K    +E   N +   + +     KQ P +RP
Sbjct: 234 --------------APERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 40/214 (18%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHD 209
           LG G FG+VY    ++T   +A+KK++     +   +  +C     LRE+K L     H 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMN---LREVKSLRKLNEHP 58

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HIAKGTSLGLQFL 268
           NI+ L  +  E  +   V+ YM  G+L    LMK           +  I      GL  +
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 269 HSREPPLIHG----DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-----VNG 319
           H       HG    D+K  N+L++      I DFGL        A  I  +      V  
Sbjct: 116 HK------HGFFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYV-S 160

Query: 320 TRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           TR Y  P   L     S+ VD++  G ++ EL T
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 67/235 (28%), Positives = 113/235 (48%), Gaps = 20/235 (8%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LGKG FGTVY  V +K  +A ++L+V + +  V  LN  +  Q+ +E + L+   H  I+
Sbjct: 8   LGKGSFGTVYL-VKDKKAVAEERLKVLK-EIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
             +    E   +C++  Y     L+ +L  +K    +L   Q         LG+ ++H R
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEFL 329
              ++H D+K+ NI L +++   IGDFG+++   G  + AT  T     GT  Y+  E L
Sbjct: 126 R--ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFT-----GTPYYMSPEAL 177

Query: 330 VGKRLSTKVDVYGFGIVLFELATGMRAYDDT-------RRSERHLKSLVEKYSEE 377
             +   +K D++  G +L+E+     A++         R  E    SL E YS +
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 149 KLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+ +LG+G FG V    ++         +AVK L+            Q       +E+  
Sbjct: 8   KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK--------RECGQQNTSGWKKEINI 59

Query: 203 LNSCRHDNILPLYGICFETGKYC--LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H+NI+   G C E G     L+  Y+P GSL D L   K+  +L   Q L  A+ 
Sbjct: 60  LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL--AQLLLFAQQ 115

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK-RVNG 319
              G+ +LHS+    IH D+ + N+LL++     IGDFGL +  P     H   + R +G
Sbjct: 116 ICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP---EGHEYYRVREDG 170

Query: 320 TRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             P  +   E L   + S   DV+ FG+ L+EL T
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 34/220 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++KLN +G+G +G VY+     +   +A+KK+   R D   + +       SLRE+  L
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPI----SSLREITLL 60

Query: 204 NSCRHDNILPLYGICFETGKYC----LVYRYMPN--GSLEDRLLMKKNTPSL--LWTQRL 255
            + RH NI+ L  +    GK+     LV  Y      SL D +    +   +  L  Q L
Sbjct: 61  LNLRHPNIVELKEVV--VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-GPIEKATHITL 314
                   GLQ+LH     +IH D+K +N+LL       I DFGL +  G    A  +T 
Sbjct: 119 R-------GLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP--AKPMTP 167

Query: 315 KRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           K V  T  Y   E L+G    T  +D++  G +L EL   
Sbjct: 168 KVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 71/277 (25%), Positives = 127/277 (45%), Gaps = 33/277 (11%)

Query: 152 ILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +LGKG FG V+KG   +KT +AVK  +        E L Q  + + L E + L    H N
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCK--------EDLPQELKIKFLSEARILKQYDHPN 53

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+ L G+C +     +V   +P G     L  KK+   L   Q +  A   + G+ +L S
Sbjct: 54  IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLES 111

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLT--QEGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    I DFG++  ++  I  ++ +    +  T P    E 
Sbjct: 112 KN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP----EA 165

Query: 329 LVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   R S++ DV+ +GI+L+E  + G+  Y     + +  +  VEK      Y +     
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--TNQQAREQVEK-----GYRMSCPQK 218

Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
            P ++      +++ ++     P+ RP+ +++   L+
Sbjct: 219 CPDDV------YKVMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.6 bits (179), Expect = 5e-14
 Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 43/223 (19%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G +G V   V ++T   +A+KK+         + L   +R   LRE+K L   R
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-----NVFDDLIDAKR--ILREIKLLRHLR 57

Query: 208 HDNILPLYGI-------CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----LH 256
           H+NI+ L  I        F       VY            LM+ +   ++ + +     H
Sbjct: 58  HENIIGLLDILRPPSPEDFND-----VYIVTE--------LMETDLHKVIKSPQPLTDDH 104

Query: 257 IAKGTS---LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATH 311
           I         GL++LHS    +IH D+K +NIL+N + D  I DFGL    +   ++   
Sbjct: 105 IQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 312 ITLKRVNGTRPYLPHE-FLVGKRLSTKVDVYGFGIVLFELATG 353
           +T   V  TR Y   E  L   R +  +D++  G +  EL T 
Sbjct: 163 LTEYVV--TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)

Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +REL+
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE------IKPAIRNQIIRELQ 55

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++   
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAV 112

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         GTR
Sbjct: 113 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 166

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L E+A G
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 24/222 (10%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           IP + L L          LG+G FG V+ G W  TT +A+K L+                
Sbjct: 3   IPRESLRLEVK-------LGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 45

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 46  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQ 103

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 104 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 159

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR 355
            +       +   E  +  R + K DV+ FGI+L EL T  R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 57/290 (19%)

Query: 153 LGKGGFGTVYK--GVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY-LNSCRHD 209
           LG+G +G V K   V   T +AVK++      RA  T+N  ++++ L +L   + S    
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI------RA--TVNSQEQKRLLMDLDISMRSVDCP 60

Query: 210 NILPLYG---------ICFETGKYCL--VYR--YMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             +  YG         IC E     L   Y+  Y    ++ + +L K             
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK------------- 107

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           IA      L++LHS+   +IH D+K +N+L+N +    + DFG++  G +  +   T+  
Sbjct: 108 IAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDA 164

Query: 317 VNGTRPYLPHEFLVG----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             G +PY+  E +      K    K DV+  GI + ELATG   YD  +   + LK +VE
Sbjct: 165 --GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222

Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
           + S +         A+               +  K+N KERP   ++   
Sbjct: 223 EPSPQ-------LPAEKFSPEFQD----FVNKCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 60/299 (20%)

Query: 144 TNNWDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             N+     +GKG F  VYK +   +   +A+KK+++       E ++   R+  L+E+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQI------FEMMDAKARQDCLKEID 54

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSL---------EDRLLMKKNTPSLLWT 252
            L    H N++       E  +  +V      G L         + RL+ ++     +W 
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT----IWK 110

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
             + +       L+ +HS+   ++H DIK AN+ +       +GD GL   G    +   
Sbjct: 111 YFVQLCS----ALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGL---GRFFSSKTT 161

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT--------GMRAYDDTRRSE 364
               + GT  Y+  E +     + K D++  G +L+E+A          M  Y   ++ E
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221

Query: 365 R-HLKSL-VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
           +     L  + YSEE + DLV +   P                   +P++RP+++ V  
Sbjct: 222 KCDYPPLPADHYSEE-LRDLVSRCINP-------------------DPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 25/222 (11%)

Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS-LRELKYLNSCRH 208
           L ++GKG FG V   V ++ T  +  ++     + VE        ++ L E + L    H
Sbjct: 5   LRVIGKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEK----GSVRNVLNERRILQELNH 59

Query: 209 DNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             ++ L+   F+  +   LV   +  G L  R  + +         +  I +   L L++
Sbjct: 60  PFLVNLW-YSFQDEENMYLVVDLLLGGDL--RYHLSQKVKFSEEQVKFWICE-IVLALEY 115

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT----LKRVNGTRPY 323
           LHS+   +IH DIK  NILL+      I DF +        AT +T        +GT  Y
Sbjct: 116 LHSKG--IIHRDIKPDNILLDEQGHVHITDFNI--------ATKVTPDTLTTSTSGTPGY 165

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER 365
           +  E L  +  S  VD +  G+  +E   G R Y    R+ R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR 207

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 9/209 (4%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           NW +  +LG+G FG VY      T   +   +V  +  + ET  +    +   E++ L +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKN 60

Query: 206 CRHDNILPLYGICFETGKYCLV--YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
            +H+ I+  YG   +  +  L     YMP GS++D+L   K   +L  +      +    
Sbjct: 61  LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILE 117

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +LHS    ++H DIK ANIL +   +  +GDFG ++       +   ++ V GT  +
Sbjct: 118 GMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           +  E + G+    K DV+  G  + E+ T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G W   T +AVK L+                E  L E + +   RHD +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKP----------GTMSPESFLEEAQIMKKLRHDKL 63

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  E   Y +V  YM  GSL D  L      +L     + +A   + G+ ++   
Sbjct: 64  VQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D++SANIL+   +   I DFGL +   IE   +   +       +   E  + 
Sbjct: 122 N--YIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 332 KRLSTKVDVYGFGIVLFELATGMR 355
            R + K DV+ FGI+L EL T  R
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 38/232 (16%)

Query: 149 KLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL+ LG+G + TV+KG  + T   +A+K++ +   + A  T        ++RE+  L + 
Sbjct: 9   KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT--------AIREVSLLKNL 60

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGT 261
           +H NI+ L+ I        LV+ Y+ +  L+  L     LM  +   +   Q L      
Sbjct: 61  KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR----- 114

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH----ITLKRV 317
             GL + H R+  ++H D+K  N+L+N   +  + DFGL +   +   T+    +TL   
Sbjct: 115 --GLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW-- 168

Query: 318 NGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAY-DDTRRSERHL 367
                Y P + L+G    ST +D++G G +L+E+ATG   +   T + E HL
Sbjct: 169 -----YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 71/239 (29%), Positives = 110/239 (46%), Gaps = 37/239 (15%)

Query: 149 KLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+ +LG G FGTVYKG+W       K  +A+K L  + + +A         ++ L E   
Sbjct: 11  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA--------NKEILDEAYV 62

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN---TPSLL-WTQRLHIA 258
           +       +  L GIC  T    LV + MP G L D +   K+   +  LL W   + IA
Sbjct: 63  MAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIA 119

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI-EKATHITLKRV 317
           KG S      +  E  L+H D+ + N+L+       I DFGL +   I E   H      
Sbjct: 120 KGMS------YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD---- 169

Query: 318 NGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK 373
            G  P  ++  E ++ +R + + DV+ +G+ ++EL T G + YD      R +  L+EK
Sbjct: 170 GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 69/282 (24%), Positives = 129/282 (45%), Gaps = 42/282 (14%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           + K+  +G+G FG   K +  K+    K+  +   +  +  ++  +RE+S +E+  L++ 
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVI--KEINISKMSPKEREESRKEVAVLSNM 56

Query: 207 RHDNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTP-----SLLWTQRLHIAKG 260
           +H NI+  Y   FE  G   +V  Y   G L  ++  ++         L W  ++     
Sbjct: 57  KHPNIV-QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI----- 110

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN-- 318
             L L+ +H R+  ++H DIKS NI L       +GDFG      I +  + T++     
Sbjct: 111 -CLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFG------IARVLNSTVELARTC 161

Query: 319 -GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
            GT  YL  E    +  + K D++  G VL+E+ T   A++       ++K+LV K    
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-----AGNMKNLVLK---- 212

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
               ++  +  P+  + +Y    +  Q  K+NP++RP +  +
Sbjct: 213 ----IIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 34/221 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++KL  +G+G +GTV+K    +T   +A+K++ +  +D  V +        +LRE+  L
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-------SALREICLL 53

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              +H NI+ LY +     K  LV+ Y       D+ L KK   S        I K    
Sbjct: 54  KELKHKNIVRLYDVLHSDKKLTLVFEYC------DQDL-KKYFDSCNGDIDPEIVKSFMF 106

Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATH--ITLK 315
               GL F HS    ++H D+K  N+L+N + +  + DFGL +    P+   +   +TL 
Sbjct: 107 QLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW 164

Query: 316 RVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMR 355
                  Y P + L G +L ST +D++  G +  ELA   R
Sbjct: 165 -------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK   ++T             + +ET ++ + E  + E++ L +C
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAA-------KVIETKSEEELEDYMVEIEILATC 66

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H  I+ L G  +  GK  ++  + P G+++   +M +    L   Q   I +     LQ
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD--AIMLELDRGLTEPQIQVICRQMLEALQ 124

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN--GTRPYL 324
           +LHS +  +IH D+K+ N+LL    D  + DFG++      K      +R +  GT  ++
Sbjct: 125 YLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFIGTPYWM 177

Query: 325 PHEFLVGKRLST-----KVDVYGFGIVLFELA 351
             E ++ + +       K D++  GI L E+A
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 44/227 (19%)

Query: 144 TNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             N +++ +LGKG +G VY    +  +  IA+K++   R+ R V+ L++        E+ 
Sbjct: 8   DENGERV-VLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHE--------EIA 57

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNTPSLLWTQRLH 256
             +  +H NI+   G   E G + +    +P GSL   L      +K N  ++++     
Sbjct: 58  LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF----- 112

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLK 315
             K    GL++LH  +  ++H DIK  N+L+N +   V I DFG ++           L 
Sbjct: 113 YTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----------LA 160

Query: 316 RVN-------GTRPYLPHEFL-VGKR-LSTKVDVYGFGIVLFELATG 353
            +N       GT  Y+  E +  G R      D++  G  + E+ATG
Sbjct: 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)

Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  +++++++ LG G  G V K   + + + + +  +H        +    R Q +REL+
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE------IKPAIRNQIIRELQ 55

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L   K  P  +  +   ++   
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAV 112

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         GTR
Sbjct: 113 LRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 166

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L ELA G
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 11/210 (5%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           NW    +LG+G FG VY      T   +   +V  +  + ET  +    +   E++ L +
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC--EIQLLKN 60

Query: 206 CRHDNILPLYGICF---ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
            RHD I+  YG C    E  K  +   YMP GS++D+L   K   +L         +   
Sbjct: 61  LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQIL 116

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+ +LHS    ++H DIK ANIL +   +  +GDFG ++       +   +K V GT  
Sbjct: 117 QGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  E + G+    K DV+     + E+ T
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 28/227 (12%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSL-----RE 199
           W K  ++G G FG+VY G+   +   +AVK++E+          +   R++S+     RE
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVS-----ASSKDRKRSMLDALARE 56

Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           +  L   +H+NI+   G   +     +   Y+P GS+   L         L     +  +
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---NFVR 113

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL +LH+R   +IH DIK ANIL+++     I DFG++++  +E   +    + NG
Sbjct: 114 QILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK--LE--ANSLSTKTNG 167

Query: 320 TRP-------YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            RP       ++  E +     + K D++  G ++ E+ TG   + D
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 63/280 (22%), Positives = 128/280 (45%), Gaps = 35/280 (12%)

Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+    ++        QR   L E   +   
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--------QRRDFLSEASIMGQF 62

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+  ++    +V  YM NGSL+    ++K+       Q + + +G + G++
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   +   +H D+ + NIL+N ++   + DFGL++   +E           G  P  + 
Sbjct: 121 YL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWT 176

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E ++ G R Y +    +  +K++ E Y         
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGYR-------- 227

Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                P  ++   A  ++     +++  ERP+  Q+ ++L
Sbjct: 228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 24/225 (10%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQR---EQSLRELKYLNSCRHD 209
           LG+G F  ++KG+  +        E+H+ +  ++ L++  R   E        ++   H 
Sbjct: 3   LGQGTFTKIFKGIRREV---GDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           +++  YG+C    +  +V  Y+  GSL+  L   KN  ++ W  +L +AK  +  L FL 
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117

Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGD---FGLTQEG--PIEKATHITLKRVNGTRPYL 324
            +   L HG++ + N+LL    D   G+     L+  G         I L+R+    P++
Sbjct: 118 DKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI----PWV 171

Query: 325 PHEFLVGKR-LSTKVDVYGFGIVLFELATG----MRAYDDTRRSE 364
           P E +   + LS   D + FG  L+E+ +G    + A D  ++ +
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 76/288 (26%), Positives = 131/288 (45%), Gaps = 37/288 (12%)

Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETL----NQCQREQSLRELKYLNS 205
            ++L +G FG ++ G+        ++      +  V+T+    ++ Q    L+E   L  
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEE------EVFVKTVKDHASEIQVTLLLQESCLLYG 64

Query: 206 CRHDNILPLYGICFE-TGKYCLVYRYMPNGSLEDRL----LMKKNTPSLLWTQRL-HIAK 259
             H NILP+  +C E      ++Y YM  G+L+  L    L + N P  L TQ+L H+A 
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
             + G+ +LH R   +IH DI + N +++  +   I D  L+++  +    +  L   N 
Sbjct: 125 QIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRD--LFPMDYHCLGD-NE 179

Query: 320 TRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE 376
            RP  ++  E LV K  S+  DV+ FG++L+EL T G   Y +           ++ +  
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-----------IDPFEM 228

Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                   + AQPI  N     F +       +P+ERP  +Q+   L+
Sbjct: 229 AAYLKDGYRLAQPI--NCPDELFAVMACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)

Query: 149 KLNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++  LG+G FG V    Y    + T   +AVK L+       +  L         +E++ 
Sbjct: 8   RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--------KEIEI 59

Query: 203 LNSCRHDNILPLYGICFETGKYC--LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H+NI+   GIC E G     L+  ++P+GSL++ L   KN  +L   Q+L  A  
Sbjct: 60  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQ 117

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +L SR+   +H D+ + N+L+       IGDFGLT+    +K  +     ++  
Sbjct: 118 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             +   E L+  +     DV+ FG+ L+EL T
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 46/222 (20%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           K+  +G+G +G VYKG  +KT   +A+KK+ +   +  V +        ++RE+  L   
Sbjct: 4   KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS-------TAIREISLLKEL 56

Query: 207 RHDNILPLYGICFETGKYCLVY--------RYM---PNGSLEDRLLMKKNTPSLLWTQRL 255
           +H NI+ L  +  +  +  L++        +Y+   P G   D  L+K     +L     
Sbjct: 57  QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----- 111

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATH-- 311
                   G+ F HSR   ++H D+K  N+L+++     + DFGL +    P+   TH  
Sbjct: 112 -------QGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162

Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
           +TL        Y   E L+G  R ST VD++  G +  E+AT
Sbjct: 163 VTLW-------YRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 26/218 (11%)

Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G W  K  +A+K +           +++   +  + E K +    H N+
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREG-------AMSE---DDFIEEAKVMMKLSHPNL 61

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR-LHIAKGTSLGLQFLHS 270
           + LYG+C +     +V  YM NG L + L   +     L T+  L +       +++L S
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLES 118

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR---PYLPHE 327
                IH D+ + N L+       + DFGL +    ++ T        GT+    + P E
Sbjct: 119 NG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-----GTKFPVKWAPPE 171

Query: 328 FLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE 364
                R S+K DV+ FG++++E+ + G   Y+    SE
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 33/223 (14%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQRE 194
           P +E TL          LG G FG V++G+W+    +A+K L+   +D   +   Q    
Sbjct: 4   PREEFTL-------ERKLGSGYFGEVWEGLWKNRVRVAIKILK--SDDLLKQQDFQ---- 50

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP---SLLW 251
              +E++ L   RH +++ L+ +C       ++   M  GSL   L     +P    L  
Sbjct: 51  ---KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL----RSPEGQVLPV 103

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKA 309
              + +A   + G+ +L  +    IH D+ + NIL+   +   + DFGL +  +  +   
Sbjct: 104 ASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YL 160

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           +         T P    E       STK DV+ FGI+L+E+ T
Sbjct: 161 SSDKKIPYKWTAP----EAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 76/292 (26%), Positives = 130/292 (44%), Gaps = 54/292 (18%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR----ELKYLNSC 206
           +++G+G FG V K   +K  +        R D A++ + +   +   R    EL+ L  C
Sbjct: 13  DVIGEGNFGQVLKARIKKDGL--------RMDAAIKRMKEYASKDDHRDFAGELEVL--C 62

Query: 207 R---HDNILPLYGICFETGKYCLVYRYMPNGSLED-----RLL-------MKKNTPSLLW 251
           +   H NI+ L G C   G   L   Y P+G+L D     R+L       +  +T S L 
Sbjct: 63  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122

Query: 252 TQR-LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           +Q+ LH A   + G+ +L  ++   IH D+ + NIL+  +    I DFGL+      +  
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS------RGQ 174

Query: 311 HITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHL 367
            + +K+  G  P  ++  E L     +T  DV+ +G++L+E+ + G   Y     +E + 
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234

Query: 368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           K L + Y  E              LN     + + +Q  ++ P ERP   Q+
Sbjct: 235 K-LPQGYRLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 32/226 (14%)

Query: 153 LGKGGFGTVYKG------VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           LG+  FG +YKG      +     +A+K L+   N    +   + Q+E SL     +   
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN---PQQWGEFQQEASL-----MAEL 64

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--------------TPSLLWT 252
            H NI+ L G+  +    C+++ Y+  G L + L+M+                  SL   
Sbjct: 65  HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
             LHIA   + G+++L S     +H D+ + NIL+   +   I D GL++E        +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
             K +   R ++P E ++  + S+  D++ FG+VL+E+ + G++ Y
Sbjct: 183 QPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 38/223 (17%)

Query: 146 NWDKLNILGKGGFGTV----YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            ++ +  LG+G +G V         E+ T+A+KK+               +R  +LRELK
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-----NVFSKKILAKR--ALRELK 53

Query: 202 YLNSCR-HDNILPLYG--ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHI 257
            L   R H NI  LY   I F  G +  +Y Y          LM+ +   ++ + Q L  
Sbjct: 54  LLRHFRGHKNITCLYDMDIVF-PGNFNELYLYEE--------LMEADLHQIIRSGQPLTD 104

Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEK 308
           A   S       GL+++HS    ++H D+K  N+L+N   +  I DFGL     E P E 
Sbjct: 105 AHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162

Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFEL 350
           A  +T      TR Y   E ++  +  TK +DV+  G +L EL
Sbjct: 163 AGFMT--EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 28/227 (12%)

Query: 149 KLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  LG+G + TV+KG  + T   +A+K++ +   + A  T        ++RE+  L   
Sbjct: 10  KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT--------AIREVSLLKDL 61

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGT 261
           +H NI+ L+ I        LV+ Y+ +  L+  +     +M  +   +   Q L      
Sbjct: 62  KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR----- 115

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL + H R+  ++H D+K  N+L+N   +  + DFGL +   +   T+         R
Sbjct: 116 --GLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYR 171

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRRSERHL 367
           P  P   L     ST++D++G G + FE+A+G   +   T   E HL
Sbjct: 172 P--PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 37/217 (17%)

Query: 149 KLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL+ LG+G + TVYKG  + T   +A+K++ +   + A  T        ++RE+  L   
Sbjct: 10  KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT--------AIREVSLLKDL 61

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGT 261
           +H NI+ L+ I        LV+ Y+ +  L+  L      +  +   L   Q L      
Sbjct: 62  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR----- 115

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH----ITLKRV 317
             GL + H R+  ++H D+K  N+L+N   +  + DFGL +   I   T+    +TL   
Sbjct: 116 --GLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLW-- 169

Query: 318 NGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATG 353
                Y P + L+G    ST++D++G G + +E++TG
Sbjct: 170 -----YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 35/270 (12%)

Query: 150 LNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
             ILG G  GTVYK   +  +  +AVK + +   D  VE      ++Q + EL+ L  C 
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPL---DITVEL-----QKQIMSELEILYKCD 57

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
              I+  YG  F   +  +   +M  GSL+    + +  P  +  +   IA     GL +
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLD----VYRKIPEHVLGR---IAVAVVKGLTY 110

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITLKRVNGTRPYLP 325
           L S +  ++H D+K +N+L+N      + DFG++ +    I K T++      GT  Y+ 
Sbjct: 111 LWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK-TYV------GTNAYMA 161

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK 385
            E + G++     DV+  GI   ELA G   Y   ++++  L  L      + +  +VD+
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL------QLLQCIVDE 215

Query: 386 NAQPIELN-IAYAFFRIGKQSTKQNPKERP 414
           +   + +   +  F     Q  ++ PKERP
Sbjct: 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 49/223 (21%)

Query: 149 KLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           K+  +G+G +G VYK   +K T   +A+KK+ +   D  V +        ++RE+  L  
Sbjct: 3   KVEKIGEGTYGVVYKAR-DKLTGEIVALKKIRLETEDEGVPS-------TAIREISLLKE 54

Query: 206 CRHDNILPLYGICFETGKYCLVY--------RYM---PNGSLEDRLLMKKNTPSLLWTQR 254
             H NI+ L  +     K  LV+        +YM   P   L D  L+K     LL    
Sbjct: 55  LNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGL-DPPLIKSYLYQLL---- 109

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-G-PIEKATH- 311
                    G+ + HS    ++H D+K  N+L++      + DFGL +  G P+   TH 
Sbjct: 110 --------QGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159

Query: 312 -ITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELAT 352
            +TL        Y   E L+G R  ST VD++  G +  E+  
Sbjct: 160 VVTLW-------YRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 54/297 (18%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR----ELKYLNSC 206
           +++G+G FG V +        A+ K +  + + A++ L +   E   R    EL+ L  C
Sbjct: 8   DVIGEGNFGQVIR--------AMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVL--C 57

Query: 207 R---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK------------NTPSLLW 251
           +   H NI+ L G C   G   +   Y P G+L D L   +             T S L 
Sbjct: 58  KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117

Query: 252 TQRL-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           +Q+L   A   + G+Q+L  ++   IH D+ + N+L+  ++   I DFGL+      +  
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLS------RGE 169

Query: 311 HITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHL 367
            + +K+  G  P  ++  E L     +TK DV+ FG++L+E+ + G   Y     +E + 
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229

Query: 368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           K L + Y  E   +  D+             + + +Q  +  P ERP   Q+   LS
Sbjct: 230 K-LPQGYRMEKPRNCDDE------------VYELMRQCWRDRPYERPPFAQISVQLS 273

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 32/217 (14%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++K+  +G+G +G VYK     T  TIA+KK+ + + D  V +        ++RE+  L 
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPS-------TAIREISLLK 56

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL- 263
             +H NI+ L  +     +  LV+ Y+      D  L K    S  + +   + K T L 
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIK-TYLY 109

Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEG--PIEKATHITLKR 316
               G+ + HS    ++H D+K  N+L++   + + + DFGL +    P+   TH  +  
Sbjct: 110 QILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-- 165

Query: 317 VNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELAT 352
              T  Y   E L+G R  ST VD++  G +  E+  
Sbjct: 166 ---TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           + KG +G V+    + T    A+K +      +  + + + Q +Q L E   L+  +   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVI------KKADMIRKNQVDQVLTERDILSQAQSPY 54

Query: 211 ILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           ++ LY   F+  K   LV  Y+P G L   LL    +       R++IA+   L L++LH
Sbjct: 55  VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVA-RIYIAE-IVLALEYLH 110

Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL-----KRVNGTRPYL 324
           S    +IH D+K  NIL++ +    + DFGL++ G + +  ++       KR+ GT  Y+
Sbjct: 111 SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
             E ++G+  S  VD +  G +L+E   G+
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGI 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 22/217 (10%)

Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V +G  +     +  +A+K L+    ++        QR   L E   +   
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK--------QRRDFLSEASIMGQF 62

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+  ++    ++  +M NG+L+    +++N       Q + + +G + G++
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEKATHITLKRVNGTRPY 323
           +L   E   +H D+ + NIL+N ++   + DFGL+   ++   +     +L      R  
Sbjct: 121 YL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDD 359
            P E +  ++ ++  DV+ +GIV++E ++ G R Y D
Sbjct: 179 AP-EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 68/237 (28%), Positives = 96/237 (40%), Gaps = 27/237 (11%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQ-SLRELKYLNSCRH 208
           LGKGGFG V      K T    A KKL+  R       L + + EQ +L E K L     
Sbjct: 1   LGKGGFGEVC-ACQVKATGKMYACKKLDKKR-------LKKRKGEQMALNEKKILEKVSS 52

Query: 209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             I+ L    FET    CLV   M  G L+  +      P     + +  A     GL+ 
Sbjct: 53  RFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHI-YNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH R   +++ D+K  N+LL+ H +  I D GL  E    K       R  GT  Y+  E
Sbjct: 111 LHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRA-GTPGYMAPE 164

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATG---MRAYD---DTRRSERHLKSLVEKYSEEN 378
            L G+     VD +  G  L+E+  G    R      +    +R    +  +Y ++ 
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 26/222 (11%)

Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V  G W  +  +A+K ++                ++ + E K +    H+ +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE----------GSMSEDEFIEEAKVMMKLSHEKL 61

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLED--RLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           + LYG+C +     +V  YM NG L +  R   K+  PS    Q L + K    G+ +L 
Sbjct: 62  VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLE 117

Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHE 327
           S++   IH D+ + N L++      + DFGL++    ++ T      V    P  + P E
Sbjct: 118 SKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPE 171

Query: 328 FLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLK 368
            L+  + S+K DV+ FG++++E+ + G   Y+    SE   K
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           N ++ L ++G+G +G V K   ++T   +A+KK +    +  V       +E +LRELK 
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV-------KETTLRELKM 53

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L + + +NI+ L       GK  LV+ Y+    LE  LL +          R +I +   
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIK 111

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
             + + H  +  ++H DIK  N+L++H+    + DFG  +   + + ++        TR 
Sbjct: 112 -AIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARN--LSEGSNANYTEYVATRW 166

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           Y   E L+G      VD++  G +L EL+ G
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 40/228 (17%)

Query: 153 LGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           LG G FG+V KGV+     ++  +AVK L   +            +++ LRE   +    
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--KQEH------IAAGKKEFLREASVMAQLD 54

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLG 264
           H  I+ L G+C       LV    P G L   L  ++  P             A   ++G
Sbjct: 55  HPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMG 107

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-GPIE---KATHITLKRVNGT 320
           + +L S+    +H D+ + N+LL +     I DFG+++  G      +AT        G 
Sbjct: 108 MAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT------AGR 159

Query: 321 RP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE 364
            P   Y P     GK  S+K DV+ +G+ L+E  + G + Y + + +E
Sbjct: 160 WPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 31/221 (14%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           +D +  +G+G +G VYK   +K T  +  L+  R D   E         ++RE+K L   
Sbjct: 9   FDIIGQIGEGTYGQVYKAR-DKDTGELVALKKVRLDNEKEGFPI----TAIREIKILRQL 63

Query: 207 RHDNILPLYGICF----------ETGKYCLVYRYMPN---GSLEDRLL-MKKNTPSLLWT 252
            H NI+ L  I            + G + LV+ YM +   G LE  L+   ++       
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           Q L        GL + H +    +H DIK +NILLN+     + DFGL +    E++   
Sbjct: 124 QLLE-------GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 313 TLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
           T K +  T  Y P E L+G +R    +DV+  G +L EL T
Sbjct: 175 TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 54/292 (18%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR----ELKYLNSC 206
           +++G+G FG V K   +K  + +        D A++ + +   +   R    EL+ L  C
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRM--------DAAIKRMKEYASKDDHRDFAGELEVL--C 50

Query: 207 R---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK------------NTPSLLW 251
           +   H NI+ L G C   G   L   Y P+G+L D L   +            +T S L 
Sbjct: 51  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110

Query: 252 T-QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           + Q LH A   + G+ +L  ++   IH D+ + NIL+  +    I DFGL+      +  
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS------RGQ 162

Query: 311 HITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHL 367
            + +K+  G  P  ++  E L     +T  DV+ +G++L+E+ + G   Y     +E + 
Sbjct: 163 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222

Query: 368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           K L + Y  E   +  D+             + + +Q  ++ P ERP   Q+
Sbjct: 223 K-LPQGYRLEKPLNCDDE------------VYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 31/214 (14%)

Query: 150 LNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAV--ETLNQCQREQSLRELKYLNS 205
           L  +G+G +GTVYK   +     +A+KK+ V  ++  +   TL    RE +L  LK L S
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----REIAL--LKQLES 57

Query: 206 CRHDNILPLYGIC-----FETGKYCLVYRYMPNGSLEDRLL---MKKNTPSLLWTQRL-H 256
             H NI+ L  +C         K  LV+ ++      D+ L   + K     L  + +  
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHV------DQDLATYLSKCPKPGLPPETIKD 111

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           + +    G+ FLHS    ++H D+K  NIL+       I DFGL +    E A    L  
Sbjct: 112 LMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LTS 165

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           V  T  Y   E L+    +T VD++  G +  EL
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 68/236 (28%), Positives = 115/236 (48%), Gaps = 31/236 (13%)

Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLN 204
           ++ +LG G FGTVYKG+W      V + E  +   A++ LN+    ++    + E   + 
Sbjct: 11  RVKVLGSGAFGTVYKGIW------VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQRLHIAKGTS 262
           S  H +++ L G+C  +    LV + MP+G L D +   K+     LL    + IAK   
Sbjct: 65  SMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK--- 120

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGT 320
            G+ +L  R   L+H D+ + N+L+       I DFGL +  EG  EK  +       G 
Sbjct: 121 -GMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD-EKEYNAD----GGK 172

Query: 321 RP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK 373
            P  ++  E +  ++ + + DV+ +G+ ++EL T G + YD      R +  L+EK
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 49/239 (20%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + KL+ LG+G + TVYKG  + T   +A+K++ +   + A  T        ++RE   L 
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFT--------AIREASLLK 58

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYM-----------PNGSLEDRLLMKKNTPSLLWTQ 253
             +H NI+ L+ I        LV+ Y+             G       +  +   L   Q
Sbjct: 59  DLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-------LSMHNVRLFLFQ 111

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH-- 311
            L        GL + H R   ++H D+K  N+L++   +  + DFGL +   +   T+  
Sbjct: 112 LLR-------GLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162

Query: 312 --ITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL 367
             +TL        Y P + L+G    ST +D++G G + +E+ATG   +  +   E  L
Sbjct: 163 EVVTLW-------YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL-RELKYLN 204
           N+ +L  LG+G + TVYKG    T   V   E+H  D    T +   RE SL +ELK   
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIREISLMKELK--- 56

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNG------SLEDRLLMKKNTPSLLWTQRLHIA 258
              H+NI+ L+ +     K  LV+ YM         +   R  +  NT      Q L   
Sbjct: 57  ---HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK-- 111

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH----ITL 314
                G+ F H  E  ++H D+K  N+L+N   +  + DFGL +   I   T     +TL
Sbjct: 112 -----GIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTL 164

Query: 315 KRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
                   Y   + L+G R  ST +D++  G ++ E+ TG
Sbjct: 165 W-------YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 22/218 (10%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++ L  +GKG FGTV K V  K+   I V K E+         + + +++Q + E+  L 
Sbjct: 2   YEVLETIGKGSFGTVRK-VRRKSDGKILVWK-EID-----YGNMTEKEKQQLVSEVNILR 54

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMP---NGSLEDRLLMK--KNTPSLLWTQRLHIAK 259
             +H NI+  Y    +      +Y  M     G L  +L+ K  K    +       I  
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQ-TLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILT 112

Query: 260 GTSLGLQFLHSREPP---LIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
              L L   H+R  P   ++H D+K ANI L+ + +  +GDFGL +   +   +      
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTY 170

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           V GT  Y+  E L       K D++  G +++EL    
Sbjct: 171 V-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 67/273 (24%), Positives = 119/273 (43%), Gaps = 30/273 (10%)

Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +  +T +AVK L+      +V+          L E   + + +HD +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQAF--------LEEANLMKTLQHDKL 63

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  +     ++  YM  GSL D  L       +L  + +  +   + G+ ++  +
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLD-FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++AN+L++  +   I DFGL +   IE   +   +       +   E +  
Sbjct: 123 N--YIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINF 178

Query: 332 KRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPI 390
              + K DV+ FGI+L+E+ T G   Y     S+  + +L   Y    M +       P 
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-MSALQRGYRMPRMENC------PD 231

Query: 391 ELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           EL      + I K   K+  +ERP    + ++L
Sbjct: 232 EL------YDIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 67/243 (27%), Positives = 103/243 (42%), Gaps = 32/243 (13%)

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRLLMKKNTPSLL 250
           QR  +  E   L +  H +I+ L G        CL+  RY  +  L   L  K+N     
Sbjct: 126 QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAI-- 181

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               L I +     +Q+LH  E  +IH DIK+ NI +NH  D  +GDFG     P++   
Sbjct: 182 -CDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVD--- 234

Query: 311 HITLKRV---NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA------YDDTR 361
            I   +     GT      E L        VD++  GIVLFE+AT   +       D   
Sbjct: 235 -INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293

Query: 362 RSERHLKSLVEKYSEENMYDLVDKNAQPI--ELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            S+R +K ++ +            N  PI  + N+   +  + K+S+++ P  RP  T +
Sbjct: 294 DSDRQIKLIIRRSG-------THPNEFPIDAQANLDEIYIGLAKKSSRK-PGSRPLWTNL 345

Query: 420 YNM 422
           Y +
Sbjct: 346 YEL 348

Length = 391

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 37/229 (16%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLE----VHRNDRAVETLNQCQREQSL 197
            +++ + ++  G +G VY  V  K T    A+KK+     + RN          Q +Q  
Sbjct: 1   EDFETIKLISNGAYGAVYL-VRHKETRQRFAMKKINKQNLILRN----------QIQQVF 49

Query: 198 RELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            E   L    +  ++ ++   FET ++ C+V  Y+  G      L+K      +   R++
Sbjct: 50  VERDILTFAENPFVVSMFC-SFETKRHLCMVMEYVEGGDCAT--LLKNIGALPVDMARMY 106

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-----------EGP 305
            A+ T L L++LH+    ++H D+K  N+L+       + DFGL++           EG 
Sbjct: 107 FAE-TVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163

Query: 306 IEKATHITL-KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           IEK T   L K+V GT  Y+  E ++ +     VD +  GI+L+E   G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 62/292 (21%), Positives = 117/292 (40%), Gaps = 36/292 (12%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL----RELK 201
           N  ++  LG+G FG V+    +       +  V      V+ L + + E       REL 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLV-----LVKALQKTKDENLQSEFRRELD 60

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK------NTPSLLWTQRL 255
                 H N++ L G+C E   + ++  Y   G L+  L   K        P L   Q++
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
            +    +LG+  L +     +H D+ + N L++   +  +    L+++       +   K
Sbjct: 121 ALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYY---K 174

Query: 316 RVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
             N   P  +L  E +     STK DV+ FG++++E+ T         + E     L + 
Sbjct: 175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSD- 224

Query: 374 YSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
             EE +  L     + P+        +++  +    NPK+RP  +++ + L 
Sbjct: 225 --EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             ++ L ++G+G +G V K   ++T   +A+KK     +D+ V       ++ ++RE++ 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV-------KKIAMREIRM 53

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L   RH+N++ L  +     +  LV+ ++ +  L+D     +  P+ L   R+       
Sbjct: 54  LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQI 109

Query: 263 L-GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATHITLKRVNG 319
           L G++F HS    +IH DIK  NIL++      + DFG   T   P E  T         
Sbjct: 110 LRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----A 162

Query: 320 TRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATG 353
           TR Y   E LVG  +    VD++  G ++ E+ TG
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRE---LKYLNS 205
           LG+G FG VY+G+ +       +  V     A++T+N+     +R + L E   +K  N 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRV-----AIKTVNENASMRERIEFLNEASVMKEFN- 67

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK------NTPSLLWTQRLH--- 256
           C H  ++ L G+        +V   M  G L+  L  ++              Q+     
Sbjct: 68  CHH--VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125

Query: 257 --IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
             IA G +    +L +++   +H D+ + N ++   +   IGDFG+T++           
Sbjct: 126 AEIADGMA----YLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           K +   R ++  E L     +TK DV+ FG+VL+E+AT
Sbjct: 180 KGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 44/225 (19%)

Query: 153 LGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLREL---KYLNSCR 207
           +G+G FGTV K + +   T +AVK++          T+++ ++++ L +L      + C 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRS--------TVDEKEQKRLLMDLDVVMRSSDC- 62

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM------KKNTPSLLWTQRLHIAKGT 261
              I+  YG  F  G  C +   + + SL D+         K   P  +      IA  T
Sbjct: 63  -PYIVKFYGALFREGD-CWICMELMDISL-DKFYKYVYEVLKSVIPEEILG---KIAVAT 116

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              L +L   E  +IH D+K +NILL+ + +  + DFG++  G +  +  I   R  G R
Sbjct: 117 VKALNYL-KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDS--IAKTRDAGCR 171

Query: 322 PYLPHEFLVGKRLST--------KVDVYGFGIVLFELATGMRAYD 358
           PY+  E     R+          + DV+  GI L+E+ATG   Y 
Sbjct: 172 PYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 9/209 (4%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           NW    +LG+G FG VY      T   +   +V  +  + ET  +    +   E++ L +
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKN 60

Query: 206 CRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
             H+ I+  YG   +  +  L     +MP GS++D+L   K+  +L         +    
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILE 117

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +LHS    ++H DIK ANIL +   +  +GDFG ++       +   +K V GT  +
Sbjct: 118 GVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           +  E + G+    K D++  G  + E+ T
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 64/249 (25%), Positives = 98/249 (39%), Gaps = 61/249 (24%)

Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
            T  ++ + ++G+G +G VYK   +KT   +A+K +++   D   E       ++    L
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEI------KEEYNIL 56

Query: 201 KYLNSCRHDNILPLYGICFETGKYC------LVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           +      H NI   YG   +           LV      GS+ D  L+K         +R
Sbjct: 57  RKY--SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD--LVKG---LRKKGKR 109

Query: 255 L---HIA---KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
           L    IA   + T  GL +LH  +  +IH DIK  NILL  + +  + DFG++ +     
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQ----- 162

Query: 309 ATHITLKRVNGTR------PY--LPHEFLVGKRLST----KVDVYGFGIVLFELATG--- 353
                L    G R      PY   P      ++       + DV+  GI   ELA G   
Sbjct: 163 -----LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Query: 354 ------MRA 356
                 MRA
Sbjct: 218 LCDMHPMRA 226

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 50/231 (21%)

Query: 152 ILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            LG+G FG V K          E +T+AVK L+    ++ +  L        + E++ + 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL--------VSEMEMMK 70

Query: 205 SC-RHDNILPLYGICFETGKYCLVYRYMPNGSLED-----RLLMKKNTPSLLWTQRLHIA 258
              +H NI+ L G+C + G   +V  Y  +G+L D     R   +  +P      R    
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP---RPPEE 127

Query: 259 KGTSL-----------GLQFLHSREPPLIHGDIKSANILL--NHHMDPVIGDFGLTQEGP 305
             T             G++FL S++   IH D+ + N+L+  +H M   I DFGL ++  
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMK--IADFGLARD-- 181

Query: 306 IEKATHITL--KRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
                HI    K  NG  P   +  E L  +  + + DV+ FG++L+E+ T
Sbjct: 182 ---IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 29/279 (10%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQRE--QSLR-EL 200
            W K  ++GKG +G VY  +   T   +AVK++E+          +  Q++  ++LR E+
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVEL--PATIAGRHDSRQKDMVKALRSEI 59

Query: 201 KYLNSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLM-KKNTPSLLWTQRLHI 257
           + L    H NI+   G  FET +    +   Y+P GS+   L    +    L+       
Sbjct: 60  ETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV----RFF 113

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +    GL +LHS+   ++H D+K+ N+L++      I DFG++++          +  +
Sbjct: 114 TEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-M 170

Query: 318 NGTRPYLPHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
            G+  ++  E +       S KVD++  G V+ E+  G R + D        K   ++ +
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230

Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
                D+   N  P+ L+   A F I       NP  RP
Sbjct: 231 PPIPPDVS-MNLSPVALDFLNACFTI-------NPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 150 LNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  + KG FG+VY  K        A+K L+  ++D  +   NQ    ++ R +  +    
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLK--KSD--MIAKNQVTNVKAERAI-MMIQGE 55

Query: 208 HDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTP-SLLWTQRLHIAKGTSLGL 265
              +  LY   F++  Y  LV  Y+  G      L+K        W  + +IA+   LG+
Sbjct: 56  SPYVAKLY-YSFQSKDYLYLVMEYLNGGDCAS--LIKTLGGLPEDWA-KQYIAE-VVLGV 110

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           + LH R   +IH DIK  N+L++      + DFGL++ G   K       +  GT  YL 
Sbjct: 111 EDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-------KFVGTPDYLA 161

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
            E ++G       D +  G V+FE   G   + 
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 27/234 (11%)

Query: 149 KLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK----Y 202
           KL +LG G FGTV+KG+W  E  +I   K+ V     A++T+      Q+ +E+      
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSI---KIPV-----AIKTIQDRSGRQTFQEITDHMLA 62

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQRLHIAKG 260
           + S  H  I+ L GIC       LV +  P GSL D +   +++  P  L    + IAKG
Sbjct: 63  MGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
                   +  E  ++H ++ + NILL       I DFG+      +   +         
Sbjct: 122 ------MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF-YSEHKTP 174

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK 373
             ++  E ++  R + + DV+ +G+ ++E+ + G   Y   R  E  +  L+EK
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 51/240 (21%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +D + ++GKGG G VY       +  +A+KK+   R D +    N   +++ LRE K   
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI---REDLSE---NPLLKKRFLREAKIAA 57

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMP--NGSLEDRLLMKKNTPSLLWTQRL---HIAK 259
              H  I+P+Y IC +      VY  MP   G     LL  K+     W +      +A+
Sbjct: 58  DLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLL--KSV----WQKESLSKELAE 108

Query: 260 GTSLG------------LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
            TS+G            ++++HS+   ++H D+K  NILL    + VI D+G      +E
Sbjct: 109 KTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166

Query: 308 KATHITLK---------------RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           +   + +                ++ GT  Y+  E L+G   S   D+Y  G++L+++ T
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 21/207 (10%)

Query: 152 ILGKGGFGTV----YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           +LGKG FG V     KG  E   + V K +V   D  VE       E+ +  L    + +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT---MTEKRVLAL----AGK 54

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  +  L+  CF+T  +   V  Y+  G L   +            +    A    LGLQ
Sbjct: 55  HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE---PRARFYAAEIVLGLQ 110

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           FLH R   +I+ D+K  N+LL+      I DFG+ +EG +   T  T     GT  Y+  
Sbjct: 111 FLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF---CGTPDYIAP 165

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E L  +     VD +  G++L+E+  G
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAG 192

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)

Query: 153 LGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G FG V+ G    + T +AVK           ETL    + + L+E + L    H N
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR--------ETLPPDLKAKFLQEARILKQYSHPN 54

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+ L G+C +     +V   +  G       ++   P L   + + + +  + G+++L S
Sbjct: 55  IVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYLES 112

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATHITLKRVNGTRPYLPHE 327
           +    IH D+ + N L+       I DFG+++E   G       +    V  T P    E
Sbjct: 113 KH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP----E 166

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
            L   R S++ DV+ FGI+L+E A  + A      S +  +  +E+              
Sbjct: 167 ALNYGRYSSESDVWSFGILLWE-AFSLGAVPYANLSNQQTREAIEQGVR----------- 214

Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            P       A +R+ ++  + +P +RP  + V+  L
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSC 206
           N LG G FG VY+G      +      +     AV+TL +   +Q     L+E   +++ 
Sbjct: 1   NFLGSGAFGEVYEGT-ATDILGPGSGPIRV---AVKTLRKGATDQEKKEFLKEAHLMSNF 56

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGS----LEDRLLMKKNTPSLLWTQRLHIAKGTS 262
            H NI+ L G+C       ++   M  G     L D  + +   P L   + L I    +
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPV-----IGDFGLTQEGPIEKATHITLKRV 317
            G  +L       IH D+ + N L++           IGDFGL ++  I K+ +   K  
Sbjct: 117 KGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD--IYKSDYYR-KEG 171

Query: 318 NGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            G  P  ++  E L+  + +T+ DV+ FG++++E+ T
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 63.3 bits (155), Expect = 3e-11
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++++ +  LG G FG V   V  K +    A+K L         + +   Q E  L E +
Sbjct: 1   DDFEFIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKA------KIVKLKQVEHVLNEKR 53

Query: 202 YLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
            L S RH  ++ LYG  F+      LV  Y+P G L    L K          R + A+ 
Sbjct: 54  ILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVA-RFYAAQV 110

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
             L L++LHS +  +++ D+K  N+LL+      I DFG  +   ++  T+ TL    GT
Sbjct: 111 V-LALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTY-TL---CGT 161

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             YL  E ++ K     VD +  GI+++E+  G
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 71/296 (23%), Positives = 114/296 (38%), Gaps = 45/296 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEK----TTIAVKKLEVHR-NDRAVETLNQCQREQSLREL 200
            +  L  LG G FG VYK V +K      +A+K++ VH       +          + E+
Sbjct: 1   EYAVLEHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59

Query: 201 KYL-NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-----TPSLLWTQR 254
             +    RH NI+  Y    E  +  +V   +    L +     K      T   +W   
Sbjct: 60  TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT-QEGPIEKATHIT 313
           + +     L L++LH +E  ++H D+   NI+L       I DFGL  Q+ P  K     
Sbjct: 120 VQMV----LALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----- 169

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
           L  V GT  Y   E +  +    K DV+ FG +L+++ T                 L   
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-----------------LQPP 212

Query: 374 YSEENMYDL----VDKNAQPIELNIAYAFFRIGKQST-KQNPKERPEMTQVYNMLS 424
           +   NM  L    V+   +P+   +          S    + + RP++ QV  M+S
Sbjct: 213 FYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 70/252 (27%), Positives = 114/252 (45%), Gaps = 40/252 (15%)

Query: 153 LGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG+++    + T+AVK L+   ND A+       +++ LRE   +    +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPAL-------KDELLREANVMQQLDN 55

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   K+      T+ +H     S+G+++L
Sbjct: 56  PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVH---QVSMGMKYL 111

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-----EGPIEKATHITLKRVNGTRP- 322
              E   +H D+ + N+LL       I DFGL++     E   +  TH       G  P 
Sbjct: 112 --EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH-------GKWPV 162

Query: 323 --YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEK 373
             Y P E +   + S+K DV+ FG++++E  +       GM+  + T+  E   +    +
Sbjct: 163 KWYAP-ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ 221

Query: 374 YSEENMYDLVDK 385
                MYDL+  
Sbjct: 222 RCPPEMYDLMKL 233

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG GGFG V   K   +  T A+K +      R +    Q  +E    E + L  C H  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQ--QEHIFSEKEILEECNHPF 54

Query: 211 ILPLYGICFETGKYCLVY---RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           I+ LY   F+  KY  +Y    Y   G L   L  +       +T R +IA    L  ++
Sbjct: 55  IVKLYR-TFKDKKY--IYMLMEYCLGGELWTILRDRGLFDE--YTARFYIA-CVVLAFEY 108

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN------GTR 321
           LH+R   +I+ D+K  N+LL+ +    + DFG  ++          LK         GT 
Sbjct: 109 LHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKK----------LKSGQKTWTFCGTP 156

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
            Y+  E ++ K     VD +  GI+L+EL TG 
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 37/223 (16%)

Query: 146 NWDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            +  L+ +G+G +G V           +A+KK+         E    CQR  +LRE+K L
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS------PFEHQTFCQR--TLREIKIL 57

Query: 204 NSCRHDNILPLYGI----CFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-- 255
              +H+NI+ +  I     FE+    Y +V   M         L K     L+ TQ L  
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVY-IVQELMETD------LYK-----LIKTQHLSN 105

Query: 256 -HIAK---GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            HI         GL+++HS    ++H D+K +N+LLN + D  I DFGL +    E    
Sbjct: 106 DHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163

Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             L     TR Y  P   L  K  +  +D++  G +L E+ + 
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 37/234 (15%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYLNSC-RHDN 210
           LG+G F  +YKGV    +              ++ L    R+  +  E   L S   H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ LYG+C       +V  Y+  G L+  L  +KN  SL W  +L +AK  +  L +L  
Sbjct: 63  LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 271 REPPLIHGDIKSANILLNHH------------MDPVIGDFGLTQEGPIEKATHITLKRVN 318
           ++  L+HG++   NIL+  +             DP I    L++E  +E+          
Sbjct: 120 KK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------- 168

Query: 319 GTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATG----MRAYDDTRRSERH 366
              P++  E +      L+   D + FG  L E+ +     +     + +   +
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY 219

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK   ++T +           + ++T ++ + E  + E+  L SC
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAA-------KVIDTKSEEELEDYMVEIDILASC 59

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L    +      ++  +   G++ D ++++   P L   Q   + K T   L 
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERP-LTEPQIRVVCKQTLEALN 117

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG-------------PIEKATHIT 313
           +LH  E  +IH D+K+ NIL     D  + DFG++ +              P   A  + 
Sbjct: 118 YLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
           +   +  RPY             K DV+  GI L E+A
Sbjct: 176 MCETSKDRPY-----------DYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 39/274 (14%)

Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYKGV---WEKT----TIAVKKLEVHRNDRAV 185
            +PY        NN      LG G FG V +       K+     +AVK L+        
Sbjct: 23  QLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-------- 74

Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK 244
            T +  +RE  + ELK ++    H+NI+ L G C   G   ++  Y   G L + L  K+
Sbjct: 75  PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR 134

Query: 245 NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG 304
            +   L    L  +   + G+ FL S+    IH D+ + N+LL H     I DFGL ++ 
Sbjct: 135 ESFLTLE-DLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARD- 190

Query: 305 PIEKATHITLKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELAT-GMRAYD 358
            I   ++  +K     R  LP +++  + +     + + DV+ +GI+L+E+ + G   Y 
Sbjct: 191 -IMNDSNYVVK--GNAR--LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245

Query: 359 DTRRSERHLKSLVEKY-------SEENMYDLVDK 385
                 +  K + E Y       +   +YD++  
Sbjct: 246 GMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKT 279

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 69/281 (24%), Positives = 119/281 (42%), Gaps = 47/281 (16%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS--LRELKYLNSCRHDN 210
           LG G FG V+ G +   T             A+++L Q        L E   +   +H  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKV-----------AIKSLKQGSMSPEAFLAEANLMKQLQHPR 62

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQF 267
           ++ LY +  +   Y ++  YM NGSL D L     TP    L   + + +A   + G+ F
Sbjct: 63  LVRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-----VNGTRP 322
           +  +    IH D+++ANIL++  +   I DFGL +   + +    T +      +  T P
Sbjct: 118 IERKN--YIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAP 172

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
               E +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +
Sbjct: 173 ----EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL------ERGYRM 222

Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +  P EL      + + +   K+ P+ERP    + ++L
Sbjct: 223 PRPDNCPEEL------YELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 24/219 (10%)

Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           + L+ LGKG +G+VYK +   T  T+A+K++ +         L++ +  Q + EL  L+ 
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--------ELDESKFNQIIMELDILHK 55

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
                I+  YG  F  G   +   YM  GSL+        T  +       I      GL
Sbjct: 56  AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL 115

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN-GTRPYL 324
           +FL   E  +IH D+K  N+L+N +    + DFG++  G +      +L + N G + Y+
Sbjct: 116 KFL-KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVA----SLAKTNIGCQSYM 168

Query: 325 PHEFLVGKRL------STKVDVYGFGIVLFELATGMRAY 357
             E +           + + DV+  G+ + E+A G   Y
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 60/271 (22%), Positives = 117/271 (43%), Gaps = 43/271 (15%)

Query: 171 IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY 230
           +AVK L    +D A        RE  L+E+K L+     NI  L G+C      C++  Y
Sbjct: 49  VAVKVLRPDASDNA--------REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEY 100

Query: 231 MPNGSL----------EDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI 280
           M NG L             L     + S  ++  L++A   + G+++L S     +H D+
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLS--FSTLLYMATQIASGMRYLESLN--FVHRDL 156

Query: 281 KSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP-----HEFLVGKRLS 335
            + N L+  +    I DFG+++             RV G R  LP      E ++  + +
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSRN-----LYSSDYYRVQG-RAPLPIRWMAWESVLLGKFT 210

Query: 336 TKVDVYGFGIVLFELATGMRA--YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ-PIEL 392
           TK DV+ FG+ L+E+ T  R   Y+     ++ +++    + ++     + +    P ++
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQPYEHL-TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDI 269

Query: 393 NIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                 + +  +  +++ ++RP   +++  L
Sbjct: 270 ------YELMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 28/205 (13%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           N++ +G  G  YKG   K  +     E++  +    +           E+  +   +H N
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----------EIADMGKLQHPN 744

Query: 211 ILPLYGIC-FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           I+ L G+C  E G Y L++ Y+   +L + L       +L W +R  IA G +  L+FLH
Sbjct: 745 IVKLIGLCRSEKGAY-LIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLH 797

Query: 270 SR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
            R  P ++ G++    I+++   +P +    L      +    I+         Y+  E 
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFIS-------SAYVAPET 849

Query: 329 LVGKRLSTKVDVYGFGIVLFELATG 353
              K ++ K D+YGFG++L EL TG
Sbjct: 850 RETKDITEKSDIYGFGLILIELLTG 874

Length = 968

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 24/220 (10%)

Query: 153 LGKGGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FG V KGV+    ++  +A+K L+   N+++V       R++ +RE + ++   +
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSV-------RDEMMREAEIMHQLDN 54

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + G+C E     LV      G L   L  KK+  ++  +  + +    S+G+++L
Sbjct: 55  PYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYL 111

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
             +    +H D+ + N+LL +     I DFGL++    + + +    R  G  P   Y P
Sbjct: 112 EGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA--RSAGKWPLKWYAP 167

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSE 364
            E +  ++ S++ DV+ +GI ++E  + G + Y   +  E
Sbjct: 168 -ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 38/217 (17%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKL-EVHRNDRAVETLNQCQREQSLRELKYLNSCR-H 208
           LGKG +G V+K +  +T   +A+KK+ +  RN          QR  + RE+ +L     H
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA------TDAQR--TFREIMFLQELGDH 66

Query: 209 DNILPLYG-ICFETGK--YCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLH---IAKG 260
            NI+ L   I  E  K  Y LV+ YM     E  L  +++ N   +L  + +H   I   
Sbjct: 67  PNIVKLLNVIKAENDKDIY-LVFEYM-----ETDLHAVIRAN---IL--EDVHKRYIMYQ 115

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEKATHITLKRV 317
               L+++HS    +IH D+K +NILLN      + DFGL     E        +    V
Sbjct: 116 LLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
             TR Y   E L+G    TK VD++  G +L E+  G
Sbjct: 174 -ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 33/224 (14%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKK---LEVHRNDR---AVETL----NQCQREQSLRELKY 202
           LG+G FG V+    E     + K   L+V  N     AV+ L    N+  R   L+E+K 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--------LMKKNTPSLLWTQR 254
           ++  +  NI+ L  +C  +   C++  YM NG L   L          K +  ++ ++  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+++L S     +H D+ + N L+  +    I DFG+++   +    +   
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRN--LYSGDYY-- 186

Query: 315 KRVNGTRPYLP------HEFLVGKRLSTKVDVYGFGIVLFELAT 352
            R+ G R  LP         L+GK  +T  DV+ FG+ L+E+ T
Sbjct: 187 -RIQG-RAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 152 ILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           +LGKG FG V+    KG  +   I   K +V   D  VE     +R  SL       +  
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-------AWE 54

Query: 208 HDNILPLYGICFETGKYCL-VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  +  LY   F+T +    V  Y+  G L   +   ++       +    A     GLQ
Sbjct: 55  HPFLTHLY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQ 110

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           FLHS+   +++ D+K  NILL+      I DFG+ +E  +  A   T     GT  Y+  
Sbjct: 111 FLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF---CGTPDYIAP 165

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           E L+G++ +T VD + FG++L+E+  G   +
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 39/277 (14%)

Query: 150 LNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L ++G+G FG   + + V      A+K++ + ++  AVE         S +E   L   +
Sbjct: 5   LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVED--------SRKEAVLLAKMK 56

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H NI+  +   FE  G   +V  Y   G L  ++ +++     L+ +   +     + L 
Sbjct: 57  HPNIVA-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK---LFPEDTILQWFVQMCLG 112

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKA-THITLKRVNGTRPY 323
             H  E  ++H DIKS NI L  +    +GDFG  +    P   A T++      GT  Y
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV------GTPYY 166

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           +P E       + K D++  G +L+EL T              LK   +  S +N+   V
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCT--------------LKHPFQANSWKNLILKV 212

Query: 384 DKNA-QPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            + + +P+  + +Y    + KQ  K+NP+ RP  T +
Sbjct: 213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 37/283 (13%)

Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ILG G FG + +G  +     +  +A+  L    +D+        QR   L E   L   
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--------QRRGFLAEALTLGQF 63

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+        +V  YM NG+L+    ++K+   L+  Q + +  G + G++
Sbjct: 64  DHSNIVRLEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGMK 121

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL-- 324
           +L   E   +H  + +  +L+N  +   I  F   QE   E A + T+    G  P L  
Sbjct: 122 YL--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE-AIYTTMS---GKSPVLWA 175

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +     S+  DV+ FGIV++E ++ G R Y D    +      V K  E+      
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAVEDGFRLPA 229

Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS 426
            +N   +         ++     ++   ERP  +Q++++LS  
Sbjct: 230 PRNCPNL-------LHQLMLDCWQKERGERPRFSQIHSILSKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 69/273 (25%), Positives = 114/273 (41%), Gaps = 43/273 (15%)

Query: 153 LGKGGFGTVYKG----VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +G G +G VYK       E   I V KLE   +   V+           +E+  +  C+H
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-----------QEIIMMKDCKH 65

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            NI+  +G      K  +   +   GSL+D   +   T  L  +Q  ++++ T  GL +L
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQD---IYHVTGPLSESQIAYVSRETLQGLYYL 122

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+    +H DIK ANILL  +    + DFG++ +     AT    K   GT  ++  E 
Sbjct: 123 HSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQ---ITATIAKRKSFIGTPYWMAPEV 177

Query: 329 LVGKR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK 385
              +R    +   D++  GI   ELA                  + + +    ++ +   
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELA-------------ELQPPMFDLHPMRALFLMTKS 224

Query: 386 NAQPIEL----NIAYAFFRIGKQSTKQNPKERP 414
           N QP +L      + +F    K +  +NPK+RP
Sbjct: 225 NFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 41/213 (19%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G G FG VY     +T   +A+KK+  +   ++ E          ++E+++L   RH N
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS-YSGKQSNEKWQDI-----IKEVRFLQQLRHPN 76

Query: 211 ILPLYG------ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA---KGT 261
            +   G        +   +YCL       GS  D L + K        Q + IA    G 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCL-------GSASDILEVHKKP-----LQEVEIAAICHGA 124

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +LHS E   IH DIK+ NILL       + DFG      +  A         GT 
Sbjct: 125 LQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFG--SASLVSPANSFV-----GTP 175

Query: 322 PYLPHEFLVGK---RLSTKVDVYGFGIVLFELA 351
            ++  E ++     +   KVDV+  GI   ELA
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 13/169 (7%)

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
           Q+  +L E   L +  H +++ +          C+V   +P+ S +    + K +  L  
Sbjct: 100 QKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI 156

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            Q L I K    GL++LH++   +IH D+K+ NI +N      IGD G  Q  P+     
Sbjct: 157 DQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAF 213

Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
           + L    GT      E L   + ++K D++  GIVLFE    M AY  T
Sbjct: 214 LGLA---GTVETNAPEVLARDKYNSKADIWSAGIVLFE----MLAYPST 255

Length = 357

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +LGKG FG V   V EK T     +++ R +  +    + +   ++ E + L + RH  +
Sbjct: 2   LLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIA---KDEVAHTVTESRVLQNTRHPFL 57

Query: 212 LPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ---RLHIAKGTSLGLQF 267
             L    F+T  + C V  Y   G L   L  ++     ++T+   R + A+  S  L++
Sbjct: 58  TAL-KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVS-ALEY 110

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K   GT  YL  E
Sbjct: 111 LHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE 165

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATG 353
            L        VD +G G+V++E+  G
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 7e-10
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 61/229 (26%)

Query: 150 LNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           +  +G G +G V   + +  +   +A+KK+       A +     +R  +LRELK L   
Sbjct: 10  IENIGSGAYGVVCSAI-DTRSGKKVAIKKIP-----HAFDVPTLAKR--TLRELKILRHF 61

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNTPSLLWTQRLH--IAK 259
           +HDNI+ +  I              P G+    +     LM+ +         LH  I  
Sbjct: 62  KHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESD---------LHHIIHS 100

Query: 260 GTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-- 303
              L              GL+++HS    +IH D+K +N+L+N   +  IGDFG+ +   
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158

Query: 304 -GPIEKATHITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             P E    +T + V  TR Y  P   L     +T +D++  G +  E+
Sbjct: 159 SSPTEHKYFMT-EYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 27/196 (13%)

Query: 171 IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY 230
           +AVK L    N  A        R   L+E+K L+  +  NI+ L G+C +    C++  Y
Sbjct: 49  VAVKILRPDANKNA--------RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEY 100

Query: 231 MPNGSLED----RLLMKKNTPS------------LLWTQRLHIAKGTSLGLQFLHSREPP 274
           M NG L        L  K                + ++  LH+A   + G+++L S    
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158

Query: 275 LIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL 334
            +H D+ + N L+  ++   I DFG+++         I  + V   R ++  E ++  + 
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR-WMAWECILMGKF 217

Query: 335 STKVDVYGFGIVLFEL 350
           +T  DV+ FG+ L+E+
Sbjct: 218 TTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 43/281 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKG----VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           ++++ +  +G G +G VYK       E   + + KLE   +   ++           +E+
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ-----------QEI 57

Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             +  C+H NI+  +G      K  +   Y   GSL+D   +   T  L   Q  ++ + 
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD---IYHVTGPLSELQIAYVCRE 114

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
           T  GL +LHS+    +H DIK ANILL  + D  + DFG+  +     AT    K   GT
Sbjct: 115 TLQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAK---ITATIAKRKSFIGT 169

Query: 321 RPYLPHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
             ++  E    ++    +   D++  GI   ELA                  + + +   
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ-------------PPMFDLHPMR 216

Query: 378 NMYDLVDKNAQPIEL----NIAYAFFRIGKQSTKQNPKERP 414
            ++ +   N QP +L      +  F    K S  +NPK+RP
Sbjct: 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 53

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++ +  L+    M  +  S +    L + K    
Sbjct: 54  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASPLSGI---PLPLIKSYLF 107

Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATH--ITLK 315
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +TL 
Sbjct: 108 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 165

Query: 316 RVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELAT 352
                  Y   E L+G +  ST VD++  G +  E+ T
Sbjct: 166 -------YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++KL+ +G+G +G V+K    +T   +A+KK     +D  +       ++ +LRE++ L 
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI-------KKIALREIRMLK 55

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             +H N++ L  +     K  LV+ Y  +  L +   ++KN   +       I   T   
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE---LEKNPRGVPEHLIKKIIWQTLQA 112

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRP 322
           + F H      IH D+K  NIL+       + DFG  +   GP +  T         TR 
Sbjct: 113 VNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-----ATRW 165

Query: 323 YLPHEFLVGK-RLSTKVDVYGFGIVLFELATG 353
           Y   E LVG  +    VDV+  G V  EL TG
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 36/226 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + ++KL  +G+G FG V+K   +KT   +A+KK+ +                 +LRE+K 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT-------ALREIKI 64

Query: 203 LNSCRHDNILPLYGICFET--------GKYCLVYRYMPNGSLED--RLLMKKN---TPSL 249
           L   +H+N++ L  IC           G + LV+ +  +    D   LL  KN   T S 
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH----DLAGLLSNKNVKFTLSE 120

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
           +      +      GL ++H  +  ++H D+K+ANIL+       + DFGL +   + K 
Sbjct: 121 IKKVMKMLLN----GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174

Query: 310 THITL--KRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELAT 352
           +       RV  T  Y P E L+G+R     +D++G G ++ E+ T
Sbjct: 175 SKPNRYTNRV-VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 26/216 (12%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + +   +G+G  GTVY  +   T   +A+K++ + +         Q ++E  + E+  + 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---------QPKKELIINEILVMR 71

Query: 205 SCRHDNI---LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
             +H NI   L  Y +  E     +V  Y+  GSL D +        +   Q   + +  
Sbjct: 72  ENKHPNIVNYLDSYLVGDE---LWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCREC 124

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              L+FLHS +  +IH DIKS NILL       + DFG   +   E++   T+    GT 
Sbjct: 125 LQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTP 179

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            ++  E +  K    KVD++  GI+  E+  G   Y
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 56/293 (19%)

Query: 152 ILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG G  GTV   K V +    AVK +++       E +++  + ++  E+  L +C   
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDM-------EGMSEADKNRAQAEVCCLLNCDFF 91

Query: 210 NILPLYGICFETGKY------------CLVYRYMPNGSL--EDRLLMKKNTP------SL 249
           +I+     C E                 LV  Y   G L  E +   K N         L
Sbjct: 92  SIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
           L+ Q L       L +  +HS+   +IH DIKSANILL  +    +GDFG ++      +
Sbjct: 148 LFIQVL-------LAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS 198

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS 369
             +  +   GT  Y+  E    K  S K D++  G++L+EL T  R +D     E   K+
Sbjct: 199 DDVG-RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257

Query: 370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
           L  +Y              P+  +I+     I       +PK RP  +++ NM
Sbjct: 258 LAGRYD-------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 49/223 (21%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L+ +G G +G V      KT   +A+KKL      R  ++    +R  + REL+ L    
Sbjct: 20  LSPVGSGAYGQVCSAFDTKTGRKVAIKKL-----SRPFQSAIHAKR--TYRELRLLKHMD 72

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRL---HI 257
           H+N++             L+  + P  SLED         LM  +  +++  Q+L   HI
Sbjct: 73  HENVI------------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120

Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS    +IH D+K +NI +N   +  I DFGL +    E   +
Sbjct: 121 ---QFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175

Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           +       TR Y   E ++      + VD++  G ++ EL TG
Sbjct: 176 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G FG V+ G W +  I V          A++ +N+     E  + E K +    H  
Sbjct: 12  LGSGQFGVVHLGKW-RAQIKV----------AIKAINEGAMSEEDFIEEAKVMMKLSHPK 60

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGLQFL 268
           ++ LYG+C +     +V  +M NG L + L  ++   +  +L    L + +    G+++L
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML----LSMCQDVCEGMEYL 116

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
                  IH D+ + N L++      + DFG+T+   +    + +         + P E 
Sbjct: 117 ERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEV 172

Query: 329 LVGKRLSTKVDVYGFGIVLFELAT 352
               + S+K DV+ FG++++E+ T
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 25/222 (11%)

Query: 150 LNILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           L +LGKG FG V     KG  E   I + K +V   D  VE     +R  +L++     +
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64

Query: 206 CRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLHIAKGTS 262
             H         CF+T  +   V  Y+  G L   +  + K   P     Q +  A   S
Sbjct: 65  QLHS--------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEIS 111

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           +GL FLH R   +I+ D+K  N++L+      I DFG+ +E  ++    +T +   GT  
Sbjct: 112 VGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPD 166

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
           Y+  E +  +     VD + +G++L+E+  G   +D     E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 30/215 (13%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
             D    +G+G  G V     + T   +AVKK+++ +  R         RE    E+  +
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---------RELLFNEVVIM 70

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTS 262
              +H NI+ +Y       +  +V  ++  G+L D +   + N       Q   +     
Sbjct: 71  RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----QIATVCLAVL 125

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVN 318
             L FLH++   +IH DIKS +ILL       + DFG    +++E P  K+       + 
Sbjct: 126 KALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-------LV 176

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           GT  ++  E +      T+VD++  GI++ E+  G
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +LGKG FG V   V EK +     +++ + +  +    + +   +L E + L + RH  +
Sbjct: 2   LLGKGTFGKVIL-VREKASGKYYAMKILKKEVIIA---KDEVAHTLTESRVLKNTRHPFL 57

Query: 212 LPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             L    F+T  + C V  Y+  G L      +R+  +  T       R + A+  S  L
Sbjct: 58  TSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-------RFYGAEIVS-AL 108

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +LHS +  +++ D+K  N++L+      I DFGL +EG  + AT   +K   GT  YL 
Sbjct: 109 DYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MKTFCGTPEYLA 163

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG 353
            E L        VD +G G+V++E+  G
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 67/240 (27%), Positives = 102/240 (42%), Gaps = 33/240 (13%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRH 208
           +LGKGGFG V       T    A KKLE  R   R  E +       +L E + L     
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-------ALNEKQILEKVNS 59

Query: 209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             ++ L    +ET    CLV   M  G L+  +    N P     + +  A   + GL+ 
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLED 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI----TLKRVNGTRPY 323
           LH     +++ D+K  NILL+ +    I D GL        A  I    T++   GT  Y
Sbjct: 118 LHRER--IVYRDLKPENILLDDYGHIRISDLGL--------AVEIPEGETIRGRVGTVGY 167

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG---MRAYDDTRRSE---RHLKSLVEKYSEE 377
           +  E +  +R +   D +G G +++E+  G    R   +  + E   R +K   E+YSE+
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQ---SLRELKYLNSCRH 208
           +LGKG FG V   V EK T     +++ + +  +       +++   +L E + L + RH
Sbjct: 2   LLGKGTFGKVIL-VREKATGKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTRH 54

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRLHIAKGTSL 263
             +  L        + C V  Y   G L      +R+  +          R + A+  S 
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAEIVS- 106

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            L +LHS +  +++ D+K  N++L+      I DFGL +EG  + AT   +K   GT  Y
Sbjct: 107 ALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEY 161

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           L  E L        VD +G G+V++E+  G
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 152 ILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
            +G+G FG VY+GV+     EK  +AVK     +N       +   RE+ L+E   +   
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVK---TCKNC-----TSPSVREKFLQEAYIMRQF 64

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H +I+ L G+  E   + +V    P G L  R  ++ N  SL     +  +   S  L 
Sbjct: 65  DHPHIVKLIGVITENPVW-IVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTALA 121

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +L S+    +H DI + N+L++      +GDFGL++   +E  ++    +      ++  
Sbjct: 122 YLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAP 177

Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL 350
           E +  +R ++  DV+ FG+ ++E+
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 19/157 (12%)

Query: 148 DKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           +++N +G G  GTVYK +   T    A+K +  +  D  V       R Q  RE++ L  
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-TV-------RRQICREIEILRD 128

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H N++  + +    G+  ++  +M  GSLE   +  +            +A+    G+
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGI 181

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            +LH R   ++H DIK +N+L+N   +  I DFG+++
Sbjct: 182 AYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSR 216

Length = 353

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 52/287 (18%)

Query: 153 LGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G F  VY+   + +   +A+KK+++       + ++   R   ++E+  L    H N
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQI------FDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL-----WTQRLHIAKGTSLGL 265
           ++  Y    E  +  +V      G L   +   K    L+     W   + +       L
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA----L 119

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           + +HSR   ++H DIK AN+ +       +GD GL   G    +       + GT  Y+ 
Sbjct: 120 EHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL---GRFFSSKTTAAHSLVGTPYYMS 174

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK----------YS 375
            E +     + K D++  G +L+E+A     +   + +   L   +E+          YS
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234

Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
           EE +  LV+    P                   +P++RP++T VY++
Sbjct: 235 EE-LRQLVNMCINP-------------------DPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 38/242 (15%)

Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVW------EKT-TIAVKKLEVHRNDRAVETLNQC 191
           E+ L+T  +  +  LG+  FG VYKG        E+T  +A+K L+    D+A   L   
Sbjct: 1   EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPL--- 51

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK-------- 243
            RE+   E    +  +H NI+ L G+  +     +++ Y  +  L + L+M+        
Sbjct: 52  -REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110

Query: 244 ----KNTPSLLW-TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF 298
               K   S L     +HI    + G++FL S    ++H D+ + N+L+   ++  I D 
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDL 168

Query: 299 GLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMR 355
           GL +E  +  A +  L   N   P  ++  E ++  + S   D++ +G+VL+E+ + G++
Sbjct: 169 GLFRE--VYAADYYKLMG-NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225

Query: 356 AY 357
            Y
Sbjct: 226 PY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 35/233 (15%)

Query: 152 ILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           +LGKG FG+V +   +        +AVK L+        +  +    E+ LRE   +   
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-------DIFSSSDIEEFLREAACMKEF 58

Query: 207 RHDNILPLYGICFET---GKY---CLVYRYMPNGSLEDRLLMKK--NTPSLLWTQRL-HI 257
            H N++ L G+   +   G+     ++  +M +G L   LLM +    P  L  Q L   
Sbjct: 59  DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
               + G+++L S+    IH D+ + N +LN +M   + DFGL+++  I    +      
Sbjct: 119 MIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKK--IYSGDYYR---- 170

Query: 318 NGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELAT-GMRAYDDTRRSE 364
            G    LP ++L  + L     +T  DV+ FG+ ++E+ T G   Y     SE
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 63/269 (23%), Positives = 123/269 (45%), Gaps = 30/269 (11%)

Query: 152 ILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           ++G+G +  V     +KT     + V K E+  +D   E ++  Q E+ + E     +  
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD---EDIDWVQTEKHVFE----QASN 54

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  ++ L+  CF+T  +   V  Y+  G L   +  ++  P      R + A+  SL L 
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHARFYSAE-ISLALN 110

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNGTRPYL 324
           +LH R   +I+ D+K  N+LL+      + D+G+ +EG  P +  +        GT  Y+
Sbjct: 111 YLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-----GTPNYI 163

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
             E L G+     VD +  G+++FE+  G   +D    S+       ++ +E+ ++ ++ 
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQNTEDYLFQVIL 218

Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKER 413
           +    I  +++     + K    ++PKER
Sbjct: 219 EKQIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +LGKG FG V   V EK T     +++ + +  V    + +   +L E + L + RH  +
Sbjct: 2   LLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVA---KDEVAHTLTENRVLQNSRHPFL 57

Query: 212 LPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             L    F+T  + C V  Y   G L      +R+  +          R + A+  S  L
Sbjct: 58  TAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAEIVS-AL 108

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +LHS E  +++ D+K  N++L+      I DFGL +EG  + AT   +K   GT  YL 
Sbjct: 109 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLA 164

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG 353
            E L        VD +G G+V++E+  G
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 15/227 (6%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++++KL  LG+G + TVYKG   K    +  L+V R      T     RE SL     L 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVIRLQEEEGTPFTAIREASL-----LK 58

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL- 263
             +H NI+ L+ I        LV+ Y+      D        P  L  + + +     L 
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL ++H R   ++H D+K  N+L++   +  + DFGL +   +   T+         RP 
Sbjct: 115 GLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP- 171

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
            P   L     ST +D++G G +  E+  G+ A+   +  +  L+ +
Sbjct: 172 -PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 61/222 (27%), Positives = 86/222 (38%), Gaps = 27/222 (12%)

Query: 153 LGKGGFGTVYKG----VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +G G FG V  G       K  + VK+L         E L   Q  Q  REL       H
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD--EQLLFLQEVQPYRELN------H 54

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRL----LMKKNTPSLLWTQRLHIAKGTSLG 264
            N+L   G C E+  Y LV  + P G L++ L     M          QR+  A   + G
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASG 112

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LH  +   IH D+   N  L   +   IGD+GL  E   E             R   
Sbjct: 113 LLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170

Query: 325 P------HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
           P       + L+ K  + K +++  G+ ++EL T   + Y D
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 68/287 (23%), Positives = 126/287 (43%), Gaps = 45/287 (15%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+G+ +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-----AIKTVNE---AASMRERIEFLNEASVMKE 65

Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM----KKNTPSLL---WTQRLH 256
            +C H  ++ L G+  +     ++   M  G L+  L       +N P        + + 
Sbjct: 66  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    K 
Sbjct: 124 MAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYRKG 178

Query: 317 VNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
             G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E  
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG- 237

Query: 375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                  L+DK       N     F + +   + NPK RP   ++ +
Sbjct: 238 ------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 45/232 (19%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRN-DRAVETLNQCQREQSLREL 200
           T+ W+ +  +GKG +G VYK   +K  +  AVK L+   + D  +E            E 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA-----------EY 69

Query: 201 KYLNSC-RHDNILPLYGICFETGKYC-----LVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
             L S   H N++  YG+ ++  K       LV      GS+ +  L+K     L+  QR
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE--LVKG---LLICGQR 124

Query: 255 L------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
           L      +I  G  LGLQ LH+    +IH D+K  NILL       + DFG++ +     
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQ----- 177

Query: 309 ATHITLKRVN--GTRPYLPHEFLVGKR-----LSTKVDVYGFGIVLFELATG 353
            T   L+R    GT  ++  E +  ++        + DV+  GI   EL  G
Sbjct: 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 49/219 (22%)

Query: 153 LGKGGFGTVYKGVWEKT------TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           +G G FG V    W  T       +A+KK+         + L  C+R    RELK L   
Sbjct: 8   IGYGAFGVV----WSVTDPRDGKRVALKKMP-----NVFQNLVSCKR--VFRELKMLCFF 56

Query: 207 RHDNILPLYGI-------CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRL--- 255
           +HDN+L    I        FE      +Y       + +  LM+ +   ++ + Q L   
Sbjct: 57  KHDNVLSALDILQPPHIDPFEE-----IY------VVTE--LMQSDLHKIIVSPQPLSSD 103

Query: 256 HIAKGTSL---GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           H+         GL++LHS    ++H DIK  N+L+N +    I DFGL +    +++ H+
Sbjct: 104 HVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM 161

Query: 313 TLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFEL 350
           T + V  T+ Y   E L+G R  ++ VD++  G +  EL
Sbjct: 162 TQEVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 31/229 (13%)

Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSL--------EDRLLMKKNTPSLL 250
           EL  L +C H  I+  +       K  L+  Y   G L        ++ L  ++    LL
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           + Q +       L L  +HSR+  ++H D+KSANI L       +GDFG +++     + 
Sbjct: 175 FYQIV-------LALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
            +      GT  YL  E    KR S K D++  G++L+EL T  R +    + E   + L
Sbjct: 226 DVA-SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284

Query: 371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
             KY              P    ++     +      +NP  RP   Q+
Sbjct: 285 YGKYD-------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQL 320

Length = 478

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 19/211 (9%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LGKGGFG V   V  K T    A KKL+  R  +      +   + +L E + L      
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKK------KSGEKMALLEKEILEKVNSP 53

Query: 210 NILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            I+ L    FE+  + CLV   M  G L+  +        L   + +H +   + G+  L
Sbjct: 54  FIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHL 111

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS +  +++ D+K  N+LL+   +  + D GL  E    K    T+ +  GT  Y+  E 
Sbjct: 112 HSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEI 165

Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
           L  +  S  VD +  G  ++E+  G   + D
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 37/228 (16%)

Query: 151 NILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQRE-----QSLRELKYL 203
             LG+G +G V K         +A+KK+++      V    Q          +LRELK +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSL----EDRLLMKKNTPSLLWTQRLHIAK 259
           N  +H+NI+ L  +  E     LV   M    L    + ++ + ++    +  Q L    
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQIL---- 129

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-------GPIEKATH- 311
               GL  LH      +H D+  ANI +N      I DFGL +          + K    
Sbjct: 130 ---NGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 312 -----ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                +T K V  T  Y   E L+G ++    VD++  G +  EL TG
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 46/225 (20%)

Query: 144 TNNWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           TN +  L  +G G FG V   +       +A+KK+       +   L +    ++ RELK
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI---MKPFSTPVLAK----RTYRELK 61

Query: 202 YLNSCRHDNIL--------PLYGICFETGKYCL-VYRYMPNGSLEDRLLMKKNTPSLLWT 252
            L   RH+NI+        PL  I F T      ++R + +  LE + +           
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQ---------- 111

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
              +       GL+++HS    ++H D+K +NIL+N + D  I DFGL +         I
Sbjct: 112 ---YFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLAR---------I 157

Query: 313 TLKRVNG---TRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              ++ G   TR Y  P   L  ++   +VD++  G +  E+  G
Sbjct: 158 QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 12/220 (5%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V + V ++ T  +  L+  R    V   ++ +   +L E   L       I+
Sbjct: 1   IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIV---SRSEVTHTLAERTVLAQVNCPFIV 56

Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
           PL        K  LV  ++  G L   L  ++     L   R + A+     L+ LH   
Sbjct: 57  PLKFSFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTAE-LLCALENLHKFN 113

Query: 273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK 332
             +I+ D+K  NILL++     + DFGL +   +            GT  YL  E L+G 
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 333 RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             +  VD +  G++L+E+ TG+  + D   +E + K L E
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 60/239 (25%), Positives = 107/239 (44%), Gaps = 24/239 (10%)

Query: 153 LGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+   + K T +AVK ++      +VE          L E   + + +HD +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAF--------LAEANVMKTLQHDKL 63

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +  +   Y ++  +M  GSL D L   + +   L  + +  +   + G+ F+  R
Sbjct: 64  VKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL-PKLIDFSAQIAEGMAFIEQR 121

Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E +  
Sbjct: 122 N--YIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINF 177

Query: 332 KRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
              + K DV+ FGI+L E+ T       GM   +  R  ER  +    +   E +Y+++
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 21/220 (9%)

Query: 150 LNILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           L +LGKG FG V     KG  E   I + K +V   D  VE         ++ E + L  
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC--------TMVEKRVLAL 56

Query: 206 CRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
                 L     CF+T  +   V  Y+  G L   +   +          +  A   ++G
Sbjct: 57  SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIG 113

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L FLHS+   +I+ D+K  N++L+      I DFG+ +E   +    +T K   GT  Y+
Sbjct: 114 LFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYI 168

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
             E +  +     VD + FG++L+E+  G   ++     E
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 20/213 (9%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + +   +G+G  GTVY  +   T   +A+K++ + +         Q ++E  + E+  + 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---------QPKKELIINEILVMR 71

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             ++ NI+          +  +V  Y+  GSL D +        +   Q   + +     
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQA 127

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L FLHS +  +IH DIKS NILL       + DFG   +   E++   T+    GT  ++
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWM 182

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
             E +  K    KVD++  GI+  E+  G   Y
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 63/277 (22%), Positives = 121/277 (43%), Gaps = 37/277 (13%)

Query: 150 LNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           + ++GKG +G V   +   +     +KKL +    R        +R+ + +E + L+  +
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-------ERKAAEQEAQLLSQLK 57

Query: 208 HDNILPLYGICFETGKYCLVYRYM---PNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
           H NI+  Y   +E G+  L+Y  M     G L  +L  +K    L   Q +      ++ 
Sbjct: 58  HPNIV-AYRESWE-GEDGLLYIVMGFCEGGDLYHKLKEQKGK-LLPENQVVEWFVQIAMA 114

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRP 322
           LQ+LH  E  ++H D+K+ N+ L       +GD G+ +  E   + A+ +      GT  
Sbjct: 115 LQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-----GTPY 167

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
           Y+  E    K  + K DV+  G  ++E+AT   A++      + + SLV        Y +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-----AKDMNSLV--------YRI 214

Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           ++    P+  + +     +      + P++RP +  +
Sbjct: 215 IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 152 ILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           +LGKG FG V     KG  E   I V K +V   D  V+     +R  +L       + +
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILAL-------AAK 54

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  +  L+  CF+T  +   V  Y+  G L     ++++        R + A+ T L L 
Sbjct: 55  HPFLTALHC-CFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVT-LALM 110

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           FLH     +I+ D+K  NILL+      + DFG+ +EG +   T  T     GT  Y+  
Sbjct: 111 FLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF---CGTPDYIAP 165

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E L        VD +  G++++E+  G
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 70/307 (22%), Positives = 133/307 (43%), Gaps = 68/307 (22%)

Query: 148 DKLNIL---GKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYL 203
           +K+ +L   G+G FG VY+G          +  V     AV+T+N+     SLRE +++L
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNE---SASLRERIEFL 57

Query: 204 N--------SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNTPSLL 250
           N        +C H  ++ L G+  +     +V   M +G L+  L       + N     
Sbjct: 58  NEASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115

Query: 251 WTQR--LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
            T +  + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++     
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD----- 168

Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELATGMRAYDDTRRS 363
             + T     G +  LP  ++  + L     +T  D++ FG+VL+E+ +          +
Sbjct: 169 -IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227

Query: 364 ERHLKSLVE-------KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM 416
           E+ LK +++           E + DL         + + + F          NPK RP  
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDL---------MRMCWQF----------NPKMRPTF 268

Query: 417 TQVYNML 423
            ++ N+L
Sbjct: 269 LEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 54.0 bits (129), Expect = 5e-08
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 20/207 (9%)

Query: 153 LGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  GTV+    V     +A+K++ + +         Q ++E  + E+  +   ++ N
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQK---------QPKKELIINEILVMKELKNPN 77

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+          +  +V  Y+  GSL D +        +   Q   + +     L+FLH+
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHA 133

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
            +  +IH DIKS N+LL       + DFG   +   E++   T+    GT  ++  E + 
Sbjct: 134 NQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT 188

Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
            K    KVD++  GI+  E+  G   Y
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 58/247 (23%), Positives = 104/247 (42%), Gaps = 27/247 (10%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + +++  +G G FG V+  V ++ +    A+K + +      V  L Q Q   + + +  
Sbjct: 2   DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAI----PEVIRLKQEQHVHNEKRV-- 54

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK---NTPSLLWTQRLHIAK 259
           L    H  I+ L+    +     ++  Y+P G L   L       N+  L +   +  A 
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA- 113

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                L++LHS+E  +++ D+K  NILL+      + DFG  ++      T      + G
Sbjct: 114 -----LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT------LCG 160

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM 379
           T  YL  E +  K  +  VD +  GI+++E+  G   + D      + K L  K      
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH 220

Query: 380 YDLVDKN 386
            DL  K+
Sbjct: 221 LDLYAKD 227

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 20/207 (9%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  G V     + +   +AVKK+++ +  R         RE    E+  +   +H+N
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHEN 78

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ +Y       +  +V  ++  G+L D +   +     +    L + K  S+    LH+
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV----LHA 134

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           +   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++  E + 
Sbjct: 135 QG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELIS 189

Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
                 +VD++  GI++ E+  G   Y
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 52/228 (22%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQR-EQSLRELKYLNSCRHD 209
           LG G  G V+  V       +AVKK+           L   Q  + +LRE+K +    HD
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKI----------VLTDPQSVKHALREIKIIRRLDHD 62

Query: 210 NILPLYGICFETGK--------------YCLVYRYMPNGSLEDRLLMKKNTPS-----LL 250
           NI+ +Y +   +G                 +V  YM     +   ++++   S     L 
Sbjct: 63  NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM---ETDLANVLEQGPLSEEHARLF 119

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV--IGDFGLTQ--EGPI 306
             Q L        GL+++HS    ++H D+K AN+ +N   D V  IGDFGL +  +   
Sbjct: 120 MYQLLR-------GLKYIHSAN--VLHRDLKPANVFINTE-DLVLKIGDFGLARIVDPHY 169

Query: 307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
               +++   V  T+ Y     L+     TK +D++  G +  E+ TG
Sbjct: 170 SHKGYLSEGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 20/207 (9%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  G V     + T   +AVKK+++ +  R         RE    E+  +    H+N
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR---------RELLFNEVVIMRDYHHEN 80

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ +Y       +  +V  ++  G+L D +   +     + T  L + +     L +LH+
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRA----LSYLHN 136

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           +   +IH DIKS +ILL       + DFG   +   E       K + GT  ++  E + 
Sbjct: 137 QG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVIS 191

Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
                T+VD++  GI++ E+  G   Y
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 152 ILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           +LGKG FG V     +++     + V K +V   D  VE     +R  SL       +  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL-------ARN 54

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  +  LY  CF+T  +   V  ++  G L     ++K+        R + A+ TS  L 
Sbjct: 55  HPFLTQLY-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITS-ALM 110

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           FLH +   +I+ D+K  N+LL+H     + DFG+ +EG     T  T     GT  Y+  
Sbjct: 111 FLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF---CGTPDYIAP 165

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E L        VD +  G++L+E+  G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 17/206 (8%)

Query: 152 ILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           ++GKG FG V   K   +    AVK L      +A+    + +   + R +  L + +H 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVL----QKKAILKKKEQKHIMAERNV-LLKNVKHP 56

Query: 210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            ++ L+   F+T  K   V  Y+  G L   L  +++ P      R + A+  S  L +L
Sbjct: 57  FLVGLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP--RARFYAAEIAS-ALGYL 112

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS    +I+ D+K  NILL+     V+ DFGL +EG     T  T     GT  YL  E 
Sbjct: 113 HSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF---CGTPEYLAPEV 167

Query: 329 LVGKRLSTKVDVYGFGIVLFELATGM 354
           L  +     VD +  G VL+E+  G+
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 23/207 (11%)

Query: 150 LNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G FG VY  + V     +A+KK+  +   ++ E     + +  ++E+++L   R
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNE-----KWQDIIKEVRFLQKLR 73

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H N +   G         LV  Y   GS  D L + K    L   +   +  G   GL +
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAY 130

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LHS    +IH D+K+ NILL+      +GDFG      +  A         GT  ++  E
Sbjct: 131 LHSHN--MIHRDVKAGNILLSEPGLVKLGDFG--SASIMAPANXFV-----GTPYWMAPE 181

Query: 328 FLVGK---RLSTKVDVYGFGIVLFELA 351
            ++     +   KVDV+  GI   ELA
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 25/236 (10%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRH 208
           +LGKGGFG V       T    A KKLE  R   R  E++       +L E + L     
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-------ALNEKQILEKVNS 59

Query: 209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             ++ L    +ET    CLV   M  G L+  +            + +  A     GL+ 
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI-YHMGEAGFEEGRAVFYAAEICCGLED 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH     +++ D+K  NILL+ H    I D GL    P  +    T+K   GT  Y+  E
Sbjct: 118 LHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPE 171

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS------ERHLKSLVEKYSEE 377
            +  +R +   D +  G +L+E+  G   +   ++       ER +K + E+YSE+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 33/220 (15%)

Query: 150 LNILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE----LK 201
           L +LGKG FG V     KG  E   I + K +V   D  VE     +R  +L      L 
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLHIA 258
            L+SC            F+T  +   V  Y+  G L   +  + K   P       +  A
Sbjct: 65  QLHSC------------FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----HAVFYA 107

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
              ++GL FLHS+   +I+ D+K  N++L+      I DFG+ +E      T  T     
Sbjct: 108 AEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF---C 162

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
           GT  Y+  E +  +     VD + FG++L+E+  G   +D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 32/226 (14%)

Query: 150 LNILGKGGFGTVY-----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           L +LG+G FG V+      G       A+K L+     +A  TL    R ++  E   L 
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-----KA--TLKVRDRVRTKMERDILA 53

Query: 205 SCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ---RLHIAKG 260
              H  I+ L+   F+T GK  L+  ++  G L  RL     +  +++T+   + ++A+ 
Sbjct: 54  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAE- 106

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI--EKATHITLKRVN 318
            +L L  LHS    +I+ D+K  NILL+      + DFGL++E  I  EK  +       
Sbjct: 107 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAY----SFC 159

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
           GT  Y+  E +  +  +   D + FG+++FE+ TG   +    R E
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 34/217 (15%)

Query: 150 LNILGKGGFGTVYKGVWEKTT-------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           L +LGKGG+G V++    K T        A+K L+     +A    NQ     +  E   
Sbjct: 1   LKVLGKGGYGKVFQV--RKVTGADTGKIFAMKVLK-----KATIVRNQKDTAHTKAERNI 53

Query: 203 LNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL----EDRLLMKKNTPSLLWTQRLHI 257
           L + +H  I+ L    F+T GK  L+  Y+  G L    E   +  ++T     ++    
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE---- 108

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA-THITLKR 316
               SL L+ LH +   +I+ D+K  NILL+      + DFGL +E   E   TH     
Sbjct: 109 ---ISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-- 161

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             GT  Y+  E L+       VD +  G +++++ TG
Sbjct: 162 --GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 20/213 (9%)

Query: 147 WDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + +   +G+G  GTVY    V     +A++++ + +         Q ++E  + E+  + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMR 72

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             ++ NI+          +  +V  Y+  GSL D +        +   Q   + +     
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQA 128

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+FLHS +  +IH DIKS NILL       + DFG   +   E++       + GT  ++
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWM 183

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
             E +  K    KVD++  GI+  E+  G   Y
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 60/253 (23%), Positives = 94/253 (37%), Gaps = 39/253 (15%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKK--LEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
                    + K     T +AVKK  L+    +       +    + L+         H 
Sbjct: 9   CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ---------HP 59

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA---KGTSLGLQ 266
           NILP         +  +V   M  GS ED  L+K + P  L    L IA   K     L 
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCED--LLKTHFPEGL--PELAIAFILKDVLNALD 115

Query: 267 FLHSREPPLIHGDIKSANILLN----------HHMDPVIGDFGLTQEGPIEKATHITLKR 316
           ++HS+    IH  +K+++ILL+           +   +I   G  Q    +       K 
Sbjct: 116 YIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH-GKRQRVVHDFPKSSV-KN 171

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE 376
           +    P +  + L G   + K D+Y  GI   ELA G   + D   +    + L+EK   
Sbjct: 172 LPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVR- 224

Query: 377 ENMYDLVDKNAQP 389
             +  L+DK+  P
Sbjct: 225 GTVPCLLDKSTYP 237

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 150 LNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L+ +G G FG VY      T   +AVKK+       + +  N+ + +  ++E+K+L   +
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSY-----SGKQTNE-KWQDIIKEVKFLQQLK 79

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H N +   G   +     LV  Y   GS  D L + K    L   +   I  G   GL +
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAY 136

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG-LTQEGPIEKATHITLKRVNGTRPYLPH 326
           LHS    +IH DIK+ NILL       + DFG  ++  P             GT  ++  
Sbjct: 137 LHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV--------GTPYWMAP 186

Query: 327 EFLVGK---RLSTKVDVYGFGIVLFELA 351
           E ++     +   KVDV+  GI   ELA
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELA 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 43/230 (18%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 71

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 72  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119

Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 120 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 177

Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDT 360
           +       TR Y   E ++     +  VD++  G ++ EL TG   +  T
Sbjct: 178 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 5/91 (5%)

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            GLQFLH +   +I+ D+K  N+LL+      I DFG+ +E    +    T     GT  
Sbjct: 107 CGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF---CGTPD 161

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           Y+  E L G++ +  VD + FG++L+E+  G
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GLQFLHS+   +I+ D+K  N++L+      I DFG+ +E         T     GT  Y
Sbjct: 108 GLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF---CGTPDY 162

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY--DD 359
           +  E L G + +  VD + FG++L+E+  G   +  DD
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 29/239 (12%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR--AVETLNQC---QREQSLR-- 198
           N++ L +LG G +G V+          V+K+  H   +  A++ L +    Q+ +++   
Sbjct: 1   NFELLKVLGTGAYGKVF---------LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT 51

Query: 199 --ELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
             E   L   R    L      F+T  K  L+  Y+  G +   L  + N        R 
Sbjct: 52  RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED--EVRF 109

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           +  +   L L+ LH  +  +++ DIK  NILL+     V+ DFGL++E   E+       
Sbjct: 110 YSGE-IILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-- 164

Query: 316 RVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
              GT  Y+  E + GK    K VD +  GI++FEL TG   +  T   ER+ +S V +
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF--TLEGERNTQSEVSR 221

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 21/212 (9%)

Query: 152 ILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           ++G+G +  V     +KT     + V K E+  +D   E ++  Q E+ + E     +  
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFE----TASN 54

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  ++ L+  CF+T  +   V  ++  G L   +  ++  P      R + A+  SL L 
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPE--EHARFYSAE-ISLALN 110

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           FLH R   +I+ D+K  N+LL+      + D+G+ +EG     T  T     GT  Y+  
Sbjct: 111 FLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF---CGTPNYIAP 165

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
           E L G+     VD +  G+++FE+  G   +D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 48/158 (30%), Positives = 66/158 (41%), Gaps = 20/158 (12%)

Query: 153 LGKGGFGTVYKGV----WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +G G FG V  G     +    + VK+L V  +    E +   +  Q  R L+      H
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRV--SASVQEQMKFLEEAQPYRSLQ------H 54

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLG 264
            N+L   G C E   Y LV  + P G L+  L   +     TP     QR+  A   +LG
Sbjct: 55  SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALG 112

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
           L  LH      IH D+   N LL   +   IGD+GL+ 
Sbjct: 113 LLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSH 148

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.9 bits (121), Expect = 5e-07
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 23/207 (11%)

Query: 150 LNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G FG VY  + V     +A+KK+  +   ++ E     + +  ++E+K+L   +
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMS-YSGKQSNE-----KWQDIIKEVKFLQRIK 83

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H N +   G         LV  Y   GS  D L + K    L   +   I  G   GL +
Sbjct: 84  HPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAY 140

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LHS    +IH DIK+ NILL       + DFG         A         GT  ++  E
Sbjct: 141 LHSHN--MIHRDIKAGNILLTEPGQVKLADFG--SASIASPANSFV-----GTPYWMAPE 191

Query: 328 FLVGK---RLSTKVDVYGFGIVLFELA 351
            ++     +   KVDV+  GI   ELA
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELA 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 153 LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           LG+G FG V +            +  T+AVK L+ +  D+ +  L        + E++ +
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL--------ISEMELM 71

Query: 204 NSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-NTPS------------L 249
               +H NI+ L G+C + G   ++  Y   G+L + L  ++   P             L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
            +   +  A   + G+++L SR    IH D+ + N+L+       I DFGL +       
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARG-----V 184

Query: 310 THITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             I    K  NG  P  ++  E L  +  + + DV+ FGI+++E+ T
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 64/249 (25%), Positives = 110/249 (44%), Gaps = 26/249 (10%)

Query: 152 ILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRH 208
           ++GKG FG V   K   +    AVK L+     + +  LN+ +++  + E    L + +H
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQ-----KKI-VLNRKEQKHIMAERNVLLKNVKH 55

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             ++ L+     T K   V  ++  G L   L  +++ P      R + A+  S  L +L
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP--RARFYAAEIAS-ALGYL 112

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS    +++ D+K  NILL+     V+ DFGL +EG  +  T  T     GT  YL  E 
Sbjct: 113 HSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF---CGTPEYLAPEV 167

Query: 329 LVGKRLSTKVDVYGFGIVLFELATGM---------RAYDDTRRSERHLKSLVEKYSEENM 379
           +  +     VD +  G VL+E+  G+           YD+       L+      +   +
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSIL 227

Query: 380 YDLVDKNAQ 388
            +L++K+ Q
Sbjct: 228 EELLEKDRQ 236

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 54/223 (24%), Positives = 98/223 (43%), Gaps = 43/223 (19%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L  +G G +G+V      +    +AVKKL      R  ++L   +R  + REL+ L 
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-----RPFQSLIHARR--TYRELRLLK 69

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  S+E+         LM  +  +++  Q+L  
Sbjct: 70  HMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD 117

Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS    +IH D+K +N+ +N   +  I DFGL ++   E   +
Sbjct: 118 EHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY 175

Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           +       TR Y   E ++     +  VD++  G ++ EL  G
Sbjct: 176 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 9/142 (6%)

Query: 218 CFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLI 276
           CF+T  +  LV  Y+  G L   +  ++  P      R + A+   + L FLH R   +I
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPE--EHARFYAAE-ICIALNFLHERG--II 118

Query: 277 HGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLST 336
           + D+K  N+LL+      + D+G+ +EG     T  T     GT  Y+  E L G+    
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF---CGTPNYIAPEILRGEEYGF 175

Query: 337 KVDVYGFGIVLFELATGMRAYD 358
            VD +  G+++FE+  G   +D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 45/206 (21%), Positives = 87/206 (42%), Gaps = 22/206 (10%)

Query: 153 LGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G F  VY+     ++  +A+KK+++       E ++   R+  ++E+  L    H N
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQI------FEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL-----WTQRLHIAKGTSLGL 265
           ++       E  +  +V      G L   +   K    L+     W   + +       +
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA----V 119

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           + +HSR   ++H DIK AN+ +       +GD GL   G    +       + GT  Y+ 
Sbjct: 120 EHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL---GRFFSSKTTAAHSLVGTPYYMS 174

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELA 351
            E +     + K D++  G +L+E+A
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 68/266 (25%), Positives = 113/266 (42%), Gaps = 29/266 (10%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRH 208
           +LGKGGFG V       T    A KKLE  R   R  E +       +L E + L     
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-------ALNEKRILEKVNS 59

Query: 209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             ++ L    +ET    CLV   M  G L+  +    N P     + +  A     GL+ 
Sbjct: 60  RFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLED 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           L      +++ D+K  NILL+      I D GL  + P  +    T++   GT  Y+  E
Sbjct: 118 LQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPE 171

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
            +  ++ +   D +G G +++E+  G   +   +R ER  +  V++  +E+  +  +K +
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPF--RKRKERVKREEVDRRVKEDQEEYSEKFS 229

Query: 388 QPIELNIAYAFFRIGKQSTKQNPKER 413
           +  +         I +    +NPKER
Sbjct: 230 EDAK--------SICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 19/218 (8%)

Query: 143 ATNNWDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           A  ++  L  LG+G + TVYKG+       +A+K + +   +    T        ++RE 
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT--------AIREA 54

Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L   +H NI+ L+ I         V+ YM      D        P  L    + +   
Sbjct: 55  SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMF 110

Query: 261 TSL-GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
             L GL ++H +   ++H D+K  N+L+++  +  + DFGL +   I   T+ +      
Sbjct: 111 QLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLW 168

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            RP  P   L     S+ +D++G G +  E+  G  A+
Sbjct: 169 YRP--PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 26  LGEGCFGQVVMA----EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------TPSLLWTQRLHI 257
             +H NI+ L G C + G   ++  Y   G+L + L  ++         P+ +  ++L  
Sbjct: 82  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 258 ------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 A   + G+++L S++   IH D+ + N+L+       I DFGL ++       H
Sbjct: 140 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IHH 192

Query: 312 ITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           I    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 21/231 (9%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRH 208
           +LGKGGFG V       T    A K+LE  R   R  E++       +L E + L     
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM-------ALNEKQILEKVNS 59

Query: 209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             ++ L    +ET    CLV   M  G L+  +    N P     + L  A     GL+ 
Sbjct: 60  QFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLED 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH      ++ D+K  NILL+ +    I D GL  + P          RV GT  Y+  E
Sbjct: 118 LHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRV-GTVGYMAPE 171

Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN 378
            L  +R +   D +G G +++E+  G   +    R E+  +  V++   E 
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPF--RGRKEKVKREEVDRRVLET 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G +GTV   +  +T   +A+KKL  +R  ++     +   +++ REL+ L   +
Sbjct: 20  LKQVGSGAYGTVCSALDRRTGAKVAIKKL--YRPFQS-----ELFAKRAYRELRLLKHMK 72

Query: 208 HDNILPLYGIC---FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--HIAKGTS 262
           H+N++ L  +        ++   Y  MP    +   LMK    S    Q L   + KG  
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG-- 130

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
             L+++H+    +IH D+K  N+ +N   +  I DFGL ++   E   ++       TR 
Sbjct: 131 --LKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV------TRW 180

Query: 323 Y-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           Y  P   L     +  VD++  G ++ E+ TG   +    +   HL  L+E
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF----KGHDHLDQLME 227

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 71/276 (25%), Positives = 113/276 (40%), Gaps = 48/276 (17%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++++ + ++G+G FG V+  V +K T  V  ++V R     + + + Q      E   L 
Sbjct: 1   DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKS---DMIKRNQIAHVRAERDILA 56

Query: 205 SCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
                 I+ LY   F+  ++  LV  YMP G L   LL++K+        R +IA+   L
Sbjct: 57  DADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETA-RFYIAE-LVL 112

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK-------ATHITLKR 316
            L  +H      IH DIK  NIL++      + DFGL ++    K        +H  L R
Sbjct: 113 ALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 317 VN-------------------GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA- 356
            N                   GT  Y+  E L G     + D +  G++L+E+  G    
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Query: 357 YDDTRRSE-----RHLKSLV----EKYSEENMYDLV 383
           Y DT +          +SL        S E + DL+
Sbjct: 231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAI-DLI 265

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 53/235 (22%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           + ++KL  +G+G +G VYK   +K T   +A+KK  +  ++  +          +LRE+ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPP-------TALREIS 52

Query: 202 YLNSCRHDN-ILPLYGICFE-----TGKYC--LVYRYMP---------NGSLEDRLLMKK 244
            L        I+ L  +  E      GK    LV+ Y+          NG    R L  K
Sbjct: 53  LLQMLSESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAK 110

Query: 245 NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQE 303
              S ++ Q L        G+   H     ++H D+K  N+L++     + I D GL + 
Sbjct: 111 TIKSFMY-QLL-------KGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160

Query: 304 G--PIEKATH--ITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATG 353
              P++  TH  +TL        Y   E L+G    ST VD++  G +  E++  
Sbjct: 161 FSIPVKSYTHEIVTLW-------YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 21/162 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++++ + ++G+G FG V + V +K T    A+KKL      R  E L + Q      E  
Sbjct: 1   DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKL------RKSEMLEKEQVAHVRAERD 53

Query: 202 YLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
            L    +  ++ LY   F+   Y  L+  Y+P G +   LLMKK+T +   T R +IA+ 
Sbjct: 54  ILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEET-RFYIAE- 109

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILL--NHHMDPVIGDFGL 300
           T L +  +H      IH DIK  N+LL    H+   + DFGL
Sbjct: 110 TILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIK--LSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|176725 cd08309, Death_IRAK, Death domain of Interleukin-1 Receptor-Associated Kinases

 Score = 45.9 bits (109), Expect = 2e-06
 Identities = 20/50 (40%), Positives = 27/50 (54%)

Query: 7  QLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILK 56
           + Q+E    R  SPT ELL  WG QN TV +L + L  +  Y+A  +L 
Sbjct: 46 DVRQIESMKQRGRSPTRELLWDWGTQNATVQDLVQVLVQLELYRAADLLT 95

Death Domains (DDs) found in Interleukin-1 (IL-1) Receptor-Associated Kinases (IRAK1-4) and similar proteins. IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. All four types are involved in signal transduction involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinase pathways. IRAK1 and IRAK4 are active kinases while IRAK2 and IRAK-M (also called IRAK3) are inactive. In general, IRAKs are expressed ubiquitously, except for IRAK-M which is detected only in macrophages. The insect homologs, Pelle and Tube, are important components of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in the innate immune response. Most members have an N-terminal DD followed by a kinase domain. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 95

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 50/226 (22%)

Query: 154 GKGGFGTVYKGVWEKTT----IAVKKLEVHRNDRAVETLNQCQREQSL-RELKYLNSCRH 208
           G+G +G VYK   +        A+KK +  +      + + C RE +L RELK      H
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC-REIALLRELK------H 61

Query: 209 DNILPLYGICFE--TGKYCLVYRYM-------------PNGSLEDRLLMKKNTPSLLWTQ 253
           +N++ L  +  E       L++ Y                       ++K    SLLW Q
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK----SLLW-Q 116

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQ--EGPIE 307
            L+       G+ +LHS    ++H D+K ANIL+           IGD GL +    P+ 
Sbjct: 117 ILN-------GVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL- 166

Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
                 L  V  T  Y   E L+G R  TK +D++  G +  EL T
Sbjct: 167 -KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 44/247 (17%)

Query: 133 PHIPYQELTLATNNWDKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHR 180
           P  P  E +      DKL +   LG+G FG V              E  T+AVK L   +
Sbjct: 5   PEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML---K 56

Query: 181 NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL 240
           +D   + L+    E  +  +K +   +H NI+ L G C + G   ++  Y   G+L + L
Sbjct: 57  DDATEKDLSDLVSEMEM--MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 112

Query: 241 LMKK-------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL 287
             ++                 + +   +      + G+++L S++   IH D+ + N+L+
Sbjct: 113 RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLV 170

Query: 288 NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGI 345
             +    I DFGL ++  +    +   K  NG  P  ++  E L  +  + + DV+ FG+
Sbjct: 171 TENNVMKIADFGLARD--VNNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 227

Query: 346 VLFELAT 352
           +++E+ T
Sbjct: 228 LMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 37/214 (17%)

Query: 192 QREQSLRELKYLNSCRHDNILPLYGIC-FETGKYCL-------VYRYMPNGSLEDRLLMK 243
           Q E  +  L  LN   H+NIL +  I   E   Y +       +Y +M + + +      
Sbjct: 209 QLENEILALGRLN---HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-----W 260

Query: 244 KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG--LT 301
           K+ P LL   R  I K     ++++H ++  LIH DIK  NI LN     V+GDFG  + 
Sbjct: 261 KDRP-LLKQTR-AIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG--MRAYDD 359
            E   E   +  +  V    P    E L G       D++  G++L ++ +       D 
Sbjct: 317 FEKEREAFDYGWVGTVATNSP----EILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372

Query: 360 TRRSERHLKSLVEKYS---EE------NMYDLVD 384
             +  + L  +++  S   EE       ++D +D
Sbjct: 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYID 406

Length = 501

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 47/202 (23%), Positives = 84/202 (41%), Gaps = 28/202 (13%)

Query: 161 VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG---- 216
           +YKG++    + ++  +       V        + +  E+K L     +NIL +YG    
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLI------DITENEIKNLRRIDSNNILKIYGFIID 89

Query: 217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS--REPP 274
           I  +  +  L+  Y   G L + L  +K+   L +  +L +A     GL  L+    +P 
Sbjct: 90  IVDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP- 145

Query: 275 LIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI-TLKRVNGTRPYLPHEFL--VG 331
             + ++ S + L+  +    I   GL      EK       K VN    Y  ++ L  + 
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGL------EKILSSPPFKNVN-FMVYFSYKMLNDIF 196

Query: 332 KRLSTKVDVYGFGIVLFELATG 353
              + K D+Y  G+VL+E+ TG
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 56/202 (27%), Positives = 82/202 (40%), Gaps = 16/202 (7%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LGKGGFG V       T    A KKL   R  +      +   E ++ E + L       
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK------RKGYEGAMVEKRILAKVHSRF 54

Query: 211 ILPLYGICFET-GKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           I+ L    F+T    CLV   M  G L   +  + +  P     +          GL+ L
Sbjct: 55  IVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           H R   +I+ D+K  N+LL++  +  I D GL  E    K      K   GT  ++  E 
Sbjct: 114 HQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVE---LKDGQSKTKGYAGTPGFMAPEL 168

Query: 329 LVGKRLSTKVDVYGFGIVLFEL 350
           L G+     VD +  G+ L+E+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 38/225 (16%)

Query: 153 LGKGGFGTVYKG---------VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           LG+G FG V              +  T+AVK L+    D+ +  L        + E++ +
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL--------VSEMEMM 71

Query: 204 NSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------------NTPSL 249
               +H NI+ L G C + G   ++  Y   G+L + L  ++                 L
Sbjct: 72  KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
            +   +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++  +   
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGLARD--VHNI 187

Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            +   K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 188 DYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 153 LGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G G +GTVYK     +   +A+K + V  N+  +       RE +L  LK L +  H N
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVAL--LKRLEAFDHPN 63

Query: 211 ILPLYGICF------ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH-IAKGTSL 263
           I+ L  +C       ET K  LV+ ++     + R  + K  P  L  + +  + +    
Sbjct: 64  IVRLMDVCATSRTDRET-KVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL FLH+    ++H D+K  NIL+       + DFGL +      +  + L  V  T  Y
Sbjct: 120 GLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWY 173

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
              E L+    +T VD++  G +  E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 61/228 (26%), Positives = 92/228 (40%), Gaps = 53/228 (23%)

Query: 153 LGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD- 209
           +G G  G VYK  ++KT   +AVK++   R        N+ + ++ L +L  +    HD 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM--RRTG------NKEENKRILMDLDVVLKS-HDC 73

Query: 210 -NILPLYG---------ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--HI 257
             I+  YG         IC E    CL           D+LL +   P     + +   +
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCL-----------DKLLKRIQGP---IPEDILGKM 119

Query: 258 AKGTSLGLQFL---HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
                  L +L   H     +IH D+K +NILL+   +  + DFG++      KA     
Sbjct: 120 TVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171

Query: 315 KRVNGTRPYLPHEFLVGKRLSTK----VDVYGFGIVLFELATGMRAYD 358
            R  G   Y+  E +     + K     DV+  GI L ELATG   Y 
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 43/234 (18%)

Query: 148 DKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            K+ +LGKG  G V+  V  K T    A+K L+     + +   N+ +R  + +E+  L 
Sbjct: 4   KKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLD----KKEMIKRNKVKRVLTEQEI--LA 56

Query: 205 SCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSL-LWTQRLHIAKGTS 262
           +  H  +  LY   F+T  Y CLV  Y P G L  RLL ++    L     R + A+   
Sbjct: 57  TLDHPFLPTLYAS-FQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVL- 113

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT--------------------- 301
           L L++LH     +++ D+K  NILL+     ++ DF L+                     
Sbjct: 114 LALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 302 --QEGPIEKATHITLKRVN---GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
                P E  +     R N   GT  Y+  E + G    + VD +  GI+L+E+
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 39/229 (17%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLE-VHRNDRAVETLNQCQREQSLREL 200
           ++ W+ +  +GKG +G V+K + +K  +  AVK L+ +H  D  +E       E ++  L
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA------EYNI--L 68

Query: 201 KYLNSCRHDNILPLYGICFE----TG-KYCLVYRYMPNGSLED--RLLMKKN--TPSLLW 251
           K L+   H N++  YG+ ++     G +  LV      GS+ D  +  +K+       + 
Sbjct: 69  KALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
              LH A    +GLQ LH  +   IH D+K  NILL       + DFG++ +      T 
Sbjct: 127 AYILHEA---LMGLQHLHVNKT--IHRDVKGNNILLTTEGGVKLVDFGVSAQ-----LTS 176

Query: 312 ITLKRVN--GTRPYLPHEFLVGKR-----LSTKVDVYGFGIVLFELATG 353
             L+R    GT  ++  E +  ++        + DV+  GI   EL  G
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 152 ILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           ++GKG FG V   K   + +  AVK L+     +  E  N    E+++     L + +H 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ-NHIMAERNV----LLKNLKHP 56

Query: 210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            ++ L+   F+T  K   V  Y+  G L     +++    L    R + A+  S  + +L
Sbjct: 57  FLVGLH-YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVAS-AIGYL 112

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS    +I+ D+K  NILL+     V+ DFGL +EG   + T  T     GT  YL  E 
Sbjct: 113 HSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF---CGTPEYLAPEV 167

Query: 329 LVGKRLSTKVDVYGFGIVLFELATGM 354
           L  +     VD +  G VL+E+  G+
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 9/102 (8%)

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           Q + I +     L +LH R   +IH D+K+ NI L+   + V+GDFG       +   H 
Sbjct: 186 QAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFG----AACKLDAHP 239

Query: 313 TLKRV---NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
              +    +GT      E L       K D++  G+VLFE++
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 50/219 (22%)

Query: 153 LGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G +G V      +T   +A+KK+       A +  N+   +++LRE+K L    H+N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI-----ANAFD--NRIDAKRTLREIKLLRHLDHEN 65

Query: 211 ILPLYGICFETGKYCLVYRYMPNG--SLEDRLLMKKNTPSLLWTQRLH--IAKGTSL--- 263
           ++ +  I              P    +  D  ++ +     L    LH  I    +L   
Sbjct: 66  VIAIKDI------------MPPPHREAFNDVYIVYE-----LMDTDLHQIIRSSQTLSDD 108

Query: 264 -----------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
                      GL+++HS    ++H D+K +N+LLN + D  I DFGL +    EK   +
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFM 165

Query: 313 TLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           T   V  TR Y  P   L     +T +DV+  G +  EL
Sbjct: 166 TEYVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR--AVETLNQC---QR----EQS 196
           N++ L +LG G +G V+          V+K+  H   +  A++ L +    Q+    E +
Sbjct: 1   NFELLRVLGTGAYGKVF---------LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT 51

Query: 197 LRELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
             E + L + R    L      F+T  K  L+  Y+  G L   L  +++        R+
Sbjct: 52  RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRV 109

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           +IA+   L L  LH     +I+ DIK  NILL+     V+ DFGL++E   E       +
Sbjct: 110 YIAE-IVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-----EEE 161

Query: 316 RVN---GTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATG 353
           R     GT  Y+  E + G        VD +  G++ FEL TG
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 24/222 (10%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCR 207
           I+G+GGFG VY G  +  T    A+K L+  R   +  ETL     E+ +  L     C 
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDC- 56

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI-AKGTSLGL 265
               +      F T  K C +   M  G L   L    +   +   + +   A    LGL
Sbjct: 57  --PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGL 110

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           + +H+R   +++ D+K ANILL+ H    I D GL  +   +K  H ++    GT  Y+ 
Sbjct: 111 EHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV----GTHGYMA 163

Query: 326 HEFLV-GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
            E L  G    +  D +  G +LF+L  G   +   +  ++H
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 18/187 (9%)

Query: 171 IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY 230
           +AVK +++ +  R         RE    E+  +   +H N++ +Y       +  ++  +
Sbjct: 49  VAVKMMDLRKQQR---------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99

Query: 231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH 290
           +  G+L D +   +     + T    + +     L +LHS+   +IH DIKS +ILL   
Sbjct: 100 LQGGALTDIVSQTRLNEEQIAT----VCESVLQALCYLHSQG--VIHRDIKSDSILLTLD 153

Query: 291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
               + DFG   +  I K      K + GT  ++  E +      T+VD++  GI++ E+
Sbjct: 154 GRVKLSDFGFCAQ--ISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210

Query: 351 ATGMRAY 357
             G   Y
Sbjct: 211 VDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 53/202 (26%), Positives = 82/202 (40%), Gaps = 37/202 (18%)

Query: 171 IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY 230
           +AVKKL      R  +  NQ   +++ REL  L    H NI+ L  +            +
Sbjct: 49  VAVKKLS-----RPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNV------------F 89

Query: 231 MPNGSLED-------RLLMKKNTPSLLWTQRLHIAKGTSL-----GLQFLHSREPPLIHG 278
            P  SLE+         LM  N   ++  +  H      L     G++ LHS    +IH 
Sbjct: 90  TPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS--AGIIHR 147

Query: 279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKV 338
           D+K +NI++       I DFGL +       T+  +     TR Y   E ++G      V
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLARTA----CTNFMMTPYVVTRYYRAPEVILGMGYKENV 203

Query: 339 DVYGFGIVLFELATGMRAYDDT 360
           D++  G ++ EL  G   +  T
Sbjct: 204 DIWSVGCIMGELVKGSVIFQGT 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 36/224 (16%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR--AVETLNQCQ-------REQS 196
           N++ L +LG G +G V+          V+K+  H + +  A++ L +          E +
Sbjct: 1   NFELLKVLGTGAYGKVF---------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT 51

Query: 197 LRELKYLNSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
             E + L   R    L      F+T  K  L+  Y+  G L   L  ++        Q +
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEV 107

Query: 256 HIAKG-TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATH 311
            I  G   L L+ LH  +  +I+ DIK  NILL+ +   V+ DFGL++E     +E+A  
Sbjct: 108 QIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165

Query: 312 ITLKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATG 353
                  GT  Y+  + + G        VD +  G++++EL TG
Sbjct: 166 FC-----GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)

Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125

Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179

Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 32/212 (15%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE---LKYLNSC 206
           +G+G +G V+K    K     +A+K++ V   +  +          ++RE   L++L + 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-------STIREVAVLRHLETF 61

Query: 207 RHDNILPLYGICF------ETGKYCLVYRYMPNG--SLEDRLLMKKNTPSLLWTQRLHIA 258
            H N++ L+ +C       ET K  LV+ ++     +  D++         +      + 
Sbjct: 62  EHPNVVRLFDVCTVSRTDRET-KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           +    GL FLHS    ++H D+K  NIL+       + DFGL +    + A    +    
Sbjct: 121 R----GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--- 171

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
            T  Y   E L+    +T VD++  G +  E+
Sbjct: 172 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +GKG FG VY+ V +K T    A+K L         E + + +   ++ E   L     D
Sbjct: 1   IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKK------EIVAKKEVAHTIGERNILVRTLLD 53

Query: 210 NILPLYGICF----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
               + G+ F    ++  Y LV  YM  G L   L  +          + +IA+   L L
Sbjct: 54  ESPFIVGLKFSFQTDSDLY-LVTDYMSGGELFWHLQKEGRFSED--RAKFYIAE-LVLAL 109

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           + LH  +  +++ D+K  NILL+      + DFGL++    +  T  T     GT  YL 
Sbjct: 110 EHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF---CGTTEYLA 164

Query: 326 HEFLVGKRLSTK-VDVYGFGIVLFELATG 353
            E L+ ++  TK VD +  G+++FE+  G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 35/215 (16%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR--ELKYLNSCRHD 209
           ++GKG FG V              L  H+ +     +   Q++  L+  E K++ S R  
Sbjct: 2   VIGKGSFGKVL-------------LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSER-- 46

Query: 210 NILP-------LYGICFE---TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           N+L        L G+ F      K   V  Y+  G L   L  ++    L    R + A+
Sbjct: 47  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE 104

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
             S  L +LHS    +++ D+K  NILL+     V+ DFGL +E      T  T     G
Sbjct: 105 IAS-ALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF---CG 158

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           T  YL  E L  +     VD +  G VL+E+  G+
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 52/197 (26%), Positives = 81/197 (41%), Gaps = 32/197 (16%)

Query: 176 LEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY--GICFETGKYCLVYRYMPN 233
           +++ R D A E  +Q  R +  RE        H NI+ L   G     G    V+ Y+P 
Sbjct: 8   IKLLRTD-APEEEHQRARFR--RETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPG 63

Query: 234 GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL----HSREPPLIHGDIKSANILLN- 288
            +L + L      P+          +   L LQ L     +    ++H D+K  NI+++ 
Sbjct: 64  RTLREVLAADGALPA---------GETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 289 -----HHMDPVIGDFGLTQEGP-IEKATHITLKR---VNGTRPYLPHEFLVGKRLSTKVD 339
                H     + DFG+    P +  A   TL R   V GT  Y   E L G+ ++   D
Sbjct: 115 TGVRPHAK---VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 340 VYGFGIVLFELATGMRA 356
           +Y +G++  E  TG R 
Sbjct: 172 LYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 58/244 (23%), Positives = 109/244 (44%), Gaps = 26/244 (10%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           ++L +   ++D + ++G+G FG V + V  K++  V  +++      ++  +     +  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 198 RELKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             + + NS     ++ L+   F+  KY  +V  YMP G L + L+   + P   W  + +
Sbjct: 95  DIMAFANS---PWVVQLF-CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEK-WA-KFY 147

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   L L  +HS    LIH D+K  N+LL+ H    + DFG   +  +++   +    
Sbjct: 148 TAE-VVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMK--MDETGMVRCDT 202

Query: 317 VNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             GT  Y+  E L  +        + D +  G+ LFE+  G   +        +  SLV 
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF--------YADSLVG 254

Query: 373 KYSE 376
            YS+
Sbjct: 255 TYSK 258

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 48/224 (21%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L  +G+G F  V K    KT    A+K ++ H     +E +N  +  Q+LR L    
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSP-- 56

Query: 205 SCRHDNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQRL 255
              H NIL L  + F+  TG+  LV+  M + +L +  L+K                Q L
Sbjct: 57  ---HPNILRLIEVLFDRKTGRLALVFELM-DMNLYE--LIKGRKRPLPEKRVKSYMYQLL 110

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFG----LTQEGPIEKA 309
                    L  +H     + H DIK  NIL+    D ++   DFG    +  + P    
Sbjct: 111 K-------SLDHMHRNG--IFHRDIKPENILIK---DDILKLADFGSCRGIYSKPPY--T 156

Query: 310 THITLKRVNGTRPYLPHE-FLVGKRLSTKVDVYGFGIVLFELAT 352
            +I+      TR Y   E  L       K+D++  G V FE+ +
Sbjct: 157 EYIS------TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 11/174 (6%)

Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
           S+ E + L    H  +L L  +    G  CLV   +P    +    +      L   Q  
Sbjct: 207 SVHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVT 263

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT--QEGPIEKATHIT 313
            +A+     + ++H     +IH DIK+ N+L+N   D  +GDFG      G      H  
Sbjct: 264 AVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA-YDDTRRSERH 366
              + GT      E L G   +  VD++  G+V+FE A    + +  +R  ER 
Sbjct: 322 ---IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372

Length = 461

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.2 bits (101), Expect = 1e-04
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 38/222 (17%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-C 206
           + ++G G +G VYKG   KT    A+K ++V  +          + E+  +E+  L    
Sbjct: 11  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----------EEEEIKQEINMLKKYS 60

Query: 207 RHDNILPLYGICFETG------KYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAK 259
            H NI   YG   +        +  LV  +   GS+ D +   K NT    W    +I +
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICR 118

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN- 318
               GL  LH  +  +IH DIK  N+LL  + +  + DFG++ +  +++    T+ R N 
Sbjct: 119 EILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDR----TVGRRNT 170

Query: 319 --GTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATG 353
             GT  ++  E +            K D++  GI   E+A G
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 42/224 (18%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-C 206
           + ++G G +G VYKG   KT    A+K ++V  +          + E+   E+  L    
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----------EEEEIKLEINMLKKYS 70

Query: 207 RHDNILPLYGICFETG------KYCLVYRYMPNGSLEDRLLMKKNTPSLL---WTQRLHI 257
            H NI   YG   +        +  LV  +   GS+ D  L+K    + L   W    +I
Sbjct: 71  HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD--LVKNTKGNALKEDWIA--YI 126

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +    GL  LH+ +  +IH DIK  N+LL  + +  + DFG++ +  +++    T+ R 
Sbjct: 127 CREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDR----TVGRR 178

Query: 318 N---GTRPYLPHEFLVGKR-----LSTKVDVYGFGIVLFELATG 353
           N   GT  ++  E +            + D++  GI   E+A G
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 41/219 (18%)

Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 70

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 71  KCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH 118

Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 119 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 172

Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             +     TR Y   E ++G      VD++  G ++ E+
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 34/128 (26%), Positives = 55/128 (42%), Gaps = 13/128 (10%)

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRV-NGTR 321
            L  LH     +IH DIK  N+L +   D + + D+GL +         I      +GT 
Sbjct: 121 ALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTL 170

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE-NMY 380
            Y   E + G       D +  G++ +EL TG   + +    E  L+SL+++  ++    
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI 230

Query: 381 DLVDKNAQ 388
             V KNA 
Sbjct: 231 KNVSKNAN 238

Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 8/105 (7%)

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K  H ++    GT  
Sbjct: 108 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV----GTHG 160

Query: 323 YLPHEFLV-GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
           Y+  E L  G    +  D +  G +LF+L  G   +   +  ++H
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 27/155 (17%)

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H +I+ LYG+C    +  +V  ++  G L+  L M + +  L    +  +AK  +  L +
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 268 LHSREPPLIHGDIKSANILLNHH------------MDPVIGDFGLTQEGPIEKATHITLK 315
           L  ++  L+HG++ + NILL                DP I    L+++  +E+   I  +
Sbjct: 121 LEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPE 178

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
            V  +           K LS   D + FG  L+E+
Sbjct: 179 CVEDS-----------KNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 20/163 (12%)

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP- 322
           G++FL SR+   IH D+ + NILL+ +    I DFGL ++  I K     +++ +   P 
Sbjct: 186 GMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARD--IYKDPDY-VRKGSARLPL 240

Query: 323 -YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
            ++  E +  K  +T+ DV+ FG++L+E+ + G   Y   + +E   + L     ++   
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-----KDGTR 295

Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
               +NA P         +RI     + +PKERP  + +  +L
Sbjct: 296 MRAPENATP-------EIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 39/218 (17%)

Query: 150 LNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G  G V       T   +A+KKL      R  +  N    +++ REL  +    
Sbjct: 21  LKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-----RPFQ--NVTHAKRAYRELVLMKLVN 73

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLED----RLLMKKNTPSL-------LWTQRLH 256
           H NI+ L  +            + P  SLE+     L+M+    +L       L  +R+ 
Sbjct: 74  HKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS 121

Query: 257 IAKGTSL-GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
                 L G++ LHS    +IH D+K +NI++       I DFGL +       T   + 
Sbjct: 122 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMT 175

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 23/205 (11%)

Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+GG+G V+  K       +A+K++        +  LN+      L E   L + + + 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRM----KKSLLFKLNE--VRHVLTERDILTTTKSEW 62

Query: 211 ILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQ-RLHIAKGTSLGLQFL 268
           ++ L    F+  +Y  L   Y+P G    R L+  N   L     R ++A+     +  L
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDF--RTLLN-NLGVLSEDHARFYMAE-MFEAVDAL 117

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           H  E   IH D+K  N L++      + DFGL++   +  A       V G+  Y+  E 
Sbjct: 118 H--ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYA-----NSVVGSPDYMAPEV 169

Query: 329 LVGKRLSTKVDVYGFGIVLFELATG 353
           L GK     VD +  G +L+E   G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 40/231 (17%)

Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLE----VHRNDRAVETLNQC 191
           +L +   ++D + ++G+G FG V + V  K++    A+K L     + R+D A       
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAF-----F 90

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLL 250
             E+ +  + + NS   + I+ L+   F+  KY  +V  YMP G L +  LM        
Sbjct: 91  WEERDI--MAHANS---EWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEK 142

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPI 306
           W  R + A+   L L  +HS     IH D+K  N+LL+      + DFG    +   G +
Sbjct: 143 WA-RFYTAE-VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 307 EKATHITLKRVNGTRPYLPHEFLVGKR----LSTKVDVYGFGIVLFELATG 353
              T +      GT  Y+  E L  +        + D +  G+ L+E+  G
Sbjct: 199 RCDTAV------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 30/214 (14%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
            L  +G G +G+V   + ++T   +A+KKL   R  ++     +   +++ REL  L   
Sbjct: 19  SLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQS-----EIFAKRAYRELTLLKHM 71

Query: 207 RHDNILPLYG------ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           +H+N++ L           E   + LV  YM         L K     L   +  ++   
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD------LQKIMGHPLSEDKVQYLVYQ 125

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              GL+++HS    +IH D+K  N+ +N   +  I DFGL +    E   ++       T
Sbjct: 126 MLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV------T 177

Query: 321 RPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           R Y  P   L     +  VD++  G ++ E+ TG
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 58/248 (23%), Positives = 109/248 (43%), Gaps = 34/248 (13%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           ++L +   +++ + ++G+G FG V + V  K+T  V  +++      ++  +     +  
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 198 RELKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             + + NS     ++ L+   F+  +Y  +V  YMP G L + L+   + P   W  R +
Sbjct: 95  DIMAFANSPW---VVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEK-WA-RFY 147

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHI 312
            A+   L L  +HS     IH D+K  N+LL+      + DFG    + +EG +   T +
Sbjct: 148 TAE-VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 313 TLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
                 GT  Y+  E L  +        + D +  G+ L+E+  G   +        +  
Sbjct: 205 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF--------YAD 250

Query: 369 SLVEKYSE 376
           SLV  YS+
Sbjct: 251 SLVGTYSK 258

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 9/99 (9%)

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           L  ++LHS++  +I+ D+K  N+LL++     + DFG  ++ P    T      + GT  
Sbjct: 129 LAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------LCGTPE 180

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA-YDDT 360
           YL  E +  K     VD +  G++L+E   G    +DDT
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219

Length = 329

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 30/217 (13%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
             ++GKG +G V   +   T   +A+KK+    ND   E ++   R   LRE+K L   R
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKI----ND-VFEHVSDATR--ILREIKLLRLLR 57

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKN---TP---SLLWTQRLHIAK 259
           H +I+ +  I     +      Y+    +E  L  ++K N   TP        Q L    
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR--- 114

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                L+++H+    + H D+K  NIL N      I DFGL +    +  T I       
Sbjct: 115 ----ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168

Query: 320 TRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATG 353
           TR Y   E L G    + +  +D++  G +  E+ TG
Sbjct: 169 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 36/172 (20%)

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR-- 321
           G++FL SR+   IH D+ + NILL+ +    I DFGL ++  I K       R    R  
Sbjct: 185 GMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARD--IYKDPDYV--RKGDARLP 238

Query: 322 -PYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY-------DDTRRSERHLKSLVE 372
             ++  E +  K  +T+ DV+ FG++L+E+ + G   Y       +  RR +   +    
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAP 298

Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           +Y+   +Y                    I       NP++RP  +++  +L 
Sbjct: 299 EYATPEIY-------------------SIMLDCWHNNPEDRPTFSELVEILG 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 52/263 (19%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQRE 194
           +++ ++T  +  L++LG+G FG V +  W+   K   AVK          V  + +  R+
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEA-WDRKRKEYCAVK---------IVRNVPKYTRD 171

Query: 195 QSLRELKYLNSCRH---DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL- 250
             + E++++   R     +  PL  I           RY  N +    ++M K  P LL 
Sbjct: 172 AKI-EIQFMEKVRQADPADRFPLMKI----------QRYFQNETGHMCIVMPKYGPCLLD 220

Query: 251 WTQR------LHIAK---GTSLGLQFLHSREPPLIHGDIKSANILL-----------NHH 290
           W  +       H+A+    T + L + H+ E  L+H D+K  NIL+           N  
Sbjct: 221 WIMKHGPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDTVVDPVTNRA 279

Query: 291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           + P      +   G      H     V+ TR Y   E ++G       D++  G +++EL
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVS-TRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338

Query: 351 ATGMRAYDDTRRSERHLKSLVEK 373
            TG   Y DT  +  HL  L+EK
Sbjct: 339 YTGKLLY-DTHDNLEHLH-LMEK 359

Length = 467

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 26/283 (9%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQ 192
           P ++  +   +++ +  LG G FG V    ++      +A+K+ E        + + Q Q
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE------KSKIIKQKQ 74

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
            +    E K LN   H   + LYG   +     LV  ++  G     L   K  P+ +  
Sbjct: 75  VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
                A    L  ++L S    +++ D+K  N+LL+      + DFG  +   ++  T+ 
Sbjct: 135 ---FYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYT 187

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG---MRAYDDTRRSERHLKS 369
               + GT  Y+  E L+        D +  GI ++E+  G     A +     ++ L+ 
Sbjct: 188 ----LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243

Query: 370 LV--EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNP 410
           ++   K+ + N   L+ K     +L   Y   + G Q+ K++P
Sbjct: 244 IIYFPKFLDNNCKHLMKKLLSH-DLTKRYGNLKKGAQNVKEHP 285

Length = 340

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 15/127 (11%)

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP- 322
           G++FL SR+   IH D+ + NILL+ +    I DFGL ++  I K     +++ +   P 
Sbjct: 191 GMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARD--IYKDPDY-VRKGDARLPL 245

Query: 323 -YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVE-------K 373
            ++  E +  +  + + DV+ FG++L+E+ + G   Y   +  E   + L E        
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 305

Query: 374 YSEENMY 380
           Y+   MY
Sbjct: 306 YTTPEMY 312

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	441
KOG1187|consensus	361		100.0
KOG0192|consensus	362		100.0
KOG0581|consensus	364		100.0
KOG0575|consensus	592		100.0
KOG0598|consensus	357		100.0
KOG0615|consensus	475		100.0
KOG0595|consensus	429		100.0
KOG0591|consensus	375		100.0
KOG0197|consensus	468		100.0
KOG0616|consensus	355		100.0
KOG0694|consensus	694		100.0
KOG0593|consensus	396		100.0
KOG0592|consensus	604		100.0
KOG0600|consensus	560		100.0
KOG0198|consensus	313		100.0
KOG0659|consensus	318		100.0
KOG0583|consensus	370		100.0
KOG1026|consensus	774		100.0
KOG0582|consensus	516		100.0
KOG0605|consensus	550		100.0
KOG0193|consensus	678		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4721|consensus	904		100.0
KOG0578|consensus	550		100.0
KOG0597|consensus	808		100.0
KOG0661|consensus	538		100.0
KOG0588|consensus	786		100.0
KOG0663|consensus	419		100.0
KOG0585|consensus	576		100.0
KOG0580|consensus	281		100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201|consensus	467		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0610|consensus	459		100.0
KOG0611|consensus	668		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0589|consensus	426		100.0
KOG0194|consensus	474		100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG2345|consensus	302		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1095|consensus	1025		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0660|consensus	359		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0594|consensus	323		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG4717|consensus	864		100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0599|consensus	411		100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0658|consensus	364		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0690|consensus	516		100.0
KOG1989|consensus	738		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0032|consensus	382		100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG1094|consensus	807		100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0196|consensus	996		100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0033|consensus	355		100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG4278|consensus	1157		100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0695|consensus	593		100.0
KOG0667|consensus	586		100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0584|consensus	632		100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0574|consensus	502		100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0986|consensus	591		100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0577|consensus	948		100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0579|consensus	1187		100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0199|consensus	1039		100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0696|consensus	683		100.0
KOG0596|consensus	677		100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4257|consensus	974		100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0586|consensus	596		100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279|consensus	1226		100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4645|consensus	1509		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0983|consensus	391		100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG1035|consensus	1351		100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0666|consensus	438		100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0612|consensus	1317		100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0604|consensus	400		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG1151|consensus	775		100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0607|consensus	463		100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG3653|consensus	534		100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG4250|consensus	732		100.0
KOG0200|consensus	609		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0603|consensus	612		100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0614|consensus	732		100.0
KOG1006|consensus	361		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG2052|consensus	513		100.0
KOG0662|consensus	292		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587|consensus	953		100.0
KOG1025|consensus	1177		100.0
KOG4236|consensus	888		100.0
KOG0608|consensus	1034		100.0
KOG0671|consensus	415		100.0
KOG0984|consensus	282		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0669|consensus	376		100.0
KOG1024|consensus	563		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0668|consensus	338		100.0
KOG1027|consensus	903		100.0
KOG1290|consensus	590		99.98
KOG0670|consensus	752		99.97
KOG0664|consensus	449		99.97
KOG0576|consensus	829		99.97
KOG1152|consensus	772		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665|consensus	369		99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167|consensus	418		99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1345|consensus	378		99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1165|consensus	449		99.94
KOG1164|consensus	322		99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1163|consensus	341		99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0195|consensus	448		99.92
KOG0590|consensus	601		99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1033|consensus	516		99.89
KOG1240|consensus	1431		99.89
KOG0603|consensus	612		99.89
cd08307	97	Death_Pelle Death domain of the protein kinase Pel	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1023|consensus	484		99.87
cd08795	88	Death_IRAK2 Death domain of Interleukin 1 Receptor	99.85
KOG4158|consensus	598		99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
cd08796	89	Death_IRAK-M Death domain of Interleukin 1 Recepto	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1166|consensus	974		99.82
KOG0606|consensus	1205		99.82
PRK10345	210	hypothetical protein; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd08793	100	Death_IRAK4 Death domain of Interleukin-1 Receptor	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
smart00090	237	RIO RIO-like kinase.	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
cd08794	84	Death_IRAK1 Death domain of Interleukin 1 Receptor	99.75
KOG0590|consensus	601		99.73
cd08309	95	Death_IRAK Death domain of Interleukin-1 Receptor-	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd08308	125	Death_Tube Death domain of Tube. Death domains (DD	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
KOG1266|consensus	458		99.49
KOG0601|consensus	524		99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG3087|consensus	229		99.37
KOG0606|consensus	1205		99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.33
KOG0601|consensus	524		99.32
KOG1243|consensus	690		99.29
COG4248	637	Uncharacterized protein with protein kinase and he	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
KOG3741|consensus	655		99.05
cd08783	97	Death_MALT1 Death domain similar to that found in	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.94
KOG2137|consensus	700		98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.74
PF14786	137	Death_2: Tube Death domain; PDB: 1D2Z_B.	98.72
cd08782	82	Death_DAPK1 Death domain found in death-associated	98.72
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.71
PRK09902	216	hypothetical protein; Provisional	98.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.53
cd08781	83	Death_UNC5-like Death domain found in Uncoordinate	98.43
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
cd08312	79	Death_MyD88 Death domain of Myeloid Differentation	98.37
KOG0576|consensus	829		98.35
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.28
cd08310	72	Death_NFkB-like Death domain of Nuclear Factor-Kap	98.27
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.25
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.22
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.12
PLN02876	822	acyl-CoA dehydrogenase	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.95
PRK10593	297	hypothetical protein; Provisional	97.94
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.9
KOG1235|consensus	538		97.85
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
PF00531	83	Death: Death domain; InterPro: IPR000488 The death	97.74
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.73
KOG1035|consensus	1351		97.69
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.45
PRK05231	319	homoserine kinase; Provisional	97.44
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.42
KOG2268|consensus	465		97.4
KOG1826|consensus	2724		97.38
cd08311	77	Death_p75NR Death domain of p75 Neurotophin Recept	97.28
KOG1093|consensus	725		97.16
smart00005	88	DEATH DEATH domain, found in proteins involved in	97.15
cd01670	79	Death Death Domain: a protein-protein interaction	97.15
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.12
cd08802	84	Death_UNC5B Death domain found in Uncoordinated-5B	97.08
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.85
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.81

>KOG1187|consensus

Probab=100.00  E-value=1.1e-53  Score=417.44  Aligned_cols=287  Identities=40%  Similarity=0.641  Sum_probs=237.7

Q ss_pred             CCCCCChhHHHHhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC
Q psy5927         131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD  209 (441)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  209 (441)
                      ....+++.++..+|++|...+.||+||||.||+|...+ +.||||++.......         ..+|.+|+.++.+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---------~~eF~~Ei~~ls~l~H~  131 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---------EREFLNEVEILSRLRHP  131 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---------hhHHHHHHHHHhcCCCc
Confidence            45568999999999999999999999999999999976 789999876433210         23477999999999999


Q ss_pred             CeecccceEEeCC-eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCeeecCCCCCCeee
Q psy5927         210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE-PPLIHGDIKSANILL  287 (441)
Q Consensus       210 nIv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-~~iiHrDikp~NiLl  287 (441)
                      |+|+|+|||.+.+ ..+||||||++|||+++|+..... +++|..|++||.++|+||+|||... ++||||||||+||||
T Consensus       132 Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  132 NLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             CcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            9999999999998 599999999999999999876554 8999999999999999999999954 489999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch-hHH-
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR-SER-  365 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~-~~~-  365 (441)
                      |+++.+||+|||+|+..... ........ .||.+|+|||++..+..+.++|||||||+|+||+||+.|.+..+. .+. 
T Consensus       211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             CCCCCEEccCccCcccCCcc-ccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            99999999999999775441 11111111 699999999999988999999999999999999999999986541 122 


Q ss_pred             HHHHHHHhhchhhhhhhhccCCC--chhH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQ--PIEL-NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      .+......+....+..++|++..  ..+. .....+..++..|++.+|++||+|.+|++.|+.+...
T Consensus       289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            23332333344567888888754  3332 5677799999999999999999999999999766544

>KOG0192|consensus

Probab=100.00  E-value=6.5e-52  Score=402.42  Aligned_cols=263  Identities=34%  Similarity=0.522  Sum_probs=217.5

Q ss_pred             CCCcCcCccccCCceeEEEEEECCee-EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC-
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG-  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  222 (441)
                      ......+.||.|+||+||+|.+.++. ||||++.....+..       ..+.+.+|+.+|++++|||||+++|+|.+.. 
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~-------~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE-------SRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH-------HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34455577999999999999999998 99999975432221       1567889999999999999999999999887 


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~DFGla  301 (441)
                      .+++|||||++|+|.++++.. ....+++..++.++.+|++|+.|||+.++ ||||||||+|||++.++ ++||+|||++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence            799999999999999999764 45569999999999999999999999876 99999999999999997 9999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCccccc--CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLV--GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +......   ...+...||..|||||+++  ...|+.|+||||||+++|||+||..||.+... ......++.       
T Consensus       192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~-------  260 (362)
T KOG0192|consen  192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVV-------  260 (362)
T ss_pred             eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh-------
Confidence            8744322   1222357999999999999  56899999999999999999999999988765 222222211       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                          ......++..++..+..|+..||+.||..||++.+++..|+.+.....
T Consensus       261 ----~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  261 ----GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             ----cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                122333455588899999999999999999999999999986655443

>KOG0581|consensus

Probab=100.00  E-value=8.3e-52  Score=384.31  Aligned_cols=254  Identities=29%  Similarity=0.447  Sum_probs=210.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++.+.++.||+|..|+||++.++  +.-+|+|.+....        +....+|+.+|+++++.++||+||.+||.|.
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--------~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--------DPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--------CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            34456677899999999999999996  5578999995332        2245668889999999999999999999999


Q ss_pred             eCCe-EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         220 ETGK-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       220 ~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      ..+. .+++||||++|||++.+...   +.+++.....|+.++++||.|||. ++  ||||||||+|||++..|.+||||
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEecc
Confidence            9985 99999999999999988533   558899999999999999999995 88  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||.+......     ...++.||..|||||.+.+..|+.++||||||++++|+++|+.||............++..+   
T Consensus       223 FGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---  294 (364)
T KOG0581|consen  223 FGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---  294 (364)
T ss_pred             ccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---
Confidence            9998764332     34667899999999999999999999999999999999999999977522122222222222   


Q ss_pred             hhhhhhccCCCchhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELN-IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .+......+.. ++.++.+++..||++||.+||++.|+++
T Consensus       295 -----v~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  295 -----VDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -----hcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 22223334444 8899999999999999999999999986

>KOG0575|consensus

Probab=100.00  E-value=7.6e-51  Score=398.33  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=213.9

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .+|...+.||+|||+.||.+++  .+..||+|++.....      .+..+++...+|+++.+.++|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l------~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL------KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh------cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            5799999999999999999998  467899999975322      23456778889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ++|||+|+|..++|..++.   ...++++.+++.++.||+.||.|||+++  |||||||..|+||+++.++||+|||||.
T Consensus        92 nVYivLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             ceEEEEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceee
Confidence            9999999999999998775   3456999999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   ..-.+.|||+.|+|||++....++..+||||+|||+|-||+|++||+...-.+.+.+...           
T Consensus       167 ~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-----------  232 (592)
T KOG0575|consen  167 QLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-----------  232 (592)
T ss_pred             eecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-----------
Confidence            754332   224567999999999999999999999999999999999999999987643222222221           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ..-..|..++.+..+||.++|+.||.+|||+++|+.
T Consensus       233 ---~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  233 ---NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               122345577888999999999999999999999986

>KOG0598|consensus

Probab=100.00  E-value=1.1e-50  Score=376.73  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=205.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|+++++||+|+||+||.++.+  ++-+|+|++++...-      ......+...|..+|.+++||+||+++..|+
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv------~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ   95 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV------EKKEVRHTKAERNILSKIKHPFIVKLIYSFQ   95 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh------hhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence            34578999999999999999999875  457999999754322      2345567789999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+++|||+||+.||.|+..|+...   .+++..++.++.+|+.||.|||++|  ||||||||+|||||.+|+++|+|||
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccc
Confidence            9999999999999999999996544   3888999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      |++......   ..+.++|||+.|||||++.+..|+.++|+||||+++|||++|.+||........ ...+.        
T Consensus       171 L~k~~~~~~---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-~~~I~--------  238 (357)
T KOG0598|consen  171 LCKEDLKDG---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-YDKIL--------  238 (357)
T ss_pred             cchhcccCC---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-HHHHh--------
Confidence            998644332   234557999999999999999999999999999999999999999987654221 11111        


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP  414 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  414 (441)
                          ..+....+.-++.+..+++.++|..||++|.
T Consensus       239 ----~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  239 ----KGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----cCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                1112233334778899999999999999996

>KOG0615|consensus

Probab=100.00  E-value=2.5e-50  Score=377.13  Aligned_cols=259  Identities=24%  Similarity=0.325  Sum_probs=207.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..+.|.+.+.||+|+||.|-+|..+  ++.||||+++..........  ......+.+|+++|++++|||||+++++|.+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~--~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA--IAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc--ccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            4567888999999999999999975  56899999986554332210  0112234599999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---CCeEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---MDPVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---~~~kl~D  297 (441)
                      .+..|+||||++||+|.+++...+   .+.+.....++.|++.|+.|||++|  |+||||||+|||+..+   ..+||+|
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999996544   3666777899999999999999999  9999999999999877   7899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCC---CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL---STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      ||+|+...    ......+.|||+.|.|||++.+..+   ..++|+||+|||||-+|+|.+||.+....+ .+++.+.. 
T Consensus       323 FGlAK~~g----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~eQI~~-  396 (475)
T KOG0615|consen  323 FGLAKVSG----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKEQILK-  396 (475)
T ss_pred             cchhhccc----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHHHHhc-
Confidence            99998743    2233567899999999999987543   348899999999999999999998776533 12222211 


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        +..     .-.......++++..+||.+||..||++|||+.|+++
T Consensus       397 --G~y-----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 --GRY-----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             --Ccc-----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence              000     0011233568899999999999999999999999875

>KOG0595|consensus

Probab=100.00  E-value=2e-49  Score=371.44  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=199.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|...++||+|+||+||+|+++  ++.||||.+.....       .....+....|+++|+.++|||||.+++++.++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~   81 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD   81 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence            468999999999999999999984  56899999875432       223455567999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC------CCeEE
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH------MDPVI  295 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~------~~~kl  295 (441)
                      +.+|||||||+||+|.++++.++   .+++..++.++.|++.||++||+++  ||||||||.||||+..      -.+||
T Consensus        82 ~~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   82 DFIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             CeEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEe
Confidence            99999999999999999997665   4889999999999999999999999  9999999999999875      45899


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||+|+.....    ....+.||++-|||||++..++|+.|+|+||+|+|||++++|+.||+.....+ .+. .++.-.
T Consensus       157 ADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e-L~~-~~~k~~  230 (429)
T KOG0595|consen  157 ADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE-LLL-YIKKGN  230 (429)
T ss_pred             cccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH-HHH-HHhccc
Confidence            999999986533    33566799999999999999999999999999999999999999998765422 222 111100


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                               .-....+..++..+.+|+...+..++++|-+..+-+
T Consensus       231 ---------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  231 ---------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             ---------cccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence                     001122333344455666666666666666655443

>KOG0591|consensus

Probab=100.00  E-value=4.3e-50  Score=358.50  Aligned_cols=257  Identities=22%  Similarity=0.331  Sum_probs=208.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc-eEEe
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG-ICFE  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~  220 (441)
                      ..+|++.++||+|+||.||++..  ++..+|.|.++....       +...++....|+.+|++++|||||++++ .+.+
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            35688999999999999999987  567799999874332       3345667789999999999999999999 4555


Q ss_pred             CCe-EEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC--CCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         221 TGK-YCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSR--EPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       221 ~~~-~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~--~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      .+. ++||||||.+|+|...+...+ ....+++..++.++.|++.||.++|+.  ...|+||||||+||+|+.+|.+||+
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            555 899999999999999886433 345688999999999999999999993  3349999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||||++......   ....+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-.+||.+..     +..+..++..
T Consensus       171 DfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~~KI~q  242 (375)
T KOG0591|consen  171 DFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLCKKIEQ  242 (375)
T ss_pred             cchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHHHHHHc
Confidence            999999754332   22356689999999999999999999999999999999999999998763     2222222222


Q ss_pred             hhhhhhhccCCCchh-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIE-LNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                      .        ...+++ ..++.++..|+..|+..||..||+...++..+
T Consensus       243 g--------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  243 G--------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             C--------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            1        122344 67889999999999999999999965554444

>KOG0197|consensus

Probab=100.00  E-value=5.7e-49  Score=381.29  Aligned_cols=256  Identities=28%  Similarity=0.433  Sum_probs=213.1

Q ss_pred             CCCcCcCccccCCceeEEEEEECCe-eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +.+..++.||+|-||.||.|.++++ .||+|.++....          ..+.+.+|+++|++++|+|||+++|+|..++.
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m----------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM----------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc----------ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            3345568999999999999999876 999999985421          23456799999999999999999999999889


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|||||||+.|+|.++|.. .....+...+.+.++.|||+|++||++++  +|||||...||||+++..+||+|||||+.
T Consensus       276 iyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccc
Confidence            9999999999999999976 34566888999999999999999999999  99999999999999999999999999994


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......+.  .....-...|.|||.+..+.++.+||||||||+||||+| |+.||..... .+.+..+-           
T Consensus       353 ~~d~~Y~~--~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~ev~~~le-----------  418 (468)
T KOG0197|consen  353 IGDDEYTA--SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-EEVLELLE-----------  418 (468)
T ss_pred             cCCCceee--cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-HHHHHHHh-----------
Confidence            33222211  111223456999999999999999999999999999999 9999987754 22222221           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                       .....+.|..|+..+++|+..||+.+|++|||+..+...|+.+..
T Consensus       419 -~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  419 -RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             -ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence             122445677899999999999999999999999999999887654

>KOG0616|consensus

Probab=100.00  E-value=1.1e-48  Score=351.90  Aligned_cols=240  Identities=23%  Similarity=0.339  Sum_probs=208.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|+.++.||.|+||.|.+++.+  +..+|+|+++..      +.++..+.++...|..+|+.+.||+++++++.|.+
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~------~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ------KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH------HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            3578999999999999999999874  457999999743      33455778888999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+.++|||||++||.|+.+|+..   +.+++..++.++.+|+.||+|||+.+  |++|||||+|||||++|.+||+|||+
T Consensus       116 ~~~lymvmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGF  190 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGF  190 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccc
Confidence            99999999999999999999654   34888999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      |+....      .+.+.|||+.|+|||.++...|+.++|+|||||++|||+.|.+||...+....+-+.+          
T Consensus       191 AK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~----------  254 (355)
T KOG0616|consen  191 AKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL----------  254 (355)
T ss_pred             eEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH----------
Confidence            976332      2567799999999999999999999999999999999999999998876633222221          


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER  413 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  413 (441)
                          ......|..++.++.+|+...|+.|-.+|
T Consensus       255 ----~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 ----EGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----hCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                22334567788899999999999999999

>KOG0694|consensus

Probab=100.00  E-value=7.9e-48  Score=381.25  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      ++..+..+..++|..+++||+|+||+|+++..++  ..+|||++++...-      .....+....|.+|+... +||.+
T Consensus       358 ~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il------~~d~Ve~~~~EkrI~~la~~HPFL  431 (694)
T KOG0694|consen  358 FPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL------QRDEVESLMCEKRIFELANRHPFL  431 (694)
T ss_pred             CCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee------ccccHHHHHHHHHHHHHhccCCeE
Confidence            3333346778899999999999999999999865  47999999865422      223455666788887766 69999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      +.|+.+|...+++|+||||+.||++..+    .....+++..+..++..++.||+|||++|  |||||||.+|||||.+|
T Consensus       432 ~~L~~~fQT~~~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eG  505 (694)
T KOG0694|consen  432 VNLFSCFQTKEHLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEG  505 (694)
T ss_pred             eecccccccCCeEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccC
Confidence            9999999999999999999999995432    23355999999999999999999999999  99999999999999999


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      ++||+||||++......   ..++++|||+.|||||++.+..|+.++|||||||+|||||.|..||.+.++++ ....  
T Consensus       506 h~kiADFGlcKe~m~~g---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-~Fds--  579 (694)
T KOG0694|consen  506 HVKIADFGLCKEGMGQG---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-VFDS--  579 (694)
T ss_pred             cEEecccccccccCCCC---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH--
Confidence            99999999999865433   34678899999999999999999999999999999999999999999876633 2222  


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                                 +-......|..++.+..+++.++|.++|++|.-+
T Consensus       580 -----------I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  580 -----------IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----------HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                       2222344667788999999999999999999866

>KOG0593|consensus

Probab=100.00  E-value=5.7e-48  Score=348.12  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=206.1

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +.|+.+.++|+|+||.||++++++  .-||||++....++..+       .+-.++|+++|++++|||+|.|+++|....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~V-------kKIAlREIrmLKqLkH~NLVnLiEVFrrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVV-------KKIALREIRMLKQLKHENLVNLIEVFRRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHH-------HHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence            468889999999999999999865  56999999866554433       345679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .++||+|||+..-| +-|....  ..++......++.|++.|+.|+|+++  +|||||||+|||++.+|.+||||||+|+
T Consensus        75 klhLVFE~~dhTvL-~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   75 KLHLVFEYCDHTVL-HELERYP--NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             eeEEEeeecchHHH-HHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhH
Confidence            99999999975444 4454333  34788899999999999999999999  9999999999999999999999999999


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EEN  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~  378 (441)
                      .....   ....+.++.|.+|.|||.+.| -+|+..+||||+||++.||++|.+-|.+..+.+ ++..+.....   +..
T Consensus       150 ~L~~p---gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD-QLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  150 TLSAP---GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID-QLYLIRKTLGNLIPRH  225 (396)
T ss_pred             hhcCC---cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH-HHHHHHHHHcccCHHH
Confidence            75432   223455678999999999998 689999999999999999999999998877644 3333333221   111


Q ss_pred             hhhhhcc-------------CCCchh---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDK-------------NAQPIE---LNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~-------------~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      + .++..             ...+++   +.++.-+.++++.||..||.+|++-++++.
T Consensus       226 q-~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  226 Q-SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             H-HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            0 01100             011111   345567899999999999999999999863

>KOG0592|consensus

Probab=100.00  E-value=2.7e-47  Score=367.73  Aligned_cols=256  Identities=22%  Similarity=0.252  Sum_probs=214.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccce
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGI  217 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  217 (441)
                      .....+|..++.||+|+|++|++|+..  ++.||||++.+....      ++...+.+..|-.+|.+| .||.|++||..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii------ke~KvkYV~~Ek~~l~~L~~hPgivkLy~T  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII------KEKKVKYVTREKEALTQLSGHPGIVKLYFT  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH------hhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence            566789999999999999999999985  568999998743322      223344556899999999 89999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      |.|...+|+|+||+++|+|.++|.+.   +.+++...+.++.+|+.||+|||++|  ||||||||+|||||.+|++||+|
T Consensus       143 FQD~~sLYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITD  217 (604)
T KOG0592|consen  143 FQDEESLYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITD  217 (604)
T ss_pred             eecccceEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEee
Confidence            99999999999999999999999654   55899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCccc----------ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH
Q psy5927         298 FGLTQEGPIEKA----------THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL  367 (441)
Q Consensus       298 FGla~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l  367 (441)
                      ||.|+.......          ......+++||..|.+||++.....+..+|+|+|||+||.|+.|.+||....+...+-
T Consensus       218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            999986543211          1112256899999999999999999999999999999999999999998876633332


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +.+.-              .-.++..+++.+.+|+.+.|..||++|++.++|.+
T Consensus       298 kI~~l--------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 KIQAL--------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHh--------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            22221              22355667788999999999999999999999876

>KOG0600|consensus

Probab=100.00  E-value=1.3e-46  Score=360.34  Aligned_cols=266  Identities=25%  Similarity=0.355  Sum_probs=209.2

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....+.|+.+++||+|+||.||+|++..  ..||+|++.....+...       ..-..+||.||+++.||||++|.+..
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-------~~t~~REI~ILr~l~HpNIikL~eiv  185 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-------PITAIREIKILRRLDHPNIIKLEEIV  185 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-------hHHHHHHHHHHHhcCCCcccceeeEE
Confidence            3455779999999999999999999854  56999999876544332       22345999999999999999999998


Q ss_pred             EeC--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         219 FET--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       219 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      .+.  +.+|||+|||+ .+|.-.+.  ...-.++..++..++.|++.||+|||++|  |+|||||.+|||||.+|.+||+
T Consensus       186 t~~~~~siYlVFeYMd-hDL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMD-HDLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             EecCCceEEEEEeccc-chhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEec
Confidence            876  78999999995 77877663  33446899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh-
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY-  374 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-  374 (441)
                      |||||++........  .+..+-|.+|.|||.+.| ..|+.++|+||.||||.||++|++.|.+..+.+ ++..+.+.. 
T Consensus       261 DFGLAr~y~~~~~~~--~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcG  337 (560)
T KOG0600|consen  261 DFGLARFYTPSGSAP--YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCG  337 (560)
T ss_pred             cccceeeccCCCCcc--cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhC
Confidence            999999754443222  334457999999999998 479999999999999999999999999887744 443333322 


Q ss_pred             c-hhhhhhhhc-------cCCC-------chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 S-EENMYDLVD-------KNAQ-------PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~-~~~~~~~~~-------~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      . .++.....+       +...       ..-..++....+|+..+|+.||.+|.|+.++++
T Consensus       338 SP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  338 SPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1 111111111       0011       112345667799999999999999999999886

>KOG0198|consensus

Probab=100.00  E-value=9.1e-47  Score=356.05  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|...+.||+|+||.||++...+  ...|||.+......         ..+.+.+|+++|++++|||||+++|.....
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---------~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~   86 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---------TSESLEREIRILSRLNHPNIVQYYGSSSSR   86 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---------hHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence            3567888999999999999999864  78999998754211         134556999999999999999999975444


Q ss_pred             C--eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEecc
Q psy5927         222 G--KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDF  298 (441)
Q Consensus       222 ~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~DF  298 (441)
                      .  .+++.|||+++|||.+++.....  .+++..+..+++||+.||.|||++|  ||||||||+|||++. ++.+||+||
T Consensus        87 ~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDF  162 (313)
T KOG0198|consen   87 ENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADF  162 (313)
T ss_pred             cCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccC
Confidence            4  68999999999999998865443  6999999999999999999999999  999999999999999 799999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCc-chhHHHHHHHHHhhch
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDT-RRSERHLKSLVEKYSE  376 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~-~~~~~~l~~~~~~~~~  376 (441)
                      |++...............+.||+.|||||++..+ ....++|||||||++.||+||.+||.+. ......+....     
T Consensus       163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~-----  237 (313)
T KOG0198|consen  163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR-----  237 (313)
T ss_pred             ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-----
Confidence            9998644311122223456799999999999953 3345999999999999999999999874 22111111111     


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                             ......++..++.+..+++.+|+..||++|||+.++++.-
T Consensus       238 -------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  238 -------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             -------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                   1123356777889999999999999999999999999844

>KOG0659|consensus

Probab=100.00  E-value=4.9e-46  Score=330.26  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=210.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .+|...++||+|.||.||+|++.  ++.||||+++........       ....++|++.|+.++|+||+.++++|...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-------~~talREIK~Lqel~h~nIi~LiD~F~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-------NRTALREIKLLQELKHPNIIELIDVFPHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-------cHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence            46888999999999999999984  568999999876544332       234569999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+.||+|||+ .+|+..+.  .....++..++..++.++++||+|||++.  |+||||||.|+|++.+|.+||+|||+|+
T Consensus        75 ~l~lVfEfm~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   75 NLSLVFEFMP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             ceEEEEEecc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchh
Confidence            9999999995 89998884  44566899999999999999999999998  9999999999999999999999999999


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EEN  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~  378 (441)
                      ..........   ..+.|.+|.|||.+.| ..|+..+|+||.|||++||+-|.+-|.+..+. +++..+.....   ++.
T Consensus       150 ~f~~p~~~~~---~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  150 FFGSPNRIQT---HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             ccCCCCcccc---cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCccc
Confidence            8654432221   1157999999999988 57999999999999999999998888877663 44444444331   111


Q ss_pred             ---hh---hhhccC------CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         379 ---MY---DLVDKN------AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       379 ---~~---~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                         +.   ++..-.      ...+-+..+.+..+|+.++|..||.+|++++|+++.
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence               11   111111      111334456778999999999999999999999873

>KOG0583|consensus

Probab=100.00  E-value=6.1e-46  Score=363.71  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=209.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  218 (441)
                      ...++|.+.+.||+|+||+|+.|.+  .+..||+|++.........    ....+.+.+|+.+++.++ ||||+++++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~----~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS----QKLDELIKREISILRRLRSHPNIIRLLEVF   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc----cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence            4567899999999999999999987  4578999976643111010    012234458999999998 99999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCeEEec
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGD  297 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~kl~D  297 (441)
                      .....+++||||+.||+|++++..   .+.+.+..+..+++|++.|++|||++|  |+||||||+|||+|.+ +++||+|
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEec
Confidence            999999999999999999999965   345888999999999999999999999  9999999999999999 9999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCC-CC-CccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR-LS-TKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      ||++....   .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||++......+.+       
T Consensus       165 FG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-------  234 (370)
T KOG0583|consen  165 FGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-------  234 (370)
T ss_pred             cccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-------
Confidence            99998753   1223356679999999999999977 75 789999999999999999999988543221111       


Q ss_pred             hhhhhhhhccCCCchhHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNI-AYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             +....-.++..+ +.++.+|+.+||..||.+|+++.++++
T Consensus       235 -------i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  235 -------IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -------HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                   223333445555 889999999999999999999999984

>KOG1026|consensus

Probab=100.00  E-value=8.3e-47  Score=383.17  Aligned_cols=273  Identities=25%  Similarity=0.415  Sum_probs=227.0

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      ..++...+-...+.||+|.||+||+|+..       .+.||||.++.....        .+...|.+|++++..++||||
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--------~~~~dF~REaeLla~l~H~nI  551 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--------QARQDFRREAELLAELQHPNI  551 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--------HHHHHHHHHHHHHHhccCCCe
Confidence            33455667777899999999999999863       356999999854322        245678899999999999999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-----------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI  280 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDi  280 (441)
                      |+|+|+|.+++.+|+|+|||..|+|.++|..+..           .++|+..+.+.||.|||.|++||-++.  +|||||
T Consensus       552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDL  629 (774)
T KOG1026|consen  552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDL  629 (774)
T ss_pred             EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccch
Confidence            9999999999999999999999999999976542           234888999999999999999999999  999999


Q ss_pred             CCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCC
Q psy5927         281 KSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD  359 (441)
Q Consensus       281 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~  359 (441)
                      ...|+||.++..+||+||||++.....+...... ...-..+|||||.|..+++|++||||||||||||+++ |+.||.+
T Consensus       630 ATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~-~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  630 ATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRG-NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             hhhhceeccceEEEecccccchhhhhhhhhcccC-CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence            9999999999999999999998755443322111 1112558999999999999999999999999999999 9999988


Q ss_pred             cchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q psy5927         360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATG  435 (441)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  435 (441)
                      ... ++.            +.........+.+.+++.++++|+..||+.+|++||++++|-.+|+.....++....
T Consensus       709 lSn-~EV------------Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~  771 (774)
T KOG1026|consen  709 LSN-QEV------------IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS  771 (774)
T ss_pred             cch-HHH------------HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence            754 211            222233445677889999999999999999999999999999999999888876543

>KOG0582|consensus

Probab=100.00  E-value=1.6e-45  Score=348.02  Aligned_cols=265  Identities=20%  Similarity=0.289  Sum_probs=212.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||.|..++||+|+.  .+..||||++...+.+..        .+.+.+|+..|+.++||||++++..|.
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--------ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--------LDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--------HHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            4567899999999999999999997  467899999986544332        345668999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+..+|+||+||.+||+.+.+...-.. .+++..+..|++++++||.|||++|  .||||||+.||||+.+|.+||+|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCce
Confidence            999999999999999999988655443 3899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcc-cccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         300 LTQEGPIEK-ATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       300 la~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      .+-...... .....+..+.||++|||||++..  ..|+.|+||||||++..||.+|..||.....-...+..+.    .
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq----n  247 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ----N  247 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc----C
Confidence            765433222 12223367789999999999543  5799999999999999999999999988765333333322    1


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ............+....++..+.+++..||.+||.+|||++++++
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111111111111223445668999999999999999999999985

>KOG0605|consensus

Probab=100.00  E-value=3.7e-46  Score=360.07  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=207.2

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .+..++|+++..||+|+||.||+|+.+  +.-+|+|++++.      +.+...+.+++..|-.+|....+|+||+||..|
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS------~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS------EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH------HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            456789999999999999999999875  456999999854      233556788889999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+...+||||||++||++...|..   .+.|++..++.++.+++.||+.||+.|  +|||||||+|+|||..|++||+||
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccc
Confidence            999999999999999999998853   345899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCC----------------------cccc----------------------cceeccccccCCCcCcccccCCCC
Q psy5927         299 GLTQEGPI----------------------EKAT----------------------HITLKRVNGTRPYLPHEFLVGKRL  334 (441)
Q Consensus       299 Gla~~~~~----------------------~~~~----------------------~~~~~~~~gt~~y~aPE~~~~~~~  334 (441)
                      ||+.-...                      ....                      .......+|||.|||||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            99842110                      0000                      001123579999999999999999


Q ss_pred             CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC
Q psy5927         335 STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP  414 (441)
Q Consensus       335 s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  414 (441)
                      +..+|+||||||+||||.|.+||......+..-+.  ..|..        .-.-+....++.+..+||++||. ||++|.
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI--~nwr~--------~l~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKI--VNWRE--------TLKFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhh--------hccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            99999999999999999999999877653322211  11110        00112223455789999999999 999997


Q ss_pred             C---HHHHH
Q psy5927         415 E---MTQVY  420 (441)
Q Consensus       415 s---~~evl  420 (441)
                      -   +.||-
T Consensus       435 G~~G~~EIK  443 (550)
T KOG0605|consen  435 GSKGAEEIK  443 (550)
T ss_pred             CcccHHHHh
Confidence            5   55554

>KOG0193|consensus

Probab=100.00  E-value=4.9e-46  Score=363.09  Aligned_cols=272  Identities=27%  Similarity=0.409  Sum_probs=220.5

Q ss_pred             CCChhHHHHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      .++..++.+..+.+.+...||+|.||+||+|.|.+. ||||++++.....       .+.+.|..|+.++++-+|.||+-
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~-------~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTP-------EQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCH-------HHHHHHHHHHHHHhhcchhhhee
Confidence            344566667777788899999999999999999884 9999999765533       46778899999999999999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      +.|+|...+. .||..+|+|-||+.+|+..+  ..+.....+.|++||+.|+.|||.++  |||||||+.||+|.+++.|
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcE
Confidence            9999988777 89999999999999997554  45888899999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCC---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      ||+||||+.....- ..........|...|||||+++.+   +|+..+||||||+|+|||+||..||.....+. .+ - 
T Consensus       528 kIgDFGLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-Ii-f-  603 (678)
T KOG0193|consen  528 KIGDFGLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-II-F-  603 (678)
T ss_pred             EEecccceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-eE-E-
Confidence            99999998653221 111223344588899999999763   68999999999999999999999998443311 11 0 


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                          ...  .-+..+.......+++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus       604 ----mVG--rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 ----MVG--RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ----Eec--ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                000  0111222333456788899999999999999999999999998887766

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-45  Score=362.46  Aligned_cols=264  Identities=25%  Similarity=0.371  Sum_probs=206.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      +..++|++.++||+|+||.||+|.+.       +..||||+++.....        .....+.+|+.++..+ +||||++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv~   75 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--------SEHKALMSELKILIHIGNHLNVVN   75 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--------HHHHHHHHHHHHHHHhccCcceee
Confidence            45678999999999999999999752       246999998643211        1234567899999999 8999999


Q ss_pred             ccceEEeC-CeEEEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q psy5927         214 LYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN-----------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------  245 (441)
                      ++++|... +.+++||||+++|+|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (338)
T cd05102          76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG  155 (338)
T ss_pred             EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence            99988764 458999999999999999865321                                               


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccce
Q psy5927         246 ------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT  313 (441)
Q Consensus       246 ------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  313 (441)
                                  ..++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++....... ...
T Consensus       156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~  232 (338)
T cd05102         156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVR  232 (338)
T ss_pred             ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcc-hhc
Confidence                        134778889999999999999999998  99999999999999999999999999975432211 111


Q ss_pred             eccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhH
Q psy5927         314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIEL  392 (441)
Q Consensus       314 ~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  392 (441)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..||............+..            ......+.
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------~~~~~~~~  300 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD------------GTRMRAPE  300 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc------------CCCCCCCC
Confidence            223346778999999998899999999999999999997 99999875442322221111            11111233


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         393 NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       393 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      .++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            456789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4721|consensus

Probab=100.00  E-value=2.7e-46  Score=361.18  Aligned_cols=243  Identities=29%  Similarity=0.461  Sum_probs=205.1

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR  229 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  229 (441)
                      ++-||.|+.|-||+|+..+..||||+++..+                ..+|+-|++|+||||+.+.|+|.....+|||||
T Consensus       129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk----------------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME  192 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK----------------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME  192 (904)
T ss_pred             hhhhccCcccceeeeeccCceehhHHHhhhh----------------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence            5779999999999999999999999986221                167888999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccc
Q psy5927         230 YMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA  309 (441)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~  309 (441)
                      ||..|.|...|...   ..+.......+..+|+.|++|||.+.  |||||||+-||||..+..+||+|||.++.....  
T Consensus       193 fCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--  265 (904)
T KOG4721|consen  193 FCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--  265 (904)
T ss_pred             ccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence            99999999998543   34777888899999999999999999  999999999999999999999999998764332  


Q ss_pred             ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCc
Q psy5927         310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP  389 (441)
Q Consensus       310 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  389 (441)
                        .+...++||..|||||+|+..+.+.|+|||||||||||||||..||.+.......       |...     -+.-..+
T Consensus       266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------wGVG-----sNsL~Lp  331 (904)
T KOG4721|consen  266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------WGVG-----SNSLHLP  331 (904)
T ss_pred             --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------Eecc-----CCccccc
Confidence              1234578999999999999999999999999999999999999999776542110       0000     0111345


Q ss_pred             hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         390 IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       390 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      .+..++..+.-|+++||+..|..||++.+++..|+=...+
T Consensus       332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            6778899999999999999999999999999988755443

>KOG0578|consensus

Probab=100.00  E-value=1.2e-45  Score=359.09  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=207.1

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|....+||+|..|.||.|..  .+..||||.+......         ..+-++.|+.+|+..+|+|||.+++.|..++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---------~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---------KKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---------chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            5688889999999999999987  4567999998765432         2345679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|.|||||+||+|.|.+...    .+++.++..|+++++.||+|||.+|  |||||||++|||++.+|.+||+|||++.
T Consensus       344 eLWVVMEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeee
Confidence            999999999999999988433    2889999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ...+.+||+.|||||++....|++++||||||++++||+-|.+||-..+. -..+..+....        
T Consensus       418 qi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-lrAlyLIa~ng--------  485 (550)
T KOG0578|consen  418 QISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATNG--------  485 (550)
T ss_pred             ccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-HHHHHHHhhcC--------
Confidence            6543322   34566899999999999999999999999999999999999999976432 11111111100        


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ......+..++..+.+++.+||..|+.+|+++.|+|+
T Consensus       486 --~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 --TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              1122335567889999999999999999999999987

>KOG0597|consensus

Probab=100.00  E-value=1.2e-45  Score=356.81  Aligned_cols=247  Identities=23%  Similarity=0.348  Sum_probs=209.9

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|.+.+.||+|+||.||||+.+.  ..||+|.+.+.....       ...+.+.+|+++++.++|||||.++++|+...
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-------k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-------KELKNLRQEVRILRSLKHPNIVEMLESFETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-------HHHHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence            578999999999999999999865  468999886544322       33456679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ++|+|.||+.| +|..+|...   +.+++..+..|+.+++.||.|||+.+  |+|||+||.|||++.+|.+|+||||+|+
T Consensus        75 ~~~vVte~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   75 HLWVVTEYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             eEEEEehhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhh
Confidence            99999999965 999988643   44899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ....   .....+++.||+.|||||...++.|+..+|.||+||++||+.+|++||....-     ..+++.         
T Consensus       149 ~m~~---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----~~Lv~~---------  211 (808)
T KOG0597|consen  149 AMST---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----TQLVKS---------  211 (808)
T ss_pred             hccc---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----HHHHHH---------
Confidence            7543   33456778899999999999999999999999999999999999999965432     111211         


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +......++...+..+.+++...|.+||..|.+..+++.
T Consensus       212 I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  212 ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            222234456678889999999999999999999999874

>KOG0661|consensus

Probab=100.00  E-value=9.7e-46  Score=351.89  Aligned_cols=262  Identities=21%  Similarity=0.305  Sum_probs=210.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  218 (441)
                      ..-++|..+++||.|+||.||+|...  +..||||+++..-..       +.+. .-++|++.|+++. ||||++|.+++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-------~ee~-~nLREvksL~kln~hpniikL~Evi   78 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-------WEEC-MNLREVKSLRKLNPHPNIIKLKEVI   78 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-------HHHH-HHHHHHHHHHhcCCCCcchhhHHHh
Confidence            45678999999999999999999974  567999998743211       1111 2258999999998 99999999999


Q ss_pred             EeCC-eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         219 FETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       219 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      .+.+ .+++||||| ..+|.+.+..+  ...+++..+..|+.||+.||+|+|.+|  +.|||+||+|||+..+..+||+|
T Consensus        79 ~d~~~~L~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   79 RDNDRILYFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             hccCceEeeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecc
Confidence            9988 999999999 58999988654  567999999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||||......    ..+.++.|.+|.|||++.. .-|+.++|+||+|||++|+.+-++-|.+..+.+ ++..+.+.+..
T Consensus       154 FGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGt  228 (538)
T KOG0661|consen  154 FGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGT  228 (538)
T ss_pred             cccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCC
Confidence            99999854433    2445678999999998754 678999999999999999999999999887744 34344433311


Q ss_pred             ---h------hhhhhhc--------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ---E------NMYDLVD--------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ---~------~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .      .+...+.        .....+-++.+.++.+|+.+||++||++|||+.++++
T Consensus       229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence               1      1111111        1122233457888999999999999999999999987

>KOG0588|consensus

Probab=100.00  E-value=5e-45  Score=358.86  Aligned_cols=256  Identities=25%  Similarity=0.355  Sum_probs=213.8

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +-|++++.||.|+.|.|-+|.+  .++..|||++......      ...+...+.+|+-+|+.+.|||++++|+++.+..
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~------s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL------SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeecccccc------ccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            4688999999999999999998  4667999999754321      1223344558999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ++|+|.||++||.|++++..+   +++++..+..+++||+.|+.|+|..+  |+||||||+|+|||.++++||+|||+|.
T Consensus        86 ~lylvlEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceee
Confidence            999999999999999999754   45888999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      .....    ....+.||++.|.+||++.|.+| +.++||||+|||||.||||..||++..-. ..+..+           
T Consensus       161 Le~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-~LLlKV-----------  224 (786)
T KOG0588|consen  161 LEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-VLLLKV-----------  224 (786)
T ss_pred             cccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-HHHHHH-----------
Confidence            64333    33566799999999999999888 67899999999999999999999965432 122221           


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGE  429 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~  429 (441)
                        ....-.+|.+++.+.++|+.+||..||.+|.++.+|++  .|.+....
T Consensus       225 --~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  225 --QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             --HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence              12223456778889999999999999999999999998  45444433

>KOG0663|consensus

Probab=100.00  E-value=8.7e-45  Score=331.57  Aligned_cols=281  Identities=23%  Similarity=0.341  Sum_probs=214.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..+.|+++++|++|+||.||+|.++.  .-||+|+++......+...       ..++|+.+|.+++|||||.+-.+...
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-------tsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-------TSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-------hhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            34678999999999999999999864  5699999998765444322       34699999999999999999887654


Q ss_pred             --CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         221 --TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       221 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                        -+.+|+|||||+ .+|...+..-.  .++...++..+..|+++|++|||.+.  |+|||||++|+|+++.|.+||+||
T Consensus       147 ~~~d~iy~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             cccceeeeeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEeccc
Confidence              367999999995 78888775433  46888999999999999999999988  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh--c
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY--S  375 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~--~  375 (441)
                      ||||......   ...+..+-|.+|.|||.+.| ..|++++|+||+|||+.||+++.+-|.+..+.+ ++..+....  .
T Consensus       222 GLAR~ygsp~---k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtP  297 (419)
T KOG0663|consen  222 GLAREYGSPL---KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTP  297 (419)
T ss_pred             chhhhhcCCc---ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCC
Confidence            9999865442   12344567999999999988 469999999999999999999999999887643 343333322  1


Q ss_pred             hhhhh-hh--------hc---cCCCc----hh-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCCCCCCC
Q psy5927         376 EENMY-DL--------VD---KNAQP----IE-LNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESPNATGP  436 (441)
Q Consensus       376 ~~~~~-~~--------~~---~~~~~----~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~~~~~p  436 (441)
                      .+.+. .+        +.   .....    .. ..+++.-++|+..+|..||++|.|+++.++  .+...-...+-..+|
T Consensus       298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~P  377 (419)
T KOG0663|consen  298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFP  377 (419)
T ss_pred             ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcC
Confidence            11111 00        00   00000    01 114577899999999999999999999986  455544444445556


Q ss_pred             CCC
Q psy5927         437 TLP  439 (441)
Q Consensus       437 ~~~  439 (441)
                      ++|
T Consensus       378 t~P  380 (419)
T KOG0663|consen  378 TWP  380 (419)
T ss_pred             CCc
Confidence            555

>KOG0585|consensus

Probab=100.00  E-value=7.5e-45  Score=345.48  Aligned_cols=267  Identities=23%  Similarity=0.320  Sum_probs=208.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhh-----HHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLN-----QCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      ....+.|++.+.||+|.||+|-+|++  .++.||||++.........-...     ....++..+|+.+|++|+|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34568999999999999999999998  46789999997655433221111     123467889999999999999999


Q ss_pred             ccceEEeC--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         214 LYGICFET--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       214 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      |+++..+.  +.+|||+|||..|.+.+   +....+.++..+++.|+++++.||+|||.+|  ||||||||+|+||+++|
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCC
Confidence            99987654  67999999999998854   2233334999999999999999999999999  99999999999999999


Q ss_pred             CeEEeccCCCccCCCc--ccccceeccccccCCCcCcccccCCC----CCCccceehHHHHHHHHHhCCCCCCCcchhHH
Q psy5927         292 DPVIGDFGLTQEGPIE--KATHITLKRVNGTRPYLPHEFLVGKR----LSTKVDVYGFGIVLFELATGMRAYDDTRRSER  365 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~  365 (441)
                      ++||+|||.+......  ......+.+..||++|+|||...++.    .+.+.||||+||+||.|+.|..||.+...-+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998754222  12223345578999999999988732    46789999999999999999999987655222


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      +-+..     .+.       -.-+..+++.+.+.+||+++|.+||+.|.++.+|....-
T Consensus       328 ~~KIv-----n~p-------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  328 FDKIV-----NDP-------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             HHHHh-----cCc-------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            22221     110       011222356788999999999999999999999876553

>KOG0580|consensus

Probab=100.00  E-value=5e-45  Score=319.42  Aligned_cols=252  Identities=27%  Similarity=0.402  Sum_probs=211.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++++.||+|-||.||.|+.+.+  -||+|++.+..      .......+++.+|++|-+.++||||+++|++|.
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq------i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ------ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH------HHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            4467899999999999999999998654  68999886432      112233456679999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +....||++||.++|+|...|.... ...+++.....+..|++.|+.|+|..+  ||||||||+|+|++..+.+||+|||
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCC
Confidence            9999999999999999999886443 345788888999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      -+...+     .....+.|||..|+|||...+..++..+|+|++|++.||++.|.+||......+.+-+..         
T Consensus       170 wsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---------  235 (281)
T KOG0580|consen  170 WSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---------  235 (281)
T ss_pred             ceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---------
Confidence            887643     233456789999999999999999999999999999999999999998765433222211         


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           +-....+..++....+||.+||..+|.+|.+..+|++
T Consensus       236 -----k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  236 -----KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -----HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                 1122344677889999999999999999999999986

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.7e-44  Score=342.29  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=201.7

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|+..+.||+|+||.||+|.+.  +..||+|.+.......      ......+.+|+++++.++|+||+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh------hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            3778899999999999999874  6789999886432111      1122345689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            999999999999998775433 345889999999999999999999999  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .....    ......||..|+|||++.+..++.++|||||||++|||++|..||........ ...+...         +
T Consensus       152 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~---------~  217 (285)
T cd05631         152 IPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRR---------V  217 (285)
T ss_pred             cCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHH---------h
Confidence            43221    12344689999999999998999999999999999999999999986543211 1111110         1


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                      .......+..++..+.+|+.+||+.||++||+     ++++++
T Consensus       218 ~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         218 KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11112233456778999999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.9e-44  Score=341.29  Aligned_cols=249  Identities=19%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe----CCeEE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE----TGKYC  225 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~  225 (441)
                      ...||+|++|.||+|.+++..||||+++......      ....+.+.+|+.+|.+++||||+++++++.+    ...++
T Consensus        25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH------KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             CeEEeeCCceEEEEEEECCEEEEEEecccccccc------HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            3679999999999999999999999987532211      1224566799999999999999999999877    35789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      +||||+++|+|.+++...   ..+++.....++.+++.||.|||+. +  ++||||||+|||+++++.+||+|||+++..
T Consensus        99 lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         99 LILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            999999999999998643   3588999999999999999999984 7  889999999999999999999999998753


Q ss_pred             CCcccccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ....      ....||..|+|||.+.+  ..++.++|||||||++|||++|..||..... ......+...         
T Consensus       174 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-~~~~~~i~~~---------  237 (283)
T PHA02988        174 SSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-KEIYDLIINK---------  237 (283)
T ss_pred             cccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhc---------
Confidence            2211      12358899999999976  6799999999999999999999999987643 1122211111         


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                        ......+..++..+.+++.+||+.||++||++++|++.|+...
T Consensus       238 --~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        238 --NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              0111233356778999999999999999999999999998653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=344.45  Aligned_cols=246  Identities=21%  Similarity=0.283  Sum_probs=201.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+.  +..+|+|++......      .....+.+.+|+++++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI------RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            47899999999999999999985  678999998642211      1123445678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcch
Confidence            999999999999999988643   34888999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .....      .....||+.|+|||.+.+..++.++|||||||++|||++|..||....... ....+..          
T Consensus       150 ~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~i~~----------  212 (291)
T cd05612         150 KLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-IYEKILA----------  212 (291)
T ss_pred             hccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----------
Confidence            54321      123469999999999999889999999999999999999999997754321 1111111          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                         ....++..++..+.+|+.+||+.||.+||+     +.++++
T Consensus       213 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         213 ---GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ---CCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence               111233345667899999999999999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-43  Score=342.50  Aligned_cols=265  Identities=23%  Similarity=0.376  Sum_probs=203.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC------------------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK------------------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS  205 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  205 (441)
                      .++|.+.++||+|+||.||+|.+++                  ..||+|.+......        .....+.+|++++.+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~   75 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--------NARNDFLKEVKILSR   75 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--------HHHHHHHHHHHHHhh
Confidence            4678999999999999999998532                  25899988643211        223456789999999


Q ss_pred             CCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy5927         206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK----------------NTPSLLWTQRLHIAKGTSLGLQFLH  269 (441)
Q Consensus       206 l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~al~~LH  269 (441)
                      ++||||+++++++.+.+..|+||||+++|+|.+++....                ....+++..+..++.|++.||.|||
T Consensus        76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH  155 (304)
T cd05096          76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS  155 (304)
T ss_pred             cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999885432                1234788899999999999999999


Q ss_pred             cCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHH
Q psy5927         270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFE  349 (441)
Q Consensus       270 ~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~e  349 (441)
                      +.+  |+||||||+|||++.++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++||
T Consensus       156 ~~~--ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         156 SLN--FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             HCC--ccccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence            999  99999999999999999999999999975432211 112223446788999999988889999999999999999


Q ss_pred             HHh--CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         350 LAT--GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       350 llt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      |++  |..||..... ................     ......+..++..+.+|+.+||+.||.+||++.+|.+.|++
T Consensus       233 l~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         233 ILMLCKEQPYGELTD-EQVIENAGEFFRDQGR-----QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHccCCCCCCcCCH-HHHHHHHHHHhhhccc-----cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            987  5677876543 2222222111111000     00011123456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201|consensus

Probab=100.00  E-value=1.9e-45  Score=347.26  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|...+.||+|+||.||+|.+..  +.||+|++........        .+.+.+|+.+|..++++||.++|+.+..+.
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--------Iediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--------IEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchh--------hHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            347777999999999999999864  5799999986554433        334558999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .++++||||.||++.+.|..   ...+.+..+..|+++++.|+.|||+++  .||||||++|||+..+|.+|++|||.+-
T Consensus        85 ~LwiiMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAG  159 (467)
T ss_pred             cHHHHHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceee
Confidence            99999999999999998843   333477788889999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ....   +.....++.||+.|||||++.+..|+.++||||||++.+||++|.+||.+.+. ...            ++.+
T Consensus       160 ql~~---~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrv------------lflI  223 (467)
T KOG0201|consen  160 QLTN---TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRV------------LFLI  223 (467)
T ss_pred             eeec---hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceE------------EEec
Confidence            6432   22233667899999999999998999999999999999999999999977653 111            1111


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......+...++..+.+++..||.+||+.||++.++++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            112222334477888999999999999999999999975

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.5e-44  Score=346.36  Aligned_cols=243  Identities=23%  Similarity=0.332  Sum_probs=197.3

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY  228 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  228 (441)
                      +.||+|+||.||+|.+.  +..||+|+++....      ........+.+|+++++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            46999999999999874  56799999874211      11223445668999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcc
Q psy5927         229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK  308 (441)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~  308 (441)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.|  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          75 EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            999999999988543   35889999999999999999999999  9999999999999999999999999987532211


Q ss_pred             cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC
Q psy5927         309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ  388 (441)
Q Consensus       309 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (441)
                         ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .......             ....
T Consensus       150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~-------------~~~~  212 (323)
T cd05571         150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELIL-------------MEEI  212 (323)
T ss_pred             ---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHH-------------cCCC
Confidence               1223456999999999999989999999999999999999999999765431 1111111             1112


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      ..+..++.++.+|+.+||+.||++||     ++.++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            23445677899999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-43  Score=346.86  Aligned_cols=247  Identities=20%  Similarity=0.270  Sum_probs=201.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||+|.+.....      ......+.+.+|+++++.++||||+++++++.++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   90 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI------LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE   90 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence            367999999999999999999985  46799999874211      1123345677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999999999988643   34788889999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +.....      .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+.    .     
T Consensus       166 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~----~-----  229 (329)
T PTZ00263        166 KKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEKIL----A-----  229 (329)
T ss_pred             eEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHHHh----c-----
Confidence            754321      12346999999999999988999999999999999999999999765431 1111111    1     


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                          .....+..++..+.+|+.+||+.||.+||+     +.++++
T Consensus       230 ----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 ----GRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----CCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                111223335667899999999999999996     677764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=346.01  Aligned_cols=255  Identities=19%  Similarity=0.285  Sum_probs=204.2

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+.  +..||+|+++.....      .......+..|++++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF------KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            47899999999999999999985  568999998743211      1123456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            999999999999999988543   35888999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ....      ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ ....+. .+..  .  +
T Consensus       150 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~i~-~~~~--~--~  217 (333)
T cd05600         150 GIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-TWENLK-YWKE--T--L  217 (333)
T ss_pred             cccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-HHHHHH-hccc--c--c
Confidence            5432      2234569999999999999899999999999999999999999997654322 111111 1100  0  0


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      ..+........++.++.+|+.+||..+|.+||++.++++.
T Consensus       218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0011111112457789999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=352.37  Aligned_cols=262  Identities=26%  Similarity=0.351  Sum_probs=205.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      +..++|++.+.||+|+||.||+|.+       .+..||||+++.....        ...+.+.+|++++..+ +||||++
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~Ei~il~~l~~HpnIv~  103 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--------TEREALMSELKVLSYLGNHINIVN  103 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--------HHHHHHHHHHHHHHHhcCCcceee
Confidence            4456799999999999999999974       2347999998643211        1234567899999999 8999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN------------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  245 (441)
                      ++++|.+.+..++|||||++|+|.+++.....                                                
T Consensus       104 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  183 (375)
T cd05104         104 LLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA  183 (375)
T ss_pred             eeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence            99999999999999999999999998864321                                                


Q ss_pred             ------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         246 ------------------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       246 ------------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                                              ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a  261 (375)
T cd05104         184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLA  261 (375)
T ss_pred             ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccc
Confidence                                    124788899999999999999999998  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..........+.+....      
T Consensus       262 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------  334 (375)
T cd05104         262 RDIRNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY------  334 (375)
T ss_pred             eeccCccccc-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc------
Confidence            7543221111 1112235667999999999899999999999999999998 8999976544332222221111      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                            ....+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus       335 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 ------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                  0111223456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-43  Score=333.54  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=205.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..++|++.+.||+|+||.||+|.++     +..+|+|.++.....        .....+.+|+.++..++||||++++++
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~   74 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--------KQRRGFLAEALTLGQFDHSNIVRLEGV   74 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--------HHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            3467899999999999999999863     357899988743221        223456789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +..++..++||||+++|+|.+++...  ...+++..++.++.+++.||+|||+.+  ++||||||+|||++.++.++++|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          75 ITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             EecCCCcEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECC
Confidence            99999999999999999999988643  245889999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||.+........  .......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ..+..+.     
T Consensus       151 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~-----  222 (266)
T cd05064         151 FRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAVE-----  222 (266)
T ss_pred             Ccccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHH-----
Confidence            998765322111  11112235678999999998899999999999999999875 99999776442 2222211     


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                             +....+.+..++..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus       223 -------~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 -------DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   1111223445677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-43  Score=346.12  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=202.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC---eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK---TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.+.+   ..||+|.+......      .....+.+.+|+++++.++||||+++++++
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII------KQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            345689999999999999999998643   46999988632211      122344567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DF  175 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDF  175 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecC
Confidence            9999999999999999999988643   34888999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..      
T Consensus       176 G~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~i~~------  242 (340)
T PTZ00426        176 GFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-LLIYQKILE------  242 (340)
T ss_pred             CCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-HHHHHHHhc------
Confidence            999753221      2345699999999999988899999999999999999999999976543 111222111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                             .....+..++..+.+++.+||+.||.+|+     +++++++
T Consensus       243 -------~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        243 -------GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                   11122334566789999999999999995     8888876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-43  Score=339.71  Aligned_cols=241  Identities=22%  Similarity=0.291  Sum_probs=194.2

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||+|+||.||+|.+.  +..||+|+++.....      .......+.+|+.++.+++||||+++++++.+.+..|+||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV------SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            799999999999985  457999998632111      122344567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT  310 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~  310 (441)
                      +++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......  
T Consensus        75 ~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--  147 (312)
T cd05585          75 INGGELFHHLQRE---GRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--  147 (312)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--
Confidence            9999999988643   34889999999999999999999999  9999999999999999999999999987532211  


Q ss_pred             cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCch
Q psy5927         311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPI  390 (441)
Q Consensus       311 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  390 (441)
                       .......||+.|+|||.+.+..++.++|||||||++|||++|..||...... .......             ......
T Consensus       148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-~~~~~~~-------------~~~~~~  212 (312)
T cd05585         148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-EMYRKIL-------------QEPLRF  212 (312)
T ss_pred             -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-HHHHHHH-------------cCCCCC
Confidence             1223457999999999999989999999999999999999999999765432 1111111             111223


Q ss_pred             hHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q psy5927         391 ELNIAYAFFRIGKQSTKQNPKERPE---MTQVYN  421 (441)
Q Consensus       391 ~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~  421 (441)
                      +..++..+.+|+.+||+.||.+||+   +.+++.
T Consensus       213 ~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            3456678999999999999999986   455553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.9e-43  Score=350.87  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=205.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      ...++|++.+.||+|+||.||+|.+..       ..||+|+++.....        ...+.+.+|+++++.+ +||||++
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~~h~nIv~  106 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--------DEREALMSELKILSHLGQHKNIVN  106 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--------HHHHHHHHHHHHHHhhccCCceee
Confidence            445689999999999999999998522       36999998743221        1234567899999999 8999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN------------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  245 (441)
                      ++++|.+.+..|+|||||++|+|.+++.....                                                
T Consensus       107 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         107 LLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             EeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            99999999999999999999999998854321                                                


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         246 -------------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       246 -------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                                         ..++++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                               124788899999999999999999998  99999999999999999999999999875432


Q ss_pred             cccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                      .... .......++..|||||++.+..++.++|||||||++|||++ |..||........... .....           
T Consensus       265 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-~~~~~-----------  331 (374)
T cd05106         265 DSNY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-MVKRG-----------  331 (374)
T ss_pred             Ccce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-HHHcc-----------
Confidence            2111 11122235667999999988899999999999999999997 9999976543222111 11100           


Q ss_pred             CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       386 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .....+...+.++.+++.+||+.||.+||++.+|++.|+++
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00111222456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5e-43  Score=341.95  Aligned_cols=243  Identities=23%  Similarity=0.320  Sum_probs=197.3

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY  228 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  228 (441)
                      +.||+|+||.||++.+.  +..||+|++......      .......+.+|+++++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            46999999999999874  568999998742211      1223456678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcc
Q psy5927         229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK  308 (441)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~  308 (441)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 Ey~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          75 EYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            999999999888543   35889999999999999999999999  9999999999999999999999999987532211


Q ss_pred             cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC
Q psy5927         309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ  388 (441)
Q Consensus       309 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (441)
                         ......+||+.|+|||.+.+..++.++|||||||++|||++|..||..... .......             .....
T Consensus       150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~-------------~~~~~  212 (328)
T cd05593         150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI-------------LMEDI  212 (328)
T ss_pred             ---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHh-------------ccCCc
Confidence               122345799999999999988999999999999999999999999976543 1111111             11112


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      ..+..++.++.+|+.+||..||++||     ++.++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            23445677899999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.1e-43  Score=333.74  Aligned_cols=259  Identities=24%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      .++|++.+.||+|+||.||+|....       ..+|+|.++.....        .....+.+|++++..++||||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~~~ei~~l~~l~h~~i~~~~~   75 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--------KVQQEFRQEAELMSDLQHPNIVCLLG   75 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--------HHHHHHHHHHHHHHhcCCcccceEEE
Confidence            3578899999999999999998743       35899988643211        22345678999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      ++.+.+..|++|||+++|+|.+++.....             ...+++..+..++.|++.||.|||+.+  ++||||||+
T Consensus        76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~  153 (283)
T cd05048          76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAAR  153 (283)
T ss_pred             EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccc
Confidence            99999999999999999999999865422             145788899999999999999999999  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcch
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR  362 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~  362 (441)
                      ||++++++.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus       154 Nil~~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         154 NCLVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             eEEEcCCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999875432211 111233356788999999988889999999999999999998 9999976543


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .. .... +   .        .......+..++.++.+|+.+||+.||.+||++.+|++.|++.
T Consensus       233 ~~-~~~~-i---~--------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 QE-VIEM-I---R--------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HH-HHHH-H---H--------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            11 1111 1   1        1111223456778999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0610|consensus

Probab=100.00  E-value=4.3e-43  Score=329.01  Aligned_cols=261  Identities=22%  Similarity=0.318  Sum_probs=211.1

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..+..++|++++.||+|.-|+||++...+  ..+|+|++......      ......+...|-+||+.+.||.++.||+.
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~------~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~  145 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA------SRKKLKRAQTEREILSLLDHPFLPTLYAS  145 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh------hhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence            35667889999999999999999999976  57899998643221      23344566689999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      |..+...|++||||+||+|...++. .....+++..++.++.+++.||+|||..|  ||+|||||+||||.++|++.|+|
T Consensus       146 fet~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  146 FETDKYSCLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             eeccceeEEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeee
Confidence            9999999999999999999886654 45567999999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCC-----------------------------------c------------------ccccceeccccccCCCc
Q psy5927         298 FGLTQEGPI-----------------------------------E------------------KATHITLKRVNGTRPYL  324 (441)
Q Consensus       298 FGla~~~~~-----------------------------------~------------------~~~~~~~~~~~gt~~y~  324 (441)
                      |.|+.....                                   .                  ..+......++||-.|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            998632110                                   0                  00112334578999999


Q ss_pred             CcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHH
Q psy5927         325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQ  404 (441)
Q Consensus       325 aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  404 (441)
                      |||+++|...+.++|||+|||++||||.|..||.+....+.+...+.+..           .. +..+.++..+.+||++
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-----------~F-p~~~~vs~~akDLIr~  370 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-----------KF-PEEPEVSSAAKDLIRK  370 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-----------cC-CCCCcchhHHHHHHHH
Confidence            99999999999999999999999999999999988776443333322111           01 1122677889999999


Q ss_pred             hcCCCCCCCCC----HHHHHH
Q psy5927         405 STKQNPKERPE----MTQVYN  421 (441)
Q Consensus       405 cl~~dp~~RPs----~~evl~  421 (441)
                      .|.+||.+|..    +.||-+
T Consensus       371 LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  371 LLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HhccChhhhhccccchHHhhc
Confidence            99999999998    777754

>KOG0611|consensus

Probab=100.00  E-value=7.9e-44  Score=332.08  Aligned_cols=250  Identities=23%  Similarity=0.360  Sum_probs=208.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|++.+.||+|.||+|-+|..  .++.||||.++........      ..-.+.+|++||+.++||||+.+|++|...
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeq------DlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQ------DLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHH------HHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            35799999999999999999986  4678999999865544332      334567999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +...|||||..+|.|.|++..+.   .|++..+..+++||++|+.|+|.++  ++|||||.+|||||+++++||+||||+
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999999996554   4999999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .......    ...++||++-|.+||++.|..| ++.+|-|||||+||-|+.|..||++.+.     +.++..+..+...
T Consensus       201 Nly~~~k----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~lvrQIs~GaYr  271 (668)
T KOG0611|consen  201 NLYADKK----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KRLVRQISRGAYR  271 (668)
T ss_pred             hhhcccc----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HHHHHHhhccccc
Confidence            7654332    3567899999999999999887 6799999999999999999999988653     2233333222211


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                                .+..+.+..-||.+||..||++|.|+.+|....
T Consensus       272 ----------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 ----------EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                      112234566789999999999999999997643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.9e-43  Score=340.27  Aligned_cols=243  Identities=24%  Similarity=0.339  Sum_probs=196.4

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY  228 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  228 (441)
                      +.||+|+||.||++.+.  +..||+|.++.....      .......+.+|+++++.++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            46999999999999874  568999998743211      1223445668999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcc
Q psy5927         229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK  308 (441)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~  308 (441)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          75 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            999999999888543   35889999999999999999999999  9999999999999999999999999987532211


Q ss_pred             cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC
Q psy5927         309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ  388 (441)
Q Consensus       309 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (441)
                         .......||+.|+|||.+.+..++.++|||||||++|||++|..||...... .......             ....
T Consensus       150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~-------------~~~~  212 (323)
T cd05595         150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELIL-------------MEEI  212 (323)
T ss_pred             ---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHh-------------cCCC
Confidence               1223456999999999999989999999999999999999999999765431 1111111             1111


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      ..+..++.++.+|+.+||+.||++||     ++.++++
T Consensus       213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            23345677889999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-42  Score=332.60  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.++  +..+|+|+++......       ...+.+.+|+++++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-------EVKETTLRELKMLRTLKQENIVELKEAFRRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-------cchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence            47999999999999999999985  4579999987532211       22345568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||++++++..+.. .  ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+++
T Consensus        74 ~~~lv~e~~~~~~l~~~~~-~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          74 KLYLVFEYVEKNMLELLEE-M--PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             EEEEEEecCCCCHHHHHHh-c--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence            9999999999887765432 2  245888999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh---chhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY---SEENM  379 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---~~~~~  379 (441)
                      ......  ........||..|+|||++.+..++.++|||||||++|||++|.+||....... .+.......   .....
T Consensus       149 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  225 (287)
T cd07848         149 NLSEGS--NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPAEQM  225 (287)
T ss_pred             cccccc--cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCHHHH
Confidence            643221  112234568999999999998889999999999999999999999998654322 221111111   00000


Q ss_pred             hhhh-c--------cC---C----CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLV-D--------KN---A----QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~-~--------~~---~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..+. +        ..   .    ......++..+.+|+.+||+.||++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000 0        00   0    0011235677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0589|consensus

Probab=100.00  E-value=1.4e-43  Score=342.76  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=215.6

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|+.++.+|+|+||.++...+  ..+.+++|++.......       ..++...+|+.++++++|||||.+.+.|.+++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~   76 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-------PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG   76 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-------hhhHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence            6789999999999999997776  45789999998665432       22335679999999999999999999999998


Q ss_pred             e-EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 K-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      . +||||+||+||+|.+.+.+++ ...+++..++.++.|++.|++|||++.  |+|||||++|||++.++.+||+|||+|
T Consensus        77 ~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   77 QLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             ceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhh
Confidence            8 999999999999999997766 456889999999999999999999888  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +......   ....++.||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+......+..           
T Consensus       154 K~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-----------  219 (426)
T KOG0589|consen  154 KILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-----------  219 (426)
T ss_pred             hhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-----------
Confidence            8754433   13455689999999999999999999999999999999999999998876533222221           


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                        .....+++...+.++..|+..||+.+|..||++.+++..
T Consensus       220 --~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 --RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              122456778889999999999999999999999999863

>KOG0194|consensus

Probab=100.00  E-value=1.3e-43  Score=349.00  Aligned_cols=273  Identities=27%  Similarity=0.402  Sum_probs=217.5

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEECC-----ee-EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK-----TT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH  208 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  208 (441)
                      ++.+.+++.-++-...++||+|+||.||+|....     .. ||||..+...      .....+...+..|.++|+.++|
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~------~~~~~~~~e~m~EArvMr~l~H  220 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS------ELTKEQIKEFMKEARVMRQLNH  220 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc------cccHHHHHHHHHHHHHHHhCCC
Confidence            3344455666666777999999999999999732     23 7888887411      1234567788899999999999


Q ss_pred             CCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       209 pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      ||||++||++.....+++|||+|+||+|.++|.....  .++..++..++.+.+.||+|||+++  +|||||...|+|++
T Consensus       221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~  296 (474)
T KOG0194|consen  221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS  296 (474)
T ss_pred             CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec
Confidence            9999999999999999999999999999999965443  5899999999999999999999999  99999999999999


Q ss_pred             CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHH
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHL  367 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l  367 (441)
                      .++.+||+||||++....-.  ... ....-...|+|||.+....|+.++|||||||++||+++ |..||.+....+..-
T Consensus       297 ~~~~vKISDFGLs~~~~~~~--~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~  373 (474)
T KOG0194|consen  297 KKGVVKISDFGLSRAGSQYV--MKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA  373 (474)
T ss_pred             CCCeEEeCccccccCCccee--ecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH
Confidence            99999999999998754111  111 01123567999999999999999999999999999999 899998876532111


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPN  432 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  432 (441)
                      +....            ....+.+...+..+..++.+|+..+|++||+|.++.+.|+.+......
T Consensus       374 kI~~~------------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 KIVKN------------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHhc------------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            11111            112233345677888999999999999999999999999877666554

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-42  Score=339.15  Aligned_cols=245  Identities=25%  Similarity=0.368  Sum_probs=196.1

Q ss_pred             cCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         150 LNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      ++.||+|+||.||++..     .+..||+|.++......     .......+..|+++++.++||||+++++++..++.+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh-----hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence            36899999999999985     35679999987432111     112234556899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      |+||||+++|+|.+++...   ..+.+..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          76 YLILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEeCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            9999999999999988543   34778888999999999999999999  999999999999999999999999998753


Q ss_pred             CCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhc
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (441)
                      ....   .......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.             
T Consensus       151 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~-------------  213 (323)
T cd05584         151 IHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKIL-------------  213 (323)
T ss_pred             ccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHH-------------
Confidence            2221   1123456999999999999888999999999999999999999999765431 1111111             


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      ......+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         214 KGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            111223445567889999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.5e-43  Score=341.74  Aligned_cols=254  Identities=23%  Similarity=0.305  Sum_probs=197.9

Q ss_pred             CCcCcCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      +|++.+.||+|+||.||++..     .+..||+|++.......     .....+.+..|++++..+ +||||+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence            588899999999999999876     35679999986422111     112334566899999999 5999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      ..+.+++||||+++|+|.+++..+   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCc
Confidence            999999999999999999988643   34888999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++.......  .......||..|+|||.+.+. .++.++|||||||++|||+||..||........ ...+...     
T Consensus       151 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~-----  222 (332)
T cd05614         151 LSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRR-----  222 (332)
T ss_pred             CCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHH-----
Confidence            9875322211  122345799999999999875 478999999999999999999999965332110 0111110     


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                          +.......+..++..+.+++.+||+.||++||     +++++++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ----ILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----HhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                00111223344667889999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.8e-43  Score=347.67  Aligned_cols=263  Identities=21%  Similarity=0.329  Sum_probs=207.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  213 (441)
                      ...++|.+.++||+|+||.||+|.+.+       ..||||+++.....        ...+.+.+|+++++++. ||||++
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~Ei~~l~~l~~HpnIv~  105 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--------SEKQALMSELKIMTHLGPHLNIVN  105 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--------HHHHHHHHHHHHHHhcCCCCCeee
Confidence            445789999999999999999998632       35999998643211        23346779999999996 999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN------------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  245 (441)
                      ++++|.+.+..|+|||||++|+|.++|.....                                                
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            99999999999999999999999998865321                                                


Q ss_pred             ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5927         246 ---------------------------------------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI  280 (441)
Q Consensus       246 ---------------------------------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDi  280 (441)
                                                                   ...+++..+..++.|++.||+|||+.+  |+||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~di  263 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDL  263 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence                                                         124788888999999999999999998  999999


Q ss_pred             CCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCC
Q psy5927         281 KSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD  359 (441)
Q Consensus       281 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~  359 (441)
                      ||+|||++.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       264 kp~Nill~~~~~~kL~DfGla~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         264 AARNVLLAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             ChHhEEEeCCCEEEEEeCCcceecccccc-ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            99999999999999999999875432211 111223346788999999988889999999999999999997 9999976


Q ss_pred             cchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ..............            .....+..++..+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       343 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         343 MIVDSTFYNKIKSG------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             cchhHHHHHHHhcC------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            54322222111110            011223456778999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-42  Score=344.37  Aligned_cols=255  Identities=21%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++++.||+|+||+||+|.+.  +..||+|++.....      ........+.+|+++++.++||||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV------LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            6889999999999999999984  45799999864221      122334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+||||++||+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999999999988643   34788889999999999999999999  99999999999999999999999999753


Q ss_pred             CCCccc--------------------------------------------ccceeccccccCCCcCcccccCCCCCCccc
Q psy5927         304 GPIEKA--------------------------------------------THITLKRVNGTRPYLPHEFLVGKRLSTKVD  339 (441)
Q Consensus       304 ~~~~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D  339 (441)
                      ......                                            .........||+.|+|||.+.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD  230 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence            211000                                            000112357999999999999888999999


Q ss_pred             eehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHh--cCCCCCCCCCHH
Q psy5927         340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQS--TKQNPKERPEMT  417 (441)
Q Consensus       340 iwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~dp~~RPs~~  417 (441)
                      ||||||++|||+||..||............ .. +..        ....+....++.++.+|+.++  +..++..||++.
T Consensus       231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i-~~-~~~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         231 WWSVGVILFEMLVGQPPFLAPTPTETQLKV-IN-WEN--------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             eeehhhHHHHHHhCCCCCcCCCHHHHHHHH-Hc-ccc--------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            999999999999999999765542222111 10 000        000111123566788899884  455666699999


Q ss_pred             HHHH
Q psy5927         418 QVYN  421 (441)
Q Consensus       418 evl~  421 (441)
                      ++++
T Consensus       301 ~~l~  304 (381)
T cd05626         301 DIKA  304 (381)
T ss_pred             HHhc
Confidence            9986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG2345|consensus

Probab=100.00  E-value=2.1e-43  Score=310.63  Aligned_cols=266  Identities=25%  Similarity=0.345  Sum_probs=210.4

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .+..++|.+.+.||+|||+.||++..  .+..||+|++.-...         ...+...+|++..++++|||+++++++.
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---------~~~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---------EDIEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---------HHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            45678999999999999999999885  566899999986542         3345667999999999999999999987


Q ss_pred             EeCC-----eEEEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         219 FETG-----KYCLVYRYMPNGSLEDRLLMKKNT-PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       219 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      ..+.     ..||+++|...|||.|.+...... ..+++.+.+.|+.++++||++||+..+|+.||||||+|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            6443     489999999999999999765543 3799999999999999999999999999999999999999999999


Q ss_pred             eEEeccCCCccCCCccccc------ceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         293 PVIGDFGLTQEGPIEKATH------ITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      ++|+|||.++.....-...      .....-..|..|.|||.+.-   ..+++++|||||||+||+|+.|..||+..-..
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999999987643221111      11122347899999999854   45789999999999999999999999643221


Q ss_pred             HHHHHHHHHhhchhhhhhhhccC--CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKN--AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      .            +.+.-.+...  ..+-...+++.+.+++++||+.||.+||++.+++..++.+.
T Consensus       248 G------------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 G------------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             C------------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            1            1111101110  11112237889999999999999999999999999988754

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-42  Score=337.31  Aligned_cols=269  Identities=21%  Similarity=0.330  Sum_probs=199.2

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC--
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET--  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  221 (441)
                      +|++.++||+|+||.||+|.+.  +..||||++......       ......+.+|+++++.++||||+++++++...  
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   73 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR   73 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence            5888999999999999999974  568999988632111       11233567899999999999999999987543  


Q ss_pred             ---CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         222 ---GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       222 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                         ..+|+||||| +++|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          74 REFKDIYVVFELM-ESDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             CCCceEEEEEecC-CCCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccC
Confidence               3589999999 57898887533   34889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc-
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS-  375 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-  375 (441)
                      |+++................||+.|+|||++.+  ..++.++|||||||++|||+||.+||...... ..+..+..... 
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-~~~~~~~~~~~~  226 (338)
T cd07859         148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-HQLDLITDLLGT  226 (338)
T ss_pred             ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCC
Confidence            999754322222222344569999999999876  57899999999999999999999999765431 11111111100 


Q ss_pred             ----------hhhhhhhh----ccCCCch---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         376 ----------EENMYDLV----DKNAQPI---ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       376 ----------~~~~~~~~----~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                                .......+    .......   ...++..+.+++.+||+.||++||++.++++  .+.+...
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                      00000000    0001111   1123567889999999999999999999986  4544444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-42  Score=330.49  Aligned_cols=260  Identities=22%  Similarity=0.340  Sum_probs=204.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +.+++|++.+.||+|+||.||+|.+.+       ..+|+|++.....        ......+.+|+.+++.++||||+++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv~~   74 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--------MRERIEFLNEASVMKEFNCHHVVRL   74 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCeeeE
Confidence            456889999999999999999998642       4689998753211        1223456789999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL  287 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl  287 (441)
                      ++++.++...++||||+++|+|.+++.....       ...+++..+..++.+++.||.|||+.+  ++||||||+|||+
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~  152 (277)
T cd05062          75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV  152 (277)
T ss_pred             EEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEE
Confidence            9999999999999999999999999865332       234678889999999999999999988  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHH
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH  366 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~  366 (441)
                      ++++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus       153 ~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~  230 (277)
T cd05062         153 AEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQV  230 (277)
T ss_pred             cCCCCEEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence            99999999999998753322111 11112245778999999998889999999999999999999 7899976543 222


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ......            ......+..++..+.+++.+||+.||++||++.++++.|++
T Consensus       231 ~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 LRFVME------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHc------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            221111            11112223456678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1095|consensus

Probab=100.00  E-value=3.2e-43  Score=369.08  Aligned_cols=265  Identities=24%  Similarity=0.398  Sum_probs=216.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+-+..+.||+|.||.||.|...+       ..||||.++....        ......|++|..+|+.+.|||||+++|
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--------~~~~~~Fl~Ea~~m~~f~HpNiv~liG  762 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--------EQEVSDFLKEALLMSKFDHPNIVSLIG  762 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--------HHHHHHHHHHHHHHhcCCCcceeeEEE
Confidence            3445667899999999999999732       2488998875432        234567889999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      +|.+....++++|||+||+|..+|+..+.    ...+.....+.++.+||+|++||++++  +|||||..+|+||++...
T Consensus       763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCc
Confidence            99999999999999999999999976532    455888999999999999999999998  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~  371 (441)
                      +||+|||||+............. ..-...|||||.+..+.++.|+|||||||+|||++| |..||.+.+. .+.+..+ 
T Consensus       841 VKIaDFGlArDiy~~~yyr~~~~-a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-~~v~~~~-  917 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDYYRKHGE-AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-FEVLLDV-  917 (1025)
T ss_pred             EEEcccchhHhhhhchheeccCc-cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-HHHHHHH-
Confidence            99999999996443332221111 111246999999999999999999999999999999 9999987764 2222222 


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPN  432 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  432 (441)
                                 +.....+.|..|+..+++|+.+||+.+|++||++..+++++..+......
T Consensus       918 -----------~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  918 -----------LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             -----------HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence                       22335566788999999999999999999999999999988877665543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-42  Score=335.81  Aligned_cols=262  Identities=22%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++.......        ....+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--------TPFTAIREASLLKGLKHANIVLLHDIIHTK   75 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--------cchhHHHHHHHHhhCCCCCcCeEEEEEecC
Confidence            478999999999999999999984  5689999987432211        122445899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ...|+||||+. ++|.+++...  ...++...+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~  150 (303)
T cd07869          76 ETLTLVFEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLA  150 (303)
T ss_pred             CeEEEEEECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcc
Confidence            99999999995 7888877543  345788899999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---h
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---E  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~  377 (441)
                      +......   .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.......+.........   .
T Consensus       151 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  227 (303)
T cd07869         151 RAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED  227 (303)
T ss_pred             eeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence            7532211   11233468999999999876 457889999999999999999999998765433344333221110   0


Q ss_pred             hhh---h--hhcc------CCCchh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMY---D--LVDK------NAQPIE-----LNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~---~--~~~~------~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...   .  ..++      ......     ...+..+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000   0  0000      000000     012356789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.5e-42  Score=336.45  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||++.+.  +..+|+|.+.....        ......+.+|+++++.++||||+++++++.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            3578999999999999999999986  45689998864321        1234467799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      ++..++||||+++|+|.+++...   ..+++..+..++.+++.||.|||+. +  |+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCc
Confidence            99999999999999999988543   3478899999999999999999984 6  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh-hc---
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK-YS---  375 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~-~~---  375 (441)
                      ++......     ......||..|+|||++.+..++.++|||||||++|||+||+.||.......  +...... ..   
T Consensus       150 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~  222 (331)
T cd06649         150 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGE  222 (331)
T ss_pred             cccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccc
Confidence            98754322     1233468999999999999899999999999999999999999997544311  1111100 00   


Q ss_pred             hh------------------------------hhhhhh-ccCCCch-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         376 EE------------------------------NMYDLV-DKNAQPI-ELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       376 ~~------------------------------~~~~~~-~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .+                              .....+ ....... ...++.++.+|+.+||+.||++||++.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00                              000000 0000000 11356789999999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=342.71  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=204.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||+||+|.+.  +..||+|+++.....      .......+..|++++..++||||+++++++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI------KRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            47899999999999999999986  678999998742211      1123445668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            999999999999999988654   45889999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcc--------------------------cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCC
Q psy5927         303 EGPIEK--------------------------ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA  356 (441)
Q Consensus       303 ~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p  356 (441)
                      ......                          ..........||+.|+|||.+.+..++.++|||||||++|||++|..|
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence            543322                          001122345699999999999999999999999999999999999999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-MTQVYNM  422 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~  422 (441)
                      |....... ....+.. +..        ....+....++.++.+|+.+||. ||.+||+ +.++++.
T Consensus       230 f~~~~~~~-~~~~i~~-~~~--------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         230 FYSDTLQE-TYNKIIN-WKE--------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCHHH-HHHHHhc-cCC--------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            98765322 1111111 000        00111111256789999999998 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-43  Score=332.85  Aligned_cols=250  Identities=32%  Similarity=0.543  Sum_probs=195.6

Q ss_pred             CcCccccCCceeEEEEEEC------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         149 KLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +.+.||.|.||.||+|.+.      +..|+||.++....        ....+.+.+|++.+++++||||++++|++...+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~   74 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS--------EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE   74 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS--------HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc--------cccceeeeecccccccccccccccccccccccc
Confidence            4578999999999999997      56899999964322        123556778999999999999999999999888


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++|+|.++|... ....+++..+..|+.|++.||+|||+++  ++|+||+++|||+++++.+||+|||++.
T Consensus        75 ~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   75 PLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSR  151 (259)
T ss_dssp             SEEEEEE--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred             ccccccccccccccccccccc-cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence            899999999999999999765 2355899999999999999999999998  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........ .......+...|+|||.+.+..++.++||||||+++|||++ |..||.+... ......+.          
T Consensus       152 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~~~----------  219 (259)
T PF07714_consen  152 PISEKSKY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEKLK----------  219 (259)
T ss_dssp             ETTTSSSE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHHHH----------
T ss_pred             cccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc----------
Confidence            65221111 12223346778999999998889999999999999999999 7899977643 22222221          


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                        +......+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       220 --~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 --QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              1111223344677899999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.4e-43  Score=340.36  Aligned_cols=243  Identities=23%  Similarity=0.323  Sum_probs=195.4

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY  228 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  228 (441)
                      +.||+|+||.||++.+.  +..||+|+++.....      .......+..|++++..++||||+++++++...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            46999999999999874  568999998743211      1123345568999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+ .+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 E~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          75 EYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            999999999888543   358899999999999999999997 78  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||+.|+|||++.+..++.++|||||||++|||+||..||...... ......             ....
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~i-------------~~~~  212 (325)
T cd05594         150 G---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELI-------------LMEE  212 (325)
T ss_pred             C---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHHHHH-------------hcCC
Confidence            1   1223456999999999999989999999999999999999999999765431 111111             1111


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      ...+..++.++.+|+.+||+.||++|+     ++.++++
T Consensus       213 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            123334567889999999999999996     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=325.58  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=205.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .++|++.+.||+|+||.||+|.+..     ..+|||.++.....        .....+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD--------KQRLDFLTEASIMGQFDHPNIIRLEGVV   74 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh--------HHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence            4679999999999999999999742     36899987643221        2334567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+..++||||+++++|.+++....  ..+++..+..++.+++.||+|||+.+  |+||||||+|||++.++.++|+||
T Consensus        75 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          75 TKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ecCCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECcc
Confidence            99999999999999999999986433  36899999999999999999999998  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..........    
T Consensus       151 g~~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~~----  224 (266)
T cd05033         151 GLSRRLEDSEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG----  224 (266)
T ss_pred             chhhcccccccc-eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHHcC----
Confidence            999865321111 11122335678999999998889999999999999999998 9999976543 1111111110    


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                              ...+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       225 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 --------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    11122334567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-42  Score=342.89  Aligned_cols=262  Identities=21%  Similarity=0.296  Sum_probs=200.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..||+|...               ...+.+|++++++++||||+++++++.
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------------~~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------------RGGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------------hhhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            34568999999999999999999985  4578998643               123458999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .....|+|+|++ +++|.+++...   ..+++..++.++.|++.||+|||+++  ||||||||+|||++.++.+||+|||
T Consensus       154 ~~~~~~lv~e~~-~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        154 YNKFTCLILPRY-KTDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             ECCeeEEEEecC-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCC
Confidence            999999999999 57898887543   34789999999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcc------hhHHHHHHHHHh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTR------RSERHLKSLVEK  373 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~------~~~~~l~~~~~~  373 (441)
                      +++......  ........||+.|+|||++.+..++.++|||||||++|||+||..||....      .....+..++..
T Consensus       228 ~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        228 AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             ccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            996532211  112234579999999999999899999999999999999999998874322      112223222221


Q ss_pred             hch----------hhhhhhh---------ccCCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         374 YSE----------ENMYDLV---------DKNAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       374 ~~~----------~~~~~~~---------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ...          .......         .....+   ....++.++.+|+.+||+.||.+|||++|+++  .++.+
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence            100          0000000         000000   11235678999999999999999999999985  55544

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-42  Score=336.80  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=193.9

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHH---HhhcCCCCCeecccceEEeC
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK---YLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~hpnIv~l~~~~~~~  221 (441)
                      |++.+.||+|+||.||+|.+.  ++.||||+++.....      .....+.+.+|++   +++.++||||+++++++.+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            677899999999999999985  567999998743211      1112233444544   45677899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+||||+++|+|..++..    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCC
Confidence            999999999999999887742    35899999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +......   .......||+.|+|||.+.+..++.++|||||||++|||++|..||...... .....+..         
T Consensus       149 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~~~~i~~---------  215 (324)
T cd05589         149 KEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EVFDSIVN---------  215 (324)
T ss_pred             ccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHh---------
Confidence            7532211   1223457999999999999989999999999999999999999999765432 12211111         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                          .....+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       216 ----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         216 ----DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                11122334567889999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=342.75  Aligned_cols=255  Identities=20%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++.....      ........+.+|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM------LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            47999999999999999999984  56899999974211      11223445668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccce
Confidence            999999999999999988643   34889999999999999999999999  9999999999999999999999999986


Q ss_pred             cCCCcccc-----------------------------------cceeccccccCCCcCcccccCCCCCCccceehHHHHH
Q psy5927         303 EGPIEKAT-----------------------------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVL  347 (441)
Q Consensus       303 ~~~~~~~~-----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl  347 (441)
                      ........                                   .......+||+.|+|||++.+..++.++|||||||++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  229 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM  229 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence            43211100                                   0011134699999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q psy5927         348 FELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE---MTQVYN  421 (441)
Q Consensus       348 ~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~  421 (441)
                      |||++|..||....... ....+.. +..        ....+....++..+.+|+.+|+. +|.+|++   +.++++
T Consensus       230 ~el~~G~~Pf~~~~~~~-~~~~i~~-~~~--------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         230 YEMLVGYPPFCSDNPQE-TYRKIIN-WKE--------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHhhcCCCCCCCCCHHH-HHHHHHc-CCC--------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999999998665322 1211111 100        00001111346678899999997 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=330.01  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||+||++.+.  ++.||+|++.......      ......+.+|+.+++.++||||+++++++.+++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh------hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            4888899999999999999974  5689999986432111      1123345689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  ++||||||+||++++++.++|+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            999999999999998875432 345899999999999999999999998  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .....    ......|+..|+|||++.+..++.++|||||||++|||++|..||..... ......+...         +
T Consensus       152 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-~~~~~~~~~~---------~  217 (285)
T cd05605         152 IPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-KVKREEVERR---------V  217 (285)
T ss_pred             cCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-hhHHHHHHHH---------h
Confidence            43221    11234689999999999988899999999999999999999999976543 1111111111         1


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      .......+..++..+.+|+.+||+.||.+||     ++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         218 KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            1111223345677889999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-42  Score=332.36  Aligned_cols=261  Identities=23%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.++||.|+||.||+|.+.  +..||+|.++......        ....+.+|+++++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--------APCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--------cchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            357999999999999999999885  5679999986432211        122445899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||++ |+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          76 RCLTLVFEYLD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             CeEEEEEeCCC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999999996 59998885433  34788899999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EE  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~  377 (441)
                      +.......   ......||+.|+|||.+.+ ..++.++|||||||++|||+||.+||...... ..+........   .+
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  226 (288)
T cd07871         151 RAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEE  226 (288)
T ss_pred             eeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChH
Confidence            75322211   1233458999999999876 56899999999999999999999999765542 22222222111   00


Q ss_pred             ---------hhhhhhccCC--C---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 ---------NMYDLVDKNA--Q---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ---------~~~~~~~~~~--~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                               .......+..  .   .....++.++.+|+.+||..||.+|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         227 TWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                     0001110000  0   011234567899999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-42  Score=352.90  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=201.3

Q ss_pred             CCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .|.+.+.||+|+||.||+|...   +..||+|.+.....         .....+.+|+.+++.++||||+++++++...+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---------~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~  138 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---------RQAAYARSELHCLAACDHFGIVKHFDDFKSDD  138 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---------HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence            4888999999999999999874   45678886643211         12234558999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      .+|+||||++||+|.+++... ....++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            999999999999999988543 23456889999999999999999999998  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +....... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+....          
T Consensus       217 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~~~~----------  284 (478)
T PTZ00267        217 KQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQVL----------  284 (478)
T ss_pred             eecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----------
Confidence            76432211 11234557999999999999989999999999999999999999999765431 1111111          


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        .....+.+..++.++.+++.+||+.||++||++.+++.
T Consensus       285 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        285 --YGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --hCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              11112233456678999999999999999999998864

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=343.07  Aligned_cols=256  Identities=18%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||+|+||+||++.+.  +..||||++.....      ........+.+|+++++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM------FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH------HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            47899999999999999999874  56799999863211      12233456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||++||+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999988543   35788899999999999999999999  9999999999999999999999999986


Q ss_pred             cCCCcccc------------c--------------------------------ceeccccccCCCcCcccccCCCCCCcc
Q psy5927         303 EGPIEKAT------------H--------------------------------ITLKRVNGTRPYLPHEFLVGKRLSTKV  338 (441)
Q Consensus       303 ~~~~~~~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~  338 (441)
                      ........            .                                ......+||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  229 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC  229 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence            32110000            0                                000124699999999999998999999


Q ss_pred             ceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCC---CC
Q psy5927         339 DVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PE  415 (441)
Q Consensus       339 DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps  415 (441)
                      |||||||++|||+||..||....... ....... +..        ....+....++.++.+|+.+||. +|.+|   ++
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~-~~~--------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHE-TYRKIIN-WRE--------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHH-HHHHHHc-cCC--------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            99999999999999999997654322 2222111 000        00001112356678999999998 66654   69


Q ss_pred             HHHHHHH
Q psy5927         416 MTQVYNM  422 (441)
Q Consensus       416 ~~evl~~  422 (441)
                      +.+++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-42  Score=324.44  Aligned_cols=257  Identities=25%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.++||+|+||.||+|... ++.+|+|.+.....          ..+.+..|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----------SVQAFLEEANLMKTLQHDKLVRLYAVVTK   72 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            34578999999999999999999874 46789998763211          23456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..+++|||+++++|.+++.... ...+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~  149 (261)
T cd05072          73 EEPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGL  149 (261)
T ss_pred             CCCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCcc
Confidence            999999999999999999886543 345888899999999999999999988  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++........  ......++..|+|||++.+..++.++|||||||++|+|+| |..||...... .....+....     
T Consensus       150 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~~-----  221 (261)
T cd05072         150 ARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSALQRGY-----  221 (261)
T ss_pred             ceecCCCcee--ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHHHHcCC-----
Confidence            9764322111  1122345678999999988889999999999999999998 99999765431 1121111110     


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                             ..+....++.++.+++.+||+.+|++||+++++.+.|++.
T Consensus       222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 -------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                   1111223566789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-42  Score=336.21  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=195.1

Q ss_pred             CCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  222 (441)
                      +|++.+.||+|+||.||+|.+.+  ..||+|++......      .....+....|..++..+ +|++|+.+++++.+.+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            58889999999999999999854  57999998743211      112233455777887777 5899999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCce
Confidence            999999999999999988543   34888999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||+||..||...... .....+..          
T Consensus       150 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~----------  215 (323)
T cd05616         150 ENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIME----------  215 (323)
T ss_pred             ecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHHh----------
Confidence            532211   1233457999999999999999999999999999999999999999875432 22221111          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                         .....+..++.++.+++.+||+.||.+|++.
T Consensus       216 ---~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         216 ---HNVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               1122334567788999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.3e-42  Score=340.11  Aligned_cols=257  Identities=20%  Similarity=0.289  Sum_probs=196.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||+||+|.+.  +..||+|++.....      ........+..|+.++..++||||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM------LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH------HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            47899999999999999999884  56899999864211      11233455668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+|||||+||+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            999999999999999988643   35889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccc--------------------------------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHH
Q psy5927         303 EGPIEKAT--------------------------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL  350 (441)
Q Consensus       303 ~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~el  350 (441)
                      ........                                .......+||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el  229 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence            53211000                                0011245799999999999998999999999999999999


Q ss_pred             HhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q psy5927         351 ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTK--QNPKERPEMTQVYNM  422 (441)
Q Consensus       351 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~evl~~  422 (441)
                      ++|..||....... ....+.. +.. .   +..    +....++.++.+++.+++.  .++..||++.+|++.
T Consensus       230 l~G~~Pf~~~~~~~-~~~~i~~-~~~-~---~~~----p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         230 LIGYPPFCSETPQE-TYKKVMN-WKE-T---LIF----PPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HhCCCCCCCCCHHH-HHHHHHc-CcC-c---ccC----CCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            99999997654322 2222111 000 0   000    0011245677788877554  233456899999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.6e-42  Score=328.96  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=195.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc---CCCCCeecccceE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS---CRHDNILPLYGIC  218 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnIv~l~~~~  218 (441)
                      ++|++.+.||+|+||.||+|.+.   +..+|+|+++........       .....+|+.+++.   ++||||+++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~hpniv~~~~~~   73 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFDVC   73 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-------hHHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence            47899999999999999999873   467999988754322211       1123355555554   5799999999988


Q ss_pred             E-----eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         219 F-----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       219 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      .     ....+++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          74 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             ecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCE
Confidence            5     2456899999995 79999886433 345889999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++.....    .......||..|+|||.+.+..++.++|||||||++|||++|.+||...... ..+..+...
T Consensus       150 kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~  224 (290)
T cd07862         150 KLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDV  224 (290)
T ss_pred             EEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHH
Confidence            99999998754322    1223456899999999998888999999999999999999999999876542 233333221


Q ss_pred             hc---hhhhhh-------hhccCCC----chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YS---EENMYD-------LVDKNAQ----PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~---~~~~~~-------~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..   .+....       .......    .....++..+.+|+.+||+.||++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            11   000000       0000000    111235667889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-42  Score=335.28  Aligned_cols=243  Identities=22%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             CccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.+.+  ..||+|+++.....      .....+.+..|.+++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            469999999999999854  57999998743211      112334456788888765 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.+++.||.|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          75 MEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            9999999999888543   34888999999999999999999999  999999999999999999999999998753222


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||+.|+|||.+.+..++.++|||||||++|||++|..||..... .........             ..
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~-------------~~  212 (321)
T cd05591         150 G---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILH-------------DD  212 (321)
T ss_pred             C---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHc-------------CC
Confidence            1   122345699999999999998999999999999999999999999987654 222222111             11


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERP-------EMTQVYN  421 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~evl~  421 (441)
                      ...+..++.++.+++.+||+.||++||       ++.++++
T Consensus       213 ~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            112233567889999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-42  Score=338.57  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=194.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|+..++||+|+||.||+|.+.  ++.||||++......        .....+.+|+++++.++|+||+++++++.+.
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--------TVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--------HHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            456788899999999999999984  578999998643211        2234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+++||||+++|+|.+..       ...+..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus       145 ~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             CeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccc
Confidence            9999999999999986532       2456778889999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      +......   .......||..|+|||.+..     ...+.++|||||||++|||++|..||.......  ........  
T Consensus       216 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~--  288 (353)
T PLN00034        216 RILAQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAI--  288 (353)
T ss_pred             eeccccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHH--
Confidence            7543211   11233469999999998743     234568999999999999999999997433211  11111100  


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                            ........+..++.++.+|+.+||+.||++||++.++++.
T Consensus       289 ------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 ------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011112234567789999999999999999999999873

>KOG0660|consensus

Probab=100.00  E-value=1.5e-42  Score=321.29  Aligned_cols=275  Identities=25%  Similarity=0.324  Sum_probs=209.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      ...|...+.||+|+||.|..|.+.  +..||||++...       +-+....++.++|+++|+.++|+||+.+++.+.- 
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            456666899999999999999984  568999998621       1123445677899999999999999999998764 


Q ss_pred             ----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         221 ----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       221 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                          -+.+|+|+|+| +.+|...+...   ..|+..++..++.|+++||.|+|+.+  |+||||||+|+|++.+..+||+
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEec
Confidence                36789999999 68888877433   34889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh-
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY-  374 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-  374 (441)
                      |||||+..... ......+.+..|.+|.|||.+.. ..|+.++||||.|||++||++|++-|.+.+. -.++..+.+.. 
T Consensus       168 DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~-v~Ql~lI~~~lG  245 (359)
T KOG0660|consen  168 DFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY-VHQLQLILELLG  245 (359)
T ss_pred             cccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch-HHHHHHHHHhcC
Confidence            99999976433 22223355678999999998754 6899999999999999999999999988765 23333333322 


Q ss_pred             --chhhh--------hhhhcc----CCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHhcCCCCCCC
Q psy5927         375 --SEENM--------YDLVDK----NAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN-----MLSGSGGESPN  432 (441)
Q Consensus       375 --~~~~~--------~~~~~~----~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~-----~L~~~~~~~~~  432 (441)
                        .++.+        ..++..    ...+   .-++......+|+.+||..||.+|+|++|.++     .+.....|...
T Consensus       246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~  325 (359)
T KOG0660|consen  246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC  325 (359)
T ss_pred             CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence              11111        111111    1111   12345567899999999999999999999976     44444444433


Q ss_pred             C
Q psy5927         433 A  433 (441)
Q Consensus       433 ~  433 (441)
                      .
T Consensus       326 ~  326 (359)
T KOG0660|consen  326 Q  326 (359)
T ss_pred             C
Confidence            3

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.1e-42  Score=335.84  Aligned_cols=243  Identities=22%  Similarity=0.327  Sum_probs=194.8

Q ss_pred             CCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC-CCeecccceEEeCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH-DNILPLYGICFETG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~  222 (441)
                      +|++.+.||+|+||.||+|.+.+  ..||||++......      .....+.+..|++++..+.| ++|+.+++++.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            58889999999999999999864  47999998743211      11234456688999998876 46888999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            999999999999999988543   34788999999999999999999999  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||+||..||...... .....+.           
T Consensus       150 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~-----------  214 (324)
T cd05587         150 ENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQSIM-----------  214 (324)
T ss_pred             ecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHH-----------
Confidence            532211   1223456999999999999989999999999999999999999999765432 1221111           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                        ......+..++.++.+++.+||..||.+|++.
T Consensus       215 --~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         215 --EHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              11122334456788999999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.3e-42  Score=333.65  Aligned_cols=242  Identities=22%  Similarity=0.326  Sum_probs=191.2

Q ss_pred             CccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc-CCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-CRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.+.+  ..||+|.++.....      .....+....|..++.. .+||||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999999854  56999998743211      11123334466666664 4899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||++||+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          75 MEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            9999999999988543   35888999999999999999999998  999999999999999999999999999753222


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   ......+||+.|+|||.+.+..++.++|||||||++|||++|..||..... ......+.             ...
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~-------------~~~  212 (316)
T cd05592         150 E---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSIL-------------NDR  212 (316)
T ss_pred             C---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-------------cCC
Confidence            1   123345799999999999998899999999999999999999999986543 22221111             111


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMT-QVY  420 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl  420 (441)
                      ...+..++.++.+|+.+||+.||.+||++. +++
T Consensus       213 ~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         213 PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            223344567789999999999999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-42  Score=336.65  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.+.  +..||+|+++......      ......+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~------~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND------DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            46999999999999985  5679999997432111      12234566889999888 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            9999999999888543   35899999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH---HHHHHHHHhhchhhhhhhhc
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE---RHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~  384 (441)
                      .   ......+||..|+|||++.+..++.++|+|||||++|||+||..||+......   ....+.        ....+.
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~  218 (329)
T cd05588         150 G---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY--------LFQVIL  218 (329)
T ss_pred             C---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH--------HHHHHH
Confidence            1   12234579999999999999899999999999999999999999996422111   000000        111111


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPE------MTQVYN  421 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~  421 (441)
                      ......+..++..+.+++.+||+.||.+||+      +.++++
T Consensus       219 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         219 EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            1222334456678899999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.9e-42  Score=335.45  Aligned_cols=238  Identities=23%  Similarity=0.321  Sum_probs=191.2

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.++  ++.||||++......      .....+.+..|..++... +||||+++++++.+.+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh------hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            46999999999999985  467999998742211      112334556788888776 699999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~Ey~~~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          75 MEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             EcCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            9999999999988543   34888999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||+.|+|||.+.+..++.++|||||||++|||++|..||...... .....+.             ...
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~-------------~~~  212 (320)
T cd05590         150 G---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAIL-------------NDE  212 (320)
T ss_pred             C---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHh-------------cCC
Confidence            1   1223457999999999999988999999999999999999999999866532 1221111             111


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                      ...+..++.++.+++.+||+.||.+||++
T Consensus       213 ~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            12233456788999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.4e-42  Score=341.74  Aligned_cols=254  Identities=19%  Similarity=0.273  Sum_probs=196.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+++++||+|+||+||+|.+.  +..+|+|++.....      ........+.+|+++++.++||||+++++.+.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV------LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh------hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            6889999999999999999984  46799999863211      122344566789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+|||||++|+|.+++...   ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999999999988543   34788889999999999999999999  99999999999999999999999999753


Q ss_pred             CCCccc--------------------------------------------ccceeccccccCCCcCcccccCCCCCCccc
Q psy5927         304 GPIEKA--------------------------------------------THITLKRVNGTRPYLPHEFLVGKRLSTKVD  339 (441)
Q Consensus       304 ~~~~~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~D  339 (441)
                      ......                                            ........+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D  230 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  230 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence            210000                                            000112356999999999999989999999


Q ss_pred             eehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC---H
Q psy5927         340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE---M  416 (441)
Q Consensus       340 iwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~  416 (441)
                      ||||||++|||++|.+||.......... .... +.        .....+....++.++.+++.+++ .+|.+|++   +
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~-~i~~-~~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         231 WWSVGVILYEMLVGQPPFLAQTPLETQM-KVIN-WQ--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             EEechHHHHHHHhCCCCCCCCCHHHHHH-HHHc-cC--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999999998654422111 1110 00        00011112235667788888876 58999987   8


Q ss_pred             HHHHH
Q psy5927         417 TQVYN  421 (441)
Q Consensus       417 ~evl~  421 (441)
                      .++++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            87765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.9e-42  Score=322.79  Aligned_cols=251  Identities=21%  Similarity=0.374  Sum_probs=200.3

Q ss_pred             CCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      ++|++.+.||+|+||.||+|.++. ..+|+|.+.....          ....+..|++++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP   73 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCC
Confidence            568889999999999999998855 4789998763221          12345689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+++|+|.+++....  ..+++..+..++.+++.||+|||+.+  |+||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~  149 (256)
T cd05114          74 LYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRY  149 (256)
T ss_pred             EEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccc
Confidence            999999999999999886433  35889999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......  ......++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ...+..+....        
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~--------  218 (256)
T cd05114         150 VLDDEYT--SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGF--------  218 (256)
T ss_pred             cCCCcee--ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC--------
Confidence            4322111  1112235668999999998889999999999999999999 9999976543 22222221110        


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                          ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         219 ----RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                00111223457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.5e-42  Score=336.13  Aligned_cols=249  Identities=20%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.+.  +..+|+|+++......      ......+..|+.++.++ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            46999999999999985  4579999987432111      12234456788888776 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.+++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~E~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            9999999999887543   35889999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH---HHHHHHHHhhchhhhhhhhc
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE---RHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~  384 (441)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|..||.......   ......        ....+.
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~i~  218 (329)
T cd05618         150 G---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--------LFQVIL  218 (329)
T ss_pred             C---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH--------HHHHHh
Confidence            1   12234579999999999999899999999999999999999999996321100   000000        111111


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPE------MTQVYN  421 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~  421 (441)
                      ......+..++..+.+|+.+||+.||++||+      +.++++
T Consensus       219 ~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         219 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            2222344556778899999999999999998      456643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-42  Score=351.61  Aligned_cols=258  Identities=23%  Similarity=0.317  Sum_probs=205.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....++|.+.+.||+|+||+||+|.+  .+..||||++.......       .....+.+|+.++..++|+||+++++.+
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-------~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-------ADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-------HHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            34567999999999999999999987  46789999987543221       2234566899999999999999998876


Q ss_pred             EeCC--------eEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC
Q psy5927         219 FETG--------KYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH  289 (441)
Q Consensus       219 ~~~~--------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~  289 (441)
                      ....        .+++||||+++|+|.+++..+. ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~  178 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCS  178 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeC
Confidence            5332        3689999999999999886533 2456889999999999999999999998  999999999999999


Q ss_pred             CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         290 HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       290 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      ++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..
T Consensus       179 ~~~vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-~~~~~  256 (496)
T PTZ00283        179 NGLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-EVMHK  256 (496)
T ss_pred             CCCEEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence            99999999999976432211 11223457999999999999989999999999999999999999999765431 11111


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .            ......+.+..++.++.+|+.+||+.||.+||++.++++
T Consensus       257 ~------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        257 T------------LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             H------------hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            1            111122344566788999999999999999999999875

>KOG0594|consensus

Probab=100.00  E-value=4.5e-42  Score=319.06  Aligned_cols=274  Identities=22%  Similarity=0.314  Sum_probs=212.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCC-eecccceEEe
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN-ILPLYGICFE  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~  220 (441)
                      ...|..+++||+|+||+||+|+..  +..||+|++.....+..       ......+|+.+|+.++|+| ||.|++++..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-------~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-------VPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-------CCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            346778899999999999999984  56799999987654322       2234569999999999999 9999999988


Q ss_pred             CC------eEEEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         221 TG------KYCLVYRYMPNGSLEDRLLMKKNT-PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       221 ~~------~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      .+      .+++|+||+ .-+|.+++...... ..++...++.++.||+.||+|||+++  |+||||||.|||+++.|.+
T Consensus        83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~l  159 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVL  159 (323)
T ss_pred             cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcE
Confidence            77      899999999 58999998765532 34666889999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      ||+|||+|+....+..   ..+...+|.+|.|||++.|. .|+..+||||+||+++||+++++-|.+..+ ..++..+.+
T Consensus       160 KlaDFGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~  235 (323)
T KOG0594|consen  160 KLADFGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFR  235 (323)
T ss_pred             eeeccchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHH
Confidence            9999999996543322   13445689999999999986 799999999999999999999999988876 334444443


Q ss_pred             hhc---hhh---hhhhhccC--------CCchhHH---HHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCCCCCC
Q psy5927         373 KYS---EEN---MYDLVDKN--------AQPIELN---IAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGSGGESP  431 (441)
Q Consensus       373 ~~~---~~~---~~~~~~~~--------~~~~~~~---~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~~~  431 (441)
                      ...   ++.   ...+.+-+        ...+...   ...+..+++.+||+.+|.+|.|++..++.  +.......+
T Consensus       236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence            331   111   11111110        1111111   22378899999999999999999999885  655544433

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.8e-42  Score=326.51  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||+|+||+||++.+.  +..+|+|.+......      .....+.+..|+++++.++||||+++++++.....+|+||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK------KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh------hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            799999999999874  567999998643211      112234566899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccc
Q psy5927         231 MPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA  309 (441)
Q Consensus       231 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~  309 (441)
                      +++|+|.+++... .....+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999998877432 23456899999999999999999999999  99999999999999999999999999875432211


Q ss_pred             ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCc
Q psy5927         310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP  389 (441)
Q Consensus       310 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  389 (441)
                         ......||+.|+|||.+.+..++.++|+|||||++|||++|..||........ ........         ......
T Consensus       153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~---------~~~~~~  219 (280)
T cd05608         153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRI---------LNDSVT  219 (280)
T ss_pred             ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhh---------cccCCC
Confidence               12334689999999999999999999999999999999999999976432111 11111100         011122


Q ss_pred             hhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         390 IELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       390 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      .+..++..+.+++.+||+.||.+||     +++++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3345677899999999999999999     6778875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG4717|consensus

Probab=100.00  E-value=2e-42  Score=331.00  Aligned_cols=258  Identities=19%  Similarity=0.312  Sum_probs=216.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .+=|++.+.||+|.|+.|-+|++  .+..||||++.+.+.+.       ....++++|++.|+..+|||||+||++....
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-------~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-------LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-------hhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            35588889999999999999875  78899999998765443       3455778999999999999999999999889


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-HHMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~~kl~DFGl  300 (441)
                      ..+|||+|+-.+|+|+|++.++..  .+.+..+.+++.||+.||.|+|+..  ||||||||+||.+. .-|-+||+|||+
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccc
Confidence            999999999999999999976654  4889999999999999999999998  99999999998765 558899999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCC-CccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS-TKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +-.+....    ...+.||+.+|.|||++.|..|+ +++||||||||||.|++|++||.+..+.+..-..          
T Consensus       166 SNkf~PG~----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------  231 (864)
T KOG4717|consen  166 SNKFQPGK----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------  231 (864)
T ss_pred             cccCCCcc----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------
Confidence            87654433    35567899999999999998885 6899999999999999999999987764433222          


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGES  430 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~  430 (441)
                         +|= .-..|..++.++.+||..||..||++|.+.++|..  +|+..-...
T Consensus       232 ---mDC-KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  232 ---MDC-KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             ---hcc-cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence               221 12456788999999999999999999999999986  555544433

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8e-42  Score=325.40  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=205.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      .++|.+.+.||+|+||.||+|...       +..+|||.++.....        ...+.+.+|+++++.++||||+++++
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~   75 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--------DARKDFEREAELLTNFQHENIVKFYG   75 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--------HHHHHHHHHHHHHHhcCCCCchheee
Confidence            457888999999999999999863       246999988643221        12345678999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKK-----------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      ++......++||||+++++|.+++....           ....+++..+..++.+++.||+|||+++  ++||||||+||
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~ni  153 (280)
T cd05049          76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNC  153 (280)
T ss_pred             EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceE
Confidence            9999999999999999999999996542           1345788999999999999999999998  99999999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhH
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE  364 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~  364 (441)
                      +++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       154 li~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-  231 (280)
T cd05049         154 LVGYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-  231 (280)
T ss_pred             EEcCCCeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999998753221111 11122235778999999999899999999999999999998 99999765432 


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      .......            .......+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       232 ~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         232 EVIECIT------------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHH------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1111111            111112223456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.3e-42  Score=340.73  Aligned_cols=257  Identities=18%  Similarity=0.256  Sum_probs=200.9

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....++|++.+.||+|+||.||+|.+.  +..||+|.+......      .......+..|+.+++.++||||+++++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~h~~iv~~~~~~  112 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI------KRSDSAFFWEERDIMAHANSEWIVQLHYAF  112 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            345678999999999999999999985  567999998632111      112233456899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+++.+|+||||++||+|.+++...    .++...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~Df  186 (370)
T cd05596         113 QDDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADF  186 (370)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999999999988532    3778888899999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC----CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |++.......  ........||+.|+|||.+.+.    .++.++|||||||++|||++|..||....... ....+....
T Consensus       187 G~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~  263 (370)
T cd05596         187 GTCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDHK  263 (370)
T ss_pred             cceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCC
Confidence            9987532211  1122345699999999998653    47899999999999999999999998654321 111111100


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYN  421 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~  421 (441)
                        .       ....+....++.++.+|+.+||..+|++  ||++.++++
T Consensus       264 --~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         264 --N-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             --C-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence              0       0001111235678899999999999988  999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0599|consensus

Probab=100.00  E-value=5.1e-43  Score=311.85  Aligned_cols=260  Identities=25%  Similarity=0.364  Sum_probs=212.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      ..-++|+..+.||+|..+.|.++..+  +..+|+|++.........+. ....++...+|+.+|+++ .||+|+++.+++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-PYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-HHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            44567888899999999999998875  45799999987655444333 345667778999999998 699999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      ..+..+++|+|.|+.|.|+|+|...   -.+++.....|++|+..|++|||.++  ||||||||+|||+|++.++||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEecc
Confidence            9999999999999999999999543   34889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC------CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG------KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      |+++....+.    .....|||++|+|||.+.-      ..|+..+|+||+||++|.||.|.+||-..+. ...++.+.+
T Consensus       168 GFa~~l~~Ge----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-mlMLR~Ime  242 (411)
T KOG0599|consen  168 GFACQLEPGE----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-MLMLRMIME  242 (411)
T ss_pred             ceeeccCCch----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HHHHHHHHh
Confidence            9998765443    3566799999999999853      4689999999999999999999999965443 222322221


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .     -+.+-    .+.-.+++....+|+.+||+.||.+|.|++|+++
T Consensus       243 G-----kyqF~----speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 G-----KYQFR----SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             c-----ccccC----CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1     11111    1122467788999999999999999999999976

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-41  Score=320.20  Aligned_cols=261  Identities=19%  Similarity=0.306  Sum_probs=208.3

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|..  .++.+|||.+......      .......+.+|+++++.++||||+++++++.+.+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM------DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC------CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            5799999999999999999987  4678999987643221      1123445678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..++++||+++|+|.+++.... ....++...+..++.+++.||.|||+++  ++||||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            9999999999999998885432 2345788899999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........   ......|+..|+|||.+.+..++.++|+||||+++|||++|..||.........+...+...       
T Consensus       154 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-------  223 (267)
T cd08228         154 RFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC-------  223 (267)
T ss_pred             eeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC-------
Confidence            76432211   11234588899999999888899999999999999999999999965433221111111100       


Q ss_pred             hhccCCCc-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         382 LVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       382 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                          ...+ ....++..+.+++.+||..+|.+||++.+|++.|+++.
T Consensus       224 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 ----DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                0111 12345678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-41  Score=325.38  Aligned_cols=257  Identities=24%  Similarity=0.431  Sum_probs=203.1

Q ss_pred             CCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ++|++.+.||+|+||+||+|.+      ....+|+|.+......        .....+.+|+++++.++||||+++++++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~   76 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--------QQWGEFQQEASLMAELHHPNIVCLLGVV   76 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--------HHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence            5788889999999999999985      2357899988643221        1234566899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCC
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKN--------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN  284 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~N  284 (441)
                      ..+...|+||||+++++|.+++.....              ...+++.....++.+++.||+|||+++  ++||||||+|
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~n  154 (283)
T cd05090          77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARN  154 (283)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccce
Confidence            999999999999999999998853321              224788899999999999999999998  9999999999


Q ss_pred             eeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchh
Q psy5927         285 ILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS  363 (441)
Q Consensus       285 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~  363 (441)
                      ||++.++.+||+|||+++......... ......++..|+|||++.+..++.++|+||||+++|||++ |..||..... 
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-  232 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-  232 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCccee-cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            999999999999999997643222111 1223345778999999988889999999999999999998 9999976542 


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      .... ..+..           ....+.+..++..+.+++.+||+.||.+||++.+|++.|..
T Consensus       233 ~~~~-~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVI-EMVRK-----------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHH-HHHHc-----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111 11110           11112334456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-42  Score=342.87  Aligned_cols=256  Identities=18%  Similarity=0.250  Sum_probs=197.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++++.||+|+||.||+|.+.  +..||||++....      .........+.+|+++++.++||||+++++.+.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD------VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH------HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            47999999999999999999985  5679999986321      111223455668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...   ..++...+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            999999999999999998543   34788888999999999999999999  9999999999999999999999999975


Q ss_pred             cCCCcc----------------------------------------cccceeccccccCCCcCcccccCCCCCCccceeh
Q psy5927         303 EGPIEK----------------------------------------ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYG  342 (441)
Q Consensus       303 ~~~~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwS  342 (441)
                      ......                                        ..........||+.|||||++.+..++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            321000                                        0000112357999999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC---CHHHH
Q psy5927         343 FGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP---EMTQV  419 (441)
Q Consensus       343 lGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~ev  419 (441)
                      |||++|||++|..||.......... .+ ..+...        ...+....++..+.+++.+|+ .+|.+|+   ++.++
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~-~i-~~~~~~--------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQL-KV-INWETT--------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHH-HH-hccCcc--------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            9999999999999998765422111 11 111000        001111235567788888876 4999999   88888


Q ss_pred             HHH
Q psy5927         420 YNM  422 (441)
Q Consensus       420 l~~  422 (441)
                      ++.
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.9e-42  Score=336.13  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      +..++|++.+.||+|+||.||+|...+       +.||+|+++.....        ...+.+..|+.++.++ +|+||++
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~~E~~~~~~l~~h~niv~   75 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--------SEYKALMTELKILIHIGHHLNVVN   75 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--------HHHHHHHHHHHHHHhhccCcchhh
Confidence            344689999999999999999997532       46999988643211        1234556899999999 8999999


Q ss_pred             ccceEEe-CCeEEEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q psy5927         214 LYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKN-----------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------  245 (441)
                      ++++|.. +..++++|||+++++|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            9998864 4678899999999999998864321                                               


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccccccee
Q psy5927         246 -----------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL  314 (441)
Q Consensus       246 -----------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  314 (441)
                                 ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++....... ....
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~  232 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRK  232 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhc
Confidence                       125889999999999999999999998  99999999999999999999999999976432211 1112


Q ss_pred             ccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHH
Q psy5927         315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELN  393 (441)
Q Consensus       315 ~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (441)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......+..... ....           .....+..
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~-----------~~~~~~~~  300 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR-LKEG-----------TRMRAPEY  300 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH-Hhcc-----------CCCCCCcc
Confidence            23346778999999999899999999999999999998 99999765432222111 1110           00111233


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         394 IAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       394 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      .+.++.+++.+||+.+|.+||++.+|++.|+.+-.
T Consensus       301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         301 ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            45678999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.5e-42  Score=333.20  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=194.8

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||+||+|.+.  +..||||+++.....      .......+..|.+++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL------QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999985  457999998743211      112234456788888877 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          75 MEYVNGGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            9999999999888543   35889999999999999999999999  999999999999999999999999998753222


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   ......+||..|+|||++.+..++.++|+|||||++|||++|..||..... ........             ...
T Consensus       150 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-~~~~~~i~-------------~~~  212 (318)
T cd05570         150 G---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL-------------EDE  212 (318)
T ss_pred             C---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-HHHHHHHH-------------cCC
Confidence            1   112334689999999999998999999999999999999999999976543 11111111             111


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEM-----TQVYN  421 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~  421 (441)
                      ...+..++..+.+|+.+||+.||++||++     .++++
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            12233456788999999999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=319.33  Aligned_cols=257  Identities=23%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|..  .+..+|+|.+.........    ......+.+|++++++++||||+++++++.+..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   77 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET----KKEVNALECEIQLLKNLQHERIVQYYGCLRDDE   77 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh----HHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence            5799999999999999999987  3578999988754322211    123445678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|.+++...   ..+++..+..++.+++.||.|||+.+  |+||||+|+||+++.++.++|+|||+++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccce
Confidence            999999999999999988543   34788899999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ................|+..|+|||.+.+..++.++||||||+++|||++|..||......... .....          
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~----------  221 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIAT----------  221 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHhc----------
Confidence            5432211111113345788999999999988999999999999999999999999765331111 11110          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                       .......+..++..+.+++.+||..+|.+||++.++++.
T Consensus       222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 -QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             011122344567789999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6e-42  Score=327.04  Aligned_cols=258  Identities=21%  Similarity=0.351  Sum_probs=205.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+|++.+.||+|+||.||+|.+.       +..+|+|+++.....        ...+.+..|+.++..++||||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~~~~l~h~~iv~~~~   75 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--------PLREEFKHEAMMRSRLQHPNIVCLLG   75 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--------HHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            346788899999999999999863       256999998743221        22345668999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKK-------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      ++.+.+..++++||+.+++|.+++....             ....+++..+..++.|++.||+|||+++  |+||||||+
T Consensus        76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~  153 (283)
T cd05091          76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATR  153 (283)
T ss_pred             EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence            9999999999999999999999985332             1234788889999999999999999999  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcch
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR  362 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~  362 (441)
                      |||+++++.+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         154 NVLVFDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             heEecCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999998764322211 11223346778999999988889999999999999999998 8889876543


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                       ......+            .+....+.+..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus       233 -~~~~~~i------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 -QDVIEMI------------RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHHH------------HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1111111            1112223345677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9e-42  Score=338.22  Aligned_cols=258  Identities=18%  Similarity=0.261  Sum_probs=200.3

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....++|++.+.||+|+||.||++.+.  +..+|+|++......      .......+.+|+.+++.++||||+++++++
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFCAF  112 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            445678999999999999999999985  457999998632111      112233456899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+++.+|+||||+++|+|.+++...    .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         113 QDDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEec
Confidence            9999999999999999999988532    3788899999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC----CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |++.......  ........||+.|+|||++.+.    .++.++|||||||++|||++|..||....... ....+....
T Consensus       187 G~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~  263 (370)
T cd05621         187 GTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHK  263 (370)
T ss_pred             ccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence            9997643211  1122355799999999998764    37889999999999999999999997654321 221111100


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYNM  422 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~  422 (441)
                      .         ....+....++..+.+++..||..++.+  |+++.++++.
T Consensus       264 ~---------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 N---------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             c---------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0         0001112245677889999999866654  8999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=321.13  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=205.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.+.||+|+||.||+|.+++ +.||+|.++....          ..+.+.+|++++++++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----------DPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----------cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            445679999999999999999998744 5799998864321          12345689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++++|.+++.... ...+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcce
Confidence            999999999999999999886543 345889999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++........  .......+..|+|||.+.+..++.++|+||||+++|||+| |..||..... ......+...      
T Consensus       150 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~------  220 (261)
T cd05068         150 ARVIKEDIYE--AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQG------  220 (261)
T ss_pred             EEEccCCccc--ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcC------
Confidence            8764322111  1111123457999999998899999999999999999999 9999976543 1111111110      


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                            ...+.+..++..+.+++.+||+.+|.+||++.++++.|+..
T Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         221 ------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  01122334567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-42  Score=337.28  Aligned_cols=254  Identities=19%  Similarity=0.231  Sum_probs=200.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||+||+|.+.  +..||+|+++.....      .......+..|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL------AQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            47899999999999999999974  568999998743211      1123445668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCe
Confidence            999999999999999988654  235889999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCccccc------CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLV------GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ........  ......||+.|+|||++.      +..++.++|||||||++|||++|..||...... .....+...   
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~---  224 (330)
T cd05601         151 RLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNF---  224 (330)
T ss_pred             ECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcC---
Confidence            64322211  223346899999999986      456789999999999999999999999765432 222221110   


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..   ..   ..+....++..+.+|+.+||+ +|.+||++.++++
T Consensus       225 ~~---~~---~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 QR---FL---KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC---cc---CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00   00   011122456778999999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-41  Score=321.58  Aligned_cols=255  Identities=24%  Similarity=0.392  Sum_probs=204.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|.+.+.||+|+||.||+|.+.  ++.+|+|.+....          .....+.+|+++++.++||||+++++++...
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   74 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----------hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence            456888899999999999999985  5679999876321          1123566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.++++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+  ++||||||+|||+++++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          75 PPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccc
Confidence            99999999999999999886433 345889999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..........       
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~-------  221 (263)
T cd05052         152 RLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKG-------  221 (263)
T ss_pred             cccccceee--ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCC-------
Confidence            764332111  1112234567999999998899999999999999999998 9999976543 2111111110       


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                           .....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       222 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 -----YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 01122334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.8e-42  Score=331.45  Aligned_cols=261  Identities=24%  Similarity=0.411  Sum_probs=204.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--Ce----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ...+|++.+.||+|+||.||+|.+.  +.    .||+|.++.....        ...+.+..|+.+++.++||||+++++
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~g   76 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--------KANKEILDEAYVMASVDNPHVCRLLG   76 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3467999999999999999999873  22    3899988632211        22345668999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      +|... ..+++++|+++|+|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~-~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~  151 (316)
T cd05108          77 ICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKIT  151 (316)
T ss_pred             EEcCC-CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEc
Confidence            88764 5789999999999999886433  34788899999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....  +......  
T Consensus       152 DfG~a~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~--  226 (316)
T cd05108         152 DFGLAKLLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK--  226 (316)
T ss_pred             cccccccccCCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhC--
Confidence            99999864332111 11122234678999999998899999999999999999998 999997654321  1111110  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                               ....+.+..++.++.+++.+||..+|.+||++.+++..|..+..+.
T Consensus       227 ---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         227 ---------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                     0111222345567899999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-41  Score=320.72  Aligned_cols=257  Identities=24%  Similarity=0.419  Sum_probs=202.4

Q ss_pred             CcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      |.+.+.||+|+||.||+|....     ..+|+|+++.....       ......+.+|+++++.++||||+++++++...
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   73 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-------YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEA   73 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-------HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence            5678999999999999998743     46999998743221       12344567899999999999999999988765


Q ss_pred             Ce------EEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         222 GK------YCLVYRYMPNGSLEDRLLMKK---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       222 ~~------~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      ..      .+++|||+++|+|.+++....   ....+++..+..++.|++.||.|||+.+  ++||||||+||++++++.
T Consensus        74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMT  151 (273)
T ss_pred             CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCe
Confidence            54      799999999999999885432   2245889999999999999999999998  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~  371 (441)
                      +||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ........
T Consensus       152 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~  229 (273)
T cd05035         152 VCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLR  229 (273)
T ss_pred             EEECCccceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH
Confidence            999999998754322211 11112235678999999988889999999999999999999 9999976543 22222211


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .            ......+..++..+.+++.+||+.||++||++.+|++.|+.+
T Consensus       230 ~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 H------------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             c------------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1            111223345677899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-41  Score=329.58  Aligned_cols=242  Identities=23%  Similarity=0.322  Sum_probs=191.5

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.+.  +..||+|.++.....      ..........|..++... +||||+++++++.+.+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            46999999999999985  457999998743211      011233445677777654 899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          75 MEFLNGGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             ECCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            9999999999988543   34788999999999999999999999  999999999999999999999999998743221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|..||..... ......+.             ...
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~-------------~~~  212 (316)
T cd05620         150 D---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIR-------------VDT  212 (316)
T ss_pred             C---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHH-------------hCC
Confidence            1   122345799999999999998999999999999999999999999976543 21221111             011


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMT-QVY  420 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl  420 (441)
                      ...+..++.++.+|+.+||+.||++||++. +++
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            122334567889999999999999999985 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-42  Score=335.07  Aligned_cols=239  Identities=23%  Similarity=0.306  Sum_probs=193.0

Q ss_pred             CccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  225 (441)
                      +.||+|+||.||++..     .++.+|+|++......       .........|++++++++||||+++++++.+.+.+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY   74 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence            6799999999999875     3568999998743211       122334568999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      +||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        75 lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          75 LILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             EEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            999999999999988543   34889999999999999999999999  9999999999999999999999999987543


Q ss_pred             CcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       306 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                      ...   .......||..|+|||.+.+..++.++|||||||++|||++|..||..... ........             .
T Consensus       150 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i~-------------~  212 (318)
T cd05582         150 DHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMIL-------------K  212 (318)
T ss_pred             CCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHHH-------------c
Confidence            221   122345799999999999988899999999999999999999999976543 11221111             1


Q ss_pred             CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q psy5927         386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ  418 (441)
Q Consensus       386 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  418 (441)
                      .....+..++..+.+|+.+||+.||.+||++.+
T Consensus       213 ~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         213 AKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            111233446678899999999999999999443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-41  Score=330.71  Aligned_cols=264  Identities=24%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.++||+|+||.||+|.+.  +..+|+|.+......        .....+.+|+++++.++||||++++++|.+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--------HHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            4578999999999999999999985  457888887643211        223456799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+.+|+||||+++|+|.+++...   ..+++..+..++.+++.||.|||+ .+  |+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCC
Confidence            99999999999999999988543   347888999999999999999997 46  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh--
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE--  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--  377 (441)
                      ++......     ......||..|+|||++.+..++.++|+|||||++|||++|..||.......  +..........  
T Consensus       150 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~  222 (333)
T cd06650         150 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDP  222 (333)
T ss_pred             cchhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCc
Confidence            98653221     1223468999999999999889999999999999999999999997543311  11111000000  


Q ss_pred             ------------------------------hhhhhh-ccCCCchh-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HH
Q psy5927         378 ------------------------------NMYDLV-DKNAQPIE-LNIAYAFFRIGKQSTKQNPKERPEMTQVYN--ML  423 (441)
Q Consensus       378 ------------------------------~~~~~~-~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L  423 (441)
                                                    .....+ .......+ ..++.++.+|+.+||+.||++||++.++++  .|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~  302 (333)
T cd06650         223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI  302 (333)
T ss_pred             cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence                                          000000 00000011 124567899999999999999999999975  44


Q ss_pred             hcC
Q psy5927         424 SGS  426 (441)
Q Consensus       424 ~~~  426 (441)
                      +..
T Consensus       303 ~~~  305 (333)
T cd06650         303 KRS  305 (333)
T ss_pred             hcC
Confidence            443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-41  Score=318.57  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=196.3

Q ss_pred             ccccCCceeEEEEEE----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         152 ILGKGGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +||+|+||.||+|.+    .+..+|+|+++....+.       ...+.+..|+.+++.+.||||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP-------ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH-------HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            689999999999976    34679999886433221       23456678999999999999999999875 5677999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          74 MELAELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            9999999999988543   34888999999999999999999999  999999999999999999999999998764332


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN  386 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  386 (441)
                      ...........++..|+|||.+.+..++.++|+|||||++|||++ |..||.......  +...+.   ..        .
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i~---~~--------~  215 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMIE---SG--------E  215 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---CC--------C
Confidence            211111122234678999999988889999999999999999998 999997654321  111111   10        1


Q ss_pred             CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         387 AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       387 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ..+.+..++.++.+++.+||+.||.+||++.+|.+.|++.
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1223345677899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-41  Score=324.15  Aligned_cols=267  Identities=25%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             CcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         147 WDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      |.+.+.||+|+||+||++..      .+..+|+|.++.....        .....+.+|+++++.++||||+++++++..
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--------QNTSGWKKEINILKTLYHENIVKYKGCCSE   77 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            38889999999999988753      3457999988643211        123455689999999999999999998765


Q ss_pred             C--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         221 T--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       221 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .  ..+++||||+++++|.+++...    .+++..+..++.+++.||+|||+++  |+||||||+|||++.++.++|+||
T Consensus        78 ~~~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~df  151 (283)
T cd05080          78 QGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDF  151 (283)
T ss_pred             CCCceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeec
Confidence            3  4589999999999999988542    3899999999999999999999998  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH-hhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE-KYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~-~~~~~  377 (441)
                      |+++................++..|+|||.+.+..++.++||||||+++|||+||..||............... .....
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05080         152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV  231 (283)
T ss_pred             ccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence            99876433221111112223566799999998888999999999999999999999998654321110000000 00011


Q ss_pred             hhhhhhccC-CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         378 NMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       378 ~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      .....++.. ..+.+..++..+.+++.+||+.+|++||++++|++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111111 12234456778999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.9e-42  Score=333.75  Aligned_cols=239  Identities=24%  Similarity=0.320  Sum_probs=189.1

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHH-HhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||+||+|.+.  +..||+|++.......      ......+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK------KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh------hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            46999999999999984  5679999986432111      112233445554 46788999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          75 LDYVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             EcCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            9999999999988543   35888999999999999999999999  999999999999999999999999998753222


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|..||..... .........             ..
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~-------------~~  212 (323)
T cd05575         150 S---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN-------------KP  212 (323)
T ss_pred             C---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-HHHHHHHHc-------------CC
Confidence            1   122345699999999999998999999999999999999999999976543 111111111             11


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMT  417 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  417 (441)
                      ...+..++..+.+++.+||+.||.+||++.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            122334567889999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-41  Score=325.70  Aligned_cols=262  Identities=23%  Similarity=0.395  Sum_probs=206.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+|.+.+.||+|+||.||++...       +..+|+|.+.....         .....+.+|++++++++||||+++++
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---------NARKDFHREAELLTNLQHEHIVKFYG   74 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---------HHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            467899999999999999999752       23588888753211         22345678999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCee
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKK----------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL  286 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiL  286 (441)
                      ++...+.+++||||+++++|.+++....          ....+++..+..++.|++.||+|||+.+  ++||||||+|||
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nil  152 (288)
T cd05093          75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCL  152 (288)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEE
Confidence            9999999999999999999999986432          1234899999999999999999999999  999999999999


Q ss_pred             ecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHH
Q psy5927         287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSER  365 (441)
Q Consensus       287 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~  365 (441)
                      ++.++.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||+| |..||...... .
T Consensus       153 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~  230 (288)
T cd05093         153 VGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-E  230 (288)
T ss_pred             EccCCcEEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-H
Confidence            99999999999999875422211 111122335778999999998889999999999999999999 99999765432 1


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      ......    ...        ....+..++.++.+|+.+||+.||.+||++.+|++.|+.+...+
T Consensus       231 ~~~~i~----~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         231 VIECIT----QGR--------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHHHH----cCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            221111    110        11122234567999999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-41  Score=326.14  Aligned_cols=261  Identities=24%  Similarity=0.403  Sum_probs=206.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+|.+.+.||+|+||.||+|.+.       ...+++|.+.....         ...+.+.+|++++++++||||+++++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---------AARKDFQREAELLTNLQHEHIVKFYG   74 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---------HHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            356888899999999999999853       23478888753221         12345668999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      ++...+..++||||+++++|.+++.....             ...+++..+..++.+++.||+|||+++  |+||||||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~  152 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATR  152 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcc
Confidence            99999999999999999999999865321             234889999999999999999999999  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcch
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR  362 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~  362 (441)
                      |||++.++.++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|||+| |..||.....
T Consensus       153 Nil~~~~~~~~l~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         153 NCLVGANLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             eEEEccCCcEEECCCCcccccCCCcee-ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999754322111 11123346788999999999899999999999999999999 9999976543


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      .. .....    ...        .....+..++..+.+++.+||+.+|++||++.+|++.|+++...
T Consensus       232 ~~-~~~~~----~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 TE-VIECI----TQG--------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HH-HHHHH----hCC--------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            21 11111    111        11112233566799999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-41  Score=325.98  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +.+..++|++.+.||+|+||.||+|.+.+       ..+|+|.+......        .....+.+|++++.++ +||||
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~i   78 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--------KDLSDLVSEMEMMKMIGKHKNI   78 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--------HHHHHHHHHHHHHHhhcCCCCe
Confidence            34666789999999999999999998742       46899988643221        1234566899999999 79999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMK-------------KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                      +++++++..++.++++|||+++|+|.+++..+             .....+++..+..++.|++.||+|||+.+  |+||
T Consensus        79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~  156 (293)
T cd05053          79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHR  156 (293)
T ss_pred             eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence            99999999999999999999999999998643             22456889999999999999999999998  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY  357 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~  357 (441)
                      ||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       157 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         157 DLAARNVLVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             ccceeeEEEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            999999999999999999999997643321111 1112234667999999988889999999999999999998 99999


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ...... ........            ......+..++..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus       236 ~~~~~~-~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         236 PGIPVE-ELFKLLKE------------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCHH-HHHHHHHc------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            765431 11111111            0111223345668899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.1e-42  Score=333.43  Aligned_cols=242  Identities=23%  Similarity=0.319  Sum_probs=189.6

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHH-HhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||+||+|.+.  +..+|+|++.......      ......+..|.. +++.++||||+++++++.+.+.+|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK------KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh------hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            46999999999999985  4569999987432111      111223334443 56788999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+....+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          75 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            9999999999988543   34778888899999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|.+||...... ........             ..
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~-------------~~  212 (325)
T cd05602         150 N---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILN-------------KP  212 (325)
T ss_pred             C---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHh-------------CC
Confidence            1   1233457999999999999989999999999999999999999999765432 22222111             11


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                      ......++..+.+++.+||+.||.+||++.+.+
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            122335667889999999999999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.1e-41  Score=330.65  Aligned_cols=243  Identities=24%  Similarity=0.340  Sum_probs=191.6

Q ss_pred             CccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc-CCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-CRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||+||+|.+.+  ..||||+++.....      ..........|..++.. ++||||+++++++.+.+.+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            469999999999999854  57999998743211      01122344567777775 4899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~ey~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          75 MEYLNGGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            9999999999988543   34788999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||..|+|||++.+..++.++|||||||++|||++|..||..... ......+.    .         ..
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~----~---------~~  212 (316)
T cd05619         150 D---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIR----M---------DN  212 (316)
T ss_pred             C---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHH----h---------CC
Confidence            1   122345699999999999998999999999999999999999999976543 11111111    0         01


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMT-QVYN  421 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~  421 (441)
                      ...+..++.++.+++.+||+.||.+||++. ++.+
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         213 PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            112234566789999999999999999997 5643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-41  Score=321.54  Aligned_cols=259  Identities=24%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..++|+..+.||+|+||.||+|....     ..+|+|.++.....        ...+.+..|+++++.++||||++++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--------KQRQDFLSEASIMGQFSHHNIIRLEGV   74 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--------HHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence            45678889999999999999998742     25888887643211        223456789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+.+..++||||+++++|.+++...  ...+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.+||+|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~d  150 (268)
T cd05063          75 VTKFKPAMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSD  150 (268)
T ss_pred             EccCCCcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECC
Confidence            99999999999999999999988543  345889999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||++..................+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+.    .
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~----~  225 (268)
T cd05063         151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIN----D  225 (268)
T ss_pred             CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHh----c
Confidence            9998754332211111111223457999999988889999999999999999998 9999976543 12221111    1


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                              ....+....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       226 --------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 --------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    011122234567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.8e-41  Score=321.13  Aligned_cols=258  Identities=23%  Similarity=0.389  Sum_probs=204.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .++|++.+.||+|+||.||+|.+.     ...+|+|.++.....        ...+.+..|+.++++++||||+++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--------KQRRDFLSEASIMGQFDHPNIIHLEGVV   74 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--------HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            467899999999999999999873     235888887643221        2234567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      ..++..|+||||+++++|.+++...  ...+++..+..++.+++.||.|||+.+  ++||||||+|||++.++.++|+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          75 TKSKPVMIVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             ecCCccEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCC
Confidence            9999999999999999999998643  245889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |++.................++..|+|||.+.+..++.++|+||||+++||+++ |..||.+.... .....+...    
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~~~----  225 (267)
T cd05066         151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIEEG----  225 (267)
T ss_pred             CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHHhCC----
Confidence            999764332211111122233567999999998889999999999999999887 99999765432 122111110    


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                              ...+.+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       226 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 --------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                    01122234567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5e-41  Score=317.67  Aligned_cols=261  Identities=20%  Similarity=0.330  Sum_probs=208.6

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+  .+..+|||.+......      .......+.+|+.+++.++||||+++++++.+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM------DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh------hHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            5788899999999999999996  5678999988643211      1123456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..+++|||+++++|.+++.... ....+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            9999999999999999886432 2346889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............+..        
T Consensus       154 ~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  222 (267)
T cd08229         154 RFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--------  222 (267)
T ss_pred             hccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc--------
Confidence            75432211   1223458899999999988889999999999999999999999996543321111111110        


Q ss_pred             hhccCCCc-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         382 LVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       382 ~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                         ....+ ....++..+.+++.+||..||.+||++.+|++.++++.
T Consensus       223 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         223 ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               00111 12346778999999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-41  Score=320.80  Aligned_cols=256  Identities=22%  Similarity=0.367  Sum_probs=207.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ...+|++.++||.|+||.||+|.+. +..+|+|.+.....         .....+..|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---------LKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---------hhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            4567899999999999999999985 46789998864321         1233456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ...++||||+++++|.+++.... ...+++..+..++.+++.||+|||+.+  |+||||||+||+++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccch
Confidence            99999999999999999986543 345899999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .........   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..+.....        
T Consensus       152 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~--------  219 (261)
T cd05148         152 RLIKEDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQITA--------  219 (261)
T ss_pred             hhcCCcccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHHh--------
Confidence            764322111   112335678999999988889999999999999999998 89999765431 12221111        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                          ....+.+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus       220 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 ----GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                111123345567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0658|consensus

Probab=100.00  E-value=2.1e-42  Score=320.83  Aligned_cols=265  Identities=21%  Similarity=0.331  Sum_probs=203.5

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC--
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET--  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  221 (441)
                      .|...+++|.|+||.||+|...  +..+|||++-....-.             -+|+++|..+.|||||+|.-+|...  
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------------nrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------------NRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------------cHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            4666799999999999999984  4689999986543211             1799999999999999998887643  


Q ss_pred             C---eEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCeEEe
Q psy5927         222 G---KYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIG  296 (441)
Q Consensus       222 ~---~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~kl~  296 (441)
                      +   ..++|||||+ .+|.+.+... .....++...+.-+..||.+||.|||+.|  |+||||||.|+|+|.+ |.+|||
T Consensus        92 ~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             CchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEec
Confidence            2   3568999996 8898888642 12345777788899999999999999998  9999999999999987 999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||.|+........    .++..|..|.|||.+.| ..|+.+.||||.|||+.||+-|.+-|.+... ..++..+++...
T Consensus       169 DFGSAK~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG  243 (364)
T KOG0658|consen  169 DFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLG  243 (364)
T ss_pred             cCCcceeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhC
Confidence            99999876554433    23357899999999988 5799999999999999999999999988665 456665555442


Q ss_pred             ---hhhhhhhh----c---c--CCCc----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-----HHHhcCCCCCC
Q psy5927         376 ---EENMYDLV----D---K--NAQP----IELNIAYAFFRIGKQSTKQNPKERPEMTQVY-----NMLSGSGGESP  431 (441)
Q Consensus       376 ---~~~~~~~~----~---~--~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl-----~~L~~~~~~~~  431 (441)
                         .+.+..+-    +   +  +...    .....+.+..+|+.++|..+|.+|.++.|++     +.|+......+
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~  320 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLP  320 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCc
Confidence               11111110    0   0  1111    3345677899999999999999999999875     45655544444

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-41  Score=335.93  Aligned_cols=260  Identities=18%  Similarity=0.253  Sum_probs=200.8

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ++....++|++.+.||+|+||.||+|.+.  +..+|+|++......      .......+..|+.+++.++||||+++++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~------~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFY  110 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh------hhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34556789999999999999999999985  457999998632111      1122334568999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+++.+|+||||+++|+|.+++...    .++...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         111 AFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEE
Confidence            999999999999999999999988532    3778888999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCC----CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      |||+++......  ........||+.|+|||++.+.    .++.++|||||||++|||++|..||....... ....+..
T Consensus       185 DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~  261 (371)
T cd05622         185 DFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMN  261 (371)
T ss_pred             eCCceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHc
Confidence            999997543221  1122345799999999998763    37899999999999999999999997654321 1111111


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYNM  422 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~  422 (441)
                      ..   .      ....+....++..+.+++.+||..++.+  |+++.++++.
T Consensus       262 ~~---~------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HK---N------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CC---C------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            00   0      0011112346778899999999854443  7899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-41  Score=322.67  Aligned_cols=260  Identities=23%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +.+++|.+.+.||+|+||.||+|.+..       ..||+|.+......        .....+..|+.+++.++|+||+++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~   74 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--------QDESDFLMEALIMSKFNHQNIVRL   74 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            345789999999999999999999854       46788877533221        122356789999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      ++++.+.+..++||||+++++|.+++.....    ...+++..+..++.+|+.||+|||+.+  ++||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~  152 (277)
T cd05036          75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCK  152 (277)
T ss_pred             EEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEecc
Confidence            9999999999999999999999998865432    235889999999999999999999999  9999999999999876


Q ss_pred             C---CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHH
Q psy5927         291 M---DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH  366 (441)
Q Consensus       291 ~---~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~  366 (441)
                      +   .+||+|||+++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~  230 (277)
T cd05036         153 GPGRVAKIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEV  230 (277)
T ss_pred             CCCcceEeccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence            5   5899999999764221111 11112223567999999998889999999999999999997 9999976543 211


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      . ..+..           ......+..++..+.+++.+||+.+|++||++.+|++.|..
T Consensus       231 ~-~~~~~-----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         231 M-EFVTG-----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             H-HHHHc-----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            1 11111           01112234456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.4e-41  Score=324.23  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             CCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      +|++.+.||+|+||.||+|....       ..+++|.+......        ...+.+.+|+.+++.++||||+++++.+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--------SELRDLLSEFNLLKQVNHPHVIKLYGAC   72 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--------HHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            57888999999999999998632       35788877643221        1234567899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKK---------------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      ...+..+++|||+.+|+|.+++....                     ....+++..++.++.|++.||+|||+.+  ++|
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH  150 (290)
T cd05045          73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVH  150 (290)
T ss_pred             ecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eeh
Confidence            99999999999999999999885422                     1235788999999999999999999998  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA  356 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p  356 (441)
                      |||||+|||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||+| |..|
T Consensus       151 ~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  229 (290)
T cd05045         151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  229 (290)
T ss_pred             hhhhhheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999998754322111 11122345678999999988889999999999999999999 9999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      |..... .. +.......           ...+.+..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus       230 ~~~~~~-~~-~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         230 YPGIAP-ER-LFNLLKTG-----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCCCH-HH-HHHHHhCC-----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            976543 21 11111110           0111233456789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-41  Score=325.22  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=201.6

Q ss_pred             CCCcCcCccccCCceeEEEEEECCe----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      ++|++.+.||+|+||.||+|.....    .+++|.++.....        ...+.+.+|++++.++ +||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   73 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--------NDHRDFAGELEVLCKLGHHPNIINLLGACE   73 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--------HHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence            5789999999999999999987432    3678777632211        1234566899999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCee
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL  286 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiL  286 (441)
                      +.+.++++|||+++++|.+++.....             ...+++..+..++.|++.||+|||+.+  |+||||||+|||
T Consensus        74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil  151 (297)
T cd05089          74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVL  151 (297)
T ss_pred             cCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEE
Confidence            99999999999999999999865321             235888999999999999999999998  999999999999


Q ss_pred             ecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHH
Q psy5927         287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSER  365 (441)
Q Consensus       287 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~  365 (441)
                      ++.++.+||+|||++.......    .......+..|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-  226 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-  226 (297)
T ss_pred             ECCCCeEEECCcCCCcccccee----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            9999999999999986422110    1111123457999999988889999999999999999998 999997654321 


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      .......            ......+..++..+.+|+.+||+.+|.+||++.++++.|..+...
T Consensus       227 ~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         227 LYEKLPQ------------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHHHHhc------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111110            011122334567899999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=323.07  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=206.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +..++|.+.+.||+|+||.||+|.+.+       ..+|+|.+......        .....+.+|+.+++.++||||+++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~i~~~   74 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--------RERIEFLNEASVMKEFNCHHVVRL   74 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--------HHHHHHHHHHHHHHhCCCCceeEE
Confidence            345789999999999999999998753       46999997633211        223456689999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL  287 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl  287 (441)
                      ++++......++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.+  ++||||||+|||+
T Consensus        75 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill  152 (277)
T cd05032          75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMV  152 (277)
T ss_pred             EEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEE
Confidence            9999999999999999999999999865432       234788899999999999999999998  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHH
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH  366 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~  366 (441)
                      +.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||+| |..||..... ...
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~  230 (277)
T cd05032         153 AEDLTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEV  230 (277)
T ss_pred             cCCCCEEECCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHH
Confidence            99999999999998754322111 11122346788999999988889999999999999999998 9999976543 222


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      .+...            +......+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       231 ~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         231 LKFVI------------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHHh------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            22211            111112233346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.7e-41  Score=322.19  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=202.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--Ce----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      .++|++.+.||+|+||+||+|.+.  +.    .+++|.+.....        ......+..|+.+++.+.||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~~~~~l~~l~h~~iv~~~~~   77 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--------RQTFQEITDHMLAMGSLDHAYIVRLLGI   77 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--------hHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence            467889999999999999999983  33    366776642211        1123345578888999999999999998


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +. +...++++||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|
T Consensus        78 ~~-~~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          78 CP-GASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             EC-CCccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcC
Confidence            75 456789999999999999986433  35889999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++...... .........++..|+|||.+.+..++.++|||||||++|||++ |..||.+...  ....+.+.... 
T Consensus       153 fg~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~-  228 (279)
T cd05111         153 FGVADLLYPDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGE-  228 (279)
T ss_pred             CccceeccCCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC-
Confidence            99997543221 1112233457788999999988889999999999999999998 9999976643  11222221110 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                                ....+..++.++.+++.+||..||.+||++.++++.|..+..++
T Consensus       229 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         229 ----------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             ----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                      01111224557889999999999999999999999999877655

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0690|consensus

Probab=100.00  E-value=1e-42  Score=316.57  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=206.9

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ++..++|+.+++||+|.||+|.+++-+  ++.||+|++++...      +.+....+.+.|-++|..++||.+..|--.|
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi------iakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI------IAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe------eehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            455689999999999999999998875  56799999975432      2234455667899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      ...+++|+||||.+||.|+-.|...+   .+++.....+-.+|+.||.|||+++  ||+||||.+|+|||.+|++||+||
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeec
Confidence            99999999999999999998885433   3778888899999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      ||++......   ...+++|||+.|+|||++....|+.++|+|.+|||+|||++|+.||....... .            
T Consensus       313 GLCKE~I~~g---~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-L------------  376 (516)
T KOG0690|consen  313 GLCKEEIKYG---DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-L------------  376 (516)
T ss_pred             ccchhccccc---ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-H------------
Confidence            9998754332   34577899999999999999999999999999999999999999998765422 2            


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP  414 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  414 (441)
                       +.++-......|..++.+...|+...|.+||++|.
T Consensus       377 -FeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  377 -FELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -HHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence             22222223345667788899999999999999995

>KOG1989|consensus

Probab=100.00  E-value=3.6e-42  Score=350.89  Aligned_cols=262  Identities=22%  Similarity=0.325  Sum_probs=209.8

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC-C-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccc
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE-K-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYG  216 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~  216 (441)
                      ++++..+.++.+.|.+|||+.||.|.+. + +.||+|++-.. +        +.......+|+++|+.|+ |+|||.+++
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-d--------e~~L~~v~~EI~~MK~L~gh~nIV~yid  102 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-D--------EEALNAVKREIDIMKLLSGHKNIVSYID  102 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-C--------HHHHHHHHHHHHHHHHhcCCCceeeEec
Confidence            4567778889999999999999999984 3 68999998754 2        233455679999999996 999999999


Q ss_pred             eE-Ee------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC
Q psy5927         217 IC-FE------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH  289 (441)
Q Consensus       217 ~~-~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~  289 (441)
                      .+ ..      .-.++|+||||.||+|-|++..+.... |++.++++|+.++++|+.+||...+||||||||-+||||+.
T Consensus       103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence            32 21      134689999999999999998766655 99999999999999999999999999999999999999999


Q ss_pred             CCCeEEeccCCCccCCCccccccee------ccccccCCCcCcccc---cCCCCCCccceehHHHHHHHHHhCCCCCCCc
Q psy5927         290 HMDPVIGDFGLTQEGPIEKATHITL------KRVNGTRPYLPHEFL---VGKRLSTKVDVYGFGIVLFELATGMRAYDDT  360 (441)
Q Consensus       290 ~~~~kl~DFGla~~~~~~~~~~~~~------~~~~gt~~y~aPE~~---~~~~~s~~~DiwSlGvvl~elltG~~p~~~~  360 (441)
                      +|+.||||||.|.............      -...-|+.|.|||.+   ++..+++|+|||+|||+||-|+....||++.
T Consensus       182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            9999999999986432221111000      012358999999987   5678999999999999999999999999876


Q ss_pred             chhHHHHHHHHHhhchhhhhhhhccC-CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         361 RRSERHLKSLVEKYSEENMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       361 ~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ...                 .+++.+ .-+..+.++..|.+||..||+.||.+||++.+|+..+..+..
T Consensus       262 g~l-----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  262 GKL-----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             cce-----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            321                 111111 122235789999999999999999999999999998866544

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2e-41  Score=330.62  Aligned_cols=244  Identities=20%  Similarity=0.302  Sum_probs=191.1

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||+||+|...  +..+|+|+++.....      .....+.+..|+.++.++ +||||+.+++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH------DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            46999999999999974  467999998743211      112344566888988888 699999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          75 IEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            9999999999887543   34899999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH-HHHHHHHhhchhhhhhhhccC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER-HLKSLVEKYSEENMYDLVDKN  386 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~  386 (441)
                      .   ......+||+.|+|||++.+..++.++|||||||++|||++|..||........ .....        ....+...
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~  218 (327)
T cd05617         150 G---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY--------LFQVILEK  218 (327)
T ss_pred             C---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH--------HHHHHHhC
Confidence            1   122345799999999999998999999999999999999999999964321110 00000        01111111


Q ss_pred             CCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         387 AQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       387 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                      ....+..++..+.+++.+||+.||++|+++
T Consensus       219 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         219 PIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            223344566778999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0032|consensus

Probab=100.00  E-value=3.2e-41  Score=330.37  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=212.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  219 (441)
                      ....|++.+.||+|.||.||++..+  ++.+|+|.+........      ...+.+.+|+++|+++. |||||.++++|.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~------~~~~~v~~Ev~il~~l~~hpniv~l~~~~e  106 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK------EDREDVRREVAILQQLSGHPNIVQLKDAFE  106 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc------ccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            4567899999999999999999985  45799999976543221      13446679999999998 999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC----CCeEE
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH----MDPVI  295 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~----~~~kl  295 (441)
                      +...+++|||+|.||.|+|++...    .+++..+..++.+++.|++|||+.|  |+||||||+|+|+...    +.+|+
T Consensus       107 ~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  107 DPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             cCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEE
Confidence            999999999999999999999776    2899999999999999999999999  9999999999999654    47999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||++.....    .......+||+.|+|||++.+..|+..+|+||+||++|.|++|.+||................+ 
T Consensus       181 ~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-  255 (382)
T KOG0032|consen  181 IDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-  255 (382)
T ss_pred             eeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-
Confidence            99999987543    2345677899999999999988999999999999999999999999988776444442222111 


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                              +-....+ ..++..+.+++..||..||.+|+++.++++.
T Consensus       256 --------~f~~~~w-~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --------DFTSEPW-DDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------CCCCCCc-cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    1112222 3568889999999999999999999999983

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=323.53  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC----------------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK----------------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR  207 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  207 (441)
                      .++|++.++||+|+||.||++...+                ..||+|.+......        .....+.+|++++++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~ei~~l~~l~   75 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--------TARNDFLKEIKIMSRLK   75 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--------HHHHHHHHHHHHHHhCC
Confidence            4689999999999999999987643                24889888643221        22345678999999999


Q ss_pred             CCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK---------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       208 hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                      ||||+++++++...+..++||||+++++|.+++....         ....+++..+..++.+++.||+|||+.+  ++||
T Consensus        76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~  153 (295)
T cd05097          76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHR  153 (295)
T ss_pred             CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eecc
Confidence            9999999999999999999999999999999885432         1234788999999999999999999999  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh--CCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT--GMRA  356 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt--G~~p  356 (441)
                      ||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++|+|||||++|||++  |..|
T Consensus       154 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p  232 (295)
T cd05097         154 DLATRNCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP  232 (295)
T ss_pred             ccChhhEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999998754322111 11222345678999999988889999999999999999998  6678


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      |..... ................     ......+..++..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       233 ~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         233 YSLLSD-EQVIENTGEFFRNQGR-----QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             CcccCh-HHHHHHHHHhhhhccc-----cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            876543 2222222111110000     00011122345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-41  Score=338.50  Aligned_cols=262  Identities=23%  Similarity=0.377  Sum_probs=206.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  213 (441)
                      +..++|.+.++||+|+||.||+|.+.+       ..||+|+++.....        ...+.+.+|+++|.++. ||||++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~E~~~l~~l~~H~niv~  105 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--------SEKQALMSELKIMSHLGPHLNIVN  105 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--------hHHHHHHHHHHHHHhcCCCCCeEE
Confidence            444578888999999999999998643       46999999743221        12345678999999997 999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN------------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  245 (441)
                      +++++...+..++||||+++|+|.+++.....                                                
T Consensus       106 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (401)
T cd05107         106 LLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE  185 (401)
T ss_pred             EEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence            99999999999999999999999999864321                                                


Q ss_pred             -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         246 -----------------------------------------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       246 -----------------------------------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                                                                     ...+++..+..++.+++.||+|||+.+  |+||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHr  263 (401)
T cd05107         186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHR  263 (401)
T ss_pred             ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcc
Confidence                                                           134677888999999999999999988  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY  357 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~  357 (441)
                      ||||+|||++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         264 DLAARNVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             cCCcceEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999998753221111 11122346788999999998889999999999999999998 89999


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ............+....            ....+..++.++.+|+.+||..+|.+||++.+|++.|+.+
T Consensus       343 ~~~~~~~~~~~~~~~~~------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         343 PELPMNEQFYNAIKRGY------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CCCCchHHHHHHHHcCC------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            76543222111111110            1122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.4e-41  Score=318.90  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=198.3

Q ss_pred             CcCcCccccCCceeEEEEEECCe----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC-
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET-  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  221 (441)
                      |.+.+.||+|+||.||+|.+...    .+|+|.++.....       ....+.+..|+++++.++||||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-------RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            35678999999999999998543    5889887643211       12345667899999999999999999987532 


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKK---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                           ...+++|||+++|+|.+++....   ....+++.....++.|++.||+|||+++  |+||||||+|||+++++.+
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~  151 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNV  151 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCE
Confidence                 24689999999999998874322   2345889999999999999999999988  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~  372 (441)
                      ||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .... ..+.
T Consensus       152 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~-~~~~  228 (272)
T cd05075         152 CVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIY-DYLR  228 (272)
T ss_pred             EECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH-HHHH
Confidence            99999999764322211 11122345678999999998889999999999999999999 8899976443 1111 1111


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                         ..        .....+..++..+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       229 ---~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 ---QG--------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---cC--------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               10        01112234566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.5e-41  Score=315.37  Aligned_cols=248  Identities=24%  Similarity=0.382  Sum_probs=195.7

Q ss_pred             CccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEE
Q psy5927         151 NILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY  228 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~  228 (441)
                      +.||+|+||.||+|.+  .++.+|+|.+.....        ......+.+|+++++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   72 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--------PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM   72 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC--------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEE
Confidence            4699999999999987  467799998753221        122345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcc
Q psy5927         229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK  308 (441)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~  308 (441)
                      ||+++++|.+++...  ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        73 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  148 (252)
T cd05084          73 ELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV  148 (252)
T ss_pred             eeccCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccccc
Confidence            999999999988533  345889999999999999999999999  9999999999999999999999999987533211


Q ss_pred             cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       309 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .. .......++..|+|||.+.+..++.++||||||+++|||++ |..||......  ........           ...
T Consensus       149 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~-----------~~~  214 (252)
T cd05084         149 YA-STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQ-----------GVR  214 (252)
T ss_pred             cc-ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHc-----------CCC
Confidence            11 00111123456999999998889999999999999999998 99999754431  11111110           011


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      ...+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1223345678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.3e-41  Score=318.51  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=200.3

Q ss_pred             CCCcCcCccccCCceeEEEEEECCe-eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      ++|.+.+.||+|+||.||+|.+.+. .+|+|.+.....          ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP   73 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC
Confidence            5688899999999999999988654 599998763221          12345689999999999999999999998899


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+.+|+|.+++....  ..+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~  149 (256)
T cd05113          74 IYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRY  149 (256)
T ss_pred             cEEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCcccee
Confidence            999999999999999886433  25899999999999999999999999  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......  ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........         
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~---------  217 (256)
T cd05113         150 VLDDEYT--SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-TVEKVSQG---------  217 (256)
T ss_pred             cCCCcee--ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHhcC---------
Confidence            4332211  1112235677999999988889999999999999999999 999997654321 11111110         


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                         .....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 ---LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               011112224578899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.1e-41  Score=322.60  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=206.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC------------------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK------------------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS  205 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  205 (441)
                      .++|++.+.||+|+||.||+|.+..                  ..+|+|.+......        ...+.+.+|++++.+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~~e~~~l~~   75 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--------NAREDFLKEVKILSR   75 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--------HHHHHHHHHHHHHHh
Confidence            4689999999999999999998743                  34788887643321        234456789999999


Q ss_pred             CCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       206 l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      ++||||+++++++..++..+++|||+++++|.+++.....        ...+++..+..++.+++.||+|||+.+  |+|
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H  153 (296)
T cd05051          76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVH  153 (296)
T ss_pred             cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccc
Confidence            9999999999999999999999999999999999865431        235889999999999999999999998  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh--CCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT--GMR  355 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt--G~~  355 (441)
                      |||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++  |..
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  232 (296)
T cd05051         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ  232 (296)
T ss_pred             cccchhceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence            99999999999999999999999875432211 111223446778999999988889999999999999999998  778


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ||..... ...+..............     ..+.+..++.++.+++.+||+.||.+||++.+|++.|+.
T Consensus       233 p~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         233 PYEHLTD-QQVIENAGHFFRDDGRQI-----YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             CCCCcCh-HHHHHHHHhccccccccc-----cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            8865543 222222222111110000     111223455789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.4e-41  Score=329.41  Aligned_cols=243  Identities=23%  Similarity=0.351  Sum_probs=194.0

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~  222 (441)
                      +|+..+.||+|+||.||+|.+.  +..||+|++......      .....+.+..|..++..+. |++|+++++++.+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            4778899999999999999984  567999998742111      1122345567888888875 577888999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEecccccc
Confidence            999999999999999988543   34889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..          
T Consensus       150 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~----------  215 (323)
T cd05615         150 EHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIME----------  215 (323)
T ss_pred             ccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHh----------
Confidence            532221   122345699999999999998899999999999999999999999987643 222222111          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                         .....+..++.++.+++.+||+.+|.+|++.
T Consensus       216 ---~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 ---HNVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               1112334456788999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-40  Score=314.16  Aligned_cols=261  Identities=20%  Similarity=0.322  Sum_probs=209.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|...  +..+|+|.++......      ....+.+.+|++++++++|+||+++++++.+.+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD------AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc------hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            68999999999999999999985  6789999887432211      123456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..++||||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecccee
Confidence            9999999999999999886432 2445889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........   ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........   ...+....     
T Consensus       154 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~-----  222 (267)
T cd08224         154 RFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEK-----  222 (267)
T ss_pred             eeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---HHHhhhhc-----
Confidence            75432211   11234588899999999988899999999999999999999999965542211   11111111     


Q ss_pred             hhccCCCchhH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         382 LVDKNAQPIEL-NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       382 ~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                         ....+.+. .++..+.+++.+||..+|.+||++.+|++.|+++.
T Consensus       223 ---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 ---CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               01111222 56678999999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3e-41  Score=323.29  Aligned_cols=262  Identities=23%  Similarity=0.347  Sum_probs=205.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +..++|++.++||+|+||.||+|..+       ...||+|.+......        .....+.+|+.+++.++||||+++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~   74 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--------RERIEFLNEASVMKGFTCHHVVRL   74 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--------HHHHHHHHHHHHHHhCCCCCeeeE
Confidence            45678999999999999999999753       236899987633211        122345689999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL  287 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl  287 (441)
                      ++++.+.+..|+||||+++|+|.+++.....       .+.+.+..+..++.|++.||.|||+++  |+||||||+|||+
T Consensus        75 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili  152 (288)
T cd05061          75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMV  152 (288)
T ss_pred             EEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEE
Confidence            9999999999999999999999999965321       244667788999999999999999998  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHH
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH  366 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~  366 (441)
                      +.++.++|+|||+++......... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||..... ...
T Consensus       153 ~~~~~~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~  230 (288)
T cd05061         153 AHDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQV  230 (288)
T ss_pred             cCCCcEEECcCCcccccccccccc-ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH
Confidence            999999999999987533221111 1122235678999999998889999999999999999999 7889976543 222


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      .....            +......+..++..+.+++.+||+.||++||++.++++.|+...
T Consensus       231 ~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 LKFVM------------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHH------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            21111            11111222344678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-41  Score=321.21  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=191.9

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||+|+||.||++...  +..||+|.+.......      .........|+++++.++||||+++++++.++..+|+||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK------KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc------chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            799999999999874  5789999986322111      01122345699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT  310 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~  310 (441)
                      ++|++|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++.......  
T Consensus        75 ~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--  149 (277)
T cd05607          75 MNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--  149 (277)
T ss_pred             CCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--
Confidence            99999998875433 344889999999999999999999999  9999999999999999999999999987543221  


Q ss_pred             cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCch
Q psy5927         311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPI  390 (441)
Q Consensus       311 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  390 (441)
                        ......||..|+|||++.+..++.++|+|||||++|||++|..||........ .........        .......
T Consensus       150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~--------~~~~~~~  218 (277)
T cd05607         150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTL--------EDEVKFE  218 (277)
T ss_pred             --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhh--------ccccccc
Confidence              12234689999999999988899999999999999999999999976433111 111111100        0001111


Q ss_pred             hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         391 ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       391 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...++.++.+|+.+||+.||.+||++.++++
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            1245677899999999999999999976553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.1e-41  Score=329.58  Aligned_cols=239  Identities=23%  Similarity=0.303  Sum_probs=188.1

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHH-HhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||.||+|.+.  +..||+|++......      .......+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL------KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH------HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            46999999999999984  567999998643211      1112233445544 57889999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..++...+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          75 LDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            9999999999887543   34778888999999999999999998  999999999999999999999999998753222


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      .   .......||+.|+|||.+.+..++.++|||||||++|||++|..||..... ......+.             ...
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~-------------~~~  212 (321)
T cd05603         150 E---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDNIL-------------HKP  212 (321)
T ss_pred             C---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHHHh-------------cCC
Confidence            1   123345799999999999988899999999999999999999999976543 11111111             111


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMT  417 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  417 (441)
                      ...+...+..+.+++.+||+.||.+||+..
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            223334566789999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.3e-41  Score=342.50  Aligned_cols=263  Identities=18%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||||++.....             ...+|+.+++.++||||+++++++..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------------~~~~Ei~il~~l~h~niv~l~~~~~~  130 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------------YKNRELLIMKNLNHINIIFLKDYYYT  130 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------------hHHHHHHHHHhcCCCCCcceeeeEee
Confidence            4568999999999999999999984  56799998853211             12269999999999999999987643


Q ss_pred             C--------CeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         221 T--------GKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       221 ~--------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      .        ..+++||||++ ++|.+++... .....+++..+..++.||+.||+|||+.+  |+||||||+|||++.++
T Consensus       131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             cccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCC
Confidence            2        24679999996 5777766432 23456889999999999999999999999  99999999999999665


Q ss_pred             -CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         292 -DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       292 -~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                       .+||+|||+++.......    .....||+.|+|||++.+. .++.++|||||||++|||+||.+||.+.... ..+..
T Consensus       208 ~~vkL~DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~  282 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVR  282 (440)
T ss_pred             CceeeeccccchhccCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence             699999999976432211    2234689999999998764 6899999999999999999999999876542 23333


Q ss_pred             HHHhhch---hhhhh----hhc-----cCCC----chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         370 LVEKYSE---ENMYD----LVD-----KNAQ----PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       370 ~~~~~~~---~~~~~----~~~-----~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      .+.....   +....    +.+     ....    ..+...+.++.+|+.+||..||.+||++.++++  .+..+
T Consensus       283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            3222110   00000    000     0000    112234568999999999999999999999984  44443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.1e-41  Score=325.70  Aligned_cols=259  Identities=26%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC--e--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK--T--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||.||+|.+..  .  .+|+|.++....        ......+.+|++++.++ +||||+++++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~Ei~~l~~l~~h~~iv~~~~   75 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--------KDDHRDFAGELEVLCKLGHHPNIINLLG   75 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC--------HHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            345688999999999999999999743  3  346666543211        12234566899999999 8999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      ++.+++.+++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+++  ++||||||+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~  153 (303)
T cd05088          76 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAAR  153 (303)
T ss_pred             EECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchh
Confidence            99999999999999999999999865431             235789999999999999999999998  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcch
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR  362 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~  362 (441)
                      |||++.++.+||+|||+++.....    .......++..|+|||.+.+..++.++|||||||++|||+| |..||.....
T Consensus       154 Nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  229 (303)
T cd05088         154 NILVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  229 (303)
T ss_pred             eEEecCCCcEEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence            999999999999999998642111    01111124667999999988889999999999999999998 9999976543


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      .. ......    .        ......+..++..+.+|+.+||+.+|++||++.++++.|..+.
T Consensus       230 ~~-~~~~~~----~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         230 AE-LYEKLP----Q--------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             HH-HHHHHh----c--------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            21 111111    0        0011112234567899999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-41  Score=315.32  Aligned_cols=249  Identities=21%  Similarity=0.388  Sum_probs=195.0

Q ss_pred             ccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         152 ILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      .||+|+||.||+|.+.    +..+|+|++.....        ....+.+.+|+.++++++||||+++++++. ....++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv   72 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLV   72 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEE
Confidence            4899999999999863    33589998864321        122345678999999999999999999875 4678999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++++|.+++...  ...+++..++.++.+++.||+|||+++  ++||||||+|||++.++.+||+|||++......
T Consensus        73 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          73 MEMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EEeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            9999999999988643  345889999999999999999999998  999999999999999999999999998753322


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN  386 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  386 (441)
                      ...........++..|+|||.+.+..++.++|||||||++||+++ |..||....... .. ..+..           ..
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~-~~~~~-----------~~  215 (257)
T cd05115         149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VM-SFIEQ-----------GK  215 (257)
T ss_pred             ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HH-HHHHC-----------CC
Confidence            111111111223568999999988889999999999999999996 999997664321 11 11111           11


Q ss_pred             CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         387 AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       387 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ....+..++.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            1223345677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.4e-41  Score=320.57  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=208.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      +..++|++.+.||+|+||.||+|.+..      ..+++|++....        .....+.+.+|+.+++.++||||++++
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni~~~~   74 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--------SEIQVTLLLQESCLLYGLSHQNILPIL   74 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            456789999999999999999999754      568888875321        123345667899999999999999999


Q ss_pred             ceEEe-CCeEEEEEEecCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC
Q psy5927         216 GICFE-TGKYCLVYRYMPNGSLEDRLLMKKNT-----PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH  289 (441)
Q Consensus       216 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~  289 (441)
                      +++.. +...+++++|+++|+|.+++......     ..+++..+..++.+++.||+|||+.+  ++||||||+||+++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~  152 (280)
T cd05043          75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDE  152 (280)
T ss_pred             EEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcC
Confidence            98776 46789999999999999998654332     46899999999999999999999998  999999999999999


Q ss_pred             CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHH
Q psy5927         290 HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLK  368 (441)
Q Consensus       290 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~  368 (441)
                      ++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++||+++ |..||......  .+.
T Consensus       153 ~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~  229 (280)
T cd05043         153 ELQVKITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMA  229 (280)
T ss_pred             CCcEEECCCCCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHH
Confidence            99999999999975432221 111122346778999999988889999999999999999999 99999765431  111


Q ss_pred             HHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ..+.   ..        ........++..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus       230 ~~~~---~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         230 AYLK---DG--------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHH---cC--------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111   10        0111223356788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-40  Score=312.70  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||.||+|.+.  +..|++|.+......       ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-------RREREEAIDEARVLAKLDSSYIIRYYESFLDKGK   73 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence            5788899999999999999984  578999988643221       1234566789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+++++|.+++.... ...+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||+++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          74 LNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             EEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEccccccee
Confidence            999999999999999987542 346889999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......   ......|+..|+|||++.+..++.++|+||||++++||++|..||..... ........            
T Consensus       151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~------------  214 (256)
T cd08529         151 LSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKII------------  214 (256)
T ss_pred             ccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH------------
Confidence            432211   12334688999999999988899999999999999999999999976543 22121111            


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .......+..++..+.+++.+||+.+|++||++.++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            111122233566789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-41  Score=331.11  Aligned_cols=240  Identities=23%  Similarity=0.319  Sum_probs=188.9

Q ss_pred             CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHH-HhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+||+||+|.+.  +..+|+|++......      .......+..|.. +++.++||||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            46999999999999974  568999998643211      1112233445554 46778999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+.|  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          75 LDFVNGGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            9999999999888533   35889999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      ..   ......||..|+|||++.+..++.++|||||||++|||++|..||...... ........             ..
T Consensus       150 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~~~~-------------~~  212 (325)
T cd05604         150 SD---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYDNILH-------------KP  212 (325)
T ss_pred             CC---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-HHHHHHHc-------------CC
Confidence            11   223456999999999999989999999999999999999999999765431 11111111             01


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQ  418 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  418 (441)
                      .......+..+.+++.+||+.+|.+||++.+
T Consensus       213 ~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         213 LVLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ccCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            1122235667889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.4e-41  Score=321.76  Aligned_cols=251  Identities=24%  Similarity=0.350  Sum_probs=199.3

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|+..+.||+|+||.||++.+.  ++.+|||.+.......      ......+..|+.+++.++|+||+.+++.+.+.+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------RKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc------hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            3778899999999999999985  4679999886432111      1122345689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++..
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            999999999999999885433 345889999999999999999999998  99999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH--HHHHHHHHhhchhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSLVEKYSEENMYD  381 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~  381 (441)
                      .....    ......||..|+|||++.+..++.++|||||||++|||++|..||.......  ..........       
T Consensus       152 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-------  220 (285)
T cd05630         152 VPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------  220 (285)
T ss_pred             cCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-------
Confidence            33221    1123468999999999999899999999999999999999999997643211  1111111110       


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                           ....+..++.++.+|+.+||+.||.+||+     +.++++
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 -----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 01122345667899999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG1094|consensus

Probab=100.00  E-value=2.8e-41  Score=327.54  Aligned_cols=268  Identities=21%  Similarity=0.363  Sum_probs=213.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..+...+.++||+|-||.|.+++..+ ..||||+++....        ...+..|.+|+++|.+|+||||++|+|+|..
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--------~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--------KNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--------hhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            344566778999999999999999877 8999999985432        2335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      ++.+|+|+|||++|+|..++..+.. +.+.-.....|+.||+.|++||.+.+  +|||||.+.|+|+|.++++||+|||+
T Consensus       607 DePicmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccc
Confidence            9999999999999999999976532 22445566789999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh--CCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT--GMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      ++.......... -.+..-..+|||||.+.-+++++++|+|+||+++||+++  ...||.+..+ +..+...-.-.....
T Consensus       684 sR~lysg~yy~v-qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  684 SRNLYSGDYYRV-QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQG  761 (807)
T ss_pred             ccccccCCceee-ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCC
Confidence            986544433222 123334678999999998999999999999999999865  7789977654 222222111111110


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      .     .-....|.-|+..+++|+..||..+-++||+++++...|++..
T Consensus       762 ~-----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  762 R-----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             c-----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            0     1122346678899999999999999999999999999887654

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-40  Score=315.24  Aligned_cols=258  Identities=22%  Similarity=0.397  Sum_probs=204.7

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|.+...||.|+||.||+|.+.  +..+|+|.+.................+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999873  57899998875433322122222344567789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .+++|||+++++|.+++...   ..+++..+..++.+++.||+|||+.+  ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999988543   45788899999999999999999998  99999999999999999999999999876


Q ss_pred             CCCcccc---cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         304 GPIEKAT---HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       304 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .......   ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... .....          
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~----------  224 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKI----------  224 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHH----------
Confidence            4321111   111123458899999999998889999999999999999999999998654311 11111          


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ........+..++..+.+++.+||+.||.+||++.+|++
T Consensus       225 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 --GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              111122233456778999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=316.39  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=199.4

Q ss_pred             CCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .+|++.+.||+|+||.||+|.+.. ..+|+|.+.....          ....+.+|+++++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP   73 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            468889999999999999998854 4789998753221          12245689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCccccee
Confidence            999999999999999886433  35889999999999999999999999  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......  ......++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ..........         
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~---------  217 (256)
T cd05059         150 VLDDQYT--SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAG---------  217 (256)
T ss_pred             ccccccc--ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHHHHHHcC---------
Confidence            4322111  1111123457999999998899999999999999999999 8999976543 2222111110         


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                         .....+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               01112233567899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.4e-41  Score=315.68  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=201.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE-eCC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF-ETG  222 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~  222 (441)
                      ..+|++.+.||+|+||.||+|...+..+|+|.++...           ..+.+.+|+.++++++|+|++++++++. +++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   73 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence            3578999999999999999999999999999886321           1234568999999999999999999764 456


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..+++|||+++++|.+++.... ...+++..+..++.+++.||+|||+++  ++||||||+||+++.++.+||+|||+++
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          74 GLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             ceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccce
Confidence            7899999999999999886543 334889999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ......      ....++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+..    .    
T Consensus       151 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~----~----  215 (256)
T cd05082         151 EASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEK----G----  215 (256)
T ss_pred             eccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhc----C----
Confidence            532211      12235668999999998889999999999999999998 9999975432 111111110    0    


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                          .....+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       216 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 ----YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                01112234567889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-40  Score=339.17  Aligned_cols=269  Identities=20%  Similarity=0.290  Sum_probs=194.2

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC------CCCC
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC------RHDN  210 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpn  210 (441)
                      ++...+++|++.++||+|+||+||+|.+.  +..||||+++.....          ......|++++..+      .|.+
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~e~~~l~~l~~~~~~~~~~  192 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY----------TRDAKIEIQFMEKVRQADPADRFP  192 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh----------HHHHHHHHHHHHHHhhcCcccCcc
Confidence            34456789999999999999999999874  567999998632110          11122344554444      4556


Q ss_pred             eecccceEEeC-CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeec
Q psy5927         211 ILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLN  288 (441)
Q Consensus       211 Iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~  288 (441)
                      ++.+++++... +++|+||+++ +++|.+++...   ..+++..+..|+.||+.||+|||+ .+  ||||||||+|||++
T Consensus       193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~  266 (467)
T PTZ00284        193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILME  266 (467)
T ss_pred             eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEe
Confidence            88898888754 5789999998 78999888643   358899999999999999999997 58  99999999999998


Q ss_pred             CCC----------------CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh
Q psy5927         289 HHM----------------DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT  352 (441)
Q Consensus       289 ~~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt  352 (441)
                      .++                .+||+|||++.....      .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence            765                499999998864221      1234579999999999999999999999999999999999


Q ss_pred             CCCCCCCcchhHHHHHHHHHhhc---h--------hhhhhhhcc------C-----------CCch-hHHHHHHHHHHHH
Q psy5927         353 GMRAYDDTRRSERHLKSLVEKYS---E--------ENMYDLVDK------N-----------AQPI-ELNIAYAFFRIGK  403 (441)
Q Consensus       353 G~~p~~~~~~~~~~l~~~~~~~~---~--------~~~~~~~~~------~-----------~~~~-~~~~~~~l~~li~  403 (441)
                      |+.||+.... ...+..+.....   .        .....+.+.      .           .... .......+.+|+.
T Consensus       341 G~~pf~~~~~-~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  419 (467)
T PTZ00284        341 GKLLYDTHDN-LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY  419 (467)
T ss_pred             CCCCCCCCCh-HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence            9999986553 222222211110   0        000000000      0           0000 0011345789999


Q ss_pred             HhcCCCCCCCCCHHHHHH--HHhcCCCCC
Q psy5927         404 QSTKQNPKERPEMTQVYN--MLSGSGGES  430 (441)
Q Consensus       404 ~cl~~dp~~RPs~~evl~--~L~~~~~~~  430 (441)
                      +||..||++||++.|+++  .|.....+.
T Consensus       420 ~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  448 (467)
T PTZ00284        420 GLLHYDRQKRLNARQMTTHPYVLKYYPEC  448 (467)
T ss_pred             HhCCcChhhCCCHHHHhcCccccccCCcc
Confidence            999999999999999997  666544433

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.6e-41  Score=334.10  Aligned_cols=255  Identities=20%  Similarity=0.305  Sum_probs=196.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||++...  +..||+|++.....      ........+..|+.++..++||||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM------LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            47899999999999999999985  56799999863211      12233456668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||++||+|.+++...   ..+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            999999999999999988543   34888999999999999999999999  9999999999999999999999999986


Q ss_pred             cCCCcccc--------------------------------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHH
Q psy5927         303 EGPIEKAT--------------------------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL  350 (441)
Q Consensus       303 ~~~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~el  350 (441)
                      ........                                .......+||+.|+|||++.+..++.++|||||||++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel  229 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence            43211000                                0011235799999999999999999999999999999999


Q ss_pred             HhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q psy5927         351 ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE---MTQVYN  421 (441)
Q Consensus       351 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~  421 (441)
                      +||..||........ ...+. .+..    .+    ..+....++.++.+|+.+++. ||.+|++   +.++++
T Consensus       230 ~tG~~Pf~~~~~~~~-~~~i~-~~~~----~~----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         230 LIGYPPFCSETPQET-YRKVM-NWKE----TL----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             ccCCCCCCCCCHHHH-HHHHH-cCCC----ce----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            999999976554221 11111 0000    00    000111245678888888774 9999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-41  Score=325.83  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=205.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +..++|.+.+.||+|+||.||+|.+.+         ..+|+|.++.....        .....+..|++++..+ +||||
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~l~~h~~i   86 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--------KDLSDLISEMEMMKMIGKHKNI   86 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--------HHHHHHHHHHHHHHHhcCCCCE
Confidence            345689999999999999999998632         35899988643211        2234566899999999 79999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                      +++++++.+.+..++||||+++|+|.+++..+..             ...+++..++.++.|++.||+|||+.+  ++||
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~  164 (307)
T cd05098          87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHR  164 (307)
T ss_pred             eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence            9999999999999999999999999999975432             134889999999999999999999998  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY  357 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~  357 (441)
                      ||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||
T Consensus       165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~  243 (307)
T cd05098         165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  243 (307)
T ss_pred             cccHHheEEcCCCcEEECCCcccccccccchhh-ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999987543211111 1111224568999999998889999999999999999998 88998


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ..... ..... .+.   .        ......+..++.++.+|+.+||..+|.+||++.+|++.|..+..
T Consensus       244 ~~~~~-~~~~~-~~~---~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         244 PGVPV-EELFK-LLK---E--------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             CcCCH-HHHHH-HHH---c--------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            66543 11111 111   0        01112234456789999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-41  Score=321.57  Aligned_cols=259  Identities=26%  Similarity=0.439  Sum_probs=203.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      ..++|++.+.||+|+||.||+|.+.       +..+|+|.+......        .....+.+|+.+++.+.||||++++
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~ei~~l~~l~h~~iv~~~   74 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--------DMQADFQREAALMAEFDHPNIVKLL   74 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--------HHHHHHHHHHHHHHhcCCCchheEE
Confidence            3568999999999999999999863       457899988643221        1234566899999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKK-------------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLI  276 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ii  276 (441)
                      +++.++...|+||||+++|+|.+++....                   ....+++..++.++.+++.||+|||+.+  ++
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~  152 (288)
T cd05050          75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FV  152 (288)
T ss_pred             EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            99999999999999999999999986432                   1235788899999999999999999998  99


Q ss_pred             ecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCC
Q psy5927         277 HGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR  355 (441)
Q Consensus       277 HrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~  355 (441)
                      ||||||+|||++.++.++|+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus       153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             cccccHhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999986432211111 1112234667999999988899999999999999999998 888


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ||..... ...+..+    .        +......+..++.++.+++.+||+.+|.+||++.|+++.|++
T Consensus       232 p~~~~~~-~~~~~~~----~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         232 PYYGMAH-EEVIYYV----R--------DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCH-HHHHHHH----h--------cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            9875543 1111111    1        111112233456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.7e-41  Score=313.90  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             CccccCCceeEEEEEECC---e--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVWEK---T--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~---~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  225 (441)
                      +.||+|+||.||+|.+..   +  .+|+|.+......        ...+.+..|++++++++||||+++++++.+ ..++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   71 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLM   71 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEE
Confidence            468999999999998743   2  5899988653321        234566789999999999999999999988 8899


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      +||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++...
T Consensus        72 ~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~  148 (257)
T cd05040          72 MVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALP  148 (257)
T ss_pred             EEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccc
Confidence            99999999999999875443 46899999999999999999999998  9999999999999999999999999987653


Q ss_pred             CcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhc
Q psy5927         306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       306 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (441)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..+.....           
T Consensus       149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~-----------  216 (257)
T cd05040         149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDKE-----------  216 (257)
T ss_pred             ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhc-----------
Confidence            32211111223457788999999998889999999999999999999 999997654422 22221110           


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      ......+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus       217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0111122345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.2e-41  Score=318.98  Aligned_cols=261  Identities=24%  Similarity=0.401  Sum_probs=204.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--Ce----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..++|++.++||+|+||+||+|.+.  +.    .||+|.++.....        .....+..|+.+++.+.||||+++++
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~i~~~~~   76 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--------KANKEILDEAYVMAGVGSPYVCRLLG   76 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--------HHHHHHHHHHHHHHhcCCCCCceEEE
Confidence            4578999999999999999999863  22    4789988643221        22345668999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.. ...+++|+|+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+
T Consensus        77 ~~~~-~~~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          77 ICLT-STVQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             EEcC-CCcEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEEC
Confidence            8875 4578999999999999988543  345889999999999999999999998  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....  ..+...+... 
T Consensus       152 dfG~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~-  227 (279)
T cd05109         152 DFGLARLLDIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKG-  227 (279)
T ss_pred             CCCceeecccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC-
Confidence            99999764332211 11112234678999999988889999999999999999998 9999976543  1122222111 


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                                ...+.+..++..+.+++.+||+.||++||++.++++.|+.+....
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 ----------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                      011122345668899999999999999999999999998886654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1e-40  Score=329.81  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=195.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..+|+|++......       ......+.+|+.+++.++||||+++++++..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-------QTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-------hhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            3578999999999999999999874  567999998643221       1223455689999999999999999998864


Q ss_pred             CC------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 TG------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~~------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      .+      .+|+||||++ ++|.+.+..     .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          92 QKSLEEFQDVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             CCCccccceeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEE
Confidence            43      5799999996 566665532     3778888999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||+++.....    .......||..|+|||.+.+..++.++|||||||++|||+||..||...... ..+.......
T Consensus       164 l~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~  238 (359)
T cd07876         164 ILDFGLARTACTN----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQL  238 (359)
T ss_pred             EecCCCccccccC----ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            9999999753221    1123346899999999999989999999999999999999999999865432 2222222111


Q ss_pred             ch----------hhhhhhhcc-------------------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SE----------ENMYDLVDK-------------------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~----------~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..          .....+...                   .........+..+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            00          000000000                   000111123567899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.3e-41  Score=324.71  Aligned_cols=263  Identities=23%  Similarity=0.355  Sum_probs=205.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      ...++|.+.++||+|+||.||+|...         ...+|+|.++.....        .....+..|+++++.+ +||||
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~i   80 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--------KDLADLISEMELMKLIGKHKNI   80 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--------HHHHHHHHHHHHHHhccCCCCe
Confidence            44568899999999999999999752         235889987643221        1234566899999999 69999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                      +++++++.+.+.++++|||+++|+|.+++.....             ...+++..+..++.|++.||.|||++|  ++||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~  158 (314)
T cd05099          81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHR  158 (314)
T ss_pred             eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence            9999999999999999999999999999965421             245889999999999999999999998  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY  357 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~  357 (441)
                      ||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             cccceeEEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999997543221111 1112234567999999988889999999999999999999 89999


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ..... .........            ......+..++.++.+++.+||+.+|++||++.++++.|.++..
T Consensus       238 ~~~~~-~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         238 PGIPV-EELFKLLRE------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CCCCH-HHHHHHHHc------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            76543 112211110            11112233456688999999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.9e-41  Score=319.03  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=201.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      .++|...++||+|+||.||++...       +..+|+|.+.....         ...+.+.+|+++++.++|+||+++++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---------SARQDFQREAELLTVLQHQHIVRFYG   74 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---------HHHHHHHHHHHHHhcCCCCCCceEEE
Confidence            457888899999999999999742       34688887753221         22345678999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKN------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN  284 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~N  284 (441)
                      ++.+....+++|||+++|+|.+++.....            ...+++..+..++.|++.||+|||+.+  ++||||||+|
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~n  152 (280)
T cd05092          75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRN  152 (280)
T ss_pred             EEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhh
Confidence            99999999999999999999999865432            134789999999999999999999999  9999999999


Q ss_pred             eeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchh
Q psy5927         285 ILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS  363 (441)
Q Consensus       285 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~  363 (441)
                      ||+++++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |.+||......
T Consensus       153 il~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         153 CLVGQGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             EEEcCCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            99999999999999998753322111 11122235678999999998889999999999999999998 99999765432


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      . ......            .......+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       232 ~-~~~~~~------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         232 E-AIECIT------------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             H-HHHHHH------------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1 111111            011111223456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=313.46  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=196.5

Q ss_pred             CccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  225 (441)
                      ++||+|+||.||+|.+..     ..+|+|.+......        ...+.+..|+++++.+.||||+++++++. .+..+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   71 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--------AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLM   71 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceE
Confidence            479999999999998732     46899988644321        12345668999999999999999999765 56789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      +||||+++|+|.+++....   .+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+++...
T Consensus        72 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~  146 (257)
T cd05060          72 LVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALG  146 (257)
T ss_pred             EEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceee
Confidence            9999999999999986433   5889999999999999999999998  9999999999999999999999999987543


Q ss_pred             CcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhc
Q psy5927         306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       306 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (441)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....... ...          
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~-~~~----------  214 (257)
T cd05060         147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAML-ESG----------  214 (257)
T ss_pred             cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHH-HcC----------
Confidence            22211111111223567999999998889999999999999999998 9999976543 2222211 110          


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                       .....+..++..+.+++.+||..+|++||++.+|++.|++..
T Consensus       215 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         215 -ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             011223345678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-40  Score=319.15  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=199.5

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|+..+.||+|+||+||+|.+.  ++.+|+|.+.......      ......+.+|+++++.++|+||+.+++++..++.
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK------RKGESMALNEKQILEKVNSQFVVNLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh------hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence            3677889999999999999985  5679999986432111      1122345689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCccee
Confidence            999999999999998875433 345899999999999999999999999  99999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .....    ......|+..|+|||.+.+..++.++|+|||||++|||++|..||....... ....+.....        
T Consensus       152 ~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~--------  218 (285)
T cd05632         152 IPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVL--------  218 (285)
T ss_pred             cCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhh--------
Confidence            32211    1223468999999999998889999999999999999999999997654311 1111111110        


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                       ......+..++..+.+|+..||+.||.+||+     +.++++
T Consensus       219 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         219 -ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             0011123345667899999999999999999     667765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.8e-41  Score=329.44  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=202.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      ...++|++.+.||+|+||.||+|.+       .++.||||+++.....        .....+.+|+.++.++ +||||++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv~   75 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------SEHRALMSELKILIHIGHHLNVVN   75 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--------HHHHHHHHHHHHHHhccCCccHhh
Confidence            3456899999999999999999974       2457999998643221        1233566899999999 6899999


Q ss_pred             ccceEEeC-CeEEEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q psy5927         214 LYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN-----------------------------------------------  245 (441)
Q Consensus       214 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------  245 (441)
                      +++++... ...+++|||+++|+|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (343)
T cd05103          76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE  155 (343)
T ss_pred             hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence            99987654 567899999999999999864321                                               


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcc
Q psy5927         246 -----------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK  308 (441)
Q Consensus       246 -----------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~  308 (441)
                                       ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~  233 (343)
T cd05103         156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDP  233 (343)
T ss_pred             CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence                             123678888999999999999999998  9999999999999999999999999987542221


Q ss_pred             cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       309 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                      . ........++..|+|||.+.+..++.++||||||+++|||++ |..||............+..    .        ..
T Consensus       234 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~--------~~  300 (343)
T cd05103         234 D-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----G--------TR  300 (343)
T ss_pred             c-hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc----c--------CC
Confidence            1 111122345678999999988889999999999999999997 99999765432222211111    0        01


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ...+...+.++.+++.+||+.||.+||++.+|++.|+.+-.
T Consensus       301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11122245578999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.8e-41  Score=322.76  Aligned_cols=261  Identities=25%  Similarity=0.362  Sum_probs=205.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      ...++|.+.+.||+|+||.||+|.+.       ...+|+|.++.....        ...+.+.+|+++++++ +||||++
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~iv~  103 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--------SEREALMSELKIMSHLGNHENIVN  103 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--------HHHHHHHHHHHHHHhccCCCCcce
Confidence            44568999999999999999999752       236889887643211        2234567899999999 7999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      +++++...+..++||||+++|+|.+++.... ...+++.++..++.+++.||+|||+.+  |+|+||||+|||++.++.+
T Consensus       104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~  180 (302)
T cd05055         104 LLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIV  180 (302)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeE
Confidence            9999999999999999999999999886433 234899999999999999999999998  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~  372 (441)
                      +|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..........+....
T Consensus       181 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~  259 (302)
T cd05055         181 KICDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE  259 (302)
T ss_pred             EECCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence            9999999875433211 111122346778999999998889999999999999999998 99999765542222111110


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .            .....+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       260 ~------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 G------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             C------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0            00111223456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=311.95  Aligned_cols=250  Identities=26%  Similarity=0.439  Sum_probs=203.8

Q ss_pred             CccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  225 (441)
                      +.||+|+||.||+|.+.     +..+++|.+.......        ..+.+.+|++++..++|+||+++++++.+...++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   72 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLY   72 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--------HHHHHHHHHHHHhhcCCCChheeeeeecCCCceE
Confidence            47999999999999985     6689999987543221        3456678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKN------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +||||+++++|.+++.....      ...+++..+..++.+++.||+|||+++  ++||||||+||+++.++.++|+|||
T Consensus        73 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          73 LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             EEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccc
Confidence            99999999999999865421      366899999999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      ++........ ........++..|+|||.+.+..++.++||||||+++|||++ |..||..... .........      
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~------  222 (262)
T cd00192         151 LSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRK------  222 (262)
T ss_pred             cccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc------
Confidence            9986543321 112233457889999999988889999999999999999999 6999987643 222221111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                            ......+..++.++.+++.+||..+|.+||++.++++.|+
T Consensus       223 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  1122334455788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8e-41  Score=319.58  Aligned_cols=270  Identities=22%  Similarity=0.341  Sum_probs=202.1

Q ss_pred             CCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ..|++.+.||+|+||.||++.+      .+..||+|.++.....        .....+.+|+++++.++||||+++++++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--------NHIADLKKEIEILRNLYHENIVKYKGIC   75 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--------HHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            4578899999999999999974      2457999998643211        1234566899999999999999999998


Q ss_pred             EeC--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         219 FET--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       219 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      .+.  ...++||||++|++|.+++...  ...+++..+..++.+++.||+|||+++  ++||||||+||+++.++.++|+
T Consensus        76 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~  151 (284)
T cd05079          76 TEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIG  151 (284)
T ss_pred             ecCCCCceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEEC
Confidence            775  5689999999999999988543  235889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH-HHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE-RHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~  375 (441)
                      |||+++................++..|+|||.+.+..++.++||||||+++|||+||..|........ ...........
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05079         152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT  231 (284)
T ss_pred             CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc
Confidence            99999764332221112233457778999999988889999999999999999999877653321100 00000000000


Q ss_pred             hh-hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         376 EE-NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       376 ~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .. ......+....+.+..++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00 0000111112223345677899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.6e-41  Score=322.99  Aligned_cols=264  Identities=21%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCC
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN  210 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  210 (441)
                      .+..++|.+.+.||+|+||.||+|.+.         ...+|+|.+......        .....+.+|+.+++.+ +|||
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~   82 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--------KDLSDLVSEMEMMKMIGKHKN   82 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--------HHHHHHHHHHHHHHhhccCCC
Confidence            355678999999999999999999752         235888887632111        2234566899999999 8999


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      |+++++++......++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+++  |+|
T Consensus        83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH  160 (304)
T cd05101          83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIH  160 (304)
T ss_pred             chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eee
Confidence            99999999999999999999999999999875432             235788899999999999999999998  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA  356 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p  356 (441)
                      |||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..|
T Consensus       161 ~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  239 (304)
T cd05101         161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  239 (304)
T ss_pred             cccccceEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999764322111 11122345678999999988889999999999999999998 8888


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      |..... ........    ..        .....+..++..+.+++.+||+.+|.+||++.+|++.|+++..
T Consensus       240 ~~~~~~-~~~~~~~~----~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         240 YPGIPV-EELFKLLK----EG--------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             cccCCH-HHHHHHHH----cC--------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            865533 11111111    10        1111233566789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7e-41  Score=332.55  Aligned_cols=260  Identities=20%  Similarity=0.280  Sum_probs=197.3

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC-
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG-  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  222 (441)
                      +|++.+.||+|+||.||+|.+  .++.||+|++.....+       ......+.+|+++++.++||||+++++++...+ 
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   73 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-------LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI   73 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-------hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence            578899999999999999997  4678999988632211       122345678999999999999999999998776 


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         223 ----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       223 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                          ..|+||||+. ++|.+++..   ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          74 DPFEEIYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             cccceEEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccc
Confidence                7899999995 688887743   345889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+++.......  .......+|..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+..+.......
T Consensus       148 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~  224 (372)
T cd07853         148 GLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTP  224 (372)
T ss_pred             cceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCC
Confidence            99975432211  112234578999999999874 4789999999999999999999999876542 2222222211100


Q ss_pred             hh----------hhhhcc--C-CC------chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NM----------YDLVDK--N-AQ------PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~----------~~~~~~--~-~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..          ...+..  . ..      ......+.++.+|+.+||+.||++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         225 SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            00          000000  0 00      111223567899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=312.49  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..++|++.+.||.|+||.||+|...+..+|+|.+.....          ..+++.+|+.+++.++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN   73 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence            356889999999999999999999999999999864321          2346678999999999999999999999899


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||+++
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~  150 (256)
T cd05039          74 PLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAK  150 (256)
T ss_pred             CeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccc
Confidence            99999999999999998865432 35899999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      .......      ...++..|+|||.+.+..++.++|+||||+++|||++ |..||...... ..........       
T Consensus       151 ~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~-------  216 (256)
T cd05039         151 EASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKGY-------  216 (256)
T ss_pred             ccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhcCC-------
Confidence            6422111      2234667999999988889999999999999999997 99999765431 1111111100       


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                           ....+..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       217 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 -----RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 1112234567899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-40  Score=323.56  Aligned_cols=258  Identities=20%  Similarity=0.287  Sum_probs=186.3

Q ss_pred             cCccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--CCe
Q psy5927         150 LNILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE--TGK  223 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~  223 (441)
                      .++||+|+||.||+|.+.    +..+|+|.+.....           .....+|+++++.++||||+++++++..  +..
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFLSHADRK   74 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcE
Confidence            478999999999999863    35799998864321           1234589999999999999999998854  456


Q ss_pred             EEEEEEecCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee----cCCCCe
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKK------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL----NHHMDP  293 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl----~~~~~~  293 (441)
                      .|++|||+. ++|.+++....      ....+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~  151 (317)
T cd07868          75 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRV  151 (317)
T ss_pred             EEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcE
Confidence            899999994 68888775322      1235888999999999999999999999  9999999999999    466889


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchh--------H
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRS--------E  364 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~--------~  364 (441)
                      ||+|||+++................||+.|+|||++.+ ..++.++||||+||++|||++|.+||......        .
T Consensus       152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~  231 (317)
T cd07868         152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  231 (317)
T ss_pred             EEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccH
Confidence            99999999764332222222344578999999999877 45899999999999999999999999643321        1


Q ss_pred             HHHHHHHHhhc---hhhhh-------------hhhccCCC--c-------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         365 RHLKSLVEKYS---EENMY-------------DLVDKNAQ--P-------IELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       365 ~~l~~~~~~~~---~~~~~-------------~~~~~~~~--~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                      ..+..+.....   .....             .+......  .       ........+.+|+.+||+.||++|||++|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~  311 (317)
T cd07868         232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  311 (317)
T ss_pred             HHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH
Confidence            11111111110   00000             00000000  0       000113457899999999999999999999


Q ss_pred             HH
Q psy5927         420 YN  421 (441)
Q Consensus       420 l~  421 (441)
                      ++
T Consensus       312 l~  313 (317)
T cd07868         312 MQ  313 (317)
T ss_pred             hc
Confidence            85

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-40  Score=315.10  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=201.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..++|++.++||+|+||.||+|.+.+ ..+|+|+++....          ..+.+.+|+++++.++||||+++++++. .
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   72 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----------CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence            34679999999999999999998754 4689998864221          1234568999999999999999999774 4


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ...++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCce
Confidence            56899999999999999986432 345789999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +........  ......++..|+|||.+.+..++.++|+||||+++|||+| |..||....... ......         
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~~---------  217 (262)
T cd05071         150 RLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVE---------  217 (262)
T ss_pred             eeccccccc--cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHh---------
Confidence            754322211  1122346678999999988889999999999999999999 888997654311 111110         


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                         .....+.+..++..+.+++.+||+.+|.+||++.++++.|+..
T Consensus       218 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 ---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               0011122345667889999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-40  Score=317.70  Aligned_cols=268  Identities=26%  Similarity=0.391  Sum_probs=200.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..+|++.+.||+|+||.||+|..      .+..||+|.+.....         ...+.+.+|+++++.++||||++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~   73 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---------EHLRDFEREIEILKSLQHDNIVKYKGV   73 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            35788999999999999999974      245799999864321         223456689999999999999999998


Q ss_pred             EEe--CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         218 CFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       218 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +..  ...+++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l  149 (284)
T cd05081          74 CYSAGRRNLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKI  149 (284)
T ss_pred             EccCCCCceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEE
Confidence            754  35689999999999999988543  235889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||+++................++..|+|||.+.+..++.++|||||||++|||++|..++.....  ...........
T Consensus       150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~  227 (284)
T cd05081         150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRMMGNDKQ  227 (284)
T ss_pred             CCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhhcccccc
Confidence            9999998643322211111122244569999999988899999999999999999999877643321  11100000000


Q ss_pred             ----hhhhhhhhc-cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         376 ----EENMYDLVD-KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       376 ----~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                          ...+...+. ....+.+..++..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                000111111 111122345667899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0196|consensus

Probab=100.00  E-value=1.6e-42  Score=345.92  Aligned_cols=263  Identities=22%  Similarity=0.374  Sum_probs=219.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..+...+.++||.|.||.|++|..+     ...||||.++....        +.++..|+.|..||-++.||||++|.|+
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--------ekqrrdFL~EAsIMGQFdHPNIIrLEGV  698 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNIIRLEGV  698 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--------HHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence            3445567789999999999999974     34699999986543        3567789999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      ........||.|||++|+|+.+|..+.  +.+.+.+...++++|+.|++||-+.+  +|||||...|||++.+..+|++|
T Consensus       699 VTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsD  774 (996)
T KOG0196|consen  699 VTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSD  774 (996)
T ss_pred             EecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEecc
Confidence            999999999999999999999996554  55999999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+|...+.......+..-.-..+|.|||.|...+++.+||||||||||||.++ |..||-+... ++.++.+.+    
T Consensus       775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~----  849 (996)
T KOG0196|consen  775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQ----  849 (996)
T ss_pred             ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHh----
Confidence            9999976444322221111112457999999999999999999999999999888 9999977654 333333222    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                              ....+-|++|+..|++|+..||++|-.+||.+.+|+..|.++....
T Consensus       850 --------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  850 --------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             --------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence                    2355678899999999999999999999999999999998876653

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-40  Score=316.60  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+.  +..+|+|.++.....        .....+.+|++++++++||||+++++++...+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   72 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--------SKFNQIIMELDILHKAVSPYIVDFYGAFFIEG   72 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--------HHHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence            46889999999999999999985  678999988643211        22345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      .+++||||+++++|..++........+++..+..++.+++.||.|||+ .+  |+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          73 AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            999999999999998887654334468999999999999999999996 57  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCC------CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKR------LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      ......     ......++..|+|||.+.+..      ++.++|+|||||++|||++|..||....... .. ...    
T Consensus       151 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~-~~~----  219 (286)
T cd06622         151 GNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IF-AQL----  219 (286)
T ss_pred             ccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HH-HHH----
Confidence            653221     122345888999999986543      5889999999999999999999997543211 11 111    


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          ....+......+..++.++.+++.+||+.+|.+||++.++++
T Consensus       220 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 ----SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----HHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                111122223344557888999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0033|consensus

Probab=100.00  E-value=7.6e-43  Score=306.37  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ..++.|++.+.||+|.|+.||++.+.  +..+|+|++.....       .....+.+.+|++|.+.++|||||+|.+...
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-------~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~   80 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-------SARDFQKLEREARICRKLQHPNIVRLHDSIQ   80 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-------ccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence            55678999999999999999998874  56788888764322       1123455669999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---CCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---MDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---~~~kl~  296 (441)
                      +.+..|||+|+|.|++|..-+..+   ...++..+..+++||+.||.|+|.++  |||||+||+|+||-..   .-+||+
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeec
Confidence            999999999999999997666544   33677888899999999999999999  9999999999999543   458999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+|.......    ..-...||+.|||||+++..+|+..+|||+.|||||-||.|++||.+......+ ..++.    
T Consensus       156 ~FGvAi~l~~g~----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-e~I~~----  226 (355)
T KOG0033|consen  156 DFGLAIEVNDGE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-EQIKA----  226 (355)
T ss_pred             ccceEEEeCCcc----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-HHHhc----
Confidence            999998765222    233457999999999999999999999999999999999999999875442221 11111    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..    .|- ..+.-.+++++..+|+.+||..||.+|.|+.|.++
T Consensus       227 g~----yd~-~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  227 GA----YDY-PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cc----cCC-CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            10    111 11122357788999999999999999999998764

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.2e-41  Score=352.79  Aligned_cols=265  Identities=22%  Similarity=0.338  Sum_probs=204.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||+|+||.||+|.+.  +..||+|++.......      ....+.+.+|+++++.++||||+++++++.+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~------e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN------PLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC------HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            57999999999999999999984  5689999986432211      123456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKN--------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ..|+||||++||+|.+++.....        ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEE
Confidence            99999999999999998864211        234567788899999999999999998  99999999999999999999


Q ss_pred             EeccCCCccCCCccc---------------ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCC
Q psy5927         295 IGDFGLTQEGPIEKA---------------THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD  359 (441)
Q Consensus       295 l~DFGla~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~  359 (441)
                      |+|||+++.......               .........||+.|||||.+.+..++.++|||||||++|||+||..||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999975421100               00111235699999999999998999999999999999999999999976


Q ss_pred             cchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCC
Q psy5927         360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-EMTQVYNMLSGSGG  428 (441)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~  428 (441)
                      ...........   .        .++........++..+.+++.+||+.||++|| +++++.+.|+....
T Consensus       234 ~~~~ki~~~~~---i--------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRKISYRDV---I--------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhhhhhhhh---c--------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            43311111100   0        00000001124566788999999999999996 56777777766544

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.3e-40  Score=318.44  Aligned_cols=265  Identities=22%  Similarity=0.373  Sum_probs=202.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC------------------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK------------------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS  205 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  205 (441)
                      .++|++.++||+|+||.||++.+.+                  ..+|+|++......        .....+.+|+++++.
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--------~~~~~~~~E~~~l~~   75 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--------NARNDFLKEIKIMSR   75 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--------HHHHHHHHHHHHHHh
Confidence            3579999999999999999986432                  35888888643211        223456789999999


Q ss_pred             CCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       206 l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      ++|+||+++++++...+..++||||+++|+|.+++.....        ...+++..+..++.+++.||+|||+.+  ++|
T Consensus        76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H  153 (296)
T cd05095          76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVH  153 (296)
T ss_pred             CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            9999999999999999999999999999999999865432        124778889999999999999999999  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh--CCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT--GMR  355 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt--G~~  355 (441)
                      |||||+|||++.++.++|+|||+++........ .......++..|+|||...++.++.++|+|||||++|||++  |..
T Consensus       154 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~  232 (296)
T cd05095         154 RDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ  232 (296)
T ss_pred             ccCChheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998754222111 11122234678999999888889999999999999999998  778


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ||..... ..........+....     .....+.+..++..+.+|+.+||+.||++||++.+|++.|+.
T Consensus       233 p~~~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         233 PYSQLSD-EQVIENTGEFFRDQG-----RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CccccCh-HHHHHHHHHHHhhcc-----ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            8865433 222211111110000     000112223456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.3e-40  Score=313.85  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.++||+|+||.||+|... ++.+|+|.+.....          ..+.+.+|+.++++++||||+++++++. 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----------SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            44578999999999999999999874 47899998864322          1235668999999999999999999864 


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..+++|||+++++|.+++.... ...+++.++..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~  148 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGL  148 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcc
Confidence            567899999999999999886543 346889999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +.........  ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ......+..       
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~-------  218 (260)
T cd05067         149 ARLIEDNEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQNLER-------  218 (260)
T ss_pred             eeecCCCCcc--cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHc-------
Confidence            8754322111  1112235678999999988889999999999999999999 9999976543 222221111       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                           ....+.+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus       219 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 -----GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 01112223456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.2e-40  Score=315.58  Aligned_cols=257  Identities=21%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             CCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ++|++.+.||+|+||.||+|.+..     ..||||.++....        ......+..|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   75 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--------EKQRRDFLSEASIMGQFDHPNIIHLEGVVT   75 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence            457889999999999999999743     2599998864321        123456778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +++..++||||+++|+|.+++...  .+.+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          76 KSRPVMIITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             CCCceEEEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCc
Confidence            999999999999999999988643  345889999999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccc--cCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         300 LTQEGPIEKATHITLKRVNG--TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ++.................+  +..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+..    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i~~----  226 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAIEQ----  226 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHHHc----
Confidence            98754322211111111112  357999999998899999999999999999987 99999765431 11111110    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                              ....+.+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 --------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    001122334567789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-40  Score=312.06  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=201.8

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||.||++.+.  +..+|+|.++.....        ...+.+..|+.+++.++||||+++++.+.+.+.
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   72 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--------SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH   72 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--------HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence            5788999999999999999874  567999988643221        123455689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|++|||+++|+|.+++.... ...++...+..++.+++.||.|||+++  |+|+||||+||+++.++.++|+|||+++.
T Consensus        73 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~  149 (255)
T cd08219          73 LYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARL  149 (255)
T ss_pred             EEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCccee
Confidence            999999999999999886433 345788999999999999999999999  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ........            
T Consensus       150 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~------------  213 (255)
T cd08219         150 LTSPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-KNLILKVC------------  213 (255)
T ss_pred             eccccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-HHHHHHHh------------
Confidence            432211   12234688999999999988899999999999999999999999976543 11111111            


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .....+.+..++..+.+++.+||+.||.+||++.+++..
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         214 QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111112334456778999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.1e-41  Score=323.25  Aligned_cols=266  Identities=22%  Similarity=0.363  Sum_probs=201.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|.+.++||+|+||.||+|.+.  +..+|+|.++......        ....+.+|++++++++||||+++++++..++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--------APCTAIREVSLLKDLKHANIVTLHDIVHTDK   77 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--------cchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence            57999999999999999999874  4679999987543221        1223457999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||++ ++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~  152 (309)
T cd07872          78 SLTLVFEYLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLAR  152 (309)
T ss_pred             eEEEEEeCCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccce
Confidence            9999999996 58888775432  34788899999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EEN  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~  378 (441)
                      .......   ......+|..|+|||.+.+ ..++.++|||||||++|||+||.+||......+ .+..+.....   ...
T Consensus       153 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~  228 (309)
T cd07872         153 AKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPTEET  228 (309)
T ss_pred             ecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHH
Confidence            5322211   1223457899999998865 468899999999999999999999997654322 2222221110   000


Q ss_pred             hhhh--------hc-cCC-----CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         379 MYDL--------VD-KNA-----QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       379 ~~~~--------~~-~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                      ....        .+ +..     ......++.++.+|+.+||+.||.+|||+.++++  .++...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            0000        00 000     0111235677899999999999999999999987  555443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-40  Score=318.12  Aligned_cols=260  Identities=23%  Similarity=0.320  Sum_probs=193.1

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc---CCCCCeecccceEEe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS---CRHDNILPLYGICFE  220 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnIv~l~~~~~~  220 (441)
                      +|++.+.||+|+||+||+|.+.  ++.+|+|.++........       .....+|+.+++.   ++||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~   73 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-------PLSTVREVALLKRLEAFDHPNIVRLMDVCAT   73 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-------chHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence            5888999999999999999985  567999988754322111       1122345555554   479999999998764


Q ss_pred             -----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         221 -----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       221 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                           ....++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          74 SRTDRETKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             ccCCCCceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence                 345899999996 58988875433 345899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||+++......    ......||..|+|||.+.+..++.++|||||||++|||++|.+||....... .+........
T Consensus       150 ~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~  224 (288)
T cd07863         150 ADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIG  224 (288)
T ss_pred             CccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhC
Confidence            9999987543221    1223458999999999998889999999999999999999999997654422 2222222110


Q ss_pred             ---hhhhhhh-------hcc----CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 ---EENMYDL-------VDK----NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ---~~~~~~~-------~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .......       ...    ........++..+.+|+.+||+.||++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0000000       000    001112345677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.6e-40  Score=313.23  Aligned_cols=254  Identities=27%  Similarity=0.414  Sum_probs=201.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..++|++.++||+|+||.||+|.+. +..+|+|.+......          .+.+.+|+.++++++|+||+++++++. .
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----------HHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            3467899999999999999999874 457899988643221          234568999999999999999999875 4


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ...+++|||+++++|.+++.... ...+++..+..++.+++.||+|||+.+  ++||||||+||++++++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceee
Confidence            56889999999999999886432 345889999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .........  ......++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ......+.         
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~---------  217 (260)
T cd05070         150 RLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVE---------  217 (260)
T ss_pred             eeccCcccc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH---------
Confidence            754322111  1112235667999999988889999999999999999999 8999976543 11111111         


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                         .....+.+...+..+.+|+.+||..+|.+||++.++.+.|+.
T Consensus       218 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 ---RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---cCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               011112334456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-40  Score=312.43  Aligned_cols=253  Identities=27%  Similarity=0.392  Sum_probs=200.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .++|++...||+|+||.||+|.+.+ ..+|+|.+.....          ..+.+.+|+++++.++||||+++++++. .+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            3568899999999999999998855 4688988753221          1234568999999999999999999875 46


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..+++|||+++|+|.+++.... ...+++..+..++.+++.||.|||+.+  ++||||||+||++++++.++|+|||+++
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccce
Confidence            6889999999999999886533 345789999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........  ......++..|+|||.+.+..++.++|+||||+++|||+| |..||.+.... .........        
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~--------  219 (260)
T cd05069         151 LIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVERG--------  219 (260)
T ss_pred             EccCCccc--ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC--------
Confidence            54322111  1112235678999999988889999999999999999999 99999765431 122111110        


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                          ...+.+...+..+.+++.+||+.||.+||++++|++.|+.
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 ----YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                0112234567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-40  Score=328.39  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..+|||++......       ......+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   86 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-------hHHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence            34578999999999999999999874  567999988643221       122345568999999999999999999886


Q ss_pred             eC------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         220 ET------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       220 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      ..      ...|+||||++ ++|.+.+..     .+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~  158 (355)
T cd07874          87 PQKSLEEFQDVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ccccccccceeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCE
Confidence            43      35799999996 567666632     3788889999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++.....    .......||..|+|||++.+..++.++|||||||++|||++|..||....... .+...+..
T Consensus       159 kl~Dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~  233 (355)
T cd07874         159 KILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ  233 (355)
T ss_pred             EEeeCcccccCCCc----cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence            99999999754322    11233468999999999999899999999999999999999999997654322 22222221


Q ss_pred             hch----------hhhhhhhccC-------------------CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         374 YSE----------ENMYDLVDKN-------------------AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       374 ~~~----------~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      ...          .....+.+..                   ........+..+.+|+.+||..||.+|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            100          0000000000                   001112235678999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-40  Score=325.84  Aligned_cols=267  Identities=23%  Similarity=0.343  Sum_probs=208.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCC
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN  210 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  210 (441)
                      ++...+|.+.+.||+|+||.||+|.+.+         ..+|+|.++.....        ...+.+.+|+++++++ +|||
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~   79 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--------KDLSDLVSEMEMMKMIGKHKN   79 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--------HHHHHHHHHHHHHHhhcCCCC
Confidence            4555689999999999999999997521         25899987632211        2344667899999999 7999


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      |++++++|.+.+..+++|||+++|+|.+++....             ....+++..+..++.|++.||.|||+++  ++|
T Consensus        80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH  157 (334)
T cd05100          80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIH  157 (334)
T ss_pred             eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            9999999999999999999999999999986532             1234788999999999999999999998  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA  356 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p  356 (441)
                      |||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccceecccccccc-cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999987543221111 1112234567999999998889999999999999999998 8899


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                      |..... ......+..            ......+..++..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus       237 ~~~~~~-~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         237 YPGIPV-EELFKLLKE------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             CCCCCH-HHHHHHHHc------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            976543 222211111            11112233456689999999999999999999999999998775443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4278|consensus

Probab=100.00  E-value=2.2e-41  Score=329.77  Aligned_cols=266  Identities=24%  Similarity=0.385  Sum_probs=216.7

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      .+++....+.....+||.|-||.||.|.|+.  ..||||.++..          ....++|+.|..+|+.++|||+|+|+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----------tMeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----------chhHHHHHHHHHHHHhhcCccHHHHh
Confidence            4445555566667899999999999999975  57999998732          13467889999999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      |+|.....+|||.|||..|+|.|+|..+... .++-...+.++.||..|++||..++  +|||||...|+|+.++..+|+
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEe
Confidence            9999999999999999999999999876543 3666677899999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +||||++.......+...  ...-..-|.|||-+....++.|+|||+|||+|||+.| |..||.+....  ++..+++.-
T Consensus       407 ADFGLsRlMtgDTYTAHA--GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--qVY~LLEkg  482 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYGLLEKG  482 (1157)
T ss_pred             eccchhhhhcCCceeccc--CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--HHHHHHhcc
Confidence            999999986544332211  1123456999999998899999999999999999999 99999887542  233333211


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                                 ..-.-+..|+..+++|+..||+++|.+||++.++.+.|+.+..+++
T Consensus       483 -----------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  483 -----------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             -----------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence                       1112355788899999999999999999999998887776655544

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-40  Score=313.65  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=198.2

Q ss_pred             CcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |++.+.||+|+||+||++...+  ..+|+|.+........       ......+|+.++++++||||+++++++.+....
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-------EREENIREIKILRRLRHPNIVQILDVFQDDNYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-------HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-------ccchhhhhhhccccccccccccccccccccccc
Confidence            6778999999999999999965  4699999986543221       122334599999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.+||+.+  |+|+||||+||+++.++.++|+|||++...
T Consensus        74 ~~v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   74 YIVMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             EEEEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             cccccccccccccccccc---ccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence            999999999999999972   344889999999999999999999999  999999999999999999999999998643


Q ss_pred             CCcccccceeccccccCCCcCccccc-CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLV-GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .   ..........++..|+|||++. +..++.++||||||+++|+|++|..||....... .............    .
T Consensus       149 ~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~----~  220 (260)
T PF00069_consen  149 S---ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-QLEIIEKILKRPL----P  220 (260)
T ss_dssp             T---STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-HHHHHHHHHHTHH----H
T ss_pred             c---ccccccccccccccccccccccccccccccccccccccccccccccccccccccchh-hhhhhhhcccccc----c
Confidence            1   1122334556899999999998 7889999999999999999999999998762211 1111111100000    0


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....  ........+.+++.+||+.||++||++.++++
T Consensus       221 ~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000  00011278999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.1e-40  Score=310.95  Aligned_cols=255  Identities=22%  Similarity=0.357  Sum_probs=198.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE--  220 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  220 (441)
                      .+|+..+.||+|+||.||+|.+.  +..+|+|++........    .......+.+|+.+++.++||||+++++++.+  
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE----TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA   77 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch----hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence            47999999999999999999874  56899998864432211    11234456689999999999999999998875  


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      ...+++++||+++++|.+++...   ..+++.....++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~  152 (266)
T cd06651          78 EKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGA  152 (266)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCC
Confidence            36788999999999999988543   34788999999999999999999988  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++................++..|+|||.+.+..++.++|+|||||++|||++|..||.......... ...   .     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-~~~---~-----  223 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-KIA---T-----  223 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH-HHh---c-----
Confidence            8754321111112233458899999999999889999999999999999999999997653311111 110   0     


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .......+..+...+.+++ +||..+|++||++++|++
T Consensus       224 ---~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 ---QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               0111223344566777887 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=313.30  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=193.8

Q ss_pred             CccccCCceeEEEEEECCe----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  225 (441)
                      +.||+|+||.||+|.+.++    .+++|.++.....        ...+.+..|++++.++ +||||+++++++...+.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   72 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   72 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--------HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCce
Confidence            4689999999999998542    4677777532211        1233556899999999 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      +||||+++|+|.+++.....             ...+++..+..++.+++.||+|||+.+  ++||||||+|||++.++.
T Consensus        73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~  150 (270)
T cd05047          73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCe
Confidence            99999999999999865331             234789999999999999999999998  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~  371 (441)
                      +||+|||++......    ........+..|+|||++.+..++.++|+|||||++|||++ |..||..... ........
T Consensus       151 ~kl~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~  225 (270)
T cd05047         151 AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP  225 (270)
T ss_pred             EEECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHHh
Confidence            999999998632111    11111224567999999988889999999999999999997 9999966433 11111111


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ..            .....+..++.++.+|+.+||+.+|.+||++.++++.|..+
T Consensus       226 ~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         226 QG------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CC------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            00            01112223556789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=321.61  Aligned_cols=257  Identities=18%  Similarity=0.232  Sum_probs=196.5

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||++...  ++.||+|++.....      ......+.+..|+.++..++|+||+++++++.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM------LKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            47999999999999999999984  56799999863211      12223445668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCcee
Confidence            999999999999999988543  234888999999999999999999999  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      .......  .......||+.|+|||++.+     ..++.++|||||||++|||++|..||........ ......   ..
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~---~~  224 (331)
T cd05597         151 RLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMN---HK  224 (331)
T ss_pred             ecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHc---CC
Confidence            5332211  11223469999999999863     4578899999999999999999999976543221 111111   00


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYNM  422 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~  422 (441)
                      ....     .......++..+.+++.+||..++++  ||++.++++.
T Consensus       225 ~~~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 EHFQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Cccc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0000     11111235677889999988654443  7899988764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-40  Score=314.86  Aligned_cols=254  Identities=26%  Similarity=0.361  Sum_probs=198.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+  .+..+|+|++......         ....+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~   78 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---------DFSLIQQEIFMVKECKHCNIVAYFGSYLSR   78 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---------hHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence            45799999999999999999997  4567999998643211         122455899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+++||||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++
T Consensus        79 ~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          79 EKLWICMEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccc
Confidence            9999999999999999988533   35889999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      .......   .......|+..|+|||.+.   ...++.++|+|||||++|||++|..||............     ....
T Consensus       154 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~~  225 (267)
T cd06646         154 AKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKSN  225 (267)
T ss_pred             eeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecCC
Confidence            7542211   1112345889999999884   345788999999999999999999999654321111000     0000


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                         + ..........++..+.+++.+||+.+|.+||+++++++.|
T Consensus       226 ---~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 ---F-QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ---C-CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence               0 0001111223567899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-40  Score=327.30  Aligned_cols=259  Identities=20%  Similarity=0.280  Sum_probs=196.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||.||+|.+.  +..||||++......       ......+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~   94 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTP   94 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-------chhHHHHHHHHHHHHhcCCCCccccceeecc
Confidence            3578999999999999999999974  567999998643211       1223455689999999999999999998754


Q ss_pred             C------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 T------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      .      ..+|+||||++ ++|.+.+..     .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875          95 QKSLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             cccccccCeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEE
Confidence            3      35799999996 577776632     3778889999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||+++......    ......||..|+|||++.+..++.++|||||||++|||++|..||...... ..+..++...
T Consensus       167 L~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~  241 (364)
T cd07875         167 ILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQL  241 (364)
T ss_pred             EEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            99999997542221    123346899999999999999999999999999999999999999766542 2222222211


Q ss_pred             chh----------hhhhhhccC-------------------CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SEE----------NMYDLVDKN-------------------AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~~----------~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...          .........                   ...........+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            100          000000000                   00011112456889999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=352.21  Aligned_cols=263  Identities=20%  Similarity=0.314  Sum_probs=202.2

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....++|++++.||+|+||+||+|.+..  ..+|+|.+......       ......+..|+.++..++|||||+++++|
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-------EREKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-------HHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            3456789999999999999999999854  56899988643221       12345667899999999999999999988


Q ss_pred             Ee--CCeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCeeecCCCCCCeeecC-
Q psy5927         219 FE--TGKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSRE-----PPLIHGDIKSANILLNH-  289 (441)
Q Consensus       219 ~~--~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~iiHrDikp~NiLl~~-  289 (441)
                      .+  ...+||||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+.+     .+||||||||+||||+. 
T Consensus        82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence            64  356899999999999999886532 2356899999999999999999999843     34999999999999964 


Q ss_pred             ----------------CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHH
Q psy5927         290 ----------------HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELA  351 (441)
Q Consensus       290 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~ell  351 (441)
                                      .+.+||+|||++.......    ......||+.|+|||++.+  ..++.++||||||||||||+
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                            2348999999997643221    1233469999999999865  45889999999999999999


Q ss_pred             hCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHhcCC
Q psy5927         352 TGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY--NMLSGSG  427 (441)
Q Consensus       352 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl--~~L~~~~  427 (441)
                      ||..||.........+..+..    .         ........+.++.+||.+||+.+|.+||++.+++  ..+..+.
T Consensus       238 TGk~PF~~~~~~~qli~~lk~----~---------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        238 SGKTPFHKANNFSQLISELKR----G---------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HCCCCCCcCCcHHHHHHHHhc----C---------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            999999765432222221110    0         0001123456789999999999999999999998  4555443

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-40  Score=313.71  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=204.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..++|.+.+.||+|+||.||+|.+..     ..+|||........        ...+.+.+|+.+++.+.||||++++++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~   75 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--------SVREKFLQEAYIMRQFDHPHIVKLIGV   75 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--------HHHHHHHHHHHHHHhCCCCchhceeEE
Confidence            34578889999999999999998743     25888887643221        234466789999999999999999998


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+ +..++||||+++|+|.+++....  ..+++..+..++.+++.||+|||+.+  ++||||||+|||++.++.++|+|
T Consensus        76 ~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d  150 (270)
T cd05056          76 ITE-NPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGD  150 (270)
T ss_pred             EcC-CCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEcc
Confidence            865 56789999999999999985432  35899999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++.......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ......    .
T Consensus       151 ~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~~----~  223 (270)
T cd05056         151 FGLSRYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIGRIE----N  223 (270)
T ss_pred             Cceeeecccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH----c
Confidence            999875433211  11112234568999999988889999999999999999996 999997665422 111111    0


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                              ......+..++..+.+++.+|+..+|.+||++.++++.|+.+..+
T Consensus       224 --------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 --------GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                    011122345567899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.4e-40  Score=321.78  Aligned_cols=257  Identities=16%  Similarity=0.202  Sum_probs=196.7

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||+|+||.||++.+++  ..+|+|++.....      ........+..|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM------LKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH------HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            478999999999999999999854  5689999863211      11223344568899999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhe
Confidence            999999999999999998643  235888999999999999999999999  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ......  ........||+.|+|||++.     ...++.++|||||||++|||++|..||....... ....+...... 
T Consensus       151 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~~~-  226 (332)
T cd05623         151 KLMEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKER-  226 (332)
T ss_pred             ecccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-HHHHHhCCCcc-
Confidence            532211  11223456999999999986     3468899999999999999999999997654311 11111110000 


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYNM  422 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~  422 (441)
                             .........++.++.+|+.+||..++++  |+++.++++.
T Consensus       227 -------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 -------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                   0011112345678899999998765554  6889988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.7e-40  Score=310.86  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=192.5

Q ss_pred             CccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE-eCCeE
Q psy5927         151 NILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF-ETGKY  224 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~  224 (441)
                      +.||+|+||.||+|.+.     ...+|+|.+.....        ....+.+.+|+.+++.++||||+++++++. .++..
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   72 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSP   72 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--------HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCc
Confidence            46899999999999863     24689998753221        122345668999999999999999999775 45568


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||+.+|+|.+++....  ..+.+..+..++.+++.||+|||+.+  ++||||||+|||++.++.+||+|||+++..
T Consensus        73 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          73 LVVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999999886432  34677788899999999999999998  999999999999999999999999998753


Q ss_pred             CCccccc-ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         305 PIEKATH-ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       305 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ....... .......++..|+|||.+.+..++.++|||||||++|||++ |.+||..... ....... .          
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~-~----------  216 (262)
T cd05058         149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-FDITVYL-L----------  216 (262)
T ss_pred             cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH-h----------
Confidence            3211111 11122345778999999988889999999999999999999 5666765432 1111111 1          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                       .......+..++..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus       217 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         217 -QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             011111223345679999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-40  Score=327.78  Aligned_cols=259  Identities=20%  Similarity=0.253  Sum_probs=198.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ....+|++.+.||+|+||.||++...    +..||+|.+....              ...+|+++++.++||||++++++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------------~~~~E~~il~~l~h~~iv~~~~~  154 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------------TPGREIDILKTISHRAIINLIHA  154 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------------cHHHHHHHHHhcCCCCccceeee
Confidence            44568999999999999999999763    3468888775321              12379999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +......|+|||++. ++|.+++.   ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|
T Consensus       155 ~~~~~~~~lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~D  228 (392)
T PHA03207        155 YRWKSTVCMVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGD  228 (392)
T ss_pred             EeeCCEEEEEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcc
Confidence            999999999999994 78888883   2345899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch--hHHHHHHHHHhhc
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR--SERHLKSLVEKYS  375 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~--~~~~l~~~~~~~~  375 (441)
                      ||+++....... ........||..|+|||++.+..++.++|||||||++|||++|..||.....  ....+..+.....
T Consensus       229 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~  307 (392)
T PHA03207        229 FGAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ  307 (392)
T ss_pred             CccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence            999975433221 1122345699999999999998999999999999999999999999965432  1223333332221


Q ss_pred             hhh--------------hhhhhccCCC--chh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EEN--------------MYDLVDKNAQ--PIE-----LNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~--------------~~~~~~~~~~--~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...              +..+......  ..+     ..++.++.+++.+||..||++||++.+++.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            100              0000000000  011     123567889999999999999999999986

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=314.05  Aligned_cols=260  Identities=23%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ...+|++.+.||+|+||.||+|.+..      ..+|+|.+.....        ......+.+|+.++++++||||+++++
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~   76 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--------PKANKEILDEAYVMASVDHPHVVRLLG   76 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            34678999999999999999998743      2478887764322        123445678999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.. ...++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+
T Consensus        77 ~~~~-~~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~  151 (279)
T cd05057          77 ICLS-SQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKIT  151 (279)
T ss_pred             EEec-CceEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEEC
Confidence            9876 7889999999999999988643  334889999999999999999999988  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++........ .......++..|+|||.+.+..++.++|+||||+++||+++ |..||......  .+...+..  
T Consensus       152 dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~--  226 (279)
T cd05057         152 DFGLAKLLDVDEKE-YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEK--  226 (279)
T ss_pred             CCcccccccCcccc-eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhC--
Confidence            99999764322111 11111224567999999988889999999999999999999 99999876431  12111111  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                               ....+.+..++..+.+++.+||..+|++||++.++++.|..+..+
T Consensus       227 ---------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         227 ---------GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                     111122233456789999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-40  Score=315.56  Aligned_cols=262  Identities=21%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||.||+|...  +..||+|++.......       .....+.+|+.+++.++||||+++++++.+++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-------GVPSTAIREISLLKELQHPNIVCLQDVLMQESR   73 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-------CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence            5888899999999999999984  5679999886532221       122345689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+||||++ ++|.+++........+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.++|+|||++..
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          74 LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceee
Confidence            999999996 789888865554466899999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---h---
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---E---  376 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~---  376 (441)
                      .....   .......++..|+|||.+.+. .++.++|+|||||++|||+||++||.......... .......   +   
T Consensus       151 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  226 (285)
T cd07861         151 FGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVW  226 (285)
T ss_pred             cCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHHHhCCCChhhh
Confidence            32221   111223478899999988763 57889999999999999999999998654322111 1111110   0   


Q ss_pred             ------hhhhhhhc----cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ------ENMYDLVD----KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ------~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            ........    .........++.++.+++.+||..||.+||++.+|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  00000000    0001111235678889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=310.94  Aligned_cols=256  Identities=28%  Similarity=0.431  Sum_probs=205.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|.+.++||+|+||.||+|.+++ ..+|||.+.....          ..+.+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----------SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----------CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            456789999999999999999998754 5789998864321          12345689999999999999999999998


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      ....++||||+++++|.+++.... ...+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECcccc
Confidence            899999999999999999886533 345899999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +........  .......++..|+|||.+.+..++.++|+||||+++|||+| |+.||..... ...+.......     
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~-----  221 (261)
T cd05034         150 ARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERGY-----  221 (261)
T ss_pred             ceeccchhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC-----
Confidence            875432111  11112234568999999998889999999999999999999 9999976543 22222221111     


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                             ..+.+...+.++.+++.+||+.+|.+||+++++++.|+.
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                   112223346689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.2e-40  Score=317.32  Aligned_cols=258  Identities=24%  Similarity=0.410  Sum_probs=199.4

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||++.+.  +..+|+|.+.....        .....++.+|++++++++||||+++++++.+++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   72 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--------PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG   72 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            47899999999999999999985  45678887764221        123445678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      .+|+||||+++++|.+++...   ..+++..+..++.|++.||.|||+ .+  ++||||||+|||++.++.++|+|||++
T Consensus        73 ~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          73 EISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             EEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCc
Confidence            999999999999999998643   458889999999999999999997 57  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc----hh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS----EE  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~----~~  377 (441)
                      ......     ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..... . ..........    ..
T Consensus       148 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~-~~~~~~~~~~~~~~~~  220 (308)
T cd06615         148 GQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-K-ELEAMFGRPVSEGEAK  220 (308)
T ss_pred             cccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-h-hHHHhhcCcccccccc
Confidence            653221     12334689999999999888899999999999999999999999965432 1 1111111000    00


Q ss_pred             -----------------hhhh----hhccCCCchh-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         378 -----------------NMYD----LVDKNAQPIE-LNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       378 -----------------~~~~----~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                                       ....    .........+ ..++.++.+++.+||+.+|++||++.+|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             0000    0000000001 1256679999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-40  Score=322.25  Aligned_cols=256  Identities=17%  Similarity=0.225  Sum_probs=196.2

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||++.+.  +..||+|.+.....      ........+..|+.++..++|+||+++++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM------LKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH------HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            47999999999999999999985  45799999864211      11223344568899999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||++||+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEecccee
Confidence            9999999999999999986432  35888999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      .......  .......||+.|+|||++.+     ..++.++|||||||++|||++|..||....... ....+..   ..
T Consensus       151 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~---~~  224 (331)
T cd05624         151 KMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMN---HE  224 (331)
T ss_pred             eccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHc---CC
Confidence            5432211  12233569999999999875     467899999999999999999999997654321 1111111   00


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~  421 (441)
                      ...     ........++.++.+++.+||..++++  |+++.++++
T Consensus       225 ~~~-----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         225 ERF-----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             Ccc-----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            000     001111235678899999999876554  467888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.6e-40  Score=309.47  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC-
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET-  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  221 (441)
                      .+|++.+.||+|+||.||+|.+.  +..||+|.+........    .....+.+.+|+.++++++||||+++++++.+. 
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   77 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPE----TSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM   77 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcc----cHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence            57899999999999999999974  56799998864322111    112345667899999999999999999988763 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 -GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       ..++++|||+++++|.+++...   ..+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~  152 (265)
T cd06652          78 ERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGA  152 (265)
T ss_pred             CceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcc
Confidence             5688999999999999988643   34778888999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++................|+..|+|||.+.+..++.++|+|||||++|||++|..||......... ....         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~---------  222 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIA---------  222 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HHHh---------
Confidence            875432211111223346899999999998888999999999999999999999999765332111 1110         


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ........+...+..+.+++.+|+. +|++||++++|++
T Consensus       223 --~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 --TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              0111223445667788999999995 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.2e-40  Score=309.52  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=202.9

Q ss_pred             CCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      +|.+.+.||.|+||.||+|.. .+..+|+|.+.........   .......+.+|+++++.++|+||+++++++.+.+..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA---AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI   77 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhh---HHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence            478899999999999999987 4567999988754322111   123345677899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      +++|||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++...
T Consensus        78 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          78 SIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            9999999999999988543   34788999999999999999999998  999999999999999999999999998753


Q ss_pred             CCcc---cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         305 PIEK---ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       305 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ....   ..........|+..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..   ..    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~---~~----  224 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GA---HR----  224 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-hh---cc----
Confidence            2111   1111223456899999999999888999999999999999999999999765432211110 00   00    


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ......+..++.++.+++.+||+.+|.+||++.++++
T Consensus       225 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 ---GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0011223346678899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.1e-40  Score=307.17  Aligned_cols=247  Identities=24%  Similarity=0.379  Sum_probs=195.6

Q ss_pred             CccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR  229 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  229 (441)
                      ++||+|+||.||+|... +..+|+|.+......        .....+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--------ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCH--------HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence            46999999999999864 467999987643221        122356689999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccc
Q psy5927         230 YMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA  309 (441)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~  309 (441)
                      |+++++|.+++...  ...+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.+||+|||++........
T Consensus        73 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (250)
T cd05085          73 LVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY  148 (250)
T ss_pred             CCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceecccccc
Confidence            99999999988543  245789999999999999999999998  99999999999999999999999999865322111


Q ss_pred             ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC
Q psy5927         310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ  388 (441)
Q Consensus       310 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (441)
                      .  ......++..|+|||++.+..++.++||||||+++||+++ |..||....... ......    ..        ...
T Consensus       149 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-~~~~~~----~~--------~~~  213 (250)
T cd05085         149 S--SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-AREQVE----KG--------YRM  213 (250)
T ss_pred             c--cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHH----cC--------CCC
Confidence            1  1111234667999999988889999999999999999998 999997654321 111111    00        011


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      ..+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-40  Score=323.61  Aligned_cols=256  Identities=22%  Similarity=0.334  Sum_probs=192.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ....+|++.+.||+|+||.||+|.+.+  ..||+|+....               ....|+.++++++||||+++++++.
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------------~~~~E~~~l~~l~h~~iv~~~~~~~  127 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------------TTLIEAMLLQNVNHPSVIRMKDTLV  127 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------------ccHHHHHHHHhCCCCCCcChhheEE
Confidence            455689999999999999999999854  47888864321               1236889999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..|+||||+ .++|.+++...  ...+++..+..|+.||+.||+|||+++  ||||||||+|||++.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        128 SGAITCMVLPHY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             eCCeeEEEEEcc-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCc
Confidence            999999999999 57888887543  345899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCC-CCcchh--------HHHHHHH
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRRS--------ERHLKSL  370 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~-~~~~~~--------~~~l~~~  370 (441)
                      +++......    ......||..|+|||++.+..++.++|||||||++|||+++..|+ ......        ...+...
T Consensus       203 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~  278 (357)
T PHA03209        203 AAQFPVVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI  278 (357)
T ss_pred             cccccccCc----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence            987532211    123346899999999999989999999999999999999865544 432211        1111111


Q ss_pred             HHhhc--hhhh---------hhhhcc---CCCc-------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         371 VEKYS--EENM---------YDLVDK---NAQP-------IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       371 ~~~~~--~~~~---------~~~~~~---~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +....  ....         ..+++.   ...+       ....++.++.+|+.+||+.||++|||+.||++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            11110  0000         000000   0000       01123456678999999999999999999986

>KOG0695|consensus

Probab=100.00  E-value=2.7e-41  Score=308.48  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=204.4

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc-CCCCCeecccce
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-CRHDNILPLYGI  217 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~  217 (441)
                      .+..++|+.+++||+|+|++|..++...+  -||+|++++...+.+ +.+++.+     .|..+..+ -+||.+|.++.+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvq-----tek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQ-----TEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHH-----hhHHHHHhccCCCeEEehhhh
Confidence            46778999999999999999999998654  689999886554433 2333434     34444433 479999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      |.....+++|.||++||+|.-.++.++   .+++.++..+..+|+.||.|||++|  ||+||||..|||+|..|++||+|
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecc
Confidence            999999999999999999976665443   4899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcc--hhHHHHHHHHHhhc
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTR--RSERHLKSLVEKYS  375 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~--~~~~~l~~~~~~~~  375 (441)
                      +|+++.+.....   .++++|||+.|.|||+++|..|+.++|+|+|||+++||+.|+.||+-..  ..+....+      
T Consensus       395 ygmcke~l~~gd---~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted------  465 (593)
T KOG0695|consen  395 YGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED------  465 (593)
T ss_pred             cchhhcCCCCCc---ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH------
Confidence            999998654443   3567899999999999999999999999999999999999999997422  11111111      


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE  415 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  415 (441)
                        -+++.+-.+...+|..++.....+++.-|++||++|..
T Consensus       466 --ylfqvilekqiriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  466 --YLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --HHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence              13334444455667777778888999999999999853

>KOG0667|consensus

Probab=100.00  E-value=2.5e-40  Score=327.74  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=204.7

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-C-----CCeecccc
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-H-----DNILPLYG  216 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~  216 (441)
                      .+|++.+.||+|+||.|-+|.+.+  ..||||+++...          .-..+...|+++|..++ |     -|+|++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            378999999999999999999854  579999998532          23445668999999986 4     38999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC--CCeE
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH--MDPV  294 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~--~~~k  294 (441)
                      +|...+++|||+|.+ ..+|.++|... ...+++...++.++.||+.||.+||+.+  |||+||||+||||.+-  ..+|
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCcee
Confidence            999999999999999 69999988654 4556999999999999999999999999  9999999999999754  3689


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||.++.....      ..++..+..|.|||+|.|.+|+.+.|+||||||++||++|.+-|.+..+ ..++..+++..
T Consensus       332 VIDFGSSc~~~q~------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl~~I~e~l  404 (586)
T KOG0667|consen  332 VIDFGSSCFESQR------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQLARIIEVL  404 (586)
T ss_pred             EEecccccccCCc------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH-HHHHHHHHHHh
Confidence            9999999874332      1255689999999999999999999999999999999999988988776 33444444332


Q ss_pred             c--hhhhh-------hhh--------------------------------ccCCCc-----hh----HHHHHHHHHHHHH
Q psy5927         375 S--EENMY-------DLV--------------------------------DKNAQP-----IE----LNIAYAFFRIGKQ  404 (441)
Q Consensus       375 ~--~~~~~-------~~~--------------------------------~~~~~~-----~~----~~~~~~l~~li~~  404 (441)
                      .  +..+.       .++                                +....+     +.    ......+.+++++
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence            1  00000       000                                110011     11    1234567999999


Q ss_pred             hcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         405 STKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       405 cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ||..||.+|+|..+.++  +|...
T Consensus       485 ~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             HhccCchhcCCHHHHhcCcccccc
Confidence            99999999999999986  45433

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.3e-40  Score=310.00  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=190.7

Q ss_pred             CccccCCceeEEEEEECC----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         151 NILGKGGFGTVYKGVWEK----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      +.||+|+||.||+|.+.+    ..+|+|.++.....        .....+.+|+.+++.++||||+++++++.+....++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   72 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--------QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLL   72 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEE
Confidence            468999999999998643    35888887643221        112356689999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         227 VYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ||||+++|+|.+++.....  ....++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++..
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccc
Confidence            9999999999999865432  234567788889999999999999999  999999999999999999999999998653


Q ss_pred             CCcccccceeccccccCCCcCcccccCC-------CCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGK-------RLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      .... .........++..|+|||++.+.       .++.++|+||||+++|||++ |..||........... .+.   .
T Consensus       151 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~~---~  225 (269)
T cd05087         151 YKED-YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TVR---E  225 (269)
T ss_pred             cCcc-eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hhh---c
Confidence            2221 11112234578889999998642       35789999999999999996 9999976544222111 111   0


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                       ......+   .......+..+.+++.+|+ .+|.+||++.+|+..|+
T Consensus       226 -~~~~~~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 -QQLKLPK---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -ccCCCCC---CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence             0001111   1112234556888999998 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.4e-40  Score=310.66  Aligned_cols=254  Identities=25%  Similarity=0.383  Sum_probs=189.5

Q ss_pred             CccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         151 NILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      +.||+|+||.||+|...    ...+++|.+......        .....+.+|+.+++.++||||+++++.+.+...+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~l   72 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--------DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLL   72 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--------HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEE
Confidence            36999999999999753    235777766532211        123456689999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         227 VYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ||||+++|+|.+++.....  ....++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEecccccccc
Confidence            9999999999999865443  223467788899999999999999999  999999999999999999999999998653


Q ss_pred             CCcccccceeccccccCCCcCcccccC-------CCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ...... .......++..|+|||++..       ..++.++|||||||++|||++ |..||..... ...+........ 
T Consensus       151 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~~~-  227 (269)
T cd05042         151 YPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVVREQD-  227 (269)
T ss_pred             ccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhhccC-
Confidence            222111 11122345678999998743       356889999999999999999 8889876543 222222221110 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                         ..   ......+..++..+.+++..|+ .||++||++++|++.|.
T Consensus       228 ---~~---~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 ---IK---LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---cc---CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence               00   1111223345677788889998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.8e-40  Score=306.89  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=204.1

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+..+.||.|+||.||.+..  ++..+++|.+.......       .....+.+|++++++++|+||+++++++.+.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   73 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-------KERRDALNEIVILSLLQHPNIIAYYNHFMDDNT   73 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-------hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence            588899999999998888776  45679999886543221       233456789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++++|||+++++|.+++.... ...+++..+..++.+++.||.|||+.+  ++||||+|+||+++.++.+||+|||++..
T Consensus        74 ~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          74 LLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             EEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            999999999999999886543 345889999999999999999999998  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......   ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..... ........            
T Consensus       151 ~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~~~------------  214 (256)
T cd08221         151 LGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVKIV------------  214 (256)
T ss_pred             cccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHH------------
Confidence            433221   12334689999999999888889999999999999999999999976543 11111111            


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                      .......+..++.++.+++.+||+.+|.+||++.++++.+
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         215 QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1111122244567899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.8e-40  Score=312.43  Aligned_cols=248  Identities=27%  Similarity=0.407  Sum_probs=195.6

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+  .+..+|+|.+......        .....+.+|++++++++||||+++++++...+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   72 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--------ELQKQIMSELEILYKCDSPYIIGFYGAFFVEN   72 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh--------HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence            3688889999999999999987  4567999988643211        22345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|..+.       .+++..+..++.|++.||+|||+.+  |+|+||||+|||++.++.++|+|||++.
T Consensus        73 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          73 RISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             EEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            999999999999996532       3678888999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH--HHHHHhhchhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL--KSLVEKYSEENMY  380 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l--~~~~~~~~~~~~~  380 (441)
                      .....     ......||..|+|||.+.+..++.++|+||||+++|+|++|..||..........  .......      
T Consensus       144 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  212 (279)
T cd06619         144 QLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI------  212 (279)
T ss_pred             ecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH------
Confidence            53222     1233468999999999999889999999999999999999999996533211110  0111100      


Q ss_pred             hhhccCCCc-hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         381 DLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       381 ~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                        .+..... .....+.++.+++.+||+.+|.+||++.++++.
T Consensus       213 --~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 --VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              0000011 112345678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.7e-40  Score=312.54  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=195.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      .++.|++.+.||+|+||.||+|.+.  +..+|+|.+......          ...+.+|+.++.++ +||||+++++++.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----------~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYYGAFI   73 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            4567899999999999999999884  567899988643211          12445788999888 6999999999987


Q ss_pred             eC------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         220 ET------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       220 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      ..      ..+|++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+||++++++.+
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             ecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCE
Confidence            53      46899999999999999886532 345889999999999999999999998  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK  368 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~  368 (441)
                      +|+|||++.......   .......|+..|+|||++.     +..++.++|+|||||++|||++|..||.......... 
T Consensus       151 ~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-  226 (272)
T cd06637         151 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-  226 (272)
T ss_pred             EEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-
Confidence            999999987532211   1123456899999999986     3357889999999999999999999997544311111 


Q ss_pred             HHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...    .       ..........++..+.+|+.+||..+|.+||++.++++
T Consensus       227 ~~~----~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         227 LIP----R-------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHh----c-------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            100    0       00111112235667899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=323.70  Aligned_cols=242  Identities=21%  Similarity=0.287  Sum_probs=186.4

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC---CCCCeecccceEEeCCeEEEE
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC---RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      ||+|+||+||+|.+.  +..||||++......      ..........|..++...   .||||+.+++++.+.+.+|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            799999999999984  578999998632211      112223344566666655   699999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.....
T Consensus        75 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          75 TDYMSGGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             EcCCCCChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            9999999999988543   34889999999999999999999999  999999999999999999999999998753221


Q ss_pred             ccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN  386 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  386 (441)
                      .   ......+||..|+|||.+.+. .++.++|||||||++|||+||..||...... .......    ...        
T Consensus       150 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-~~~~~i~----~~~--------  213 (330)
T cd05586         150 N---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-QMYRNIA----FGK--------  213 (330)
T ss_pred             C---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-HHHHHHH----cCC--------
Confidence            1   112345799999999998764 4899999999999999999999999765431 1111111    000        


Q ss_pred             CCchhHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q psy5927         387 AQPIELNIAYAFFRIGKQSTKQNPKERP----EMTQVYN  421 (441)
Q Consensus       387 ~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~  421 (441)
                      .......++.++.+++.+||+.||++||    ++.++++
T Consensus       214 ~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         214 VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0000112466788999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0584|consensus

Probab=100.00  E-value=5.3e-41  Score=329.80  Aligned_cols=246  Identities=25%  Similarity=0.398  Sum_probs=202.9

Q ss_pred             cCccccCCceeEEEEEECCeeEEEE--EeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe--EE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVK--KLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK--YC  225 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK--~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~  225 (441)
                      ..+||+|+|-+||+|.+..+.+.|.  -++....     .-.....+.+..|+.+|+.|+||||+++|.++.+...  ..
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~-----~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV-----TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHh-----hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            4789999999999999976654432  1211100     1123445788899999999999999999999987755  77


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCeEEeccCCCccC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGDFGLTQEG  304 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~kl~DFGla~~~  304 (441)
                      +|+|.|..|+|..|+...+.   +.......|++||++||.|||++.+||||||||-+||+|+.+ |.+||||+|||...
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            89999999999999976554   677889999999999999999999999999999999999765 89999999999875


Q ss_pred             CCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhc
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (441)
                      ....+     ..+.|||.|||||.+- ..|+..+||||||+.++||+|+..||.+-....+..+.+.....+..+...-|
T Consensus       197 r~s~a-----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d  270 (632)
T KOG0584|consen  197 RKSHA-----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD  270 (632)
T ss_pred             hcccc-----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence            44332     3367999999999987 58999999999999999999999999887776677777776666665544443


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +           ++.++|.+||.. ..+|||+.|+++
T Consensus       271 P-----------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 P-----------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             H-----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence            3           688999999999 999999999986

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-39  Score=306.26  Aligned_cols=251  Identities=21%  Similarity=0.333  Sum_probs=200.1

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-CC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-TG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~  222 (441)
                      +|++.+.||+|+||.||++.+.  +..+|+|++......       ....+.+.+|++++++++|+|++++++.+.. ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG   73 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC
Confidence            5889999999999999999874  457999998643221       1223445689999999999999999988764 45


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|++|||+++++|.+++.... ...+++.++..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          74 LLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             EEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceE
Confidence            6899999999999999886532 345899999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......|++.|+|||.+.+..++.++|+||||+++++|++|..||....... .......          
T Consensus       151 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~----------  216 (257)
T cd08223         151 VLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIE----------  216 (257)
T ss_pred             EecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh----------
Confidence            542211   12234468999999999999889999999999999999999999997654311 1111111          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                        ......+..++..+.+++.+||+.+|.+||++.++++.
T Consensus       217 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 --GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              11112334567789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-40  Score=309.54  Aligned_cols=247  Identities=23%  Similarity=0.389  Sum_probs=199.6

Q ss_pred             CCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      ++|.+.+.||+|+||.||+|...+..+|+|.+....           ..+.+.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence            568999999999999999999888899999886321           123566899999999999999999988654 57


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~  150 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVG  150 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceec
Confidence            99999999999999986543 335788999999999999999999988  999999999999999999999999998753


Q ss_pred             CCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ...      ......+..|+|||.+.+..++.++|+||||+++|||++ |..||...... ... ....   ..      
T Consensus       151 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~-~~~~---~~------  213 (254)
T cd05083         151 SMG------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVK-ECVE---KG------  213 (254)
T ss_pred             ccc------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHH-HHHh---CC------
Confidence            221      111234567999999988889999999999999999998 99999765431 111 1111   00      


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                        .....+..++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       214 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 --YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              0111123456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.6e-40  Score=308.00  Aligned_cols=255  Identities=23%  Similarity=0.363  Sum_probs=202.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.++||+|+||.||+|.+. +..+|+|.+....          ...+.+.+|+++++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            34578999999999999999999864 4568998876321          123456789999999999999999999877


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       ...+++|||+++++|.+++.... ...+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.+||+|||+
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~  148 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGL  148 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcc
Confidence             78899999999999999986543 345788899999999999999999988  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +........  .......++..|+|||.+.+..++.++|+|||||++|+++| |..||...... .........      
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~------  219 (260)
T cd05073         149 ARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG------  219 (260)
T ss_pred             eeeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHhCC------
Confidence            875432211  11112235677999999988889999999999999999999 99999765431 111111100      


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                            ...+.+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       220 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  0111223456679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.6e-39  Score=310.29  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=196.0

Q ss_pred             CcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |++.+.||.|+||.||+|.+..  ..+++|.+.....         ...+.+.+|+++++.++||||+++++++...+..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---------HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence            6788999999999999999864  4567777753211         2234566899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||+++++|.+++...  ..++++..+..++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||++...
T Consensus        78 ~~v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          78 WILIEFCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccc
Confidence            9999999999998877532  346899999999999999999999999  999999999999999999999999998753


Q ss_pred             CCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ....   .......|+..|+|||++.     +..++.++|+|||||++|||++|.+||.......... ......     
T Consensus       154 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~-----  224 (282)
T cd06643         154 TRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSE-----  224 (282)
T ss_pred             cccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH-HHhhcC-----
Confidence            2211   1123346899999999984     3457889999999999999999999997654322111 111100     


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           ......+..++..+.+++.+||+.+|.+||++.++++
T Consensus       225 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 -----PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0011123345678999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.1e-40  Score=317.44  Aligned_cols=258  Identities=20%  Similarity=0.298  Sum_probs=185.6

Q ss_pred             cCccccCCceeEEEEEECC----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--CCe
Q psy5927         150 LNILGKGGFGTVYKGVWEK----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE--TGK  223 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~  223 (441)
                      ..+||+|+||.||+|....    ..+|+|.+.....           ...+.+|+++++.++||||+++++++..  ...
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------SMSACREIALLRELKHPNVIALQKVFLSHSDRK   74 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence            3689999999999999642    5789998763221           1234589999999999999999998853  567


Q ss_pred             EEEEEEecCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee----cCCCCe
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKK------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL----NHHMDP  293 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl----~~~~~~  293 (441)
                      +++||||+. ++|.+++....      ....+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~  151 (317)
T cd07867          75 VWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRV  151 (317)
T ss_pred             EEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcE
Confidence            899999995 67877764321      1235888999999999999999999999  9999999999999    567899


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhH--------
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--------  364 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--------  364 (441)
                      ||+|||+++................||..|+|||.+.+ ..++.++|||||||++|||+||.+||.......        
T Consensus       152 kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~  231 (317)
T cd07867         152 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH  231 (317)
T ss_pred             EEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccH
Confidence            99999999764332222222334568999999999876 458999999999999999999999996533211        


Q ss_pred             HHHHHHHHhhc---hhhhhh---------h---hccC----------CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         365 RHLKSLVEKYS---EENMYD---------L---VDKN----------AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       365 ~~l~~~~~~~~---~~~~~~---------~---~~~~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                      ..+........   ......         .   ....          ...........+.+|+.+||..||.+|||+.|+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~  311 (317)
T cd07867         232 DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQA  311 (317)
T ss_pred             HHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHH
Confidence            11111111100   000000         0   0000          000001123458899999999999999999999


Q ss_pred             HH
Q psy5927         420 YN  421 (441)
Q Consensus       420 l~  421 (441)
                      ++
T Consensus       312 l~  313 (317)
T cd07867         312 LQ  313 (317)
T ss_pred             hc
Confidence            85

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-40  Score=320.68  Aligned_cols=258  Identities=21%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||.||+|.+.  +..||||++......       ....+.+.+|+++++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-------LIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-------hHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            3578999999999999999999874  457999988642211       1223455689999999999999999998754


Q ss_pred             C------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 T------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      .      ...|++++++ +++|.+++..    ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          86 ATSIENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             cccccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEE
Confidence            3      4578999998 8999887742    34889999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |+|||+++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ...+..+...
T Consensus       159 l~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~  231 (343)
T cd07878         159 ILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEV  231 (343)
T ss_pred             EcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHH
Confidence            9999999764321      223468999999999877 5689999999999999999999999976543 2222222211


Q ss_pred             hc-----------hhhhhhhhccC----CC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YS-----------EENMYDLVDKN----AQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~-----------~~~~~~~~~~~----~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..           .......+...    ..   .........+.+|+.+||..||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10           00000010000    00   000112345789999999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-40  Score=313.34  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=202.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..+|+|++......        .....+.+|+++++.++||||+++++++...
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--------SVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--------hHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            467889999999999999999985  678999987643211        2234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      +.+++||||+++++|.+++..   .+.+++..+..++.+++.||.|||+ .+  ++||||||+||+++.++.++|+|||+
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl  150 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGV  150 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCc
Confidence            999999999999999988754   2358899999999999999999997 57  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH------HHHHHHHhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER------HLKSLVEKY  374 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~------~l~~~~~~~  374 (441)
                      +......     ......|+..|+|||++.+..++.++|+|||||++|+|+||..||........      .+...... 
T Consensus       151 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  224 (284)
T cd06620         151 SGELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-  224 (284)
T ss_pred             ccchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-
Confidence            8643211     12234689999999999888899999999999999999999999976543111      01111111 


Q ss_pred             chhhhhhhhccCCCchh-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIE-LNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                             .+.......+ ..++..+.+|+.+||+.||.+||++.+|++..
T Consensus       225 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         225 -------IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -------HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence                   1111111111 23667899999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-39  Score=308.35  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=198.9

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ...++++.....||+|+||.||+|.+.  +..+|+|.+.....         ...+.+.+|+++++.++|+||+++++++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   74 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHRNIVQYLGSD   74 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---------HHHHHHHHHHHHHHhcCCCCeeeeeeee
Confidence            455677777789999999999999874  45689998764321         1234566899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEec
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGD  297 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~D  297 (441)
                      ..++..++|+||+++++|.+++.........++..+..++.|++.||.|||+.+  |+||||||+||+++. ++.++|+|
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEec
Confidence            999999999999999999998865422211277888899999999999999998  999999999999986 67999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCC--CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK--RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      ||++........   ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||.............     
T Consensus       153 fg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-----  224 (268)
T cd06624         153 FGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-----  224 (268)
T ss_pred             chhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-----
Confidence            999865322111   12233588999999998664  37889999999999999999999997643311111100     


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            .........+..+..++.+++.+||+.+|.+||++.++++
T Consensus       225 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         225 ------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ------hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                  0001122234456778999999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-39  Score=311.23  Aligned_cols=270  Identities=23%  Similarity=0.361  Sum_probs=203.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ++|++.+.||+|+||.||+|.+.      +..+|||.+......        ...+.+.+|+++++.+.||||+++++++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~ei~~l~~l~~~~i~~~~~~~   75 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------QHRSDFEREIEILRTLDHENIVKYKGVC   75 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence            46788899999999999999864      457999998754322        1234567899999999999999999998


Q ss_pred             Ee--CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         219 FE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       219 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ..  ....+++|||+++++|.+++....  ..+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.++|+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~  151 (284)
T cd05038          76 EKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKIS  151 (284)
T ss_pred             ecCCCCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEc
Confidence            77  567899999999999999986433  35889999999999999999999998  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH-hhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE-KYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~-~~~  375 (441)
                      |||++.................++..|+|||.+.+..++.++||||||++++||+||..|+............... ...
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd05038         152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI  231 (284)
T ss_pred             ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence            9999976542222111111223556799999998888999999999999999999999998654321100000000 000


Q ss_pred             hhhhhhhhcc-CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         376 EENMYDLVDK-NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       376 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .......+.. ...+.+..++.++.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0000011111 11122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.5e-40  Score=309.60  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=196.8

Q ss_pred             CccccCCceeEEEEEECC--------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         151 NILGKGGFGTVYKGVWEK--------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +.||+|+||.||+|.+..        ..+|+|.+.....        ......+.+|+++++.++||||+++++++...+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE   72 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC
Confidence            469999999999998743        4588888753221        122345668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-----Ce
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKK----NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-----DP  293 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-----~~  293 (441)
                      ..++||||+++++|.+++....    ....+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++     .+
T Consensus        73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~  150 (269)
T cd05044          73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVV  150 (269)
T ss_pred             CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcce
Confidence            9999999999999999986532    2344788999999999999999999998  99999999999999887     89


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~  372 (441)
                      +|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||+| |..||....... .....  
T Consensus       151 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-~~~~~--  226 (269)
T cd05044         151 KIGDFGLARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-VLQHV--  226 (269)
T ss_pred             EECCccccccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-HHHHH--
Confidence            99999998754322111 11112235678999999998899999999999999999998 999997654311 11111  


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                        ..        ......+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       227 --~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 --TA--------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --hc--------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              00        11112234567789999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.9e-40  Score=318.59  Aligned_cols=272  Identities=19%  Similarity=0.269  Sum_probs=198.2

Q ss_pred             CcCccccC--CceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         149 KLNILGKG--GFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       149 ~~~~LG~G--~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      ++++||+|  +||+||++...  +..||+|++.......       ...+.+.+|+++++.++||||+++++++..++..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~   74 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-------EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL   74 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence            46889999  78999999874  5679999986432211       1233455799999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      |+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++++|||.+...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          75 WVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             EEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            99999999999999885432 234889999999999999999999999  999999999999999999999999865432


Q ss_pred             CCccc----ccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---
Q psy5927         305 PIEKA----THITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---  375 (441)
Q Consensus       305 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---  375 (441)
                      .....    .........++..|+|||++.+  ..++.++|||||||++|||++|..||..................   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence            11100    0001112346788999999976  46899999999999999999999999765432211111110000   


Q ss_pred             ------hhhhhh-----hhc------------------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHh
Q psy5927         376 ------EENMYD-----LVD------------------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLS  424 (441)
Q Consensus       376 ------~~~~~~-----~~~------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~  424 (441)
                            .+....     ..+                  ....+....++..+.+|+.+||+.||++|||+.+|++  .++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                  000000     000                  0001122335668899999999999999999999987  465


Q ss_pred             cCCCCC
Q psy5927         425 GSGGES  430 (441)
Q Consensus       425 ~~~~~~  430 (441)
                      .+....
T Consensus       312 ~~~~~~  317 (327)
T cd08227         312 QIKRRA  317 (327)
T ss_pred             hcchhh
Confidence            554444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6e-40  Score=308.33  Aligned_cols=252  Identities=22%  Similarity=0.433  Sum_probs=199.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..+|++.+.||.|+||.||+|.+. +..+|+|.+......          ...+.+|++++++++||||+++++++....
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            357888899999999999999885 678999987643211          124568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+++++|.+++....  ..+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||+++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCccee
Confidence            9999999999999999885432  35788999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........  ......++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ...+.......      .
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~------~  219 (256)
T cd05112         149 FVLDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGF------R  219 (256)
T ss_pred             ecccCccc--ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCCC------C
Confidence            54322111  1111234568999999998889999999999999999998 9999976443 22222211100      0


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      .      ..+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus       220 ~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         220 L------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            0      111223567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.8e-40  Score=316.96  Aligned_cols=268  Identities=23%  Similarity=0.360  Sum_probs=202.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.++||.|+||.||+|.+.  +..||+|.+.......        ....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--------APCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--------chhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            357999999999999999999885  5679999886433221        122345799999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||++ ++|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcch
Confidence            99999999996 6898888543  335788999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EE  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~  377 (441)
                      ........   ......++..|+|||.+.+ ..++.++|||||||++|||+||.+||..... ...+..+.....   ..
T Consensus       152 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~  227 (301)
T cd07873         152 RAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEE  227 (301)
T ss_pred             hccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChh
Confidence            75332211   1122357889999999866 3578899999999999999999999976543 222222221110   00


Q ss_pred             hhhhhhc---------cC-----CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         378 NMYDLVD---------KN-----AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       378 ~~~~~~~---------~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      ......+         +.     .......++..+.+|+.+||+.||.+|||++++++  .++..+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            0000000         00     00112235667899999999999999999999987  5655553

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-39  Score=313.68  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=199.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .+|++.+.||+|+||.||+|.+.  +..+|+|.+......         ..+.+.+|+.+++.++||||+++++.+..+.
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            57899999999999999999873  568999988643321         1234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+++++|.+++..    ..+++.++..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++.
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccch
Confidence            99999999999999998843    24788999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......... ...   ...     
T Consensus       165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-~~~---~~~-----  232 (296)
T cd06654         165 QITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIA---TNG-----  232 (296)
T ss_pred             hcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-HHh---cCC-----
Confidence            5322111   1123358899999999988888999999999999999999999997654321111 110   000     


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ......+..++..+.+++.+||..+|.+||++.+|++
T Consensus       233 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         233 --TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence              0011123456677899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574|consensus

Probab=100.00  E-value=3e-42  Score=310.62  Aligned_cols=245  Identities=25%  Similarity=0.413  Sum_probs=206.8

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      -|+++.+||+|+||.||+|.++  +..+|+|.+.+..           ..+.+..|+.+|.+|..|++|++||.+.....
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD  102 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD  102 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence            3788899999999999999985  5678999887532           34566799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+|||||..||+.|.+..+  ..+|++..+..+++..++||+|||...  -||||||..||||+.+|+.||+|||.|-.
T Consensus       103 LWIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccch
Confidence            99999999999999988654  456999999999999999999999987  89999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ..   .+.....++.||+.|||||++..-.|..++||||||+...||..|++||.+.+.-.             .++.+.
T Consensus       179 LT---DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------------AIFMIP  242 (502)
T KOG0574|consen  179 LT---DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------------AIFMIP  242 (502)
T ss_pred             hh---hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------------eeEecc
Confidence            32   34445567889999999999999899999999999999999999999998765310             011111


Q ss_pred             cc--CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DK--NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .+  ..-..+...+.++.+++++||-++|++|-++.++++
T Consensus       243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            11  111235667889999999999999999999999876

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=309.19  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=200.7

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||.|+||.||+|.+.  +..+|+|.+......        .....+.+|+++++.++||||+++++++.++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--------DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS   72 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--------hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence            46888999999999999999984  568999988643211        12334568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++|+||+++++|.+++...    .+++..+..++.|++.||.|||+.+  ++||||+|+||++++++.++|+|||+++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          73 KLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             eEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccce
Confidence            999999999999999988543    5889999999999999999999998  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......|+..|+|||.+.+..++.++|+||||+++|+|+||..||...... .........         
T Consensus       147 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~---------  213 (274)
T cd06609         147 QLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIPKN---------  213 (274)
T ss_pred             eecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHHHHhhhc---------
Confidence            654321   1123345888999999999888999999999999999999999999765431 111111100         


Q ss_pred             hccCCCchhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELN-IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .....+.. ++.++.+++.+||..+|++||++.++++
T Consensus       214 ---~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 ---NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               01111112 5677899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=304.32  Aligned_cols=253  Identities=26%  Similarity=0.370  Sum_probs=202.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||.|+||.||+|.+.  ++.+++|.+......         ..+.+.+|++++++++||||+++++++.+.
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   72 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------DFEIIQQEISMLKECRHPNIVAYFGSYLRR   72 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---------hHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence            367999999999999999999974  467999998743221         234566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|++|||+++++|.+++...  ...++...+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~l~~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~  148 (262)
T cd06613          73 DKLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVS  148 (262)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccc
Confidence            9999999999999999988543  245889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCC---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      .......   .......++..|+|||.+.+.   .++.++|+||||+++|||+||..||.................    
T Consensus       149 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~----  221 (262)
T cd06613         149 AQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----  221 (262)
T ss_pred             hhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----
Confidence            7532211   112234588899999999776   789999999999999999999999976553222111111000    


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           ...........+.++.+++.+||..+|.+||++.+|+.
T Consensus       222 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 -----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 01111123456678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-39  Score=313.86  Aligned_cols=274  Identities=23%  Similarity=0.367  Sum_probs=210.2

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|...  +..+|+|.+.......      ....+.+..|+++++.++||||+++++.+.++.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK------RNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch------HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            47889999999999999999984  5789999987542221      123455678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhh
Confidence            999999999999999988643 3356899999999999999999999998  9999999999999999999999999986


Q ss_pred             cCCCcccc--------------------------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCC
Q psy5927         303 EGPIEKAT--------------------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA  356 (441)
Q Consensus       303 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p  356 (441)
                      ........                          ........||..|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence            53221100                          0111234688999999999988899999999999999999999999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH--HHhcC-CCC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE----MTQVYN--MLSGS-GGE  429 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~evl~--~L~~~-~~~  429 (441)
                      |........ +......    .       ...+.....+..+.+++.+||+.||++||+    +.++++  .+++. ...
T Consensus       232 f~~~~~~~~-~~~~~~~----~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         232 FKGSNRDET-FSNILKK----E-------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             CCCCchHHH-HHHHhcC----C-------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            976654222 2111110    0       000111125778999999999999999999    777776  34332 233


Q ss_pred             CCCCCCCCCC
Q psy5927         430 SPNATGPTLP  439 (441)
Q Consensus       430 ~~~~~~p~~~  439 (441)
                      .+..++|..|
T Consensus       300 ~~~~~~~~~~  309 (316)
T cd05574         300 IRHTTPPIIP  309 (316)
T ss_pred             cccCCCCCCC
Confidence            3344555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9e-40  Score=309.21  Aligned_cols=252  Identities=23%  Similarity=0.360  Sum_probs=197.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||+|+||.||+|.+  .+..+|+|.++.....         ....+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---------DFAVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---------HHHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            35788899999999999999987  4578999988643211         123455799999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+++||||+++++|.+++...   ..+++..+..++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceee
Confidence            9999999999999999988543   35889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      .......   .......|+..|+|||.+.   ...++.++|+|||||++|||++|..||..................   
T Consensus       154 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---  227 (267)
T cd06645         154 AQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---  227 (267)
T ss_pred             eEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---
Confidence            6543211   1123346899999999874   446889999999999999999999998654431211111000000   


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            .........++..+.+++.+||+.+|++||++.+|++
T Consensus       228 ------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 ------PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ------CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                  0000011124567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3e-39  Score=309.94  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=197.7

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||.|+||.||+|.+.  +..+++|.+....         ....+.+.+|+++++.++||||+++++++..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---------EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            57999999999999999999985  4678888886431         122445668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+++++|..++....  ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999988775432  35889999999999999999999998  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ......   .......++..|+|||++.+     ..++.++|+|||||++|||++|..||........ ......   . 
T Consensus       159 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~---~-  230 (292)
T cd06644         159 KNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK---S-  230 (292)
T ss_pred             eccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHHHhc---C-
Confidence            532211   11223458889999999853     4568899999999999999999999976543111 111110   0 


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            .......+..++.++.+++.+||+.+|++||++.++++
T Consensus       231 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 ------EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ------CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  00011123345667899999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-39  Score=309.65  Aligned_cols=257  Identities=23%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ++|++...||+|+||.||+|..+       ...+++|.+......        ...+.+.+|++++.+++||||++++++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~   76 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--------NLQSEFRRELDMFRKLSHKNVVRLLGL   76 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--------HHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence            67899999999999999999963       245888877543211        123456789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNT------PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      +.+.+..|+||||+++|+|.+++......      ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~  154 (275)
T cd05046          77 CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR  154 (275)
T ss_pred             ECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCC
Confidence            99989999999999999999998655422      25899999999999999999999999  99999999999999999


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHH
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~  370 (441)
                      .++|+|||++.......  ........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+...
T Consensus       155 ~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~  231 (275)
T cd05046         155 EVKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRL  231 (275)
T ss_pred             cEEEcccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHH
Confidence            99999999986432211  112223346778999999988888999999999999999999 8889965543 2222211


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ..    ...       ....+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       232 ~~----~~~-------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 QA----GKL-------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             Hc----CCc-------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            10    000       011122456689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-39  Score=307.31  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=203.2

Q ss_pred             CCcCcCccccCCceeEEEEEECC---eeEEEEEeeeccchhHH-HhhhHHHHHHHHHHHHHhhc-CCCCCeecccceEEe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK---TTIAVKKLEVHRNDRAV-ETLNQCQREQSLRELKYLNS-CRHDNILPLYGICFE  220 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~---~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~  220 (441)
                      +|++.+.||+|+||.||+|.+..   ..+|+|.+......... ..........+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48888999999999999999854   67999988644322110 00112334556688888865 799999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+  ++||||+|+|||++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999987542 234568899999999999999999996 67  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |++.......    ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..... .........      
T Consensus       159 g~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~------  227 (269)
T cd08528         159 GLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-LSLATKIVE------  227 (269)
T ss_pred             cceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-HHHHHHHhh------
Confidence            9987643322    22345689999999999988899999999999999999999999976543 111111111      


Q ss_pred             hhhhhccCCCch-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         379 MYDLVDKNAQPI-ELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       379 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                            ....+. ...++..+.+++.+||+.||++||++.+|.+.++
T Consensus       228 ------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 ------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  000111 1134567899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-39  Score=309.66  Aligned_cols=238  Identities=20%  Similarity=0.316  Sum_probs=184.3

Q ss_pred             ccccCCceeEEEEEECC--------------------------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc
Q psy5927         152 ILGKGGFGTVYKGVWEK--------------------------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS  205 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~~--------------------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  205 (441)
                      .||+|+||.||+|....                          ..+++|++.....         .....+..|+.+++.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---------~~~~~~~~~~~~~~~   72 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---------DIALAFFETASLMSQ   72 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---------HHHHHHHHHHHHHhc
Confidence            69999999999997421                          2477887753211         123456688999999


Q ss_pred             CCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       206 l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      ++||||+++++++.+....++||||+++|+|.+++...  .+.+++..+..++.|++.||+|||+.+  |+||||||+||
T Consensus        73 l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Ni  148 (274)
T cd05076          73 VSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNI  148 (274)
T ss_pred             CCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccE
Confidence            99999999999999999999999999999999888532  345888999999999999999999998  99999999999


Q ss_pred             eecCCC-------CeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHH-hCCCC
Q psy5927         286 LLNHHM-------DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELA-TGMRA  356 (441)
Q Consensus       286 Ll~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~ell-tG~~p  356 (441)
                      |++..+       .+|++|||++......       ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..|
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  221 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP  221 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            998654       3799999987542211       12247888999998875 56899999999999999995 69999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      |.......  .......             ....+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       222 ~~~~~~~~--~~~~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         222 LKERTPSE--KERFYEK-------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ccccChHH--HHHHHHh-------------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            97654321  1111110             00111123356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-40  Score=331.77  Aligned_cols=258  Identities=20%  Similarity=0.263  Sum_probs=194.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|.+.+.||+|+||.||+|.+.+  ..||||....               ..+.+|+++|++++|||||++++++..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            4579999999999999999999864  5689885421               1234799999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+|||++ .++|.+++...  ...+++..++.|+.|++.||+|||+++  ||||||||+|||++.++.+||+|||++
T Consensus       233 ~~~~lv~e~~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        233 GLTCLVLPKY-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             CEEEEEEEcc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999999999 57898887543  235899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch------hHHHHHHHHHhhc
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR------SERHLKSLVEKYS  375 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~------~~~~l~~~~~~~~  375 (441)
                      +........ .......||..|+|||++.+..++.++|||||||++|||++|..|+.....      ....+..++....
T Consensus       308 ~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~  386 (461)
T PHA03211        308 CFARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ  386 (461)
T ss_pred             eeccccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhc
Confidence            754322111 112345699999999999998999999999999999999998766532211      1112222222110


Q ss_pred             h--hhh--------h-hhhc-------c--CCCchh--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         376 E--ENM--------Y-DLVD-------K--NAQPIE--LNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       376 ~--~~~--------~-~~~~-------~--~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .  ...        . .+..       .  ....+.  .....++.+|+.+||+.||++|||+.|+++.
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        387 VHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0  000        0 0000       0  000011  1234578899999999999999999999873

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-39  Score=306.00  Aligned_cols=239  Identities=20%  Similarity=0.332  Sum_probs=184.8

Q ss_pred             CccccCCceeEEEEEECC--------------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         151 NILGKGGFGTVYKGVWEK--------------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +.||+|+||.||+|....              ..+++|.+.....         .....+..|+.+++.++||||+++++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---------~~~~~~~~~~~~l~~l~hp~iv~~~~   71 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---------DISLAFFETASMMRQVSHKHIVLLYG   71 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---------hHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            468999999999998532              2477777643211         12334568889999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC----
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD----  292 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~----  292 (441)
                      ++.+....++||||+++|+|..++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.    
T Consensus        72 ~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          72 VCVRDVENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             EEecCCCCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCC
Confidence            999999999999999999998877533  345889999999999999999999998  999999999999987764    


Q ss_pred             ---eEEeccCCCccCCCcccccceeccccccCCCcCccccc-CCCCCCccceehHHHHHHHHH-hCCCCCCCcchhHHHH
Q psy5927         293 ---PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-GKRLSTKVDVYGFGIVLFELA-TGMRAYDDTRRSERHL  367 (441)
Q Consensus       293 ---~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlGvvl~ell-tG~~p~~~~~~~~~~l  367 (441)
                         ++++|||++......       ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.......  .
T Consensus       148 ~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~  218 (262)
T cd05077         148 GPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--K  218 (262)
T ss_pred             CceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--H
Confidence               899999998653211       1234788999999886 456899999999999999998 5888886543211  1


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      .....    ..         .........++.+|+.+||+.||.+||++.+|++.|+
T Consensus       219 ~~~~~----~~---------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ERFYE----GQ---------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHh----cC---------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11110    00         0011123457899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.1e-40  Score=308.61  Aligned_cols=239  Identities=23%  Similarity=0.379  Sum_probs=186.6

Q ss_pred             CccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         151 NILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +.||.|+||.||+|.+..         ..+|+|.+....         ....+.+..|+.+++.+.||||+++++++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~   71 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---------RNYSESFFEAASMMSQLSHKHLVLNYGVCVCG   71 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---------HHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence            469999999999998743         236777664211         12234566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC--------e
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD--------P  293 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~--------~  293 (441)
                      ...++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.        +
T Consensus        72 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          72 DESIMVQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             CCcEEEEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceE
Confidence            99999999999999999886443  35889999999999999999999999  999999999999988765        5


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCC-CCCCCcchhHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGM-RAYDDTRRSERHLKSLV  371 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~-~p~~~~~~~~~~l~~~~  371 (441)
                      +++|||++.....       .....++..|+|||.+.+ ..++.++||||||+++|||++|. .||....... .. ...
T Consensus       148 ~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~-~~~  218 (258)
T cd05078         148 KLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KL-QFY  218 (258)
T ss_pred             EecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HH-HHH
Confidence            8999998864321       122457889999999987 45799999999999999999985 5655433211 11 111


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      .             .....+.....++.+|+.+||+.||++||++.++++.|+
T Consensus       219 ~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 E-------------DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             H-------------ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0             011122234467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.4e-39  Score=304.21  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=201.9

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||.||++..  .+..+|+|.+.......       .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-------KEREESRKEVAVLSNMKHPNIVQYQESFEENGN   73 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-------HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence            588899999999999999987  45689999987432211       223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          74 LYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            999999999999999886433 234788999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......   ......|+..|+|||++.+..++.++|+|||||++++|++|..||....... ......            
T Consensus       151 ~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~------------  214 (256)
T cd08218         151 LNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-LVLKII------------  214 (256)
T ss_pred             cCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-HHHHHh------------
Confidence            432211   1123458889999999998889999999999999999999999997654321 111111            


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......+..++.++.+++.+||+.+|.+||++.+|++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         215 RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11112233456778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-39  Score=303.41  Aligned_cols=249  Identities=27%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||.|+||.||+|.+.  +..+++|.+....           ..+.+.+|+++++.++||||+++++++.+.
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   70 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----------DLQEIIKEISILKQCDSPYIVKYYGSYFKN   70 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence            367999999999999999999985  4679999886321           134567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ...|+++||+++++|.+++...  ...+++..+..++.+++.||.|||+.+  ++||||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~l~~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~  146 (256)
T cd06612          71 TDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVS  146 (256)
T ss_pred             CcEEEEEecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccc
Confidence            9999999999999999988543  345899999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........   ......|+..|+|||++.+..++.++||||||+++|+|++|..||.......... ..    ..     
T Consensus       147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~----~~-----  213 (256)
T cd06612         147 GQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MI----PN-----  213 (256)
T ss_pred             hhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hh----cc-----
Confidence            76432211   1223457889999999998889999999999999999999999997654321111 00    00     


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ........+..++..+.+++.+||+.||++||++.+|++
T Consensus       214 -~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 -KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             001111223456678999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-39  Score=310.63  Aligned_cols=246  Identities=23%  Similarity=0.335  Sum_probs=201.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||++.+.  +..+|+|.+.....      ......+.+.+|+++++++.||||+++++++.+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI------VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            47889999999999999999984  57899998863221      11233456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||+++++|.+++...   ..++...+..++.|++.||.|||+.+  ++||||+|+|||++.++.+||+|||++.
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            999999999999999988654   45889999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .....      .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........           
T Consensus       150 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~-----------  211 (290)
T cd05580         150 RVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-IQIYEKIL-----------  211 (290)
T ss_pred             ccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh-----------
Confidence            64332      2334689999999999888889999999999999999999999976542 11111111           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                        ......+..++..+.+++.+||..||.+|+     ++.++++
T Consensus       212 --~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         212 --EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              111123334567889999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0986|consensus

Probab=100.00  E-value=5.1e-41  Score=317.50  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=205.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..+.|...++||+||||.||-+..  .++-||+|++...+....      .-....+.|-.+|.+++.+.||.+--.|.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr------~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR------KGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh------hhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            3456789999999999999998775  456789998865443221      11223468999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      ..+.+|||+..|+||+|.-+|.... .+.+++..+..++.+|+.||++||+.+  ||+||+||+|||||+.|+++|+|.|
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccc
Confidence            9999999999999999987776544 467999999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ||...+.....    ...+||.+|||||++.+..|+...|+|||||+||||+.|+.||....+..          ..+.+
T Consensus       333 LAvei~~g~~~----~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----------k~eEv  398 (591)
T KOG0986|consen  333 LAVEIPEGKPI----RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----------KREEV  398 (591)
T ss_pred             eEEecCCCCcc----ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------hHHHH
Confidence            99886654432    23379999999999999999999999999999999999999997544311          11122


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                      ...+.......+..++++..+|....|.+||.+|.-.
T Consensus       399 drr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  399 DRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            2222223334556788999999999999999999644

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.1e-39  Score=309.28  Aligned_cols=257  Identities=22%  Similarity=0.324  Sum_probs=198.5

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      ..++....+.|++.+.||.|+||.||+|.+.  +..+|+|.+....          .....+..|+.+++++ +||||++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----------~~~~~~~~e~~~l~~~~~h~~i~~   77 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----------DEEEEIKLEINMLKKYSHHRNIAT   77 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----------HHHHHHHHHHHHHHHhcCCCcEEE
Confidence            3344455678999999999999999999984  4678999876421          1223455788888888 6999999


Q ss_pred             ccceEEe------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee
Q psy5927         214 LYGICFE------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL  287 (441)
Q Consensus       214 l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl  287 (441)
                      +++++..      ...+|++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+||++
T Consensus        78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili  154 (282)
T cd06636          78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLL  154 (282)
T ss_pred             EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence            9999853      467899999999999999886533 344788889999999999999999999  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcch
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRR  362 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~  362 (441)
                      +.++.++|+|||++.......   .......|+..|+|||.+.     +..++.++|+|||||++|||++|..||.....
T Consensus       155 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~  231 (282)
T cd06636         155 TENAEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP  231 (282)
T ss_pred             CCCCCEEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence            999999999999987532211   1123346899999999986     34678899999999999999999999976543


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..... ....           ..........++..+.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~~-~~~~-----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         232 MRALF-LIPR-----------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             Hhhhh-hHhh-----------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111 0000           00011112345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.7e-40  Score=312.13  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=198.1

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||.||+|.+.  +..+|+|.+.......       .....+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   73 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLYDVLHSDKK   73 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-------cCccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence            5888899999999999999984  5679999986532211       112345579999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +++|+||++ ++|.+++...  ...+++..+..++.||+.||.|||+.+  |+||||||+||+++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          74 LTLVFEYCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             eEEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            999999996 6888877543  345899999999999999999999999  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hh-
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---EN-  378 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~-  378 (441)
                      ......   ......++..|+|||.+.+. .++.++|||||||++|||+||..|+.........+.........   .. 
T Consensus       149 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07839         149 FGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW  225 (284)
T ss_pred             cCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence            432211   12233578899999998774 47899999999999999999988865443333344333222110   00 


Q ss_pred             --hhhhhccC-------C---CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 --MYDLVDKN-------A---QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 --~~~~~~~~-------~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        .....+..       .   ......++.++.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              00000000       0   0112245678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.2e-39  Score=305.92  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|+..++||.|+||.||+|.+.  +..+|+|.+......        .....+.+|+.+++.+.||||+++++++.+++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT   75 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            35778899999999999999974  568999988643221        22345668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+++|+|.+++..    .++++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~  149 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccce
Confidence            99999999999999998853    34788899999999999999999998  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......++..|+|||.+.+..++.++|+|||||++|||+||..||....... .....    .       
T Consensus       150 ~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~----~-------  214 (277)
T cd06640         150 QLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VLFLI----P-------  214 (277)
T ss_pred             eccCCc---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-Hhhhh----h-------
Confidence            543221   11223457889999999988889999999999999999999999997654311 11100    0       


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                       .......+..++..+.+++.+||+.+|.+||++.+++..
T Consensus       215 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 -KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             011122344577889999999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.4e-39  Score=302.95  Aligned_cols=251  Identities=28%  Similarity=0.456  Sum_probs=200.7

Q ss_pred             CcCcCccccCCceeEEEEEECC------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEK------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      |++.+.||.|+||.||+|.+..      ..+|+|.+......        ...+.+..|+.++..++|+||+++++++.+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--------QQIEEFLREARIMRKLDHPNIVKLLGVCTE   72 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--------HHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            4567899999999999999865      66999998643221        134566789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~  149 (258)
T smart00219       73 EEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGL  149 (258)
T ss_pred             CCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCC
Confidence            9999999999999999998864332 22889999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +...........  ....++..|+|||.+.+..++.++|+||||+++++|++ |.+||..... .........       
T Consensus       150 ~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~-------  219 (258)
T smart00219      150 SRDLYDDDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEYLKK-------  219 (258)
T ss_pred             ceeccccccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhc-------
Confidence            976543311111  11236789999999988889999999999999999998 8899876433 222222111       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                           ......+..++.++.+++.+||..+|.+||++.++++.|
T Consensus       220 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 -----GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 111122333677899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-39  Score=309.29  Aligned_cols=246  Identities=27%  Similarity=0.412  Sum_probs=198.3

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|+..+.||+|+||.||+|.+.  +..+|+|.+......        ...+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--------DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK   76 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--------HHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence            4667789999999999999874  467899987643211        223456689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .|+||||+++++|.+++..    ..+++..+..++.+++.|+.|||+.+  ++|+||+|+||++++++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccccc
Confidence            9999999999999998742    35888999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .....   .......|+..|+|||++.+..++.++|+|||||++|||++|..||....... .....            .
T Consensus       151 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~------------~  214 (277)
T cd06642         151 LTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLFLI------------P  214 (277)
T ss_pred             ccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHhhh------------h
Confidence            43221   11223457889999999999889999999999999999999999997543211 11100            0


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......+..++..+.+++.+||+.+|.+||++.+|++
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            11111223345678899999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.1e-39  Score=310.75  Aligned_cols=248  Identities=20%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .+|++.+.||.|+||.||+|.+  .+..+++|.+......         ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---------KKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---------hHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            4699999999999999999986  4578999988643221         2234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++|+||+++++|.+++..    ..+++.++..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccch
Confidence            99999999999999998743    24889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......... .....         
T Consensus       164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-~~~~~---------  230 (296)
T cd06655         164 QITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN---------  230 (296)
T ss_pred             hcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc---------
Confidence            5332211   1223458899999999998889999999999999999999999997754422111 11100         


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       .......+..++..+.+++.+||..||.+||++.+|+.
T Consensus       231 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 -GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             00111123345677899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-39  Score=304.42  Aligned_cols=259  Identities=22%  Similarity=0.365  Sum_probs=204.0

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||.|+||+||+|..  .+..+++|++.......        ....+.+|+++++.++|+||+++++.+..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD   72 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence            4799999999999999999987  44678999886432211        2345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|.+++........+++..+..++.|++.||.|||+.+  ++||||||+||++++++.++|+|||++.
T Consensus        73 ~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~  150 (267)
T cd06610          73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSA  150 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHH
Confidence            99999999999999999865444456899999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCccccc-ceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         303 EGPIEKATH-ITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       303 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ......... .......|+..|+|||.+... .++.++|+|||||++|||++|..||....... ...........    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----  225 (267)
T cd06610         151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPP----  225 (267)
T ss_pred             HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCC----
Confidence            544332211 112334689999999998776 78999999999999999999999997654422 22221111000    


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ...  .......++..+.+++.+||..||.+||++.+|++
T Consensus       226 -~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 -SLE--TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             -CcC--CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             000  00011256678899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-39  Score=306.15  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=202.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|+..+.||.|+||.||++.+.  +..+|+|.+......        .....+.+|++++++++||||+++++++...+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   72 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--------AIQKQILRELDILHKCNSPYIVGFYGAFYNNG   72 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--------HHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence            46888899999999999999985  567999988754221        23345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      .+++++||+++++|.+++....  ..++...+..++.+++.||+|||+ .+  ++||||||+||+++.++.++|+|||++
T Consensus        73 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          73 DISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             EEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccc
Confidence            9999999999999999886443  568889999999999999999999 88  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      .......     .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.................       
T Consensus       149 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  216 (265)
T cd06605         149 GQLVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-------  216 (265)
T ss_pred             hhhHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-------
Confidence            6532111     1115688999999999998999999999999999999999999976532111111211111       


Q ss_pred             hhccCCCchhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELN-IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ........+.. ++..+.+++.+||..||++||++.+++.
T Consensus       217 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         217 -VNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -hcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             11111112222 6778999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0577|consensus

Probab=100.00  E-value=1.7e-40  Score=322.20  Aligned_cols=246  Identities=26%  Similarity=0.355  Sum_probs=202.8

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|..++.||.|+||-||-|++.  +..||||++........      +.+..++.|++.|.+++|||++.+-|+|.....
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~------EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN------EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH------HHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            4777899999999999999984  46799999986554332      345567899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .||||||| -||-.|.+.-.+  .++.+..+..|+.+.+.||.|||+++  .||||||..||||++.|.+||+|||.|..
T Consensus       101 aWLVMEYC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhh
Confidence            99999999 688888886543  45888899999999999999999999  99999999999999999999999998864


Q ss_pred             CCCcccccceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ..       ...+++|||.|||||+|..   +.|+-++||||||++..||.-.++|+-+.+. .-.+.-+..+.++    
T Consensus       176 ~~-------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-MSALYHIAQNesP----  243 (948)
T KOG0577|consen  176 MA-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQNESP----  243 (948)
T ss_pred             cC-------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-HHHHHHHHhcCCC----
Confidence            22       2356789999999999864   6899999999999999999999999877654 2122222111100    


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             .--..+.+..+.+++..||++-|.+|||..+++.
T Consensus       244 -------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 -------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                   0113467888999999999999999999999875

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-39  Score=301.05  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=197.4

Q ss_pred             CccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR  229 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  229 (441)
                      ++||.|+||.||+|.+. +..+|+|.+......        ...+.+..|+++++++.||||+++++++.+....++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence            47999999999999985 688999988643321        123456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccc
Q psy5927         230 YMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA  309 (441)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~  309 (441)
                      |+++++|.+++...  ...+++..+..++.+++.||+|||+++  ++||||||+|||++.++.++|+|||++........
T Consensus        73 ~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  148 (251)
T cd05041          73 LVPGGSLLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY  148 (251)
T ss_pred             cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence            99999999988543  235788999999999999999999998  99999999999999999999999999875432111


Q ss_pred             ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC
Q psy5927         310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ  388 (441)
Q Consensus       310 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (441)
                       ........++..|+|||.+.+..++.++|+||||+++|||+| |..||.......  .......           ....
T Consensus       149 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~-----------~~~~  214 (251)
T cd05041         149 -TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIES-----------GYRM  214 (251)
T ss_pred             -eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhc-----------CCCC
Confidence             111111234567999999988889999999999999999999 889997654311  1111110           0011


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ..+..++..+.+++.+||..+|++||++.+|++.|+.
T Consensus       215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            1233456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0579|consensus

Probab=100.00  E-value=1.1e-40  Score=325.37  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=204.7

Q ss_pred             CCCcCcCccccCCceeEEEEEECCee--EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +.|+++..||.|+||+||+|..+.+.  .|-|++...         .....+.++-|++||..|.||+||+|++.|...+
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---------seEELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            46888999999999999999987654  355665432         2245667789999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++++|||.||-....+...  ..+|.+.++..++.+++.||.|||+++  |||||||..|||+..+|.++|+|||.+-
T Consensus       103 kLwiliEFC~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccc
Confidence            999999999999998877544  345999999999999999999999999  9999999999999999999999999875


Q ss_pred             cCCCcccccceeccccccCCCcCcccc-----cCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFL-----VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ..   ..+.-...++.||+.|||||+.     ...+|+.++||||||++|.||..+.+|..+...-...++....     
T Consensus       179 Kn---~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS-----  250 (1187)
T KOG0579|consen  179 KN---KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-----  250 (1187)
T ss_pred             cc---hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-----
Confidence            42   2233345667899999999986     4568999999999999999999999998876542222222110     


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            ++...--|...+..+.+++..||..||..||++.++++
T Consensus       251 ------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 ------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                  12222335677888999999999999999999999986

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4e-39  Score=309.81  Aligned_cols=272  Identities=24%  Similarity=0.308  Sum_probs=203.8

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|+||.||+|.+.  ++.||||.+.........    ......+..|+++++.++|+||+++++++.+.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK----DGINFTALREIKLLQELKHPNIIGLLDVFGHKSN   76 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc----chhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence            4788899999999999999984  568999999754332111    1123345589999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+++  |+||||||+||+++.++.++|+|||+++.
T Consensus        77 ~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          77 INLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeee
Confidence            99999999 999999885432  36899999999999999999999999  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---ENM  379 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~  379 (441)
                      ......   ......++..|+|||.+.+ ..++.++|+|||||++|||++|.+||..... ...+.........   ...
T Consensus       152 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         152 FGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-IDQLGKIFEALGTPTEENW  227 (298)
T ss_pred             ccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-HHHHHHHHHHcCCCchhhh
Confidence            433211   1122346788999998865 4578999999999999999999888875543 2222222221100   000


Q ss_pred             h------hhhc------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCCCCC
Q psy5927         380 Y------DLVD------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGSGGES  430 (441)
Q Consensus       380 ~------~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~~  430 (441)
                      .      ....      ..........+..+.+++.+||+.+|++||++.+|++.  +++.....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            0      0000      00011123456789999999999999999999999983  55444333

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-39  Score=303.81  Aligned_cols=237  Identities=22%  Similarity=0.384  Sum_probs=187.0

Q ss_pred             CccccCCceeEEEEEECCee------------EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         151 NILGKGGFGTVYKGVWEKTT------------IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~~------------vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      +.||+|+||.||+|.+..+.            +++|.+.....          ....+.+|+.+++.++||||+++++++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----------DSLAFFETASLMSQLSHKHLVKLYGVC   70 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----------hHHHHHHHHHHHHcCCCcchhheeeEE
Confidence            46999999999999986443            67776653211          134566899999999999999999998


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-------
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-------  291 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-------  291 (441)
                      .. ...++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+++  |+||||||+|||++.++       
T Consensus        71 ~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          71 VR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             ec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCce
Confidence            88 778999999999999998865432  5889999999999999999999998  99999999999999888       


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC--CCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHH
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK--RLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLK  368 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~  368 (441)
                      .+||+|||++.....       .....++..|+|||++.+.  .++.++||||||+++|||++ |..||....... ...
T Consensus       146 ~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~  217 (259)
T cd05037         146 FIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-KER  217 (259)
T ss_pred             eEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-HHH
Confidence            799999999876332       1123467789999999876  78999999999999999999 578886654211 111


Q ss_pred             HHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      .. .           .....+.+  ....+.+++.+||..+|.+||++.+|++.|+
T Consensus       218 ~~-~-----------~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 FY-Q-----------DQHRLPMP--DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HH-h-----------cCCCCCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11 0           00000111  1267899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-39  Score=313.35  Aligned_cols=261  Identities=23%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--Ce----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..++|+..+.||+|+||.||+|.+.  +.    .+|+|.+......        .....+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~~~~l~h~niv~~~~   76 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--------KANVEFMDEALIMASMDHPHLVRLLG   76 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            4567889999999999999999873  22    4688877533211        12234668999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.. ...++++||+++|+|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        77 ~~~~-~~~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          77 VCLS-PTIQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             EEcC-CCceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEc
Confidence            8865 4567999999999999988643  234788999999999999999999998  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+...  ......+... 
T Consensus       152 Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~-  227 (303)
T cd05110         152 DFGLARLLEGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEKG-  227 (303)
T ss_pred             cccccccccCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCC-
Confidence            9999975432211 111222345778999999998889999999999999999998 9999976532  1122222110 


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                                ...+.+..++..+.+++.+||..+|++||++.++++.|+.+..+.
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         228 ----------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence                      011112234567899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.2e-39  Score=302.72  Aligned_cols=252  Identities=21%  Similarity=0.337  Sum_probs=202.1

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--C
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE--T  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~  221 (441)
                      +|++.+.||.|+||.||++.+.  +..+|+|.+......       ....+++..|+++++.++||||+++++++..  +
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN   73 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence            5888999999999999999874  467899988643221       1234566789999999999999999998754  4


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLH-----SREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH-----~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      ...+++|||+++++|.+++.... ....+++..+..++.+++.||.|||     +.+  ++||||||+||+++.++.+||
T Consensus        74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEE
Confidence            56899999999999999986532 2456899999999999999999999     777  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||++........   ......|+..|+|||.+.+..++.++|+||||+++++|++|..||..... ...... +   .
T Consensus       152 ~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~-~---~  223 (265)
T cd08217         152 GDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASK-I---K  223 (265)
T ss_pred             ecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHHH-H---h
Confidence            99999876433221   12234589999999999988899999999999999999999999986542 211111 1   1


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                              .......+..++..+.+++.+||+.+|++||++.+|++.
T Consensus       224 --------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 --------EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    111223445667889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-39  Score=302.49  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+..+.||+|+||.||+|...  +..|++|.+........    .....+.+.+|+++++.++||||+++++++.++..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   76 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT----GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN   76 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc----chHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence            4778899999999999999984  67899998865332111    12234566789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++++|||+++++|.+++...   ..+++..+..++.+++.||+|||+.+  |+|+||+|+||+++.++.+||+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          77 LYIFLELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEEEEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCcccee
Confidence            99999999999999988543   35889999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCC-CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .....    ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||....... .......   .      
T Consensus       152 ~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~---~------  217 (258)
T cd06632         152 VVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGR---S------  217 (258)
T ss_pred             ccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHh---c------
Confidence            43222    123446889999999987766 8999999999999999999999997654211 1111100   0      


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ......+..++..+.+++.+||+.+|.+||++.+++.
T Consensus       218 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 --KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              0111223345678899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=307.98  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=199.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||.|+||.||+|.+.  +..+|+|.+.....         ...+.+..|++++++++||||+++++++...
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE---------EELEDFMVEIDILSECKHPNIVGLYEAYFYE   74 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH---------HHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence            457999999999999999999984  56799998864321         2234566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ...|+||||+++++|.+++....  ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          75 NKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             CeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccc
Confidence            99999999999999999885432  35889999999999999999999999  999999999999999999999999988


Q ss_pred             ccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ........   ......|+..|+|||.+.     +..++.++|+||||+++|||++|..||....... ......    .
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~  222 (280)
T cd06611         151 AKNKSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKIL----K  222 (280)
T ss_pred             hhhccccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHh----c
Confidence            65332211   122345899999999975     3457789999999999999999999997654321 111111    0


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .      .......+..++.++.+++.+||+.+|.+||++.+|++
T Consensus       223 ~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         223 S------EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             C------CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            0      00011123345678899999999999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.6e-39  Score=302.08  Aligned_cols=259  Identities=23%  Similarity=0.373  Sum_probs=202.7

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+..+.||+|+||.||+|..  .+..+|+|.+.........   .....+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSE---QEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchh---HHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence            588889999999999999987  4568999998754322211   11234567799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEeccCCCc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGDFGLTQ  302 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~DFGla~  302 (441)
                      +++||||+++++|.+++...   .++++..+..++.|++.||+|||+++  ++||||||+||+++.++ .++|+|||++.
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            99999999999999988543   35888999999999999999999999  99999999999998876 58999999987


Q ss_pred             cCCCcccc-cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKAT-HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........ ........|+..|+|||.+.+..++.++|+||+|+++++|++|..||....... ....... .       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~-~-------  223 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFK-I-------  223 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHH-H-------
Confidence            64322111 111223458889999999988889999999999999999999999996543211 1111100 0       


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .........+..++.++.+++.+||..+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0001122344567788999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.6e-39  Score=301.44  Aligned_cols=249  Identities=25%  Similarity=0.421  Sum_probs=200.6

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+..+.||+|+||.||++..  .+..+|+|.+......       ......+.+|+++++.++||||+++++.+..++.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA   73 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence            588899999999999999887  4567999998643221       1234566789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEeccCCCc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGDFGLTQ  302 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~DFGla~  302 (441)
                      .++||||+++++|.+++.... ...+++..+..++.+++.||+|||+++  ++||||||+||+++.++ .+||+|||++.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          74 LMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             EEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            999999999999999986543 345889999999999999999999998  99999999999998654 57999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......    .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......           
T Consensus       151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~-----------  214 (256)
T cd08220         151 ILSSKSK----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIM-----------  214 (256)
T ss_pred             ecCCCcc----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-HHHHHH-----------
Confidence            6433221    223458899999999998888999999999999999999999997654321 111111           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       .....+.+..++..+.+++.+||+.+|.+||++.++++
T Consensus       215 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         215 -SGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -hcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             11112233346778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.1e-39  Score=305.87  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=198.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|+..+.||+|+||.||+|.+.  +..+|+|++........       ..+.+.+|+++++.++||||+++++++....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV-------IKKIALREIRMLKQLKHPNLVNLIEVFRRKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc-------ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence            47899999999999999999985  57899998864322111       1234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|..++..   ...+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          74 KLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             EEEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccce
Confidence            99999999998888776532   235899999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch--hhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE--ENM  379 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~  379 (441)
                      .......   ......++..|+|||.+.+ ..++.++|+||||+++|||++|..||.+....+ .+.........  ...
T Consensus       149 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  224 (286)
T cd07847         149 ILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRH  224 (286)
T ss_pred             ecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHH
Confidence            6433221   1223357889999999876 457899999999999999999999997655422 22221111100  000


Q ss_pred             hhhh----------ccCC---C---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLV----------DKNA---Q---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~----------~~~~---~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....          .+..   .   .....++..+.+|+.+||+.+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000          0000   0   011234677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0199|consensus

Probab=100.00  E-value=2.6e-40  Score=326.34  Aligned_cols=249  Identities=26%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             CcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ....++||+|.||.|++|.|+.     -.||||.++......        ....|++|+.+|.+++|||+++|||+..+ 
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--------~mddflrEas~M~~L~H~hliRLyGvVl~-  182 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--------IMDDFLREASHMLKLQHPHLIRLYGVVLD-  182 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--------hHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence            3456899999999999999953     258999998654332        34568899999999999999999999887 


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ....+|||+++.|||.++|.. .....|.....+.++.||+.|++||.+++  +|||||...|+||-....+||+||||.
T Consensus       183 qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  183 QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccce
Confidence            778899999999999999987 45667888999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +................-...|+|||.++...++.++|||+|||+||||+| |..||.+.+... .++            
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-IL~------------  326 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-ILK------------  326 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-HHH------------
Confidence            976554433322222234567999999999999999999999999999999 899998876522 222            


Q ss_pred             hhhc-cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVD-KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       .+| ....+-+..|+++++++++.||..+|.+||++..|.+
T Consensus       327 -~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  327 -NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             -hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence             222 2344567789999999999999999999999999974

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.3e-39  Score=309.50  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=199.0

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPL  214 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  214 (441)
                      ..+....++|++.+.||+|+||.||+|.+.  ++.+|+|.+.....          ....+..|+.+++.+ +||||+++
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~e~~~l~~l~~h~~i~~~   80 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----------IDEEIEAEYNILKALSDHPNVVKF   80 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----------hHHHHHHHHHHHHHHhcCCCeeee
Confidence            344567789999999999999999999884  46799998753211          112345788899998 69999999


Q ss_pred             cceEE-----eCCeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         215 YGICF-----ETGKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       215 ~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      ++++.     .++.+++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+  ++||||||+||+++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~  158 (286)
T cd06638          81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT  158 (286)
T ss_pred             eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC
Confidence            99874     346789999999999999987532 23346888999999999999999999998  99999999999999


Q ss_pred             CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      .++.++|+|||+++......   .......|+..|+|||.+..     ..++.++|||||||++|||++|..||......
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~  235 (286)
T cd06638         159 TEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM  235 (286)
T ss_pred             CCCCEEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence            99999999999987543221   11223458999999998853     45788999999999999999999999765431


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .. +....    ...      ......+..++..+.+|+.+||+.||.+||++.+|++.
T Consensus       236 ~~-~~~~~----~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 RA-LFKIP----RNP------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HH-Hhhcc----ccC------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11 11100    000      00011122345678999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.5e-39  Score=302.73  Aligned_cols=254  Identities=20%  Similarity=0.324  Sum_probs=187.3

Q ss_pred             CccccCCceeEEEEEEC-Ce---eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         151 NILGKGGFGTVYKGVWE-KT---TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      +.||+|+||.||+|... ..   .+++|.+......        ...+.+.+|+.+++.++||||+++++.|.+....|+
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~l   72 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLL   72 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--------HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEE
Confidence            36999999999999753 22   3445554432111        123466789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      ||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.++|+|||++....
T Consensus        73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccC
Confidence            9999999999999865432 334667778899999999999999998  9999999999999999999999999986422


Q ss_pred             CcccccceeccccccCCCcCcccccC-------CCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         306 IEKATHITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       306 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      .... ........|+..|+|||++..       ..++.++|||||||++|||++ |..||..... ..........    
T Consensus       151 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~~~----  224 (268)
T cd05086         151 KEDY-IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKD----  224 (268)
T ss_pred             cchh-hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhh----
Confidence            1111 111223467889999998753       245789999999999999997 5778866543 2222222111    


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      ....+.+   ...+..++..+.+++..|| .+|++||++.+|++.|.
T Consensus       225 ~~~~~~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 QQVKLFK---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cccccCC---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111111   1122235667888999999 67999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9e-39  Score=301.44  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=201.0

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|.+.+.||+|+||.||+|..  .+..+++|.++.....       ......+..|+.+++.++|+||+++++++...+.
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   73 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK   73 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence            588889999999999999987  4568999998754322       1345567799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +++|+||+++++|.+++...   ..+++..+..++.+++.||+|||+.+  |+|+||+|+||++++++.+||+|||++..
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~  148 (264)
T cd06626          74 VYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVK  148 (264)
T ss_pred             EEEEEecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccc
Confidence            99999999999999988543   34788899999999999999999999  99999999999999999999999999876


Q ss_pred             CCCcccccce-eccccccCCCcCcccccCCC---CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         304 GPIEKATHIT-LKRVNGTRPYLPHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       304 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      .......... .....++..|+|||++.+..   ++.++||||||+++|||++|..||...............    .  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~--  222 (264)
T cd06626         149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----G--  222 (264)
T ss_pred             cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----C--
Confidence            4433221111 22346788999999998766   889999999999999999999999765332211111110    0  


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          .....+....++..+.+++.+||+.+|.+||++.+++.
T Consensus       223 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 ----HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                00011112234677889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.8e-39  Score=306.51  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||.|+||.||+|.+  .++.+|+|++.......       .....+.+|+.++++++||||+++++++.++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   73 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-------GIPNQALREIKALQACQHPYVVKLLDVFPHGSG   73 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-------hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence            588899999999999999997  45789999987543211       123456689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +++||||+ +++|.+++....  ..+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        74 ~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          74 FVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             eEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence            99999999 999999885433  55899999999999999999999999  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh---h
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN---M  379 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---~  379 (441)
                      ......  .......|+..|+|||.+.+. .++.++||||||++++||+||.+||..... ...+...........   .
T Consensus       149 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         149 FSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETW  225 (286)
T ss_pred             ccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHH
Confidence            433221  112234589999999998764 468999999999999999999888866543 333333332221100   0


Q ss_pred             h---hh--------hccCC---CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 Y---DL--------VDKNA---QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~---~~--------~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .   .+        .....   .....+.+..+.+++.+||+.+|.+||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   00        00000   0111234678999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0696|consensus

Probab=100.00  E-value=3e-40  Score=308.78  Aligned_cols=246  Identities=23%  Similarity=0.348  Sum_probs=203.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccce
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGI  217 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  217 (441)
                      .+...+|..+.+||+|+||+|.+|..+++  .||||+++....-.+      ...+-...|-++|... +-|.+++++.+
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd------DDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD------DDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec------CcccceehhhhheecCCCCchHHHHHHH
Confidence            35567899999999999999999998776  589999875432111      1122234677777776 57899999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      |...+++|+||||+.||+|.-.+++..   .+.+..+..++.+|+.||-|||++|  ||+||||.+||+||.+|++||+|
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeee
Confidence            999999999999999999988886544   3667889999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+++.......   ++.++|||+.|+|||++..++|+.++|+|||||+||||+.|.+||++.++++ ....+.      
T Consensus       494 FGmcKEni~~~~---TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~aI~------  563 (683)
T KOG0696|consen  494 FGMCKENIFDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQAIM------  563 (683)
T ss_pred             cccccccccCCc---ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH------
Confidence            999987554433   4567899999999999999999999999999999999999999999887633 222221      


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP  414 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  414 (441)
                             ......|..++.+..++.+..|.+.|.+|.
T Consensus       564 -------ehnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 -------EHNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -------HccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence                   223356778888999999999999999995

>KOG0596|consensus

Probab=100.00  E-value=1e-39  Score=315.48  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccce
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGI  217 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  217 (441)
                      +.+....|+++++||+||.+.||++... ++.||+|++.....+       .....-+..|+..|.++ .|.+|++||+|
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-------~qtl~gy~nEI~lL~KLkg~~~IIqL~DY  428 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-------NQTLDGYRNEIALLNKLKGHDKIIQLYDY  428 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-------HHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence            3456678999999999999999999874 567888887643332       23345677999999999 59999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      -..++.+|+||||= ..+|..+|.++.... ..| .+..+..|++.|+.++|.+|  |||.||||+|+|+- .|.+||+|
T Consensus       429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLID  502 (677)
T KOG0596|consen  429 EVTDGYLYMVMECG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLID  502 (677)
T ss_pred             eccCceEEEEeecc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeee
Confidence            99999999999975 689999987655433 334 67889999999999999999  99999999999985 46899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCC-----------CCCCccceehHHHHHHHHHhCCCCCCCcchhHHH
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-----------RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH  366 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~  366 (441)
                      ||+|...... .+......-+||..||+||++...           ++++++||||||||||+|+.|++||.......  
T Consensus       503 FGIA~aI~~D-TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--  579 (677)
T KOG0596|consen  503 FGIANAIQPD-TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--  579 (677)
T ss_pred             echhcccCcc-ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--
Confidence            9999865433 345555667899999999998642           25789999999999999999999997654311  


Q ss_pred             HHHHHHhhchhhhhhhhccC----CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         367 LKSLVEKYSEENMYDLVDKN----AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ..         +..+.++.    ....+..  .++.++++.||+.||++||++.+|++
T Consensus       580 -aK---------l~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -AK---------LHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -HH---------HHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence             11         11122221    1112211  12899999999999999999999986

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-38  Score=304.42  Aligned_cols=257  Identities=27%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC-
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET-  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  221 (441)
                      ++|+..++||.|++|.||+|.+.  ++.+|+|.+......        .....+.+|+++++.++||||+++++++.+. 
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   72 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--------DLQKQILRELEINKSCKSPYIVKYYGAFLDES   72 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence            46888999999999999999984  578999988743221        1234567899999999999999999988653 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         222 -GKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       222 -~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                       +.+|+||||+++++|.+++.... ....++...+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecc
Confidence             47899999999999998775422 3445888999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch---hHHHHHHHHHhhch
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR---SERHLKSLVEKYSE  376 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~---~~~~l~~~~~~~~~  376 (441)
                      ++.......     .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ....+........ 
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  224 (287)
T cd06621         151 VSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-  224 (287)
T ss_pred             ccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-
Confidence            986543221     1233578899999999988999999999999999999999999976532   1111111111100 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ...+.+.  .......+..+.+++.+||..+|.+||++.+|++
T Consensus       225 --~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 --NPELKDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             --chhhccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence              0000000  0111234677899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-38  Score=304.30  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=193.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHH-hhcCCCCCeecccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY-LNSCRHDNILPLYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~  221 (441)
                      ++|++.+.||+|+||.||+|.+.  +..||+|.++.......        ......|+.+ ++..+||||+++++++..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~   72 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--------QKRLLMDLDISMRSVDCPYTVTFYGALFRE   72 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--------HHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence            47899999999999999999985  57899998875322111        1233455554 5667899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +..|++|||++ |+|.+++... .....+++..+..++.|++.||+|||++ +  ++||||||+|||++.++.+||+|||
T Consensus        73 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          73 GDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             CcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999995 7888877542 2335689999999999999999999986 7  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccC----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVG----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +++......    ......|+..|+|||.+.+    ..++.++|+|||||++|||++|..||.........+....... 
T Consensus       150 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  224 (283)
T cd06617         150 ISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-  224 (283)
T ss_pred             ccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-
Confidence            987543211    1122458899999998865    4568899999999999999999999975433222222221110 


Q ss_pred             hhhhhhhhccCCCch-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPI-ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                                 .... ...++.++.+++.+||..+|.+||++.+|++
T Consensus       225 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 -----------SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -----------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       0111 1235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.9e-39  Score=308.75  Aligned_cols=259  Identities=20%  Similarity=0.321  Sum_probs=200.5

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||++.+..  ..|++|.+......      .......+..|+++++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI------LRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            478999999999999999999854  57999988643211      1123446668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||++|++|.+++...   ..+++..+..++.+++.||+|||+.+  ++||||||+||+++.++.++|+|||+++
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            999999999999999998543   35888999999999999999999998  9999999999999999999999999986


Q ss_pred             cCCCcccc------------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         303 EGPIEKAT------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       303 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      ........            ........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+... .......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~~~~~~~  228 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQV  228 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence            42111000            0011124578899999999888899999999999999999999999976533 2212111


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ..    ...   .   .......++..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       229 ~~----~~~---~---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 IS----DDI---E---WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             Hh----ccc---C---CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11    000   0   001112456778999999999999999997666665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-38  Score=302.64  Aligned_cols=262  Identities=21%  Similarity=0.333  Sum_probs=200.5

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHH-HhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAV-ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +|.+.+.||.|+||.||+|..  .+..+|+|.++........ +.......+.+..|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            577889999999999999986  4567999988643221111 0111123456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|.+++...   ..+++..+..++.+++.||.|||+.+  ++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999988543   45888999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCC--CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ...... .........|+..|+|||.+.+..  ++.++|+||||+++||+++|..||.......... ...   ... ..
T Consensus       157 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~---~~~-~~  230 (272)
T cd06629         157 KSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLG---NKR-SA  230 (272)
T ss_pred             cccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH-Hhh---ccc-cC
Confidence            543211 111123345889999999987654  7899999999999999999999996544322111 110   000 00


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..+   .......++..+.+++.+||..+|.+||++.+|++
T Consensus       231 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 PPI---PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000   01122345778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-38  Score=302.83  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=198.0

Q ss_pred             CcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      |.+.+.||+|+||.||+|.+.     +..+|||.+.......       ...+++.+|+++++.++||||+++++++...
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-------SDIEEFLREAACMKEFDHPNVIKLIGVSLRS   73 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-------HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            567889999999999999863     3579999986433211       2345567899999999999999999988653


Q ss_pred             C------eEEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         222 G------KYCLVYRYMPNGSLEDRLLMKK---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       222 ~------~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      .      ..+++++|+.+|+|.+++....   ....+++.....++.|++.||+|||+.+  |+||||||+||+++.++.
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~  151 (273)
T cd05074          74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMT  151 (273)
T ss_pred             CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCC
Confidence            2      3478999999999998875332   2234788899999999999999999998  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~  371 (441)
                      +||+|||+++........ .......++..|++||.+.+..++.++||||||+++|||++ |.+||.......  +...+
T Consensus       152 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~  228 (273)
T cd05074         152 VCVADFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYL  228 (273)
T ss_pred             EEECcccccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHH
Confidence            999999998754322111 11112235678999999988889999999999999999999 899987654311  11111


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ...           .....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~~-----------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKG-----------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcC-----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110           01112234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-39  Score=306.88  Aligned_cols=262  Identities=23%  Similarity=0.376  Sum_probs=197.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|...  ++.||+|.+.......        ....+.+|+++++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--------APFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--------CchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            367999999999999999999974  5789999986432211        112345799999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          76 KTLTLVFEYLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             CeEEEEEecCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccc
Confidence            99999999997 59999886433  35888999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---h
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---E  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~  377 (441)
                      +........   .....++..|+|||.+.+ ..++.++||||||+++|||++|..||.........+.........   +
T Consensus       151 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07844         151 RAKSVPSKT---YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE  227 (291)
T ss_pred             cccCCCCcc---ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence            653221111   112246888999999876 457899999999999999999999997655333333332221110   0


Q ss_pred             hhhhhhc------c-----CCCch---hHHHH--HHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVD------K-----NAQPI---ELNIA--YAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~------~-----~~~~~---~~~~~--~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......      .     .....   ...+.  ..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0000000      0     00000   01122  67789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7e-39  Score=307.63  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=197.0

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|.....||+|+||.||++..  .+..+|||.+....         ....+.+.+|+.+++.++||||+++++.+..++.
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~   93 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE   93 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence            445567899999999999987  45679999886421         1223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+++++|.+++..    ..+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||++..
T Consensus        94 ~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          94 LWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EEEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            9999999999999998742    24788999999999999999999998  99999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......   ......|+..|+|||.+.+..++.++|+||||+++|||++|..||...... ..+..+....         
T Consensus       168 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~---------  234 (292)
T cd06658         168 VSKEVP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRRIRDNL---------  234 (292)
T ss_pred             cccccc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcC---------
Confidence            322211   122345899999999998888999999999999999999999999765431 1111111100         


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      . .........+..+.+++.+||..||.+||++.++++.
T Consensus       235 ~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         235 P-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             C-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0 0111122345678899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.4e-39  Score=302.94  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||.|+||.||+|.+.  +..+|+|.+......      .....+.+.+|++++++++||||+++++++.++..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV------EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc------chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            5888999999999999999985  678999998743211      11234566789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++|+||+.+++|.+++...   .++++..+..++.+++.||.|||+.+  ++|+||+|+||++++++.++|+|||++..
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            99999999999999988543   46889999999999999999999998  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .....    ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......  ....+...         .
T Consensus       150 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~---------~  214 (258)
T cd05578         150 VTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAK---------Q  214 (258)
T ss_pred             cCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHH---------h
Confidence            43321    122345888999999998888999999999999999999999999865431  11111111         1


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM--TQVY  420 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~evl  420 (441)
                      .......+...+..+.+++.+||+.||.+||++  ++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         215 ETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            112223344566889999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4257|consensus

Probab=100.00  E-value=7.8e-40  Score=319.33  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=208.4

Q ss_pred             CcCcCccccCCceeEEEEEECC------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEK------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ....++||+|-||.||+|.+..      -.||||.-+..-.        ....+.|+.|.-+|+.++||||++|+|+|.+
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--------~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--------PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--------hhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            3445789999999999999732      2588887764221        1236778899999999999999999999875


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       ...|+|||.++-|.|..+|+.++  ..++......++.||+.||.|||+..  +|||||...|||+...--+||+||||
T Consensus       463 -~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  463 -QPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             -cceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence             57899999999999999997654  45888888999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +|...+......  ++..-..-|||||.+.-..++.++|||.|||.+||+|. |..||.+....+             -+
T Consensus       538 SR~~ed~~yYka--S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------VI  602 (974)
T KOG4257|consen  538 SRYLEDDAYYKA--SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------VI  602 (974)
T ss_pred             hhhccccchhhc--cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------eE
Confidence            998655443322  22233556999999999999999999999999999988 999998765422             12


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ..+-.....+.|++|+..++.|+.+||+.+|.+||.+.++...|+.+-
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            222334567888999999999999999999999999999988776543

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.3e-39  Score=309.21  Aligned_cols=255  Identities=21%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .+|.+.+.||.|+||.||+|..  .+..||+|.+......         ..+.+.+|+.+++.++||||+++++++..++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            6899999999999999999987  4678999988643221         1234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..|+||||+++++|.+++..    ..+++..+..++.+++.||.|||+.+  ++||||||+|||++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccce
Confidence            99999999999999998843    24788899999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.......... ...   ..      
T Consensus       164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~~---~~------  230 (297)
T cd06656         164 QITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIA---TN------  230 (297)
T ss_pred             EccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-eec---cC------
Confidence            5322211   1123458889999999998889999999999999999999999997643311100 000   00      


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                       .......+..++..+.+++.+||..+|++||++.+|++  .++....
T Consensus       231 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         231 -GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             -CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence             00011123345677899999999999999999999987  5544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=314.17  Aligned_cols=272  Identities=22%  Similarity=0.328  Sum_probs=201.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +++|++.+.||+|+||.||+|.+.  +..||+|.+......        .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--------TFCQRTLREIKILRRFKHENIIGILDIIRPP   75 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--------hhHHHHHHHHHHHHhCCCCCcCchhheeecc
Confidence            478999999999999999999874  568999988632211        1233456899999999999999999987644


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                           ...|+|+||+. ++|.+.+..    ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          76 SFESFNDVYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             cccccceEEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEC
Confidence                 35799999995 688776632    34889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||++.................||..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ......+.....
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~  227 (336)
T cd07849         149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLG  227 (336)
T ss_pred             cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcC
Confidence            99998764332221112233568999999998755 4689999999999999999999999976543 112222211111


Q ss_pred             ---hhhhhhhhc------------cCCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCCCCCC
Q psy5927         376 ---EENMYDLVD------------KNAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGSGGESP  431 (441)
Q Consensus       376 ---~~~~~~~~~------------~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~~~  431 (441)
                         .+......+            ....+   .....+.++.+++.+||+.+|.+||++.++++.  |+.....++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~  303 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD  303 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence               111110000            00111   112346778999999999999999999999984  766665544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=306.23  Aligned_cols=271  Identities=16%  Similarity=0.203  Sum_probs=190.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCe-----eEEEEEeeeccchhHHH--hhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKT-----TIAVKKLEVHRNDRAVE--TLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~vavK~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +..++|.+.++||+|+||+||+|.+.++     .+|+|+..........+  ............+...+..+.|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4457899999999999999999997543     45555543322111111  1111111223345556677899999999


Q ss_pred             cceEEeCC----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         215 YGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       215 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      ++++....    ..+++++++ ..++.+.+...   ...++..+..++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~  162 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence            99766543    346788877 45676655332   23567888999999999999999998  9999999999999999


Q ss_pred             CCeEEeccCCCccCCCcccc----cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHH
Q psy5927         291 MDPVIGDFGLTQEGPIEKAT----HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH  366 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~  366 (441)
                      +.++|+|||+++........    ........||+.|+|||+..+..++.++|||||||++|||++|..||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999754321110    11122346999999999999999999999999999999999999999876432322


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      .......+    ...+...+  .....++..+.+++..|+..+|.+||++.++++.|.
T Consensus       243 ~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDF----IKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHH----HHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            22211111    01111110  012234677999999999999999999999998763

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.5e-39  Score=306.09  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=198.0

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+..+.||.|+||.||+|.+.  +..+|||++.......       .....+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   73 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-------GVPSTAIREISLLKELNHPNIVKLLDVIHTENK   73 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-------ccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence            5888999999999999999884  5679999886432211       122356689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+. ++|.+++.... ...+++..+..++.+++.||+|||+.+  ++||||+|+||+++.++.+||+|||++..
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          74 LYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             EEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            999999995 68988876543 345889999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCC-CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch--hhh-
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE--ENM-  379 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~-  379 (441)
                      ......   ......++..|+|||.+.+.. ++.++||||||+++|||+||..||........ +.........  ... 
T Consensus       150 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  225 (284)
T cd07860         150 FGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVW  225 (284)
T ss_pred             cccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhh
Confidence            432211   112234688999999887644 68899999999999999999999976544222 2222211100  000 


Q ss_pred             -------------hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 -------------YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                                   ..............++.++.+++.+||+.||.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                         000000011112235567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0586|consensus

Probab=100.00  E-value=1.5e-39  Score=319.32  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=208.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      .....|.+...||+|.|++|.+|.+  .++.||+|.+.+...+       ...+..+.+|+++|+.+.|||||+++.+..
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-------~~~~~k~~rev~imk~l~HPnIvkl~~v~~  125 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-------PSKRQKLGREVDIMKSLNHPNIVKLFSVIE  125 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-------hHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence            4457899999999999999999998  4678999998755433       234455779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      ....+|+||||+.+|.++++|.....   +....+..++.|+++|++|||+++  |||||||.+||||+.+.++||+|||
T Consensus       126 t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  126 TEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             ecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccc
Confidence            99999999999999999999976654   445788899999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      ++......    ....+.||++.|.|||++.|.+| ++++|+||+|++||-|+.|..||++..-..  ++       +. 
T Consensus       201 fS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--Lr-------~r-  266 (596)
T KOG0586|consen  201 FSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--LR-------PR-  266 (596)
T ss_pred             cceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--cc-------ch-
Confidence            99875432    34567799999999999999776 679999999999999999999998754211  10       00 


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        .+  ...-.++.-++.++.+|++++|-.+|.+|++++++.+
T Consensus       267 --vl--~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  267 --VL--RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             --he--eeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence              00  1111234456678899999999999999999999865

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=305.10  Aligned_cols=262  Identities=24%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+.  +..||+|+++.....       ....+.+.+|+++++.++|+||+++++++.+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-------EDVKKTALREVKVLRQLRHENIVNLKEAFRRKG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-------ccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence            47899999999999999999985  467999988643221       123456678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||++++.+..+...   ...+++..+..++.+++.||.|||+.+  ++||||+|+||+++.++.+||+|||++.
T Consensus        74 ~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          74 RLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             EEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            99999999988777654432   234889999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh--hh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE--NM  379 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~  379 (441)
                      .......  .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||....... .+......+...  ..
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~  225 (288)
T cd07833         149 ALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSH  225 (288)
T ss_pred             ccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence            6443321  122335688999999999887 78999999999999999999999997654322 222211111000  00


Q ss_pred             h------------hhhccCCC-----chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 Y------------DLVDKNAQ-----PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~------------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .            .+......     ..+..++.++.+|+.+||..+|++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0            00000000     011224678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=299.66  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC-
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET-  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  221 (441)
                      .+|++.+.||+|+||.||+|.+.  +..+|+|.+........    .......+.+|++++++++||||+++++++.+. 
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   77 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE----TSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE   77 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch----hhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence            57899999999999999999974  56799998754221111    112345667899999999999999999988764 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 -GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       +.+++++||+++++|.+++...   ..+++.....++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          78 EKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccc
Confidence             5688999999999999988543   34788899999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++................|+..|+|||.+.+..++.++|+|||||++|||++|..||.+........ ...         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~---------  222 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIA---------  222 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHH---------
Confidence            9764322111112233568999999999998889999999999999999999999997654321111 110         


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ........+..++..+.+++.+||. +|.+||+..+++.
T Consensus       223 --~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 --TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              0011223455677889999999999 4799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-38  Score=307.70  Aligned_cols=281  Identities=23%  Similarity=0.304  Sum_probs=207.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|.++.......       ......+|+.++++++|+||+++++++.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-------IPISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-------CcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            3468999999999999999999984  56899999875432211       11234579999999999999999999875


Q ss_pred             C--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         221 T--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       221 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .  +.+++||||+. ++|.+++....  ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          78 KHLDSIFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             CCCCeEEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcc
Confidence            5  56899999996 58888775432  45899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch-
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE-  376 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-  376 (441)
                      |++........   ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||..... ...+..+...... 
T Consensus       153 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~  228 (309)
T cd07845         153 GLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTP  228 (309)
T ss_pred             ceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCC
Confidence            99876433211   1122235788999999876 4578999999999999999999999976544 2333333222110 


Q ss_pred             -hhhhh---------hhc---cCCCch---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCCCCCCCCC
Q psy5927         377 -ENMYD---------LVD---KNAQPI---ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESPNATGPTL  438 (441)
Q Consensus       377 -~~~~~---------~~~---~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~~~~~p~~  438 (441)
                       .....         ...   .....+   ....+..+.+++.+||+.||++||++.+++.  .+++.+....-...|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~  308 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTF  308 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCC
Confidence             00000         000   000000   1124667889999999999999999999986  55555555444444555


Q ss_pred             C
Q psy5927         439 P  439 (441)
Q Consensus       439 ~  439 (441)
                      |
T Consensus       309 ~  309 (309)
T cd07845         309 P  309 (309)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.5e-39  Score=306.28  Aligned_cols=261  Identities=22%  Similarity=0.377  Sum_probs=198.9

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||+|+||.||+|.+.  +..+|+|++.......       ...+.+.+|+++++.++||||+++++++.+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence            47889999999999999999985  5679999876432211       12344568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+++++|.++...   ...+++..+..++.+++.||.|||+.+  ++||||+|+||++++++.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846          74 RLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             eEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            99999999999988876542   234899999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch--hhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE--ENM  379 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~  379 (441)
                      ......   .......++..|+|||.+.+ ..++.++||||||+++|||++|.+||..... ...+.........  ...
T Consensus       149 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         149 TLAAPG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eccCCc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCCCchhh
Confidence            543221   11233457889999999875 4578899999999999999999999976543 2222222211100  000


Q ss_pred             hhhhc----------cCC------CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVD----------KNA------QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~----------~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....+          ...      ......++..+.+|+.+||+.+|.+||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000          000      0112245678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-38  Score=305.62  Aligned_cols=262  Identities=22%  Similarity=0.332  Sum_probs=197.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +++|.+.+.||+|+||.||+|..  .+..+|+|.+.......        ....+.+|+.+++.++|+||+++++++.++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   75 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--------VPFTAIREASLLKGLKHANIVLLHDIIHTK   75 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--------CcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence            57899999999999999999987  46789999986432211        112345799999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+||||+. ++|.+++...  ...+.+..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          76 ETLTFVFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             CeEEEEEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccc
Confidence            99999999995 7777766433  234778888999999999999999998  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch--hh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE--EN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~  378 (441)
                      +.......   ......++..|+|||.+.+. .++.++|||||||++|||++|..||.........+...+.....  ..
T Consensus       151 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07870         151 RAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED  227 (291)
T ss_pred             cccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence            75322211   11223478899999998763 57889999999999999999999998765544444433322110  00


Q ss_pred             h----hh-------hhccC-CCch-----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 M----YD-------LVDKN-AQPI-----ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~----~~-------~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .    ..       ..... ....     ....+..+.+++.+|+..||++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0    00       00000 0000     0012457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-38  Score=305.00  Aligned_cols=258  Identities=25%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPL  214 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  214 (441)
                      .++...+++|++.+.||+|+||.||+|...  ++.+|+|.+.....          ....+.+|+.++.++ +||||+++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----------VDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----------HHHHHHHHHHHHHHhcCCCCeEEE
Confidence            344456789999999999999999999984  56799998864221          122345788888888 79999999


Q ss_pred             cceEEeC-----CeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         215 YGICFET-----GKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       215 ~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      ++++...     +.+++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+  ++||||||+||+++
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~  162 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc
Confidence            9998753     4689999999999999987532 22345889999999999999999999998  99999999999999


Q ss_pred             CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-----CCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-----RLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      .++.+||+|||++........   ......|+..|+|||.+...     .++.++|||||||++|||++|+.||......
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             CCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            999999999999875432211   11234588999999998643     3688999999999999999999999765431


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      . .+....    ......+      ..+......+.+++.+||+.+|.+||++.++++
T Consensus       240 ~-~~~~~~----~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 K-TLFKIP----RNPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H-HHHHHh----cCCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1 111111    0000000      112234567999999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279|consensus

Probab=100.00  E-value=1e-39  Score=321.59  Aligned_cols=242  Identities=25%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             ccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEE
Q psy5927         152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR  229 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  229 (441)
                      +||+|.||+||-|++..+  .+|||.+......         ..+-...|+.+-+.++|.|||+++|.+.+++.+-+.||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch---------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            699999999999998765  4677777533221         12334579999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEeccCCCccCCC
Q psy5927         230 YMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~DFGla~~~~~  306 (441)
                      -++||||.+.|...-  +++  .+...-.+..||+.||.|||.+.  |||||||-+|||++. .|.+||+|||-++....
T Consensus       653 qVPGGSLSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             cCCCCcHHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            999999999886543  345  67888899999999999999999  999999999999964 68999999998876432


Q ss_pred             cccccceeccccccCCCcCcccccCC--CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh-h
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLVGK--RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL-V  383 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~-~  383 (441)
                         .+..+.++.||..|||||++..+  .|+.++|||||||++.||.||++||.+.....            ..+++. +
T Consensus       729 ---inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------------AAMFkVGm  793 (1226)
T KOG4279|consen  729 ---INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------------AAMFKVGM  793 (1226)
T ss_pred             ---CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------------Hhhhhhcc
Confidence               23345667799999999999653  58999999999999999999999998765422            111111 1


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      =+...++|..++.+...+|.+|+..||.+||++++++.
T Consensus       794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            12345788899999999999999999999999999986

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=301.24  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=198.1

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      .+++|++.+.||.|+||.||+|.+.  +..+++|.+.....          ..+.+.+|+.+++++ .|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----------hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            4689999999999999999999985  45799998864321          223566899999998 6999999999997


Q ss_pred             eCC------eEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         220 ETG------KYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       220 ~~~------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      +..      .+++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCe
Confidence            644      4899999999999999886432 2356889999999999999999999999  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL  367 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l  367 (441)
                      ++|+|||++.......   .......|+..|+|||.+..     ..++.++|||||||++|+|++|..||....... .+
T Consensus       152 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~  227 (275)
T cd06608         152 VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-AL  227 (275)
T ss_pred             EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HH
Confidence            9999999986532211   11223458999999998754     346789999999999999999999997543311 11


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......          ......+..++..+.+|+.+||..||++|||+.+|++
T Consensus       228 ~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 FKIPRNP----------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHhhccC----------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111100          0011122346678999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-38  Score=298.42  Aligned_cols=249  Identities=28%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|++|.||+|.+.  +..+++|++......        .....+..|++++.+++|+||+++++++...+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG   72 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence            47889999999999999999985  567999988754321        22345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      .+++||||+++++|.+++...   ..++...+..++.|++.|++|||+ .+  ++||||+|+||+++.++.++|+|||++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          73 EISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             eEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccc
Confidence            999999999999999998643   458899999999999999999999 99  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch--hHHHHHHHHHhhchhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR--SERHLKSLVEKYSEENM  379 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~--~~~~l~~~~~~~~~~~~  379 (441)
                      .........   .....++..|+|||.+.+..++.++|+||||+++|+|+||..||.....  .........        
T Consensus       148 ~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------  216 (264)
T cd06623         148 KVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--------  216 (264)
T ss_pred             eecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--------
Confidence            754322211   1234578899999999988899999999999999999999999976642  111111111        


Q ss_pred             hhhhccCCCchhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELN-IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          .......+.. ++..+.+++.+||+.+|++||++.++++
T Consensus       217 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         217 ----DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ----cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                1111223334 6778999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.1e-38  Score=300.58  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=198.2

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      -|++.+.||.|+||.||+|.+.  +..+|+|.+......        .....+.+|+.++++++||||+++++++.++..
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   76 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   76 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--------HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe
Confidence            3677899999999999999874  567999987533211        123456689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+++++|.+++..    ..+++..+..++.+++.|+.|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeeccccee
Confidence            9999999999999998842    34889999999999999999999998  99999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .....   .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...... ..... +.           
T Consensus       151 ~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~-~~-----------  214 (277)
T cd06641         151 LTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFL-IP-----------  214 (277)
T ss_pred             cccch---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHH-Hh-----------
Confidence            33211   1122345888999999998888899999999999999999999999764431 11111 10           


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......+..++.++.+++.+||+.+|.+||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         215 KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            01111223345677899999999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-38  Score=306.30  Aligned_cols=247  Identities=21%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             CcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |+....||+|+||.||+|.+  .+..||+|.+.....         ...+.+.+|+.++..++||||+++++++..++..
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---------QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---------chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            44456899999999999987  467899999864321         1223456899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||+++++|.+++..    ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        94 ~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             EEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            999999999999987633    34789999999999999999999999  999999999999999999999999998653


Q ss_pred             CCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhc
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (441)
                      ....   .......|+..|+|||.+.+..++.++|+|||||++|||++|..||...... ..+..+.. ...        
T Consensus       168 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~-~~~--------  234 (297)
T cd06659         168 SKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLRD-SPP--------  234 (297)
T ss_pred             cccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc-cCC--------
Confidence            2221   1122346899999999999888999999999999999999999999765431 12211110 000        


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                       ........++..+.+++.+||+.+|.+||++.+|++.
T Consensus       235 -~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 -PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0001112345678899999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.5e-38  Score=301.78  Aligned_cols=243  Identities=22%  Similarity=0.314  Sum_probs=186.9

Q ss_pred             ccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHH---HHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         152 ILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLREL---KYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      .||+|+||.||++.+.  ++.+|+|.+..........      ......|.   .++...+||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG------ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH------HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            4899999999999974  5689999886433221110      11112333   34445589999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++.....
T Consensus        75 v~e~~~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          75 ILDLMNGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            99999999999988543   35899999999999999999999999  99999999999999999999999999865322


Q ss_pred             cccccceeccccccCCCcCccccc-CCCCCCccceehHHHHHHHHHhCCCCCCCcchhH-HHHHHHHHhhchhhhhhhhc
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLV-GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE-RHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~  384 (441)
                      ..     .....||..|+|||.+. +..++.++|+|||||++|||++|..||....... ..+....            .
T Consensus       150 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------~  212 (279)
T cd05633         150 KK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------L  212 (279)
T ss_pred             cC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------------h
Confidence            11     12235899999999986 4568999999999999999999999997543211 1111110            0


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYNM  422 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~  422 (441)
                      ......+..++.++.+++.+||..||.+||     +++++++.
T Consensus       213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            111223445677899999999999999999     59999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=308.35  Aligned_cols=267  Identities=20%  Similarity=0.284  Sum_probs=196.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +|++.+.||+|+||.||+|.+.    +..||+|.+.......      ....+...+|+.+++.++||||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY------TGISQSACREIALLRELKHENVVSLVEVFLEH   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc------cCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence            4788899999999999999984    4689999987532100      01223456899999999999999999999988


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC----CCCe
Q psy5927         222 --GKYCLVYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH----HMDP  293 (441)
Q Consensus       222 --~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~----~~~~  293 (441)
                        ..+++||||++ ++|.+.+.....  ...++...+..++.|++.||+|||+.+  |+||||||+||+++.    ++.+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          75 ADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             CCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceE
Confidence              88999999996 577776643322  236888999999999999999999999  999999999999999    9999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhH--------
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--------  364 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--------  364 (441)
                      ||+|||++.................++..|+|||.+.+. .++.++|||||||+++||++|.+||.......        
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            999999987643332212223345688999999988764 57899999999999999999999997554321        


Q ss_pred             HHHHHHHHhhchh------------hhhh---hhcc-CC--CchhH------HHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         365 RHLKSLVEKYSEE------------NMYD---LVDK-NA--QPIEL------NIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       365 ~~l~~~~~~~~~~------------~~~~---~~~~-~~--~~~~~------~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                      ..+..++......            ....   .... ..  .....      ..+.++.+++.+||+.||++|||+.+++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            1111111111000            0000   0000 00  00101      3345789999999999999999999997


Q ss_pred             H
Q psy5927         421 N  421 (441)
Q Consensus       421 ~  421 (441)
                      +
T Consensus       312 ~  312 (316)
T cd07842         312 E  312 (316)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.9e-38  Score=300.76  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=192.9

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||+|+||+||++.+.  +..+|+|.+.......      ......+..|+++++.++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK------RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh------hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            699999999999874  5689999886432111      12233456899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT  310 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~  310 (441)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|||++.......  
T Consensus        75 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  149 (277)
T cd05577          75 MNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--  149 (277)
T ss_pred             CCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--
Confidence            999999998865432 45889999999999999999999999  9999999999999999999999999987543211  


Q ss_pred             cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCch
Q psy5927         311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPI  390 (441)
Q Consensus       311 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  390 (441)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...+..         .........
T Consensus       150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~~~~  217 (277)
T cd05577         150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKR---------RTLEMAVEY  217 (277)
T ss_pred             --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHh---------ccccccccC
Confidence              12233578899999999888899999999999999999999999976543110 001110         011111223


Q ss_pred             hHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         391 ELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       391 ~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      +..++..+.+++.+||+.+|.+||     ++.++++
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            334577889999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=301.31  Aligned_cols=246  Identities=23%  Similarity=0.394  Sum_probs=195.3

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---CCCeecccceEEe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---HDNILPLYGICFE  220 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~  220 (441)
                      .|+..+.||.|+||.||+|.+.  +..+|+|.+......        .....+.+|+++++.++   |||++++++++.+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~   73 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--------DDVSDIQREVALLSQLRQSQPPNITKYYGSYLK   73 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--------hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence            5788899999999999999974  567999988643221        12334557888888886   9999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      +...|+||||+++++|.+++..    ..+++..+..++.+++.||.|||+.+  |+||||+|+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06917          74 GPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGV  147 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCc
Confidence            9999999999999999998743    25889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +........   ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... ... .   ...   
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~-~---~~~---  216 (277)
T cd06917         148 AALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-AMM-L---IPK---  216 (277)
T ss_pred             eeecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-hhh-c---ccc---
Confidence            876433221   1223458899999998875 456899999999999999999999997654311 110 0   000   


Q ss_pred             hhhhccCCCchhH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIEL-NIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .....++. .++.++.+++.+||..||++||++.+++.
T Consensus       217 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         217 -----SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -----CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                 00111111 25567899999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-38  Score=325.71  Aligned_cols=275  Identities=19%  Similarity=0.253  Sum_probs=191.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCe---eEEEEEeeeccchh------HHH--hhhHHHHHHHHHHHHHhhcCCCCC
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKT---TIAVKKLEVHRNDR------AVE--TLNQCQREQSLRELKYLNSCRHDN  210 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~---~vavK~~~~~~~~~------~~~--~~~~~~~~~~~~E~~~l~~l~hpn  210 (441)
                      ...++|+++++||+|+||+||++..+..   ..+.|.+.......      ...  ........++.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            3467899999999999999999876432   12222111000000      000  001123345678999999999999


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      |+++++++.+.+..|+|++++ +++|.+++.....  ........+..|+.|++.||+|||+++  ||||||||+|||++
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~  301 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN  301 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence            999999999999999999999 5677777643221  122335667789999999999999999  99999999999999


Q ss_pred             CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCC-CCCCcch-hHHH
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR-AYDDTRR-SERH  366 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~-p~~~~~~-~~~~  366 (441)
                      .++.+||+|||+++.......  .......||..|+|||++.+..++.++|||||||++|||++|.. ||..... ....
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999976432211  11223569999999999999899999999999999999999875 4543321 1233


Q ss_pred             HHHHHHhhc--hh-------hhhhhhccC-----CCchh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         367 LKSLVEKYS--EE-------NMYDLVDKN-----AQPIE-----LNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       367 l~~~~~~~~--~~-------~~~~~~~~~-----~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +...+....  .+       ....+++..     ....+     ..++.++.+++.+||+.||++||++.|+++
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            333322211  00       111111110     00111     123456788899999999999999999986

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-38  Score=298.51  Aligned_cols=251  Identities=25%  Similarity=0.418  Sum_probs=199.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||.|+||.||+|.++  +..+|+|.+......       ....+.+.+|+++++.++|+||+++++.+.+.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~   73 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-------VKEKEASKKEVILLAKMKHPNIVTFFASFQENGR   73 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-------chhhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence            5788899999999999999984  467899988643211       1123455689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC-eEEeccCCCc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFGLTQ  302 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~-~kl~DFGla~  302 (441)
                      .++|+||+++++|.+++.... ...+++..+..++.+++.||.|||+.+  ++|+||||+||++++++. ++|+|||.+.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          74 LFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             EEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccch
Confidence            999999999999999886433 235789999999999999999999998  999999999999998864 6999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ......|+..|+|||.+.+..++.++|+||||++++||++|..||....... .......          
T Consensus       151 ~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----------  216 (257)
T cd08225         151 QLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-LVLKICQ----------  216 (257)
T ss_pred             hccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHhc----------
Confidence            5432211   1123458899999999988889999999999999999999999997553311 1111111          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                        .........++.++.+++.+||..+|++||++.+|++.
T Consensus       217 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 --GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              11112233456689999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4645|consensus

Probab=100.00  E-value=1.2e-40  Score=348.23  Aligned_cols=256  Identities=27%  Similarity=0.366  Sum_probs=206.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+-+|.....||.|.||.||.|...++  ..|+|-++.....  .     .......+|++++..++|||+|++||+-.+
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~-----k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--H-----KTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--c-----ccCcchHHHHHHHHhccCccccccCceeec
Confidence            345788899999999999999998554  5688888765433  1     223455689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..+|.||||.+|+|.+.+...+   -.++.....+..|++.|+.|||++|  ||||||||+||||+.+|.+|++|||.
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccc
Confidence            999999999999999999875332   2556667778899999999999999  99999999999999999999999999


Q ss_pred             CccCCCcc-cccceeccccccCCCcCcccccCC---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         301 TQEGPIEK-ATHITLKRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       301 a~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |....... ..........||+.|||||++.|.   ....+.||||+|||..||+||+.||.+.+..-.           
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----------- 1449 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----------- 1449 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-----------
Confidence            97654332 112234566799999999999873   456789999999999999999999987654211           


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                       -++..--....++|..++.+-.+++.+||..||++|.++.|+++.
T Consensus      1450 -IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 -IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence             122222223445677789999999999999999999999888763

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.9e-38  Score=302.76  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=200.0

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.++||.|++|.||+|.+.  +..+|||.++......        ....+.+|+++++.++||||+++++++.+.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   72 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--------TPSTAIREISLMKELKHENIVRLHDVIHTENK   72 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc--------chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence            5888999999999999999984  5679999987543211        12345579999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||++ ++|.+++........+++..+..++.|++.||+|||+.+  ++||||||+||++++++.++|+|||++..
T Consensus        73 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~  149 (284)
T cd07836          73 LMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARA  149 (284)
T ss_pred             EEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence            999999997 589888866554456899999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EENM  379 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~~  379 (441)
                      ......   ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ............   ...+
T Consensus       150 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         150 FGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN-EDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCChhhH
Confidence            322111   1122347889999998866 3568899999999999999999999976543 222222222110   0000


Q ss_pred             hhhhc-------------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVD-------------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..+.+             .........++..+.+++.+||+.||.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000             0011122345677899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.9e-38  Score=297.12  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||.|+||.||+|.+.  +..+|+|.+.......      ....+.+.+|+++++.++||||+++++++.++...+++|||
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE------TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh------hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            799999999999996  6789999986432111      12334567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT  310 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~  310 (441)
                      +++++|.+++...   ..+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        75 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          75 CLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            9999999988543   34888999999999999999999998  9999999999999999999999999987643322  


Q ss_pred             cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH-HHHHHHHhhchhhhhhhhccCCCc
Q psy5927         311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER-HLKSLVEKYSEENMYDLVDKNAQP  389 (441)
Q Consensus       311 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~  389 (441)
                        ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ .......           ......
T Consensus       148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~  214 (262)
T cd05572         148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK-----------GNGKLE  214 (262)
T ss_pred             --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc-----------cCCCCC
Confidence              12234688999999999888899999999999999999999999976653111 1111110           011222


Q ss_pred             hhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         390 IELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       390 ~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                      .+...+..+.+++.+||+.+|.+||+     +.++++
T Consensus       215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            33344678999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-38  Score=303.75  Aligned_cols=263  Identities=19%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  221 (441)
                      ++|++.+.||+|+||.||+|.+.  +..||+|++.......       .....+.+|+.+++.++ ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~   73 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-------GIPPTALREISLLQMLSESIYIVRLLDVEHVE   73 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-------CCchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence            47899999999999999999984  5689999876432211       12235568999999995 69999999998876


Q ss_pred             Ce-----EEEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCe
Q psy5927         222 GK-----YCLVYRYMPNGSLEDRLLMKKN--TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDP  293 (441)
Q Consensus       222 ~~-----~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~  293 (441)
                      +.     .|+||||+++ +|.+++.....  ...+++..+..++.||+.||+|||+.+  |+||||||+||+++. ++.+
T Consensus        74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~  150 (295)
T cd07837          74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLL  150 (295)
T ss_pred             CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeE
Confidence            65     8999999974 88888765432  346899999999999999999999998  999999999999999 8999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      ||+|||+++.......   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ +..+..
T Consensus       151 kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~  226 (295)
T cd07837         151 KIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFK  226 (295)
T ss_pred             EEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHH
Confidence            9999999875422211   1112246888999998865 4578999999999999999999999976544222 222222


Q ss_pred             hhchhh---hh---hhhc---------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         373 KYSEEN---MY---DLVD---------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       373 ~~~~~~---~~---~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ......   ..   ...+         .........++..+.+++.+||..||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            111000   00   0000         0000111245678999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0983|consensus

Probab=100.00  E-value=1.5e-39  Score=289.85  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=198.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEe
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFE  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  220 (441)
                      .++.+.+..||.|+.|.|++++...  .-.|||.+....        +.+..+++++.+.++.... +|.||+.+|+|..
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            4556667889999999999999865  678999887443        3345667788888877765 9999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +...++.||.| +.-++..+ .+ ...++++..+-.+...+++||.||.. ++  |||||+||+|||+|+.|++|+||||
T Consensus       163 n~dV~IcMelM-s~C~ekLl-kr-ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  163 NTDVFICMELM-STCAEKLL-KR-IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             CchHHHHHHHH-HHHHHHHH-HH-hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccc
Confidence            99999999998 34444444 32 23458888888899999999999987 56  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ++-....+.+.    ++..|.+.|||||.+.-   ..|+.++||||||+.++||.||..||.....+-+.+..+.++.. 
T Consensus       238 IsGrlvdSkAh----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-  312 (391)
T KOG0983|consen  238 ISGRLVDSKAH----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-  312 (391)
T ss_pred             ccceeeccccc----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-
Confidence            99765544432    34469999999999854   47899999999999999999999999987654444444443211 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                               ...+....++..+.+++..||.+|+.+||...++++
T Consensus       313 ---------P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 ---------PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ---------CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                     111222337889999999999999999999998764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.8e-38  Score=300.04  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+++|+..+.||.|+||.||+|.+.  +..+++|.+.....          ..+.+..|+++++.++|+||+++++++..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----------NKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            4567888899999999999999986  67899999874322          23355689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++|+||+++++|.+++....  ..+++..+..++.+++.||.|||+.|  ++|+||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccch
Confidence            999999999999999999987543  36899999999999999999999988  99999999999999999999999998


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +........   ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ...    ...  
T Consensus       163 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-~~~----~~~--  232 (286)
T cd06614         163 AAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LIT----TKG--  232 (286)
T ss_pred             hhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHH----hcC--
Confidence            764332211   1123347889999999998889999999999999999999999997654321111 110    000  


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                          .........++..+.+++.+||+.+|.+||++.+|++  .+..
T Consensus       233 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         233 ----IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             ----CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence                0011112235678999999999999999999999985  4444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.2e-38  Score=302.94  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC-
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET-  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-  221 (441)
                      ++|++.+.||.|+||.||+|.+.  ++.+|+|.++......       .....+.+|+.++.+++||||+++++++... 
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   77 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-------GFPITSLREINILLKLQHPNIVTVKEVVVGSN   77 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-------cchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence            57899999999999999999985  5679999987543221       1223455899999999999999999998877 


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 -GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       +..|+||||+. ++|.+++....  ..+++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||+
T Consensus        78 ~~~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          78 LDKIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             CCcEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCc
Confidence             89999999996 59998886533  35899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---h
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---E  376 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~  376 (441)
                      +.......   .......++..|+|||.+.+. .++.++|+||||+++|||++|.+||...... .....+.....   .
T Consensus       153 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~  228 (293)
T cd07843         153 AREYGSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTE  228 (293)
T ss_pred             eeeccCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCch
Confidence            87643321   112233578899999998764 4689999999999999999999999765432 22222221110   0


Q ss_pred             hhhh---hhh--c------c---C-CCchhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMY---DLV--D------K---N-AQPIELN-IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~---~~~--~------~---~-~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....   .+.  .      .   . ....+.. ++..+.+++.+||+.+|++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000   000  0      0   0 0011111 3677899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.1e-38  Score=301.96  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=196.0

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|++.+.||+|+||.||+|..  .+..||+|.+.......      ......+.+|+++++.++||||+++++++.+.+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            5688899999999999999987  46789999886432111      122345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+.+  |+||||+|+||+++.++.++|+|||++.
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcce
Confidence            9999999996 67777665332  35899999999999999999999998  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      .....       ....|+..|+|||.+.   ...++.++||||||+++|||+||..||....... ......    ..  
T Consensus       164 ~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-~~~~~~----~~--  229 (307)
T cd06607         164 LVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIA----QN--  229 (307)
T ss_pred             ecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-HHHHHh----cC--
Confidence            53221       2235788999999874   3568899999999999999999999997654311 111110    00  


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                           .........++..+.+++.+||+.+|.+||++.+|+..
T Consensus       230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         230 -----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 00111123356789999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=300.77  Aligned_cols=260  Identities=20%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             CcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |++.+.||.|++|.||+|.+  .++.||+|++.......       .....+.+|+++++.++||||+++++++.+++..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-------GVPSTAIREISLLKELNHPNIVRLLDVVHSENKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-------cchhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence            67789999999999999987  46789999987543211       1123456899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      |++|||+ +++|.+++..... ..+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++...
T Consensus        74 ~iv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          74 YLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             EEEEecc-CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            9999999 4799998864432 35899999999999999999999998  999999999999999999999999998754


Q ss_pred             CCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc-hh-h---
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS-EE-N---  378 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-~~-~---  378 (441)
                      ......   .....++..|+|||++.+. .++.++|+||||+++|+|++|.+||........ +........ .. .   
T Consensus       150 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         150 GVPVRT---YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             CCCccc---cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhh
Confidence            322111   1222468899999988664 578899999999999999999999976554222 222222110 00 0   


Q ss_pred             ----hhhh-------hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 ----MYDL-------VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ----~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          ...+       ...........++..+.+++.+||+.+|.+||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0000       001111122345578999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1035|consensus

Probab=100.00  E-value=4e-39  Score=335.40  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=195.0

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ..-..+|+.+..||+||||.||+++.  +++.||||++.....        ......+++|+++|++++|||||++|..+
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s--------~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS--------DKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchH--------HHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            45567899999999999999999987  689999999976431        13445677999999999999999998654


Q ss_pred             E-------------------------------------------------------------------------------
Q psy5927         219 F-------------------------------------------------------------------------------  219 (441)
Q Consensus       219 ~-------------------------------------------------------------------------------  219 (441)
                      .                                                                               
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            3                                                                               


Q ss_pred             ---------------------------------eC-------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q psy5927         220 ---------------------------------ET-------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK  259 (441)
Q Consensus       220 ---------------------------------~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  259 (441)
                                                       +.       ..+||-||||+..+|.+++.......  .....+.+++
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFr  704 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFR  704 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHH
Confidence                                             00       24689999999888888775433211  3567789999


Q ss_pred             HHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC----C-----------cccccceeccccccCCCc
Q psy5927         260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP----I-----------EKATHITLKRVNGTRPYL  324 (441)
Q Consensus       260 ~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~----~-----------~~~~~~~~~~~~gt~~y~  324 (441)
                      +|+.||.|+|+.|  ||||||||.||+||+++.+||+|||+|....    .           ........+...||.-|+
T Consensus       705 eIlEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv  782 (1351)
T KOG1035|consen  705 EILEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV  782 (1351)
T ss_pred             HHHHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence            9999999999999  9999999999999999999999999997611    0           011111345567999999


Q ss_pred             CcccccCC---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHH
Q psy5927         325 PHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRI  401 (441)
Q Consensus       325 aPE~~~~~---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  401 (441)
                      |||++.+.   .|+.|+|+||||||++||+   .||....+....+..+....-+.. ..+.+        .-...-..+
T Consensus       783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~-~~f~~--------~~~~~e~sl  850 (1351)
T KOG1035|consen  783 APELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP-ADFFD--------PEHPEEASL  850 (1351)
T ss_pred             cHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC-ccccc--------ccchHHHHH
Confidence            99999774   4999999999999999999   678776554444443321111111 11111        122234689


Q ss_pred             HHHhcCCCCCCCCCHHHHHH
Q psy5927         402 GKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       402 i~~cl~~dp~~RPs~~evl~  421 (441)
                      |.++|+.||.+|||+.|+++
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhh
Confidence            99999999999999999986

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.2e-38  Score=309.76  Aligned_cols=259  Identities=20%  Similarity=0.295  Sum_probs=196.1

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+  .+..+|+|.+.......       .....+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-------THAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-------hHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            457899999999999999999997  45689999886322111       123345689999999999999999998764


Q ss_pred             C------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 T------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      .      ...|+||||+. ++|.+.+...     ++...+..++.|++.||+|||+.+  |+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEE
Confidence            3      35799999995 6888877422     788889999999999999999998  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||+++......    ......++..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+....
T Consensus       159 L~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~  233 (353)
T cd07850         159 ILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNKIIEQL  233 (353)
T ss_pred             EccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhc
Confidence            99999997643221    12234578999999999998999999999999999999999999976543 22222222111


Q ss_pred             ch--hhh--------hhhhccCC--------------------CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SE--ENM--------YDLVDKNA--------------------QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~--~~~--------~~~~~~~~--------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..  ..+        ....+...                    .......+..+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00  000        00000000                    0001234667899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.7e-38  Score=298.24  Aligned_cols=245  Identities=21%  Similarity=0.273  Sum_probs=187.8

Q ss_pred             ccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEE
Q psy5927         152 ILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYR  229 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e  229 (441)
                      .||+|+||.||+|.+.  +..||+|.+..........   ..........++.++...||||+.+++++.+.+..|+|||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh---HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence            4899999999999874  5689999887533221110   0011111233445566789999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccc
Q psy5927         230 YMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA  309 (441)
Q Consensus       230 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~  309 (441)
                      |++||+|.+++..   ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++|+|||++....... 
T Consensus        78 ~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-  151 (278)
T cd05606          78 LMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (278)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence            9999999988753   345899999999999999999999998  9999999999999999999999999987543221 


Q ss_pred             ccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhH-HHHHHHHHhhchhhhhhhhccCC
Q psy5927         310 THITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSE-RHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       310 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                          .....|+..|+|||.+.++ .++.++||||+||++|||++|..||....... .....            ......
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~  215 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------MTLTMA  215 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH------------HhhccC
Confidence                1234689999999998754 68999999999999999999999997653211 11110            011111


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                      ...+..++..+.+++.+||..+|.+||     ++.++++
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            223334577899999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.7e-38  Score=298.53  Aligned_cols=256  Identities=22%  Similarity=0.297  Sum_probs=192.8

Q ss_pred             CcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeC--
Q psy5927         147 WDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFET--  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--  221 (441)
                      |++.++||+|+||.||+|..  ++..+|+|+++.......        ......|+.++.++. ||||+++++++.+.  
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   72 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--------QVNNLREIQALRRLSPHPNILRLIEVLFDRKT   72 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--------hhhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence            67789999999999999987  457899998864322111        112347888888885 99999999999987  


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+++||||++ |+|.+.+....  ..+++..+..++.|++.||+|||+.+  ++||||||+||+++. +.+||+|||++
T Consensus        73 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~  146 (282)
T cd07831          73 GRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSC  146 (282)
T ss_pred             CcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccc
Confidence            88999999996 68888775432  45899999999999999999999998  999999999999999 99999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc--hhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS--EEN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~  378 (441)
                      +.......    .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+ .+........  ...
T Consensus       147 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~  221 (282)
T cd07831         147 RGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAE  221 (282)
T ss_pred             cccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHH
Confidence            76432211    123457899999997654 557889999999999999999999997654422 2222211110  000


Q ss_pred             hhhhhcc--------------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDK--------------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......              ........++..+.+++.+||+.+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000              001112346788999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.8e-38  Score=302.53  Aligned_cols=265  Identities=22%  Similarity=0.237  Sum_probs=198.5

Q ss_pred             CcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      |.+.+.+|.|+++.||++...++.+|||++.....       .....+.+..|+++++.++||||+++++++.+.+..++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV   76 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEE
Confidence            34556677777888888877888999999875321       11234567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      +|||+++|+|.+++..... ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||.+.....
T Consensus        77 ~~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             EEeccCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecc
Confidence            9999999999998865432 34888899999999999999999999  99999999999999999999999998864322


Q ss_pred             ccc----ccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc----h
Q psy5927         307 EKA----THITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS----E  376 (441)
Q Consensus       307 ~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~----~  376 (441)
                      ...    .........++..|+|||.+.+  ..++.++|+|||||++|||++|..||.........+........    .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            111    1111233457888999999876  35889999999999999999999999876543322222110000    0


Q ss_pred             h-------hhh---------hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 E-------NMY---------DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~-------~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .       ...         .............++.++.+++.+||..||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0       000         00000111223455678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7e-38  Score=300.85  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|.+.+.||.|+||.||+|..  .+..+|+|.+.....         ...+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   89 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKHPNIVNYLDSYLVGD   89 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---------hHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence            6899999999999999999986  456799998753221         12345668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++|+||+++++|.+++...    .+++..+..++.+++.||.|||+.+  ++||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999999988532    3778899999999999999999999  9999999999999999999999999886


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ......|+..|+|||.+.+..++.++|+||||+++|++++|..||........ +....   ...     
T Consensus       164 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~~---~~~-----  231 (293)
T cd06647         164 QITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIA---TNG-----  231 (293)
T ss_pred             ccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeehh---cCC-----
Confidence            5332211   12234588899999999888899999999999999999999999976543111 11000   000     


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                        ......+..++..+.+++.+||..+|.+||++.+++.  .++...
T Consensus       232 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         232 --TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence              0011122345667899999999999999999999986  344444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9.7e-38  Score=298.62  Aligned_cols=247  Identities=22%  Similarity=0.346  Sum_probs=196.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|...+.||+|++|.||+|.+.  +..+++|++.....         ...+.+.+|+.+++.++||||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            4555689999999999999874  46799998753221         123346689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .|+++||+++++|.+++..    ..+++..+..++.+++.||+|||+++  ++||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EEEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchh
Confidence            9999999999999998854    34888999999999999999999999  99999999999999999999999998865


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......   ......|+..|+|||.+.+..++.++|+||||+++|||++|..||...... ..........         
T Consensus       165 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~~---------  231 (285)
T cd06648         165 VSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDNL---------  231 (285)
T ss_pred             hccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhcC---------
Confidence            322111   122345899999999998888999999999999999999999999765431 1111111100         


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ......+..++..+.+++.+||+.+|++||++.++++
T Consensus       232 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 -PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             0011111235668999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.4e-38  Score=301.90  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=193.0

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  221 (441)
                      ++|+..+.||+|+||.||++.+.  +..+|+|.+......        .....+..|+.++.++. ||||+++++++...
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            45677789999999999999984  567999988643221        12345668999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLM--KKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      +..+++|||+. ++|.+....  ......+++..+..++.+++.||+|||+ .+  ++||||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeec
Confidence            99999999985 566554321  1223568999999999999999999997 47  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |+++.......    .....|+..|+|||.+.+.   .++.++|||||||++|||++|..||.........+....   .
T Consensus       153 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~  225 (288)
T cd06616         153 GISGQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV---K  225 (288)
T ss_pred             chhHHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc---C
Confidence            99875332211    1223588999999999775   689999999999999999999999976542111111110   0


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       .....    ........++.++.+|+.+||+.+|.+||++.+|++
T Consensus       226 -~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         226 -GDPPI----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             -CCCCc----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00000    011112346778999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-37  Score=292.26  Aligned_cols=252  Identities=24%  Similarity=0.384  Sum_probs=204.7

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC--
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET--  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  221 (441)
                      +|.+.+.||+|++|.||+|...  ++.+++|.+......       ....+.+.+|++++++++||||+++++.+.+.  
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-------EEELEALEREIRILSSLQHPNIVRYYGSERDEEK   73 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence            4788899999999999999986  678999998754322       23345667899999999999999999999988  


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..+++++||+++++|.+++....   .+++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||.+
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          74 NTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             CeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccE
Confidence            88999999999999999886543   6899999999999999999999988  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ......... .......++..|+|||.+.+...+.++|+||||+++++|++|..||..............    .     
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~-----  218 (260)
T cd06606         149 KRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG----S-----  218 (260)
T ss_pred             Eeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc----c-----
Confidence            764433211 012234588899999999888899999999999999999999999987652111111110    0     


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        .......+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       219 --~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 --SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              01122344455788999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-37  Score=292.15  Aligned_cols=251  Identities=27%  Similarity=0.441  Sum_probs=205.2

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||.|+||.||++.+.  +..+++|++......       ......+..|+++++.++|||++++++.+...+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~   73 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-------EKEREDALNEVKILKKLNHPNIIKYYESFEEKGK   73 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence            5888899999999999999986  678999998754322       1234456689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .++|+||+++++|.+++.... ....+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~  151 (258)
T cd08215          74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISK  151 (258)
T ss_pred             EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCcccee
Confidence            999999999999999886542 2356899999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||..... .......            
T Consensus       152 ~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~------------  215 (258)
T cd08215         152 VLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKI------------  215 (258)
T ss_pred             ecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HHHHHHH------------
Confidence            643322   122334688999999999888899999999999999999999999976542 1111111            


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ........+..++..+.+++.+||..+|.+||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111122333456778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.3e-38  Score=292.99  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.++||+|+||.||++.+.  +..+++|.+......       ......+.+|+++++.++|+||+++++++.+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-------QKEREDAVNEIRILASVNHPNIISYKEAFLDGNK   73 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence            5888999999999999999874  457999988643221       1233455689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .++||||+++++|.+++..... ...+++..+..++.+++.||+|||+.+  ++||||+|+||+++.++.+||+|||++.
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~  151 (256)
T cd08530          74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISK  151 (256)
T ss_pred             EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchh
Confidence            9999999999999998865322 345889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .....     ......++..|+|||.+.+..++.++|+||||+++|||++|..||..... .......            
T Consensus       152 ~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~------------  213 (256)
T cd08530         152 VLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKV------------  213 (256)
T ss_pred             hhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH------------
Confidence            64332     11223578899999999998899999999999999999999999976543 1111111            


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ........+..++.++.+++.+||+.+|++||++.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111122334467788999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.3e-38  Score=301.01  Aligned_cols=254  Identities=22%  Similarity=0.324  Sum_probs=194.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.++  +..+|||.++.....        .....+..|+.++... .||||+++++++
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--------EENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--------HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            44578999999999999999999996  778999998743221        1223445677766666 499999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      .+....|++|||+ +++|.+.+....  ..+++..+..++.+++.||+|||+ .+  |+||||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~v~e~~-~~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          84 ITDSDVFICMELM-STCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             ecCCeEEEEeecc-CcCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECc
Confidence            9999999999998 467777664322  368999999999999999999997 57  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCC----CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR----LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||++........    .....++..|+|||.+.+..    ++.++||||||+++|||++|..||.........+......
T Consensus       159 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  234 (296)
T cd06618         159 FGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE  234 (296)
T ss_pred             cccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence            999865322211    12234788999999987653    7889999999999999999999997643322222222111


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .          ....+....++.++.+|+.+||+.||.+||++.++++.
T Consensus       235 ~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         235 E----------PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C----------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0          00011111356789999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-37  Score=289.62  Aligned_cols=248  Identities=29%  Similarity=0.476  Sum_probs=201.0

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|+..+.||+|+||.||++.+.  +..+++|++.....         .....+.+|+++++.++||||+++++++.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            4788899999999999999985  67799999875332         123456689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++++||+++++|.+++....  ..+++..+..++.+++.||.|||+.+  ++||||+|+||+++.++.++|+|||++..
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccc
Confidence            999999999999999886542  45899999999999999999999988  99999999999999999999999999876


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      ......    .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...          .
T Consensus       148 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~----------~  212 (253)
T cd05122         148 LSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IAT----------N  212 (253)
T ss_pred             cccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHh----------c
Confidence            443221    2334688999999999988889999999999999999999999976533111111 100          0


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..........++..+.+++.+||+.||++||++.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            01111112223677999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.1e-38  Score=300.05  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=196.3

Q ss_pred             CCcCcCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      +|++.+.||.|+||.||++..     ++..||+|.+.......     .....+.+..|++++.++ +|+||+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-----cchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence            578889999999999999986     45779999986422111     112234556899999999 5999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+...|+||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCc
Confidence            999999999999999999998643   34788899999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCC--CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK--RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ++........  .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||....... ....+..     
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~-----  222 (290)
T cd05613         151 LSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISR-----  222 (290)
T ss_pred             cceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHH-----
Confidence            9876432211  112235689999999998753  46789999999999999999999996432211 1111111     


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                          .+.....+.+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 ----RILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----HhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                111112223344667889999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-37  Score=305.47  Aligned_cols=271  Identities=24%  Similarity=0.342  Sum_probs=200.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..+|+|++.......       .....+.+|+.+++++ +||||+++++++.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-------TDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-------hhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            4578999999999999999999984  5679999885321111       1223455899999999 9999999999886


Q ss_pred             eC--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         220 ET--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       220 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      ..  ..+|+||||++ ++|.+++...    .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          78 AENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             cCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEee
Confidence            43  46899999996 6998877432    5788999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCcccc--cceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         298 FGLTQEGPIEKAT--HITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       298 FGla~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      ||++.........  ........||..|+|||.+.+ ..++.++|+||||+++|+|+||+.||....... ....+....
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~  229 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVI  229 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHh
Confidence            9998754332211  112334568999999998765 457899999999999999999999997654322 222211111


Q ss_pred             c---h--------hhhhhhhc---c----CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCCC
Q psy5927         375 S---E--------ENMYDLVD---K----NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGSGG  428 (441)
Q Consensus       375 ~---~--------~~~~~~~~---~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~  428 (441)
                      .   .        .....+++   .    ........++.++.+++.+||+.||.+||++.++++.  ++....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence            0   0        00000111   0    0111112356789999999999999999999999863  544433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=345.58  Aligned_cols=263  Identities=23%  Similarity=0.397  Sum_probs=201.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ...|...+.||+|+||.||+|.+  .+..||||++......             ...|++++++++|||||+++++|.+.
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------------PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------------cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            35677788999999999999997  4678999988632110             11457889999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      +..|+|||||++|+|.+++.      .++|..+..|+.|++.||+|||.. .++|+||||||+||+++.++.+++. ||.
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            99999999999999999884      288999999999999999999943 2339999999999999999988875 665


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH-hhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE-KYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~-~~~~~~~  379 (441)
                      +......       ....||..|||||++.+..++.++|||||||++|||+||+.||+........+..... .+.....
T Consensus       829 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  901 (968)
T PLN00113        829 PGLLCTD-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL  901 (968)
T ss_pred             ccccccC-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch
Confidence            5432111       1225789999999999989999999999999999999999999643321112222111 1111122


Q ss_pred             hhhhccCC---CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q psy5927         380 YDLVDKNA---QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNA  433 (441)
Q Consensus       380 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~  433 (441)
                      ...+++..   ...+.....++.+++.+||+.||++||+|.+|++.|+++....+.+
T Consensus       902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~  958 (968)
T PLN00113        902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSC  958 (968)
T ss_pred             hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccccc
Confidence            22333221   1233455667899999999999999999999999999887755533

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8e-38  Score=294.61  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=195.9

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||.|+||.||++.+.  +..+++|.+......      .....+.+.+|++++++++||||+++++.+..+...|++|||
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI------RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhh------hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            689999999999985  678999988643221      123345667899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT  310 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~  310 (441)
                      +++++|.+++....   .+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++.........
T Consensus        75 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          75 LPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            99999999886433   5889999999999999999999998  999999999999999999999999998754332111


Q ss_pred             -----cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         311 -----HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       311 -----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                           ........++..|+|||...+..++.++|+||||+++|+|++|..||....... .......             
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~-------------  215 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-IFQNILN-------------  215 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhc-------------
Confidence                 112233457889999999988888999999999999999999999997654321 1111110             


Q ss_pred             CCCchhHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         386 NAQPIELN--IAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       386 ~~~~~~~~--~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      .....+..  .+..+.+++.+||+.+|++||++..+.+.|+
T Consensus       216 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         216 GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            00111112  3678899999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.4e-38  Score=300.14  Aligned_cols=262  Identities=21%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||.||+|.+.  ++.+|+|.+.......       .....+.+|++++++++||||+++++++.+..
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-------cchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence            57899999999999999999975  5679999876432211       12234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~DFGla  301 (441)
                      .+|+||||++ ++|.+.+.... ...+++..+..++.+|+.||+|||+++  ++||||+|+||+++. ++.+||+|||++
T Consensus        75 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         75 RLYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             eEEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccc
Confidence            9999999995 68888775433 234677888899999999999999998  999999999999985 557899999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch--hh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE--EN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~  378 (441)
                      .......   .......++..|+|||.+.+ ..++.++|||||||++|+|+||.+||....... .+......+..  +.
T Consensus       151 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~  226 (294)
T PLN00009        151 RAFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEE  226 (294)
T ss_pred             cccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChh
Confidence            7532211   11123357889999999876 357899999999999999999999997654422 22222211110  00


Q ss_pred             h-------hhhhc-------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 M-------YDLVD-------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~-------~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .       ..+..       .........++.++.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0       00000       0000111234667899999999999999999999986

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.7e-37  Score=300.06  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=197.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|+..+.||+|+||.||+|.+.  +..+|+|.+.......      ......+..|+++++.++|||++++++++.++..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc------hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            3778899999999999999974  5679999886432211      1223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+. |+|.+.+...  ..++++..+..++.+++.||.|||+.+  |+||||+|+||+++.++.++|+|||++..
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccc
Confidence            999999996 5887776533  345899999999999999999999999  99999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ...       .....|+..|+|||.+.   ++.++.++|+|||||++|||++|..||........ .......       
T Consensus       175 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~-------  239 (317)
T cd06635         175 ASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN-------  239 (317)
T ss_pred             cCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhc-------
Confidence            322       12335888999999974   45688999999999999999999999976543211 1111110       


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                          .........++..+.+++.+||+.+|.+||++.+|++.+-...
T Consensus       240 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         240 ----ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ----cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                0011112345667899999999999999999999998654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.8e-38  Score=299.46  Aligned_cols=259  Identities=22%  Similarity=0.286  Sum_probs=199.8

Q ss_pred             CCcCcCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      +|++.+.||+|+||.||++..     +++.+|||.++......     .....+.+..|++++.++ +||||+++++.+.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-----KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh-----hhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence            478889999999999999875     34679999986422111     112344566899999999 5999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+...|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||||.||+++.++.++|+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECc
Confidence            999999999999999999988543   34788899999999999999999988  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCC--CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      +++.......  .......|+..|+|||.+.+..  .+.++|+||||+++|||++|..||....... ....+....   
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~---  224 (288)
T cd05583         151 LSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRI---  224 (288)
T ss_pred             cccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHH---
Confidence            9876432211  1122345889999999987754  7889999999999999999999996432211 111111110   


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                            .....+.+..++..+.+++.+||+.||++||++.++.+.|+..
T Consensus       225 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         225 ------LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ------HccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                  0111223344567889999999999999999998887766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-37  Score=293.64  Aligned_cols=247  Identities=22%  Similarity=0.267  Sum_probs=192.1

Q ss_pred             HHHHhhCCCcCcCcc--ccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc-CCCCCeec
Q psy5927         139 ELTLATNNWDKLNIL--GKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-CRHDNILP  213 (441)
Q Consensus       139 ~~~~~~~~~~~~~~L--G~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~  213 (441)
                      +.....++|++.+.+  |.|+||.||++...  +..+|+|.+.......              .|+..... .+||||++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------------~e~~~~~~~~~h~~iv~   73 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------------IEPMVHQLMKDNPNFIK   73 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------------hhHHHHHHhhcCCCEEE
Confidence            344456788888877  99999999999874  4678888876432110              11211211 26999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-C
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-D  292 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~  292 (441)
                      +++++...+.+|+||||+++++|.+++....   .+++..+..++.|++.||.|||+.+  ++||||||+||+++.++ .
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             EEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCe
Confidence            9999999999999999999999999885432   6899999999999999999999999  99999999999999998 9


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      ++|+|||+++.....       ....|+..|+|||++.+..++.++|+||||+++|||++|..||............+..
T Consensus       149 ~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  221 (267)
T PHA03390        149 IYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK  221 (267)
T ss_pred             EEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence            999999998753221       1235889999999999888999999999999999999999999754332211111111


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-MTQVYN  421 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~  421 (441)
                      ..          .........++..+.+++.+||+.+|.+||+ ++++++
T Consensus       222 ~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 RQ----------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hh----------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            11          1111223356778999999999999999995 688874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=294.58  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=196.4

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC---CCCCeecccceEEeC
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC---RHDNILPLYGICFET  221 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~  221 (441)
                      |++.+.||+|+||.||+|.++  +..+|+|+++.......       ....+.+|+.+++++   .||||+++++++.+.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   73 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-------IPLSTLREIALLKQLESFEHPNIVRLLDVCHGP   73 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-------hhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence            677899999999999999985  57899999875433211       122334566666555   699999999999887


Q ss_pred             Ce-----EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 GK-----YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 ~~-----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      +.     .+++|||+. ++|.+++..... ..+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.+||+
T Consensus        74 ~~~~~~~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          74 RTDRELKLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             cCCCCceeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEe
Confidence            76     999999996 589888754332 35899999999999999999999998  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||++........    .....++..|+|||.+.+..++.++|+|||||++|||++|.+||..... .+.+..+......
T Consensus       150 dfg~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~  224 (287)
T cd07838         150 DFGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGL  224 (287)
T ss_pred             ccCcceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCC
Confidence            9999876432211    1233478899999999988899999999999999999999999986554 3333333332211


Q ss_pred             hhhh--------------hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMY--------------DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....              ..............+..+.+++.+||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000              00000111122345678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-37  Score=299.55  Aligned_cols=265  Identities=24%  Similarity=0.323  Sum_probs=198.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  ++.||+|.++......       .....+.+|+++++.++||||+++++++.
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-------GFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-------CchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            45678999999999999999999984  5679999987543211       11224457999999999999999999987


Q ss_pred             eCC----------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC
Q psy5927         220 ETG----------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH  289 (441)
Q Consensus       220 ~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~  289 (441)
                      +..          .+|+|+||+++ +|.+.+...  ...+++..+..++.|++.||+|||+.+  |+||||||+||++++
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~  151 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNN  151 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence            654          78999999975 777766533  345899999999999999999999998  999999999999999


Q ss_pred             CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHH
Q psy5927         290 HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK  368 (441)
Q Consensus       290 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~  368 (441)
                      ++.+||+|||++........  .......++..|+|||.+.+ ..++.++|||||||+++||++|++||..... ...+.
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~  228 (302)
T cd07864         152 KGQIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLE  228 (302)
T ss_pred             CCcEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Confidence            99999999999876433221  11122346788999998865 3578899999999999999999999976543 23333


Q ss_pred             HHHHhhchh---hhhhh--------hcc------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         369 SLVEKYSEE---NMYDL--------VDK------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       369 ~~~~~~~~~---~~~~~--------~~~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .+.......   .....        .+.      ........++..+.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            332221110   00000        000      000111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=289.87  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=202.8

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|++.+.||+|++|.||+|.+.  +..+++|.+......       ....+.+.+|++++++++|||++++++++.+.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS   73 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence            5788999999999999999874  467999998754321       1234567799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .+++|||+++++|.+++...   ..+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||++..
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  148 (254)
T cd06627          74 LYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATK  148 (254)
T ss_pred             EEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEecccccee
Confidence            99999999999999988543   45899999999999999999999998  99999999999999999999999999976


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  383 (441)
                      .......   .....++..|+|||...+..++.++|+||||+++|+|++|..||........... ..            
T Consensus       149 ~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~------------  212 (254)
T cd06627         149 LNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IV------------  212 (254)
T ss_pred             cCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-Hh------------
Confidence            4432221   2334588899999999887889999999999999999999999976543211111 10            


Q ss_pred             ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......+..++..+.+++.+||..+|++||++.+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11122233455678999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0666|consensus

Probab=100.00  E-value=1e-38  Score=289.05  Aligned_cols=270  Identities=21%  Similarity=0.313  Sum_probs=203.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ....|+.+..||+|+||.||+|...+      ..+|+|+++..++..++   .    ....+|+.+++.++|||++.|..
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi---S----~SAcREiaL~REl~h~nvi~Lv~   94 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI---S----MSACREIALLRELKHPNVISLVK   94 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc---C----HHHHHHHHHHHHhcCCcchhHHH
Confidence            44679999999999999999997532      26899999866543332   1    13348999999999999999999


Q ss_pred             eEEe-CCeEEEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---
Q psy5927         217 ICFE-TGKYCLVYRYMPNGSLEDRLLMKK--NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---  290 (441)
Q Consensus       217 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---  290 (441)
                      +|.. +..+++++||.+ .+|...+..++  ....++...+.+|+.||+.|+.|||++-  |+||||||+|||+..+   
T Consensus        95 Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgpe  171 (438)
T KOG0666|consen   95 VFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPE  171 (438)
T ss_pred             HHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCc
Confidence            9887 788999999995 78888776543  2356888999999999999999999977  9999999999999887   


Q ss_pred             -CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchh-----
Q psy5927         291 -MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRS-----  363 (441)
Q Consensus       291 -~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~-----  363 (441)
                       |.+||+|||++|.....-........++-|.+|.|||.+.| ..||.+.|+||.|||+.||||-.+-|......     
T Consensus       172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~  251 (438)
T KOG0666|consen  172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN  251 (438)
T ss_pred             cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence             99999999999987665545445667788999999999988 46899999999999999999998888653321     


Q ss_pred             ---HHHHHHHHHhhc---hhhhhh----------hhccC---CCc--hhH------HHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         364 ---ERHLKSLVEKYS---EENMYD----------LVDKN---AQP--IEL------NIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       364 ---~~~l~~~~~~~~---~~~~~~----------~~~~~---~~~--~~~------~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                         -.++..+.+...   ++....          +.+..   ...  +..      .-+...++|+.++|..||.+|.++
T Consensus       252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta  331 (438)
T KOG0666|consen  252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA  331 (438)
T ss_pred             CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence               112222222221   111000          00000   000  000      012236899999999999999999


Q ss_pred             HHHHHH
Q psy5927         417 TQVYNM  422 (441)
Q Consensus       417 ~evl~~  422 (441)
                      ++.++.
T Consensus       332 ~qAleh  337 (438)
T KOG0666|consen  332 EQALEH  337 (438)
T ss_pred             HHHhcc
Confidence            998874

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=291.80  Aligned_cols=245  Identities=20%  Similarity=0.260  Sum_probs=187.8

Q ss_pred             CccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHH-hhcCCCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY-LNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||.|+||.||+|.+  .++.+|+|.+........      .....+..|..+ .....|+||+++++++..++.+++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK------NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH------HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            5799999999999998  456899998864321111      112223345444 3455899999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|||+++.... 
T Consensus        76 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          76 MEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             EeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence            9999999999988543   35788999999999999999999998  99999999999999999999999999875322 


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA  387 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  387 (441)
                            .....|+..|+|||.+.+..++.++||||||+++|||++|..||....... .......    ..    .. ..
T Consensus       150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~----~~-~~  213 (260)
T cd05611         150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILS----RR----IN-WP  213 (260)
T ss_pred             ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh----cc----cC-CC
Confidence                  123458889999999988888999999999999999999999997654321 1111110    00    00 01


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                      ......++..+.+++.+||+.+|++||++.++.+.|
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            112224567899999999999999999776555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.8e-38  Score=304.74  Aligned_cols=270  Identities=24%  Similarity=0.310  Sum_probs=205.9

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC-
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG-  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-  222 (441)
                      +|++.+.||.|+||.||+|...  +..+|+|++......       ....+.+.+|+.+++.++||||+++++++.... 
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-------LIDAKRILREIKLLRHLRHENIIGLLDILRPPSP   73 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-------chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence            5888999999999999999974  578999988643211       123345678999999999999999999988775 


Q ss_pred             ----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         223 ----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       223 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                          .+|++|||++ ++|.+++...   ..+++..+..++.+++.||.|||+.|  |+||||||+|||++.++.++|+||
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          74 EDFNDVYIVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             ccccceEEEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccc
Confidence                7899999996 6888877532   36899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch-
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE-  376 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-  376 (441)
                      |++.................++..|+|||.+.+. .++.++|+||||+++|+|++|.+||..... ............. 
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~  226 (330)
T cd07834         148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTP  226 (330)
T ss_pred             CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCC
Confidence            9997654332111223334578999999999887 789999999999999999999999977654 2222222221110 


Q ss_pred             --h--------hhhhhhcc----C---CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCC
Q psy5927         377 --E--------NMYDLVDK----N---AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGE  429 (441)
Q Consensus       377 --~--------~~~~~~~~----~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~  429 (441)
                        .        .....+..    .   .......++..+.+++.+||+.+|.+||++.+++.  .|++....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence              0        00001000    0   01112235678899999999999999999999998  46665554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.8e-37  Score=301.45  Aligned_cols=261  Identities=20%  Similarity=0.254  Sum_probs=191.9

Q ss_pred             CccccC--CceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         151 NILGKG--GFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       151 ~~LG~G--~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      ..||+|  +||+||++.+  .++.||+|++.......       ...+.+.+|+.+++.++||||++++++|..++..|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~   76 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-------EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWV   76 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEE
Confidence            456666  9999999998  56889999987543221       223456689999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      ||||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++++||+.+.....
T Consensus        77 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          77 ISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             EEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            999999999999886543 234888999999999999999999998  99999999999999999999999985432111


Q ss_pred             ccc----ccceeccccccCCCcCcccccCC--CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh-chh--
Q psy5927         307 EKA----THITLKRVNGTRPYLPHEFLVGK--RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY-SEE--  377 (441)
Q Consensus       307 ~~~----~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-~~~--  377 (441)
                      ...    .........++..|+|||++.+.  .++.++|||||||++|||++|..||............+.... ...  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence            100    00001112356679999999763  478999999999999999999999977654222221111000 000  


Q ss_pred             --------h-------hh--------------hhh-ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 --------N-------MY--------------DLV-DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 --------~-------~~--------------~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              .       ..              ... .....+....++..+.+|+.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                    0       00              000 00011223456778999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0612|consensus

Probab=100.00  E-value=1.1e-38  Score=329.68  Aligned_cols=279  Identities=21%  Similarity=0.265  Sum_probs=215.9

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      .++....++|+++++||+|+||.|..++.++  +-||+|+++..      +.++......|..|-.+|.-...+-|+.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~------eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW------EMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH------HHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            3556677899999999999999999999864  56999998742      122333445666888899999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      -.|.+..++|+|||||+||+|...+....   .+++..+.+++..|+.||.-||+.|  +|||||||+|||||..|++||
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEee
Confidence            99999999999999999999999885433   6899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      +|||.+-....  .........+|||.|++||+++.     +.|++.+||||+||++||||.|..||....-.+.+-+.+
T Consensus       217 ADFGsClkm~~--dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm  294 (1317)
T KOG0612|consen  217 ADFGSCLKMDA--DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM  294 (1317)
T ss_pred             ccchhHHhcCC--CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh
Confidence            99998755332  23344566789999999999853     568999999999999999999999997654433332222


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH--HHhcC-CCCCCCCCCCCCCC
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE---MTQVYN--MLSGS-GGESPNATGPTLPV  440 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~--~L~~~-~~~~~~~~~p~~~~  440 (441)
                      -    ......+      |....++....+||++.+.. |..|..   +.++-.  ++.++ +.......+|..|-
T Consensus       295 ~----hk~~l~F------P~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe  359 (1317)
T KOG0612|consen  295 N----HKESLSF------PDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE  359 (1317)
T ss_pred             c----hhhhcCC------CcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence            1    1111111      11244788999999999874 677776   888765  22222 24445556666664

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=295.17  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=197.2

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC--C
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET--G  222 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~  222 (441)
                      |++.+.||.|+||.||+|.+.  +..+|+|++.......       .....+.+|+++++.++|||++++++++.+.  +
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE-------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG   73 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc-------cchHHHHHHHHHHHhccCCCeeeheeeEecCCCC
Confidence            677899999999999999985  4789999998543111       2234556899999999999999999999888  8


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||++ ++|.+++....  ..+++..+..++.+++.||+|||+.+  ++|+||||+||++++++.++|+|||++.
T Consensus        74 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          74 SIYMVFEYMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             cEEEEecccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999999996 58888775432  46889999999999999999999998  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---EN  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~  378 (441)
                      .......  .......++..|+|||.+.+ ..++.++||||||+++|||+||..||..... ...+.........   ..
T Consensus       149 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         149 PYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhh
Confidence            6433321  11222346888999998765 4578999999999999999999999977654 3333332221110   00


Q ss_pred             hhhhhc--------cC------CCchhHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVD--------KN------AQPIELN-IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~--------~~------~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .....+        ..      ....... ++..+.+++.+||+.+|.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000        00      0000111 2677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-37  Score=304.58  Aligned_cols=274  Identities=21%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE--
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF--  219 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--  219 (441)
                      .++|++.+.||.|+||.||+|...  +..||+|++.......       .....+.+|+.+++.++||||+++++++.  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   76 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-------TLAKRTLRELKILRHFKHDNIIAIRDILRPP   76 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-------cchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence            378999999999999999999974  5689999886432111       12344568999999999999999999875  


Q ss_pred             --eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         220 --ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       220 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                        .....++||||+. |+|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          77 GADFKDVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             CCCCceEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecc
Confidence              3357899999995 7898887432   34899999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCccccc-ceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh-
Q psy5927         298 FGLTQEGPIEKATH-ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY-  374 (441)
Q Consensus       298 FGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-  374 (441)
                      ||++.......... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+....... 
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g  229 (334)
T cd07855         151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLG  229 (334)
T ss_pred             cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhC
Confidence            99987543221111 11223468999999999865 468999999999999999999999997654321 111111110 


Q ss_pred             ----------chhhhhhhhcc----CCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCC
Q psy5927         375 ----------SEENMYDLVDK----NAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESP  431 (441)
Q Consensus       375 ----------~~~~~~~~~~~----~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~  431 (441)
                                .........+.    ....   .....+.++.+++.+||+.+|.+||++.+++.  .+++......
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence                      00011111110    0111   11335778999999999999999999999987  4544444443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3e-37  Score=298.12  Aligned_cols=265  Identities=23%  Similarity=0.364  Sum_probs=193.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.++||+|+||.||+|...  +..||||.+........       ....+.+|++++++++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-------FPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-------chhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            467999999999999999999984  56899998864322111       122345799999999999999999988755


Q ss_pred             C--------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         222 G--------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       222 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      +        ..++||||+. ++|.+.+...  ...+++..+..++.|++.||+|||+++  ++|+||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGIL  158 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcE
Confidence            3        4599999995 6888877533  235889999999999999999999998  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccc-cceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      ||+|||++......... ........++..|+|||.+.+. .++.++|+||||+++|||+||.+||..... ...+..+.
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~  237 (310)
T cd07865         159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLIS  237 (310)
T ss_pred             EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence            99999999754332211 1112234578899999988764 478899999999999999999999976543 21211111


Q ss_pred             Hhh---chhhhh-----hhhc------cCCCchh-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         372 EKY---SEENMY-----DLVD------KNAQPIE-----LNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       372 ~~~---~~~~~~-----~~~~------~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...   ..+...     ...+      .......     ......+.+|+.+||..||.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            100   000000     0000      0000000     012345789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=294.03  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=199.9

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |++.+.||.|++|.||+|...  +..+++|.+.......       .....+..|++++++++|+||+++++++.+++..
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   73 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-------GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL   73 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence            567889999999999999974  5679999886433221       1234556899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||++ ++|.+++....  ..+++..+..++.+++.||.|||+.+  |+|+||||+||+++.++.++|+|||.+...
T Consensus        74 ~~v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          74 YLVFEFMD-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             EEEEeccC-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            99999996 58888876533  46899999999999999999999999  999999999999999999999999998764


Q ss_pred             CCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---ENMY  380 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~~  380 (441)
                      ....   .......++..|+|||.+.+. .++.++|+||||+++|+|+||..||....... .+.........   ....
T Consensus       149 ~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         149 GSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             CCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcc
Confidence            3322   112223578899999998876 78999999999999999999999997655422 22222221110   0000


Q ss_pred             hhh--------------ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLV--------------DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...              ..........++.++.+++.+||+.||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000              00111223456788999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.4e-37  Score=303.03  Aligned_cols=270  Identities=22%  Similarity=0.319  Sum_probs=200.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||+|+||+||+|.+.  +..||||.+.......       .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-------IDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-------chhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            457999999999999999999974  5689999886432111       1223455899999999999999999987644


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                           ...|+||||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          77 HREAFNDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             cccccCcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEC
Confidence                 35899999995 789887753   245889999999999999999999998  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh-
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY-  374 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~-  374 (441)
                      |||+++......   .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||....... ......... 
T Consensus       151 Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  226 (337)
T cd07858         151 DFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLG  226 (337)
T ss_pred             cCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhC
Confidence            999997643221   11223457889999998765 468999999999999999999999997653211 111111110 


Q ss_pred             --chhh--------hhhhhc-------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCCCCC
Q psy5927         375 --SEEN--------MYDLVD-------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGSGGES  430 (441)
Q Consensus       375 --~~~~--------~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~~~  430 (441)
                        ..+.        ....+.       .........++.++.+++.+||+.+|.+||++.++++.  ++......
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence              0000        000000       00111223467788999999999999999999999874  65544433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0604|consensus

Probab=100.00  E-value=5.5e-38  Score=283.08  Aligned_cols=253  Identities=20%  Similarity=0.292  Sum_probs=197.5

Q ss_pred             HhhCCCcCc-CccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc-CCCCCeecccce
Q psy5927         142 LATNNWDKL-NILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-CRHDNILPLYGI  217 (441)
Q Consensus       142 ~~~~~~~~~-~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~  217 (441)
                      ..+++|.+. ++||-|-.|+|-.+..+.  ..+|+|++.-              .....+|++.--. -.|||||.++++
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------------s~KARrEVeLHw~~s~h~~iV~IidV  123 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------------SPKARREVELHWMASGHPHIVSIIDV  123 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------------CHHHHhHhhhhhhhcCCCceEEeehh
Confidence            456788775 689999999999988754  4688888752              1233467776433 379999999998


Q ss_pred             EEe----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---C
Q psy5927         218 CFE----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---H  290 (441)
Q Consensus       218 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~  290 (441)
                      +..    ..++.+|||.|+||.|+.+++.++. ..+++.++..|..||+.|+.|||+.+  |.||||||+|+|...   +
T Consensus       124 yeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~n  200 (400)
T KOG0604|consen  124 YENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPN  200 (400)
T ss_pred             hhhhccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCC
Confidence            753    4677899999999999999987654 45899999999999999999999999  999999999999964   4


Q ss_pred             CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      ..+||+|||+|+....    .....+.|-|+.|.|||++...+|+...|+||+||++|-||+|.+||...+... .-..+
T Consensus       201 a~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispgM  275 (400)
T KOG0604|consen  201 APLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGM  275 (400)
T ss_pred             cceEecccccccccCC----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChhH
Confidence            5689999999986432    334556788999999999999999999999999999999999999998765411 11122


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...+.... +.+   .. +.-..++++..++|+.+|..+|.+|.++.++++
T Consensus       276 k~rI~~gq-y~F---P~-pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  276 KRRIRTGQ-YEF---PE-PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HhHhhccC-ccC---CC-hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            22111110 011   11 122467889999999999999999999999986

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-37  Score=303.61  Aligned_cols=275  Identities=19%  Similarity=0.313  Sum_probs=204.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||||++......       ....+.+.+|+++++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            4678999999999999999999874  567999988642211       1123456689999999999999999998875


Q ss_pred             CC------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 TG------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~~------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      +.      .+|+||||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CccccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEE
Confidence            43      468999999 7899887742    34889999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |+|||++......      .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ......
T Consensus       159 l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-~~~~~~  231 (343)
T cd07880         159 ILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL-MEIMKV  231 (343)
T ss_pred             EeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHh
Confidence            9999998753221      123357889999999876 45889999999999999999999999765432221 111111


Q ss_pred             -----------hchhhhhhhhcc-------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHhcCCCCCCCC
Q psy5927         374 -----------YSEENMYDLVDK-------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY--NMLSGSGGESPNA  433 (441)
Q Consensus       374 -----------~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl--~~L~~~~~~~~~~  433 (441)
                                 +.......+...       ........++..+.+++.+||+.||++||++.+++  ..++......+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~  311 (343)
T cd07880         232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET  311 (343)
T ss_pred             cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc
Confidence                       000000000000       00011123456789999999999999999999998  4666665555544


Q ss_pred             CCCCC
Q psy5927         434 TGPTL  438 (441)
Q Consensus       434 ~~p~~  438 (441)
                      ..+..
T Consensus       312 ~~~~~  316 (343)
T cd07880         312 EAPPY  316 (343)
T ss_pred             CCCCc
Confidence            44443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.5e-37  Score=291.32  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             CCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      +|.+.+.||+|+||.||++.+..  ..+++|.++.......    ......++..|+.+++.++||||+++++++.+...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL----NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA   76 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc----CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence            58888999999999999998854  3456666553221110    11122345578999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+  ++|+||||+||+++. +.++|+|||++.
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~  153 (260)
T cd08222          77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSR  153 (260)
T ss_pred             eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCcee
Confidence            99999999999999988642 23456899999999999999999999998  999999999999975 569999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... .......            
T Consensus       154 ~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~~~~~~------------  217 (260)
T cd08222         154 LLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRI------------  217 (260)
T ss_pred             ecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHH------------
Confidence            5432211   12334588899999999888889999999999999999999999965432 1111111            


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ........+..++.++.+++.+||..+|.+||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111122234456778999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.5e-37  Score=298.80  Aligned_cols=265  Identities=26%  Similarity=0.349  Sum_probs=194.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.++||+|+||.||+|.+.  +..+|+|++........       ....+.+|+++++.++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-------FPITALREIKILKKLKHPNVVPLIDMAVER   79 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-------cchhHHHHHHHHHhcCCCCccchhhheecc
Confidence            578999999999999999999984  56799998865432111       112345899999999999999999987543


Q ss_pred             --------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         222 --------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       222 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                              ..+++||||+. ++|...+...  ...+++..+..++.|++.||+|||+.+  |+||||||+||++++++.+
T Consensus        80 ~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          80 PDKSKRKRGSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             cccccccCceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCE
Confidence                    34699999995 5777766432  345899999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccc--------cceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         294 VIGDFGLTQEGPIEKAT--------HITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      +|+|||+++........        ........|++.|+|||.+.+ ..++.++|||||||++|||++|.+||..... .
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~  233 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-I  233 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-H
Confidence            99999998753322111        111233457889999998865 3578999999999999999999999976544 2


Q ss_pred             HHHHHHHHhhc---hhhhh------h----hhccCCC-ch---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         365 RHLKSLVEKYS---EENMY------D----LVDKNAQ-PI---ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       365 ~~l~~~~~~~~---~~~~~------~----~~~~~~~-~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...........   +....      .    ....... ..   -......+.+++.+||+.||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            22222222111   00000      0    0000000 00   0123367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-37  Score=294.65  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  221 (441)
                      ++|.+.+.||.|+||.||+|..  .+..+|+|++......      .......+..|++++++++ ||||+++++++.+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            4789999999999999999998  4678999988643211      1122345668999999998 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccc
Confidence            9999999999999999988643   35899999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccc-----------------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         302 QEGPIEKAT-----------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       302 ~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      .........                 ........|+..|+|||.+.+..++.++|+||||++++++++|..||..... .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-Y  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-H
Confidence            754322110                 1222344578899999999888899999999999999999999999986653 1


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM----TQVYN  421 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~evl~  421 (441)
                      .......             ......+..++..+.+++.+||+.+|.+||++    .++++
T Consensus       229 ~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTFQKIL-------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHH-------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            1121111             11122334457789999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1151|consensus

Probab=100.00  E-value=3.9e-38  Score=296.94  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=205.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE-e
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF-E  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~  220 (441)
                      .++|-.+..||+|||+.||+|.+  .++.||||+-...+.-++.+  +....+..-+|.+|-+.+.||.||++|++|. +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEK--KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEK--KENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHh--hhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            35677788999999999999997  46789999876554433322  2334556679999999999999999999986 5


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---CCCeEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---HMDPVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~~~~kl~D  297 (441)
                      .+.+|-|+|||+|.+|.-+|...+   .+++..+..|+.||+.||.||....+||||-||||.||||-.   .|.+||+|
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            577899999999999988885543   488999999999999999999999999999999999999954   47899999


Q ss_pred             cCCCccCCCcccc----cceeccccccCCCcCcccccC----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         298 FGLTQEGPIEKAT----HITLKRVNGTRPYLPHEFLVG----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       298 FGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      |||++........    ...++...||.+|+|||.+.-    .+++.++||||.|||+|..+.|+.||.......+.+..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            9999875543322    123456789999999998753    35799999999999999999999999876543333221


Q ss_pred             HHHhhchhhhhhhhccCCC--chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         370 LVEKYSEENMYDLVDKNAQ--PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .       .+   +.....  +..+.++.+..++|.+||+...++|....++..
T Consensus       697 N-------TI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 N-------TI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             h-------ch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            1       01   111111  112346678899999999999999999888753

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.2e-37  Score=294.14  Aligned_cols=251  Identities=21%  Similarity=0.352  Sum_probs=196.9

Q ss_pred             CcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         149 KLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      ...+||+|+||.||+|...  +..+|+|++.....         .....+.+|+.+++.++|+||+++++++..++..++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   94 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV   94 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEE
Confidence            3478999999999999884  56899998753211         123456689999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      ||||+++++|.+++..    ..+++..+..++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|||++.....
T Consensus        95 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657          95 VMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             EEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            9999999999987642    24788999999999999999999998  99999999999999999999999998865432


Q ss_pred             cccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccC
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN  386 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  386 (441)
                      ...   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...+........         . 
T Consensus       169 ~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~---------~-  234 (292)
T cd06657         169 EVP---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNLP---------P-  234 (292)
T ss_pred             ccc---cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhCC---------c-
Confidence            211   12234588999999999888889999999999999999999999976433 112211111110         0 


Q ss_pred             CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         387 AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       387 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      .......++..+.+++.+||..+|.+||++.++++  .|.....
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            00011234567889999999999999999999987  4555543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-37  Score=292.00  Aligned_cols=258  Identities=24%  Similarity=0.337  Sum_probs=194.4

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCCe
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETGK  223 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~  223 (441)
                      |++.+.||.|+||+||+|...  +..+++|++.......        ......+|+..+.+++ ||||+++++++.+++.
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   72 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--------EECMNLREVKSLRKLNEHPNIVKLKEVFRENDE   72 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--------hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc
Confidence            677899999999999999984  4679999876432211        1112347889999998 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||+ +|+|.+.+.... ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        73 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~  148 (283)
T cd07830          73 LYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLARE  148 (283)
T ss_pred             EEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeeccccee
Confidence            99999999 889998886543 345899999999999999999999998  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh-----
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE-----  377 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-----  377 (441)
                      .....    ......++..|+|||.+.+ ..++.++|+||||++++||++|.+||....... ............     
T Consensus       149 ~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  223 (283)
T cd07830         149 IRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYKICSVLGTPTKQDW  223 (283)
T ss_pred             ccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHHHHHhcCCCChhhh
Confidence            43221    1223457889999998754 457899999999999999999999997654422 222111111000     


Q ss_pred             ----hhhhhhc----c----CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 ----NMYDLVD----K----NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ----~~~~~~~----~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          ......+    .    .........+..+.+++.+||+.+|.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                0000000    0    000111122467899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.2e-37  Score=300.35  Aligned_cols=270  Identities=25%  Similarity=0.277  Sum_probs=196.8

Q ss_pred             CCCcC-cCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHh----hhH-HHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         145 NNWDK-LNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVET----LNQ-CQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       145 ~~~~~-~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~----~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ++|.. .+.||.|+||+||+|.+.  ++.||||+++..........    ... .....+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45654 577999999999999874  56799999864332211000    000 00123568999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++...+..|+||||+. |+|.+++...   ..+++.....++.|++.||+|||+.+  |+||||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 7899888532   34888999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcc-----------cccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         297 DFGLTQEGPIEK-----------ATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       297 DFGla~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      |||+++......           ..........++..|+|||.+.+. .++.++|+|||||++|||++|.+||...... 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-  240 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-  240 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence            999987543110           001111223468889999998764 4689999999999999999999999876542 


Q ss_pred             HHHHHHHHhhchhh---hhhh------------hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         365 RHLKSLVEKYSEEN---MYDL------------VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       365 ~~l~~~~~~~~~~~---~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..+..+........   ....            ............+..+.+++.+||+.+|.+||++.+++.
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            22322222111000   0000            000000111234667899999999999999999999987

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-36  Score=293.97  Aligned_cols=245  Identities=25%  Similarity=0.379  Sum_probs=192.8

Q ss_pred             CcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |...++||+|+||.||+|.+  .+..+++|++.......      ......+..|+++++.++|||++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT------NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc------hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            66678899999999999987  45679999886432211      12234566899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      |+||||+. |+|.+.+...  ..++++..+..++.+++.||.|||+.+  ++||||+|+||+++.++.+||+|||++...
T Consensus        97 ~lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            99999995 6888877543  345889999999999999999999998  999999999999999999999999998642


Q ss_pred             CCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ..       .....|+..|+|||.+.   +..++.++|||||||++|||++|..||....... .+.......       
T Consensus       172 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~-------  236 (313)
T cd06633         172 SP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQND-------  236 (313)
T ss_pred             CC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcC-------
Confidence            21       12346889999999984   3568889999999999999999999997654312 111111100       


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          ........++..+.+|+.+||+.+|.+||++.+++.
T Consensus       237 ----~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         237 ----SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000112234567899999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-37  Score=302.78  Aligned_cols=265  Identities=23%  Similarity=0.318  Sum_probs=194.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||.|+||.||+|.+.  +..||+|++.....         ...+.+.+|+++++.++||||+++++++...
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~   74 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---------QSVKHALREIKIIRRLDHDNIVKVYEVLGPS   74 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---------chHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence            368999999999999999999985  56799998865432         1234566899999999999999999876543


Q ss_pred             --------------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee
Q psy5927         222 --------------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL  287 (441)
Q Consensus       222 --------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl  287 (441)
                                    ...|+||||++ ++|.+.+..    ..+++..+..++.|++.||+|||+.+  |+||||||+||++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili  147 (342)
T cd07854          75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFI  147 (342)
T ss_pred             ccccccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEE
Confidence                          35789999996 688887742    34888999999999999999999999  9999999999999


Q ss_pred             cC-CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHH
Q psy5927         288 NH-HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER  365 (441)
Q Consensus       288 ~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~  365 (441)
                      +. ++.+||+|||+++................|+..|+|||.+.+ ..++.++|||||||++|||++|..||........
T Consensus       148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  227 (342)
T cd07854         148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ  227 (342)
T ss_pred             cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            74 567899999998753221111111223357889999998654 5678899999999999999999999976554222


Q ss_pred             HHHHHHHhhc---hhhhh-------hhhc--cC--CC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         366 HLKSLVEKYS---EENMY-------DLVD--KN--AQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       366 ~l~~~~~~~~---~~~~~-------~~~~--~~--~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                      . ........   .....       ....  ..  ..   .....++.++.+|+.+||+.||.+||++.+++.  .++.
T Consensus       228 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         228 M-QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             H-HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            1 11111110   00000       0000  00  00   111235677899999999999999999999984  5554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0607|consensus

Probab=100.00  E-value=1.7e-37  Score=282.07  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             CccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         151 NILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      +.||+|+|+.|--+..  .+..||||++.+...         -.+..+++|++++..+ .|+||++|+++|.++..+|||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---------HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---------HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            7899999999998775  567899999975532         2355778999999999 599999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---eEEeccCCCccC
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEG  304 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---~kl~DFGla~~~  304 (441)
                      ||-|.||+|..+++.++.   +++..+..+..+|+.||.|||.+|  |.||||||+|||......   +|||||.|....
T Consensus       155 fEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeecccccccc
Confidence            999999999999987654   788999999999999999999999  999999999999976654   699999887543


Q ss_pred             CC----cccccceeccccccCCCcCccccc---C--CCCCCccceehHHHHHHHHHhCCCCCCCcchhH----------H
Q psy5927         305 PI----EKATHITLKRVNGTRPYLPHEFLV---G--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE----------R  365 (441)
Q Consensus       305 ~~----~~~~~~~~~~~~gt~~y~aPE~~~---~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~----------~  365 (441)
                      ..    +........+.+|+..|||||+..   +  ..|+.++|.||||||||-||+|.+||.+....+          .
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            22    122334456678999999999762   2  358999999999999999999999997543211          1


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGE  429 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~  429 (441)
                      -.+.+.+.+.++ .+.+.|+   +| ..++.+..+|+...|..|+.+|.++.++++  ..+....+
T Consensus       310 CQ~~LFesIQEG-kYeFPdk---dW-ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  310 CQNKLFESIQEG-KYEFPDK---DW-AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHHHHHHHhcc-CCcCChh---hh-HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            112222222221 1222222   22 367888999999999999999999999987  44444333

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-36  Score=294.44  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=196.4

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|...+.||+|+||.||+|.+.  +..+|+|.+.......      ......+.+|+++++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC------hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            34777899999999999999984  4679999886422111      122345668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||+. |+|.+.+...  ..++++..+..++.+++.||.|||+.+  ++||||||+|||++.++.++|+|||++.
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccce
Confidence            9999999996 6887776533  245888999999999999999999998  9999999999999999999999999986


Q ss_pred             cCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ....       .....|+..|+|||.+.   ...++.++|||||||++|||++|..||........ ........     
T Consensus       164 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~-----  230 (308)
T cd06634         164 IMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE-----  230 (308)
T ss_pred             eecC-------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhhcC-----
Confidence            5321       12335888999999974   34678899999999999999999999876543211 11111100     


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                            ........++..+.+|+.+||+.+|.+||++.+|++.---..
T Consensus       231 ------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         231 ------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                  001112345677899999999999999999999987544333

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG3653|consensus

Probab=100.00  E-value=3e-37  Score=293.76  Aligned_cols=270  Identities=27%  Similarity=0.390  Sum_probs=197.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc--CCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS--CRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~  221 (441)
                      .......+.||+|.||.||+|..+++.||||++..            ...+.+..|-+|.+.  ++|+||++++++-..+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~------------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE------------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCH------------HHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            45666778999999999999999999999999963            234455677777655  4899999999987655


Q ss_pred             C----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCeeecCCCCCCeeecCC
Q psy5927         222 G----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-------EPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       222 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-------~~~iiHrDikp~NiLl~~~  290 (441)
                      .    .++||++|.+.|||.++|..+    .++|.....|+..+++||+|||+.       .++|+|||||+.||||.++
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence            5    799999999999999999643    389999999999999999999972       3579999999999999999


Q ss_pred             CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CC-----CCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RL-----STKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~-----s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      +...|+|||||............ -.-+||.+|||||++.|. .+     -.+.||||+|.|||||++....++... .+
T Consensus       353 lTccIaDFGLAl~~~p~~~~~d~-~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~-vp  430 (534)
T KOG3653|consen  353 LTCCIADFGLALRLEPGKPQGDT-HGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP-VP  430 (534)
T ss_pred             CcEEeeccceeEEecCCCCCcch-hhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC-CC
Confidence            99999999999875543332222 225799999999999762 12     246999999999999999776553210 01


Q ss_pred             HHHHHHHHhh----chhhhhhh-hccCCCc-hhH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         365 RHLKSLVEKY----SEENMYDL-VDKNAQP-IEL-----NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       365 ~~l~~~~~~~----~~~~~~~~-~~~~~~~-~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                      .+-.-+-.+.    .-+.+..+ +.++..+ ++.     .-..-+.+.+..||..|++.|.|+.=|.+++..+..-.+
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            1110000010    11111111 1111221 111     224457899999999999999999888877766554443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-36  Score=297.57  Aligned_cols=262  Identities=21%  Similarity=0.315  Sum_probs=196.5

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ++...+++|++.+.||+|+||.||+|.+  .+..||+|+++.....       ....+.+.+|+.++++++||||+++++
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-------hHHHHHHHHHHHHHHHcCCCcccceee
Confidence            3455678999999999999999999986  3567999988642211       112345668999999999999999999


Q ss_pred             eEEeC------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         217 ICFET------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       217 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      ++...      ...|++++++ +++|.+++..    ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~  156 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED  156 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC
Confidence            87643      3478888887 8899887743    24889999999999999999999999  9999999999999999


Q ss_pred             CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      +.+||+|||+++.....      .....|+..|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+..
T Consensus       157 ~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~  229 (345)
T cd07877         157 CELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKL  229 (345)
T ss_pred             CCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            99999999998753221      223457899999999876 46889999999999999999999999765432 22222


Q ss_pred             HHHhhc--hhhhh---------hh---hccC----CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         370 LVEKYS--EENMY---------DL---VDKN----AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~--~~~~~---------~~---~~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ......  .....         .+   +...    ........+..+.+++.+||+.||.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            221110  00000         00   0000    00000123557889999999999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4250|consensus

Probab=100.00  E-value=1.2e-37  Score=309.77  Aligned_cols=268  Identities=25%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|...+.||+|+||.||+|+++  +..||||.++......        ..+..-+|+++|++++|||||+++++-.+..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--------~~e~~~~EieilkKLnh~NIVk~f~iee~~~   84 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--------PRERWCREIEILKKLNHPNIVKLFDIEETKF   84 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--------hHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence            34667789999999999999975  5679999987544222        2344458999999999999999999754433


Q ss_pred             ------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec--CCCC--
Q psy5927         223 ------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN--HHMD--  292 (441)
Q Consensus       223 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~--~~~~--  292 (441)
                            ...+|||||.||||+..|..-.+...|++...+.++..++.||.|||.+|  |+||||||.||++-  .+|.  
T Consensus        85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceE
Confidence                  46799999999999999988888888999999999999999999999999  99999999999984  3233  


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhH----HHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE----RHL  367 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~----~~l  367 (441)
                      -||+|||.|+......    .+.++.||..|++||.... +.|+..+|.|||||++||.+||..||.......    ..+
T Consensus       163 yKLtDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~  238 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW  238 (732)
T ss_pred             EeeecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence            5999999999865443    5677889999999999984 788999999999999999999999997655422    112


Q ss_pred             HHHHHhhchhhhh-hhhc----------cCCCchhHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhcC
Q psy5927         368 KSLVEKYSEENMY-DLVD----------KNAQPIELNIAYAFFRIGKQSTKQNPKERP--EMTQVYNMLSGS  426 (441)
Q Consensus       368 ~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~evl~~L~~~  426 (441)
                      ....+......+. ...+          +....+.......+-..+..+|..+|++|-  ...+.+..+..+
T Consensus       239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            2221111100000 0000          011122334445566777888889999998  666666655544

>KOG0200|consensus

Probab=100.00  E-value=6.7e-37  Score=319.65  Aligned_cols=263  Identities=25%  Similarity=0.420  Sum_probs=212.8

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCC
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHD  209 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  209 (441)
                      +++..++..+.+.||+|.||.|++|...         ...||||.++.....        .+.+.+..|+++|+.+ +||
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--------~~~~~~~~El~~m~~~g~H~  362 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--------SEKKDLMSELNVLKELGKHP  362 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--------HHHHHHHHHHHHHHHhcCCc
Confidence            4455566677789999999999999853         347999999855433        3455677999999998 599


Q ss_pred             CeecccceEEeCCeEEEEEEecCCCCHHHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5927         210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-----NT--------PSLLWTQRLHIAKGTSLGLQFLHSREPPLI  276 (441)
Q Consensus       210 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~al~~LH~~~~~ii  276 (441)
                      ||+.++|+|...+.+++|+||+..|+|.++|..++     ..        ..+.....+.++.||+.|++||++..  +|
T Consensus       363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v  440 (609)
T KOG0200|consen  363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV  440 (609)
T ss_pred             chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence            99999999999999999999999999999997766     01        23888999999999999999999988  99


Q ss_pred             ecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccC--CCcCcccccCCCCCCccceehHHHHHHHHHh-C
Q psy5927         277 HGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--PYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-G  353 (441)
Q Consensus       277 HrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~--~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G  353 (441)
                      ||||...|||+.++..+||+|||+|+..........  ..-.|+.  .|||||.+....|+.++|||||||+||||+| |
T Consensus       441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG  518 (609)
T KOG0200|consen  441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG  518 (609)
T ss_pred             chhhhhhhEEecCCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence            999999999999999999999999986444333221  1112333  3999999999999999999999999999999 9


Q ss_pred             CCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         354 MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       354 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ..||.+......... .+           .+......|..+..+++++++.||+.+|++||++.++.+.|...
T Consensus       519 ~~PYp~~~~~~~l~~-~l-----------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  519 GTPYPGIPPTEELLE-FL-----------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             CCCCCCCCcHHHHHH-HH-----------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            999987442222222 11           12233355677889999999999999999999999999998873

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=288.23  Aligned_cols=259  Identities=25%  Similarity=0.350  Sum_probs=198.0

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |+..+.||+|+||.||+|...  +..+|+|.+.......       ...+.+..|+.+++.++|+||+++++++.+.+..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-------GIPSTALREISLLKELKHPNIVKLLDVIHTERKL   73 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc-------cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence            567789999999999999985  5789999987543111       1223455899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++||||++ ++|.+++....  ..+++..+..++.+++.||+|||+.+  |+||||+|+||+++.++.++|+|||+++..
T Consensus        74 ~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          74 YLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             EEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCccccc
Confidence            99999997 69999886542  35889999999999999999999998  999999999999999999999999998764


Q ss_pred             CCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhhhh
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EENMY  380 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~~~  380 (441)
                      .....   ......++..|+|||.+.+. .++.++|+|||||++|||++|.+||..... ...+..+.....   +....
T Consensus       149 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         149 GIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             CCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHH
Confidence            33211   12223467789999998776 789999999999999999999999976553 222222222110   00000


Q ss_pred             hhh-----c--------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLV-----D--------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~-----~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...     +        ..........+..+.+++.+||..||++||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000     0        0000111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.8e-36  Score=295.80  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ...+++|++.+.||.|+||.||+|.+.  +..+|+|++.......       ...+.+..|+++++.++||||+++++++
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~   78 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-------VLAKRTYRELKLLKHLRHENIISLSDIF   78 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-------chhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence            346789999999999999999999874  5679999876422111       1234556899999999999999999988


Q ss_pred             Ee-CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         219 FE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       219 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      .. ....++++||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|
T Consensus        79 ~~~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          79 ISPLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             ecCCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCc
Confidence            75 56789999999 6789887742    24778888899999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh--
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY--  374 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~--  374 (441)
                      ||++......      .....++..|+|||.+.+ ..++.++|+||||+++|+|+||..||..... ......+.+..  
T Consensus       152 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~  224 (328)
T cd07856         152 FGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGT  224 (328)
T ss_pred             cccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCC
Confidence            9998753221      123357889999998766 5689999999999999999999999976543 11111111110  


Q ss_pred             ---------chhhhhhhhc----cCCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         375 ---------SEENMYDLVD----KNAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       375 ---------~~~~~~~~~~----~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                               .......+..    ....+   ....++..+.+++.+||+.+|++||++.+++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                     0000001100    00111   112346789999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-36  Score=298.72  Aligned_cols=263  Identities=19%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||+|+||.||+|.+.  +..+|+|++.......       .....+.+|+++++.++||||+++++++...
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~   86 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-------IFAKRAYRELTLLKHMQHENVIGLLDVFTSA   86 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-------cchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence            478999999999999999999974  5789999886422111       1223456899999999999999999988654


Q ss_pred             ------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 ------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                            ..+|+|+||+. .+|..++     ...+++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          87 VSGDEFQDFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             ccCCCCceEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEE
Confidence                  34699999995 5776654     124888999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++.....      .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+...+...
T Consensus       159 ~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~  231 (342)
T cd07879         159 LDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT  231 (342)
T ss_pred             eeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            999998753221      123357889999999876 46889999999999999999999999865432 2222222111


Q ss_pred             c--hhhh---------hhhhcc----CCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         375 S--EENM---------YDLVDK----NAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       375 ~--~~~~---------~~~~~~----~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      .  ....         ......    ...   ...+..+..+.+|+.+||+.||.+||++.+++.  .++....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0  0000         000000    000   011134567889999999999999999999984  4666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-37  Score=300.13  Aligned_cols=266  Identities=21%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++......       ......+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-------AIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-------hhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            4578999999999999999999985  567999987643211       1223455689999999999999999998766


Q ss_pred             CCe------EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 TGK------YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~~~------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      .+.      .++|+||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEE
Confidence            554      89999999 7899998753    35899999999999999999999998  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |+|||++......      .....++..|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+..+...
T Consensus       159 L~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~  231 (343)
T cd07851         159 ILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNL  231 (343)
T ss_pred             Ecccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHh
Confidence            9999998764321      223457889999999865 3678999999999999999999999976543 2222222221


Q ss_pred             h-----------chhhhhhhhcc----CCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCC
Q psy5927         374 Y-----------SEENMYDLVDK----NAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGE  429 (441)
Q Consensus       374 ~-----------~~~~~~~~~~~----~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~  429 (441)
                      .           .......++..    ...   .....++..+.+++.+||+.||.+||++.+|++  .+......
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            1           00000011100    000   111224678999999999999999999999986  45444443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0603|consensus

Probab=100.00  E-value=2.6e-37  Score=305.07  Aligned_cols=239  Identities=19%  Similarity=0.238  Sum_probs=195.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      .+..|+....+|.|+|+.|-.+..  ++...+||++.....+.             ..|+.++... .||||+++.+.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~-------------~~e~~~~~~~~~h~niv~~~~v~~  386 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN-------------QDEIPISLLVRDHPNIVKSHDVYE  386 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccccc-------------ccccchhhhhcCCCcceeecceec
Confidence            366788888999999999999987  45679999997542221             1566665555 7999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee-cCCCCeEEecc
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL-NHHMDPVIGDF  298 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl-~~~~~~kl~DF  298 (441)
                      ++.+.|+|||++.|+.|.+++.....   .. ..+..|+.+|+.|+.|||++|  ||||||||+|||+ ++.++++|+||
T Consensus       387 ~~~~~~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  387 DGKEIYLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             CCceeeeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEe
Confidence            99999999999999999998865442   22 677889999999999999999  9999999999999 69999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |.++.....      ..+.+-|..|.|||++....|+.++||||||++||+||+|+.||....... .+...+   .   
T Consensus       461 G~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-ei~~~i---~---  527 (612)
T KOG0603|consen  461 GFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-EIHTRI---Q---  527 (612)
T ss_pred             chhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-HHHHhh---c---
Confidence            999875443      233456889999999999999999999999999999999999998765531 111111   1   


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              .......++....+|+.+||+.||.+||++.++..
T Consensus       528 --------~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 --------MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --------CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                    11222567889999999999999999999999865

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-36  Score=295.63  Aligned_cols=262  Identities=21%  Similarity=0.312  Sum_probs=192.2

Q ss_pred             CCcCcCccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFE  220 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  220 (441)
                      +|++.+.||+|+||.||++.+.    +..+|+|++.......       ...+.+.+|+++++++ .||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-------ILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc-------hhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            4788899999999999999985    4479999886422111       1233456899999999 59999999987543


Q ss_pred             C----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         221 T----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       221 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      .    ...+++++|+. ++|.+++..   ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeC
Confidence            2    45788999985 789888843   345889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccc-cceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         297 DFGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       297 DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |||+++........ ........||..|+|||.+.+ ..++.++|+|||||++|+|++|.+||..... ...+...+...
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~  226 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVL  226 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHh
Confidence            99999754322111 111234568999999998766 4689999999999999999999999976543 12222222111


Q ss_pred             c---hhhhhhh-----------hcc-CCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 S---EENMYDL-----------VDK-NAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~---~~~~~~~-----------~~~-~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .   .+....+           ... ...   .....++..+.+++.+||+.||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0   0000000           000 000   111123567899999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0614|consensus

Probab=100.00  E-value=3.8e-38  Score=301.38  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=206.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECCee--EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ...+++++..||-||||.|=+...++..  +|+|++++..      ..+..+.++++.|-++|..++.|.||++|-.|.+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~h------IVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd  491 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKH------IVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD  491 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhh------ccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence            4467788899999999999998876654  7888887432      3344677888999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      ...+|++||-|-||.|...|..+.   .++......++..++.|++|||++|  ||+|||||+|++||.+|-+||.|||+
T Consensus       492 ~kyvYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  492 SKYVYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             chhhhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhh
Confidence            999999999999999999886543   4777888999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      |+......    .+.++|||+.|.|||++.....+.++|.||||+++||||||.+||...+.- +....++..+.     
T Consensus       567 AKki~~g~----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILkGid-----  636 (732)
T KOG0614|consen  567 AKKIGSGR----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILKGID-----  636 (732)
T ss_pred             HHHhccCC----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHhhhh-----
Confidence            98754443    356789999999999999999999999999999999999999999887642 22222222221     


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE  415 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  415 (441)
                            ...+|..++....+|+++....+|.+|.-
T Consensus       637 ------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                  12345667778889999999999999976

>KOG1006|consensus

Probab=100.00  E-value=1.3e-38  Score=282.77  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=195.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHH-hhcCCCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY-LNSCRHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~  219 (441)
                      ..++.+.+..||.|+||+|++-.++  +...|||++......        ....+++.|.+. ++.-..||||++||.+.
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--------keq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--------KEQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--------HHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            3445566789999999999998885  467899999865442        233456677775 55568999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLM--KKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      .++..|+.||+| ..||..+...  ......+++.-.-.|...++.||.||.. ..  ||||||||+|||||..|.+|||
T Consensus       134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeee
Confidence            999999999999 5777543311  1123347777777888889999999987 45  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |||++-....+-+    .+.-.|..+|||||.+..  ..|+.+||+||||++|||+.||..||......-+++..++..-
T Consensus       211 DFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd  286 (361)
T KOG1006|consen  211 DFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD  286 (361)
T ss_pred             cccchHhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC
Confidence            9999865433322    223358999999999854  3589999999999999999999999998776445554443221


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .    ..+..   .....+++..+..++..||.+|...||...++.+
T Consensus       287 p----p~l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  287 P----PILLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             C----CeecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            1    11110   1112346778999999999999999999998865

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.8e-36  Score=318.35  Aligned_cols=148  Identities=24%  Similarity=0.325  Sum_probs=129.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.++||+|+||+||+|.+.  +..||||+++.....      .......+..|+.++..++||||+++++++...
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~   76 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI------NKNMVHQVQAERDALALSKSPFIVHLYYSLQSA   76 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc------CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence            368999999999999999999986  678999998743211      122345667899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..+|+||||+.+++|.+++...   ..+++..++.|+.||+.||+|||+.+  ||||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            9999999999999999988543   34788899999999999999999998  999999999999999999999999998


Q ss_pred             c
Q psy5927         302 Q  302 (441)
Q Consensus       302 ~  302 (441)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=279.82  Aligned_cols=238  Identities=26%  Similarity=0.332  Sum_probs=192.3

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||.|+||.||++.+.  +..+|+|.+.......      ......+..|+++++.++||||+++++.+..++..|+||||
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK------RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc------hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            799999999999985  5789999886432211      12344566899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT  310 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~  310 (441)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        75 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--  147 (250)
T cd05123          75 APGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--  147 (250)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC--
Confidence            9999999988643   24889999999999999999999988  9999999999999999999999999987643221  


Q ss_pred             cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCch
Q psy5927         311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPI  390 (441)
Q Consensus       311 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  390 (441)
                       .......++..|+|||.+.+...+.++|+||||+++|+|++|..||..... .........             .....
T Consensus       148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~-------------~~~~~  212 (250)
T cd05123         148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK-------------DPLRF  212 (250)
T ss_pred             -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc-------------CCCCC
Confidence             122344688899999999888889999999999999999999999976543 222222111             11223


Q ss_pred             hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q psy5927         391 ELNIAYAFFRIGKQSTKQNPKERPEMTQ  418 (441)
Q Consensus       391 ~~~~~~~l~~li~~cl~~dp~~RPs~~e  418 (441)
                      +...+..+.+++.+||..||++||++.+
T Consensus       213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         213 PEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            3344678899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG2052|consensus

Probab=100.00  E-value=1.6e-36  Score=286.88  Aligned_cols=268  Identities=25%  Similarity=0.359  Sum_probs=198.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc--CCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS--CRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~  220 (441)
                      ..+...+.+.||+|.||.||+|.|.+..||||++.....            +..++|.++...  ++|+||+.+++.-..
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------------~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------------RSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             hhheeEEEEEecCccccceeeccccCCceEEEEecccch------------hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            346677889999999999999999999999999974321            123466666654  599999999987554


Q ss_pred             C----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCCeeecCCCCCCeeecCC
Q psy5927         221 T----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS------REPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       221 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~------~~~~iiHrDikp~NiLl~~~  290 (441)
                      +    ..++||.+|.+.|||+|+|..    ..++....+.++..++.||+|||.      ..+.|.|||||+.|||+..+
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            3    368999999999999999964    238888999999999999999995      23569999999999999999


Q ss_pred             CCeEEeccCCCccCCCc-ccccceeccccccCCCcCcccccCCC------CCCccceehHHHHHHHHHhC----------
Q psy5927         291 MDPVIGDFGLTQEGPIE-KATHITLKRVNGTRPYLPHEFLVGKR------LSTKVDVYGFGIVLFELATG----------  353 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DiwSlGvvl~elltG----------  353 (441)
                      +...|+|+|||...... .......+..+||.+|||||++...-      --..+||||||.|+||++..          
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999999654332 22333445668999999999986521      12469999999999999863          


Q ss_pred             CCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         354 MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       354 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ..||.+.-..+-...++.+..=...+...++.+..  .......+.+|++.||..||.-|-++--+-+.|.++..
T Consensus       433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCCHHHHhcceeecccCCCCCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            45776543323223232221111111111111111  22456678999999999999999999999988887764

>KOG0662|consensus

Probab=100.00  E-value=2.3e-36  Score=254.12  Aligned_cols=261  Identities=26%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             CCCcCcCccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .+|...++||+|.||+||+|+..++  -||+|.++....+..+       ....++|+.+|+.++|.|||++++....++
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-------pssalreicllkelkhknivrl~dvlhsdk   74 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-------PSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-------cHHHHHHHHHHHHhhhcceeehhhhhccCc
Confidence            3577789999999999999998654  6899999876555443       235579999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+-+|+||| ..+|..+....  ++.++...+..++.|+++||.|+|+++  +.|||+||.|+|++.+|.+|++|||+++
T Consensus        75 kltlvfe~c-dqdlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglar  149 (292)
T KOG0662|consen   75 KLTLVFEFC-DQDLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLAR  149 (292)
T ss_pred             eeEEeHHHh-hHHHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhh
Confidence            999999999 57888777544  345888899999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhh---chh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY---SEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~---~~~  377 (441)
                      ....+-   ..++...-|.+|.+|.++.|. -|+++.|+||-||++.|+.. |++-|.+..- ..+++.+....   .++
T Consensus       150 afgipv---rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed  225 (292)
T KOG0662|consen  150 AFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTED  225 (292)
T ss_pred             hcCCce---EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccc
Confidence            755432   123334579999999999985 58999999999999999987 7777777655 44555444333   111


Q ss_pred             ---hhhhhhccCCCc----------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 ---NMYDLVDKNAQP----------IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ---~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .+..+.|-+.-+          +-+.+...=.+|+.+.|.-+|..|.+++..++
T Consensus       226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               122333322211          11223334478999999999999999988765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-35  Score=274.74  Aligned_cols=218  Identities=18%  Similarity=0.101  Sum_probs=174.6

Q ss_pred             CCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEecCC
Q psy5927         156 GGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPN  233 (441)
Q Consensus       156 G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  233 (441)
                      |.||.||++.+.  ++.+|+|.+.....              ...|...+....||||+++++++.+.+..|+||||+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            899999999984  56799999864321              11344444556799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccce
Q psy5927         234 GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT  313 (441)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  313 (441)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.++++|||++......      
T Consensus        70 ~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------  138 (237)
T cd05576          70 GKLWSHISKF---LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------  138 (237)
T ss_pred             CCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc------
Confidence            9999988643   34889999999999999999999998  999999999999999999999999987543221      


Q ss_pred             eccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHH
Q psy5927         314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELN  393 (441)
Q Consensus       314 ~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (441)
                      .....++..|+|||.+.+..++.++|+||+|+++|||++|..|+.......          ..        ......+..
T Consensus       139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~--------~~~~~~~~~  200 (237)
T cd05576         139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NT--------HTTLNIPEW  200 (237)
T ss_pred             cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------cc--------ccccCCccc
Confidence            122346778999999988889999999999999999999998875432100          00        001123344


Q ss_pred             HHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         394 IAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       394 ~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                      ++..+.+++.+||+.||.+||++
T Consensus       201 ~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         201 VSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCHHHHHHHHHHccCCHHHhcCC
Confidence            56788999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587|consensus

Probab=100.00  E-value=1.7e-35  Score=299.68  Aligned_cols=256  Identities=21%  Similarity=0.330  Sum_probs=206.2

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      +..+...++-|++.+.||.|.+|.||++..  +++..|+|++........          .+..|.++|+.. .|||++.
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de----------EiE~eynil~~~~~hpnv~~   80 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE----------EIELEYNMLKKYSHHPNVAT   80 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH----------HHHHHHHHHHhccCCCCcce
Confidence            334445567899999999999999998875  567899999876543322          233678888777 6999999


Q ss_pred             ccceEEe-----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         214 LYGICFE-----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       214 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      +||+|..     ++.+|||||||.|||..|.+..-. +..+.|..+..|+.+++.|+.+||.+.  +||||||-.|||++
T Consensus        81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT  157 (953)
T KOG0587|consen   81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT  157 (953)
T ss_pred             EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe
Confidence            9999863     578999999999999999886555 677999999999999999999999988  99999999999999


Q ss_pred             CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      .++.+||+|||++....   .+.....+..||+.|||||++..     ..|+.++|+||||++..||.-|.+|+.+.+.-
T Consensus       158 ~e~~VKLvDFGvSaQld---sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm  234 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLD---STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM  234 (953)
T ss_pred             ccCcEEEeeeeeeeeee---cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence            99999999999987532   23334556789999999999954     34778999999999999999999999877641


Q ss_pred             HHHHHHHHHhhchhhhhhhhccC--CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKN--AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ..+            +......  ...-+...++++.++|..||.+|..+||++.++++
T Consensus       235 -raL------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 -RAL------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -hhh------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence             111            1111111  11225677889999999999999999999999875

>KOG1025|consensus

Probab=100.00  E-value=3.6e-36  Score=301.66  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=209.4

Q ss_pred             CcCcCccccCCceeEEEEEE--C----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         147 WDKLNILGKGGFGTVYKGVW--E----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ....++||.|+||+||+|.|  +    +-+||+|++......        .....++.|+-+|.++.|||+++|+|+|..
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--------~~s~e~LdeAl~masldHpnl~RLLgvc~~  769 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--------KASIELLDEALRMASLDHPNLLRLLGVCML  769 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--------hhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence            34568999999999999998  2    236899988643322        234567789999999999999999999976


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .. +-||++||++|+|.|+++.++  ..+.....+.|..||++|+.|||.+.  ++||||...|||+.+-..+||.|||+
T Consensus       770 s~-~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  770 ST-LQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             ch-HHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecch
Confidence            54 789999999999999997654  44777889999999999999999988  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++....... ........-.+.|||-|.++...|+.++|||||||++||++| |..||++....  .+.++++       
T Consensus       845 a~ll~~d~~-ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dlle-------  914 (1177)
T KOG1025|consen  845 AKLLAPDEK-EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLLE-------  914 (1177)
T ss_pred             hhccCcccc-cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHHh-------
Confidence            987543322 222222233557999999999999999999999999999999 99999987642  2222221       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                          +....+.|+.++.+++.++.+||..|++.||.++++.+.+.+...+..
T Consensus       915 ----~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  915 ----KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             ----ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence                122355678899999999999999999999999999999988776654

>KOG4236|consensus

Probab=100.00  E-value=3.1e-36  Score=289.29  Aligned_cols=244  Identities=21%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             cCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         150 LNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      .+.||.|-||+||-|.+  .++.||||++.+.+....       +..+...|+.||..++||.||.+-..|+..+..+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-------qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV  641 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-------QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV  641 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc-------hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence            47899999999999987  467899999986654332       234667999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---CCeEEeccCCCccC
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---MDPVIGDFGLTQEG  304 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---~~~kl~DFGla~~~  304 (441)
                      ||-+. |+..+++.... .+.|++.....++.||+.||.|||-++  |+|.||||+||||...   -.+||||||+|+..
T Consensus       642 MEKl~-GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  642 MEKLH-GDMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             ehhhc-chHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeec
Confidence            99995 55555554433 345888888999999999999999999  9999999999999654   46899999999985


Q ss_pred             CCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhc
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD  384 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  384 (441)
                      ....    ...++.||++|+|||+++.+.|....|+||.||++|--|+|..||.+..+..+++....-.+          
T Consensus       718 gEks----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy----------  783 (888)
T KOG4236|consen  718 GEKS----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY----------  783 (888)
T ss_pred             chhh----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc----------
Confidence            4332    23456899999999999999999999999999999999999999987654333322211111          


Q ss_pred             cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       385 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                       ...+| .+++....+||...|+..-.+|-|+.+.+
T Consensus       784 -Pp~PW-~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  784 -PPNPW-SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -CCCch-hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence             11222 35677888999999999999999988754

>KOG0608|consensus

Probab=100.00  E-value=1.7e-35  Score=289.54  Aligned_cols=207  Identities=21%  Similarity=0.301  Sum_probs=174.6

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .-|..++.||-|+||.|-+++...  ..||+|.+.+      ...+++.+..++..|-.||..-..+-||+||-.|.+.+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK------aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd  702 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK------ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD  702 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHH------HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence            457778899999999999988644  4688888753      24556677778889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||+|++||++..+|...+   -+.+..+..++.++.+|+++.|..|  +|||||||+|||||.+|++||+||||+.
T Consensus       703 nLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccc
Confidence            9999999999999999886543   4788899999999999999999999  9999999999999999999999999985


Q ss_pred             cCCCcc---------------------------------------cccceeccccccCCCcCcccccCCCCCCccceehH
Q psy5927         303 EGPIEK---------------------------------------ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGF  343 (441)
Q Consensus       303 ~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSl  343 (441)
                      -+....                                       .........+||+.|+|||++....|+..+|+||.
T Consensus       778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence            321100                                       00011123579999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCCcch
Q psy5927         344 GIVLFELATGMRAYDDTRR  362 (441)
Q Consensus       344 Gvvl~elltG~~p~~~~~~  362 (441)
                      |||||||+.|++||.....
T Consensus       858 gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  858 GVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             hHHHHHHhhCCCCccCCCC
Confidence            9999999999999976554

>KOG0671|consensus

Probab=100.00  E-value=2.1e-35  Score=274.83  Aligned_cols=266  Identities=23%  Similarity=0.316  Sum_probs=203.4

Q ss_pred             CCChhHHHHhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-C-C
Q psy5927         134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-H-D  209 (441)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p  209 (441)
                      +.-|......+++|.+...+|+|.||.|-.+.+..  ..||||+++...          ..++...-|+++|.++. + |
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----------kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----------KYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----------HHhhHHHHHHHHHHHHHhcCC
Confidence            34455556668999999999999999999988854  578999987321          23455668999999983 2 2


Q ss_pred             ----CeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         210 ----NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       210 ----nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                          -+|.+.++|.-.++.|+|+|.+ |-|+.|+|.. ++..+++..++..++.|++.+++|||+.+  ++|-||||+||
T Consensus       148 ~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENI  223 (415)
T KOG0671|consen  148 NGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENI  223 (415)
T ss_pred             CCceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheE
Confidence                3788889999999999999998 7799998853 35667899999999999999999999999  99999999999


Q ss_pred             eecC--------------------CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHH
Q psy5927         286 LLNH--------------------HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGI  345 (441)
Q Consensus       286 Ll~~--------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGv  345 (441)
                      |+.+                    +..++|+|||.|+......      +.++.|..|.|||++.|-.++..+||||+||
T Consensus       224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGC  297 (415)
T KOG0671|consen  224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGLGWSQPCDVWSIGC  297 (415)
T ss_pred             EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheeccCcCCccCceeeee
Confidence            9832                    3458899999998643221      4456899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCcchhHHHHHHHHHhh-c--hhhh------hhhhccCCCc-------------------h------h
Q psy5927         346 VLFELATGMRAYDDTRRSERHLKSLVEKY-S--EENM------YDLVDKNAQP-------------------I------E  391 (441)
Q Consensus       346 vl~elltG~~p~~~~~~~~~~l~~~~~~~-~--~~~~------~~~~~~~~~~-------------------~------~  391 (441)
                      ||+|+.||..-|..... .+++ .+++.+ .  +..+      .+++.....+                   +      .
T Consensus       298 IL~ElytG~~LFqtHen-~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~  375 (415)
T KOG0671|consen  298 ILVELYTGETLFQTHEN-LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD  375 (415)
T ss_pred             EEEEeeccceecccCCc-HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence            99999999999976553 3344 222222 1  0000      0111111111                   0      1


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       392 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ......+++|+.+||..||.+|+|+.|++.
T Consensus       376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  376 DLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            123456899999999999999999999875

>KOG0984|consensus

Probab=100.00  E-value=3.1e-35  Score=252.54  Aligned_cols=220  Identities=27%  Similarity=0.374  Sum_probs=177.9

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccc
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYG  216 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  216 (441)
                      +++..++...+..||+|+||.|-+-++  .++-.|+|.+.....+.        ..++.++|+.+..+. .+|.+|.+||
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--------~q~r~L~dldi~~r~~~CPf~V~FyG  112 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--------EQKRLLMDLDIIMRTVDCPFTVHFYG  112 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--------HHHHHHHhhhhhccCCCCCeEEEeeh
Confidence            455566677789999999998876665  67889999998655422        234567899987776 6999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeE
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLM-KKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ...+.+..++.||.| ..||..+-.. ......+++...-+|+..+++||.|||++ .  |||||+||+|||++.+|++|
T Consensus       113 a~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVK  189 (282)
T KOG0984|consen  113 ALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVK  189 (282)
T ss_pred             hhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEE
Confidence            999999999999999 5788765432 12345578888889999999999999984 5  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccC----CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      |||||++-....+-+.+.    -.|...|||||.+..    ..|+.++||||||+.+.||.+++.||+.....-++++.+
T Consensus       190 iCDFGIsG~L~dSiAkt~----daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  190 ICDFGISGYLVDSIAKTM----DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             EcccccceeehhhhHHHH----hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence            999999876544333222    248889999999854    368999999999999999999999999988767778777


Q ss_pred             HHhh
Q psy5927         371 VEKY  374 (441)
Q Consensus       371 ~~~~  374 (441)
                      +++-
T Consensus       266 Veep  269 (282)
T KOG0984|consen  266 VEEP  269 (282)
T ss_pred             hcCC
Confidence            6543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.5e-34  Score=297.60  Aligned_cols=260  Identities=19%  Similarity=0.196  Sum_probs=167.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      ...++|++.++||+|+||.||+|.+.      +..||+|++......   +.        ...|  .+....+.++..+.
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~--------~~~e--~l~~~~~~~~~~~~  195 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EI--------WMNE--RVRRACPNSCADFV  195 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HH--------HHHH--HHHhhchhhHHHHH
Confidence            35689999999999999999999984      457999987532211   00        0001  11111222222222


Q ss_pred             ce------EEeCCeEEEEEEecCCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy5927         216 GI------CFETGKYCLVYRYMPNGSLEDRLLMKKNT-----------------PSLLWTQRLHIAKGTSLGLQFLHSRE  272 (441)
Q Consensus       216 ~~------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~al~~LH~~~  272 (441)
                      ..      +..+..+++||||+++++|.+++......                 .......+..++.|++.||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g  275 (566)
T PLN03225        196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG  275 (566)
T ss_pred             HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence            21      24567789999999999999988643210                 01112345679999999999999998


Q ss_pred             CCeeecCCCCCCeeecC-CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-------------------
Q psy5927         273 PPLIHGDIKSANILLNH-HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-------------------  332 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------  332 (441)
                        |+||||||+|||++. ++.+||+|||+++......  ........+|+.|||||.+...                   
T Consensus       276 --IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l  351 (566)
T PLN03225        276 --IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL  351 (566)
T ss_pred             --EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence              999999999999986 5899999999997543221  1122345789999999966432                   


Q ss_pred             ---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc--hhhhhhhhccCCCch-h------HHHHHHHHH
Q psy5927         333 ---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS--EENMYDLVDKNAQPI-E------LNIAYAFFR  400 (441)
Q Consensus       333 ---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~-~------~~~~~~l~~  400 (441)
                         .++.++|||||||+||||+++..+++...   ..+...+....  ............... .      ........+
T Consensus       352 ~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d  428 (566)
T PLN03225        352 WQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE  428 (566)
T ss_pred             ccccCCCCcccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence               23456799999999999999776654321   11111111110  001111111110000 0      001223558


Q ss_pred             HHHHhcCCCCCCCCCHHHHHH
Q psy5927         401 IGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       401 li~~cl~~dp~~RPs~~evl~  421 (441)
                      |+.+||+.||++|||+.++++
T Consensus       429 Li~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        429 LLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHHccCCcccCCCHHHHhC
Confidence            999999999999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.6e-34  Score=288.37  Aligned_cols=272  Identities=18%  Similarity=0.219  Sum_probs=184.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE------------------CCeeEEEEEeeeccchhHHHhhh-----HHHHHHHHH
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW------------------EKTTIAVKKLEVHRNDRAVETLN-----QCQREQSLR  198 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~~~-----~~~~~~~~~  198 (441)
                      ...++|++.++||+|+||+||+|.+                  .+..||||+++........++++     ....+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            4578999999999999999999974                  23469999987543322111111     111233446


Q ss_pred             HHHHhhcCCCCCe-----ecccceEEe--------CCeEEEEEEecCCCCHHHHHhhcCC--------------------
Q psy5927         199 ELKYLNSCRHDNI-----LPLYGICFE--------TGKYCLVYRYMPNGSLEDRLLMKKN--------------------  245 (441)
Q Consensus       199 E~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------  245 (441)
                      |+.++.+++|.++     ++++++|..        .+..+|||||+++++|.+++.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777888876654     677777653        3568999999999999998864321                    


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCc
Q psy5927         246 -TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL  324 (441)
Q Consensus       246 -~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~  324 (441)
                       ...+++..+..++.+++.||.|||+.+  |+||||||+|||++.++.+||+|||+++........  ......+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCccee
Confidence             123467788899999999999999998  999999999999999999999999999653322111  111123478999


Q ss_pred             CcccccCCC--------------------C--CCccceehHHHHHHHHHhCCC-CCCCcchhHHHHHH---HHHhhchhh
Q psy5927         325 PHEFLVGKR--------------------L--STKVDVYGFGIVLFELATGMR-AYDDTRRSERHLKS---LVEKYSEEN  378 (441)
Q Consensus       325 aPE~~~~~~--------------------~--s~~~DiwSlGvvl~elltG~~-p~~~~~~~~~~l~~---~~~~~~~~~  378 (441)
                      |||.+....                    +  ..+.|+||+||++|+|++|.. ||.........++.   ....+... 
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-  456 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-  456 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-
Confidence            999886432                    1  124799999999999999875 77543221111111   01111000 


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNP---KERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~evl~  421 (441)
                        .-..... ......+....+|++++|..+|   .+|+|++|+++
T Consensus       457 --~~~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 --KGQKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             --cccCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence              0000001 1122356778999999999766   68999999986

>KOG0669|consensus

Probab=100.00  E-value=3e-36  Score=265.89  Aligned_cols=267  Identities=23%  Similarity=0.392  Sum_probs=196.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      .+.|+...+||+|.||.||+|+.++  +.||+|++-......+.       ....++|+++|..++|+|++.+++.|.. 
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf-------pitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC-------cHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            3567788999999999999998754  46788776543222211       2244689999999999999999998852 


Q ss_pred             -------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         221 -------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       221 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                             ...+++||.+|+ .+|...|...  ...++..++..+..+++.||.|+|+..  |+|||+|++|+||+.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceE
Confidence                   345899999995 7788777432  245888999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCccc-ccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHH---
Q psy5927         294 VIGDFGLTQEGPIEKA-THITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK---  368 (441)
Q Consensus       294 kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~---  368 (441)
                      ||+|||+++....++. .....+..+-|.+|.+||.+.| ..|+++.|||.-|||+.||+||.+.+.+..+.. .+.   
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~~Is  242 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLHLIS  242 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH-HHHHHH
Confidence            9999999976543332 1222334456999999999988 579999999999999999999999998776522 222   


Q ss_pred             HHHHhhchh--------hhhhhhccC-----CCchhHHH------HHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         369 SLVEKYSEE--------NMYDLVDKN-----AQPIELNI------AYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       369 ~~~~~~~~~--------~~~~~~~~~-----~~~~~~~~------~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                      .+...+..+        .+...+...     ....-.+.      ..+..+|+.++|..||.+|+.+.++++.-
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            121111111        111111000     00001111      23678999999999999999999998643

>KOG1024|consensus

Probab=100.00  E-value=1.3e-34  Score=269.61  Aligned_cols=268  Identities=25%  Similarity=0.358  Sum_probs=215.8

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD  209 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  209 (441)
                      .+++.+...+++....+-+|.||.||+|.|..       +.+-||.++...        .+.+...++.|-..+....||
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--------S~iQv~~~L~es~lly~~sH~  347 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--------SQIQVNLLLQESMLLYGASHP  347 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--------cHHHHHHHHHHHHHHhcCcCC
Confidence            45677778889999999999999999997742       235566665332        234566778899999999999


Q ss_pred             CeecccceEEeC-CeEEEEEEecCCCCHHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN-----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       210 nIv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      |+..+.+++.++ ...+.+|.++.-|+|..+|..++.     ...++-.+...++.|++.|++|||+++  |||.||...
T Consensus       348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaR  425 (563)
T KOG1024|consen  348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAAR  425 (563)
T ss_pred             CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhh
Confidence            999999998654 678899999999999999984432     234666788899999999999999999  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcch
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR  362 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~  362 (441)
                      |++||+..++||+|=.++|..-..+ .+.-...-.....||+||.+....|+.++|+|||||+||||+| |..||.+.+.
T Consensus       426 NCvIdd~LqVkltDsaLSRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP  504 (563)
T KOG1024|consen  426 NCVIDDQLQVKLTDSALSRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP  504 (563)
T ss_pred             cceehhheeEEeccchhccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence            9999999999999999998754332 2222223335667999999999999999999999999999999 9999987754


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      .+..             .-+.|......|.+|+.+++.++..||+.+|++||+++|+...|++...
T Consensus       505 fEm~-------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  505 FEME-------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             HHHH-------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            2211             1123444556678899999999999999999999999999999987543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.7e-33  Score=260.84  Aligned_cols=238  Identities=28%  Similarity=0.424  Sum_probs=189.7

Q ss_pred             CceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEecCCC
Q psy5927         157 GFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNG  234 (441)
Q Consensus       157 ~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  234 (441)
                      +||.||+|.+.+  ..+++|++........        .+.+.+|++.+++++|+||+++++++......++++||++++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   72 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGG   72 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCC
Confidence            689999999854  7899999875432110        345668999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccccccee
Q psy5927         235 SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL  314 (441)
Q Consensus       235 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~  314 (441)
                      +|.+++.....   +++..+..++.+++.++.|||+.+  ++|+||+|+||+++.++.++|+|||++.......    ..
T Consensus        73 ~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~  143 (244)
T smart00220       73 DLFDLLKKRGR---LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LL  143 (244)
T ss_pred             CHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc----cc
Confidence            99998864332   788999999999999999999998  9999999999999999999999999987643321    22


Q ss_pred             ccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHH
Q psy5927         315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNI  394 (441)
Q Consensus       315 ~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (441)
                      ....++..|+|||.+.+..++.++|+||||+++++|++|..||..................          ........+
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~  213 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP----------PFPPPEWKI  213 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC----------CCccccccC
Confidence            3445888999999998888999999999999999999999999764322222211110000          000000115


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         395 AYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       395 ~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +.++.+++.+||..+|++||++.++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhh
Confidence            678999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668|consensus

Probab=100.00  E-value=2e-34  Score=251.10  Aligned_cols=265  Identities=17%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             CCCChhHHHH---hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC
Q psy5927         133 PHIPYQELTL---ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR  207 (441)
Q Consensus       133 ~~~~~~~~~~---~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  207 (441)
                      ..|.|+...+   ..++|++.+++|+|.|+.||.|..  ++..++||+++..+            .+.+.+|+++|..++
T Consensus        23 eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------------kkKIkREikIL~nL~   90 (338)
T KOG0668|consen   23 EYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------------KKKIKREIKILQNLR   90 (338)
T ss_pred             hhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------------HHHHHHHHHHHHhcc
Confidence            3455555433   346899999999999999999984  67789999997532            335569999999996


Q ss_pred             -CCCeecccceEEeC--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCC
Q psy5927         208 -HDNILPLYGICFET--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN  284 (441)
Q Consensus       208 -hpnIv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~N  284 (441)
                       ||||+.|++...+.  ..+.||+||+++.+.....      +.++...+..++.++++||.|+|+.|  |+|||+||.|
T Consensus        91 gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhN  162 (338)
T KOG0668|consen   91 GGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHN  162 (338)
T ss_pred             CCCCeeehhhhhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcce
Confidence             99999999998765  5678999999988776533      33666788999999999999999999  9999999999


Q ss_pred             eeecCC-CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcch
Q psy5927         285 ILLNHH-MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRR  362 (441)
Q Consensus       285 iLl~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~  362 (441)
                      +++|.. -.++|+|+|||.+.......+    ....+..|-.||.+.. +.|+.+.|+|||||+++.|+..+.||-....
T Consensus       163 vmIdh~~rkLrlIDWGLAEFYHp~~eYn----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d  238 (338)
T KOG0668|consen  163 VMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  238 (338)
T ss_pred             eeechhhceeeeeecchHhhcCCCceee----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence            999976 458999999998865544333    3346788999999876 5689999999999999999999999866555


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhH-----------------------H-HHHHHHHHHHHhcCCCCCCCCCHHH
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIEL-----------------------N-IAYAFFRIGKQSTKQNPKERPEMTQ  418 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~-~~~~l~~li~~cl~~dp~~RPs~~e  418 (441)
                      ...++..+......+.+..++++....+++                       . .+.+..+|+.+.|..|..+|+|++|
T Consensus       239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence            455554444443333333332221111111                       1 2367889999999999999999999


Q ss_pred             HHH
Q psy5927         419 VYN  421 (441)
Q Consensus       419 vl~  421 (441)
                      .+.
T Consensus       319 am~  321 (338)
T KOG0668|consen  319 AMA  321 (338)
T ss_pred             Hhc
Confidence            764

>KOG1027|consensus

Probab=100.00  E-value=9e-35  Score=293.22  Aligned_cols=247  Identities=24%  Similarity=0.379  Sum_probs=190.9

Q ss_pred             CCcCcCccccCCcee-EEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGT-VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~  223 (441)
                      -|...+.+|.|+-|+ ||+|...++.||||++-..            ......+|+..|... .|||||++|+.-.+...
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e------------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE------------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhH------------hHHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            344557899998875 8999999999999998532            122345899999888 69999999999889999


Q ss_pred             EEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---C--CCeEEec
Q psy5927         224 YCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---H--MDPVIGD  297 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~--~~~kl~D  297 (441)
                      .|+..|.| ..+|.|++... ...........+.+..|++.||++||+.+  ||||||||.||||+.   +  ..++|+|
T Consensus       578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecc
Confidence            99999999 69999999763 11111111345788999999999999999  999999999999976   3  4679999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC-CCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG-MRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++................||-+|+|||++....-+.++||||+|||+|+.++| .+||.+.-..+..+  +.   ..
T Consensus       655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l~---~~  729 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--LT---GN  729 (903)
T ss_pred             cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--hc---Cc
Confidence            99999876665555556677899999999999998888899999999999999995 99998764422111  10   00


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                      .....     ..+.+ ++  +..+||.+|++.+|..||++.+|+
T Consensus       730 ~~L~~-----L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  730 YTLVH-----LEPLP-DC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             cceee-----eccCc-hH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            00000     01111 11  678999999999999999999996

>KOG1290|consensus

Probab=99.98  E-value=2.3e-31  Score=254.29  Aligned_cols=266  Identities=25%  Similarity=0.328  Sum_probs=194.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-----C---CCee
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-----H---DNIL  212 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv  212 (441)
                      ..++|.+.++||.|.|++||+|.+  .++.||+|+.+..          +-..+..+.|+++|++++     |   ..||
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----------qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV  145 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----------QHYTEAALDEIKLLQQVREGDPNDPGKKCVV  145 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----------hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence            348999999999999999999998  4578999998732          123455678999998873     2   3699


Q ss_pred             cccceEE----eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeee
Q psy5927         213 PLYGICF----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILL  287 (441)
Q Consensus       213 ~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl  287 (441)
                      +|+++|.    .+.++|+|+|++ |.+|..+|... +...++...+..|++||+.||.|||. .|  |||-||||+|||+
T Consensus       146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence            9999986    456899999999 88999888654 44569999999999999999999998 45  9999999999999


Q ss_pred             cCC-----------C-----------------------------------------------------------------
Q psy5927         288 NHH-----------M-----------------------------------------------------------------  291 (441)
Q Consensus       288 ~~~-----------~-----------------------------------------------------------------  291 (441)
                      ..+           +                                                                 
T Consensus       222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~  301 (590)
T KOG1290|consen  222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE  301 (590)
T ss_pred             eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence            211           0                                                                 


Q ss_pred             --------------------------------------------------------------------------------
Q psy5927         292 --------------------------------------------------------------------------------  291 (441)
Q Consensus       292 --------------------------------------------------------------------------------  291 (441)
                                                                                                      
T Consensus       302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~  381 (590)
T KOG1290|consen  302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN  381 (590)
T ss_pred             ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence                                                                                            


Q ss_pred             ----------CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCC--
Q psy5927         292 ----------DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD--  359 (441)
Q Consensus       292 ----------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~--  359 (441)
                                .+||+|||-|+..      ...++.-..|..|.|||++.|..|++.+||||++|+++||+||..-|+.  
T Consensus       382 p~~~~~~~di~vKIaDlGNACW~------~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs  455 (590)
T KOG1290|consen  382 PDIPLPECDIRVKIADLGNACWV------HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS  455 (590)
T ss_pred             CCCCCCccceeEEEeeccchhhh------hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence                      0111112111110      0011112367889999999999999999999999999999999998853  


Q ss_pred             ---cchhHHHHHHHHHhhchh---------hhhhhhccC--------CC------------chhHHHHHHHHHHHHHhcC
Q psy5927         360 ---TRRSERHLKSLVEKYSEE---------NMYDLVDKN--------AQ------------PIELNIAYAFFRIGKQSTK  407 (441)
Q Consensus       360 ---~~~~~~~l~~~~~~~~~~---------~~~~~~~~~--------~~------------~~~~~~~~~l~~li~~cl~  407 (441)
                         ...++.++..+++....-         .-.++++..        ..            .++...+.++.+++.-||+
T Consensus       456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe  535 (590)
T KOG1290|consen  456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE  535 (590)
T ss_pred             CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence               223455555554433211         111222221        11            2345677889999999999


Q ss_pred             CCCCCCCCHHHHHH--HHhcCCC
Q psy5927         408 QNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       408 ~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      .+|++|||+.+.++  +|.....
T Consensus       536 f~PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  536 FDPEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             cCccccccHHHHhcCccccCCCC
Confidence            99999999999986  5554444

>KOG0670|consensus

Probab=99.97  E-value=6.3e-32  Score=259.48  Aligned_cols=269  Identities=20%  Similarity=0.265  Sum_probs=210.0

Q ss_pred             CCChhHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC---
Q psy5927         134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH---  208 (441)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---  208 (441)
                      ++.+.-.++.-++|.+....|+|-|++|-+|.+.  +..||||++....          ...+.-+.|+++|++|..   
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----------~M~KtGl~EleiLkKL~~AD~  490 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----------VMHKTGLKELEILKKLNDADP  490 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----------HHhhhhhHHHHHHHHhhccCc
Confidence            4444455667789999999999999999999984  5689999997422          223344689999999842   


Q ss_pred             ---CCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         209 ---DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       209 ---pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                         -++++|+-.|...+++|||+|-+ ..+|.+.|...+....|....+..++.|+..||..|...|  |+|.||||.||
T Consensus       491 Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNi  567 (752)
T KOG0670|consen  491 EDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNI  567 (752)
T ss_pred             hhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccce
Confidence               37999999999999999999988 6999999988888888999999999999999999999999  99999999999


Q ss_pred             eecCCC-CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         286 LLNHHM-DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       286 Ll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      |+++.. .+||||||.|........+..     .-+..|.|||++.|-.|+...|+||.||.||||.||+.-|.+.....
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~eneitPY-----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~  642 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASENEITPY-----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ  642 (752)
T ss_pred             EeccCcceeeeccCccccccccccccHH-----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence            999874 579999999976544433332     34667999999999999999999999999999999999998765532


Q ss_pred             HHHHHHHHh---hchh-----hhh-hhhc--------------------------c------------CCCchhHHHHHH
Q psy5927         365 RHLKSLVEK---YSEE-----NMY-DLVD--------------------------K------------NAQPIELNIAYA  397 (441)
Q Consensus       365 ~~l~~~~~~---~~~~-----~~~-~~~~--------------------------~------------~~~~~~~~~~~~  397 (441)
                       .|+.+++.   +...     .+. +-+|                          +            ........+...
T Consensus       643 -MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~  721 (752)
T KOG0670|consen  643 -MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ  721 (752)
T ss_pred             -HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence             33322221   1100     000 0000                          0            011223446677


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         398 FFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       398 l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +.+|+.+||..||.+|.+..+.+.
T Consensus       722 ~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHhccChhhcCCHHHHhc
Confidence            899999999999999999999875

>KOG0664|consensus

Probab=99.97  E-value=4.1e-33  Score=248.63  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=190.0

Q ss_pred             CCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC--
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET--  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  221 (441)
                      +.+..+.||.|+||.||..++  +++.||+|++...-.       +-...+.+++|+++|..++|.|++..++...-.  
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-------~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~  126 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-------NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP  126 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-------HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence            445568999999999999887  567899998753211       123456788999999999999999998875433  


Q ss_pred             ---CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         222 ---GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       222 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                         ..+|.+.|.| ..+|...+.   ....++-..+.-+..||++||.|||+.+  |.||||||.|+|++.+..+|||||
T Consensus       127 dfFqEiYV~TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  127 SFFQELYVLTELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             hHHHHHHHHHHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEeccc
Confidence               2356788888 467776653   2345777888889999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh---
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY---  374 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---  374 (441)
                      |+++........+++  ...-|..|.|||.+.| ..|+.++||||.||++.|||..+--|...... +++.-+.+-.   
T Consensus       201 GLARvee~d~~~hMT--qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItdLLGTP  277 (449)
T KOG0664|consen  201 GLARTWDQRDRLNMT--HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIIDLLGTP  277 (449)
T ss_pred             ccccccchhhhhhhH--HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHHHhCCC
Confidence            999875443333322  2245889999999988 46899999999999999999888878655432 2332222222   


Q ss_pred             chhhhhh--------hhccC--CCc--------hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         375 SEENMYD--------LVDKN--AQP--------IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       375 ~~~~~~~--------~~~~~--~~~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                      ..+.+..        ++...  ...        .+..-..+...+.+++|..||++|.+..+.+..+
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            2222211        11110  000        0112233567888999999999999998887644

>KOG0576|consensus

Probab=99.97  E-value=9.2e-33  Score=272.29  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=200.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|+.+.++|.|+||.|||+++.  +...|+|+++....+...         -..+|+-+++.++|||||.++|.+...
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~---------~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS---------GIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccc---------ccccceeeeecCCCcChHHHHhhhhhh
Confidence            367999999999999999999985  457899999876543321         223788999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..+++.||||.||+|+|.-   ..++++++.++..++++.+.|++|||+.|  -+|||||-.|||+++.|.+|+.|||.+
T Consensus        85 dklwicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             cCcEEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCch
Confidence            9999999999999999965   35778999999999999999999999999  899999999999999999999999987


Q ss_pred             ccCCCcccccceeccccccCCCcCcccc---cCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFL---VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      -...   .+-.....+.||+.|||||+-   +.+.|...+|||++|+...|+---.+|..+... ...+.-+-.      
T Consensus       160 aqit---ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-mr~l~LmTk------  229 (829)
T KOG0576|consen  160 AQIT---ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-MRALFLMTK------  229 (829)
T ss_pred             hhhh---hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-HHHHHHhhc------
Confidence            5532   233445677899999999975   345799999999999999999888887655443 111111110      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                        ...++.........++.+.++++.||.++|++||+++.++
T Consensus       230 --S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  230 --SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             --cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence              0111112222334566789999999999999999998764

>KOG1152|consensus

Probab=99.97  E-value=1.6e-32  Score=266.59  Aligned_cols=204  Identities=22%  Similarity=0.321  Sum_probs=169.8

Q ss_pred             CCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---CCCeecccceEE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---HDNILPLYGICF  219 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~  219 (441)
                      .+|..++.+|+|+||.|++|.++.  ..|+||.+.+.+.-.+. ++.....-.+-.|++||+.++   |+||++++++|+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~Dt-WvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDT-WVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhh-hhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            468899999999999999999854  56888888755432221 111112223447999999997   999999999999


Q ss_pred             eCCeEEEEEEec-CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         220 ETGKYCLVYRYM-PNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       220 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      +++.+||+||-. +|-+|+|++..+   +.+++..+..|+.|++.|+++||+.|  |||||||-+||.++.+|-+||+||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEeec
Confidence            999999999976 467899988544   45899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCC
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDD  359 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~  359 (441)
                      |.|.....     ..+..+.||..|.|||++.|.+| +..-|||++|++||.++....||.+
T Consensus       715 gsaa~~ks-----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  715 GSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cchhhhcC-----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            98865332     23566789999999999999877 6779999999999999998888854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.5e-30  Score=232.61  Aligned_cols=211  Identities=34%  Similarity=0.552  Sum_probs=180.2

Q ss_pred             cccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         153 LGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       153 LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ||+|++|.||++...  +..+++|++.......        ..+.+.+|+++++.++|++|+++++++......++++||
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~   72 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEY   72 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEec
Confidence            689999999999997  7889999987543221        234567899999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEeccCCCccCCCccc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDFGLTQEGPIEKA  309 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~DFGla~~~~~~~~  309 (441)
                      +++++|.+++....  ..+++..+..++.+++.++++||+.+  ++|+||+|.||+++. ++.++|+|||.+........
T Consensus        73 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~  148 (215)
T cd00180          73 CEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS  148 (215)
T ss_pred             CCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence            99999999886442  35888999999999999999999998  999999999999999 89999999999876433221


Q ss_pred             ccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC
Q psy5927         310 THITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ  388 (441)
Q Consensus       310 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  388 (441)
                         ......+...|++||.+... .++.++|+|++|+++++|                                      
T Consensus       149 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         149 ---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             ---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence               12234578889999999876 788999999999999999                                      


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                             ..+.+++.+|++.+|.+||++.++++.+
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   3577899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665|consensus

Probab=99.97  E-value=4.9e-31  Score=240.49  Aligned_cols=257  Identities=23%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|..+..+|.|.- .|-.|.+  .+..||+|++.....       +....+...+|..++..+.|+||+.++.+|.-.
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-------n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-------NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-------cCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            357777889999988 5656665  467899998764422       223345667999999999999999999998633


Q ss_pred             ------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 ------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                            ...|+||||| ..+|...++.     .++......|+.|++.|++|||+.+  |+||||||+||++..++.+||
T Consensus        88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             ccHHHHHhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheee
Confidence                  4579999999 5888887752     3667888999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      .|||+|+...    .....+.+..|..|.|||++.+..+.+.+||||+||++.||++|.--|.+....+.+.+. .+...
T Consensus       160 ~dfg~ar~e~----~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki-~~~lg  234 (369)
T KOG0665|consen  160 LDFGLARTED----TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI-IEQLG  234 (369)
T ss_pred             ccchhhcccC----cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH-HHHhc
Confidence            9999998532    223445567899999999999988999999999999999999999988765543322221 11110


Q ss_pred             --hhhhh-----------------------h-hhccCC---CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 --EENMY-----------------------D-LVDKNA---QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 --~~~~~-----------------------~-~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ...+.                       . +.|...   ..-+..-+.-+.+|+.+||-.||++|.|+.+++.
T Consensus       235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence              00000                       0 000000   0001112334688999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.7e-29  Score=228.76  Aligned_cols=199  Identities=34%  Similarity=0.486  Sum_probs=168.1

Q ss_pred             CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      |.+.+.||.|++|.||+|...  +..+++|.+......        ...+.+.+|++.+..++|+|++++++++......
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~   72 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL   72 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce
Confidence            567789999999999999985  478999998754322        1344566899999999999999999999998999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++++||+++++|.+++......  +++..+..++.+++.++.+||+.+  ++|+||+|.||+++.++.++|+|||++...
T Consensus        73 ~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~  148 (225)
T smart00221       73 YLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFI  148 (225)
T ss_pred             EEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence            9999999999999988654321  788999999999999999999998  999999999999999999999999998765


Q ss_pred             CCcccccceeccccccCCCcCcccc-cCCCCCCccceehHHHHHHHHHhCCCCCCC
Q psy5927         305 PIEKATHITLKRVNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELATGMRAYDD  359 (441)
Q Consensus       305 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DiwSlGvvl~elltG~~p~~~  359 (441)
                      .....  .......++..|++||.+ ....++.++|+||||++++||++|+.||..
T Consensus       149 ~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      149 HRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            43320  012334578889999998 666788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167|consensus

Probab=99.96  E-value=1.8e-29  Score=238.33  Aligned_cols=263  Identities=22%  Similarity=0.323  Sum_probs=194.6

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      .....+.|..+++||+|+|++||+|.+.     ...||+|.+.....           ...+..|+++|..+ .+.||++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----------p~ri~~El~~L~~~gG~~ni~~   99 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----------PSRILNELEMLYRLGGSDNIIK   99 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----------chHHHHHHHHHHHhccchhhhc
Confidence            3445678999999999999999999863     35799999875432           22456899999999 5999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CC
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MD  292 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~  292 (441)
                      +.+++..++..++|+||++..+..+++.      .++...+..+++.++.||.++|.+|  ||||||||+|+|.+.. +.
T Consensus       100 ~~~~~rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  100 LNGCFRNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             chhhhccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCC
Confidence            9999999999999999999998888763      2667889999999999999999999  9999999999999865 56


Q ss_pred             eEEeccCCCccC-----------------CC--c------------cccc----------ceeccccccCCCcCcccccC
Q psy5927         293 PVIGDFGLTQEG-----------------PI--E------------KATH----------ITLKRVNGTRPYLPHEFLVG  331 (441)
Q Consensus       293 ~kl~DFGla~~~-----------------~~--~------------~~~~----------~~~~~~~gt~~y~aPE~~~~  331 (441)
                      -.|.|||||...                 ..  .            ....          .......||++|.|||++..
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            789999998610                 00  0            0000          00112469999999999876


Q ss_pred             -CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh---------------------------hh
Q psy5927         332 -KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD---------------------------LV  383 (441)
Q Consensus       332 -~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~---------------------------~~  383 (441)
                       +.-++++||||.|||++.+++++.||-....+-..+..+........+.+                           -+
T Consensus       252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~  331 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL  331 (418)
T ss_pred             ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence             45688999999999999999999999654433333322222111111100                           00


Q ss_pred             c-----c------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 D-----K------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~-----~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +     +      .........+..+++|+.+||..||.+|.++++.++
T Consensus       332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            0     0      001111223447899999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.4e-29  Score=272.49  Aligned_cols=198  Identities=17%  Similarity=0.164  Sum_probs=140.5

Q ss_pred             hcCCC-CCeecccceE-------EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5927         204 NSCRH-DNILPLYGIC-------FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPL  275 (441)
Q Consensus       204 ~~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~i  275 (441)
                      +.++| +||+.++++|       .+...+++++||+ +++|.++|...  ...+++.+++.++.||+.||.|||++|  |
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--I  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--I  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence            34456 5888888877       3334677889988 67999999532  345899999999999999999999999  9


Q ss_pred             eecCCCCCCeeecCC-------------------CCeEEeccCCCccCCCccc-------------ccceeccccccCCC
Q psy5927         276 IHGDIKSANILLNHH-------------------MDPVIGDFGLTQEGPIEKA-------------THITLKRVNGTRPY  323 (441)
Q Consensus       276 iHrDikp~NiLl~~~-------------------~~~kl~DFGla~~~~~~~~-------------~~~~~~~~~gt~~y  323 (441)
                      |||||||+||||+..                   +.+||+|||+++.......             .........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4456666666643210000             00001124589999


Q ss_pred             cCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHH
Q psy5927         324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGK  403 (441)
Q Consensus       324 ~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  403 (441)
                      ||||++.+..++.++|||||||+||||++|.+|+.....   ....+....        ...    ..........+++.
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~--------~~~----~~~~~~~~~~~~~~  246 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV--------LPP----QILLNWPKEASFCL  246 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh--------cCh----hhhhcCHHHHHHHH
Confidence            999999999999999999999999999999988754321   111111100        000    00011234568889


Q ss_pred             HhcCCCCCCCCCHHHHHH
Q psy5927         404 QSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       404 ~cl~~dp~~RPs~~evl~  421 (441)
                      +||+.+|.+||++.+|++
T Consensus       247 ~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        247 WLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HhCCCChhhCcChHHHhh
Confidence            999999999999999976

>KOG1345|consensus

Probab=99.96  E-value=2e-29  Score=225.06  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=180.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccce-E
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGI-C  218 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~  218 (441)
                      ..+.|.+.+.||+|.||.+-+++++  ++.+++|.+....          .....|.+|...--.+ .|.||+.-|+. |
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----------TTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----------hhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            3467999999999999999999986  4678998886321          2344567888765555 59999998775 5


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec--CCCCeEEe
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN--HHMDPVIG  296 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~--~~~~~kl~  296 (441)
                      ...+.+++++||++.|+|..-+.    ...+.+.....++.|+++||.|+|+++  +||||||.+|||+-  +...+|||
T Consensus        92 qt~d~YvF~qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   92 QTSDAYVFVQEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             hcCceEEEeeccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEee
Confidence            66678889999999999987553    244778888999999999999999999  99999999999994  23479999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC---C--CCCCccceehHHHHHHHHHhCCCCCCCcchhH-HHHHHH
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG---K--RLSTKVDVYGFGIVLFELATGMRAYDDTRRSE-RHLKSL  370 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~-~~l~~~  370 (441)
                      |||+.+...      .......-+..|.+||....   +  ...+.+|+|.||++++.++||..||......+ .+... 
T Consensus       166 DFG~t~k~g------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~-  238 (378)
T KOG1345|consen  166 DFGLTRKVG------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW-  238 (378)
T ss_pred             ecccccccC------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH-
Confidence            999986421      22333445778999997643   2  34678999999999999999999997432211 12111 


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                       ..|...     ...+....-..+++.+..+.++-|..++++|--+.++
T Consensus       239 -~~w~~r-----k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  239 -EQWLKR-----KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             -HHHhcc-----cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence             111111     0111111222356677888899999999999544444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.5e-27  Score=211.30  Aligned_cols=167  Identities=20%  Similarity=0.218  Sum_probs=129.1

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccce
Q psy5927         234 GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT  313 (441)
Q Consensus       234 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~  313 (441)
                      |||.+++..+  ..++++..+..|+.|++.||+|||+.+        ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc------
Confidence            7899988643  345999999999999999999999876        999999999999999  9998754321      


Q ss_pred             eccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHH
Q psy5927         314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELN  393 (441)
Q Consensus       314 ~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  393 (441)
                        ...||+.|||||++.+..++.++|||||||++|||+||..||.........+..+.......      +.........
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~  134 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------DPRDRSNLES  134 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------CccccccHHH
Confidence              12589999999999999999999999999999999999999976543233333332221111      0111112233


Q ss_pred             HHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         394 IAY--AFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       394 ~~~--~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      +..  .+.+++.+||..+|.+||++.++++.+...
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            444  699999999999999999999999987544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165|consensus

Probab=99.94  E-value=3e-26  Score=210.15  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=201.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      +..-+|.++++||+|+||.++.|..  ++..||||.-....           ...++..|.+..+.| ..++|..+|-+.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----------~APQLrdEYr~YKlL~g~~GIP~vYYFG   93 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----------EAPQLRDEYRTYKLLGGTEGIPQVYYFG   93 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC-----------CcchHHHHHHHHHHHcCCCCCCceeeec
Confidence            3445899999999999999999986  78899999765332           123445677776666 579999999998


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-----CCe
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-----MDP  293 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-----~~~  293 (441)
                      .++.+-.||||++ |.||+|.+.-+.+  .++...++-||.|++.-++|+|++.  +|+|||||+|+||..-     ..+
T Consensus        94 qeG~~NiLVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~I  168 (449)
T KOG1165|consen   94 QEGKYNILVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVI  168 (449)
T ss_pred             cccchhhhhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceE
Confidence            9988889999999 8999998876654  3888999999999999999999999  9999999999999754     347


Q ss_pred             EEeccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      .|+|||+|+...+.....    .......||..||+--...|.+-+.+.|+-|||-|+++.|-|..||.+...+.  .+.
T Consensus       169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~  246 (449)
T KOG1165|consen  169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKE  246 (449)
T ss_pred             EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHH
Confidence            899999999876554322    12345679999999999999999999999999999999999999999876532  222


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      ..+.+.+..    .......++..++.++..-+...-+.+-.+-|..+-+...+.
T Consensus       247 kYeKIGe~K----r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  247 KYEKIGETK----RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             HHHHhcccc----ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            222222211    011122345667778877777777778888898876655443

>KOG1164|consensus

Probab=99.94  E-value=1.4e-25  Score=218.16  Aligned_cols=263  Identities=19%  Similarity=0.186  Sum_probs=192.6

Q ss_pred             CCcCcCccccCCceeEEEEEECCe---eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC----CCCeecccceE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEKT---TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR----HDNILPLYGIC  218 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----hpnIv~l~~~~  218 (441)
                      +|.+.++||+|+||.||.+.+...   .+|+|..........         ..+..|..++..+.    -+++..+++.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G   89 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---------SVLKIEIQVLKKLEKKNGPSHFPKLLDHG   89 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---------ccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence            899999999999999999998654   588887764322111         02336777777775    25788888888


Q ss_pred             -EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-----CC
Q psy5927         219 -FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-----MD  292 (441)
Q Consensus       219 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-----~~  292 (441)
                       ......|+||+.+ |.+|.+...... ...++......|+.|++.+|++||+.|  +|||||||+|+++...     ..
T Consensus        90 ~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~  165 (322)
T KOG1164|consen   90 RSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRT  165 (322)
T ss_pred             cCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccce
Confidence             4777889999988 899999664444 567999999999999999999999999  9999999999999865     35


Q ss_pred             eEEeccCCCccCC--Ccccc---cce--eccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH
Q psy5927         293 PVIGDFGLTQEGP--IEKAT---HIT--LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER  365 (441)
Q Consensus       293 ~kl~DFGla~~~~--~~~~~---~~~--~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~  365 (441)
                      ++|.|||+++...  .....   ...  .....||..|+++....+...+.+.|+||++.++.|++.|..||........
T Consensus       166 ~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  166 LYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             EEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            8999999998322  11111   111  1234599999999999999999999999999999999999999976543222


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                       ...+......    .....    .....+..+.++...+-+.+...+|....+...|+......
T Consensus       246 -~~~~~~~~~~----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 -KSKFEKDPRK----LLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -HHHHHHHhhh----hcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence             1111100000    00000    12223455666667777789999999999999886665543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.1e-25  Score=219.07  Aligned_cols=170  Identities=21%  Similarity=0.210  Sum_probs=127.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec-ccce
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP-LYGI  217 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~  217 (441)
                      ...++|.+.+.||+|+||+||+|.+.   ++.+|||++........    .....+.+.+|+++|+.++|+||++ +++ 
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS----KPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc----cHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            45578999999999999999999873   45679988652211000    1122345679999999999999985 443 


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC-CCCCeeecCCCCeEEe
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI-KSANILLNHHMDPVIG  296 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDi-kp~NiLl~~~~~~kl~  296 (441)
                         .+..|+||||++|++|.. +.  . ..      ...++.+++.||.|||+.|  |+|||| ||+|||++.++.+||+
T Consensus        90 ---~~~~~LVmE~~~G~~L~~-~~--~-~~------~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHL-AR--P-HG------DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHH-hC--c-cc------hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEE
Confidence               256899999999999963 21  1 11      1467889999999999999  999999 9999999999999999


Q ss_pred             ccCCCccCCCccccc-----ceeccccccCCCcCcccccC
Q psy5927         297 DFGLTQEGPIEKATH-----ITLKRVNGTRPYLPHEFLVG  331 (441)
Q Consensus       297 DFGla~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~  331 (441)
                      |||+|+.........     .......+++.|+|||.+..
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999998654322111     11235678999999999865

>KOG1163|consensus

Probab=99.93  E-value=8.7e-26  Score=198.66  Aligned_cols=259  Identities=20%  Similarity=0.258  Sum_probs=197.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  218 (441)
                      +..+.|.++++||.|+||.+|.|..  .+..||||.-.....           ..+...|.++...++ ...|..+..++
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----------hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----------HPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----------CcchhHHHHHHHHhccCCCCchhhhhc
Confidence            5568899999999999999999986  567899998764322           224457888888886 46788888888


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---CCeEE
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---MDPVI  295 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---~~~kl  295 (441)
                      .+...-.+||+.+ |.||++.+..+...  ++....+-++-|++.-++|+|.++  +|||||||+|+|..-+   ..+.+
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEE
Confidence            8888899999999 89999988766543  778889999999999999999999  9999999999999644   55789


Q ss_pred             eccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         296 GDFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      +|||||+...+.....    ..-....||..|.+--+..+..-+.+.|+-|+|.+|..+..|..||.+.....+..+.  
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy--  233 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY--  233 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH--
Confidence            9999998654432211    1223456999999999888878899999999999999999999999987664332211  


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      +.+.+    ..+......++..++.++.-.+..|-..--++-|...-+.+.
T Consensus       234 EkI~E----kK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  234 EKISE----KKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             HHHHH----hhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            11111    112222334556667788888888888878888887655443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=3.1e-24  Score=206.41  Aligned_cols=263  Identities=30%  Similarity=0.412  Sum_probs=197.0

Q ss_pred             CcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC-CeecccceEEeCCeEE
Q psy5927         147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD-NILPLYGICFETGKYC  225 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~  225 (441)
                      |.....||.|+||.||++.+. ..+++|.+........      .....+.+|+.++..+.|+ +|+++++++......+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEE
Confidence            677889999999999999988 7788898875433221      2345667899999999988 7999999997777789


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEeccCCCccC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGDFGLTQEG  304 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~DFGla~~~  304 (441)
                      ++++|+.++++.+.+........+.......++.+++.++.|+|+.+  ++|||+||+||+++..+ .++++|||+++..
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~  152 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLL  152 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence            99999999999966643221125888899999999999999999999  99999999999999998 7999999998754


Q ss_pred             CCccccc---ceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcch---hHHHHHHHHHhhc
Q psy5927         305 PIEKATH---ITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRR---SERHLKSLVEKYS  375 (441)
Q Consensus       305 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~---~~~~l~~~~~~~~  375 (441)
                      .......   .......||..|+|||.+.+   ..++...|+||+|++++++++|..||.....   .......+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  232 (384)
T COG0515         153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT  232 (384)
T ss_pred             CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence            3322211   12456679999999999987   5788999999999999999999999876543   1122222111110


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      . ......   ...........+.+++..|+..+|..|.+..+....
T Consensus       233 ~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPL---SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-cccccc---CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000   000002234568899999999999999998877653

>KOG0195|consensus

Probab=99.92  E-value=3.6e-26  Score=204.30  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             CCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC  225 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  225 (441)
                      ......+|.+...|..|+|+|.+..+++|++++.....       ...+.|-.|.-.|+-+.||||++++|.|....++.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~-------risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTA-------RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcch-------hhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            34455789999999999999999999999987543221       11223446777888899999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe--ccCCCcc
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQE  303 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~--DFGla~~  303 (441)
                      ++..||+.|||+..|+...+ -..+..++..++.++++|++|||+..+-|----|.+..+++|++...+|+  |--++-.
T Consensus       264 ~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq  342 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ  342 (448)
T ss_pred             EeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence            99999999999999975543 33667789999999999999999987634445689999999999988773  3222211


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCC---CccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLS---TKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .          ....-.+.||+||.++..+-+   .++|+|||++++|||.|...||.+...-+.-.+..++        
T Consensus       343 e----------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale--------  404 (448)
T KOG0195|consen  343 E----------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE--------  404 (448)
T ss_pred             c----------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc--------
Confidence            0          011247889999999875433   4799999999999999999999887653333333222        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                          .-...+++.++..+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus       405 ----glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  405 ----GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                2234567788999999999999999999999999999988764

>KOG0590|consensus

Probab=99.91  E-value=3.1e-25  Score=229.45  Aligned_cols=259  Identities=21%  Similarity=0.224  Sum_probs=189.4

Q ss_pred             cCcCccccCCceeEEEEEE--CCeeEEEEEeeecc-chhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeE
Q psy5927         148 DKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY  224 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  224 (441)
                      .....+|.|.+|.|+....  .....+.|...... ......    .....+..|+.+-..++|||++..+..+.+....
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~----~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESER----KYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHH----HHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            3467899999997776654  23334444433110 111111    1111255788888999999999988887776666


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      .-.||||++ +|+.++...   ..+....+..++.|++.|++|||+.|  |.|||+|++|+++..+|.+||+|||.+..+
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceee
Confidence            666999998 999987533   34777889999999999999999999  999999999999999999999999998765


Q ss_pred             CCccc-ccceeccccccCCCcCcccccCCCCCC-ccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         305 PIEKA-THITLKRVNGTRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       305 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~-~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ..... .......++|+.+|+|||++.+..|.+ ..||||.|++++.|++|+.||......+........     .....
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-----~~~~~  545 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-----SDQRN  545 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----ccccc
Confidence            43322 223445678999999999999998876 599999999999999999999765443222111100     00011


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +......+...++.....++.++|+.+|.+|.++++|++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            111223344567788899999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=5.3e-24  Score=193.21  Aligned_cols=182  Identities=12%  Similarity=0.104  Sum_probs=137.2

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+..++|+..+.||.|+||.||+...++..+|+|.+.................+.+.+|++.+.++.|++|..+.+++..
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            45678999999999999999999887778899999975443322111110112235689999999999999999988664


Q ss_pred             C--------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         221 T--------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       221 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      .        +..+|||||++|.+|.+...       ++.    ....+++.+|..||+.|  ++|||+||+||+++.+| 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-
Confidence            3        35789999999999988631       222    34568999999999999  99999999999999988 


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA  351 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ell  351 (441)
                      ++|+|||............               .+.....|..++|+||||+.+.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~d---------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD---------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH---------------HHHHHhHhcccccccceeEeehHHH
Confidence            9999999886543221111               1333345778999999999877654

>KOG1033|consensus

Probab=99.89  E-value=1.5e-24  Score=210.99  Aligned_cols=174  Identities=24%  Similarity=0.361  Sum_probs=131.5

Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++.|++|.-.+|.+||..+......++.....++.|++.|+.|   ++  .+|||+||.||+...+..+||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhee
Confidence            478999999999999999877777778889999999999999999   67  9999999999999999999999999986


Q ss_pred             cCCCcc---cccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         303 EGPIEK---ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       303 ~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ......   ......+.-.||..||+||.+.|..|+.++||||||++|+|+++   +|....+....+.+          
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d----------  471 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTD----------  471 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhh----------
Confidence            543322   01112334569999999999999999999999999999999996   33222211111111          


Q ss_pred             hhhhccCCCchhHHH---HHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         380 YDLVDKNAQPIELNI---AYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~---~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                        +-   .+.+++.+   ...-+.|+.++|+..|.+||++.++
T Consensus       472 --~r---~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  472 --IR---DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             --hh---cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence              11   11222111   2234688999999999999955443

>KOG1240|consensus

Probab=99.89  E-value=3.8e-24  Score=221.86  Aligned_cols=255  Identities=21%  Similarity=0.250  Sum_probs=186.2

Q ss_pred             CCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC  225 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  225 (441)
                      +|...+.||.+.|=+|.+|.+++..|+||++-...+.-..     ....+.+.|++ ...++|||.+++--+-......|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL-----~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAy   97 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL-----RPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAY   97 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc-----hHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHH
Confidence            5777799999999999999998888999998765433322     22334456666 66679999999887766667778


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      ||-+|. ..+|.|+|.   -.+.+...+...|+.|++.||.-+|..|  |+|||||.+|||++.=+.+.|+||.--+-..
T Consensus        98 lvRqyv-khnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtY  171 (1431)
T KOG1240|consen   98 LVRQYV-KHNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTY  171 (1431)
T ss_pred             HHHHHH-hhhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCcc
Confidence            888999 689999994   3455778899999999999999999999  9999999999999999999999998665332


Q ss_pred             Cccccc----ceeccccccCCCcCcccccCC-----------CCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHH
Q psy5927         306 IEKATH----ITLKRVNGTRPYLPHEFLVGK-----------RLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS  369 (441)
Q Consensus       306 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~  369 (441)
                      .+.+..    ..+.+...-..|+|||-+...           ..+++.||||+|||++||++ |+++|.-.     ++-.
T Consensus       172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~a  246 (1431)
T KOG1240|consen  172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLA  246 (1431)
T ss_pred             CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHh
Confidence            222222    222333344469999987431           15789999999999999998 89998532     1111


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      +.... .......+.. ..      ...+..|+..|++.||.+|.++++.++.-++
T Consensus       247 Yr~~~-~~~~e~~Le~-Ie------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  247 YRSGN-ADDPEQLLEK-IE------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HhccC-ccCHHHHHHh-Cc------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            11110 0011111111 00      1157899999999999999999999886443

>KOG0603|consensus

Probab=99.89  E-value=4.4e-24  Score=211.59  Aligned_cols=226  Identities=24%  Similarity=0.274  Sum_probs=178.4

Q ss_pred             ccccCCceeEEEEE-----ECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCCeEE
Q psy5927         152 ILGKGGFGTVYKGV-----WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETGKYC  225 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  225 (441)
                      .+|.|.||.|++..     +.+..+|+|.++........       ......|..++..++ ||.+|++...+..+...+
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-------~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~   73 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-------RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLY   73 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-------ccccccHHHHHhhccCCCceeeeeeeeccccchh
Confidence            37999999999643     35667888887754332211       113346777788886 999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      ++++|..||.|..++...   ..+.......+...++.|++++|+.+  |+|||+|++||+++.+|++++.|||+++..-
T Consensus        74 l~ld~~rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   74 LILDFLRGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             HhhhhcccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhH
Confidence            999999999998877433   33566667777888999999999999  9999999999999999999999999998643


Q ss_pred             CcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       306 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                      ..+..       |||..|||||++.  ....++|+||||++++||+||..||...     ..+.             +-+
T Consensus       149 ~~~~~-------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-----~~~~-------------Il~  201 (612)
T KOG0603|consen  149 KEKIA-------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-----TMKR-------------ILK  201 (612)
T ss_pred             hhhhc-------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-----HHHH-------------Hhh
Confidence            33221       8999999999998  4678899999999999999999999771     1111             112


Q ss_pred             CCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       386 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                      .....+...+....+++.+++..+|.+|.-.
T Consensus       202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2334566778888899999999999999755

>cd08307 Death_Pelle Death domain of the protein kinase Pelle

Probab=99.87  E-value=7.4e-23  Score=157.99  Aligned_cols=66  Identities=42%  Similarity=0.739  Sum_probs=63.9

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhccCccCCcccc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTC   66 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~~~~~~~~~~   66 (441)
                      |+|++.||+.||.++++|+|||+|||++||++||||+|||++|.+++|+|||++|+++|++++|.+
T Consensus        32 ~~ys~~~v~~i~~~~~~g~SPt~eLL~~WG~~n~Tv~~L~~~L~k~kl~~Am~ilk~~v~~~~h~~   97 (97)
T cd08307          32 MGYSNDDVEGIQRCCLRGRSPTEELLDIWGNKNHTITELFVLLYREKLFRAMRIIKDLVDPKYHYL   97 (97)
T ss_pred             hcCCHHHHHHHHHHHcCCCChHHHHHHHHhhcCCCHHHHHHHHHHhchHHHHHHHHHhcChhcccC
Confidence            579999999999999999999999999999999999999999999999999999999999999974

Death domain (DD) of the protein kinase Pelle from Drosophila melanogaster and simlar proteins. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and in mediating innate immune responses to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Pelle also functions in photoreceptor axon targeting. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes.

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=7.9e-22  Score=176.57  Aligned_cols=146  Identities=16%  Similarity=0.106  Sum_probs=107.8

Q ss_pred             cCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHH--h---------------hhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         150 LNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVE--T---------------LNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~--~---------------~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      ...||+|+||.||+|.. ++..||||+++.........  .               ...........|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            47899999999999997 47789999998643211100  0               000111233469999999988777


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeeecCCCCCCeeecCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL-HSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~iiHrDikp~NiLl~~~  290 (441)
                      .....+..  ...+|||||++|+++......   ...++......++.|++.+|.|+ |+.|  |+||||||+|||++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence            44333222  223899999998877654322   23588899999999999999999 7888  99999999999998 4


Q ss_pred             CCeEEeccCCCcc
Q psy5927         291 MDPVIGDFGLTQE  303 (441)
Q Consensus       291 ~~~kl~DFGla~~  303 (441)
                      +.++|+|||+|..
T Consensus       154 ~~v~LiDFG~a~~  166 (190)
T cd05147         154 GKLYIIDVSQSVE  166 (190)
T ss_pred             CcEEEEEcccccc
Confidence            7899999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=6.9e-22  Score=175.76  Aligned_cols=192  Identities=17%  Similarity=0.069  Sum_probs=139.7

Q ss_pred             cCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCCeEEE
Q psy5927         148 DKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETGKYCL  226 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  226 (441)
                      .+...|++|+||+||.+...+..++.+.+.....     .........+.+|+++|+++. |++|++++++    +..++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~-----~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~l   75 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPW-----WLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHL   75 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchh-----hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEE
Confidence            3457899999999998888788888777653221     111122334668999999995 5889998885    45699


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC-CCCCeeecCCCCeEEeccCCCccCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI-KSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDi-kp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                      +|||+.|.+|...+..          ....++.+++.+|+++|+.|  |+|||| ||+|||++.++.++|+|||+|....
T Consensus        76 vmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         76 DRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             EEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            9999999998654310          11357789999999999999  999999 7999999999999999999998543


Q ss_pred             Ccccc----c------ceeccccccCCCcCcccccCC-CCC-CccceehHHHHHHHHHhCCCCCCCc
Q psy5927         306 IEKAT----H------ITLKRVNGTRPYLPHEFLVGK-RLS-TKVDVYGFGIVLFELATGMRAYDDT  360 (441)
Q Consensus       306 ~~~~~----~------~~~~~~~gt~~y~aPE~~~~~-~~s-~~~DiwSlGvvl~elltG~~p~~~~  360 (441)
                      .....    .      ........++.|++|+...-- ..+ .+.++++.|.-+|.++||..+.-+.
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            32210    0      000112367788888865431 223 5689999999999999988876443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.3e-21  Score=174.04  Aligned_cols=147  Identities=18%  Similarity=0.130  Sum_probs=109.8

Q ss_pred             cCccccCCceeEEEEEEC-CeeEEEEEeeeccchhH--HHh---------------hhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRA--VET---------------LNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~--~~~---------------~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      ...||+|+||.||+|.+. ++.||||+++.......  .+.               ...........|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            578999999999999975 78999999986532110  000               001112233478999999999987


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~  290 (441)
                      .....+...  ..+|||||++|+++......   ...++......++.+++.++.++|+ .|  |+||||||+|||++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence            554443332  24899999998865443221   1346778889999999999999999 99  99999999999999 8


Q ss_pred             CCeEEeccCCCccC
Q psy5927         291 MDPVIGDFGLTQEG  304 (441)
Q Consensus       291 ~~~kl~DFGla~~~  304 (441)
                      +.++|+|||++...
T Consensus       154 ~~~~liDFG~a~~~  167 (190)
T cd05145         154 GKPYIIDVSQAVEL  167 (190)
T ss_pred             CCEEEEEcccceec
Confidence            99999999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023|consensus

Probab=99.87  E-value=1.1e-21  Score=194.42  Aligned_cols=220  Identities=21%  Similarity=0.323  Sum_probs=163.1

Q ss_pred             hhcCCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe-eecCCC
Q psy5927         203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPL-IHGDIK  281 (441)
Q Consensus       203 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~i-iHrDik  281 (441)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+..  ....++|.....+.++++.||+|||...  | .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4568899999999999999999999999999999999865  3455899999999999999999999865  4 999999


Q ss_pred             CCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCC-------CCCccceehHHHHHHHHHhCC
Q psy5927         282 SANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR-------LSTKVDVYGFGIVLFELATGM  354 (441)
Q Consensus       282 p~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~~DiwSlGvvl~elltG~  354 (441)
                      +.|+++|....+||+|||+........ .........-..-|.|||.+++..       .+.+.|+||||++++|+++..
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999987643200 000000111234589999998731       467899999999999999999


Q ss_pred             CCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       355 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      .||+........ ..++..... .....+.+...... ....++..++.+||..+|.+||++.+|...++.+....
T Consensus       156 ~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  156 GPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             CccccccccCCh-HHHHHHHHh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            999874432222 111111111 00000111111111 34457899999999999999999999999998877654

>cd08795 Death_IRAK2 Death domain of Interleukin 1 Receptor Associated Kinase-2

Probab=99.85  E-value=9.8e-22  Score=147.02  Aligned_cols=53  Identities=28%  Similarity=0.325  Sum_probs=50.5

Q ss_pred             ChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           4 TSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         4 ~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      |++|+++||++.+||+|||+||||+||++||||+|||++|.+++|||||++|+
T Consensus        36 ~q~~vr~ie~~~~~G~SpT~eLL~~Wg~~N~TV~~L~~lL~~~~l~rA~~iil   88 (88)
T cd08795          36 DQTQLRKIKSMEWTGVSITRELMWWWGMRLATVQQLVDLLQRLELYRAAQIIL   88 (88)
T ss_pred             cHHHHHHHHHHHHcCCChHHHHHHHHHcCCCCHHHHHHHHHHCccHHHHHHhC
Confidence            35699999999999999999999999999999999999999999999999874

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors (TLRs), nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK2 is an essential component of several signaling pathways, including NF-kappaB and the IL-1 signaling pathways. It is an inactive kinase that participates in septic shock mediated by TLR4 and TLR9. It plays a redundant role with IRAK1 in early NF-kB and MAPK responses, and remains present at later stages whereas IRAK1 disappears. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-as

>KOG4158|consensus

Probab=99.85  E-value=2.1e-21  Score=182.21  Aligned_cols=196  Identities=17%  Similarity=0.229  Sum_probs=140.0

Q ss_pred             CCCCeecccceEE---------------------------eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q psy5927         207 RHDNILPLYGICF---------------------------ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK  259 (441)
Q Consensus       207 ~hpnIv~l~~~~~---------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  259 (441)
                      +|||||.+.++|.                           ++..+|+||.-. ..+|..++-.+.    .+...+.-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence            6999999998876                           234689999877 488999885433    45566778899


Q ss_pred             HHHHHHHHHHcCCCCeeecCCCCCCeee--cCCC--CeEEeccCCCccCCCc---ccccceeccccccCCCcCcccccCC
Q psy5927         260 GTSLGLQFLHSREPPLIHGDIKSANILL--NHHM--DPVIGDFGLTQEGPIE---KATHITLKRVNGTRPYLPHEFLVGK  332 (441)
Q Consensus       260 ~i~~al~~LH~~~~~iiHrDikp~NiLl--~~~~--~~kl~DFGla~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~  332 (441)
                      |+++|+.|||.+|  |.|||+|++|||+  |+++  .+.|+|||.+-.....   -......-...|....||||+....
T Consensus       349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999999  9999999999998  3443  4578999976321110   0011111223477889999998652


Q ss_pred             C-----C-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhc
Q psy5927         333 R-----L-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQST  406 (441)
Q Consensus       333 ~-----~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  406 (441)
                      +     . -.++|.|+.|.+.||+++...||....+-....+.    +.        ......++..++..+.+|+...|
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----Yq--------e~qLPalp~~vpp~~rqlV~~lL  494 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----YQ--------ESQLPALPSRVPPVARQLVFDLL  494 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----hh--------hhhCCCCcccCChHHHHHHHHHh
Confidence            2     1 24799999999999999999999763321111111    11        12234456677888999999999


Q ss_pred             CCCCCCCCCHHHHHH
Q psy5927         407 KQNPKERPEMTQVYN  421 (441)
Q Consensus       407 ~~dp~~RPs~~evl~  421 (441)
                      +.||.+|++..-..+
T Consensus       495 ~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  495 KRDPSKRVSPNIAAN  509 (598)
T ss_pred             cCCccccCCccHHHh
Confidence            999999998754433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=5.1e-21  Score=178.90  Aligned_cols=235  Identities=21%  Similarity=0.258  Sum_probs=146.3

Q ss_pred             CCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC----------CCeec
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH----------DNILP  213 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pnIv~  213 (441)
                      .+.....||.|+|+.||.+++..  ..+|||++..... ...     ...+++.+|.-....+.+          -.++-
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-~~~-----~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-ASA-----NEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-THT-----THHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc-cch-----HHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            44567899999999999999955  7899999887652 221     123344444433333322          11111


Q ss_pred             ccceEE---------eC---C-----eEEEEEEecCCCCHHHHHhh---cCCC-CCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy5927         214 LYGICF---------ET---G-----KYCLVYRYMPNGSLEDRLLM---KKNT-PSLLWTQRLHIAKGTSLGLQFLHSRE  272 (441)
Q Consensus       214 l~~~~~---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~-~~l~~~~~~~i~~~i~~al~~LH~~~  272 (441)
                      -++...         ..   .     ..+++|+-+ -++|.+.+..   .... ..+....+..+..|+++.+++||+.|
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            111111         11   1     347888888 6888887532   1111 22445566777899999999999999


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC--------CCCCCccceehHH
Q psy5927         273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--------KRLSTKVDVYGFG  344 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DiwSlG  344 (441)
                        ++|+||||+|++++.+|.++|+||+........      ......+..|.|||....        -.++.+.|.|+||
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG  237 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG  237 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence              999999999999999999999999876542211      111234678999997643        2478899999999


Q ss_pred             HHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCC
Q psy5927         345 IVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER  413 (441)
Q Consensus       345 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  413 (441)
                      +++|.|.+|..||.......          ..+.       ...... ++++.+..||..+|+.||.+|
T Consensus       238 ~~ly~lWC~~lPf~~~~~~~----------~~~~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  238 ITLYSLWCGRLPFGLSSPEA----------DPEW-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHSS-STCCCGGGS----------TSGG-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHccCCCCCCCccc----------cccc-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999998653211          0000       112233 788999999999999999988

>cd08796 Death_IRAK-M Death domain of Interleukin 1 Receptor Associated Kinase-M

Probab=99.83  E-value=5.7e-21  Score=144.42  Aligned_cols=55  Identities=27%  Similarity=0.408  Sum_probs=52.6

Q ss_pred             CCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           2 NFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      .+++.++++||++.++|+|||+||||+||++||||+|||++|.+|+|||||++|+
T Consensus        35 ~~~~~~vr~ie~~~~~G~SPT~eLL~~Wg~~n~TV~eL~~~L~~~~l~rA~~li~   89 (89)
T cd08796          35 SSSWLEVRHIEKYVVQGKSGTRELLWSWAQKNKTVGDLLQVLDEMGHARAISLFT   89 (89)
T ss_pred             hccHHHHHHHHHHHHcCCCcHHHHHHHHHccCCCHHHHHHHHHHcCcHHHHHhhC
Confidence            4679999999999999999999999999999999999999999999999999884

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase M (IRAK-M). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors(TLRs), nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK-M, also called IRAK-3, is an inactive kinase present only in macrophages in an inducible manner. It is a negative regulator of TLR signaling and it contributes to the attenuation of NF-kB activation. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitme

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.2e-20  Score=168.00  Aligned_cols=142  Identities=20%  Similarity=0.323  Sum_probs=115.6

Q ss_pred             CccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      +.||+|++|.||+|.+.+..+++|+......... +.........+.+|++++..++|++|.....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHP-ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcCh-HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999999888999998653221111 111112334566899999999999988877777778888999999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++|++|.+.+....      . .+..++.+++.+|.++|+.+  ++|||++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999875321      1 77889999999999999999  99999999999999 78999999998865

>KOG1166|consensus

Probab=99.82  E-value=5e-20  Score=194.75  Aligned_cols=199  Identities=20%  Similarity=0.239  Sum_probs=157.4

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---CCCeecc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---HDNILPL  214 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l  214 (441)
                      +..+....|.+.+.||+|+||+||+|.. ++..+|+|+-+....-.   +.         -=.+++.+|+   -+.|.++
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fY---------I~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FY---------ICLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---ee---------ehHHHHHhhchhhhcchHHH
Confidence            4456677899999999999999999997 45779999876433211   11         1122233333   2445666


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-----
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-----  289 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-----  289 (441)
                      ..+....+.-+||+||.+.|||.|++.   ....++|.....++.+++..+++||..+  ||||||||+|+||..     
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCC
Confidence            666666677789999999999999885   5566999999999999999999999999  999999999999953     


Q ss_pred             --CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCC
Q psy5927         290 --HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR  355 (441)
Q Consensus       290 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~  355 (441)
                        ...++|+|||.+.....-... ..+...++|-.+-.+|...|..++..+|.|.|+.+++-||.|+.
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              345899999998765433222 45667789999999999999999999999999999999999874

>KOG0606|consensus

Probab=99.82  E-value=1.2e-20  Score=196.03  Aligned_cols=210  Identities=24%  Similarity=0.373  Sum_probs=146.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|+.++.|..|+||-||..+++  .+.+|+|+-+..       .        +++-  ++..-..|.+|         
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------l--------ilRn--ilt~a~npfvv---------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------L--------ILRN--ILTFAGNPFVV---------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-------h--------hhhc--cccccCCccee---------
Confidence            468999999999999999999886  567787332210       0        0010  22222333333         


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                                  |+-...+   ++.++++...        +.+++|||+.+  |+|||+||+|.||..-|++|++|||+.
T Consensus       136 ------------gDc~tll---k~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  136 ------------GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ------------chhhhhc---ccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeecccccccchhhh
Confidence                        3333333   3334444333        67899999999  999999999999999999999999998


Q ss_pred             ccCCCcccc------------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         302 QEGPIEKAT------------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       302 ~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      +.+.....+            ...-+.++||+.|.|||++..+.|+.-+|||++|+|+||.+-|+.||.+... ++.+..
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~  269 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQ  269 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhh
Confidence            754322111            1122456899999999999999999999999999999999999999988765 334444


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE  415 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  415 (441)
                      ++.....          ........+.+..+++.++|+.+|..|--
T Consensus       270 visd~i~----------wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  270 VISDDIE----------WPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhcc----------ccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            3332110          00012234567899999999999999953

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.9e-19  Score=162.91  Aligned_cols=136  Identities=18%  Similarity=0.186  Sum_probs=100.7

Q ss_pred             cCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-----CCCCeecccceEEeCC
Q psy5927         148 DKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-----RHDNILPLYGICFETG  222 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~  222 (441)
                      ...+.||+|+||.||.-. .....+||++.....         ...+.+.+|+++++.+     .||||++++|++.++.
T Consensus         5 ~~~~~LG~G~~~~Vy~hp-~~~~k~IKv~~~~~~---------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~   74 (210)
T PRK10345          5 SEQSPLGTGRHRKCYAHP-EDAQRCIKIVYHRGD---------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC   74 (210)
T ss_pred             CCcceecCCCceEEEECC-CCcCeEEEEEecccc---------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence            345789999999999622 222346777754321         1224567999999999     5799999999998763


Q ss_pred             ---eE-EEEEEe--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCeeecCCCCCCeeecC----CC
Q psy5927         223 ---KY-CLVYRY--MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL-QFLHSREPPLIHGDIKSANILLNH----HM  291 (441)
Q Consensus       223 ---~~-~lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al-~~LH~~~~~iiHrDikp~NiLl~~----~~  291 (441)
                         .. .+|+||  +.+|+|.+++...    .+++.  ..++.+++.++ +|||+++  ||||||||+|||++.    ++
T Consensus        75 g~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         75 GTGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             CCeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCC
Confidence               43 478999  5579999999532    24444  35577788777 9999999  999999999999974    34


Q ss_pred             CeEEeccCCC
Q psy5927         292 DPVIGDFGLT  301 (441)
Q Consensus       292 ~~kl~DFGla  301 (441)
                      .++|+||+.+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            7999995433

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.6e-19  Score=163.18  Aligned_cols=138  Identities=19%  Similarity=0.282  Sum_probs=109.0

Q ss_pred             ccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEec
Q psy5927         152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYM  231 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  231 (441)
                      .||+|+||.||+|.+.+..+++|.......... +.........+.+|++++..++|+++.....++.+.+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHP-ELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCc-hHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999999899999998653221110 0001123455668999999999887666665666777789999999


Q ss_pred             CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         232 PNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       232 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|++|.+.+....          ..++.+++.+|.+||+.+  ++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998774211          078899999999999999  99999999999999 89999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd08793 Death_IRAK4 Death domain of Interleukin-1 Receptor-Associated Kinase 4

Probab=99.80  E-value=5.7e-20  Score=140.72  Aligned_cols=57  Identities=28%  Similarity=0.444  Sum_probs=55.4

Q ss_pred             CCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhccC
Q psy5927           2 NFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPY   58 (441)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~~   58 (441)
                      +|++.||+.||++++||+|||+|||++||++||||++||++|.+++||+||++++|.
T Consensus        39 ~y~~~ei~~ie~~~~~g~SPT~~LL~dWgt~N~TV~~L~~lL~k~~l~~am~~l~p~   95 (100)
T cd08793          39 RYSQFHIRRFEALVQQGKSPTCELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPD   95 (100)
T ss_pred             CCCHHHHHHHHHHHHcCCChHHHHHHHHccCCCcHHHHHHHHHHcccHHHHHHHCCC
Confidence            699999999999999999999999999999999999999999999999999999983

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinases. IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK4 is an active kinase that is also involved in T-cell receptor signaling pathways, implying that it may function in acquired immunity and not just in innate immunity. It is known as the master IRAK member because its absence strongly impairs TLR- and IL-1-mediated signaling and innate immune defenses, while the absence of other IRAK proteins only shows slight effects. IRAK4-deficient patients have impaired inflammatory responses and recurrent life-threatening infections. DDs are protein-protein int

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=3.6e-19  Score=184.59  Aligned_cols=145  Identities=18%  Similarity=0.242  Sum_probs=116.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      ...|...+.||+|+||+||+|.+.+..+++|+......... ........+.+.+|+++++.++|++|+....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHP-ELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccch-hHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44567789999999999999999877777775432211110 11111234556799999999999999988877777778


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||++|++|.+++.           ....++.+++.+|.|||+.+  ++||||||+|||+ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999999874           35678999999999999999  9999999999999 678999999999875

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=2.3e-18  Score=159.45  Aligned_cols=149  Identities=17%  Similarity=0.141  Sum_probs=108.3

Q ss_pred             CCcCcCccccCCceeEEEEE-E--CCeeEEEEEeeeccchhHH--H-------------hhhHHHHHHHHHHHHHhhcCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGV-W--EKTTIAVKKLEVHRNDRAV--E-------------TLNQCQREQSLRELKYLNSCR  207 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~-~--~~~~vavK~~~~~~~~~~~--~-------------~~~~~~~~~~~~E~~~l~~l~  207 (441)
                      .|.+.+.||+|+||.||+|. +  +++.||+|+++........  .             .........+..|++++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 3  5689999998754321000  0             000111223457999999997


Q ss_pred             CCC--eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         208 HDN--ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       208 hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      +.+  +.+++++    ...++||||++|++|......   ...+.......++.+++.++++||+.| .|+||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhE
Confidence            532  3333332    235899999999888765422   223555667889999999999999865 299999999999


Q ss_pred             eecCCCCeEEeccCCCcc
Q psy5927         286 LLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~  303 (441)
                      +++ ++.++|+|||++..
T Consensus       181 li~-~~~i~LiDFg~a~~  197 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EEE-CCCEEEEEChhhhc
Confidence            999 88999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=4.8e-18  Score=153.50  Aligned_cols=145  Identities=17%  Similarity=0.124  Sum_probs=107.6

Q ss_pred             CCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHH-----hh--------hHHHHHHHHHHHHHhhcCCCCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVE-----TL--------NQCQREQSLRELKYLNSCRHDN  210 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~-----~~--------~~~~~~~~~~E~~~l~~l~hpn  210 (441)
                      ..|.+.+.||+|+||.||+|.. ++..+|||++..........     ..        ..........|..++..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3488889999999999999988 47899999976533111000     00        0011223457888888887774


Q ss_pred             --eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         211 --ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       211 --Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                        +...++    ....++||||++|++|.+....         .....++.+++.++.++|+.+  |+||||||+||+++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~  159 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc
Confidence              333333    3456899999999999764320         234578889999999999988  99999999999999


Q ss_pred             CCCCeEEeccCCCccC
Q psy5927         289 HHMDPVIGDFGLTQEG  304 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~  304 (441)
                      +++.++|+|||++...
T Consensus       160 ~~~~~~liDfg~~~~~  175 (198)
T cd05144         160 DDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcEEEEECCccccC
Confidence            9999999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd08794 Death_IRAK1 Death domain of Interleukin 1 Receptor Associated Kinase-1

Probab=99.75  E-value=1.2e-18  Score=125.14  Aligned_cols=49  Identities=22%  Similarity=0.285  Sum_probs=46.2

Q ss_pred             ChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           4 TSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         4 ~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      ||+++|++|+    ++|+|+||||+||++|+||+||+++|.++|||||+++|+
T Consensus        36 dqtelR~~E~----~~s~T~elmw~W~~Rn~tV~~Ll~iL~~L~l~RA~~iil   84 (84)
T cd08794          36 DQTELRLLEQ----SGRRTDWVMWRWENRNGRVGELLDILERLQLLRARDVIL   84 (84)
T ss_pred             cHHHHHHHHH----cCCcHHHHHHHHHhcccHHHHHHHHHHHhhhhhhhhhhC
Confidence            7999999995    559999999999999999999999999999999999884

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK1 is an active kinase and also plays adaptor functions. It binds to the MyD88-IRAK4 complex via its DD, which facilitates its phosphorylation by IRAK4, activating it for further auto-phosphorylation. Hyper-phosphorylated IRAK1 forms a cytosolic complex with TRAF6, leading to the activation of NF-kB and MAPK pathways. IRAK1 is involved in autoimmunity and may be associated with lupus pathogenesis. DDs are protein-protein interaction domains found in a variety of domain architectures.

>KOG0590|consensus

Probab=99.73  E-value=5e-19  Score=183.43  Aligned_cols=254  Identities=23%  Similarity=0.286  Sum_probs=188.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFET  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  221 (441)
                      .|.+.+.||+|+|+.|-.....   ...+|+|.+.......       ...++...|..+-+.+. |+|++.+++...+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~-------~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~   93 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE-------DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP   93 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc-------chhhhcCccccccccccccccccccCCccCCC
Confidence            4666778999999999877652   3346666665432111       11223335666666675 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeeecCCCCCCeeecCCC-CeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH-SREPPLIHGDIKSANILLNHHM-DPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~iiHrDikp~NiLl~~~~-~~kl~DFG  299 (441)
                      ...+++++|..|+++.+.+. .......+......++.|+..++.|+| ..+  +.||||||+|.+++..+ .++++|||
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             cccccccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCch
Confidence            99999999999999998773 122223555667789999999999999 888  99999999999999999 99999999


Q ss_pred             CCccCCCcccccceeccccc-cCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         300 LTQEGPIEKATHITLKRVNG-TRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      +|................+| ++.|+|||...+. ......|+||.|+++.-+++|..||+.........          
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------  240 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------  240 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------
Confidence            99876653334445566778 9999999999884 44778999999999999999999998765422111          


Q ss_pred             hhhhhhccC---CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKN---AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ..+...+   .......+.....+++.+++..+|..|.+.+++..
T Consensus       241 --~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  241 --SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence              1111111   11112344556778889999999999999988743

>cd08309 Death_IRAK Death domain of Interleukin-1 Receptor-Associated Kinases

Probab=99.70  E-value=2e-17  Score=129.31  Aligned_cols=54  Identities=37%  Similarity=0.544  Sum_probs=52.8

Q ss_pred             CChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           3 FTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         3 ~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      |++.||+.||.++++|+|||++||++||++||||++|+++|.++++||||++|+
T Consensus        42 ~~~~~i~~~e~~~~~g~SPt~~LL~~W~~~~~Tv~~L~~~L~~~~l~~A~~~i~   95 (95)
T cd08309          42 YDLTDVRQIESMKQRGRSPTRELLWDWGTQNATVQDLVQVLVQLELYRAADLLT   95 (95)
T ss_pred             cCHHHHHHHHHHhhcCCChHHHHHHHHHhcCCCHHHHHHHHHHcccHHHHHHhC
Confidence            999999999999999999999999999999999999999999999999999985

Death Domains (DDs) found in Interleukin-1 (IL-1) Receptor-Associated Kinases (IRAK1-4) and similar proteins. IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. All four types are involved in signal transduction involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinase pathways. IRAK1 and IRAK4 are active kinases while IRAK2 and IRAK-M (also called IRAK3) are inactive. In general, IRAKs are expressed ubiquitously, except for IRAK-M which is detected only in macrophages. The insect homologs, Pelle and Tube, are important components of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in the innate immune response. Most members have an N-terminal DD followed by a kinase domain. In general, DDs are protein-protein interaction domains found in a variety of domain a

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.1e-16  Score=145.49  Aligned_cols=144  Identities=14%  Similarity=0.118  Sum_probs=105.9

Q ss_pred             cCccc-cCCceeEEEEEECCeeEEEEEeeeccchhHH---H-hhhHHHHHHHHHHHHHhhcCCCCCe--ecccceEEeC-
Q psy5927         150 LNILG-KGGFGTVYKGVWEKTTIAVKKLEVHRNDRAV---E-TLNQCQREQSLRELKYLNSCRHDNI--LPLYGICFET-  221 (441)
Q Consensus       150 ~~~LG-~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~---~-~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~-  221 (441)
                      ...|| .||.|+||+....+..++||.+.....-...   . .........+.+|++++..++|++|  +..+++.... 
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            35687 8899999999888889999988632210000   0 0011233456789999999998875  5666654332 


Q ss_pred             C---eEEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         222 G---KYCLVYRYMPN-GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       222 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      .   ..++||||++| .+|.+++..    ..++..    .+.+++.+|.+||+.|  |+||||||.|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEE
Confidence            2   23599999997 689887743    224433    3568999999999999  99999999999999999999999


Q ss_pred             cCCCcc
Q psy5927         298 FGLTQE  303 (441)
Q Consensus       298 FGla~~  303 (441)
                      ||.++.
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=3.8e-16  Score=139.62  Aligned_cols=144  Identities=19%  Similarity=0.163  Sum_probs=96.2

Q ss_pred             cCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhh---------------HHHHHHHHHHHHHhhcCCCCC--e
Q psy5927         150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLN---------------QCQREQSLRELKYLNSCRHDN--I  211 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~---------------~~~~~~~~~E~~~l~~l~hpn--I  211 (441)
                      .+.||+|+||.||+|.+. +..||||++.............               .........|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            578999999999999986 7889999987532211100000               000011124555555554332  3


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~  290 (441)
                      .+.+++    ...++||||++++++.........   .. ..+..++.+++.++.++|. .+  |+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-C
Confidence            333332    346899999998544321111100   11 5567899999999999999 88  99999999999999 8


Q ss_pred             CCeEEeccCCCccC
Q psy5927         291 MDPVIGDFGLTQEG  304 (441)
Q Consensus       291 ~~~kl~DFGla~~~  304 (441)
                      +.++|+|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            99999999999653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=4.4e-16  Score=133.25  Aligned_cols=134  Identities=19%  Similarity=0.144  Sum_probs=110.0

Q ss_pred             CcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC--CCeecccceEEeCCeEEE
Q psy5927         149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH--DNILPLYGICFETGKYCL  226 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~l  226 (441)
                      +.+.||.|+++.||++...+..+++|.......           ...+..|+.++..++|  .++.++++++...+..++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----------GADREREVAILQLLARKGLPVPKVLASGESDGWSYL   70 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc-----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEE
Confidence            457899999999999999888899998764321           2244578888888866  588888888877788999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE-PPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|||++++++...          +......++.+++.++.+||... .+++|+|++|+||+++..+.+++.|||+++.
T Consensus        71 v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          71 LMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999998877542          44566788999999999999842 2399999999999999999999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd08308 Death_Tube Death domain of Tube

Probab=99.64  E-value=2.6e-16  Score=125.92  Aligned_cols=57  Identities=25%  Similarity=0.345  Sum_probs=54.3

Q ss_pred             CCCChHHHHHHHHHHH-hCCCchHHHHHHhhcCC---CCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAIL-RRESPTEELLSKWGAQN---HTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~-~~~s~t~~ll~~w~~~n---~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |.|++.|++.||++++ +|+|||++||.+|||+|   |||++||++|.+++|||||+++.+
T Consensus        43 ~~Y~~~hv~~ie~~~~~~grSpte~LL~eWGT~g~~r~Tv~~L~~LL~k~~L~~Aa~~la~  103 (125)
T cd08308          43 AKYNAEHFKLIEQAANKQRRSCSEILLDEWGTSGKVRPTLGVLLQLLVKAELFRAADYVAV  103 (125)
T ss_pred             cccCHHHHHHHHHHHHhcCCChHHHHHHHHhhcCCCCCcHHHHHHHHHHhhHHHHHHHHHH
Confidence            5799999999999996 59999999999999999   999999999999999999999976

Death domains (DDs) similar to the DD in the protein Tube from Drosophila melanogaster. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in mediating innate immune response to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Some members of this subfamily contain a C-terminal kinase domain, like Pelle, in addition to the DD. Tube has no counterpart in vertebrates. It contains an N-terminal DD and a C-terminal region with five copies of the Tube repeat, an 8-amino acid motif. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (D

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=1.4e-13  Score=138.59  Aligned_cols=147  Identities=17%  Similarity=0.210  Sum_probs=97.0

Q ss_pred             CccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhh-----------------------------hHHHHH--HHHH
Q psy5927         151 NILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETL-----------------------------NQCQRE--QSLR  198 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~-----------------------------~~~~~~--~~~~  198 (441)
                      +.||.|++|.||+|+. +++.||||+.+.........++                             ......  .+.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            6799999999999998 5789999998754322111000                             000000  1334


Q ss_pred             HHHHhhcC----CCCCeecccceEE-eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHcCC
Q psy5927         199 ELKYLNSC----RHDNILPLYGICF-ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL-GLQFLHSRE  272 (441)
Q Consensus       199 E~~~l~~l----~hpnIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-al~~LH~~~  272 (441)
                      |.+.+.++    +|.+-+.+-..+. ..+..+|||||++|++|.+........  .   .+..++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence            55555554    2332233222222 234568999999999998876432211  2   23456666655 478889988


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                        ++|+|++|.||+++.++.++++|||++...
T Consensus       278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             --ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence              999999999999999999999999998754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266|consensus

Probab=99.49  E-value=5e-14  Score=130.10  Aligned_cols=202  Identities=19%  Similarity=0.275  Sum_probs=137.6

Q ss_pred             hhcCCCCCeecccceEEeC-----CeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5927         203 LNSCRHDNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLI  276 (441)
Q Consensus       203 l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ii  276 (441)
                      |-++-|.|||+++.|+.+.     ....++.|||..|+|..+|..-+ ....+......+++.||+.||.|||+..++|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            4455799999999987654     45789999999999999996533 34457777788999999999999999999999


Q ss_pred             ecCCCCCCeeecCCCCeEEeccCCCccCC-CcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCC
Q psy5927         277 HGDIKSANILLNHHMDPVIGDFGLTQEGP-IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR  355 (441)
Q Consensus       277 HrDikp~NiLl~~~~~~kl~DFGla~~~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~  355 (441)
                      |+++...-|++..+|-+||+--.-..... .............|-++|.+||.-.....+.++|||+||....||.-|..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            99999999999999999985322111000 00001111223346788999998766677889999999999999987653


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                      --.+... ...        .++.+...+-......       -..++.+|+...|..||+|.+++
T Consensus       281 q~tnseS-~~~--------~ee~ia~~i~~len~l-------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  281 QSTNSES-KVE--------VEENIANVIIGLENGL-------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             ccCCCcc-eee--------hhhhhhhheeeccCcc-------ccCcCcccccCCCCCCcchhhhh
Confidence            2211111 000        0111111100000000       13466899999999999999875

>KOG0601|consensus

Probab=99.46  E-value=7.2e-14  Score=139.23  Aligned_cols=252  Identities=19%  Similarity=0.188  Sum_probs=178.0

Q ss_pred             hhCCCcCcCcccc--CCceeEEEEEE----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeeccc
Q psy5927         143 ATNNWDKLNILGK--GGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLY  215 (441)
Q Consensus       143 ~~~~~~~~~~LG~--G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  215 (441)
                      ....|.+...+|.  |.+|.||.+..    ....+|+|+-+........       ...-.+|+...+.+ .|+|.++.+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-------~~~k~~~~~s~~~i~~~~~~v~~~  184 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-------SKRKLREFLSHHKIDSHENPVRDS  184 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-------cccccchhhcccccCccccccccC
Confidence            3456777899999  99999998876    3456888874332221111       11223566666666 599999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCeeecCCCCCCeeecCC-
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL----GLQFLHSREPPLIHGDIKSANILLNHH-  290 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----al~~LH~~~~~iiHrDikp~NiLl~~~-  290 (441)
                      ..+.+++..++-+|+| +.+|..+...  ....++....+.++.+...    ||.++|+.+  ++|-|+||+||++..+ 
T Consensus       185 ~~~e~~~~lfiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  185 PAWEGSGILFIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cccccCCcceeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheeccccc
Confidence            9999999999999999 5888776543  3333666777788888888    999999988  9999999999999999 


Q ss_pred             CCeEEeccCCCccCCCcccccc--eeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcc-hhHHHH
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHI--TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTR-RSERHL  367 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~-~~~~~l  367 (441)
                      ...+++|||+............  ...+..|..-|++||...+ -++...|+||+|.++++..+|........ ..-..+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            8899999999876544432211  1133357888999999887 78899999999999999999876553321 100000


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +.         .   .  .........+.++...+.+++..+|..|++.+.+.+
T Consensus       339 r~---------~---~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQ---------G---Y--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc---------c---c--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00         0   0  011122233445666889999999999999877653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=5.8e-13  Score=116.88  Aligned_cols=130  Identities=16%  Similarity=0.106  Sum_probs=94.0

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec-ccceEEeCCeEEEEE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP-LYGICFETGKYCLVY  228 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~~~lv~  228 (441)
                      ++.|+.|.++.||++...+..+++|........          ......|+.++..+.+.++++ ++.+  +....++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----------~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----------LINRENEAENSKLAAEAGIGPKLYYF--DPETGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCccc----------ccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEE
Confidence            367899999999999998889999987532210          112236778888776555443 4433  233457999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---CeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREP---PLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       229 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~---~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ||++|.++.+.    .    .   ....++.+++.+|..||+.+.   .++|+|++|.||+++ ++.++++|||.+..
T Consensus        71 e~i~G~~l~~~----~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE----D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc----c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999888642    0    1   113456789999999999761   259999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=3.4e-12  Score=110.00  Aligned_cols=139  Identities=22%  Similarity=0.271  Sum_probs=104.8

Q ss_pred             CccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEe
Q psy5927         151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY  230 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  230 (441)
                      ..+++|+-+.+|.+.+.+..+.+|.-.. +.-...+.-.....+...+|.+++.+++--.|.--+-+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~-K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIP-KRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecC-cccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4678999999999988776766664332 222222222334556677999999998655555555556777888899999


Q ss_pred             cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         231 MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       231 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++|-.|.+.+...          ...++..+-.-+.-||..|  |||+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998898888533          2457777888889999999  99999999999997765 99999999864

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=6.3e-13  Score=135.58  Aligned_cols=150  Identities=13%  Similarity=0.112  Sum_probs=89.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchh---HHHhh----------------------hHHHHHHHH
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDR---AVETL----------------------NQCQREQSL  197 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~----------------------~~~~~~~~~  197 (441)
                      ..|+. +.||.|++|.||+|+.+  ++.||||+.+......   +...+                      -.+..+...
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 89999999999999984  6899999997543211   00000                      001112222


Q ss_pred             H------HHHHhhcC----CCCCeecccceEEe-CCeEEEEEEecCCCCHHHHHhhcCCC---CCCCHHHHHHHHHHHHH
Q psy5927         198 R------ELKYLNSC----RHDNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNT---PSLLWTQRLHIAKGTSL  263 (441)
Q Consensus       198 ~------E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~i~~  263 (441)
                      +      |...+.++    .+.+.+.+-.++.+ ....+|||||+.|+.+.+.-.-....   ..+.......++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence            3      33333333    23333332222222 34457999999999998742211111   01222222233333   


Q ss_pred             HHHHHHcCCCCeeecCCCCCCeeecCCC----CeEEeccCCCccC
Q psy5927         264 GLQFLHSREPPLIHGDIKSANILLNHHM----DPVIGDFGLTQEG  304 (441)
Q Consensus       264 al~~LH~~~~~iiHrDikp~NiLl~~~~----~~kl~DFGla~~~  304 (441)
                          +...|  ++|+|+||.||+++.++    .+++.|||++...
T Consensus       276 ----if~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        276 ----VFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             ----HHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                34577  99999999999999988    9999999998654

>KOG3087|consensus

Probab=99.37  E-value=1.4e-11  Score=105.77  Aligned_cols=150  Identities=23%  Similarity=0.350  Sum_probs=111.8

Q ss_pred             CcCccccCCceeEEEEEECCeeEEEEEeeecc-chhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      ....|-+|+-+.|+++.+.+..+.||.--... .....+  .+..+....+|++.|.+++--.|.--.-++.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD--~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALD--QKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHH--HHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            56788999999999999999988888543221 122211  223455667899999998655555555567778888999


Q ss_pred             EEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---eEEeccCCCcc
Q psy5927         228 YRYMPN-GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQE  303 (441)
Q Consensus       228 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---~kl~DFGla~~  303 (441)
                      |||++| .++.+++...-.....+ .....++..|-..+.-||..+  ||||||..+||+|..++.   +.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence            999976 47888887655443332 233678889999999999999  999999999999976654   47999999854

>KOG0606|consensus

Probab=99.35  E-value=3.8e-13  Score=140.83  Aligned_cols=255  Identities=18%  Similarity=0.200  Sum_probs=172.5

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....+.|.+.+-+-+|.|+.++.+.-...  ..+.|.......      +...+.+....+-.++-..+||-++...-.+
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~------i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~  873 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK------IRTNDYESIRSKSNILITPRSPAVVRSFPSF  873 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchh------hccccccccCCccCccccCCCCceecccCCC
Confidence            34567788888999999999997664332  233333321100      0001111222333333334567777666655


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .-....+|+++|..+++|...|+.-   +..+..-.......+..+++|||+..  ++|||++|.|+|...+++.+++||
T Consensus       874 ~~rsP~~L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~  948 (1205)
T KOG0606|consen  874 PCRSPLPLVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDF  948 (1205)
T ss_pred             CCCCCcchhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcc
Confidence            5677889999999999999887533   23444455566677888999999987  999999999999999999999999


Q ss_pred             CCCcc-CCC----------c-----------------ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHH
Q psy5927         299 GLTQE-GPI----------E-----------------KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL  350 (441)
Q Consensus       299 Gla~~-~~~----------~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~el  350 (441)
                      |+... +..          .                 ......-....||+.|.+||...+......+|+|++|++++|.
T Consensus       949 ~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~ 1028 (1205)
T KOG0606|consen  949 GTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEV 1028 (1205)
T ss_pred             ccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhh
Confidence            84321 100          0                 0000112345689999999999999999999999999999999


Q ss_pred             HhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHH
Q psy5927         351 ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMT  417 (441)
Q Consensus       351 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  417 (441)
                      ++|.+||........+ ..+.    .      .+......+...+....+++...+..+|.+|-.+.
T Consensus      1029 l~g~pp~na~tpq~~f-~ni~----~------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1029 LTGIPPFNAETPQQIF-ENIL----N------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hcCCCCCCCcchhhhh-hccc----c------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999876552221 1111    0      01112223445667788999999999999998775

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.33  E-value=1.5e-11  Score=109.49  Aligned_cols=144  Identities=15%  Similarity=0.112  Sum_probs=98.0

Q ss_pred             cCccccCCceeEEEEEEC--------CeeEEEEEeeeccchh--HHHhh-----------hHHHHHH----HHHHHHHhh
Q psy5927         150 LNILGKGGFGTVYKGVWE--------KTTIAVKKLEVHRNDR--AVETL-----------NQCQREQ----SLRELKYLN  204 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~--------~~~vavK~~~~~~~~~--~~~~~-----------~~~~~~~----~~~E~~~l~  204 (441)
                      ...||.|--+.||.|...        +..+|||+.+......  ....+           .......    ..+|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999864        2689999987433211  00000           0011222    237999998


Q ss_pred             cCCC--CCeecccceEEeCCeEEEEEEecCCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeeecCC
Q psy5927         205 SCRH--DNILPLYGICFETGKYCLVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKGTSLGLQFL-HSREPPLIHGDI  280 (441)
Q Consensus       205 ~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~iiHrDi  280 (441)
                      ++..  -++...+++    ...+|||||+.+..+.. .+.    ...++......+..+++.+|..| |..|  ||||||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence            8843  345555543    45689999997653322 121    11244456677889999999999 8888  999999


Q ss_pred             CCCCeeecCCCCeEEeccCCCccC
Q psy5927         281 KSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       281 kp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      ++.|||++ ++.++|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 468999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=99.32  E-value=1.7e-12  Score=129.46  Aligned_cols=246  Identities=17%  Similarity=0.176  Sum_probs=171.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccce
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGI  217 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  217 (441)
                      ..+.+|..+..||.|.|+.|+....+   +..|++|.+.........       ....+.|+-+...+ .|.+++.++..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-------di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-------DIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-------hhcchhhhhHhhHhhcccccCCCCCC
Confidence            44568899999999999999986643   467888877644332221       12234666666666 58888988877


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCeEEe
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIG  296 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~kl~  296 (441)
                      +......++--|||+++++...+....   -+....++.+..+++.++.++|+..  ++|+|+||+||++..+ +..+++
T Consensus       335 W~~~r~~~ip~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  335 WSQLRQGYIPLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             ccccccccCchhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcc
Confidence            777777789999999999887663222   2556677889999999999999988  9999999999999886 788999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCc--CcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYL--PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |||.+........      ...++-+++  ++.......+..+.|++|||.-+.|.++|.. +.....   +.       
T Consensus       410 ~~~~~t~~~~~~~------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~~~~---~~-------  472 (524)
T KOG0601|consen  410 DFGCWTRLAFSSG------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSESGV---QS-------  472 (524)
T ss_pred             ccccccccceecc------cccccccccccchhhccccccccccccccccccccccccCcc-cCcccc---cc-------
Confidence            9998864221111      112233344  5555555677889999999999999999854 222111   00       


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                            ..+.....+........+..+.+.+...++..||.+.++...
T Consensus       473 ------~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  473 ------LTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ------eeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence                  001111112223334677888899999999999998876543

>KOG1243|consensus

Probab=99.29  E-value=7.7e-11  Score=118.98  Aligned_cols=145  Identities=23%  Similarity=0.244  Sum_probs=108.8

Q ss_pred             HHHHHHHHhhcCCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5927         195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPP  274 (441)
Q Consensus       195 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~  274 (441)
                      ...+-++-|+.+|||||++++..+...+..|||+|-+  ..|..++....      .......+.||+.||.|||..+. 
T Consensus        55 ~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~v~~Gl~qIl~AL~FL~~d~~-  125 (690)
T KOG1243|consen   55 LAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEEVCLGLFQILAALSFLNDDCN-  125 (690)
T ss_pred             HHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHHHHHHHHHHHHHHHHHhccCC-
Confidence            3446788899999999999999999999999999988  56776664332      45667778999999999986432 


Q ss_pred             eeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC
Q psy5927         275 LIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG  353 (441)
Q Consensus       275 iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG  353 (441)
                      ++|++|.-+.|+++..|..||++|-++........   ......--..|..|+.+....  -..|.|-||++++|++.|
T Consensus       126 lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  126 LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            99999999999999999999999988754322111   000001112355666543322  347999999999999998

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.19  E-value=8.5e-10  Score=105.80  Aligned_cols=263  Identities=15%  Similarity=0.177  Sum_probs=160.6

Q ss_pred             CcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec--------ccceEE
Q psy5927         149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP--------LYGICF  219 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~--------l~~~~~  219 (441)
                      ....||+|+-+.+|-----...| -|+.......-.         .   .-+..|... .||-+-.        |+|- .
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~---------a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~   80 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQ---------A---QKVAELAATPDAPLLNYRVAWPQATLHGG-R   80 (637)
T ss_pred             CCccccCCccceeeecchhhchh-heeecCCCchHH---------H---HHHHHhccCCCCcchhhhhcccHHHhhCC-C
Confidence            35789999999999532222223 355543221110         0   112223332 4553322        2221 1


Q ss_pred             eCCeEEEEEEecCCCC-HHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         220 ETGKYCLVYRYMPNGS-LEDRL---LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gs-L~~~l---~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      .+...-++|+.++|.. +.+++   ..+...+...|...+.+++.++.+.+-||..|  .+-||+.++|+|+++++.+.|
T Consensus        81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEE
Confidence            2233678888887653 22222   12344677889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhC-CCCCCCcchh---HHH
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATG-MRAYDDTRRS---ERH  366 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG-~~p~~~~~~~---~~~  366 (441)
                      .|-..-...    ..........|...|.+||.-+     +-.-+...|-|.||++++++|.| ++||.+....   ..-
T Consensus       159 VdsDsfqi~----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p  234 (637)
T COG4248         159 VDSDSFQIN----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP  234 (637)
T ss_pred             Ecccceeec----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence            884322211    1222334456899999999765     33456789999999999999886 9999764321   111


Q ss_pred             HH-HHHHh---hchhhhhhhhccCCCchh-HHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHhcCCCCCCC
Q psy5927         367 LK-SLVEK---YSEENMYDLVDKNAQPIE-LNIAYAFFRIGKQSTKQ--NPKERPEMTQVYNMLSGSGGESPN  432 (441)
Q Consensus       367 l~-~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~--dp~~RPs~~evl~~L~~~~~~~~~  432 (441)
                      +. ++...   +..+...-+.. ....++ .-++.++..|..+|+..  ++.-||+.+..+..|..+..+...
T Consensus       235 ~E~~Ia~g~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         235 LETDIAHGRFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             chhhhhcceeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            11 11000   00110000111 111122 34567788889999964  467899999988877766555443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=2e-10  Score=105.18  Aligned_cols=142  Identities=23%  Similarity=0.272  Sum_probs=103.8

Q ss_pred             CccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC--CCeecccceEEeC---CeE
Q psy5927         151 NILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH--DNILPLYGICFET---GKY  224 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~---~~~  224 (441)
                      +.||.|.++.||++...+ ..+++|........        .....+..|.+++..+++  .++.+++.+....   +..
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~   75 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP   75 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence            678999999999998876 78999987543211        012244578888888865  3456666665543   367


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q psy5927         225 CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE--------------------------------  272 (441)
Q Consensus       225 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--------------------------------  272 (441)
                      ++||||++|.++.+.+..    ..++......++.+++.+|..||+..                                
T Consensus        76 ~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          76 FYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             eEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            899999999988764421    24666777778888888888888521                                


Q ss_pred             ----------------------CCeeecCCCCCCeeecC--CCCeEEeccCCCccC
Q psy5927         273 ----------------------PPLIHGDIKSANILLNH--HMDPVIGDFGLTQEG  304 (441)
Q Consensus       273 ----------------------~~iiHrDikp~NiLl~~--~~~~kl~DFGla~~~  304 (441)
                                            ..++|+|+.|.||+++.  ++.+.|+||+.+..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                  23799999999999998  667899999988653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=2.5e-09  Score=100.53  Aligned_cols=150  Identities=12%  Similarity=-0.008  Sum_probs=99.2

Q ss_pred             CccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhH--HHHHHHHHHHHHhhcCCCCCe--ecccceEEe-----C
Q psy5927         151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDNI--LPLYGICFE-----T  221 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~-----~  221 (441)
                      +.+-......|++....+..+.||...........+.+..  .....+.+|...+.+|..-+|  ...++++..     .
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            3333344445778888889999997743221111111000  001135578887777743333  334444433     2


Q ss_pred             CeEEEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-------CCCe
Q psy5927         222 GKYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-------HMDP  293 (441)
Q Consensus       222 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-------~~~~  293 (441)
                      ...+||+|++++. +|.+++.... ..+.+...+..++.+++..+.-||..|  |+|+|+++.|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceE
Confidence            3578999999875 8998875322 223455677789999999999999999  999999999999985       4678


Q ss_pred             EEeccCCCcc
Q psy5927         294 VIGDFGLTQE  303 (441)
Q Consensus       294 kl~DFGla~~  303 (441)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>KOG3741|consensus

Probab=99.05  E-value=8.8e-09  Score=101.32  Aligned_cols=167  Identities=20%  Similarity=0.248  Sum_probs=122.2

Q ss_pred             ceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE----eCCeEEEEEEec
Q psy5927         158 FGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF----ETGKYCLVYRYM  231 (441)
Q Consensus       158 fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~lv~e~~  231 (441)
                      -.+.|++..  ++..|.+|+++..+.....         ....-+++++++.|+|+|++.++|.    .+..+++||+|.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcc---------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            357888876  5677888988433221110         1114577899999999999999886    446789999999


Q ss_pred             CC-CCHHHHHhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         232 PN-GSLEDRLLMKK------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       232 ~~-gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      ++ ++|.+......            .....++...+.++.|+..||.++|+.|  +..+-|.|.+||++.+.+++|+..
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C  437 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGC  437 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecc
Confidence            85 67877553221            1344678899999999999999999999  888999999999999999999887


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCC
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR  355 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~  355 (441)
                      |+........               .  +-+.+   -.+-|.=.||.+++.|.||..
T Consensus       438 ~i~Dvl~~d~---------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  438 GIMDVLQEDP---------------T--EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cceeeecCCC---------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            7654321111               0  11111   235788899999999999964

>cd08783 Death_MALT1 Death domain similar to that found in Mucosa-associated lymphoid tissue-lymphoma-translocation gene 1

Probab=99.02  E-value=5.2e-10  Score=83.94  Aligned_cols=54  Identities=31%  Similarity=0.394  Sum_probs=48.7

Q ss_pred             ChHHH-HHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           4 TSRQL-FQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         4 ~~~~~-~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      .+.|+ +-.+++...|+|||..|||.||.+++||.||++.|.+|+|-+|+++|++
T Consensus        41 S~~el~~cslkvl~p~gSPsk~LL~~~~~rg~Tv~~Ll~~L~~Mgh~eAl~lL~~   95 (97)
T cd08783          41 SCLDLEQCSLKVLEPEGSPSRSLLKLLGERGCTVTELSEFLQAMEHTEALQLLSP   95 (97)
T ss_pred             CHHHHHHHHHHHhcCCCCchHHHHHHHHHcCCcHHHHHHHHHHhhhHHHHHHhcC
Confidence            45667 5566777899999999999999999999999999999999999999986

Death domain (DD) similar to that found in Malt1 (mucosa-associated lymphoid tissue-lymphoma-translocation gene 1). Malt1, together with Bcl10 (B-cell lymphoma 10), are the integral components of the CBM signalosome. They associate with CARD9 to form M-CBM (CBM complex in myeloid immune cells) and with CARMA1 to form L-CBM (CBM complex in lymphoid immune cells), to mediate activation of NF-kB and MAPK by ITAM-coupled receptors expressed on immune cells. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.94  E-value=7.8e-09  Score=91.75  Aligned_cols=133  Identities=21%  Similarity=0.259  Sum_probs=80.9

Q ss_pred             eEEEEEE-CCeeEEEEEeeeccchhH-----------------HHhhhHHHHHHHHHHHHHhhcCCCC--CeecccceEE
Q psy5927         160 TVYKGVW-EKTTIAVKKLEVHRNDRA-----------------VETLNQCQREQSLRELKYLNSCRHD--NILPLYGICF  219 (441)
Q Consensus       160 ~Vy~~~~-~~~~vavK~~~~~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~  219 (441)
                      .||.|.. ++..+|||+.+.......                 .............+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899997 567899999875432110                 0011122334556899999999765  455555432 


Q ss_pred             eCCeEEEEEEecC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         220 ETGKYCLVYRYMP--NGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF-LHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~-LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                         ..+|||||++  |..+.. |....    ++......++.+++..+.. +|..|  ||||||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDVD----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhh-HHhcc----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEE
Confidence               3379999998  555544 32221    1123345677777775555 57888  9999999999999988 99999


Q ss_pred             ccCCCccC
Q psy5927         297 DFGLTQEG  304 (441)
Q Consensus       297 DFGla~~~  304 (441)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137|consensus

Probab=98.83  E-value=1.2e-09  Score=111.03  Aligned_cols=152  Identities=18%  Similarity=0.258  Sum_probs=104.3

Q ss_pred             HHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCccc------ccceeccccccCCCcCcccccCC
Q psy5927         259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA------THITLKRVNGTRPYLPHEFLVGK  332 (441)
Q Consensus       259 ~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~  332 (441)
                      .+++.|+.|+|+.- .+||++|.|++|.++.++..||+.|+++........      .........-...|.|||++.+.
T Consensus       106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            34458999999852 399999999999999999999999998754322111      00001112245679999999997


Q ss_pred             CCCCccceehHHHHHHHHH-hCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCC
Q psy5927         333 RLSTKVDVYGFGIVLFELA-TGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPK  411 (441)
Q Consensus       333 ~~s~~~DiwSlGvvl~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  411 (441)
                      ..+.++|+||+|+++|-+. .|..-+........+-..          ....+........+++.++.+-+.+++..++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----------RNLLNAGAFGYSNNLPSELRESLKKLLNGDSA  254 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----------hcccccccccccccCcHHHHHHHHHHhcCCcc
Confidence            8889999999999999998 455555443321111000          01111122223356778888999999999999


Q ss_pred             CCCCHHHHHH
Q psy5927         412 ERPEMTQVYN  421 (441)
Q Consensus       412 ~RPs~~evl~  421 (441)
                      .||++.++..
T Consensus       255 ~rp~~~~l~~  264 (700)
T KOG2137|consen  255 VRPTLDLLLS  264 (700)
T ss_pred             cCcchhhhhc
Confidence            9998877653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.81  E-value=3.2e-08  Score=90.63  Aligned_cols=142  Identities=20%  Similarity=0.160  Sum_probs=97.8

Q ss_pred             CcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchh-------HH----Hhhh--HHHHHHHHHHHHHhhcCCCC--C
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDR-------AV----ETLN--QCQREQSLRELKYLNSCRHD--N  210 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~-------~~----~~~~--~~~~~~~~~E~~~l~~l~hp--n  210 (441)
                      ..++.+||-|--+.||.|... +..+|||.-+..+...       +.    +...  ...+....+|.++|..+...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345689999999999999985 7889999865443221       00    0111  12334456899999988644  5


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      +...++    .+..++||||++|-.|.. +.       +.......|+..|+.-+.-+-..|  |||+|+++-||+++++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~-~r-------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYR-LR-------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCccc----cccceeeeehcccceeec-cc-------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEecC
Confidence            666655    367799999999877654 21       122233445555555555445677  9999999999999999


Q ss_pred             CCeEEeccCCCc
Q psy5927         291 MDPVIGDFGLTQ  302 (441)
Q Consensus       291 ~~~kl~DFGla~  302 (441)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999997553

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.74  E-value=1.1e-07  Score=85.29  Aligned_cols=149  Identities=15%  Similarity=0.096  Sum_probs=97.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC---CCCCeecccce
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC---RHDNILPLYGI  217 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~  217 (441)
                      .+..++|...+.+-......|.+-..++..+.+|..+............-..-....+++..+.++   .--.+..++.+
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            456678998899988888999998889999999988653322211111100111222344433333   23333343333


Q ss_pred             EE-----eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         218 CF-----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       218 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      ..     -....+|+|||++|..|.+...       ++.    .++..+..++.-||+.|  +.|+|..|.|++++.++ 
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-
Confidence            22     1245578999999998876431       221    34566778899999999  99999999999998655 


Q ss_pred             eEEeccCCCcc
Q psy5927         293 PVIGDFGLTQE  303 (441)
Q Consensus       293 ~kl~DFGla~~  303 (441)
                      +++.||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF14786 Death_2: Tube Death domain; PDB: 1D2Z_B

Probab=98.72  E-value=2.6e-08  Score=80.11  Aligned_cols=55  Identities=25%  Similarity=0.387  Sum_probs=46.3

Q ss_pred             CCChHHHHHHHHHHH--hCCCchHHHHHHhhcC-----CCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           2 NFTSRQLFQMEQAIL--RRESPTEELLSKWGAQ-----NHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         2 ~~~~~~~~~~~~~~~--~~~s~t~~ll~~w~~~-----n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      -|+.+|++.||+...  +++|+|.-||..|||.     ++||+.|+++|.+.++|||++.+.
T Consensus        53 KYt~~hi~~Ie~~a~r~~~~s~s~illdEWgTSGr~~eRPTl~~Ll~LLvkael~rAADyva  114 (137)
T PF14786_consen   53 KYTSQHISLIEEAAERLQNRSCSEILLDEWGTSGRKNERPTLGHLLQLLVKAELFRAADYVA  114 (137)
T ss_dssp             SS-HHHHHHHHHHHHHSTTS-HHHHHHHHHHT-SSTTTS-BHHHHHHHHHHTT-HHHHHHHH
T ss_pred             ccchhHHHHHHHHHHhccCCcHHHHHHHHhhccCcccCCCcHHHHHHHHHHHHHHHHHHHHH
Confidence            388999999999994  7999999999999974     599999999999999999998875

>cd08782 Death_DAPK1 Death domain found in death-associated protein kinase 1

Probab=98.72  E-value=1.9e-08  Score=76.02  Aligned_cols=55  Identities=24%  Similarity=0.342  Sum_probs=45.6

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCC-CCHHHHHHHHHhcChhhHHHhhc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQN-HTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n-~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      |||... ...+++..++|.|||++||.+|++++ +||++|+.+|.+++-..|+++|.
T Consensus        27 Lg~~~~-~~~~~~~~~~~~sPT~~LL~~W~~~~~~tvg~L~~~L~~~gR~Da~~~l~   82 (82)
T cd08782          27 LGLTDL-VPQLDTNSSSLPSPTDALLQEWATAPPSTIGTLIDKLRELGREDAADVLL   82 (82)
T ss_pred             cCChhh-HHHHHhcCCCCCCcHHHHHHHHhcCCcccHHHHHHHHHHcCcHHHHHHhC
Confidence            466655 34455544567999999999999999 99999999999999999998763

Death domain (DD) found in death-associated protein kinase 1 (DAPK1). DAPK1 is composed of several functional domains, including a kinase domain, a CaM regulatory domain, ankyrin repeats, a cytoskeletal binding domain and a C-terminal DD. It plays important roles in a diverse range of signal transduction pathways including apoptosis, growth factor signalling, and autophagy. Loss of DAPK1 expression, usually because of DNA methylation, is implicated in many tumor types. DAPK1 is highly abundant in the brain and has also been associated with neurodegeneration. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as ad

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=7.7e-08  Score=87.31  Aligned_cols=104  Identities=20%  Similarity=0.199  Sum_probs=78.3

Q ss_pred             HHHHHHHHhhcCCCC--CeecccceEEeC----CeEEEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q psy5927         195 QSLRELKYLNSCRHD--NILPLYGICFET----GKYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF  267 (441)
Q Consensus       195 ~~~~E~~~l~~l~hp--nIv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~  267 (441)
                      ...+|...+..+..-  ...+.+++....    ...+||+|++++. +|.+++.....   .+......++.+++..+.-
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHH
Confidence            445677766666322  234455555442    2458999999874 79988864322   4556778899999999999


Q ss_pred             HHcCCCCeeecCCCCCCeeecCCC---CeEEeccCCCcc
Q psy5927         268 LHSREPPLIHGDIKSANILLNHHM---DPVIGDFGLTQE  303 (441)
Q Consensus       268 LH~~~~~iiHrDikp~NiLl~~~~---~~kl~DFGla~~  303 (441)
                      ||..|  |+|+|+++.|||++.++   .+.++||+-++.
T Consensus       134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999  99999999999999887   789999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=2.6e-06  Score=76.28  Aligned_cols=143  Identities=15%  Similarity=0.103  Sum_probs=100.1

Q ss_pred             ccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC--CeecccceEEe-----CCeEEE
Q psy5927         154 GKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD--NILPLYGICFE-----TGKYCL  226 (441)
Q Consensus       154 G~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~-----~~~~~l  226 (441)
                      |+||.+-|++-...+..+-+|.-.......-. .  ..-...+.+|...|..+..-  .+.+.. ++..     .-..+|
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r-~--P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVR-Y--PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCccccccc-C--CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            56899999998888877888876422111100 0  11233456888888777422  244444 3321     123679


Q ss_pred             EEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC--eEEeccCCCcc
Q psy5927         227 VYRYMPN-GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD--PVIGDFGLTQE  303 (441)
Q Consensus       227 v~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~--~kl~DFGla~~  303 (441)
                      |+|-++| -+|.+++... ...+.+...+..++.+++..+.-||+.|  +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997754 6888887543 2334677788899999999999999999  999999999999987777  89999986654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.53  E-value=1.3e-06  Score=80.36  Aligned_cols=138  Identities=17%  Similarity=0.198  Sum_probs=81.0

Q ss_pred             CccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCC--eecccceEEeCCeEEEEE
Q psy5927         151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN--ILPLYGICFETGKYCLVY  228 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~  228 (441)
                      ..||.|..+.||+.  .+..+++|.......           .....+|.++++.+..-+  +.+.+++..+.+...+||
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~-----------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD-----------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCC-----------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence            67899999999984  244567777653221           112347888887775333  356677777777888999


Q ss_pred             EecCCCC-HHHH---------------------HhhcCCCCCCCHHHHH-HHHH----------HHHH-HHHHHH--cCC
Q psy5927         229 RYMPNGS-LEDR---------------------LLMKKNTPSLLWTQRL-HIAK----------GTSL-GLQFLH--SRE  272 (441)
Q Consensus       229 e~~~~gs-L~~~---------------------l~~~~~~~~l~~~~~~-~i~~----------~i~~-al~~LH--~~~  272 (441)
                      |+++|.+ +...                     |+... .......... .+..          .+.. ...+|.  ...
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            9998863 2111                     11100 0111111111 0100          0111 122222  222


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ..++|+|+.|.||++++++ +.|+||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            3478999999999999988 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd08781 Death_UNC5-like Death domain found in Uncoordinated-5 homolog family

Probab=98.43  E-value=3.2e-07  Score=69.77  Aligned_cols=43  Identities=26%  Similarity=0.376  Sum_probs=38.0

Q ss_pred             HHHHhCCCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhh
Q psy5927          13 QAILRRESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLIL   55 (441)
Q Consensus        13 ~~~~~~~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~   55 (441)
                      .+..++.|||+.||+.|..+   ++||++|+.+|.+|+...|+++|
T Consensus        37 ~~~~~~~SPT~~LL~~We~~~~~~~tv~~L~~~L~~mgr~da~~ll   82 (83)
T cd08781          37 NYFATKPSPTGVILDLWEARHRDDGALNDLAQILEEMGRTDAVNLL   82 (83)
T ss_pred             HHHcCCCChHHHHHHHHHhcCCCcchHHHHHHHHHHcCcHHHHHHh
Confidence            34446899999999999765   79999999999999999999876

Death Domain (DD) found in Uncoordinated-5 (UNC-5) homolog family, which includes Unc5A, B, C and D in vertebrates. UNC5 proteins are receptors for secreted netrins (netrin-1, -3 and -4) that are involved in diverse processes like axonal guidance, neuronal migration, blood vessel patterning, and apoptosis. They are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=4.4e-06  Score=76.76  Aligned_cols=142  Identities=22%  Similarity=0.172  Sum_probs=78.8

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC--CeecccceEE---eCCeE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD--NILPLYGICF---ETGKY  224 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~---~~~~~  224 (441)
                      ++.|+.|..+.||+....+..+++|.....           ........|..++..+...  .+..++.+..   .....
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~   70 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFP   70 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH-----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC-----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccc
Confidence            367899999999999998888999986532           1122333666666666322  3445555432   33457


Q ss_pred             EEEEEecCCCCHHH----------------HHh---hc-CCCCCCCHHHH---------HHH------------HHHHHH
Q psy5927         225 CLVYRYMPNGSLED----------------RLL---MK-KNTPSLLWTQR---------LHI------------AKGTSL  263 (441)
Q Consensus       225 ~lv~e~~~~gsL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~~i~~  263 (441)
                      +++|++++|.++..                .+.   .. ....+..+...         ...            ...+..
T Consensus        71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (239)
T PF01636_consen   71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE  150 (239)
T ss_dssp             EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence            89999999988877                111   11 01111111110         000            011222


Q ss_pred             -HHHHHHc-----CCCCeeecCCCCCCeeec-CCCCeEEeccCCCc
Q psy5927         264 -GLQFLHS-----REPPLIHGDIKSANILLN-HHMDPVIGDFGLTQ  302 (441)
Q Consensus       264 -al~~LH~-----~~~~iiHrDikp~NiLl~-~~~~~kl~DFGla~  302 (441)
                       .++.+++     ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence             2333332     223499999999999999 56666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd08312 Death_MyD88 Death domain of Myeloid Differentation primary response protein MyD88

Probab=98.37  E-value=7.1e-07  Score=67.25  Aligned_cols=49  Identities=27%  Similarity=0.455  Sum_probs=43.3

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCC--CCHHHHHHHHHhcChhhHHH
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQN--HTVLELFKHLYAMRHYQAML   53 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n--~tv~~l~~~l~~~~~~~a~~   53 (441)
                      |||+..+|+.||.    ..|||+.||..|+++|  +||+.|+.+|.+++-..+++
T Consensus        26 Lg~~~~~I~~f~~----~~sPt~~lL~~W~~r~~~atv~~L~~~L~~~~R~Dv~~   76 (79)
T cd08312          26 MGFEYLEIRNFET----KPSPTEKVLEDWETRPDGATVGNLLELLEKLERRDVLH   76 (79)
T ss_pred             cCCCHHHHHHHcc----CCChHHHHHHHHHhcCCCCcHHHHHHHHHHcChHHHHH
Confidence            7999999999974    5799999999999996  99999999999998766653

Death Domain (DD) of Myeloid Differentiation primary response protein 88 (MyD88). MyD88 is an adaptor protein involved in interleukin-1 receptor (IL-1R)- and Toll-like receptor (TLR)-induced activation of nuclear factor-kappaB (NF-kB) and mitogen activated protein kinase pathways that lead to the induction of proinflammatory cytokines. It is a key component in the signaling pathway of pathogen recognition in the innate immune system. MyD88 contains an N-terminal DD and a C-terminal Toll/IL-1 Receptor (TIR) homology domain that mediates interaction with TLRs and IL-1R. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and

>KOG0576|consensus

Probab=98.35  E-value=8e-08  Score=96.94  Aligned_cols=187  Identities=15%  Similarity=0.079  Sum_probs=130.6

Q ss_pred             CCCcCcCccccCCceeEEEEEECCee-EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCC-eecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN-ILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~  222 (441)
                      .-+...+-+++|+++++||.+...+. ...+.+...              ....-++++|.+++||| .+..++-+..+.
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------------LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------------hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            33444567899999999998764432 223333211              12235788999999999 777777777778


Q ss_pred             eEEEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         223 KYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       223 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      ..++.++++.++ +-.+-.  ......+...+...+.+.-+++++++|+.-  =+|+|    ||+..+ +..+.+||+..
T Consensus       308 ~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             ccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCC
Confidence            889999999877 221101  001111223344456667778999999864  48998    877765 67899999987


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCC
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD  358 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~  358 (441)
                      .......    ..+...+|+.++|||......+....|.||+|+-..++.-|.+|-.
T Consensus       379 ~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  379 PQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            6543221    3455679999999999999999999999999998788887877653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.28  E-value=6.7e-06  Score=83.94  Aligned_cols=148  Identities=19%  Similarity=0.184  Sum_probs=90.0

Q ss_pred             CccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHH-----------------------------hhhHHHHH--HHHH
Q psy5927         151 NILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVE-----------------------------TLNQCQRE--QSLR  198 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~-----------------------------~~~~~~~~--~~~~  198 (441)
                      ..|+.++-|.||+|+.. +..||||+....-......                             .+.+....  .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999996 7999999987543221110                             00000111  1224


Q ss_pred             HHHHhhcCC-----CCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHHHcCC
Q psy5927         199 ELKYLNSCR-----HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG-LQFLHSRE  272 (441)
Q Consensus       199 E~~~l~~l~-----hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~a-l~~LH~~~  272 (441)
                      |..-+.+++     .|++.=-.-+..-.+.-.|+|||++|-.+.+......  ...+   +..++..++.+ +..+=..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHHHHHHHHHHHHHHHHhcC
Confidence            444444432     2322211111122355679999999999988753333  2233   22333333322 33333467


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeccCCCccCC
Q psy5927         273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~  305 (441)
                        ++|.|..|.||+++.+|.+.+.|||+.....
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence              9999999999999999999999999986543

>cd08310 Death_NFkB-like Death domain of Nuclear Factor-KappaB precursor proteins

Probab=98.27  E-value=1.5e-06  Score=63.93  Aligned_cols=50  Identities=20%  Similarity=0.211  Sum_probs=42.2

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhh
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLIL   55 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~   55 (441)
                      |||+.. +..|    .++.|||..||+.|..+++||++|+..|.+|+...|+.+|
T Consensus        22 L~~~~~-i~~~----~~~~sPt~~LL~~we~~~~tv~~L~~~L~~mgr~dav~~l   71 (72)
T cd08310          22 LDLGHL-VNFI----RLSPSPTKMLLDYFEMQGGTLERLRDALEVLGETEAVELI   71 (72)
T ss_pred             cCcHHH-HHHH----hcCCCHHHHHHHHHHhCCCCHHHHHHHHHHcCcHHHHHhc
Confidence            456532 4444    4688999999999999999999999999999999999876

Death Domain (DD) of Nuclear Factor-KappaB (NF-kB) precursor proteins. The NF-kB family of transcription factors play a central role in cardiovascular growth, stress response, and inflammation by controlling the expression of a network of different genes. There are five NF-kB proteins, all containing an N-terminal REL Homology Domain (RHD). Two of these, NF-kB1 and NF-kB2 are produced from the processing of the precursor proteins p105 and p100, respectively. In addition to RHD, p105 and p100 contain ANK repeats and a C-terminal DD. NF-kBs are regulated by the Inhibitor of NF-kB (IkB) Kinase (IKK) complex through classical and non-canonical pathways, which differ in the IKK subunits involved and downstream targets. IKKs facilitate the release of NF-kB dimers from an inactive state, allowing them to migrate to the nucleus where they regulate gene transcription. The precursor proteins p105 and p100 function

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.1e-05  Score=75.10  Aligned_cols=140  Identities=16%  Similarity=0.058  Sum_probs=80.8

Q ss_pred             ccccCCc-eeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCCeEEEEEE
Q psy5927         152 ILGKGGF-GTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETGKYCLVYR  229 (441)
Q Consensus       152 ~LG~G~f-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e  229 (441)
                      .|-.|.. ..||+....+..+.||+.....            .....+|+++++.+. +--+.+++++....+..++||+
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEE
Confidence            3445555 7899987766667777764321            012336777776663 3345567777666667899999


Q ss_pred             ecCCCCHHHHH-------------------hhcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHH
Q psy5927         230 YMPNGSLEDRL-------------------LMKKN-TPSLLW--TQRLHIAK--------------------GTSLGLQF  267 (441)
Q Consensus       230 ~~~~gsL~~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~i~~al~~  267 (441)
                      +++|.+|....                   +.... ..++..  ........                    .+...++.
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99998876432                   11100 001110  00000000                    01111222


Q ss_pred             HHc-----CCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         268 LHS-----REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       268 LH~-----~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      |-.     ..+.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            211     123489999999999999987788999997754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.25  E-value=1.9e-05  Score=70.29  Aligned_cols=134  Identities=19%  Similarity=0.251  Sum_probs=92.1

Q ss_pred             CCCcCcCccccCCc-eeEEEEEECCeeEEEEEeee---ccchhHHHhhh---------HHHHHHHHHHHHHhhcC---CC
Q psy5927         145 NNWDKLNILGKGGF-GTVYKGVWEKTTIAVKKLEV---HRNDRAVETLN---------QCQREQSLRELKYLNSC---RH  208 (441)
Q Consensus       145 ~~~~~~~~LG~G~f-g~Vy~~~~~~~~vavK~~~~---~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l---~h  208 (441)
                      .+++.++.||.|.- |.||++..++..||+|.++.   .......+.+.         .....-|..|.+...++   .+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78899999999999 99999999999999999432   11111100000         01233566788877666   35


Q ss_pred             CCe--ecccceEEeC------------------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q psy5927         209 DNI--LPLYGICFET------------------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL  268 (441)
Q Consensus       209 pnI--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~L  268 (441)
                      .++  |+.+||..-.                  ....||.||++...            .+.    ..-+.+|.+-+..+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHH
Confidence            566  8888887322                  12357888776543            112    23345677788899


Q ss_pred             HcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       269 H~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      |..|  |+-+|+++.|..     .-+|+|||.+
T Consensus       181 ~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC--eeeccCcccccc-----CCEEEecccC
Confidence            9999  999999999986     4689999854

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.22  E-value=2e-05  Score=71.83  Aligned_cols=154  Identities=16%  Similarity=0.129  Sum_probs=92.0

Q ss_pred             HHHhhCCCcCcC---ccccCCceeEEEEEE-CCeeEEEEEeeeccchhHH-----------H----hhhHHHHHHHHHHH
Q psy5927         140 LTLATNNWDKLN---ILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAV-----------E----TLNQCQREQSLREL  200 (441)
Q Consensus       140 ~~~~~~~~~~~~---~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~-----------~----~~~~~~~~~~~~E~  200 (441)
                      +....++..+..   .|+.|--+.||+|.. ++..+|||+.+........           .    ...+....-...|.
T Consensus        40 l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf  119 (268)
T COG1718          40 LRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEF  119 (268)
T ss_pred             HHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHH
Confidence            333344444433   456677779999986 5788999999854432111           0    00011111223566


Q ss_pred             HHhhcCC--CCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeee
Q psy5927         201 KYLNSCR--HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIH  277 (441)
Q Consensus       201 ~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiH  277 (441)
                      .-|+++.  +-.+.+-+++.    .-.|||||+....+   -.-.-...++.......+..+++..+.-|-. .+  +||
T Consensus       120 ~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVH  190 (268)
T COG1718         120 RNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG--LVH  190 (268)
T ss_pred             HHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--ccc
Confidence            6666652  33333444432    33699999954311   0000011122233566677788888777766 67  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +||+.=|||+. ++.+.|+|||-|..
T Consensus       191 gDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         191 GDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             ccchhhheEEE-CCeEEEEECccccc
Confidence            99999999999 88999999997754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.12  E-value=1.5e-05  Score=68.74  Aligned_cols=129  Identities=20%  Similarity=0.167  Sum_probs=87.3

Q ss_pred             cCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec-ccceEEeCCeEEE
Q psy5927         148 DKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP-LYGICFETGKYCL  226 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~~~~~l  226 (441)
                      ...+.||+|++|.||+|.+.+..+|+|+-.....           +..+..|.++|..+.-.++-+ +|.|..    .++
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-----------r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i   89 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-----------RRNLEKEAKILEILAGEGVTPEVYFYGE----DFI   89 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCcc-----------hhhHHHHHHHHHHhhhcCCCceEEEech----hhh
Confidence            3457899999999999999999999998764322           234457888888886655543 444432    245


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCC-CCCeeecCCCCeEEeccCCCcc
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIK-SANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDik-p~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .|||+.|-+|.+.-..      .+-.+..    .++.+---|-..|  |-|+.|. |...+|-.++.+.|+||.-|+.
T Consensus        90 ~me~i~G~~L~~~~~~------~~rk~l~----~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          90 RMEYIDGRPLGKLEIG------GDRKHLL----RVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcCcchhhhhhc------ccHHHHH----HHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            6999998898775421      1223333    3344433445567  8898886 5555555666999999998864

>PLN02876 acyl-CoA dehydrogenase

Probab=98.08  E-value=3.7e-05  Score=84.19  Aligned_cols=148  Identities=16%  Similarity=0.213  Sum_probs=87.6

Q ss_pred             cCccccCCceeEEEEEECC----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCe--ecccceEEeC-
Q psy5927         150 LNILGKGGFGTVYKGVWEK----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNI--LPLYGICFET-  221 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~-  221 (441)
                      .+.|+.|.++.+|+....+    ..+++|+........        ....+.+|.++|+.+. |+++  .+++.+|.+. 
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--------~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~  114 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--------SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS  114 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--------cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence            4778999999999877654    356666653221100        1123458999998885 6654  6777777654 


Q ss_pred             --CeEEEEEEecCCCCHHH--------------------H---HhhcCCC--------CCCCH--HHHHHHH--------
Q psy5927         222 --GKYCLVYRYMPNGSLED--------------------R---LLMKKNT--------PSLLW--TQRLHIA--------  258 (441)
Q Consensus       222 --~~~~lv~e~~~~gsL~~--------------------~---l~~~~~~--------~~l~~--~~~~~i~--------  258 (441)
                        +..|+||||++|..+.+                    .   |+.....        .+..+  .+...+.        
T Consensus       115 v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~  194 (822)
T PLN02876        115 VIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTG  194 (822)
T ss_pred             cCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhc
Confidence              46789999998765321                    1   1111000        01111  1111111        


Q ss_pred             -------HHHHHHHHHHHcCC---------CCeeecCCCCCCeeecCC-CC-eEEeccCCCccCC
Q psy5927         259 -------KGTSLGLQFLHSRE---------PPLIHGDIKSANILLNHH-MD-PVIGDFGLTQEGP  305 (441)
Q Consensus       259 -------~~i~~al~~LH~~~---------~~iiHrDikp~NiLl~~~-~~-~kl~DFGla~~~~  305 (441)
                             -.+...+++|..+-         ..+||+|+++.|||++.+ +. .-|.||.++..+.
T Consensus       195 ~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        195 EGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             ccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence                   11233456664321         239999999999999853 33 5799999987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=2.1e-05  Score=72.90  Aligned_cols=29  Identities=28%  Similarity=0.449  Sum_probs=25.4

Q ss_pred             eeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         275 LIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       275 iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++|+|+.+.|||++.++..-|+||+.+..
T Consensus       166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         166 WFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             EEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            89999999999998776567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.95  E-value=2.8e-05  Score=69.30  Aligned_cols=101  Identities=21%  Similarity=0.115  Sum_probs=77.1

Q ss_pred             HHHHHhhcCCC-CCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCe
Q psy5927         198 RELKYLNSCRH-DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE-PPL  275 (441)
Q Consensus       198 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-~~i  275 (441)
                      .|.-++..+.+ +++.+++|+|-.    ++|.||...+++...-..-...-..+|..|.+|+.+++..+++|+..- .++
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47777888865 699999999832    568999987766431000011223689999999999999999999721 138


Q ss_pred             eecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         276 IHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       276 iHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .-.|++++|+-+++++.+|++|...+.
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcc
Confidence            889999999999999999999998664

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00011  Score=70.65  Aligned_cols=76  Identities=9%  Similarity=0.076  Sum_probs=52.1

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC---CCeecccceEEe---CCe
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH---DNILPLYGICFE---TGK  223 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~---~~~  223 (441)
                      .+.||.|..+.||+....+..+.+|..+....           ...+..|.+.|+.+.-   -.+.++++++.+   .+.
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~-----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGNPMPLMARSFST-----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeecCCccceeEEEEEcCCCCEEEEEeccccc-----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            46799999999999876555666676442111           1234477887777742   356677776654   366


Q ss_pred             EEEEEEecCCCCH
Q psy5927         224 YCLVYRYMPNGSL  236 (441)
Q Consensus       224 ~~lv~e~~~~gsL  236 (441)
                      .+||||+++|+++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.90  E-value=0.00026  Score=63.45  Aligned_cols=142  Identities=20%  Similarity=0.306  Sum_probs=90.2

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhH-------HHhhhHHHHHHHHHHHHHhhcCC------CCCeecccc
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRA-------VETLNQCQREQSLRELKYLNSCR------HDNILPLYG  216 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~  216 (441)
                      ...||+|+.-.||.-- .+....||+.........       ..........+..+|+.....+.      +.+|.+++|
T Consensus         6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            4679999999999632 344567788775540000       00001112334445555544444      888999999


Q ss_pred             eEEeCCeEEEEEEecCC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         217 ICFETGKYCLVYRYMPN------GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      +...+.-.-+|+|.+.+      .||.+++...    .++.    .+...+-.-.+||-..+  |+.+|++|.||++...
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~----~~~~~L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE----ELRQALDEFKRYLLDHH--IVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH----HHHHHHHHHHHHHHHcC--CeecCCCcccEEEEec
Confidence            99988888899988753      3577777322    2443    23333344556777777  9999999999999644


Q ss_pred             C----CeEEec-cCCCc
Q psy5927         291 M----DPVIGD-FGLTQ  302 (441)
Q Consensus       291 ~----~~kl~D-FGla~  302 (441)
                      .    .+.|+| ||-..
T Consensus       155 ~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCCceEEEEEeCCCCcc
Confidence            2    477888 67543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235|consensus

Probab=97.85  E-value=0.00017  Score=73.68  Aligned_cols=145  Identities=16%  Similarity=0.116  Sum_probs=86.8

Q ss_pred             CccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHH----------------------hhhHHHHHH------HHHHHH
Q psy5927         151 NILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVE----------------------TLNQCQREQ------SLRELK  201 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~----------------------~~~~~~~~~------~~~E~~  201 (441)
                      +.||.-+.|.||+|+.+ +..||||+-+..-......                      ++-.+..+.      |.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            67999999999999985 5779999976443221110                      000111111      223333


Q ss_pred             Hh----hcCCCCC------eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHc
Q psy5927         202 YL----NSCRHDN------ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL-QFLHS  270 (441)
Q Consensus       202 ~l----~~l~hpn------Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al-~~LH~  270 (441)
                      -.    +.++|-+      |.++|-.+  ...-.|+||||+|..+.|.-......  ++..   .|+..+.++. +-|=.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~---~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG--ISPH---DILNKLVEAYLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC--CCHH---HHHHHHHHHHHHHHHh
Confidence            22    2234544      44444322  34568999999999887754333322  3333   3333333321 22223


Q ss_pred             CCCCeeecCCCCCCeeecC----CCCeEEeccCCCccC
Q psy5927         271 REPPLIHGDIKSANILLNH----HMDPVIGDFGLTQEG  304 (441)
Q Consensus       271 ~~~~iiHrDikp~NiLl~~----~~~~kl~DFGla~~~  304 (441)
                      .|  ++|.|-.|.||+++.    ++.+.+-|||+....
T Consensus       320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            56  999999999999984    678999999998754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00012  Score=68.81  Aligned_cols=138  Identities=12%  Similarity=0.050  Sum_probs=75.1

Q ss_pred             ccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCee-cccceEEeCCeEEEEEEe
Q psy5927         152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL-PLYGICFETGKYCLVYRY  230 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~  230 (441)
                      .+..|-.+.+|+....+..+++|...........         ...+|.++++.+...+++ +++..+  .  -++||||
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~---------~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGV---------DRQREYQILQALSALGLAPKPILVN--E--HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccccC---------cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEe
Confidence            3556778899998877778888865422111000         113577777777533332 333332  2  2689999


Q ss_pred             cCCCCHHHH-----------------HhhcCC-CCCCCHHHH-HHHHHHH---------HHHHHHHHcC------CCCee
Q psy5927         231 MPNGSLEDR-----------------LLMKKN-TPSLLWTQR-LHIAKGT---------SLGLQFLHSR------EPPLI  276 (441)
Q Consensus       231 ~~~gsL~~~-----------------l~~~~~-~~~l~~~~~-~~i~~~i---------~~al~~LH~~------~~~ii  276 (441)
                      ++|.++...                 |+.... ..+++.... ..+..++         ...+..+-..      ...++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            998765321                 111111 111222111 1111111         1112222111      12489


Q ss_pred             ecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         277 HGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       277 HrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      |+|+.|.||++++++ +.|+||..+..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999877 78999998865

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF00531 Death: Death domain; InterPro: IPR000488 The death domain (DD) is a homotypic protein interaction module composed of a bundle of six alpha-helices

Probab=97.74  E-value=1.9e-05  Score=60.23  Aligned_cols=57  Identities=18%  Similarity=0.288  Sum_probs=49.7

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||+..+|..|+..-.+..+||.++|..|.++   ++||++|++.|.+++...+++.|..
T Consensus        22 Lg~~~~~i~~i~~~~~~~~~~~~~~L~~W~~~~~~~at~~~L~~aL~~~~~~d~~~~i~~   81 (83)
T PF00531_consen   22 LGLSESEIENIEEENPDLREQTYEMLQRWRQREGPNATVDQLIQALRDIGRNDLAEKIEQ   81 (83)
T ss_dssp             TTS-HHHHHHHHHHSTSHHHHHHHHHHHHHHHHGSTSSHHHHHHHHHHTTHHHHHHHHHH
T ss_pred             hCcCHHHHHHHHHhCCChHHHHHHHHHHHHHhcCCCCcHHHHHHHHHHCCcHHHHHHHHh
Confidence            68999999999985544568999999999977   9999999999999999999988754

DD is related in sequence and structure to the death effector domain (DED, see IPR001875 from INTERPRO) and the caspase recruitment domain (CARD, see IPR001315 from INTERPRO), which work in similar pathways and show similar interaction properties []. DD bind each other forming oligomers. Mammals have numerous and diverse DD-containing proteins []. Within these proteins, the DD domains can be found in combination with other domains, including: CARDs, DEDs, ankyrin repeats (IPR002110 from INTERPRO), caspase-like folds, kinase domains, leucine zippers (IPR002158 from INTERPRO), leucine-rich repeats (LRR) (IPR001611 from INTERPRO), TIR domains (IPR000157 from INTERPRO), and ZU5 domains (IPR000906 from INTERPRO) []. Some DD-containing proteins are involved in the regulation of apoptosis and inflammation through their activation of caspases and NF-kappaB, which typically involves interactions with TNF (tumour necrosis factor) cytokine receptors [, ]. In humans, eight of the over 30 known TNF receptors contain DD in their cytoplasmic tails; several of these TNF receptors use caspase activation as a signalling mechanism. The DD mediates self-association of these receptors, thus giving the signal to downstream events that lead to apoptosis. Other DD-containing proteins, such as ankyrin, MyD88 and pelle, are probably not directly involved in cell death signalling. DD-containing proteins also have links to innate immunity, communicating with Toll family receptors through bipartite adapter proteins such as MyD88 [].; GO: 0005515 protein binding, 0007165 signal transduction; PDB: 3OQ9_L 3EZQ_F 1E41_A 1E3Y_A 2GF5_A 2OF5_L 3EWV_E 3G5B_A 3MOP_L 2A9I_A ....

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.73  E-value=0.00027  Score=65.32  Aligned_cols=30  Identities=23%  Similarity=0.293  Sum_probs=26.5

Q ss_pred             CeeecCCCCCCeeecC-CCCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNH-HMDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~-~~~~kl~DFGla~~  303 (441)
                      .++|+|+.+.|||++. ++.+.++||..|..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            4999999999999998 57899999987754

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035|consensus

Probab=97.69  E-value=0.00012  Score=79.21  Aligned_cols=194  Identities=16%  Similarity=0.142  Sum_probs=132.4

Q ss_pred             HHHHHHhhcCCCCCeecccceEEeCCeEE----EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy5927         197 LRELKYLNSCRHDNILPLYGICFETGKYC----LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE  272 (441)
Q Consensus       197 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~  272 (441)
                      ..|+..+....|+|++.++.|..+....-    +.-++|..-++...+..   ...++....+.+..++.+|+.|+|+..
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            35777788889999999999876553332    34578888888877743   344777888889999999999999976


Q ss_pred             CCeeecCCCCC---CeeecCCCCeEEe--ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCC--ccceehHHH
Q psy5927         273 PPLIHGDIKSA---NILLNHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLST--KVDVYGFGI  345 (441)
Q Consensus       273 ~~iiHrDikp~---NiLl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~~DiwSlGv  345 (441)
                        ..|.-+..+   +...+..+...++  ||+..............    .-+..+.++|......+..  ..|+|.+|.
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~----~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD----LLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCcccchhh----cCccccccccccccccchhhhhhHHHHHHH
Confidence              555555444   5555666777777  99887765443322211    1344567777776654444  479999999


Q ss_pred             HHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         346 VLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       346 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                      .+..+..|..+-.....                +..+++       ......+.+...+|+..+.++|++..+++..
T Consensus       381 l~~~~~~~~~i~~~~~~----------------~~~~l~-------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV----------------PVSLLD-------VLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHhhhhhcCcccccccc----------------hhhhhc-------cccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            99999987654322211                001111       1111156778899999999999999999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.0013  Score=63.47  Aligned_cols=143  Identities=13%  Similarity=0.104  Sum_probs=77.8

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-----CCCCeecccc---eEEeC
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-----RHDNILPLYG---ICFET  221 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~---~~~~~  221 (441)
                      +..++.|....+|+...++..+.+|+........           ....|.+++..+     ..|.+++-..   +....
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~-----------~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAE-----------ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCCCHH-----------HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            4567777778999987766678888765421111           111334444443     2333333211   11224


Q ss_pred             CeEEEEEEecCCCCHH-----------H---HHhhcCCC--C-------CCCHHHHH------------HHHHHHHHHHH
Q psy5927         222 GKYCLVYRYMPNGSLE-----------D---RLLMKKNT--P-------SLLWTQRL------------HIAKGTSLGLQ  266 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~-----------~---~l~~~~~~--~-------~l~~~~~~------------~i~~~i~~al~  266 (441)
                      +..+++++|++|.++.           .   .++.....  .       .-.|....            .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            6678999999885532           1   11111110  0       01111100            01112334455


Q ss_pred             HHHc-----CCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         267 FLHS-----REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       267 ~LH~-----~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++..     ....++|+|+.+.||+++.++...|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            5542     123499999999999999988778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.45  E-value=0.0014  Score=62.74  Aligned_cols=142  Identities=16%  Similarity=0.115  Sum_probs=81.1

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC--Ceecccce------EEeC
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD--NILPLYGI------CFET  221 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~------~~~~  221 (441)
                      ++.|..|....+|+....+..+++|+... ...           .....|++++..+.+.  .+.+++..      ....
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~~~-----------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-VSA-----------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCC-CCh-----------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            56777788889999877777889988753 111           1122455555555322  23343331      1234


Q ss_pred             CeEEEEEEecCCCCHHH--------------HHhhcC-C-C------CCCCHHHHH----------HHHHHHHHHHHHHH
Q psy5927         222 GKYCLVYRYMPNGSLED--------------RLLMKK-N-T------PSLLWTQRL----------HIAKGTSLGLQFLH  269 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~--------------~l~~~~-~-~------~~l~~~~~~----------~i~~~i~~al~~LH  269 (441)
                      +..++|++|++|.++..              .++... . .      ....|....          .....+..++.++.
T Consensus        87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  166 (296)
T cd05153          87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD  166 (296)
T ss_pred             CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence            56789999999876521              011100 0 0      011222111          01112333445554


Q ss_pred             c-----CCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         270 S-----REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       270 ~-----~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +     ....++|+|+.|.|||+++++.+.|.||+.+..
T Consensus       167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3     112499999999999999987788999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.44  E-value=0.0051  Score=59.67  Aligned_cols=30  Identities=23%  Similarity=0.267  Sum_probs=26.1

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      ++||+|+.|.|||++.+...-|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            499999999999999766668999998865

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.42  E-value=0.0025  Score=63.34  Aligned_cols=81  Identities=12%  Similarity=0.074  Sum_probs=49.7

Q ss_pred             CccccCCceeEEEEEECCe--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---CCCeecccceEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---HDNILPLYGICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~  225 (441)
                      +.||.|.+..||+....+.  .+.||.-..........+  ....+....|.+.|..+.   -.++.+++.+  +.+..+
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w--pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW--PLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc--cccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence            6789999999999988653  788887431110000000  012234446677776652   2356667665  446678


Q ss_pred             EEEEecCCCC
Q psy5927         226 LVYRYMPNGS  235 (441)
Q Consensus       226 lv~e~~~~gs  235 (441)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998754

>KOG2268|consensus

Probab=97.40  E-value=0.00022  Score=67.44  Aligned_cols=139  Identities=17%  Similarity=0.150  Sum_probs=91.9

Q ss_pred             CcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchh--------------HHHhhhHHHHHHHHHHHHHhhcCC-CCC
Q psy5927         147 WDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDR--------------AVETLNQCQREQSLRELKYLNSCR-HDN  210 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~--------------~~~~~~~~~~~~~~~E~~~l~~l~-hpn  210 (441)
                      +.+++.||-|--+.||.+-+. ++..++|.-...+...              ...++ ...+-...+|...|+.+. |-.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWl-yLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWL-YLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchh-hhHHHHHHHHHHHHHHHHHcCC
Confidence            567899999999999999885 6777777644322110              00011 112223447888888873 333


Q ss_pred             ee-cccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC
Q psy5927         211 IL-PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH  289 (441)
Q Consensus       211 Iv-~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~  289 (441)
                      -| +.+    +.+..|+|||++.|..|...- ...     .   .-.+...++.-|--|-.+|  +||+|..-=||++++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~-~v~-----d---~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVR-HVE-----D---PPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeee-ecC-----C---hHHHHHHHHHHHHHHHHcC--ceecccchheeEEec
Confidence            22 333    446789999999998886522 111     1   1234444555566677788  999999999999999


Q ss_pred             CCCeEEeccCCC
Q psy5927         290 HMDPVIGDFGLT  301 (441)
Q Consensus       290 ~~~~kl~DFGla  301 (441)
                      ++.++++||--.
T Consensus       238 d~~i~vIDFPQm  249 (465)
T KOG2268|consen  238 DDKIVVIDFPQM  249 (465)
T ss_pred             CCCEEEeechHh
Confidence            999999999644

>KOG1826|consensus

Probab=97.38  E-value=3.5e-05  Score=85.15  Aligned_cols=167  Identities=13%  Similarity=0.044  Sum_probs=120.3

Q ss_pred             hhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--CCeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHH
Q psy5927         188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLG  264 (441)
Q Consensus       188 ~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~a  264 (441)
                      +.+...+..+.|..-++...|+++...+.-...  ....+.+++|+.+|.+++.+.+.. ..+++....+...-.+.+.+
T Consensus      1268 LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1268 LSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred             HhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhc
Confidence            334445555667776777789998877654432  345688999999999999886533 23444444444444444566


Q ss_pred             HHHHHc---CCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCcccee
Q psy5927         265 LQFLHS---REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVY  341 (441)
Q Consensus       265 l~~LH~---~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Diw  341 (441)
                      ..-+|+   .|...+|+++|+.|.+|..+-.+|++++|+.+....   .........+++.|+.|+....-.++.++|+|
T Consensus      1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred             cchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc---hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence            666665   334589999999999999999999999999983221   12223444578889999998888888889999


Q ss_pred             hHHHHHHHHHhCCCCC
Q psy5927         342 GFGIVLFELATGMRAY  357 (441)
Q Consensus       342 SlGvvl~elltG~~p~  357 (441)
                      ..|+.+|+...|..+|
T Consensus      1425 r~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHhcccHHH
Confidence            9999999998888776

>cd08311 Death_p75NR Death domain of p75 Neurotophin Receptor

Probab=97.28  E-value=0.00063  Score=50.74  Aligned_cols=51  Identities=20%  Similarity=0.352  Sum_probs=44.1

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhh-cCCCCHHHHHHHHHhcChhhHHHhh
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWG-AQNHTVLELFKHLYAMRHYQAMLIL   55 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~-~~n~tv~~l~~~l~~~~~~~a~~~~   55 (441)
                      |||+..+|+.|+..    .+||..||..|. +.++||+-|...|.+++....++.|
T Consensus        25 LG~~~~~I~~i~~~----~~p~~~lL~~W~~r~~ATv~~L~~aL~~i~R~Di~~~L   76 (77)
T cd08311          25 LGYEDEAIDTFGRE----ESPVRTLLADWSAQEGATLDALCTALRRIQREDIAESL   76 (77)
T ss_pred             cCCCHHHHHHHHcC----hhHHHHHHHHHHHCcCchHHHHHHHHHHcChHHHHHhc
Confidence            79999999999843    589999999998 5569999999999999988777654

Death Domain (DD) found in p75 neurotrophin receptor (p75NTR, NGFR, TNFRSF16). p75NTR binds members of the neurotrophin (NT) family including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and NT3, among others. It contains an NT-binding extracellular region that bears four cysteine-rich repeats, a transmembrane domain, and an intracellular DD. p75NTR plays roles in the immune, vascular, and nervous systems, and has been shown to promote cell death or survival, and to induce neurite outgrowth or collapse depending on its ligands and co-receptors. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptor

>KOG1093|consensus

Probab=97.16  E-value=0.0013  Score=65.92  Aligned_cols=162  Identities=22%  Similarity=0.270  Sum_probs=94.0

Q ss_pred             HHHHHHHHhhcCCCCCeecccceEEeC-CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q psy5927         195 QSLRELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREP  273 (441)
Q Consensus       195 ~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~  273 (441)
                      +.+-...+++.+.|+|...++++.... .+..+|+|++ +.||+|.+..+. ..         +...+        .++ 
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~---------~~s~~--------~~~-   87 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LK---------DESLL--------AHG-   87 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cc---------hhhhc--------ccc-
Confidence            344567788999999999998876533 4578999999 799999875433 11         11111        222 


Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG  353 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG  353 (441)
                       +.|-     |       ..+++| -++..                   |  |-     ...+|+||||+|.++.|+.-|
T Consensus        88 -~~~~-----~-------~~~~td-~~~t~-------------------~--~~-----~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   88 -VLHL-----N-------IIYITD-HFLTK-------------------Y--PS-----PIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             -ccee-----h-------hhhccc-ccccc-------------------C--CC-----CCCcchhhhhHHHHHHHHHHh
Confidence             4332     1       233444 11110                   0  10     112499999999999999999


Q ss_pred             CCCCCCcchhHHHHHHHHHhh-chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         354 MRAYDDTRRSERHLKSLVEKY-SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       354 ~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                      ..-+..... .++++.+..-+ .+......  .........+...+..+..+|+...|..||...++
T Consensus       128 ~~l~~~~~~-s~~l~~i~k~~~~d~~~~~~--a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  128 ISLEAELTE-SEYLEILLKYYTDDQELLST--AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             hHHHHHHHH-HHHHHHHHHhccCchhHHHH--HHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            876655443 22333332222 11111100  01112334556678889999999999999855443

>smart00005 DEATH DEATH domain, found in proteins involved in cell death (apoptosis)

Probab=97.15  E-value=0.00041  Score=53.54  Aligned_cols=57  Identities=19%  Similarity=0.314  Sum_probs=49.5

Q ss_pred             CCCChHHHHHHHHHHHh-CCCchHHHHHHhhcCC---CCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILR-RESPTEELLSKWGAQN---HTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~-~~s~t~~ll~~w~~~n---~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||...+|..|+..-.+ ..+|+.++|..|.+++   +||+.|++.|.++++..+++.+..
T Consensus        27 Lg~~~~~i~~i~~~~~~~~~~~~~~lL~~W~~~~g~~at~~~L~~aL~~~~~~d~a~~i~~   87 (88)
T smart00005       27 LGLSEADIDQIRTEAPRDLAEQSVQLLRLWEQREGKNATLGTLLEALRKMGRDDAVELLRS   87 (88)
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHHccchhhHHHHHHHHHHHcChHHHHHHHhc
Confidence            68999999999987643 4689999999999766   599999999999999999987753

Alpha-helical domain present in a variety of proteins with apoptotic functions. Some (but not all) of these domains form homotypic and heterotypic dimers.

>cd01670 Death Death Domain: a protein-protein interaction domain

Probab=97.15  E-value=0.00041  Score=52.32  Aligned_cols=52  Identities=21%  Similarity=0.311  Sum_probs=45.5

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCC---CCHHHHHHHHHhcChhhHH
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQN---HTVLELFKHLYAMRHYQAM   52 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n---~tv~~l~~~l~~~~~~~a~   52 (441)
                      +||+..+|..|+..-.+..+|+.++|..|.+++   +||++|+..|.+++.+..+
T Consensus        20 Lgl~~~~I~~i~~~~~~~~~~~~~mL~~W~~~~~~~at~~~L~~aL~~~~~~~~a   74 (79)
T cd01670          20 LGLSDGEIDQIEEDNPRVREQAYQLLLKWEEREGDNATVGNLIEALREIGRRDDA   74 (79)
T ss_pred             hCCCHHHHHHHHHhCCCHHHHHHHHHHHHHhccCcCcHHHHHHHHHHHcCHHHHH
Confidence            589999999999887667799999999998776   6999999999999995444

Death Domains (DDs) are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. Structural analysis of DD-DD complexes show that the domains interact with each other in many different ways. DD-containing proteins serve as adaptors in signaling pathways and they can recruit other proteins into signaling complexes. In mammals, they are prominent components of the programmed cell death (apoptosis) pathway and are found in a number of other signaling pathways. In invertebrates, they are involved in transcriptional regulation of zygotic patterning genes in insect embryogenesis, and are components of the ToII/NF-kappaB pathway, a conserved innate immune pathway in a

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.12  E-value=0.0028  Score=60.99  Aligned_cols=30  Identities=30%  Similarity=0.397  Sum_probs=26.8

Q ss_pred             CeeecCCCCCCeeecCC----CCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNHH----MDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~----~~~kl~DFGla~~  303 (441)
                      .++|+|+.+.|||++.+    +.++++||..|..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            48999999999999985    8899999998854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd08802 Death_UNC5B Death domain found in Uncoordinated-5B

Probab=97.08  E-value=0.0013  Score=49.56  Aligned_cols=48  Identities=19%  Similarity=0.335  Sum_probs=38.3

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCC---CCHHHHHHHHHhcChhhHHH
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQN---HTVLELFKHLYAMRHYQAML   53 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n---~tv~~l~~~l~~~~~~~a~~   53 (441)
                      ||||-    .+| +-....|||..||..|-.+|   +||++|+.+|.+|+--.++.
T Consensus        30 L~ld~----yl~-~f~~~psPT~~LLd~WE~~~~~~~~v~~L~~~L~~mgR~D~~~   80 (84)
T cd08802          30 LSMDR----YLN-YFATKASPTGVILDLWEARHQDDGDLNSLASALEEMGKSEMLV   80 (84)
T ss_pred             cCchh----HHH-HHHcCCCcHHHHHHHHHhcCCCcccHHHHHHHHHHcCcchHHH
Confidence            55652    344 44557899999999999765   99999999999999888774

Death Domain (DD) found in Uncoordinated-5B (UNC5B). UNC5B is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5B signaling is involved in the netrin-1-induced proliferation and migration of renal proximal tubular cells. It is also required for vascular patterning during embryonic development, and its activation inhibits sprouting angiogenesis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activatio

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.85  E-value=0.018  Score=55.52  Aligned_cols=29  Identities=28%  Similarity=0.312  Sum_probs=25.4

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +++|||+.+.||+++. +.+.|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            4999999999999988 6789999997754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.81  E-value=0.014  Score=56.03  Aligned_cols=34  Identities=24%  Similarity=0.396  Sum_probs=29.9

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      .++|+|+.+.|++++.++-+-+.||+++..+...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            3999999999999999999999999999875443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	441
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-40
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-39
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-32
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-32
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-23
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-15
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-04
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		5e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-04

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 107/294 (36%), Positives = 156/294 (53%), Gaps = 16/294 (5%)
Query: 137 YQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           + EL   TNN+D+       N +G+GGFG VYKG    TT+AVKKL        V+   +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA-----MVDITTE 71
Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             ++Q  +E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     TP L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           W  R  IA+G + G+ FLH  E   IH DIKSANILL+      I DFGL +    + A 
Sbjct: 132 WHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFAQ 188
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL-KS 369
            +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +  L   
Sbjct: 189 TVMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +  E+ + D +DK     +     A + +  Q   +   +RP++ +V  +L
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 107/294 (36%), Positives = 156/294 (53%), Gaps = 16/294 (5%)
Query: 137 YQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           + EL   TNN+D+       N +G+GGFG VYKG    TT+AVKKL        V+   +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA-----MVDITTE 71
Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             ++Q  +E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     TP L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           W  R  IA+G + G+ FLH  E   IH DIKSANILL+      I DFGL +    + A 
Sbjct: 132 WHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFAQ 188
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL-KS 369
            +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +  L   
Sbjct: 189 TVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +  E+ + D +DK     +     A + +  Q   +   +RP++ +V  +L
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 107/294 (36%), Positives = 156/294 (53%), Gaps = 16/294 (5%)
Query: 137 YQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           + EL   TNN+D+       N +G+GGFG VYKG    TT+AVKKL        V+   +
Sbjct: 11  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAA-----MVDITTE 65
Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             ++Q  +E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     TP L 
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           W  R  IA+G + G+ FLH  E   IH DIKSANILL+      I DFGL +    + A 
Sbjct: 126 WHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASE-KFAQ 182
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL-KS 369
            +   R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +  L   
Sbjct: 183 XVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 241
Query: 370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +  E+ + D +DK     +     A + +  Q   +   +RP++ +V  +L
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 108/295 (36%), Positives = 153/295 (51%), Gaps = 18/295 (6%)
Query: 137 YQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           + EL   TNN+D+       N  G+GGFG VYKG    TT+AVKKL        V+   +
Sbjct: 8   FYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAA-----MVDITTE 62
Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             ++Q  +E+K    C+H+N++ L G   +    CLVY Y PNGSL DRL     TP L 
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK-A 309
           W  R  IA+G + G+ FLH  E   IH DIKSANILL+      I DFGL +    EK A
Sbjct: 123 WHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARAS--EKFA 178
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL-K 368
             +   R+ GT  Y   E L G+ ++ K D+Y FG+VL E+ TG+ A D+ R  +  L  
Sbjct: 179 QXVXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 237
Query: 369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
               +  E+ + D +DK     +     A + +  Q   +   +RP++ +V  +L
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 166/312 (53%), Gaps = 28/312 (8%)
Query: 129 LGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG-VWEKTTIAVKKLEVHRNDRAVET 187
           LG       +EL +A++N+   NILG+GGFG VYKG + + T +AVK+L+  R       
Sbjct: 22  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERX------ 75
Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK-KNT 246
             Q    Q   E++ ++   H N+L L G C    +  LVY YM NGS+   L  + ++ 
Sbjct: 76  --QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
           P L W +R  IA G++ GL +LH   +P +IH D+K+ANILL+   + V+GDFGL +   
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
Query: 306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER 365
             K  H+    V GT  ++  E+L   + S K DV+G+G++L EL TG RA+D  R +  
Sbjct: 194 Y-KDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 251
Query: 366 HLKSLVE----KYSEENMYDLVDKNAQ------PIELNIAYAFFRIGKQSTKQNPKERPE 415
               L++       E+ +  LVD + Q       +E  I  A        T+ +P ERP+
Sbjct: 252 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL-----CTQSSPMERPK 306
Query: 416 MTQVYNMLSGSG 427
           M++V  ML G G
Sbjct: 307 MSEVVRMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 109/312 (34%), Positives = 164/312 (52%), Gaps = 28/312 (8%)
Query: 129 LGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG-VWEKTTIAVKKLEVHRNDRAVET 187
           LG       +EL +A++N+   NILG+GGFG VYKG + +   +AVK+L+  R       
Sbjct: 14  LGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERT------ 67
Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK-KNT 246
             Q    Q   E++ ++   H N+L L G C    +  LVY YM NGS+   L  + ++ 
Sbjct: 68  --QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
           P L W +R  IA G++ GL +LH   +P +IH D+K+ANILL+   + V+GDFGL +   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER 365
             K  H+    V G   ++  E+L   + S K DV+G+G++L EL TG RA+D  R +  
Sbjct: 186 Y-KDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 366 HLKSLVE----KYSEENMYDLVDKNAQ------PIELNIAYAFFRIGKQSTKQNPKERPE 415
               L++       E+ +  LVD + Q       +E  I  A        T+ +P ERP+
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL-----CTQSSPMERPK 298
Query: 416 MTQVYNMLSGSG 427
           M++V  ML G G
Sbjct: 299 MSEVVRMLEGDG 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 153/291 (52%), Gaps = 19/291 (6%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQR 193
           +P  +L  ATNN+D   ++G G FG VYKGV  +   +A+K+       R  E+    + 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-------RTPESSQGIEE 81
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP--SLLW 251
            ++  E++ L+ CRH +++ L G C E  +  L+Y+YM NG+L+ R L   + P  S+ W
Sbjct: 82  FET--EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK-RHLYGSDLPTMSMSW 138
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            QRL I  G + GL +LH+R   +IH D+KS NILL+ +  P I DFG++++G     TH
Sbjct: 139 EQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT--RRSERHLKS 369
           +    V GT  Y+  E+ +  RL+ K DVY FG+VLFE+     A   +  R      + 
Sbjct: 197 LX-XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 370 LVEKYSEENMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            VE ++   +  +VD N A  I       F     +    + ++RP M  V
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 99/291 (34%), Positives = 153/291 (52%), Gaps = 19/291 (6%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQR 193
           +P  +L  ATNN+D   ++G G FG VYKGV  +   +A+K+       R  E+    + 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-------RTPESSQGIEE 81
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP--SLLW 251
            ++  E++ L+ CRH +++ L G C E  +  L+Y+YM NG+L+ R L   + P  S+ W
Sbjct: 82  FET--EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK-RHLYGSDLPTMSMSW 138
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            QRL I  G + GL +LH+R   +IH D+KS NILL+ +  P I DFG++++G     TH
Sbjct: 139 EQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTH 196
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT--RRSERHLKS 369
           +    V GT  Y+  E+ +  RL+ K DVY FG+VLFE+     A   +  R      + 
Sbjct: 197 LX-XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 370 LVEKYSEENMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            VE ++   +  +VD N A  I       F     +    + ++RP M  V
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 112/210 (53%), Gaps = 15/210 (7%)
Query: 147 WDKLNI---LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           W  LNI   +G G FGTV++  W  + +AVK L     D   E +N+      LRE+  +
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL--MEQDFHAERVNEF-----LREVAIM 88
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT-PSLLWTQRLHIAKGTS 262
              RH NI+   G   +     +V  Y+  GSL  RLL K      L   +RL +A   +
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVA 147
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+ +LH+R PP++H ++KS N+L++      + DFGL++   ++ +T ++ K   GT  
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPE 204
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  E L  +  + K DVY FG++L+ELAT
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 15/210 (7%)
Query: 147 WDKLNI---LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           W  LNI   +G G FGTV++  W  + +AVK L     D   E +N+      LRE+  +
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL--MEQDFHAERVNEF-----LREVAIM 88
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT-PSLLWTQRLHIAKGTS 262
              RH NI+   G   +     +V  Y+  GSL  RLL K      L   +RL +A   +
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY-RLLHKSGAREQLDERRRLSMAYDVA 147
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+ +LH+R PP++H D+KS N+L++      + DFGL++   ++ +  +  K   GT  
Sbjct: 148 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR---LKASXFLXSKXAAGTPE 204
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  E L  +  + K DVY FG++L+ELAT
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 152/306 (49%), Gaps = 31/306 (10%)
Query: 128 VLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAV 185
            +GG+     +  TLA N  +    +GKGGFG V+KG  V +K+ +A+K L +  ++   
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
           E + + Q  Q  RE+  +++  H NI+ LYG+     +  +V  ++P G L  RLL K +
Sbjct: 62  EMIEKFQEFQ--REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL-----NHHMDPVIGDFGL 300
              + W+ +L +    +LG++++ ++ PP++H D++S NI L     N  +   + DFGL
Sbjct: 118 --PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS--TKVDVYGFGIVLFELATGMRAYD 358
           +Q+     + H ++  + G   ++  E +  +  S   K D Y F ++L+ + TG   +D
Sbjct: 176 SQQ-----SVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 359 DTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
           +    +    +++    EE +   + ++  P   N+        +     +PK+RP  + 
Sbjct: 230 EYSYGKIKFINMIR---EEGLRPTIPEDCPPRLRNVI-------ELCWSGDPKKRPHFSY 279
Query: 419 VYNMLS 424
           +   LS
Sbjct: 280 IVKELS 285

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 130/300 (43%), Gaps = 44/300 (14%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           I + ELTL         I+G GGFG VY+  W    +AVK      ++   +T+   ++E
Sbjct: 4   IDFAELTLE-------EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
             L  +      +H NI+ L G+C +    CLV  +   G L   L  K+  P +L    
Sbjct: 57  AKLFAM-----LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA 111
Query: 255 LHIAKGTSLGLQFLHSRE-PPLIHGDIKSANILLNHHMDP--------VIGDFGLTQEGP 305
           + IA+    G+ +LH     P+IH D+KS+NIL+   ++          I DFGL +E  
Sbjct: 112 VQIAR----GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-- 165
Query: 306 IEKATHITLK-RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
                H T K    G   ++  E +     S   DV+ +G++L+EL TG   +       
Sbjct: 166 ----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------- 214
Query: 365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           R +  L   Y        ++K A PI       F ++ +     +P  RP  T + + L+
Sbjct: 215 RGIDGLAVAYGVA-----MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 151/306 (49%), Gaps = 31/306 (10%)
Query: 128 VLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAV 185
            +GG+     +  TLA N  +    +GKGGFG V+KG  V +K+ +A+K L +  ++   
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
           E + + Q  Q  RE+  +++  H NI+ LYG+     +  +V  ++P G L  RLL K +
Sbjct: 62  EMIEKFQEFQ--REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL-----NHHMDPVIGDFGL 300
              + W+ +L +    +LG++++ ++ PP++H D++S NI L     N  +   + DFG 
Sbjct: 118 --PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT 175
Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS--TKVDVYGFGIVLFELATGMRAYD 358
           +Q+     + H ++  + G   ++  E +  +  S   K D Y F ++L+ + TG   +D
Sbjct: 176 SQQ-----SVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 359 DTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
           +    +    +++    EE +   + ++  P   N+        +     +PK+RP  + 
Sbjct: 230 EYSYGKIKFINMIR---EEGLRPTIPEDCPPRLRNVI-------ELCWSGDPKKRPHFSY 279
Query: 419 VYNMLS 424
           +   LS
Sbjct: 280 IVKELS 285

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/306 (25%), Positives = 151/306 (49%), Gaps = 31/306 (10%)
Query: 128 VLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAV 185
            +GG+     +  TLA N  +    +GKGGFG V+KG  V +K+ +A+K L +  ++   
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
           E + + Q  Q  RE+  +++  H NI+ LYG+     +  +V  ++P G L  RLL K +
Sbjct: 62  EMIEKFQEFQ--REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH 117
Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL-----NHHMDPVIGDFGL 300
              + W+ +L +    +LG++++ ++ PP++H D++S NI L     N  +   + DF L
Sbjct: 118 --PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL 175
Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS--TKVDVYGFGIVLFELATGMRAYD 358
           +Q+     + H ++  + G   ++  E +  +  S   K D Y F ++L+ + TG   +D
Sbjct: 176 SQQ-----SVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 359 DTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
           +    +    +++    EE +   + ++  P   N+        +     +PK+RP  + 
Sbjct: 230 EYSYGKIKFINMIR---EEGLRPTIPEDCPPRLRNVI-------ELCWSGDPKKRPHFSY 279
Query: 419 VYNMLS 424
           +   LS
Sbjct: 280 IVKELS 285

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           ++G+G FG V K  W    +A+K++E           ++ +R+  + EL+ L+   H NI
Sbjct: 16  VVGRGAFGVVCKAKWRAKDVAIKQIE-----------SESERKAFIVELRQLSRVNHPNI 64
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LYG C      CLV  Y   GSL + L   +  P       +      S G+ +LHS 
Sbjct: 65  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 272 EP-PLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFL 329
           +P  LIH D+K  N+LL      + I DFG       +  TH+T  +  G+  ++  E  
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNK--GSAAWMAPEVF 176
Query: 330 VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP 389
            G   S K DV+ +GI+L+E+ T  + +D+       +           M+ + +    P
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-----------MWAVHNGTRPP 225
Query: 390 IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
           +  N+      +  +   ++P +RP M ++  +++      P A  P
Sbjct: 226 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           ++G+G FG V K  W    +A+K++E           ++ +R+  + EL+ L+   H NI
Sbjct: 15  VVGRGAFGVVCKAKWRAKDVAIKQIE-----------SESERKAFIVELRQLSRVNHPNI 63
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LYG C      CLV  Y   GSL + L   +  P       +      S G+ +LHS 
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 272 EP-PLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFL 329
           +P  LIH D+K  N+LL      + I DFG       +  TH+T  +  G+  ++  E  
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNK--GSAAWMAPEVF 175
Query: 330 VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP 389
            G   S K DV+ +GI+L+E+ T  + +D+       +           M+ + +    P
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-----------MWAVHNGTRPP 224
Query: 390 IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
           +  N+      +  +   ++P +RP M ++  +++      P A  P
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 16  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 67  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 123
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL  E      +H   ++++G+  ++  E +  
Sbjct: 124 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH-QFEQLSGSILWMAPEVIRM 180
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 232
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 36  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 87  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 143
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL  E      +H   ++++G+  ++  E +  
Sbjct: 144 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH-QFEQLSGSILWMAPEVIRM 200
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 252
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 253 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 283

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 44  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 151
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL  E      +H   ++++G+  ++  E +  
Sbjct: 152 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH-QFEQLSGSILWMAPEVIRM 208
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y        +  +  
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY--------LSPDLS 260
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 261 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 291

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 37/285 (12%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +LGKG FG   K    +T   +   E+ R D       + QR   L+E+K +    H N+
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFD------EETQR-TFLKEVKVMRCLEHPNV 69
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G+ ++  +   +  Y+  G+L  R ++K       W+QR+  AK  + G+ +LHS 
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTL--RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-----------VNGT 320
              +IH D+ S N L+  + + V+ DFGL +    EK     L+            V G 
Sbjct: 128 N--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD--TRRSERHLKSLVEKYSEEN 378
             ++  E + G+    KVDV+ FGIVL E+   + A  D   R  +  L          N
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------N 235
Query: 379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           +   +D+   P   N   +FF I  +    +P++RP   ++ + L
Sbjct: 236 VRGFLDRYCPP---NCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 16  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 212 LPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           L   G  + T  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH+
Sbjct: 67  LLFMG--YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA 122
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           +   +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E + 
Sbjct: 123 KS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIR 179
Query: 331 GKR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
            +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++        
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL-------- 231
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
             +  N   A  R+  +  K+   ERP   Q+
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 16  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 67  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 123
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 124 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 180
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 232
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 21  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 72  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 128
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 129 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 185
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 237
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 268

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 21  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 72  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 128
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 129 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 185
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 186 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 237
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 18  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 69  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 125
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 126 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 182
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 183 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 234
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 235 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 265

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 43  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 94  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 150
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 151 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 207
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 259
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 260 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 290

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 127/271 (46%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 44  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L + +    ++  + + IA+ T+ G+ +LH++
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAK 151
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 152 S--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 208
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y   ++         
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDL--------S 260
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +  N   A  R+  +  K+   ERP   Q+
Sbjct: 261 KVRSNCPKAMKRLMAECLKKKRDERPLFPQI 291

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 96
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 154
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 155 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 210
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 211 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 19  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 69
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 127
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 128 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 183
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 184 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 20  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 70
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 128
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 129 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 184
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 185 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 63
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 121
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 122 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 177
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 178 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 68
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 126
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 127 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 182
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 183 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 21  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 71
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 129
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 130 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 185
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 186 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 64
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 122
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 123 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 178
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 179 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 22  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 72
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 130
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 131 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 186
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 187 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 65
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 123
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 179
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 180 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 65
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 123
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 179
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 180 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 83
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 141
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 142 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 197
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 198 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 83
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 141
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 142 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 197
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 198 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 65
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 123
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 124 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV--KEPGES 179
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 180 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 32  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 212 LPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           L   G  + T  +  +V ++    SL   L   +    +   + + IA+ T+ G+ +LH+
Sbjct: 83  LLFMG--YSTAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHA 138
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           +   +IH D+KS NI L+      IGDFGL  E      +H   ++++G+  ++  E + 
Sbjct: 139 KS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH-QFEQLSGSILWMAPEVIR 195
Query: 331 GKR---LSTKVDVYGFGIVLFELATGMRAYDD 359
            +     S + DVY FGIVL+EL TG   Y +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 32  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L   +    +   + + IA+ T+ G+ +LH++
Sbjct: 83  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAK 139
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+      IGDFGL  E      +H   ++++G+  ++  E +  
Sbjct: 140 S--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH-QFEQLSGSILWMAPEVIRM 196
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDD 359
           +     S + DVY FGIVL+EL TG   Y +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 66
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+   +   + L      
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQI 124
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH ++ + NIL+ +     IGDFGLT+  P +K  +    +  G  
Sbjct: 125 CKGMEYLGTKR--YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV--KEPGES 180
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 181 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 68
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  Y+P GSL D L  + +   +   + L      
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQI 126
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 127 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 182
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 183 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 37/221 (16%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG V+           +K  +AVK L+   +D A        R+   RE + L +
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNA--------RKDFHREAELLTN 71
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLE--------DRLLMKKNTP--SLLWTQRL 255
            +H++I+  YG+C E     +V+ YM +G L         D +LM +  P   L  +Q L
Sbjct: 72  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           HIA+  + G+ +L S+    +H D+ + N L+  ++   IGDFG++++            
Sbjct: 132 HIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRD-----VYSTDYY 184
Query: 316 RVNGTR----PYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           RV G       ++P E ++ ++ +T+ DV+  G+VL+E+ T
Sbjct: 185 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 41/277 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 89
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + +V  YMP G+L D  L + N   +     L++A   S  +++L  
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLD-YLRECNREEVTAVVLLYMATQISSAMEYLEK 148
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 149 KN--FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 202
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN- 386
           L     S K DV+ FG++L+E+AT GM  Y     S+              +YDL++K  
Sbjct: 203 LAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------VYDLLEKGY 248
Query: 387 --AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
              QP         + + +   K +P +RP   + + 
Sbjct: 249 RMEQP--EGCPPKVYELMRACWKWSPADRPSFAETHQ 283

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 32/279 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETL----NQCQREQSLRELKYLNSCR 207
           ++G G FG VYKG+  KT+   K++ V     A++TL     + QR   L E   +    
Sbjct: 51  VIGAGEFGEVYKGML-KTSSGKKEVPV-----AIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H NI+ L G+  +     ++  YM NG+L+  L  K    S+L  Q + + +G + G+++
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKY 162
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLP 325
           L +     +H D+ + NIL+N ++   + DFGL++   +E     T     G  P  +  
Sbjct: 163 LANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTA 218
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
            E +  ++ ++  DV+ FGIV++E+ T G R Y              E  + E M  + D
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-------------WELSNHEVMKAIND 265
Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
               P  ++   A +++  Q  +Q    RP+   + ++L
Sbjct: 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G FG VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 128 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP----ES 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+              +Y+L++K+ 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ--------------VYELLEKDY 227
Query: 388 QPIEL--NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
           + +E         + + +   + NP +RP   +++        ES
Sbjct: 228 R-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LGKG FG+V    Y  + + T   +AVKKL+ H  +  +            RE++ L
Sbjct: 18  LRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE--------REIEIL 68
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            S +HDNI+   G+C+  G+    L+  ++P GSL  R  ++K+   +   + L      
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL--REYLQKHKERIDHIKLLQYTSQI 126
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L ++    IH D+ + NIL+ +     IGDFGLT+  P +K       +  G  
Sbjct: 127 CKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV--KEPGES 182
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 183 PIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 39/246 (15%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           GT ++ +Q + L       L +  +G FG V+K       +AVK   +            
Sbjct: 15  GTENLYFQSMPLQL-----LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK--------- 60
Query: 191 CQREQSLRELKYLNSCRHDNILPLYG-----ICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
            Q  Q+  E+  L   +H+NIL   G        +   + L+  +   GSL D   +K N
Sbjct: 61  -QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW-LITAFHEKGSLSD--FLKAN 116
Query: 246 TPSLLWTQRLHIAKGTSLGLQFLH--------SREPPLIHGDIKSANILLNHHMDPVIGD 297
             S  W +  HIA+  + GL +LH          +P + H DIKS N+LL +++   I D
Sbjct: 117 VVS--WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELAT 352
           FGL  +    K+   T  +V GTR Y+  E L G     +    ++D+Y  G+VL+ELA+
Sbjct: 175 FGLALKFEAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 353 GMRAYD 358
              A D
Sbjct: 234 RCTAAD 239

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 32/291 (10%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFG--TVYKGVWEKTTIAVKKLEVHRNDRAVETL 188
           GT ++ +Q +      + +L  +G+G FG   + K   +     +K++ + R       +
Sbjct: 14  GTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-------M 62
Query: 189 NQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
           +  +RE+S RE+  L + +H NI+       E G   +V  Y   G L  R+  +K    
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-L 121
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               Q L       L L+ +H R+  ++H DIKS NI L       +GDFG+ +   +  
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIAR---VLN 176
Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
           +T    +   GT  YL  E    K  + K D++  G VL+EL T   A++        +K
Sbjct: 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMK 231
Query: 369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           +LV K        ++  +  P+ L+ +Y    +  Q  K+NP++RP +  +
Sbjct: 232 NLVLK--------IISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 131 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP----ES 184
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 237
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 238 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L V        T    Q+ Q+ + E+  L   RH NI
Sbjct: 20  IGSGSFGTVYKGKWH-GDVAVKMLNV--------TAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G   +  +  +V ++    SL   L   +    +   + + IA+ T+ G+ +LH++
Sbjct: 71  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAK 127
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+      IGDFGL         +H   ++++G+  ++  E +  
Sbjct: 128 S--IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRM 184
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDD 359
           +     S + DVY FGIVL+EL TG   Y +
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 128 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP----ES 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVY--ELLEK-----DYRMERPEG 234
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 235 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 135 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP----ES 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 241
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 242 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           +G G FGTVYKG W    +AVK L+V   D   E        Q+ R E+  L   RH NI
Sbjct: 44  IGSGSFGTVYKGKWH-GDVAVKILKV--VDPTPEQF------QAFRNEVAVLRKTRHVNI 94
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           L   G         +V ++    SL   L +++    +   Q + IA+ T+ G+ +LH++
Sbjct: 95  LLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAK 151
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+KS NI L+  +   IGDFGL         +   +++  G+  ++  E +  
Sbjct: 152 N--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ-QVEQPTGSVLWMAPEVIRM 208
Query: 332 KR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     S + DVY +GIVL+EL TG   Y      ++ +  +   Y+  ++  L      
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK---- 264
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
               N   A  R+     K+  +ERP   Q+
Sbjct: 265 ----NCPKAMKRLVADCVKKVKEERPLFPQI 291

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 130 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 236
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 237 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 135 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 241
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 242 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 130 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 236
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 237 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 134 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 187
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 240
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 241 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 132 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP----ES 185
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 238
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 239 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 130 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 236
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 237 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 130 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 236
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 237 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 71
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 131 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP----ES 184
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 185 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 237
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 238 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 35/274 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 135 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 241
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            P ++      + + +   + NP +RP   +++ 
Sbjct: 242 CPEKV------YELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 83
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 143 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 196
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 249
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 250 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 286

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 130 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 236
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 237 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 35/274 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 135 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 241
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            P ++      + + +   + NP +RP   +++ 
Sbjct: 242 CPEKV------YELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 132 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 185
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 238
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 239 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 37/269 (13%)
Query: 117 RKVSDPLTPMNVLGGTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW----EKTT 170
           R++ +PLTP      +   P Q L   L    + K+ +LG G FGTVYKG+W    EK  
Sbjct: 25  RELVEPLTP------SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK 78
Query: 171 IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRY 230
           I V  +E+       E  +    ++ L E   + S  + ++  L GIC  T    L+ + 
Sbjct: 79  IPVAIMELR------EATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQL 131
Query: 231 MPNGSLEDRLLMKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN 288
           MP G L D +   K+      L    + IAK    G+ +L  R   L+H D+ + N+L+ 
Sbjct: 132 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVK 185
Query: 289 HHMDPVIGDFGLTQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGI 345
                 I DFGL +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+
Sbjct: 186 TPQHVKITDFGLAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGV 241
Query: 346 VLFELAT-GMRAYDDTRRSERHLKSLVEK 373
            ++EL T G + YD    SE  + S++EK
Sbjct: 242 TVWELMTFGSKPYDGIPASE--ISSILEK 268

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 72
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 132 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 185
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 186 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 238
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 239 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 35/283 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 75
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 135 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 189 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 241
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
            P ++      + + +   + NP +RP   +++        ES
Sbjct: 242 CPEKV------YELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 35/274 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 130 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 236
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            P ++      + + +   + NP +RP   +++ 
Sbjct: 237 CPEKV------YELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 68
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH D+ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 128 KN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAP----ES 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+              +Y+L++K+ 
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ--------------VYELLEKDY 227
Query: 388 QPIEL--NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
           + +E         + + +   + NP +RP   +++        ES
Sbjct: 228 R-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/222 (33%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 149 KLNI-LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           K +I +G+G F TVYKG+  +TT+ V   E+   DR    L + +R++   E + L   +
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ--DRK---LTKSERQRFKEEAEXLKGLQ 83
Query: 208 HDNILPLYGICFET--GKYC--LVYRYMPNGSLEDRL-LMKKNTPSLLWTQRLHIAKGTS 262
           H NI+  Y     T  GK C  LV     +G+L+  L   K     +L +    I KG  
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKG-- 141
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTR 321
             LQFLH+R PP+IH D+K  NI +      V IGD GL     +++A+    K V GT 
Sbjct: 142 --LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL---ATLKRASF--AKAVIGTP 194
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
            +   E    ++    VDVY FG    E AT    Y + + +
Sbjct: 195 EFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNA 235

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 127/276 (46%), Gaps = 35/276 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH ++ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 337 KN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 390
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+ +   L+EK      Y +     
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLEK-----DYRMERPEG 443
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            P ++      + + +   + NP +RP   +++   
Sbjct: 444 CPEKV------YELMRACWQWNPSDRPSFAEIHQAF 473

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 127/276 (46%), Gaps = 35/276 (12%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           LG G +G VY+GVW+K ++ V          AV+TL +   + E+ L+E   +   +H N
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTMEVEEFLKEAAVMKEIKHPN 316
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ L G+C     + ++  +M  G+L D  L + N   +     L++A   S  +++L  
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTRPYLPHEF 328
           +    IH ++ + N L+  +    + DFGL++   G    A       +  T P    E 
Sbjct: 376 KN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 429
Query: 329 LVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA 387
           L   + S K DV+ FG++L+E+AT GM  Y     S+  +  L+EK      Y +     
Sbjct: 430 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEK-----DYRMERPEG 482
Query: 388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            P ++      + + +   + NP +RP   +++   
Sbjct: 483 CPEKV------YELMRACWQWNPSDRPSFAEIHQAF 512

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +REL+
Sbjct: 6   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRELQ 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++   
Sbjct: 60  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAV 116
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +   E A         GTR
Sbjct: 117 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV-----GTR 170
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L E+A G
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +REL+
Sbjct: 65  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRELQ 118
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++   
Sbjct: 119 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAV 175
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         GTR
Sbjct: 176 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 229
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L E+A G
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+V   ++        QR   L E   +   
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK--------QRRDFLGEASIMGQF 80
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+  ++    +V  YM NGSL+    +KKN       Q + + +G S G++
Sbjct: 81  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLD--TFLKKNDGQFTVIQLVGMLRGISAGMK 138
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   +   +H D+ + NIL+N ++   + DFGL++   +E           G  P  + 
Sbjct: 139 YLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWT 194
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y +    +  +K++ E Y         
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-IKAVEEGYR-------- 245
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                P  ++   A +++     ++    RP+  ++ NML 
Sbjct: 246 ----LPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLD 282

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 40/224 (17%)
Query: 153 LGKGGFGTVYKG-------VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG V+           +K  +AVK L+    D  +      QRE  L     L +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAEL-----LTN 73
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLE--------DRLLMKKNTP-----SLLWT 252
            +H++I+  YG+C +     +V+ YM +G L         D +++    P      L  +
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           Q LHIA   + G+ +L S+    +H D+ + N L+  ++   IGDFG++++         
Sbjct: 134 QMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRD-----VYST 186
Query: 313 TLKRVNGTR----PYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              RV G       ++P E ++ ++ +T+ DV+ FG++L+E+ T
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +RE
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRE 54
Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L+ L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSI 111
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         G
Sbjct: 112 AVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----G 165
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TR Y+  E L G   S + D++  G+ L E+A G
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +REL+
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRELQ 83
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++   
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAV 140
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         GTR
Sbjct: 141 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 194
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L E+A G
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +RE
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRE 54
Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L+ L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSI 111
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         G
Sbjct: 112 AVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----G 165
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TR Y+  E L G   S + D++  G+ L E+A G
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +RE
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRE 54
Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L+ L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSI 111
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         G
Sbjct: 112 AVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----G 165
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TR Y+  E L G   S + D++  G+ L E+A G
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +RE
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRE 54
Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L+ L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSI 111
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         G
Sbjct: 112 AVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----G 165
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TR Y+  E L G   S + D++  G+ L E+A G
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +RE
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRE 54
Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L+ L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSI 111
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         G
Sbjct: 112 AVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----G 165
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TR Y+  E L G   S + D++  G+ L E+A G
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 35/257 (13%)
Query: 131 GTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRND 182
           G+   P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +  
Sbjct: 61  KA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVRE 111
Query: 243 KKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
            K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL
Sbjct: 112 HKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 165
Query: 301 TQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA 356
            +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + 
Sbjct: 166 AKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221
Query: 357 YDDTRRSERHLKSLVEK 373
           YD    SE  + S++EK
Sbjct: 222 YDGIPASE--ISSILEK 236

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 32/240 (13%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           +P ++ T+  +++D +  LGKG FG VY    ++    +          A++ L + Q E
Sbjct: 6   MPKRKFTI--DDFDIVRPLGKGKFGNVYLAREKQNKFIM----------ALKVLFKSQLE 53
Query: 195 ------QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
                 Q  RE++  +  RH NIL +Y    +  +  L+  + P G L   L   +    
Sbjct: 54  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGR 110
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               +     +  +  L + H R+  +IH DIK  N+L+ +  +  I DFG +   P   
Sbjct: 111 FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP--- 165
Query: 309 ATHITLKR--VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
               +L+R  + GT  YLP E + GK    KVD++  G++ +E   GM  +D    +E H
Sbjct: 166 ----SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 35/257 (13%)
Query: 131 GTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRND 182
           G+   P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +  
Sbjct: 61  KA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE 111
Query: 243 KKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
            K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL
Sbjct: 112 HKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 165
Query: 301 TQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA 356
            +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + 
Sbjct: 166 AKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221
Query: 357 YDDTRRSERHLKSLVEK 373
           YD    SE  + S++EK
Sbjct: 222 YDGIPASE--ISSILEK 236

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +D L  LG+G +G+VYK + ++T   +A+K++ V  + + +           ++E+  + 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI-----------IKEISIMQ 79
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
            C   +++  YG  F+     +V  Y   GS+ D + ++  T  L   +   I + T  G
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKG 137
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRP 322
           L++LH      IH DIK+ NILLN      + DFG+  +      T    KR  V GT  
Sbjct: 138 LEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQ-----LTDXMAKRNXVIGTPF 190
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
           ++  E +     +   D++  GI   E+A G   Y D
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 57/310 (18%)
Query: 145 NNWDKLNILGKGGFGTVYKG------VWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           NN + +  +G+G FG V++        +E  T +AVK L   + + + +     QRE +L
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAAL 103
Query: 198 RELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL----------------- 240
                +    + NI+ L G+C      CL++ YM  G L + L                 
Sbjct: 104 -----MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 241 ----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG 296
               +     P L   ++L IA+  + G+ +L  R+   +H D+ + N L+  +M   I 
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIA 216
Query: 297 DFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-G 353
           DFGL++   I  A +      N   P  ++P E +   R +T+ DV+ +G+VL+E+ + G
Sbjct: 217 DFGLSRN--IYSADYYKADG-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273
Query: 354 MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER 413
           ++ Y                  EE +Y + D N      N     + + +    + P +R
Sbjct: 274 LQPYYGMAH-------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320
Query: 414 PEMTQVYNML 423
           P    ++ +L
Sbjct: 321 PSFCSIHRIL 330

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 120/257 (46%), Gaps = 35/257 (13%)
Query: 131 GTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRND 182
           G+   P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + 
Sbjct: 24  GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 83
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +  
Sbjct: 84  KA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE 134
Query: 243 KKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
            K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL
Sbjct: 135 HKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGL 188
Query: 301 TQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA 356
            +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + 
Sbjct: 189 AKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244
Query: 357 YDDTRRSERHLKSLVEK 373
           YD    SE  + S++EK
Sbjct: 245 YDGIPASE--ISSILEK 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 26  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 77
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               +   YG   +  K  ++  Y+  GS  D L        L  TQ   I +    GL 
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 133
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS +   IH DIK+AN+LL+ H +  + DFG+  +      T I      GT  ++  
Sbjct: 134 YLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNXFVGTPFWMAP 188
Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +      +K D++  GI   ELA G
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  ++++K++ LG G  G V+K   + + + + +  +H        +    R Q +REL+
Sbjct: 22  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE------IKPAIRNQIIRELQ 75
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L      P  +  +   ++   
Sbjct: 76  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAV 132
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         GTR
Sbjct: 133 IKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 186
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L E+A G
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+    D+        QR   L E   +   
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK--------QRRDFLSEASIMGQF 87
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+  +     ++  YM NGSL+    ++KN       Q + + +G   G++
Sbjct: 88  DHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L       +H D+ + NIL+N ++   + DFG+++   +E           G  P  + 
Sbjct: 146 YLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWT 201
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y D    +  +K++ E Y         
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEEGYR-------- 252
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                P  ++   A  ++     ++   +RP+  Q+ NML
Sbjct: 253 ----LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 109/242 (45%), Gaps = 27/242 (11%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-------HQLRREVEIQSHLRHP 72
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + +       T    +A      L + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA----LSYC 128
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL  + +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 129 HSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGM-----RAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   GM       Y +T R    ++     +  E   DL+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 241
Query: 384 DK 385
            +
Sbjct: 242 SR 243

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 119/258 (46%), Gaps = 35/258 (13%)
Query: 130 GGTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRN 181
           G     P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    +
Sbjct: 1   GSMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 60
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL 241
            +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D + 
Sbjct: 61  PKA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVR 111
Query: 242 MKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG 299
             K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG
Sbjct: 112 EHKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 165
Query: 300 LTQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR 355
           L +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G +
Sbjct: 166 LAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 356 AYDDTRRSERHLKSLVEK 373
            YD    SE  + S++EK
Sbjct: 222 PYDGIPASE--ISSILEK 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 119/258 (46%), Gaps = 35/258 (13%)
Query: 130 GGTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRN 181
           G     P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    +
Sbjct: 1   GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 60
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL 241
            +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D + 
Sbjct: 61  PKA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR 111
Query: 242 MKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG 299
             K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG
Sbjct: 112 EHKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 165
Query: 300 LTQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR 355
           L +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G +
Sbjct: 166 LAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 356 AYDDTRRSERHLKSLVEK 373
            YD    SE  + S++EK
Sbjct: 222 PYDGIPASE--ISSILEK 237

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 119/258 (46%), Gaps = 35/258 (13%)
Query: 130 GGTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRN 181
           G     P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    +
Sbjct: 1   GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 60
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL 241
            +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D + 
Sbjct: 61  PKA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR 111
Query: 242 MKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG 299
             K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG
Sbjct: 112 EHKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 165
Query: 300 LTQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR 355
           L +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G +
Sbjct: 166 LAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 356 AYDDTRRSERHLKSLVEK 373
            YD    SE  + S++EK
Sbjct: 222 PYDGIPASE--ISSILEK 237

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 62
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               +   YG   +  K  ++  Y+  GS  D L        L  TQ   I +    GL 
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 118
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS +   IH DIK+AN+LL+ H +  + DFG+  +      T I      GT  ++  
Sbjct: 119 YLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNXFVGTPFWMAP 173
Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +      +K D++  GI   ELA G
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L  +++++++ LG G  G V K     + + + +  +H        +    R Q +REL+
Sbjct: 13  LKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLE------IKPAIRNQIIRELQ 66
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+ C    I+  YG  +  G+  +   +M  GSL+  L   K  P  +  +   ++   
Sbjct: 67  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VSIAV 123
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A         GTR
Sbjct: 124 LRGLAYLREKH-QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTR 177
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G   S + D++  G+ L ELA G
Sbjct: 178 SYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+    D+        QR   L E   +   
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK--------QRRDFLSEASIMGQF 72
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+  +     ++  YM NGSL+    ++KN       Q + + +G   G++
Sbjct: 73  DHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   +   +H D+ + NIL+N ++   + DFG+++   +E           G  P  + 
Sbjct: 131 YLS--DMSYVHRDLAARNILVNSNLVCKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWT 186
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y D    +  +K++ E Y         
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEEGYR-------- 237
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                P  ++   A  ++     ++   +RP+  Q+ NML
Sbjct: 238 ----LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGFVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 62
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               +   YG   +  K  ++  Y+  GS  D L        L  TQ   I +    GL 
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLD 118
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS +   IH DIK+AN+LL+ H +  + DFG+  +      T I      GT  ++  
Sbjct: 119 YLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNTFVGTPFWMAP 173
Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +      +K D++  GI   ELA G
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 119/258 (46%), Gaps = 35/258 (13%)
Query: 130 GGTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRN 181
           G     P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    +
Sbjct: 1   GSMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 60
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL 241
            +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D + 
Sbjct: 61  PKA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVR 111
Query: 242 MKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG 299
             K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG
Sbjct: 112 EHKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFG 165
Query: 300 LTQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR 355
           L +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G +
Sbjct: 166 LAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 356 AYDDTRRSERHLKSLVEK 373
            YD    SE  + S++EK
Sbjct: 222 PYDGIPASE--ISSILEK 237

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 64
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 123
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 124 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 178 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 231
Query: 370 LVEK 373
           ++EK
Sbjct: 232 ILEK 235

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 121/259 (46%), Gaps = 37/259 (14%)
Query: 131 GTP--HIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHR 180
           G+P    P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    
Sbjct: 1   GSPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 60
Query: 181 NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL 240
           + +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +
Sbjct: 61  SPKA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYV 111
Query: 241 LMKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF 298
              K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DF
Sbjct: 112 REHKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDF 165
Query: 299 GLTQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GM 354
           GL +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G 
Sbjct: 166 GLAKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 221
Query: 355 RAYDDTRRSERHLKSLVEK 373
           + YD    SE  + S++EK
Sbjct: 222 KPYDGIPASE--ISSILEK 238

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 115/276 (41%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 73
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G +   L  + K       T    +A      L + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA----LSYC 129
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 130 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 182
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 243 SR-------------------LLKHNPSQRPMLREV 259

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--------EITVLS 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
            C    +   YG   +  K  ++  Y+  GS  D L        L  TQ   I +    G
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 136
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LHS +   IH DIK+AN+LL+ H +  + DFG+  +      T I      GT  ++
Sbjct: 137 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQ---LTDTQIKRNTFVGTPFWM 191
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             E +      +K D++  GI   ELA G
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARG 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 64
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW 123
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 124 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 178 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 231
Query: 370 LVEK 373
           ++EK
Sbjct: 232 ILEK 235

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 115/274 (41%), Gaps = 42/274 (15%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LGKG FG VY    EK +  +  L+V    +    L +   E  LR E++  +  RH NI
Sbjct: 16  LGKGKFGNVYLAR-EKNSKFILALKVLFKAQ----LEKAGVEHQLRREVEIQSHLRHPNI 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           L LYG   ++ +  L+  Y P G++   L  + K       T    +A      L + HS
Sbjct: 71  LRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHS 126
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           ++  +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP E + 
Sbjct: 127 KK--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC-----GTLDYLPPEMIE 179
Query: 331 GKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLVDK 385
           G+    KVD++  G++ +E   G        Y DT +    ++     +  E   DL+ +
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISR 239
Query: 386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                                K NP +RP + +V
Sbjct: 240 -------------------LLKHNPSQRPMLREV 254

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 68
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 124
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 125 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC-----GTLDYLPPEM 177
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 238 SR-------------------LLKHNPSQRPMLREV 254

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 63
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 123 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 177 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230
Query: 370 LVEK 373
           ++EK
Sbjct: 231 ILEK 234

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+    D+        QR   L E   +   
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK--------QRRDFLSEASIMGQF 66
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+  +     ++  YM NGSL+    ++KN       Q + + +G   G++
Sbjct: 67  DHPNIIHLEGVVTKCKPVMIITEYMENGSLD--AFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   +   +H D+ + NIL+N ++   + DFG+++   +E           G  P  + 
Sbjct: 125 YLS--DMSYVHRDLAARNILVNSNLVCKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWT 180
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y D    +  +K++ E Y         
Sbjct: 181 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEEGYR-------- 231
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                P  ++   A  ++     ++   +RP+  Q+ NML
Sbjct: 232 ----LPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 73
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 74  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 132
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 133 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 187 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 240
Query: 370 LVEK 373
           ++EK
Sbjct: 241 ILEK 244

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 138 QELTLATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLN 189
           Q   LA + W+      +L + LG+G FG V+ G W  TT +A+K L+            
Sbjct: 253 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------G 302
Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
               E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L
Sbjct: 303 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGETGKYL 360
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              Q + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE  
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDN 416
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR 355
            +   +       +   E  +  R + K DV+ FGI+L EL T  R
Sbjct: 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 94
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 150
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 151 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 203
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 264 SR-------------------LLKHNPSQRPMLREV 280

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           L I  +G FG V+K       +AVK          +  L   Q  QS RE+      +H+
Sbjct: 20  LEIKARGRFGCVWKAQLMNDFVAVK----------IFPLQDKQSWQSEREIFSTPGMKHE 69
Query: 210 NILPLY-----GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
           N+L        G   E   + L+  +   GSL D L  K N   + W +  H+A+  S G
Sbjct: 70  NLLQFIAAEKRGSNLEVELW-LITAFHDKGSLTDYL--KGNI--ITWNELCHVAETMSRG 124
Query: 265 LQFLH---------SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           L +LH           +P + H D KS N+LL   +  V+ DFGL       K    T  
Sbjct: 125 LSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHG 184
Query: 316 RVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYD 358
           +V GTR Y+  E L G     +    ++D+Y  G+VL+EL +  +A D
Sbjct: 185 QV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 69
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 70  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 128
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 129 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 183 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 236
Query: 370 LVEK 373
           ++EK
Sbjct: 237 ILEK 240

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 63
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 123 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 177 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230
Query: 370 LVEK 373
           ++EK
Sbjct: 231 ILEK 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 117/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 69
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T ++     GT  YLP E 
Sbjct: 126 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS-----GTLDYLPPEM 178
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 239 SR-------------------LLKHNPSQRPMLREV 255

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 27  KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 78
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               +   YG   +  K  ++  Y+  GS  D L         + T    I KG    L 
Sbjct: 79  DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKG----LD 134
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS +   IH DIK+AN+LL+   D  + DFG+  +      T I      GT  ++  
Sbjct: 135 YLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQ---LTDTQIKRNTFVGTPFWMAP 189
Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +      +K D++  GI   ELA G
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 70
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 130 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 184 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 237
Query: 370 LVEK 373
           ++EK
Sbjct: 238 ILEK 241

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 68
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 124
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 125 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEM 177
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 238 SR-------------------LLKHNPSQRPMLREV 254

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 32/240 (13%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           +P ++ T+  +++D    LGKG FG VY    ++    +          A++ L + Q E
Sbjct: 7   MPKRKFTI--DDFDIGRPLGKGKFGNVYLAREKQNKFIM----------ALKVLFKSQLE 54
Query: 195 ------QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
                 Q  RE++  +  RH NIL +Y    +  +  L+  + P G L   L   +    
Sbjct: 55  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGR 111
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               +     +  +  L + H R+  +IH DIK  N+L+ +  +  I DFG +   P   
Sbjct: 112 FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAP--- 166
Query: 309 ATHITLKR--VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
               +L+R  + GT  YLP E + GK    KVD++  G++ +E   GM  +D    +E H
Sbjct: 167 ----SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 222

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 63
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 123 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 177 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230
Query: 370 LVEK 373
           ++EK
Sbjct: 231 ILEK 234

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 5   TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 59
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 60  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 112
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 168
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 169 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 222
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 223 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 423 L 423
           L
Sbjct: 275 L 275

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 1   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 50
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 51  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGETGKYLRLPQ 108
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 109 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 164
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
            +       +   E  +  R + K DV+ FGI+L EL T  R 
Sbjct: 165 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 207

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 223
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGETGKYLRLPQ 281
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 282 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 337
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
            +       +   E  +  R + K DV+ FGI+L EL T  R 
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 69
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 126 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEM 178
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 239 SR-------------------LLKHNPSQRPMLREV 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 68
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 124
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 125 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEM 177
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 238 SR-------------------LLKHNPSQRPMLREV 254

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 223
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGETGKYLRLPQ 281
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 282 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 337
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
            +       +   E  +  R + K DV+ FGI+L EL T  R 
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 68
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 124
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 125 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 177
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 237
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 238 SR-------------------LLKHNPSQRPMLREV 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 85
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 141
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 142 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 194
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 254
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 255 SR-------------------LLKHNPSQRPMLREV 271

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 22  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 76
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 77  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 129
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 185
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 186 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 239
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 240 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 291
Query: 423 L 423
           L
Sbjct: 292 L 292

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 71
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 128 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 180
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 241 SR-------------------LLKHNPSQRPMLREV 257

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 73
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 129
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 130 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTLDYLPPEM 182
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 243 SR-------------------LLKHNPSQRPMLREV 259

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 139/301 (46%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 32  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 86
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 87  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 139
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 140 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 195
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 196 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 249
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 250 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 301
Query: 423 L 423
           L
Sbjct: 302 L 302

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 73
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 129
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 130 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 182
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 243 SR-------------------LLKHNPSQRPMLREV 259

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 73
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 129
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 130 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEX 182
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 243 SR-------------------LLKHNPSQRPXLREV 259

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVIEYMSKGSLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 57
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 58  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 117 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 171 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 224
Query: 370 LVEK 373
           ++EK
Sbjct: 225 ILEK 228

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKIRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 124/285 (43%), Gaps = 51/285 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           +G G FG V+ G W           ++++  A++T+ +     E  + E + +    H  
Sbjct: 15  IGSGQFGLVHLGYW-----------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 63
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF--- 267
           ++ LYG+C E    CLV+ +M +G L D L           TQR   A  T LG+     
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVC 113
Query: 268 ---LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--- 321
               +  E  +IH D+ + N L+  +    + DFG+T+    ++ T  T     GT+   
Sbjct: 114 EGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPV 168
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
            +   E     R S+K DV+ FG++++E+ + G   Y++   SE     +VE  S    +
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS--TGF 221
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
            L         +      ++I     K+ P++RP  +++   L+ 
Sbjct: 222 RLYKPRLASTHV------YQIMNHCWKERPEDRPAFSRLLRQLAA 260

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 63
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 123 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 177 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230
Query: 370 LVEK 373
           ++EK
Sbjct: 231 ILEK 234

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVCEYMSKGSLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL +   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLAR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 67
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 123
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 124 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 176
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 236
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 237 SR-------------------LLKHNPSQRPMLREV 253

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 52/279 (18%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE------QSLRELKYLNSC 206
           LGKG FG VY    +++   +          A++ L + Q E      Q  RE++  +  
Sbjct: 16  LGKGKFGNVYLAREKQSKFIL----------ALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGL 265
           RH NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----L 121
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            + HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC-----GTLDYLP 174
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMY 380
            E + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           DL+ +                     K NP +RP + +V
Sbjct: 235 DLISR-------------------LLKHNPSQRPMLREV 254

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 223
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVGEYMSKGSLLD-FLKGETGKYLRLPQ 281
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 282 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 337
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
            +       +   E  +  R + K DV+ FGI+L EL T  R 
Sbjct: 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 380

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 72
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 128
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 129 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 241
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 242 SR-------------------LLKHNPSQRPMLREV 258

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 35/257 (13%)
Query: 131 GTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRND 182
           G+   P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +  
Sbjct: 61  KA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVRE 111
Query: 243 KKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
            K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG 
Sbjct: 112 HKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGR 165
Query: 301 TQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA 356
            +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + 
Sbjct: 166 AKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221
Query: 357 YDDTRRSERHLKSLVEK 373
           YD    SE  + S++EK
Sbjct: 222 YDGIPASE--ISSILEK 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 35/257 (13%)
Query: 131 GTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRND 182
           G+   P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +  
Sbjct: 61  KA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVRE 111
Query: 243 KKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
            K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG 
Sbjct: 112 HKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGR 165
Query: 301 TQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA 356
            +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + 
Sbjct: 166 AKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221
Query: 357 YDDTRRSERHLKSLVEK 373
           YD    SE  + S++EK
Sbjct: 222 YDGIPASE--ISSILEK 236

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 71
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 128 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 180
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 241 SR-------------------LLKHNPSQRPMLREV 257

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 65
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 121
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  YLP E 
Sbjct: 122 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEM 174
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 234
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 235 SR-------------------LLKHNPSQRPMLREV 251

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 35/257 (13%)
Query: 131 GTPHIPYQEL--TLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRND 182
           G+   P Q L   L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + 
Sbjct: 1   GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 60
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +A         ++ L E   + S  + ++  L GIC  T    L+ + MP G L D +  
Sbjct: 61  KA--------NKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE 111
Query: 243 KKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
            K+      L    + IAK    G+ +L  R   L+H D+ + N+L+       I DFG 
Sbjct: 112 HKDNIGSQYLLNWCVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGR 165
Query: 301 TQ-EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA 356
            +  G  EK  H       G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + 
Sbjct: 166 AKLLGAEEKEYHAE----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221
Query: 357 YDDTRRSERHLKSLVEK 373
           YD    SE  + S++EK
Sbjct: 222 YDGIPASE--ISSILEK 236

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           +G G FG V+ G W           ++++  A++T+ +     E  + E + +    H  
Sbjct: 15  IGSGQFGLVHLGYW-----------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 63
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF--- 267
           ++ LYG+C E    CLV+ +M +G L D L           TQR   A  T LG+     
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVC 113
Query: 268 ---LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--- 321
               +  E  +IH D+ + N L+  +    + DFG+T+    ++ T  T     GT+   
Sbjct: 114 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPV 168
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
            +   E     R S+K DV+ FG++++E+ + G   Y++   SE
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 27/242 (11%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-------HQLRREVEIQSHLRHP 72
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + +       T    +A      L + 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA----LSYC 128
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL  + +  I DFG +   P  +   +      GT  YLP E 
Sbjct: 129 HSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC-----GTLDYLPPEM 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGM-----RAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   GM       Y +T R    ++     +  E   DL+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 241
Query: 384 DK 385
            +
Sbjct: 242 SR 243

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           +G G FG V+ G W           ++++  A++T+ +     E  + E + +    H  
Sbjct: 13  IGSGQFGLVHLGYW-----------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF--- 267
           ++ LYG+C E    CLV+ +M +G L D L           TQR   A  T LG+     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVC 111
Query: 268 ---LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--- 321
               +  E  +IH D+ + N L+  +    + DFG+T+    ++ T  T     GT+   
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPV 166
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
            +   E     R S+K DV+ FG++++E+ + G   Y++   SE
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V  YM NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL +   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++ LGKG FG+V    Y  + + T   +AVK+L+    D         Q+    RE++ L
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---------QQRDFQREIQIL 65
Query: 204 NSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            +   D I+   G+ +  G+  L  V  Y+P+G L D   ++++   L  ++ L  +   
Sbjct: 66  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQI 123
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L SR    +H D+ + NIL+       I DFGL +  P++K  ++   R  G  
Sbjct: 124 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV--REPGQS 179
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L     S + DV+ FG+VL+EL T
Sbjct: 180 PIFWYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE------QSLRELKYLNSC 206
           LGKG FG VY    +++   +          A++ L + Q E      Q  RE++  +  
Sbjct: 21  LGKGKFGNVYLAREKQSKFIL----------ALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGL 265
           RH NIL LYG   +  +  L+  Y P G +   L  + K       T    +A      L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA----L 126
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            + HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP
Sbjct: 127 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX-----GTLDYLP 179
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMY 380
            E + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           DL+ +                     K NP +RP + +V
Sbjct: 240 DLISR-------------------LLKHNPSQRPMLREV 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           +G G FG V+ G W           ++++  A++T+ +     E  + E + +    H  
Sbjct: 18  IGSGQFGLVHLGYW-----------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 66
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF--- 267
           ++ LYG+C E    CLV+ +M +G L D L           TQR   A  T LG+     
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVC 116
Query: 268 ---LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--- 321
               +  E  +IH D+ + N L+  +    + DFG+T+    ++ T  T     GT+   
Sbjct: 117 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPV 171
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
            +   E     R S+K DV+ FG++++E+ + G   Y++   SE
Sbjct: 172 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++ LGKG FG+V    Y  + + T   +AVK+L+    D         Q+    RE++ L
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---------QQRDFQREIQIL 66
Query: 204 NSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            +   D I+   G+ +  G+  L  V  Y+P+G L D   ++++   L  ++ L  +   
Sbjct: 67  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQI 124
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L SR    +H D+ + NIL+       I DFGL +  P++K  ++   R  G  
Sbjct: 125 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV--REPGQS 180
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L     S + DV+ FG+VL+EL T
Sbjct: 181 PIFWYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++ LGKG FG+V    Y  + + T   +AVK+L+    D         Q+    RE++ L
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---------QQRDFQREIQIL 78
Query: 204 NSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            +   D I+   G+ +  G+  L  V  Y+P+G L D   ++++   L  ++ L  +   
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQI 136
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L SR    +H D+ + NIL+       I DFGL +  P++K  ++   R  G  
Sbjct: 137 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV--REPGQS 192
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L     S + DV+ FG+VL+EL T
Sbjct: 193 PIFWYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 43/270 (15%)
Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG+G FG V+ G W  TT +A+K L+                E  L+E + +   RH+ +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSPEAFLQEAQVMKKLRHEKL 64
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  E   Y +V  YM  GSL D  L  +    L   Q + +A   + G+ ++   
Sbjct: 65  VQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               +H D+++ANIL+  ++   + DFGL +   IE   +   +       +   E  + 
Sbjct: 123 N--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALY 178
Query: 332 KRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
            R + K DV+ FGI+L EL T       GM   +   + ER  +        E+++DL+ 
Sbjct: 179 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM- 237
Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
                              Q  +++P+ERP
Sbjct: 238 ------------------CQCWRKDPEERP 249

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVIEYMSKGSLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE      
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEXTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 43/270 (15%)
Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG+G FG V+ G W  TT +A+K L+                E  L+E + +   RH+ +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSPEAFLQEAQVMKKLRHEKL 66
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  E   Y +V  YM  GSL D  L  +    L   Q + +A   + G+ ++   
Sbjct: 67  VQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               +H D+++ANIL+  ++   + DFGL +   IE   +   +       +   E  + 
Sbjct: 125 N--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALY 180
Query: 332 KRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYSEENMYDLVD 384
            R + K DV+ FGI+L EL T       GM   +   + ER  +        E+++DL+ 
Sbjct: 181 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM- 239
Query: 385 KNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
                              Q  +++P+ERP
Sbjct: 240 ------------------CQCWRKDPEERP 251

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 18/228 (7%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           +++ + +L  LG G + TVYKG+ + T + V   EV  +        +     ++RE+  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE------EGTPSTAIREISL 56
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNG---SLEDRLLMKKNTPSLLWTQRLHIAK 259
           +   +H+NI+ LY +     K  LV+ +M N     ++ R +   NTP  L    +   +
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTV--GNTPRGLELNLVKYFQ 114
Query: 260 GTSL-GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
              L GL F H  E  ++H D+K  N+L+N      +GDFGL +   I      T     
Sbjct: 115 WQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEV 169
Query: 319 GTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSER 365
            T  Y   + L+G R  ST +D++  G +L E+ TG   +  T   E+
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ 217

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+ +ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 60
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 61  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 119
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IA+    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 120 CVQIAE----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 174 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 227
Query: 370 LVEK 373
           ++EK
Sbjct: 228 ILEK 231

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 94
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 150
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP E 
Sbjct: 151 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-----GTLDYLPPEM 203
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 264 SR-------------------LLKHNPSQRPMLREV 280

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 71
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP E 
Sbjct: 128 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC-----GTLDYLPPEM 180
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 241 SR-------------------LLKHNPSQRPMLREV 257

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 175 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GNMSP 224
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 225 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGEMGKYLRLPQ 282
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 283 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGR--LIEDNEYTA 338
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
            +       +   E  +  R + K DV+ FGI+L EL T  R 
Sbjct: 339 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 381

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +L  G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 70
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 130 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 184 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 237
Query: 370 LVEK 373
           ++EK
Sbjct: 238 ILEK 241

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  G L D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVMEYMSKGCLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 5   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 54
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMNKGSLLD-FLKGETGKYLRLPQ 112
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + ++   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 113 LVDMSAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 168
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
            +       +   E  +  R + K DV+ FGI+L EL T  R 
Sbjct: 169 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 70
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 126
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP E 
Sbjct: 127 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC-----GTLDYLPPEM 179
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 240 SR-------------------LLKHNPSQRPMLREV 256

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE------QSLRELKYLNSC 206
           LGKG FG VY    +++   +          A++ L + Q E      Q  RE++  +  
Sbjct: 16  LGKGKFGNVYLAREKQSKFIL----------ALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGL 265
           RH NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----L 121
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            + HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC-----GTLDYLP 174
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMY 380
            E + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           DL+ +                     K NP +RP + +V
Sbjct: 235 DLISR-------------------LLKHNPSQRPMLREV 254

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 67
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW 126
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFG  +  G  EK  H 
Sbjct: 127 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 180
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 181 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 234
Query: 370 LVEK 373
           ++EK
Sbjct: 235 ILEK 238

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +L  G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 63
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 123 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 177 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230
Query: 370 LVEK 373
           ++EK
Sbjct: 231 ILEK 234

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 50/288 (17%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 8   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 57
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  G L D  L  +    L   Q
Sbjct: 58  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGCLLD-FLKGEMGKYLRLPQ 115
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   +  
Sbjct: 116 LVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTA 171
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERH 366
            +       +   E  +  R + K DV+ FGI+L EL T       GM   +   + ER 
Sbjct: 172 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 231
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +        E+++DL+                    Q  +++P+ERP
Sbjct: 232 YRMPCPPECPESLHDLM-------------------CQCWRKDPEERP 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 70
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 126
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I +FG +   P  + T +      GT  YLP E 
Sbjct: 127 HSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC-----GTLDYLPPEM 179
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 240 SR-------------------LLKHNPSQRPMLREV 256

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 38  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 146
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++  ++K       +     P  
Sbjct: 147 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD-MLDKEFDSVHNKTGAKLPVK 203
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 263
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 264 PDPLYEVMLKCWHP 277

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +L  G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 70
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFGL +  G  EK  H 
Sbjct: 130 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 184 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 237
Query: 370 LVEK 373
           ++EK
Sbjct: 238 ILEK 241

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 116/276 (42%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 71
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I +FG +   P  + T +      GT  YLP E 
Sbjct: 128 HSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC-----GTLDYLPPEM 180
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 241 SR-------------------LLKHNPSQRPMLREV 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE------QSLRELKYLNSC 206
           LGKG FG VY    +++   +          A++ L + Q E      Q  RE++  +  
Sbjct: 16  LGKGKFGNVYLAREKQSKFIL----------ALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGL 265
           RH NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----L 121
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            + HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP
Sbjct: 122 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC-----GTLDYLP 174
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMY 380
            E + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           DL+ +                     K NP +RP + +V
Sbjct: 235 DLISR-------------------LLKHNPSQRPMLREV 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE------QSLRELKYLNSC 206
           LGKG FG VY    +++   +          A++ L + Q E      Q  RE++  +  
Sbjct: 19  LGKGKFGNVYLAREKQSKFIL----------ALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGL 265
           RH NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----L 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            + HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC-----GTLDYLP 177
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMY 380
            E + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           DL+ +                     K NP +RP + +V
Sbjct: 238 DLISR-------------------LLKHNPSQRPMLREV 257

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 63
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFG  +  G  EK  H 
Sbjct: 123 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 176
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 177 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 230
Query: 370 LVEK 373
           ++EK
Sbjct: 231 ILEK 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 114/244 (46%), Gaps = 33/244 (13%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           L    + K+ +LG G FGTVYKG+W       K  +A+K+L    + +A         ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--------NKE 70
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQ 253
            L E   + S  + ++  L GIC  T    L+ + MP G L D +   K+      L   
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 129
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-EGPIEKATHI 312
            + IAK    G+ +L  R   L+H D+ + N+L+       I DFG  +  G  EK  H 
Sbjct: 130 CVQIAK----GMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHA 183
Query: 313 TLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 G  P  ++  E ++ +  + + DV+ +G+ ++EL T G + YD    SE  + S
Sbjct: 184 E----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS 237
Query: 370 LVEK 373
           ++EK
Sbjct: 238 ILEK 241

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 124/284 (43%), Gaps = 51/284 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           +G G FG V+ G W           ++++  A++T+ +     +  + E + +    H  
Sbjct: 35  IGSGQFGLVHLGYW-----------LNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPK 83
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF--- 267
           ++ LYG+C E    CLV+ +M +G L D L           TQR   A  T LG+     
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVC 133
Query: 268 ---LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--- 321
               +  E  +IH D+ + N L+  +    + DFG+T+    ++ T  T     GT+   
Sbjct: 134 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPV 188
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
            +   E     R S+K DV+ FG++++E+ + G   Y++   SE     +VE  S    +
Sbjct: 189 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS--TGF 241
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
            L         +      ++I     K+ P++RP  +++   L+
Sbjct: 242 RLYKPRLASTHV------YQIMNHCWKERPEDRPAFSRLLRQLA 279

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 115/276 (41%), Gaps = 46/276 (16%)
Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRA-VETLNQCQREQSLRELKYLNSCRHD 209
           LGKG FG VY  +    K  +A+K L   + ++A VE        Q  RE++  +  RH 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRREVEIQSHLRHP 69
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L + 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYC 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP E 
Sbjct: 126 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC-----GTLDYLPPEM 178
Query: 329 LVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   DL+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +                     K NP +RP + +V
Sbjct: 239 SR-------------------LLKHNPSQRPMLREV 255

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE------QSLRELKYLNSC 206
           LGKG FG VY    +++   +          A++ L + Q E      Q  RE++  +  
Sbjct: 19  LGKGKFGNVYLAREKQSKFIL----------ALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGL 265
           RH NIL LYG   +  +  L+  Y P G++   L  + K       T    +A      L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----L 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            + HS+   +IH DIK  N+LL    +  I DFG +   P  +   +      GT  YLP
Sbjct: 125 SYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC-----GTLDYLP 177
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVEKYSEENMY 380
            E + G+    KVD++  G++ +E   G        Y +T +    ++     +  E   
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           DL+ +                     K NP +RP + +V
Sbjct: 238 DLISR-------------------LLKHNPSQRPMLREV 257

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 149 KLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL+ +GKG FG VYKG+    K  +A+K +++   +  +E + Q        E+  L+ C
Sbjct: 23  KLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ--------EITVLSQC 74
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
               I   +G   ++ K  ++  Y+  GS  D L       + + T    I KG    L 
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LD 130
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS     IH DIK+AN+LL+   D  + DFG+  +      T I      GT  ++  
Sbjct: 131 YLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQ---LTDTQIKRNXFVGTPFWMAP 185
Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +       K D++  GI   ELA G
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKG 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 28/241 (11%)
Query: 130 GGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN 189
            GTP I  +  T+  ++++    LGKG FG VY    +K+   V          A++ L 
Sbjct: 10  SGTPDILTRHFTI--DDFEIGRPLGKGKFGNVYLAREKKSHFIV----------ALKVLF 57
Query: 190 QCQRE------QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK 243
           + Q E      Q  RE++      H NIL LY   ++  +  L+  Y P G L   L   
Sbjct: 58  KSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--- 114
Query: 244 KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE 303
           + + +    +   I +  +  L + H ++  +IH DIK  N+LL    +  I DFG +  
Sbjct: 115 QKSCTFDEQRTATIMEELADALMYCHGKK--VIHRDIKPENLLLGLKGELKIADFGWSVH 172
Query: 304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
            P      +  K + GT  YLP E + G+  + KVD++  G++ +EL  G   ++    +
Sbjct: 173 AP-----SLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHN 227
Query: 364 E 364
           E
Sbjct: 228 E 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 150 LNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++ LGKG FG+V    Y  + + T   +AVK+L+    D         Q+    RE++ L
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---------QQRDFQREIQIL 62
Query: 204 NSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            +   D I+   G+ +  G+    LV  Y+P+G L D   ++++   L  ++ L  +   
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQI 120
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+++L SR    +H D+ + NIL+       I DFGL +  P++K   +   R  G  
Sbjct: 121 CKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVV--REPGQS 176
Query: 322 P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           P   Y P E L     S + DV+ FG+VL+EL T
Sbjct: 177 PIFWYAP-ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 57
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 58  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 109
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 110 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 163
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 57
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 58  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 109
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 110 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 163
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 60
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 61  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 112
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 113 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 166
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 167 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V   M NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGAVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 57/300 (19%)
Query: 146 NWDKL---NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR---- 198
           +W+ +   +++G+G FG V K   +K  +        R D A++ + +   +   R    
Sbjct: 13  DWNDIKFQDVIGEGNFGQVLKARIKKDGL--------RMDAAIKRMKEYASKDDHRDFAG 64
Query: 199 ELKYLNSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------------LMK 243
           EL+ L  C+   H NI+ L G C   G   L   Y P+G+L D L             + 
Sbjct: 65  ELEVL--CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 244 KNTPSLLWTQR-LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            +T S L +Q+ LH A   + G+ +L  ++   IH D+ + NIL+  +    I DFGL+ 
Sbjct: 123 NSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS- 179
Query: 303 EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
                +   + +K+  G  P  ++  E L     +T  DV+ +G++L+E+ + G   Y  
Sbjct: 180 -----RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 234
Query: 360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
              +E + K L + Y  E          +P  LN     + + +Q  ++ P ERP   Q+
Sbjct: 235 MTCAELYEK-LPQGYRLE----------KP--LNCDDEVYDLMRQCWREKPYERPSFAQI 281

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 57
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 58  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 109
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 110 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 163
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 149 KLNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++  LG+G FG V    Y    + T   +AVK L+       +  L         +E++ 
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--------KEIEI 76
Query: 203 LNSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H+NI+   GIC E G     L+  ++P+GSL++ L   KN  +L   Q+L  A  
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQ 134
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +L SR+   +H D+ + N+L+       IGDFGLT+    +K         +  
Sbjct: 135 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             +   E L+  +     DV+ FG+ L EL T
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 62
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 63  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 114
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 115 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 168
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSLRELKYLNSCRHDN 210
           +G G FG V+ G W           ++++  A++T+ +     E  + E + +    H  
Sbjct: 16  IGSGQFGLVHLGYW-----------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF--- 267
           ++ LYG+C E    CLV  +M +G L D L           TQR   A  T LG+     
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR----------TQRGLFAAETLLGMCLDVC 114
Query: 268 ---LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR--- 321
               +  E  +IH D+ + N L+  +    + DFG+T+    ++ T  T     GT+   
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPV 169
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
            +   E     R S+K DV+ FG++++E+ + G   Y++   SE
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK    K T A+   +V      +ET ++ + E  + E++ L +C
Sbjct: 21  WEIVGELGDGAFGKVYKAK-NKETGALAAAKV------IETKSEEELEDYIVEIEILATC 73
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H  I+ L G  +  GK  ++  + P G+++   +M +    L   Q   + +     L 
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD--AIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN--GTRPYL 324
           FLHS+   +IH D+K+ N+L+    D  + DFG++      K      KR +  GT  ++
Sbjct: 132 FLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGTPYWM 184
Query: 325 PHEFLVGKRLST-----KVDVYGFGIVLFELA 351
             E ++ + +       K D++  GI L E+A
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 5   TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 59
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V   M NGSL+    ++K+ 
Sbjct: 60  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHD 112
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 168
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 169 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 222
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 223 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 423 L 423
           L
Sbjct: 275 L 275

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 57/300 (19%)
Query: 146 NWDKL---NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR---- 198
           +W+ +   +++G+G FG V K   +K  +        R D A++ + +   +   R    
Sbjct: 23  DWNDIKFQDVIGEGNFGQVLKARIKKDGL--------RMDAAIKRMKEYASKDDHRDFAG 74
Query: 199 ELKYLNSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------------LMK 243
           EL+ L  C+   H NI+ L G C   G   L   Y P+G+L D L             + 
Sbjct: 75  ELEVL--CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 244 KNTPSLLWTQR-LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            +T S L +Q+ LH A   + G+ +L  ++   IH D+ + NIL+  +    I DFGL+ 
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS- 189
Query: 303 EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
                +   + +K+  G  P  ++  E L     +T  DV+ +G++L+E+ + G   Y  
Sbjct: 190 -----RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
Query: 360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
              +E + K L + Y  E              LN     + + +Q  ++ P ERP   Q+
Sbjct: 245 MTCAELYEK-LPQGYRLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQI 291

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 96  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 204
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 205 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVK 261
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 322 PDPLYEVMLKCWHP 335

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK    K T A+   +V      +ET ++ + E  + E++ L +C
Sbjct: 13  WEIVGELGDGAFGKVYKAK-NKETGALAAAKV------IETKSEEELEDYIVEIEILATC 65
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H  I+ L G  +  GK  ++  + P G++ D ++++ +   L   Q   + +     L 
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDR-GLTEPQIQVVCRQMLEALN 123
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN--GTRPYL 324
           FLHS+   +IH D+K+ N+L+    D  + DFG++      K      KR +  GT  ++
Sbjct: 124 FLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGTPYWM 176
Query: 325 PHEFLVGKRLST-----KVDVYGFGIVLFELA 351
             E ++ + +       K D++  GI L E+A
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEMA 208

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 57
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 58  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 109
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 110 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 163
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 142 LATNNWD------KLNI-LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           LA + W+      +L + LG+G FG V+ G W  TT +A+K L+                
Sbjct: 5   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSP 54
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L   Q
Sbjct: 55  EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMNKGSLLD-FLKGETGKYLRLPQ 112
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-----EGPIEK 308
            + ++   + G+ ++       +H D+++ANIL+  ++   + DFGL +     E    +
Sbjct: 113 LVDMSAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQ 170
Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
                +K         P   L G R + K DV+ FGI+L EL T  R 
Sbjct: 171 GAKFPIKWTA------PEAALYG-RFTIKSDVWSFGILLTELTTKGRV 211

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK   ++T++           + ++T ++ + E  + E+  L SC
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAA-------KVIDTKSEEELEDYMVEIDILASC 91
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L    +      ++  +   G++ D ++++   P L  +Q   + K T   L 
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERP-LTESQIQVVCKQTLDALN 149
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG-------------PIEKATHIT 313
           +LH  +  +IH D+K+ NIL     D  + DFG++ +              P   A  + 
Sbjct: 150 YLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVV 207
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
           +   +  RPY             K DV+  GI L E+A
Sbjct: 208 MCETSKDRPY-----------DYKADVWSLGITLIEMA 234

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 138/301 (45%), Gaps = 39/301 (12%)
Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVE 186
           T H   +EL     + DK  ++G G FG V  G  +     + ++A+K L+V   ++   
Sbjct: 34  TVHEFAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--- 88
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                QR   L E   +    H NI+ L G+  ++    +V   M NGSL+    ++K+ 
Sbjct: 89  -----QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS--FLRKHD 141
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
                 Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++   +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSR--VL 197
Query: 307 EKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS 363
           E           G  P  +   E +  ++ ++  DV+ +GIVL+E+ + G R Y      
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------ 251
Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
                    + S +++   VD+  + P  ++   A +++     +++   RP+  Q+ ++
Sbjct: 252 --------WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 423 L 423
           L
Sbjct: 304 L 304

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N++D L +LGKG FG V   V EK T     +++ R +  +    + +   ++ E +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVII---AKDEVAHTVTESR 57
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  ++         R 
Sbjct: 58  VLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RF 109
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L++LHSR+  +++ DIK  N++L+      I DFGL +EG  + AT   +K
Sbjct: 110 YGAEIVS-ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MK 163
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK   ++T++           + ++T ++ + E  + E+  L SC
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAA-------KVIDTKSEEELEDYMVEIDILASC 91
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L    +      ++  +   G++ D ++++   P L  +Q   + K T   L 
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERP-LTESQIQVVCKQTLDALN 149
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG-------------PIEKATHIT 313
           +LH  +  +IH D+K+ NIL     D  + DFG++ +              P   A  + 
Sbjct: 150 YLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVV 207
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
           +   +  RPY             K DV+  GI L E+A
Sbjct: 208 MCETSKDRPY-----------DYKADVWSLGITLIEMA 234

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 149 KLNILGKGGFGTV----YKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++  LG+G FG V    Y    + T   +AVK L+       +  L         +E++ 
Sbjct: 13  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--------KEIEI 64
Query: 203 LNSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H+NI+   GIC E G     L+  ++P+GSL++ L   KN  +L   Q+L  A  
Sbjct: 65  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQ 122
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +L SR+   +H D+ + N+L+       IGDFGLT+    +K         +  
Sbjct: 123 ICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             +   E L+  +     DV+ FG+ L EL T
Sbjct: 181 VFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 37  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 145
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 146 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVK 202
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 263 PDPLYEVMLKCWHP 276

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           W+ +  LG G FG VYK   ++T++           + ++T ++ + E  + E+  L SC
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAA-------KVIDTKSEEELEDYMVEIDILASC 91
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L    +      ++  +   G++ D ++++   P L  +Q   + K T   L 
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERP-LTESQIQVVCKQTLDALN 149
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG-------------PIEKATHIT 313
           +LH  +  +IH D+K+ NIL     D  + DFG++ +              P   A  + 
Sbjct: 150 YLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 207
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
           +   +  RPY             K DV+  GI L E+A
Sbjct: 208 MCETSKDRPY-----------DYKADVWSLGITLIEMA 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 37  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 145
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 146 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVK 202
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 263 PDPLYEVMLKCWHP 276

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 31/265 (11%)
Query: 118 KVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLE 177
           ++ +PLTP     GT     Q   L      ++ +LG G FGTVYKG+W      V + E
Sbjct: 15  ELVEPLTP----SGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIW------VPEGE 64
Query: 178 VHRNDRAVETLNQCQREQS----LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPN 233
             +   A++ LN+    ++    + E   + S  H +++ L G+C  +    LV + MP+
Sbjct: 65  TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPH 123
Query: 234 GSLEDRLLMKKNT--PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM 291
           G L + +   K+     LL    + IAK    G+ +L  R   L+H D+ + N+L+    
Sbjct: 124 GCLLEYVHEHKDNIGSQLLLNWCVQIAK----GMMYLEERR--LVHRDLAARNVLVKSPN 177
Query: 292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFE 349
              I DFGL +   + +          G  P  ++  E +  ++ + + DV+ +G+ ++E
Sbjct: 178 HVKITDFGLAR---LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE 234
Query: 350 LAT-GMRAYDDTRRSERHLKSLVEK 373
           L T G + YD      R +  L+EK
Sbjct: 235 LMTFGGKPYDGI--PTREIPDLLEK 257

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 38  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 146
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 147 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVK 203
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 204 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 263
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 264 PDPLYEVMLKCWHP 277

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 35  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 143
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 144 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVK 200
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 260
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 261 PDPLYEVMLKCWHP 274

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 42  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 94
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 150
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           ++FL S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 151 MKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVHNKTGAKLPVK 207
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 208 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 267
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 268 PDPLYEVMLKCWHP 281

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 36  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 144
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 145 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 201
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 261
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 262 PDPLYEVMLKCWHP 275

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 56  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 108
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 164
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 165 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 221
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 222 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 281
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 282 PDPLYEVMLKCWHP 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 55  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 107
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 163
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 164 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 220
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 221 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 280
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 281 PDPLYEVMLKCWHP 294

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 29  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 81
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 137
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 138 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 194
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 195 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 254
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 255 PDPLYEVMLKCWHP 268

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 37  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 145
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 146 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 202
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 263 PDPLYEVMLKCWHP 276

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 37  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 145
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 146 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 202
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 203 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 262
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 263 PDPLYEVMLKCWHP 276

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 46/226 (20%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++KL  +G+G +GTV+K    +T   +A+K++ +  +D  V +        +LRE+  L 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-------SALREICLLK 56
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMP----------NGSLEDRLLMKKNTPSLLWTQR 254
             +H NI+ L+ +     K  LV+ +            NG L+         P ++ +  
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFL 107
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE----KAT 310
             + KG    L F HSR   ++H D+K  N+L+N + +  + DFGL +   I      A 
Sbjct: 108 FQLLKG----LGFCHSRN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161
Query: 311 HITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMR 355
            +TL        Y P + L G +L ST +D++  G +  ELA   R
Sbjct: 162 VVTLW-------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 32  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 140
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 141 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 197
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 257
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 258 PDPLYEVMLKCWHP 271

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 35  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 143
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 144 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 200
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 201 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 260
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 261 PDPLYEVMLKCWHP 274

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G W   T +A+K L+                E  L E + +   +HD +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKP----------GTMSPESFLEEAQIMKKLKHDKL 66
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  E   Y +V  YM  GSL D  L      +L     + +A   + G+ ++   
Sbjct: 67  VQLYAVVSEEPIY-IVTEYMNKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D++SANIL+ + +   I DFGL +   IE       +       +   E  + 
Sbjct: 125 N--YIHRDLRSANILVGNGLICKIADFGLARL--IEDNEXTARQGAKFPIKWTAPEAALY 180
Query: 332 KRLSTKVDVYGFGIVLFELATGMRA 356
            R + K DV+ FGI+L EL T  R 
Sbjct: 181 GRFTIKSDVWSFGILLTELVTKGRV 205

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 34  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 142
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K  +    +     P  
Sbjct: 143 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEYYSVHNKTGAKLPVK 199
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 260 PDPLYEVMLKCWHP 273

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 16/219 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQR---EQSLRELKYLNSCRHD 209
           LG+G F  ++KGV  +        ++H  +  ++ L++  R   E        ++   H 
Sbjct: 16  LGQGTFTKIFKGVRREVG---DYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           +++  YG+CF   +  LV  ++  GSL+  L   KN  ++LW  +L +AK  +  + FL 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL- 129
Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR-PYLPHEF 328
             E  LIHG++ + NILL    D   G+    +      +  +  K +   R P++P E 
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 329 LVG-KRLSTKVDVYGFGIVLFELATG----MRAYDDTRR 362
           +   K L+   D + FG  L+E+ +G    + A D  R+
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 122/254 (48%), Gaps = 30/254 (11%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSCR 207
           ++G+G FG VY G    T +     ++H    AV++LN+     +  Q L E   +    
Sbjct: 36  VIGRGHFGCVYHG----TLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
           H N+L L GIC  + G   +V  YM +G L + +  + + P++  L    L +AKG    
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 144
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-- 322
           +++L S++   +H D+ + N +L+      + DFGL ++   +K       +     P  
Sbjct: 145 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEXXSVHNKTGAKLPVK 201
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-------GMRAYDDTRRSERHLKSLVEKYS 375
           ++  E L  ++ +TK DV+ FG++L+EL T        +  +D T    +  + L  +Y 
Sbjct: 202 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 261
Query: 376 EENMYDLVDKNAQP 389
            + +Y+++ K   P
Sbjct: 262 PDPLYEVMLKCWHP 275

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG+G FG V+ G W  TT +A+K L+                E  L+E + +   RH+ +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKP----------GTMSPEAFLQEAQVMKKLRHEKL 65
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  E     +V  YM  GSL D  L  +    L   Q + +A   + G+ ++   
Sbjct: 66  VQLYAVVSEE-PIXIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               +H D+++ANIL+  ++   + DFGL +   IE       +       +   E  + 
Sbjct: 124 N--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEXTARQGAKFPIKWTAPEAALY 179
Query: 332 KRLSTKVDVYGFGIVLFELATGMRA 356
            R + K DV+ FGI+L EL T  R 
Sbjct: 180 GRFTIKSDVWSFGILLTELTTKGRV 204

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           L  +GKG FG V  G +    +AVK +   +ND   +          L E   +   RH 
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF--------LAEASVMTQLRHS 246
Query: 210 NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           N++ L G+  E  G   +V  YM  GSL D  L  +    L     L  +      +++L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-VNGTRPYLPHE 327
                  +H D+ + N+L++      + DFGLT+E     +T  T K  V  T P    E
Sbjct: 306 EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP----E 356
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L  K+ STK DV+ FGI+L+E+
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEI 379

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++KL+ LG+G F TVYK   + T   +A+KK+++     A + +N+     +LRE+K L 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT----ALREIKLLQ 67
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
              H NI+ L           LV+ +M     +  +++K N+  L  +        T  G
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITLKRVNGTRP 322
           L++LH     ++H D+K  N+LL+ +    + DFGL +    P     H  +     TR 
Sbjct: 125 LEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-----TRW 177
Query: 323 YLPHEFLVGKRL-STKVDVYGFGIVLFEL 350
           Y   E L G R+    VD++  G +L EL
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           L  +GKG FG V  G +    +AVK +   +ND   +          L E   +   RH 
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF--------LAEASVMTQLRHS 74
Query: 210 NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           N++ L G+  E  G   +V  YM  GSL D  L  +    L     L  +      +++L
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-VNGTRPYLPHE 327
                  +H D+ + N+L++      + DFGLT+E     +T  T K  V  T P    E
Sbjct: 134 EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP----E 184
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L  K+ STK DV+ FGI+L+E+
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEI 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 35/238 (14%)
Query: 149 KLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+ +LG G FGTVYKG+W       K  +A+K L  + + +A         ++ L E   
Sbjct: 21  KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA--------NKEILDEAYV 72
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL----LWTQRLHIA 258
           +       +  L GIC  T    LV + MP G L D +  ++N   L    L    + IA
Sbjct: 73  MAGVGSPYVSRLLGICL-TSTVQLVTQLMPYGCLLDHV--RENRGRLGSQDLLNWCMQIA 129
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           KG S      +  +  L+H D+ + N+L+       I DFGL +   I++  +       
Sbjct: 130 KGMS------YLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY---HADG 180
Query: 319 GTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK 373
           G  P  ++  E ++ +R + + DV+ +G+ ++EL T G + YD      R +  L+EK
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI--PAREIPDLLEK 236

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           L  +GKG FG V  G +    +AVK +   +ND   +          L E   +   RH 
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF--------LAEASVMTQLRHS 59
Query: 210 NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           N++ L G+  E  G   +V  YM  GSL D  L  +    L     L  +      +++L
Sbjct: 60  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-VNGTRPYLPHE 327
                  +H D+ + N+L++      + DFGLT+E     +T  T K  V  T P    E
Sbjct: 119 EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP----E 169
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L  K+ STK DV+ FGI+L+E+
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEI 192

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 57/300 (19%)
Query: 146 NWDKL---NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR---- 198
           +W+ +   +++G+G FG V K   +K  +        R D A++ + +   +   R    
Sbjct: 20  DWNDIKFQDVIGEGNFGQVLKARIKKDGL--------RMDAAIKRMKEYASKDDHRDFAG 71
Query: 199 ELKYLNSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------------LMK 243
           EL+ L  C+   H NI+ L G C   G   L   Y P+G+L D L             + 
Sbjct: 72  ELEVL--CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 244 KNTPSLLWTQR-LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            +T S L +Q+ LH A   + G+ +L  ++   IH ++ + NIL+  +    I DFGL+ 
Sbjct: 130 NSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRNLAARNILVGENYVAKIADFGLS- 186
Query: 303 EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
                +   + +K+  G  P  ++  E L     +T  DV+ +G++L+E+ + G   Y  
Sbjct: 187 -----RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 241
Query: 360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
              +E + K L + Y  E          +P  LN     + + +Q  ++ P ERP   Q+
Sbjct: 242 MTCAELYEK-LPQGYRLE----------KP--LNCDDEVYDLMRQCWREKPYERPSFAQI 288

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 149 KLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL+ LG+G + TVYKG  + T   +A+K++ +   + A  T        ++RE+  L   
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVSLLKDL 57
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGT 261
           +H NI+ L+ I        LV+ Y+ +  L+  L     ++  +   L   Q L      
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLR----- 111
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL + H ++  ++H D+K  N+L+N   +  + DFGL +   I   T+        T 
Sbjct: 112 --GLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY---DNEVVTL 164
Query: 322 PYLPHEFLVGKR-LSTKVDVYGFGIVLFELATG 353
            Y P + L+G    ST++D++G G + +E+ATG
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 20/225 (8%)
Query: 136 PYQELTLATNNWDK--LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETL 188
           P Q LT      D   L  LG G FG V +G W+       ++AVK L+        + L
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVL 59
Query: 189 NQCQR-EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
           +Q +  +  +RE+  ++S  H N++ LYG+   T    +V    P GSL DRL  +K+  
Sbjct: 60  SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQG 116
Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
             L       A   + G+ +L S+    IH D+ + N+LL       IGDFGL +  P  
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              ++  +       +   E L  +  S   D + FG+ L+E+ T
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 22/238 (9%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLN 189
           GT  + Y    +   +   L  LG G FG V  G W  +  +A+K ++            
Sbjct: 1   GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----------G 50
Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
               ++ + E K + +  H+ ++ LYG+C +     ++  YM NG L + L  ++     
Sbjct: 51  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRF 108
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              Q L + K     +++L S++   +H D+ + N L+N      + DFGL++    ++ 
Sbjct: 109 QTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 166
Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
           T      V    P  + P E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 167 T----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 23/234 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+  L  +GKG F  V      +  +  K++ V   D+    LN    ++  RE++ +  
Sbjct: 15  NYRLLKTIGKGNFAKVK---LARHILTGKEVAVRIIDKT--QLNSSSLQKLFREVRIMKV 69
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGT 261
             H NI+ L+ +        LV  Y   G + D L+    MK+      + Q +      
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----- 124
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E          L    G+ 
Sbjct: 125 --AVQYCHQK--FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDEFCGSP 176
Query: 322 PYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V +G  +     ++ +A+K L+    +R        QR + L E   +   
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER--------QRREFLSEASIMGQF 74
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+   +    ++  +M NG+L+    ++ N       Q + + +G + G++
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDS--FLRLNDGQFTVIQLVGMLRGIASGMR 132
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   E   +H D+ + NIL+N ++   + DFGL++      +       + G  P  + 
Sbjct: 133 YLA--EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
             E +  ++ ++  D + +GIV++E+ + G R Y D
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 226

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 123/281 (43%), Gaps = 35/281 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +        +A+K L+V   ++        QR   L E   +   
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK--------QRRDFLCEASIMGQF 101
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H N++ L G+        +V  +M NG+L+    ++K+       Q + + +G + G++
Sbjct: 102 DHPNVVHLEGVVTRGKPVMIVIEFMENGALD--AFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   +   +H D+ + NIL+N ++   + DFGL++   IE           G  P  + 
Sbjct: 160 YLA--DMGYVHRDLAARNILVNSNLVCKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWT 215
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y D    +  +K++ E Y         
Sbjct: 216 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-IKAIEEGYR-------- 266
Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                P  ++      ++     ++   ERP+  Q+  +L 
Sbjct: 267 ----LPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 136 PYQELTLATNNWDK--LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETL 188
           P Q LT      D   L  LG G FG V +G W+       ++AVK L+        + L
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVL 59
Query: 189 NQCQR-EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
           +Q +  +  +RE+  ++S  H N++ LYG+   T    +V    P GSL DRL  +K+  
Sbjct: 60  SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQG 116
Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
             L       A   + G+ +L S+    IH D+ + N+LL       IGDFGL +  P  
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
               +  +       +   E L  +  S   D + FG+ L+E+ T
Sbjct: 175 DDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 27/236 (11%)
Query: 146 NWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V   + +     +AVK ++  +       LN    ++  RE++ +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-------LNSSSLQKLFREVRIM 67
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAK 259
               H NI+ L+ +        LV  Y   G + D L+    MK+      + Q +    
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--- 124
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E          L    G
Sbjct: 125 ----AVQYCHQK--FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTFCG 174
Query: 320 TRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           + PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLN 204
           ++ +LG G FGTVYKG+W      V + E  +   A++ LN+    ++    + E   + 
Sbjct: 19  RVKVLGSGAFGTVYKGIW------VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 72
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQRLHIAKGTS 262
           S  H +++ L G+C  +    LV + MP+G L + +   K+     LL    + IAK   
Sbjct: 73  SMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK--- 128
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+ +L  R   L+H D+ + N+L+       I DFGL +   + +          G  P
Sbjct: 129 -GMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLAR---LLEGDEKEYNADGGKMP 182
Query: 323 --YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK 373
             ++  E +  ++ + + DV+ +G+ ++EL T G + YD      R +  L+EK
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--PTREIPDLLEK 234

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 27/236 (11%)
Query: 146 NWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V   + +     +AVK ++  +       LN    ++  RE++ +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-------LNSSSLQKLFREVRIM 67
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAK 259
               H NI+ L+ +        LV  Y   G + D L+    MK+      + Q +    
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--- 124
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E          L    G
Sbjct: 125 ----AVQYCHQK--FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTFCG 174
Query: 320 TRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           + PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 23/234 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+  L  +GKG F  V      +  +  K++ V   D+    LN    ++  RE++ +  
Sbjct: 15  NYRLLKTIGKGNFAKVK---LARHILTGKEVAVRIIDKT--QLNSSSLQKLFREVRIMKV 69
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGT 261
             H NI+ L+ +        LV  Y   G + D L+    MK+      + Q +      
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----- 124
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E          L    G+ 
Sbjct: 125 --AVQYCHQK--FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTFCGSP 176
Query: 322 PYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 150 LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQR-EQSLRELKYL 203
           L  LG G FG V +G W+       ++AVK L+        + L+Q +  +  +RE+  +
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVLSQPEAMDDFIREVNAM 69
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +S  H N++ LYG+   T    +V    P GSL DRL  +K+    L       A   + 
Sbjct: 70  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 126
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +L S+    IH D+ + N+LL       IGDFGL +  P     ++  +       +
Sbjct: 127 GMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              E L  +  S   D + FG+ L+E+ T
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 23/238 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           L   N+  L  +GKG F  V      +  +  K++ V   D+    LN    ++  RE++
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLA---RHILTGKEVAVKIIDKT--QLNSSSLQKLFREVR 58
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
            +    H NI+ L+ +        LV  Y   G + D L+    MK+      + Q +  
Sbjct: 59  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS- 117
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                  +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E          L   
Sbjct: 118 ------AVQYCHQK--FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDTF 165
Query: 318 NGTRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
            G+ PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 166 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 223

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 109/237 (45%), Gaps = 25/237 (10%)
Query: 130 GGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETL 188
           GG+  I  ++LT        L  LG G FG V  G W  +  +A+K ++           
Sbjct: 1   GGSWEIDPKDLTF-------LKELGTGQFGVVKYGKWRGQYDVAIKMIKE---------- 43
Query: 189 NQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
                ++ + E K + +  H+ ++ LYG+C +     ++  YM NG L + L  ++    
Sbjct: 44  GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHR 101
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               Q L + K     +++L S++   +H D+ + N L+N      + DFGL++   +  
Sbjct: 102 FQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLD 157
Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
             + + +       + P E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 158 DEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V +G  +     ++ +A+K L+    +R        QR + L E   +   
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER--------QRREFLSEASIMGQF 72
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L G+   +    ++  +M NG+L+    ++ N       Q + + +G + G++
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDS--FLRLNDGQFTVIQLVGMLRGIASGMR 130
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L   E   +H D+ + NIL+N ++   + DFGL++      +       + G  P  + 
Sbjct: 131 YLA--EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
             E +  ++ ++  D + +GIV++E+ + G R Y D
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 27/236 (11%)
Query: 146 NWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V   + +     +AVK ++  +       LN    ++  RE++ +
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-------LNSSSLQKLFREVRIM 67
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAK 259
               H NI+ L+ +        LV  Y   G + D L+    MK+      + Q +    
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS--- 124
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E          L    G
Sbjct: 125 ----AVQYCHQK--FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN----KLDAFCG 174
Query: 320 TRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
             PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 80
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 81  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 135
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E 
Sbjct: 136 EERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEA 191
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 245
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 246 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  LG G FG V  G W  +  +A+K ++                ++ + E K + +  H
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKE----------GSMSEDEFIEEAKVMMNLSH 78
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           + ++ LYG+C +     ++  YM NG L + L  ++        Q L + K     +++L
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPH 326
            S++   +H D+ + N L+N      + DFGL++    ++ T      V    P  + P 
Sbjct: 137 ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEET----SSVGSKFPVRWSPP 190
Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
           E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 46/226 (20%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           ++KL  +G+G +GTV+K    +T   +A+K++ +  +D  V +        +LRE+  L 
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-------SALREICLLK 56
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMP----------NGSLEDRLLMKKNTPSLLWTQR 254
             +H NI+ L+ +     K  LV+ +            NG L+         P ++ +  
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFL 107
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE----KAT 310
             + KG    L F HSR   ++H D+K  N+L+N + +  + +FGL +   I      A 
Sbjct: 108 FQLLKG----LGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 311 HITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMR 355
            +TL        Y P + L G +L ST +D++  G +  ELA   R
Sbjct: 162 VVTLW-------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQR---EQSLRELKYLNSCRHD 209
           LG+G F  ++KGV  +        ++H  +  ++ L++  R   E        ++   H 
Sbjct: 16  LGQGTFTKIFKGVRREVG---DYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           +++  YG+C    +  LV  ++  GSL+  L   KN  ++LW  +L +AK  +  + FL 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL- 129
Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR-PYLPHEF 328
             E  LIHG++ + NILL    D   G+    +      +  +  K +   R P++P E 
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 329 LVG-KRLSTKVDVYGFGIVLFELATG----MRAYDDTRR 362
           +   K L+   D + FG  L+E+ +G    + A D  R+
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  LG G FG V  G W  +  +A+K ++                ++ + E K + +  H
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKE----------GSMSEDEFIEEAKVMMNLSH 58
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           + ++ LYG+C +     ++  YM NG L + L  ++        Q L + K     +++L
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPH 326
            S++   +H D+ + N L+N      + DFGL++    ++ T      V    P  + P 
Sbjct: 117 ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPP 170
Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
           E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 150 LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQR-EQSLRELKYL 203
           L  LG G FG V +G W+       ++AVK L+        + L+Q +  +  +RE+  +
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVLSQPEAMDDFIREVNAM 65
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +S  H N++ LYG+   T    +V    P GSL DRL  +K+    L       A   + 
Sbjct: 66  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +L S+    IH D+ + N+LL       IGDFGL +  P     ++  +       +
Sbjct: 123 GMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              E L  +  S   D + FG+ L+E+ T
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  LG G FG V  G W  +  +A+K ++                ++ + E K + +  H
Sbjct: 13  LKELGTGQFGVVKYGKWRGQYDVAIKMIKE----------GSMSEDEFIEEAKVMMNLSH 62
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           + ++ LYG+C +     ++  YM NG L + L  ++        Q L + K     +++L
Sbjct: 63  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 120
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPH 326
            S++   +H D+ + N L+N      + DFGL++    ++ T      V    P  + P 
Sbjct: 121 ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPP 174
Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
           E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 175 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 76
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 77  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E 
Sbjct: 132 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 187
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 241
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 242 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 75
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 76  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 130
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E 
Sbjct: 131 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 186
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 240
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 241 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVE 186
           HI  +++ L    W+    LG+G FG V+           +K  +AVK         A++
Sbjct: 14  HIKRRDIVL---KWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK---------ALK 57
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
             ++  R+   RE + L   +H +I+  +G+C E     +V+ YM +G L +R L     
Sbjct: 58  EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP 116
Query: 247 PSLLWT-------------QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP 293
            + L               Q L +A   + G+ +L       +H D+ + N L+   +  
Sbjct: 117 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVV 174
Query: 294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            IGDFG++++        +  + +   R ++P E ++ ++ +T+ DV+ FG+VL+E+ T
Sbjct: 175 KIGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVE 186
           HI  +++ L    W+    LG+G FG V+           +K  +AVK         A++
Sbjct: 37  HIKRRDIVL---KWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK---------ALK 80
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
             ++  R+   RE + L   +H +I+  +G+C E     +V+ YM +G L +R L     
Sbjct: 81  EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP 139
Query: 247 PSLLWT-------------QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP 293
            + L               Q L +A   + G+ +L       +H D+ + N L+   +  
Sbjct: 140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVV 197
Query: 294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            IGDFG++++        +  + +   R ++P E ++ ++ +T+ DV+ FG+VL+E+ T
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  LG G FG V  G W  +  +A+K ++                ++ + E K + +  H
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKE----------GSMSEDEFIEEAKVMMNLSH 78
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           + ++ LYG+C +     ++  YM NG L + L  ++        Q L + K     +++L
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPH 326
            S++   +H D+ + N L+N      + DFGL++    ++ T      V    P  + P 
Sbjct: 137 ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPP 190
Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
           E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 65
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 66  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E 
Sbjct: 121 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 176
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 230
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 231 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 110/239 (46%), Gaps = 40/239 (16%)
Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVE 186
           HI  +++ L    W+    LG+G FG V+           +K  +AVK         A++
Sbjct: 8   HIKRRDIVL---KWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK---------ALK 51
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
             ++  R+   RE + L   +H +I+  +G+C E     +V+ YM +G L +R L     
Sbjct: 52  EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP 110
Query: 247 PSLLWT-------------QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP 293
            + L               Q L +A   + G+ +L       +H D+ + N L+   +  
Sbjct: 111 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVV 168
Query: 294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            IGDFG++++        +  + +   R ++P E ++ ++ +T+ DV+ FG+VL+E+ T
Sbjct: 169 KIGDFGMSRDIYSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  LG G FG V  G W  +  +A+K ++                ++ + E K + +  H
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYDVAIKMIKE----------GSMSEDEFIEEAKVMMNLSH 63
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           + ++ LYG+C +     ++  YM NG L + L  ++        Q L + K     +++L
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 121
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPH 326
            S++   +H D+ + N L+N      + DFGL++    ++ T      V    P  + P 
Sbjct: 122 ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPP 175
Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSE 364
           E L+  + S+K D++ FG++++E+ + G   Y+    SE
Sbjct: 176 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 214

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 150 LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQR-EQSLRELKYL 203
           L  LG G FG V +G W+       ++AVK L+        + L+Q +  +  +RE+  +
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVLSQPEAMDDFIREVNAM 65
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +S  H N++ LYG+   T    +V    P GSL DRL  +K+    L       A   + 
Sbjct: 66  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +L S+    IH D+ + N+LL       IGDFGL +  P     ++  +       +
Sbjct: 123 GMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              E L  +  S   D + FG+ L+E+ T
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 71  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E 
Sbjct: 126 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 235
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 236 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 150 LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQR-EQSLRELKYL 203
           L  LG G FG V +G W+       ++AVK L+        + L+Q +  +  +RE+  +
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVLSQPEAMDDFIREVNAM 69
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +S  H N++ LYG+   T    +V    P GSL DRL  +K+    L       A   + 
Sbjct: 70  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 126
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +L S+    IH D+ + N+LL       IGDFGL +  P     ++  +       +
Sbjct: 127 GMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              E L  +  S   D + FG+ L+E+ T
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKL--EVHRNDRAVETLNQC 191
           P  ++ L   +++   +LGKG FG V+   ++KT    A+K L  +V   D  VE     
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
           +R  SL       +  H  +  ++           V  Y+  G L   +   ++      
Sbjct: 69  KRVLSL-------AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDL 118
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           ++    A    LGLQFLHS+   +++ D+K  NILL+      I DFG+ +E  +  A  
Sbjct: 119 SRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 175
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
                  GT  Y+  E L+G++ +  VD + FG++L+E+  G   +
Sbjct: 176 --TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/282 (20%), Positives = 129/282 (45%), Gaps = 35/282 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+    ++        QR   L E   +   
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--------QRRDFLSEASIMGQF 91
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H N++ L G+  ++    ++  +M NGSL+    +++N       Q + + +G + G++
Sbjct: 92  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L       +H D+ + NIL+N ++   + DFGL++    + +       + G  P  + 
Sbjct: 150 YLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y D               + +++ + +
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------------TNQDVINAI 253
Query: 384 DKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           +++ + P  ++   A  ++     +++   RP+  Q+ N L 
Sbjct: 254 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 295

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 93
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ Q+  I +A++    R  G  
Sbjct: 154 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQD--IYRASYY---RKGGCA 206
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 261
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 262 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 312
Query: 437 TLPV 440
            LP+
Sbjct: 313 ALPI 316

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   Y    E T +  K++   +       L   Q+E+   E+    S  + ++
Sbjct: 49  FLGKGGFAKCY----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  VY  +        L + K   ++   +  +  + T  G+Q+LH+ 
Sbjct: 105 VGFHGF-FEDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  MD  IGDFGL  +   +     TL    GT  Y+  E L  
Sbjct: 162 R--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL---CGTPNYIAPEVLCK 216
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VD++  G +L+ L  G   ++ +   E +++    +YS       V ++  P  
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-------VPRHINP-- 267
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP 431
             +A A  R   +    +P  RP + ++      + G +P
Sbjct: 268 --VASALIR---RMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLNSCR 207
           KL +LG G FGTV+KGVW     ++K   +    + +E  +  Q  Q++ + +  + S  
Sbjct: 35  KLKVLGSGVFGTVHKGVWIPEGESIK---IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQRLHIAKGTSLGL 265
           H +I+ L G+C       LV +Y+P GSL D +   +    P LL    + IAKG     
Sbjct: 92  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG----- 145
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
              +  E  ++H ++ + N+LL       + DFG+    P +    +          ++ 
Sbjct: 146 -MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-KQLLYSEAKTPIKWMA 203
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK----------- 373
            E +   + + + DV+ +G+ ++EL T G   Y   R +E  +  L+EK           
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLAQPQICT 261
Query: 374 ---YSEENMYDLVDKNAQPIELNIAYAFFRIGK 403
              Y       ++D+N +P    +A  F R+ +
Sbjct: 262 IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 294

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 121/300 (40%), Gaps = 61/300 (20%)
Query: 153 LGKGGFGTVYK-------GVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG V K       G    TT+AVK L+        E  +  +    L E   L  
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--------ENASPSELRDLLSEFNVLKQ 82
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL---------------------LMKK 244
             H +++ LYG C + G   L+  Y   GSL   L                     L   
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 245 NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG 304
           +  +L     +  A   S G+Q+L   E  L+H D+ + NIL+       I DFGL+++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA--EMSLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 305 PIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTR 361
             E +    +KR  G  P  ++  E L     +T+ DV+ FG++L+E+ T G   Y    
Sbjct: 201 YEEDS---XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 256
Query: 362 RSERHLKSLVEKYSEENMYDLVDKNAQPIEL--NIAYAFFRIGKQSTKQNPKERPEMTQV 419
                          E +++L+ K    +E   N +   +R+  Q  KQ P +RP    +
Sbjct: 257 -------------PPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 31/273 (11%)
Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLNSCR 207
           KL +LG G FGTV+KGVW     ++K   +    + +E  +  Q  Q++ + +  + S  
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIK---IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--PSLLWTQRLHIAKGTSLGL 265
           H +I+ L G+C       LV +Y+P GSL D +   +    P LL    + IAKG     
Sbjct: 74  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG----- 127
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
              +  E  ++H ++ + N+LL       + DFG+    P +    +          ++ 
Sbjct: 128 -MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-KQLLYSEAKTPIKWMA 185
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK----------- 373
            E +   + + + DV+ +G+ ++EL T G   Y   R +E  +  L+EK           
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLAQPQICT 243
Query: 374 ---YSEENMYDLVDKNAQPIELNIAYAFFRIGK 403
              Y       ++D+N +P    +A  F R+ +
Sbjct: 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 78
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 79  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 133
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 134 EERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEA 189
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 243
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 244 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 27/236 (11%)
Query: 146 NWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V   + +     +A+K ++  +       LN    ++  RE++ +
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-------LNPTSLQKLFREVRIM 65
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAK 259
               H NI+ L+ +        L+  Y   G + D L+    MK+      + Q +    
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--- 122
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E  +       L    G
Sbjct: 123 ----AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDTFCG 172
Query: 320 TRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           + PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 228

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 79
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 80  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 134
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 135 EERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEA 190
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 244
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 245 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 76
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 77  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 132 EERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEA 187
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 241
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 242 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 29/243 (11%)
Query: 135 IPYQELTLATNNWDK--------LNILGKGGFGTVY----KGVWEKTTIAVKKLEVHRND 182
           +P ++    +NN D+        L +LGKG FG V     KG  E   I + K +V   D
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLL 241
             VE         ++ E + L        L     CF+T  +   V  Y+  G L   + 
Sbjct: 61  DDVEC--------TMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MY 109
Query: 242 MKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             +        Q +  A   S+GL FLH R   +I+ D+K  N++L+      I DFG+ 
Sbjct: 110 HIQQVGKFKEPQAVFYAAEISIGLFFLHKRG--IIYRDLKLDNVMLDSEGHIKIADFGMC 167
Query: 302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
           +E  ++    +T +   GT  Y+  E +  +     VD + +G++L+E+  G   +D   
Sbjct: 168 KEHMMDG---VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 224
Query: 362 RSE 364
             E
Sbjct: 225 EDE 227

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 71  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 126 EERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEXTAREGAKFPIKWTAPEA 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 235
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 236 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 121/300 (40%), Gaps = 61/300 (20%)
Query: 153 LGKGGFGTVYK-------GVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG V K       G    TT+AVK L+        E  +  +    L E   L  
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--------ENASPSELRDLLSEFNVLKQ 82
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL---------------------LMKK 244
             H +++ LYG C + G   L+  Y   GSL   L                     L   
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 245 NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG 304
           +  +L     +  A   S G+Q+L   E  L+H D+ + NIL+       I DFGL+++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 305 PIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTR 361
             E +    +KR  G  P  ++  E L     +T+ DV+ FG++L+E+ T G   Y    
Sbjct: 201 YEEDS---XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 256
Query: 362 RSERHLKSLVEKYSEENMYDLVDKNAQPIEL--NIAYAFFRIGKQSTKQNPKERPEMTQV 419
                          E +++L+ K    +E   N +   +R+  Q  KQ P +RP    +
Sbjct: 257 -------------PPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 72
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 73  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 128 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 183
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 237
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 238 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 27/229 (11%)
Query: 153 LGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +GKG F  V   + V     +AVK ++  +       LN    ++  RE++ +    H N
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQ-------LNPTSLQKLFREVRIMKILNHPN 75
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQ 266
           I+ L+ +        LV  Y   G + D L+    MK+      + Q +         +Q
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-------AVQ 128
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           + H +   ++H D+K+ N+LL+  M+  I DFG + E  +       L    G+ PY   
Sbjct: 129 YCHQKY--IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAP 182
Query: 327 EFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 149 KLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+  LG+G FG V    ++ T       +AVK L+     +         R    +E+  
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--------HRSGWKQEIDI 86
Query: 203 LNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H++I+   G C + G   L  V  Y+P GSL D L       S+   Q L  A+ 
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQ 142
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +LH++    IH D+ + N+LL++     IGDFGL +  P  +       R +G 
Sbjct: 143 ICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEXYRVREDGD 198
Query: 321 RP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            P   Y P E L   +     DV+ FG+ L+EL T
Sbjct: 199 SPVFWYAP-ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           L  +GKG FG V  G +    +AVK +   +ND   +          L E   +   RH 
Sbjct: 17  LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF--------LAEASVMTQLRHS 65
Query: 210 NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
           N++ L G+  E  G   +V  YM  GSL D  L  +    L     L  +      +++L
Sbjct: 66  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 124
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR-VNGTRPYLPHE 327
                  +H D+ + N+L++      + DFGLT+E     +T  T K  V  T P    E
Sbjct: 125 EGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP----E 175
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L     STK DV+ FGI+L+E+
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEI 198

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   Y    E T +  K++   +       L   Q+E+   E+    S  + ++
Sbjct: 49  FLGKGGFAKCY----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  VY  +        L + K   ++   +  +  + T  G+Q+LH+ 
Sbjct: 105 VGFHGF-FEDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  MD  IGDFGL  +   +       K + GT  Y+  E L  
Sbjct: 162 R--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KXLCGTPNYIAPEVLCK 216
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VD++  G +L+ L  G   ++ +   E +++    +YS       V ++  P  
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-------VPRHINP-- 267
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP 431
             +A A  R   +    +P  RP + ++      + G +P
Sbjct: 268 --VASALIR---RMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 61/300 (20%)
Query: 153 LGKGGFGTVYK-------GVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+G FG V K       G    TT+AVK L+        E  +  +    L E   L  
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--------ENASPSELRDLLSEFNVLKQ 82
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL---------------------LMKK 244
             H +++ LYG C + G   L+  Y   GSL   L                     L   
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 245 NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG 304
           +  +L     +  A   S G+Q+L   E  L+H D+ + NIL+       I DFGL+++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRD- 199
Query: 305 PIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTR 361
             E+ +++  KR  G  P  ++  E L     +T+ DV+ FG++L+E+ T G   Y    
Sbjct: 200 VYEEDSYV--KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI- 256
Query: 362 RSERHLKSLVEKYSEENMYDLVDKNAQPIEL--NIAYAFFRIGKQSTKQNPKERPEMTQV 419
                          E +++L+ K    +E   N +   +R+  Q  KQ P +RP    +
Sbjct: 257 -------------PPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 71  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 126 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 235
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 236 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 71
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 72  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 126
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE       +       +   E 
Sbjct: 127 EERN--YIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEXTAREGAKFPIKWTAPEA 182
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 236
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 237 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 35/277 (12%)
Query: 153 LGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G FG V+ G    + T +AVK           ETL    + + L+E + L    H N
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR--------ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+ L G+C +     +V   +  G       ++     L     L +    + G+++L S
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDF--LTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATHITLKRVNGTRPYLPHE 327
           +    IH D+ + N L+       I DFG+++E   G    +  +    V  T P    E
Sbjct: 232 K--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAP----E 285
Query: 328 FLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN 386
            L   R S++ DV+ FGI+L+E  + G   Y +   S +  +  VEK       +L    
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGGRLPCPELCPD- 342
Query: 387 AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                     A FR+ +Q     P +RP  + +Y  L
Sbjct: 343 ----------AVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 27/236 (11%)
Query: 146 NWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V   + +     +A+K ++  +       LN    ++  RE++ +
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-------LNPTSLQKLFREVRIM 68
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAK 259
               H NI+ L+ +        L+  Y   G + D L+    MK+      + Q +    
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS--- 125
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
                +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E  +       L    G
Sbjct: 126 ----AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCG 175
Query: 320 TRPYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
             PY   E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 150 LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQR-EQSLRELKYL 203
           L  LG G FG V +G W+       ++AVK L+        + L+Q +  +  +RE+  +
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-------DVLSQPEAMDDFIREVNAM 65
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +S  H N++ LYG+   T    +V    P GSL DRL  +K+    L       A   + 
Sbjct: 66  HSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAE 122
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +L S+    IH D+ + N+LL       IGDFGL +  P      +  +       +
Sbjct: 123 GMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
              E L  +  S   D + FG+ L+E+ T
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 104/242 (42%), Gaps = 17/242 (7%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K L
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--KML 62
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           N   H+N++  YG   E     L   Y   G L DR+      P     +  H       
Sbjct: 63  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT PY
Sbjct: 117 GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPY 173
Query: 324 LPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
           +  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +  
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 383 VD 384
           +D
Sbjct: 234 ID 235

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   Y    E T +  K++   +       L   Q+E+   E+    S  + ++
Sbjct: 33  FLGKGGFAKCY----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 88
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  VY  +        L + K   ++   +  +  + T  G+Q+LH+ 
Sbjct: 89  VGFHGF-FEDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 145
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  MD  IGDFGL  +   +       K + GT  Y+  E L  
Sbjct: 146 R--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCK 200
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VD++  G +L+ L  G   ++ +   E +++    +YS       V ++  P  
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-------VPRHINP-- 251
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP 431
             +A A  R   +    +P  RP + ++      + G +P
Sbjct: 252 --VASALIR---RMLHADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 104/242 (42%), Gaps = 17/242 (7%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K L
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--KML 61
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           N   H+N++  YG   E     L   Y   G L DR+      P     +  H       
Sbjct: 62  N---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 115
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT PY
Sbjct: 116 GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTLPY 172
Query: 324 LPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
           +  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +  
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 232
Query: 383 VD 384
           +D
Sbjct: 233 ID 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 26/280 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   Y    E T +  K++   +       L   Q+E+   E+    S  + ++
Sbjct: 49  FLGKGGFAKCY----EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  VY  +        L + K   ++   +  +  + T  G+Q+LH+ 
Sbjct: 105 VGFHGF-FEDDDF--VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  MD  IGDFGL  +   +       K + GT  Y+  E L  
Sbjct: 162 R--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCK 216
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VD++  G +L+ L  G   ++ +   E +++    +YS       V ++  P  
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYS-------VPRHINP-- 267
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP 431
             +A A  R   +    +P  RP + ++      + G +P
Sbjct: 268 --VASALIR---RMLHADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 35/277 (12%)
Query: 153 LGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G FG V+ G    + T +AVK           ETL    + + L+E + L    H N
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCR--------ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+ L G+C +     +V   +  G       ++     L     L +    + G+++L S
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDF--LTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATHITLKRVNGTRPYLPHE 327
           +    IH D+ + N L+       I DFG+++E   G    +  +    V  T P    E
Sbjct: 232 K--CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP----E 285
Query: 328 FLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN 386
            L   R S++ DV+ FGI+L+E  + G   Y +   S +  +  VEK       +L    
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--SNQQTREFVEKGGRLPCPELCPD- 342
Query: 387 AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                     A FR+ +Q     P +RP  + +Y  L
Sbjct: 343 ----------AVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 60
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 61  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 60
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 61  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 20/227 (8%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE--QSLRELKYLNSCRHD 209
           ILG+G FG+V +G  ++      K+ V    + ++  N  QRE  + L E   +    H 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAV----KTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 210 NILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKK--NTPSLLWTQRL-HIAKGT 261
           N++ L G+C E       K  ++  +M  G L   LL  +    P  +  Q L       
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT- 320
           +LG+++L +R    +H D+ + N +L   M   + DFGL+++  I    +    R+    
Sbjct: 157 ALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDYYRQGRIAKMP 212
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH 366
             ++  E L  +  ++K DV+ FG+ ++E+AT GM  Y   +  E +
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 60
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 61  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKLNH 93
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 154 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 206
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 261
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 262 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 312
Query: 437 TLPV 440
            LP+
Sbjct: 313 ALPI 316

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEIXIN--K 60
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 61  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 114
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G  G V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 71  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH D+++ANIL++  +   I DFGL +   IE A     +       +   E 
Sbjct: 126 EERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDAEXTAREGAKFPIKWTAPEA 181
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 235
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 236 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 58
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 59  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 112
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 113 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 169
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229
Query: 381 DLVD 384
             +D
Sbjct: 230 KKID 233

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEIXIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMXGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 60
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 61  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 114
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 26/228 (11%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETL 188
           GT ++ +Q +      ++ L ++G+G +G V K   + T   +A+KK     +D+ V+ +
Sbjct: 15  GTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI 70
Query: 189 NQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
                  ++RE+K L   RH+N++ L  +C +  ++ LV+ ++ +  L+D  L       
Sbjct: 71  -------AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPI 306
            +  + L        G+ F HS    +IH DIK  NIL++      + DFG   T   P 
Sbjct: 124 QVVQKYLFQIIN---GIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 307 EKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATG 353
           E            TR Y   E LVG  +    VDV+  G ++ E+  G
Sbjct: 179 E-----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 93  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 153 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 205
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 260
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 261 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 311
Query: 437 TLPV 440
            LP+
Sbjct: 312 ALPI 315

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 43/225 (19%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS-LRELKYLNSC-- 206
           +  +GKG +G V++G+W   ++AVK             +   + EQS  RE +  N+   
Sbjct: 13  VECVGKGRYGEVWRGLWHGESVAVK-------------IFSSRDEQSWFRETEIYNTVLL 59
Query: 207 RHDNILPLYGICF----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           RHDNIL            + +  L+  Y  +GSL D L  +   P L     L +A   +
Sbjct: 60  RHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAA 115
Query: 263 LGLQFLHSR------EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL-- 314
            GL  LH        +P + H D KS N+L+  ++   I D GL      + + ++ +  
Sbjct: 116 CGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHS-QGSDYLDIGN 174
Query: 315 -KRVNGTRPYLPHEFLVGKRLSTKV-------DVYGFGIVLFELA 351
             RV GT+ Y+  E L  +++ T         D++ FG+VL+E+A
Sbjct: 175 NPRV-GTKRYMAPEVL-DEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 153 LGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +   T +AVK L+                +  L E   +   +H  +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ----------GSMSPDAFLAEANLMKQLQHQRL 66
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS---LLWTQRLHIAKGTSLGLQFL 268
           + LY +  +   Y ++  YM NGSL D L     TPS   L   + L +A   + G+ F+
Sbjct: 67  VRLYAVVTQEPIY-IITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             R    IH ++++ANIL++  +   I DFGL +   IE   +   +       +   E 
Sbjct: 122 EERN--YIHRNLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEA 177
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +     + K DV+ FGI+L E+ T  R       +   +++L      E  Y +V  +  
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRPDNC 231
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           P EL      +++ +   K+ P++RP    + ++L
Sbjct: 232 PEEL------YQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKLNH 107
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 168 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 220
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 275
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 276 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 326
Query: 437 TLPV 440
            LP+
Sbjct: 327 ALPI 330

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 153 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 205
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 260
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 261 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 311
Query: 437 TLPV 440
            LP+
Sbjct: 312 ALPI 315

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   +    E +    K++   +       L   QRE+   E+    S  H ++
Sbjct: 24  FLGKGGFAKCF----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 79
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  V+  +        L + K   +L   +  +  +   LG Q+LH  
Sbjct: 80  VGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  ++  IGDFGL  +   +     TL    GT  Y+  E L  
Sbjct: 137 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL---CGTPNYIAPEVLSK 191
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VDV+  G +++ L  G   ++ +   E +L+    +YS       + K+  P+ 
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------IPKHINPVA 244
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            ++        ++  + +P  RP + ++ N
Sbjct: 245 ASLI-------QKMLQTDPTARPTINELLN 267

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 60
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 61  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA- 116
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEIXIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 119
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 120 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 180 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 232
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 233 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 287
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 288 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 338
Query: 437 TLPV 440
            LP+
Sbjct: 339 ALPI 342

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   +    E +    K++   +       L   QRE+   E+    S  H ++
Sbjct: 24  FLGKGGFAKCF----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 79
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  V+  +        L + K   +L   +  +  +   LG Q+LH  
Sbjct: 80  VGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  ++  IGDFGL  +   +     TL    GT  Y+  E L  
Sbjct: 137 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL---CGTPNYIAPEVLSK 191
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VDV+  G +++ L  G   ++ +   E +L+    +YS       + K+  P+ 
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------IPKHINPVA 244
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            ++        ++  + +P  RP + ++ N
Sbjct: 245 ASLI-------QKMLQTDPTARPTINELLN 267

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           + + + ++  LG+G +G VYK +   T  T+A+K++ +   +  V          ++RE+
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG-------TAIREV 84
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L   +H NI+ L  +     +  L++ Y  N   + +  M KN    +   +  + + 
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPV--IGDFGLTQEG--PIEKATHIT 313
            + G+ F HSR    +H D+K  N+LL   +    PV  IGDFGL +    PI + TH  
Sbjct: 142 IN-GVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 314 LKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFEL 350
           +     T  Y P E L+G R  ST VD++    +  E+
Sbjct: 199 I-----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVYSEQDELDFLMEALIISKFNH 107
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 168 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 220
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 275
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 276 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 326
Query: 437 TLPV 440
            LP+
Sbjct: 327 ALPI 330

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 107
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 108 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 168 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 220
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 275
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 276 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 326
Query: 437 TLPV 440
            LP+
Sbjct: 327 ALPI 330

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   +    E +    K++   +       L   QRE+   E+    S  H ++
Sbjct: 28  FLGKGGFAKCF----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 83
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  V+  +        L + K   +L   +  +  +   LG Q+LH  
Sbjct: 84  VGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  ++  IGDFGL  +   +     TL    GT  Y+  E L  
Sbjct: 141 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL---CGTPNYIAPEVLSK 195
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VDV+  G +++ L  G   ++ +   E +L+    +YS       + K+  P+ 
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------IPKHINPVA 248
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            ++        ++  + +P  RP + ++ N
Sbjct: 249 ASLI-------QKMLQTDPTARPTINELLN 271

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 84
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 85  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 145 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 197
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 198 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 252
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 253 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 303
Query: 437 TLPV 440
            LP+
Sbjct: 304 ALPI 307

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G+G +G VYK       T A+KK+ + + D  + +        ++RE+  L   +H
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-------TTIREISILKELKH 59
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLL------MKKNTPSLLWTQRLHIAKGTS 262
            NI+ LY +     +  LV+ ++       +LL      ++  T      Q L+      
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLN------ 111
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNGT 320
            G+ + H R   ++H D+K  N+L+N   +  I DFGL +    P+ K TH  +     T
Sbjct: 112 -GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----T 163
Query: 321 RPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
             Y   + L+G K+ ST +D++  G +  E+  G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G+G +G VYK       T A+KK+ + + D  + +        ++RE+  L   +H
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-------TTIREISILKELKH 59
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLL------MKKNTPSLLWTQRLHIAKGTS 262
            NI+ LY +     +  LV+ ++       +LL      ++  T      Q L+      
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLN------ 111
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNGT 320
            G+ + H R   ++H D+K  N+L+N   +  I DFGL +    P+ K TH  +     T
Sbjct: 112 -GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----T 163
Query: 321 RPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
             Y   + L+G K+ ST +D++  G +  E+  G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 19/226 (8%)
Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKL--EVHRNDRAVETLNQC 191
           P  ++ L   ++    +LGKG FG V+   ++KT    A+K L  +V   D  VE     
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
           +R  SL       +  H  +  ++           V  Y+  G L   +   ++      
Sbjct: 68  KRVLSL-------AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDL 117
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           ++    A    LGLQFLHS+   +++ D+K  NILL+      I DFG+ +E  +  A  
Sbjct: 118 SRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 174
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
                  GT  Y+  E L+G++ +  VD + FG++L+E+  G   +
Sbjct: 175 --TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 93
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 154 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 206
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 261
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 262 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 312
Query: 437 TLPV 440
            LP+
Sbjct: 313 ALPI 316

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 37/240 (15%)
Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           + LG G FG V  G  E T   +AVK L    N + + +L+   + +  RE++ L   RH
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKIL----NRQKIRSLDVVGKIR--REIQNLKLFRH 75
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLG 264
            +I+ LY +        +V  Y+  G L D +     + +     L+ Q L        G
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-------G 128
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEKATHITLKRVNGTR 321
           + + H     ++H D+K  N+LL+ HM+  I DFGL+    +G         L+   G+ 
Sbjct: 129 VDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-------LRXSCGSP 179
Query: 322 PYLPHEFLVGKRLS-TKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
            Y   E + G+  +  +VD++  G++L+ L  G   +DD      H+ +L +K  +   Y
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-----HVPTLFKKICDGIFY 234

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 99
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 100 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 160 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 212
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 213 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 267
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 268 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 318
Query: 437 TLPV 440
            LP+
Sbjct: 319 ALPI 322

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 109
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 110 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A++    R  G  
Sbjct: 170 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYY---RKGGCA 222
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 223 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 277
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 278 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 328
Query: 437 TLPV 440
            LP+
Sbjct: 329 ALPI 332

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 128/278 (46%), Gaps = 26/278 (9%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           +L   ++D L ++G+G +  V     +KT     + V K E+  +D   E ++  Q E+ 
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD---EDIDWVQTEKH 104
Query: 197 LRELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
           + E     +  H  ++ L+  CF+T  +   V  Y+  G L   +  ++  P      R 
Sbjct: 105 VFE----QASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHARF 157
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  SL L +LH R   +I+ D+K  N+LL+      + D+G+ +EG     T  T  
Sbjct: 158 YSAE-ISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 213
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
              GT  Y+  E L G+     VD +  G+++FE+  G   +D    S+       ++ +
Sbjct: 214 --CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQNT 266
Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER 413
           E+ ++ ++ +    I  +++     + K    ++PKER
Sbjct: 267 EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G+G +G VYK       T A+KK+ + + D  + +        ++RE+  L   +H
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-------TTIREISILKELKH 59
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLL------MKKNTPSLLWTQRLHIAKGTS 262
            NI+ LY +     +  LV+ ++       +LL      ++  T      Q L+      
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLN------ 111
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNGT 320
            G+ + H R   ++H D+K  N+L+N   +  I DFGL +    P+ K TH  +     T
Sbjct: 112 -GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----T 163
Query: 321 RPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
             Y   + L+G K+ ST +D++  G +  E+  G
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 132/310 (42%), Gaps = 46/310 (14%)
Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYK----GVWEKTTI---AVKKLEVHRNDRAV 185
            +PY E      NN      LG G FG V +    G+ ++  +   AVK L+        
Sbjct: 26  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-------- 77
Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL---- 240
            T +  ++E  + ELK ++   +H+NI+ L G C   G   ++  Y   G L + L    
Sbjct: 78  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKA 137
Query: 241 ---LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD 297
              L K++   L     LH +   + G+ FL S+    IH D+ + N+LL +     IGD
Sbjct: 138 EADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGD 195
Query: 298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRA 356
           FGL ++  +  + +I          ++  E +     + + DV+ +GI+L+E+ + G+  
Sbjct: 196 FGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 254
Query: 357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA---FFRIGKQSTKQNPKER 413
           Y     + +  K + + Y          + AQP     A+A    + I +      P  R
Sbjct: 255 YPGILVNSKFYKLVKDGY----------QMAQP-----AFAPKNIYSIMQACWALEPTHR 299
Query: 414 PEMTQVYNML 423
           P   Q+ + L
Sbjct: 300 PTFQQICSFL 309

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 104/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G +G V   V   T   +AVK +++ R   AV+     ++E  +  + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINAM- 61
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 62  -LN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 114
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 115 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 171
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 381 DLVD 384
             +D
Sbjct: 232 KKID 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 151 NILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
            I+G G  G V  G           +A+K L+    +R        QR   L E   +  
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--------QRRDFLSEASIMGQ 106
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H NI+ L G+        +V  YM NGSL+  L       +++  Q + + +G   G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGM 164
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--Y 323
           ++L   +   +H D+ + N+L++ ++   + DFGL++   +E           G  P  +
Sbjct: 165 RYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRW 220
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
              E +  +  S+  DV+ FG+V++E LA G R Y +   + R + S VE+      Y L
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEE-----GYRL 273
Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
                 P  +   +A  ++      ++  +RP  +Q+ ++L  
Sbjct: 274 ------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 149 KLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+  LG+G FG V    ++ T       +AVK L+     +         R    +E+  
Sbjct: 18  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQ--------HRSGWKQEIDI 69
Query: 203 LNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H++I+   G C + G+  L  V  Y+P GSL D L       S+   Q L  A+ 
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQ 125
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +LHS+    IH ++ + N+LL++     IGDFGL +  P  +       R +G 
Sbjct: 126 ICEGMAYLHSQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGD 181
Query: 321 RP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            P   Y P E L   +     DV+ FG+ L+EL T
Sbjct: 182 SPVFWYAP-ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 151 NILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
            I+G G  G V  G           +A+K L+    +R        QR   L E   +  
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--------QRRDFLSEASIMGQ 106
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H NI+ L G+        +V  YM NGSL+  L       +++  Q + + +G   G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGM 164
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--Y 323
           ++L   +   +H D+ + N+L++ ++   + DFGL++   +E           G  P  +
Sbjct: 165 RYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRW 220
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
              E +  +  S+  DV+ FG+V++E LA G R Y +   + R + S VE+      Y L
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--TNRDVISSVEE-----GYRL 273
Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
                 P  +   +A  ++      ++  +RP  +Q+ ++L  
Sbjct: 274 ------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 77/317 (24%), Positives = 133/317 (41%), Gaps = 46/317 (14%)
Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYK----GVWEKTTI---AVKKLEVHRNDRAV 185
            +PY E      NN      LG G FG V +    G+ ++  +   AVK L+        
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-------- 85
Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL---- 240
            T +  ++E  + ELK ++   +H+NI+ L G C   G   ++  Y   G L + L    
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKA 145
Query: 241 ---LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD 297
              L K++   L     LH +   + G+ FL S+    IH D+ + N+LL +     IGD
Sbjct: 146 EADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGD 203
Query: 298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRA 356
           FGL ++  +  + +I          ++  E +     + + DV+ +GI+L+E+ + G+  
Sbjct: 204 FGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 262
Query: 357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA---FFRIGKQSTKQNPKER 413
           Y     + +  K + + Y          + AQP     A+A    + I +      P  R
Sbjct: 263 YPGILVNSKFYKLVKDGY----------QMAQP-----AFAPKNIYSIMQACWALEPTHR 307
Query: 414 PEMTQVYNMLSGSGGES 430
           P   Q+ + L     E 
Sbjct: 308 PTFQQICSFLQEQAQED 324

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   +    E +    K++   +       L   QRE+   E+    S  H ++
Sbjct: 48  FLGKGGFAKCF----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  V+  +        L + K   +L   +  +  +   LG Q+LH  
Sbjct: 104 VGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  ++  IGDFGL  +   +       K + GT  Y+  E L  
Sbjct: 161 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSK 215
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VDV+  G +++ L  G   ++ +   E +L+    +YS       + K+  P+ 
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------IPKHINPVA 268
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            ++        ++  + +P  RP + ++ N
Sbjct: 269 ASLI-------QKMLQTDPTARPTINELLN 291

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N ++ L +LGKG FG V   V EK T     +++ + +  V    + +   +L E +
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENR 200
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  +          R 
Sbjct: 201 VLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RF 252
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L +LHS E  +++ D+K  N++L+      I DFGL +EG  + AT   +K
Sbjct: 253 YGAEIVS-ALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MK 307
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N ++ L +LGKG FG V   V EK T     +++ + +  V    + +   +L E +
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENR 61
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  +          R 
Sbjct: 62  VLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RF 113
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L +LHS E  +++ D+K  N++L+      I DFGL +EG  + AT   +K
Sbjct: 114 YGAEIVS-ALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MK 168
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N ++ L +LGKG FG V   V EK T     +++ + +  V    + +   +L E +
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENR 60
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  +          R 
Sbjct: 61  VLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RF 112
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L +LHS E  +++ D+K  N++L+      I DFGL +EG  + AT   +K
Sbjct: 113 YGAEIVS-ALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MK 167
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 205

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N ++ L +LGKG FG V   V EK T     +++ + +  V    + +   +L E +
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENR 203
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  +          R 
Sbjct: 204 VLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RF 255
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L +LHS E  +++ D+K  N++L+      I DFGL +EG  + AT   +K
Sbjct: 256 YGAEIVS-ALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MK 310
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 311 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/323 (23%), Positives = 134/323 (41%), Gaps = 54/323 (16%)
Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYK----GVWEKTTI---AVKKLEVHRNDRAV 185
            +PY E      NN      LG G FG V +    G+ ++  +   AVK L+        
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-------- 85
Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK 244
            T +  ++E  + ELK ++   +H+NI+ L G C   G   ++  Y   G L +  L +K
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRK 144
Query: 245 NTPSLLWTQR--------------LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH 290
             P L ++                LH +   + G+ FL S+    IH D+ + N+LL + 
Sbjct: 145 RPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNG 202
Query: 291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
               IGDFGL ++  +  + +I          ++  E +     + + DV+ +GI+L+E+
Sbjct: 203 HVAKIGDFGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261
Query: 351 -ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA---FFRIGKQST 406
            + G+  Y     + +  K + + Y          + AQP     A+A    + I +   
Sbjct: 262 FSLGLNPYPGILVNSKFYKLVKDGY----------QMAQP-----AFAPKNIYSIMQACW 306
Query: 407 KQNPKERPEMTQVYNMLSGSGGE 429
              P  RP   Q+ + L     E
Sbjct: 307 ALEPTHRPTFQQICSFLQEQAQE 329

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   +    E +    K++   +       L   QRE+   E+    S  H ++
Sbjct: 22  FLGKGGFAKCF----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  V+  +        L + K   +L   +  +  +   LG Q+LH  
Sbjct: 78  VGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  ++  IGDFGL  +   +       K + GT  Y+  E L  
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSK 189
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VDV+  G +++ L  G   ++ +   E +L+    +YS       + K+  P+ 
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------IPKHINPVA 242
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP 431
            ++        ++  + +P  RP + ++ N    + G  P
Sbjct: 243 ASLI-------QKMLQTDPTARPTINELLNDEFFTSGYIP 275

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 22/223 (9%)
Query: 150 LNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  LG G FG V  G W+ +  +AVK ++                ++  +E + +    H
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKE----------GSMSEDEFFQEAQTMMKLSH 62
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             ++  YG+C +     +V  Y+ NG L + L  + +   L  +Q L +      G+ FL
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRPYLPH 326
            S +   IH D+ + N L++  +   + DFG+T+    ++       +  V  + P + H
Sbjct: 121 ESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 327 EFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLK 368
            F    + S+K DV+ FGI+++E+ + G   YD    SE  LK
Sbjct: 179 YF----KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 26/270 (9%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
            LGKGGF   +    E +    K++   +       L   QRE+   E+    S  H ++
Sbjct: 46  FLGKGGFAKCF----EISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 101
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           +  +G  FE   +  V+  +        L + K   +L   +  +  +   LG Q+LH  
Sbjct: 102 VGFHGF-FEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
              +IH D+K  N+ LN  ++  IGDFGL  +   +       K + GT  Y+  E L  
Sbjct: 159 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSK 213
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
           K  S +VDV+  G +++ L  G   ++ +   E +L+    +YS       + K+  P+ 
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS-------IPKHINPVA 266
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            ++        ++  + +P  RP + ++ N
Sbjct: 267 ASLI-------QKMLQTDPTARPTINELLN 289

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N ++ L +LGKG FG V   V EK T     +++ + +  V    + +   +L E +
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVIL-VKEKATGRYYAMKILKKEVIV---AKDEVAHTLTENR 62
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----EDRLLMKKNTPSLLWTQRL 255
            L + RH  +  L    F+T  + C V  Y   G L      +R+  +          R 
Sbjct: 63  VLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RF 114
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           + A+  S  L +LHS E  +++ D+K  N++L+      I DFGL +EG  + AT   +K
Sbjct: 115 YGAEIVS-ALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MK 169
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              GT  YL  E L        VD +G G+V++E+  G
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 207

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 122/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 110
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 111 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A +    R  G  
Sbjct: 171 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYY---RKGGCA 223
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 224 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 278
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 279 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 329
Query: 437 TLPV 440
            LP+
Sbjct: 330 ALPI 333

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 129/280 (46%), Gaps = 30/280 (10%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           +L   ++D L ++G+G +  V     +KT     + V K E+  +D   E ++  Q E+ 
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKH 57
Query: 197 LRELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
           + E     +  H  ++ L+  CF+T  +   V  Y+  G L   +  ++  P      R 
Sbjct: 58  VFE----QASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARF 110
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHIT 313
           + A+  SL L +LH R   +I+ D+K  N+LL+      + D+G+ +EG  P +  +   
Sbjct: 111 YSAE-ISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC 167
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
                GT  Y+  E L G+     VD +  G+++FE+  G   +D    S+       ++
Sbjct: 168 -----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQ 217
Query: 374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER 413
            +E+ ++ ++ +    I  +++     + K    ++PKER
Sbjct: 218 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/281 (19%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 152 ILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++G G FG V  G  +     +  +A+K L+    ++        QR   L E   +   
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--------QRRDFLSEASIMGQF 65
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H N++ L G+  ++    ++  +M NGSL+    +++N       Q + + +G + G++
Sbjct: 66  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YL 324
           +L       +H  + + NIL+N ++   + DFGL++    + +       + G  P  + 
Sbjct: 124 YLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
             E +  ++ ++  DV+ +GIV++E+ + G R Y D               + +++ + +
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------------TNQDVINAI 227
Query: 384 DKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           +++ + P  ++   A  ++     +++   RP+  Q+ N L
Sbjct: 228 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 122/304 (40%), Gaps = 42/304 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS----LRELKYLNSCRH 208
           LG G FG VY+G           L+V     AV+TL +   EQ     L E   ++   H
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQV-----AVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLG 264
            NI+   G+  ++    ++   M  G L+  L   +  PS    L     LH+A+  + G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            Q+L       IH DI + N LL          IGDFG+ ++  I +A +    R  G  
Sbjct: 194 CQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYY---RKGGCA 246
Query: 322 ----PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSE 376
                ++P E  +    ++K D + FG++L+E+ + G   Y      E     ++E  + 
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFVTS 301
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP 436
               D       P+        +RI  Q  +  P++RP    +   +     + P+    
Sbjct: 302 GGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAIILERIEYC-TQDPDVINT 352
Query: 437 TLPV 440
            LP+
Sbjct: 353 ALPI 356

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 44/246 (17%)
Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR 198
           E +L  +N   L ++G+G +G VYKG  ++  +AVK          +   N         
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKN--------- 57
Query: 199 ELKYLNSCRHDNILP-LYGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
            +  +    HDNI   + G    T     +Y LV  Y PNGSL   L +  +     W  
Sbjct: 58  -IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVS 112
Query: 254 RLHIAKGTSLGLQFLHSR-------EPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--- 303
              +A   + GL +LH+        +P + H D+ S N+L+ +    VI DFGL+     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 304 ----GPIEKATHITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFELAT 352
                P E+  +  +  V GT  Y+  E L G       +    +VD+Y  G++ +E+  
Sbjct: 173 NRLVRPGEE-DNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF- 229
Query: 353 GMRAYD 358
            MR  D
Sbjct: 230 -MRCTD 234

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 149 KLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+  LG+G FG V    ++ T       +AVK L+        E      R    RE++ 
Sbjct: 12  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK--------EGCGPQLRSGWQREIEI 63
Query: 203 LNSCRHDNILPLYGICFETGKYC--LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H++I+   G C + G+    LV  Y+P GSL D L   ++   L   Q L  A+ 
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGL--AQLLLFAQQ 119
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +LH++    IH  + + N+LL++     IGDFGL +  P  +       R +G 
Sbjct: 120 ICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGD 175
Query: 321 RP---YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
            P   Y P E L   +     DV+ FG+ L+EL T    Y D+ +S
Sbjct: 176 SPVFWYAP-ECLKECKFYYASDVWSFGVTLYELLT----YCDSNQS 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 149 KLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+  LG+G FG V    ++ T       +AVK L+        E      R    RE++ 
Sbjct: 13  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK--------EGCGPQLRSGWQREIEI 64
Query: 203 LNSCRHDNILPLYGICFETGKYC--LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H++I+   G C + G+    LV  Y+P GSL D L   ++   L   Q L  A+ 
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGL--AQLLLFAQQ 120
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +LH++    IH  + + N+LL++     IGDFGL +  P  +       R +G 
Sbjct: 121 ICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGD 176
Query: 321 RP---YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
            P   Y P E L   +     DV+ FG+ L+EL T    Y D+ +S
Sbjct: 177 SPVFWYAP-ECLKECKFYYASDVWSFGVTLYELLT----YCDSNQS 217

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +  +T +AVK L+      +V+          L E   + + +HD +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQAF--------LEEANLMKTLQHDKL 70
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +        ++  YM  GSL D L   +    LL  + +  +   + G+ ++  +
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIERK 129
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++AN+L++  +   I DFGL +   IE   +   +       +   E +  
Sbjct: 130 N--YIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINF 185
Query: 332 KRLSTKVDVYGFGIVLFELAT 352
              + K DV+ FGI+L+E+ T
Sbjct: 186 GCFTIKSDVWSFGILLYEIVT 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 103/244 (42%), Gaps = 17/244 (6%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             +WD +  LG+G  G V   V   T   +AVK +++ R   AV+     ++E  +   K
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICIN--K 59
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            LN   H+N++  YG   E     L   Y   G L DR+      P     +  H     
Sbjct: 60  MLN---HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH---QL 113
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             G+ +LH     + H DIK  N+LL+   +  I DFGL           + L ++ GT 
Sbjct: 114 MAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-LNKMCGTL 170
Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
           PY+  E L  +    + VDV+  GIVL  +  G   +D    S +      EK +  N +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230
Query: 381 DLVD 384
             +D
Sbjct: 231 KKID 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 129/280 (46%), Gaps = 30/280 (10%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           +L   ++D L ++G+G +  V     +KT     + V K E+  +D   E ++  Q E+ 
Sbjct: 16  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKH 72
Query: 197 LRELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
           + E     +  H  ++ L+  CF+T  +   V  Y+  G L   +  ++  P      R 
Sbjct: 73  VFE----QASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE--EHARF 125
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHIT 313
           + A+  SL L +LH R   +I+ D+K  N+LL+      + D+G+ +EG  P +  +   
Sbjct: 126 YSAE-ISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC 182
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
                GT  Y+  E L G+     VD +  G+++FE+  G   +D    S+       ++
Sbjct: 183 -----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQ 232
Query: 374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER 413
            +E+ ++ ++ +    I  +++     + K    ++PKER
Sbjct: 233 NTEDYLFQVILEKQIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 35/239 (14%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +N++  +++G+G +G VY   ++K   A K + + + +R  E L  C+R   LRE+  LN
Sbjct: 28  DNYEIKHLIGRGSYGYVYLA-YDKN--ANKNVAIKKVNRMFEDLIDCKR--ILREITILN 82
Query: 205 SCRHDNILPLYGICF--ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH-IAKGT 261
             + D I+ L+ +    +  K+  +Y  +     + + L K  TP  L  Q +  I    
Sbjct: 83  RLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFK--TPIFLTEQHVKTILYNL 140
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT-------- 313
            LG +F+H  E  +IH D+K AN LLN      I DFGL +    +K  HI         
Sbjct: 141 LLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 314 --------------LKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
                         L     TR Y  P   L+ +  +  +D++  G +  EL   M+++
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSH 257

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 149 KLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           K+  LG+G FG V    ++ T       +AVK L+     +         R    +E+  
Sbjct: 18  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQ--------HRSGWKQEIDI 69
Query: 203 LNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           L +  H++I+   G C + G+  L  V  Y+P GSL D L       S+   Q L  A+ 
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQ 125
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              G+ +LH++    IH ++ + N+LL++     IGDFGL +  P  +       R +G 
Sbjct: 126 ICEGMAYLHAQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVP--EGHEYYRVREDGD 181
Query: 321 RP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            P   Y P E L   +     DV+ FG+ L+EL T
Sbjct: 182 SPVFWYAP-ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 20/237 (8%)
Query: 122 PLTPMNVLGGTPHIPYQELT-LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHR 180
           P + M+ L  TP +  Q  T + ++ +    +LGKG FG V   +  K  I  ++  V  
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKV 58
Query: 181 -NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDR 239
            + R V+   +  +E  LRE++ L    H NI+ LY    + G + LV      G L D 
Sbjct: 59  ISKRQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE 116
Query: 240 LLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IG 296
           ++ +K    +       I +    G+ ++H  +  ++H D+K  N+LL          I 
Sbjct: 117 IISRKRFSEV---DAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRII 171
Query: 297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           DFGL+      K     +K   GT  Y+  E L G     K DV+  G++L+ L +G
Sbjct: 172 DFGLSTHFEASKK----MKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 145 NNWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            +++ +  LG+GGFG V+  K   +    A+K++ +   + A        RE+ +RE+K 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--------REKVMREVKA 56
Query: 203 LNSCRHDNILPLYGICFETG-------KYCLVYRYMP-----NGSLEDRLLMKKNTPSLL 250
           L    H  I+  +    E             VY Y+        +L+D +  +       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEK 308
            +  LHI    +  ++FLHS+   L+H D+K +NI     MD V+  GDFGL      ++
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDE 172
Query: 309 ATHITLKRVN---------GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
                L  +          GT+ Y+  E + G   S KVD++  G++LFEL
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSL 197
           L  +N++ + +LGKG FG V     ++T     + V K +V   D  VE         ++
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC--------TM 71
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            E + L+  R+   L     CF+T  +   V  ++  G L     ++K+        R +
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY 129
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+  S  L FLH +   +I+ D+K  N+LL+H     + DFG+ +EG     T  T   
Sbjct: 130 AAEIIS-ALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-- 184
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
             GT  Y+  E L        VD +  G++L+E+  G   ++
Sbjct: 185 -CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/279 (23%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSL 197
           L   ++D L ++G+G +  V     +KT     + V K E+  +D   E ++  Q E+ +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---EDIDWVQTEKHV 62
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            E     +  H  ++ L+  CF+T  +   V  Y+  G L   +  ++  P      R +
Sbjct: 63  FE----QASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE--HARFY 115
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
            A+  SL L +LH R   +I+ D+K  N+LL+      + D+G+ +EG  P +  +    
Sbjct: 116 SAE-ISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC- 171
Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
               GT  Y+  E L G+     VD +  G+++FE+  G   +D    S+       ++ 
Sbjct: 172 ----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-----DQN 222
Query: 375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER 413
           +E+ ++ ++ +    I  +++     + K    ++PKER
Sbjct: 223 TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 151 NILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           N+LGKG F  VY+   +     +A+K ++     +A+      QR Q+  E+K     +H
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMID----KKAMYKAGMVQRVQN--EVKIHCQLKH 70
Query: 209 DNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
            +IL LY   FE   Y  LV     NG + +R L  +  P     +  H       G+ +
Sbjct: 71  PSILELYNY-FEDSNYVYLVLEMCHNGEM-NRYLKNRVKP-FSENEARHFMHQIITGMLY 127
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LHS    ++H D+  +N+LL  +M+  I DFGL  +  +    H TL    GT  Y+  E
Sbjct: 128 LHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CGTPNYISPE 182
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
                    + DV+  G + + L  G   +D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 153 LGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+ G +  +T +AVK L+      +V+          L E   + + +HD +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK--PGTMSVQAF--------LEEANLMKTLQHDKL 69
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +  +     ++  +M  GSL D L   +    LL  + +  +   + G+ ++  +
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIERK 128
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++AN+L++  +   I DFGL +   IE   +   +       +   E +  
Sbjct: 129 N--YIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINF 184
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
              + K +V+ FGI+L+E+ T  +     R +   + +L + Y    M +  D+      
Sbjct: 185 GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDE------ 238
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                  + I K   K+  +ERP    + ++L 
Sbjct: 239 ------LYDIMKMCWKEKAEERPTFDYLQSVLD 265

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 29/273 (10%)
Query: 153 LGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+   + K T +AVK ++      +VE          L E   + + +HD +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAF--------LAEANVMKTLQHDKL 72
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +  +   Y ++  +M  GSL D L   + +   L  + +  +   + G+ F+  R
Sbjct: 73  VKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL-PKLIDFSAQIAEGMAFIEQR 130
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E +  
Sbjct: 131 N--YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINF 186
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
              + K DV+ FGI+L E+ T  R       +   +++L   Y              P  
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------MPRP 234
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
            N     + I  +  K  P+ERP    + ++L 
Sbjct: 235 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 78
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 79  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 134
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 135 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IXETDXXR 189
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 250 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 284

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 40/246 (16%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +N+   +++G+G +G VY   ++K T   +A+KK+     +R  E L  C+R   LRE+ 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLA-YDKNTEKNVAIKKV-----NRMFEDLIDCKR--ILREIT 77
Query: 202 YLNSCRHDNILPLYGICF--ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH-IA 258
            LN  + D I+ LY +    +  K+  +Y  +     + + L K  TP  L  + +  I 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK--TPIFLTEEHIKTIL 135
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT----- 313
               LG  F+H  E  +IH D+K AN LLN      + DFGL +    EK T+I      
Sbjct: 136 YNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 314 --------------LKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY- 357
                         L     TR Y  P   L+ +  +  +D++  G +  EL   ++++ 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253
Query: 358 -DDTRR 362
            D T R
Sbjct: 254 NDPTNR 259

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 29/272 (10%)
Query: 153 LGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+   + K T +AVK ++      +VE          L E   + + +HD +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAF--------LAEANVMKTLQHDKL 245
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +  +   Y ++  +M  GSL D L   + +   L  + +  +   + G+ F+  R
Sbjct: 246 VKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL-PKLIDFSAQIAEGMAFIEQR 303
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG 331
               IH D+++ANIL++  +   I DFGL +   IE   +   +       +   E +  
Sbjct: 304 N--YIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 332 KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIE 391
              + K DV+ FGI+L E+ T  R       +   +++L   Y              P  
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------MPRP 407
Query: 392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            N     + I  +  K  P+ERP    + ++L
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 131/320 (40%), Gaps = 50/320 (15%)
Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYK----GVWEKTTI---AVKKLEVHRNDRAV 185
            +PY E      NN      LG G FG V +    G+ ++  +   AVK L+        
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-------- 85
Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK 244
            T +  ++E  + ELK ++   +H+NI+ L G C   G   ++  Y   G L + L  K 
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 245 NT-----------PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP 293
                         +L     LH +   + G+ FL S+    IH D+ + N+LL +    
Sbjct: 146 RVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA 203
Query: 294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL-AT 352
            IGDFGL ++  +  + +I          ++  E +     + + DV+ +GI+L+E+ + 
Sbjct: 204 KIGDFGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 353 GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA---FFRIGKQSTKQN 409
           G+  Y     + +  K + + Y          + AQP     A+A    + I +      
Sbjct: 263 GLNPYPGILVNSKFYKLVKDGY----------QMAQP-----AFAPKNIYSIMQACWALE 307
Query: 410 PKERPEMTQVYNMLSGSGGE 429
           P  RP   Q+ + L     E
Sbjct: 308 PTHRPTFQQICSFLQEQAQE 327

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 128/269 (47%), Gaps = 35/269 (13%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           + +L  +G+G +G V   Y  V  KT +A+KK+         E    CQR  +LRE++ L
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHV-RKTRVAIKKIS------PFEHQTYCQR--TLREIQIL 95
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+N++ +  I   +    +   Y+    ++D  LM+ +   LL +Q+L   HI   
Sbjct: 96  LRFRHENVIGIRDILRASTLEAMRDVYI----VQD--LMETDLYKLLKSQQLSNDHICYF 149
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+L+N   D  I DFGL +    E      L   
Sbjct: 150 LYQILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSER--HLKSLVEKY 374
             TR Y   E ++  +  TK +D++  G +L E+ +    +      ++  H+  ++   
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 267
Query: 375 SEENMYDLVDKNAQ------PIELNIAYA 397
           S+E++  +++  A+      P +  +A+A
Sbjct: 268 SQEDLNCIINMKARNYLQSLPSKTKVAWA 296

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 132/320 (41%), Gaps = 50/320 (15%)
Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYK----GVWEKTTI---AVKKLEVHRNDRAV 185
            +PY E      NN      LG G FG V +    G+ ++  +   AVK L+        
Sbjct: 34  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-------- 85
Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK- 243
            T +  ++E  + ELK ++   +H+NI+ L G C   G   ++  Y   G L + L  K 
Sbjct: 86  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 244 ---KNTPSLLWTQR-------LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP 293
              +  P+             LH +   + G+ FL S+    IH D+ + N+LL +    
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVA 203
Query: 294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL-AT 352
            IGDFGL ++  +  + +I          ++  E +     + + DV+ +GI+L+E+ + 
Sbjct: 204 KIGDFGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 353 GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA---FFRIGKQSTKQN 409
           G+  Y     + +  K + + Y          + AQP     A+A    + I +      
Sbjct: 263 GLNPYPGILVNSKFYKLVKDGY----------QMAQP-----AFAPKNIYSIMQACWALE 307
Query: 410 PKERPEMTQVYNMLSGSGGE 429
           P  RP   Q+ + L     E
Sbjct: 308 PTHRPTFQQICSFLQEQAQE 327

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 20/234 (8%)
Query: 125 PMNVLGGTPHIPYQELT-LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHR-ND 182
           P + L  TP +  Q  T + ++ +    +LGKG FG V   +  K  I  ++  V   + 
Sbjct: 28  PGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISK 84
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           R V+   +  +E  LRE++ L    H NI+ LY    + G + LV      G L D ++ 
Sbjct: 85  RQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 142
Query: 243 KKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFG 299
           +K    +       I +    G+ ++H  +  ++H D+K  N+LL          I DFG
Sbjct: 143 RKRFSEV---DAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG 197
Query: 300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           L+      K     +K   GT  Y+  E L G     K DV+  G++L+ L +G
Sbjct: 198 LSTHFEASK----KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 84
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M  N     PSL  ++ 
Sbjct: 85  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL--SKM 140
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 141 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYR 195
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 256 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 84
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 85  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 140
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 141 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYR 195
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 256 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 290

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 39/296 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            ++K+  +G+G +G V+K     T   +A+KK     +D  ++ +       +LRE++ L
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI-------ALREIRML 56
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              +H N++ L  +     +  LV+ Y  +  L +    ++  P  L      I   T  
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS---ITWQTLQ 113
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKATHITLKRVNGTR 321
            + F H      IH D+K  NIL+  H    + DFG  +   GP +            TR
Sbjct: 114 AVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-----ATR 166
Query: 322 PYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAY------DDTRRSERHLKSLVEKY 374
            Y   E LVG  +    VDV+  G V  EL +G+  +      D      + L  L+ ++
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 375 SE---ENMY----DLVD-KNAQPIEL---NIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +    N Y     + D ++ +P+EL   NI+Y    + K     +P ER    Q+
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 78/323 (24%), Positives = 132/323 (40%), Gaps = 59/323 (18%)
Query: 134 HIPYQE-LTLATNNWDKLNILGKGGFGTVYK----GVWEKTTI---AVKKLEVHRNDRAV 185
            +PY E      NN      LG G FG V +    G+ ++  +   AVK L+        
Sbjct: 19  QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-------- 70
Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK 244
            T +  ++E  + ELK ++   +H+NI+ L G C   G   ++  Y   G L + L  K 
Sbjct: 71  STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKA 130
Query: 245 NT---PSLLWTQR-----------------LHIAKGTSLGLQFLHSREPPLIHGDIKSAN 284
                PSL   Q                  LH +   + G+ FL S+    IH D+ + N
Sbjct: 131 EAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARN 188
Query: 285 ILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFG 344
           +LL +     IGDFGL ++  +  + +I          ++  E +     + + DV+ +G
Sbjct: 189 VLLTNGHVAKIGDFGLARD-IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 247
Query: 345 IVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYA---FFR 400
           I+L+E+ + G+  Y     + +  K + + Y          + AQP     A+A    + 
Sbjct: 248 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGY----------QMAQP-----AFAPKNIYS 292
Query: 401 IGKQSTKQNPKERPEMTQVYNML 423
           I +      P  RP   Q+ + L
Sbjct: 293 IMQACWALEPTHRPTFQQICSFL 315

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 20/234 (8%)
Query: 125 PMNVLGGTPHIPYQELT-LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHR-ND 182
           P + L  TP +  Q  T + ++ +    +LGKG FG V   +  K  I  ++  V   + 
Sbjct: 29  PGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISK 85
Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           R V+   +  +E  LRE++ L    H NI+ LY    + G + LV      G L D ++ 
Sbjct: 86  RQVK--QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 143
Query: 243 KKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFG 299
           +K    +       I +    G+ ++H  +  ++H D+K  N+LL          I DFG
Sbjct: 144 RKRFSEV---DAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFG 198
Query: 300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           L+      K     +K   GT  Y+  E L G     K DV+  G++L+ L +G
Sbjct: 199 LSTHFEASK----KMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 19/232 (8%)
Query: 146 NWDKLNILGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V   + +     +AVK ++  +       LN    ++  RE++  
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQ-------LNSSSLQKLFREVRIX 67
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L+ +        LV  Y   G + D L+            R    +  S 
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKE--KEARAKFRQIVS- 124
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            +Q+ H +   ++H D+K+ N+LL+   +  I DFG + E          L    G  PY
Sbjct: 125 AVQYCHQK--FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN----KLDAFCGAPPY 178
Query: 324 LPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
              E   GK+    +VDV+  G++L+ L +G   +D     E   + L  KY
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 230

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 77
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 78  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 133
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 134 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDI---YETDYYR 188
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 249 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 283

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 51/306 (16%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG G FG V +             T+AVK L+         + +  +RE  + ELK L+ 
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--------PSAHLTEREALMSELKVLSY 98
Query: 206 C-RHDNILPLYGICFETGKYCLVYRYMPNGSL-------EDRLLMKKNTPSLLWTQRL-- 255
              H NI+ L G C   G   ++  Y   G L        D  +  K +P+++    L  
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 256 ------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                   +   + G+ FL S+    IH D+ + NILL H     I DFGL ++  I+  
Sbjct: 159 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARD--IKND 214
Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERH 366
           ++  +K  N   P  ++  E +     + + DV+ +GI L+EL + G   Y       + 
Sbjct: 215 SNYVVKG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS 426
            K + E +       ++     P E+      + I K     +P +RP   Q+  ++   
Sbjct: 274 YKMIKEGFR------MLSPEHAPAEM------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 321
Query: 427 GGESPN 432
             ES N
Sbjct: 322 ISESTN 327

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 51/306 (16%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG G FG V +             T+AVK L+         + +  +RE  + ELK L+ 
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--------PSAHLTEREALMSELKVLSY 100
Query: 206 C-RHDNILPLYGICFETGKYCLVYRYMPNGSL-------EDRLLMKKNTPSLLWTQRL-- 255
              H NI+ L G C   G   ++  Y   G L        D  +  K +P+++    L  
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 256 ------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                   +   + G+ FL S+    IH D+ + NILL H     I DFGL ++  I+  
Sbjct: 161 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARD--IKND 216
Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERH 366
           ++  +K  N   P  ++  E +     + + DV+ +GI L+EL + G   Y       + 
Sbjct: 217 SNYVVKG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 275
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS 426
            K + E +       ++     P E+      + I K     +P +RP   Q+  ++   
Sbjct: 276 YKMIKEGFR------MLSPEHAPAEM------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 323
Query: 427 GGESPN 432
             ES N
Sbjct: 324 ISESTN 329

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 71
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 72  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 127
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 128 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYR 182
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 243 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 277

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
            + RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 131
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 132 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 128/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 74
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-----LMKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M  N     PSL  ++ 
Sbjct: 75  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL--SKM 130
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 131 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYR 185
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 245
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 246 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 280

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 77
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 78  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 133
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 134 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYR 188
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 248
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 249 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 283

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 78
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 79  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 134
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 135 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYR 189
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 249
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 250 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 284

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 51/306 (16%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG G FG V +             T+AVK L+         + +  +RE  + ELK L+ 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--------PSAHLTEREALMSELKVLSY 82
Query: 206 C-RHDNILPLYGICFETGKYCLVYRYMPNGSL-------EDRLLMKKNTPSLLWTQRL-- 255
              H NI+ L G C   G   ++  Y   G L        D  +  K +P+++    L  
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 256 ------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                   +   + G+ FL S+    IH D+ + NILL H     I DFGL ++  I+  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARD--IKND 198
Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERH 366
           ++  +K  N   P  ++  E +     + + DV+ +GI L+EL + G   Y       + 
Sbjct: 199 SNYVVKG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS 426
            K + E +       ++     P E+      + I K     +P +RP   Q+  ++   
Sbjct: 258 YKMIKEGFR------MLSPEHAPAEM------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 427 GGESPN 432
             ES N
Sbjct: 306 ISESTN 311

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 51/306 (16%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG G FG V +             T+AVK L+         + +  +RE  + ELK L+ 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--------PSAHLTEREALMSELKVLSY 105
Query: 206 C-RHDNILPLYGICFETGKYCLVYRYMPNGSL-------EDRLLMKKNTPSLLWTQRL-- 255
              H NI+ L G C   G   ++  Y   G L        D  +  K +P+++    L  
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 256 ------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                   +   + G+ FL S+    IH D+ + NILL H     I DFGL ++  I+  
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARD--IKND 221
Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERH 366
           ++  +K  N   P  ++  E +     + + DV+ +GI L+EL + G   Y       + 
Sbjct: 222 SNYVVKG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS 426
            K + E +       ++     P E+      + I K     +P +RP   Q+  ++   
Sbjct: 281 YKMIKEGFR------MLSPEHAPAEM------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 328
Query: 427 GGESPN 432
             ES N
Sbjct: 329 ISESTN 334

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 113/274 (41%), Gaps = 43/274 (15%)
Query: 153 LGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G FG V+   + K T +AVK ++      +VE          L E   + + +HD +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK--PGSMSVEAF--------LAEANVMKTLQHDKL 239
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +  +   Y ++  +M  GSL D L   + +   L  + +  +   + G+ F+  R
Sbjct: 240 VKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL-PKLIDFSAQIAEGMAFIEQR 297
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFL 329
               IH D+++ANIL++  +   I DFGL               RV    P  +   E +
Sbjct: 298 N--YIHRDLRAANILVSASLVCKIADFGLA--------------RVGAKFPIKWTAPEAI 341
Query: 330 VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP 389
                + K DV+ FGI+L E+ T  R       +   +++L   Y              P
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------MP 389
Query: 390 IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              N     + I  +  K  P+ERP    + ++L
Sbjct: 390 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++++   ++G G    V       +K  +A+K++ + +   +++ L        L+E++ 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--------LKEIQA 66
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED---RLLMKKNTPSLLWTQR--LHI 257
           ++ C H NI+  Y       +  LV + +  GS+ D    ++ K    S +  +     I
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +    GL++LH      IH D+K+ NILL       I DFG++    +     IT  +V
Sbjct: 127 LREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGDITRNKV 182
Query: 318 N----GTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAY 357
                GT  ++  E +   R    K D++ FGI   ELATG   Y
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 75
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 76  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 131
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 132 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYR 186
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 246
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 247 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 281

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC--RHDN 210
           +GKG +G V+ G W    +AVK                 +     RE +   +   RH+N
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVK------------VFFTTEEASWFRETEIYQTVLMRHEN 92
Query: 211 ILPLYGICFE-TGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           IL       + TG +    L+  Y  NGSL D L     + +L     L +A  +  GL 
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 267 FLHSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-------TQEGPIEKATHIT 313
            LH+       +P + H D+KS NIL+  +    I D GL       T E  I   T + 
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV- 207
Query: 314 LKRVNGTRPYLPHEFLVGK------RLSTKVDVYGFGIVLFELA 351
                GT+ Y+P E L         +     D+Y FG++L+E+A
Sbjct: 208 -----GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 106
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 107 FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 162
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 163 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IYETDYYR 217
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 277
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N     F + +   + NPK RP   ++
Sbjct: 278 G-------GLLDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEI 312

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
            + RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 131
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 132 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 190 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 56
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 110
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 111 QLLQGLSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 165
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 54
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 108
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +
Sbjct: 109 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 166
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 63
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 117
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 118 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 172
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 173 --TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 75
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 129
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 130 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 56
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 110
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 111 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 165
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 55
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 109
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 164
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 165 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 60
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 114
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 115 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 169
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 56
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 110
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 111 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 165
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 --TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 55
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 109
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 164
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 165 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 75
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 129
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 130 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++++   ++G G    V       +K  +A+K++ + +   +++ L        L+E++ 
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--------LKEIQA 61
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED---RLLMKKNTPSLLWTQR--LHI 257
           ++ C H NI+  Y       +  LV + +  GS+ D    ++ K    S +  +     I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +    GL++LH      IH D+K+ NILL       I DFG++    +     IT  +V
Sbjct: 122 LREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGDITRNKV 177
Query: 318 N----GTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAY 357
                GT  ++  E +   R    K D++ FGI   ELATG   Y
Sbjct: 178 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 29/229 (12%)
Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           + LG G FG V  G  + T   +AVK L    N + + +L+   + +  RE++ L   RH
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKIL----NRQKIRSLDVVGKIK--REIQNLKLFRH 70
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            +I+ LY +      + +V  Y+  G L D  + K      +  +RL     +++     
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEKATHITLKRVNGTRPYLP 325
           H     ++H D+K  N+LL+ HM+  I DFGL+    +G         L+   G+  Y  
Sbjct: 130 HM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-------LRTSCGSPNYAA 178
Query: 326 HEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
            E + G+  +  +VD++  G++L+ L  G   +DD      H+ +L +K
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-----EHVPTLFKK 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 75
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 129
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 130 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 63
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 117
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 118 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 172
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 173 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              RH+NI+ +  I        +   Y+    +E  L     T  L      +       
Sbjct: 78  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y
Sbjct: 138 GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 324 LPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
              E ++  +  TK +D++  G +L E+ +
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 56
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 110
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +   
Sbjct: 111 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--- 165
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS-----LRELKYLNSC 206
           +LGKG FG V K           K  + + + AV+ +N+   +       LRE++ L   
Sbjct: 29  MLGKGSFGEVLKC----------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L+ I  ++  + +V      G L D ++ +K            I K    G+ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGIT 135
Query: 267 FLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           ++H     ++H D+K  NILL       D  I DFGL+     ++ T   +K   GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTK--MKDRIGTAYY 189
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +  E L G     K DV+  G++L+ L +G
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 75
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 129
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 130 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 51/306 (16%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG G FG V +             T+AVK L+         + +  +RE  + ELK L+ 
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--------PSAHLTEREALMSELKVLSY 105
Query: 206 C-RHDNILPLYGICFETGKYCLVYRYMPNGSL-------EDRLLMKKNTPSLLWTQRL-- 255
              H NI+ L G C   G   ++  Y   G L        D  +  K +P+++    L  
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 256 ------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                   +   + G+ FL S+    IH D+ + NILL H     I DFGL +   I+  
Sbjct: 166 DLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARH--IKND 221
Query: 310 THITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERH 366
           ++  +K  N   P  ++  E +     + + DV+ +GI L+EL + G   Y       + 
Sbjct: 222 SNYVVKG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS 426
            K + E +       ++     P E+      + I K     +P +RP   Q+  ++   
Sbjct: 281 YKMIKEGFR------MLSPEHAPAEM------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 328
Query: 427 GGESPN 432
             ES N
Sbjct: 329 ISESTN 334

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 95
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 149
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 150 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 29/229 (12%)
Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           + LG G FG V  G  + T   +AVK L    N + + +L+   + +  RE++ L   RH
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKIL----NRQKIRSLDVVGKIK--REIQNLKLFRH 70
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            +I+ LY +      + +V  Y+  G L D  + K      +  +RL     +++     
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFD-YICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEKATHITLKRVNGTRPYLP 325
           H     ++H D+K  N+LL+ HM+  I DFGL+    +G         L+   G+  Y  
Sbjct: 130 HM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-------LRDSCGSPNYAA 178
Query: 326 HEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
            E + G+  +  +VD++  G++L+ L  G   +DD      H+ +L +K
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-----EHVPTLFKK 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 129/289 (44%), Gaps = 49/289 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 69
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 70  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 125
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T++      T    
Sbjct: 126 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRD---IXETDXXR 180
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 240
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                    L+DK       N       + +   + NPK RP   ++ +
Sbjct: 241 G-------GLLDKPD-----NCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 56
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++      D+ L K    S L    L + K 
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEHV------DQDLKKFMDASALTGIPLPLIKS 110
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 111 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 83
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 84  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 137
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 138 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 196 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 75
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI   
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYF 129
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 130 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 188 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 129/299 (43%), Gaps = 44/299 (14%)
Query: 81  QSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKV--SDPLTPMNVLGGTPHIPYQ 138
           Q SV S Q H++ S    +       +E +P  E    V  ++ L P++      +   +
Sbjct: 37  QGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVD------YEYRE 90
Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKK--LEVHRNDRAVETLNQCQRE 194
           E+  AT+       LG+G FG V++   ++T    AVKK  LEV R     E L  C   
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR----AEELMACAGL 142
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
            S R            I+PLYG   E     +    +  GSL    L+K+     L   R
Sbjct: 143 TSPR------------IVPLYGAVREGPWVNIFMELLEGGSLGQ--LVKEQ--GCLPEDR 186
Query: 255 LHIAKGTSL-GLQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFG---LTQEGPIEKA 309
                G +L GL++LHSR   ++HGD+K+ N+LL+       + DFG     Q   + K+
Sbjct: 187 ALYYLGQALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKS 244
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
             +T   + GT  ++  E ++G+    KVDV+    ++  +  G   +    R    LK
Sbjct: 245 L-LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK-- 259
             RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI    
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYFL 134
Query: 260 -GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L    
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 319 GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
            TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 81
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK-- 259
             RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI    
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYFL 135
Query: 260 -GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L    
Sbjct: 136 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 319 GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
            TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 74
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 135 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK-- 259
             RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI    
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYFL 134
Query: 260 -GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L    
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 319 GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
            TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 74
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 135 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 192
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 81
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 142 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 199
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 82
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 142
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 143 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 200
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 73
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 133
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 134 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 191
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC----QREQSLRELKYLNSC 206
            ++GKG FG VY G  E    A  +++      A+++L++     Q E  LRE   +   
Sbjct: 27  RVIGKGHFGVVYHG--EYIDQAQNRIQC-----AIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 207 RHDNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSL 263
            H N+L L GI     G   ++  YM +G L   +   +  P++  L +  L +A+G   
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG--- 136
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP- 322
            +++L   E   +H D+ + N +L+      + DFGL ++  +++  +   +  +   P 
Sbjct: 137 -MEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPV 192
Query: 323 -YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            +   E L   R +TK DV+ FG++L+EL T
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS-----LRELKYLNSC 206
           +LGKG FG V K           K  + + + AV+ +N+   +       LRE++ L   
Sbjct: 29  MLGKGSFGEVLKC----------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L+ I  ++  + +V      G L D ++ +K            I K    G+ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGIT 135
Query: 267 FLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           ++H     ++H D+K  NILL       D  I DFGL+     ++ T   +K   GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTK--MKDRIGTAYY 189
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +  E L G     K DV+  G++L+ L +G
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQS-----LRELKYLNSC 206
           +LGKG FG V K           K  + + + AV+ +N+   +       LRE++ L   
Sbjct: 29  MLGKGSFGEVLKC----------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L+ I  ++  + +V      G L D ++ +K            I K    G+ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGIT 135
Query: 267 FLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           ++H     ++H D+K  NILL       D  I DFGL+     ++ T   +K   GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTK--MKDRIGTAYY 189
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +  E L G     K DV+  G++L+ L +G
Sbjct: 190 IAPEVLRGT-YDEKCDVWSAGVILYILLSG 218

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  GTVY  +   T   +A++++ + +         Q ++E  + E+  +   ++ N
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPN 78
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+          +  +V  Y+  GSL D +        +   Q   + +     L+FLHS
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
            +  +IH DIKS NILL       + DFG   +   E++   T+    GT  ++  E + 
Sbjct: 135 NQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT 189
Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
            K    KVD++  GI+  E+  G   Y
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 55
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++ +  L+D +     T   L   + ++ + 
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL 114
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVN 318
              GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +    
Sbjct: 115 LQ-GLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---- 167
Query: 319 GTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
            T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 168 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 56
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++ +  L+D +     T   L   + ++ + 
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL 115
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVN 318
              GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +    
Sbjct: 116 LQ-GLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---- 168
Query: 319 GTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
            T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 169 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 53
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++ +  L+D +     T   L   + ++ + 
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL 112
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVN 318
              GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +    
Sbjct: 113 LQ-GLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---- 165
Query: 319 GTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
            T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 56
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++   S++ +  M     S L    L + K 
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDA---SALTGIPLPLIKS 110
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 111 YLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 54
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++   S++ +  M     S L    L + K 
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDA---SALTGIPLPLIKS 108
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 109 YLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + ++ +  +G G +G V       T   +A+KK+       A + +   +R  +LRELK 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-----NAFDVVTNAKR--TLRELKI 106
Query: 203 LNSCRHDNILPLYGICFET---GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L   +HDNI+ +  I   T   G++  VY  +     +   ++  + P  L   R  + +
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ 166
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH-ITLKRVN 318
               GL+++HS +  +IH D+K +N+L+N + +  IGDFG+ +      A H   +    
Sbjct: 167 LLR-GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 319 GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFEL 350
            TR Y   E ++     T+ +D++  G +  E+
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 256

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC--R 207
           L  +GKG +G V++G W+   +AVK     R++++             RE +  N+   R
Sbjct: 13  LECVGKGRYGEVWRGSWQGENVAVKIFS-SRDEKS-----------WFRETELYNTVMLR 60
Query: 208 HDNILPLYGICF----ETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQRLHIAKGTS 262
           H+NIL            + +  L+  Y   GSL D L L   +T S      L I    +
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIA 115
Query: 263 LGLQFLHSR------EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            GL  LH        +P + H D+KS NIL+  +    I D GL     +   +   L  
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDV 172
Query: 317 VN----GTRPYLPHEFL-----VGKRLSTK-VDVYGFGIVLFELATGM 354
            N    GT+ Y+  E L     V    S K VD++ FG+VL+E+A  M
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC--R 207
           L  +GKG +G V++G W+   +AVK     R++++             RE +  N+   R
Sbjct: 13  LECVGKGRYGEVWRGSWQGENVAVKIFS-SRDEKS-----------WFRETELYNTVMLR 60
Query: 208 HDNILPLYGICF----ETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQRLHIAKGTS 262
           H+NIL            + +  L+  Y   GSL D L L   +T S      L I    +
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIA 115
Query: 263 LGLQFLHSR------EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            GL  LH        +P + H D+KS NIL+  +    I D GL     +   +   L  
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDV 172
Query: 317 VN----GTRPYLPHEFL-----VGKRLSTK-VDVYGFGIVLFELATGM 354
            N    GT+ Y+  E L     V    S K VD++ FG+VL+E+A  M
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ------RE 194
            + ++ +    +LGKG FG V           + K ++   + AV+ +++ Q      +E
Sbjct: 28  AIFSDRYKGQRVLGKGSFGEV----------ILCKDKITGQECAVKVISKRQVKQKTDKE 77
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
             LRE++ L    H NI+ LY    + G + LV      G L D ++ +K    +     
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DA 134
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATH 311
             I +    G+ ++H  +  ++H D+K  N+LL          I DFGL+      K   
Sbjct: 135 ARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-- 190
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +K   GT  Y+  E L G     K DV+  G++L+ L +G
Sbjct: 191 --MKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 229

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 42/298 (14%)
Query: 81  QSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKV--SDPLTPMNVLGGTPHIPYQ 138
           Q SV S Q H++ S    +       +E +P  E    V  ++ L P++      +   +
Sbjct: 18  QGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVD------YEYRE 71
Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKK--LEVHRNDRAVETLNQCQRE 194
           E+  AT+       LG+G FG V++   ++T    AVKK  LEV R     E L  C   
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR----AEELMACAGL 123
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
            S R            I+PLYG   E     +    +  GSL     + K    L   + 
Sbjct: 124 TSPR------------IVPLYGAVREGPWVNIFMELLEGGSLGQ---LVKEQGCLPEDRA 168
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFG---LTQEGPIEKAT 310
           L+       GL++LHSR   ++HGD+K+ N+LL+       + DFG     Q   + K  
Sbjct: 169 LYYLGQALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
            +T   + GT  ++  E ++G+    KVDV+    ++  +  G   +    R    LK
Sbjct: 227 -LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + ++ +  +G G +G V       T   +A+KK+       A + +   +R  +LRELK 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-----NAFDVVTNAKR--TLRELKI 107
Query: 203 LNSCRHDNILPLYGICFET---GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L   +HDNI+ +  I   T   G++  VY  +     +   ++  + P  L   R  + +
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH-ITLKRVN 318
               GL+++HS +  +IH D+K +N+L+N + +  IGDFG+ +      A H   +    
Sbjct: 168 LLR-GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 319 GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFEL 350
            TR Y   E ++     T+ +D++  G +  E+
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEM 257

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 53
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 107
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 108 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L+ +G+G +G V   Y  V  K  +A+KK+         E    CQR  +LRE+K L
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKIS------PFEHQTYCQR--TLREIKIL 95
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK- 259
              RH+NI+ +  I        +   Y+         LM  +   LL TQ L   HI   
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYLVTH------LMGADLYKLLKTQHLSNDHICYF 149
Query: 260 --GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L   
Sbjct: 150 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 55
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 109
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 110 YLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A++K+         E    CQR  +LRE+K L 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS------PFEHQTYCQR--TLREIKILL 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L     T  L      +       G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 53
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 107
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 108 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 55
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 109
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 110 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 56
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 110
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 111 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 55
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 56  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 109
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 110 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 53
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 107
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 108 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 54
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 108
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 109 YLFQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+ K+  +G+G +G VYK    K T  V  L   R D   E +       ++RE+  L  
Sbjct: 4   NFQKVEKIGEGTYGVVYKAR-NKLTGEVVALXKIRLDTETEGVPST----AIREISLLKE 58
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL-- 263
             H NI+ L  +     K  LV+ ++         L K    S L    L + K      
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLFQL 112
Query: 264 --GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNG 319
             GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +     
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----- 165
Query: 320 TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
           T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+ K+  +G+G +G VYK    K T  V  L   R D   E +       ++RE+  L  
Sbjct: 3   NFQKVEKIGEGTYGVVYKAR-NKLTGEVVALXKIRLDTETEGVPST----AIREISLLKE 57
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL-- 263
             H NI+ L  +     K  LV+ ++         L K    S L    L + K      
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLFQL 111
Query: 264 --GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNG 319
             GL F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +     
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----- 164
Query: 320 TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
           T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 54
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 55  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 108
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 109 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 57
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 58  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 111
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 112 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 170 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 56
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 110
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 111 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 55
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 109
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +   
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 164
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 165 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 53
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             L    H NI+ L  +     K  LV+ ++         L K    S L    L + K 
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKS 107
Query: 261 TSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITL 314
                  GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +
Sbjct: 108 YLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
                T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 55
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 109
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +   
Sbjct: 110 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 164
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 165 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 43/228 (18%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC--R 207
           L  +GKG +G V++G W+   +AVK     R++++             RE +  N+   R
Sbjct: 42  LECVGKGRYGEVWRGSWQGENVAVKIFS-SRDEKS-----------WFRETELYNTVMLR 89
Query: 208 HDNILPLYGICF----ETGKYCLVYRYMPNGSLEDRL-LMKKNTPSLLWTQRLHIAKGTS 262
           H+NIL            + +  L+  Y   GSL D L L   +T S      L I    +
Sbjct: 90  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIA 144
Query: 263 LGLQFLHSR------EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            GL  LH        +P + H D+KS NIL+  +    I D GL     +   +   L  
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL---AVMHSQSTNQLDV 201
Query: 317 VN----GTRPYLPHEFL-----VGKRLSTK-VDVYGFGIVLFELATGM 354
            N    GT+ Y+  E L     V    S K VD++ FG+VL+E+A  M
Sbjct: 202 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK     R +R+        RE  + +   L   RH+NIL
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFS-SREERS------WFREAEIYQTVML---RHENIL 61
Query: 213 PLYGI-CFETGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                   + G +    LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 62  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 117
Query: 269 HSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 322 PYLPHEFLVG----KRLST--KVDVYGFGIVLFELA 351
            Y+  E L      K   +  + D+Y  G+V +E+A
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK     R +R+        RE  + +   L   RH+NIL
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFS-SREERS------WFREAEIYQTVML---RHENIL 60
Query: 213 PLYGI-CFETGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                   + G +    LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 269 HSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 322 PYLPHEFLVG----KRLST--KVDVYGFGIVLFELA 351
            Y+  E L      K   +  + D+Y  G+V +E+A
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E A  
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 275

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             +D  +++G+G    V + V   T    AVK +EV     + E L +  RE + RE   
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV-REATRRETHI 152
Query: 203 LNSCR-HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
           L     H +I+ L      +    LV+  M  G L D L  K    +L   +   I +  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSL 209
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT-QEGPIEKATHITLKRVNGT 320
              + FLH+    ++H D+K  NILL+ +M   + DFG +    P EK     L+ + GT
Sbjct: 210 LEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-----LRELCGT 262
Query: 321 RPYLPHEFLVGKRLST------KVDVYGFGIVLFELATG 353
             YL  E L      T      +VD++  G++LF L  G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 55
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNG--SLEDRLLMKKNTPSLLWTQRLHIAKGT 261
               H NI+ L  +     K  LV+ ++     +  D   +      L+ +    + +G 
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQG- 114
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVNG 319
              L F HS    ++H D+K  N+L+N      + DFGL +    P+   TH  +     
Sbjct: 115 ---LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----- 164
Query: 320 TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
           T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGV-WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            + KL  +G+G +G VYK    +   +A+K++ +   D  + +        ++RE+  L 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS-------TAIREISLLK 74
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ----RLHIAKG 260
              H NI+ L  +        LV+ +M     + + ++ +N   L  +Q       + +G
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK---DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVN 318
            +      H  +  ++H D+K  N+L+N      + DFGL +    P+   TH  +    
Sbjct: 132 VA------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV---- 181
Query: 319 GTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
            T  Y   + L+G K+ ST VD++  G +  E+ TG
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+  L
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREISLL 57
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++         L K    S L    L + K    
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD------LKKFMDASALTGIPLPLIKSYLF 111
Query: 264 ----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRV 317
               GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +   
Sbjct: 112 QLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--- 166
Query: 318 NGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
             T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 146 NWDKLNILGKGGFGTVYKGV-WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            + KL  +G+G +G VYK    +   +A+K++ +   D  + +        ++RE+  L 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS-------TAIREISLLK 74
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ----RLHIAKG 260
              H NI+ L  +        LV+ +M     + + ++ +N   L  +Q       + +G
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK---DLKKVLDENKTGLQDSQIKIYLYQLLRG 131
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKRVN 318
            +      H  +  ++H D+K  N+L+N      + DFGL +    P+   TH  +    
Sbjct: 132 VA------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV---- 181
Query: 319 GTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
            T  Y   + L+G K+ ST VD++  G +  E+ TG
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK     R +R+        RE  + +   L   RH+NIL
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFS-SREERS------WFREAEIYQTVML---RHENIL 66
Query: 213 PLYGI-CFETGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                   + G +    LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 67  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 122
Query: 269 HSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 322 PYLPHEFLVG----KRLST--KVDVYGFGIVLFELA 351
            Y+  E L      K   +  + D+Y  G+V +E+A
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK     R +R+        RE  + +   L   RH+NIL
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFS-SREERS------WFREAEIYQTVML---RHENIL 63
Query: 213 PLYGI-CFETGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                   + G +    LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 64  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 119
Query: 269 HSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 322 PYLPHEFLVG----KRLST--KVDVYGFGIVLFELA 351
            Y+  E L      K   +  + D+Y  G+V +E+A
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 152 ILGKGGFGTVYKGV---WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-R 207
           +LG G FG V         KT ++++       ++A    +  +RE  + ELK +     
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGS 107
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSL--------------------EDRLLMKKNTP 247
           H+NI+ L G C  +G   L++ Y   G L                    + RL  +++  
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
            L +   L  A   + G++FL  +    +H D+ + N+L+ H     I DFGL ++  + 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKICDFGLARD-IMS 224
Query: 308 KATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            + ++   R N   P  ++  E L     + K DV+ +GI+L+E+ +
Sbjct: 225 DSNYVV--RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           +   +++ L +LGKG FG V     KG  E   + + K +V   D  VE         ++
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC--------TM 389
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            E + L        L     CF+T  +   V  Y+  G L   +   +          + 
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF 446
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A   ++GL FL S+   +I+ D+K  N++L+      I DFG+ +E   +    +T K 
Sbjct: 447 YAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKX 501
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
             GT  Y+  E +  +     VD + FG++L+E+  G   ++     E
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 72
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 73  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E A  
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF 178
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 179 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 231
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 271

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 21/228 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVY----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           +   +++ L +LGKG FG V     KG  E   + + K +V   D  VE         ++
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC--------TM 68
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            E + L        L     CF+T  +   V  Y+  G L   +   +          + 
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVF 125
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A   ++GL FL S+   +I+ D+K  N++L+      I DFG+ +E   +    +T K 
Sbjct: 126 YAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKX 180
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
             GT  Y+  E +  +     VD + FG++L+E+  G   ++     E
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK     R +R+        RE  + +   L   RH+NIL
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFS-SREERS------WFREAEIYQTVML---RHENIL 99
Query: 213 PLYGI-CFETGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                   + G +    LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 155
Query: 269 HSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 322 PYLPHEFLVG----KRLST--KVDVYGFGIVLFELA 351
            Y+  E L      K   +  + D+Y  G+V +E+A
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/300 (20%), Positives = 124/300 (41%), Gaps = 47/300 (15%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+  FG VYKG         +   +A+K L+    D+A   L    RE+   E      
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPL----REEFRHEAMLRAR 85
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----------- 254
            +H N++ L G+  +     +++ Y  +G L + L+M+     +  T             
Sbjct: 86  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 145
Query: 255 --LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
             +H+    + G+++L S    ++H D+ + N+L+   ++  I D GL +E        +
Sbjct: 146 DFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 203
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV 371
               +   R   P   + GK  S   D++ +G+VL+E+ + G++ Y              
Sbjct: 204 LGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYC------------- 249
Query: 372 EKYSEENMYDLV-DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES 430
             YS +++ +++ ++   P   +     + +  +   + P  RP    +++ L   G  S
Sbjct: 250 -GYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNLS 308

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+         E    CQR  +LRE+K L 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS------PFEHQTYCQR--TLREIKILL 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH+NI+ +  I        +   Y+    +E  L        L      +       G
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRG 140
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR Y 
Sbjct: 141 LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 325 PHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
             E ++  +  TK +D++  G +L E+ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 45/292 (15%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 19  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 70
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 71  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 128
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++      T   
Sbjct: 129 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD---IXETDXX 183
Query: 314 LKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV 371
            K   G  P  ++  E L     +T  D++ FG+VL+E+         T  +E+  + L 
Sbjct: 184 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQGL- 233
Query: 372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +E+ +  ++D        N       + +   + NPK RP   ++ N+L
Sbjct: 234 --SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 65  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 121
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 122 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 177
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEI 202

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK     R +R+        RE  + +   L   RH+NIL
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFS-SREERS------WFREAEIYQTVML---RHENIL 86
Query: 213 PLYGI-CFETGKYC---LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                   + G +    LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 87  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 142
Query: 269 HSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 143 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 202
Query: 322 PYLPHEFLVG----KRLST--KVDVYGFGIVLFELA 351
            Y+  E L      K   +  + D+Y  G+V +E+A
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  GTVY  +   T   +A++++ + +         Q ++E  + E+  +   ++ N
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPN 78
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+          +  +V  Y+  GSL D +        +   Q   + +     L+FLHS
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
            +  +IH DIKS NILL       + DFG   +   E++       + GT  ++  E + 
Sbjct: 135 NQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVT 189
Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
            K    KVD++  GI+  E+  G   Y
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 45/292 (15%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 73
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 74  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++      T   
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD---IXETDXX 186
Query: 314 LKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV 371
            K   G  P  ++  E L     +T  D++ FG+VL+E+         T  +E+  + L 
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQGL- 236
Query: 372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +E+ +  ++D        N       + +   + NPK RP   ++ N+L
Sbjct: 237 --SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + ++KL  +G+G FG V+K    KT   +A+KK+ +                 +LRE+K
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-------TALREIK 69
Query: 202 YLNSCRHDNILPLYGICFE--------TGKYCLVYRYMPN--GSLEDRLLMKKNTPSLLW 251
            L   +H+N++ L  IC           G   LV+ +  +    L   +L+K     +  
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 129
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
             ++ +      GL ++H  +  ++H D+K+AN+L+       + DFGL +   + K + 
Sbjct: 130 VMQMLLN-----GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 312 IT--LKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELAT 352
                 RV  T  Y P E L+G+R     +D++G G ++ E+ T
Sbjct: 183 PNRYXNRV-VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ----CQREQSLRELKYLNSCRH 208
           LG G FG+V +GV+        ++   + D A++ L Q       E+ +RE + ++   +
Sbjct: 18  LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQF 267
             I+ L G+C +     LV      G L   L+ K+   P     + LH     S+G+++
Sbjct: 70  PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---QVSMGMKY 125
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YL 324
           L   E   +H D+ + N+LL +     I DFGL++    + + +    R  G  P   Y 
Sbjct: 126 LE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA--RSAGKWPLKWYA 181
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSE 364
           P E +  ++ S++ DV+ +G+ ++E L+ G + Y   +  E
Sbjct: 182 P-ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 73
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 74  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++      T   
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD---IXETDXX 186
Query: 314 LKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            K   G  P  ++  E L     +T  D++ FG+VL+E+ +
Sbjct: 187 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 82
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 83  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 131 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 189 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 241
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 242 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 281

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 69
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 70  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 126
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 127 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 182
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEI 207

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 95
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 96  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 152
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 153 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 208
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEI 233

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           +  N+ K+  +G+G +G VYK   + T   +A+KK+ +      V +        ++RE+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------TAIREI 56
Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNG--SLEDRLLMKKNTPSLLWTQRLHIA 258
             L    H NI+ L  +     K  LV+ ++     +  D   +      L+ +    + 
Sbjct: 57  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEG--PIEKATHITLKR 316
           +    GL F HS    ++H D+K  N+L+N      + DFGL +    P+    H  +  
Sbjct: 117 Q----GLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 317 VNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELAT 352
              T  Y   E L+G K  ST VD++  G +  E+ T
Sbjct: 169 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 73  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 129
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 130 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 185
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEI 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 138 QELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           Q   +  ++ + +  LG+G +G V K   V     +AVK++          T+N  ++++
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--------TVNSQEQKR 95
Query: 196 SLRELKY-LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED---RLLMKKNT-PSLL 250
            L +L   + +      +  YG  F  G   +    M + SL+    +++ K  T P  +
Sbjct: 96  LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDI 154
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
             +   IA      L+ LHS+   +IH D+K +N+L+N      + DFG++  G +  + 
Sbjct: 155 LGK---IAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV 208
Query: 311 HITLKRVNGTRPYLPHEF----LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
             T+    G +PY+  E     L  K  S K D++  GI + ELA     YD      + 
Sbjct: 209 AKTID--AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 266
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
           LK +VE+ S +   D             +  F     Q  K+N KERP
Sbjct: 267 LKQVVEEPSPQLPAD-----------KFSAEFVDFTSQCLKKNSKERP 303

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ--REQSLRELKYL 203
           ++ ++ ++G GGFG V+K               HR D     + + +   E++ RE+K L
Sbjct: 12  DFKEIELIGSGGFGQVFKAK-------------HRIDGKTYVIKRVKYNNEKAEREVKAL 58
Query: 204 NSCRHDNILPLYGICFETGKY---------------CLVYR--YMPNGSLEDRLLMKKNT 246
               H NI+   G C++   Y               CL  +  +   G+LE + + K+  
Sbjct: 59  AKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRG 116
Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
             L     L + +  + G+ ++HS++  LI+ D+K +NI L       IGDFGL      
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           +        R  GT  Y+  E +  +    +VD+Y  G++L EL
Sbjct: 175 DGKRX----RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 70
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 71  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 127
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 128 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 183
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEI 208

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 275

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 49/287 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN------- 204
           LG+G FG VY+GV +       +  V     A++T+N+     S+RE +++LN       
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAA---SMRERIEFLNEASVMKE 71
Query: 205 -SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL-----MKKNT----PSLLWTQR 254
            +C H  ++ L G+  +     ++   M  G L+  L      M+ N     PSL  ++ 
Sbjct: 72  FNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL--SKM 127
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + +A   + G+ +L++ +   +H D+ + N  +       IGDFG+T++      T    
Sbjct: 128 IQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDI---YETDYYR 182
Query: 315 KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
           K   G  P  ++  E L     +T  DV+ FG+VL+E+AT          +E+ L+ ++E
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 242
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    L+DK       N       + +   + NPK RP   ++
Sbjct: 243 G-------GLLDKPD-----NCPDMLLELMRMCWQYNPKMRPSFLEI 277

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 68  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 125 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 180
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEI 205

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 96
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 97  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 145 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 202
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 203 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 255
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 256 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 295

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL-RELKYLNSCRHDNI 211
           LG+G FG V      KT   V    + R     + L +      + RE+ YL   RH +I
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISR-----QLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + LY +        +V  Y   G L D ++ KK        +     +     +++ H  
Sbjct: 72  IKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTE---DEGRRFFQQIICAIEYCHRH 127
Query: 272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---EGPIEKATHITLKRVNGTRPYLPHEF 328
           +  ++H D+K  N+LL+ +++  I DFGL+    +G         LK   G+  Y   E 
Sbjct: 128 K--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-------LKTSCGSPNYAAPEV 178
Query: 329 LVGKRLS-TKVDVYGFGIVLFELATGMRAYDD 359
           + GK  +  +VDV+  GIVL+ +  G   +DD
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 95
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 96  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 143
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 144 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 201
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 202 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 254
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 255 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 294

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 147 WDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G+G +G V        K  +A+KK+    +        Q   +++LRE+K L 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--------QTYXQRTLREIKILL 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAK-- 259
             RH+NI+ +  I        +   Y+    ++D  LM+ +   LL TQ L   HI    
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYI----VQD--LMETDLYKLLKTQHLSNDHICYFL 134
Query: 260 -GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L    
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 319 GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
            TR Y   E ++  +  TK +D++  G +L E+ +
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  GTVY  +   T   +A++++ + +         Q ++E  + E+  +   ++ N
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPN 79
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+          +  +V  Y+  GSL D +        +   Q   + +     L+FLHS
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 135
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
            +  +IH DIKS NILL       + DFG   +   E++       + GT  ++  E + 
Sbjct: 136 NQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVT 190
Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
            K    KVD++  GI+  E+  G   Y
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  GTVY  +   T   +A++++ + +         Q ++E  + E+  +   ++ N
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPN 78
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+          +  +V  Y+  GSL D +        +   Q   + +     L+FLHS
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
            +  +IH DIKS NILL       + DFG   +   E++       + GT  ++  E + 
Sbjct: 135 NQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVT 189
Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
            K    KVD++  GI+  E+  G   Y
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 72
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 73  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 179 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 231
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 271

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 129/297 (43%), Gaps = 55/297 (18%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 73
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 74  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++       + T
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD------IYET 183
Query: 314 LKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
                G +  LP  ++  + L     +T  D++ FG+VL+E+ +          +E+ LK
Sbjct: 184 AYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
Query: 369 SLVEKYSEENMYDLVDKNAQPIE--LNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            +++        D  D   + +   + + + F          NPK RP   ++ N+L
Sbjct: 244 FVMDG----GYLDQPDNCPERVTDLMRMCWQF----------NPKMRPTFLEIVNLL 286

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 68  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 125 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 180
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 447
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 448 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 504
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T+    +      ++ 
Sbjct: 505 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 560
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEI 585

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 42/301 (13%)
Query: 78  LQEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKV--SDPLTPMNVLGGTPHI 135
            Q   SV S Q H++ S    + + +   Q   P  E    V  ++ L P++        
Sbjct: 13  FQGSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-------Y 65
Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTI--AVKK--LEVHRNDRAVETLNQC 191
            Y+E      +  +L   G+G FG V++   ++T    AVKK  LEV R    VE L  C
Sbjct: 66  EYREEVHWMTHQPRL---GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVAC 118
Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
               S R            I+PLYG   E     +    +  GSL   +   K    L  
Sbjct: 119 AGLSSPR------------IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPE 163
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFG---LTQEGPIE 307
            + L+       GL++LH+R   ++HGD+K+ N+LL+       + DFG     Q   + 
Sbjct: 164 DRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 221
Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL 367
           K+  +T   + GT  ++  E ++GK    KVD++    ++  +  G   +    R    L
Sbjct: 222 KSL-LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280
Query: 368 K 368
           K
Sbjct: 281 K 281

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  GTVY  +   T   +A++++ + +         Q ++E  + E+  +   ++ N
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQ---------QPKKELIINEILVMRENKNPN 79
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           I+          +  +V  Y+  GSL D +        +   Q   + +     L+FLHS
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 135
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
            +  +IH +IKS NILL       + DFG   +   E++   T+    GT  ++  E + 
Sbjct: 136 NQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVT 190
Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
            K    KVD++  GI+  E+  G   Y
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPPY 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/297 (19%), Positives = 125/297 (42%), Gaps = 47/297 (15%)
Query: 153 LGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LG+  FG VYKG         +   +A+K L+    D+A   L +  R +++   +    
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK----DKAEGPLREEFRHEAMLRAR---- 68
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----------- 254
            +H N++ L G+  +     +++ Y  +G L + L+M+     +  T             
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 255 --LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
             +H+    + G+++L S    ++H D+ + N+L+   ++  I D GL +E        +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV 371
               +   R   P   + GK  S   D++ +G+VL+E+ + G++ Y              
Sbjct: 187 LGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPY-------------- 231
Query: 372 EKYSEENMYDLV-DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG 427
             YS +++ +++ ++   P   +     + +  +   + P  RP    +++ L   G
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 29/239 (12%)
Query: 130 GGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVET 187
           G +P +P Q        W+    LG GGFG V + + + T   +A+K+          + 
Sbjct: 3   GRSPSLPTQ----TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR--------QE 50
Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC------LVYRYMPNGSLEDRLL 241
           L+   RE+   E++ +    H N++    +     K        L   Y   G L   L 
Sbjct: 51  LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN 110
Query: 242 MKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIGDF 298
             +N   L       +    S  L++LH  E  +IH D+K  NI+L      +   I D 
Sbjct: 111 QFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           G  +E  +++    T     GT  YL  E L  K+ +  VD + FG + FE  TG R +
Sbjct: 169 GYAKE--LDQGELCT--EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + ++KL  +G+G FG V+K    KT   +A+KK+ +                 +LRE+K
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-------TALREIK 68
Query: 202 YLNSCRHDNILPLYGICFE--------TGKYCLVYRYMPN--GSLEDRLLMKKNTPSLLW 251
            L   +H+N++ L  IC           G   LV+ +  +    L   +L+K     +  
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
             ++ +      GL ++H  +  ++H D+K+AN+L+       + DFGL +   + K + 
Sbjct: 129 VMQMLLN-----GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 312 IT--LKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELAT 352
                 RV  T  Y P E L+G+R     +D++G G ++ E+ T
Sbjct: 182 PNRYXNRV-VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  G V     + T   +AVKK+++ +  R         RE    E+  +    HDN
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR---------RELLFNEVVIMRDYHHDN 103
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ +Y       +  +V  ++  G+L D +   +     + T  L + +     L +LH+
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHN 159
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           +   +IH DIKS +ILL       + DFG   +   E       K + GT  ++  E + 
Sbjct: 160 QG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KXLVGTPYWMAPEVIS 214
Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAY 357
                T+VD++  GI++ E+  G   Y
Sbjct: 215 RLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 29/239 (12%)
Query: 130 GGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVET 187
           G +P +P Q        W+    LG GGFG V + + + T   +A+K+          + 
Sbjct: 4   GRSPSLPTQ----TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR--------QE 51
Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC------LVYRYMPNGSLEDRLL 241
           L+   RE+   E++ +    H N++    +     K        L   Y   G L   L 
Sbjct: 52  LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN 111
Query: 242 MKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIGDF 298
             +N   L       +    S  L++LH  E  +IH D+K  NI+L      +   I D 
Sbjct: 112 QFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDL 169
Query: 299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           G  +E  +++    T     GT  YL  E L  K+ +  VD + FG + FE  TG R +
Sbjct: 170 GYAKE--LDQGELCT--EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 55/274 (20%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L   +H+N
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLKHMKHEN 92
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHIAKGTSL 263
           ++ L  +            + P  SLE+         LM  +  +++  Q+L       L
Sbjct: 93  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 140
Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   ++     
Sbjct: 141 IYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----- 193
Query: 318 NGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-------- 368
             TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK        
Sbjct: 194 -ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGT 251
Query: 369 ---SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
               L++K S E+  + +   AQ  ++N A  F 
Sbjct: 252 PGAELLKKISSESARNYIQSLAQMPKMNFANVFI 285

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 149 KLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           K  ILG G FG V+K   E+T   +K        + ++T     +E+   E+  +N   H
Sbjct: 93  KTEILGGGRFGQVHKC--EETATGLKLAA-----KIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            N++ LY          LV  Y+  G L DR++    + +L     +   K    G++ +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICEGIRHM 203
Query: 269 HSREPPLIHGDIKSANIL-LNHHMDPV-IGDFGLTQE-GPIEKATHITLKRVNGTRPYLP 325
           H  +  ++H D+K  NIL +N     + I DFGL +   P EK     LK   GT  +L 
Sbjct: 204 H--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-----LKVNFGTPEFLA 256
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +    +S   D++  G++ + L +G+  +
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   E L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEEDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + ++KL  +G+G FG V+K    KT   +A+KK+ +                 +LRE+K
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-------TALREIK 69
Query: 202 YLNSCRHDNILPLYGICFETGK---YCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLH 256
            L   +H+N++ L  IC         C    Y+     E  L  L+         ++   
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 129
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT--L 314
           + +    GL ++H  +  ++H D+K+AN+L+       + DFGL +   + K +      
Sbjct: 130 VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 315 KRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELAT 352
            RV  T  Y P E L+G+R     +D++G G ++ E+ T
Sbjct: 188 NRV-VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 125/298 (41%), Gaps = 42/298 (14%)
Query: 81  QSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKV--SDPLTPMNVLGGTPHIPYQ 138
           Q SV S Q H++ S    + + +   Q   P  E    V  ++ L P++         Y+
Sbjct: 18  QGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-------YEYR 70
Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKK--LEVHRNDRAVETLNQCQRE 194
           E      +  ++   G+G FG V++   ++T    AVKK  LEV R    VE L  C   
Sbjct: 71  EEVHWMTHQPRV---GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGL 123
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
            S R            I+PLYG   E     +    +  GSL   +   K    L   + 
Sbjct: 124 SSPR------------IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRA 168
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFG---LTQEGPIEKAT 310
           L+       GL++LH+R   ++HGD+K+ N+LL+       + DFG     Q   + K+ 
Sbjct: 169 LYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 226
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
            +T   + GT  ++  E ++GK    KVD++    ++  +  G   +    R    LK
Sbjct: 227 -LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 145 NNWDKLNILGKGGFGTVY-----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + ++ L +LG+G FG V+      G   +   A+K L+         TL    R ++  E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-------ATLKVRDRVRTKME 76
Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ---RLH 256
              L    H  I+ L+      GK  L+  ++  G L  RL     +  +++T+   + +
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFY 131
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           +A+  +L L  LHS    +I+ D+K  NILL+      + DFGL++E    +    +   
Sbjct: 132 LAE-LALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-- 186
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
             GT  Y+  E +  +  +   D + FG+++FE+ TG   +    R E
Sbjct: 187 -CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 20/237 (8%)
Query: 122 PLTPMNVLGGTPHIPYQELT-LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHR 180
           P +  + L  TP    Q  T + ++ +    +LGKG FG V   +  K  I  ++  V  
Sbjct: 2   PGSXXDHLHATPGXFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKV 58
Query: 181 -NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDR 239
            + R V+   +  +E  LRE++ L    H NI  LY    + G + LV      G L D 
Sbjct: 59  ISKRQVK--QKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDE 116
Query: 240 LLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IG 296
           ++ +K    +       I +    G+ + H  +  ++H D+K  N+LL          I 
Sbjct: 117 IISRKRFSEV---DAARIIRQVLSGITYXHKNK--IVHRDLKPENLLLESKSKDANIRII 171
Query: 297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           DFGL+      K     +    GT  Y+  E L G     K DV+  G++L+ L +G
Sbjct: 172 DFGLSTHFEASKKXKDKI----GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 150 LNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G FG VY  + V     +A+KK+  +   ++ E     + +  ++E+++L   R
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNE-----KWQDIIKEVRFLQKLR 112
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK---GTSLG 264
           H N +   G         LV  Y   GS  D L + K        Q + IA    G   G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-----LQEVEIAAVTHGALQG 166
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LHS    +IH D+K+ NILL+      +GDFG         +         GT  ++
Sbjct: 167 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPYWM 217
Query: 325 PHEFLVGK---RLSTKVDVYGFGIVLFELA 351
             E ++     +   KVDV+  GI   ELA
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + ++KL  +G+G FG V+K    KT   +A+KK+ +                 +LRE+K
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-------TALREIK 69
Query: 202 YLNSCRHDNILPLYGICFE--------TGKYCLVYRYMPN--GSLEDRLLMKKNTPSLLW 251
            L   +H+N++ L  IC           G   LV+ +  +    L   +L+K     +  
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 129
Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
             ++ +      GL ++H  +  ++H D+K+AN+L+       + DFGL +   + K + 
Sbjct: 130 VMQMLLN-----GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182
Query: 312 IT--LKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELAT 352
                 RV  T  Y P E L+G+R     +D++G G ++ E+ T
Sbjct: 183 PNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 109/226 (48%), Gaps = 22/226 (9%)
Query: 145 NNWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++++ L +LG+G FG V+  + V    +  +  ++V +      TL    R ++  E   
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKK----ATLKVRDRVRTKMERDI 83
Query: 203 LNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ---RLHIA 258
           L    H  ++ L+   F+T GK  L+  ++  G L  RL     +  +++T+   + ++A
Sbjct: 84  LADVNHPFVVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLA 137
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           +  +LGL  LHS    +I+ D+K  NILL+      + DFGL++E    +    +     
Sbjct: 138 E-LALGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF---C 191
Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
           GT  Y+  E +  +  S   D + +G+++FE+ TG   +    R E
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKE 237

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 21  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 72
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 73  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++       + T
Sbjct: 131 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD------IYET 182
Query: 314 LKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
                G +  LP  ++  + L     +T  D++ FG+VL+E+         T  +E+  +
Sbjct: 183 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQ 233
Query: 369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            L    +E+ +  ++D        N       + +   + NPK RP   ++ N+L
Sbjct: 234 GL---SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 73
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 74  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H D+ + N ++ H     IGDFG+T++       + T
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD------IYET 183
Query: 314 LKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
                G +  LP  ++  + L     +T  D++ FG+VL+E+         T  +E+  +
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQPYQ 234
Query: 369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            L    +E+ +  ++D        N       + +   + NPK RP   ++ N+L
Sbjct: 235 GL---SNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 145 NNWDKLNILGKGGFGTVY-----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + ++ L +LG+G FG V+      G   +   A+K L+         TL    R ++  E
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-------ATLKVRDRVRTKME 77
Query: 200 LKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ---RL 255
              L    H  I+ L+   F+T GK  L+  ++  G L  RL     +  +++T+   + 
Sbjct: 78  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKF 131
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           ++A+  +L L  LHS    +I+ D+K  NILL+      + DFGL++E    +    +  
Sbjct: 132 YLAE-LALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF- 187
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
              GT  Y+  E +  +  +   D + FG+++FE+ TG   +    R E
Sbjct: 188 --CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E A  
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 150 LNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G FG VY  + V     +A+KK+  +   ++ E     + +  ++E+++L   R
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNE-----KWQDIIKEVRFLQKLR 73
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK---GTSLG 264
           H N +   G         LV  Y   GS  D L + K        Q + IA    G   G
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-----LQEVEIAAVTHGALQG 127
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LHS    +IH D+K+ NILL+      +GDFG         +         GT  ++
Sbjct: 128 LAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPYWM 178
Query: 325 PHEFLVGK---RLSTKVDVYGFGIVLFELA 351
             E ++     +   KVDV+  GI   ELA
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 145 NNWDKLNILGKGGFGTVY-----KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           + ++ L +LG+G FG V+      G   +   A+K L+         TL    R ++  E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-------ATLKVRDRVRTKME 76
Query: 200 LKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ---RL 255
              L    H  I+ L+   F+T GK  L+  ++  G L  RL     +  +++T+   + 
Sbjct: 77  RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKF 130
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
           ++A+  +L L  LHS    +I+ D+K  NILL+      + DFGL++E    +    +  
Sbjct: 131 YLAE-LALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF- 186
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
              GT  Y+  E +  +  +   D + FG+++FE+ TG   +    R E
Sbjct: 187 --CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 28/271 (10%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G FG V+  V E+++   + ++    DR+     Q   EQ   E++ L S  H NI+
Sbjct: 30  LGSGAFGDVHL-VEERSSGLERVIKTINKDRS-----QVPMEQIEAEIEVLKSLDHPNII 83
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HIAKGTSLGLQFLHSR 271
            ++ +  +     +V      G L +R++  +     L    +  + K     L + HS+
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 272 EPPLIHGDIKSANILLNH---HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
              ++H D+K  NIL      H    I DFGL +    +   H T     GT  Y+  E 
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAE--LFKSDEHST--NAAGTALYMAPE- 196
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ 388
           +  + ++ K D++  G+V++ L TG   +  T   E   K+    Y E N Y +  +   
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA---TYKEPN-YAVECRPLT 252
Query: 389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           P  +++        KQ   ++P+ RP   QV
Sbjct: 253 PQAVDLL-------KQMLTKDPERRPSAAQV 276

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 447
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 448 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 504
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++      +GDFGL++   +E +T+    +      ++ 
Sbjct: 505 AYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 560
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEI 585

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 147 WDKLNILGKGGFGTVYK-----GVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ L +LGKGG+G V++     G       A+K L+     +A+   N      +  E  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-----KAMIVRNAKDTAHTKAERN 73
Query: 202 YLNSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
            L   +H  I+ L    F+TG K  L+  Y+  G L   + +++    +  T   ++A+ 
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE- 129
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
            S+ L  LH +   +I+ D+K  NI+LNH     + DFGL +E   +     T     GT
Sbjct: 130 ISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF---CGT 184
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
             Y+  E L+    +  VD +  G +++++ TG   +    R +
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 96
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 97  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E    
Sbjct: 145 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGX 202
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 203 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 255
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +   AQ  ++N A  F 
Sbjct: 256 LRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFI 295

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 68  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++ +    +GDFGL++   +E +T     +      ++ 
Sbjct: 125 AYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTXXKASKGKLPIKWMA 180
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEI 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 20/224 (8%)
Query: 147 WDKLNILGKGGFGTVYK-----GVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ L +LGKGG+G V++     G       A+K L+     +A+   N      +  E  
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-----KAMIVRNAKDTAHTKAERN 73
Query: 202 YLNSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
            L   +H  I+ L    F+TG K  L+  Y+  G L   + +++    +  T   ++A+ 
Sbjct: 74  ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE- 129
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
            S+ L  LH +   +I+ D+K  NI+LNH     + DFGL +E  I   T        GT
Sbjct: 130 ISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT--VTHXFCGT 184
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
             Y+  E L+    +  VD +  G +++++ TG   +    R +
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+  +  LG+G FG V K  +  TT     L++       ++  Q + E   RE+ YL  
Sbjct: 5   NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRL 60
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            RH +I+ LY +     +  +V  Y  N   +   +++++  S    +R    +     +
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD--YIVQRDKMSEQEARRFF--QQIISAV 116
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---EGPIEKATHITLKRVNGTRP 322
           ++ H  +  ++H D+K  N+LL+ H++  I DFGL+    +G         LK   G+  
Sbjct: 117 EYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-------LKTSCGSPN 167
Query: 323 YLPHEFLVGKRLS-TKVDVYGFGIVLFELATGMRAYDD 359
           Y   E + GK  +  +VDV+  G++L+ +      +DD
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 146 NWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N D++ +LGKG +G VY G  +  +  IA+K++   R+ R  + L++        E+   
Sbjct: 24  NGDRV-VLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHE--------EIALH 73
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              +H NI+   G   E G   +    +P GSL   LL  K  P     Q +       L
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 264 -GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQE-GPIEKATHITLKRVNGT 320
            GL++LH  +  ++H DIK  N+L+N +   + I DFG ++    I   T    +   GT
Sbjct: 133 EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT----ETFTGT 186
Query: 321 RPYLPHEFL-VGKRLSTK-VDVYGFGIVLFELATG 353
             Y+  E +  G R   K  D++  G  + E+ATG
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+  +  LG+G FG V K  +  TT     L++       ++  Q + E   RE+ YL  
Sbjct: 15  NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRL 70
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            RH +I+ LY +     +  +V  Y  N   +   +++++  S    +R    +     +
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD--YIVQRDKMSEQEARRFF--QQIISAV 126
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---EGPIEKATHITLKRVNGTRP 322
           ++ H  +  ++H D+K  N+LL+ H++  I DFGL+    +G         LK   G+  
Sbjct: 127 EYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-------LKTSCGSPN 177
Query: 323 YLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDD 359
           Y   E + GK  +  +VDV+  G++L+ +      +DD
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
             +LG+GGFG V+    + T     KL   +         +   + ++ E K L    H 
Sbjct: 190 FRVLGRGGFGEVFACQMKATG----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HS 244
Query: 210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQF 267
             +      FET    CLV   M  G +   +  + ++ P     + +        GL+ 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH R   +I+ D+K  N+LL+   +  I D GL  E    KA     K   GT  ++  E
Sbjct: 305 LHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPE 359
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L+G+     VD +  G+ L+E+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
             +LG+GGFG V+    + T     KL   +         +   + ++ E K L    H 
Sbjct: 190 FRVLGRGGFGEVFACQMKATG----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HS 244
Query: 210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQF 267
             +      FET    CLV   M  G +   +  + ++ P     + +        GL+ 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH R   +I+ D+K  N+LL+   +  I D GL  E    KA     K   GT  ++  E
Sbjct: 305 LHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPE 359
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L+G+     VD +  G+ L+E+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
             +LG+GGFG V+    + T     KL   +         +   + ++ E K L    H 
Sbjct: 190 FRVLGRGGFGEVFACQMKATG----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HS 244
Query: 210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQF 267
             +      FET    CLV   M  G +   +  + ++ P     + +        GL+ 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH R   +I+ D+K  N+LL+   +  I D GL  E    KA     K   GT  ++  E
Sbjct: 305 LHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPE 359
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L+G+     VD +  G+ L+E+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEM 382

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 153 LGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQ----REQSLRELKYLNS 205
           +G+G FG V++G++   E   +AV          A++T   C     RE+ L+E   +  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAV----------AIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             H +I+ L G+  E   + ++      G L   L ++K +  L     +  A   S  L
Sbjct: 68  FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
            +L S+    +H DI + N+L++      +GDFGL++   +E +T+    +      ++ 
Sbjct: 125 AYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA 180
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFEL 350
            E +  +R ++  DV+ FG+ ++E+
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 83
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 84  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 190 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 242
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 81
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 82  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 130 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 188 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 240
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 241 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 280

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+  +  LG+G FG V K  +  TT     L++       ++  Q + E   RE+ YL  
Sbjct: 14  NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRL 69
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            RH +I+ LY +     +  +V  Y  N   +   +++++  S    +R    +     +
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD--YIVQRDKMSEQEARRFF--QQIISAV 125
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---EGPIEKATHITLKRVNGTRP 322
           ++ H  +  ++H D+K  N+LL+ H++  I DFGL+    +G         LK   G+  
Sbjct: 126 EYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-------LKTSCGSPN 176
Query: 323 YLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDD 359
           Y   E + GK  +  +VDV+  G++L+ +      +DD
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
             +LG+GGFG V+    + T     KL   +         +   + ++ E K L    H 
Sbjct: 190 FRVLGRGGFGEVFACQMKATG----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HS 244
Query: 210 NILPLYGICFETG-KYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKGTSLGLQF 267
             +      FET    CLV   M  G +   +  + ++ P     + +        GL+ 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           LH R   +I+ D+K  N+LL+   +  I D GL  E    KA     K   GT  ++  E
Sbjct: 305 LHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVE---LKAGQTKTKGYAGTPGFMAPE 359
Query: 328 FLVGKRLSTKVDVYGFGIVLFEL 350
            L+G+     VD +  G+ L+E+
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEM 382

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 83
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 84  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 190 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 242
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 82
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 83  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 131 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 189 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 241
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 242 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 281

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           N+  +  LG+G FG V K  +  TT     L++       ++  Q + E   RE+ YL  
Sbjct: 9   NYQIVKTLGEGSFGKV-KLAYHTTTGQKVALKIINKKVLAKSDMQGRIE---REISYLRL 64
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            RH +I+ LY +     +  +V  Y  N   +   +++++  S    +R    +     +
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD--YIVQRDKMSEQEARRFF--QQIISAV 120
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---EGPIEKATHITLKRVNGTRP 322
           ++ H  +  ++H D+K  N+LL+ H++  I DFGL+    +G         LK   G+  
Sbjct: 121 EYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-------LKTSCGSPN 171
Query: 323 YLPHEFLVGKRLS-TKVDVYGFGIVLFELATGMRAYDD 359
           Y   E + GK  +  +VDV+  G++L+ +      +DD
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 78
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 79  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 127 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 184
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 185 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 237
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 238 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 277

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 78
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 79  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 127 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 184
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 185 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 237
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 238 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 277

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 83
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 84  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 190 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 242
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 78
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 79  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 127 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 184
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 185 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 237
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 238 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 277

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 81
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 82  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 130 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 187
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 188 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 240
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 241 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 280

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 27/227 (11%)
Query: 150 LNILGKGGFGTVY------KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L  LG G FG V+       G +    +  K++ V         L Q +     R +  L
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--------LKQVEHTNDERLM--L 60
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +   H  I+ ++G   +  +  ++  Y+  G L   L   +  P+ +   + + A+   L
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV--AKFYAAE-VCL 117
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            L++LHS++  +I+ D+K  NILL+ +    I DFG  +  P    T+     + GT  Y
Sbjct: 118 ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTY----XLCGTPDY 169
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
           +  E +  K  +  +D + FGI+++E+  G   + D+   + + K L
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 83
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 84  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 189
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 190 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 242
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 88
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 89  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 136
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 137 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 194
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 195 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 247
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 248 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 287

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 99
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 100 HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 147
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 148 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY 205
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 206 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 258
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 259 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 298

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 88
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 89  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 136
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 137 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 194
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 195 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 247
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 248 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 287

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 81
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 82  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 130 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 187
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 188 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 240
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 241 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 280

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 75
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 76  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 123
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 124 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 181
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 182 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 234
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 235 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 274

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 82
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 83  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 131 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 189 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 241
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 242 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 281

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 33/212 (15%)
Query: 153 LGKGGFGTVYKGVWEKTT----IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG GG  TVY  + E T     +A+K + +   ++  ETL + +RE     +   +   H
Sbjct: 19  LGGGGMSTVY--LAEDTILNIKVAIKAIFIPPREKE-ETLKRFERE-----VHNSSQLSH 70
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            NI+ +  +  E   Y LV  Y+   +L + +  + + P       L +    +   Q L
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGP-------LSVDTAINFTNQIL 121
Query: 269 ----HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---EGPIEKATHITLKRVNGTR 321
               H+ +  ++H DIK  NIL++ +    I DFG+ +   E  + +  H+      GT 
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-----GTV 176
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y   E   G+      D+Y  GIVL+E+  G
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++ +Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY 182
Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y   E ++     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 99
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 100 HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 147
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 148 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 205
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 206 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 258
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 259 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 298

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 87
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 88  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 135
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 136 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 193
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 194 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 246
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 247 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 286

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 87
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 88  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 135
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 136 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 193
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 194 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 246
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 247 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 286

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 124/286 (43%), Gaps = 39/286 (13%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           + +  ++ + +  LG+G +G V K   V     +AVK++      RA  T+N  ++++ L
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI------RA--TVNSQEQKRLL 53
Query: 198 RELKY-LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED---RLLMKKNT-PSLLWT 252
            +L   + +      +  YG  F  G   +    M + SL+    +++ K  T P  +  
Sbjct: 54  MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG 112
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           +   IA      L+ LHS+   +IH D+K +N+L+N      + DFG++     + A  I
Sbjct: 113 K---IAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI 168
Query: 313 TLKRVNGTRPYLPHEF----LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
                 G +PY+  E     L  K  S K D++  GI + ELA     YD      + LK
Sbjct: 169 D----AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 224
Query: 369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
            +VE+ S +   D             +  F     Q  K+N KERP
Sbjct: 225 QVVEEPSPQLPAD-----------KFSAEFVDFTSQCLKKNSKERP 259

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ----CQREQSLRELKYLNSCRH 208
           LG G FG+V +GV+        ++   + D A++ L Q       E+ +RE + ++   +
Sbjct: 344 LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQF 267
             I+ L G+C +     LV      G L   L+ K+   P     + LH     S+G+++
Sbjct: 396 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---QVSMGMKY 451
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YL 324
           L  +    +H ++ + N+LL +     I DFGL++    + + +    R  G  P   Y 
Sbjct: 452 LEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA--RSAGKWPLKWYA 507
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSE 364
           P E +  ++ S++ DV+ +G+ ++E L+ G + Y   +  E
Sbjct: 508 P-ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRH 208
           + +LG G F  V+  V ++ T  +  L+  +   A        R+ SL  E+  L   +H
Sbjct: 14  MEVLGSGAFSEVFL-VKQRLTGKLFALKCIKKSPAF-------RDSSLENEIAVLKKIKH 65
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK----KNTPSLLWTQRLHIAKGTSLG 264
           +NI+ L  I   T  Y LV + +  G L DR+L +    +   SL+  Q L   K     
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK----- 120
Query: 265 LQFLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLT---QEGPIEKATHITLKRVN 318
             +LH  E  ++H D+K  N+L      +   +I DFGL+   Q G +  A         
Sbjct: 121 --YLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-------- 168
Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           GT  Y+  E L  K  S  VD +  G++ + L  G
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 95
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 96  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 143
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 144 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 201
Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y   E ++     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 202 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 254
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 255 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 294

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 53/237 (22%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ--REQSLRELKYL 203
           ++ ++ ++G GGFG V+K               HR D     + + +   E++ RE+K L
Sbjct: 13  DFKEIELIGSGGFGQVFKAK-------------HRIDGKTYVIRRVKYNNEKAEREVKAL 59
Query: 204 NSCRHDNILPLYGICFETGKY----------------------------CLVYR--YMPN 233
               H NI+  Y  C++   Y                            CL  +  +   
Sbjct: 60  AKLDHVNIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 234 GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP 293
           G+LE + + K+    L     L + +  + G+ ++HS++  LIH D+K +NI L      
Sbjct: 119 GTLE-QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LIHRDLKPSNIFLVDTKQV 175
Query: 294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
            IGDFGL     ++     T  R  GT  Y+  E +  +    +VD+Y  G++L EL
Sbjct: 176 KIGDFGLVT--SLKNDGKRT--RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 146 NWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N D++ +LGKG +G VY G  +  +  IA+K++   R+ R  + L++        E+   
Sbjct: 10  NGDRV-VLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHE--------EIALH 59
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              +H NI+   G   E G   +    +P GSL   LL  K  P     Q +       L
Sbjct: 60  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQIL 118
Query: 264 -GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTR 321
            GL++LH  +  ++H DIK  N+L+N +   + I DFG ++        +   +   GT 
Sbjct: 119 EGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR---LAGINPCTETFTGTL 173
Query: 322 PYLPHEFL-VGKRLSTK-VDVYGFGIVLFELATG 353
            Y+  E +  G R   K  D++  G  + E+ATG
Sbjct: 174 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 207

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 81
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 82  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 129
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 130 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 187
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 188 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 240
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 241 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 280

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 96
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 97  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 145 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 202
Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y   E ++     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 203 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 255
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 256 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 295

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/277 (21%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 153 LGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G F  VY+   + +   +A+KK+++       + ++   R   ++E+  L    H N
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQI------FDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL-----WTQRLHIAKGTSLGL 265
           ++  Y    E  +  +V      G L   +   K    L+     W   + +       L
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----L 149
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           + +HSR   ++H DIK AN+ +       +GD GL   G    +       + GT  Y+ 
Sbjct: 150 EHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL---GRFFSSKTTAAHSLVGTPYYMS 204
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK 385
            E +     + K D++  G +L+E+A     +   + +   L SL +K  E+  Y  +  
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI-EQCDYPPLPS 260
Query: 386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM 422
           +    EL       ++       +P++RP++T VY++
Sbjct: 261 DHYSEELR------QLVNMCINPDPEKRPDVTYVYDV 291

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 39/272 (14%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 72
Query: 205 SCRHDNILPLYGI-----CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
             +H+N++ L  +       E      +  ++    L + +   K T   +      I +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
           G    L+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   ++       
Sbjct: 133 G----LKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV------A 180
Query: 320 TRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK---------- 368
           TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK          
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPG 239
Query: 369 -SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
             L++K S E+  + +   AQ  ++N A  F 
Sbjct: 240 AELLKKISSESARNYIQSLAQMPKMNFANVFI 271

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 82
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 83  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 130
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 131 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 188
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 189 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 241
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 242 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 281

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 73
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 74  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 121
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 122 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 179
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 180 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 232
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 233 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 272

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 72
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 73  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 121 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 179 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 231
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 73
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 74  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 121
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 122 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 179
Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y   E ++     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 180 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 232
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 233 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 272

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 74
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 75  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 122
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 123 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 180
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 181 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 233
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 234 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 273

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      K+   IAVKKL      R  +++   +R  + REL+ L 
Sbjct: 53  YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-----RPFQSIIHAKR--TYRELRLLK 105
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 106 HMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 153
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 154 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 211
Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           +       TR Y   E ++     +  VD++  G ++ EL TG
Sbjct: 212 V------ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 78
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 79  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 126
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 127 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY 184
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 185 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 237
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 238 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 277

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 28  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L +  L  +  P L ++            
Sbjct: 84  --KHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQLS 140
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 141 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 193
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 25  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L +  L  +  P L ++            
Sbjct: 81  --KHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 138 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 190
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           IP+++L +         ++GKG FG VY G W    +A++ +++ R+       N+ Q +
Sbjct: 30  IPFEQLEIG-------ELIGKGRFGQVYHGRWH-GEVAIRLIDIERD-------NEDQLK 74
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
              RE+      RH+N++   G C       ++       +L    +++     L   + 
Sbjct: 75  AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS--VVRDAKIVLDVNKT 132
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA--THI 312
             IA+    G+ +LH++   ++H D+KS N+  ++    VI DFGL     + +A     
Sbjct: 133 RQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRED 189
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKV-----------DVYGFGIVLFEL 350
            L+  NG   +L  E +  ++LS              DV+  G + +EL
Sbjct: 190 KLRIQNGWLCHLAPEII--RQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 29  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L +  L  +  P L ++            
Sbjct: 85  --KHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 142 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 194
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 36  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L +  L  +  P L ++            
Sbjct: 92  --KHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 149 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 201
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 149 KLNILGKGGFGTVY-----KGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSLRELKY 202
           K+  LG G +G V       G  EK    +KK +  +   + +  N +   E+   E+  
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 203 LNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
           L S  H NI+ L+ + FE  KY  LV  +   G L ++++   N          +I K  
Sbjct: 100 LKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQI 155
Query: 262 SLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
             G+ +LH     ++H DIK  NILL   N  ++  I DFGL+       +    L+   
Sbjct: 156 LSGICYLHKH--NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF----SKDYKLRDRL 209
Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           GT  Y+  E L  K+ + K DV+  G++++ L  G
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 36  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L +  L  +  P L ++            
Sbjct: 92  --KHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 149 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 201
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 146 NWDKLNIL---GKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           N+D   IL   GKG FG V   V +  T  +  ++     + VE   + +     +EL+ 
Sbjct: 13  NFDHFEILRAIGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVE---RNEVRNVFKELQI 68
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +    H  ++ L+    +     +V   +  G L  R  +++N      T +L I +   
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICE-LV 125
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           + L +L ++   +IH D+K  NILL+ H    I DF +    P E  T IT   + GT+P
Sbjct: 126 MALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQIT--TMAGTKP 179
Query: 323 YLPHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAY 357
           Y+  E    ++    S  VD +  G+  +EL  G R Y
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++           K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RDI---NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 36  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L +  L  +  P L ++            
Sbjct: 92  --KHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 149 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 201
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 77  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT------------ 252
             +H NI+ L G C + G   ++  Y   G+L + L  ++  P L ++            
Sbjct: 133 --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR-PPGLEYSYNPSHNPEEQLS 189
Query: 253 --QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               +  A   + G+++L S++   IH D+ + N+L+       I DFGL ++       
Sbjct: 190 SKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IH 242
Query: 311 HITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           HI    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 42/297 (14%)
Query: 82  SSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKV--SDPLTPMNVLGGTPHIPYQE 139
            SV S Q H++ S    + + +   Q   P  E    V  ++ L P++         Y+E
Sbjct: 3   GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-------YEYRE 55
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTI--AVKK--LEVHRNDRAVETLNQCQREQ 195
                 +  ++   G+G FG V++   ++T    AVKK  LEV R    VE L  C    
Sbjct: 56  EVHWMTHQPRV---GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLS 108
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
           S R            I+PLYG   E     +    +  GSL   +   K    L   + L
Sbjct: 109 SPR------------IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRAL 153
Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-PVIGDFG---LTQEGPIEKATH 311
           +       GL++LH+R   ++HGD+K+ N+LL+       + DFG     Q   + K+  
Sbjct: 154 YYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL- 210
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
           +T   + GT  ++  E ++GK    KVD++    ++  +  G   +    R    LK
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 152 ILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ILG+G FG VY+GV+     EK  +AVK     + D  ++      +E+ + E   + + 
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLD-----NKEKFMSEAVIMKNL 82
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
            H +I+ L GI  E   + ++  Y P G L   L   KN+  +  L    L I K     
Sbjct: 83  DHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYLERNKNSLKVLTLVLYSLQICK----A 137
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           + +L S     +H DI   NIL+       +GDFGL++    E     ++ R+     ++
Sbjct: 138 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 193
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             E +  +R +T  DV+ F + ++E+ +
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 21  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK------------NTPSLLWT 252
             +H NI+ L G C + G   ++  Y   G+L + L  ++            N    L +
Sbjct: 77  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 253 QRL-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           + L   A   + G+++L S++   IH D+ + N+L+       I DFGL ++       H
Sbjct: 135 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IHH 187
Query: 312 ITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           I    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 152 ILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ILG+G FG VY+GV+     EK  +AVK     + D  ++      +E+ + E   + + 
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLD-----NKEKFMSEAVIMKNL 66
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
            H +I+ L GI  E   + ++  Y P G L   L   KN+  +  L    L I K     
Sbjct: 67  DHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYLERNKNSLKVLTLVLYSLQICK----A 121
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           + +L S     +H DI   NIL+       +GDFGL++    E     ++ R+     ++
Sbjct: 122 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 177
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             E +  +R +T  DV+ F + ++E+ +
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 152 ILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ILG+G FG VY+GV+     EK  +AVK     + D  ++      +E+ + E   + + 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLD-----NKEKFMSEAVIMKNL 70
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL--LWTQRLHIAKGTSLG 264
            H +I+ L GI  E   + ++  Y P G L   L   KN+  +  L    L I K     
Sbjct: 71  DHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYLERNKNSLKVLTLVLYSLQICK----A 125
Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           + +L S     +H DI   NIL+       +GDFGL++    E     ++ R+     ++
Sbjct: 126 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWM 181
Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             E +  +R +T  DV+ F + ++E+ +
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 39/232 (16%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK----------- 244
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++           
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDIN 147
Query: 245 NTPSLLWTQRLHIAKGTSL--GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
             P    T +  ++    L  G+++L S++   IH D+ + N+L+  +    I DFGL +
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 303 EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           +           K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 206 DI---NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           D    +G+G  G V       +   +AVKK+++ +  R         RE    E+  +  
Sbjct: 154 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRD 204
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H+N++ +Y       +  +V  ++  G+L D +   +     +    L + +  S+  
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-- 262
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             LH++   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++ 
Sbjct: 263 --LHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMA 315
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +       +VD++  GI++ E+  G   Y
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 118/253 (46%), Gaps = 42/253 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+LN+   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 78
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN------TPS 248
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N      TP 
Sbjct: 79  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE 138
Query: 249 LLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL +
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 303 EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDD 359
           +  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y  
Sbjct: 197 D--IXKDPD-XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 360 TRRSERHLKSLVE 372
            +  E   + L E
Sbjct: 254 VKIDEEFCRRLKE 266

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           D    +G+G  G V       +   +AVKK+++ +  R         RE    E+  +  
Sbjct: 32  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRD 82
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H+N++ +Y       +  +V  ++  G+L D +   +     +    L + +  S+  
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-- 140
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             LH++   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++ 
Sbjct: 141 --LHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMA 193
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +       +VD++  GI++ E+  G   Y
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           D    +G+G  G V       +   +AVKK+++ +  R         RE    E+  +  
Sbjct: 77  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRD 127
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H+N++ +Y       +  +V  ++  G+L D +   +     +    L + +  S+  
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-- 185
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             LH++   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++ 
Sbjct: 186 --LHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMA 238
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +       +VD++  GI++ E+  G   Y
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 429
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 430 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 485
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 486 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 541
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSE-------- 376
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK           
Sbjct: 542 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCP 598
Query: 377 ENMYDLVD 384
             MYDL++
Sbjct: 599 REMYDLMN 606

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 31/248 (12%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N + +  +LGKGGFG V          A  K+   +         +     +L E +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLHIA 258
            L       ++ L    +ET    CLV   M  G L+  +  + +   P     + +  A
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE---ARAVFYA 292
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI----TL 314
                GL+ LH     +++ D+K  NILL+ H    I D GL        A H+    T+
Sbjct: 293 AEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGL--------AVHVPEGQTI 342
Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS------ERHLK 368
           K   GT  Y+  E +  +R +   D +  G +L+E+  G   +   ++       ER +K
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 369 SLVEKYSE 376
            + E+YSE
Sbjct: 403 EVPEEYSE 410

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 31/248 (12%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  N + +  +LGKGGFG V          A  K+   +         +     +L E +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLHIA 258
            L       ++ L    +ET    CLV   M  G L+  +  + +   P     + +  A
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE---ARAVFYA 292
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI----TL 314
                GL+ LH     +++ D+K  NILL+ H    I D GL        A H+    T+
Sbjct: 293 AEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGL--------AVHVPEGQTI 342
Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS------ERHLK 368
           K   GT  Y+  E +  +R +   D +  G +L+E+  G   +   ++       ER +K
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 369 SLVEKYSE 376
            + E+YSE
Sbjct: 403 EVPEEYSE 410

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 87
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 88  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 143
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 144 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 199
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 200 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 245

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 87
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 88  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 143
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 144 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 199
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 200 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 245

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 85
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 86  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 141
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 142 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 197
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 198 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 243

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           D    +G+G  G V       +   +AVKK+++ +  R         RE    E+  +  
Sbjct: 34  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRD 84
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H+N++ +Y       +  +V  ++  G+L D +   +     +    L + +  S+  
Sbjct: 85  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-- 142
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             LH++   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++ 
Sbjct: 143 --LHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMA 195
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +       +VD++  GI++ E+  G   Y
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR-AVETLNQCQREQSLREL-------KYLN 204
           LG+G FG V         I + K + +R  + AV+ L     E+ L +L       K + 
Sbjct: 36  LGEGAFGQVVLA----EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK------------NTPSLLWT 252
             +H NI+ L G C + G   ++  Y   G+L + L  ++            N    L +
Sbjct: 92  --KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 253 QRL-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           + L   A   + G+++L S++   IH D+ + N+L+       I DFGL ++       H
Sbjct: 150 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARD-----IHH 202
Query: 312 ITL--KRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           I    K  NG  P  ++  E L  +  + + DV+ FG++L+E+ T
Sbjct: 203 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 34/248 (13%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 430
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 431 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 486
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 487 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 542
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEKYSE-------- 376
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK           
Sbjct: 543 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERMGCPAGCP 599
Query: 377 ENMYDLVD 384
             MYDL++
Sbjct: 600 REMYDLMN 607

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 39/224 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 23  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 74
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 75  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 132
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H ++ + N ++ H     IGDFG+T++       + T
Sbjct: 133 MIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRD------IYET 184
Query: 314 LKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELAT 352
                G +  LP  ++  + L     +T  D++ FG+VL+E+ +
Sbjct: 185 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E    
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGX 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 18/232 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIA-VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G F  V K   + T +    K    R  RA  +     RE+  RE+  L    H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVSREEIEREVSILRQVLHHNV 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LH++
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK 134
Query: 272 EPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           +  + H D+K  NI+L     P+    + DFGL  E  IE    +  K + GT  ++  E
Sbjct: 135 K--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG--VEFKNIFGTPEFVAPE 188
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAY--DDTRRSERHLKSLVEKYSEE 377
            +  + L  + D++  G++ + L +G   +  D  + +  ++ S+   + EE
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 39/224 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE-LKYLN---- 204
           L  LG+G FG VY+G          +  V     AV+T+N+     SLRE +++LN    
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRV-----AVKTVNESA---SLRERIEFLNEASV 73
Query: 205 ----SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQ 253
               +C H  ++ L G+  +     +V   M +G L+  L   +         P     +
Sbjct: 74  MKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 131
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +A   + G+ +L++++   +H ++ + N ++ H     IGDFG+T++       + T
Sbjct: 132 MIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRD------IYET 183
Query: 314 LKRVNGTRPYLPHEFLVGKRL-----STKVDVYGFGIVLFELAT 352
                G +  LP  ++  + L     +T  D++ FG+VL+E+ +
Sbjct: 184 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      +  +++   +R  + REL+ L 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----KPFQSIIHAKR--TYRELRLLK 88
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 89  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 136
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   +
Sbjct: 137 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 194
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 195 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 247
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 248 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 287

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 77
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 78  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 133
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 134 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 189
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 190 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 235

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I D+GL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 65
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 66  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 121
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 122 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 177
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 178 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 223

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 67
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 68  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 123
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 124 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 179
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 180 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           D    +G+G  G V       +   +AVKK+++ +  R         RE    E+  +  
Sbjct: 23  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRD 73
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H+N++ +Y       +  +V  ++  G+L D +   +     +    L + +  S+  
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-- 131
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             LH++   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++ 
Sbjct: 132 --LHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMA 184
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +       +VD++  GI++ E+  G   Y
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 71
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 72  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 128 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENXYKAQTHGKWPVKWYAP 183
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 184 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 229

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 29/230 (12%)
Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G +G V   V  +T   +A+KKL      R  ++  +   +++ REL+ L   R
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-----RPFQS--ELFAKRAYRELRLLKHMR 82
Query: 208 HDNILPLYGICF--ET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL- 263
           H+N++ L  +    ET   +   Y  MP    +   LMK      L   R+       L 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLK 139
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL+++H+    +IH D+K  N+ +N   +  I DFGL ++   E    +       TR Y
Sbjct: 140 GLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV------TRWY 191
Query: 324 -LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             P   L   R +  VD++  G ++ E+ TG   +    +   HL  L E
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF----KGSDHLDQLKE 237

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 41/237 (17%)
Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLN 189
           IP Q+ TL         +LGKG FG+V +   ++       +AVK L+        + + 
Sbjct: 20  IPEQQFTLG-------RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-------DIIA 65
Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFET---GKY---CLVYRYMPNGSLEDRLLMK 243
               E+ LRE   +    H ++  L G+   +   G+     ++  +M +G L   LL  
Sbjct: 66  SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 244 K---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
           +   N  +L     +      + G+++L SR    IH D+ + N +L   M   + DFGL
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKV-----DVYGFGIVLFELAT 352
           +++  I    +       G    LP ++L  + L+  +     DV+ FG+ ++E+ T
Sbjct: 184 SRK--IYSGDYYR----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 148 DKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           D    +G+G  G V       +   +AVKK+++ +  R         RE    E+  +  
Sbjct: 27  DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRD 77
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H+N++ +Y       +  +V  ++  G+L D +   +     +    L + +  S+  
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSV-- 135
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             LH++   +IH DIKS +ILL H     + DFG   +   E       K + GT  ++ 
Sbjct: 136 --LHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KXLVGTPYWMA 188
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            E +       +VD++  GI++ E+  G   Y
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 137
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 138 EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 192
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 251 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKK----LEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FGTV KG ++   +        L+   ND A+       +++ L E   +    +
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------KDELLAEANVMQQLDN 71
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ + GIC E   + LV      G L   L   ++         + +    S+G+++L
Sbjct: 72  PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL 127
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
              E   +H D+ + N+LL       I DFGL++   +    +    + +G  P   Y P
Sbjct: 128 E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAP 183
Query: 326 HEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLVEK 373
            E +   + S+K DV+ FG++++E  + G + Y   + SE  + +++EK
Sbjct: 184 -ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK 229

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 83
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 84  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 138
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 139 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 196
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 197 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 80
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 81  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 135
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 136 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 193
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 194 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 16/231 (6%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           GT ++ +Q  ++  ++++    LG G F  V K   +K T      +  +  R   +   
Sbjct: 14  GTENLYFQ--SMVEDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLXSSRRG 70
Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             RE+  RE+  L   RH NI+ L+ I        L+   +  G L D L  K++     
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE 130
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPI 306
            TQ L   K    G+ +LHS+   + H D+K  NI+L     P     + DFG+  +  I
Sbjct: 131 ATQFL---KQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--I 183
Query: 307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           E       K + GT  ++  E +  + L  + D++  G++ + L +G   +
Sbjct: 184 EAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 43/234 (18%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 91
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 92  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 146
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 302 QE-GPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++   I+   + T    NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 205 RDINNIDYYKNTT----NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 18/232 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIA-VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G F  V K   + T +    K    R  RA  +     RE+  RE+  L    H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVSREEIEREVSILRQVLHHNV 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LH++
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK 134
Query: 272 EPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           +  + H D+K  NI+L     P+    + DFGL  E  IE    +  K + GT  ++  E
Sbjct: 135 K--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG--VEFKNIFGTPEFVAPE 188
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAY--DDTRRSERHLKSLVEKYSEE 377
            +  + L  + D++  G++ + L +G   +  D  + +  ++ S+   + EE
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 18/232 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIA-VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G F  V K   + T +    K    R  RA  +     RE+  RE+  L    H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVSREEIEREVSILRQVLHHNV 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LH++
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK 134
Query: 272 EPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           +  + H D+K  NI+L     P+    + DFGL  E  IE    +  K + GT  ++  E
Sbjct: 135 K--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG--VEFKNIFGTPEFVAPE 188
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAY--DDTRRSERHLKSLVEKYSEE 377
            +  + L  + D++  G++ + L +G   +  D  + +  ++ S+   + EE
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE 240

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 148 DKLNI---LGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           DKL +   LG+G FG V              E  T+AVK L   ++D   + L+    E 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEM 78
Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            + ++      +H NI+ L G C + G   ++  Y   G+L + L  ++  P + ++  +
Sbjct: 79  EMMKM----IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-PPGMEYSYDI 133
Query: 256 HIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +      +              G+++L S++   IH D+ + N+L+  +    I DFGL 
Sbjct: 134 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIADFGLA 191
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           ++  I    +   K  NG  P  ++  E L  +  + + DV+ FG++++E+ T
Sbjct: 192 RD--INNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 23/231 (9%)
Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQR 193
           P Q       +   L  +G+G +G+V K V + +   +AVK++          T+++ ++
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--------STVDEKEQ 64
Query: 194 EQSLRELKY-LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
           +Q L +L   + S     I+  YG  F  G  C +   + + S +       +    +  
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGD-CWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 253 QRLHIAKGTSLGLQFL-HSREP-PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           + + + K T   ++ L H +E   +IH DIK +NILL+   +  + DFG++     +   
Sbjct: 124 EEI-LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG----QLVD 178
Query: 311 HITLKRVNGTRPYLPHEFL----VGKRLSTKVDVYGFGIVLFELATGMRAY 357
            I   R  G RPY+  E +      +    + DV+  GI L+ELATG   Y
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 17/216 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIA-VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G F  V K   + T +    K    R  RA  +     RE+  RE+  L    H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVSREEIEREVSILRQVLHHNV 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LH++
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK 134
Query: 272 EPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           +  + H D+K  NI+L     P+    + DFGL  E  IE    +  K + GT  ++  E
Sbjct: 135 K--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG--VEFKNIFGTPEFVAPE 188
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
            +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIA-----VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           LG G F  V K   + T +      +KK +   + R V     C RE+  RE+  L    
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV-----C-REEIEREVSILRQVL 73
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H NI+ L+ +        L+   +  G L D L  K+   SL   +     K    G+ +
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNY 130
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           LH+++  + H D+K  NI+L     P+    + DFGL  E  IE    +  K + GT  +
Sbjct: 131 LHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG--VEFKNIFGTPEF 184
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           +  E +  + L  + D++  G++ + L +G   +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 153 LGKGGFGTVYKGVWEKTTIA-VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           LG G F  V K   + T +    K    R  RA  +     RE+  RE+  L    H N+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA--SRRGVSREEIEREVSILRQVLHHNV 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LH++
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK 134
Query: 272 EPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHE 327
           +  + H D+K  NI+L     P+    + DFGL  E  IE    +  K + GT  ++  E
Sbjct: 135 K--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG--VEFKNIFGTPEFVAPE 188
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
            +  + L  + D++  G++ + L +G   +
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 44/183 (24%)
Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEKATHI 312
           LHI    +  ++FLHS+   L+H D+K +NI     MD V+  GDFGL      ++    
Sbjct: 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 313 TLKRVN---------GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL----ATGM---RA 356
            L  +          GT+ Y+  E + G   S KVD++  G++LFEL    +T M   R 
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI 282
Query: 357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM 416
             D R  +  L    +KY +E+M  +V     P                   +P ERPE 
Sbjct: 283 ITDVRNLKFPL-LFTQKYPQEHM--MVQDMLSP-------------------SPTERPEA 320
Query: 417 TQV 419
           T +
Sbjct: 321 TDI 323

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 49/244 (20%)
Query: 144 TNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            ++++++ +LG+G FG V K     +    A+KK  +   +  + T+        L E+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTI--------LSEVM 54
Query: 202 YLNSCRHDNILPLYGICFETGKYC-------------LVYRYMPNGSLEDRLLMKKNTPS 248
            L S  H  ++  Y    E   +              +   Y  NG+L D  L+     +
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD--LIHSENLN 112
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               +   + +     L ++HS+   +IH D+K  NI ++   +  IGDFGL +   + +
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKN--VHR 168
Query: 309 ATHI-------------TLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFEL---- 350
           +  I              L    GT  Y+  E L G    + K+D+Y  GI+ FE+    
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
Query: 351 ATGM 354
           +TGM
Sbjct: 229 STGM 232

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 43/220 (19%)
Query: 150 LNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G +G+V        +  +AVKKL      R  ++L   +R  + REL+ L   +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKL-----SRPFQSLIHARR--TYRELRLLKHLK 85
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHIAKG 260
           H+N++ L  +            + P  S+ED         LM  +  +++ +Q L     
Sbjct: 86  HENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHV 133
Query: 261 TSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
             L      GL+++HS    +IH D+K +N+ +N   +  I DFGL ++   E   ++  
Sbjct: 134 QFLVYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV-- 189
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                TR Y   E ++     +  VD++  G ++ EL  G
Sbjct: 190 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           ++LG+G +G V     + T   +A+KK+E    D+ +  L      ++LRE+K L   +H
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFAL------RTLREIKILKHFKH 68
Query: 209 DNILPLYGI----CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HIA 258
           +NI+ ++ I     FE      + +           LM+ +   ++ TQ L      +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQE----------LMQTDLHRVISTQMLSDDHIQYFI 118
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---------EGPIEKA 309
             T   ++ LH     +IH D+K +N+L+N + D  + DFGL +           P  + 
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 310 THITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           + +T      TR Y  P   L   + S  +DV+  G +L EL
Sbjct: 177 SGMT--EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 24/177 (13%)
Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQ 190
           PH  +Q      + ++  +++G G +G V +     EK  +A+KK+      R  E L  
Sbjct: 45  PHSDWQ----IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-----RVFEDLID 95
Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICF--ETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
           C+R   LRE+  LN   HD+++ +  I    +  K+  +Y  +     + + L +  TP 
Sbjct: 96  CKR--ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR--TP- 150
Query: 249 LLWTQRLHIAK---GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            ++   LHI        +G++++HS    ++H D+K AN L+N      + DFGL +
Sbjct: 151 -VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 43/220 (19%)
Query: 150 LNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G +G+V        +  +AVKKL      R  ++L   +R  + REL+ L   +
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKL-----SRPFQSLIHARR--TYRELRLLKHLK 77
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHIAKG 260
           H+N++ L  +            + P  S+ED         LM  +  +++  Q L     
Sbjct: 78  HENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV 125
Query: 261 TSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
             L      GL+++HS    +IH D+K +N+ +N   +  I DFGL ++   E   ++  
Sbjct: 126 QFLVYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV-- 181
Query: 315 KRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                TR Y  P   L     +  VD++  G ++ EL  G
Sbjct: 182 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           ++LG+G +G V     + T   +A+KK+E    D+ +  L      ++LRE+K L   +H
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFAL------RTLREIKILKHFKH 68
Query: 209 DNILPLYGI----CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HIA 258
           +NI+ ++ I     FE      + +           LM+ +   ++ TQ L      +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQE----------LMQTDLHRVISTQMLSDDHIQYFI 118
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ---------EGPIEKA 309
             T   ++ LH     +IH D+K +N+L+N + D  + DFGL +           P  + 
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 310 THITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           + +T      TR Y  P   L   + S  +DV+  G +L EL
Sbjct: 177 SGMT--EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           +AT+ ++ +  +G G +GTVYK     +   +A+K + V   +  +       RE +L  
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVAL-- 56
Query: 200 LKYLNSCRHDNILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           L+ L +  H N++ L  +C  +      K  LV+ ++     + R  + K  P  L  + 
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAET 113
Query: 255 L-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           +  + +    GL FLH+    ++H D+K  NIL+       + DFGL +      +  + 
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR----IYSYQMA 167
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           +AT+ ++ +  +G G +GTVYK     +   +A+K + V   +  +       RE +L  
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVAL-- 56
Query: 200 LKYLNSCRHDNILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           L+ L +  H N++ L  +C  +      K  LV+ ++     + R  + K  P  L  + 
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAET 113
Query: 255 L-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           +  + +    GL FLH+    ++H D+K  NIL+       + DFGL +      +  + 
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR----IYSYQMA 167
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I  FGL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 43/220 (19%)
Query: 150 LNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  +G G +G+V        +  +AVKKL      R  ++L   +R  + REL+ L   +
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKL-----SRPFQSLIHARR--TYRELRLLKHLK 85
Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHIAKG 260
           H+N++ L  +            + P  S+ED         LM  +  +++  Q L     
Sbjct: 86  HENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV 133
Query: 261 TSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
             L      GL+++HS    +IH D+K +N+ +N   +  I DFGL ++   E   ++  
Sbjct: 134 QFLVYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV-- 189
Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                TR Y   E ++     +  VD++  G ++ EL  G
Sbjct: 190 ----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I DF L +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 152 ILGKGGFGTVYKGV-WEKTTIAVKKLEVHRND-RAVETLNQ---CQREQSLRELKYLNSC 206
            +  G +G V  GV  E   +A+K++    +D R V  L+    C+R   LRE++ LN  
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR--VLREIRLLNHF 86
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG------ 260
            H NIL L  I     +  +   Y+         LM+ +   ++  QR+ I+        
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTE------LMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 261 --TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK-ATHITLKRV 317
               LGL  LH  E  ++H D+   NILL  + D  I DF L +E   +   TH    R 
Sbjct: 141 YHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
               P L  +F   K  +  VD++  G V+ E+
Sbjct: 199 YRA-PELVMQF---KGFTKLVDMWSAGCVMAEM 227

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I D GL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 152 ILGKGGFGTVYKGV-WEKTTIAVKKLEVHRND-RAVETLNQ---CQREQSLRELKYLNSC 206
            +  G +G V  GV  E   +A+K++    +D R V  L+    C+R   LRE++ LN  
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR--VLREIRLLNHF 86
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG------ 260
            H NIL L  I     +  +   Y+         LM+ +   ++  QR+ I+        
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTE------LMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 261 --TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK-ATHITLKRV 317
               LGL  LH  E  ++H D+   NILL  + D  I DF L +E   +   TH    R 
Sbjct: 141 YHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
               P L  +F   K  +  VD++  G V+ E+
Sbjct: 199 YRA-PELVMQF---KGFTKLVDMWSAGCVMAEM 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 20/219 (9%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLN-QCQREQSL 197
           ++AT+ ++ +  +G G +GTVYK     +   +A+K + V         L     RE +L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 198 RELKYLNSCRHDNILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
             L+ L +  H N++ L  +C  +      K  LV+ ++     + R  + K  P  L  
Sbjct: 65  --LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPA 119
Query: 253 QRL-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           + +  + +    GL FLH+    ++H D+K  NIL+       + DFGL +      +  
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR----IYSYQ 173
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           + L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 40/220 (18%)
Query: 151 NILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           ++LG+G +G V     + T   +A+KK+E    D+ +  L      ++LRE+K L   +H
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFAL------RTLREIKILKHFKH 68
Query: 209 DNILPLYGI----CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HIA 258
           +NI+ ++ I     FE      + +           LM+ +   ++ TQ L      +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQE----------LMQTDLHRVISTQMLSDDHIQYFI 118
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ-------EGPIEKATH 311
             T   ++ LH     +IH D+K +N+L+N + D  + DFGL +       +        
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             +     TR Y  P   L   + S  +DV+  G +L EL
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 32/236 (13%)
Query: 144 TNNWDKLNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ +D +  +G G FG   + +    K  +AVK +E      A++       E   RE+ 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAID-------ENVQREII 68
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
              S RH NI+    +        ++  Y   G L +R+       ++     + Q L  
Sbjct: 69  NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS- 127
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLK 315
                 G+ + HS +  + H D+K  N LL+    P   I DFG ++        H   K
Sbjct: 128 ------GVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS----VLHSQPK 175
Query: 316 RVNGTRPYLPHEFLVGKRLSTKV-DVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
              GT  Y+  E L+ +    K+ DV+  G+ L+ +  G   ++D      + K++
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   +K T      +  +  R   +     RE+  RE+  L   RH NI+
Sbjct: 20  LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ I        L+   +  G L D L  K++      TQ L   K    G+ +LHS+ 
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL---KQILDGVHYLHSKR 135
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     + DFG+  +  IE       K + GT  ++  E 
Sbjct: 136 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNE--FKNIFGTPEFVAPEI 189
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           +  + L  + D++  G++ + L +G   +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           + ++  LG G +G V     +K T   + +++ R      + N     + L E+  L   
Sbjct: 39  YQRVKKLGSGAYGEVLL-CRDKVTHVERAIKIIRKTSVSTSSNS----KLLEEVAVLKLL 93
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL--MKKNTPSLLWTQRLHIAKGTSLG 264
            H NI+ LY    +   Y LV      G L D ++  MK N           I K    G
Sbjct: 94  DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE-----VDAAVIIKQVLSG 148
Query: 265 LQFLHSREPPLIHGDIKSANILL-NHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGTR 321
           + +LH     ++H D+K  N+LL +   D +I   DFGL+     +K     +K   GT 
Sbjct: 149 VTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTA 202
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L  K+   K DV+  G++LF L  G
Sbjct: 203 YYIAPEVL-RKKYDEKCDVWSIGVILFILLAG 233

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 14/209 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   +K T      +  +  R   +     RE+  RE+  L   RH NI+
Sbjct: 13  LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ I        L+   +  G L D L  K++      TQ L   K    G+ +LHS+ 
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL---KQILDGVHYLHSKR 128
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     + DFG+  +  IE       K + GT  ++  E 
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNE--FKNIFGTPEFVAPEI 182
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           +  + L  + D++  G++ + L +G   +
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 34/264 (12%)
Query: 128 VLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAV 185
           +LG      +++     + +D  ++LG G F  V     ++T   +A+K +       A 
Sbjct: 1   MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-------AK 53
Query: 186 ETLNQCQREQSLR-ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK- 243
           E L    +E S+  E+  L+  +H NI+ L  I    G   L+ + +  G L DR++ K 
Sbjct: 54  EALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 244 ---KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL---LNHHMDPVIGD 297
              +   S L  Q L   K       +LH  +  ++H D+K  N+L   L+     +I D
Sbjct: 112 FYTERDASRLIFQVLDAVK-------YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 298 FGLTQ-EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
           FGL++ E P        L    GT  Y+  E L  K  S  VD +  G++ + L  G   
Sbjct: 163 FGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
Query: 357 YDDTRRSERHLKSLVEKYSEENMY 380
           + D   ++   + L  +Y  ++ Y
Sbjct: 218 FYDENDAKLFEQILKAEYEFDSPY 241

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I D GL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+ L 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELRLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
             +H+N++ L  +            + P  SLE+         LM  +  +++  Q+L  
Sbjct: 77  HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 258 AKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                L      GL+++HS +  +IH D+K +N+ +N   +  I D GL +    E   +
Sbjct: 125 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY 182
Query: 312 ITLKRVNGTRPY-LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-- 368
           +       TR Y  P   L     +  VD++  G ++ EL TG   +  T   ++ LK  
Sbjct: 183 V------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLI 235
Query: 369 ---------SLVEKYSEENMYDLVDKNAQPIELNIAYAFF 399
                     L++K S E+  + +    Q  ++N A  F 
Sbjct: 236 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 34/264 (12%)
Query: 128 VLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAV 185
           +LG      +++     + +D  ++LG G F  V     ++T   +A+K +       A 
Sbjct: 1   MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-------AK 53
Query: 186 ETLNQCQREQSLR-ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK- 243
           E L    +E S+  E+  L+  +H NI+ L  I    G   L+ + +  G L DR++ K 
Sbjct: 54  EALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 244 ---KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL---LNHHMDPVIGD 297
              +   S L  Q L   K       +LH  +  ++H D+K  N+L   L+     +I D
Sbjct: 112 FYTERDASRLIFQVLDAVK-------YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 298 FGLTQ-EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
           FGL++ E P        L    GT  Y+  E L  K  S  VD +  G++ + L  G   
Sbjct: 163 FGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
Query: 357 YDDTRRSERHLKSLVEKYSEENMY 380
           + D   ++   + L  +Y  ++ Y
Sbjct: 218 FYDENDAKLFEQILKAEYEFDSPY 241

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 34/245 (13%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYL 203
           +D  ++LG G F  V     ++T   +A+K +       A E L    +E S+  E+  L
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-------AKEALEG--KEGSMENEIAVL 70
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK----KNTPSLLWTQRLHIAK 259
           +  +H NI+ L  I    G   L+ + +  G L DR++ K    +   S L  Q L   K
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANIL---LNHHMDPVIGDFGLTQ-EGPIEKATHITLK 315
                  +LH  +  ++H D+K  N+L   L+     +I DFGL++ E P        L 
Sbjct: 131 -------YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----GSVLS 176
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
              GT  Y+  E L  K  S  VD +  G++ + L  G   + D   ++   + L  +Y 
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 376 EENMY 380
            ++ Y
Sbjct: 237 FDSPY 241

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           +AT+ ++ +  +G G +GTVYK     +   +A+K + V   +  +       RE +L  
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVAL-- 56
Query: 200 LKYLNSCRHDNILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           L+ L +  H N++ L  +C  +      K  LV+ ++     + R  + K  P  L  + 
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAET 113
Query: 255 L-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           +  + +    GL FLH+    ++H D+K  NIL+       + DFGL +      +  + 
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLAR----IYSYQMA 167
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 168 LFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N++   ILG+G    V + + + T    AVK ++V           Q  RE +L+E+  L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 204 NSCR-HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
                H NI+ L         + LV+  M  G L D  L +K T S   T++  I +   
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRK--IMRALL 134
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT-QEGPIEKATHITLKRVNGTR 321
             +  LH     ++H D+K  NILL+  M+  + DFG + Q  P EK     L+ V GT 
Sbjct: 135 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTP 187
Query: 322 PYLPHEFLVGKR------LSTKVDVYGFGIVLFELATG 353
            YL  E +             +VD++  G++++ L  G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 34/245 (13%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYL 203
           +D  ++LG G F  V     ++T   +A+K +      +A+E      +E S+  E+  L
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA----KKALEG-----KEGSMENEIAVL 70
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK----KNTPSLLWTQRLHIAK 259
           +  +H NI+ L  I    G   L+ + +  G L DR++ K    +   S L  Q L   K
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANIL---LNHHMDPVIGDFGLTQ-EGPIEKATHITLK 315
                  +LH  +  ++H D+K  N+L   L+     +I DFGL++ E P        L 
Sbjct: 131 -------YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-----VLS 176
Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
              GT  Y+  E L  K  S  VD +  G++ + L  G   + D   ++   + L  +Y 
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 376 EENMY 380
            ++ Y
Sbjct: 237 FDSPY 241

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  +G G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTIGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  YMP G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + ++++  +G G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTIGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  YMP G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 47/254 (18%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+LN+   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGI-DKTATXRTVAVKMLK--------EGATHSEHRAL 77
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN--------- 245
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 246 ----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
               T   L      +AKG    ++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 138 KDFLTLEHLIXYSFQVAKG----MEFLASRK--XIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 192 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 248
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 249 GVKIDEEFXRRLKE 262

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 132/305 (43%), Gaps = 47/305 (15%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLN 189
           GT ++ +Q +++    +  L  +G GG   V++ + EK  I A+K + +   D   +TL+
Sbjct: 14  GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLD 71
Query: 190 QCQREQSLRELKYLNSCRH--DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
             + E     + YLN  +   D I+ LY     T +Y  +Y  M  G+++    +KK   
Sbjct: 72  SYRNE-----IAYLNKLQQHSDKIIRLYDYEI-TDQY--IYMVMECGNIDLNSWLKKKKS 123
Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
              W +R    K     +  +H     ++H D+K AN L+   M  +I DFG+  +   +
Sbjct: 124 IDPW-ERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPD 179
Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTK-------------VDVYGFGIVLFELATGM 354
             + +   +V GT  Y+P E +  K +S+               DV+  G +L+ +  G 
Sbjct: 180 TTSVVKDSQV-GTVNYMPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER- 413
             +         L ++++   E    D+ +K+ Q            + K   K++PK+R 
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-----------DVLKCCLKRDPKQRI 285
Query: 414 --PEM 416
             PE+
Sbjct: 286 SIPEL 290

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 115/254 (45%), Gaps = 47/254 (18%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+LN+   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGI-DKTATXRTVAVKMLK--------EGATHSEHRAL 77
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN--------- 245
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 246 ----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
               T   L      +AKG    ++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 138 KDFLTLEHLICYSFQVAKG----MEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 192 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 248
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 249 GVKIDEEFCRRLKE 262

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++ + ++  LG G +G V     +K T A + +++ +      T N       L E+  L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLL-CKDKLTGAERAIKIIKKSSVTTTSNSGAL---LDEVAVL 75
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ LY    +   Y LV      G L D +++++    +       I K    
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV---DAAVIMKQVLS 132
Query: 264 GLQFLHSREPPLIHGDIKSANILL-NHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGT 320
           G  +LH     ++H D+K  N+LL +   D +I   DFGL+    +       +K   GT
Sbjct: 133 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG----KMKERLGT 186
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             Y+  E L  K+   K DV+  G++L+ L  G
Sbjct: 187 AYYIAPEVL-RKKYDEKCDVWSCGVILYILLCG 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N++   ILG+G    V + + + T    AVK ++V           Q  RE +L+E+  L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 204 NSCR-HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
                H NI+ L         + LV+  M  G L D  L +K T S   T++  I +   
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRK--IMRALL 134
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT-QEGPIEKATHITLKRVNGTR 321
             +  LH     ++H D+K  NILL+  M+  + DFG + Q  P EK     L+ V GT 
Sbjct: 135 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-----LRSVCGTP 187
Query: 322 PYLPHEFLVGKR------LSTKVDVYGFGIVLFELATG 353
            YL  E +             +VD++  G++++ L  G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 146 NWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N++   ILG+G    V + + + T    AVK ++V           Q  RE +L+E+  L
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 204 NSCR-HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
                H NI+ L         + LV+  M  G L D  L +K T S   T++  I +   
Sbjct: 65  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRK--IMRALL 121
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT-QEGPIEKATHITLKRVNGTR 321
             +  LH     ++H D+K  NILL+  M+  + DFG + Q  P EK     L+ V GT 
Sbjct: 122 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTP 174
Query: 322 PYLPHEFLVGKR------LSTKVDVYGFGIVLFELATG 353
            YL  E +             +VD++  G++++ L  G
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 110/239 (46%), Gaps = 19/239 (7%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLR 198
            L  + ++   ++GKG F  V + +  +T    AVK ++V +      +      E   R
Sbjct: 20  VLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAK----FTSSPGLSTEDLKR 75
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--H 256
           E    +  +H +I+ L       G   +V+ +M    L   ++ K+     ++++ +  H
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASH 134
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILL--NHHMDPV-IGDFGLTQEGPIEKATHIT 313
             +     L++ H     +IH D+K  N+LL    +  PV +GDFG+  +  + ++  + 
Sbjct: 135 YMRQILEALRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVA 190
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             RV GT  ++  E +  +     VDV+G G++LF L +G   +  T+  ER  + +++
Sbjct: 191 GGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIK 246

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 45/250 (18%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           W   +ILG+G    V++G  +KT    A+K        R V+          +RE + L 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--------QMREFEVLK 62
Query: 205 SCRHDNILPLYGICFETGKY--CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
              H NI+ L+ I  ET      L+  + P GSL   L    N   L  ++ L + +   
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG----------DFGLTQEGPIEKATHI 312
            G+   H RE  ++H +IK  NI+       VIG          DFG  +E  +E     
Sbjct: 123 GGMN--HLRENGIVHRNIKPGNIM------RVIGEDGQSVYKLTDFGAARE--LEDDEQF 172
Query: 313 TLKRVNGTRPYL---PHEFLV-----GKRLSTKVDVYGFGIVLFELATG---MRAYDDTR 361
               + GT  YL    +E  V      K+    VD++  G+  +  ATG    R ++  R
Sbjct: 173 V--SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 362 RSERHLKSLV 371
           R++  +  ++
Sbjct: 231 RNKEVMYKII 240

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++ + ++  LG G +G V     +K T A + +++ +      T N       L E+  L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLL-CKDKLTGAERAIKIIKKSSVTTTSNSGAL---LDEVAVL 58
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ LY    +   Y LV      G L D +++++    +       I K    
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV---DAAVIMKQVLS 115
Query: 264 GLQFLHSREPPLIHGDIKSANILL-NHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGT 320
           G  +LH     ++H D+K  N+LL +   D +I   DFGL+    +       +K   GT
Sbjct: 116 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK----MKERLGT 169
Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             Y+  E L  K+   K DV+  G++L+ L  G
Sbjct: 170 AYYIAPEVL-RKKYDEKCDVWSCGVILYILLCG 201

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 257 -----IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                +     +G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G+++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 91
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 147
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 148 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-----GTAQY 200
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K  S   D++  G ++++L  G+
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGL 231

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 17/220 (7%)
Query: 150 LNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L ++GKG FG V   +   E+   AVK L+     +A+    + +   S R +  L + +
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQ----KKAILKKKEEKHIMSERNV-LLKNVK 97
Query: 208 HDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
           H  ++ L+   F+T  K   V  Y+  G L   L  ++     L  +    A   +  L 
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALG 153
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LHS    +++ D+K  NILL+     V+ DFGL +E     +T  T     GT  YL  
Sbjct: 154 YLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF---CGTPEYLAP 208
Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
           E L  +     VD +  G VL+E+  G+  +     +E +
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 153 LGKGGFGTV--YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG+GGF  V   +G+ +    A+K++  H          Q  RE++ RE        H N
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCH---------EQQDREEAQREADMHRLFNHPN 87
Query: 211 ILPLYGICF-ETG---KYCLVYRYMPNGSLEDRLLMKKNTPSLLW-TQRLHIAKGTSLGL 265
           IL L   C  E G   +  L+  +   G+L + +   K+  + L   Q L +  G   GL
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE---KATHITLKRVNGTRP 322
           + +H++     H D+K  NILL     PV+ D G   +  I        +TL+     R 
Sbjct: 148 EAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 323 YL----PHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYD 358
            +    P  F V     +  + DV+  G VL+ +  G   YD
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 48/230 (20%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKL--------EVHRNDRAVETLNQCQREQSLRELKY 202
           LGKG +G V+K +  +T   +AVKK+        +  R  R +  L +    +++  L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL-- 74
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           LN  R DN   +Y          LV+ YM     E  L        L    + ++     
Sbjct: 75  LNVLRADNDRDVY----------LVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLI 119
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP-IEKATHITLKRVN--- 318
             +++LHS    L+H D+K +NILLN      + DFGL++    I + T+     +N   
Sbjct: 120 KVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 319 --------------GTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
                          TR Y   E L+G    TK +D++  G +L E+  G
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 257 -----IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                +     +G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G+++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 128
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 129 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 182
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 129
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 130 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 183
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 135
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 136 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 189
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 129
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 130 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 183
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 129
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 130 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 183
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSL----- 197
           ++ ++   ILG GG   V+           + L +HR D AV+ L     R+ S      
Sbjct: 11  SDRYELGEILGFGGMSEVHLA---------RDLRLHR-DVAVKVLRADLARDPSFYLRFR 60
Query: 198 RELKYLNSCRHDNILPLYGIC-FETGKYCLVY---RYMPNGSLEDRLLMKKNTPSLLWTQ 253
           RE +   +  H  I+ +Y     ET    L Y    Y+   +L D  ++    P +   +
Sbjct: 61  REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-MTPKR 117
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            + +       L F H     +IH D+K ANI+++      + DFG+ +       +   
Sbjct: 118 AIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              V GT  YL  E   G  +  + DVY  G VL+E+ TG
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG  +     K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTW 197
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TL    GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 198 TL---CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSL----- 197
           ++ ++   ILG GG   V+           + L +HR D AV+ L     R+ S      
Sbjct: 11  SDRYELGEILGFGGMSEVHLA---------RDLRLHR-DVAVKVLRADLARDPSFYLRFR 60
Query: 198 RELKYLNSCRHDNILPLYGICFETGKY--------CLVYRYMPNGSLEDRLLMKKNTPSL 249
           RE +   +  H  I+ +Y    +TG+          +V  Y+   +L D  ++    P +
Sbjct: 61  REAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-M 113
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              + + +       L F H     +IH D+K ANI+++      + DFG+ +       
Sbjct: 114 TPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +      V GT  YL  E   G  +  + DVY  G VL+E+ TG
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 116/252 (46%), Gaps = 41/252 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATXRTVAVKMLK--------EGATHSEHRAL 79
Query: 197 LRELKYL-NSCRHDNILPLYGICFETGKYCLV-YRYMPNGSLEDRLLMKKN-----TPSL 249
           + ELK L +   H N++ L G C + G   +V   +   G+L   L  K+N      P  
Sbjct: 80  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPED 139
Query: 250 LWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE 303
           L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL ++
Sbjct: 140 LYKDFLTLEHLIXYSFQVAKGMEFLASRK--XIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 304 GPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDT 360
             I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y   
Sbjct: 198 --IXKDPD-XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 361 RRSERHLKSLVE 372
           +  E   + L E
Sbjct: 255 KIDEEFCRRLKE 266

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 254
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 255 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 308
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 77
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N        P
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 196 RD--IXKDPD-XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 253 GVKIDEEFCRRLKE 266

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 96
Query: 209 DNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQ 266
              + LY  CF+   K      Y  NG L   L   +   S   T  R + A+  S  L+
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALE 151
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRP 322
           +LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  
Sbjct: 152 YLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQ 204
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           Y+  E L  K      D++  G ++++L  G+
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 68
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N        P
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 187 RD--IXKDPD-XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 244 GVKIDEEFCRRLKE 257

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 23  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 72
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 73  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 128
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG  +     K    
Sbjct: 129 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTW 182
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           TL    GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 183 TL---CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 131/305 (42%), Gaps = 47/305 (15%)
Query: 131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLN 189
           GT ++ +Q +++    +  L  +G GG   V++ + EK  I A+K + +   D   +TL+
Sbjct: 14  GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLD 71
Query: 190 QCQREQSLRELKYLNSCRH--DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
             + E     + YLN  +   D I+ LY     T +Y  +Y  M  G+++    +KK   
Sbjct: 72  SYRNE-----IAYLNKLQQHSDKIIRLYDYEI-TDQY--IYMVMECGNIDLNSWLKKKKS 123
Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE 307
              W +R    K     +  +H     ++H D+K AN L+   M  +I DFG+  +   +
Sbjct: 124 IDPW-ERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPD 179
Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRLSTK-------------VDVYGFGIVLFELATGM 354
               +   +V GT  Y+P E +  K +S+               DV+  G +L+ +  G 
Sbjct: 180 XXXVVKDSQV-GTVNYMPPEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER- 413
             +         L ++++   E    D+ +K+ Q            + K   K++PK+R 
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-----------DVLKCCLKRDPKQRI 285
Query: 414 --PEM 416
             PE+
Sbjct: 286 SIPEL 290

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 68
Query: 197 LRELKYL-NSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G   +V   +   G+L   L  K+N        P
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 187 RD--IXKDPD-XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 244 GVKIDEEFCRRLKE 257

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 51/288 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHR-NDRAVETLN-QCQREQSLRELKYLNSCR 207
           L  L +   G ++KG W+   I VK L+V   + R     N +C R         L    
Sbjct: 15  LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPR---------LRIFS 65
Query: 208 HDNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
           H N+LP+ G C         L+  +MP GSL + L    N   +  +Q +  A   + G+
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGM 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEKATHITLKRVNGTRPY 323
            FLH+ EP +    + S +++++  M   I   D   + + P               R Y
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--------------GRMY 170
Query: 324 LPHEFLVGKRLSTK--------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
            P  ++  + L  K         D++ F ++L+EL T    + D    E  +K  +E   
Sbjct: 171 AP-AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                         I   I+    ++ K    ++P +RP+   +  +L
Sbjct: 230 PT------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLR-ELKYLNSCRHDNI 211
           LG G  G V      KT   V    + +   A+ +  +     ++  E++ L    H  I
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHIAKGTSLGLQF 267
           + +    F+   Y +V   M  G L D+++    +K+ T  L + Q L       L +Q+
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LAVQY 268
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           LH  E  +IH D+K  N+LL+   +     I DFG ++   I   T + ++ + GT  YL
Sbjct: 269 LH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSL-MRTLCGTPTYL 322
Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
             E LV       +  VD +  G++LF   +G   + + R
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 33/244 (13%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           W   +ILG+G    V++G  +KT    A+K        R V+          +RE + L 
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--------QMREFEVLK 62
Query: 205 SCRHDNILPLYGICFETGKY--CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
              H NI+ L+ I  ET      L+  + P GSL   L    N   L  ++ L + +   
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 263 LGLQFLHSREPPLIHGDIKSANIL--LNHHMDPV--IGDFGLTQEGPIEKATHITLKRVN 318
            G+   H RE  ++H +IK  NI+  +      V  + DFG  +E  +E         + 
Sbjct: 123 GGMN--HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV--XLY 176
Query: 319 GTRPYL---PHEFLV-----GKRLSTKVDVYGFGIVLFELATG---MRAYDDTRRSERHL 367
           GT  YL    +E  V      K+    VD++  G+  +  ATG    R ++  RR++  +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 368 KSLV 371
             ++
Sbjct: 237 YKII 240

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 33/224 (14%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSL----- 197
           ++ ++   ILG GG   V+           + L +HR D AV+ L     R+ S      
Sbjct: 28  SDRYELGEILGFGGMSEVHLA---------RDLRLHR-DVAVKVLRADLARDPSFYLRFR 77
Query: 198 RELKYLNSCRHDNILPLYGICFETGKY--------CLVYRYMPNGSLEDRLLMKKNTPSL 249
           RE +   +  H  I+ +Y    +TG+          +V  Y+   +L D  ++    P +
Sbjct: 78  REAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-M 130
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              + + +       L F H     +IH D+K ANI+++      + DFG+ +       
Sbjct: 131 TPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +      V GT  YL  E   G  +  + DVY  G VL+E+ TG
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGKFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +++D    LG G FG V++ V E+ T    A K          V T ++  +E   +E++
Sbjct: 51  DHYDIHEELGTGAFGVVHR-VTERATGNNFAAK---------FVMTPHESDKETVRKEIQ 100
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            ++  RH  ++ L+    +  +  ++Y +M  G L +++  + N  S    + +   +  
Sbjct: 101 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--DEAVEYMRQV 158
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKATHITLKRVNG 319
             GL  +H  E   +H D+K  NI+        +   DFGLT     +++  +T     G
Sbjct: 159 CKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TG 212
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKS 369
           T  +   E   GK +    D++  G++ + L +G+  +      E  R++KS
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 264

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 100/244 (40%), Gaps = 49/244 (20%)
Query: 144 TNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            ++++++ +LG+G FG V K     +    A+KK  +   +  + T+        L E+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTI--------LSEVM 54
Query: 202 YLNSCRHDNILPLYGICFETGKYC-------------LVYRYMPNGSLEDRLLMKKNTPS 248
            L S  H  ++  Y    E   +              +   Y  N +L D  L+     +
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD--LIHSENLN 112
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               +   + +     L ++HS+   +IH D+K  NI ++   +  IGDFGL +   + +
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFIDESRNVKIGDFGLAKN--VHR 168
Query: 309 ATHI-------------TLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFEL---- 350
           +  I              L    GT  Y+  E L G    + K+D+Y  GI+ FE+    
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228
Query: 351 ATGM 354
           +TGM
Sbjct: 229 STGM 232

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 18  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 187
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 13/157 (8%)
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSL----EDRLLMKKNTPSLLWTQR 254
           EL+ +   +++  L   GI     +  ++Y YM N S+    E   ++ KN    +  Q 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 255 LH-IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           +  I K       ++H+ E  + H D+K +NIL++ +    + DFG   E  ++K     
Sbjct: 153 IKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG-ESEYMVDKK---- 206
Query: 314 LKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLF 348
           +K   GT  ++P EF   +      KVD++  GI L+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 77
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N        P
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 196 RD--IYKDPD-XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 253 GVKIDEEFCRRLKE 266

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 18  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 134 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 187
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 32/236 (13%)
Query: 144 TNNWDKLNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ ++ +  +G G FG   + +       +AVK +E  R ++  E +         RE+ 
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE--RGEKIDENVK--------REII 67
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
              S RH NI+    +        +V  Y   G L +R+       ++     + Q +  
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 126
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLK 315
                 G+ + H+ +  + H D+K  N LL+    P   I DFG ++        H   K
Sbjct: 127 ------GVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKAS----VLHSQPK 174
Query: 316 RVNGTRPYLPHEFLVGKRLSTKV-DVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
              GT  Y+  E L+ K    KV DV+  G+ L+ +  G   ++D    +   K++
Sbjct: 175 SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +++D    LG G FG V++ V E+ T    A K          V T ++  +E   +E++
Sbjct: 157 DHYDIHEELGTGAFGVVHR-VTERATGNNFAAK---------FVMTPHESDKETVRKEIQ 206
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            ++  RH  ++ L+    +  +  ++Y +M  G L +++  + N  S    + +   +  
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--DEAVEYMRQV 264
Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKATHITLKRVNG 319
             GL  +H  E   +H D+K  NI+        +   DFGLT     +++  +T     G
Sbjct: 265 CKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TG 318
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKS 369
           T  +   E   GK +    D++  G++ + L +G+  +      E  R++KS
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 68
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 124
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 125 LHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 177
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 67
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 123
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 124 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 176
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSL----- 197
           ++ ++   ILG GG   V+           + L  HR D AV+ L     R+ S      
Sbjct: 11  SDRYELGEILGFGGMSEVHLA---------RDLRDHR-DVAVKVLRADLARDPSFYLRFR 60
Query: 198 RELKYLNSCRHDNILPLYGICFETGKY--------CLVYRYMPNGSLEDRLLMKKNTPSL 249
           RE +   +  H  I+ +Y    +TG+          +V  Y+   +L D  ++    P +
Sbjct: 61  REAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-M 113
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              + + +       L F H     +IH D+K ANIL++      + DFG+ +       
Sbjct: 114 TPKRAIEVIADACQALNFSHQNG--IIHRDVKPANILISATNAVKVVDFGIARAIADSGN 171
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +      V GT  YL  E   G  +  + DVY  G VL+E+ TG
Sbjct: 172 SVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 69
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 125
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 126 LHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 178
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 209

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + ++++  +G G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTIGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 66
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 122
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 123 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 175
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGVFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 77
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N        P
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 196 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 253 GVKIDEEFCRRLKE 266

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 89
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 145
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 146 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 198
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 89
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 145
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 146 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 198
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++N+D    LGKG F  V + V + T +      ++    +     + +RE  +      
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI------ 58
Query: 204 NSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             CR   H NI+ L+    E   + LV+  +  G L + ++ ++           H  + 
Sbjct: 59  --CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 113
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRV 317
               + + HS    ++H ++K  N+LL          + DFGL  E    +A H      
Sbjct: 114 ILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GF 167
Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            GT  YL  E L     S  VD++  G++L+ L  G   + D
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 92
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 148
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 149 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-----GTAQY 201
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 106/242 (43%), Gaps = 26/242 (10%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           L +   ++D + ++G+G FG V + V  K +  V  +++      ++  +     +    
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 200 LKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
           + + NS     ++ L+   F+  KY  +V  YMP G L + L+   + P   W  + + A
Sbjct: 129 MAFANSPW---VVQLF-CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEK-WA-KFYTA 181
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           +   L L  +HS    LIH D+K  N+LL+ H    + DFG   +  +++   +      
Sbjct: 182 E-VVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMK--MDETGMVHCDTAV 236
Query: 319 GTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
           GT  Y+  E L  +        + D +  G+ LFE+  G   +        +  SLV  Y
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF--------YADSLVGTY 288
Query: 375 SE 376
           S+
Sbjct: 289 SK 290

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 257 -----IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                +     +G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLVGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++N+D    LGKG F  V + V + T +      ++    +     + +RE  +      
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI------ 81
Query: 204 NSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             CR   H NI+ L+    E   + LV+  +  G L + ++ ++           H  + 
Sbjct: 82  --CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 136
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRV 317
               + + HS    ++H ++K  N+LL          + DFGL  E    +A H      
Sbjct: 137 ILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GF 190
Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            GT  YL  E L     S  VD++  G++L+ L  G   + D
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 79
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N        P
Sbjct: 80  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAP 139
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 140 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 197
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 198 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 254
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 255 GVKIDEEFCRRLKE 268

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 88
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 144
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 145 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 197
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 88
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 144
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 145 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-----GTAQY 197
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 68
Query: 197 LRELKYL-NSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G   +V   +   G+L   L  K+N        P
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 187 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 244 GVKIDEEFCRRLKE 257

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPAFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           +  + L  + D++  G++ + L +G   +
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++N+D    LGKG F  V + V + T +      ++    +     + +RE  +      
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI------ 58
Query: 204 NSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             CR   H NI+ L+    E   + LV+  +  G L + ++ ++           H  + 
Sbjct: 59  --CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 113
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRV 317
               + + HS    ++H ++K  N+LL          + DFGL  E    +A H      
Sbjct: 114 ILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GF 167
Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            GT  YL  E L     S  VD++  G++L+ L  G   + D
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 114
Query: 197 LRELKYL-NSCRHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G    ++  +   G+L   L  K+N        P
Sbjct: 115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 174
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 175 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 232
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 233 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 290 GVKIDEEFCRRLKE 303

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 23/222 (10%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++N+D    LGKG F  V + V + T +      ++    +     + +RE  +      
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI------ 57
Query: 204 NSCR---HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             CR   H NI+ L+    E   + LV+  +  G L + ++ ++           H  + 
Sbjct: 58  --CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 112
Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRV 317
               + + HS    ++H ++K  N+LL          + DFGL  E    +A H      
Sbjct: 113 ILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GF 166
Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            GT  YL  E L     S  VD++  G++L+ L  G   + D
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 208

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 92
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 148
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 149 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 201
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 151 NILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +++GKG FG V K     E+  +A+K   + +N +A   LNQ Q E  L EL  +N  +H
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAF--LNQAQIEVRLLEL--MN--KH 110
Query: 209 DNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           D  +  Y +  +         CLV+  M + +L D LL   N   +        A+    
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYD-LLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGTR 321
            L FL + E  +IH D+K  NILL +     I   DFG + +        I       +R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQ------SR 222
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y   E L+G      +D++  G +L E+ TG
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 73
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 129
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 130 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 182
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 213

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 91
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 147
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 148 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 200
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 91
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 147
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 148 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 200
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 89
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 145
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 146 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-----GTAQY 198
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSL----- 197
           ++ ++   ILG GG   V+           + L  HR D AV+ L     R+ S      
Sbjct: 11  SDRYELGEILGFGGMSEVHLA---------RDLRDHR-DVAVKVLRADLARDPSFYLRFR 60
Query: 198 RELKYLNSCRHDNILPLYGICFETGKY--------CLVYRYMPNGSLEDRLLMKKNTPSL 249
           RE +   +  H  I+ +Y    +TG+          +V  Y+   +L D  ++    P +
Sbjct: 61  REAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-M 113
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              + + +       L F H     +IH D+K ANI+++      + DFG+ +       
Sbjct: 114 TPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +      V GT  YL  E   G  +  + DVY  G VL+E+ TG
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLN-QCQREQSL----- 197
           ++ ++   ILG GG   V+           + L  HR D AV+ L     R+ S      
Sbjct: 11  SDRYELGEILGFGGMSEVHLA---------RDLRDHR-DVAVKVLRADLARDPSFYLRFR 60
Query: 198 RELKYLNSCRHDNILPLYGICFETGKY--------CLVYRYMPNGSLEDRLLMKKNTPSL 249
           RE +   +  H  I+ +Y    +TG+          +V  Y+   +L D  ++    P +
Sbjct: 61  REAQNAAALNHPAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-M 113
Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
              + + +       L F H     +IH D+K ANI+++      + DFG+ +       
Sbjct: 114 TPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +      V GT  YL  E   G  +  + DVY  G VL+E+ TG
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 151 NILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +++GKG FG V K     E+  +A+K   + +N +A   LNQ Q E  L EL  +N  +H
Sbjct: 41  SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAF--LNQAQIEVRLLEL--MN--KH 91
Query: 209 DNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           D  +  Y +  +         CLV+  M + +L D LL   N   +        A+    
Sbjct: 92  DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYD-LLRNTNFRGVSLNLTRKFAQQMCT 149
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGTR 321
            L FL + E  +IH D+K  NILL +     I   DFG + +  + +  +  ++    +R
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQXIQ----SR 203
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y   E L+G      +D++  G +L E+ TG
Sbjct: 204 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 235

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 148 DKLNI---LGKGGFGTVYK----GVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQS 196
           D+L +   LG+G FG V +    G+ +KT    T+AVK L+        E     +    
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLK--------EGATHSEHRAL 68
Query: 197 LRELKYL-NSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRLLMKKN-------TP 247
           + ELK L +   H N++ L G C + G   +V   +   G+L   L  K+N        P
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 248 SLLWTQRLHI------AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             L+   L +      +   + G++FL SR+   IH D+ + NILL+      I DFGL 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYD 358
           ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+ + G   Y 
Sbjct: 187 RD--IYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 243
Query: 359 DTRRSERHLKSLVE 372
             +  E   + L E
Sbjct: 244 GVKIDEEFCRRLKE 257

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 91
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 147
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 148 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 200
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 32/236 (13%)
Query: 144 TNNWDKLNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ ++ +  +G G FG   + +       +AVK +E  R ++  E +         RE+ 
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE--RGEKIDENVK--------REII 66
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
              S RH NI+    +        +V  Y   G L +R+       ++     + Q +  
Sbjct: 67  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 125
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLK 315
                 G+ + H+ +  + H D+K  N LL+    P   I DFG ++        H   K
Sbjct: 126 ------GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS----VLHSQPK 173
Query: 316 RVNGTRPYLPHEFLVGKRLSTKV-DVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
              GT  Y+  E L+ K    KV DV+  G+ L+ +  G   ++D    +   K++
Sbjct: 174 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 229

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + +   P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           +  + L  + D++  G++ + L +G   +
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 26/212 (12%)
Query: 151 NILGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +++GKG FG V K     E+  +A+K   + +N +A   LNQ Q E  L EL  +N  +H
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAF--LNQAQIEVRLLEL--MN--KH 110
Query: 209 DNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           D  +  Y +  +         CLV+  M + +L D LL   N   +        A+    
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYD-LLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKATHITLKRVNGTR 321
            L FL + E  +IH D+K  NILL +     I   DFG + +        I       +R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQ------SR 222
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y   E L+G      +D++  G +L E+ TG
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ--CQREQSL----RELKYLN 204
            ILG+G F T         T+  ++L   R + A++ L +    +E  +    RE   ++
Sbjct: 36  KILGEGSFST---------TVLARELATSR-EYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSL 263
              H   + LY    +  K      Y  NG L   L   +   S   T  R + A+  S 
Sbjct: 86  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS- 141
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNG 319
            L++LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         G
Sbjct: 142 ALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----G 194
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           T  Y+  E L  K      D++  G ++++L  G+
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 91
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 147
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 148 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 200
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 35/226 (15%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           + +L  +G G  G V        T+    + V +  R  +  NQ   +++ REL  L   
Sbjct: 26  YQQLKPIGSGAQGIVCAAF---DTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCV 80
Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHIAK 259
            H NI+ L  +            + P  +LE+         LM  N   ++  +  H   
Sbjct: 81  NHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERM 128
Query: 260 GTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
              L     G++ LHS    +IH D+K +NI++       I DFGL +       T+  +
Sbjct: 129 SYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNFMM 182
Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
                TR Y   E ++G   +  VD++  G ++ EL  G   +  T
Sbjct: 183 TPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGT 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 91
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 147
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 148 LHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 200
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGL 231

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 15/215 (6%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           LG G F  V K   EK+T      +  +  R   +     RE   RE+  L   +H N++
Sbjct: 19  LGSGQFAVV-KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE 272
            L+ +        L+   +  G L D L  K+   SL   +     K    G+ +LHS +
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 273 PPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
             + H D+K  NI+L     P     I DFGL  +  I+       K + GT  ++  E 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNE--FKNIFGTPEFVAPEI 188
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAY-DDTRR 362
           +  + L  + D++  G++ + L +G   +  DT++
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 107
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 163
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG  +   ++ AT  
Sbjct: 164 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGATWT 218
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 219 ----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 24/211 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            ILG+G F TV       T+   A+K LE          + + +     RE   ++   H
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDH 94
Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT-QRLHIAKGTSLGLQF 267
              + LY    +  K      Y  NG L   L   +   S   T  R + A+  S  L++
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVS-ALEY 150
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHITLKRVNGTRPY 323
           LH +   +IH D+K  NILLN  M   I DFG    L+ E    +A         GT  Y
Sbjct: 151 LHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-----GTAQY 203
Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           +  E L  K      D++  G ++++L  G+
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 78
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 79  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 126
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 127 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 180
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 79
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 80  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 127
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 128 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 181
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 182 FMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 138 QELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           +   +  ++ + +  LG+G +G V K   V      AVK++      RA  T+N  ++++
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI------RA--TVNSQEQKR 78
Query: 196 SLRELKY-LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED---RLLMKKNT-PSLL 250
            L +L     +      +  YG  F  G   +    + + SL+    +++ K  T P  +
Sbjct: 79  LLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDI 137
Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
             +   IA      L+ LHS+   +IH D+K +N+L+N        DFG++     + A 
Sbjct: 138 LGK---IAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAK 193
Query: 311 HITLKRVNGTRPYLPHEF----LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
            I      G +PY   E     L  K  S K D++  GI   ELA     YD      + 
Sbjct: 194 DID----AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQ 249
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
           LK +VE+ S +   D             +  F     Q  K+N KERP
Sbjct: 250 LKQVVEEPSPQLPAD-----------KFSAEFVDFTSQCLKKNSKERP 286

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 35/243 (14%)
Query: 131 GTPHIPYQELTLATNNWDKLNI---LGKGGFGTVYKGV-------WEKTTIAVKKLEVHR 180
           GT ++ +Q +   T   D   +   LGKG F  V + V       +    I  KKL   R
Sbjct: 14  GTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-R 72
Query: 181 NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL 240
           + + +E           RE +     +H NI+ L+    E G + LV+  +  G L + +
Sbjct: 73  DHQKLE-----------REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI 121
Query: 241 LMKKNTPSLLWTQRLH-IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IG 296
           + ++       +  +H I +  +      H  +  ++H D+K  N+LL          + 
Sbjct: 122 VAREYYSEADASHCIHQILESVN------HIHQHDIVHRDLKPENLLLASKCKGAAVKLA 175
Query: 297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
           DFGL  E   E+          GT  YL  E L        VD++  G++L+ L  G   
Sbjct: 176 DFGLAIEVQGEQQAWFGFA---GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232
Query: 357 YDD 359
           + D
Sbjct: 233 FWD 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 39/251 (15%)
Query: 153 LGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG+G    VY+   + T    A+K L+   + + V T           E+  L    H N
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-----------EIGVLLRLSHPN 109
Query: 211 ILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQF 267
           I+ L  I FET  +  LV   +  G L DR++ K       +++R      K     + +
Sbjct: 110 IIKLKEI-FETPTEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAY 163
Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV------IGDFGLTQEGPIEKATHITLKRVNGTR 321
           LH  E  ++H D+K  N+L   +  P       I DFGL++   +E    + +K V GT 
Sbjct: 164 LH--ENGIVHRDLKPENLL---YATPAPDAPLKIADFGLSK--IVEH--QVLMKTVCGTP 214
Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV--EKYSEENM 379
            Y   E L G     +VD++  GI+ + L  G   + D R  +   + ++  E Y     
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274
Query: 380 YDLVDKNAQPI 390
           +D V  NA+ +
Sbjct: 275 WDEVSLNAKDL 285

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 95/236 (40%), Gaps = 32/236 (13%)
Query: 144 TNNWDKLNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ ++ +  +G G FG   + +       +AVK +E  R ++    +         RE+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE--RGEKIAANVK--------REII 67
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
              S RH NI+    +        +V  Y   G L +R+       ++     + Q +  
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 126
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLK 315
                 G+ + H+ +  + H D+K  N LL+    P   I DFG ++        H   K
Sbjct: 127 ------GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS----VLHSQPK 174
Query: 316 RVNGTRPYLPHEFLVGKRLSTKV-DVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
              GT  Y+  E L+ K    KV DV+  G+ L+ +  G   ++D    +   K++
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             +     TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 180 FMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       + E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKEIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFGL       K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQR------E 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++ +       E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKEIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y P G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFGL       K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 30  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 79
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 135
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 136 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 186
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 58  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 107
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + + + P     
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---- 163
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 164 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 214
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 215 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLR 198
           T   + ++++  LG G FG V     ++T    A+K L+  +    V  L Q   E +L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQK----VVKLKQI--EHTLN 90
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLH 256
           E + L +     ++ L     +     +V  Y+P G +   L  + + + P      R +
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH----ARFY 146
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K        
Sbjct: 147 AAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWX 197
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y P G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLR 198
           T   + ++++  LG G FG V     ++T    A+K L+  +    V  L Q   E +L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQK----VVKLKQI--EHTLN 90
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLH 256
           E + L +     ++ L     +     +V  Y+P G +   L  + + + P      R +
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH----ARFY 146
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K        
Sbjct: 147 AAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWX 197
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLR 198
           T   + ++++  LG G FG V     ++T    A+K L+  +    V  L Q   E +L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQK----VVKLKQI--EHTLN 90
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWTQRLH 256
           E + L +     ++ L     +     +V  Y+P G +   L  + + + P      R +
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH----ARFY 146
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K        
Sbjct: 147 AAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKGRTWX 197
Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 198 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             ++    TR Y   E ++G      VD++  G ++ E+  
Sbjct: 180 FMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVC 220

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 38/222 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-C 206
           + ++G G +G VYKG   KT    A+K ++V  +          + E+  +E+  L    
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----------EEEEIKQEINMLKKYS 78
Query: 207 RHDNILPLYGICFETG------KYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAK 259
            H NI   YG   +        +  LV  +   GS+ D +   K NT    W    +I +
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICR 136
Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN- 318
               GL  LH  +  +IH DIK  N+LL  + +  + DFG++ +         T+ R N 
Sbjct: 137 EILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ------LDRTVGRRNT 188
Query: 319 --GTRPYLPHEFLVGKR-----LSTKVDVYGFGIVLFELATG 353
             GT  ++  E +            K D++  GI   E+A G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 39/228 (17%)
Query: 147 WDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + +L  +G G  G V           +AVKKL      R  +  NQ   +++ REL  L 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-----RPFQ--NQTHAKRAYRELVLLK 76
Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLHI 257
              H NI+ L  +            + P  +LE+         LM  N   ++  +  H 
Sbjct: 77  CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE 124
Query: 258 AKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
                L     G++ LHS    +IH D+K +NI++       I DFGL +      +T+ 
Sbjct: 125 RMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----STNF 178
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
            +     TR Y   E ++G      VD++  G ++ EL  G   +  T
Sbjct: 179 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 226

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     +  L     +     +V  Y P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     +  L     +     +V  Y P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQS 196
           L  A   ++ +  +G+G +G V+K    K     +A+K++ V   +  +          +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-------ST 58
Query: 197 LRE---LKYLNSCRHDNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPS 248
           +RE   L++L +  H N++ L+ +C  +      K  LV+ ++         L K   P 
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPG 116
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
           +       +      GL FLHS    ++H D+K  NIL+       + DFGL +    + 
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           A    L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 175 A----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 30  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 79
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+P G +   L  + +   P     
Sbjct: 80  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH---- 135
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 136 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 186
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNI 211
           LG+G F    K V +K+  A           AV+ +++     + +E+  L  C  H NI
Sbjct: 19  LGEGSFSICRKCVHKKSNQAF----------AVKIISKRMEANTQKEITALKLCEGHPNI 68
Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
           + L+ +  +     LV   +  G L +R+  KK+      T+  +I +     +  +H  
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMH-- 123
Query: 272 EPPLIHGDIKSANILL---NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEF 328
           +  ++H D+K  N+L    N +++  I DFG  +  P +      LK    T  Y   E 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---PLKTPCFTLHYAAPEL 180
Query: 329 LVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
           L         D++  G++L+ + +G   +    RS
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS 215

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 22/231 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHR-NDRAVETLNQCQREQSL 197
           L  N++    I+G+GGFG VY G  +  T    A+K L+  R   +  ETL     E+ +
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIM 241
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             L     C     +      F T  K   +   M  G L   L   ++        R +
Sbjct: 242 LSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFY 296
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K  H ++  
Sbjct: 297 AAE-IILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV-- 350
Query: 317 VNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
             GT  Y+  E L  G    +  D +  G +LF+L  G   +   +  ++H
Sbjct: 351 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 399

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 22/231 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHR-NDRAVETLNQCQREQSL 197
           L  N++    I+G+GGFG VY G  +  T    A+K L+  R   +  ETL     E+ +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIM 242
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             L     C     +      F T  K   +   M  G L   L   ++        R +
Sbjct: 243 LSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFY 297
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K  H ++  
Sbjct: 298 AAE-IILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV-- 351
Query: 317 VNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
             GT  Y+  E L  G    +  D +  G +LF+L  G   +   +  ++H
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G+G  G V     + +   +AVK +++ +  R         RE    E+  +   +H N
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMRDYQHFN 103
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           ++ +Y       +  ++  ++  G+L D +   +     + T    + +     L +LH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT----VCEAVLQALAYLHA 159
Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
           +   +IH DIKS +ILL       + DFG   +  I K      K + GT  ++  E + 
Sbjct: 160 Q--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVP-KRKXLVGTPYWMAPEVIS 214
Query: 331 GKRLSTKVDVYGFGIVLFELATG 353
               +T+VD++  GI++ E+  G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 22/231 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHR-NDRAVETLNQCQREQSL 197
           L  N++    I+G+GGFG VY G  +  T    A+K L+  R   +  ETL     E+ +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIM 242
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             L     C     +      F T  K   +   M  G L   L   ++        R +
Sbjct: 243 LSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFY 297
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K  H ++  
Sbjct: 298 AAE-IILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV-- 351
Query: 317 VNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
             GT  Y+  E L  G    +  D +  G +LF+L  G   +   +  ++H
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 22/231 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHR-NDRAVETLNQCQREQSL 197
           L  N++    I+G+GGFG VY G  +  T    A+K L+  R   +  ETL     E+ +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIM 242
Query: 198 RELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             L     C     +      F T  K   +   M  G L   L   ++        R +
Sbjct: 243 LSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFY 297
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
            A+   LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K  H ++  
Sbjct: 298 AAE-IILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV-- 351
Query: 317 VNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
             GT  Y+  E L  G    +  D +  G +LF+L  G   +   +  ++H
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 115
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 116 KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 217
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 193 REQSLR-ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK----KNTP 247
           +E S+  E+  L   +H+NI+ L  I        LV + +  G L DR++ K    +   
Sbjct: 63  KESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDA 122
Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLTQ-E 303
           S L  Q L         + +LH     ++H D+K  N+L    +     +I DFGL++ E
Sbjct: 123 STLIRQVLD-------AVYYLHRM--GIVHRDLKPENLLYYSQDEESKIMISDFGLSKME 173
Query: 304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
           G  +      +    GT  Y+  E L  K  S  VD +  G++ + L  G   + D   S
Sbjct: 174 GKGD-----VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDS 228
Query: 364 ERHLKSLVEKYSEENMY-DLVDKNAQPIELNI 394
           +   + L  +Y  ++ Y D +  +A+    N+
Sbjct: 229 KLFEQILKAEYEFDSPYWDDISDSAKDFIRNL 260

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 152 ILGKGGFGTV-YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN-SCRHD 209
           ILG G  GTV ++G ++   +AVK++ +   D A            L E+K L  S  H 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA------------LMEIKLLTESDDHP 69
Query: 210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----LHIAKGTSLG 264
           N++  Y  C ET  ++  +   + N +L+D +  K  +   L  Q+    + + +  + G
Sbjct: 70  NVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 265 LQFLHSREPPLIHGDIKSANILLN-------------HHMDPVIGDFGLTQEGPIEKATH 311
           +  LHS +  +IH D+K  NIL++              ++  +I DFGL ++    +++ 
Sbjct: 128 VAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 312 IT-LKRVNGTRPYLPHEFL-------VGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRR 362
            T L   +GT  +   E L         +RL+  +D++  G V +  L+ G   + D   
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            E ++   +  +S + M  L D++       IA A   I  Q    +P +RP   +V
Sbjct: 246 RESNIIRGI--FSLDEMKCLHDRSL------IAEATDLIS-QMIDHDPLKRPTAMKV 293

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 38  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 49/287 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K + +   D   +TL+  + E     + YLN  + 
Sbjct: 17  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNE-----IAYLNKLQQ 69
Query: 209 --DNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             D I+ LY   +E T +Y  +Y  M  G+++    +KK      W +R    K     +
Sbjct: 70  HSDKIIRLYD--YEITDQY--IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAV 124
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             +H     ++H D+K AN L+   M  +I DFG+  +   +  + +   +V GT  Y+P
Sbjct: 125 HTIHQHG--IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMP 180
Query: 326 HEFLVGKRLSTK-------------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
            E +  K +S+               DV+  G +L+ +  G   +         L ++++
Sbjct: 181 PEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 238
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEM 416
              E    D+ +K+ Q            + K   K++PK+R   PE+
Sbjct: 239 PNHEIEFPDIPEKDLQ-----------DVLKCCLKRDPKQRISIPEL 274

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     +  L     +     +V  Y P G +   L  + +   P     
Sbjct: 88  HTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIKTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y P G +   L  + + + P     
Sbjct: 88  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N++++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + ++++  LG G FG V         + VK +E   N  A++ L++       Q E
Sbjct: 37  TAHLDQFERIKTLGTGSFGRV---------MLVKHMETG-NHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 49/287 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K + +   D   +TL+  + E     + YLN  + 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNE-----IAYLNKLQQ 113
Query: 209 --DNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             D I+ LY   +E T +Y  +Y  M  G+++    +KK      W +R    K     +
Sbjct: 114 HSDKIIRLYD--YEITDQY--IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAV 168
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             +H     ++H D+K AN L+   M  +I DFG+  +   +  + +   +V GT  Y+P
Sbjct: 169 HTIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMP 224
Query: 326 HEFLVGKRLSTK-------------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
            E +  K +S+               DV+  G +L+ +  G   +         L ++++
Sbjct: 225 PEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEM 416
              E    D+ +K+ Q            + K   K++PK+R   PE+
Sbjct: 283 PNHEIEFPDIPEKDLQ-----------DVLKCCLKRDPKQRISIPEL 318

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             ++    TR Y   E ++G      VD++  G ++ E+  
Sbjct: 180 FMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 220

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 71
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 72  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 119
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 120 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 173
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             +     TR Y   E ++G      VD++  G ++ E+  
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 214

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 152 ILGKGGFGTV-YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN-SCRHD 209
           ILG G  GTV ++G ++   +AVK++ +   D A            L E+K L  S  H 
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA------------LMEIKLLTESDDHP 87
Query: 210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----LHIAKGTSLG 264
           N++  Y  C ET  ++  +   + N +L+D +  K  +   L  Q+    + + +  + G
Sbjct: 88  NVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 265 LQFLHSREPPLIHGDIKSANILLN-------------HHMDPVIGDFGLTQE-GPIEKAT 310
           +  LHS +  +IH D+K  NIL++              ++  +I DFGL ++    +   
Sbjct: 146 VAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 311 HITLKRVNGTRPYLPHEFL---VGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERH 366
              L   +GT  +   E L     +RL+  +D++  G V +  L+ G   + D    E +
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           +   +  +S + M  L D++       IA A   I  Q    +P +RP   +V
Sbjct: 264 IIRGI--FSLDEMKCLHDRSL------IAEATDLIS-QMIDHDPLKRPTAMKV 307

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 41/221 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  + E+  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 82
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  SLE+         LM  N   ++  +  H
Sbjct: 83  KCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 130
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 131 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 184
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
             +     TR Y   E ++G      VD++  G ++ E+  
Sbjct: 185 FMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVC 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQS 196
           L  A   ++ +  +G+G +G V+K    K     +A+K++ V   +  +          +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-------ST 58
Query: 197 LRE---LKYLNSCRHDNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPS 248
           +RE   L++L +  H N++ L+ +C  +      K  LV+ ++         L K   P 
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPG 116
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
           +       +      GL FLHS    ++H D+K  NIL+       + DFGL +    + 
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           A    L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 175 A----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 49/287 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K + +   D   +TL+  + E     + YLN  + 
Sbjct: 13  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNE-----IAYLNKLQQ 65
Query: 209 --DNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             D I+ LY   +E T +Y  +Y  M  G+++    +KK      W +R    K     +
Sbjct: 66  HSDKIIRLYD--YEITDQY--IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAV 120
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             +H     ++H D+K AN L+   M  +I DFG+  +   +  + +   +V GT  Y+P
Sbjct: 121 HTIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMP 176
Query: 326 HEFLVGKRLSTK-------------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
            E +  K +S+               DV+  G +L+ +  G   +         L ++++
Sbjct: 177 PEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 234
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEM 416
              E    D+ +K+ Q +            K   K++PK+R   PE+
Sbjct: 235 PNHEIEFPDIPEKDLQDVL-----------KCCLKRDPKQRISIPEL 270

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLXGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 152 ILGKGGFGTV-YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN-SCRHD 209
           ILG G  GTV ++G ++   +AVK++ +   D A            L E+K L  S  H 
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA------------LMEIKLLTESDDHP 87
Query: 210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----LHIAKGTSLG 264
           N++  Y  C ET  ++  +   + N +L+D +  K  +   L  Q+    + + +  + G
Sbjct: 88  NVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 265 LQFLHSREPPLIHGDIKSANILLN-------------HHMDPVIGDFGLTQE-GPIEKAT 310
           +  LHS +  +IH D+K  NIL++              ++  +I DFGL ++    +   
Sbjct: 146 VAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 311 HITLKRVNGTRPYLPHEFL---VGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERH 366
              L   +GT  +   E L     +RL+  +D++  G V +  L+ G   + D    E +
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           +   +  +S + M  L D++       IA A   I  Q    +P +RP   +V
Sbjct: 264 IIRGI--FSLDEMKCLHDRSL------IAEATDLIS-QMIDHDPLKRPTAMKV 307

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 115
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 116 KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 217
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 218 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQS 196
           L  A   ++ +  +G+G +G V+K    K     +A+K++ V   +  +          +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-------ST 58
Query: 197 LRE---LKYLNSCRHDNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPS 248
           +RE   L++L +  H N++ L+ +C  +      K  LV+ ++         L K   P 
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPG 116
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
           +       +      GL FLHS    ++H D+K  NIL+       + DFGL +    + 
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
           A    L  V  T  Y   E L+    +T VD++  G +  E+
Sbjct: 175 A----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 95/236 (40%), Gaps = 32/236 (13%)
Query: 144 TNNWDKLNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ ++ +  +G G FG   + +       +AVK +E  R ++  E +         RE+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE--RGEKIDENVK--------REII 67
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
              S RH NI+    +        +V  Y   G L +R+       ++     + Q +  
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 126
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLK 315
                 G+ + H+ +  + H D+K  N LL+    P   I  FG ++        H   K
Sbjct: 127 ------GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSS----VLHSQPK 174
Query: 316 RVNGTRPYLPHEFLVGKRLSTKV-DVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
              GT  Y+  E L+ K    KV DV+  G+ L+ +  G   ++D    +   K++
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 70
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 71  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 118
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 119 ERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTS 172
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 78  KXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 78  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 78
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 79  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 126
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 127 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 180
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 24  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 73
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 74  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 129
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 130 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFA------KRVKG 180
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 181 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 49/287 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K + +   D   +TL+  + E     + YLN  + 
Sbjct: 14  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNE-----IAYLNKLQQ 66
Query: 209 --DNILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
             D I+ LY   +E T +Y  +Y  M  G+++    +KK      W +R    K     +
Sbjct: 67  HSDKIIRLYD--YEITDQY--IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAV 121
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
             +H     ++H D+K AN L+   M  +I DFG+  +   +  + +   +V GT  Y+P
Sbjct: 122 HTIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMP 177
Query: 326 HEFLVGKRLSTK-------------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
            E +  K +S+               DV+  G +L+ +  G   +         L ++++
Sbjct: 178 PEAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
Query: 373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEM 416
              E    D+ +K+ Q +            K   K++PK+R   PE+
Sbjct: 236 PNHEIEFPDIPEKDLQDVL-----------KCCLKRDPKQRISIPEL 271

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 78
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 79  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 126
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 180
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 76
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 77  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 124
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 125 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 178
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 179 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 32  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 81
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + +   P     
Sbjct: 82  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH---- 137
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 138 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 188
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 189 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 58  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 107
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + +   P     
Sbjct: 108 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH---- 163
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 164 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 214
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 215 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 71
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 72  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 119
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 120 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 173
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 47/286 (16%)
Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K + +   D   +TL+  + E     + YLN  + 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNE-----IAYLNKLQQ 113
Query: 209 --DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
             D I+ LY     T +Y  +Y  M  G+++    +KK      W +R    K     + 
Sbjct: 114 HSDKIIRLYDYEI-TDQY--IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVH 169
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
            +H     ++H D+K AN L+   M  +I DFG+  +   +  + +   +V GT  Y+P 
Sbjct: 170 TIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GTVNYMPP 225
Query: 327 EFLVGKRLSTK-------------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
           E +  K +S+               DV+  G +L+ +  G   +         L ++++ 
Sbjct: 226 EAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEM 416
             E    D+ +K+ Q +            K   K++PK+R   PE+
Sbjct: 284 NHEIEFPDIPEKDLQDVL-----------KCCLKRDPKQRISIPEL 318

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 71
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 72  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 119
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 120 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 173
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 174 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 70
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 71  KCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 118
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTS 172
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 95/236 (40%), Gaps = 32/236 (13%)
Query: 144 TNNWDKLNILGKGGFGT--VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ ++ +  +G G FG   + +       +AVK +E  R ++  E +         RE+ 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE--RGEKIDENVK--------REII 67
Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLL----MKKNTPSLLWTQRLHI 257
              S RH NI+    +        +V  Y   G L +R+       ++     + Q +  
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 126
Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLK 315
                 G+ + H+ +  + H D+K  N LL+    P   I  FG ++        H   K
Sbjct: 127 ------GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSS----VLHSQPK 174
Query: 316 RVNGTRPYLPHEFLVGKRLSTKV-DVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
              GT  Y+  E L+ K    KV DV+  G+ L+ +  G   ++D    +   K++
Sbjct: 175 DTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 78  KXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + +   P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 41/220 (18%)
Query: 147 WDKLNILGKGGFGTV---YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +  L  +G G  G V   Y  V ++  +A+KKL      R  +  NQ   +++ REL  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RPFQ--NQTHAKRAYRELVLM 77
Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-------RLLMKKNTPSLLWTQRLH 256
               H NI+ L  +            + P  +LE+         LM  N   ++  +  H
Sbjct: 78  KXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 125
Query: 257 IAKGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
                 L     G++ LHS    +IH D+K +NI++       I DFGL +       T 
Sbjct: 126 ERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLARTA----GTS 179
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
             +     TR Y   E ++G      VD++  G ++ E+ 
Sbjct: 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 45/235 (19%)
Query: 144 TNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            ++++++ +LG+G FG V K     +    A+KK  +   +  + T+        L E+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTI--------LSEVX 54
Query: 202 YLNSCRHDNILPLYGICFETGKYC-------------LVYRYMPNGSLEDRLLMKKNTPS 248
            L S  H  ++  Y    E   +              +   Y  N +L D  L+     +
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD--LIHSENLN 112
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
               +   + +     L ++HS+   +IH ++K  NI ++   +  IGDFGL +   + +
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQ--GIIHRNLKPXNIFIDESRNVKIGDFGLAKN--VHR 168
Query: 309 ATHI-------------TLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFE 349
           +  I              L    GT  Y+  E L G    + K+D Y  GI+ FE
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           ++L +   +++ + ++G+G FG V + V  K+T  V  +++      ++  +     +  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 198 RELKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             + + NS     ++ L+   F+  +Y  +V  YMP G L + L+   + P   W  R +
Sbjct: 121 DIMAFANSPW---VVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEK-WA-RFY 173
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHI 312
            A+   L L  +HS     IH D+K  N+LL+      + DFG    + +EG +   T +
Sbjct: 174 TAE-VVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 313 TLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATG 353
                 GT  Y+  E L  +        + D +  G+ L+E+  G
Sbjct: 231 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           ++L +   +++ + ++G+G FG V + V  K+T  V  +++      ++  +     +  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 198 RELKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             + + NS     ++ L+   F+  +Y  +V  YMP G L + L+   + P   W  R +
Sbjct: 126 DIMAFANSPW---VVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEK-WA-RFY 178
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHI 312
            A+   L L  +HS     IH D+K  N+LL+      + DFG    + +EG +   T +
Sbjct: 179 TAE-VVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 313 TLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATG 353
                 GT  Y+  E L  +        + D +  G+ L+E+  G
Sbjct: 236 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++++A G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR-- 321
           G++FL SR+   IH D+ + NILL+ +    I DFGL ++  I K       R   TR  
Sbjct: 211 GMEFLSSRK--CIHRDLAARNILLSENNVVKICDFGLARD--IYKNPDYV--RKGDTRLP 264
Query: 322 -PYLPHEFLVGKRLSTKVDVYGFGIVLFEL-ATGMRAYDDTRRSERHLKSLVEKYSEENM 379
             ++  E +  K  STK DV+ +G++L+E+ + G   Y   +  E     L      E M
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL-----REGM 319
Query: 380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                + + P         ++I      ++PKERP   ++   L
Sbjct: 320 RMRAPEYSTP-------EIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           + T L L  LHS+   L+H D+K ANI L       +GDFGL     +E  T    +   
Sbjct: 164 RDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLL----VELGTAGAGEVQE 217
Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           G   Y+  E L G    T  DV+  G+ + E+A  M
Sbjct: 218 GDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNM 252

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 22/225 (9%)
Query: 142 LATNNWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           +   N++ L +LG G +G V+  + +    T  +  ++V +    V+     +  ++ R+
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 200 LKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
           +  L   R    L      F+T  K  L+  Y+  G L   L  ++          + I 
Sbjct: 111 V--LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIY 164
Query: 259 KG-TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE---GPIEKATHITL 314
            G   L L+ LH  +  +I+ DIK  NILL+ +   V+ DFGL++E      E+A     
Sbjct: 165 VGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC- 221
Query: 315 KRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATGMRAY 357
               GT  Y+  + + G        VD +  G++++EL TG   +
Sbjct: 222 ----GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + ++++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 38  TAHLDQFERIRTLGTGSFGRV---------MLVKHKETG-NHYAMKILDKQKVVKLKQIE 87
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E +   +     ++ L     +     +V  Y P G +   L  + + + P     
Sbjct: 88  HTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPH---- 143
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 144 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFA------KRVKG 194
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL  E ++ K  +  VD +  G++++E+A G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G G +G+V   + +++   +A+KKL      R  ++    +R  + REL  L   +H+N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-----RPFQSEIFAKR--AYRELLLLKHMQHEN 84
Query: 211 ILPLYGICFETGK---YCLVYRYMPNGSLEDRLLM----KKNTPSLLWTQRLHIAKGTSL 263
           ++ L  +         +   Y  MP    + + +M     +     L  Q L        
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK------- 137
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL+++HS    ++H D+K  N+ +N   +  I DFGL +    E   ++       TR Y
Sbjct: 138 GLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV------TRWY 189
Query: 324 -LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             P   L     +  VD++  G ++ E+ TG
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 32/229 (13%)
Query: 153 LGKGGFGTVYKGV-------WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
           LGKG F  V + V       +    I  KKL   R+ + +E           RE +    
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA-RDHQKLE-----------REARICRL 77
Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H NI+ L+    E G + L++  +  G L + ++ ++       +  +       +  
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-----QILE 132
Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRP 322
             LH  +  ++H D+K  N+LL   +      + DFGL  E   E+          GT  
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA---GTPG 189
Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY--DDTRRSERHLKS 369
           YL  E L        VD++  G++L+ L  G   +  +D  R  + +K+
Sbjct: 190 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 238

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 26/225 (11%)
Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           ++L +   +++ + ++G+G FG V + V  K+T  V  +++      ++  +     +  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 198 RELKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
             + + NS     ++ L+   F+  +Y  +V  YMP G L + L+   + P   W  R +
Sbjct: 126 DIMAFANSPW---VVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEK-WA-RFY 178
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHI 312
            A+   L L  +HS     IH D+K  N+LL+      + DFG    + +EG +   T +
Sbjct: 179 TAE-VVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 313 TLKRVNGTRPYLPHEFLVGK----RLSTKVDVYGFGIVLFELATG 353
                 GT  Y+  E L  +        + D +  G+ L+E+  G
Sbjct: 236 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 26/241 (10%)
Query: 123 LTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHR 180
           + P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 181 NDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDR 239
                E  N  +    +  LK ++S     ++ L         + L+  R  P   L D 
Sbjct: 81  ISDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 139
Query: 240 L-----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV 294
           +     L ++   S  W Q L   +         H     ++H DIK  NIL++ +   +
Sbjct: 140 ITERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 295 -IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELAT 352
            + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  
Sbjct: 190 KLIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
Query: 353 G 353
           G
Sbjct: 245 G 245

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           +G G +G+V   + +++   +A+KKL      R  ++    +R  + REL  L   +H+N
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-----RPFQSEIFAKR--AYRELLLLKHMQHEN 102
Query: 211 ILPLYGICFETGK---YCLVYRYMPNGSLEDRLLM----KKNTPSLLWTQRLHIAKGTSL 263
           ++ L  +         +   Y  MP    + + +M     +     L  Q L        
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLK------- 155
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL+++HS    ++H D+K  N+ +N   +  I DFGL +    E   ++       TR Y
Sbjct: 156 GLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV------TRWY 207
Query: 324 -LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             P   L     +  VD++  G ++ E+ TG
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 54/297 (18%)
Query: 152 ILGKGGFGTV-YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN-SCRHD 209
           ILG G  GTV ++G ++   +AVK++ +   D A            L E+K L  S  H 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA------------LMEIKLLTESDDHP 69
Query: 210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR----LHIAKGTSLG 264
           N++  Y  C ET  ++  +   + N +L+D +  K  +   L  Q+    + + +  + G
Sbjct: 70  NVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 265 LQFLHSREPPLIHGDIKSANILLN-------------HHMDPVIGDFGLTQE-GPIEKAT 310
           +  LHS +  +IH D+K  NIL++              ++  +I DFGL ++    +   
Sbjct: 128 VAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 311 HITLKRVNGTRPYLPHEFL-------VGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRR 362
              L   +GT  +   E L         +RL+  +D++  G V +  L+ G   + D   
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            E ++   +  +S + M  L D++       IA A   I  Q    +P +RP   +V
Sbjct: 246 RESNIIRGI--FSLDEMKCLHDRSL------IAEATDLIS-QMIDHDPLKRPTAMKV 293

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           ++LG+G +G V K V +  T+  + +++ +  +     N        +E++ L   RH N
Sbjct: 11  DLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNG--EANVKKEIQLLRRLRHKN 67
Query: 211 ILPLYGICF--ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL----- 263
           ++ L  + +  E  K  +V  Y   G  E    M  + P     +R  + +         
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQE----MLDSVPE----KRFPVCQAHGYFCQLI 119
Query: 264 -GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            GL++LHS+   ++H DIK  N+LL       I   G+  E     A   T +   G+  
Sbjct: 120 DGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVA-EALHPFAADDTCRTSQGSPA 176
Query: 323 YLPHEFLVGKRLST--KVDVYGFGIVLFELATGMRAYD 358
           + P E   G    +  KVD++  G+ L+ + TG+  ++
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 36/238 (15%)
Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQ 195
           Q      N+ + L  +G G  G V+K  + KT   IAVK++    N           +E+
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-----------KEE 66
Query: 196 SLRELKYLNSCRHDNILPLYGICFET----GKYCLVYRYMPNGSLEDRLLMKKNTP---S 248
           + R L  L+     +  P    CF T        +    M  G+  ++L  +   P    
Sbjct: 67  NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPER 124
Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
           +L    + I K     L +L  +   +IH D+K +NILL+      + DFG++     +K
Sbjct: 125 ILGKMTVAIVKA----LYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179
Query: 309 ATHITLKRVNGTRPYLPHEFL-----VGKRLSTKVDVYGFGIVLFELATGMRAYDDTR 361
           A      R  G   Y+  E +            + DV+  GI L ELATG   Y + +
Sbjct: 180 AKD----RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 30/226 (13%)
Query: 144 TNNWDKLNILGKGGFGTVYKGV-------WEKTTIAVKKLEVHRNDRAVETLNQCQREQS 196
           T+ +     +GKG F  V + V       +    I  KKL   R+ + +E          
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSA-RDHQKLE---------- 51
Query: 197 LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            RE +     +H NI+ L+    E G + LV+  +  G L + ++ ++       +  + 
Sbjct: 52  -REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ 110
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHIT 313
                 +    LH  +  ++H D+K  N+LL          + DFGL  E   ++     
Sbjct: 111 -----QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
                GT  YL  E L  +     VD++  G++L+ L  G   + D
Sbjct: 166 FA---GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWD 208

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 30  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 89
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 90  SDWGELPNGTRVPMEVVLLKKVSSG-FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 148
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 149 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 198
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 199 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 151 NILGKGGFGT-VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYLNSCRH 208
           ++LG G  GT VY+G+++   +AVK++         E  +   RE Q LRE     S  H
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRE-----SDEH 77
Query: 209 DNILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
            N++  +  C E  + +  +   +   +L++   +++   + L  + + + + T+ GL  
Sbjct: 78  PNVIRYF--CTEKDRQFQYIAIELCAATLQE--YVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 268 LHSREPPLIHGDIKSANILL---NHH--MDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           LHS    ++H D+K  NIL+   N H  +  +I DFGL ++  + + +      V GT  
Sbjct: 134 LHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 323 YLPHEFL---VGKRLSTKVDVYGFGIVLF 348
           ++  E L     +  +  VD++  G V +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFY 220

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 74
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 75  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 133
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 134 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 184 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 74
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 75  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 133
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 134 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 184 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 75
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 76  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 134
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 135 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 185 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 75
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 76  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 134
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 135 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 185 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 75
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 76  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 134
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 135 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 185 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 121
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 122 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 171
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 172 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 121
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 122 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 171
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 172 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 30  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 89
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 90  SDWGELPNGTRVPMEVVLLKKVSSG-FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 148
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 149 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 198
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 199 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 61
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 62  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 120
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 121 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 170
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 171 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 61
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 62  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 120
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 121 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 170
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 171 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKK 244
           ++ + +++  + E+  L   +H NI+  Y    +     L  V  Y   G L    ++ K
Sbjct: 43  SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS--VITK 100
Query: 245 NTPSLLWTQR---LHIAKGTSLGLQFLHSREP---PLIHGDIKSANILLNHHMDPVIGDF 298
            T    +      L +    +L L+  H R      ++H D+K AN+ L+   +  +GDF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           GL +   I        K   GT  Y+  E +     + K D++  G +L+EL   M
Sbjct: 161 GLAR---ILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 74
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 75  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 133
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 134 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 184 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC------QRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT  YL    ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 75
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 76  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 134
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 135 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 185 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 74
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 75  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 133
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 134 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 184 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 62
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 63  SDWGELPNGTRVPMEVVLLKKVSS-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 121
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 122 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 171
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 172 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 101/240 (42%), Gaps = 26/240 (10%)
Query: 124 TPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRN 181
            P N L  T   P +E     + +    +LG GGFG+VY G  V +   +A+K +E  R 
Sbjct: 35  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 94
Query: 182 DRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY-RYMPNGSLEDRL 240
               E  N  +    +  LK ++S     ++ L         + L+  R  P   L D +
Sbjct: 95  SDWGELPNGTRVPMEVVLLKKVSSG-FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 153
Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV- 294
                L ++   S  W Q L   +         H     ++H DIK  NIL++ +   + 
Sbjct: 154 TERGALQEELARSFFW-QVLEAVR---------HCHNCGVLHRDIKDENILIDLNRGELK 203
Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           + DFG    G + K T  T    +GTR Y P E++   R   +   V+  GI+L+++  G
Sbjct: 204 LIDFG---SGALLKDTVYT--DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 47/286 (16%)
Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K + +   D   +TL+  + E     + YLN  + 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN--QTLDSYRNE-----IAYLNKLQQ 113
Query: 209 --DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
             D I+ LY     T +Y  +Y  M  G+++    +KK      W +R    K     + 
Sbjct: 114 HSDKIIRLYDYEI-TDQY--IYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVH 169
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
            +H     ++H D+K AN L+   M  +I DFG+  +   +  + +   +V G   Y+P 
Sbjct: 170 TIHQH--GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQV-GAVNYMPP 225
Query: 327 EFLVGKRLSTK-------------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
           E +  K +S+               DV+  G +L+ +  G   +         L ++++ 
Sbjct: 226 EAI--KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEM 416
             E    D+ +K+ Q +            K   K++PK+R   PE+
Sbjct: 284 NHEIEFPDIPEKDLQDVL-----------KCCLKRDPKQRISIPEL 318

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 108/239 (45%), Gaps = 19/239 (7%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLR 198
            L  + ++   ++GKG F  V + +  +T    AVK ++V +      +      E   R
Sbjct: 22  VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK----FTSSPGLSTEDLKR 77
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--H 256
           E    +  +H +I+ L       G   +V+ +M    L   ++ K+     ++++ +  H
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASH 136
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILL--NHHMDPV-IGDFGLTQEGPIEKATHIT 313
             +     L++ H     +IH D+K   +LL    +  PV +G FG+  +  + ++  + 
Sbjct: 137 YMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVA 192
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             RV GT  ++  E +  +     VDV+G G++LF L +G   +  T+  ER  + +++
Sbjct: 193 GGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIK 248

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 73
Query: 210 NILPLYGICFETGKYCLVYRYM-PNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+   M P   L D +     L ++   S  W Q L   +    
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 128
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 129 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 178
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 108/239 (45%), Gaps = 19/239 (7%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLR 198
            L  + ++   ++GKG F  V + +  +T    AVK ++V +      +      E   R
Sbjct: 20  VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK----FTSSPGLSTEDLKR 75
Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--H 256
           E    +  +H +I+ L       G   +V+ +M    L   ++ K+     ++++ +  H
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASH 134
Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILL--NHHMDPV-IGDFGLTQEGPIEKATHIT 313
             +     L++ H     +IH D+K   +LL    +  PV +G FG+  +  + ++  + 
Sbjct: 135 YMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVA 190
Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
             RV GT  ++  E +  +     VDV+G G++LF L +G   +  T+  ER  + +++
Sbjct: 191 GGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIK 246

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGV-------WEKTTIAVKKLEVHRNDRAVETLNQCQR 193
           T  T  +     LGKG F  V + V       +    I  KKL   R+ + +E       
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLE------- 58
Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
               RE +     +H NI+ L+    E G + L++  +  G L + ++ ++       + 
Sbjct: 59  ----REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 114
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKAT 310
            +       +    LH  +  ++H ++K  N+LL   +      + DFGL  E   E+  
Sbjct: 115 CIQ-----QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
                   GT  YL  E L        VD++  G++L+ L  G   + D
Sbjct: 170 WFGFA---GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKK 244
           ++ + +++  + E+  L   +H NI+  Y    +     L  V  Y   G L    ++ K
Sbjct: 43  SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS--VITK 100
Query: 245 NTPSLLWTQR---LHIAKGTSLGLQFLHSREP---PLIHGDIKSANILLNHHMDPVIGDF 298
            T    +      L +    +L L+  H R      ++H D+K AN+ L+   +  +GDF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           GL +   I        K   GT  Y+  E +     + K D++  G +L+EL   M
Sbjct: 161 GLAR---ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKK 244
           ++ + +++  + E+  L   +H NI+  Y    +     L  V  Y   G L    ++ K
Sbjct: 43  SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS--VITK 100
Query: 245 NTPSLLWTQR---LHIAKGTSLGLQFLHSREP---PLIHGDIKSANILLNHHMDPVIGDF 298
            T    +      L +    +L L+  H R      ++H D+K AN+ L+   +  +GDF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           GL +   I        K   GT  Y+  E +     + K D++  G +L+EL   M
Sbjct: 161 GLAR---ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 23/218 (10%)
Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + +D L  LG G FG V++ V EK T  + V K         + T     +     E+  
Sbjct: 51  DYYDILEELGSGAFGVVHRCV-EKATGRVFVAKF--------INTPYPLDKYTVKNEISI 101
Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +N   H  ++ L+    +  +  L+  ++  G L DR+  +    S    + ++  +   
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE--AEVINYMRQAC 159
Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGL-TQEGPIEKATHITLKRVNG 319
            GL+ +H  E  ++H DIK  NI+        +   DFGL T+  P E      +K    
Sbjct: 160 EGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTA 212
Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
           T  +   E +  + +    D++  G++ + L +G+  +
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)
Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ------CQRE 194
           T   + +D++  LG G FG V         + VK  E   N  A++ L++       Q E
Sbjct: 37  TAQLDQFDRIKTLGTGSFGRV---------MLVKHKE-SGNHYAMKILDKQKVVKLKQIE 86
Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--LMKKNTPSLLWT 252
            +L E + L +     ++ L     +     +V  Y+  G +   L  + + + P     
Sbjct: 87  HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---- 142
Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
            R + A+   L  ++LHS +  LI+ D+K  N+L++      + DFG        K    
Sbjct: 143 ARFYAAQ-IVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA------KRVKG 193
Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               + GT   L  E ++ K  +  VD +  G++++E+A G
Sbjct: 194 RTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 74
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 129
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 130 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 179
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 74
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 129
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 130 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 179
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 69
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 124
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 125 -----HCHNXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 174
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 105/287 (36%), Gaps = 49/287 (17%)
Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  L +   G ++KG W+   I VK L+V   + R     N+        E   L    H
Sbjct: 15  LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNE--------ECPRLRIFSH 66
Query: 209 DNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            N+LP+ G C         L+  + P GSL + L    N   +  +Q +  A   + G  
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF-VVDQSQAVKFALDXARGXA 125
Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           FLH+ EP +    + S ++ ++      I   D   + + P               R Y 
Sbjct: 126 FLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSP--------------GRXYA 171
Query: 325 PHEFLVGKRLSTK--------VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE 376
           P  ++  + L  K         D + F ++L+EL T    + D    E   K  +E    
Sbjct: 172 P-AWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRP 230
Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                        I   I+    ++ K    ++P +RP+   +  +L
Sbjct: 231 T------------IPPGISPHVSKLXKICXNEDPAKRPKFDXIVPIL 265

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 150 LNILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  LG GG G V+  V       +A+KK+ V  + ++V+         +LRE+K +    
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVK--------HALREIKIIRRLD 66
Query: 208 HDNILPLYGICFETGKYC--------------LVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           HDNI+ ++ I   +G                 +V  YM      D   + +  P L    
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHA 122
Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV--IGDFGLTQEGPIEKATH 311
           RL + +    GL+++HS    ++H D+K AN+ +N   D V  IGDFGL +      +  
Sbjct: 123 RLFMYQLLR-GLKYIHSAN--VLHRDLKPANLFINTE-DLVLKIGDFGLARIMDPHYSHK 178
Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
             L     T+ Y     L+     TK +D++  G +  E+ TG
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 72
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 127
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 128 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 177
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 43/272 (15%)
Query: 142 LATNNWDKLNILGKGGFGTVY-------KGVWEKTTIAVKK---------LEVHRNDRAV 185
           +A   W     +G+GGFG +Y       + V       VK           E+    RA 
Sbjct: 32  MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAA 91
Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLY---GICFETGKYCLVYRYMPNGSLEDRL-- 240
           +   Q Q+    R+LKYL        +P Y   G+  + GK    YR+M        L  
Sbjct: 92  KP-EQIQKWIRTRKLKYLG-------VPKYWGSGLHDKNGK---SYRFMIMDRFGSDLQK 140
Query: 241 LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPV-IGDF 298
           + + N         L ++      L+++H  E   +HGDIK++N+LLN+ + D V + D+
Sbjct: 141 IYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 299 GLTQ----EGPIEKATHITLKRV-NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           GL      EG + KA     KR  +GT  +   +   G   S + D+   G  + +  TG
Sbjct: 199 GLAYRYCPEG-VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTG 257
Query: 354 MRAYDDTRRSERHLKSLVEKYSEENMYDLVDK 385
              ++D  +  ++++    +Y  EN+  L+DK
Sbjct: 258 HLPWEDNLKDPKYVRDSKIRY-RENIASLMDK 288

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 69
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 124
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 125 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 174
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 74
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 129
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 130 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 179
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 96
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 151
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 152 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 201
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 73
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 128
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 129 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 178
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 152 ILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +LG GGFG+VY G  V +   +A+K +E  R     E  N  +    +  LK ++S    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG-FS 69
Query: 210 NILPLYGICFETGKYCLVY-RYMPNGSLEDRL-----LMKKNTPSLLWTQRLHIAKGTSL 263
            ++ L         + L+  R  P   L D +     L ++   S  W Q L   +    
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLEAVR---- 124
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRP 322
                H     ++H DIK  NIL++ +   + + DFG    G + K T  T    +GTR 
Sbjct: 125 -----HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDTVYT--DFDGTRV 174
Query: 323 YLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
           Y P E++   R   +   V+  GI+L+++  G
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+++LH ++  +IH DIK +N+L+       I DFG++ E    K +   L    GT  +
Sbjct: 149 GIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF---KGSDALLSNTVGTPAF 203
Query: 324 LPHEFLVGKR--LSTK-VDVYGFGIVLFELATGMRAYDDTRRSERH--LKSLVEKYSE-- 376
           +  E L   R   S K +DV+  G+ L+    G   + D R    H  +KS   ++ +  
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP 263
Query: 377 ---ENMYDLV----DKNAQ 388
              E++ DL+    DKN +
Sbjct: 264 DIAEDLKDLITRMLDKNPE 282

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++ L ++GKG FG V K    K    V  L++ RN++        Q  + +R L++L   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-ALKMVRNEKRFHR----QAAEEIRILEHLRKQ 153
Query: 207 RHDN----ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
             DN    I  L    F     C+ +  +     E   L+KKN             +G S
Sbjct: 154 DKDNTMNVIHMLENFTFRN-HICMTFELLSMNLYE---LIKKNK-----------FQGFS 198
Query: 263 LGL--QFLHS--------REPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKAT 310
           L L  +F HS         +  +IH D+K  NILL       I   DFG +        T
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            I       +R Y   E ++G R    +D++  G +L EL TG
Sbjct: 259 XIQ------SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 153 LGKGGFGTVYKGV--WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG+G FG V++ V    K T   K ++V   D+ +            +E+  LN  RH N
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----------KEISILNIARHRN 62
Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQFL 268
           IL L+       +  +++ ++    + +R+    NT +    +R  +         LQFL
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFL 118
Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP-YLPHE 327
           HS    + H DI+  NI+        I      Q   ++   +    R+  T P Y   E
Sbjct: 119 HSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPE 173
Query: 328 FLVGKRLSTKVDVYGFGIVLFELATGMRAY 357
                 +ST  D++  G +++ L +G+  +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 147 WDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           ++ L ++GKG FG V K    K    V  L++ RN++        Q  + +R L++L   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHV-ALKMVRNEKRFHR----QAAEEIRILEHLRKQ 153
Query: 207 RHDN----ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
             DN    I  L    F     C+ +  +     E   L+KKN             +G S
Sbjct: 154 DKDNTMNVIHMLENFTFRN-HICMTFELLSMNLYE---LIKKNK-----------FQGFS 198
Query: 263 LGL--QFLHS--------REPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKAT 310
           L L  +F HS         +  +IH D+K  NILL       I   DFG +        T
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            I       +R Y   E ++G R    +D++  G +L EL TG
Sbjct: 259 XIQ------SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	441
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-86
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-80
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-80
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-52
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-30
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-28
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-25
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-22
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-22
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-19
1d2z_A	108	Death domain of pelle; six-helix bundle, linear ar	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-18
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-15
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-13
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-13
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
1wh4_A	127	IRAK4, interleukin-1 receptor-associated kinase 4;	2e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-12
2a9i_A	113	IRAK-4, interleukin-1 receptor-associated kinase-4	2e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-12
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-12
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-10
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-09
3mop_K	111	IRAK-2, interleukin-1 receptor-associated kinase-l	7e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-05
3mop_A	110	Myeloid differentiation primary response protein;	1e-04
2g7r_A	117	Mucosa-associated lymphoid tissue lymphoma transl	1e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-04
2dbf_A	100	Nuclear factor NF-kappa-B P105 subunit; apoptosis,	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  264 bits (678), Expect = 3e-86
 Identities = 107/297 (36%), Positives = 157/297 (52%), Gaps = 18/297 (6%)

Query: 137 YQELTLATNNWDK------LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQ 190
           + EL   TNN+D+       N +G+GGFG VYKG    TT+AVKKL    +        +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT----EE 72

Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
            +++   +E+K +  C+H+N++ L G   +    CLVY YMPNGSL DRL     TP L 
Sbjct: 73  LKQQ-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           W  R  IA+G + G+ FLH  E   IH DIKSANILL+      I DFGL +       T
Sbjct: 132 WHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
            +T  R+ GT  Y+  E L G+ ++ K D+Y FG+VL E+ TG+ A D+  R  + L  +
Sbjct: 190 VMT-SRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDI 246

Query: 371 VEKY--SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
            E+    E+ + D +DK     +     A + +  Q   +   +RP++ +V  +L  
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  249 bits (639), Expect = 4e-80
 Identities = 113/320 (35%), Positives = 168/320 (52%), Gaps = 24/320 (7%)

Query: 119 VSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGV-WEKTTIAVKKLE 177
           V     P   LG       +EL +A++N+   NILG+GGFG VYKG   + T +AVK+L+
Sbjct: 4   VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63

Query: 178 VHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLE 237
             R         Q    Q   E++ ++   H N+L L G C    +  LVY YM NGS+ 
Sbjct: 64  EERT--------QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115

Query: 238 DRLL-MKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVI 295
             L    ++ P L W +R  IA G++ GL +LH   +P +IH D+K+ANILL+   + V+
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175

Query: 296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMR 355
           GDFGL +     K TH+T   V GT  ++  E+L   + S K DV+G+G++L EL TG R
Sbjct: 176 GDFGLAKLMD-YKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

Query: 356 AYDDTRRSERHLKSLVEK----YSEENMYDLVDKNAQ----PIELNIAYAFFRIGKQSTK 407
           A+D  R +      L++       E+ +  LVD + Q      E+       ++    T+
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV---EQLIQVALLCTQ 290

Query: 408 QNPKERPEMTQVYNMLSGSG 427
            +P ERP+M++V  ML G G
Sbjct: 291 SSPMERPKMSEVVRMLEGDG 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  248 bits (636), Expect = 9e-80
 Identities = 101/319 (31%), Positives = 156/319 (48%), Gaps = 22/319 (6%)

Query: 115 PTRKVSDPLTPMNVLGGTPH-IPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIA 172
            T  ++D L+   ++    + +P  +L  ATNN+D   ++G G FG VYKGV      +A
Sbjct: 8   ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67

Query: 173 VKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMP 232
           +K+             +Q   E    E++ L+ CRH +++ L G C E  +  L+Y+YM 
Sbjct: 68  LKRRT--------PESSQGIEE-FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 233 NGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM 291
           NG+L+  L      T S+ W QRL I  G + GL +LH     +IH D+KS NILL+ + 
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENF 176

Query: 292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
            P I DFG++++G     TH++   V GT  Y+  E+ +  RL+ K DVY FG+VLFE+ 
Sbjct: 177 VPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

Query: 352 TGMRAYDDTRRSERHLKSLVE----KYSEENMYDLVDKN-AQPIELNIAYAFFRIGKQST 406
               A   +   E    +L E     ++   +  +VD N A  I       F     +  
Sbjct: 236 CARSAIVQSLPREMV--NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293

Query: 407 KQNPKERPEMTQVYNMLSG 425
             + ++RP M  V   L  
Sbjct: 294 ALSSEDRPSMGDVLWKLEY 312

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  202 bits (515), Expect = 8e-62
 Identities = 77/316 (24%), Positives = 136/316 (43%), Gaps = 36/316 (11%)

Query: 114 EPTRKVSDPLTPMNVLGGTP-----HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK 168
            P      P T      G        IP+ +L +          +G G FGTV++  W  
Sbjct: 8   HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNI-------KEKIGAGSFGTVHRAEWHG 60

Query: 169 TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVY 228
           + +AVK L         +  +  +  + LRE+  +   RH NI+   G   +     +V 
Sbjct: 61  SDVAVKILME-------QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113

Query: 229 RYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN 288
            Y+  GSL   L        L   +RL +A   + G+ +LH+R PP++H ++KS N+L++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173

Query: 289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLF 348
                 + DFGL++   ++ +T ++ K   GT  ++  E L  +  + K DVY FG++L+
Sbjct: 174 KKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230

Query: 349 ELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTK 407
           ELAT  + + +       L         + +  +  K  +  I  N+      I +    
Sbjct: 231 ELATLQQPWGN-------LNPA------QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277

Query: 408 QNPKERPEMTQVYNML 423
             P +RP    + ++L
Sbjct: 278 NEPWKRPSFATIMDLL 293

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  201 bits (513), Expect = 1e-61
 Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 41/292 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           I Y+E+ +         ++G+G FG V K  W    +A+K++E           ++ +R+
Sbjct: 5   IDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVAIKQIE-----------SESERK 46

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
             + EL+ L+   H NI+ LYG C      CLV  Y   GSL + L   +  P       
Sbjct: 47  AFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA 104

Query: 255 LHIAKGTSLGLQFLHSREP-PLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHI 312
           +      S G+ +LHS +P  LIH D+K  N+LL      + I DFG   +         
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQT 158

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
            +    G+  ++  E   G   S K DV+ +GI+L+E+ T  + +D+             
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI------------ 206

Query: 373 KYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                 +   V    +P +  N+      +  +   ++P +RP M ++  ++
Sbjct: 207 GGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  195 bits (498), Expect = 3e-59
 Identities = 78/318 (24%), Positives = 128/318 (40%), Gaps = 41/318 (12%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ 192
             +  + L   +     L +  +G FG V+K       +AVK   +             Q
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK----------Q 61

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGK----YCLVYRYMPNGSLEDRLLMKKNTPS 248
             Q+  E+  L   +H+NIL   G             L+  +   GSL D L  K N  S
Sbjct: 62  SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVS 119

Query: 249 LLWTQRLHIAKGTSLGLQFLHS--------REPPLIHGDIKSANILLNHHMDPVIGDFGL 300
             W +  HIA+  + GL +LH          +P + H DIKS N+LL +++   I DFGL
Sbjct: 120 --WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMR 355
             +    K+   T  +V GTR Y+  E L G     +    ++D+Y  G+VL+ELA+   
Sbjct: 178 ALKFEAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 356 AYDDTRRSERHL--KSLVEKYSEENMYDLVD-KNAQPI------ELNIAYAFFRIGKQST 406
           A D           + + +  S E+M ++V  K  +P+      +           ++  
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296

Query: 407 KQNPKERPEMTQVYNMLS 424
             + + R     V   ++
Sbjct: 297 DHDAEARLSAGCVGERIT 314

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  191 bits (487), Expect = 5e-58
 Identities = 66/299 (22%), Positives = 133/299 (44%), Gaps = 40/299 (13%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQ 192
           +   E+            +GKGGFG V+KG     K+ +A+K L     D   ET    +
Sbjct: 16  LADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSL--ILGDSEGETEMIEK 66

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
            ++  RE+  +++  H NI+ LYG+        +V  ++P G L  RL        + W+
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRL--LDKAHPIKWS 122

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL-----NHHMDPVIGDFGLTQEGPIE 307
            +L +    +LG++++ ++ PP++H D++S NI L     N  +   + DFGL+Q+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178

Query: 308 KATHITLKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATGMRAYDDTRRSER 365
             +  ++  + G   ++  E +  +    + K D Y F ++L+ + TG   +D+    + 
Sbjct: 179 --SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236

Query: 366 HLKSLVEKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
              +++            ++  +P I  +       + +     +PK+RP  + +   L
Sbjct: 237 KFINMI-----------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (472), Expect = 5e-56
 Identities = 59/296 (19%), Positives = 110/296 (37%), Gaps = 42/296 (14%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQR 193
            I +++L         L  L +   G ++KG W+   I VK L+V               
Sbjct: 6   GIDFKQLNF-------LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKS------- 51

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
                E   L    H N+LP+ G C         L+  +MP GSL + +L +     +  
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQ 110

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           +Q +  A   + G+ FLH+ EP +    + S +++++  M   I    +           
Sbjct: 111 SQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV--------KFS 162

Query: 312 ITLKRVNGTRPYLPHEFLVGKRL---STKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
                      ++  E L  K         D++ F ++L+EL T    + D       L 
Sbjct: 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-------LS 215

Query: 369 SLVEKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           ++      E    +  +  +P I   I+    ++ K    ++P +RP+   +  +L
Sbjct: 216 NM------EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  181 bits (461), Expect = 3e-54
 Identities = 74/300 (24%), Positives = 119/300 (39%), Gaps = 44/300 (14%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQR 193
            I + ELTL         I+G GGFG VY+  W    +AVK      ++   +T+   ++
Sbjct: 3   EIDFAELTL-------EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQ 55

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L         +H NI+ L G+C +    CLV  +   G L   +L  K  P      
Sbjct: 56  EAKL-----FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIP---PDI 106

Query: 254 RLHIAKGTSLGLQFLHSREP-PLIHGDIKSANILLNHHMDPV--------IGDFGLTQEG 304
            ++ A   + G+ +LH     P+IH D+KS+NIL+   ++          I DFGL +E 
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE- 165

Query: 305 PIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
                   T     G   ++  E +     S   DV+ +G++L+EL TG   +       
Sbjct: 166 ----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG----- 216

Query: 365 RHLKSLVEKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
             +  L         Y +        I       F ++ +     +P  RP  T + + L
Sbjct: 217 --IDGL------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (450), Expect = 3e-52
 Identities = 69/292 (23%), Positives = 116/292 (39%), Gaps = 36/292 (12%)

Query: 146 NWDKLNI---LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
               L     LGKG FG   K    +T   +   E+ R D          +   L+E+K 
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-------TQRTFLKEVKV 60

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +    H N+L   G+ ++  +   +  Y+  G+L   +  K       W+QR+  AK  +
Sbjct: 61  MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIA 118

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL-----------TQEGPIEKATH 311
            G+ +LHS    +IH D+ S N L+  + + V+ DFGL                ++K   
Sbjct: 119 SGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV 371
                V G   ++  E + G+    KVDV+ FGIVL E+   + A  D           V
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236

Query: 372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
             + +           +    N   +FF I  +    +P++RP   ++ + L
Sbjct: 237 RGFLD-----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  176 bits (447), Expect = 1e-51
 Identities = 65/326 (19%), Positives = 112/326 (34%), Gaps = 50/326 (15%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
               E +L  +N   L ++G+G +G VYKG  ++  +AVK                   E
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFS-------FANRQNFINE 55

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTPSL 249
           +++  +  +    HDNI                +Y LV  Y PNGSL   L    +  + 
Sbjct: 56  KNIYRVPLM---EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTS 108

Query: 250 LWTQRLHIAKGTSLGLQFLHS-------REPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
            W     +A   + GL +LH+        +P + H D+ S N+L+ +    VI DFGL+ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 303 -----EGPIEKATHITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFEL 350
                                GT  Y+  E L G       +    +VD+Y  G++ +E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 351 ATGMRAYDDTRRSERHL----KSLVEKYSEENMYDLVDKNAQ--------PIELNIAYAF 398
                          +       +    + E+M  LV +  Q                + 
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288

Query: 399 FRIGKQSTKQNPKERPEMTQVYNMLS 424
               +    Q+ + R         ++
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMA 314

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  175 bits (445), Expect = 2e-51
 Identities = 62/302 (20%), Positives = 114/302 (37%), Gaps = 47/302 (15%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           IP+++L +         ++GKG FG VY G W    +A++ +++       E  N+ Q +
Sbjct: 30  IPFEQLEI-------GELIGKGRFGQVYHGRW-HGEVAIRLIDI-------ERDNEDQLK 74

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
              RE+      RH+N++   G C       ++       +L   +   K        + 
Sbjct: 75  AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD--VNKT 132

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT- 313
             IA+    G+ +LH++   ++H D+KS N+  ++    VI DFGL     + +A     
Sbjct: 133 RQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRED 189

Query: 314 -LKRVNGTRPYL---------PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS 363
            L+  NG   +L         P         S   DV+  G + +EL      +      
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---- 245

Query: 364 ERHLKSLVEKYSEENMYDLVDKNAQP--IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                        E +   +    +P   ++ +      I         +ERP  T++ +
Sbjct: 246 ----------QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295

Query: 422 ML 423
           ML
Sbjct: 296 ML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  175 bits (445), Expect = 3e-51
 Identities = 72/315 (22%), Positives = 118/315 (37%), Gaps = 46/315 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
              +++ +       +  +GKG +G V+ G W    +AVK       + A        RE
Sbjct: 34  TIAKQIQM-------VKQIGKGRYGEVWMGKWRGEKVAVKVF--FTTEEASW-----FRE 79

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             + +   +   RH+NIL       +      +  L+  Y  NGSL D L     + +L 
Sbjct: 80  TEIYQTVLM---RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLD 132

Query: 251 WTQRLHIAKGTSLGLQFLHSR------EPPLIHGDIKSANILLNHHMDPVIGDFGL-TQE 303
               L +A  +  GL  LH+       +P + H D+KS NIL+  +    I D GL  + 
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRL------STKVDVYGFGIVLFELATGMRAY 357
                   I      GT+ Y+P E L               D+Y FG++L+E+A    + 
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 358 DDTRRSERHLKSLV-EKYSEENMYDLV-DKNAQP------IELNIAYAFFRIGKQSTKQN 409
                 +     LV    S E+M ++V  K  +P                ++  +    N
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312

Query: 410 PKERPEMTQVYNMLS 424
           P  R    +V   L+
Sbjct: 313 PASRLTALRVKKTLA 327

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  167 bits (426), Expect = 6e-49
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           IP  ++T+          +G G FGTVYKG W    +AVK L V             Q +
Sbjct: 21  IPDGQITV-------GQRIGSGSFGTVYKGKW-HGDVAVKMLNV-------TAPTPQQLQ 65

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
               E+  L   RH NIL   G      +  +V ++    SL   L    +       + 
Sbjct: 66  AFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKL 122

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           + IA+ T+ G+ +LH++   +IH D+KS NI L+      IGDFGL  E      +H   
Sbjct: 123 IDIARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH-QF 179

Query: 315 KRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV 371
           ++++G+  ++  E +  +     S + DVY FGIVL+EL TG   Y +    ++ ++ + 
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239

Query: 372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                 ++          +  N      R+  +  K+   ERP   ++   +
Sbjct: 240 RGSLSPDL--------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (422), Expect = 6e-48
 Identities = 69/300 (23%), Positives = 107/300 (35%), Gaps = 39/300 (13%)

Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
              +GKG FG V++G W    +AVK                  RE  + +   L   RH+
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFSS-------REERSWFREAEIYQTVML---RHE 96

Query: 210 NILPLYGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
           NIL       +      +  LV  Y  +GSL D   + + T +      + +A  T+ GL
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVT--VEGMIKLALSTASGL 152

Query: 266 QFLHSRE------PPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVN 318
             LH         P + H D+KS NIL+  +    I D GL  +         I      
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 319 GTRPYLPHEFLVGKRL------STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV- 371
           GT+ Y+  E L             + D+Y  G+V +E+A            +     LV 
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272

Query: 372 EKYSEENMYDLV-DKNAQP------IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
              S E M  +V ++  +P                +I ++    N   R    ++   LS
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (419), Expect = 8e-48
 Identities = 74/315 (23%), Positives = 115/315 (36%), Gaps = 46/315 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
              +++TL       L  +GKG +G V++G W+   +AVK                  RE
Sbjct: 5   TVARDITL-------LECVGKGRYGEVWRGSWQGENVAVKIFSS-------RDEKSWFRE 50

Query: 195 QSLRELKYLNSCRHDNILPLYGIC----FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             L     L   RH+NIL            + +  L+  Y   GSL D L  +  T    
Sbjct: 51  TELYNTVML---RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLD-- 103

Query: 251 WTQRLHIAKGTSLGLQFLHSRE------PPLIHGDIKSANILLNHHMDPVIGDFGL-TQE 303
               L I    + GL  LH         P + H D+KS NIL+  +    I D GL    
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163

Query: 304 GPIEKATHITLKRVNGTRPYLPHEFLVGK------RLSTKVDVYGFGIVLFELATGMRAY 357
                   +      GT+ Y+  E L             +VD++ FG+VL+E+A  M + 
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223

Query: 358 DDTRRSERHLKSLV-EKYSEENMYDLV-DKNAQP------IELNIAYAFFRIGKQSTKQN 409
                 +     +V    S E+M  +V     +P             +  ++ K+   QN
Sbjct: 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283

Query: 410 PKERPEMTQVYNMLS 424
           P  R    ++   L+
Sbjct: 284 PSARLTALRIKKTLT 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 5e-36
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 24/221 (10%)

Query: 147 WDKLN-ILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           + K +  +G+G F TVYKG+  +T   +A  +L+  +  ++       +R++   E + L
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-------ERQRFKEEAEML 79

Query: 204 NSCRHDNILPLYGICFETGKY----CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
              +H NI+  Y     T K      LV   M +G+L+  L   K    +         +
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCR 136

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVN 318
               GLQFLH+R PP+IH D+K  NI +      V IGD GL              K V 
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-----LKRASFAKAVI 191

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
           GT  ++  E +  ++    VDVY FG+ + E+AT    Y +
Sbjct: 192 GTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  132 bits (333), Expect = 2e-35
 Identities = 62/320 (19%), Positives = 114/320 (35%), Gaps = 56/320 (17%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
             + +   ++  +  LG+GGF  V   +G+ +    A+K++  H          Q  RE+
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---------EQQDREE 72

Query: 196 SLRELKYLNSCRHDNILPLYGICFE----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
           + RE        H NIL L   C        +  L+  +   G+L + +   K+  + L 
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 252 TQR-LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
             + L +  G   GL+ +H+      H D+K  NILL     PV+ D G   +  I    
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 311 HITLKRV------NGTRPYLPHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAYDDTR 361
                 +        T  Y   E    +    +  + DV+  G VL+ +  G   YD   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 362 RSERHLKSLVE---------KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE 412
           +    +   V+         ++S   ++ L++                        +P +
Sbjct: 251 QKGDSVALAVQNQLSIPQSPRHSSA-LWQLLNSMMTV-------------------DPHQ 290

Query: 413 RPEMTQVYNMLSGSGGESPN 432
           RP +  + + L      +P 
Sbjct: 291 RPHIPLLLSQLEALQPPAPG 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (312), Expect = 2e-32
 Identities = 64/302 (21%), Positives = 115/302 (38%), Gaps = 62/302 (20%)

Query: 148 DKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + +  LG+GGFG V++    K      A+K++ +   +          RE+ +RE+K L 
Sbjct: 8   EPIQCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNREL--------AREKVMREVKALA 58

Query: 205 SCRHDNILPLYGICFETGKY-------------CLVYRYMPNGSLEDRLLMKKNTPSLLW 251
              H  I+  +   +                   +  +     +L+D +  +        
Sbjct: 59  KLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKA 309
           +  LHI    +  ++FLHS+   L+H D+K +NI         +GDFGL    +   E+ 
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 310 THITLKRVN-------GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR 362
           T +T            GT+ Y+  E + G   S KVD++  G++LFEL        +  R
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR 235

Query: 363 SERHLKS-----LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMT 417
           +   +++     L  +      Y +V                   +     +P ERPE  
Sbjct: 236 TLTDVRNLKFPPLFTQKYPC-EYVMV-------------------QDMLSPSPMERPEAI 275

Query: 418 QV 419
            +
Sbjct: 276 NI 277

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  124 bits (313), Expect = 7e-32
 Identities = 73/317 (23%), Positives = 120/317 (37%), Gaps = 41/317 (12%)

Query: 117 RKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVK 174
                PLT  + +     +P  +  L   +      +G+G FG V+ G    + T +AVK
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145

Query: 175 KLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNG 234
                      ETL    + + L+E + L    H NI+ L G+C +     +V   +  G
Sbjct: 146 SCR--------ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197

Query: 235 SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV 294
                L  +     L     L +    + G+++L S+    IH D+ + N L+       
Sbjct: 198 DFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVTEKNVLK 253

Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           I DFG+++E       +          P      E L   R S++ DV+ FGI+L+E  +
Sbjct: 254 ISDFGMSRE--EADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

Query: 353 -GMRAYDDTRRSERHLKSLVEK----YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTK 407
            G   Y     S +  +  VEK       E           P  +      FR+ +Q   
Sbjct: 311 LGASPYP--NLSNQQTREFVEKGGRLPCPELC---------PDAV------FRLMEQCWA 353

Query: 408 QNPKERPEMTQVYNMLS 424
             P +RP  + +Y  L 
Sbjct: 354 YEPGQRPSFSTIYQELQ 370

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (307), Expect = 7e-32
 Identities = 59/301 (19%), Positives = 118/301 (39%), Gaps = 72/301 (23%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            ++ ++ ++G GGFG V+K    +       +K+++                E++ RE+K
Sbjct: 11  MDFKEIELIGSGGFGQVFK-AKHRIDGKTYVIKRVK-------------YNNEKAEREVK 56

Query: 202 YLNSCRHDNILPLYGICFETGKY-----------------CLVYRYMPNGSLEDRLLMKK 244
            L    H NI+   G C++   Y                  +   +   G+LE  +  ++
Sbjct: 57  ALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115

Query: 245 NTP---SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL- 300
                  L       + +  + G+ ++HS++  LI+ D+K +NI L       IGDFGL 
Sbjct: 116 GEKLDKVLAL----ELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLV 169

Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
           T      K T        GT  Y+  E +  +    +VD+Y  G++L EL        +T
Sbjct: 170 TSLKNDGKRTRSK-----GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224

Query: 361 RRSERHLKSLV--EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
            +    L+  +  + + ++    L+                   ++   + P++RP  ++
Sbjct: 225 SKFFTDLRDGIISDIFDKK-EKTLL-------------------QKLLSKKPEDRPNTSE 264

Query: 419 V 419
           +
Sbjct: 265 I 265

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  122 bits (308), Expect = 2e-31
 Identities = 61/296 (20%), Positives = 115/296 (38%), Gaps = 27/296 (9%)

Query: 129 LGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVE 186
           L        +   L  ++++K++ LG G  G V+K         +A K + +        
Sbjct: 17  LEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--- 73

Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
                 R Q +REL+ L+ C    I+  YG  +  G+  +   +M  GSL+   ++KK  
Sbjct: 74  -----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ--VLKKAG 126

Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
             +       ++     GL +L   +  ++H D+K +NIL+N   +  + DFG++ +   
Sbjct: 127 R-IPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184

Query: 307 EKA-THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAY------DD 359
             A + +      GTR Y+  E L G   S + D++  G+ L E+A G          + 
Sbjct: 185 SMANSFV------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

Query: 360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE 415
                  ++    +            N   ++     A F +      + P + P 
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (305), Expect = 2e-31
 Identities = 64/230 (27%), Positives = 100/230 (43%), Gaps = 33/230 (14%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVET 187
           H   + L         +  LG+G FG V    +          +AVK L+       +  
Sbjct: 17  HFEKRFLKR-------IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY--CLVYRYMPNGSLEDRLLMKKN 245
           L         +E++ L +  H+NI+   GIC E G     L+  ++P+GSL++ L   KN
Sbjct: 70  L--------KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKN 119

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
              +   Q+L  A     G+ +L SR+   +H D+ + N+L+       IGDFGLT+   
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA-- 175

Query: 306 IEKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           IE        + +   P   Y P E L+  +     DV+ FG+ L EL T
Sbjct: 176 IETDKEYYTVKDDRDSPVFWYAP-ECLMQSKFYIASDVWSFGVTLHELLT 224

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 3e-31
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 34/280 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             + +L  +G+G FG        +      +K++ + R       ++  +RE+S RE+  
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-------MSSKEREESRREVAV 76

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP---SLLWTQRLHIAK 259
           L + +H NI+       E G   +V  Y   G L  R+  +K        +         
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFV 132

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
              L L+ +H R+  ++H DIKS NI L       +GDFG+ +   +  +T    +   G
Sbjct: 133 QICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIAR---VLNSTVELARACIG 187

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM 379
           T  YL  E    K  + K D++  G VL+EL T   A++        +K+LV K    + 
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-----GSMKNLVLKIISGSF 242

Query: 380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                    P+ L+ +Y    +  Q  K+NP++RP +  +
Sbjct: 243 --------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  122 bits (308), Expect = 1e-30
 Identities = 68/296 (22%), Positives = 130/296 (43%), Gaps = 44/296 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC--Q 192
           +   ++T+        + LG G +G VY+GVW+K ++ V          AV+TL +   +
Sbjct: 217 MERTDITM-------KHKLGGGQYGEVYEGVWKKYSLTV----------AVKTLKEDTME 259

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
            E+ L+E   +   +H N++ L G+C     + ++  +M  G+L D  L + N   +   
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAV 318

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ--EGPIEKAT 310
             L++A   S  +++L  +    IH ++ + N L+  +    + DFGL++   G    A 
Sbjct: 319 VLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS 369
                 +  T P    E L   + S K DV+ FG++L+E+AT GM  Y            
Sbjct: 377 AGAKFPIKWTAP----ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------------ 420

Query: 370 LVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                    +Y+L++K+ +           + + +   + NP +RP   +++    
Sbjct: 421 --PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  119 bits (300), Expect = 1e-30
 Identities = 62/322 (19%), Positives = 122/322 (37%), Gaps = 35/322 (10%)

Query: 105 VRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG 164
           + +++     P      P   +      P + Y  L     N+     +G+G F  VY+ 
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALR-----PDMGYNTL----ANFRIEKKIGRGQFSEVYRA 51

Query: 165 VWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG 222
                   +A+KK+++     A        R   ++E+  L    H N++  Y    E  
Sbjct: 52  ACLLDGVPVALKKVQIFDLMDAKA------RADCIKEIDLLKQLNHPNVIKYYASFIEDN 105

Query: 223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLW-TQRLHIAKGTSLGLQFLHSREPPLIHGDIK 281
           +  +V      G L   +   K    L+               L+ +HSR   ++H DIK
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIK 163

Query: 282 SANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVY 341
            AN+ +       +GD GL +      +       + GT  Y+  E +     + K D++
Sbjct: 164 PANVFITATGVVKLGDLGLGR---FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220

Query: 342 GFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPI-ELNIAYAFFR 400
             G +L+E+A     +   + +   L SL +K        +   +  P+   + +    +
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMN---LYSLCKK--------IEQCDYPPLPSDHYSEELRQ 269

Query: 401 IGKQSTKQNPKERPEMTQVYNM 422
           +       +P++RP++T VY++
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDV 291

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (301), Expect = 1e-30
 Identities = 62/284 (21%), Positives = 112/284 (39%), Gaps = 36/284 (12%)

Query: 83  SVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKV--SDPLTPMNVLGGTPHIPYQEL 140
           SV S Q H++ S    + + +   Q   P  E    V  ++ L P++             
Sbjct: 4   SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE------- 56

Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLR 198
               +       +G+G FG V++   ++T    AVKK+ +                  + 
Sbjct: 57  ---VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL--------------EVFRVE 99

Query: 199 ELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
           EL          I+PLYG   E     +    +  GSL    L+K+    L   + L+  
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ--LIKQMGC-LPEDRALYYL 156

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQ--EGPIEKATHITLK 315
                GL++LH+R   ++HGD+K+ N+LL+       + DFG     +      + +T  
Sbjct: 157 GQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            + GT  ++  E ++GK    KVD++    ++  +  G   +  
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  119 bits (300), Expect = 1e-30
 Identities = 71/308 (23%), Positives = 128/308 (41%), Gaps = 48/308 (15%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETL 188
              + L         ++ LGKG FG+V    +          +AVK+L+    D      
Sbjct: 20  FEERHLKY-------ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD------ 66

Query: 189 NQCQREQSLRELKYLNSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNT 246
              Q+    RE++ L +   D I+   G+ +  G+    LV  Y+P+G L D L  +++ 
Sbjct: 67  ---QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHR 121

Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
             L  ++ L  +     G+++L SR    +H D+ + NIL+       I DFGL +   +
Sbjct: 122 ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL--L 177

Query: 307 EKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR 362
                  + R  G  P   Y P E L     S + DV+ FG+VL+EL T   ++   +  
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAP-ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236

Query: 363 SERHLKSLVEKYSEENMYDLVDKNAQ-------PIELNIAYAFFRIGKQSTKQNPKERPE 415
             R +    +  +   + +L+++  +       P E+        + K     +P++RP 
Sbjct: 237 FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEV------HELMKLCWAPSPQDRPS 290

Query: 416 MTQVYNML 423
            + +   L
Sbjct: 291 FSALGPQL 298

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  117 bits (295), Expect = 4e-30
 Identities = 53/239 (22%), Positives = 95/239 (39%), Gaps = 32/239 (13%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQ 192
             I  ++L            LG+G F  ++KGV  +     +  E    +  ++ L++  
Sbjct: 3   HKIRNEDLIF-------NESLGQGTFTKIFKGVRREVGDYGQLHET---EVLLKVLDKAH 52

Query: 193 REQS---LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
           R  S         ++   H +++  YG+C    +  LV  ++  GSL+  L  KKN   +
Sbjct: 53  RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCI 110

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV--------IGDFGLT 301
               +L +AK  +  + FL      LIHG++ + NILL    D          + D G++
Sbjct: 111 NILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

Query: 302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
               +     I  +R+       P      K L+   D + FG  L+E+ + G +    
Sbjct: 169 IT--VLPKD-ILQERI---PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (294), Expect = 4e-30
 Identities = 55/291 (18%), Positives = 103/291 (35%), Gaps = 41/291 (14%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            +++ L  +G G +G   K +  K+    +  K+L+          + + +++  + E+ 
Sbjct: 6   EDYEVLYTIGTGSYGRCQK-IRRKSDGKILVWKELDYGS-------MTEAEKQMLVSEVN 57

Query: 202 YLNSCRHDNILPLYG--ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR-LHIA 258
            L   +H NI+  Y   I        +V  Y   G L   +         L  +  L + 
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117

Query: 259 KGTSLGLQFLHSREPPL---IHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
              +L L+  H R       +H D+K AN+ L+   +  +GDFGL +   I        K
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSFAK 174

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
              GT  Y+  E +     + K D++  G +L+EL   M  +                  
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---------------- 218

Query: 376 EENMYDLVDK--NAQPIELNIAY--AFFRIGKQSTKQNPKERPEMTQVYNM 422
             +  +L  K    +   +   Y      I  +        RP + ++   
Sbjct: 219 -FSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  117 bits (295), Expect = 4e-30
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 34/230 (14%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVET 187
               + L         L  LGKG FG+V    +          +AVKKL+    +     
Sbjct: 6   QFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE----- 53

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY--CLVYRYMPNGSLEDRLLMKKN 245
                     RE++ L S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+
Sbjct: 54  ----HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKH 107

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
              +   + L        G+++L ++    IH D+ + NIL+ +     IGDFGLT+   
Sbjct: 108 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV-- 163

Query: 306 IEKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           + +       +  G  P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 164 LPQDKEFFKVKEPGESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  117 bits (295), Expect = 5e-30
 Identities = 70/320 (21%), Positives = 125/320 (39%), Gaps = 53/320 (16%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETL 188
              + L         +  LG+G FG V    +          +AVK L+     +     
Sbjct: 28  FHKRYLKK-------IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW 80

Query: 189 NQCQREQSLRELKYLNSCRHDNILPLYGICFETGK--YCLVYRYMPNGSLEDRLLMKKNT 246
                    +E+  L +  H++I+   G C + G     LV  Y+P GSL D L   +++
Sbjct: 81  --------KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHS 130

Query: 247 PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI 306
             L   Q L  A+    G+ +LH++    IH D+ + N+LL++     IGDFGL +   +
Sbjct: 131 IGL--AQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA--V 184

Query: 307 EKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR 362
            +       R +G  P   Y P E L   +     DV+ FG+ L+EL T    +     +
Sbjct: 185 PEGHEYYRVREDGDSPVFWYAP-ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243

Query: 363 SERHLKSLVEKYSEENMYDLVDKNAQ-------PIELNIAYAFFRIGKQSTKQNPKERPE 415
               +     + +   + +L+++  +       P E+      + + K   +     RP 
Sbjct: 244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEV------YHLMKNCWETEASFRPT 297

Query: 416 MTQVYNML----SGSGGESP 431
              +  +L        G++P
Sbjct: 298 FENLIPILKTVHEKYQGQAP 317

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (293), Expect = 2e-29
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 36/239 (15%)

Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAV 185
              +   E          + +LG G FGTVYKG+W       K  +A+K+L         
Sbjct: 9   LRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------- 53

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
           E  +    ++ L E   + S  + ++  L GIC  +    L+ + MP G L D +  +++
Sbjct: 54  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV--REH 110

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             ++     L+     + G+ +L  R   L+H D+ + N+L+       I DFGL +   
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 306 IEKATHITLKRVNGTR-P---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            E+  +       G + P       E ++ +  + + DV+ +G+ ++EL T G + YD 
Sbjct: 169 AEEKEYHA----EGGKVPIKWMAL-ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (289), Expect = 2e-29
 Identities = 55/300 (18%), Positives = 99/300 (33%), Gaps = 66/300 (22%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           T  + +L  +G G FG+V+K V        A+K+ +                + +LRE+ 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK-------KPLAGSVDEQNALREVY 62

Query: 202 YLNS-CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL-----WTQRL 255
                 +H +++  +    E     +   Y   GSL D +       S           L
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-------------------IG 296
            +      GL+++HS    L+H DIK +NI ++    P                    IG
Sbjct: 123 QVG----RGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 297 DFGLTQEGPIEKATHITLKRVN-GTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGM 354
           D G          T I+  +V  G   +L +E L        K D++   + +   A   
Sbjct: 177 DLGH--------VTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

Query: 355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
               +                 +  +++       I   ++  F  + K     +P+ RP
Sbjct: 229 PLPRN----------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP 272

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (291), Expect = 3e-29
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 34/230 (14%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVET 187
               + L         L  LGKG FG+V    +          +AVKKL+    +     
Sbjct: 37  QFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE----- 84

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY--CLVYRYMPNGSLEDRLLMKKN 245
                     RE++ L S +HDNI+   G+C+  G+    L+  Y+P GSL D L  +K+
Sbjct: 85  ----HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKH 138

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
              +   + L        G+++L ++    IH D+ + NIL+ +     IGDFGLT+   
Sbjct: 139 KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV-- 194

Query: 306 IEKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           + +       +  G  P   Y P E L   + S   DV+ FG+VL+EL T
Sbjct: 195 LPQDKEYYKVKEPGESPIFWYAP-ESLTESKFSVASDVWSFGVVLYELFT 243

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  115 bits (291), Expect = 6e-29
 Identities = 63/273 (23%), Positives = 116/273 (42%), Gaps = 34/273 (12%)

Query: 100 ENEAGVRQENNPGNEPTRKVS-DPLT----PMNVLGGTPHIPYQELTLATNNWDKLNILG 154
            +E  +   N     P  +   DP T       V      +    +++         ++G
Sbjct: 2   SDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISI-------DKVVG 54

Query: 155 KGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
            G FG V  G       ++ ++A+K L+V   ++        QR   L E   +    H 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--------QRRDFLGEASIMGQFDHP 106

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH 269
           NI+ L G+  ++    +V  YM NGSL+  L  +K+       Q + + +G + G+++L 
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLS 164

Query: 270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL--PHE 327
                 +H D+ + NIL+N ++   + DFGL +   +E           G  P      E
Sbjct: 165 DMG--YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPE 220

Query: 328 FLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            +  ++ ++  DV+ +GIVL+E+ + G R Y +
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  117 bits (294), Expect = 7e-29
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 29/225 (12%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           +  +EL L       L  +GKG FG V  G +    +AVK +   +ND   +        
Sbjct: 190 LNMKELKL-------LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF------ 233

Query: 195 QSLRELKYLNSCRHDNILPLYGICF-ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
             L E   +   RH N++ L G+   E G   +V  YM  GSL D  L  +    L    
Sbjct: 234 --LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDC 290

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            L  +      +++L       +H D+ + N+L++      + DFGLT+E          
Sbjct: 291 LLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTG 346

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
              V  T P    E L  K+ STK DV+ FGI+L+E+ + G   Y
Sbjct: 347 KLPVKWTAP----EALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  113 bits (285), Expect = 1e-28
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 28/233 (12%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLN 189
           I  ++L L       L  LG G FG V +G W     +  ++AVK L      +      
Sbjct: 15  IGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL------KPDVLSQ 61

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
               +  +RE+  ++S  H N++ LYG+        +V    P GSL DRL  +K+    
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGHF 118

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
           L       A   + G+ +L S+    IH D+ + N+LL       IGDFGL +   + + 
Sbjct: 119 LLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR--ALPQN 174

Query: 310 THITLKRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
               + + +   P+     E L  +  S   D + FG+ L+E+ T G   +  
Sbjct: 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (285), Expect = 1e-28
 Identities = 64/237 (27%), Positives = 113/237 (47%), Gaps = 34/237 (14%)

Query: 131 GTPH-----IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAV 185
           G+P+     +   ++T+        + LG G +G VY+GVW+K ++ V          AV
Sbjct: 1   GSPNYDKWEMERTDITM-------KHKLGGGQYGEVYEGVWKKYSLTV----------AV 43

Query: 186 ETLNQC--QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK 243
           +TL +   + E+ L+E   +   +H N++ L G+C     + ++  +M  G+L D  L +
Sbjct: 44  KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRE 102

Query: 244 KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ- 302
            N   +     L++A   S  +++L  +    IH D+ + N L+  +    + DFGL++ 
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL 160

Query: 303 -EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
             G    A       +  T P    E L   + S K DV+ FG++L+E+AT GM  Y
Sbjct: 161 MTGDTYTAHAGAKFPIKWTAP----ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  113 bits (286), Expect = 1e-28
 Identities = 69/248 (27%), Positives = 116/248 (46%), Gaps = 30/248 (12%)

Query: 120 SDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVH 179
           SDP     VL  T  I    +T          ++G G FG VYKG+  KT+   K++ V 
Sbjct: 28  SDPNQA--VLKFTTEIHPSCVTR-------QKVIGAGEFGEVYKGML-KTSSGKKEVPV- 76

Query: 180 RNDRAVETLNQC----QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGS 235
               A++TL       QR   L E   +    H NI+ L G+  +     ++  YM NG+
Sbjct: 77  ----AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 132

Query: 236 LEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
           L+  L  ++        Q + + +G + G+++L +     +H D+ + NIL+N ++   +
Sbjct: 133 LDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKV 188

Query: 296 GDFGLTQEGPIEKATHITLKRVNGTRPYL---PHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            DFGL++   +E     T     G  P     P E +  ++ ++  DV+ FGIV++E+ T
Sbjct: 189 SDFGLSRV--LEDDPEATYTTSGGKIPIRWTAP-EAISYRKFTSASDVWSFGIVMWEVMT 245

Query: 353 -GMRAYDD 359
            G R Y +
Sbjct: 246 YGERPYWE 253

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (284), Expect = 2e-28
 Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 33/248 (13%)

Query: 121 DPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKK 175
           +P         T  I    + +         I+G G  G V  G           +A+K 
Sbjct: 34  EPGRA--GRSFTREIEASRIHI-------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA 84

Query: 176 LEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGS 235
           L+            + QR   L E   +    H NI+ L G+        +V  YM NGS
Sbjct: 85  LK--------AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGS 136

Query: 236 LEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
           L+  L  + +       Q + + +G   G+++L       +H D+ + N+L++ ++   +
Sbjct: 137 LDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKV 192

Query: 296 GDFGLTQEGPIEKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
            DFGL++   +E           G  P     P E +  +  S+  DV+ FG+V++E+  
Sbjct: 193 SDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAP-EAIAFRTFSSASDVWSFGVVMWEVLA 249

Query: 353 -GMRAYDD 359
            G R Y +
Sbjct: 250 YGERPYWN 257

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (282), Expect = 3e-28
 Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 38/229 (16%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           W+ +  LG G FG VYK   ++T    A K +E    +           E  + E++ L 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---------LEDYIVEIEILA 71

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
           +C H  I+ L G  +  GK  ++  + P G+++   +M +    L   Q   + +     
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA--IMLELDRGLTEPQIQVVCRQMLEA 129

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRP 322
           L FLHS+   +IH D+K+ N+L+    D  + DFG++      K      KR    GT P
Sbjct: 130 LNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNLKTLQKRDSFIGT-P 181

Query: 323 Y------LPHEFLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
           Y      +  E +       K D++  GI L E+A           MR 
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (281), Expect = 5e-28
 Identities = 67/339 (19%), Positives = 111/339 (32%), Gaps = 46/339 (13%)

Query: 89  NHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWD 148
           +H+   +         +  ++    +P R+VS        L    + P +  +    ++ 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMHQLQP-RRVSFRGEASETLQSPGYDPSRPESFFQQSFQ 60

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS- 205
           +L+ LG G +G V+K   ++     AVK+                 R + L E+      
Sbjct: 61  RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-------PFRGPKDRARKLAEVGSHEKV 113

Query: 206 CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGL 265
            +H   + L     E G   L        SL+     +    SL   Q     + T L L
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLAL 170

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT----LKRVNGTR 321
             LHS+   L+H D+K ANI L       +GDFGL           +      +   G  
Sbjct: 171 AHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGL--------LVELGTAGAGEVQEGDP 220

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
            Y+  E L G    T  DV+  G+ + E+A  M                      E    
Sbjct: 221 RYMAPELLQGSY-GTAADVFSLGLTILEVACNMELPHGG----------------EGWQQ 263

Query: 382 LVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           L      P     ++     +     + +PK R     +
Sbjct: 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (286), Expect = 6e-28
 Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 33/229 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQC-- 191
           IP + L L          LG+G FG V+ G W  TT +A+K            TL     
Sbjct: 181 IPRESLRL-------EVKLGQGCFGEVWMGTWNGTTRVAIK------------TLKPGTM 221

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
             E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L  
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGETGKYLRL 279

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            Q + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +     + T 
Sbjct: 280 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337

Query: 312 ITLKR--VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
               +  +  T P    E  +  R + K DV+ FGI+L EL T G   Y
Sbjct: 338 RQGAKFPIKWTAP----EAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (278), Expect = 9e-28
 Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 30/226 (13%)

Query: 140 LTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL 197
           + +  ++ + +  LG+G +G V K   V     +AVK++          T+N  ++++ L
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--------TVNSQEQKRLL 53

Query: 198 RELK-YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL- 255
            +L   + +      +  YG  F  G   +    M + SL+       +    +    L 
Sbjct: 54  MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG 112

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATH 311
            IA      L+ LHS +  +IH D+K +N+L+N      + DFG    L  +  + K   
Sbjct: 113 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDID 169

Query: 312 ITLKRVNGTRPYLPHEFLVGKRL----STKVDVYGFGIVLFELATG 353
                  G +PY+  E +  +      S K D++  GI + ELA  
Sbjct: 170 A------GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  114 bits (287), Expect = 9e-28
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 33/229 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQC-- 191
           IP + L L          LG+G FG V+ G W   T +A+K            TL     
Sbjct: 264 IPRESLRL-------EVKLGQGCFGEVWMGTWNGTTRVAIK------------TLKPGTM 304

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
             E  L+E + +   RH+ ++ LY +  E   Y +V  YM  GSL D  L  +    L  
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLD-FLKGETGKYLRL 362

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            Q + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +     + T 
Sbjct: 363 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420

Query: 312 ITLKR--VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
               +  +  T P    E  +  R + K DV+ FGI+L EL T G   Y
Sbjct: 421 RQGAKFPIKWTAP----EAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (276), Expect = 1e-27
 Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 33/229 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           I   ELT        +  +G G FG V+ G W     +A+K            T+ +   
Sbjct: 5   IDPSELTF-------VQEIGSGQFGLVHLGYWLNKDKVAIK------------TIREGAM 45

Query: 194 EQS--LRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
            +   + E + +    H  ++ LYG+C E    CLV  +M +G L D L  +        
Sbjct: 46  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAA 103

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
              L +      G+ +L      +IH D+ + N L+  +    + DFG+T+   +    +
Sbjct: 104 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY 159

Query: 312 ITLKRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
                     P      E     R S+K DV+ FG++++E+ + G   Y
Sbjct: 160 T--SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  111 bits (279), Expect = 1e-27
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 37/242 (15%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAV 185
             +P + +TL       +  LG G FG VY+G             +AVK L    +++  
Sbjct: 25  KEVPRKNITL-------IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 77

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK- 244
                      L E   ++   H NI+   G+  ++    ++   M  G L+  L   + 
Sbjct: 78  LDF--------LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP 129

Query: 245 ---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDF 298
                 SL     LH+A+  + G Q+L       IH DI + N LL          IGDF
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 187

Query: 299 GLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR 355
           G+ ++  I +      K      P  ++P E  +    ++K D + FG++L+E+ + G  
Sbjct: 188 GMARD--IYR-ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244

Query: 356 AY 357
            Y
Sbjct: 245 PY 246

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  109 bits (276), Expect = 1e-27
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 41/231 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE 194
           +  +EL L       L  +GKG FG V  G +    +AVK +   +ND   +        
Sbjct: 18  LNMKELKL-------LQTIGKGEFGDVMLGDYRGNKVAVKCI---KNDATAQAF------ 61

Query: 195 QSLRELKYLNSCRHDNILPLYGICF-ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
             L E   +   RH N++ L G+   E G   +V  YM  GSL D  L  +    L    
Sbjct: 62  --LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDC 118

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            L  +      +++L       +H D+ + N+L++      + DFGLT+E         +
Sbjct: 119 LLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE--------AS 168

Query: 314 LKRVNG------TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
             +  G      T P    E L  K+ STK DV+ FGI+L+E+ + G   Y
Sbjct: 169 STQDTGKLPVKWTAP----EALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  110 bits (278), Expect = 2e-27
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 34/238 (14%)

Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAV 185
              +   E          + +LG G FGTVYKG+W       K  +A+K+L         
Sbjct: 9   LRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------- 53

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
           E  +    ++ L E   + S  + ++  L GIC  +    L+ + MP G L D +  +++
Sbjct: 54  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV--REH 110

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             ++     L+     + G+ +L  R   L+H D+ + N+L+       I DFGL +   
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

Query: 306 IEKATHITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            E+  +       G  P       E ++ +  + + DV+ +G+ ++EL T G + YD 
Sbjct: 169 AEEKEY---HAEGGKVPIKWMAL-ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (277), Expect = 2e-27
 Identities = 65/309 (21%), Positives = 113/309 (36%), Gaps = 49/309 (15%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           Q + L         +L +GGF  VY  + V      A+K+L  +          + +   
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---------EEEKNRA 71

Query: 196 SLRELKYLNSCR-HDNILPLYGICF------ETGKY-CLVYRYMPNGSLEDRLLMKKNTP 247
            ++E+ ++     H NI+             +TG+   L+   +  G L +  L K  + 
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESR 130

Query: 248 SLLWTQR-LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QE 303
             L     L I   T   +Q +H ++PP+IH D+K  N+LL++     + DFG       
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190

Query: 304 GPIEKATHITLKRV------NGTRPYLPHE---FLVGKRLSTKVDVYGFGIVLFELATGM 354
            P    +      V      N T  Y   E         +  K D++  G +L+ L    
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

Query: 355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
             ++D       L+ +  KYS             P        F  + +   + NP+ER 
Sbjct: 251 HPFED----GAKLRIVNGKYSI------------PPHDTQYTVFHSLIRAMLQVNPEERL 294

Query: 415 EMTQVYNML 423
            + +V + L
Sbjct: 295 SIAEVVHQL 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (276), Expect = 3e-27
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 25/234 (10%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQR 193
           P Q       +   L  +G+G +G+V K         +AVK++          T+++ ++
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--------TVDEKEQ 64

Query: 194 EQSLRELK-YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
           +Q L +L   + S     I+  YG  F  G   +    M + S +       +    +  
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123

Query: 253 QRL--HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           + +   I   T   L  L      +IH DIK +NILL+   +  + DFG++ +       
Sbjct: 124 EEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ-----LV 177

Query: 311 HITLKRVN-GTRPYLPHEFLVGKRL----STKVDVYGFGIVLFELATGMRAYDD 359
               K  + G RPY+  E +           + DV+  GI L+ELATG   Y  
Sbjct: 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (272), Expect = 4e-27
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 39/232 (16%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQC-- 191
           +  +E+TL       L  LG G FG V  G W  +  +AVK             + +   
Sbjct: 5   LKREEITL-------LKELGSGQFGVVKLGKWKGQYDVAVK------------MIKEGSM 45

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
             ++  +E + +    H  ++  YG+C +     +V  Y+ NG L + L  + +   L  
Sbjct: 46  SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEP 103

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
           +Q L +      G+ FL S +   IH D+ + N L++  +   + DFG+T+   +    +
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY 159

Query: 312 ITLKRVNGTRPYLPH-----EFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
           +      GT+   P      E     + S+K DV+ FGI+++E+ + G   Y
Sbjct: 160 V---SSVGTK--FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  109 bits (274), Expect = 4e-27
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)

Query: 151 NILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
            ++GKG FG VY G +      +   A+K L      + VE          LRE   +  
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--------LREGLLMRG 78

Query: 206 CRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             H N+L L GI     G   ++  YM +G L   +  +    +      +      + G
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARG 136

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           +++L  ++   +H D+ + N +L+      + DFGL ++  I    + ++++    R  L
Sbjct: 137 MEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHAR--L 190

Query: 325 P-----HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
           P      E L   R +TK DV+ FG++L+EL T G   Y
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (273), Expect = 4e-27
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 28/220 (12%)

Query: 150 LNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
             ++G+G FG VY G       +K   AVK L            +  +  Q L E   + 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--------RITDIGEVSQFLTEGIIMK 81

Query: 205 SCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              H N+L L GIC  + G   +V  YM +G L + +  +  T +      +      + 
Sbjct: 82  DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAK 139

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+++L S++   +H D+ + N +L+      + DFGL ++  +    + ++    G +  
Sbjct: 140 GMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAK-- 193

Query: 324 LP-----HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
           LP      E L  ++ +TK DV+ FG++L+EL T G   Y
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  109 bits (274), Expect = 7e-27
 Identities = 58/249 (23%), Positives = 100/249 (40%), Gaps = 50/249 (20%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK----TTIAVKKLEVHRNDRAVETL 188
           P + + ++          +++G+G FG V K   +K       A+K+++        E  
Sbjct: 20  PVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--------EYA 64

Query: 189 NQCQREQSLRELKYLNS-CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------- 240
           ++        EL+ L     H NI+ L G C   G   L   Y P+G+L D L       
Sbjct: 65  SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 241 ------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV 294
                 +      +L   Q LH A   + G+ +L  ++   IH D+ + NIL+  +    
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 182

Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLP-----HEFLVGKRLSTKVDVYGFGIVLFE 349
           I DFGL++   +     +           LP      E L     +T  DV+ +G++L+E
Sbjct: 183 IADFGLSRGQEVYVKKTMGR---------LPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

Query: 350 LAT-GMRAY 357
           + + G   Y
Sbjct: 234 IVSLGGTPY 242

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (273), Expect = 7e-27
 Identities = 49/232 (21%), Positives = 81/232 (34%), Gaps = 28/232 (12%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRNDRAVETLNQCQREQ 195
           Q      N+ + L  +G G  G V+K         IAVK++          + N+ + ++
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR--------SGNKEENKR 69

Query: 196 SLRELKYL-NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
            L +L  +  S     I+  +G         +    M     E   L K+    +     
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK--LKKRMQGPIPERIL 126

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHI 312
             +       L +L  +   +IH D+K +NILL+      + DFG++        K    
Sbjct: 127 GKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185

Query: 313 TLKRVNGTRPY-----LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
                 G   Y     +            + DV+  GI L ELATG   Y +
Sbjct: 186 ------GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  108 bits (271), Expect = 7e-27
 Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 33/228 (14%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            +      +LGKG +G VY G        IA+K++   R+ R  + L++        E+ 
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-RDSRYSQPLHE--------EIA 71

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--HIAK 259
                +H NI+   G   E G   +    +P GSL    L++     L   ++      K
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA--LLRSKWGPLKDNEQTIGFYTK 129

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHIT----- 313
               GL++LH  +  ++H DIK  N+L+N +   + I DFG         +  +      
Sbjct: 130 QILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT--------SKRLAGINPC 179

Query: 314 LKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATGMRAYDD 359
            +   GT  Y+  E +           D++  G  + E+ATG   + +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  108 bits (271), Expect = 8e-27
 Identities = 53/232 (22%), Positives = 102/232 (43%), Gaps = 39/232 (16%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQC-- 191
           I  ++LT        L  LG G FG V  G W     +A+K             + +   
Sbjct: 21  IDPKDLTF-------LKELGTGQFGVVKYGKWRGQYDVAIK------------MIKEGSM 61

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
             ++ + E K + +  H+ ++ LYG+C +     ++  YM NG L + L  ++       
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQT 119

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            Q L + K     +++L S++   +H D+ + N L+N      + DFGL++   +    +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY 175

Query: 312 ITLKRVNGTRPYLP-----HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
                  G++   P      E L+  + S+K D++ FG++++E+ + G   Y
Sbjct: 176 ---TSSVGSK--FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  108 bits (272), Expect = 9e-27
 Identities = 61/242 (25%), Positives = 94/242 (38%), Gaps = 43/242 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
            P   L+           LG G FG V +             T+AVK L+   +    E 
Sbjct: 20  FPRNRLSF-------GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 72

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------- 240
           L     E  +  L YL    H NI+ L G C   G   ++  Y   G L + L       
Sbjct: 73  L---MSELKV--LSYLG--NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 241 --------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD 292
                   +M+ +  +L     L  +   + G+ FL S+    IH D+ + NILL H   
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRI 183

Query: 293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             I DFGL ++  I+      + + N   P   +  E +     + + DV+ +GI L+EL
Sbjct: 184 TKICDFGLARD--IKN-DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

Query: 351 AT 352
            +
Sbjct: 241 FS 242

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  108 bits (272), Expect = 9e-27
 Identities = 53/240 (22%), Positives = 99/240 (41%), Gaps = 34/240 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETL 188
               EL         L +LG G FGTV+KGVW       K  + +K +E     ++ + +
Sbjct: 10  FKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62

Query: 189 NQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS 248
                      +  + S  H +I+ L G+C  +    LV +Y+P GSL D +  +++  +
Sbjct: 63  --------TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV--RQHRGA 111

Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGP 305
           L     L+     + G+ +L      ++H ++ + N+LL       + DFG+        
Sbjct: 112 LGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169

Query: 306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE 364
            +         +         E +   + + + DV+ +G+ ++EL T G   Y   R +E
Sbjct: 170 KQLLYSEAKTPIKWMAL----ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (271), Expect = 1e-26
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 34/226 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           ++++   ++G G    V           +A+K++ + +   +++ L        L+E++ 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--------LKEIQA 66

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL----HIA 258
           ++ C H NI+  Y       +  LV + +  GS+ D  ++K           +     IA
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD--IIKHIVAKGEHKSGVLDESTIA 124

Query: 259 ---KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATH 311
              +    GL++LH      IH D+K+ NILL       I DFG    L   G I +   
Sbjct: 125 TILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR--- 179

Query: 312 ITLKR--VNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               R    GT P    P      +    K D++ FGI   ELATG
Sbjct: 180 -NKVRKTFVGT-PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (270), Expect = 1e-26
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 153 LGKGGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           LG G FG+V +GV+    ++  +A+K L+        +   +   E+ +RE + ++   +
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK--------QGTEKADTEEMMREAQIMHQLDN 69

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
             I+ L G+C       LV      G L   L        +  +    +    S+G+++L
Sbjct: 70  PYIVRLIGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL 126

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLP 325
             +    +H D+ + N+LL +     I DFGL++   +         R  G  P   Y P
Sbjct: 127 EEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKA--LGADDSYYTARSAGKWPLKWYAP 182

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            E +  ++ S++ DV+ +G+ ++E  + G + Y  
Sbjct: 183 -ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  107 bits (269), Expect = 2e-26
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 30/233 (12%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQ 190
           +  + LTL      +   LG G FGTV KG +       T+AVK L+        E  + 
Sbjct: 13  LDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK-------NEANDP 59

Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
             +++ L E   +    +  I+ + GIC E   + LV      G L   L   +    + 
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVK 115

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
               + +    S+G+++L       +H D+ + N+LL       I DFGL++   +    
Sbjct: 116 DKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADE 171

Query: 311 HITLKRVNGTRP---YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
           +    + +G  P   Y P E +   + S+K DV+ FG++++E  + G + Y  
Sbjct: 172 NYYKAQTHGKWPVKWYAP-ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  108 bits (271), Expect = 2e-26
 Identities = 45/267 (16%), Positives = 85/267 (31%), Gaps = 25/267 (9%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC---Q 192
           P  E  L +      ++LG+G F  VY+        A  K +       ++        +
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF-----VLKVQKPANPWE 110

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
                + ++ L        +  Y          LV      G+L + + + KNTP  +  
Sbjct: 111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170

Query: 253 QRL--HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP-----------VIGDFG 299
           Q L    A      ++ +H  E  +IHGDIK  N +L +                + D G
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            + +  +             T  +   E L  K  + ++D +G    ++ +  G      
Sbjct: 229 QSIDMKLFPKGT-IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287

Query: 360 TRRSERHLKSLVEKY-SEENMYDLVDK 385
               E   + L  +    +   +    
Sbjct: 288 NEGGECKPEGLFRRLPHLDMWNEFFHV 314

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  106 bits (268), Expect = 2e-26
 Identities = 60/244 (24%), Positives = 114/244 (46%), Gaps = 36/244 (14%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC- 191
            HI  +++ L          LG+G FG V+       +    K+ V     AV+ L    
Sbjct: 10  QHIKRRDIVL-------KRELGEGAFGKVFLAECYNLSPTKDKMLV-----AVKALKDPT 57

Query: 192 --QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--------- 240
              R+   RE + L + +H++I+  YG+C +     +V+ YM +G L   L         
Sbjct: 58  LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117

Query: 241 ----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG 296
                 ++    L  +Q LHIA   + G+ +L S+    +H D+ + N L+  ++   IG
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIG 175

Query: 297 DFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-G 353
           DFG++++  +   T       +   P  ++P E ++ ++ +T+ DV+ FG++L+E+ T G
Sbjct: 176 DFGMSRD--VYS-TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232

Query: 354 MRAY 357
            + +
Sbjct: 233 KQPW 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  108 bits (271), Expect = 2e-26
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 37/242 (15%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAV 185
             +P + +TL       +  LG G FG VY+G             +AVK L    +++  
Sbjct: 66  KEVPRKNITL-------IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-- 116

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK- 244
                      L E   ++   H NI+   G+  ++    ++   M  G L+  L   + 
Sbjct: 117 ------DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 170

Query: 245 ---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDF 298
                 SL     LH+A+  + G Q+L       IH DI + N LL          IGDF
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 228

Query: 299 GLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR 355
           G+ ++  I +      K      P  ++P E  +    ++K D + FG++L+E+ + G  
Sbjct: 229 GMARD--IYR-AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285

Query: 356 AY 357
            Y
Sbjct: 286 PY 287

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (272), Expect = 2e-26
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 26/223 (11%)

Query: 144 TNNWDKLNILGKG--GFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
              ++ L ++GKG     TV    ++ T   + V+++ +       E  +         E
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL-------EACSNEMVTFLQGE 76

Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA- 258
           L       H NI+P         +  +V  +M  GS +D  L+  +    +    L IA 
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGM--NELAIAY 132

Query: 259 --KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG----LTQEGPIEKATHI 312
             +G    L ++H      +H  +K+++IL++      +        +   G  ++  H 
Sbjct: 133 ILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 313 TLKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATG 353
             K      P+L  E L         K D+Y  GI   ELA G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  107 bits (269), Expect = 3e-26
 Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 35/234 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLN 189
           IP Q+ TL         +LGKG FG+V +            +AVK L+        + + 
Sbjct: 20  IPEQQFTL-------GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-------DIIA 65

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETG------KYCLVYRYMPNGSLEDRLLMK 243
               E+ LRE   +    H ++  L G+   +          ++  +M +G L   LL  
Sbjct: 66  SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125

Query: 244 K---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
           +   N  +L     +      + G+++L SR    IH D+ + N +L   M   + DFGL
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGL 183

Query: 301 TQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           +++  I        +      P  +L  E L     +   DV+ FG+ ++E+ T
Sbjct: 184 SRK--IYS-GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (268), Expect = 3e-26
 Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 35/239 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLN 189
           I    L L         ILG+G FG+V +G           +AVK +++       +  +
Sbjct: 31  IDRNLLIL-------GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL-------DNSS 76

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYC-----LVYRYMPNGSLEDRLLMKK 244
           Q + E+ L E   +    H N++ L G+C E          ++  +M  G L   LL  +
Sbjct: 77  QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136

Query: 245 ---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
                  +     L      +LG+++L +R    +H D+ + N +L   M   + DFGL+
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLS 194

Query: 302 QEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
           ++  I        +      P  ++  E L  +  ++K DV+ FG+ ++E+AT GM  Y
Sbjct: 195 KK--IYS-GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  109 bits (273), Expect = 3e-26
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 29/227 (12%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           IP + L L          LG G FG V+   + K T +AVK ++                
Sbjct: 185 IPRESLKL-------EKKLGAGQFGEVWMATYNKHTKVAVKTMKP----------GSMSV 227

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           E  L E   + + +HD ++ L+ +  +   Y ++  +M  GSL D  L           +
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLD-FLKSDEGSKQPLPK 285

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            +  +   + G+ F+  R    IH D+++ANIL++  +   I DFGL +     + T   
Sbjct: 286 LIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343

Query: 314 LKR--VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
             +  +  T P    E +     + K DV+ FGI+L E+ T G   Y
Sbjct: 344 GAKFPIKWTAP----EAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (267), Expect = 4e-26
 Identities = 53/238 (22%), Positives = 105/238 (44%), Gaps = 31/238 (13%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC-- 191
            +  +++T+          LG+G FG VY+GV +       +  V     A++T+N+   
Sbjct: 21  EVAREKITM-------SRELGQGSFGMVYEGVAKGVVKDEPETRV-----AIKTVNEAAS 68

Query: 192 --QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK----- 244
             +R + L E   +      +++ L G+  +     ++   M  G L+  L   +     
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128

Query: 245 --NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
                    ++ + +A   + G+ +L++ +   +H D+ + N ++       IGDFG+T+
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTR 186

Query: 303 EGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
           +  I + T    K   G  P  ++  E L     +T  DV+ FG+VL+E+AT   + Y
Sbjct: 187 D--IYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  105 bits (265), Expect = 4e-26
 Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 40/237 (16%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLN 189
           I  + + L          +G+G FG V++G++         +A+K  +   +D       
Sbjct: 12  IQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS------ 58

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
              RE+ L+E   +    H +I+ L G+  E   + ++      G L   L  +    SL
Sbjct: 59  --VREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL--QVRKYSL 113

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                +  A   S  L +L S+    +H DI + N+L++ +    +GDFGL++   +E +
Sbjct: 114 DLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDS 169

Query: 310 THITLKRVNG------TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
           T+   K   G        P    E +  +R ++  DV+ FG+ ++E+   G++ +  
Sbjct: 170 TYY--KASKGKLPIKWMAP----ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 4e-26
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 24/218 (11%)

Query: 150 LNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
             ++G+G FG VY G       +K   AVK L            +  +  Q L E   + 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--------RITDIGEVSQFLTEGIIMK 145

Query: 205 SCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              H N+L L GIC  + G   +V  YM +G L + +  +  T +      +      + 
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAK 203

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI-EKATHITLKRVNGTRP 322
           G++FL S++   +H D+ + N +L+      + DFGL ++  + +K       +     P
Sbjct: 204 GMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLP 259

Query: 323 --YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
             ++  E L  ++ +TK DV+ FG++L+EL T G   Y
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  106 bits (266), Expect = 5e-26
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 36/225 (16%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + KL  +GKG FG V+KG+  +T   +A+K +++   +  +E + Q        E+  L+
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ--------EITVLS 75

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
            C    +   YG   +  K  ++  Y+  GS  D  L++     L  TQ   I +    G
Sbjct: 76  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGP--LDETQIATILREILKG 131

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRP 322
           L +LHS +   IH DIK+AN+LL+ H +  + DFG+       + T   +KR    GT P
Sbjct: 132 LDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGT-P 183

Query: 323 Y--LPHEFLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
           +   P E +      +K D++  GI   ELA G         M+ 
Sbjct: 184 FWMAP-EVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  105 bits (264), Expect = 6e-26
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 38/236 (16%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLN 189
           I  +++ L         ILG+G FG VY+GV+     EK  +AVK  +        +   
Sbjct: 9   IAREDVVL-------NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK--------KDCT 53

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
              +E+ + E   + +  H +I+ L GI  E   + ++    P G L   L  ++N  SL
Sbjct: 54  LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL--ERNKNSL 110

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                +  +      + +L S     +H DI   NIL+       +GDFGL++   IE  
Sbjct: 111 KVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDE 166

Query: 310 THITLKRVNGTRPYLP-----HEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            +    + + TR  LP      E +  +R +T  DV+ F + ++E+ + G + +  
Sbjct: 167 DYY---KASVTR--LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 7e-26
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 37/225 (16%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           + +   +G+G  GTVY  +   T   +A++++ + +  +         +E  + E+  + 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMR 72

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             ++ NI+          +  +V  Y+  GSL D  ++ +    +   Q   + +     
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD--VVTETC--MDEGQIAAVCRECLQA 128

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRP 322
           L+FLHS +  +IH DIKS NILL       + DFG        + T    KR  + GT P
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCA-----QITPEQSKRSTMVGT-P 180

Query: 323 Y--LPHEFLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
           Y   P E +  K    KVD++  GI+  E+  G         +RA
Sbjct: 181 YWMAP-EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  104 bits (262), Expect = 1e-25
 Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 33/229 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQC-- 191
           +P + L L       +  LG G FG V+ G +   T +AVK            +L Q   
Sbjct: 10  VPRETLKL-------VERLGAGQFGEVWMGYYNGHTKVAVK------------SLKQGSM 50

Query: 192 QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLW 251
             +  L E   +   +H  ++ LY +  +   Y ++  YM NGSL D  L   +   L  
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVD-FLKTPSGIKLTI 108

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
            + L +A   + G+ F+  R    IH D+++ANIL++  +   I DFGL +   IE   +
Sbjct: 109 NKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY 164

Query: 312 ITLKRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY 357
               R     P      E +     + K DV+ FGI+L E+ T G   Y
Sbjct: 165 TA--REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  104 bits (262), Expect = 2e-25
 Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 43/239 (17%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLREL 200
            ++++++ +LG+G FG V K           A+KK+             + +    L E+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKIR----------HTEEKLSTILSEV 53

Query: 201 KYLNSCRHDNILPLYG-------------ICFETGKYCLVYRYMPNGSLEDRLLMKKNTP 247
             L S  H  ++  Y                 +     +   Y  NG+L D +  +    
Sbjct: 54  MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113

Query: 248 SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL------- 300
                +   + +     L ++HS+   +IH D+K  NI ++   +  IGDFGL       
Sbjct: 114 QR--DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

Query: 301 ----TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGM 354
                 +      +   L    GT  Y+  E L G    + K+D+Y  GI+ FE+    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF 228

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 2e-25
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +D L  LG+G +G+VYK + ++T   +A+K++ V           +   ++ ++E+ 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-----------ESDLQEIIKEIS 76

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            +  C   +++  YG  F+     +V  Y   GS+ D  +++    +L   +   I + T
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTEDEIATILQST 134

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNG 319
             GL++LH      IH DIK+ NILLN      + DFG+       + T    KR  V G
Sbjct: 135 LKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAG-----QLTDTMAKRNTVIG 187

Query: 320 TRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
           T P+   P E +     +   D++  GI   E+A G         MRA
Sbjct: 188 T-PFWMAP-EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  108 bits (270), Expect = 2e-25
 Identities = 58/330 (17%), Positives = 127/330 (38%), Gaps = 26/330 (7%)

Query: 40  FKHLYAM-RHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVN 98
           F  L+ +  + +       Y   +         +         +   +  +   +   +N
Sbjct: 229 FDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLN 288

Query: 99  FENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNI-LGKGG 157
            +            ++P     D     +       +  ++L L  +N    +I LG G 
Sbjct: 289 SDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGN 348

Query: 158 FGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP 213
           FG+V +GV+    ++  +A+K L+        +   +   E+ +RE + ++   +  I+ 
Sbjct: 349 FGSVRQGVYRMRKKQIDVAIKVLK--------QGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREP 273
           L G+C       LV      G L   L        +  +    +    S+G+++L  +  
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 456

Query: 274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP---YLPHEFLV 330
             +H ++ + N+LL +     I DFGL++    + + +    R  G  P   Y P E + 
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA--RSAGKWPLKWYAP-ECIN 512

Query: 331 GKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            ++ S++ DV+ +G+ ++E  + G + Y  
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  104 bits (261), Expect = 2e-25
 Identities = 50/245 (20%), Positives = 100/245 (40%), Gaps = 37/245 (15%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC- 191
             I    +         +  LG+  FG VYKG         +   V     A++TL    
Sbjct: 4   KEISLSAVRF-------MEELGEDRFGKVYKGHLFGPAPGEQTQAV-----AIKTLKDKA 51

Query: 192 ---QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL-------- 240
               RE+   E       +H N++ L G+  +     +++ Y  +G L + L        
Sbjct: 52  EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSD 111

Query: 241 -----LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
                  +    +L     +H+    + G+++L S    ++H D+ + N+L+   ++  I
Sbjct: 112 VGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKI 169

Query: 296 GDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT- 352
            D GL +E  +  A +      N   P  ++  E ++  + S   D++ +G+VL+E+ + 
Sbjct: 170 SDLGLFRE--VYAADYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226

Query: 353 GMRAY 357
           G++ Y
Sbjct: 227 GLQPY 231

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  104 bits (262), Expect = 3e-25
 Identities = 55/240 (22%), Positives = 85/240 (35%), Gaps = 43/240 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
            P   L            LG G FG V +              +AVK L+   +    E 
Sbjct: 43  FPRNNLQF-------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 95

Query: 188 LNQCQREQSLRELKYLNS-CRHDNILPLYGICFETGKYCLVYRYMPNGSL---------- 236
           L        + ELK ++   +H+NI+ L G C   G   ++  Y   G L          
Sbjct: 96  L--------MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147

Query: 237 -EDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI 295
            E          +      LH +   + G+ FL S+    IH D+ + N+LL +     I
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKI 205

Query: 296 GDFGLT---QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           GDFGL                   V    P    E +     + + DV+ +GI+L+E+ +
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAP----ESIFDCVYTVQSDVWSYGILLWEIFS 261

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (261), Expect = 3e-25
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 37/225 (16%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            D    +G+G  G V     + +   +AVK +++ +  R         RE    E+  + 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMR 97

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             +H N++ +Y       +  ++  ++  G+L D  ++ +    L   Q   + +     
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD--IVSQVR--LNEEQIATVCEAVLQA 153

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VNGTRP 322
           L +LH++   +IH DIKS +ILL       + DFG        + +    KR  + GT P
Sbjct: 154 LAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCA-----QISKDVPKRKSLVGT-P 205

Query: 323 Y--LPHEFLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
           Y   P E +     +T+VD++  GI++ E+  G         ++A
Sbjct: 206 YWMAP-EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  104 bits (262), Expect = 3e-25
 Identities = 68/316 (21%), Positives = 125/316 (39%), Gaps = 62/316 (19%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQC- 191
            HI  +++ L          LG+G FG V+            K+ V     AV+ L +  
Sbjct: 36  HHIKRRDIVL-------KWELGEGAFGKVFLAECHNLLPEQDKMLV-----AVKALKEAS 83

Query: 192 --QREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--------- 240
              R+   RE + L   +H +I+  +G+C E     +V+ YM +G L   L         
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143

Query: 241 ---LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD 297
                      L   Q L +A   + G+ +L       +H D+ + N L+   +   IGD
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGD 201

Query: 298 FGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GM 354
           FG++++  I   T           P  ++P E ++ ++ +T+ DV+ FG+VL+E+ T G 
Sbjct: 202 FGMSRD--IYS-TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

Query: 355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ-------PIELNIAYAFFRIGKQSTK 407
           + +                 S     D + +  +       P E+      + I +   +
Sbjct: 259 QPWYQ--------------LSNTEAIDCITQGRELERPRACPPEV------YAIMRGCWQ 298

Query: 408 QNPKERPEMTQVYNML 423
           + P++R  +  V+  L
Sbjct: 299 REPQQRHSIKDVHARL 314

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  107 bits (268), Expect = 3e-25
 Identities = 56/243 (23%), Positives = 92/243 (37%), Gaps = 27/243 (11%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            W+    LG GGFG V + + + T   +A+K+     + +  E            E++ +
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW--------CLEIQIM 66

Query: 204 NSCRHDNILPLYGICFETGK-------YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
               H N++    +  +  +         L   Y   G L   L   +N   L       
Sbjct: 67  KKLNHPNVVSAREV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHIT 313
           +    S  L++LH     +IH D+K  NI+L      +   I D G  +E    +     
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----L 179

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
                GT  YL  E L  K+ +  VD + FG + FE  TG R +    +  +    + EK
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 374 YSE 376
            +E
Sbjct: 240 SNE 242

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  103 bits (260), Expect = 4e-25
 Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 50/248 (20%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
            P + L L          LG+G FG V K            TT+AVK L+ + +   +  
Sbjct: 20  FPRKNLVL-------GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL------- 240
           L        L E   L    H +++ LYG C + G   L+  Y   GSL   L       
Sbjct: 73  L--------LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124

Query: 241 --------------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL 286
                         L   +  +L     +  A   S G+Q+L   +  L+H D+ + NIL
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNIL 182

Query: 287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFG 344
           +       I DFGL+++  + +     +KR  G  P  ++  E L     +T+ DV+ FG
Sbjct: 183 VAEGRKMKISDFGLSRD--VYE-EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239

Query: 345 IVLFELAT 352
           ++L+E+ T
Sbjct: 240 VLLWEIVT 247

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  107 bits (268), Expect = 5e-25
 Identities = 52/234 (22%), Positives = 101/234 (43%), Gaps = 34/234 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLN 189
           I  + + L          +G+G FG V++G++         +A+K  +   +D       
Sbjct: 387 IQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS------ 433

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
              RE+ L+E   +    H +I+ L G+  E   + ++      G L   L  +    SL
Sbjct: 434 --VREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL--QVRKFSL 488

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPI 306
                +  A   S  L +L S+    +H DI + N+L++ +    +GDFGL+   ++   
Sbjct: 489 DLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546

Query: 307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
            KA+   L  +    P    E +  +R ++  DV+ FG+ ++E+   G++ +  
Sbjct: 547 YKASKGKLP-IKWMAP----ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  103 bits (260), Expect = 5e-25
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 43/242 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAV 185
            P  +LTL          LG+G FG V              E  T+AVK L+    ++ +
Sbjct: 32  FPRDKLTL-------GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 84

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
             L     E  +  +K +   +H NI+ L G C + G   ++  Y   G+L + L  ++ 
Sbjct: 85  SDL---VSEMEM--MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137

Query: 246 T-------------PSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD 292
                           + +   +      + G+++L S++   IH D+ + N+L+  +  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV 195

Query: 293 PVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             I DFGL ++  I        K  NG  P  ++  E L  +  + + DV+ FG++++E+
Sbjct: 196 MKIADFGLARD--INN-IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

Query: 351 AT 352
            T
Sbjct: 253 FT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  104 bits (261), Expect = 6e-25
 Identities = 67/317 (21%), Positives = 121/317 (38%), Gaps = 63/317 (19%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAV 185
            P  +LTL          LG+G FG V              E  T+AVK L+    ++ +
Sbjct: 78  FPRDKLTL-------GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 130

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN 245
             L     E  +  +K +   +H NI+ L G C + G   ++  Y   G+L + L  ++ 
Sbjct: 131 SDL---VSEMEM--MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183

Query: 246 TPSLLWTQR-------------LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD 292
                                 +      + G+++L S++   IH D+ + N+L+  +  
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNV 241

Query: 293 PVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             I DFGL ++  I        K  NG  P  ++  E L  +  + + DV+ FG++++E+
Sbjct: 242 MKIADFGLARD--INN-IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

Query: 351 AT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKN---AQPIELNIAYAFFRIGKQST 406
            T G   Y                   E ++ L+ +     +P   N     + + +   
Sbjct: 299 FTLGGSPY--------------PGIPVEELFKLLKEGHRMDKP--ANCTNELYMMMRDCW 342

Query: 407 KQNPKERPEMTQVYNML 423
              P +RP   Q+   L
Sbjct: 343 HAVPSQRPTFKQLVEDL 359

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  103 bits (258), Expect = 9e-25
 Identities = 56/242 (23%), Positives = 95/242 (39%), Gaps = 44/242 (18%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
            P   L L          LG+G FG V +             T+AVK L+          
Sbjct: 24  FPRDRLKL-------GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76

Query: 188 LNQCQREQSLRELKYLNS-CRHDNILPLYGICFETGK-YCLVYRYMPNGSLEDRL----- 240
           L        + ELK L     H N++ L G C + G    ++  +   G+L   L     
Sbjct: 77  L--------MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 128

Query: 241 --------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD 292
                           L     +  +   + G++FL SR+   IH D+ + NILL+    
Sbjct: 129 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNV 186

Query: 293 PVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             I DFGL ++  I K     +++ +   P  ++  E +  +  + + DV+ FG++L+E+
Sbjct: 187 VKICDFGLARD--IYK-DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

Query: 351 AT 352
            +
Sbjct: 244 FS 245

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  102 bits (257), Expect = 1e-24
 Identities = 59/271 (21%), Positives = 99/271 (36%), Gaps = 33/271 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + W   +ILG+G    V++G  +KT    A+K        R V+          +RE + 
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--------MREFEV 60

Query: 203 LNSCRHDNILPLYGICFETG---KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L    H NI+ L+ I  E        L+  + P GSL   L    N   L  ++ L + +
Sbjct: 61  LKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLK 315
               G+  L      ++H +IK  NI+     D      + DFG  +E  +E        
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ--FV 173

Query: 316 RVNGTRPYL--------PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL 367
            + GT  YL               K+    VD++  G+  +  ATG   +       R+ 
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN- 232

Query: 368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAF 398
           K ++ K         +    +     I ++ 
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSG 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 1e-24
 Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 33/220 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVK---KLEVHRNDRAVETLNQCQREQSLRE 199
            ++   N+LGKG F  VY+     T   +A+K   K  +++             ++   E
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG---------MVQRVQNE 61

Query: 200 LKYLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
           +K     +H +IL LY   FE   Y  LV     NG +   L  K         +  H  
Sbjct: 62  VKIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFM 118

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT----- 313
                G+ +LHS    ++H D+  +N+LL  +M+  I DFGL        AT +      
Sbjct: 119 HQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGL--------ATQLKMPHEK 168

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              + GT  Y+  E         + DV+  G + + L  G
Sbjct: 169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (254), Expect = 1e-24
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 34/219 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            +++    LGKG FG VY    EK +   +A+K L      +A +        Q  RE++
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAR-EKQSKFILALKVL-----FKA-QLEKAGVEHQLRREVE 61

Query: 202 YLNSCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQRL----- 255
             +  RH NIL LYG  F       L+  Y P G++   L             +      
Sbjct: 62  IQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLS---------KFDEQRT 111

Query: 256 -HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
                  +  L + HS+   +IH DIK  N+LL    +  I DFG +   P         
Sbjct: 112 ATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRR 164

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             + GT  YLP E + G+    KVD++  G++ +E   G
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  103 bits (259), Expect = 1e-24
 Identities = 57/242 (23%), Positives = 97/242 (40%), Gaps = 43/242 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW---------EKTTIAVKKLEVHRNDRAV 185
           +P   L L          LG+G FG V                T +AVK L+    ++ +
Sbjct: 66  LPRDRLVL-------GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 118

Query: 186 ETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL----- 240
             L     E  +  +K +   +H NI+ L G C + G   ++  Y   G+L + L     
Sbjct: 119 SDL---ISEMEM--MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171

Query: 241 --------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD 292
                           L     +  A   + G+++L S++   IH D+ + N+L+     
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNV 229

Query: 293 PVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
             I DFGL ++  I        K  NG  P  ++  E L  +  + + DV+ FG++L+E+
Sbjct: 230 MKIADFGLARD--IHH-IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

Query: 351 AT 352
            T
Sbjct: 287 FT 288

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (256), Expect = 2e-24
 Identities = 62/342 (18%), Positives = 118/342 (34%), Gaps = 91/342 (26%)

Query: 145 NNWDKLNILGKGGFGTVYKG--VWEKTTIAVKKLEVHRND-------RAVETL------- 188
            +++ +  +G+GGFG V++     +    A+K++ +   +       R V+ L       
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 189 -----------------------------------NQCQREQSLRELKYLNSCRHDNILP 213
                                              +    +    +++ ++     N + 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREP 273
                       +  +     +L+D +  + +         LHI    +  ++FLHS+  
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184

Query: 274 PLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATHITLKRVN-------GTRPYL 324
            L+H D+K +NI         +GDFGL    +   E+ T +T            GT+ Y+
Sbjct: 185 -LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELA----TGM---RAYDDTRRSERHLKSLVEKYSEE 377
             E + G   S KVD++  G++LFEL     T M   R   D R  +     L  +   +
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK--FPLLFTQKYPQ 301

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
             + +V                   +     +P ERPE T +
Sbjct: 302 -EHMMV-------------------QDMLSPSPTERPEATDI 323

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  101 bits (255), Expect = 2e-24
 Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 40/258 (15%)

Query: 110 NPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT 169
           +PG      V+ P  P                 +   + +   LGKGGF   ++     T
Sbjct: 6   DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADT 65

Query: 170 --TIAVK---KLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY 224
               A K   K  + +           QRE+   E+    S  H +++  +G  FE   +
Sbjct: 66  KEVFAGKIVPKSLLLKPH---------QREKMSMEISIHRSLAHQHVVGFHG-FFEDNDF 115

Query: 225 -CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HIAKGTSLGLQFLHSREPPLIH 277
             +V       SL +    +K          L      +  +   LG Q+LH     +IH
Sbjct: 116 VFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLHRNR--VIH 164

Query: 278 GDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS 335
            D+K  N+ LN  ++  IGDFGL    E   E+      K + GT  Y+  E L  K  S
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-----KKVLCGTPNYIAPEVLSKKGHS 219

Query: 336 TKVDVYGFGIVLFELATG 353
            +VDV+  G +++ L  G
Sbjct: 220 FEVDVWSIGCIMYTLLVG 237

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  102 bits (256), Expect = 2e-24
 Identities = 50/279 (17%), Positives = 108/279 (38%), Gaps = 36/279 (12%)

Query: 115 PTRKVSDPLT-PMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKG--------- 164
           P   + D L+   N++    ++  ++  +  N++  +  L +G F  +            
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYI--NDYRIIRTLNQGKFNKIILCEKDNKFYAL 59

Query: 165 -VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK 223
             +EK+ +  K+     N+  +   ++   +    EL+ +   +++  L   GI      
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSK--YDDFKNELQIITDIKNEYCLTCEGI-ITNYD 116

Query: 224 Y-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HIAKGTSLGLQFLHSREPPLI 276
              ++Y YM N S+              +T  +       I K       ++H+ +  + 
Sbjct: 117 EVYIIYEYMENDSILK-FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NIC 174

Query: 277 HGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-- 334
           H D+K +NIL++ +    + DFG ++    +K     +K   GT  ++P EF   +    
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYN 229

Query: 335 STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
             KVD++  GI L+ +   +  +      +  L  L   
Sbjct: 230 GAKVDIWSLGICLYVMFYNVVPFSL----KISLVELFNN 264

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (254), Expect = 3e-24
 Identities = 66/291 (22%), Positives = 99/291 (34%), Gaps = 48/291 (16%)

Query: 83  SVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTL 142
           S +   +H+                +  P       + DP          P         
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDP--------- 52

Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
               +  L  +G G FG VY     +    +A+KK+         +       +  ++E+
Sbjct: 53  -EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW------QDIIKEV 105

Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
           ++L   RH N +   G         LV  Y   GS  D  L++ +   L   +   +  G
Sbjct: 106 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD--LLEVHKKPLQEVEIAAVTHG 162

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR--VN 318
              GL +LHS    +IH D+K+ NILL+      +GDFG         A+ +        
Sbjct: 163 ALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS--------ASIMA-PANSFV 211

Query: 319 GTRPY--LPHEFLVGKRLS--TKVDVYGFGIVLFELATG---------MRA 356
           GT PY   P   L         KVDV+  GI   ELA           M A
Sbjct: 212 GT-PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  101 bits (253), Expect = 6e-24
 Identities = 59/248 (23%), Positives = 97/248 (39%), Gaps = 50/248 (20%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
            P + L           +LG G FG V                +AVK L+   +    E 
Sbjct: 42  FPRENLEF-------GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA 94

Query: 188 LNQCQREQSLRELKYLNS-CRHDNILPLYGICFETGKYCLVYRYMPNGSL---------- 236
           L        + ELK +     H+NI+ L G C  +G   L++ Y   G L          
Sbjct: 95  L--------MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146

Query: 237 ----------EDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL 286
                     + RL  +++   L +   L  A   + G++FL  +    +H D+ + N+L
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVL 204

Query: 287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP--YLPHEFLVGKRLSTKVDVYGFG 344
           + H     I DFGL ++  I       + R N   P  ++  E L     + K DV+ +G
Sbjct: 205 VTHGKVVKICDFGLARD--IMS-DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261

Query: 345 IVLFELAT 352
           I+L+E+ +
Sbjct: 262 ILLWEIFS 269

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  101 bits (254), Expect = 1e-23
 Identities = 61/285 (21%), Positives = 118/285 (41%), Gaps = 39/285 (13%)

Query: 146 NWDKLNILGKGGFGT-VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYL 203
           ++   ++LG G  GT VY+G+++   +AVK++       A        RE Q LRE    
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA-------DREVQLLRESD-- 75

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H N++  +    +     +        +L++ +  K      L  + + + + T+ 
Sbjct: 76  ---EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTS 129

Query: 264 GLQFLHSREPPLIHGDIKSANILL-----NHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
           GL  LHS    ++H D+K  NIL+     +  +  +I DFGL ++  + + +      V 
Sbjct: 130 GLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 319 GTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY 374
           GT  ++  E L     +  +  VD++  G V + + + G   +      +R    L+   
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK--SLQRQANILLGAC 245

Query: 375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           S + ++    ++    EL        I K     +P++RP    V
Sbjct: 246 SLDCLHPEKHEDVIAREL--------IEKMIAM-DPQKRPSAKHV 281

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 59/236 (25%), Positives = 93/236 (39%), Gaps = 42/236 (17%)

Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVK---KLEVHRNDRAVE 186
            P +     +     + +   LGKGGF   ++     T    A K   K  + +      
Sbjct: 4   IPEVLVDPRSR--RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---- 57

Query: 187 TLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKN 245
                QRE+   E+    S  H +++  +G  FE   +  +V       SL +    +K 
Sbjct: 58  -----QREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRK- 110

Query: 246 TPSLLWTQRL------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG 299
                    L      +  +   LG Q+LH     +IH D+K  N+ LN  ++  IGDFG
Sbjct: 111 --------ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFG 160

Query: 300 L--TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           L    E   E+      K + GT  Y+  E L  K  S +VDV+  G +++ L  G
Sbjct: 161 LATKVEYDGER-----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  100 bits (251), Expect = 2e-23
 Identities = 59/271 (21%), Positives = 99/271 (36%), Gaps = 33/271 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + W   +ILG+G    V++G  +KT    A+K        R V+          +RE + 
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--------MREFEV 60

Query: 203 LNSCRHDNILPLYGICFETG---KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L    H NI+ L+ I  E        L+  + P GSL   L    N   L  ++ L + +
Sbjct: 61  LKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLK 315
               G+  L      ++H +IK  NI+     D      + DFG  +E  +E        
Sbjct: 120 DVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ--FV 173

Query: 316 RVNGTRPYL--------PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL 367
            + GT  YL               K+    VD++  G+  +  ATG   +       R+ 
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN- 232

Query: 368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAF 398
           K ++ K         +    +     I ++ 
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSG 263

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 61/311 (19%), Positives = 115/311 (36%), Gaps = 50/311 (16%)

Query: 130 GGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETL 188
            GT ++ +Q +++    +  L  +G GG   V++ + EK  I A+K +        +E  
Sbjct: 13  LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN-------LEEA 65

Query: 189 NQCQREQSLRELKYLNSCRH--DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
           +    +    E+ YLN  +   D I+ LY          +V     N  L   L  KK+ 
Sbjct: 66  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI 124

Query: 247 P----SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLT 301
                   W   L         +  +H     ++H D+K AN L+   M  + + DFG+ 
Sbjct: 125 DPWERKSYWKNMLE-------AVHTIHQHG--IVHSDLKPANFLIVDGM--LKLIDFGIA 173

Query: 302 QEGPIEKATHITLKRVNGT-----------RPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
            +   +  T +      GT                       ++S K DV+  G +L+ +
Sbjct: 174 NQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

Query: 351 ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNP 410
             G   +         L ++++   E    D+ +K+ Q            + K   K++P
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ-----------DVLKCCLKRDP 281

Query: 411 KERPEMTQVYN 421
           K+R  + ++  
Sbjct: 282 KQRISIPELLA 292

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.4 bits (243), Expect = 8e-23
 Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 51/239 (21%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYL 203
           ++ + ++G G +G VYKG   KT    A+K ++V  ++   E +   ++E   L++    
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEI---KQEINMLKKY--- 77

Query: 204 NSCRHDNILPLYG------ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
               H NI   YG            +  LV  +   GS+ D  L+K    + L  +   I
Sbjct: 78  --SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTL--KEEWI 131

Query: 258 A---KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
           A   +    GL  LH  +  +IH DIK  N+LL  + +  + DFG++      +      
Sbjct: 132 AYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTVG 184

Query: 315 KR--VNGTRPY------LPHEFLVGKRLSTKVDVYGFGIVLFELATG---------MRA 356
           +R    GT PY      +  +         K D++  GI   E+A G         MRA
Sbjct: 185 RRNTFIGT-PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 32/294 (10%), Positives = 65/294 (22%), Gaps = 56/294 (19%)

Query: 97  VNFENEAGVRQENNPGNEPT---RKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNIL 153
           +  E E           EP      V+  + P              L+        +  L
Sbjct: 15  LKREEELIGYCREEALKEPAAMVEAVTATVWP----QNAETTVDSLLSQGERKLKLVEPL 70

Query: 154 GKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
             G    V+     +     A+K   +   +   E       E+             ++ 
Sbjct: 71  RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL------ERLHEATFAAARLLGESP 124

Query: 212 LPLYGIC--------------------------FETGKYCLVYRYMPNGSLEDRL----L 241
                                            +    Y L+     +  LE        
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDF 183

Query: 242 MKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
           +              +          L S+   L+HG     N+ +      ++GD    
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATG 353
                           +    Y P EFL       +  ++ +  G+ ++ +   
Sbjct: 242 ------WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 60/277 (21%), Positives = 105/277 (37%), Gaps = 56/277 (20%)

Query: 106 RQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGV 165
           R   NP  +    + +P         +   P   +         +  +G+G FG V++  
Sbjct: 21  RLHPNPMYQRMPLLLNPKLL------SLEYPRNNIEY-------VRDIGEGAFGRVFQAR 67

Query: 166 W-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC 218
                     T +AVK L+   +                RE   +    + NI+ L G+C
Sbjct: 68  APGLLPYEPFTMVAVKMLKEEASADMQADF--------QREAALMAEFDNPNIVKLLGVC 119

Query: 219 FETGKYCLVYRYMPNGSLEDRLLMKK---------------------NTPSLLWTQRLHI 257
                 CL++ YM  G L + L                           P L   ++L I
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
           A+  + G+ +L  R+   +H D+ + N L+  +M   I DFGL++   I           
Sbjct: 180 ARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRN--IYS-ADYYKADG 234

Query: 318 NGTRP--YLPHEFLVGKRLSTKVDVYGFGIVLFELAT 352
           N   P  ++P E +   R +T+ DV+ +G+VL+E+ +
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 22/224 (9%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLN 189
             +P ++ T+  +++D    LGKG FG VY    EK     +A+K L      ++ +   
Sbjct: 4   AEMPKRKFTI--DDFDIGRPLGKGKFGNVYLAR-EKQNKFIMALKVL-----FKS-QLEK 54

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
           +    Q  RE++  +  RH NIL +Y    +  +  L+  + P G L   L         
Sbjct: 55  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE- 113

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                  + +  +  L + H R+  +IH DIK  N+L+ +  +  I DFG +   P  + 
Sbjct: 114 -QRSATFMEE-LADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                + + GT  YLP E + GK    KVD++  G++ +E   G
Sbjct: 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 34/238 (14%), Positives = 73/238 (30%), Gaps = 45/238 (18%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVK----------------KLEVHRNDRAVETLNQCQR 193
           +LG+       +   ++T  +  V                 K EV R        NQ Q 
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYM----PNGSLEDRL----LMKKN 245
           +  LR +   +  +      +  +  +     ++ R+        +L+            
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             SL+   RL +       L  LH     L+H  ++  +I+L+      +  F       
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 260

Query: 306 IEKATHITLKRVNGTRPYLPHEFLVGKRL----------STKVDVYGFGIVLFELATG 353
            + A+ ++       R + P E    + L          +   D +  G+ ++ +   
Sbjct: 261 -DGASAVSP----IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 60/351 (17%), Positives = 117/351 (33%), Gaps = 50/351 (14%)

Query: 90  HNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDK 149
           H+               +E        + +  P    +          + +++    +  
Sbjct: 1   HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60

Query: 150 LNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           L  +G GG   V++ + EK  I A+K +        +E  +    +    E+ YLN  + 
Sbjct: 61  LKQIGSGGSSKVFQVLNEKKQIYAIKYVN-------LEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 209 --DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP----SLLWTQRLHIAKGTS 262
             D I+ LY          +V     N  L   L  KK+         W   L       
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE------ 166

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGT- 320
             +  +H     ++H D+K AN L+   M  + + DFG+  +   +  T +      G  
Sbjct: 167 -AVHTIHQHG--IVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT-TSVVKDSQVGAV 220

Query: 321 ----------RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
                                 ++S K DV+  G +L+ +  G   +         L ++
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280

Query: 371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
           ++   E    D+ +K+ Q            + K   K++PK+R  + ++  
Sbjct: 281 IDPNHEIEFPDIPEKDLQ-----------DVLKCCLKRDPKQRISIPELLA 320

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 58/296 (19%), Positives = 106/296 (35%), Gaps = 50/296 (16%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTI-AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
             +  L  +G GG   V++ + EK  I A+K +        +E  +    +    E+ YL
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN-------LEEADNQTLDSYRNEIAYL 61

Query: 204 NSCRH--DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTP----SLLWTQRLHI 257
           N  +   D I+ LY          +V     N  L   L  KK+         W   L  
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE- 119

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKR 316
                  +  +H     ++H D+K AN L+   M  + + DFG+  +   +  T +    
Sbjct: 120 ------AVHTIHQHG--IVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT-TSVVKDS 168

Query: 317 VNGT-----------RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER 365
             GT                       ++S K DV+  G +L+ +  G   +        
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228

Query: 366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            L ++++   E    D+ +K+ Q            + K   K++PK+R  + ++  
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQ-----------DVLKCCLKRDPKQRISIPELLA 273

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 23/216 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             ++KL+ LG+G F TVYK   +K T   +A+KK+++     A + +N+     +LRE+K
Sbjct: 10  KRYEKLDFLGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKDGINR----TALREIK 64

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKG 260
            L    H NI+ L           LV+ +M      D  +++K N+  L  +        
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITLKRVN 318
           T  GL++LH     ++H D+K  N+LL+ +    + DFGL +    P    TH    +V 
Sbjct: 121 TLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH----QVV 174

Query: 319 GTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
            TR Y   E L G R+    VD++  G +L EL   
Sbjct: 175 -TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 92.6 bits (231), Expect = 4e-21
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 29/217 (13%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             + KL  +G+G +G VYK   +     +A+K++   R D   E +       ++RE+  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRI---RLDAEDEGIPS----TAIREISL 72

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKGT 261
           L    H NI+ L  +        LV+ +M      D + ++ +N   L  +Q        
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQL 128

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATH--ITLKRV 317
             G+   H     ++H D+K  N+L+N      + DFGL +    P+   TH  +TL   
Sbjct: 129 LRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW-- 184

Query: 318 NGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
                Y   + L+G +  ST VD++  G +  E+ TG
Sbjct: 185 -----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 33/219 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             + KL+ LG+G + TVYKG  + T   +A+K++ +   + A  T        ++RE+  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVSL 53

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPN---GSLEDR--LLMKKNTPSLLWTQRLHI 257
           L   +H NI+ L+ I        LV+ Y+       L+D   ++   N    L+ Q L  
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF-QLLR- 111

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATHITLK 315
                 GL + H ++  ++H D+K  N+L+N   +  + DFGL   +  P +   +    
Sbjct: 112 ------GLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---- 159

Query: 316 RVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
            V  T  Y P + L+G    ST++D++G G + +E+ATG
Sbjct: 160 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.4 bits (228), Expect = 7e-21
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 30/222 (13%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             ++KL  +G+G +GTV+K    + T   +A+K++   R D   E +       +LRE+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKA-KNRETHEIVALKRV---RLDDDDEGVPS----SALREIC 53

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKG 260
            L   +H NI+ L+ +     K  LV+ +       D +         L           
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATH--ITLKR 316
              GL F HSR   ++H D+K  N+L+N + +  + +FGL      P+   +   +TL  
Sbjct: 110 LLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW- 166

Query: 317 VNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAY 357
                 Y P + L G +L ST +D++  G +  ELA   R  
Sbjct: 167 ------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 54/300 (18%)

Query: 151 NILGKGGFGTV-YKGVWEKTTIAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYLNSCRH 208
            ILG G  GTV ++G ++   +AVK++ +   D A         E + L E        H
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA-------LMEIKLLTESD-----DH 68

Query: 209 DNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQR----LHIAKGTSL 263
            N++  Y     T ++  +      N +L+D +  K  +   L  Q+    + + +  + 
Sbjct: 69  PNVIRYYCS-ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV-------------IGDFGL-TQEGPIEKA 309
           G+  LHS +  +IH D+K  NIL++                   I DFGL  +    + +
Sbjct: 127 GVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 310 THITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFELAT-GMRAYDDTR 361
               L   +GT  +   E L         +RL+  +D++  G V + + + G   + D  
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-- 242

Query: 362 RSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
           +  R    +   +S + M  L D++        A        Q    +P +RP   +V  
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIA----EATDLI---SQMIDHDPLKRPTAMKVLR 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 34/220 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             ++ L ++G+G +G V K    K T   +A+KK     +D+ V       ++ ++RE+K
Sbjct: 25  EKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFLESDDDKMV-------KKIAMREIK 76

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPN---GSLEDR--LLMKKNTPSLLWTQRLH 256
            L   RH+N++ L  +C +  ++ LV+ ++ +     LE     L  +     L+ Q ++
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF-QIIN 135

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITL 314
                  G+ F HS     IH DIK  NIL++      + DFG  +    P E       
Sbjct: 136 -------GIGFCHSHNI--IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD--- 183

Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
             V  TR Y   E LVG  +    VDV+  G ++ E+  G
Sbjct: 184 -EV-ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 29/217 (13%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             +  L  +G+G +G VYK        T A+KK+   R ++  E +       ++RE+  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKI---RLEKEDEGIPS----TTIREISI 53

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKGT 261
           L   +H NI+ LY +     +  LV+ ++      D + L+      L            
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQL 109

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIEKATH--ITLKRV 317
             G+ + H R   ++H D+K  N+L+N   +  I DFGL      P+ K TH  +TL   
Sbjct: 110 LNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW-- 165

Query: 318 NGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
                Y   + L+G +  ST +D++  G +  E+  G
Sbjct: 166 -----YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
             ++K+  +G+G +G V+K    + T   +A+KK     +D  ++         +LRE++
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKFLESEDDPVIKK-------IALREIR 54

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPN---GSLEDR--LLMKKNTPSLLWTQRLH 256
            L   +H N++ L  +     +  LV+ Y  +     L+     + +    S+ W Q L 
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW-QTLQ 113

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATHITL 314
                   + F H      IH D+K  NIL+  H    + DFG  +   GP +       
Sbjct: 114 -------AVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--- 161

Query: 315 KRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
             V  TR Y   E LVG       VDV+  G V  EL +G
Sbjct: 162 -EV-ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 32/223 (14%)

Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           +++ + +L  LG G + TVYKG   KTT   +A+K++++   +    T        ++RE
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPST--------AIRE 53

Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           +  +   +H+NI+ LY +     K  LV+ +M N  L+ + +  +   +      L++ K
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLK-KYMDSRTVGNTPRGLELNLVK 111

Query: 260 GTSL----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE--GPIEKATH-- 311
                   GL F H  +  ++H D+K  N+L+N      +GDFGL +    P+   +   
Sbjct: 112 YFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169

Query: 312 ITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATG 353
           +TL        Y   + L+G R  ST +D++  G +L E+ TG
Sbjct: 170 VTLW-------YRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 30/225 (13%)

Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           AT+ ++ +  +G G +GTVYK   +  +   +A+K + V         L       ++RE
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKAR-DPHSGHFVALKSVRVPNGGGGGGGLPI----STVRE 61

Query: 200 ---LKYLNSCRHDNILPLYGIC-----FETGKYCLVYRYMPNGSLED--RLLMKKNTPSL 249
              L+ L +  H N++ L  +C         K  LV+ ++      D    L K   P L
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGL 117

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-GPIEK 308
                  + +    GL FLH+    ++H D+K  NIL+       + DFGL +       
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175

Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            T + +     T  Y   E L+    +T VD++  G +  E+   
Sbjct: 176 LTPVVV-----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 90.1 bits (223), Expect = 6e-20
 Identities = 33/239 (13%), Positives = 70/239 (29%), Gaps = 46/239 (19%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVK----------------KLEVHRNDRAVETLNQCQR 193
           +LG+       +   ++T  +  V                 K EV R        NQ Q 
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYM----PNGSLEDRL----LMKKN 245
           +  LR +   +  +      +  +  +     ++ R+        +L+            
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 246 TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGP 305
             SL+   RL +       L  LH     L+H  ++  +I+L+      +  F       
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 306 IEKATHITLKRVNGTRPYLPHEFLV-----------GKRLSTKVDVYGFGIVLFELATG 353
                       + +R + P E                 ++   D +  G+V++ +   
Sbjct: 258 -------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.8 bits (221), Expect = 8e-20
 Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 59/268 (22%)

Query: 107 QENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVW 166
             ++ G    +        ++       I         + + ++  LG+G +G VYK   
Sbjct: 5   HHHHMGTLEAQTQGPGSMSVSAAPSATSI---------DRYRRITKLGEGTYGEVYKA-I 54

Query: 167 EKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK 223
           +  T   +A+K++   R +   E +       ++RE+  L   +H NI+ L  +     +
Sbjct: 55  DTVTNETVAIKRI---RLEHEEEGVPG----TAIREVSLLKELQHRNIIELKSVIHHNHR 107

Query: 224 YCLVYRYMPNGSLED-RLLMKKNTP-------SLLWTQRLHIAKGTSLGLQFLHSREPPL 275
             L++ Y  N    D +  M KN         S L+ Q ++       G+ F HSR    
Sbjct: 108 LHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLY-QLIN-------GVNFCHSRRC-- 153

Query: 276 IHGDIKSANILLNHHMDPV-----IGDFGL--TQEGPIEKATH--ITLKRVNGTRPYLPH 326
           +H D+K  N+LL+           IGDFGL      PI + TH  ITL        Y P 
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-------YRPP 206

Query: 327 EFLVGKRL-STKVDVYGFGIVLFELATG 353
           E L+G R  ST VD++    +  E+   
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMK 234

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 32/223 (14%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE-- 199
             ++ +  +G+G +G V+K    K     +A+K++ V   +  +          ++RE  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-------STIREVA 63

Query: 200 -LKYLNSCRHDNILPLYGIC-----FETGKYCLVYRYMPNGSLED--RLLMKKNTPSLLW 251
            L++L +  H N++ L+ +C         K  LV+ ++      D    L K   P +  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPT 119

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-GPIEKAT 310
                +      GL FLHS    ++H D+K  NIL+       + DFGL +        T
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            + +     T  Y   E L+    +T VD++  G +  E+   
Sbjct: 178 SVVV-----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>1d2z_A Death domain of pelle; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 PDB: 1ik7_A 1ygo_A Length = 108

 Score = 80.4 bits (198), Expect = 1e-18
 Identities = 22/68 (32%), Positives = 32/68 (47%), Gaps = 1/68 (1%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYV 59
           +     Q+ Q+     R  S + E L+ WG Q NHTV  LF     ++ + AM ++K YV
Sbjct: 41  VKLYPDQVEQISSQKQRGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYV 100

Query: 60  ESKYHTCI 67
               H  I
Sbjct: 101 SEDLHKYI 108

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 38/228 (16%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + ++KL  +G+G FG V+K    KT   +A+KK+ +                 +LRE+K 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-------PITALREIKI 69

Query: 203 LNSCRHDNILPLYGICFETGKYC--------LVYRYMPNGSLED--RLLMKKNTPSLLWT 252
           L   +H+N++ L  IC               LV+ +  +    D   LL          +
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVK-FTLS 124

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL------TQEGPI 306
           +   + +    GL ++H  +  ++H D+K+AN+L+       + DFGL       +    
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 307 EKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
            + T+    RV  T  Y P E L+G +     +D++G G ++ E+ T 
Sbjct: 183 NRYTN----RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 85.1 bits (211), Expect = 4e-18
 Identities = 54/214 (25%), Positives = 84/214 (39%), Gaps = 29/214 (13%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG G  G V     E+ T   +A++ +   R                  E++ L    H 
Sbjct: 143 LGSGACGEVKLAF-ERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLGL 265
            I+ +    F+   Y +V   M  G L D+++  K     T  L + Q L         +
Sbjct: 201 CIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-------AV 252

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGLTQEGPIEKATHITLKRVNGTRP 322
           Q+LH     +IH D+K  N+LL+   +     I DFG ++   I   T +      GT  
Sbjct: 253 QYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLC-GTPT 306

Query: 323 YLPHEFLVGKRL---STKVDVYGFGIVLFELATG 353
           YL  E LV       +  VD +  G++LF   +G
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 27/214 (12%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVH-RNDRAVETLNQCQRE-QSLRELKYLNSCRH 208
           LG GG  TVY          +A+K + +  R     ETL + +RE  +  +L       H
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE--ETLKRFEREVHNSSQLS------H 70

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
            NI+ +  +  E   Y LV  Y+   +L +   ++ + P L     ++       G++  
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSE--YIESHGP-LSVDTAINFTNQILDGIKHA 127

Query: 269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA---THITL-KRVNGTRPYL 324
           H     ++H DIK  NIL++ +    I DFG      I KA   T +T    V GT  Y 
Sbjct: 128 HDMR--IVHRDIKPQNILIDSNKTLKIFDFG------IAKALSETSLTQTNHVLGTVQYF 179

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
             E   G+      D+Y  GIVL+E+  G   ++
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.0 bits (205), Expect = 9e-18
 Identities = 48/246 (19%), Positives = 84/246 (34%), Gaps = 52/246 (21%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           +G+G +G V   + E  T    A+K +    N   +  +N    E+   E++ +    H 
Sbjct: 34  IGQGSYGVVRVAI-ENQTRAIRAIKIM----NKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL------ 263
           NI  LY +  +    CLV      G L D+L +  +  +      +   +          
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 264 -------------------------------GLQFLHSREPPLIHGDIKSANILL--NHH 290
                                           L +LH++   + H DIK  N L   N  
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKS 206

Query: 291 MDPVIGDFGL-TQEGPIEKATHITLKRVNGTRPYLPHEFL--VGKRLSTKVDVYGFGIVL 347
            +  + DFGL  +   +    +  +    GT  ++  E L    +    K D +  G++L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 348 FELATG 353
             L  G
Sbjct: 267 HLLLMG 272

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 23/212 (10%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKL--EVHRNDRAVETLNQCQRE-QSLRELKYLNSCR 207
           +G+GG G VY+         +A+K +   +  +      +   QRE ++   L      +
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRM---QREARTAGRL------Q 92

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
             +++P++      G+  +  R +    L   L  ++  P L   + + I +     L  
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGP-LAPPRAVAIVRQIGSALDA 149

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT-LKRVNGTRPYLPH 326
            H+      H D+K  NIL++      + DFG+           +T L    GT  Y+  
Sbjct: 150 AHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATT---DEKLTQLGNTVGTLYYMAP 204

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
           E       + + D+Y    VL+E  TG   Y 
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQ 236

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 83.8 bits (207), Expect = 2e-17
 Identities = 53/309 (17%), Positives = 100/309 (32%), Gaps = 71/309 (22%)

Query: 153 LGKGGFGTVYKG---VWEKTTIAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYLNSCRH 208
           +  GG G +Y           + +K L    +  A         E Q L E+       H
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMA---MAERQFLAEV------VH 138

Query: 209 DNILPLY------GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
            +I+ ++          +   Y +V  Y+   SL+           L   + +       
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGY-IVMEYVGGQSLKRSK----GQK-LPVAEAIAYLLEIL 192

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFG----LTQEGPIEKATHITLKRV 317
             L +LHS    L++ D+K  NI+L    + + + D G    +   G            +
Sbjct: 193 PALSYLHSI--GLVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY-----------L 237

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
            GT  +   E +     +   D+Y  G  L  L   +   +      R++  L E     
Sbjct: 238 YGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG-----RYVDGLPE----- 286

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP----EM-TQVYNMLSGSGGESPN 432
                         L    ++ R+ +++   +P++R     EM  Q+  +L     +   
Sbjct: 287 ----------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336

Query: 433 ATGPTLPVM 441
              P L  +
Sbjct: 337 VPRPGLSTI 345

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.3 bits (199), Expect = 5e-17
 Identities = 56/225 (24%), Positives = 86/225 (38%), Gaps = 24/225 (10%)

Query: 136 PYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTI---AVK---KLEVHRNDRAVETLN 189
           P Q       ++    ILG+G F TV     E  T    A+K   K  + + +       
Sbjct: 21  PPQPRKKRPEDFKFGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKEN------- 72

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPS 248
             +     RE   ++   H   + LY   F+  +       Y  NG L   +  +K    
Sbjct: 73  --KVPYVTRERDVMSRLDHPFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYI--RKIGSF 127

Query: 249 LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK 308
                R + A+     L++LH +   +IH D+K  NILLN  M   I DFG  +    E 
Sbjct: 128 DETCTRFYTAEIV-SALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                   V GT  Y+  E L  K      D++  G ++++L  G
Sbjct: 185 KQARANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 81.0 bits (200), Expect = 1e-16
 Identities = 55/214 (25%), Positives = 84/214 (39%), Gaps = 18/214 (8%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           + +    +LG+GGFG V+     K T    A KKL      R  +   +   + ++ E K
Sbjct: 185 DWFLDFRVLGRGGFGEVF-ACQMKATGKLYACKKL---NKKRLKK---RKGYQGAMVEKK 237

Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI-AK 259
            L       I+ L    FET    CLV   M  G +   +             R      
Sbjct: 238 ILAKVHSRFIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
               GL+ LH R   +I+ D+K  N+LL+   +  I D GL  E    +    T     G
Sbjct: 297 QIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA-G 351

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T  ++  E L+G+     VD +  G+ L+E+   
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 50/239 (20%), Positives = 85/239 (35%), Gaps = 61/239 (25%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + +    + G+G FGTV  G  + T  ++A+KK+                RE  L+ ++
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--------RNRE--LQIMQ 71

Query: 202 YLNSCRHDNILPLYGICFETGK-------YCLVYRYMPNGSLED--RLLMKKNTPSLLWT 252
            L    H NI+ L    +  G+         +V  Y+P    +   R             
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCC----------- 116

Query: 253 QRLHIAKGTSL--------------GLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGD 297
            R +  +  +                +  LH     + H DIK  N+L+N       + D
Sbjct: 117 -RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175

Query: 298 FGLT-QEGPIEKATH-ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           FG   +  P E     I       +R Y   E + G +  +T VD++  G +  E+  G
Sbjct: 176 FGSAKKLSPSEPNVAYIC------SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            LG G F  V K   EK+T    A K ++  +   +  +     RE+  RE+  L    H
Sbjct: 19  ELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQ---SRASRRGVSREEIEREVSILRQVLH 74

Query: 209 DNILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGL 265
            N++ L+ + +E      L+   +  G L D L  K++      ++       K    G+
Sbjct: 75  HNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATSFIKQILDGV 128

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQE-GPIEKATHITLKRVNGT 320
            +LH+++  + H D+K  NI+L     P+    + DFGL  E     +      K + GT
Sbjct: 129 NYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGT 181

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             ++  E +  + L  + D++  G++ + L +G
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 55/276 (19%), Positives = 98/276 (35%), Gaps = 40/276 (14%)

Query: 104 GVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYK 163
           G    ++  +         + P N L  T   P +E     + +    +LG GGFG+VY 
Sbjct: 2   GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61

Query: 164 GVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD--NILPLYGICF 219
           G+       +A+K +E  R     E  N     +   E+  L         ++ L    F
Sbjct: 62  GIRVSDNLPVAIKHVEKDRISDWGELPNG---TRVPMEVVLLKKVSSGFSGVIRLLDW-F 117

Query: 220 ET-GKYCLVYRY-MPNGSLEDRLLMKKNTPSLLWTQRL------HIAKGTSLGLQFLHSR 271
           E    + L+     P   L D +  +           L               ++  H+ 
Sbjct: 118 ERPDSFVLILERPEPVQDLFDFITER---------GALQEELARSFFWQVLEAVRHCHNC 168

Query: 272 EPPLIHGDIKSANILLN-HHMDPVIGDFGL---TQEGPIEKATHITLKRVNGTRPYLPHE 327
              ++H DIK  NIL++ +  +  + DFG     ++              +GTR Y P E
Sbjct: 169 G--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--------YTDFDGTRVYSPPE 218

Query: 328 FLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRR 362
           ++   R       V+  GI+L+++  G   ++    
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 31/220 (14%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L  +G G  G V           +A+KKL      R  +     +R  + REL 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-----RPFQNQTHAKR--AYRELV 76

Query: 202 YLNSCRHDNILPLYGI---CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
            +    H NI+ L  +        ++  VY  M         LM  N   ++  +  H  
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME--------LMDANLCQVIQMELDHER 128

Query: 259 KGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
               L     G++ LHS    +IH D+K +NI++       I DFGL +      +  +T
Sbjct: 129 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              V  TR Y   E ++G      VD++  G ++ E+  G
Sbjct: 185 PYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 59/270 (21%), Positives = 95/270 (35%), Gaps = 49/270 (18%)

Query: 111 PGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT- 169
           P   P      P  P                     +    +LGKGGFGTV+ G      
Sbjct: 6   PLQGPPAPPGTPTPPPGGKDREAFE---------AEYRLGPLLGKGGFGTVFAGHRLTDR 56

Query: 170 -TIAVKKLEVHR--NDRAVETLNQCQREQSLRELKYLNS-CRHDNILPLYGICFET-GKY 224
             +A+K +  +R      +     C  E +L  L  + +   H  ++ L    FET   +
Sbjct: 57  LQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL--LWKVGAGGGHPGVIRLLDW-FETQEGF 113

Query: 225 CLVYRY-MPNGSLEDRLLMKKNTPSLLWTQRL------HIAKGTSLGLQFLHSREPPLIH 277
            LV    +P   L D +  K           L               +Q  HSR   ++H
Sbjct: 114 MLVLERPLPAQDLFDYITEK---------GPLGEGPSRCFFGQVVAAIQHCHSRG--VVH 162

Query: 278 GDIKSANILLNHHMDPV-IGDFGL---TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR 333
            DIK  NIL++       + DFG      + P            +GTR Y P E++   +
Sbjct: 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDEP--------YTDFDGTRVYSPPEWISRHQ 214

Query: 334 -LSTKVDVYGFGIVLFELATGMRAYDDTRR 362
             +    V+  GI+L+++  G   ++  + 
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPFERDQE 244

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 43/209 (20%), Positives = 83/209 (39%), Gaps = 29/209 (13%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG G FG V++   E+ T    A K +                +E   +E++ ++  RH 
Sbjct: 165 LGTGAFGVVHRVT-ERATGNNFAAKFVMTPHES---------DKETVRKEIQTMSVLRHP 214

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQF 267
            ++ L+    +  +  ++Y +M  G L +++  + N      ++   +   +    GL  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCH 270

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPVI--GDFGL-TQEGPIEKATHITLKRVNGTRPYL 324
           +H      +H D+K  NI+        +   DFGL     P +     T     GT  + 
Sbjct: 271 MHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-----GTAEFA 323

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             E   GK +    D++  G++ + L +G
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.9 bits (190), Expect = 8e-16
 Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 31/216 (14%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            LG G  G V     E+ T   +A+K +   R                  E++ L    H
Sbjct: 17  TLGSGACGEVKLAF-ERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLG 264
             I+ +    F+   Y +V   M  G L D+++  K     T  L + Q L         
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-------A 126

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPV---IGDFGL-TQEGPIEKATHITLKRVNGT 320
           +Q+LH     +IH D+K  N+LL+   +     I DFG     G         ++ + GT
Sbjct: 127 VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-----MRTLCGT 179

Query: 321 RPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATG 353
             YL  E LV       +  VD +  G++LF   +G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 78.3 bits (193), Expect = 9e-16
 Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 19/213 (8%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           N + +  +LGKGGFG V      + T    A KKL      R  +   +     +L E +
Sbjct: 184 NTFRQYRVLGKGGFGEVC-ACQVRATGKMYACKKL---EKKRIKK---RKGEAMALNEKQ 236

Query: 202 YLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
            L       ++ L    +ET    CLV   M  G L+  +               + A+ 
Sbjct: 237 ILEKVNSRFVVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE- 294

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              GL+ LH     +++ D+K  NILL+ H    I D GL    P  +       RV GT
Sbjct: 295 ICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRV-GT 348

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             Y+  E +  +R +   D +  G +L+E+  G
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 28/212 (13%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG G F  V K   EK+T    A K ++     ++  +     RE+  RE+  L    H 
Sbjct: 20  LGSGQFAIVKKCR-EKSTGLEYAAKFIKK---RQSRASRRGVCREEIEREVSILRQVLHP 75

Query: 210 NILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQ 266
           NI+ L+ + +E      L+   +  G L D L  K++      ++       K    G+ 
Sbjct: 76  NIITLHDV-YENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATSFIKQILDGVN 129

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQE-GPIEKATHITLKRVNGTR 321
           +LH+++  + H D+K  NI+L     P+    + DFGL  E     +      K + GT 
Sbjct: 130 YLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTP 182

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            ++  E +  + L  + D++  G++ + L +G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 26/217 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLE---VHRNDRAVETLNQCQREQSLR 198
           N++    I+G+GGFG VY G  +  T    A+K L+   +         LN    E+ + 
Sbjct: 189 NDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALN----ERIM- 242

Query: 199 ELKYLNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
            L  +++     I+ +    F T  K   +   M  G L   L   ++        R + 
Sbjct: 243 -LSLVSTGDCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYA 298

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
           A+   LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K        V
Sbjct: 299 AE-IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351

Query: 318 NGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATG 353
            GT  Y+  E L          D +  G +LF+L  G
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 36/237 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+  L  +GKG F  V       T   +A+K +     D+    LN    ++  RE++ +
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII-----DK--TQLNPTSLQKLFREVRIM 68

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL------HI 257
               H NI+ L+ +        L+  Y   G + D L+            R+        
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---------GRMKEKEARSK 119

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +     +Q+ H +   ++H D+K+ N+LL+  M+  I DFG + E  +       L   
Sbjct: 120 FRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAF 173

Query: 318 NGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
            G  PY   E   GK+    +VDV+  G++L+ L +G   +D      ++LK L E+
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-----QNLKELRER 225

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 56/281 (19%), Positives = 103/281 (36%), Gaps = 52/281 (18%)

Query: 87  AQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNN 146
           + +H+   ++V  + +     + +   E   K   P  P+ V  G+ +  Y         
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVP-QPVEVKQGSVYDYY--------- 53

Query: 147 WDKLNILGKGGFGTVYKGVWEKTT--------IAVKKLEVHRNDRAVETLNQCQREQSLR 198
            D L  LG G FG V++ V EK T        I                     +     
Sbjct: 54  -DILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPL--------------DKYTVKN 97

Query: 199 ELKYLNSCRHDNILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--L 255
           E+  +N   H  ++ L+   FE      L+  ++  G L DR+  +        ++   +
Sbjct: 98  EISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVI 152

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV--IGDFGLTQE-GPIEKATHI 312
           +  +    GL+ +H     ++H DIK  NI+          I DFGL  +  P E     
Sbjct: 153 NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---- 206

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            +K    T  +   E +  + +    D++  G++ + L +G
Sbjct: 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 37/235 (15%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG+G +G V + +  +T    AVK L+  +  R        ++E     ++ L   RH N
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE-----IQLLRRLRHKN 67

Query: 211 ILPLYG-ICFET-GKYCLVYRYMPNGSLE--DRLLMKKNTPSLLWTQRLHIAKGTSL--- 263
           ++ L   +  E   K  +V  Y   G  E  D +  K          R  + +       
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------RFPVCQAHGYFCQ 117

Query: 264 ---GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
              GL++LHS+   ++H DIK  N+LL       I   G+ +      A   T +   G+
Sbjct: 118 LIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD-TCRTSQGS 174

Query: 321 RPYLPHEFLVGKRL--STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
             + P E   G       KVD++  G+ L+ + TG+  ++       ++  L E 
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-----DNIYKLFEN 224

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 58/254 (22%), Positives = 91/254 (35%), Gaps = 53/254 (20%)

Query: 150 LNILGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           +  LG G F TV+         T +A+K   + R D+          E +  E+K L   
Sbjct: 24  VRKLGWGHFSTVWL-AKDMVNNTHVAMK---IVRGDKVY-------TEAAEDEIKLLQRV 72

Query: 207 R-----------HDNILPLYGICFE-TGKY----CLVYRYMPNGSLEDRLLMKKNTPSLL 250
                        ++IL L    F   G       +V+  +   +L    L+KK     +
Sbjct: 73  NDADNTKEDSMGANHILKLLD-HFNHKGPNGVHVVMVFEVL-GENLLA--LIKKYEHRGI 128

Query: 251 WTQRL-HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV------IGDFGLTQE 303
               +  I+K   LGL ++H R   +IH DIK  N+L+     P       I D G    
Sbjct: 129 PLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM-----RAYD 358
                   I       TR Y   E L+G       D++    ++FEL TG          
Sbjct: 188 YDEHYTNSIQ------TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241

Query: 359 DTRRSERHLKSLVE 372
              + + H+  ++E
Sbjct: 242 SYTKDDDHIAQIIE 255

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 74.1 bits (183), Expect = 4e-15
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 42/219 (19%)

Query: 153 LGKGGFGTVYKGVWEKTT--------IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           LG G F  V K   +K T        I  ++L   R   + E +         RE+  L 
Sbjct: 13  LGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEI--------EREVNILR 63

Query: 205 SCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTP----SLLWTQRLHIAK 259
             RH NI+ L+ I FE      L+   +  G L D L  K++      +    Q L    
Sbjct: 64  EIRHPNIITLHDI-FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD--- 119

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQE-GPIEKATHITL 314
               G+ +LHS+   + H D+K  NI+L     P     + DFG+  +     +      
Sbjct: 120 ----GVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-----F 168

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           K + GT  ++  E +  + L  + D++  G++ + L +G
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 19/217 (8%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           ++GKG F  V + +  + T    AVK ++V        +      E   RE    +  +H
Sbjct: 31  VIGKGPFSVVRRCI-NRETGQQFAVKIVDV----AKFTSSPGLSTEDLKREASICHMLKH 85

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--HIAKGTSLGLQ 266
            +I+ L       G   +V+ +M    L   ++ + +   +  ++ +  H  +     L+
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEAVASHYMRQILEALR 144

Query: 267 FLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           + H     +IH D+K   +LL    +  PV +G FG+  +  + ++  +   RV GT  +
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRV-GTPHF 199

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
           +  E +  +     VDV+G G++LF L +G   +  T
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 42/231 (18%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++++   ++LG+G +G V     + T   +A+KK+         +      R  +LRE+K
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFALR--TLREIK 61

Query: 202 YLNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRL---H 256
            L   +H+NI+ ++ I           VY            LM+ +   ++ TQ L   H
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQE--------LMQTDLHRVISTQMLSDDH 113

Query: 257 IAKGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
           I             ++ LH     +IH D+K +N+L+N + D  + DFGL +      A 
Sbjct: 114 IQ---YFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 311 HITLKRVNG-------TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           +               TR Y   E ++   + S  +DV+  G +L EL   
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L+ +G+G +G V           +A+KK+         E    CQR  +LRE+K
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQR--TLREIK 77

Query: 202 YLNSCRHDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRL---- 255
            L   RH+NI+ +  I        +  VY            LM+ +   LL TQ L    
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD--------LMETDLYKLLKTQHLSNDH 129

Query: 256 ------HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL--TQEGPIE 307
                  I +G    L+++HS    ++H D+K +N+LLN   D  I DFGL    +   +
Sbjct: 130 ICYFLYQILRG----LKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 308 KATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
               +T      TR Y   E ++  K  +  +D++  G +L E+ + 
Sbjct: 184 HTGFLTEYVA--TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 47/223 (21%)

Query: 148 DKLNILGKGGFGTVYKGVWEKTT--------IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
            K  ILG G FG V+K   E  T        I  + ++               +E+   E
Sbjct: 92  SKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRGMK--------------DKEEVKNE 136

Query: 200 LKYLNSCRHDNILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPS-----LLWTQ 253
           +  +N   H N++ LY   FE+     LV  Y+  G L DR++ +    +     L   Q
Sbjct: 137 ISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGL-TQEGPIEKAT 310
                     G++ +H     ++H D+K  NIL  +     I   DFGL  +  P EK  
Sbjct: 196 ICE-------GIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              LK   GT  +L  E +    +S   D++  G++ + L +G
Sbjct: 245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 38/213 (17%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG+G FG V++ V E ++      K ++V   D+              +E+  LN  RH 
Sbjct: 13  LGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQ----------VLVKKEISILNIARHR 61

Query: 210 NILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPS-----LLWTQRLHIAKGTSL 263
           NIL L+   FE+ +   +++ ++    + +R+       +         Q          
Sbjct: 62  NILHLHES-FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE------- 113

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPV--IGDFGLTQE-GPIEKATHITLKRVNGT 320
            LQFLHS    + H DI+  NI+          I +FG  ++  P +       + +   
Sbjct: 114 ALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-----FRLLFTA 166

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             Y   E      +ST  D++  G +++ L +G
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE---LKYLNS 205
           ILG+G    V + +  K T    AVK ++V           Q  RE +L+E   L+ ++ 
Sbjct: 24  ILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS- 81

Query: 206 CRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTS 262
             H NI+ L    +ET  +  LV+  M  G L D L  K        +++    I +   
Sbjct: 82  -GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALL 134

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
             +  LH     ++H D+K  NILL+  M+  + DFG   Q  P EK     L+ V GT 
Sbjct: 135 EVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTP 187

Query: 322 PYLPHEFLVG------KRLSTKVDVYGFGIVLFELATG 353
            YL  E +             +VD++  G++++ L  G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +WD +  LG+G +G V   V   T   +AVK ++     RAV+     ++E     +   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKE-----ICIN 59

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H+N++  YG   E     L   Y   G L DR+              +        
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRF 110

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 G+ +LH     + H DIK  N+LL+   +  I DFGL             L ++
Sbjct: 111 FHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKM 167

Query: 318 NGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
            GT PY+  E L  +   +  VDV+  GIVL  +  G   +D    S +   
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 23/218 (10%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVK--KLEVHRNDRAVETLNQCQRE-QSLRELKYLN 204
             ILG GG   V+     +    +AVK  + ++ R+          +RE Q+   L    
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF---RREAQNAAALN--- 70

Query: 205 SCRHDNILPLYGICFETGKYC----LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
              H  I+ +Y              +V  Y+   +L D  ++    P +   + + +   
Sbjct: 71  ---HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGP-MTPKRAIEVIAD 124

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
               L F H     +IH D+K ANI+++      + DFG+ +       +      V GT
Sbjct: 125 ACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD 358
             YL  E   G  +  + DVY  G VL+E+ TG   + 
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 30/220 (13%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           L  LG GG G V+  V       +A+KK+        +      +   +LRE+K +    
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKI-------VLTDPQSVKH--ALREIKIIRRLD 66

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLED----RLLMKKNTPSLLWTQRLHIAKGTSL 263
           HDNI+ ++ I        L         L      +  M+ +  ++L    L        
Sbjct: 67  HDNIVKVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGDFGL--TQEGPIEKATHITL 314
                 GL+++HS    ++H D+K AN+ +N   +   IGDFGL    +       H++ 
Sbjct: 126 MYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
             V  T+ Y     L+     +  +D++  G +  E+ TG
Sbjct: 184 GLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 69/269 (25%), Positives = 111/269 (41%), Gaps = 51/269 (18%)

Query: 104 GVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYK 163
           G++++     +         +    +  +   P   +T+  N ++ L +LGKG FG V  
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM--NEFEYLKLLGKGTFGKVIL 166

Query: 164 GVWEKTT---IAVKKLE----VHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG 216
            V EK T    A+K L+    V +++             +L E + L + RH  +  L  
Sbjct: 167 -VKEKATGRYYAMKILKKEVIVAKDEV----------AHTLTENRVLQNSRHPFLTALKY 215

Query: 217 ICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             F+T  + C V  Y   G L           EDR              R + A+     
Sbjct: 216 -SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-------------ARFYGAE-IVSA 260

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LHS +  +++ D+K  N++L+      I DFGL +EG  + AT  T     GT  YL
Sbjct: 261 LDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF---CGTPEYL 316

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             E L        VD +G G+V++E+  G
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 36/216 (16%)

Query: 153 LGKGGFGTVYKGVWEKTT--------IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           LG G F  V K   EK+T        I  ++ +  R   + E +         RE+  L 
Sbjct: 19  LGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDI--------EREVSILK 69

Query: 205 SCRHDNILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGT 261
             +H N++ L+ + +E      L+   +  G L D L  K++      T+       K  
Sbjct: 70  EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQI 123

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRV 317
             G+ +LHS +  + H D+K  NI+L     P     I DFGL  +  I+       K +
Sbjct: 124 LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGN--EFKNI 177

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            GT  ++  E +  + L  + D++  G++ + L +G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 46/221 (20%), Positives = 92/221 (41%), Gaps = 34/221 (15%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +     +G G +G+V   + +++   +A+KKL      R  ++    +R  + REL 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-----RPFQSEIFAKR--AYRELL 75

Query: 202 YLNSCRHDNILPLYGI---CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
            L   +H+N++ L  +         +   Y  MP         M+ +   ++  +     
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP--------FMQTDLQKIMGLKFSEEK 127

Query: 259 KGTSL-----GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
               +     GL+++HS    ++H D+K  N+ +N   +  I DFGL +    E   ++ 
Sbjct: 128 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185

Query: 314 LKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                 TR Y   E ++     +  VD++  G ++ E+ TG
Sbjct: 186 ------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 30/232 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVK---KLEVHRNDRAVETLNQCQREQSLR 198
           ++++ L  +GKG FG V   V +  T    A+K   K +    +         +     +
Sbjct: 15  DHFEILRAIGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERN---------EVRNVFK 64

Query: 199 ELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
           EL+ +    H  ++ L+   F+  +   +V   +  G L  R  +++N      T +L I
Sbjct: 65  ELQIMQGLEHPFLVNLWY-SFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFI 121

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +   + L +L ++   +IH D+K  NILL+ H    I DF +    P E     T+   
Sbjct: 122 CE-LVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-TM--- 174

Query: 318 NGTRPYLPHEFLVGKRL---STKVDVYGFGIVLFELATGMRAYDDTRRSERH 366
            GT+PY+  E    ++    S  VD +  G+  +EL  G R Y     +   
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 54/221 (24%), Positives = 85/221 (38%), Gaps = 33/221 (14%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L  +G G  G V           +A+KKL      R  +     +R  + REL 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-----RPFQNQTHAKR--AYRELV 113

Query: 202 YLNSCRHDNILPLYGI-----CFETGK--YCLVYRYMPN--GSLEDRLLMKKNTPSLLWT 252
            +    H NI+ L  +       E  +  Y LV   M      +    L  +    LL+ 
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVY-LVMELMDANLCQVIQMELDHERMSYLLY- 171

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           Q L        G++ LHS    +IH D+K +NI++       I DFGL +      +  +
Sbjct: 172 QML-------CGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM 220

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T   V  TR Y   E ++G      VD++  G ++ E+   
Sbjct: 221 TPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 25/227 (11%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQRE 194
           +E+ L  ++++ L ++G+G F  V   V  K T    A+K +         + L + +  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAV-VKMKQTGQVYAMKIM------NKWDMLKRGEVS 106

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
               E   L +     I  L+   F+   Y  LV  Y   G L   LL K          
Sbjct: 107 CFREERDVLVNGDRRWITQLHF-AFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMA 164

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           R ++A+   + +  +H      +H DIK  NILL+      + DFG   +   +      
Sbjct: 165 RFYLAE-IVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYG-------FGIVLFELATG 353
           +    GT  YL  E L           YG        G+  +E+  G
Sbjct: 222 V--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 47/223 (21%)

Query: 101 NEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNW------DKLNILG 154
           +EA   Q++N G + T   S               P   +    ++W      +  +++G
Sbjct: 4   HEAAAAQQHNSGTQHTVSGSQQEGQ-QRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 155 KGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
            G +G V +   +     +A+KK+      R  E L  C+R   LRE+  LN   HD+++
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKI-----LRVFEDLIDCKR--ILREIAILNRLNHDHVV 115

Query: 213 PLYGICFETGK------YCLVYRYMPNGSLEDRL--LMKKNTP-------SLLWTQRLHI 257
            +  I            Y +V         +     L +           +LL+   L  
Sbjct: 116 KVLDIVIPKDVEKFDELY-VVLEIA-----DSDFKKLFRTPVYLTELHIKTLLY-NLLV- 167

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
                 G++++HS    ++H D+K AN L+N      + DFGL
Sbjct: 168 ------GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGL 202

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 48/223 (21%), Positives = 91/223 (40%), Gaps = 41/223 (18%)

Query: 153 LGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +G+G +G VYK   +        A+K++E          ++      + RE+  L   +H
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEG-------TGISMS----ACREIALLRELKH 77

Query: 209 DNILPLYGICFETGKYC--LVYRYMPNGSLED-RLLMKKNTPSLLWTQRLHIAKGT--SL 263
            N++ L  +          L++ Y  +    D   ++K +  S    + + + +G   SL
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQE--GPIEKATH 311
                 G+ +LH+    ++H D+K ANIL+           I D G  +    P++    
Sbjct: 134 LYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 312 ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           +    V  T  Y   E L+G +  +  +D++  G +  EL T 
Sbjct: 192 LDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 40/220 (18%)

Query: 149 KLNILGKGGFGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
              ++G G FG V++    ++  +A+KK+     D          +    REL+ +   +
Sbjct: 44  NCKVIGNGSFGVVFQAKLVESDEVAIKKV---LQD----------KRFKNRELQIMRIVK 90

Query: 208 HDNILPLYGICFETGKYC------LVYRYMP---NGSLEDRLLMKKNTPSLLWTQRLH-I 257
           H N++ L    +  G         LV  Y+P     +      +K+  P LL    ++ +
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQE-GPIEKATH-ITL 314
            +     L ++HS    + H DIK  N+LL+     + + DFG  +     E     I  
Sbjct: 151 LR----SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC- 203

Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                +R Y   E + G    +T +D++  G V+ EL  G
Sbjct: 204 -----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 35/222 (15%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L  +G G +G V   V  +T   +A+KKL      R  ++    +R  + REL+
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-----RPFQSELFAKR--AYRELR 76

Query: 202 YLNSCRHDNILPLYGI---CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
            L   RH+N++ L  +         +   Y  MP         M  +   L+  ++L   
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP--------FMGTDLGKLMKHEKLGED 128

Query: 259 KGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
           +   L      GL+++H+    +IH D+K  N+ +N   +  I DFGL ++   E   ++
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186

Query: 313 TLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                  TR Y   E ++   R +  VD++  G ++ E+ TG
Sbjct: 187 V------TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 72.2 bits (176), Expect = 4e-14
 Identities = 32/193 (16%), Positives = 55/193 (28%), Gaps = 35/193 (18%)

Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRND--------RAVETLNQCQR 193
           L T    +   +G+G FG V++ + + T +A+K + +   D           E L +   
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKY----CLVYRYMP--NGSLEDRL------- 240
            + L  L      R +  + L  +    G Y       + +     GS  DR        
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 241 -------------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL 287
                        L +  T          I    +  L           H D+   N+LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLL 195

Query: 288 NHHMDPVIGDFGL 300
                  +     
Sbjct: 196 KKTSLKKLHYTLN 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 29/232 (12%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +WD +  LG+G +G V   V   T   +AVK ++     RAV+     ++E     +   
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKE-----ICIN 59

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H+N++  YG   E     L   Y   G L DR+              +        
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRF 110

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                 G+ +LH     + H DIK  N+LL+   +  I DFGL             L ++
Sbjct: 111 FHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKM 167

Query: 318 NGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK 368
            GT PY+  E L  +   +  VDV+  GIVL  +  G   +D    S +   
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 50/235 (21%), Positives = 87/235 (37%), Gaps = 37/235 (15%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVK-----KLEVHRNDRAVETLNQCQR---- 193
           N +   + +GKG +G V     E      A+K     KL               +     
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 194 --------EQSLRELKYLNSCRHDNILPLYGI--CFETGKYCLVYRYMPNGSLEDRLLMK 243
                   EQ  +E+  L    H N++ L  +          +V+  +  G + +   +K
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 244 KNTPSL--LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT 301
             +      + Q L        G+++LH ++  +IH DIK +N+L+       I DFG++
Sbjct: 133 PLSEDQARFYFQDLI------KGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS---TKVDVYGFGIVLFELATG 353
            E    K +   L    GT  ++  E L   R       +DV+  G+ L+    G
Sbjct: 185 NE---FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 18/210 (8%), Positives = 52/210 (24%), Gaps = 45/210 (21%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
            G       ++ +       +A+  ++                +++L     L+      
Sbjct: 39  HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDV------LQETLSRTLRLSRIDKPG 92

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
           +  +  +        +V  ++  GSL++         S      +   +  +      H 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV 330
               +       + + ++   D V+                            +P     
Sbjct: 148 A--GVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMPDA--- 179

Query: 331 GKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
               + + D+ G G  L+ L        + 
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEA 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 47/224 (20%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
              ++G G FG VY+     +   +A+KK+   +                 REL+ +   
Sbjct: 58  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------------RFKNRELQIMRKL 104

Query: 207 RHDNILPLYGICFETGKYC------LVYRYMP---NGSLEDRLLMKKNTPSL---LWT-Q 253
            H NI+ L    + +G+        LV  Y+P             K+  P +   L+  Q
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQE-GPIEKATH 311
                      L ++HS    + H DIK  N+LL+     + + DFG  ++    E    
Sbjct: 165 LFR-------SLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

Query: 312 -ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
            I       +R Y   E + G    ++ +DV+  G VL EL  G
Sbjct: 216 YIC------SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.3 bits (173), Expect = 9e-14
 Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 37/238 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++   + LG G FG V  G  + T   +AVK L    N + + +L+     +  RE++ L
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL----NRQKIRSLDV--VGKIKREIQNL 65

Query: 204 NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
              RH +I+ LY +   T   + +V  Y+  G L D +             R+   +   
Sbjct: 66  KLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKH---------GRVEEMEARR 115

Query: 263 L------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           L       + + H     ++H D+K  N+LL+ HM+  I DFGL     +       L+ 
Sbjct: 116 LFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL---SNMMSDGEF-LRT 169

Query: 317 VNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
             G+  Y   E + G+     +VD++  G++L+ L  G   +DD      H+ +L +K
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-----EHVPTLFKK 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 27/216 (12%)

Query: 151 NILGKGGFGTVYKGVWEKTT---IAVKKLE----VHRNDRAVETLNQCQREQSLRELKYL 203
             LG G +G V     EK      A+K ++                +   E+   E+  L
Sbjct: 42  RKLGSGAYGEVLLCK-EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGT 261
            S  H NI+ L+ +  +   + LV  +   G L ++++ +       + +    +I K  
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-----FDECDAANIMKQI 155

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGL-TQEGPIEKATHITLKRV 317
             G+ +LH     ++H DIK  NILL +        I DFGL +      K     L+  
Sbjct: 156 LSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-----LRDR 208

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            GT  Y+  E L  K  + K DV+  G++++ L  G
Sbjct: 209 LGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCG 243

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L+ +G G +G+V      KT   +AVKKL      R  +++   +R  + REL+
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-----RPFQSIIHAKR--TYRELR 80

Query: 202 YLNSCRHDNILPLYGI---CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
            L   +H+N++ L  +        ++  VY            LM  +  +++  Q+L   
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH--------LMGADLNNIVKCQKLTDD 132

Query: 259 KGTSL------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
               L      GL+++HS +  +IH D+K +N+ +N   +  I DFGL +    E   ++
Sbjct: 133 HVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190

Query: 313 TLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
                  TR Y   E ++     +  VD++  G ++ EL TG
Sbjct: 191 A------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 32/220 (14%)

Query: 150 LNILGKGGFGTVYKGV-WEKTTIAVKKL----EVHRNDRAVETLNQCQREQSLRELKYLN 204
              +  G +G V  GV  E   +A+K++       R    +     C+R   LRE++ LN
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR--VLREIRLLN 84

Query: 205 SCRHDNILPLYGI--CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG-- 260
              H NIL L  I   FE      +Y            LM+ +   ++  QR+ I+    
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTE--------LMRTDLAQVIHDQRIVISPQHI 136

Query: 261 ------TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
                   LGL  LH     ++H D+   NILL  + D  I DF L +E       + T 
Sbjct: 137 QYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLARE--DTADANKT- 191

Query: 315 KRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
             V   R Y   E ++  K  +  VD++  G V+ E+   
Sbjct: 192 HYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 56/223 (25%), Positives = 85/223 (38%), Gaps = 30/223 (13%)

Query: 151 NILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
             LG G +G V     +K T    A+K +           ++     + L E+  L    
Sbjct: 43  KKLGSGAYGEVLLCR-DKVTHVERAIKIIRKTS-------VSTSSNSKLLEEVAVLKLLD 94

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGL 265
           H NI+ LY    +   Y LV      G L D ++ +       + +     I K    G+
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVIIKQVLSGV 149

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
            +LH     ++H D+K  N+LL          I DFGL       +K     +K   GT 
Sbjct: 150 TYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-----MKERLGTA 202

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE 364
            Y+  E L  K+   K DV+  G++LF L  G   +      E
Sbjct: 203 YYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 53/258 (20%), Positives = 90/258 (34%), Gaps = 66/258 (25%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
            +++G+G +G VY    + T   +A+KK+      R  E L  C+R   LRE+  LN  +
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-----RMFEDLIDCKR--ILREITILNRLK 83

Query: 208 HDNILPLYGICFETGKYCL--VYRYMPNGSLEDRLLMKKNTPSLLWTQRLH--IAKGTSL 263
            D I+ LY +           +Y  +         +   +         L         L
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLE--------IADSD---------LKKLFKTPIFL 126

Query: 264 --------------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL----TQEGP 305
                         G  F+H     +IH D+K AN LLN      + DFGL      E  
Sbjct: 127 TEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 306 IEKATHITLKRVNG---------------TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFE 349
                 +      G               TR Y   E ++  +  +  +D++  G +  E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

Query: 350 LATGMRAYDDTRRSERHL 367
           L   ++++ +   +   L
Sbjct: 245 LLNMLQSHINDPTNRFPL 262

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 36/218 (16%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRE---LKYLN 204
            +++GKG FG V K         +A+K   + +N +A          Q+  E   L+ +N
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAF-------LNQAQIEVRLLELMN 108

Query: 205 SCRHD-----NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HI 257
             +HD      I+ L    F      CLV+  + + +L D  L++      +        
Sbjct: 109 --KHDTEMKYYIVHLKR-HFMFRNHLCLVFEML-SYNLYD--LLRNTNFRGVSLNLTRKF 162

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG--DFGLTQEGPIEKATHITLK 315
           A+     L FL + E  +IH D+K  NILL +     I   DFG + +       +I   
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ-- 220

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               +R Y   E L+G      +D++  G +L E+ TG
Sbjct: 221 ----SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 46/223 (20%)

Query: 150 LNILGKGGFGTVY--KGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           L +LGKGG+G V+  + V    T    A+K L   +    V          +  E   L 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL---KKAMIVRNAKD--TAHTKAERNILE 76

Query: 205 SCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLLWT 252
             +H  I+ L    F+T GK  L+  Y+  G L           ED              
Sbjct: 77  EVKHPFIVDLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT------------- 122

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFGLTQEGPIEKAT 310
              ++A+  S+ L  LH +   +I+ D+K  NI+LNH  H+   + DFGL +E   +   
Sbjct: 123 ACFYLAE-ISMALGHLHQKG--IIYRDLKPENIMLNHQGHV--KLTDFGLCKESIHDGTV 177

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             T     GT  Y+  E L+    +  VD +  G +++++ TG
Sbjct: 178 THTF---CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 56/253 (22%), Positives = 99/253 (39%), Gaps = 30/253 (11%)

Query: 112 GNEPTRKVSDPLTPMNVLGGTPHIPYQEL-------TLATNNWDKLNILGKGGFGTVYKG 164
           GN    K       +          + +        T   + +D++  LG G FG V   
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML- 59

Query: 165 VWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET 221
           V  K +    A+K L         + +   Q E +L E + L +     ++ L    F+ 
Sbjct: 60  VKHKESGNHYAMKIL------DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF-SFKD 112

Query: 222 GKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI 280
                +V  Y+  G +   L             R + A+   L  ++LHS +  LI+ D+
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIV-LTFEYLHSLD--LIYRDL 167

Query: 281 KSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDV 340
           K  N+L++      + DFG  +   ++  T  TL    GT   L  E ++ K  +  VD 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKR--VKGRTW-TL---CGTPEALAPEIILSKGYNKAVDW 221

Query: 341 YGFGIVLFELATG 353
           +  G++++E+A G
Sbjct: 222 WALGVLIYEMAAG 234

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 151 NILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
            +LGKG FG V     +K T    AVK +   +  +  +      +E  LRE++ L    
Sbjct: 32  RVLGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLD 84

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL--HIAKGTSLGL 265
           H NI+ LY    + G + LV      G L D ++ +K      +++     I +    G+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-----FSEVDAARIIRQVLSGI 139

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
            ++H  +  ++H D+K  N+LL          I DFGL T     +K     +K   GT 
Sbjct: 140 TYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-----MKDKIGTA 192

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L G     K DV+  G++L+ L +G
Sbjct: 193 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 43/204 (21%), Positives = 80/204 (39%), Gaps = 24/204 (11%)

Query: 152 ILGKGGFGTVYKGVWEKTTI--AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
            LGKG F  V + V        A   +   +       L+    ++  RE +     +H 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-------LSARDHQKLEREARICRLLKHP 70

Query: 210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQF 267
           NI+ L+    E G + L++  +  G L + ++ ++      +++    H  +     +  
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQILEAVLH 125

Query: 268 LHSREPPLIHGDIKSANILLNHHMDP---VIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
            H     ++H ++K  N+LL   +      + DFGL  E  +E           GT  YL
Sbjct: 126 CHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFA-GTPGYL 180

Query: 325 PHEFLVGKRLSTKVDVYGFGIVLF 348
             E L        VD++  G++L+
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILY 204

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 52/224 (23%)

Query: 150 LNILGKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L +LGKG FG V   V EK T        ++K  +   D    T+          E + L
Sbjct: 10  LKLLGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVT---------ESRVL 59

Query: 204 NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLLW 251
            + RH  +  L    F+T  + C V  Y   G L           E+R            
Sbjct: 60  QNTRHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------------ 106

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFGLTQEGPIEKA 309
             R + A+     L++LHSR+  +++ DIK  N++L+   H+   I DFGL +EG  + A
Sbjct: 107 -ARFYGAE-IVSALEYLHSRD--VVYRDIKLENLMLDKDGHI--KITDFGLCKEGISDGA 160

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T  T     GT  YL  E L        VD +G G+V++E+  G
Sbjct: 161 TMKTF---CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 44/229 (19%), Positives = 88/229 (38%), Gaps = 30/229 (13%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            +  ++ LG G FG V+  V ++    + VK ++  +       +   +  +   E+  L
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV-LEDCWIEDPKLGKVTLEIAIL 83

Query: 204 NSCRHDNILPLYGICFET-GKYCLVY-RYMPNGSLEDRLLMKKNTP----SLLWTQRLHI 257
           +   H NI+ +  I FE  G + LV  ++     L   +           S ++ Q +  
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS- 141

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT---QEGPIEKATHITL 314
                  + +L  ++  +IH DIK  NI++       + DFG     + G +        
Sbjct: 142 ------AVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-------F 186

Query: 315 KRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRR 362
               GT  Y   E L+G      +++++  G+ L+ L      + +   
Sbjct: 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 35/214 (16%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            LGKG F  V + V  KTT    A K +   +       L+    ++  RE +     +H
Sbjct: 13  ELGKGAFSVVRRCV-HKTTGLEFAAKIINTKK-------LSARDFQKLEREARICRKLQH 64

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQ 266
            NI+ L+    E   + LV+  +  G L + ++ ++      +++    H  +     + 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIA 119

Query: 267 FLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGLTQEGPIEKATHI----TLKRVNG 319
           + HS    ++H ++K  N+LL        V + DFGL        A  +          G
Sbjct: 120 YCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL--------AIEVNDSEAWHGFAG 169

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T  YL  E L     S  VD++  G++L+ L  G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 45/208 (21%), Positives = 85/208 (40%), Gaps = 26/208 (12%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDN 210
            LG+G F    K V  K +             AV+ +++     + +E+  L  C  H N
Sbjct: 18  PLGEGSFSICRKCV-HKKS---------NQAFAVKIISKRMEANTQKEITALKLCEGHPN 67

Query: 211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQFL 268
           I+ L+ +  +     LV   +  G L +R+  KK+     +++    +I +     +  +
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-----FSETEASYIMRKLVSAVSHM 122

Query: 269 HSREPPLIHGDIKSANILLNHHMD--PV-IGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           H     ++H D+K  N+L     D   + I DFG  +   ++   +  LK    T  Y  
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR---LKPPDNQPLKTPCFTLHYAA 177

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATG 353
            E L         D++  G++L+ + +G
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSG 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 36/213 (16%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +LG G F  V+    ++ T    A+K          ++     +      E+  L   +H
Sbjct: 16  VLGSGAFSEVFLVK-QRLTGKLFALKC---------IKKSPAFRDSSLENEIAVLKKIKH 65

Query: 209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSL 263
           +NI+ L  I +E+   Y LV + +  G L DR+L +        SL+  Q L        
Sbjct: 66  ENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS------- 117

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDP---VIGDFGLTQEGPIEKATHITLKRVNGT 320
            +++LH     ++H D+K  N+L     +    +I DFGL++           +    GT
Sbjct: 118 AVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGT 170

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             Y+  E L  K  S  VD +  G++ + L  G
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 35/209 (16%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
            LGKG F  V + V  KTT    A K +   +       L+    ++  RE +     +H
Sbjct: 36  ELGKGAFSVVRRCV-HKTTGLEFAAKIINTKK-------LSARDFQKLEREARICRKLQH 87

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQ 266
            NI+ L+    E   + LV+  +  G L + ++ ++      +++    H  +     + 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIA 142

Query: 267 FLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGLTQEGPIEKATHI----TLKRVNG 319
           + HS    ++H ++K  N+LL        V + DFGL        A  +          G
Sbjct: 143 YCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL--------AIEVNDSEAWHGFAG 192

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLF 348
           T  YL  E L     S  VD++  G++L+
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILY 221

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 23/225 (10%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQRE 194
           +++ L   +++ L ++G+G FG V   V  K      A+K L         E L + +  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAV-VKLKNADKVFAMKIL------NKWEMLKRAETA 119

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
               E   L +     I  L+   F+      LV  Y   G L   LL K          
Sbjct: 120 CFREERDVLVNGDSKWITTLHY-AFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMA 177

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           R ++A+   + +  +H      +H DIK  NIL++ +    + DFG   +  +E  T  +
Sbjct: 178 RFYLAE-MVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQS 233

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTK-----VDVYGFGIVLFELATG 353
              V GT  Y+  E L              D +  G+ ++E+  G
Sbjct: 234 SVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 30/227 (13%)

Query: 138 QELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQRE 194
           ++L +   +++ + ++G+G FG V   V  K+T    A+K L         E + +    
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQL-VRHKSTRKVYAMKLL------SKFEMIKRSDSA 114

Query: 195 QSLRELKYLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
               E   +       ++ L+   F+  +Y  +V  YMP G L   L+   + P      
Sbjct: 115 FFWEERDIMAFANSPWVVQLFY-AFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEK--WA 170

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
           R + A+   L L  +HS     IH D+K  N+LL+      + DFG   +   E      
Sbjct: 171 RFYTAEVV-LALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--- 224

Query: 314 LKRVN---GTRPYLPHEFLVGKRLSTK----VDVYGFGIVLFELATG 353
             R +   GT  Y+  E L  +          D +  G+ L+E+  G
Sbjct: 225 --RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 38/216 (17%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG+G F  V + +  K+T    A K L+  R         Q  R + L E+  L   +  
Sbjct: 37  LGRGKFAVVRQCI-SKSTGQEYAAKFLKKRR-------RGQDCRAEILHEIAVLELAKSC 88

Query: 210 -NILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKNTP------SLLWTQRLHIAKGT 261
             ++ L+ + +E      L+  Y   G +    L +            L  Q L      
Sbjct: 89  PRVINLHEV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE----- 142

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGL-TQEGPIEKATHITLKRV 317
             G+ +LH     ++H D+K  NILL+       + I DFG+  + G   +     L+ +
Sbjct: 143 --GVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-----LREI 193

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            GT  YL  E L    ++T  D++  GI+ + L T 
Sbjct: 194 MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 48/256 (18%), Positives = 99/256 (38%), Gaps = 44/256 (17%)

Query: 113 NEPTRKVSDPLTPMNVLGGTPHIPYQELTLA---TNNWDKLNILGKGGFGTVYKGVWEKT 169
           + P    +   T +N      +  Y+   +     +++  +  LG+G +  V++ +    
Sbjct: 1   SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 60

Query: 170 --TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL-NSCRHDNILPLYGIC--FETGKY 224
              + VK L+  +  +              RE+K L N     NI+ L  I     +   
Sbjct: 61  NEKVVVKILKPVKKKKI------------KREIKILENLRGGPNIITLADIVKDPVSRTP 108

Query: 225 CLVYRYMPNGSLEDRLLMKKNTP----SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI 280
            LV+ ++ N     + L +  T       ++ + L         L + HS    ++H D+
Sbjct: 109 ALVFEHVNNTDF--KQLYQTLTDYDIRFYMY-EILK-------ALDYCHSMG--IMHRDV 156

Query: 281 KSANILLNH-HMDPVIGDFGLTQEG-PIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTK 337
           K  N++++H H    + D+GL +   P ++       RV  +R +   E LV  +     
Sbjct: 157 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RV-ASRYFKGPELLVDYQMYDYS 211

Query: 338 VDVYGFGIVLFELATG 353
           +D++  G +L  +   
Sbjct: 212 LDMWSLGCMLASMIFR 227

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 52/225 (23%)

Query: 150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR--AV-----ETLNQCQREQSLRELKY 202
           L +LG+G FG V+          VKK+      +  A+      TL    R ++  E   
Sbjct: 29  LKVLGQGSFGKVFL---------VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79

Query: 203 LNSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLL 250
           L    H  I+ L+   F+T GK  L+  ++  G L           E+ +          
Sbjct: 80  LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV---------- 128

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFGLTQEGPIEK 308
              + ++A+  +L L  LHS    +I+ D+K  NILL+   H+   + DFGL++E    +
Sbjct: 129 ---KFYLAE-LALALDHLHSLG--IIYRDLKPENILLDEEGHI--KLTDFGLSKESIDHE 180

Query: 309 ATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               +     GT  Y+  E +  +  +   D + FG+++FE+ TG
Sbjct: 181 KKAYSF---CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 38/218 (17%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRE---LKYLN 204
           L ++GKG FG V K    K    +A+K   + RN++           Q+  E   L++L 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRF-------HRQAAEEIRILEHLR 151

Query: 205 SCRHD---NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HIAK 259
               D   N++ +    F      C+ +  + + +L +  L+KKN         +   A 
Sbjct: 152 KQDKDNTMNVIHMLE-NFTFRNHICMTFELL-SMNLYE--LIKKNKFQGFSLPLVRKFAH 207

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEKATHI--TLK 315
                L  LH     +IH D+K  NILL       I   DFG         + +    + 
Sbjct: 208 SILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGS--------SCYEHQRVY 257

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               +R Y   E ++G R    +D++  G +L EL TG
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>1wh4_A IRAK4, interleukin-1 receptor-associated kinase 4; death domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: a.77.1.2 Length = 127

 Score = 63.1 bits (153), Expect = 2e-12
 Identities = 16/57 (28%), Positives = 25/57 (43%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKP 57
             +    + + E  +   +SPT ELL  WG  N TV +L   L  +  +    +L P
Sbjct: 53  DRYNQFHIRRFEALLQTGKSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLP 109

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 29/211 (13%)

Query: 153 LGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD 209
           LG G FG V+    E+++     +K +   R+   +E +          E++ L S  H 
Sbjct: 30  LGSGAFGDVHLVE-ERSSGLERVIKTINKDRSQVPMEQI--------EAEIEVLKSLDHP 80

Query: 210 NILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQ 266
           NI+ ++ + FE      +V      G L +R++  +     L ++     + K     L 
Sbjct: 81  NIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKAL-SEGYVAELMKQMMNALA 138

Query: 267 FLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTRP 322
           + HS+   ++H D+K  NIL    + H    I DFGL       E           GT  
Sbjct: 139 YFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-----STNAAGTAL 191

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           Y+  E      ++ K D++  G+V++ L TG
Sbjct: 192 YMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 63/259 (24%), Positives = 98/259 (37%), Gaps = 49/259 (18%)

Query: 114 EPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT--- 170
           EP    ++P  P          P        +++  L ++GKG FG V      K     
Sbjct: 7   EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLL-ARHKAEEVF 65

Query: 171 IAVK---KLEVHRNDRAVETLNQCQREQSLRELKYL-NSCRHDNILPLYGICFET-GKYC 225
            AVK   K  + +           + +  + E   L  + +H  ++ L+   F+T  K  
Sbjct: 66  YAVKVLQKKAILKKK---------EEKHIMSERNVLLKNVKHPFLVGLHF-SFQTADKLY 115

Query: 226 LVYRYMPNGSL-----------EDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPP 274
            V  Y+  G L           E R              R + A+  +  L +LHS    
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPR-------------ARFYAAE-IASALGYLHSLN-- 159

Query: 275 LIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL 334
           +++ D+K  NILL+     V+ DFGL +E     +T  T     GT  YL  E L  +  
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF---CGTPEYLAPEVLHKQPY 216

Query: 335 STKVDVYGFGIVLFELATG 353
              VD +  G VL+E+  G
Sbjct: 217 DRTVDWWCLGAVLYEMLYG 235

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 43/272 (15%)

Query: 88  QNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNW 147
            +H+  S+ V+        +     +  +   S      +++            L ++ +
Sbjct: 2   HHHHHHSSGVD-----LGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL-SDFF 55

Query: 148 DKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSL-RELKYLNSC 206
           +  + LG+G    VY+   +K T         +   A++ L +   ++ +  E+  L   
Sbjct: 56  EVESELGRGATSIVYRCK-QKGT---------QKPYALKVLKKTVDKKIVRTEIGVLLRL 105

Query: 207 RHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSL 263
            H NI+ L  I FET  +  LV   +  G L DR++ K       +++R      K    
Sbjct: 106 SHPNIIKLKEI-FETPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILE 159

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDP---VIGDFGLTQEGPIEKATHI----TLKR 316
            + +LH     ++H D+K  N+L           I DFGL        +  +     +K 
Sbjct: 160 AVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGL--------SKIVEHQVLMKT 209

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLF 348
           V GT  Y   E L G     +VD++  GI+ +
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITY 241

>2a9i_A IRAK-4, interleukin-1 receptor-associated kinase-4; hexahelical bundle, transferase; 1.70A {Mus musculus} PDB: 3mop_G Length = 113

 Score = 62.4 bits (151), Expect = 2e-12
 Identities = 16/57 (28%), Positives = 24/57 (42%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKP 57
             +    + + E  +    SPT ELL  WG  N TV +L   L  +  +    +L P
Sbjct: 46  DRYNQFHIRRFEALLQTGLSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLP 102

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 35/283 (12%)

Query: 79  QEQSSVFSAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQ 138
           Q ++ + S ++   +SA +  E +     +         +   P   +            
Sbjct: 36  QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--- 92

Query: 139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQ 195
                   +D  +++G+G    V + V  + T    AVK +EV   +R      +  RE 
Sbjct: 93  -----YQKYDPKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEV-TAERLSPEQLEEVREA 145

Query: 196 SLRELKYLNS-CRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           + RE   L     H +I+ L      +    LV+  M  G L D L  K        +++
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-----LSEK 200

Query: 255 --LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATH 311
               I +     + FLH+    ++H D+K  NILL+ +M   + DFG      P EK   
Sbjct: 201 ETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--- 255

Query: 312 ITLKRVNGTRPYLPHEFLVGKRL------STKVDVYGFGIVLF 348
             L+ + GT  YL  E L             +VD++  G++LF
Sbjct: 256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 30/211 (14%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
           +LGKG FG V K   ++ T    AVK +                    LRE++ L    H
Sbjct: 29  MLGKGSFGEVLKCK-DRITQQEYAVKVINKAS-------AKNKDTSTILREVELLKKLDH 80

Query: 209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQ 266
            NI+ L+ I  ++  + +V      G L D ++ +K      +++     I K    G+ 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGIT 135

Query: 267 FLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGL-TQEGPIEKATHITLKRVNGTRP 322
           ++H     ++H D+K  NILL        + I DFGL T      K     +K   GT  
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-----MKDRIGTAY 188

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           Y+  E L       K DV+  G++L+ L +G
Sbjct: 189 YIAPEVL-RGTYDEKCDVWSAGVILYILLSG 218

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 37/231 (16%)

Query: 153 LGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN 210
           LG G FG V  G  E T   +AVK L    N + + +L+     +  RE++ L   RH +
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL----NRQKIRSLDV--VGKIRREIQNLKLFRHPH 77

Query: 211 ILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL------ 263
           I+ LY +   T     +V  Y+  G L D +             RL   +   L      
Sbjct: 78  IIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKN---------GRLDEKESRRLFQQILS 127

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ + H     ++H D+K  N+LL+ HM+  I DFGL     +       L+   G+  Y
Sbjct: 128 GVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL---SNMMSDGEF-LRTSCGSPNY 181

Query: 324 LPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
              E + G+     +VD++  G++L+ L  G   +DD      H+ +L +K
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-----DHVPTLFKK 227

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 45/211 (21%), Positives = 92/211 (43%), Gaps = 30/211 (14%)

Query: 151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHD 209
             +G G +    + +  K T           + AV+ +++  +     E++ L    +H 
Sbjct: 28  EDIGVGSYSVCKRCI-HKAT---------NMEFAVKIIDK-SKRDPTEEIEILLRYGQHP 76

Query: 210 NILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGLQ 266
           NI+ L  + ++ GKY  +V   M  G L D++L +K      +++R    +    +  ++
Sbjct: 77  NIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQKF-----FSEREASAVLFTITKTVE 130

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPV----IGDFGLTQEGPIEKATHITLKRVNGTRP 322
           +LH++   ++H D+K +NIL            I DFG  +     +A +  L     T  
Sbjct: 131 YLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAK---QLRAENGLLMTPCYTAN 185

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           ++  E L  +      D++  G++L+ + TG
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 30/212 (14%)

Query: 151 NILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
            +LGKG FG V K   ++ T    AVK +                    LRE++ L    
Sbjct: 28  CMLGKGSFGEVLKCK-DRITQQEYAVKVINKAS-------AKNKDTSTILREVELLKKLD 79

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLGL 265
           H NI+ L+ I  ++  + +V      G L D ++ +K      +++     I K    G+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGI 134

Query: 266 QFLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGL-TQEGPIEKATHITLKRVNGTR 321
            ++H     ++H D+K  NILL        + I DFGL T      K     +K   GT 
Sbjct: 135 TYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-----MKDRIGTA 187

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            Y+  E L       K DV+  G++L+ L +G
Sbjct: 188 YYIAPEVL-RGTYDEKCDVWSAGVILYILLSG 218

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 48/254 (18%), Positives = 81/254 (31%), Gaps = 65/254 (25%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           +  +     LG G FG V +    ++    A+KK+               +     REL 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----------RY--KNRELD 52

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ-------- 253
            +    H NI+ L    + TG         P+   +                        
Sbjct: 53  IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112

Query: 254 ----------------RLHIAKGTSL--------------GLQFLHSREPPLIHGDIKSA 283
                           +  I  G S+               + F+HS    + H DIK  
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQ 170

Query: 284 NILLNHHMDPV-IGDFGLTQE-GPIEKATH-ITLKRVNGTRPYLPHEFLVG-KRLSTKVD 339
           N+L+N   + + + DFG  ++  P E +   I       +R Y   E ++G    +  +D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC------SRFYRAPELMLGATEYTPSID 224

Query: 340 VYGFGIVLFELATG 353
           ++  G V  EL  G
Sbjct: 225 LWSIGCVFGELILG 238

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 59/292 (20%)

Query: 86  SAQNHNVKSARVNFENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATN 145
           +  +H+ +    +    AG   +   G E    V   L   N+ G    +          
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV-------GIE 54

Query: 146 NWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDR--AVETL-------NQCQREQS 196
           N++ L +LG G +G V+          V+K+  H   +  A++ L            E +
Sbjct: 55  NFELLKVLGTGAYGKVFL---------VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105

Query: 197 LRELKYLNSCRHDN-ILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMK 243
             E + L   R    ++ L+   F+T  K  L+  Y+  G L           E  +   
Sbjct: 106 RTERQVLEHIRQSPFLVTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEHEV--- 161

Query: 244 KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE 303
                     ++++ +   L L+ LH     +I+ DIK  NILL+ +   V+ DFGL++E
Sbjct: 162 ----------QIYVGE-IVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKE 208

Query: 304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRL--STKVDVYGFGIVLFELATG 353
             +   T        GT  Y+  + + G        VD +  G++++EL TG
Sbjct: 209 F-VADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 57/327 (17%), Positives = 117/327 (35%), Gaps = 31/327 (9%)

Query: 40  FKHLYAMRHYQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNF 99
           F+   + +  +  + +  +  +  +  +         + +     +       +    N 
Sbjct: 230 FQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNV 289

Query: 100 ------ENEAGVRQENNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNIL 153
                        ++     +  +    P                   +   +++ L +L
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349

Query: 154 GKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           GKG FG V      K T        +KK  V ++D    T+   ++    R L      +
Sbjct: 350 GKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTM--VEK----RVLALPG--K 400

Query: 208 HDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
              +  L+  CF+T  +   V  Y+  G L   +  ++           + A+  ++GL 
Sbjct: 401 PPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAE-IAIGLF 456

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           FL S+   +I+ D+K  N++L+      I DFG+ +E   +  T  T     GT  Y+  
Sbjct: 457 FLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF---CGTPDYIAP 511

Query: 327 EFLVGKRLSTKVDVYGFGIVLFELATG 353
           E +  +     VD + FG++L+E+  G
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 39/217 (17%), Positives = 79/217 (36%), Gaps = 42/217 (19%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN 210
           +LG G  G V +    + T             A++ L    + +  +E+ +        +
Sbjct: 36  VLGLGVNGKVLECF-HRRT---------GQKCALKLLYDSPKAR--QEVDHHWQASGGPH 83

Query: 211 ILPLYGICFETGKYC-----LVYRYMPNGSLEDRLLMKKNTP------SLLWTQRLHIAK 259
           I+ +  + +E   +      ++   M  G L  R+  + +        + +      I  
Sbjct: 84  IVCILDV-YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD---IGT 139

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGLTQEGPIEKATHITLKR 316
                +QFLHS    + H D+K  N+L         + + DFG  +E          L+ 
Sbjct: 140 ----AIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQT 188

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
              T  Y+  E L  ++     D++  G++++ L  G
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 41/219 (18%)

Query: 150 LNILGKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
             +LGKG FG V+     K T       A+KK  V  +D    T+     E+ +  L   
Sbjct: 22  HKMLGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMV----EKRVLSL--- 73

Query: 204 NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL------EDRLLMKKNTPSLLWTQRLH 256
            +  H  +  ++   F+T      V  Y+  G L        +  +             +
Sbjct: 74  -AWEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--------RATFY 123

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFGLTQEGPIEKATHITL 314
            A+   LGLQFLHS+   +++ D+K  NILL+   H+   I DFG+ +E  +  A   T 
Sbjct: 124 AAE-IILGLQFLHSKG--IVYRDLKLDNILLDKDGHI--KIADFGMCKENMLGDAKTNTF 178

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
               GT  Y+  E L+G++ +  VD + FG++L+E+  G
Sbjct: 179 ---CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 56/235 (23%), Positives = 91/235 (38%), Gaps = 52/235 (22%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
           +  LGKG +G V+K +  +T   +AVKK+       A +     QR  + RE+  L    
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-----DAFQNSTDAQR--TFREIMILTELS 66

Query: 208 -HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL---HIAKGTSL 263
            H+NI+ L  +         VY             M+ +  +++    L   H      +
Sbjct: 67  GHENIVNLLNV-LRADNDRDVYLVFD--------YMETDLHAVIRANILEPVHKQ---YV 114

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL------TQEGPIEKATH 311
                  +++LHS    L+H D+K +NILLN      + DFGL       +         
Sbjct: 115 VYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 312 ITLKRVNG------------TRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG 353
           I     N             TR Y   E L+G  + +  +D++  G +L E+  G
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 49/219 (22%), Positives = 79/219 (36%), Gaps = 36/219 (16%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            +D +  +G G FG       + T   +AVK +     +R          E   RE+   
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI-----ER-----GAAIDENVQREIINH 70

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
            S RH NI+    +        ++  Y   G L +R+             R    +    
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA---------GRFSEDEARFF 121

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPV--IGDFGLTQEGPIEKATHITLK 315
                 G+ + HS +  + H D+K  N LL+    P   I DFG ++        H   K
Sbjct: 122 FQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPK 175

Query: 316 RVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATG 353
              GT  Y+  E L+ +       DV+  G+ L+ +  G
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 49/223 (21%)

Query: 150 LNILGKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L ++G+G +  V   V  K T        VKK  V+ ++           +    E    
Sbjct: 14  LRVIGRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDDE---------DIDWVQTEKHVF 63

Query: 204 -NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLL 250
             +  H  ++ L+  CF+T  +   V  Y+  G L           E+            
Sbjct: 64  EQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---------- 112

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
              R + A+  SL L +LH R   +I+ D+K  N+LL+      + D+G+ +EG     T
Sbjct: 113 ---RFYSAE-ISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             T     GT  Y+  E L G+     VD +  G+++FE+  G
Sbjct: 167 TSTF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 49/223 (21%)

Query: 150 LNILGKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           + +LGKG FG V      K T        +KK  + ++D           E ++ E + L
Sbjct: 28  IRVLGKGSFGKVML-ARVKETGDLYAVKVLKKDVILQDD---------DVECTMTEKRIL 77

Query: 204 -NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLL 250
             +  H  +  L+  CF+T  +   V  ++  G L           E R           
Sbjct: 78  SLARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA---------- 126

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
              R + A+     L FLH +   +I+ D+K  N+LL+H     + DFG+ +EG     T
Sbjct: 127 ---RFYAAE-IISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
             T     GT  Y+  E L        VD +  G++L+E+  G
Sbjct: 181 TATF---CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.5 bits (153), Expect = 4e-11
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 45/224 (20%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            ++  L  LG G FG V+  +  +      A+K L      +    +   Q E +  E  
Sbjct: 6   QDFQILRTLGTGSFGRVHL-IRSRHNGRYYAMKVL------KKEIVVRLKQVEHTNDERL 58

Query: 202 YLNSCRHDNILPLYGICFETGKY-CLVYRYMPNGSL-----------EDRLLMKKNTPSL 249
            L+   H  I+ ++G  F+  +   ++  Y+  G L                        
Sbjct: 59  MLSIVTHPFIIRMWG-TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---------- 107

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
               + + A+   L L++LHS++  +I+ D+K  NILL+ +    I DFG  +   +   
Sbjct: 108 ---AKFYAAE-VCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDV 159

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T+ TL    GT  Y+  E +  K  +  +D + FGI+++E+  G
Sbjct: 160 TY-TL---CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 51/224 (22%)

Query: 150 LNILGKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L +LGKG FG V      K T        +KK  V ++D    T+     E+ +  L   
Sbjct: 25  LMVLGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMV----EKRVLAL--- 76

Query: 204 NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLLW 251
              +   +  L+  CF+T  +   V  Y+  G L           E              
Sbjct: 77  -PGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH------------ 122

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFGLTQEGPIEKA 309
               + A+  ++GL FL S+   +I+ D+K  N++L+   H+   I DFG+ +E   +  
Sbjct: 123 -AVFYAAE-IAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHI--KIADFGMCKENIWDGV 176

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           T  T     GT  Y+  E +  +     VD + FG++L+E+  G
Sbjct: 177 TTKTF---CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 47/222 (21%)

Query: 150 LNILGKGGFGTVYKGVWEKTTI------AVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           L ++G+G +  V   V  K T        VKK  V+ ++           E+ + E    
Sbjct: 57  LRVIGRGSYAKVLL-VRLKKTDRIYAMRVVKKELVNDDEDIDWVQT----EKHVFEQ--- 108

Query: 204 NSCRHDNILPLYGICFET-GKYCLVYRYMPNGSL-----------EDRLLMKKNTPSLLW 251
            +  H  ++ L+  CF+T  +   V  Y+  G L           E+             
Sbjct: 109 -ASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA----------- 155

Query: 252 TQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATH 311
             R + A+  SL L +LH R   +I+ D+K  N+LL+      + D+G+ +EG     T 
Sbjct: 156 --RFYSAE-ISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210

Query: 312 ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
            T     GT  Y+  E L G+     VD +  G+++FE+  G
Sbjct: 211 STF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.3 bits (152), Expect = 7e-11
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 36/237 (15%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            +     LG+G FG V      KT   +A+K +    + + ++  +     +  RE+ YL
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFI----SRQLLKKSDM--HMRVEREISYL 63

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              RH +I+ LY +        +V  Y   G L D ++ K         +R+   +G   
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK---------KRMTEDEGRRF 113

Query: 264 ------GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                  +++ H  +  ++H D+K  N+LL+ +++  I DFGL     I    +  LK  
Sbjct: 114 FQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGL---SNIMTDGNF-LKTS 167

Query: 318 NGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
            G+  Y   E + GK     +VDV+  GIVL+ +  G   +DD       + +L +K
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-----EFIPNLFKK 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 28/159 (17%)

Query: 152 ILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQRE-QSLRELKYLNSCR 207
           +LG+G    V   +    T    AVK +      +     ++  RE + L + +      
Sbjct: 20  VLGEGAHARVQTCI-NLITSQEYAVKII----EKQPGHIRSRVFREVEMLYQCQ-----G 69

Query: 208 HDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGTSLG 264
           H N+L L    FE      LV+  M  GS+   +  +++     + +     + +  +  
Sbjct: 70  HRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH-----FNELEASVVVQDVASA 123

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGL 300
           L FLH++   + H D+K  NIL  H     PV I DF L
Sbjct: 124 LDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDL 160

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.8 bits (149), Expect = 3e-10
 Identities = 75/564 (13%), Positives = 142/564 (25%), Gaps = 176/564 (31%)

Query: 1   MNFTSRQLFQ-MEQAILRR------ESPTEELLSKWGAQNHTVLELFKHLYAMRH----- 48
             +  + +    E A +        +   + +LSK         E   H+   +      
Sbjct: 14  HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK---------EEIDHIIMSKDAVSGT 64

Query: 49  YQAMLILKPYVESKYHTCIPEGCSDNRTILQEQSSVFSAQNHNVKSARVNFENEAGVRQE 108
            +    L    E      + E    N   L         +          +  +      
Sbjct: 65  LRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP---IKTEQRQPSMMTRMYIEQRDRLYN 121

Query: 109 NNPGNEPTRKVSDPLTPMNVLGGTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK 168
           +N                NV    P++  ++  L       + I G  G G        K
Sbjct: 122 DNQ----------VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG--------K 163

Query: 169 TTIAVKKLEVHRNDRAVE---------TLNQCQREQSLRELKYLNSCRHDNILPLYGICF 219
           T +A   L+V  + +             L  C   +++  L+ L    +           
Sbjct: 164 TWVA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETV--LEMLQKLLYQIDPNWTSRSD 218

Query: 220 ETGKYCLVYRYMPNGSLED---RLLMKKNTP-SLL-----WTQRLHIAKGTSLGLQFLHS 270
            +         +   S++    RLL  K     LL        +       +L  + L  
Sbjct: 219 HSSNI-----KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK--AWNAFNLSCKIL-- 269

Query: 271 REPPLIHGDIKSANILLNHHMDPVIGDF---GLTQEGPIEKATHITLKRVNGTRPYLPHE 327
               L     +  + L       +  D     LT +    +   + LK ++     LP E
Sbjct: 270 ----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPD----EVKSLLLKYLDCRPQDLPRE 321

Query: 328 ------FLVG---------------------KRLSTKVDV-------------Y-GFGI- 345
                   +                       +L+T ++              +    + 
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381

Query: 346 ---------VLFELATGMRAYDDTRR--SERHLKSLVEKYSEENMY-------DLVDKNA 387
                    +L  +   +    D     ++ H  SLVEK  +E+         +L  K  
Sbjct: 382 PPSAHIPTILLSLIWFDV-IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440

Query: 388 QPIEL--------NIA---------------YAFFRIGKQ-STKQNPKERPEMTQVY--- 420
               L        NI                Y +  IG      ++P+       V+   
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF 500

Query: 421 NMLSG---SGGESPNATGPTLPVM 441
             L         + NA+G  L  +
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTL 524

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 45/219 (20%), Positives = 79/219 (36%), Gaps = 48/219 (21%)

Query: 152 ILGKGGFGTVYKGVWEKT-------TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
            +G+G +G V   V + T        I    +E                ++  +E++ + 
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--------------DVDRFKQEIEIMK 61

Query: 205 SCRHDNILPLYGICFETGKYC-LVYRYMPNGSLEDRLLMKKNTPSLLWTQR--LHIAKGT 261
           S  H NI+ LY   FE      LV      G L +R++ K+      + +     I K  
Sbjct: 62  SLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRV-----FRESDAARIMKDV 115

Query: 262 SLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIGDFGLTQEGPIEKATHI----TL 314
              + + H     + H D+K  N L    +      + DFGL        A        +
Sbjct: 116 LSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGL--------AARFKPGKMM 165

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
           +   GT  Y+  + L G     + D +  G++++ L  G
Sbjct: 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCG 203

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 32/138 (23%), Positives = 48/138 (34%), Gaps = 24/138 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
            P   L L          LG+G FG V +             T+AVK L+        E 
Sbjct: 19  FPRDRLKL-------GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--------EG 63

Query: 188 LNQCQREQSLRELKYLNS-CRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN 245
               +    + ELK L     H N++ L G C +  G   ++  +   G+L   L  K+N
Sbjct: 64  ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123

Query: 246 TPSLLWTQRLHIAKGTSL 263
                 T+     +G   
Sbjct: 124 EFVPYKTKGARFRQGKDY 141

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 43/215 (20%), Positives = 82/215 (38%), Gaps = 17/215 (7%)

Query: 180 RNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDR 239
           R+ R      + +  +  +   Y+ +   D    L  I          +    + S  + 
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

Query: 240 LLMKKNTPSLLWTQR--LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD 297
               ++      T    +  +   + G++FL SR    IH D+ + NILL+      I D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICD 236

Query: 298 FGLTQEGPIEKATHITLKRVNGTRPY--LPHEFLVGKRLSTKVDVYGFGIVLFELAT-GM 354
           FGL ++  I K      ++ +   P   +  E +  +  + + DV+ FG++L+E+ + G 
Sbjct: 237 FGLARD--IYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293

Query: 355 RAYDDTRRSERHLKSLVE-------KYSEENMYDL 382
             Y   +  E   + L E        Y+   MY  
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 59/285 (20%), Positives = 102/285 (35%), Gaps = 81/285 (28%)

Query: 153 LGKGGFGTVY--KGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--- 207
           LG G F TV+    +  K  +A+K          V    +   E +L E++ L S R   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMK----------VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 208 -----HDNILPLYGICFE-TGKY----CLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRL- 255
                 + ++ L    F+ +G      C+V+  +  G  L     + K+    L    + 
Sbjct: 95  PNDPNREMVVQLLD-DFKISGVNGTHICMVFEVL--GHHLLK--WIIKSNYQGLPLPCVK 149

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLN--------------------------- 288
            I +    GL +LH+ +  +IH DIK  NILL+                           
Sbjct: 150 KIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 289 --------------HHMDPVIGDFGLTQEGPIEKATHITLKRVNG--TRPYLPHEFLVGK 332
                         + ++P   +    +   +  A  +         TR Y   E L+G 
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268

Query: 333 RLSTKVDVYGFGIVLFELATG-----MRAYDDTRRSERHLKSLVE 372
             +T  D++    + FELATG       + ++  R E H+  ++E
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 41/212 (19%), Positives = 81/212 (38%), Gaps = 41/212 (19%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN 210
           +LG G  G V +    K T         +   A++ L  C + +  RE++      +  +
Sbjct: 69  VLGLGINGKVLQIF-NKRT---------QEKFALKMLQDCPKAR--REVELHWRASQCPH 116

Query: 211 ILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTP------SLLWTQRLHIAK 259
           I+ +  + +E          +V   +  G L  R+  + +        S +      I +
Sbjct: 117 IVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS---IGE 172

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGLTQEGPIEKATHITLKR 316
                +Q+LHS    + H D+K  N+L         + + DFG       E  +H +L  
Sbjct: 173 ----AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFA----KETTSHNSLTT 222

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLF 348
              T  Y+  E L  ++     D++  G++++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 49/228 (21%), Positives = 83/228 (36%), Gaps = 40/228 (17%)

Query: 150 LNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS- 205
           +  LG+G FG V + +        +A+K   + RN           RE +  E+  L   
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALK---IIRN-------VGKYREAARLEINVLKKI 73

Query: 206 CRHD-----NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL-HIA 258
              D       + +    F   G  C+ +  +   +  +   +K+N         + H+A
Sbjct: 74  KEKDKENKFLCVLMSD-WFNFHGHMCIAFELL-GKNTFE--FLKENNFQPYPLPHVRHMA 129

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL---- 314
                 L+FLH  +  L H D+K  NIL  +     + +   + E    K T I +    
Sbjct: 130 YQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 315 ------KRVNG---TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                 +       TR Y P E ++    +   DV+  G +LFE   G
Sbjct: 188 SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 49/230 (21%), Positives = 82/230 (35%), Gaps = 44/230 (19%)

Query: 150 LNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS- 205
           ++ LG+G FG V + +  K     +AVK   + +N            E +  E++ L   
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVK---IVKNVDRY-------CEAARSEIQVLEHL 68

Query: 206 CRHD-----NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKN--TP-SLLWTQRLH 256
              D       + +    FE  G  C+V+  +   S  D   +K+N   P  L   +   
Sbjct: 69  NTTDPNSTFRCVQMLE-WFEHHGHICIVFELL-GLSTYD--FIKENGFLPFRLDHIR--K 122

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL-- 314
           +A      + FLH     L H D+K  NIL          +  + ++        I +  
Sbjct: 123 MAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180

Query: 315 --------KRVNG---TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                   +  +    TR Y   E ++    S   DV+  G +L E   G
Sbjct: 181 FGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 48/237 (20%), Positives = 74/237 (31%), Gaps = 54/237 (22%)

Query: 150 LNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE---LKYL 203
           +  +G G FG V             AVK   V RN        +     +  E   LK +
Sbjct: 40  IRKMGDGTFGRVLL-CQHIDNKKYYAVK---VVRN-------IKKYTRSAKIEADILKKI 88

Query: 204 NSCRHD--NILPLYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKN-----TPSLLWTQRL 255
            +   +  NI+  +G  F      CL++  +   SL +  ++ +N         +     
Sbjct: 89  QNDDINNNNIVKYHG-KFMYYDHMCLIFEPL-GPSLYE--IITRNNYNGFHIEDIK---- 140

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEK------- 308
                    L +L      L H D+K  NILL+                  +        
Sbjct: 141 LYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 309 ----------ATHI--TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG 353
                     AT        +  TR Y   E ++        D++ FG VL EL TG
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>3mop_K IRAK-2, interleukin-1 receptor-associated kinase-like 2; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens} Length = 111

 Score = 52.5 bits (125), Expect = 7e-09
 Identities = 14/42 (33%), Positives = 21/42 (50%)

Query: 20 SPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVES 61
          S T ELL  WG +  TV +L   L  +  Y+A  I+  +  +
Sbjct: 54 SITRELLWWWGMRQATVQQLVDLLCRLELYRAAQIILNWKPA 95

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 30/182 (16%), Positives = 59/182 (32%), Gaps = 42/182 (23%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVK---------KLEVHRNDRAVETLNQCQREQ 195
             W   +   +   G +Y+     T              KL+  ++ R     N  QR  
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLD-AKDGRLFNEQNFFQRAA 100

Query: 196 SLRELKY---LNSCRHDNILPLYGICFETGKYCLVYRYM------PNGSLED------RL 240
              ++     L S     I    G     G +   YR++         SL+       + 
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMG----FGVHQDKYRFLVLPSLGR--SLQSALDVSPKH 154

Query: 241 LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDF 298
           ++ + +   +  + L         L+FLH  E   +HG++ + NI ++      +    +
Sbjct: 155 VLSERSVLQVACRLLDA-------LEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGY 205

Query: 299 GL 300
           G 
Sbjct: 206 GF 207

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 8e-08
 Identities = 37/163 (22%), Positives = 65/163 (39%), Gaps = 23/163 (14%)

Query: 153 LGKGGFGTVYKG--VWEKTTIAVK--KLEVHRN---DRAVETLNQCQREQSLRELKYLNS 205
           +G GGFG +Y      +    A    K+E   N      ++   +  ++  +++      
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 206 CRHDNILPLYGICFETGKYCLVYRYM------PNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
             +  I   YG    T      YR+M          L+  +  +  T        L +  
Sbjct: 105 LDYLGIPLFYG-SGLTEFKGRSYRFMVMERLGI--DLQK-ISGQNGTFKKSTV--LQLGI 158

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPV-IGDFGL 300
                L+++H  E   +HGDIK+AN+LL + + D V + D+GL
Sbjct: 159 RMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGL 199

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 37/164 (22%)

Query: 152 ILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN 210
           +LG G  G V +    K T         +   A++ L  C + +  RE++      +  +
Sbjct: 25  VLGLGINGKVLQIF-NKRT---------QEKFALKMLQDCPKAR--REVELHWRASQCPH 72

Query: 211 ILPLYGICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTP------SLLWTQRLHIAK 259
           I+ +  + +E          +V   +  G L  R+  + +        S +      I +
Sbjct: 73  IVRIVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS---IGE 128

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMD--PV-IGDFGL 300
                +Q+LHS    + H D+K  N+L         + + DFG 
Sbjct: 129 ----AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 32/165 (19%), Positives = 63/165 (38%), Gaps = 24/165 (14%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEV------HRNDR---AVETLNQCQREQSLRELKYL 203
           +G+GGFG +Y      +                 N      ++   +  + + +++    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYM------PNGSLEDRLLMKKNTPSLLWTQRLHI 257
              ++  +   +G      K    YR+M          L+          S      L +
Sbjct: 103 RKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKRFSRKTV--LQL 157

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPV-IGDFGL 300
           +      L+++H  E   +HGDIK++N+LLN+ + D V + D+GL
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGL 200

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 53/228 (23%), Positives = 79/228 (34%), Gaps = 30/228 (13%)

Query: 153 LGKGGFGTVYKGVWEKTTIAV-KKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +G G FG +Y G        V  KLE  +         Q   E  +   K +       I
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKI--YKMMQGGVG--I 67

Query: 212 LPLYGICFETGKYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
             +     E     +V   +  G SLED         SL     L +A      ++++HS
Sbjct: 68  PTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS 123

Query: 271 REPPLIHGDIKSANILLNHHMDP---VIGDFGLTQE-GPIEKATHITLKRVN---GTRPY 323
           +    IH D+K  N L+          I DFGL ++        HI  +      GT  Y
Sbjct: 124 KN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATG------MRAYDDTRRSER 365
                 +G   S + D+   G VL     G      ++A    ++ ER
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 43/164 (26%), Positives = 61/164 (37%), Gaps = 24/164 (14%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            N+     +G G FG +  G    T   +A+K LE     R        Q     R  K 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LE-PMKSR------APQLHLEYRFYKQ 60

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGT 261
           L S     I  +Y          +V   +  G SLED   +   T SL     L IA   
Sbjct: 61  LGSGDG--IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV--LMIAIQL 114

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPV-----IGDFGL 300
              ++++HS+   LI+ D+K  N L+    +       I DF L
Sbjct: 115 ISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156

>3mop_A Myeloid differentiation primary response protein; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens} Length = 110

 Score = 40.2 bits (94), Expect = 1e-04
 Identities = 18/67 (26%), Positives = 29/67 (43%), Gaps = 8/67 (11%)

Query: 1  MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYV 59
          M+F   ++ Q+E     +  PT  LL  W  +   +V  L + L  +     +L L P +
Sbjct: 36 MDFEYLEIRQLET----QADPTGRLLDAWQGRPGASVGRLLELLTKLGRDDVLLELGPSI 91

Query: 60 ES---KY 63
          E    KY
Sbjct: 92 EEDCQKY 98

>2g7r_A Mucosa-associated lymphoid tissue lymphoma transl protein 1; death domain, chromosomal translocation, hydrolase; 2.70A {Homo sapiens} Length = 117

 Score = 40.6 bits (94), Expect = 1e-04
 Identities = 15/39 (38%), Positives = 20/39 (51%)

Query: 20  SPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPY 58
           SP+  LL   G +  TV EL   L AM H + + +L P 
Sbjct: 78  SPSLCLLKLMGEKGCTVTELSDFLQAMEHTEVLQLLSPP 116

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 43/156 (27%), Positives = 62/156 (39%), Gaps = 24/156 (15%)

Query: 153 LGKGGFGTVYKGVWEKTTIAV-KKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +G+G FG +++G        V  K E  R+D         Q     R  K L  C    I
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTG--I 68

Query: 212 LPLYGICFETGKYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS 270
             +Y    E     LV   +  G SLED L +     S+        AK     +Q +H 
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV--AMAAKQMLARVQSIHE 124

Query: 271 REPPLIHGDIKSANILL------NHHMDPVIGDFGL 300
           +   L++ DIK  N L+      N +M  V+ DFG+
Sbjct: 125 KS--LVYRDIKPDNFLIGRPNSKNANMIYVV-DFGM 157

>2dbf_A Nuclear factor NF-kappa-B P105 subunit; apoptosis, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 100

 Score = 38.7 bits (90), Expect = 4e-04
 Identities = 11/51 (21%), Positives = 24/51 (47%)

Query: 11 MEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVES 61
          +  A     +P++ L+  +     TV EL + L  M + +A+ +++    S
Sbjct: 45 LNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSS 95

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 39/155 (25%), Positives = 56/155 (36%), Gaps = 18/155 (11%)

Query: 153 LGKGGFGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI 211
           +G G FG +Y G   +T      KLE  +         Q   E  +   + L       I
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKI--YRILQGGTG--I 65

Query: 212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR 271
             +     E     LV   +   SLED         SL     L +A      ++F+HS+
Sbjct: 66  PNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVHSK 122

Query: 272 EPPLIHGDIKSANILLNHHMDP---VIGDFGLTQE 303
               +H DIK  N L+          I DFGL ++
Sbjct: 123 S--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	441
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
3mop_K	111	IRAK-2, interleukin-1 receptor-associated kinase-l	99.84
1d2z_A	108	Death domain of pelle; six-helix bundle, linear ar	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
2a9i_A	113	IRAK-4, interleukin-1 receptor-associated kinase-4	99.72
1wh4_A	127	IRAK4, interleukin-1 receptor-associated kinase 4;	99.64
1d2z_B	153	Death domain of tube; six-helix bundle, linear arr	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.01
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.74
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
1wmg_A	103	Netrin receptor UNC5H2; six helix bundle, death do	98.48
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.44
2g7r_A	117	Mucosa-associated lymphoid tissue lymphoma transl	98.41
3mop_A	110	Myeloid differentiation primary response protein;	98.31
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.9
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.86
1ngr_A	85	P75 low affinity neurotrophin receptor; intracellu	97.8
2dbf_A	100	Nuclear factor NF-kappa-B P105 subunit; apoptosis,	97.65
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.51
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.28
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.25
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.23
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.2
2ib1_A	91	Death domain containing membrane protein nradd; ap	97.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.97
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.86
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.81
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.68
2d96_A	109	Nuclear factor NF-kappa-B P100 subunit; six helix	96.54
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.29
3g5b_A	405	Netrin receptor UNC5B; ZU5, death domain, UPA, apo	96.24
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.23
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.72
1wxp_A	110	THO complex subunit 1; death domain, structural ge	94.94
2of5_H	118	Leucine-rich repeat and death domain-containing pr	94.08
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.64
3oq9_A	86	Tumor necrosis factor receptor superfamily member;	92.21
2yqf_A	111	Ankyrin-1; death domain, structural genomics, NPPS	91.56
1ich_A	112	TNF-1, tumor necrosis factor receptor-1; death dom	89.27
3ezq_B	122	Protein FADD; apoptosis, DISC, FAS, membrane,recep	87.94
1fad_A	99	Protein (FADD protein); apoptosis, death domain; N	87.31
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.8
2o71_A	115	Death domain-containing protein cradd; raidd, apop	85.67
2of5_A	114	Death domain-containing protein cradd; death domai	85.47
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.32
3ezq_A	115	Tumor necrosis factor receptor superfamily member;	82.18
2gf5_A	191	FADD protein; death domain, death effector domain,	80.65

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-59  Score=449.60  Aligned_cols=267  Identities=27%  Similarity=0.416  Sum_probs=211.0

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ++..+++.+.++||+|+||+||+|.+++ .||||+++.....       ....+.+.+|+++|++++|||||+++|++.+
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~-------~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  103 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPT-------PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK  103 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence            3455778889999999999999998765 5999998754332       1335577899999999999999999998765


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       +.+|||||||+||+|.++|...  ...+++.++..|+.||+.||+|||+++  ||||||||+||||++++.+||+|||+
T Consensus       104 -~~~~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          104 -DNLAIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             -CeEEEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccC
Confidence             5689999999999999999643  345999999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+...... ........+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+..... .+...+..    
T Consensus       179 a~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~----  252 (307)
T 3omv_A          179 ATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGR----  252 (307)
T ss_dssp             CBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHT----
T ss_pred             ceecccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhc----
Confidence            98643222 1223445689999999999964   358999999999999999999999998765422 22222211    


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                         ....+.....+.+++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       253 ---~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          253 ---GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             ---TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             ---CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence               0111222234456778899999999999999999999999999877643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.3e-60  Score=450.92  Aligned_cols=264  Identities=23%  Similarity=0.397  Sum_probs=215.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      ..++|.+.++||+|+||+||+|.+.       +..||||+++...         ....+.+.+|+++|++++|||||+++
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnIV~l~   81 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIVKFY   81 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---------hHHHHHHHHHHHHHHhCCCCCCccEE
Confidence            3467888999999999999999873       4579999997432         12345678999999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKK----------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      |+|.+++.+|||||||++|+|.++|....          ....++|.++..|+.||+.||+|||+++  ||||||||+||
T Consensus        82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NI  159 (299)
T 4asz_A           82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNC  159 (299)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhE
Confidence            99999999999999999999999997542          2356999999999999999999999998  99999999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhH
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE  364 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~  364 (441)
                      ||++++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.... 
T Consensus       160 Ll~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-  237 (299)
T 4asz_A          160 LVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-  237 (299)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred             EECCCCcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            999999999999999975432221 112234569999999999999999999999999999999999 99999876542 


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                      .....+..            ....+.+..++.++.+|+.+||+.||++|||+.+|.+.|+++...+|
T Consensus       238 ~~~~~i~~------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p  292 (299)
T 4asz_A          238 EVIECITQ------------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP  292 (299)
T ss_dssp             HHHHHHHH------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHc------------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence            22222111            11223455678899999999999999999999999999988765443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-59  Score=450.32  Aligned_cols=260  Identities=20%  Similarity=0.357  Sum_probs=214.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      .++++.++||+|+||+||+|.+.       ++.||||+++.....        ...+.+.+|+.++++++|||||+++|+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------~~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------PLREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--------HHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            45677899999999999999873       467999999743321        223567799999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCC
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN  284 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~N  284 (441)
                      |.+.+.+|||||||++|+|.++|..+..             ...++|..+..|+.||+.||+|||+++  ||||||||+|
T Consensus        98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~N  175 (308)
T 4gt4_A           98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRN  175 (308)
T ss_dssp             ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccc
Confidence            9999999999999999999999965432             245899999999999999999999999  9999999999


Q ss_pred             eeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchh
Q psy5927         285 ILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS  363 (441)
Q Consensus       285 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~  363 (441)
                      |||++++.+||+|||+|+....... ........||+.|||||++.++.|+.++|||||||+||||+| |..||.+....
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             eEECCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986432221 122345679999999999999999999999999999999999 89999876542


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                       ..... +           ......+.+.+++..+.+|+.+||+.||++|||+.+|++.|+...+
T Consensus       255 -~~~~~-i-----------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          255 -DVVEM-I-----------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             -HHHHH-H-----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             -HHHHH-H-----------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence             12111 1           1122334556778899999999999999999999999999998654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.4e-59  Score=451.23  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=210.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      .++|.+.++||+|+||+||+|++.       ++.||||+++...         ....+.+.+|+++|++++|||||+++|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~il~~l~HpnIV~l~g  110 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTMLQHQHIVRFFG  110 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            457788899999999999999874       4679999996421         123456789999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKN------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN  284 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~N  284 (441)
                      +|.+.+.+|||||||++|+|.++|.....            ..+++|.+++.|+.||+.||+|||+++  ||||||||+|
T Consensus       111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~N  188 (329)
T 4aoj_A          111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRN  188 (329)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGG
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhh
Confidence            99999999999999999999999976432            346999999999999999999999998  9999999999


Q ss_pred             eeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchh
Q psy5927         285 ILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS  363 (441)
Q Consensus       285 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~  363 (441)
                      |||++++.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....
T Consensus       189 ILl~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          189 CLVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             EEEETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             EEECCCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999986433221 122344679999999999999999999999999999999999 99999876542


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                       ..+..+..            ....+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       268 -~~~~~i~~------------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 -EAIDCITQ------------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -HHHHHHHH------------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -HHHHHHHc------------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence             22222111            112234556778899999999999999999999999999887543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.8e-59  Score=450.56  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=206.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|+++++||+|+||+||+|++.  ++.||||++.......       ...+.+.+|+++|++++|||||++++++.+.
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   95 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-------KEREESRREVAVLANMKHPNIVQYRESFEEN   95 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-------HHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            368999999999999999999985  6789999997543322       2355678999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|||||||+||+|.++|..++ ...+++..++.|+.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla  172 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIA  172 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccc
Confidence            99999999999999999996543 345789999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +.....   .......+||+.|||||++.+..|+.++|||||||++|||+||.+||....... .+..+..         
T Consensus       173 ~~~~~~---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~---------  239 (350)
T 4b9d_A          173 RVLNST---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIIS---------  239 (350)
T ss_dssp             SCCCHH---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH---------
T ss_pred             eeecCC---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHc---------
Confidence            864322   122345679999999999999999999999999999999999999998765422 2222211         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ....+.+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       240 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 ---GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1112334456788999999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.6e-58  Score=440.21  Aligned_cols=250  Identities=21%  Similarity=0.261  Sum_probs=208.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++++.||+|+||+||+|++.  ++.||||++......      .....+.+.+|+++|++++|||||++++++.+.
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  104 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII------KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD  104 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            367999999999999999999985  568999999743211      112345677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|||||||+||+|.+++...   +.+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            9999999999999999999654   34899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +...... ......+.+||+.|||||++.+..|+.++|||||||++|||+||.+||...... .....+...        
T Consensus       180 ~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~--------  249 (311)
T 4aw0_A          180 KVLSPES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG-LIFAKIIKL--------  249 (311)
T ss_dssp             EECCTTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHT--------
T ss_pred             eecCCCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcC--------
Confidence            8643221 222345678999999999999999999999999999999999999999876542 222222111        


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                           ....+..++.++.+|+.+||..||++|||+.|+
T Consensus       250 -----~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          250 -----EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             -----CCCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence                 112334567789999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.2e-57  Score=438.95  Aligned_cols=253  Identities=21%  Similarity=0.349  Sum_probs=210.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..|++.++||+|+||+||+|.+.  +..||||++.......         .+.+.+|+++|+.++|||||+++++|.+.+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---------GGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---------HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            56999999999999999999985  5689999997543221         234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|||||||+||+|.+++..    ..+++..+..|+.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCce
Confidence            99999999999999998854    24899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   ......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+... ...+..+....        
T Consensus       219 ~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~--------  286 (346)
T 4fih_A          219 QVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNL--------  286 (346)
T ss_dssp             ECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSS--------
T ss_pred             ecCCCC---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCC--------
Confidence            643321   223456899999999999999999999999999999999999999987654 22222222111        


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                        .........++.++.+|+.+||..||++|||+.|+++  +|.+.
T Consensus       287 --~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          287 --PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             --CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             --CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence              0111223456788999999999999999999999987  56544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-57  Score=429.56  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=199.9

Q ss_pred             cCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe----C
Q psy5927         148 DKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE----T  221 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~  221 (441)
                      +..++||+|+||+||+|.+.  +..||+|++......       ....+.+.+|+++|++++|||||+++++|.+    .
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            56678999999999999986  457999998743322       2334567899999999999999999999865    3


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~DFGl  300 (441)
                      +.+|||||||+||+|.+++...   ..+++..+..++.||+.||+|||+++++||||||||+||||+. ++.+||+|||+
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence            5689999999999999999654   3589999999999999999999998878999999999999984 79999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      |+.....     .....+||+.|||||++.+ .|+.++|||||||++|||+||.+||.+..........+....      
T Consensus       179 a~~~~~~-----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~------  246 (290)
T 3fpq_A          179 ATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------  246 (290)
T ss_dssp             GGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC------
T ss_pred             CEeCCCC-----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC------
Confidence            9753322     2345689999999999876 699999999999999999999999976544222222211110      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .....+..++.++.+|+.+||+.||++|||+.++++
T Consensus       247 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 011223334567899999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.9e-58  Score=441.19  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=207.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .+.|++.++||+|+||+||+|++.  +..||||+++....              ..+|+.+|+.++|||||++++++.++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~~~~~~  122 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYGAVREG  122 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            457888999999999999999985  56899999974321              12699999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~DFGl  300 (441)
                      +.+|||||||+||+|.++|...   +.+++..+..|+.||+.||+|||+++  ||||||||+||||+.+| .+||+|||+
T Consensus       123 ~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          123 PWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             CEEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            9999999999999999999654   35899999999999999999999999  99999999999999988 699999999


Q ss_pred             CccCCCccc--ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         301 TQEGPIEKA--THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       301 a~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+.......  .......++||+.|||||++.+..|+.++|||||||++|||+||.+||.+...... ...+....    
T Consensus       198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~----  272 (336)
T 4g3f_A          198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP----  272 (336)
T ss_dssp             CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC----
T ss_pred             CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC----
Confidence            986543221  11223456899999999999999999999999999999999999999977544222 21221110    


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                            ......+..++..+.+|+.+||+.||++|||+.|+++.|.....
T Consensus       273 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          273 ------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             ------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                  01112345677889999999999999999999999987765433

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-56  Score=422.42  Aligned_cols=247  Identities=22%  Similarity=0.362  Sum_probs=193.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++.......      ......+.+|+++|++++|||||++++++.+.+
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            68999999999999999999984  6789999997543221      123446779999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||| +|+|.+++..+   ..+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EEEEEEeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCe
Confidence            999999999 78999998654   35999999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ......    ...+.+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+... ......+..         
T Consensus       161 ~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-~~~~~~i~~---------  226 (275)
T 3hyh_A          161 IMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-PVLFKNISN---------  226 (275)
T ss_dssp             ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH---------
T ss_pred             ecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHc---------
Confidence            643221    2345689999999999998776 5799999999999999999999987543 222222211         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          .....+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       227 ----~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          227 ----GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ----TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                112233456778999999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.8e-57  Score=441.12  Aligned_cols=267  Identities=22%  Similarity=0.334  Sum_probs=218.7

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC-
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH-  208 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-  208 (441)
                      ..++++..++|++.++||+|+||+||+|.+.+       +.||||+++.....        ...+.+.+|+++|.+++| 
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--------~~~~~~~~E~~il~~l~hh  127 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------SEHRALMSELKILIHIGHH  127 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHCCC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--------HHHHHHHHHHHHHHHcCCC
Confidence            34567778899999999999999999999754       36999998743322        234567799999999965 


Q ss_pred             CCeecccceEEeC-CeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy5927         209 DNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPP  274 (441)
Q Consensus       209 pnIv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~  274 (441)
                      ||||+++|+|.+. +.+|||||||++|+|.++|.....             ...+++..+..++.||+.||+|||+++  
T Consensus       128 pnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--  205 (353)
T 4ase_A          128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--  205 (353)
T ss_dssp             TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--
Confidence            9999999999764 568999999999999999975432             345899999999999999999999999  


Q ss_pred             eeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-C
Q psy5927         275 LIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-G  353 (441)
Q Consensus       275 iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G  353 (441)
                      ||||||||+|||+++++.+||+|||+|+...... ........+||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus       206 iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G  284 (353)
T 4ase_A          206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  284 (353)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             eecCccCccceeeCCCCCEEECcchhhhhcccCC-CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence            9999999999999999999999999998654332 2223445679999999999999999999999999999999998 9


Q ss_pred             CCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         354 MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       354 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ..||.+..........+...            .....+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       285 ~~Pf~~~~~~~~~~~~i~~g------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          285 ASPYPGVKIDEEFCRRLKEG------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCSSTTCCCSHHHHHHHHHT------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcC------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            99998765433333322211            12233445677899999999999999999999999998764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.4e-56  Score=440.64  Aligned_cols=253  Identities=21%  Similarity=0.350  Sum_probs=210.0

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +.|+++++||+|+||+||+|.+.  +..||||++.......         .+.+.+|+++|+.++|||||+++++|.+.+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---------RELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---------GGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            56999999999999999999985  5789999997543221         234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|||||||+||+|.+++...    .+++..+..|+.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|+
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccce
Confidence            999999999999999988542    3899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   ......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+... ...+..+.....       
T Consensus       296 ~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~~~~-------  364 (423)
T 4fie_A          296 QVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNLP-------  364 (423)
T ss_dssp             ECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHSCC-------
T ss_pred             ECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HHHHHHHHcCCC-------
Confidence            643322   223456899999999999999999999999999999999999999987654 222222221110       


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                         ........++.++.+|+.+||..||++|||+.|+++  +|.+.
T Consensus       365 ---~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          365 ---PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ---CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ---CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence               011122346778999999999999999999999987  56553

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.2e-57  Score=430.96  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=199.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ++|++++.||+|+||+||+|++.     +..||||+++.......       ....+.+|+++|++++|||||++++++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-------DRVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-------ECC------CCCCCCCCTTEECEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-------HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            57999999999999999999872     45799999875432211       1124568999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+|||||+||+|.+++...   ..+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccc
Confidence            999999999999999999999654   35899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +|+......   ....+.+||+.|||||++.+..|+.++|||||||++|||+||.+||.+....+ .+..+..       
T Consensus       172 la~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~-------  240 (304)
T 3ubd_A          172 LSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILK-------  240 (304)
T ss_dssp             EEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-------
T ss_pred             cceeccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHc-------
Confidence            997643221   22345689999999999999999999999999999999999999998765422 2222211       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                            .....+..++.++.+|+.+||+.||++|||     ++|+++
T Consensus       241 ------~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          241 ------AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                  112234456788999999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-55  Score=421.30  Aligned_cols=257  Identities=23%  Similarity=0.402  Sum_probs=196.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++++.||+|+||+||+|++.  +..||||+++.....        ...+.+.+|+++|++++|||||++++++.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   76 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--------LAREKVMREVKALAKLEHPGIVRYFNAWLEKN   76 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH--------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence            56999999999999999999985  678999999754321        23456779999999999999999999987654


Q ss_pred             ------------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         223 ------------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       223 ------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                                  .+|+|||||+||+|.+++..+......++..++.|+.||+.||+|||+++  ||||||||+|||++.+
T Consensus        77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~  154 (299)
T 4g31_A           77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD  154 (299)
T ss_dssp             ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred             ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC
Confidence                        37999999999999999976655556677888999999999999999999  9999999999999999


Q ss_pred             CCeEEeccCCCccCCCcccc---------cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcc
Q psy5927         291 MDPVIGDFGLTQEGPIEKAT---------HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTR  361 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~  361 (441)
                      +.+||+|||+|+........         .......+||+.|||||++.+..|+.++|||||||++|||++   ||....
T Consensus       155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~  231 (299)
T 4g31_A          155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM  231 (299)
T ss_dssp             CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence            99999999999864332211         112344679999999999999999999999999999999996   776533


Q ss_pred             hhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         362 RSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       362 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      .....+...            ......+.....+..+.+|+.+||+.||++|||+.++++  .++++
T Consensus       232 ~~~~~~~~~------------~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          232 ERVRTLTDV------------RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHHH------------HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHHHH------------hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            211111111            111222334455566789999999999999999999987  45443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-55  Score=423.90  Aligned_cols=266  Identities=23%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             CCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC--
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG--  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  222 (441)
                      ++|.+.++||+|+||+||+|.++++.||||+++....          .......|+..+.+++|||||+++++|.+.+  
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~----------~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE----------RSWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH----------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch----------hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence            4577889999999999999999999999999863211          1111225777778899999999999998754  


Q ss_pred             --eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeeecCCCCCCeeecCCCCeE
Q psy5927         223 --KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR------EPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       223 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                        .+|||||||++|+|.++|...    +++|..+..++.|++.||+|||++      .++||||||||+||||+.++.+|
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence              589999999999999999643    489999999999999999999986      22499999999999999999999


Q ss_pred             EeccCCCccCCCccc-ccceeccccccCCCcCcccccCC------CCCCccceehHHHHHHHHHhCCCCCCCcchhH---
Q psy5927         295 IGDFGLTQEGPIEKA-THITLKRVNGTRPYLPHEFLVGK------RLSTKVDVYGFGIVLFELATGMRAYDDTRRSE---  364 (441)
Q Consensus       295 l~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~---  364 (441)
                      |+|||+|+....... ........+||+.|||||++.+.      .++.++|||||||+||||+||.+||.......   
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            999999975432221 11223346799999999999764      46789999999999999999988774322110   


Q ss_pred             -------HHHHHHHHhhchhhhhhhhccCCC--chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         365 -------RHLKSLVEKYSEENMYDLVDKNAQ--PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       365 -------~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                             .....+......    ...++...  .....++..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                   001111111100    01111111  1123567789999999999999999999999999987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-52  Score=412.19  Aligned_cols=270  Identities=19%  Similarity=0.300  Sum_probs=207.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      .++|++++.||+|+||+||+|.+.  +..||||+++.....       ....+.+.+|+++|+.++|||||++++++.. 
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  125 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-------VTNAKRTLRELKILKHFKHDNIIAIKDILRPT  125 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-------hHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence            368999999999999999999985  678999999643321       1234567799999999999999999998753 


Q ss_pred             -----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         221 -----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       221 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                           .+.+|||||||+ |+|.+++..   ...+++..+..++.||+.||+|||++|  ||||||||+|||++.++.+||
T Consensus       126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki  199 (398)
T 4b99_A          126 VPYGEFKSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKI  199 (398)
T ss_dssp             SCTTTCCCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEE
T ss_pred             cccccCCEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEE
Confidence                 367999999995 789998854   346999999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcc-cccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         296 GDFGLTQEGPIEK-ATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       296 ~DFGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      +|||+|+...... .........+||+.|||||++.+. .++.++||||+||++|||++|.+||.+.... ..+..+...
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~  278 (398)
T 4b99_A          200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMV  278 (398)
T ss_dssp             CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHH
T ss_pred             eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh
Confidence            9999998643322 122234567899999999998875 5699999999999999999999999876652 333333322


Q ss_pred             hchh--h---------hhhhh----ccCCCch---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         374 YSEE--N---------MYDLV----DKNAQPI---ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       374 ~~~~--~---------~~~~~----~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                      ....  .         ....+    .....++   ...++.++.+|+.+||..||++|||+.|+++  .|.+..
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            2100  0         00000    0011111   1234678899999999999999999999987  565543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.4e-52  Score=408.25  Aligned_cols=261  Identities=19%  Similarity=0.248  Sum_probs=200.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  215 (441)
                      ...++|++.++||+|+||+||+|+++     +..||||++.....           ..++.+|+++|+.+ +|||||+++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~E~~~l~~~~~h~nIv~l~   86 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----------PIRIAAELQCLTVAGGQDNVMGVK   86 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----------HHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----------HHHHHHHHHHHHHhcCCCCCceEE
Confidence            45678999999999999999999863     45799998864321           22456899999988 699999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCeE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPV  294 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~k  294 (441)
                      +++.+.+++|+|||||+||+|.+++.      .+++.++..++.|++.||+|||++|  ||||||||+|||++.+ +.+|
T Consensus        87 ~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           87 YCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEE
Confidence            99999999999999999999999882      3889999999999999999999999  9999999999999877 7999


Q ss_pred             EeccCCCccCCCccc-------------------------ccceeccccccCCCcCcccccCC-CCCCccceehHHHHHH
Q psy5927         295 IGDFGLTQEGPIEKA-------------------------THITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLF  348 (441)
Q Consensus       295 l~DFGla~~~~~~~~-------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~  348 (441)
                      |+|||+|+.......                         ........+||+.|||||++.+. .|+.++||||+||++|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            999999975432211                         01123446799999999999875 5899999999999999


Q ss_pred             HHHhCCCCCCCcchhHHHHHHHHHhhchhhh----------------------hhh---h---ccC-------------C
Q psy5927         349 ELATGMRAYDDTRRSERHLKSLVEKYSEENM----------------------YDL---V---DKN-------------A  387 (441)
Q Consensus       349 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~----------------------~~~---~---~~~-------------~  387 (441)
                      ||+||+.||.........+..+.........                      ...   +   +..             .
T Consensus       239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  318 (361)
T 4f9c_A          239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN  318 (361)
T ss_dssp             HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred             HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence            9999999997655444444433322110000                      000   0   000             0


Q ss_pred             CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         388 QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       388 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ......++.++.+|+.+||..||++|||++|+++
T Consensus       319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0011234567899999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.4e-51  Score=425.24  Aligned_cols=255  Identities=21%  Similarity=0.269  Sum_probs=203.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|+++++||+|+||+||+|++.  +..||||++.........   ..........++.+++.++|||||+++++|.+
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~---~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT---CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh---hHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            4578999999999999999999985  568999999743221110   11112222345778888999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+.+|||||||+||+|.++|...   +.+++..+..++.||+.||+|||++|  ||||||||+||||+.+|++||+|||+
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccce
Confidence            99999999999999999999654   34899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      |+.....     ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.......  .+...      
T Consensus       339 A~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~------  405 (689)
T 3v5w_A          339 ACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM------  405 (689)
T ss_dssp             CEECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHH------
T ss_pred             eeecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHh------
Confidence            9864332     2345689999999999964 57999999999999999999999999764332111  11111      


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                         +.......+..++.++.+|+.+||..||.+|++     +.+|++
T Consensus       406 ---i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          406 ---TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---HHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               111122344557788999999999999999998     678764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-50  Score=416.97  Aligned_cols=256  Identities=19%  Similarity=0.303  Sum_probs=210.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||+|++.....         ...+.+.+|+++|+.++|||||+++++|.+.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---------SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---------hhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            468999999999999999999985  56899999875321         2234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC--CCeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH--MDPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~--~~~kl~DFG  299 (441)
                      +.+|||||||+||+|.++|..+  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.+  +.+||+|||
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             CEEEEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeecc
Confidence            9999999999999999988533  345899999999999999999999999  9999999999999854  899999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +|+......    .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+..... .+..+.....    
T Consensus       303 ~a~~~~~~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-~~~~i~~~~~----  373 (573)
T 3uto_A          303 LTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDW----  373 (573)
T ss_dssp             SCEECCTTS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCC----
T ss_pred             ceeEccCCC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHhCCC----
Confidence            998754322    2345689999999999999999999999999999999999999998765422 2222211100    


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                           .........++.++.+|+.+||..||.+||++.|+++  +|+..
T Consensus       374 -----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          374 -----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             -----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence                 0011223456778999999999999999999999987  45543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8e-50  Score=385.32  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=212.5

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+..++|++.+.||+|+||+||+|.++++.||||++.......       ...+.+.+|++++++++||||+++++++.+
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA-------ERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            4556789999999999999999999999999999987543221       234567799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++|+|.+++........+++..++.++.|++.||+|||+.+++|+||||||+|||++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            99999999999999999999654433448899999999999999999999887799999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++......   .......||+.|+|||.+.+..++.++|||||||++|||++|..||....... .......        
T Consensus       186 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~--------  253 (309)
T 3p86_A          186 SRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-VVAAVGF--------  253 (309)
T ss_dssp             -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-HHHHHHH--------
T ss_pred             Cccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh--------
Confidence            97532221   12234569999999999999999999999999999999999999998765422 1111110        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                         .......+..++..+.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus       254 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          254 ---KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ---SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ---cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence               111223445567789999999999999999999999999988776543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.5e-48  Score=370.09  Aligned_cols=286  Identities=37%  Similarity=0.629  Sum_probs=234.3

Q ss_pred             CCCChhHHHHhhCCCcCc------CccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC
Q psy5927         133 PHIPYQELTLATNNWDKL------NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC  206 (441)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~------~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  206 (441)
                      ..+++.++...+++|...      +.||+|+||.||+|.++++.||||++........     ....+.+.+|+++++.+
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l   87 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-----EELKQQFDQEIKVMAKC   87 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT-----TTHHHHHHHHHHHHHHC
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcch-----HHHHHHHHHHHHHHHhc
Confidence            457888888999998877      8999999999999999999999999875322111     12344667999999999


Q ss_pred             CCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCee
Q psy5927         207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL  286 (441)
Q Consensus       207 ~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiL  286 (441)
                      +||||+++++++.+.+..++||||+++|+|.+++.......++++..++.++.|++.||+|||+.+  |+||||||+|||
T Consensus        88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil  165 (307)
T 2nru_A           88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANIL  165 (307)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEE
T ss_pred             CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEE
Confidence            999999999999999999999999999999999977666677999999999999999999999999  999999999999


Q ss_pred             ecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHH
Q psy5927         287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH  366 (441)
Q Consensus       287 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~  366 (441)
                      ++.++.+||+|||+++....... ........||+.|+|||.+.+ .++.++||||||+++|+|++|..||....... .
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-L  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-B
T ss_pred             EcCCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH-H
Confidence            99999999999999876433221 122334569999999999876 58999999999999999999999998755422 1


Q ss_pred             HHHHHHhh--chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         367 LKSLVEKY--SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       367 l~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      +..+....  ....+...++......+...+..+.+++.+||+.||.+||++.+|++.|+++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            11221111  122344556666666677889999999999999999999999999999987653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.2e-48  Score=375.53  Aligned_cols=291  Identities=35%  Similarity=0.576  Sum_probs=229.7

Q ss_pred             CCCCCChhHHHHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC
Q psy5927         131 GTPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD  209 (441)
Q Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  209 (441)
                      ....+++.++...+++|++.+.||+|+||.||+|.+. ++.||||++.......        ....+.+|+++++.++||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~   87 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--------GELQFQTEVEMISMAVHR   87 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------------CCCHHHHHHHGGGTCCCT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--------HHHHHHHHHHHHHhccCC
Confidence            3446788999999999999999999999999999874 6789999987533211        112456899999999999


Q ss_pred             CeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCeeecCCCCCCe
Q psy5927         210 NILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQFLHSR---EPPLIHGDIKSANI  285 (441)
Q Consensus       210 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~---~~~iiHrDikp~Ni  285 (441)
                      ||+++++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +  |+||||||+||
T Consensus        88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Ni  165 (326)
T 3uim_A           88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANI  165 (326)
T ss_dssp             TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGE
T ss_pred             CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhE
Confidence            999999999999999999999999999999976543 44599999999999999999999998   8  99999999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch---
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR---  362 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~---  362 (441)
                      |++.++.+||+|||+++......  ........||+.|+|||.+.+..++.++|||||||++|||+||..||.....   
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (326)
T 3uim_A          166 LLDEEFEAVVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND  243 (326)
T ss_dssp             EECTTCCEEECCCSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred             EECCCCCEEeccCccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence            99999999999999997643322  1223445699999999999888899999999999999999999999963221   


Q ss_pred             hHHHHHHHHHhh-chhhhhhhhccC-CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q psy5927         363 SERHLKSLVEKY-SEENMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNA  433 (441)
Q Consensus       363 ~~~~l~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~  433 (441)
                      ............ .........+.. ....+...+..+.+++.+||+.||.+|||+.+|++.|++.....+-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~  316 (326)
T 3uim_A          244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE  316 (326)
T ss_dssp             SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred             cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence            011122222111 112222222222 23445678889999999999999999999999999999765554433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.9e-48  Score=373.67  Aligned_cols=250  Identities=22%  Similarity=0.398  Sum_probs=207.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+  .++.||||++......       ....+.+.+|+++++.++||||+++++++.
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3457899999999999999999998  4678999999754322       223456779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+||||+++|+|.+++....   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCEEEEEEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999999999999986543   4889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCC-CccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLS-TKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++......    .....+||+.|+|||.+.+..++ .++|||||||++|||++|..||.+..... ....+..      
T Consensus       160 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~------  228 (328)
T 3fe3_A          160 FSNEFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-LRERVLR------  228 (328)
T ss_dssp             CCGGGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH------
T ss_pred             CceecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh------
Confidence            997543221    23456799999999999987765 79999999999999999999998765421 1111111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             .....+..++.++.+|+.+||..||.+|||+.++++
T Consensus       229 -------~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          229 -------GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   111233345678899999999999999999999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=375.11  Aligned_cols=265  Identities=22%  Similarity=0.337  Sum_probs=213.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||.||+|.+.     +..||||+++.....        ...+.+.+|+++++.++||||+++++
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~  117 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--------RQRRDFLSEASIMGQFDHPNIIRLEG  117 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--------HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            44578999999999999999999984     345999999743221        23456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.+..|+||||+++|+|.+++...  ...+++..+..++.+++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~  193 (325)
T 3kul_A          118 VVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVS  193 (325)
T ss_dssp             EECGGGCCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeCCccEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEEC
Confidence            999999999999999999999998543  345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++................+|..|+|||++.+..++.++|||||||++|||++ |..||...... .....+.    
T Consensus       194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~----  268 (325)
T 3kul_A          194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-DVISSVE----  268 (325)
T ss_dssp             CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHH----
T ss_pred             CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH----
Confidence            99999865443322223333456788999999998899999999999999999999 99999776542 1221111    


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                              .....+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus       269 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          269 --------EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             --------cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                    111223344567789999999999999999999999999988765443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-47  Score=370.48  Aligned_cols=281  Identities=35%  Similarity=0.546  Sum_probs=221.4

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      +++.++...+++|++.+.||+|+||.||+|.+. +..||||++......         ..+.+.+|+++++.++||||++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~   99 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---------GIEEFETEIETLSFCRHPHLVS   99 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---------HHHHHHHHHHGGGSCCCTTBCC
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---------HHHHHHHHHHHHHhCCCCCEee
Confidence            344455667899999999999999999999975 678999988643221         2345678999999999999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      +++++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCC
T ss_pred             EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCC
Confidence            99999999999999999999999998854332 235899999999999999999999999  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH--HHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSL  370 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--~~l~~~  370 (441)
                      +||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......  ......
T Consensus       178 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~  256 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA  256 (321)
T ss_dssp             EEECCCTTCEECSSSSCC-CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred             EEEeeccccccccccccc-ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence            999999999754322211 11234468999999999988899999999999999999999999997543211  111111


Q ss_pred             HHhhchhhhhhhhccC-CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         371 VEKYSEENMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ............++.. .......++..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1111122222333332 22346778899999999999999999999999999998653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.5e-47  Score=362.04  Aligned_cols=249  Identities=21%  Similarity=0.342  Sum_probs=206.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+  .+..||||++......         ..+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---------HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            46899999999999999999987  4678999998744322         123456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+||||+++|+|.+++...    .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999988643    4889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........   ......||+.|+|||.+.+..++.++|||||||++|||+||..||........ ........       
T Consensus       164 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~-------  232 (297)
T 3fxz_A          164 AQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNG-------  232 (297)
T ss_dssp             EECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHC-------
T ss_pred             eecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC-------
Confidence            76433221   23345799999999999999999999999999999999999999977654222 11111110       


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ......+..++..+.+|+.+||+.||.+||++.++++
T Consensus       233 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 ---TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               1111224456778999999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5e-47  Score=369.95  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=207.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||+||+|.+.  +..||+|+++.....      .......+.+|+++++.++||||+++++++.+
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            3478999999999999999999985  578999999742110      11234566789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999886543   4889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++......   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..        
T Consensus       152 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~--------  219 (337)
T 1o6l_A          152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILM--------  219 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH--------
T ss_pred             hhhcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-HHHHHHHc--------
Confidence            97532221   1234567999999999999999999999999999999999999999765432 12211111        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                           .....+..++.++.+|+.+||+.||++||     ++.+|++
T Consensus       220 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          220 -----EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 11123345677899999999999999999     8999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.3e-47  Score=376.19  Aligned_cols=262  Identities=21%  Similarity=0.335  Sum_probs=212.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      ...++|++.+.||+|+||.||+|.+.         +..||||+++....        ....+.+.+|+++++.+ +||||
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~hpnI  149 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--------EKDLSDLVSEMEMMKMIGKHKNI  149 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--------HHHHHHHHHHHHHHHHSCCCTTB
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--------HHHHHHHHHHHHHHHHhcCCCCE
Confidence            44578999999999999999999873         23599999874322        12345677999999999 89999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                      +++++++.+.+.+|+||||+++|+|.+++.....             ...+++..+..++.||+.||+|||+++  |+||
T Consensus       150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHr  227 (370)
T 2psq_A          150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHR  227 (370)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence            9999999999999999999999999999976542             235889999999999999999999999  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY  357 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~  357 (441)
                      ||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||
T Consensus       228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          228 DLAARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             CCCGGGEEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccchhhEEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999754322111 11223457889999999999899999999999999999999 99999


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ....... ....+.            .......+..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       307 ~~~~~~~-~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          307 PGIPVEE-LFKLLK------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             TTCCGGG-HHHHHH------------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHH-HHHHHh------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            8764321 111111            11122334456778999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.1e-47  Score=361.61  Aligned_cols=271  Identities=20%  Similarity=0.324  Sum_probs=213.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++.......      ....+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   81 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK------EETLKRFEREVHNSSQLSHQNIVSMIDVDE   81 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC------HHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc------HHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence            34578999999999999999999984  5689999986543222      123456779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+||||++|++|.+++...   .++++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999999998654   35899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +++......  ........||+.|+|||.+.+..++.++||||||+++|||+||..||..............    .. .
T Consensus       157 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----~~-~  229 (294)
T 4eqm_A          157 IAKALSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ----DS-V  229 (294)
T ss_dssp             SSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS----SC-C
T ss_pred             Ccccccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh----cc-C
Confidence            997643221  1223345699999999999999999999999999999999999999987654322221111    00 0


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCCCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-EMTQVYNMLSGSGGESPNAT  434 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~~~~~~~  434 (441)
                      ...    .......++..+.+++.+||+.||.+|| +++++.+.|+.+..+.....
T Consensus       230 ~~~----~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~  281 (294)
T 4eqm_A          230 PNV----TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE  281 (294)
T ss_dssp             CCH----HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred             CCc----chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence            000    0112234567899999999999999999 89999999998876655443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=365.19  Aligned_cols=263  Identities=25%  Similarity=0.415  Sum_probs=209.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|.+.++||+|+||+||+|.+.  +..||+|++....         ....+.+.+|+++++.++||||+++++++.
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   77 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---------EETQRTFLKEVKVMRCLEHPNVLKFIGVLY   77 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence            34578999999999999999999985  5679999885321         123456779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +++..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg  153 (310)
T 3s95_A           78 KDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFG  153 (310)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCT
T ss_pred             cCCeeEEEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecc
Confidence            999999999999999999998653  345899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCccccc-----------ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHH
Q psy5927         300 LTQEGPIEKATH-----------ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK  368 (441)
Q Consensus       300 la~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~  368 (441)
                      +++.........           .......||+.|+|||++.+..++.++||||||+++|||++|..||...........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~  233 (310)
T 3s95_A          154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG  233 (310)
T ss_dssp             TCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS
T ss_pred             cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh
Confidence            997643322111           111245799999999999999999999999999999999999999865432111000


Q ss_pred             HHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         369 SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      .        ......+.   ..+..++..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       234 ~--------~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          234 L--------NVRGFLDR---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             B--------CHHHHHHH---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             h--------hhhccccc---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0        00000000   0123345678999999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-47  Score=372.15  Aligned_cols=252  Identities=22%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      +..++|++.+.||+|+||+||+|.+.  +..||||+++.....      .....+...+|..++..+ +||||+++++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~   93 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL------QDDDVECTMTEKRILSLARNHPFLTQLFCCF   93 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH------HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc------chhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence            55689999999999999999999985  568999999743211      123345667899999988 699999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+|+|||||+||+|.+++....   .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccc
Confidence            99999999999999999999986543   4889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++.....   .......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+..      
T Consensus       169 G~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~------  238 (353)
T 3txo_A          169 GMCKEGICN---GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILN------  238 (353)
T ss_dssp             TTCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH------
T ss_pred             cceeecccC---CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHc------
Confidence            999753322   122345679999999999999889999999999999999999999998765422 2222211      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM------TQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~  421 (441)
                             .....+..++..+.+|+.+||+.||.+||++      .++++
T Consensus       239 -------~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          239 -------DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   1122334466789999999999999999998      77764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-47  Score=374.89  Aligned_cols=269  Identities=22%  Similarity=0.329  Sum_probs=216.1

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-  206 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  206 (441)
                      +....+.+..++|++.+.||+|+||.||+|.+.       ++.||||+++.....        ...+.+.+|++++.++ 
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~   83 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------SEHRALMSELKILIHIG   83 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--------HHHHHHHHHHHHHHhhc
Confidence            445667788899999999999999999999853       257999999743221        2345677999999999 


Q ss_pred             CCCCeecccceEEeCCe-EEEEEEecCCCCHHHHHhhcCC----------------------------------------
Q psy5927         207 RHDNILPLYGICFETGK-YCLVYRYMPNGSLEDRLLMKKN----------------------------------------  245 (441)
Q Consensus       207 ~hpnIv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------  245 (441)
                      +||||+++++++.+.+. +++||||+++|+|.+++.....                                        
T Consensus        84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (359)
T 3vhe_A           84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA  163 (359)
T ss_dssp             CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred             CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence            79999999999887654 8999999999999999976432                                        


Q ss_pred             -----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         246 -----------------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       246 -----------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                                             ...+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~  241 (359)
T 3vhe_A          164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR  241 (359)
T ss_dssp             --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEecccee
Confidence                                   122889999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ....... ........||+.|+|||++.+..++.++|||||||++|||+| |..||............+...        
T Consensus       242 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------  312 (359)
T 3vhe_A          242 DIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--------  312 (359)
T ss_dssp             CTTSCTT-CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--------
T ss_pred             eeccccc-chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--------
Confidence            6433221 122334568999999999998899999999999999999998 999998765433332222211        


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                          .....+..++.++.+++.+||+.||.+||++.+|++.|+.+
T Consensus       313 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          313 ----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                11222334567899999999999999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-47  Score=368.38  Aligned_cols=271  Identities=25%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+..++|++.++||+|+||+||+|.+.+..||||++.....          .......|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK----------QSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH----------HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch----------HHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            45668899999999999999999999999999999864321          12233468999999999999999999987


Q ss_pred             CC----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCeeecCCCCCCee
Q psy5927         221 TG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR----------EPPLIHGDIKSANIL  286 (441)
Q Consensus       221 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~----------~~~iiHrDikp~NiL  286 (441)
                      ..    .+++||||+++|+|.+++...    .+++..+..++.|++.||+|||+.          +  |+||||||+|||
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nil  163 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVL  163 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEE
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEE
Confidence            54    479999999999999998643    389999999999999999999998          8  999999999999


Q ss_pred             ecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcc
Q psy5927         287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTR  361 (441)
Q Consensus       287 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~  361 (441)
                      ++.++.+||+|||+++....... ........||+.|+|||++.+     ..++.++|||||||++|||+||..||....
T Consensus       164 l~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          164 LKNNLTACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             ECTTCCEEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             ECCCCeEEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            99999999999999975432221 112334569999999999987     356778999999999999999999997643


Q ss_pred             hhHHH-HHHHHH-hhchhhhhhhh-c----cCCCc--hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         362 RSERH-LKSLVE-KYSEENMYDLV-D----KNAQP--IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       362 ~~~~~-l~~~~~-~~~~~~~~~~~-~----~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ..... ...... ......+.... .    +....  .....+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            21100 000000 00000011100 0    00111  123466779999999999999999999999999987653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.2e-47  Score=375.92  Aligned_cols=261  Identities=20%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      +..++|++.++||+|+||+||+|++.  +..||+|+++.......      ...+.+.+|..++.++ +||||+++++++
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~------~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD------EDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH------HHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            44578999999999999999999985  46799999975432211      1233456888888876 899999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeec
Confidence            99999999999999999999886543   4899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...........     .....
T Consensus       198 Gla~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-----~~~~~  269 (396)
T 4dc2_A          198 GMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----NTEDY  269 (396)
T ss_dssp             TTCBCCCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------CCHHH
T ss_pred             ceeeecccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----hhHHH
Confidence            9998532221   223456899999999999999999999999999999999999999964322110000     00011


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM------TQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~  421 (441)
                      +...+.......+..++.++.+|+.+||+.||.+||++      .+|++
T Consensus       270 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          270 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             HHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            11111222233455577889999999999999999985      56654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3e-47  Score=376.81  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||.||+|.+.     +..||||+++....        ....+.+.+|++++++++||||+++++
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~  113 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--------EKQRRDFLGEASIMGQFDHPNIIRLEG  113 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--------HHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            44578999999999999999999874     45699999875322        123456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~  189 (373)
T 2qol_A          114 VVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVS  189 (373)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEeeCCceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEEC
Confidence            999999999999999999999998643  345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++................+|..|+|||++.+..++.++|||||||++|||++ |..||..... ......+...  
T Consensus       190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~~~~~~i~~~--  266 (373)
T 2qol_A          190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG--  266 (373)
T ss_dssp             CC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-HHHHHHHHTT--
T ss_pred             cCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC--
Confidence            99999865433222222222345778999999998899999999999999999998 9999977654 2222111110  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                                ...+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       267 ----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          267 ----------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ----------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                      0112233456789999999999999999999999999977643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.7e-47  Score=355.47  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=212.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +..++|++.+.||+|+||.||+|.++++.+|||+++......       ...+.+.+|+.++++++||||+++++++.+.
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   79 (271)
T 3kmu_A            7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST-------RKSRDFNEECPRLRIFSHPNVLPVLGACQSP   79 (271)
T ss_dssp             CCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCH-------HHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred             CCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCH-------HHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence            345689999999999999999999999999999997643222       2345677999999999999999999999877


Q ss_pred             --CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         222 --GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       222 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                        +..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+.+|+||||||+|||++.++.++|+|||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           80 PAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             TSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             CCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence              78899999999999999996533 335899999999999999999999988789999999999999999999999998


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCC---ccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLST---KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ++.....        ....||+.|+|||.+.+..++.   ++||||||+++|||++|..||........ ......    
T Consensus       159 ~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----  225 (271)
T 3kmu_A          159 VKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVAL----  225 (271)
T ss_dssp             SCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHH----
T ss_pred             ceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHh----
Confidence            8754211        2235899999999998765554   79999999999999999999987654222 111111    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                             .......+..++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       226 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 -------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                   111223344567789999999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-47  Score=369.45  Aligned_cols=269  Identities=24%  Similarity=0.403  Sum_probs=216.3

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      .+....++|++.+.||+|+||.||+|.+.+       ..||||+++.....        ...+.+.+|+++++.++||||
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hp~i  112 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--------DMQADFQREAALMAEFDNPNI  112 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--------HHHHHHHHHHHHHHTCCCTTB
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--------HHHHHHHHHHHHHHhCCCCCE
Confidence            345667899999999999999999999864       67999998743221        234566799999999999999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHc
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN---------------------TPSLLWTQRLHIAKGTSLGLQFLHS  270 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~al~~LH~  270 (441)
                      +++++++.+.+..|+||||+++|+|.+++.....                     ...+++..++.++.|++.||+|||+
T Consensus       113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  192 (343)
T 1luf_A          113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE  192 (343)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999976432                     2568999999999999999999999


Q ss_pred             CCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHH
Q psy5927         271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL  350 (441)
Q Consensus       271 ~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~el  350 (441)
                      ++  |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||
T Consensus       193 ~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el  269 (343)
T 1luf_A          193 RK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  269 (343)
T ss_dssp             TT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             CC--eecCCCCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence            99  99999999999999999999999999875322211 1112334578999999999988899999999999999999


Q ss_pred             Hh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         351 AT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       351 lt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      +| |..||....... ....+            .+......+..++..+.+|+.+||+.||.+||++.+|++.|+++...
T Consensus       270 ~t~g~~p~~~~~~~~-~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          270 FSYGLQPYYGMAHEE-VIYYV------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HTTTCCTTTTSCHHH-HHHHH------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             HhcCCCcCCCCChHH-HHHHH------------hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            99 999998765421 11111            11112223445677899999999999999999999999999998776


Q ss_pred             CC
Q psy5927         430 SP  431 (441)
Q Consensus       430 ~~  431 (441)
                      ..
T Consensus       337 ~~  338 (343)
T 1luf_A          337 AE  338 (343)
T ss_dssp             --
T ss_pred             hh
Confidence            54

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=362.96  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=205.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..++|++.+.||+|+||.||+|.+.++.||||++...           ...+.+.+|++++++++||||+++++++.  +
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~   72 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----------SERKAFIVELRQLSRVNHPNIVKLYGACL--N   72 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred             CHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence            3467899999999999999999999999999998632           12345678999999999999999999876  4


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCeeecCCCCCCeeecCCCC-eEEecc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS---REPPLIHGDIKSANILLNHHMD-PVIGDF  298 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~---~~~~iiHrDikp~NiLl~~~~~-~kl~DF  298 (441)
                      ..|+||||+++|+|.+++......+.+++..+..++.|++.||+|||+   ++  |+||||||+|||++.++. +||+||
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccc
Confidence            578999999999999999766555568889999999999999999999   66  999999999999998887 799999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |++......      .....||+.|+|||.+.+..++.++||||||+++|||+||..||...............      
T Consensus       151 g~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------  218 (307)
T 2eva_A          151 GTACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH------  218 (307)
T ss_dssp             CC------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH------
T ss_pred             ccccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh------
Confidence            998753221      22345899999999999989999999999999999999999999765432211111111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNA  433 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~  433 (441)
                           ..........++..+.+|+.+||+.||.+||++.++++.|+.+....+..
T Consensus       219 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          219 -----NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             -----TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             -----cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence                 11122233456678999999999999999999999999998876555443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-46  Score=361.42  Aligned_cols=254  Identities=19%  Similarity=0.252  Sum_probs=207.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|.+.....          ....+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----------DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----------HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----------cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            478999999999999999999985  56799999874321          223456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC--CCCeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~--~~~~kl~DFG  299 (441)
                      +.+++|||||+||+|.+++...  ...+++..+..++.|++.||+|||++|  |+||||||+|||++.  ++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            9999999999999999988532  345899999999999999999999999  999999999999987  7899999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +++......    ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+......   
T Consensus       150 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~---  221 (321)
T 1tki_A          150 QARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYT---  221 (321)
T ss_dssp             TCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC---
T ss_pred             CCeECCCCC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHHcCCCC---
Confidence            997653322    23345699999999999998899999999999999999999999987654 2222222211100   


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                            ........++.++.+|+.+||..||.+|||+.++++  .+..
T Consensus       222 ------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          222 ------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence                  000112245678999999999999999999999987  4444

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-46  Score=368.05  Aligned_cols=257  Identities=20%  Similarity=0.253  Sum_probs=207.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|+++.........   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc---hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            3578999999999999999999985  5689999998654322100   0123456799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC----CeEEe
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM----DPVIG  296 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~----~~kl~  296 (441)
                      .+.+++||||++||+|.+++..   ...+++..+..++.||+.||+|||+.|  |+||||||+|||++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEE
Confidence            9999999999999999999854   345899999999999999999999999  99999999999998877    79999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......    .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... .+..+.... .
T Consensus       162 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~-~  235 (361)
T 2yab_A          162 DFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAVS-Y  235 (361)
T ss_dssp             CCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTC-C
T ss_pred             ecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcC-C
Confidence            999997643321    2344579999999999999899999999999999999999999998765422 222211100 0


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              .........++..+.+|+.+||..||.+||++.++++
T Consensus       236 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 --------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             --------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    0001112345678899999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-46  Score=358.72  Aligned_cols=267  Identities=27%  Similarity=0.435  Sum_probs=203.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ++..++|++.++||+|+||+||+|.+.+ .+|||+++......       ...+.+.+|+++++.++||||+++++++ .
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-------QQLQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCH-------HHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            4566889999999999999999998765 59999997654322       2345677999999999999999999965 5


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      ....++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~  166 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGL  166 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred             CCccEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEcccee
Confidence            56789999999999999988543  345899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ++...... .........||+.|+|||.+.   +..++.++||||||+++|||++|..||.................   
T Consensus       167 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---  242 (289)
T 3og7_A          167 ATEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS---  242 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS---
T ss_pred             cccccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc---
Confidence            97543211 112234456999999999986   56788899999999999999999999987654332222221111   


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                           ...........++..+.+|+.+||+.||.+||++.++++.|+.+..+
T Consensus       243 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          243 -----LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             -----CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             -----cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence                 11111223345677899999999999999999999999999988653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.3e-47  Score=356.17  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=200.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ..++|++.+.||+|+||.||+|.+.++.+|||+++.......     ....+.+.+|+++++.++||||+++++++.+.+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI-----SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP   79 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-
T ss_pred             chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH-----HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            457899999999999999999999999999999875432211     122345678999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeeecCCCCCCeeecC--------CCCe
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREP-PLIHGDIKSANILLNH--------HMDP  293 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~iiHrDikp~NiLl~~--------~~~~  293 (441)
                      ..++||||+++++|.+++.    ...+++..+..++.|++.||+|||+++. +|+||||||+|||++.        ++.+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             ceEEEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999999884    2358999999999999999999999873 3889999999999986        7789


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++......     .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.......... ...  
T Consensus       156 kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~--  227 (271)
T 3dtc_A          156 KITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-GVA--  227 (271)
T ss_dssp             EECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-HHH--
T ss_pred             EEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-hhh--
Confidence            999999997543221     123468999999999998889999999999999999999999998765422111 110  


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                               ......+.+..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 ---------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                     01112233445667899999999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.3e-47  Score=362.60  Aligned_cols=273  Identities=25%  Similarity=0.366  Sum_probs=209.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      +..++|++.+.||+|+||+||+|.+      .+..||||++....         ....+.+.+|++++++++||||++++
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~   77 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------EEHLRDFEREIEILKSLQHDNIVKYK   77 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4557899999999999999999985      45689999987432         12344667999999999999999999


Q ss_pred             ceEEe--CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         216 GICFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       216 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      +++..  ...+++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+
T Consensus        78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRV  153 (295)
T ss_dssp             EEECHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEE
T ss_pred             EEEecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeE
Confidence            99864  356899999999999999996543  34889999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++................+|..|+|||.+.+..++.++||||||+++|||+||..||.......   ......
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~  230 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGN  230 (295)
T ss_dssp             EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCT
T ss_pred             EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcC
Confidence            99999999865433222222333457788999999999899999999999999999999999987643211   111000


Q ss_pred             hch------hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         374 YSE------ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       374 ~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      ...      ............+.+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            000      001111222233445567788999999999999999999999999998875543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-46  Score=353.65  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=211.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.+.||+|+||.||+|.+.+ ..||+|+++.....          .+.+.+|++++.+++||||+++++++.+
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----------EDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            456789999999999999999999865 47999999754321          2345689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             CCceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCcc
Confidence            999999999999999999986543  34889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +........  .......+|..|+|||.+.+..++.++||||||+++|||+| |..||....... .......       
T Consensus       151 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~-------  220 (268)
T 3sxs_A          151 TRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-VVLKVSQ-------  220 (268)
T ss_dssp             EEECCTTCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT-------
T ss_pred             ceecchhhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-HHHHHHc-------
Confidence            976433321  11223346778999999998889999999999999999999 999998765422 1111110       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                           ......+..++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       221 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          221 -----GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -----TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -----CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence                 1111122334567899999999999999999999999999987653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-46  Score=370.58  Aligned_cols=278  Identities=17%  Similarity=0.241  Sum_probs=212.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchh--HHHhhhHHHHHHHHHHHHHhhcCCCCCee
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDR--AVETLNQCQREQSLRELKYLNSCRHDNIL  212 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  212 (441)
                      ...++|++.+.||+|+||.||+|.+..       ..||||++.......  ....+..........|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            445789999999999999999999843       579999987543211  12222223334556788888999999999


Q ss_pred             cccceEEeC----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         213 PLYGICFET----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       213 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      ++++++...    ...|+||||+ |++|.+++...  ...+++..++.++.||+.||+|||+++  |+||||||+|||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence            999998765    4589999999 99999998653  345999999999999999999999999  99999999999999


Q ss_pred             --CCCCeEEeccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch
Q psy5927         289 --HHMDPVIGDFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR  362 (441)
Q Consensus       289 --~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~  362 (441)
                        .++.+||+|||+++.........    .......||+.|+|||++.+..++.++|||||||++|||+||..||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999997643222111    112345699999999999998999999999999999999999999986544


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ............. ..+..+++....  ...++.++.+++..||+.||.+||++.+|++.|+.+-
T Consensus       267 ~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          267 DPKYVRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             CHHHHHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            3433333222221 112222222110  1234678999999999999999999999999887654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-46  Score=368.48  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=204.7

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccce
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGI  217 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  217 (441)
                      ....++|++.+.||+|+||.||+|.++  +..||||+++.....      .....+....|..++..+ +||||++++++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~il~~~~~hp~iv~l~~~   86 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHMFCT   86 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh------hhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            456789999999999999999999985  578999999743211      112334566888888876 89999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+.+.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|
T Consensus        87 ~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~D  161 (345)
T 1xjd_A           87 FQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIAD  161 (345)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeE
Confidence            999999999999999999999986543   4889999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..     
T Consensus       162 FG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~-----  232 (345)
T 1xjd_A          162 FGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRM-----  232 (345)
T ss_dssp             CTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH-----
T ss_pred             ChhhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHh-----
Confidence            99997643221   1234567999999999999999999999999999999999999999876542 22222111     


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMT-QVY  420 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl  420 (441)
                              .....+..++.++.+|+.+||..||.+||++. +|+
T Consensus       233 --------~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          233 --------DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --------CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                    11123344667899999999999999999997 664

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.5e-46  Score=365.26  Aligned_cols=260  Identities=20%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|+++......      ....+.+.+|..++.++ +||||+++++++.
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc------hHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            3468999999999999999999985  5689999997543221      12344566899999887 8999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecc
Confidence            9999999999999999999886543   4889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +++......   ......+||+.|+|||++.+..++.++|||||||++|||++|..||............     ....+
T Consensus       156 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-----~~~~~  227 (345)
T 3a8x_A          156 MCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----TEDYL  227 (345)
T ss_dssp             GCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------CHHHH
T ss_pred             ccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-----cHHHH
Confidence            997532221   1234567999999999999999999999999999999999999999753211100000     00001


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM------TQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~  421 (441)
                      ...+.......+..++..+.+|+.+||+.||.+||++      .++++
T Consensus       228 ~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          228 FQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            1111112223445567789999999999999999995      66654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.1e-47  Score=356.48  Aligned_cols=258  Identities=21%  Similarity=0.390  Sum_probs=211.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.+.||+|+||.||+|.+ ++..||+|++......          .+.+.+|++++++++||||+++++++.+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~   76 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGVCLE   76 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----------HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4557899999999999999999998 5678999999743321          2346689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~  152 (269)
T 4hcu_A           77 QAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM  152 (269)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred             CCceEEEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccc
Confidence            99999999999999999998543  345899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++.......  .......+|..|+|||.+.+..++.++||||||+++|||++ |..||...... ........       
T Consensus       153 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-~~~~~~~~-------  222 (269)
T 4hcu_A          153 TRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDIST-------  222 (269)
T ss_dssp             GGGBCCHHH--HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT-------
T ss_pred             ccccccccc--ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhc-------
Confidence            975432211  12233456788999999998899999999999999999999 99999876542 22222111       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                           ......+..++..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          223 -----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                 11112233346779999999999999999999999999987643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-46  Score=358.86  Aligned_cols=265  Identities=24%  Similarity=0.361  Sum_probs=201.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc--CCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS--CRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||+||+|.++++.||||++....            ...+..|.+++..  ++||||+++++++.
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~   72 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------------EKSWFRETELYNTVMLRHENILGFIASDM   72 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence            345789999999999999999999999999999986321            1223345555555  79999999999876


Q ss_pred             eC----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeeecCCCCCCeee
Q psy5927         220 ET----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH--------SREPPLIHGDIKSANILL  287 (441)
Q Consensus       220 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~iiHrDikp~NiLl  287 (441)
                      +.    ..+++||||+++|+|.+++..    ..+++..+..++.|++.||+|||        +.+  |+||||||+|||+
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill  146 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILV  146 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEE
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEE
Confidence            53    458999999999999999842    35899999999999999999999        878  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCcccc-cceeccccccCCCcCcccccCC------CCCCccceehHHHHHHHHHhC-------
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVGK------RLSTKVDVYGFGIVLFELATG-------  353 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlGvvl~elltG-------  353 (441)
                      +.++.+||+|||+++........ ........||+.|+|||.+.+.      .++.++|||||||++|||+||       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            99999999999999653222111 1112334799999999999876      556799999999999999999       


Q ss_pred             ---CCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         354 ---MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       354 ---~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                         ..||.......................  ...........++..+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQR--PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCC--CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCcchhhhhHHHhccCCC--CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence               888865432221111111111100000  00001112345788999999999999999999999999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-46  Score=360.72  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=206.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||+||+|...  +..||+|+++.....      .....+.+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV------RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            3478999999999999999999984  678999999742211      11234556689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+.+|+||||++||+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCc
Confidence            99999999999999999998653   34889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++.....      ....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+..        
T Consensus       153 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~--------  217 (318)
T 1fot_A          153 AKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILN--------  217 (318)
T ss_dssp             CEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH--------
T ss_pred             ceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh--------
Confidence            9764321      234579999999999999999999999999999999999999997765422 2222211        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                           .....+..++.++.+|+.+||..||.+||     ++.++++
T Consensus       218 -----~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          218 -----AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 01123345667899999999999999999     8899874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.2e-47  Score=376.44  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=212.1

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      +.+..++|.+.+.||+|+||.||+|.+.  ++.||||.++....        ....+.+.+|+++++.++||||++++++
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~  180 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--------PDLKAKFLQEARILKQYSHPNIVRLIGV  180 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--------HHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--------HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456678999999999999999999995  67899999874321        1223456689999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+.+..|+||||+++|+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus       181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          181 CTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECc
Confidence            999999999999999999999986533  34889999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++........ .......++..|+|||.+.+..++.++|||||||++|||+| |..||.......  ....+..   
T Consensus       257 fG~s~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~---  330 (377)
T 3cbl_A          257 FGMSREEADGVYA-ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEK---  330 (377)
T ss_dssp             GGGCEECTTSEEE-CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHT---
T ss_pred             CCCceecCCCcee-ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc---
Confidence            9999764322111 11112235778999999998899999999999999999998 999998765421  1111111   


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                              ....+.+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       331 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          331 --------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                    1112234456778999999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.2e-47  Score=365.62  Aligned_cols=276  Identities=22%  Similarity=0.326  Sum_probs=200.0

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCe-----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKT-----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      .+..++|++.+.||+|+||.||+|.+..+     .||||+++......       ...+.+.+|++++++++||||++++
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-------SDIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-------HHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-------HHHHHHHHHHHHHHHCCCCceehhh
Confidence            45667899999999999999999987543     68999986432111       2345677999999999999999999


Q ss_pred             ceEEeCCeE------EEEEEecCCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCee
Q psy5927         216 GICFETGKY------CLVYRYMPNGSLEDRLLMKKN---TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL  286 (441)
Q Consensus       216 ~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiL  286 (441)
                      +++......      ++||||+++|+|.+++.....   ...+++..+..++.|++.||+|||+.+  |+||||||+|||
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIl  169 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCM  169 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEE
Confidence            999877655      999999999999999865432   225899999999999999999999999  999999999999


Q ss_pred             ecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHH
Q psy5927         287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSER  365 (441)
Q Consensus       287 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~  365 (441)
                      ++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       170 i~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-  247 (323)
T 3qup_A          170 LAEDMTVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-  247 (323)
T ss_dssp             ECTTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred             EcCCCCEEEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-
Confidence            999999999999999764332211 11223346788999999999899999999999999999999 999998765422 


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGPTLP  439 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~p~~~  439 (441)
                      ......            .......+..++..+.+|+.+||+.||.+||++.++++.|+++............|
T Consensus       248 ~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          248 IYNYLI------------GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             HHHHHH------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             HHHHHh------------cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence            221111            11122334456678999999999999999999999999998876655544444333

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-46  Score=365.60  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||+|+||+||+|.+  .++.||||++.......      ......+.+|+++++.++||||+++++++.+.
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK------SDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc------hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            47899999999999999999998  45789999986422111      01223566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+ +|+|.+++....   .+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s  155 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLS  155 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCT
T ss_pred             CEEEEEEECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccc
Confidence            9999999999 789999886543   4889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      .......    .....+||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.....              ..
T Consensus       156 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------------~~  217 (336)
T 3h4j_B          156 NIMTDGN----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------------LF  217 (336)
T ss_dssp             BTTTTSB----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------------CB
T ss_pred             eeccCCc----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------------HH
Confidence            7643322    1234579999999999998776 789999999999999999999997643211              11


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..+.......+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       218 ~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11222222344456778999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=372.40  Aligned_cols=268  Identities=22%  Similarity=0.332  Sum_probs=216.5

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCC
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN  210 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  210 (441)
                      .+..++|.+.++||+|+||.||+|.+.+         ..||||+++.....        .....+.+|+++++.+ +|||
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~hpn  136 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--------KDLSDLISEMEMMKMIGKHKN  136 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHCCCTT
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH--------HHHHHHHHHHHHHHHhcCCch
Confidence            4556789999999999999999999732         46999998743221        2345677999999999 8999


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      |+++++++.+.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+  |+|
T Consensus       137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH  214 (382)
T 3tt0_A          137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH  214 (382)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--Eec
Confidence            99999999999999999999999999999976542             245899999999999999999999999  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA  356 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p  356 (441)
                      |||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus       215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             SCCCGGGEEECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCCcceEEEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999986433221 112233457889999999999999999999999999999999 9999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPN  432 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  432 (441)
                      |...... .....+..            ......+..++.++.+|+.+||+.||.+||++.+|++.|+.+....+.
T Consensus       294 ~~~~~~~-~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          294 YPGVPVE-ELFKLLKE------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             STTCCHH-HHHHHHHT------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHH-HHHHHHHc------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            9876532 12211111            111122334567899999999999999999999999999877654443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-46  Score=358.51  Aligned_cols=270  Identities=19%  Similarity=0.284  Sum_probs=212.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||+||+|.+.  +..||||++......        ...+.+.+|++++++++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--------RPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--------chHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            3468999999999999999999996  678999998743221        123445689999999999999999999887


Q ss_pred             CC--eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee----cCCCCeE
Q psy5927         221 TG--KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL----NHHMDPV  294 (441)
Q Consensus       221 ~~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl----~~~~~~k  294 (441)
                      ..  ..|+||||+++|+|.+++........+++..+..++.|++.||+|||+.+  |+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEE
Confidence            65  78999999999999999977665556999999999999999999999999  9999999999999    8888899


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCccccc--------CCCCCCccceehHHHHHHHHHhCCCCCCCcchh---
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV--------GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS---  363 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~---  363 (441)
                      |+|||+++.......    .....||+.|+|||++.        +..++.++|||||||++|||+||..||......   
T Consensus       157 L~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          157 LTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             ECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EccCCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            999999976433221    23456999999999986        567899999999999999999999999643321   


Q ss_pred             HHHHHHHHHhhchhhhhhhh------------ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         364 ERHLKSLVEKYSEENMYDLV------------DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ......+.............            -+........++..+.+|+.+||+.||++||++.|+++..+..
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            22222222221111000000            0111234567888999999999999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-47  Score=368.63  Aligned_cols=273  Identities=23%  Similarity=0.365  Sum_probs=212.7

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEE-------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +.+..++|++.+.||+|+||.||+|.+       .+..||||++......        ...+.+.+|+.+++++ +||||
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~i  111 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--------SEREALMSELKMMTQLGSHENI  111 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTB
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--------HHHHHHHHHHHHHHhhcCCCCe
Confidence            345668899999999999999999997       2346999998743211        2234667999999999 89999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHcC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT--------------------PSLLWTQRLHIAKGTSLGLQFLHSR  271 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~al~~LH~~  271 (441)
                      +++++++.+.+..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||++
T Consensus       112 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  191 (344)
T 1rjb_A          112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK  191 (344)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            99999999999999999999999999999754321                    3478999999999999999999999


Q ss_pred             CCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHH
Q psy5927         272 EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA  351 (441)
Q Consensus       272 ~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ell  351 (441)
                      +  |+||||||+|||++.++.+||+|||++....... .........||+.|+|||.+.+..++.++||||||+++|||+
T Consensus       192 ~--ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          192 S--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             T--EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             C--cccCCCChhhEEEcCCCcEEeCCCccCcccccCc-cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            9  9999999999999999999999999997543221 112233445788999999998889999999999999999999


Q ss_pred             h-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         352 T-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       352 t-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      | |..||............ +..           ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       269 t~g~~p~~~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          269 SLGVNPYPGIPVDANFYKL-IQN-----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             TTSCCSSTTCCCSHHHHHH-HHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cCCCCCcccCCcHHHHHHH-Hhc-----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            8 99999876543322221 111           0111223345678999999999999999999999999999988877


Q ss_pred             CCCCC
Q psy5927         431 PNATG  435 (441)
Q Consensus       431 ~~~~~  435 (441)
                      +.+..
T Consensus       337 ~~~~~  341 (344)
T 1rjb_A          337 EEAMY  341 (344)
T ss_dssp             -----
T ss_pred             HHHHh
Confidence            76554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=364.45  Aligned_cols=284  Identities=18%  Similarity=0.190  Sum_probs=210.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-----CeeEEEEEeeeccchh--HHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-----KTTIAVKKLEVHRNDR--AVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-----~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      ..++|.+.+.||+|+||.||+|.+.     +..+|||++.......  ....+.......+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3578999999999999999999984     3579999987543321  12222223334567899999999999999999


Q ss_pred             ceEEe----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         216 GICFE----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       216 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      +++.+    ....|+||||+ +++|.+++....   .+++..++.++.|++.||+|||+.+  |+||||||+|||++.++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence            99988    77899999999 999999886543   5899999999999999999999999  99999999999999887


Q ss_pred             --CeEEeccCCCccCCCccc----ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH
Q psy5927         292 --DPVIGDFGLTQEGPIEKA----THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER  365 (441)
Q Consensus       292 --~~kl~DFGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~  365 (441)
                        .+||+|||+++.......    .........||+.|+|||++.+..++.++|||||||++|||+||..||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999976432211    11112345799999999999998899999999999999999999999965433233


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATG  435 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  435 (441)
                      ............ ....+.....  ...++.++.+++.+||+.||++||++.+|++.|+......+...+
T Consensus       269 ~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~  335 (345)
T 2v62_A          269 AVQTAKTNLLDE-LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDF  335 (345)
T ss_dssp             HHHHHHHHHHHT-TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCC
T ss_pred             HHHHHHHhhccc-ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCc
Confidence            222222221111 0000000000  013566899999999999999999999999999988765554443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=373.25  Aligned_cols=255  Identities=20%  Similarity=0.271  Sum_probs=206.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||+||+|.+  .+..+|+|++.......       ...+.+.+|+++++.++||||+++++++.
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-------RDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-------HHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-------HHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            4567899999999999999999998  46789999987544321       23445679999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec---CCCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~---~~~~~kl~  296 (441)
                      +.+..|+|||||+||+|.+++...   ..+++..+..++.||+.||+|||++|  |+||||||+|||++   .++.+||+
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEc
Confidence            999999999999999999988654   34899999999999999999999999  99999999999998   56889999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......   .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.... .....+..... 
T Consensus       156 DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~-  230 (444)
T 3soa_A          156 DFGLAIEVEGEQ---QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKAGAY-  230 (444)
T ss_dssp             CCSSCBCCCTTC---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCC-
T ss_pred             cCceeEEecCCC---ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCC-
Confidence            999997643322   1223457999999999999989999999999999999999999999776542 22222211110 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          .+    ..+....++.++.+|+.+||+.||++||++.++++
T Consensus       231 ----~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 ----DF----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ----CC----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----CC----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                00    01111245678999999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.4e-46  Score=352.37  Aligned_cols=263  Identities=25%  Similarity=0.474  Sum_probs=208.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||+||+|.+  .+..||+|++...........  ....+.+.+|+++++.++||||+++++++.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM--IEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH--HCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH--HHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            4457899999999999999999998  467899999875433222111  111256679999999999999999999986


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC-----eE
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-----PV  294 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~-----~k  294 (441)
                      +..  ++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+++++|+||||||+|||++.++.     +|
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             CCC--eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            654  6999999999999988543  34689999999999999999999998777999999999999988876     99


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCccccc--CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV--GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      |+|||+++....      ......||+.|+|||.+.  +..++.++|||||||++|||++|..||...............
T Consensus       170 l~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          170 VADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             ECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence            999999975322      123456999999999984  456789999999999999999999999876543322222111


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ..          ......+..++..+.+|+.+||+.||.+||++.+|++.|+++
T Consensus       244 ~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 EE----------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HS----------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cc----------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            10          111223445677899999999999999999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-46  Score=379.37  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=210.0

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+..++|++.+.||+|+||.||+|.++++.||||+++...           ..+.+.+|+++|++++||||+++++++.+
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~  257 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE  257 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----------TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----------HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence            3556789999999999999999999999999999997432           12356789999999999999999999877


Q ss_pred             CC-eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TG-KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .. .+|+|||||++|+|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus       258 ~~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          258 EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             TTSCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred             CCCceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCC
Confidence            65 7999999999999999997543 334789999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++.....      .....++..|+|||.+.+..++.++|||||||++|||+| |..||....... ....+.       
T Consensus       335 ~a~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~-------  400 (450)
T 1k9a_A          335 LTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVE-------  400 (450)
T ss_dssp             TCEECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-HHHHHH-------
T ss_pred             Cccccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH-------
Confidence            99753221      112257889999999999999999999999999999998 999998765422 111111       


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                           .......+..++..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus       401 -----~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          401 -----KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                 11122334556788999999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.4e-46  Score=364.57  Aligned_cols=247  Identities=19%  Similarity=0.286  Sum_probs=206.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||+|++......      .....+.+.+|+++++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  113 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV------KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN  113 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc------cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            468999999999999999999985  578999998643211      112345677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a  188 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccc
Confidence            99999999999999999986543   4889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +.....      ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..         
T Consensus       189 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~---------  252 (350)
T 1rdq_E          189 KRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKIVS---------  252 (350)
T ss_dssp             EECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH---------
T ss_pred             eeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH-HHHHHHHc---------
Confidence            764322      23457999999999999999999999999999999999999999876432 22222111         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                          .....+..++..+.+|+.+||+.||.+||+     +.+|++
T Consensus       253 ----~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          253 ----GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                111233456778999999999999999998     888875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-46  Score=370.42  Aligned_cols=249  Identities=23%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHH-hhcCCCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY-LNSCRHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||+||+|.++  +..||||+++......      ......+.+|..+ ++.++||||+++++++
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~------~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~  108 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK------KKEEKHIMSERNVLLKNVKHPFLVGLHFSF  108 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh------hHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence            34578999999999999999999985  4579999997543221      1223345577776 5778999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||++|  |+||||||+|||++.+|.+||+||
T Consensus       109 ~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          109 QTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeC
Confidence            99999999999999999999886543   4788999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++.....   .......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+..      
T Consensus       184 G~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~------  253 (373)
T 2r5t_A          184 GLCKENIEH---NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILN------  253 (373)
T ss_dssp             CBCGGGBCC---CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHH------
T ss_pred             ccccccccC---CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh------
Confidence            999753221   122345689999999999999999999999999999999999999998765422 2222211      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ  418 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  418 (441)
                             .....+..++..+.+|+.+||+.||.+||++.+
T Consensus       254 -------~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          254 -------KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             -------SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             -------cccCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                   111223446678999999999999999999853

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.9e-46  Score=365.10  Aligned_cols=252  Identities=22%  Similarity=0.326  Sum_probs=205.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||+||+|.+..  ..||||+++.....      .....+.+..|..++..+ +||||+++++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   90 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI------QDDDVECTMVEKRVLALPGKPPFLTQLHSCF   90 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------cchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence            456789999999999999999999965  56999998743211      112345567899999888 899999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+|+||||++||+|.+++....   .+++..+..++.||+.||+|||++|  |+||||||+|||++.+|.+||+||
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DF  165 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADF  165 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeC
Confidence            99999999999999999999986543   4889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..      
T Consensus       166 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~~------  235 (353)
T 2i0e_A          166 GMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIME------  235 (353)
T ss_dssp             TTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH------
T ss_pred             CcccccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHHh------
Confidence            9997633221   1234567999999999999999999999999999999999999999876442 22222211      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                             .....+..++.++.+|+.+||+.||.+||+     +.+|++
T Consensus       236 -------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          236 -------HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                   111233456778999999999999999995     477764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-45  Score=355.51  Aligned_cols=258  Identities=20%  Similarity=0.324  Sum_probs=208.7

Q ss_pred             CChhHHHHhhCC----------CcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHH
Q psy5927         135 IPYQELTLATNN----------WDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKY  202 (441)
Q Consensus       135 ~~~~~~~~~~~~----------~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~  202 (441)
                      +++.++...++.          |+..++||+|+||.||+|.+.  ++.||||++......         ..+.+.+|+.+
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---------~~~~~~~E~~~   95 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---------RRELLFNEVVI   95 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------SHHHHHHHHHH
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---------HHHHHHHHHHH
Confidence            455555555543          777789999999999999984  678999998743321         23456689999


Q ss_pred             hhcCCCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCC
Q psy5927         203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKS  282 (441)
Q Consensus       203 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp  282 (441)
                      ++.++||||+++++++...+..++||||+++|+|.+++..    ..+++..+..++.|++.||+|||+.+  |+||||||
T Consensus        96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp  169 (321)
T 2c30_A           96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKS  169 (321)
T ss_dssp             HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCH
Confidence            9999999999999999999999999999999999998743    34899999999999999999999999  99999999


Q ss_pred             CCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch
Q psy5927         283 ANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR  362 (441)
Q Consensus       283 ~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~  362 (441)
                      +|||++.++.+||+|||++........   ......||+.|+|||.+.+..++.++||||||+++|||++|..||.....
T Consensus       170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          170 DSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             HHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999876433211   12345799999999999998999999999999999999999999976543


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      . .....+....          .........++..+.+++.+||+.||++||++.++++
T Consensus       247 ~-~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 V-QAMKRLRDSP----------PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             H-HHHHHHHHSS----------CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             H-HHHHHHhcCC----------CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2 2222211110          0011122345678999999999999999999999987

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=9e-46  Score=366.74  Aligned_cols=254  Identities=22%  Similarity=0.351  Sum_probs=205.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..||+|++......      .....+.+.+|+++++.++||||+++++++.
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   85 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV------ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ   85 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc------cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34578999999999999999999985  456999998743211      1123456779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+||||+.||+|.+++..   ...+++..+..++.||+.||.|||+.|  |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           86 DEEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccc
Confidence            99999999999999999998864   345899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      +++.....    ......+||+.|+|||++.+   ..++.++|||||||++|||++|..||........  ......   
T Consensus       161 ~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~---  231 (384)
T 4fr4_A          161 IAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHT---  231 (384)
T ss_dssp             TCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHH---
T ss_pred             eeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHH---
Confidence            99764322    12345679999999999964   4589999999999999999999999975432111  111111   


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-MTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~  421 (441)
                            +.......+..++..+.+|+.+||+.||.+||+ +.+|.+
T Consensus       232 ------~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          232 ------FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                  111122334456778999999999999999998 777764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-45  Score=356.13  Aligned_cols=269  Identities=21%  Similarity=0.298  Sum_probs=206.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ...++|++.++||+|+||+||+|.+ ++..||+|++......       ......+.+|++++++++||||+++++++.+
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   90 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-------EGIPSTAIREISLLKELHHPNIVSLIDVIHS   90 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-------chhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence            3457899999999999999999998 4678999998743221       1223456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+.+++||||++ |+|.+.+...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A           91 ERCLTLVFEFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEcCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcC
Confidence            999999999997 5888877543  345899999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh--
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE--  377 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--  377 (441)
                      ++......   .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||....... .+..+.......  
T Consensus       166 a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~  241 (311)
T 3niz_A          166 ARAFGIPV---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNP  241 (311)
T ss_dssp             CEETTSCC---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCT
T ss_pred             ceecCCCc---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCCh
Confidence            97643221   12233468999999999876 568999999999999999999999998765433 233332221110  


Q ss_pred             -hhhh------hhcc--------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         378 -NMYD------LVDK--------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       378 -~~~~------~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                       ....      ....        ........++.++.+|+.+||+.||++|||+.++++  .++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence             0000      0000        000112335678899999999999999999999987  45544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-46  Score=360.23  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=206.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++..........   ....+.+.+|+.+++.++||||+++++++.+
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3467999999999999999999985  5789999997654322110   0123456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC----CeEEe
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM----DPVIG  296 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~----~~kl~  296 (441)
                      .+.+++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++    .+||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            9999999999999999999853   345899999999999999999999999  99999999999999888    79999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......    ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..+.... .
T Consensus       161 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~-~  234 (326)
T 2y0a_A          161 DFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVN-Y  234 (326)
T ss_dssp             CCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHTC-C
T ss_pred             ECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHhcC-C
Confidence            999997643222    123456999999999999889999999999999999999999999765442 2222221110 0


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              .........++..+.+|+.+||+.||++|||+.++++
T Consensus       235 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 --------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             --------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                    0011112345677899999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.2e-46  Score=359.90  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||||+++.....        ...+.+.+|++++++++||||+++++++.+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   75 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--------LAREKVMREVKALAKLEHPGIVRYFNAWLE   75 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--------THHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            3568999999999999999999984  678999999754322        223456799999999999999999999866


Q ss_pred             CC---------------------------------------------------------eEEEEEEecCCCCHHHHHhhc
Q psy5927         221 TG---------------------------------------------------------KYCLVYRYMPNGSLEDRLLMK  243 (441)
Q Consensus       221 ~~---------------------------------------------------------~~~lv~e~~~~gsL~~~l~~~  243 (441)
                      ..                                                         ..++|||||++|+|.+++...
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  155 (332)
T 3qd2_B           76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR  155 (332)
T ss_dssp             CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred             eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence            53                                                         389999999999999999876


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccc---------ccee
Q psy5927         244 KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT---------HITL  314 (441)
Q Consensus       244 ~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~---------~~~~  314 (441)
                      .......+..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++........         ....
T Consensus       156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          156 CSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             CSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             cCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            66666778889999999999999999999  999999999999999999999999999764432211         1122


Q ss_pred             ccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHH
Q psy5927         315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNI  394 (441)
Q Consensus       315 ~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  394 (441)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|..|+....   .....            .............
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---~~~~~------------~~~~~~~~~~~~~  298 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITD------------VRNLKFPLLFTQK  298 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---HHHHH------------HHTTCCCHHHHHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---HHHHH------------hhccCCCcccccC
Confidence            34569999999999999999999999999999999999877653211   11111            1111222334456


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         395 AYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       395 ~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +..+.+|+.+||+.||++||++.++++
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            677899999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.2e-46  Score=359.96  Aligned_cols=263  Identities=26%  Similarity=0.379  Sum_probs=213.3

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      .+..++|.+.+.||+|+||.||+|.+.       +..||||++.....        ....+.+.+|+++++.++||||++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~   90 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--------PSELRDLLSEFNVLKQVNHPHVIK   90 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--------HHHHHHHHHHHHHHhhCCCCceee
Confidence            455678999999999999999999872       26799999874322        123456779999999999999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN---------------------TPSLLWTQRLHIAKGTSLGLQFLHSRE  272 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~al~~LH~~~  272 (441)
                      +++++.+.+..++||||+++|+|.+++.....                     ...+++..+..++.|++.||+|||+++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999976543                     234889999999999999999999999


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh
Q psy5927         273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT  352 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt  352 (441)
                        |+||||||+|||++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||+|
T Consensus       171 --ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             --EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             --CcccccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence              99999999999999999999999999976433221 112233457888999999998889999999999999999999


Q ss_pred             -CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         353 -GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       353 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                       |..||....... .. ..+..           ......+..++..+.+|+.+||+.||.+||++.+|++.|+++.
T Consensus       248 ~g~~p~~~~~~~~-~~-~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          248 LGGNPYPGIPPER-LF-NLLKT-----------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             TSCCSSTTCCGGG-HH-HHHHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHH-HH-HHhhc-----------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             999997765422 11 11111           1112233456778999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-46  Score=361.90  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=203.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||++.......        ..+.+.+|+.+++.++||||+++++++.++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   77 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--------CPENIKKEICINKMLNHENVVKFYGHRREG   77 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--------hHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            478999999999999999999985  6789999987543211        123456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+||||+++|+|.+++..   ...+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeecc
Confidence            999999999999999998743   345899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +...... .........||+.|+|||++.+..+ +.++|||||||++|||++|..||.................      
T Consensus       153 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------  225 (323)
T 3tki_A          153 TVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------  225 (323)
T ss_dssp             EECEETT-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC------
T ss_pred             ceeccCC-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc------
Confidence            7542221 1122345679999999999988765 7799999999999999999999987654322222221110      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           ........++..+.+|+.+||+.||.+||++.++++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          226 -----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             -----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                 011112345677899999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-46  Score=356.29  Aligned_cols=259  Identities=20%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      .+..++|++.+.||+|+||.||+|.+..     ..||+|++.....        ....+.+.+|+.++++++||||++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~   82 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIVKLI   82 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCccceEE
Confidence            4556789999999999999999999843     3588888764321        12345677999999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +++. .+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        83 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl  157 (281)
T 1mp8_A           83 GVIT-ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKL  157 (281)
T ss_dssp             EEEC-SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEE
T ss_pred             EEEc-cCccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEE
Confidence            9874 56789999999999999998654  345899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++.......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ....+.   
T Consensus       158 ~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-~~~~i~---  231 (281)
T 1mp8_A          158 GDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE---  231 (281)
T ss_dssp             CC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH---
T ss_pred             CccccccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-HHHHHH---
Confidence            99999976433211  11223356788999999998889999999999999999997 999998765422 111111   


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                               .....+.+..++..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       232 ---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          232 ---------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     11122334556778999999999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.8e-46  Score=359.68  Aligned_cols=265  Identities=20%  Similarity=0.258  Sum_probs=199.1

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+  .++.||||++.......      ......+.+|++++++++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS------HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC------HHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            457899999999999999999997  46789999997543221      1234566799999999999999999999876


Q ss_pred             CC----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         221 TG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       221 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ..    ..|+||||++||+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEEC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEe
Confidence            54    349999999999999998654   34899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++................||+.|+|||++.+..++.++||||||+++|||+||..||............ ......
T Consensus       159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~  237 (311)
T 3ork_A          159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPI  237 (311)
T ss_dssp             CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCC
T ss_pred             eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCC
Confidence            9999976443322222334456999999999999999999999999999999999999999876542221111 111000


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhcCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY-NMLSGSGG  428 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl-~~L~~~~~  428 (441)
                               ........++.++.+|+.+||+.||.+||+..+++ ..|.....
T Consensus       238 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 ---------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ---------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ---------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                     00011223567899999999999999999766544 45544433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.5e-46  Score=360.34  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||.||+|.+     .+..||+|+++.......     ......+.+|+++++.++||||+++++
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~   88 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-----AKDTAHTKAERNILEEVKHPFIVDLIY   88 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCEEE
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh-----hhHHHHHHHHHHHHHhCCCCCccceeE
Confidence            3457899999999999999999987     457899999975422111     122344568999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.+.+|+||||+++|+|.+++....   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           89 AFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             EEECSSCEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEEC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEE
Confidence            9999999999999999999999986543   4888999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......   ......+||+.|+|||.+.+..++.++|||||||++|||++|..||...... .....+...   
T Consensus       164 Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~---  236 (327)
T 3a62_A          164 DFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKC---  236 (327)
T ss_dssp             CCSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHT---
T ss_pred             eCCcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhC---
Confidence            999987532211   1234457999999999999989999999999999999999999999876542 222222111   


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                                ....+..++..+.+|+.+||+.||.+||     ++.++++
T Consensus       237 ----------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 ----------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                      1123345677899999999999999999     7788875

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-46  Score=372.80  Aligned_cols=259  Identities=18%  Similarity=0.257  Sum_probs=207.1

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ++....++|++.++||+|+||+||+|.+.  +..||+|+++.....      .....+.+.+|+.+++.++||||+++++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~------~~~~~~~~~~E~~il~~l~hp~Iv~l~~  136 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI------KRSDSAFFWEERDIMAFANSPWVVQLFY  136 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh------hhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            44566789999999999999999999985  467999998742111      1112234568999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.+.+|+|||||+||+|.+++...    .+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+
T Consensus       137 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          137 AFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEe
Confidence            999999999999999999999988542    3889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCC----CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR----LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      |||+++......  .......+||+.|+|||++.+..    ++.++|||||||++|||++|.+||....... ....+..
T Consensus       211 DFG~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~  287 (410)
T 3v8s_A          211 DFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMN  287 (410)
T ss_dssp             CCTTCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHT
T ss_pred             ccceeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHh
Confidence            999997643322  12234568999999999998755    8899999999999999999999998765422 2222211


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYN  421 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~  421 (441)
                      ..   .  .    ...+....++.++.+|+.+||..+|++  ||++.+|++
T Consensus       288 ~~---~--~----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          288 HK---N--S----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HH---H--H----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             cc---c--c----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            00   0  0    001111235678999999999999998  999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.1e-46  Score=354.14  Aligned_cols=258  Identities=21%  Similarity=0.362  Sum_probs=207.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      .+..++|++.+.||+|+||.||+|.+.+ ..||+|+++.....          .+.+.+|++++..++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----------HHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            4566789999999999999999999865 47999999743321          234568999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||+++++|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             cCCCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccc
Confidence            9999999999999999999986432  34899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++.......  .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....... ....+..      
T Consensus       166 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~------  236 (283)
T 3gen_A          166 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQ------  236 (283)
T ss_dssp             GGGGBCCHHH--HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT------
T ss_pred             cccccccccc--ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-HHHHHhc------
Confidence            9975433211  11223346788999999998889999999999999999998 999998765421 1111111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                            ......+..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       237 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          237 ------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                  1111222334567999999999999999999999999998754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-45  Score=362.52  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=206.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++......       ....+.+.+|+++++.++||||+++++++.
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-------ARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            44678999999999999999999985  568999999754322       123455679999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC---CeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM---DPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~---~~kl~  296 (441)
                      +.+..|+||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++.++   .+||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEe
Confidence            999999999999999999988543   45899999999999999999999999  99999999999998654   59999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||++.......    ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... .....+..... 
T Consensus       174 DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~~~-  247 (362)
T 2bdw_A          174 DFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAY-  247 (362)
T ss_dssp             CCTTCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC-
T ss_pred             ecCcceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCC-
Confidence            999997654322    123457999999999999989999999999999999999999999776542 22222111100 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             + ........++.++.+|+.+||+.||.+||++.++++
T Consensus       248 -------~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 -------D-YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             -------C-CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -------C-CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   0 011112345678999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-46  Score=362.80  Aligned_cols=281  Identities=23%  Similarity=0.315  Sum_probs=213.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      +..++|++.+.||+|+||.||+|.+      .+..||||++.....         ...+.+.+|++++++++||||++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~   90 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---------DQQRDFQREIQILKALHSDFIVKYR   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---------HHHHHHHHHHHHHHhcCCCceeEEE
Confidence            3457899999999999999999985      356799999874321         2234567999999999999999999


Q ss_pred             ceEE--eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         216 GICF--ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       216 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      +++.  +....++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~  166 (327)
T 3lxl_A           91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHV  166 (327)
T ss_dssp             EEEECSSSCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEE
T ss_pred             EEEecCCCceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCE
Confidence            9886  4567899999999999999986533  24899999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++................||..|+|||.+.+..++.++||||||+++|+|++|..||................
T Consensus       167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  246 (327)
T 3lxl_A          167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD  246 (327)
T ss_dssp             EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----
T ss_pred             EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccc
Confidence            99999999865443332233344568888999999998889999999999999999999999997654311100000000


Q ss_pred             h-chhhhhh-hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q psy5927         374 Y-SEENMYD-LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATG  435 (441)
Q Consensus       374 ~-~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  435 (441)
                      . ....... .........+..++..+.+|+.+||+.||.+||++.+|++.|+.+.........
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          247 VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             cccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence            0 0001111 111223334556778899999999999999999999999999998877665544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.2e-46  Score=378.98  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=214.4

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+.+..++|++.+.||+|+||+||+|.++ +..||||+++....          ..+.+.+|+++|+.++||||+++++
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~l~~  250 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----------SVEAFLAEANVMKTLQHDKLVKLHA  250 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----------CHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----------cHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            345667788999999999999999999985 57899999974321          2346679999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++. .+..++|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+
T Consensus       251 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~  326 (454)
T 1qcf_A          251 VVT-KEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIA  326 (454)
T ss_dssp             EEC-SSSCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEEC
T ss_pred             EEe-CCccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEe
Confidence            886 667899999999999999996432 224788899999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++........  ......+|..|+|||.+.+..++.++|||||||++|||+| |..||.+.... .....+...  
T Consensus       327 DFG~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~~~--  401 (454)
T 1qcf_A          327 DFGLARVIEDNEYT--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG--  401 (454)
T ss_dssp             STTGGGGBCCHHHH--TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHHT--
T ss_pred             eCCCceEcCCCcee--ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcC--
Confidence            99999864322111  1122346778999999998899999999999999999999 99999876542 222222111  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                                ...+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       402 ----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          402 ----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                      112233456778999999999999999999999999999986543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.8e-46  Score=364.18  Aligned_cols=259  Identities=19%  Similarity=0.287  Sum_probs=205.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||+||+|.+.  +..||||++........    .....+.+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS----PGLSTEDLKREASICHMLKHPHIVELLETYSS   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS----SSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc----ccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            4567999999999999999999984  57899999864321110    00123456799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---eEEe
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIG  296 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---~kl~  296 (441)
                      .+.+|+|||||+||+|.+.+.... ....+++..+..++.||+.||+|||+++  |+||||||+|||++.++.   +||+
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEe
Confidence            999999999999999998886543 3345889999999999999999999999  999999999999987655   9999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......   .......||+.|+|||++.+..++.++|||||||++|||++|..||.....  .....+......
T Consensus       176 Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~  250 (351)
T 3c0i_A          176 GFGVAIQLGESG---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK  250 (351)
T ss_dssp             CCTTCEECCTTS---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC
T ss_pred             cCcceeEecCCC---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC
Confidence            999997643321   112345799999999999998999999999999999999999999987532  222222111000


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                               ........++..+.+|+.+||+.||++||++.++++
T Consensus       251 ---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 ---------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ---------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                     000111235678999999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-45  Score=351.07  Aligned_cols=262  Identities=23%  Similarity=0.319  Sum_probs=204.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||+|+||+||+|.+.  +..||||++.......       .....+.+|++++++++||||+++++++.+++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-------THHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-------CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence            57999999999999999999984  5679999997544322       22345668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||++ |+|.+.+...  ...+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~  149 (292)
T 3o0g_A           75 KLTLVFEFCD-QDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             EEEEEEECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccce
Confidence            9999999996 4666666433  345899999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCC-CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh---h
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE---N  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~  378 (441)
                      ......   .......||+.|+|||.+.+.. ++.++|||||||++|||++|..||.........+..+.......   .
T Consensus       150 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          150 AFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             ECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            643221   1223446899999999998765 79999999999999999998888654444344444444332110   0


Q ss_pred             h---hhhhc----------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 M---YDLVD----------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~---~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .   ....+          .........++..+.+|+.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0   00000          0111222346778899999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-45  Score=360.25  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=204.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCe------eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKT------TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      +..++|.+.+.||+|+||.||+|.+..+      .||||+++....        ......+.+|+++++.++||||++++
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~  112 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------EKQRVDFLGEAGIMGQFSHHNIIRLE  112 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--------HHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3456788899999999999999987532      499999874322        12344567999999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +++.+.+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl  188 (333)
T 1mqb_A          113 GVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKV  188 (333)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEE
T ss_pred             EEEecCCCcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEE
Confidence            9999999999999999999999998643  345899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++................+|..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.   
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~---  264 (333)
T 1mqb_A          189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIN---  264 (333)
T ss_dssp             CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH---
T ss_pred             CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH---
Confidence            999999764433222222233346788999999998899999999999999999999 99999765432 1111111   


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                               +....+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       265 ---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          265 ---------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ---------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     111122334567789999999999999999999999999876543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=369.78  Aligned_cols=264  Identities=23%  Similarity=0.346  Sum_probs=210.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +..++|++.+.||+|+||+||+|.+.       +..||||+++.....        .....+.+|+.++++++||||+++
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~  139 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--------QDELDFLMEALIISKFNHQNIVRC  139 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--------hhHHHHHHHHHHHHhCCCCCCCeE
Confidence            34578999999999999999999953       347999998643221        223356789999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      ++++.+.+..++||||+++|+|.+++.....    ...+++..++.++.|++.||+|||+++  |+||||||+|||++.+
T Consensus       140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~  217 (367)
T 3l9p_A          140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCP  217 (367)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCS
T ss_pred             EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecC
Confidence            9999999999999999999999999976542    245899999999999999999999999  9999999999999955


Q ss_pred             C---CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHH
Q psy5927         291 M---DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH  366 (441)
Q Consensus       291 ~---~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~  366 (441)
                      +   .+||+|||+++...... .........||+.|+|||++.+..++.++|||||||++|||+| |..||..... ...
T Consensus       218 ~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~~  295 (367)
T 3l9p_A          218 GPGRVAKIGDFGMARDIYRAG-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEV  295 (367)
T ss_dssp             STTCCEEECCCHHHHHHHHHS-SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHH
T ss_pred             CCCceEEECCCcccccccccc-ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHH
Confidence            5   59999999986421111 1111233457899999999988899999999999999999998 9999987654 222


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      ...+..            ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+..+
T Consensus       296 ~~~i~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          296 LEFVTS------------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHc------------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            211111            111222345567899999999999999999999999999776544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6e-46  Score=373.95  Aligned_cols=264  Identities=16%  Similarity=0.198  Sum_probs=209.2

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +.++....++|++.++||+|+||+||+|.+.  +..||+|+++.....      .......+.+|+.++..++||||+++
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~~E~~il~~~~hp~Iv~l  139 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML------KRAETACFREERDVLVNGDSKWITTL  139 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH------HTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh------hHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            3455667789999999999999999999985  467999999742211      11122335689999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      +++|.+.+.+|+|||||+||+|.+++...  ...+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+|
T Consensus       140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vk  215 (437)
T 4aw2_A          140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIR  215 (437)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred             EEEEeeCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEE
Confidence            99999999999999999999999998643  345899999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      |+|||+++......  .......+||+.|+|||++.     +..++.++|||||||++|||++|.+||........ ...
T Consensus       216 L~DFGla~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~  292 (437)
T 4aw2_A          216 LADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGK  292 (437)
T ss_dssp             ECCCTTCEECCTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHH
T ss_pred             EcchhhhhhcccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHh
Confidence            99999997643322  12234467999999999997     45789999999999999999999999987654222 222


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHH
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKE--RPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~  421 (441)
                      +....   .  .   .........++.++.+|+.+||..+|++  ||+++++++
T Consensus       293 i~~~~---~--~---~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          293 IMNHK---E--R---FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHTHH---H--H---CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhhcc---c--c---ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            21100   0  0   0011111235678899999999988888  999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=367.88  Aligned_cols=263  Identities=17%  Similarity=0.189  Sum_probs=207.4

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      ..+.....++|++.+.||+|+||+||+|.++  ++.||||+++.....      .....+.+.+|..++..++||||+++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~------~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML------KRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh------hHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            3445567789999999999999999999984  678999999742111      11223446689999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ++++.+.+.+|+||||++||+|.+++....  ..+++..+..++.||+.||+|||+++  ||||||||+|||++.++++|
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEE
Confidence            999999999999999999999999996543  35889999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCccccc-------CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-------GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL  367 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l  367 (441)
                      |+|||+++.......  ......+||+.|+|||++.       +..++.++|||||||++|||++|..||........ .
T Consensus       203 L~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~  279 (412)
T 2vd5_A          203 LADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-Y  279 (412)
T ss_dssp             ECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-H
T ss_pred             EeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-H
Confidence            999999976433221  1233467999999999997       35789999999999999999999999987654222 2


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHH
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER---PEMTQVYN  421 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~evl~  421 (441)
                      ..+... ..       .......+..++.++.+|+.+||. +|.+|   |++.++++
T Consensus       280 ~~i~~~-~~-------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          280 GKIVHY-KE-------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHTH-HH-------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHhc-cc-------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            221110 00       000111223467789999999999 99988   68999976

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-45  Score=365.51  Aligned_cols=275  Identities=20%  Similarity=0.276  Sum_probs=207.6

Q ss_pred             hhCCCcCcCccccC--CceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         143 ATNNWDKLNILGKG--GFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       143 ~~~~~~~~~~LG~G--~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ..++|++.++||+|  +||+||+|.+.  +..||||++......       ....+.+.+|+++++.++||||+++++++
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-------NEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            34689999999999  99999999985  678999999754322       12345666899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+|+|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEccc
Confidence            99999999999999999999886543 345899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCccc----ccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         299 GLTQEGPIEKA----THITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       299 Gla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      |++........    .........||+.|+|||++.+  ..++.++|||||||++|||++|..||.+.............
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            98764321111    1111223468999999999987  57999999999999999999999999775543322221111


Q ss_pred             hhch---------hh-------------hhh----------hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q psy5927         373 KYSE---------EN-------------MYD----------LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       373 ~~~~---------~~-------------~~~----------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  420 (441)
                      ....         +.             ...          ..+....+.+..++..+.+|+.+||+.||++|||+.+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            0000         00             000          000011123345667899999999999999999999998


Q ss_pred             H--HHhcCC
Q psy5927         421 N--MLSGSG  427 (441)
Q Consensus       421 ~--~L~~~~  427 (441)
                      +  .++.+.
T Consensus       333 ~hp~f~~~~  341 (389)
T 3gni_B          333 NHSFFKQIK  341 (389)
T ss_dssp             TSGGGGGC-
T ss_pred             cCHHHHHHh
Confidence            6  355544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-46  Score=381.95  Aligned_cols=264  Identities=24%  Similarity=0.393  Sum_probs=216.7

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      .+.+...+|++.++||+|+||.||+|.+.  +..||||+++....          ..+.+.+|+++|++++||||+++++
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~l~~  283 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLLG  283 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----------chHHHHHHHHHHHhcCCCCEeeEEE
Confidence            34556678999999999999999999996  57899999874321          2345679999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      +|.+.+.+|+|||||++|+|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus       284 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~  360 (495)
T 1opk_A          284 VCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVA  360 (495)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEEC
T ss_pred             EEecCCcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEe
Confidence            9999999999999999999999997543 345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++.......  .......++..|+|||.+.+..++.++|||||||++|||+| |..||....... .. ..+..  
T Consensus       361 DFG~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~-~~~~~--  434 (495)
T 1opk_A          361 DFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VY-ELLEK--  434 (495)
T ss_dssp             CTTCEECCTTCCE--ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HH-HHHHT--
T ss_pred             ecccceeccCCce--eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HH-HHHHc--
Confidence            9999986433211  11223346788999999998899999999999999999999 999998765422 11 11110  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                               ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+..+.
T Consensus       435 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          435 ---------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence                     1112234456778999999999999999999999999999986554

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.7e-46  Score=359.30  Aligned_cols=269  Identities=26%  Similarity=0.352  Sum_probs=216.6

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEE-------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +.+..++|++.+.||+|+||.||+|.+       .+..||||+++.....        ...+.+.+|+++++++ +||||
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~i   89 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--------TEREALMSELKVLSYLGNHMNI   89 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--------HHHHHHHHHHHHHhhcccCCCe
Confidence            345668899999999999999999986       2357999998743221        2345667999999999 99999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN---------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLI  276 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~ii  276 (441)
                      +++++++.+.+..++||||+++|+|.+++.....               ...+++..+..++.|++.||+|||+++  |+
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~  167 (313)
T 1t46_A           90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CI  167 (313)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence            9999999999999999999999999999976542               225899999999999999999999999  99


Q ss_pred             ecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCC
Q psy5927         277 HGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR  355 (441)
Q Consensus       277 HrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~  355 (441)
                      ||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||+| |..
T Consensus       168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          168 HRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCccceEEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999976543322 112233457889999999988899999999999999999999 999


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                      ||.................            ....+..++..+.+|+.+||+.||.+||++.++++.|+++..++.
T Consensus       247 p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          247 PYPGMPVDSKFYKMIKEGF------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             SSTTCCSSHHHHHHHHHTC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCcccchhHHHHHhccCC------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            9987654332222211111            111223456789999999999999999999999999987665443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-46  Score=352.69  Aligned_cols=261  Identities=20%  Similarity=0.350  Sum_probs=210.3

Q ss_pred             HhhCCCcCcC-ccccCCceeEEEEEE----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLN-ILGKGGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~-~LG~G~fg~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|.+.+ .||+|+||.||+|.+    .+..||||+++....        ....+.+.+|+++++.++||||+++++
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~   77 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVRLIG   77 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--------hhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            3456777777 999999999999986    356799999975422        123456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++ ..+..++||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus        78 ~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~  152 (287)
T 1u59_A           78 VC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKIS  152 (287)
T ss_dssp             EE-ESSSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEEC
T ss_pred             Ee-cCCCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEEC
Confidence            98 56779999999999999998853  3345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++................||+.|+|||.+.+..++.++||||||+++|||+| |..||....... .... +.   
T Consensus       153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~-i~---  227 (287)
T 1u59_A          153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAF-IE---  227 (287)
T ss_dssp             CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-HHHH-HH---
T ss_pred             cccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HHHH-Hh---
Confidence            99999865433222222233457889999999988889999999999999999999 999998765421 1111 11   


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                              .......+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       228 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          228 --------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             --------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                    111123344567889999999999999999999999999977643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-46  Score=376.72  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..||||+++.....      .......+.+|+++++.++||||+++++++.
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~  218 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQ  218 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------------CCCCCSCTTSCCEEEEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh------hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence            44578999999999999999999984  568999998742111      1123345668999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      +.+.+|+|||||++|+|.+++....   .+++..+..++.|++.||+|||+ .+  ||||||||+|||++.++.+||+||
T Consensus       219 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DF  293 (446)
T 4ejn_A          219 THDRLCFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDF  293 (446)
T ss_dssp             ETTEEEEEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCC
T ss_pred             eCCEEEEEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccC
Confidence            9999999999999999999886543   48899999999999999999998 88  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..      
T Consensus       294 G~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~------  363 (446)
T 4ejn_A          294 GLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILM------  363 (446)
T ss_dssp             CCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH------
T ss_pred             CCceeccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHHh------
Confidence            9997533221   2234567999999999999999999999999999999999999999776542 22211111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                             .....+..++.++.+|+.+||+.||.+||     ++.++++
T Consensus       364 -------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          364 -------EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                   11123344567899999999999999999     9999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=386.25  Aligned_cols=258  Identities=19%  Similarity=0.356  Sum_probs=202.4

Q ss_pred             hhCCCcCcC-ccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLN-ILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~-~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..+++.+.+ .||+|+||.||+|.+.    +..||||+++.....        ...+.+.+|+++|+.++|||||+++++
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~~E~~il~~l~hpniv~l~~~  404 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--------ADTEEMMREAQIMHQLDNPYIVRLIGV  404 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--------TTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            344555555 7999999999999873    346999999754221        123467799999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+ +.+++|||||++|+|.+++...  ...+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus       405 ~~~-~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~D  479 (613)
T 2ozo_A          405 CQA-EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISD  479 (613)
T ss_dssp             EES-SSEEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC
T ss_pred             ecc-CCeEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEee
Confidence            875 6799999999999999998543  456899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++................+|..|+|||++.+..++.++|||||||++|||+| |..||......+ ... .+.    
T Consensus       480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~~-~i~----  553 (613)
T 2ozo_A          480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMA-FIE----  553 (613)
T ss_dssp             CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-HHH-HHH----
T ss_pred             ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHH-HHH----
Confidence            9999865432222112222346789999999998899999999999999999998 999998765422 111 111    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                             .......+..++..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       554 -------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          554 -------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   1112233455778899999999999999999999999988764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.6e-46  Score=357.00  Aligned_cols=269  Identities=22%  Similarity=0.349  Sum_probs=209.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..++|++.+.||+|+||.||+|.+      .+..||||++......        ...+.+.+|+++++.++||||+++++
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--------NHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--------hhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            346689999999999999999985      4578999998743211        22345678999999999999999999


Q ss_pred             eEEeC--CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         217 ICFET--GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       217 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ++.+.  ..+++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEE
Confidence            99876  67899999999999999985443  44899999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||+++................||..|+|||.+.+..++.++||||||+++|||+||..|+......   ........
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~  243 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPT  243 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSC
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCc
Confidence            999999986544333223334456888999999999889999999999999999999999987543211   00000000


Q ss_pred             c----hhhh-hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         375 S----EENM-YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       375 ~----~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .    .... .........+.+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             CGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            0    0000 11111223334456778899999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.7e-46  Score=360.96  Aligned_cols=271  Identities=24%  Similarity=0.340  Sum_probs=210.0

Q ss_pred             CCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      .|++.++||+|+||+||++.+      .+..||||+++....        ....+.+.+|+++++.++||||+++++++.
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--------PQHRSGWKQEIDILRTLYHEHIIKYKGCCE  103 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence            349999999999999999875      456799999974322        123455679999999999999999999998


Q ss_pred             e--CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         220 E--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       220 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +  ...+++||||+++|+|.+++...    .+++..+..++.+++.||+|||+.+  |+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~D  177 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGD  177 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECC
Confidence            7  46789999999999999988543    3889999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH-Hhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV-EKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~-~~~~~  376 (441)
                      ||+++................||..|+|||.+.+..++.++||||||+++|||+||..||.............. .....
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV  257 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence            99998654433222233445688889999999998899999999999999999999999976432111100000 00000


Q ss_pred             hhhhhhhc-cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         377 ENMYDLVD-KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       377 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      ......+. ....+.+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            01111111 1223344566788999999999999999999999999998765443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=354.99  Aligned_cols=272  Identities=24%  Similarity=0.329  Sum_probs=205.4

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc--CCCCCeecc
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS--CRHDNILPL  214 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l  214 (441)
                      ........++|++.+.||+|+||.||+|.+.+..||||++.....            .....|.+++..  ++||||+++
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~------------~~~~~e~~~~~~~~~~h~~i~~~   96 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE------------ASWFRETEIYQTVLMRHENILGF   96 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH------------HHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc------------chhhhHHHHHHHHhhcCCCeeeE
Confidence            334455668999999999999999999999999999999863211            122344455444  499999999


Q ss_pred             cceEEeC----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCeeecCCCC
Q psy5927         215 YGICFET----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR--------EPPLIHGDIKS  282 (441)
Q Consensus       215 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~--------~~~iiHrDikp  282 (441)
                      ++++.+.    ...++||||+++|+|.+++...    .+++..+..++.+++.||+|||+.        +  |+||||||
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp  170 (337)
T 3mdy_A           97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKS  170 (337)
T ss_dssp             EEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCG
T ss_pred             EEEEccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccch
Confidence            9999887    7899999999999999999543    489999999999999999999998        7  99999999


Q ss_pred             CCeeecCCCCeEEeccCCCccCCCcccc-cceeccccccCCCcCcccccCCCCCCc------cceehHHHHHHHHHhC--
Q psy5927         283 ANILLNHHMDPVIGDFGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVGKRLSTK------VDVYGFGIVLFELATG--  353 (441)
Q Consensus       283 ~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~------~DiwSlGvvl~elltG--  353 (441)
                      +|||++.++.+||+|||+++........ ........||+.|+|||++.+...+..      +|||||||++|||+||  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            9999999999999999999754332211 111234579999999999988766665      9999999999999999  


Q ss_pred             --------CCCCCCcchhHHHHHHHHHhhchhhhhhhhccCC--CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         354 --------MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNA--QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       354 --------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                              ..||....................    ......  ......++..+.+|+.+||+.||.+||++.+|++.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cccccccccccHhhhcCCCCchhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence                    667754322111111111111000    000111  111347888999999999999999999999999999


Q ss_pred             hcCCCCC
Q psy5927         424 SGSGGES  430 (441)
Q Consensus       424 ~~~~~~~  430 (441)
                      +.+....
T Consensus       327 ~~l~~~~  333 (337)
T 3mdy_A          327 AKMSESQ  333 (337)
T ss_dssp             HHHHHTT
T ss_pred             HHHHhhc
Confidence            8876543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.2e-46  Score=358.64  Aligned_cols=266  Identities=21%  Similarity=0.325  Sum_probs=214.2

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      ++.+..++|++.+.||+|+||.||+|.+.       +..||||.+......        .....+.+|+++++.++||||
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i   90 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--------RERIEFLNEASVMKEFNCHHV   90 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--------HHHHHHHHHHHHGGGCCCTTB
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--------HHHHHHHHHHHHHHhcCCCCE
Confidence            44567789999999999999999999865       457999998643221        233456799999999999999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSAN  284 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~N  284 (441)
                      +++++++.+.+..++||||+++|+|.+++.....       ...+++..+..++.|++.||+|||+++  |+||||||+|
T Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~N  168 (322)
T 1p4o_A           91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARN  168 (322)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGG
T ss_pred             eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccce
Confidence            9999999999999999999999999999865331       245789999999999999999999999  9999999999


Q ss_pred             eeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchh
Q psy5927         285 ILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRS  363 (441)
Q Consensus       285 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~  363 (441)
                      ||++.++.+||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus       169 Ili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  247 (322)
T 1p4o_A          169 CMVAEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE  247 (322)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred             EEEcCCCeEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence            9999999999999999975322211 111223357889999999998889999999999999999999 89999776432


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                       .....+.            .......+..++..+.+|+.+||+.||.+||++.++++.|+....
T Consensus       248 -~~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 -QVLRFVM------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHHHHH------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHHHH------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             1111111            111222334567789999999999999999999999999987644

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-45  Score=351.51  Aligned_cols=269  Identities=21%  Similarity=0.299  Sum_probs=212.1

Q ss_pred             CCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .|...++||+|+||+||+|.+..     ..+|+|++.....        ....+.+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   93 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--------MQQVEAFLREGLLMRGLNHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            46667999999999999998732     2589998864322        1234567799999999999999999999987


Q ss_pred             CCeE-EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKY-CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~-~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+.. ++||||+.+|+|.+++..  ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           94 PEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             SSSCCEEEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             CCCCcEEEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCC
Confidence            6655 999999999999999854  3355889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCccc-ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCC-CCCcchhHHHHHHHHHhhchh
Q psy5927         300 LTQEGPIEKA-THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA-YDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       300 la~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p-~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      +++....... .........+|..|+|||.+.+..++.++||||||+++|||++|..| |..... .... ..+..    
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~-~~~~~----  243 (298)
T 3pls_A          170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLT-HFLAQ----  243 (298)
T ss_dssp             SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHH-HHHHT----
T ss_pred             CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHH-HHhhc----
Confidence            9976433221 11223345688999999999998999999999999999999995554 544332 2111 11111    


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGPTLP  439 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~p~~~  439 (441)
                             ......+..++..+.+++.+||+.||.+|||+.++++.|+++...........+|
T Consensus       244 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~~~lp  298 (298)
T 3pls_A          244 -------GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP  298 (298)
T ss_dssp             -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCBCCCC
T ss_pred             -------CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccchhhCC
Confidence                   1112233445678999999999999999999999999999988777777666665

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.9e-46  Score=361.59  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=202.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC--e----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK--T----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      +..++|++.+.||+|+||+||+|.+..  .    .||+|.+.....        ....+.+.+|+.++++++||||++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~   83 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLL   83 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--------HHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence            345789999999999999999999743  3    357777653211        12345677999999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +++.+. ..++|++|+.+|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        84 ~~~~~~-~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl  158 (327)
T 3poz_A           84 GICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             EEEESS-SEEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEE
T ss_pred             EEEecC-CeEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEE
Confidence            998875 4789999999999999986543  45899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++....... ........||..|+|||.+.+..++.++|||||||++|||+| |..||.......  +...+.. 
T Consensus       159 ~Dfg~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~-  234 (327)
T 3poz_A          159 TDFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK-  234 (327)
T ss_dssp             CCTTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT-
T ss_pred             ccCcceeEccCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHc-
Confidence            99999875332221 112223457889999999999999999999999999999999 999998765422  1111111 


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                                ......+..++..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       235 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 ----------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                      11122334456789999999999999999999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=352.61  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=197.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHH-----------------hhhHHHHHHHHHHHHH
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVE-----------------TLNQCQREQSLRELKY  202 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~-----------------~~~~~~~~~~~~E~~~  202 (441)
                      ...++|++.+.||+|+||.||+|.+.  ++.||||++..........                 .......+.+.+|+++
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            34578999999999999999999984  5789999987543211100                 0011123457799999


Q ss_pred             hhcCCCCCeecccceEEe--CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5927         203 LNSCRHDNILPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI  280 (441)
Q Consensus       203 l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDi  280 (441)
                      ++.++||||+++++++.+  .+.+|+||||+++++|.+++    ....+++..+..++.|++.||+|||+++  |+||||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl  163 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDI  163 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCC
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCC
Confidence            999999999999999986  57899999999999998754    2346899999999999999999999999  999999


Q ss_pred             CCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCC---CCCccceehHHHHHHHHHhCCCCC
Q psy5927         281 KSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAY  357 (441)
Q Consensus       281 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlGvvl~elltG~~p~  357 (441)
                      ||+|||++.++.+||+|||+++......   .......||+.|+|||.+.+..   ++.++|||||||++|||++|..||
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            9999999999999999999997643321   1233457999999999998754   478899999999999999999999


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....... ....+..    ..       ...+....++..+.+|+.+||+.||++||++.++++
T Consensus       241 ~~~~~~~-~~~~~~~----~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          241 MDERIMC-LHSKIKS----QA-------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CCSSHHH-HHHHHHH----CC-------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccHHH-HHHHHhc----cc-------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            7654311 1111111    00       001112245678999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-45  Score=356.51  Aligned_cols=262  Identities=19%  Similarity=0.220  Sum_probs=205.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      ..++|++.+.||+|+||.||+|.+  .+..||||++......           +.+.+|+++++.+ +||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~E~~~l~~l~~h~~i~~~~~~~~   75 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----------PQLHLEYRFYKQLGSGDGIPQVYYFGP   75 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----------CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----------HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence            457899999999999999999997  4678999998643221           2345899999999 9999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC-----eE
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-----PV  294 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~-----~k  294 (441)
                      +.+..++||||+ +++|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.     +|
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~k  150 (330)
T 2izr_A           76 CGKYNAMVLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIH  150 (330)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEE
T ss_pred             cCCccEEEEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEE
Confidence            999999999999 99999998654  346899999999999999999999999  999999999999999887     99


Q ss_pred             EeccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         295 IGDFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      |+|||+++.........    .......||+.|+|||++.+..++.++|||||||++|||++|..||.......  ....
T Consensus       151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~  228 (330)
T 2izr_A          151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKER  228 (330)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHH
T ss_pred             EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHH
Confidence            99999997543221111    11245679999999999999999999999999999999999999998754211  1111


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ...+........    .......++ ++.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       229 ~~~i~~~~~~~~----~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          229 YQKIGDTKRATP----IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHHHHHHSC----HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHhhhccCC----HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            111110000000    000111234 8999999999999999999999999887554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-45  Score=352.96  Aligned_cols=263  Identities=23%  Similarity=0.351  Sum_probs=208.2

Q ss_pred             HHHhhCCCcCcC-ccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         140 LTLATNNWDKLN-ILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       140 ~~~~~~~~~~~~-~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +.+..++|.+.+ .||+|+||.||+|.+.    +..||||+++.....       ....+.+.+|+++++.++||||+++
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~   83 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQLDNPYIVRM   83 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-------HHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            345567888888 9999999999999652    357999998743221       1234567799999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ++++ +.+..++||||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+|
T Consensus        84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           84 IGIC-EAESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             EEEE-ESSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred             EEEE-CCCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEE
Confidence            9998 677889999999999999999653   34889999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |+|||+++................+|..|+|||.+.+..++.++||||||+++|||+| |..||.......  +...+..
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~  235 (291)
T 1xbb_A          158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEK  235 (291)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT
T ss_pred             EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHc
Confidence            9999999765433222222223346788999999988889999999999999999999 999998765421  1111111


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                                 ......+..++..+.+++.+||+.||.+||++.+|++.|+.+-.
T Consensus       236 -----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          236 -----------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       11122344567789999999999999999999999999987543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-46  Score=352.73  Aligned_cols=261  Identities=23%  Similarity=0.381  Sum_probs=214.6

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      .+.+..++|++.+.||+|+||.||+|.+.  +..||+|++.....          ..+.+.+|+++++.++||||+++++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~   76 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLLG   76 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            44567789999999999999999999996  56899999874321          2345678999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.+..++||||+++++|.+++.... ...+++..+..++.+++.||+|||+.+  |+||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           77 VCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEc
Confidence            9999999999999999999999986543 355899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||++.......  ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+..   
T Consensus       154 Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~~~~~~---  227 (288)
T 3kfa_A          154 DFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEK---  227 (288)
T ss_dssp             CCCGGGTSCSSS--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHT---
T ss_pred             cCccceeccCCc--cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhc---
Confidence            999997644322  122333457889999999998899999999999999999999 999998765422 1111111   


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                               ......+..++..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       228 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          228 ---------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                     1111223455678999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=361.23  Aligned_cols=251  Identities=22%  Similarity=0.293  Sum_probs=193.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||+++...           ..+.+.+|++++++++||||+++++++.
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~  118 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----------DKKIVRTEIGVLLRLSHPNIIKLKEIFE  118 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----------hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence            45678999999999999999999995  4579999987432           1234558999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---CCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---HMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~~~~kl~  296 (441)
                      +.+..++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          119 TPTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEc
Confidence            999999999999999999988543   45899999999999999999999999  999999999999975   8999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......    ......||+.|+|||++.+..++.++|||||||++|||++|..||............+..... 
T Consensus       194 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-  268 (349)
T 2w4o_A          194 DFGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-  268 (349)
T ss_dssp             CCC--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-
T ss_pred             cCccccccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-
Confidence            999997643221    223456999999999999989999999999999999999999999766543322222221100 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              ....+....++.++.+|+.+||+.||++||++.++++
T Consensus       269 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 --------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0011222345678999999999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.9e-45  Score=346.83  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=207.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+..  ..||+|++......      .......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE------KAGVEHQLRREVEIQSHLRHPNILRLYGYFH   79 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc------hhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence            345789999999999999999999854  46999998642211      1122345678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEecc
Confidence            999999999999999999988654   34889999999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++.......     .....||+.|+|||.+.+..++.++||||||+++|+|++|..||....... ....+..       
T Consensus       155 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~-------  221 (279)
T 3fdn_A          155 WSVHAPSSR-----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISR-------  221 (279)
T ss_dssp             EESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH-------
T ss_pred             ccccCCccc-----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-HHHHHHh-------
Confidence            986533221     233468999999999999899999999999999999999999998654321 1111111       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESP  431 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~  431 (441)
                            .....+..++..+.+|+.+||+.||.+||++.++++  .+........
T Consensus       222 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          222 ------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             ------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence                  111223345677899999999999999999999996  5555444433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-45  Score=350.89  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=200.5

Q ss_pred             CCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      ++|++.+.||+|+||+||+|.+. +..||+|++.......       ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-------GIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-------ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57999999999999999999985 6789999987543221       122355689999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++||||++ ++|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           75 LVLVFEHLD-QDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             EEEEEECCS-EEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EEEEEEecC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            999999997 5999988643  345889999999999999999999999  99999999999999999999999999865


Q ss_pred             CCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh---h-
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE---N-  378 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~-  378 (441)
                      .....   .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||....... .+..+.......   . 
T Consensus       150 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  225 (288)
T 1ob3_A          150 FGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNW  225 (288)
T ss_dssp             HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred             cCccc---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhc
Confidence            32211   11233468999999999976 458999999999999999999999998765422 333332221100   0 


Q ss_pred             --hhh--hhccC--------CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 --MYD--LVDKN--------AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 --~~~--~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ...  ..+..        .......++.++.+|+.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              000  00000        00112345678899999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-45  Score=361.78  Aligned_cols=251  Identities=18%  Similarity=0.271  Sum_probs=204.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|++.....         .....+.+|+++++.++||||+++++++.+.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---------LDKYTVKNEISIMNQLHHPKLINLHDAFEDK  120 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---------hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence            468999999999999999999985  56799999874321         1223566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC--CCCeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH--HMDPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~--~~~~kl~DFG  299 (441)
                      +.+++||||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+  |+||||||+|||++.  ++.+||+|||
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecc
Confidence            9999999999999999988533  345899999999999999999999999  999999999999974  5779999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +++.......    .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..+.....    
T Consensus       197 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~----  267 (387)
T 1kob_A          197 LATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDW----  267 (387)
T ss_dssp             TCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCC----
T ss_pred             cceecCCCcc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC----
Confidence            9986433221    23346999999999999989999999999999999999999999876542 22222211100    


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .........++.++.+|+.+||+.||.+||++.++++
T Consensus       268 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          268 -----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                 0011122345678999999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=351.68  Aligned_cols=267  Identities=21%  Similarity=0.297  Sum_probs=200.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC---CCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC---RHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~  216 (441)
                      ...++|++.++||+|+||+||+|.+  .++.||||++...........    ......+|+++++.+   +||||+++++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG----LPISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC----CCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc----cchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            5578999999999999999999996  467899999975442211100    011233555555554   5999999999


Q ss_pred             eEEeCC-----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         217 ICFETG-----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       217 ~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      ++....     ..++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGG  157 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTS
T ss_pred             eeeccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCC
Confidence            998765     5899999996 69999886543 344899999999999999999999999  99999999999999999


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      .+||+|||+++......    ......||+.|+|||++.+..++.++|||||||++|||++|.+||...... ..+..+.
T Consensus       158 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~  232 (308)
T 3g33_A          158 TVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIF  232 (308)
T ss_dssp             CEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHH
T ss_pred             CEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence            99999999997643222    223457999999999999989999999999999999999999999876652 3333333


Q ss_pred             Hhhch---hhhhh-------hhc-cC---CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         372 EKYSE---ENMYD-------LVD-KN---AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       372 ~~~~~---~~~~~-------~~~-~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .....   .....       ... ..   .......++..+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            32211   00000       000 00   00112345678899999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.3e-45  Score=358.20  Aligned_cols=267  Identities=21%  Similarity=0.252  Sum_probs=207.1

Q ss_pred             CCChhHHHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC----
Q psy5927         134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR----  207 (441)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----  207 (441)
                      .+++.+.....++|++.++||+|+||+||+|.+  .+..||||+++...          ........|+.+++.++    
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~   93 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----------KYTRSAKIEADILKKIQNDDI   93 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----------HHHHHHHHHHHHHHHTCCCST
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----------hhhhhhHHHHHHHHHhcccCC
Confidence            344555567789999999999999999999998  46789999986321          12234457888888886    


Q ss_pred             -CCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCee
Q psy5927         208 -HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL  286 (441)
Q Consensus       208 -hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiL  286 (441)
                       ||||+++++++...+..|+||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+  |+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIl  169 (360)
T 3llt_A           94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENIL  169 (360)
T ss_dssp             TGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             CCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEE
Confidence             999999999999999999999999 999999887543 345899999999999999999999999  999999999999


Q ss_pred             ecC-------------------------CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCcccee
Q psy5927         287 LNH-------------------------HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVY  341 (441)
Q Consensus       287 l~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Diw  341 (441)
                      ++.                         ++.+||+|||+++.....      .....||+.|+|||++.+..++.++|||
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Diw  243 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMW  243 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchH
Confidence            975                         789999999999753321      2345689999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hhh--------hhhhcc----------------------CCC
Q psy5927         342 GFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---ENM--------YDLVDK----------------------NAQ  388 (441)
Q Consensus       342 SlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~--------~~~~~~----------------------~~~  388 (441)
                      ||||++|||+||..||..... ...+..+......   ...        ....+.                      ...
T Consensus       244 slG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  322 (360)
T 3llt_A          244 SFGCVLAELYTGSLLFRTHEH-MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP  322 (360)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHCCCCCCCCcH-HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence            999999999999999987654 2222222221110   000        000000                      000


Q ss_pred             chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         389 PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       389 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .........+.+|+.+||+.||.+|||+.++++
T Consensus       323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            011111266889999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.9e-46  Score=359.40  Aligned_cols=260  Identities=22%  Similarity=0.374  Sum_probs=202.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC--ee----EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK--TT----IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..++|++.+.||+|+||+||+|.+..  ..    +|+|.+.......        ....+.+|+.+++.++||||+++++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~   82 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--------SFQAVTDHMLAIGSLDHAHIVRLLG   82 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--------CBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--------HHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            34689999999999999999999843  33    6777764322111        1123447899999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++. ++..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~  157 (325)
T 3kex_A           83 LCP-GSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVA  157 (325)
T ss_dssp             EEC-BSSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEEC
T ss_pred             EEc-CCccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEEC
Confidence            886 56789999999999999998643  245888999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++....... ........||..|+|||.+.+..++.++|||||||++|||+| |..||.......  +...+... 
T Consensus       158 Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~-  233 (325)
T 3kex_A          158 DFGVADLLPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKG-  233 (325)
T ss_dssp             SCSGGGGSCCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTT-
T ss_pred             CCCcccccCcccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcC-
Confidence            9999986543322 122334568889999999998899999999999999999999 999998765422  11111110 


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                                .....+..++.++.+++.+||+.||.+||++.++++.|+.+..+
T Consensus       234 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 ----------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                      11112223455688999999999999999999999999877543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.3e-45  Score=360.87  Aligned_cols=270  Identities=22%  Similarity=0.333  Sum_probs=195.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++......       ........+|+.+++.+. ||||+++++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-------STDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            45689999999999999999999984  578999998633211       123455679999999997 99999999999


Q ss_pred             EeCC--eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         219 FETG--KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       219 ~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ...+  .+|+|||||+ |+|.+++..    ..+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           79 RADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             ECTTSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             ecCCCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEec
Confidence            7544  7899999996 789988854    24889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcc------------------cccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCC
Q psy5927         297 DFGLTQEGPIEK------------------ATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAY  357 (441)
Q Consensus       297 DFGla~~~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~  357 (441)
                      |||+++......                  .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            999997532210                  01122344679999999999987 67899999999999999999999999


Q ss_pred             CCcchhHHHHHHHHHhhch---hhhhhhh------------------ccCCCch-------------hHHHHHHHHHHHH
Q psy5927         358 DDTRRSERHLKSLVEKYSE---ENMYDLV------------------DKNAQPI-------------ELNIAYAFFRIGK  403 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~---~~~~~~~------------------~~~~~~~-------------~~~~~~~l~~li~  403 (441)
                      .+... ...+..+......   +.+....                  .......             ...++.++.+|+.
T Consensus       232 ~~~~~-~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          232 PGSST-MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CCSSH-HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCCCH-HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            87654 2333333322210   0000000                  0000000             0134567899999


Q ss_pred             HhcCCCCCCCCCHHHHHHH--HhcC
Q psy5927         404 QSTKQNPKERPEMTQVYNM--LSGS  426 (441)
Q Consensus       404 ~cl~~dp~~RPs~~evl~~--L~~~  426 (441)
                      +||..||++|||+.++++.  |+..
T Consensus       311 ~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             HhhccCcccCCCHHHHhCCHHHHHh
Confidence            9999999999999999874  4443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.9e-46  Score=360.36  Aligned_cols=269  Identities=21%  Similarity=0.329  Sum_probs=213.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +..++|.+.+.||+|+||.||+|.+.         +..||||+++.....        ...+.+.+|+++++++ +||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~i  103 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--------KDLSDLVSEMEMMKMIGKHKNI  103 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--------HHHHHHHHHHHHHHHhhcCCCE
Confidence            45678999999999999999999974         346999998743221        2345667899999999 89999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeec
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHG  278 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHr  278 (441)
                      +++++++.+.+..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+  |+||
T Consensus       104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~  181 (334)
T 2pvf_A          104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHR  181 (334)
T ss_dssp             CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCC
Confidence            9999999999999999999999999999975442             234889999999999999999999999  9999


Q ss_pred             CCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCC
Q psy5927         279 DIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAY  357 (441)
Q Consensus       279 Dikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~  357 (441)
                      ||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||+| |..||
T Consensus       182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          182 DLAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCccceEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999976433221 111223457888999999988889999999999999999999 99999


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNAT  434 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~  434 (441)
                      ...... .....+...            .....+..++..+.+++.+||+.||.+||++.+|++.|+.+....+...
T Consensus       261 ~~~~~~-~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~  324 (334)
T 2pvf_A          261 PGIPVE-ELFKLLKEG------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE  324 (334)
T ss_dssp             TTCCHH-HHHHHHHHT------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             CcCCHH-HHHHHHhcC------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCc
Confidence            876432 222211111            1112334566789999999999999999999999999988765544433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-45  Score=355.40  Aligned_cols=270  Identities=22%  Similarity=0.323  Sum_probs=215.4

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-  206 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  206 (441)
                      +....+....++|++.+.||+|+||.||+|.+.       +..||||+++.....        ...+.+.+|++++.++ 
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~   88 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------SEHRALMSELKILIHIG   88 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHC
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--------HHHHHHHHHHHHHHhcc
Confidence            344566677889999999999999999999862       357999998743221        2334567899999999 


Q ss_pred             CCCCeecccceEEeCC-eEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy5927         207 RHDNILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSRE  272 (441)
Q Consensus       207 ~hpnIv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~  272 (441)
                      +||||+++++++...+ .+++||||+++|+|.+++.....             ...+++..+..++.|++.||+|||+.+
T Consensus        89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  168 (316)
T 2xir_A           89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK  168 (316)
T ss_dssp             CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            7999999999987754 58999999999999999975443             123789999999999999999999999


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh
Q psy5927         273 PPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT  352 (441)
Q Consensus       273 ~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt  352 (441)
                        |+||||||+|||++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++||||||+++|||+|
T Consensus       169 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          169 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             --CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --cccccCccceEEECCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence              9999999999999999999999999997643322 1122334568899999999998899999999999999999998


Q ss_pred             -CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         353 -GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       353 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                       |..||............+...            .....+..++..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       246 ~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          246 LGASPYPGVKIDEEFCRRLKEG------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHT------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcccchhHHHHHHhccC------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             999998765433332222211            111223345668999999999999999999999999998653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.2e-45  Score=352.30  Aligned_cols=268  Identities=24%  Similarity=0.396  Sum_probs=193.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||+|+++......        ..+.+.+|+++++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   75 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--------TPSTAIREISLMKELKHENIVRLYDVIHTE   75 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--------SCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--------cHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence            468999999999999999999875  5689999997543211        123456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKK---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      +.+|+||||++ |+|.+++....   ....+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+||
T Consensus        76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred             CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcC
Confidence            99999999997 69999886543   2245889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch-
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE-  376 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-  376 (441)
                      |+++.......   ......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ...+..+...... 
T Consensus       153 g~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          153 GLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTP  228 (317)
T ss_dssp             SSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSC
T ss_pred             ccceecCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence            99976432211   1234468999999999977 4689999999999999999999999987654 2333333322110 


Q ss_pred             -hhhhhhhc------c-----CCC--------chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         377 -ENMYDLVD------K-----NAQ--------PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       377 -~~~~~~~~------~-----~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                       ........      .     ...        .....++.++.+|+.+||+.||++|||+.++++  .+.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  300 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY  300 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence             00000000      0     000        011134568999999999999999999999986  45443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.9e-45  Score=358.86  Aligned_cols=252  Identities=21%  Similarity=0.325  Sum_probs=192.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||+||+|.+.  +..||||++......          .+.+.+|+.+++.++||||+++++++.+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~   87 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----------DENVQREIINHRSLRHPNIVRFKEVILT   87 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----------CHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----------cHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence            3578999999999999999999984  568999998743221          1245589999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC--eEEecc
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD--PVIGDF  298 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~--~kl~DF  298 (441)
                      .+.+|+||||+++|+|.+++....   .+++..+..++.|++.||+|||++|  |+||||||+|||++.++.  +||+||
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeec
Confidence            999999999999999999886543   4899999999999999999999999  999999999999987766  999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCc-cceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+++......    ......||+.|+|||++.+..++.+ +|||||||++|||++|..||.......... .........
T Consensus       163 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-~~~~~~~~~  237 (361)
T 3uc3_A          163 GYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-KTIQRILSV  237 (361)
T ss_dssp             CCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH-HHHHHHHTT
T ss_pred             CccccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhcC
Confidence            9997432221    2234469999999999988777655 999999999999999999997654322221 111111000


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             ....+....++..+.+|+.+||+.||.+|||+.++++
T Consensus       238 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          238 -------KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -------CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -------CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                   0011112234667899999999999999999999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-45  Score=370.74  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=208.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|.+.+.||+|+||.||+|.+.  +..||||++......      .....+.+.+|+++++.++||||+++++++.
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~   86 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR------SLDVVGKIRREIQNLKLFRHPHIIKLYQVIS   86 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH------HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34578999999999999999999985  678999999743211      1122446679999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+||||++||+|.+++..   ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCS
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEecc
Confidence            99999999999999999998853   345899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++......    .....+||+.|+|||.+.+..+ +.++|||||||++|||++|..||.+... ......+..      
T Consensus       162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~------  230 (476)
T 2y94_A          162 LSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFKKICD------  230 (476)
T ss_dssp             SCEECCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHHHHHT------
T ss_pred             chhhccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhc------
Confidence            997643322    2334579999999999998765 6899999999999999999999987654 222222111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                             .....+..++.++.+|+.+||+.||.+|||+.++++  .+..
T Consensus       231 -------~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          231 -------GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             -------TCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             -------CCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                   011223345667899999999999999999999987  5554

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-45  Score=373.10  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=209.8

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      .+.+..++|++.++||+|+||.||+|.+++ ..||||+++....          ..+.+.+|+++|++++||||++++++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~  247 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYAV  247 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----------CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            345667789999999999999999999975 5799999874321          12356799999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+ +..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus       248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D  323 (452)
T 1fmk_A          248 VSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVAD  323 (452)
T ss_dssp             ECS-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECC
T ss_pred             EcC-CceEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECC
Confidence            876 67899999999999999996432 234889999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++.......  .......++..|+|||.+.+..++.++|||||||++|||+| |..||......+ ....+.     
T Consensus       324 fG~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~-----  395 (452)
T 1fmk_A          324 FGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVE-----  395 (452)
T ss_dssp             CCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHH-----
T ss_pred             CccceecCCCce--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH-----
Confidence            999986432211  11223346788999999998899999999999999999999 999998765421 221111     


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                             .....+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus       396 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          396 -------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             -------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence                   111223344567889999999999999999999999999998865543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-44  Score=342.95  Aligned_cols=259  Identities=22%  Similarity=0.290  Sum_probs=208.5

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++......       ....+.+.+|++++++++||||+++++++.+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-------ARDFQKLEREARICRKLQHPNIVRLHDSIQE   76 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence            4578999999999999999999985  568999998754322       1234456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---eEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---~kl~D  297 (441)
                      .+..++||||+++++|.+.+...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.   +||+|
T Consensus        77 ~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~D  151 (284)
T 3kk8_A           77 ESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLAD  151 (284)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEee
Confidence            99999999999999999988654   34889999999999999999999999  999999999999987665   99999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||++........    .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ...........  
T Consensus       152 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~--  224 (284)
T 3kk8_A          152 FGLAIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAY--  224 (284)
T ss_dssp             CTTCEECCSSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCC--
T ss_pred             ceeeEEcccCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhccc--
Confidence            999976433221    23356999999999999989999999999999999999999999776542 22222111100  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                             ....+....++..+.+|+.+||+.||.+||++.++++  .+....
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          225 -------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             -------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             -------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence                   0011112345677899999999999999999999987  454443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-45  Score=351.35  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCee
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL  212 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  212 (441)
                      +..++|.+.+.||+|+||+||+|.+..         ..||+|++.....         ...+.+.+|+++++.++||||+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv   75 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---------NYSESFFEAASMMSKLSHKHLV   75 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---------GGHHHHHHHHHHHHTSCCTTBC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---------HHHHHHHHHHHHHHhCCCCCEe
Confidence            345789999999999999999998754         3599999864321         2234567999999999999999


Q ss_pred             cccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       213 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      ++++++.+.+..++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~  151 (289)
T 4fvq_A           76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREED  151 (289)
T ss_dssp             CEEEEECCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCB
T ss_pred             EEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCc
Confidence            99999999999999999999999999996543  34889999999999999999999999  999999999999999887


Q ss_pred             --------eEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhC-CCCCCCcch
Q psy5927         293 --------PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATG-MRAYDDTRR  362 (441)
Q Consensus       293 --------~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG-~~p~~~~~~  362 (441)
                              +||+|||++......       ....||..|+|||.+.+ ..++.++||||||+++|||++| .+||.....
T Consensus       152 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          152 RKTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             GGGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ccccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence                    999999998653221       22358999999999987 6789999999999999999995 455544332


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                       ....... ..             ....+...+.++.+|+.+||+.||.+||++.++++.|+++...
T Consensus       225 -~~~~~~~-~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          225 -QRKLQFY-ED-------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             -HHHHHHH-HT-------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             -HHHHHHh-hc-------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence             2111111 10             0111122345688999999999999999999999999988763

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-45  Score=378.35  Aligned_cols=255  Identities=24%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..||||++......      .......+.+|+++|+.++||||+++++++.
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  254 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALNEKQILEKVNSRFVVSLAYAYE  254 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh------hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            45678999999999999999999984  678999999743211      1122345678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+.+|+||||++||+|.+++.... ...+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFG  331 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLG  331 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecc
Confidence            9999999999999999999886543 345899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchh--HHHHHHHHHhhchh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS--ERHLKSLVEKYSEE  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~  377 (441)
                      +++......    .....+||+.|+|||++.+..++.++|||||||++|||++|..||......  ...+...+.     
T Consensus       332 la~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-----  402 (576)
T 2acx_A          332 LAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-----  402 (576)
T ss_dssp             TCEECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-----
T ss_pred             cceecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-----
Confidence            997643322    123457999999999999989999999999999999999999999765321  111111111     


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                             ......+..++.++.+|+.+||+.||.+||     ++.+|++
T Consensus       403 -------~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          403 -------EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -------cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                   111223345677899999999999999999     7888875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-44  Score=364.99  Aligned_cols=259  Identities=20%  Similarity=0.285  Sum_probs=198.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||+||+|.+.  +..||||++.....       .....+.+.+|+.+++.++||||+++++++..
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  132 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTP  132 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-------ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence            3578999999999999999999984  57899999974321       12334567799999999999999999999865


Q ss_pred             C------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         221 T------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       221 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      .      ..+|+|||||++ +|.+.+..     .+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+|
T Consensus       133 ~~~~~~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          133 QKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             CCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEE
T ss_pred             CCccccCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEE
Confidence            4      467999999965 56666632     3889999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||+++.....    ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+....
T Consensus       205 l~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~l  279 (464)
T 3ttj_A          205 ILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQL  279 (464)
T ss_dssp             ECCCCCC-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHH
T ss_pred             EEEEEeeeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhc
Confidence            9999999764322    123445799999999999999999999999999999999999999987654 23333333322


Q ss_pred             chh----------hhhhhhcc-------------------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SEE----------NMYDLVDK-------------------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~~----------~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...          ....++..                   .........+.++.+|+.+||..||++|||+.|+++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100          00011110                   011112233678999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-44  Score=346.60  Aligned_cols=264  Identities=18%  Similarity=0.219  Sum_probs=209.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      +..++|++.+.||+|+||.||+|.+  .+..||||++......           +.+.+|+.++..+ +|+||+++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~~~~l~~~~~i~~~~~~~   75 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----------PQLRDEYRTYKLLAGCTGIPNVYYFG   75 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----------CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----------HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence            4567899999999999999999996  5678999998643221           1345788999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC-----e
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-----P  293 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~-----~  293 (441)
                      .+....++||||+ +++|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.     +
T Consensus        76 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           76 QEGLHNVLVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCE
T ss_pred             CCCceeEEEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeE
Confidence            9999999999999 99999998654  335899999999999999999999999  999999999999987776     9


Q ss_pred             EEeccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchh--HHHH
Q psy5927         294 VIGDFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS--ERHL  367 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~--~~~l  367 (441)
                      ||+|||+++.........    .......||+.|+|||.+.+..++.++||||||+++|||++|..||......  ....
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            999999997643322111    1234557999999999999989999999999999999999999999874321  1112


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      ..+.......        ........++..+.+|+.+||+.||.+||++.+|++.|+++...
T Consensus       231 ~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          231 ERIGEKKQST--------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHHHHHHS--------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHhhccCc--------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            2211111000        01111224567899999999999999999999999999876544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.3e-46  Score=360.45  Aligned_cols=265  Identities=24%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +.+..++|++.+.||+|+||.||+|.+.+       ..||+|.+......        ...+.+.+|+++++.+ +||||
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~~i  112 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--------DEKEALMSELKIMSHLGQHENI  112 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--------HHHHHHHHHHHHHHhhcCCCCe
Confidence            45667899999999999999999999853       26999998743321        2345667999999999 89999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-----------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDI  280 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDi  280 (441)
                      +++++++.+.+..++||||+++|+|.+++.....           ...+++..+..++.|++.||+|||+.+  |+||||
T Consensus       113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dl  190 (333)
T 2i1m_A          113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDV  190 (333)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred             eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCc
Confidence            9999999999999999999999999999865431           345889999999999999999999999  999999


Q ss_pred             CCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCC
Q psy5927         281 KSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD  359 (441)
Q Consensus       281 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~  359 (441)
                      ||+|||++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus       191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          191 AARNVLLTNGHVAKIGDFGLARDIMNDS-NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             SGGGCEEEGGGEEEBCCCGGGCCGGGCT-TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ccceEEECCCCeEEECcccccccccccc-ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            9999999999999999999997532221 1112233457889999999988889999999999999999999 9999987


Q ss_pred             cchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      ...............            ....+..++..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus       270 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          270 ILVNSKFYKLVKDGY------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             CCSSHHHHHHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHhcCC------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            654332222211111            11122334668899999999999999999999999998653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.8e-45  Score=375.51  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=207.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  ++.||+|++......      .....+.+.+|+++++.++||||+++++++.+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  256 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK------KRKGYQGAMVEKKILAKVHSRFIVSLAYAFET  256 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh------hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence            4578999999999999999999984  678999999743211      11224466789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+.+|+||||++||+|.+++..... ...+++..+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecc
Confidence            9999999999999999999865432 456999999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +++.......   .....+||+.|+|||++.+..++.++|||||||++|||+||..||....... ....+...+     
T Consensus       335 la~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i-----  405 (543)
T 3c4z_A          335 LAVELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRV-----  405 (543)
T ss_dssp             TCEECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHH-----
T ss_pred             eeeeccCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHH-----
Confidence            9976433221   1234579999999999999999999999999999999999999997653211 001111111     


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM-----TQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~  421 (441)
                          .......+..++..+.+|+.+||+.||.+||++     .+|++
T Consensus       406 ----~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          406 ----LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ----HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ----hhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                011122344567789999999999999999975     66654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.1e-45  Score=351.82  Aligned_cols=269  Identities=23%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      ++.+..++|.+.+.||+|+||.||+|.+..     ..||+|+++.....       ....+.+.+|+.++++++||||++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~  100 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-------QREIEEFLSEAACMKDFSHPNVIR  100 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-------hhHHHHHHHHHHHHhcCCCCCeee
Confidence            344667889999999999999999998742     36999998754322       123456779999999999999999


Q ss_pred             ccceEEeCC-----eEEEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         214 LYGICFETG-----KYCLVYRYMPNGSLEDRLLMKK---NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       214 l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      +++++.+.+     ..++||||+++|+|.+++....   ....+++..++.++.|++.||.|||+.+  |+||||||+||
T Consensus       101 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NI  178 (313)
T 3brb_A          101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNC  178 (313)
T ss_dssp             CCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGE
T ss_pred             eeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceE
Confidence            999988654     4599999999999999985432   3456999999999999999999999999  99999999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhH
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSE  364 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~  364 (441)
                      |++.++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  257 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE  257 (313)
T ss_dssp             EECTTSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEcCCCcEEEeecCcceeccccccc-CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            9999999999999999764322111 11223457889999999999899999999999999999999 999997765422


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                       ......            .......+..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus       258 -~~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          258 -MYDYLL------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             -HHHHHH------------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -HHHHHH------------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             111111            11122234456678999999999999999999999999998765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-45  Score=355.24  Aligned_cols=272  Identities=19%  Similarity=0.251  Sum_probs=206.4

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....++|++.+.||+|+||.||+|.+.  +..||+|++......    .......+.+.+|+++++.++||||+++++++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   97 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR----QINPKDVERIKTEVRLMKKLHHPNIARLYEVY   97 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----C---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhc----ccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence            456788999999999999999999985  457999998743211    11123445677999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCC-------------------------------------CCCCCHHHHHHHHHHH
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKN-------------------------------------TPSLLWTQRLHIAKGT  261 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i  261 (441)
                      .+.+..|+||||+++|+|.+++.....                                     ...+++..+..++.|+
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            999999999999999999998842110                                     1123567788999999


Q ss_pred             HHHHHHHHcCCCCeeecCCCCCCeeecCCC--CeEEeccCCCccCCCcc-cccceeccccccCCCcCcccccC--CCCCC
Q psy5927         262 SLGLQFLHSREPPLIHGDIKSANILLNHHM--DPVIGDFGLTQEGPIEK-ATHITLKRVNGTRPYLPHEFLVG--KRLST  336 (441)
Q Consensus       262 ~~al~~LH~~~~~iiHrDikp~NiLl~~~~--~~kl~DFGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~--~~~s~  336 (441)
                      +.||+|||+.+  |+||||||+|||++.++  .+||+|||+++...... ..........||+.|+|||.+.+  ..++.
T Consensus       178 ~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          178 FSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            99999999999  99999999999998776  89999999997532211 11112344569999999999975  67899


Q ss_pred             ccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH
Q psy5927         337 KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM  416 (441)
Q Consensus       337 ~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  416 (441)
                      ++|||||||++|||++|..||....... ....+.....         ....+....++..+.+|+.+||+.||.+||++
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKL---------CFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC---------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhccc---------ccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            9999999999999999999998765422 2222221110         00112223456789999999999999999999


Q ss_pred             HHHHH--HHhcCCC
Q psy5927         417 TQVYN--MLSGSGG  428 (441)
Q Consensus       417 ~evl~--~L~~~~~  428 (441)
                      .++++  .+++...
T Consensus       326 ~~~l~hp~~~~~~~  339 (345)
T 3hko_A          326 MRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHSHHHHTTSS
T ss_pred             HHHhcChhhccChH
Confidence            99987  5665543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-45  Score=344.82  Aligned_cols=258  Identities=21%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.+.||+|+||.||+|.+ ++..||+|++......          .+.+.+|+++++.++||||+++++++.+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   74 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGVCLE   74 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4457899999999999999999998 4568999998753321          2346689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++++|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~  150 (267)
T 3t9t_A           75 QAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGM  150 (267)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTG
T ss_pred             CCCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccc
Confidence            999999999999999999986543  45889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++......  ........+|..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+...      
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~i~~~------  221 (267)
T 3t9t_A          151 TRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTG------  221 (267)
T ss_dssp             GGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTT------
T ss_pred             cccccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-HHHHHHhcC------
Confidence            87643221  111223457788999999998889999999999999999999 89999876442 222221111      


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                            .....+..++..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       222 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 ------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  1111223456788999999999999999999999999987643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=363.58  Aligned_cols=266  Identities=22%  Similarity=0.319  Sum_probs=199.9

Q ss_pred             CCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ..|++.+.||+|+||+||+|.+..     ..+|||.++.....        ...+.+.+|+.++++++||||+++++++.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~~~~~~~  160 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--------GEVSQFLTEGIIMKDFSHPNVLSLLGICL  160 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--------HHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--------HHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            357778999999999999998731     25788888643221        23456779999999999999999999875


Q ss_pred             e-CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         220 E-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       220 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      + .+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+||
T Consensus       161 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          161 RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeec
Confidence            4 46789999999999999998543  345788999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccc-cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         299 GLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       299 Gla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |+++........ ........+|..|+|||.+.+..++.++|||||||++|||+| |.+||........ .....     
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-~~~~~-----  310 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLL-----  310 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-HHHHH-----
T ss_pred             cccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-HHHHH-----
Confidence            999754322211 111223457888999999998899999999999999999999 7888876543221 11111     


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATG  435 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  435 (441)
                             .......+..++..+.+++.+||+.||++||++.+|++.|+.+.........
T Consensus       311 -------~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~  362 (373)
T 3c1x_A          311 -------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  362 (373)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence                   1111222344667899999999999999999999999999887666554443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.6e-45  Score=348.44  Aligned_cols=263  Identities=22%  Similarity=0.329  Sum_probs=204.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEECCe-----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEKT-----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ..+|++.+.||+|+||+||+|.+...     .+|+|.+.....        ....+.+.+|+.++++++||||+++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--------HHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            35688899999999999999997432     478888764322        12345677999999999999999999986


Q ss_pred             E-eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         219 F-ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       219 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      . ..+..++||||+++|+|.+++..  ....+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        96 ~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A           96 LRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             CCSSSCCEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECS
T ss_pred             EcCCCceEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECc
Confidence            5 45678999999999999999854  3345889999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccc-cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         298 FGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       298 FGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      ||+++........ ........||+.|+|||.+.+..++.++||||||+++|||++ |.+||....... ......    
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~~~~~~----  246 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYLL----  246 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-HHHHHH----
T ss_pred             ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHh----
Confidence            9999765432211 122234457889999999998899999999999999999999 666776554322 111111    


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                              .......+..++..+.+++.+||+.||.+||++.++++.|+++.....
T Consensus       247 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          247 --------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             --------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                    111122233456789999999999999999999999999988755443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=346.40  Aligned_cols=262  Identities=23%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||++.......       ...+.+.+|++++++++||||+++++++.+.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-------VIKKIALREIRMLKQLKHPNLVNLLEVFRRK   74 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H-------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCCccchhheeecC
Confidence            368999999999999999999985  6789999986543322       2344566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+++++|.+++...   ..+++..+..++.+++.||+|||+.|  |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~  149 (311)
T 4agu_A           75 RRLHLVFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFA  149 (311)
T ss_dssp             TEEEEEEECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CeEEEEEEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence            9999999999999998877533   34889999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---h
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---E  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~  377 (441)
                      +.......   ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||....... ....+......   .
T Consensus       150 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~  225 (311)
T 4agu_A          150 RLLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-QLYLIRKTLGDLIPR  225 (311)
T ss_dssp             EECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred             hhccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhcccccc
Confidence            76432211   1234468999999999976 568999999999999999999999998765432 22222211110   0


Q ss_pred             hhh-----hhhccC-------CCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMY-----DLVDKN-------AQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~-----~~~~~~-------~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...     ......       ...   ....++..+.+|+.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000     000000       000   01245677899999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=349.45  Aligned_cols=248  Identities=24%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      ...++|++.++||+|+||+||+|.+.  +..||||++.......       ........|+..+..+ +||||+++++++
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~~~~~~~h~~iv~l~~~~  126 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-------KDRARKLAEVGSHEKVGQHPCCVRLEQAW  126 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-------HHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence            45578999999999999999999985  6789999876432221       1223344566555554 899999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+++.+|+||||+ +++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus       127 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          127 EEGGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCC
T ss_pred             EeCCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccc
Confidence            9999999999999 789999886543  45999999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |++.......    ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....    ...+.    .. 
T Consensus       202 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~~~~----~~-  267 (311)
T 3p1a_A          202 GLLVELGTAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----WQQLR----QG-  267 (311)
T ss_dssp             TTCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHT----TT-
T ss_pred             eeeeecccCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHh----cc-
Confidence            9987643222    1234469999999999987 799999999999999999999777654322    11111    00 


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            ......+..++.++.+|+.+||+.||++||++.++++
T Consensus       268 ------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          268 ------YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                  0011223345678999999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=343.74  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=184.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+  .+..||||++......      .....+.+.+|+++++.++||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY------KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh------hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            46799999999999999999998  4678999998632211      111234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~  159 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLA  159 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecce
Confidence            9999999999999999988643  346899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........   ......||+.|+|||.+.+..++.++||||||+++|||++|..||....... .+.    ...      
T Consensus       160 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~------  225 (278)
T 3cok_A          160 TQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLN----KVV------  225 (278)
T ss_dssp             EECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC------
T ss_pred             eeccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHH----HHh------
Confidence            76432211   1223568999999999998889999999999999999999999997654311 110    000      


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ......+..++.++.+|+.+||+.||.+||++.++++
T Consensus       226 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 ---LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               0111223345678899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=357.98  Aligned_cols=271  Identities=23%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      +..++|++.+.||+|+||.||+|.++++.||||++......          ......|+..+..++||||+++++.+.. 
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~----------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ----------NFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHH----------HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchh----------hHHHHHHHHHHHhccCcchhhheeccccc
Confidence            44578999999999999999999999999999998643211          0111244445566899999999986542 


Q ss_pred             ----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCeeecCCCCCCeee
Q psy5927         221 ----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR---------EPPLIHGDIKSANILL  287 (441)
Q Consensus       221 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~---------~~~iiHrDikp~NiLl  287 (441)
                          ...+++||||+++|+|.+++....    .++..+..++.|++.||+|||+.         +  |+||||||+|||+
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill  153 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLV  153 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEE
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEE
Confidence                236789999999999999985432    57899999999999999999998         7  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCccc-----ccceeccccccCCCcCcccccC-------CCCCCccceehHHHHHHHHHhCCC
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKA-----THITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFELATGMR  355 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlGvvl~elltG~~  355 (441)
                      +.++.+||+|||+++.......     .........||+.|+|||++.+       ..++.++|||||||++|||++|..
T Consensus       154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            9999999999999976432211     1122334569999999999987       456789999999999999999977


Q ss_pred             CCCCcchhHHHHHHHHHhh----chhhhhhhhcc--------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q psy5927         356 AYDDTRRSERHLKSLVEKY----SEENMYDLVDK--------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML  423 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~----~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  423 (441)
                      ||.................    ...........        ........++..+.+|+.+||+.||++|||+.+|++.|
T Consensus       234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L  313 (336)
T 3g2f_A          234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM  313 (336)
T ss_dssp             GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence            7643221111000000000    00000000000        01111235777899999999999999999999999998


Q ss_pred             hcCCC
Q psy5927         424 SGSGG  428 (441)
Q Consensus       424 ~~~~~  428 (441)
                      +.+..
T Consensus       314 ~~ll~  318 (336)
T 3g2f_A          314 AELMM  318 (336)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.5e-44  Score=352.52  Aligned_cols=273  Identities=25%  Similarity=0.335  Sum_probs=210.4

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc--CCCCCee
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS--CRHDNIL  212 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv  212 (441)
                      .+........++|.+.+.||+|+||.||+|.++++.||||++....            ...+.+|.+++..  ++||||+
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~ni~   99 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------------ERSWFREAEIYQTVMLRHENIL   99 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHSCCCCTTBC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------------HHHHHHHHHHHHHhhcCCCcEE
Confidence            4444455667899999999999999999999999999999986321            1234577888776  7999999


Q ss_pred             cccceEEeCC----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeeecCC
Q psy5927         213 PLYGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH--------SREPPLIHGDI  280 (441)
Q Consensus       213 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~iiHrDi  280 (441)
                      ++++++....    ..++||||+++|+|.+++...    .+++..++.++.|++.||+|||        +.+  |+||||
T Consensus       100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dl  173 (342)
T 1b6c_B          100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDL  173 (342)
T ss_dssp             CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCC
T ss_pred             EEEeeecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCC
Confidence            9999998776    899999999999999999643    4899999999999999999999        777  999999


Q ss_pred             CCCCeeecCCCCeEEeccCCCccCCCcccc-cceeccccccCCCcCcccccCC------CCCCccceehHHHHHHHHHhC
Q psy5927         281 KSANILLNHHMDPVIGDFGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVGK------RLSTKVDVYGFGIVLFELATG  353 (441)
Q Consensus       281 kp~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlGvvl~elltG  353 (441)
                      ||+|||++.++.+||+|||+++........ ........||+.|+|||.+.+.      .++.++|||||||++|||+||
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999999999999753322111 1123445799999999999875      344789999999999999999


Q ss_pred             ----------CCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCC--chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         354 ----------MRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQ--PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       354 ----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                                ..||............+.......    .......  .....++..+.+|+.+||+.||.+||++.+|++
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCcCCcccccccCccccCcCcccHHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                      778865432111111111111110    0111111  123467788999999999999999999999999


Q ss_pred             HHhcCCCC
Q psy5927         422 MLSGSGGE  429 (441)
Q Consensus       422 ~L~~~~~~  429 (441)
                      .|+.+...
T Consensus       330 ~L~~i~~~  337 (342)
T 1b6c_B          330 TLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHH
Confidence            99876543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-44  Score=346.76  Aligned_cols=265  Identities=19%  Similarity=0.271  Sum_probs=202.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++......      .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS------DPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc------CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            478999999999999999999984  678999998643221      122345677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+||||+++++|.+++...   ..+++..+..++.+++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             CeEEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            9999999999999999998654   34889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........  .......||+.|+|||.+.+..++.++||||||+++|||++|..||......  .....+....      
T Consensus       182 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~------  251 (309)
T 2h34_A          182 SATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAI------  251 (309)
T ss_dssp             -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCC------
T ss_pred             cccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCC------
Confidence            76433211  1223456899999999999989999999999999999999999999876532  1111111100      


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCCCCC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-EMTQVYNMLSGSGGESPN  432 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~~~~~  432 (441)
                         ......+..++..+.+++.+||+.||++|| ++.++++.|+........
T Consensus       252 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          252 ---PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             ---CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             ---CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence               011122345567899999999999999999 999999999987666543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=356.73  Aligned_cols=245  Identities=22%  Similarity=0.278  Sum_probs=195.2

Q ss_pred             cCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         150 LNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      .+.||+|+||.||+|.+.  +..||+|+++....         ...+.+.+|++++++++||||+++++++.+.+.+++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            578999999999999984  57899999875321         1234567999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee--cCCCCeEEeccCCCccCC
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL--NHHMDPVIGDFGLTQEGP  305 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl--~~~~~~kl~DFGla~~~~  305 (441)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||+.+  |+||||||+|||+  +.++.+||+|||+++...
T Consensus       165 ~E~~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             EECCTTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999999886432  34889999999999999999999999  9999999999999  567889999999998643


Q ss_pred             CcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         306 IEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       306 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+..+......         
T Consensus       241 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~---------  306 (373)
T 2x4f_A          241 PREK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWD---------  306 (373)
T ss_dssp             TTCB----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC---------
T ss_pred             Cccc----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC---------
Confidence            3221    2334699999999999998999999999999999999999999987654 2223222221100         


Q ss_pred             CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       386 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ........++.++.+|+.+||+.||.+||++.++++
T Consensus       307 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            011112345678999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-45  Score=348.11  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=204.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|.+.+.||+|+||+||+|.+.+     ..||+|.+......        ...+.+.+|+.+++.++||||+++++
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~   80 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--------DNKEKFMSEAVIMKNLDHPHIVKLIG   80 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--------HHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--------hHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            456789999999999999999998743     24899998743211        23456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+ +..++||||+++++|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        81 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  155 (281)
T 3cc6_A           81 IIEE-EPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLG  155 (281)
T ss_dssp             EECS-SSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEEC
T ss_pred             EEcC-CCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeC
Confidence            8765 45689999999999999986543  45889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||++........  .......+|..|+|||.+.+..++.++||||||+++|||+| |..||....... ....+..   
T Consensus       156 Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-~~~~~~~---  229 (281)
T 3cc6_A          156 DFGLSRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-VIGVLEK---  229 (281)
T ss_dssp             CCCGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-HHHHHHH---
T ss_pred             ccCCCcccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-HHHHHhc---
Confidence            9999976433221  11233457889999999988889999999999999999998 999997654322 1111111   


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                               ....+.+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus       230 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          230 ---------GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                     111122334567899999999999999999999999999765

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=349.37  Aligned_cols=274  Identities=22%  Similarity=0.332  Sum_probs=210.2

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .+..++|++.+.||+|+||.||+|.+  .+..||||++.....         ...+.+.+|+++++.++||||+++++++
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---------QDREEAQREADMHRLFNHPNILRLVAYC   95 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---------HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---------HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35567899999999999999999997  467899999865321         2344567899999999999999999998


Q ss_pred             Ee----CCeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         219 FE----TGKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       219 ~~----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      ..    ....++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+
T Consensus        96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~  173 (317)
T 2buj_A           96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQP  173 (317)
T ss_dssp             EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCE
T ss_pred             EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCE
Confidence            73    347899999999999999886532 3456899999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCccccc------ceeccccccCCCcCcccccCCC---CCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         294 VIGDFGLTQEGPIEKATH------ITLKRVNGTRPYLPHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      ||+|||++..........      .......||+.|+|||.+.+..   ++.++||||||+++|||++|..||.......
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            999999987543211110      1112345799999999987643   6899999999999999999999996432211


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATGP  436 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~p  436 (441)
                      ........           .....+....++..+.+|+.+||+.||.+||++.+|++.|+.+....+.....
T Consensus       254 ~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~  314 (317)
T 2buj_A          254 DSVALAVQ-----------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTT  314 (317)
T ss_dssp             SCHHHHHH-----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC----
T ss_pred             chhhHHhh-----------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCCCC
Confidence            11111111           01111222345678999999999999999999999999999998777765543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=353.94  Aligned_cols=261  Identities=25%  Similarity=0.417  Sum_probs=201.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--Cee----EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTT----IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..    +|+|.+......        ...+.+.+|+.+++.++||||++++
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~   83 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--------KANKEILDEAYVMASVDNPHVCRLL   83 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--------CCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--------HHHHHHHHHHHHHHhCCCCCeeEEE
Confidence            34578999999999999999999984  333    466666432211        1234567899999999999999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +++... ..++|++|+.+|+|.+++....  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        84 ~~~~~~-~~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL  158 (327)
T 3lzb_A           84 GICLTS-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             EEEESS-SEEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEE
T ss_pred             EEEecC-CceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEE
Confidence            998865 4889999999999999986543  45889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++....... ........||..|+|||.+.+..++.++|||||||++|||++ |..||....... . ...+.. 
T Consensus       159 ~DfG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~-~~~~~~-  234 (327)
T 3lzb_A          159 TDFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-I-SSILEK-  234 (327)
T ss_dssp             CCTTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-H-HHHHHT-
T ss_pred             ccCcceeEccCccc-cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-H-HHHHHc-
Confidence            99999976433221 112223346888999999999899999999999999999999 999998765422 1 111111 


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                                ....+.+..++.++.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       235 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          235 ----------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                      112223344667899999999999999999999999999876543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-44  Score=350.96  Aligned_cols=257  Identities=20%  Similarity=0.263  Sum_probs=206.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++..........   ....+.+.+|+++++.++||||+++++++.+
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVSREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc---chhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            3567999999999999999999985  5689999997644322110   0123456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC----CeEEe
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM----DPVIG  296 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~----~~kl~  296 (441)
                      .+.+++||||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEc
Confidence            99999999999999999998643   45889999999999999999999999  99999999999999988    79999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......    ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ..+..+... ..
T Consensus       162 Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~-~~  235 (321)
T 2a2a_A          162 DFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITSV-SY  235 (321)
T ss_dssp             CCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTT-CC
T ss_pred             cCccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhc-cc
Confidence            999997643321    123456999999999999989999999999999999999999999776442 222221110 00


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              .........++..+.+|+.+||+.||++||++.++++
T Consensus       236 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 --------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0001112345677899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-45  Score=349.84  Aligned_cols=254  Identities=25%  Similarity=0.366  Sum_probs=202.4

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      .+..++|++.+.||+|+||.||+|.++++.||||+++...           ..+.+.+|++++++++||||+++++++.+
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             cCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            3456789999999999999999999999999999986432           23456689999999999999999998765


Q ss_pred             C-CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 T-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      . +..++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+++  |+||||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           86 EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CCCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecc
Confidence            4 47899999999999999986543 223788899999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++.....      .....++..|+|||.+.+..++.++||||||+++|||+| |..||....... ....+    .   
T Consensus       163 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~----~---  228 (278)
T 1byg_A          163 LTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV----E---  228 (278)
T ss_dssp             C------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHH----T---
T ss_pred             cccccccc------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH----h---
Confidence            98753322      122357889999999998889999999999999999998 999997654321 11111    1   


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                           .......+..++..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       229 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          229 -----KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence                 11112233456778999999999999999999999999998753

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.9e-45  Score=347.61  Aligned_cols=264  Identities=24%  Similarity=0.358  Sum_probs=210.6

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ++.+..++|++.+.||+|+||.||+|.+.+ ..||||.+.....          ..+.+.+|+++++.++||||++++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----------SPDAFLAEANLMKQLQHQRLVRLYAV   76 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----------cHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            345566889999999999999999999864 5799999864321          12356689999999999999999998


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +. .+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~D  152 (279)
T 1qpc_A           77 VT-QEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIAD  152 (279)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECC
T ss_pred             Ec-CCCcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECC
Confidence            76 456899999999999999885432 125889999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++.......  .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+..    
T Consensus       153 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~----  225 (279)
T 1qpc_A          153 FGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLER----  225 (279)
T ss_dssp             CTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT----
T ss_pred             CcccccccCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHHhc----
Confidence            999976433221  11223457889999999988889999999999999999999 99999876542 22221111    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                              ......+..++..+.+|+.+||+.||++||++.++++.|+.+.....
T Consensus       226 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          226 --------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             --------ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                    11112233456789999999999999999999999999987654433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=363.65  Aligned_cols=272  Identities=19%  Similarity=0.276  Sum_probs=212.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.++||+|+||+||+|.+.  +..||||++......        ...+.+.+|+++++.++||||+++++++.+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--------RPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--------chHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            3468999999999999999999986  678999998743221        123445689999999999999999999887


Q ss_pred             CC--eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee----cCCCCeE
Q psy5927         221 TG--KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL----NHHMDPV  294 (441)
Q Consensus       221 ~~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl----~~~~~~k  294 (441)
                      .+  ..|+||||+++|+|.+++........+++..++.++.|++.||+|||+.+  |+||||||+|||+    +.++.+|
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  156 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYK  156 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEE
Confidence            65  78999999999999999976655555999999999999999999999999  9999999999999    7888899


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccC--------CCCCCccceehHHHHHHHHHhCCCCCCCcch---h
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--------KRLSTKVDVYGFGIVLFELATGMRAYDDTRR---S  363 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~---~  363 (441)
                      |+|||+++......    ......||+.|+|||++.+        ..++.++|||||||++|||+||..||.....   .
T Consensus       157 L~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          157 LTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             ECCGGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EecCCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            99999997643322    2234569999999999865        4678899999999999999999999964332   1


Q ss_pred             HHHHHHHHHhhchhhhhhhh------------ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLV------------DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ......+.............            .+....+...++..+.+++.+||+.||++||++.++++.++.+-.
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            22222222211111000000            011223446788899999999999999999999999998876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.1e-44  Score=345.80  Aligned_cols=264  Identities=20%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+  ++..||||++......      .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  104 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM------DAKARADCIKEIDLLKQLNHPNVIKYYASFIED  104 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            46799999999999999999997  4678999998743221      112345667899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      +..++||||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence            99999999999999999886432 3455889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++......   .......||..|+|||.+.+..++.++||||||+++|||++|..||.........+...+...   .. 
T Consensus       183 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-  255 (310)
T 2wqm_A          183 GRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DY-  255 (310)
T ss_dssp             -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---CS-
T ss_pred             eeeecCCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---cC-
Confidence            87543221   112334689999999999998999999999999999999999999976543222222111110   00 


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                            .......++.++.+|+.+||+.||.+||++.+|++.|+.+.+
T Consensus       256 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          256 ------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             ------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence                  001113456789999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-44  Score=353.73  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .+.|++.+.||+|+||+||+|.+  .+..||||++.......      ....+.+.+|+++++.++||||+++++++.+.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  126 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE  126 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            35689999999999999999997  46789999987543221      12345677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+. |+|.+.+....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       127 ~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a  201 (348)
T 1u5q_A          127 HTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA  201 (348)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             CeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence            99999999996 78888775433  45899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +....       .....||+.|+|||++.   +..++.++|||||||++|||++|..||....... .+..+....    
T Consensus       202 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~----  269 (348)
T 1u5q_A          202 SIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE----  269 (348)
T ss_dssp             BSSSS-------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC----
T ss_pred             eecCC-------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcC----
Confidence            76432       12346999999999984   4678999999999999999999999997765422 222221110    


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             ........++..+.+|+.+||+.||++||++.++++
T Consensus       270 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          270 -------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                   011112345667899999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.1e-45  Score=363.10  Aligned_cols=248  Identities=18%  Similarity=0.264  Sum_probs=189.7

Q ss_pred             hCCCcCc-CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHh-hcCCCCCeecccceEE
Q psy5927         144 TNNWDKL-NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL-NSCRHDNILPLYGICF  219 (441)
Q Consensus       144 ~~~~~~~-~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~  219 (441)
                      .++|.+. +.||+|+||+||+|.+.  +..||||++...              ..+.+|+.++ +..+||||+++++++.
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~~~~  125 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE  125 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence            4567776 78999999999999985  567999998631              1234677776 4458999999999987


Q ss_pred             e----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---CCC
Q psy5927         220 E----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---HMD  292 (441)
Q Consensus       220 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~~~  292 (441)
                      .    ...+|+|||||+||+|.+++.... ...+++..+..|+.||+.||+|||+.+  |+||||||+|||++.   ++.
T Consensus       126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~  202 (400)
T 1nxk_A          126 NLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI  202 (400)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCC
T ss_pred             ecccCCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCcc
Confidence            5    567899999999999999986533 345899999999999999999999999  999999999999998   789


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH---HHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER---HLKS  369 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~---~l~~  369 (441)
                      +||+|||+++.....    ......+||+.|+|||++.+..++.++|||||||++|||++|..||........   ....
T Consensus       203 ~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  278 (400)
T 1nxk_A          203 LKLTDFGFAKETTSH----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  278 (400)
T ss_dssp             EEECCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH
T ss_pred             EEEEecccccccCCC----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH
Confidence            999999999864322    123455799999999999999999999999999999999999999976543110   1111


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +...    .    ... .......++.++.+|+.+||+.||.+||++.++++
T Consensus       279 i~~~----~----~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          279 IRMG----Q----YEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             HHHT----C----CCC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHcC----c----ccC-CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1100    0    000 01111345678999999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-45  Score=349.78  Aligned_cols=269  Identities=25%  Similarity=0.388  Sum_probs=201.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC---e--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK---T--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~---~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||+||+|.+..   +  .||||+++......      ....+.+.+|+++++.++||||+++++
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNAMHSLDHRNLIRLYG   88 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC------HHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            445789999999999999999998632   2  58999886432111      123456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.. .++||||+++++|.+++....  ..+++..+..++.+++.||+|||+++  |+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~  163 (291)
T 1u46_A           89 VVLTPP-MKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIG  163 (291)
T ss_dssp             EECSSS-CEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEEC
T ss_pred             EEccCC-ceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEc
Confidence            987654 889999999999999986543  34889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++................+|..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+...  
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~--  240 (291)
T 1u46_A          164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKE--  240 (291)
T ss_dssp             CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTS--
T ss_pred             cccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHcc--
Confidence            99999765433322222334467889999999998889999999999999999999 99999876542 222111110  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNA  433 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~  433 (441)
                               ....+.+..++..+.+++.+||+.||.+||++.++++.|+++......+
T Consensus       241 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  289 (291)
T 1u46_A          241 ---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA  289 (291)
T ss_dssp             ---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             ---------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhh
Confidence                     0111223456778999999999999999999999999999887655443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-44  Score=352.02  Aligned_cols=262  Identities=26%  Similarity=0.388  Sum_probs=206.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--Cee--EEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..  +|+|.++.....        ...+.+.+|+++++++ +||||+++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--------HHHHHHHHHHHHHHhccCCCchhhhce
Confidence            33478999999999999999999874  343  488888642211        2234566899999999 8999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKK-------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      ++.+.+..++||||+++|+|.+++....             ....+++..++.++.|++.||+|||+++  |+||||||+
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~  171 (327)
T 1fvr_A           94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAAR  171 (327)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             eeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccc
Confidence            9999999999999999999999986543             2346899999999999999999999999  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcch
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRR  362 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~  362 (441)
                      |||++.++.+||+|||+++......    ......+++.|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus       172 NIl~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          172 NILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             GEEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             eEEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            9999999999999999987432211    1223347889999999998889999999999999999998 9999977654


Q ss_pred             hHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         363 SERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       363 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      .. ..    .....        ......+..++..+.+|+.+||+.||.+||++.++++.|+.+..+.
T Consensus       248 ~~-~~----~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          248 AE-LY----EKLPQ--------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HH-HH----HHGGG--------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HH-HH----HHhhc--------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            21 11    11111        1112233455678999999999999999999999999987765444

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.6e-44  Score=362.98  Aligned_cols=270  Identities=19%  Similarity=0.295  Sum_probs=189.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||++......       ....+.+.+|+++|+.++||||+++++++...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-------LIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-------HHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            478999999999999999999875  568999998643221       12345677999999999999999999998533


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                           ..+|+||||+ +|+|.+++..   ...+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEEC
T ss_pred             CcccCceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeec
Confidence                 5789999998 6899998853   345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccc------------------------cceeccccccCCCcCcccc-cCCCCCCccceehHHHHHHHHH
Q psy5927         297 DFGLTQEGPIEKAT------------------------HITLKRVNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELA  351 (441)
Q Consensus       297 DFGla~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DiwSlGvvl~ell  351 (441)
                      |||+++........                        .......+||+.|+|||++ .+..++.++|||||||++|||+
T Consensus       199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999864322110                        0123456789999999986 4567999999999999999999


Q ss_pred             h-----------CCCCCCCcch-------------------hHHHHHHHHHhhc---hhhh--------hhhhc---c--
Q psy5927         352 T-----------GMRAYDDTRR-------------------SERHLKSLVEKYS---EENM--------YDLVD---K--  385 (441)
Q Consensus       352 t-----------G~~p~~~~~~-------------------~~~~l~~~~~~~~---~~~~--------~~~~~---~--  385 (441)
                      |           |.++|.+...                   ....+..+.....   .+.+        ..++.   .  
T Consensus       279 tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~  358 (458)
T 3rp9_A          279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE  358 (458)
T ss_dssp             TTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC
T ss_pred             HhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC
Confidence            9           6666654321                   0111211111110   0000        00000   0  


Q ss_pred             --CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         386 --NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       386 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                        .........+.++.+|+.+||..||++|||+.|+++  .++..
T Consensus       359 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          359 GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence              001112334678899999999999999999999998  45554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.3e-44  Score=348.61  Aligned_cols=254  Identities=18%  Similarity=0.279  Sum_probs=203.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEe
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFE  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  220 (441)
                      .++|++.+.||+|+||+||+|.+  .+..||||+++...            .+.+.+|+++++.++ ||||+++++++.+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~  102 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD  102 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence            47899999999999999999987  46789999986322            234568999999997 9999999999987


Q ss_pred             --CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEec
Q psy5927         221 --TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGD  297 (441)
Q Consensus       221 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~D  297 (441)
                        ....++||||+++++|.+++.      .+++..+..++.|++.||+|||+++  |+||||||+|||++.++ .+||+|
T Consensus       103 ~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~D  174 (330)
T 3nsz_A          103 PVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLID  174 (330)
T ss_dssp             TTTCCEEEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCCCceEEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEe
Confidence              678899999999999998773      2788999999999999999999999  99999999999999777 899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++.......    .....||..|+|||.+.+ ..++.++|||||||++|||++|..||.........+.........
T Consensus       175 fg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~  250 (330)
T 3nsz_A          175 WGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT  250 (330)
T ss_dssp             CTTCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred             CCCceEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC
Confidence            999976433221    233468999999999987 678999999999999999999999996654444444443333332


Q ss_pred             hhhhhhhccCCC------------------------chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQ------------------------PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ......++....                        .....++.++.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            222222221111                        112235778999999999999999999999987

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-45  Score=355.26  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=197.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC--CCeecccce
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH--DNILPLYGI  217 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~  217 (441)
                      .+..++|++.+.||+|+||.||+|.+. +..||||++.......       ...+.+.+|+++++.++|  |||++++++
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   77 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-------QTLDSYRNEIAYLNKLQQHSDKIIRLYDY   77 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH-------HHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch-------HHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence            345678999999999999999999874 5679999987543221       234566789999999976  999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+.+.+|+|||+ .+|+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++ ++.+||+|
T Consensus        78 ~~~~~~~~lv~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           78 EITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             EECSSEEEEEECC-CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECC
T ss_pred             EeeCCEEEEEEeC-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEee
Confidence            9999999999995 589999999653   35889999999999999999999999  99999999999997 57899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccC-----------CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHH
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----------KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH  366 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~  366 (441)
                      ||+++...... .........||+.|+|||++.+           ..++.++|||||||++|||++|..||.........
T Consensus       151 FG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  229 (343)
T 3dbq_A          151 FGIANQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  229 (343)
T ss_dssp             CSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             cccccccCccc-ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence            99998653322 1112334579999999999864           57889999999999999999999999765432222


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +......           ......+...+..+.+|+.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          230 LHAIIDP-----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HHHHHCT-----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhcC-----------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            2221110           1111222333567899999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.8e-45  Score=355.72  Aligned_cols=250  Identities=18%  Similarity=0.280  Sum_probs=198.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||||++......             ..+|++++.++ +||||+++++++.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------~~~E~~~l~~~~~hp~iv~~~~~~~   86 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------------PTEEIEILLRYGQHPNIITLKDVYD   86 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------------CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------------hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            4578999999999999999999985  568999999743221             12677788777 7999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC----CCeEE
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH----MDPVI  295 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~----~~~kl  295 (441)
                      +.+.+|+|||||+||+|.+++...   ..+++..+..++.+|+.||+|||++|  |+||||||+|||+..+    +.+||
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           87 DGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEE
Confidence            999999999999999999988643   35899999999999999999999999  9999999999998443    34999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch-hHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR-SERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~  374 (441)
                      +|||+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+...+.  
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~--  236 (342)
T 2qr7_A          162 CDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG--  236 (342)
T ss_dssp             CCCTTCEECBCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH--
T ss_pred             EECCCcccCcCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc--
Confidence            9999997643221   123445799999999999888899999999999999999999999976422 1111111111  


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ....    . ........++.++.+|+.+||..||++||++.++++
T Consensus       237 -~~~~----~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          237 -SGKF----S-LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -HCCC----C-CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -cCCc----c-cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             1000    0 011122346778999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.3e-44  Score=340.41  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=200.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      ...|.+.+.||+|+||.||+|.+..  ..||+|++......       ....+.+.+|+.+++.++||||+++++++.. 
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence            3458888999999999999999854  56888888743322       2334567799999999999999999998875 


Q ss_pred             ---CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCCeEEe
Q psy5927         221 ---TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-HHMDPVIG  296 (441)
Q Consensus       221 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~~kl~  296 (441)
                         ...+++||||+++|+|.+++...   ..+++..+..++.+++.||.|||+.+.+|+||||||+|||++ .++.+||+
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A           98 VKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             cCCCceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence               35689999999999999999654   348899999999999999999999876799999999999998 78999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||++.......     .....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.................  
T Consensus       175 Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--  246 (290)
T 1t4h_A          175 DLGLATLKRASF-----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--  246 (290)
T ss_dssp             CTTGGGGCCTTS-----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--
T ss_pred             eCCCcccccccc-----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--
Confidence            999997533221     233469999999999876 699999999999999999999999987554332222221111  


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                               .....+...+.++.+|+.+||+.||.+||++.++++
T Consensus       247 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 ---------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     011222334467899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-44  Score=381.85  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=206.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||+||+|.+..  ..||||+++.....      .....+.+..|..++..+ +||||+.+++++
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~------~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI------QDDDVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH------HTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            456789999999999999999999854  56999999743211      112344566899999887 799999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+||||||++||+|.+++....   .+++..+..++.||+.||+|||+++  ||||||||+||||+.++.+||+||
T Consensus       412 ~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          412 QTMDRLYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             BCSSEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCC
T ss_pred             EeCCEEEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeec
Confidence            99999999999999999999997543   4899999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+++......   ......+||+.|+|||++.+..++.++|||||||++|||++|.+||....... ....+.       
T Consensus       487 Gla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~-------  555 (674)
T 3pfq_A          487 GMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIM-------  555 (674)
T ss_dssp             TTCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-------
T ss_pred             ceeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHH-------
Confidence            9998533222   22345689999999999999999999999999999999999999998765422 221111       


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM-----TQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~  421 (441)
                            ......+..++.++.+|+.+||+.||.+||++     .+|++
T Consensus       556 ------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          556 ------EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ------SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ------hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                  11223445577889999999999999999997     77764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-44  Score=342.00  Aligned_cols=256  Identities=25%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++.......      ....+.+.+|+++++.++||||+++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK------EGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch------HHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            34478999999999999999999985  4679999986422111      112345678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||+++|+|.+++....   .+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEeccc
Confidence            9999999999999999999986543   4889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++......     ......||+.|+|||.+.+..++.++||||||+++|||++|..||....... ....+.        
T Consensus       160 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~--------  225 (284)
T 2vgo_A          160 WSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-THRRIV--------  225 (284)
T ss_dssp             TCEECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHH--------
T ss_pred             ccccCccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-HHHHHh--------
Confidence            98654322     1234568999999999999899999999999999999999999998764422 111111        


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                           ......+..++..+.+++.+||+.||.+||++.++++  .+....
T Consensus       226 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          226 -----NVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             -----TTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             -----ccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                 0111233445678899999999999999999999986  555433

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=354.46  Aligned_cols=265  Identities=21%  Similarity=0.303  Sum_probs=192.2

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccc
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYG  216 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~  216 (441)
                      +.+...+|++.+.||+|+||.||+|.+  .+..||||++.....         ...+.+.+|+.++.++. ||||+++++
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~~h~~iv~~~~   93 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---------EKNRAIIQEVCFMKKLSGHPNIVQFCS   93 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---------HHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---------HHHHHHHHHHHHHHHhccCCChhhccc
Confidence            455667899999999999999999998  567899999864321         22345678999999996 999999999


Q ss_pred             eEE--------eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         217 ICF--------ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       217 ~~~--------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      ++.        ....+++||||+. |+|.+++........+++..++.++.|++.||+|||+.+++|+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~  172 (337)
T 3ll6_A           94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS  172 (337)
T ss_dssp             EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC
T ss_pred             cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC
Confidence            984        3445899999995 8999988765556679999999999999999999999877799999999999999


Q ss_pred             CCCCeEEeccCCCccCCCccccc---------ceeccccccCCCcCcccc---cCCCCCCccceehHHHHHHHHHhCCCC
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATH---------ITLKRVNGTRPYLPHEFL---VGKRLSTKVDVYGFGIVLFELATGMRA  356 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~---~~~~~s~~~DiwSlGvvl~elltG~~p  356 (441)
                      .++.+||+|||+++.........         .......||+.|+|||.+   .+..++.++|||||||++|||+||..|
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p  252 (337)
T 3ll6_A          173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP  252 (337)
T ss_dssp             TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            99999999999997643322111         111234689999999998   566789999999999999999999999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      |....... ...   ...            ..+.....+..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       253 ~~~~~~~~-~~~---~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          253 FEDGAKLR-IVN---GKY------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             C----------------C------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CcchhHHH-hhc---Ccc------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            97543211 000   000            00111222345789999999999999999999999998776543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.2e-45  Score=352.73  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=177.4

Q ss_pred             cCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCCeEEE
Q psy5927         150 LNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETGKYCL  226 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~l  226 (441)
                      .+.||+|+||+||+|.+.  +..||||++...            ......+|+.+++.+. ||||+++++++.+....|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            378999999999999985  568999998632            1223458999999997 9999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC---CeEEeccCCCcc
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM---DPVIGDFGLTQE  303 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~---~~kl~DFGla~~  303 (441)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++   .+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           84 VMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999654   45899999999999999999999999  99999999999998766   799999999975


Q ss_pred             CCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH--HHHHHHHHhhchhhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSLVEKYSEENMYD  381 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~  381 (441)
                      .....   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......  .........+.....  
T Consensus       159 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~--  233 (325)
T 3kn6_A          159 KPPDN---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF--  233 (325)
T ss_dssp             CCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC--
T ss_pred             cCCCC---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC--
Confidence            43221   12334568999999999999899999999999999999999999997643211  001111111111100  


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .........++.++.+|+.+||+.||.+||++.++++
T Consensus       234 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 ---SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               0011122346778999999999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.9e-44  Score=338.74  Aligned_cols=250  Identities=21%  Similarity=0.287  Sum_probs=202.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.+  ..+|+|++......         ..+.+.+|+++++.++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---------DVDRFKQEIEIMKSLDHPNIIRLYETFED   77 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34679999999999999999999864  47899998743221         23456689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~D  297 (441)
                      .+..++||||+++++|.+++....   .+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            999999999999999999886543   4889999999999999999999999  9999999999999   8889999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||++.......    ......||+.|+|||.+.+ .++.++||||||+++|||++|..||....... ....+...... 
T Consensus       153 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-  225 (277)
T 3f3z_A          153 FGLAARFKPGK----MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-VMLKIREGTFT-  225 (277)
T ss_dssp             CTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCC-
T ss_pred             cccceeccCcc----chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence            99997643322    2234469999999999877 49999999999999999999999998765422 22222111000 


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              ........++..+.+|+.+||+.||.+||++.++++
T Consensus       226 --------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 --------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             --------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    000011135678999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-44  Score=351.39  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=208.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||.||++.+.  +..+|+|++......      .....+.+.+|+.+++.++||||+++++++.+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  112 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL------KPHQREKMSMEISIHRSLAHQHVVGFHGFFED  112 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            4578999999999999999999985  467999998743221      12344566789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..|+||||+++++|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~  187 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGL  187 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccC
Confidence            99999999999999999988654   34889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++.......   ......||..|+|||.+.+..++.++||||||+++|||++|..||........ ...+..        
T Consensus       188 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~--------  255 (335)
T 2owb_A          188 ATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKK--------  255 (335)
T ss_dssp             CEECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH--------
T ss_pred             ceecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhc--------
Confidence            976432211   12345699999999999998899999999999999999999999987654221 111111        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                           .....+..++..+.+|+.+||+.||.+||++.++++  .+..
T Consensus       256 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          256 -----NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             -----TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             -----CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                 011223345667899999999999999999999987  4544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-44  Score=342.95  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=198.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.++||+|+||.||+|.+.  +..+|+|++......        ...+.+.+|+++++.++||||+++++++.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--------VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--------hhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            367999999999999999999985  568999998754321        1234566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEec
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIGD  297 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~D  297 (441)
                      +..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+  |+||||||+|||+   +.++.+||+|
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEe
Confidence            99999999999999999886432 2456899999999999999999999999  9999999999999   5568899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+++......    ......||+.|+|||.+.+ .++.++||||||+++|||++|..||......... .....  .  
T Consensus       171 fg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~-~~~~~--~--  240 (285)
T 3is5_A          171 FGLAELFKSDE----HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ-QKATY--K--  240 (285)
T ss_dssp             CCCCCC--------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH--C--
T ss_pred             eecceecCCcc----cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH-hhhcc--C--
Confidence            99997643221    1234568999999999875 7899999999999999999999999876542211 11110  0  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            ..........++..+.+|+.+||+.||++||++.+|++
T Consensus       241 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 ------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00011111124567889999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.3e-45  Score=344.26  Aligned_cols=263  Identities=19%  Similarity=0.293  Sum_probs=208.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||+|.+......       ....+.+.+|++++++++||||+++++++.+ 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR   77 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence            468999999999999999999984  578999999754322       1234567799999999999999999998854 


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC---CCeeecCCCCCCeeecCCCCeEE
Q psy5927         221 -TGKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSRE---PPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       221 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~---~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                       .+.+++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+   .+|+||||||+|||++.++.+||
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence             578999999999999999987543 2345899999999999999999999965   34999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||+++.......   ......||..|+|||.+.+..++.++||||||+++|||++|..||...... .....+..   
T Consensus       158 ~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~~---  230 (279)
T 2w5a_A          158 GDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIRE---  230 (279)
T ss_dssp             CCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH---
T ss_pred             ecCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-HHHHHHhh---
Confidence            99999875432211   122346899999999999988999999999999999999999999876431 11111111   


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                               ......+..++..+.+++.+||+.||.+||++.+|++.+......
T Consensus       231 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          231 ---------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             ---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             ---------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence                     111223345677899999999999999999999999877655543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.8e-44  Score=341.91  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=206.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||.||+|.+.  +..+|+|++......      .....+.+.+|+.+++.++||||+++++++.+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   86 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL------KPHQREKMSMEISIHRSLAHQHVVGFHGFFED   86 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc------CHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            3468999999999999999999985  567999998643221      12334566789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++++|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~  161 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGL  161 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccC
Confidence            99999999999999999988654   34889999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +........   ......||+.|+|||.+.+..++.++||||||+++|||++|..||......... ....         
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~---------  228 (294)
T 2rku_A          162 ATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIK---------  228 (294)
T ss_dssp             CEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHH---------
T ss_pred             ceecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHh---------
Confidence            976432211   123356899999999999988999999999999999999999999876542211 1111         


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          ......+..++..+.+++.+||+.||++||++.++++
T Consensus       229 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          229 ----KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ----TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----hccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                0111223345667899999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-44  Score=380.60  Aligned_cols=250  Identities=23%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             CccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         151 NILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      ++||+|+||.||+|.+.    +..||||+++......       ...+.+.+|++++++++|||||++++++. .+..++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-------ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-------GGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence            47999999999999762    3579999987532211       23456779999999999999999999886 456899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      |||||++|+|.+++...   ..+++..+..|+.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++....
T Consensus       447 v~E~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             EEEccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            99999999999999643   35889999999999999999999999  99999999999999999999999999976543


Q ss_pred             cccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                      ............||..|+|||++.+..++.++|||||||++|||++ |..||....... .. ..+.           ..
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-~~-~~i~-----------~~  588 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VT-AMLE-----------KG  588 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HH-HHHH-----------TT
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH-HHHH-----------cC
Confidence            3222222233457888999999999899999999999999999998 999998765421 11 1111           11


Q ss_pred             CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       386 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      .....+..++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12233445678899999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.8e-44  Score=341.29  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=203.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||+|+++.........   ....+.+.+|+++++.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR---GVSREEIEREVNILREIRHPNIITLHDIFENK   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc---chHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence            467999999999999999999985  6789999987654322110   01234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC----CeEEec
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM----DPVIGD  297 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~----~~kl~D  297 (441)
                      +..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++    .+||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             CeEEEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEe
Confidence            9999999999999999998653   34889999999999999999999999  99999999999999887    899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||++.......    ......||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ..+..+... .  
T Consensus       156 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-~--  227 (283)
T 3bhy_A          156 FGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAV-N--  227 (283)
T ss_dssp             CTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTT-C--
T ss_pred             cccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhc-c--
Confidence            99997643221    123446899999999999889999999999999999999999999876542 222111110 0  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            ..........++..+.+|+.+||+.||.+||++.++++
T Consensus       228 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 ------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                  00011122345667899999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-44  Score=351.31  Aligned_cols=274  Identities=25%  Similarity=0.306  Sum_probs=201.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++.........    ....+.+.+|+++++.++||||+++++++.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK----DGINRTALREIKLLQELSHPNIIGLLDAFG   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhh----hhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence            34578999999999999999999985  568999998753322111    111235668999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||+++ +|.+++..  ....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             eCCceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecc
Confidence            99999999999974 89888754  3345888899999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh-
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE-  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-  377 (441)
                      +++......   .......||+.|+|||.+.+. .++.++|||||||++|||++|.+||..... ...+..+....... 
T Consensus       158 ~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          158 LAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPT  233 (346)
T ss_dssp             GGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCC
T ss_pred             cceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCC
Confidence            997643221   122345689999999999764 589999999999999999999999987654 33333333322110 


Q ss_pred             --hhhh------hhccC-CC-----chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         378 --NMYD------LVDKN-AQ-----PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       378 --~~~~------~~~~~-~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                        ....      .+... ..     .....++.++.+|+.+||+.||.+|||+.++++  .+.....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence              0000      00000 00     011344678999999999999999999999997  4544433

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-45  Score=358.50  Aligned_cols=260  Identities=21%  Similarity=0.305  Sum_probs=202.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  215 (441)
                      ...++|++.+.||+|+||.||+|.+     .+..||||+++........     ...+.+.+|+++++.+ +||||++++
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~  125 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTLH  125 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh-----hHHHHHHHHHHHHHHccCCCceeEEE
Confidence            3457899999999999999999998     4678999998643211100     0112234788999998 699999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +++.+.+.+++||||+++|+|.+++....   .+++..+..++.|++.||.|||+++  |+||||||+|||++.++.+||
T Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          126 YAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeeCceEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEE
Confidence            99999999999999999999999996543   4889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      +|||+++.......  ......+||+.|+|||++.+  ..++.++|||||||++|||++|..||......... ..+...
T Consensus       201 ~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~  277 (355)
T 1vzo_A          201 TDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRR  277 (355)
T ss_dssp             SCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHH
T ss_pred             eeCCCCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHH
Confidence            99999976432221  12334579999999999986  34789999999999999999999999754321111 111110


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYNML  423 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  423 (441)
                               +.......+..++..+.+|+.+||..||++||     ++.++++..
T Consensus       278 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          278 ---------ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---------HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---------HhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                     00112233445667889999999999999999     999998743

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-44  Score=351.71  Aligned_cols=264  Identities=21%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++......       ....+.+.+|+++++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-------HHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            468999999999999999999984  578999998643221       12345677999999999999999999998765


Q ss_pred             ------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 ------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                            ..+|+||||+ +++|.+++..    ..+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl  169 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKI  169 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEE
Confidence                  3469999999 8999998864    34889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.... ..+..+....
T Consensus       170 ~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~  242 (367)
T 1cm8_A          170 LDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVT  242 (367)
T ss_dssp             CCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             Eeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence            999999864321      234568999999999887 67999999999999999999999999876542 2333332221


Q ss_pred             ch--h---------hhhhhhc-------cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         375 SE--E---------NMYDLVD-------KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       375 ~~--~---------~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      ..  .         ....++.       ..........+..+.+|+.+||..||.+|||+.++++  .++....
T Consensus       243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence            10  0         0000000       0111222345678999999999999999999999988  5665543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.9e-45  Score=375.50  Aligned_cols=264  Identities=24%  Similarity=0.359  Sum_probs=213.8

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+.+..++|++.++||+|+||.||+|.+++ ..||||+++....          ..+.+.+|+++|++++||||+++++
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~  329 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----------SPEAFLQEAQVMKKLRHEKLVQLYA  329 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----------CHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3445667789999999999999999999975 5799999974321          1235679999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+ +.+|+|||||++|+|.+++.... ...+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+
T Consensus       330 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~  405 (535)
T 2h8h_A          330 VVSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVA  405 (535)
T ss_dssp             EECS-SSCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEee-ccceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEc
Confidence            9876 67899999999999999996432 234889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++.......  .......++..|+|||.+.+..++.++|||||||++|||+| |..||...... ..+..+..   
T Consensus       406 DFG~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~~i~~---  479 (535)
T 2h8h_A          406 DFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER---  479 (535)
T ss_dssp             CTTSTTTCCCHHH--HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHHHHHT---
T ss_pred             ccccceecCCCce--ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc---
Confidence            9999986533211  11122346788999999998899999999999999999999 99999876442 12211111   


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                               ....+.+..++..+.+|+.+||+.||++||++.+|++.|+.+....
T Consensus       480 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          480 ---------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                     1112234456778999999999999999999999999999886644

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.8e-44  Score=356.65  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=197.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC--CCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--HDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.+. +..||||++......       ....+.+.+|+++++.++  ||||+++++++
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~  125 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE  125 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-------HHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence            34467999999999999999999875 567999999754322       123456779999999996  59999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      ...+.+|+||| +.+++|.+++....   .+++..+..++.||+.||+|||+.+  |+||||||+|||++ ++.+||+||
T Consensus       126 ~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          126 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             ECSSEEEEEEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCC
T ss_pred             ecCCEEEEEEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEec
Confidence            99999999999 56899999986543   5888899999999999999999999  99999999999995 589999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccC-----------CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----------KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL  367 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l  367 (441)
                      |+++...... ........+||+.|+|||++.+           ..++.++|||||||++|||++|..||.........+
T Consensus       199 G~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~  277 (390)
T 2zmd_A          199 GIANQMQPDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  277 (390)
T ss_dssp             SSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred             CccccccCCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH
Confidence            9998643322 1122345579999999999875           368899999999999999999999997654322222


Q ss_pred             HHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         368 KSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..++..           ......+...+.++.+|+.+||+.||++||++.+|++
T Consensus       278 ~~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          278 HAIIDP-----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHHCT-----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCc-----------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            222110           0011122223567899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.8e-44  Score=341.40  Aligned_cols=248  Identities=20%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++.......       .....+.+|+..+..+ +||||+++++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~~~~l~~h~~iv~~~~~~   80 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-------VDEQNALREVYAHAVLGQHSHVVRYFSAW   80 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-------HHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-------HHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            34578999999999999999999985  6789999987543222       1234566899999999 999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-------
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKN-TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-------  290 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-------  290 (441)
                      .+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.+       
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC---------
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccc
Confidence            999999999999999999999965432 255899999999999999999999999  9999999999999844       


Q ss_pred             ------------CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCC
Q psy5927         291 ------------MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAY  357 (441)
Q Consensus       291 ------------~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~  357 (441)
                                  ..+||+|||++......       ....||+.|+|||.+.+. .++.++|||||||++|||++|.+++
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             cccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                        47999999998764322       123489999999999875 5678999999999999999999877


Q ss_pred             CCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         358 DDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       358 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .....    ...+            ........+..++..+.+|+.+||+.||.+||++.++++
T Consensus       232 ~~~~~----~~~~------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          232 RNGDQ----WHEI------------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SSSHH----HHHH------------HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cchhH----HHHH------------HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            54422    1111            111122333456678999999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-44  Score=350.01  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.++||+|+||+||+|.+.  +..||||+++......       ...+.+.+|+++++.++||||+++++++.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-------GVPGTAIREVSLLKELQHRNIIELKSVIH  103 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-------ccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence            44578999999999999999999874  6789999997543221       22345568999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-----CCCCeE
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-----HHMDPV  294 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-----~~~~~k  294 (441)
                      +.+.+|+||||++ |+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++     .++.+|
T Consensus       104 ~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          104 HNHRLHLIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEE
T ss_pred             cCCEEEEEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEE
Confidence            9999999999997 6999988654   34889999999999999999999999  99999999999994     455699


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |+|||+++......   .......||+.|+|||++.+. .++.++|||||||++|||++|..||....... .+......
T Consensus       178 l~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~  253 (329)
T 3gbz_A          178 IGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEV  253 (329)
T ss_dssp             ECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             ECcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHH
Confidence            99999987532211   122334689999999999874 48999999999999999999999998765532 33333322


Q ss_pred             hch---hhhhhh------h----ccCCC----chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YSE---ENMYDL------V----DKNAQ----PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~~---~~~~~~------~----~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...   ......      .    .....    ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            110   000000      0    00000    011225678899999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=350.38  Aligned_cols=270  Identities=23%  Similarity=0.352  Sum_probs=202.2

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|.+.+.||+|+||+||+|.+.  +..||||++........        ...+.+|+++++.++||||+++++++.+.+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIIHTEK   73 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--------chhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence            57999999999999999999985  56799999864332111        112347999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++||||++ |+|.+++...  ...+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  148 (324)
T 3mtl_A           74 SLTLVFEYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLAR  148 (324)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred             EEEEEecccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccc
Confidence            9999999996 6999988654  345889999999999999999999999  9999999999999999999999999987


Q ss_pred             cCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EEN  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~  378 (441)
                      ......   .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||..... ...+..+.....   ...
T Consensus       149 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~  224 (324)
T 3mtl_A          149 AKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEET  224 (324)
T ss_dssp             CC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTT
T ss_pred             cccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHh
Confidence            543221   12234468999999999877 5689999999999999999999999987654 233333332211   000


Q ss_pred             hhhhhc---------c--CC---CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCC
Q psy5927         379 MYDLVD---------K--NA---QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESP  431 (441)
Q Consensus       379 ~~~~~~---------~--~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~  431 (441)
                      ......         .  ..   ......++.++.+|+.+||+.||.+|||+.++++  .+.+......
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  293 (324)
T 3mtl_A          225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH  293 (324)
T ss_dssp             STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred             chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence            000000         0  00   0112245677899999999999999999999987  6666554433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=349.47  Aligned_cols=250  Identities=19%  Similarity=0.270  Sum_probs=201.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+  .+..||||++......... .........+.+|+++++.++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC-WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS-EEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc-ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            457899999999999999999987  4678999999754321110 0000011233479999999999999999999999


Q ss_pred             CCeEEEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKYCLVYRYMPNG-SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      .+.+++||||+.+| +|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecc
Confidence            99999999999776 999988543   35899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      +++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.......              
T Consensus       176 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------  237 (335)
T 3dls_A          176 SAAYLERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------  237 (335)
T ss_dssp             TCEECCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred             cceECCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence            9976433221    234569999999999988776 789999999999999999999997643210              


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM  422 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  422 (441)
                       .     .....+..++.++.+|+.+||+.||++||++.++++.
T Consensus       238 -~-----~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 -E-----AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -T-----TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -h-----hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0     0111122356679999999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=351.94  Aligned_cols=276  Identities=21%  Similarity=0.338  Sum_probs=206.5

Q ss_pred             CChhHHHHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      ....+..+..++|++.+.||+|+||.||+|.+.+ .+|+|+++.......       ..+.+.+|+.++++++||||+++
T Consensus        23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~   94 (319)
T 2y4i_B           23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNED-------QLKAFKREVMAYRQTRHENVVLF   94 (319)
T ss_dssp             CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCC-------CCCCCCTTGGGGTTCCCTTBCCC
T ss_pred             cccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHH-------HHHHHHHHHHHHhcCCCCCEeEE
Confidence            3445556777899999999999999999999876 599999875432211       11234478999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ++++.+.+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++ ++.+|
T Consensus        95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~  169 (319)
T 2y4i_B           95 MGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVV  169 (319)
T ss_dssp             CEEEECSSCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCE
T ss_pred             EEEEecCCceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEE
Confidence            99999999999999999999999988543  345889999999999999999999999  99999999999998 68999


Q ss_pred             EeccCCCccCCCccc--ccceeccccccCCCcCcccccC---------CCCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         295 IGDFGLTQEGPIEKA--THITLKRVNGTRPYLPHEFLVG---------KRLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       295 l~DFGla~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      |+|||+++.......  .........||+.|+|||.+.+         ..++.++||||||+++|||++|..||......
T Consensus       170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999875322111  1112234468999999999875         35788999999999999999999999876542


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNATG  435 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  435 (441)
                      . .........         ..  ......++..+.+++.+||+.||.+||++.+|++.|+.+.........
T Consensus       250 ~-~~~~~~~~~---------~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~  309 (319)
T 2y4i_B          250 A-IIWQMGTGM---------KP--NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH  309 (319)
T ss_dssp             H-HHHHHHTTC---------CC--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------
T ss_pred             H-HHHHhccCC---------CC--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence            2 211111100         00  011113455789999999999999999999999999999887655443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.2e-44  Score=341.91  Aligned_cols=255  Identities=23%  Similarity=0.362  Sum_probs=205.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++.....             .+.+|+++++.++||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~e~~~l~~l~h~~i~~~~~~~~   74 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------------KAEREVKALAKLDHVNIVHYNGCWD   74 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-------------GGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-------------HHHHHHHHHHhCCCCCEEEEeeeEe
Confidence            45578999999999999999999985  67899999975321             2347999999999999999999885


Q ss_pred             e----------------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCC
Q psy5927         220 E----------------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSA  283 (441)
Q Consensus       220 ~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~  283 (441)
                      .                ...+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+  |+||||||+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~  151 (284)
T 2a19_B           75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPS  151 (284)
T ss_dssp             EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHH
Confidence            4                456899999999999999997543 345899999999999999999999999  999999999


Q ss_pred             CeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         284 NILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       284 NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      |||++.++.+||+|||++.......    ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..... 
T Consensus       152 Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-  226 (284)
T 2a19_B          152 NIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-  226 (284)
T ss_dssp             GEEEEETTEEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-
T ss_pred             HEEEcCCCCEEECcchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-
Confidence            9999999999999999987643322    12334689999999999998999999999999999999999988743211 


Q ss_pred             HHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q psy5927         364 ERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNAT  434 (441)
Q Consensus       364 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~  434 (441)
                        ....+    ..           ...+..++..+.+++.+||+.||.+||++.++++.|..+.......+
T Consensus       227 --~~~~~----~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~  280 (284)
T 2a19_B          227 --FFTDL----RD-----------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE  280 (284)
T ss_dssp             --HHHHH----HT-----------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred             --HHHHh----hc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence              11111    00           01122345678899999999999999999999999998887666544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.8e-44  Score=339.16  Aligned_cols=251  Identities=22%  Similarity=0.358  Sum_probs=197.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|.+.+.||+|+||.||+|.+.  +..||||++......      .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR------SLDVVGKIKREIQNLKLFRHPHIIKLYQVIS   81 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc------chhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            44578999999999999999999985  678999998642211      1123445678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||+++++|.+++....   .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecc
Confidence            9999999999999999999986543   4889999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      ++.......    ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ......+..      
T Consensus       157 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~------  225 (276)
T 2h6d_A          157 LSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLFKKIRG------  225 (276)
T ss_dssp             GGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH------
T ss_pred             cccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhc------
Confidence            987643321    1233468999999999988665 6899999999999999999999976543 112211111      


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             .....+..++..+.+++.+||+.||.+||++.++++
T Consensus       226 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          226 -------GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                   111223345677899999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1e-43  Score=343.01  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=196.7

Q ss_pred             hCCCcCc-CccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEE
Q psy5927         144 TNNWDKL-NILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICF  219 (441)
Q Consensus       144 ~~~~~~~-~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~  219 (441)
                      .+.|++. +.||+|+||.||+|.+  .+..||||++......         ..+.+.+|++++.++ +||||+++++++.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~   81 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---------IRSRVFREVEMLYQCQGHRNVLELIEFFE   81 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---------CHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---------hHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4678885 7899999999999987  4678999998754221         233566899999885 7999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---eEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---~kl~  296 (441)
                      +.+.+|+||||+++|+|.+++....   .+++..+..++.|++.||+|||+++  |+||||||+|||++.++.   +||+
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           82 EEDRFYLVFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEE
Confidence            9999999999999999999997543   4889999999999999999999999  999999999999998876   9999


Q ss_pred             ccCCCccCCCccc----ccceeccccccCCCcCcccccC-----CCCCCccceehHHHHHHHHHhCCCCCCCcchhH---
Q psy5927         297 DFGLTQEGPIEKA----THITLKRVNGTRPYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE---  364 (441)
Q Consensus       297 DFGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~---  364 (441)
                      |||+++.......    .........||+.|+|||.+.+     ..++.++|||||||++|||++|..||.......   
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  236 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW  236 (316)
T ss_dssp             CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred             EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence            9999875432111    1112234569999999999875     468999999999999999999999997653211   


Q ss_pred             -------HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         365 -------RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       365 -------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                             .....+...+.....     .........++..+.+|+.+||+.||.+||++.++++  .+++.
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEGKY-----EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHCCC-----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             cccccchhHHHHHHHHHhccCc-----ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                   000111111100000     0000011235678999999999999999999999998  44443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=354.64  Aligned_cols=266  Identities=14%  Similarity=0.181  Sum_probs=206.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC----------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE----------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      .++|.+.+.||+|+||.||+|.+.          +..||||++...              +.+.+|++++++++||||++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv~  106 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQVN  106 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchhh
Confidence            478999999999999999999985          467999998732              13458899999999999888


Q ss_pred             ---------------ccceEEe-CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         214 ---------------LYGICFE-TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       214 ---------------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                                     +++++.. ++..|+||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++  |+|
T Consensus       107 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH  182 (352)
T 2jii_A          107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE--YVH  182 (352)
T ss_dssp             HHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBC
T ss_pred             hhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccC
Confidence                           5667766 68899999999 999999997542 345899999999999999999999999  999


Q ss_pred             cCCCCCCeeecCCC--CeEEeccCCCccCCCcccc----cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHH
Q psy5927         278 GDIKSANILLNHHM--DPVIGDFGLTQEGPIEKAT----HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA  351 (441)
Q Consensus       278 rDikp~NiLl~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ell  351 (441)
                      |||||+|||++.++  .+||+|||+++........    ........||+.|+|||.+.+..++.++|||||||++|||+
T Consensus       183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999998  8999999999764332211    11123447999999999999989999999999999999999


Q ss_pred             hCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         352 TGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       352 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      +|..||.........+......+... ...+.+..  .....++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKFVDK-PGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHS-CCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hCCCCcccCCcCHHHHHHHHHhccCC-hhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            99999987643233333322221110 00111100  001134678999999999999999999999999998776443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-43  Score=349.25  Aligned_cols=267  Identities=24%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++......        ...+.+.+|++++++++||||+++++++...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--------TYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--------HHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--------HHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            468999999999999999999984  567999998743221        2334567999999999999999999998755


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                           ...|+||||+. |+|.+++...    .+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             STTTCCCEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             CccccceEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEE
Confidence                 46899999996 6999988542    4889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++................||+.|+|||++.+ ..++.++|||||||++|||++|..||....... .+..+.....
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~  249 (364)
T 3qyz_A          171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILG  249 (364)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHC
T ss_pred             eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhC
Confidence            99999865433222222345579999999998755 458999999999999999999999998765422 3322222111


Q ss_pred             ---hhhhh--------h----hhccCCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         376 ---EENMY--------D----LVDKNAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       376 ---~~~~~--------~----~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                         .+...        .    .......+   ....++.++.+|+.+||+.||.+|||+.++++  .++..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence               00000        0    00011111   11335678999999999999999999999987  45544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.4e-44  Score=337.01  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++......        ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--------THHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--------hhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            468999999999999999999985  678999998754322        1234566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..++||||+++++|.+++..   ...+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCc
Confidence            999999999999999998743   345889999999999999999999999  999999999999999999999999998


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ........ ........||+.|+|||.+.+..+ +.++||||||+++|||++|..||.................      
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  225 (276)
T 2yex_A          153 TVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------  225 (276)
T ss_dssp             EECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC------
T ss_pred             cccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc------
Confidence            75322111 112344568999999999988665 7789999999999999999999987654322222221110      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           ........++..+.+|+.+||+.||.+||++.++++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 -----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 011112345678899999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.7e-44  Score=341.67  Aligned_cols=263  Identities=19%  Similarity=0.246  Sum_probs=201.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE-E
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC-F  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~  219 (441)
                      ..++|++.+.||+|+||.||+|.+  .+..||||++......           ..+.+|+++++.++|++++..++.+ .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----------CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----------hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence            457899999999999999999996  4678999987643221           2345799999999988877766665 6


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~  296 (441)
                      +.+..++||||+ +++|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           76 EGDYNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             CCCceEEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEe
Confidence            677889999999 99999988643  235899999999999999999999999  9999999999999   889999999


Q ss_pred             ccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH--HHHHHH
Q psy5927         297 DFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSL  370 (441)
Q Consensus       297 DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--~~l~~~  370 (441)
                      |||+++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|..||.......  ......
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            999997643322111    12234579999999999999999999999999999999999999997643211  111111


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      ......        .........++..+.+|+.+||+.||++||++.+|++.|+++..+
T Consensus       231 ~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          231 SEKKMS--------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHH--------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hccccc--------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            111000        000111123467899999999999999999999999999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.7e-44  Score=357.06  Aligned_cols=260  Identities=20%  Similarity=0.259  Sum_probs=193.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|.+.+.||+|+||+||+|.+.  +..||||++.......... ........+.+|+++|++++||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA-READPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccc-ccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45689999999999999999999985  4689999997543211100 01112234568999999999999999999874


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC---CeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM---DPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~---~~kl~  296 (441)
                       .+..|+||||+++|+|.+++..   ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++   .+||+
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEe
Confidence             5678999999999999987743   345899999999999999999999999  99999999999997544   59999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |||+++.....    ......+||+.|+|||++.+   ..++.++|||||||++|||+||..||........ +...+..
T Consensus       285 DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~~  359 (419)
T 3i6u_A          285 DFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITS  359 (419)
T ss_dssp             CSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHHT
T ss_pred             ecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHhc
Confidence            99999864322    12344579999999999864   5688899999999999999999999976543221 1111111


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...        .........++..+.+|+.+||+.||++||++.++++
T Consensus       360 ~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 GKY--------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC--------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000        0001112235678999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=348.19  Aligned_cols=269  Identities=26%  Similarity=0.401  Sum_probs=208.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE------CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW------EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..++|++.+.||+|+||.||+|.+      .+..||||++.....         ...+.+.+|++++++++||||+++++
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~~~  109 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---------EHLRDFEREIEILKSLQHDNIVKYKG  109 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            356799999999999999999985      456899999874321         23345679999999999999999999


Q ss_pred             eEEeCC--eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeE
Q psy5927         217 ICFETG--KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       217 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                      ++...+  .+++||||+++++|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+|
T Consensus       110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             EECC----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEE
T ss_pred             EEEecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEE
Confidence            886543  7899999999999999996543  45899999999999999999999999  99999999999999999999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|||+++................++..|+|||.+.+..++.++||||||+++|||+||..||......  ... .....
T Consensus       186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~-~~~~~  262 (326)
T 2w1i_A          186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMR-MIGND  262 (326)
T ss_dssp             ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHH-HHCTT
T ss_pred             EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHH-hhccc
Confidence            999999986543322212223345778899999999888999999999999999999999998653211  110 00000


Q ss_pred             c-----hhhhhhhh-ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         375 S-----EENMYDLV-DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       375 ~-----~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      .     ...+...+ .....+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0     00011111 11122334556788999999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.2e-44  Score=351.21  Aligned_cols=261  Identities=23%  Similarity=0.370  Sum_probs=203.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++.....        ....+.+.+|+++++.++||||+++++++.+
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--------HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            3568999999999999999999996  67899999875422        1234567799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      ++..|+||||+++|+|.+++....   .+++..+..++.+++.||+|||+. +  |+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECC
Confidence            999999999999999999986543   488999999999999999999985 8  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh------
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK------  373 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~------  373 (441)
                      ++....     ........||+.|+|||++.+..++.++|||||||++|||++|..||................      
T Consensus       178 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          178 VSGQLI-----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCHHHH-----HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCcccc-----cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            986421     112234579999999999999899999999999999999999999998654422111000000      


Q ss_pred             --------------h-----chhh----hhhhhccCCC-chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 --------------Y-----SEEN----MYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 --------------~-----~~~~----~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                                    +     ....    .......... .....++.++.+|+.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                          0     0000    0000111111 111235668999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.2e-44  Score=341.15  Aligned_cols=255  Identities=25%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|++.+.||+|+||+||+|.+  .++.||||+++......       ...+....+...++.++||||+++++++.
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~~~~~~~h~~iv~~~~~~~   76 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-------EQKRLLMDLDISMRTVDCPFTVTFYGALF   76 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-------HHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence            4567899999999999999999998  56789999987543221       12223334555678889999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+..++||||++ |+|.+++... .....+++..+..++.|++.||+|||++ +  |+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~D  153 (290)
T 3fme_A           77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCD  153 (290)
T ss_dssp             CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCC
T ss_pred             ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEee
Confidence            9999999999996 6888877542 2345699999999999999999999997 8  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccc----cCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFL----VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+++.......    .....||+.|+|||.+    .+..++.++||||||+++|||+||..||.........+......
T Consensus       154 fg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  229 (290)
T 3fme_A          154 FGISGYLVDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE  229 (290)
T ss_dssp             C-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS
T ss_pred             cCCccccccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc
Confidence            999976433221    2233699999999996    45678999999999999999999999998654433333332221


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..           .......++.++.+|+.+||+.||++|||+.++++
T Consensus       230 ~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 PS-----------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CC-----------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-----------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            10           11112245678999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-44  Score=353.61  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=197.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ....++|++.+.||+|+||+||+|.+  .+..||||++......             ..+|+++++.++||||+++++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------------~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------------KNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------------HHHHHHHHHHcCCCCccchhhee
Confidence            45668999999999999999999998  4578999998643211             12699999999999999999998


Q ss_pred             Ee--------------------------------------CCeEEEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHH
Q psy5927         219 FE--------------------------------------TGKYCLVYRYMPNGSLEDRLLMK-KNTPSLLWTQRLHIAK  259 (441)
Q Consensus       219 ~~--------------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~  259 (441)
                      ..                                      ...+++||||++ |+|.+.+... .....+++..+..++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            44                                      334899999997 6888777532 2345699999999999


Q ss_pred             HHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCc
Q psy5927         260 GTSLGLQFLHSREPPLIHGDIKSANILLN-HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTK  337 (441)
Q Consensus       260 ~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~  337 (441)
                      |++.||+|||+.|  |+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||.+.+. .++.+
T Consensus       149 qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          149 QLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcc
Confidence            9999999999999  99999999999998 688999999999976433221    2334689999999998874 48999


Q ss_pred             cceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hhhhhh---------hccCCCc----hhHHHHHHHHHH
Q psy5927         338 VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---ENMYDL---------VDKNAQP----IELNIAYAFFRI  401 (441)
Q Consensus       338 ~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~~~~---------~~~~~~~----~~~~~~~~l~~l  401 (441)
                      +|||||||++|||++|.+||...... ..+..++.....   +.+...         .......    .+..++.++.+|
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  301 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence            99999999999999999999876553 333333332211   111000         0000111    123356779999


Q ss_pred             HHHhcCCCCCCCCCHHHHHH
Q psy5927         402 GKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       402 i~~cl~~dp~~RPs~~evl~  421 (441)
                      +.+||+.||.+|||+.++++
T Consensus       302 i~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHccCChhhCCCHHHHhc
Confidence            99999999999999999974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.3e-43  Score=347.72  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=196.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++......       ....+.+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   96 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   96 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-------hHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence            478999999999999999999984  678999998753221       12345667999999999999999999998765


Q ss_pred             C------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 G------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +      ..|+||||++ |+|.+.+.     ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        97 ~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl  168 (371)
T 2xrw_A           97 KSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  168 (371)
T ss_dssp             CSTTTCCEEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEE
T ss_pred             cccccccceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEE
Confidence            4      7899999996 67888774     23889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +|||+++.....    .......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+..+.....
T Consensus       169 ~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~  243 (371)
T 2xrw_A          169 LDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLG  243 (371)
T ss_dssp             CCCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CC
T ss_pred             EEeecccccccc----cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            999999764322    12234569999999999999899999999999999999999999998765422 2222222110


Q ss_pred             hh----------hhhhhh-------------------ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHh
Q psy5927         376 EE----------NMYDLV-------------------DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLS  424 (441)
Q Consensus       376 ~~----------~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~  424 (441)
                      ..          ......                   -+.........+..+.+|+.+||..||++|||+.++++  .++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence            00          000000                   01111223345778999999999999999999999987  454


Q ss_pred             c
Q psy5927         425 G  425 (441)
Q Consensus       425 ~  425 (441)
                      .
T Consensus       324 ~  324 (371)
T 2xrw_A          324 V  324 (371)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=353.24  Aligned_cols=256  Identities=15%  Similarity=0.168  Sum_probs=201.6

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEE-------ECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGV-------WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---  207 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---  207 (441)
                      .++.+..++|.+.+.||+|+||+||+|.       ..+..||||+++...            ...+..|++++..++   
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~l~~~~  125 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------PWEFYIGTQLMERLKPSM  125 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------HHHHHHHHHHHHHSCGGG
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------hhHHHHHHHHHHHhhhhh
Confidence            3455677899999999999999999994       246789999986432            112345666666665   


Q ss_pred             CCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK--NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       208 hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      |+||+.+++++...+..|+|||||++|+|.+++....  ....+++..+..|+.|++.||+|||+++  ||||||||+||
T Consensus       126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NI  203 (365)
T 3e7e_A          126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNF  203 (365)
T ss_dssp             GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGE
T ss_pred             hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHE
Confidence            9999999999999999999999999999999996533  3456999999999999999999999999  99999999999


Q ss_pred             eecC-----------CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCC
Q psy5927         286 LLNH-----------HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM  354 (441)
Q Consensus       286 Ll~~-----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~  354 (441)
                      |++.           ++.+||+|||+++...... ........+||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus       204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  282 (365)
T 3e7e_A          204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT  282 (365)
T ss_dssp             EECGGGTCC------CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             EecccccCccccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            9998           8999999999996532111 122345567999999999999989999999999999999999999


Q ss_pred             CCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcC
Q psy5927         355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKER-PEMTQVYNMLSGS  426 (441)
Q Consensus       355 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~evl~~L~~~  426 (441)
                      .||.......            ...    .......  .....+.+++..||+.+|.+| |++.++.+.|+..
T Consensus       283 ~pf~~~~~~~------------~~~----~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          283 YMKVKNEGGE------------CKP----EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             CCCEEEETTE------------EEE----CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             CccccCCCCc------------eee----chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            9996543210            000    0000011  124567889999999999998 5778777776654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-44  Score=348.44  Aligned_cols=265  Identities=21%  Similarity=0.278  Sum_probs=209.3

Q ss_pred             CCCChhHHHHhhCCCcCc-CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CC
Q psy5927         133 PHIPYQELTLATNNWDKL-NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RH  208 (441)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~-~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  208 (441)
                      +.+.++......++|.+. +.||+|+||.||+|.+.  ++.||+|+++......       .....+.+|+.++..+ +|
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~   88 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-------DCRAEILHEIAVLELAKSC   88 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-------ECHHHHHHHHHHHHHTTTC
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-------HHHHHHHHHHHHHHhccCC
Confidence            345556667777888887 89999999999999985  6789999987543322       1234566899999999 56


Q ss_pred             CCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         209 DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       209 pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      |||+++++++.+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+  |+||||||+|||++
T Consensus        89 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~  165 (327)
T 3lm5_A           89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLS  165 (327)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEES
T ss_pred             CCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEe
Confidence            99999999999999999999999999999987432 2356899999999999999999999999  99999999999999


Q ss_pred             C---CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHH
Q psy5927         289 H---HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSER  365 (441)
Q Consensus       289 ~---~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~  365 (441)
                      .   ++.+||+|||+++......    ......||+.|+|||++.+..++.++||||||+++|||++|..||........
T Consensus       166 ~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  241 (327)
T 3lm5_A          166 SIYPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET  241 (327)
T ss_dssp             CBTTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCCCcEEEeeCccccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence            8   7899999999997643221    22345699999999999999999999999999999999999999987654222


Q ss_pred             HHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         366 HLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       366 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       ...+....         ..........++..+.+|+.+||+.||.+||++.++++
T Consensus       242 -~~~i~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          242 -YLNISQVN---------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -HHHHHHTC---------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -HHHHHhcc---------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence             21111110         01111222345677899999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.3e-44  Score=346.72  Aligned_cols=262  Identities=22%  Similarity=0.389  Sum_probs=200.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++.......       ...+.+.+|+++++.++||||+++++++.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   96 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-------MVKKIAMREIKLLKQLRHENLVNLLEVCKKK   96 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-------HHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence            468999999999999999999985  5689999986543322       2334566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +..|+||||+++++|.+++..   ...+++..+..++.+++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCc
Confidence            999999999999999887643   234899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---h
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---E  377 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~  377 (441)
                      +......   .......||+.|+|||.+.+. .++.++|||||||++|||++|..||....... .+.........   .
T Consensus       172 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  247 (331)
T 4aaa_A          172 RTLAAPG---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGNLIPR  247 (331)
T ss_dssp             ---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHH
T ss_pred             eeecCCc---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCChh
Confidence            7543221   122344689999999999875 78999999999999999999999998765533 22222211100   0


Q ss_pred             h--------hhh-hhccC---CC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 N--------MYD-LVDKN---AQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~--------~~~-~~~~~---~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .        ... .....   ..   .....++..+.+|+.+||+.||.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0        000 00000   00   111245778999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=336.64  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=201.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.....||+|+||.||+|.+.  +..||||.+.....         ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   91 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---------RYSQPLHEEIALHKHLKHKNIVQYLGSFSEN   91 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------------HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---------HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence            345666679999999999999984  56799999875321         1234566899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-CCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-~~~~kl~DFGl  300 (441)
                      +..++||||+++++|.+++........+++..+..++.|++.||+|||+.+  |+||||||+|||++. ++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A           92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeeccc
Confidence            999999999999999999977655556788999999999999999999999  999999999999998 89999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCC--CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      ++......   .......||+.|+|||.+.+..  ++.++||||||+++|||++|..||..............       
T Consensus       170 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------  239 (295)
T 2clq_A          170 SKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-------  239 (295)
T ss_dssp             CEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-------
T ss_pred             ccccCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-------
Confidence            97643221   1123456899999999997643  78999999999999999999999976443221111100       


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                          ........+..++..+.+|+.+||+.||++||++.++++
T Consensus       240 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          240 ----MFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----HHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                001112234456778999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-43  Score=340.65  Aligned_cols=248  Identities=26%  Similarity=0.412  Sum_probs=204.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .+.|++.+.||+|+||.||+|.+.  +..||||++......        ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--------DEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--------TTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--------HHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            356999999999999999999984  568999998754322        1234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+++||||+++++|.+++..    ..+++..+..++.+++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccc
Confidence            999999999999999998843    35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      .......   .......||+.|+|||.+.+..++.++||||||+++|||++|..||....... .......         
T Consensus       167 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---------  233 (303)
T 3a7i_A          167 GQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-VLFLIPK---------  233 (303)
T ss_dssp             EECBTTB---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH---------
T ss_pred             eecCccc---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-HHHHhhc---------
Confidence            7643221   12234568999999999999899999999999999999999999998765422 1111111         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ......+..++..+.+|+.+||+.||.+||++.++++
T Consensus       234 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          234 ---NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ---SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               1111223345677999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-43  Score=340.63  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=205.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||.||+|.+.  +..||+|++......         ..+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---------RDSSLENEIAVLKKIKHENIVTLEDIYES   77 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---------chHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence            3468999999999999999999984  678999999743211         12345689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~D  297 (441)
                      .+..++||||+++++|.+++....   .+++..+..++.|++.||+|||+.+  |+||||||+|||+   +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             CCEEEEEEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEcc
Confidence            999999999999999999886543   4889999999999999999999999  9999999999999   7889999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+++.....     ......||+.|+|||.+.+..++.++||||||+++|||++|..||..... ......+.....  
T Consensus       153 fg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~--  224 (304)
T 2jam_A          153 FGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIKEGYY--  224 (304)
T ss_dssp             CSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHCCC--
T ss_pred             CCcceecCCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCC--
Confidence            9998754322     12334689999999999998999999999999999999999999977654 222222221110  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                             ....+....++..+.+|+.+||+.||.+||++.++++  .+++
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          225 -------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             -------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             -------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence                   0011222345678999999999999999999999986  4544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-44  Score=350.41  Aligned_cols=264  Identities=23%  Similarity=0.347  Sum_probs=205.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPL  214 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  214 (441)
                      +..++|++.+.||+|+||.||+|.+.       +..||||++......        .....+.+|+.++++++||||+++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~   98 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--------QDELDFLMEALIISKFNHQNIVRC   98 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--------hhHHHHHHHHHHHhhCCCCCCCeE
Confidence            44578999999999999999999842       346999998643221        223456789999999999999999


Q ss_pred             cceEEeCCeEEEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-
Q psy5927         215 YGICFETGKYCLVYRYMPNGSLEDRLLMKKN----TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-  289 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-  289 (441)
                      ++++.+.+..|+||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+.+  |+||||||+|||++. 
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A           99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCP  176 (327)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCS
T ss_pred             EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecC
Confidence            9999999999999999999999999976542    245889999999999999999999999  999999999999994 


Q ss_pred             --CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHH
Q psy5927         290 --HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERH  366 (441)
Q Consensus       290 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~  366 (441)
                        +..+||+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|||+| |..||...... ..
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~  254 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EV  254 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HH
T ss_pred             CCcceEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HH
Confidence              45699999999864211111 111223457889999999988889999999999999999998 99999776431 11


Q ss_pred             HHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         367 LKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       367 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                      ...+.            .......+..++..+.+|+.+||+.||.+||++.+|++.|+.+..+
T Consensus       255 ~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          255 LEFVT------------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHHH------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHh------------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            11111            1111122344567899999999999999999999999999876543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-43  Score=348.42  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=207.7

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeeccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLY  215 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  215 (441)
                      ......++|++.+.||+|+||.||+|.+.  +..||||++........... .....+.+.+|+.+++.+ +||||++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ-LEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHH-HHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHH-HHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            33455678999999999999999999985  67899999875432111111 123345667899999999 799999999


Q ss_pred             ceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         216 GICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +++...+..|+||||++|++|.+++...   ..+++..+..++.|++.||.|||+.|  |+||||||+|||++.++.+||
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999998653   34889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC------CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHH
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG------KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS  369 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~  369 (441)
                      +|||++.......    ......||+.|+|||++.+      ..++.++|||||||++|||++|..||..... ...+..
T Consensus       242 ~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~  316 (365)
T 2y7j_A          242 SDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRM  316 (365)
T ss_dssp             CCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH
T ss_pred             EecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-HHHHHH
Confidence            9999987643322    2234579999999999863      3588999999999999999999999977543 222222


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +......         ...+....++..+.+|+.+||+.||++||++.++++
T Consensus       317 i~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          317 IMEGQYQ---------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHTCCC---------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhCCCC---------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2111000         000111234567899999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.3e-44  Score=365.09  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=198.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.++||+|+||+||+|.+.  +..+|+|++.......       .....+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-------SSNSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-------hHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            3457999999999999999999985  5679999987543211       123456689999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---CCeEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---MDPVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---~~~kl~D  297 (441)
                      .+.+|+|||||++|+|.+++...   ..+++..+..++.||+.||+|||+++  |+||||||+|||++..   +.+||+|
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEE
Confidence            99999999999999999988654   34889999999999999999999999  9999999999999764   4599999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ...+..+.....  
T Consensus       183 fG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~--  254 (494)
T 3lij_A          183 FGLSAVFENQK----KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKY--  254 (494)
T ss_dssp             CTTCEECBTTB----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC--
T ss_pred             CCCCeECCCCc----cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--
Confidence            99997643221    2334579999999999875 699999999999999999999999987654 222222221110  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             ....+....++..+.+|+.+||+.||.+|||+.++++
T Consensus       255 -------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          255 -------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                   0011112345678999999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-43  Score=363.17  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=207.7

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.++||+|+||+||+|.+.  +..||||++......       ......+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-------NKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-------chHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            4578999999999999999999985  678999998643211       1123456799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec---CCCCeEEec
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIGD  297 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~---~~~~~kl~D  297 (441)
                      .+.+|+|||||.+|+|.+++....   .+++..+..++.|++.||.|||+++  |+||||||+|||++   .++.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEE
Confidence            999999999999999999886543   4889999999999999999999999  99999999999995   456799999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ...+..+.....  
T Consensus       168 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~--  239 (486)
T 3mwu_A          168 FGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKY--  239 (486)
T ss_dssp             CSCTTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC--
T ss_pred             CCcCeECCCCC----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--
Confidence            99997543221    2334569999999999987 599999999999999999999999987654 222222221100  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGE  429 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~  429 (441)
                             ....+....++..+.+|+.+||+.||.+|||+.++++  .++.....
T Consensus       240 -------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             -------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             -------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence                   0011222346778999999999999999999999997  46655443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-43  Score=337.54  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=206.8

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++.................+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999984  5789999997543211111111234556779999999995 99999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+..++||||+++++|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999998654   34889999999999999999999999  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCccccc------CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLV------GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      |++.......    ......||+.|+|||.+.      ...++.++||||||+++|||++|..||...... .....+..
T Consensus       169 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~  243 (298)
T 1phk_A          169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMS  243 (298)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred             cchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhc
Confidence            9997643222    123456899999999985      456889999999999999999999999765442 22222211


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...         ....+....++..+.+|+.+||+.||.+||++.++++
T Consensus       244 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 GNY---------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             TCC---------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCc---------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            100         0011122346778999999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.1e-43  Score=353.97  Aligned_cols=273  Identities=22%  Similarity=0.299  Sum_probs=200.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++.....       .....+.+.+|+++|+.++||||+++++++...
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-------DLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-------ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            478999999999999999999985  46799999974322       122345677999999999999999999998766


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                           ..+|+||||+. |+|.+++..   ...+++..+..++.||+.||+|||+.|  |+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A           98 DLLKFDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcCCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEc
Confidence                 57999999995 799998853   345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccc-------------------cceeccccccCCCcCcccc-cCCCCCCccceehHHHHHHHHHhCCCC
Q psy5927         297 DFGLTQEGPIEKAT-------------------HITLKRVNGTRPYLPHEFL-VGKRLSTKVDVYGFGIVLFELATGMRA  356 (441)
Q Consensus       297 DFGla~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DiwSlGvvl~elltG~~p  356 (441)
                      |||+++........                   .......+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus       172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  251 (432)
T 3n9x_A          172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS  251 (432)
T ss_dssp             CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred             cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence            99999864332211                   0123556799999999986 556799999999999999999985544


Q ss_pred             CC-----------Ccch----------------hHHHHHHHHHhhch-----------hhhhhhhcc----CCCc---hh
Q psy5927         357 YD-----------DTRR----------------SERHLKSLVEKYSE-----------ENMYDLVDK----NAQP---IE  391 (441)
Q Consensus       357 ~~-----------~~~~----------------~~~~l~~~~~~~~~-----------~~~~~~~~~----~~~~---~~  391 (441)
                      |.           +...                ...++..+.+....           ......+..    ....   ..
T Consensus       252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (432)
T 3n9x_A          252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY  331 (432)
T ss_dssp             TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred             cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence            43           2210                01122222221110           011111110    0000   11


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCC
Q psy5927         392 LNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGE  429 (441)
Q Consensus       392 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~  429 (441)
                      ..++.++.+|+.+||..||++|||+.++++  .|+.....
T Consensus       332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            345778999999999999999999999987  56655443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-43  Score=364.49  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=205.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHH----HhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAV----ETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..++|.+.++||+|+||+||+|.+.  +..||||++.........    ........+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999985  467999999754322110    0000122456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC---Ce
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM---DP  293 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~---~~  293 (441)
                      ++.+.+.+|+|||||+||+|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999988654   34899999999999999999999999  99999999999999876   69


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ...+..+...
T Consensus       189 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~  262 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEKG  262 (504)
T ss_dssp             EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHC
T ss_pred             EEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC
Confidence            999999997643321    2234569999999999875 699999999999999999999999987654 2222222111


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      ...         ...+....++.++.+|+.+||+.||.+|||+.++++  .+.....
T Consensus       263 ~~~---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          263 KYY---------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCC---------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCC---------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            000         000111245678999999999999999999999986  4554443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=337.79  Aligned_cols=261  Identities=21%  Similarity=0.295  Sum_probs=201.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE--
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF--  219 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--  219 (441)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|+++.......     ....+.+.+|+++++.++||||+++++++.  
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-----PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS-----TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc-----chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            478999999999999999999984  56799999874321110     123456779999999999999999999984  


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||++++ |.+.+.... ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeeccc
Confidence            456889999999866 777775543 356899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCC--CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ++....... .........||+.|+|||.+.+..  ++.++||||||+++|||++|..||...... .....+..     
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~~-----  227 (305)
T 2wtk_C          155 VAEALHPFA-ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFENIGK-----  227 (305)
T ss_dssp             TCEECCTTC-SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH-----
T ss_pred             cccccCccc-cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHHhc-----
Confidence            997643221 112234456999999999998643  478999999999999999999999875431 11111111     


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                              .....+..++..+.+|+.+||+.||.+||++.++++  .+.....
T Consensus       228 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          228 --------GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             --------CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             --------CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                    111223345678899999999999999999999996  5555433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-43  Score=338.85  Aligned_cols=264  Identities=19%  Similarity=0.243  Sum_probs=205.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE-E
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC-F  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~  219 (441)
                      ..++|++.+.||+|+||.||+|.+  .+..||||++......           +.+.+|+.+++.++|++++..+.++ .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~i~~~~~~~~   75 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGA   75 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----------CHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----------hHHHHHHHHHHHhhcCCCCCccccccC
Confidence            357899999999999999999997  5678999998653321           2355899999999988877666655 5


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~  296 (441)
                      +.+..++||||+ +++|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+
T Consensus        76 ~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           76 EGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             CCCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEe
Confidence            677889999999 999999986433  45899999999999999999999999  9999999999999   588999999


Q ss_pred             ccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH--HHHHHH
Q psy5927         297 DFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSL  370 (441)
Q Consensus       297 DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--~~l~~~  370 (441)
                      |||+++.........    .......||+.|+|||.+.+..++.++|||||||++|||++|..||.......  ......
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            999997643322111    11234579999999999999899999999999999999999999997643211  112111


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      ......        .........++.++.+++.+||+.||.+||++.+|++.|+.+..+.
T Consensus       231 ~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          231 SEKKMS--------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHH--------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccccC--------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            111000        0001122345678999999999999999999999999998765443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-43  Score=347.15  Aligned_cols=280  Identities=22%  Similarity=0.270  Sum_probs=206.1

Q ss_pred             hhHHHHhhCCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHH--HhhhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         137 YQELTLATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAV--ETLNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       137 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      ..++....++|.+.+.||+|+||.||+|.+ .+..||||++.........  ........+.+.+|+++++.++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            456677889999999999999999999987 4578999998654332110  0112233467789999999999999999


Q ss_pred             ccceEEe-----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec
Q psy5927         214 LYGICFE-----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN  288 (441)
Q Consensus       214 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~  288 (441)
                      +++++..     ...+|+||||++ |+|.+.+..  ....+++..+..++.|++.||+|||+.+  |+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA  168 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc
Confidence            9999854     346899999996 788888863  3346899999999999999999999999  99999999999999


Q ss_pred             CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH
Q psy5927         289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL  367 (441)
Q Consensus       289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l  367 (441)
                      .++.+||+|||+++......    ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ...+
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~  243 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-YNQL  243 (362)
T ss_dssp             TTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHH
T ss_pred             CCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-HHHH
Confidence            99999999999997533221    1233468999999999877 6789999999999999999999999987654 2333


Q ss_pred             HHHHHhhchhh-----------hhhhhccC--------CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         368 KSLVEKYSEEN-----------MYDLVDKN--------AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       368 ~~~~~~~~~~~-----------~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ..+........           ....+...        .......++..+.+|+.+||+.||.+|||+.++++  .++.+
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            33332221100           01111110        01122334667899999999999999999999987  44443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-43  Score=347.08  Aligned_cols=265  Identities=22%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++........       ....+.+|+++++.++||||+++++++.+ 
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-------FPITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS-------SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc-------chHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            468999999999999999999984  56899999865433221       12345689999999999999999999887 


Q ss_pred             -------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         221 -------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       221 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                             .+.+|+||||++ |+|.+.+...  ...+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+
T Consensus        89 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~  163 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCE-HDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVL  163 (351)
T ss_dssp             --------CEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCE
T ss_pred             ccccccCCceEEEEEeccC-CCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCE
Confidence                   456899999996 5787777533  345899999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCccc-ccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKA-THITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       294 kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      ||+|||+++....... .........||+.|+|||++.+ ..++.++|||||||++|||+||.+||...... ..+..+.
T Consensus       164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~  242 (351)
T 3mi9_A          164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALIS  242 (351)
T ss_dssp             EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH
T ss_pred             EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            9999999976432211 1222344578999999999876 45899999999999999999999999876542 2222222


Q ss_pred             Hhhc---hhhhhh-----h------hccCCCchhHH-----HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         372 EKYS---EENMYD-----L------VDKNAQPIELN-----IAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       372 ~~~~---~~~~~~-----~------~~~~~~~~~~~-----~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....   ......     .      ...........     .+..+.+|+.+||+.||++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            2111   100000     0      00001111111     1456889999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=338.93  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=199.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||.+.....           .+.+.+|+++++.++||||+++++++.
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            44578999999999999999999985  67899999874321           234568999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..++||||+++++|.+++...  ...+++..+..++.+++.||.|||+.+  |+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A           95 KNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             eCCEEEEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecc
Confidence            999999999999999999988633  345899999999999999999999999  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++.......   .......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ........     
T Consensus       171 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-----  241 (314)
T 3com_A          171 VAGQLTDTM---AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-IFMIPTNP-----  241 (314)
T ss_dssp             TCEECBTTB---SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC-----
T ss_pred             cchhhhhhc---cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhcCC-----
Confidence            997543221   122345689999999999998999999999999999999999999987654221 11111100     


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           ......+..++..+.+|+.+||+.||.+||++.++++
T Consensus       242 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 -----PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -----CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 0111123345678999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=355.43  Aligned_cols=264  Identities=19%  Similarity=0.276  Sum_probs=183.5

Q ss_pred             hCCCcC-cCccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         144 TNNWDK-LNILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       144 ~~~~~~-~~~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .+.|++ .++||+|+||+||+|.+.    +..||||++......           ..+.+|+++|+.++||||+++++++
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~~~~~   87 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----------MSACREIALLRELKHPNVISLQKVF   87 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----------HHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----------HHHHHHHHHHHhcCCCCeeeEeeEE
Confidence            345666 568999999999999974    467999998643221           2345899999999999999999999


Q ss_pred             Ee--CCeEEEEEEecCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---
Q psy5927         219 FE--TGKYCLVYRYMPNGSLEDRLLMKK------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---  287 (441)
Q Consensus       219 ~~--~~~~~lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---  287 (441)
                      ..  ...+|+||||+. |+|.+++....      ....+++..++.++.||+.||+|||+.+  |+||||||+|||+   
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~  164 (405)
T 3rgf_A           88 LSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGE  164 (405)
T ss_dssp             EETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCS
T ss_pred             ecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecC
Confidence            64  678999999995 68888775332      2234899999999999999999999999  9999999999999   


Q ss_pred             -cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchh--
Q psy5927         288 -NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRS--  363 (441)
Q Consensus       288 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~--  363 (441)
                       +.++.+||+|||+++................||+.|+|||++.+. .++.++|||||||++|||++|.+||......  
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  244 (405)
T 3rgf_A          165 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK  244 (405)
T ss_dssp             STTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             CCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccc
Confidence             778999999999998654322222334456799999999999874 5899999999999999999999999754431  


Q ss_pred             ------HHHHHHHHHhhch---hhhhhhh-------------ccC--CCchh-------HHHHHHHHHHHHHhcCCCCCC
Q psy5927         364 ------ERHLKSLVEKYSE---ENMYDLV-------------DKN--AQPIE-------LNIAYAFFRIGKQSTKQNPKE  412 (441)
Q Consensus       364 ------~~~l~~~~~~~~~---~~~~~~~-------------~~~--~~~~~-------~~~~~~l~~li~~cl~~dp~~  412 (441)
                            ...+..+......   .......             ...  .....       ...+..+.+|+.+||..||.+
T Consensus       245 ~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~  324 (405)
T 3rgf_A          245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK  324 (405)
T ss_dssp             --CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGG
T ss_pred             ccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCccc
Confidence                  1222222222110   0000000             000  00000       011456889999999999999


Q ss_pred             CCCHHHHHH
Q psy5927         413 RPEMTQVYN  421 (441)
Q Consensus       413 RPs~~evl~  421 (441)
                      |||+.++++
T Consensus       325 R~ta~e~L~  333 (405)
T 3rgf_A          325 RITSEQAMQ  333 (405)
T ss_dssp             SCCHHHHHT
T ss_pred             CCCHHHHhc
Confidence            999999997

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-43  Score=354.49  Aligned_cols=259  Identities=20%  Similarity=0.285  Sum_probs=200.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC------CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC------RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~  213 (441)
                      ....+|++.+.||+|+||+||+|.+.  +..||||++....          .....+.+|++++..+      .|+||++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----------RFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----------chHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            34578999999999999999999985  5789999986421          1122344566666555      6789999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC-
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD-  292 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~-  292 (441)
                      +++++...+.+|+||||+. ++|.+++.... ...+++..+..++.||+.||+|||+.+  ||||||||+|||++.++. 
T Consensus       164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          164 MLENFTFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             EEEEEEETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSC
T ss_pred             EEeecccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCc
Confidence            9999999999999999995 79999886543 345899999999999999999999999  999999999999999987 


Q ss_pred             -eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         293 -PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 -~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                       +||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||+||.+||..... ...+..+.
T Consensus       240 ~vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~-~~~l~~i~  312 (429)
T 3kvw_A          240 GIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE-GDQLACMI  312 (429)
T ss_dssp             CEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred             ceEEeecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence             999999999753221      2345789999999999999999999999999999999999999987655 23333333


Q ss_pred             Hhhch--hhh-------hhhhccC---------------------------------CCch----hHHHHHHHHHHHHHh
Q psy5927         372 EKYSE--ENM-------YDLVDKN---------------------------------AQPI----ELNIAYAFFRIGKQS  405 (441)
Q Consensus       372 ~~~~~--~~~-------~~~~~~~---------------------------------~~~~----~~~~~~~l~~li~~c  405 (441)
                      +....  ..+       ..+++..                                 ...+    ....+..+.+|+.+|
T Consensus       313 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~  392 (429)
T 3kvw_A          313 ELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC  392 (429)
T ss_dssp             HHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHH
T ss_pred             HHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHH
Confidence            22210  000       0011100                                 0000    011256789999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q psy5927         406 TKQNPKERPEMTQVYN  421 (441)
Q Consensus       406 l~~dp~~RPs~~evl~  421 (441)
                      |+.||++|||+.|+++
T Consensus       393 L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          393 LEWDPAVRMTPGQALR  408 (429)
T ss_dssp             TCSSTTTSCCHHHHHT
T ss_pred             CCCChhhCCCHHHHhC
Confidence            9999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.2e-44  Score=345.13  Aligned_cols=267  Identities=21%  Similarity=0.360  Sum_probs=189.7

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .+..++|++.+.||+|+||.||+|.+  .+..||||++......        ...+.+.+|+.+++.++||||+++++++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--------TSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEEEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--------hhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            46678999999999999999999987  5678999988643211        2234566899999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMK-----KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      ...+..++||||+++++|.+++...     .....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~  160 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSV  160 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCE
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCE
Confidence            9999999999999999999988642     12455899999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCccc--ccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKA--THITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       294 kl~DFGla~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      ||+|||++........  .........||+.|+|||.+.+ ..++.++||||||+++|||++|..||.......... ..
T Consensus       161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~  239 (303)
T 2vwi_A          161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LT  239 (303)
T ss_dssp             EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HH
T ss_pred             EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HH
Confidence            9999998865432211  1111234569999999999876 568999999999999999999999998765432221 11


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...... ......  ........++..+.+|+.+||+.||.+||++.++++
T Consensus       240 ~~~~~~-~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQNDPP-SLETGV--QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTSSCC-CTTC-------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccCCC-cccccc--ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111000 000000  001112234567899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.2e-44  Score=365.19  Aligned_cols=260  Identities=23%  Similarity=0.355  Sum_probs=208.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++........      ...+.+.+|++++++++||||+++++++.
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~   96 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK------TDKESLLREVQLLKQLDHPNIMKLYEFFE   96 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS------SCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc------hHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34578999999999999999999984  57899999864332111      12345679999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~  296 (441)
                      +.+.+|+||||+.+|+|.+++...   ..+++..+..++.|++.||+|||+++  |+||||||+|||+   +.++.+||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A           97 DKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEE
Confidence            999999999999999999988643   34899999999999999999999999  9999999999999   567899999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... ..+..+..... 
T Consensus       172 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~-  244 (484)
T 3nyv_A          172 DFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKY-  244 (484)
T ss_dssp             CTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCC-
T ss_pred             eeeeeEEccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCC-
Confidence            999987543222    1234469999999999987 6999999999999999999999999876542 22222211100 


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                              ....+....++..+.+|+.+||+.||.+|||+.++++  .++...
T Consensus       245 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          245 --------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             --------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             --------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence                    0011222356778999999999999999999999986  555443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=344.31  Aligned_cols=255  Identities=23%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeeccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLY  215 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  215 (441)
                      ++....++|++.+.||+|+||.||+|.+  .+..||||++......          .+.+.+|+.+++++ +||||++++
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~~h~~i~~~~   87 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYY   87 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----------THHHHHHHHHHHHHCCSTTBCCEE
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----------HHHHHHHHHHHHhccCCCCeeeee
Confidence            3445678999999999999999999998  5678999998754321          23456899999998 799999999


Q ss_pred             ceEEe------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC
Q psy5927         216 GICFE------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH  289 (441)
Q Consensus       216 ~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~  289 (441)
                      +++..      .+.+++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTE  164 (326)
T ss_dssp             EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECT
T ss_pred             eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcC
Confidence            99987      568999999999999999987543 345889999999999999999999999  999999999999999


Q ss_pred             CCCeEEeccCCCccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         290 HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       290 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      ++.+||+|||++.......   .......||+.|+|||.+.     +..++.++|||||||++|||++|..||.......
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             TCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CCCEEEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            9999999999987543211   1123446899999999987     4578999999999999999999999997665422


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                       .+......           .........++..+.+|+.+||+.||.+||++.++++
T Consensus       242 -~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 -ALFLIPRN-----------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -HHHHHHHS-----------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -HHHHhhcC-----------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             11111110           0011112234668999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.9e-45  Score=359.34  Aligned_cols=244  Identities=13%  Similarity=0.117  Sum_probs=188.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHH---HHhhcCCCCCeeccc---
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLREL---KYLNSCRHDNILPLY---  215 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~l~---  215 (441)
                      .++|.+.+.||+|+||+||+|.+.  +..||||++........      ...+.+.+|+   ++++.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT------THHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch------HHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            468999999999999999999963  67899999975322111      1234566888   556666899999998   


Q ss_pred             ----ceEEeCC-----------------eEEEEEEecCCCCHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHc
Q psy5927         216 ----GICFETG-----------------KYCLVYRYMPNGSLEDRLLMKKNT----PSLLWTQRLHIAKGTSLGLQFLHS  270 (441)
Q Consensus       216 ----~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~i~~al~~LH~  270 (441)
                          +++.+.+                 ..|+||||+ +|+|.+++......    ..+++..+..|+.||+.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                5555443                 388999999 68999999754321    224458888999999999999999


Q ss_pred             CCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-----------CCCCccc
Q psy5927         271 REPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-----------RLSTKVD  339 (441)
Q Consensus       271 ~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~D  339 (441)
                      ++  |+||||||+|||++.++.+||+|||+++....      ......| +.|+|||++.+.           .++.++|
T Consensus       225 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             CC--eecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            99  99999999999999999999999999975321      2334567 999999999887           7999999


Q ss_pred             eehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       340 iwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                      ||||||++|||+||..||.......             ...... ..    ...++.++.+|+.+||+.||.+||++.++
T Consensus       296 vwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~-~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPITKDAALG-------------GSEWIF-RS----CKNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC------C-------------CSGGGG-SS----CCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCccccccc-------------chhhhh-hh----ccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            9999999999999999996543211             000111 11    12345678999999999999999999999


Q ss_pred             HH
Q psy5927         420 YN  421 (441)
Q Consensus       420 l~  421 (441)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            85

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.8e-43  Score=350.36  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=200.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC--------CCCe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--------HDNI  211 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnI  211 (441)
                      ...++|++.++||+|+||+||+|.+.  +..||||+++...          ...+.+.+|+++++.++        |+||
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----------HYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----------cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            34578999999999999999999884  5789999986321          22345668999888885        7889


Q ss_pred             ecccceEE----eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCee
Q psy5927         212 LPLYGICF----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANIL  286 (441)
Q Consensus       212 v~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiL  286 (441)
                      +++++++.    +...+|+||||+ +++|.+.+.... ...+++..+..++.||+.||+|||++ |  |+||||||+|||
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIl  179 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENIL  179 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEE
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHee
Confidence            99999987    456899999999 677777775443 34589999999999999999999998 8  999999999999


Q ss_pred             ecCCC-------------------------------------------------CeEEeccCCCccCCCcccccceeccc
Q psy5927         287 LNHHM-------------------------------------------------DPVIGDFGLTQEGPIEKATHITLKRV  317 (441)
Q Consensus       287 l~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~  317 (441)
                      ++.++                                                 .+||+|||+++.....      ....
T Consensus       180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~  253 (397)
T 1wak_A          180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTED  253 (397)
T ss_dssp             ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSC
T ss_pred             EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccC
Confidence            99775                                                 8999999999764321      2334


Q ss_pred             cccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch-----hHHHHHHHHHhhchhh--h-------hhhh
Q psy5927         318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR-----SERHLKSLVEKYSEEN--M-------YDLV  383 (441)
Q Consensus       318 ~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~-----~~~~l~~~~~~~~~~~--~-------~~~~  383 (441)
                      .||+.|+|||++.+..++.++|||||||++|||+||..||.....     ....+..+........  .       ..+.
T Consensus       254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            689999999999998999999999999999999999999975432     1122222222111000  0       0000


Q ss_pred             cc--------------------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         384 DK--------------------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       384 ~~--------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..                    .....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00                    011234667888999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-43  Score=353.46  Aligned_cols=265  Identities=18%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ...+|.+.+.||+|+||+||+|.+. ...+|+|++......             ..+|+++++.++||||+++++++...
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------------~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------------KNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------------HHHHHHHHHhCCCCCcceEEEEEEec
Confidence            3467999999999999999999984 456999988643211             12699999999999999999998654


Q ss_pred             Ce------EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCCeE
Q psy5927         222 GK------YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-HHMDPV  294 (441)
Q Consensus       222 ~~------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~~k  294 (441)
                      +.      +++||||++++.+............+++..+..++.|++.||+|||+++  |+||||||+|||++ .++.+|
T Consensus       105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred             CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEE
Confidence            43      8899999976544443333334456899999999999999999999999  99999999999999 799999


Q ss_pred             EeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       295 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |+|||+++.......    .....||+.|+|||.+.+. .++.++|||||||++|||++|.+||.+.... ..+..+...
T Consensus       183 L~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~  257 (394)
T 4e7w_A          183 LIDFGSAKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKV  257 (394)
T ss_dssp             ECCCTTCEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred             EeeCCCcccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Confidence            999999976433221    2234689999999998764 5899999999999999999999999876653 333333322


Q ss_pred             hch---hhhhh----hhcc-----CCCc----hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         374 YSE---ENMYD----LVDK-----NAQP----IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       374 ~~~---~~~~~----~~~~-----~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                      ...   +.+..    +...     ...+    ....++.++.+|+.+||+.||.+||++.++++  .++++.
T Consensus       258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            210   00000    0000     0111    11235678999999999999999999999987  355443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.8e-43  Score=355.25  Aligned_cols=262  Identities=20%  Similarity=0.272  Sum_probs=197.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      ..+|++.+.||+|+||.||+|.+.  +..||||++.....             ...+|+++++.++||||+++++++...
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~E~~il~~l~hpniv~l~~~~~~~  119 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHCNIVRLRYFFYSS  119 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHcCCCCccceeeEEecc
Confidence            347999999999999999999984  67899999864321             112699999999999999999988542


Q ss_pred             ------CeEEEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCe
Q psy5927         222 ------GKYCLVYRYMPNGSLEDRLLM-KKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDP  293 (441)
Q Consensus       222 ------~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~  293 (441)
                            ..+++||||+++ +|.+.+.. ......+++..+..++.||+.||+|||+++  |+||||||+|||++.+ +.+
T Consensus       120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~  196 (420)
T 1j1b_A          120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVL  196 (420)
T ss_dssp             ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEE
T ss_pred             CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeE
Confidence                  236799999974 66665543 223456999999999999999999999999  9999999999999965 568


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      ||+|||+++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.... ..+..++.
T Consensus       197 kl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~  271 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIK  271 (420)
T ss_dssp             EECCCTTCEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred             EeccchhhhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            9999999986432221    2335689999999999774 7899999999999999999999999876542 33333333


Q ss_pred             hhch---hhhhhhh---------ccCCCch----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         373 KYSE---ENMYDLV---------DKNAQPI----ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       373 ~~~~---~~~~~~~---------~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ....   +.+....         .....++    +..++.++.+|+.+||..||.+||++.++++  .++.+
T Consensus       272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            2211   1111100         0001111    2234678999999999999999999999986  44443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.1e-43  Score=343.75  Aligned_cols=274  Identities=20%  Similarity=0.253  Sum_probs=195.3

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeeccc
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLY  215 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  215 (441)
                      .......++|++.+.||+|+||+||+|.+.  +..||||++......          .....++++.+..++||||++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~~l~~l~h~niv~~~   85 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----------RNRELQIMQDLAVLHHPNIVQLQ   85 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----------CCHHHHHHHHHHHHCCTTBCCEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----------cHHHHHHHHHHHhcCCCCcccHH
Confidence            344567789999999999999999999985  568999988643211          11334677888889999999999


Q ss_pred             ceEEeCCe-------EEEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCeeecCCCCCCe
Q psy5927         216 GICFETGK-------YCLVYRYMPNGSLEDRLLM-KKNTPSLLWTQRLHIAKGTSLGLQFLH--SREPPLIHGDIKSANI  285 (441)
Q Consensus       216 ~~~~~~~~-------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~al~~LH--~~~~~iiHrDikp~Ni  285 (441)
                      +++...+.       +++||||+++ +|.+.+.. ......+++..+..++.+++.||.|||  +.+  |+||||||+||
T Consensus        86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NI  162 (360)
T 3e3p_A           86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNV  162 (360)
T ss_dssp             EEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGE
T ss_pred             HhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHE
Confidence            99976443       8899999975 55444432 234556889999999999999999999  777  99999999999


Q ss_pred             eecC-CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchh
Q psy5927         286 LLNH-HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRS  363 (441)
Q Consensus       286 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~  363 (441)
                      |++. ++.+||+|||+++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|..||..... 
T Consensus       163 ll~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-  237 (360)
T 3e3p_A          163 LVNEADGTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-  237 (360)
T ss_dssp             EEETTTTEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred             EEeCCCCcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-
Confidence            9997 89999999999986443221    2344689999999998764 489999999999999999999999987655 


Q ss_pred             HHHHHHHHHhhch--hhhhh----------hhccCCCch-------hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--H
Q psy5927         364 ERHLKSLVEKYSE--ENMYD----------LVDKNAQPI-------ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--M  422 (441)
Q Consensus       364 ~~~l~~~~~~~~~--~~~~~----------~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~  422 (441)
                      ...+..+......  .....          ..+....++       ....+..+.+|+.+||+.||.+|||+.++++  .
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            2333333322210  01111          111111111       1125678999999999999999999999987  5


Q ss_pred             HhcCCCC
Q psy5927         423 LSGSGGE  429 (441)
Q Consensus       423 L~~~~~~  429 (441)
                      +++....
T Consensus       318 f~~~~~~  324 (360)
T 3e3p_A          318 FDELHDP  324 (360)
T ss_dssp             GGGGGCT
T ss_pred             ccccCCc
Confidence            6655443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.7e-43  Score=346.70  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=188.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||.||+|.+.  +..||||++......       ....+.+.+|+++++.++||||+++++++...
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            478999999999999999999874  678999998643211       12345667999999999999999999998654


Q ss_pred             ------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 ------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                            ...|+|+||+ +++|.+++..    ..+++..+..++.||+.||+|||+.|  |+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL  173 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKI  173 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEE
Confidence                  5689999999 7999887743    35899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++.....      .....||+.|+|||.+.+ ..++.++|||||||++|||++|..||.+... ...+..+....
T Consensus       174 ~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~  246 (367)
T 2fst_X          174 LDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLV  246 (367)
T ss_dssp             CC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHH
T ss_pred             eecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh
Confidence            999999763221      234569999999999987 6789999999999999999999999987654 23333333221


Q ss_pred             ch-----------hhhhhhhcc----CCCch---hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         375 SE-----------ENMYDLVDK----NAQPI---ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       375 ~~-----------~~~~~~~~~----~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ..           .....++..    ....+   ....+..+.+|+.+||..||.+|||+.++++  .++..
T Consensus       247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            10           001111110    01111   1234567899999999999999999999987  44443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.3e-43  Score=339.13  Aligned_cols=259  Identities=20%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE---CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC------Cee
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW---EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD------NIL  212 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv  212 (441)
                      ...++|++.+.||+|+||.||+|.+   .+..||||+++...          ...+.+.+|++++..++|+      +|+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~i~   80 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----------RYCEAARSEIQVLEHLNTTDPNSTFRCV   80 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----------HHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----------chhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence            4567999999999999999999987   35789999986321          1233455788887777655      599


Q ss_pred             cccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---
Q psy5927         213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---  289 (441)
Q Consensus       213 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---  289 (441)
                      ++++++.+.+..|+||||+ +++|.+++.... ..++++..+..++.|++.||+|||+++  |+||||||+|||++.   
T Consensus        81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~  156 (339)
T 1z57_A           81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDY  156 (339)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCE
T ss_pred             eeecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecccc
Confidence            9999999999999999999 899999886543 345889999999999999999999999  999999999999988   


Q ss_pred             ----------------CCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC
Q psy5927         290 ----------------HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG  353 (441)
Q Consensus       290 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG  353 (441)
                                      ++.+||+|||+++.....      .....||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence                            678999999999753221      2344689999999999998999999999999999999999


Q ss_pred             CCCCCCcchhHHHHHHHHHhhch--hhhhh------h-----------------hc------cCCCchhHHHHHHHHHHH
Q psy5927         354 MRAYDDTRRSERHLKSLVEKYSE--ENMYD------L-----------------VD------KNAQPIELNIAYAFFRIG  402 (441)
Q Consensus       354 ~~p~~~~~~~~~~l~~~~~~~~~--~~~~~------~-----------------~~------~~~~~~~~~~~~~l~~li  402 (441)
                      ..||....... .+..+......  ..+..      .                 ..      ..........+..+.+|+
T Consensus       231 ~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  309 (339)
T 1z57_A          231 FTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI  309 (339)
T ss_dssp             SCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence            99998765422 22222111110  00000      0                 00      000111235678899999


Q ss_pred             HHhcCCCCCCCCCHHHHHH
Q psy5927         403 KQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       403 ~~cl~~dp~~RPs~~evl~  421 (441)
                      .+||+.||.+|||+.++++
T Consensus       310 ~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          310 QKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHTCSSTTTSCCHHHHTT
T ss_pred             HHHhCcCcccccCHHHHhc
Confidence            9999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.1e-43  Score=338.47  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..+|+|++.....         ...+.+.+|+++++.++||||+++++++.+
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   87 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---------EELEDYIVEIEILATCDHPYIVKLLGAYYH   87 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---------HHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence            3478999999999999999999995  56799999864321         123456789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+..++||||+++++|.+++....  ..+++..+..++.+++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~  163 (302)
T 2j7t_A           88 DGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGV  163 (302)
T ss_dssp             C-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred             CCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCC
Confidence            999999999999999999886533  34889999999999999999999999  99999999999999999999999998


Q ss_pred             CccCCCcccccceeccccccCCCcCcccc-----cCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFL-----VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +.....   .........||+.|+|||.+     .+..++.++||||||+++|||++|..||....... ........  
T Consensus       164 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--  237 (302)
T 2j7t_A          164 SAKNLK---TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKS--  237 (302)
T ss_dssp             HHHHHH---HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHS--
T ss_pred             Cccccc---cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHhcc--
Confidence            753111   11112334689999999998     35678999999999999999999999998765422 11111110  


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                              +......+..++..+.+++.+||+.||.+||++.++++
T Consensus       238 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 --------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    01111223456678999999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=338.77  Aligned_cols=266  Identities=23%  Similarity=0.339  Sum_probs=197.1

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE-
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF-  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-  219 (441)
                      ..++|++.+.||+|+||.||+|.+.  +..||+|++.....         ...+.+.+|+++++.++||||+++++++. 
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   79 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---------QSVKHALREIKIIRRLDHDNIVKVFEILGP   79 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH---------HHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh---------HHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence            3578999999999999999999986  67899999874321         23456679999999999999999998873 


Q ss_pred             -------------eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCee
Q psy5927         220 -------------ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANIL  286 (441)
Q Consensus       220 -------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiL  286 (441)
                                   +....++||||++ |+|.+++..    .++++..+..++.|++.||+|||+++  |+||||||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil  152 (320)
T 2i6l_A           80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLF  152 (320)
T ss_dssp             TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEE
T ss_pred             cccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEE
Confidence                         4478899999997 799998842    45889999999999999999999999  999999999999


Q ss_pred             ec-CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         287 LN-HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       287 l~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      ++ .++.+||+|||+++................+|..|+|||.+.+ ..++.++||||||+++|||++|..||...... 
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  231 (320)
T 2i6l_A          153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-  231 (320)
T ss_dssp             EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred             EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-
Confidence            97 5678999999999864322222222334567999999998865 67899999999999999999999999876542 


Q ss_pred             HHHHHHHHhhc---hhhhhhhh-----------ccCCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         365 RHLKSLVEKYS---EENMYDLV-----------DKNAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       365 ~~l~~~~~~~~---~~~~~~~~-----------~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                      .....+.....   .+....+.           .....   .....++.++.+|+.+||+.||.+||++.++++  .++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (320)
T 2i6l_A          232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI  311 (320)
T ss_dssp             HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence            22333322211   00000000           00011   112345778999999999999999999999987  4553

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-43  Score=344.07  Aligned_cols=272  Identities=20%  Similarity=0.275  Sum_probs=206.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHh--------hhHHHHHHHHHHHHHhhcCCCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVET--------LNQCQREQSLRELKYLNSCRHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpnIv~  213 (441)
                      ...++|++.+.||+|+||.||+|.+.+..||||++...........        ......+.+.+|++++++++||||++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            3457899999999999999999999889999999974321110000        00001156679999999999999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCee
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDR------LLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANIL  286 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiL  286 (441)
                      +++++.+.+..++||||+++|+|.++      +.. .....+++..+..++.|++.||+|||+ .|  |+||||||+|||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil  184 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL  184 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence            99999999999999999999999987      432 224669999999999999999999999 88  999999999999


Q ss_pred             ecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCC-ccceehHHHHHHHHHhCCCCCCCcchhH
Q psy5927         287 LNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLST-KVDVYGFGIVLFELATGMRAYDDTRRSE  364 (441)
Q Consensus       287 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DiwSlGvvl~elltG~~p~~~~~~~~  364 (441)
                      ++.++.+||+|||++......     ......||..|+|||.+.+. .++. ++||||||+++|||++|..||.......
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999764322     23445699999999999886 6666 9999999999999999999998765422


Q ss_pred             HHHHHHHHhhchhh------hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         365 RHLKSLVEKYSEEN------MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       365 ~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .....+........      ...............++..+.+|+.+||+.||.+||++.++++
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22222211100000      0000000000111345678999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-43  Score=341.51  Aligned_cols=260  Identities=20%  Similarity=0.262  Sum_probs=196.7

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|.+.+.||+|+||.||+|.+.  +..||||++......... .........+.+|+++++.++||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS-AREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcc-cccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            34578999999999999999999985  468999998743221100 001122334668999999999999999999886


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---eEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---~kl~  296 (441)
                      .. ..|+||||+++++|.+++..   ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.   +||+
T Consensus        86 ~~-~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           86 AE-DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-SEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             CC-ceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEc
Confidence            55 48999999999999998853   345899999999999999999999999  999999999999987665   9999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |||+++......    ......||+.|+|||++.   +..++.++|||||||++|||++|..||......... ...+..
T Consensus       160 Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~  234 (322)
T 2ycf_A          160 DFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-KDQITS  234 (322)
T ss_dssp             CCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-HHHHHH
T ss_pred             cCccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-HHHHHh
Confidence            999997643221    123446899999999974   457899999999999999999999999765432211 111111


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ...        .........++..+.+|+.+||+.||++||++.++++
T Consensus       235 ~~~--------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 GKY--------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Ccc--------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            000        0001112345678999999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.3e-43  Score=355.62  Aligned_cols=260  Identities=21%  Similarity=0.266  Sum_probs=204.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC-CCeecccceEE
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH-DNILPLYGICF  219 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~  219 (441)
                      ..++|++.++||+|+||.||+|.+.  +..||||++......           .++..|+++++.++| ++|..+..++.
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~il~~L~~~~~i~~i~~~~~   73 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKIYRILQGGTGIPNVRWFGV   73 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----------CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            3578999999999999999999974  678999987643321           134589999999976 55666666777


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee---cCCCCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL---NHHMDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl---~~~~~~kl~  296 (441)
                      +.+..++||||+ +++|.+++....  ..+++..++.|+.||+.||+|||+++  ||||||||+||||   +.++.+||+
T Consensus        74 ~~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           74 EGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             eCCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEE
Confidence            888999999999 999999986433  35899999999999999999999999  9999999999999   688999999


Q ss_pred             ccCCCccCCCccccc----ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhH--HHHHHH
Q psy5927         297 DFGLTQEGPIEKATH----ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSL  370 (441)
Q Consensus       297 DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~--~~l~~~  370 (441)
                      |||+++.........    .......||..|+|||.+.+..++.++|||||||+||||++|..||.......  ..+..+
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence            999997643322111    11235679999999999999999999999999999999999999998754311  111111


Q ss_pred             HHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         371 VEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ...    ..    ......+...++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus       229 ~~~----~~----~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          229 SEK----KV----ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHH----HH----HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             hhc----cc----cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            111    01    0111122234567899999999999999999999999988776

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.4e-43  Score=343.22  Aligned_cols=271  Identities=20%  Similarity=0.273  Sum_probs=204.9

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|.+.+.||+|+||.||+|.+.  +..||||++......        .....+.+|+++++.++||||+++++++..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   80 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--------LFALRTLREIKILKHFKHENIITIFNIQRP   80 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--------HHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--------hHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence            3578999999999999999999986  678999998643221        223456689999999999999999998765


Q ss_pred             C-----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         221 T-----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       221 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      .     ...++||||+. |+|.+++..    ..+++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEE
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEE
Confidence            4     67899999996 799998864    34889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCccccc-------ceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHH
Q psy5927         296 GDFGLTQEGPIEKATH-------ITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHL  367 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l  367 (441)
                      +|||+++.........       .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||....... .+
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~  232 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QL  232 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH
Confidence            9999997643221111       11234578999999998764 678999999999999999999999998765422 22


Q ss_pred             HHHHHhhchh------------hhhhhhcc----CCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         368 KSLVEKYSEE------------NMYDLVDK----NAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       368 ~~~~~~~~~~------------~~~~~~~~----~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ..+.......            .....+..    ...   .....++.++.+|+.+||+.||++||++.++++  .|+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            2222111000            00000000    000   112345678899999999999999999999987  56655


Q ss_pred             CCC
Q psy5927         427 GGE  429 (441)
Q Consensus       427 ~~~  429 (441)
                      ...
T Consensus       313 ~~~  315 (353)
T 2b9h_A          313 HDP  315 (353)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-43  Score=373.05  Aligned_cols=261  Identities=20%  Similarity=0.346  Sum_probs=207.5

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCee
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL  212 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  212 (441)
                      ....+..++|++.+.||+|+||.||+|.+..     ..+|||+++....        ....+.+.+|+.++++++||||+
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv  454 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIV  454 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--------HHHHHHHHHHHHHHHhCCCCCCC
Confidence            3445566789999999999999999999843     3588888764321        12345677999999999999999


Q ss_pred             cccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC
Q psy5927         213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD  292 (441)
Q Consensus       213 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~  292 (441)
                      ++++++. .+..|+||||+++|+|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||++.++.
T Consensus       455 ~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~  529 (656)
T 2j0j_A          455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC  529 (656)
T ss_dssp             CEEEEEC-SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTE
T ss_pred             eEEEEEe-cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCC
Confidence            9999885 46789999999999999998643  335889999999999999999999999  999999999999999999


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~  371 (441)
                      +||+|||+++.......  .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+..... ....+.
T Consensus       530 vkL~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~~~i~  606 (656)
T 2j0j_A          530 VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE  606 (656)
T ss_dssp             EEECCCCCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHH
T ss_pred             EEEEecCCCeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH
Confidence            99999999986533221  12233457789999999998899999999999999999997 999998765422 221111


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                                  .....+.+..++..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       607 ------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          607 ------------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                        1112233455677899999999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-42  Score=337.24  Aligned_cols=270  Identities=20%  Similarity=0.295  Sum_probs=205.2

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc---CCCCCeeccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS---CRHDNILPLY  215 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnIv~l~  215 (441)
                      ...++|++.+.||+|+||.||+|.+.   +..||+|++.........       ...+.+|+.+++.   ++||||++++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-------CchhhHHHHHHHhhhccCCCCeEeee
Confidence            45678999999999999999999983   567999998754432211       1122355555554   4899999999


Q ss_pred             ceEE-----eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         216 GICF-----ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       216 ~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      +++.     .....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.|  |+||||||+|||++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~  156 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS  156 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC
Confidence            9987     5567899999997 79999886543 345899999999999999999999999  9999999999999999


Q ss_pred             CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      +.+||+|||+++......    ......||..|+|||.+.+..++.++|||||||++|||++|..||..... ...+..+
T Consensus       157 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i  231 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKI  231 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHH
T ss_pred             CCEEEecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH
Confidence            999999999997643221    22345689999999999998999999999999999999999999987654 2333333


Q ss_pred             HHhhch---hhhhh--------hhc---cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         371 VEKYSE---ENMYD--------LVD---KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       371 ~~~~~~---~~~~~--------~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                      ......   .....        +..   .........++..+.+|+.+||+.||.+||++.++++  .++...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            332210   00000        000   0011122346778899999999999999999999995  455443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-42  Score=344.06  Aligned_cols=261  Identities=18%  Similarity=0.277  Sum_probs=200.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++......       ......+.+|+.+++.++||||+++++++...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            478999999999999999999984  678999998743222       12345667999999999999999999999877


Q ss_pred             CeE------EEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 GKY------CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ~~~------~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +..      |+||||+. ++|.+.+.     ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL  185 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKI  185 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEE
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEE
Confidence            654      99999996 78888662     23899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++.....      .....||+.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+..+....
T Consensus       186 ~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~  258 (371)
T 4exu_A          186 LDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT  258 (371)
T ss_dssp             CSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred             EecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHh
Confidence            999999753221      234568999999999987 67899999999999999999999999876542 2232222211


Q ss_pred             ch--hhh---------hhh----hccCCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         375 SE--ENM---------YDL----VDKNAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       375 ~~--~~~---------~~~----~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ..  ...         ...    ......   .....++..+.+|+.+||+.||.+||++.++++  .++..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            10  000         000    000111   112234678999999999999999999999987  45443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-42  Score=340.70  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CC-----Cee
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HD-----NIL  212 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv  212 (441)
                      ....++|++.+.||+|+||+||+|.+.  +..||||+++...          .....+..|++++..++ |+     +|+
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----------AFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----------HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----------HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            455689999999999999999999985  5679999987321          11234456777777764 44     499


Q ss_pred             cccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec--CC
Q psy5927         213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN--HH  290 (441)
Q Consensus       213 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~--~~  290 (441)
                      ++++++...+..|+||||++ |+|.+++.... ...+++..+..++.|++.||.|||++..+||||||||+|||++  .+
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred             EeeeeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence            99999999999999999995 69999886543 3458999999999999999999996433499999999999994  57


Q ss_pred             CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHH
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL  370 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~  370 (441)
                      +.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||+||.+||...... ..+..+
T Consensus       198 ~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~-~~~~~i  270 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKI  270 (382)
T ss_dssp             CCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             CcEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            88999999999764321      23456899999999999999999999999999999999999999876542 333333


Q ss_pred             HHhhc--hhhh-------hhhhcc------------------------------------------CCCchhHHHHHHHH
Q psy5927         371 VEKYS--EENM-------YDLVDK------------------------------------------NAQPIELNIAYAFF  399 (441)
Q Consensus       371 ~~~~~--~~~~-------~~~~~~------------------------------------------~~~~~~~~~~~~l~  399 (441)
                      .....  ....       ..+++.                                          ............+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (382)
T 2vx3_A          271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK  350 (382)
T ss_dssp             HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred             HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence            32211  0000       000000                                          00001123345789


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHH
Q psy5927         400 RIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       400 ~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +|+.+||+.||++|||+.++++
T Consensus       351 dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          351 DLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhcCCChhhCCCHHHHhc
Confidence            9999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-43  Score=349.54  Aligned_cols=254  Identities=11%  Similarity=0.046  Sum_probs=180.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHH---HHHhhcCCCCCeeccc---
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRE---LKYLNSCRHDNILPLY---  215 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~hpnIv~l~---  215 (441)
                      ..+|.+.+.||+|+||.||+|.+.  +..||||++........      ...+.+.+|   +++|+. +||||++++   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~  133 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR------SELERLHEATFAAARLLG-ESPEEARDRRRL  133 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH------HHHHHHHHHHHHHHHHHC-----------CB
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc------cHHHHHHHHHHHHHHhcc-cChhhhhhceeE
Confidence            345889999999999999999984  57899999986543221      223345566   455555 799988755   


Q ss_pred             ----ceEEeC-----------------CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHH
Q psy5927         216 ----GICFET-----------------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR------LHIAKGTSLGLQFL  268 (441)
Q Consensus       216 ----~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~al~~L  268 (441)
                          +++...                 ..+|+|||||+ |+|.+++.....  .+.+..+      ..++.||+.||+||
T Consensus       134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~L  210 (371)
T 3q60_A          134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANL  210 (371)
T ss_dssp             CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHH
Confidence                444333                 34899999998 999999976432  2344555      77889999999999


Q ss_pred             HcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC--CCCCCccceehHHHH
Q psy5927         269 HSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIV  346 (441)
Q Consensus       269 H~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvv  346 (441)
                      |+++  |+||||||+|||++.++.+||+|||+++.....      .....+|+.|+|||++.+  ..++.++|||||||+
T Consensus       211 H~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i  282 (371)
T 3q60_A          211 QSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS  282 (371)
T ss_dssp             HHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred             HHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence            9999  999999999999999999999999999764321      113457799999999987  679999999999999


Q ss_pred             HHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhc-cCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         347 LFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVD-KNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       347 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      +|||+||..||.........      .+.......... ....+....++..+.+|+.+||+.||++||++.++++
T Consensus       283 l~elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          283 IYRVWCLFLPFGLVTPGIKG------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHSSCSTTBCCTTCTT------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHhCCCCCCCcCccccc------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999999766331100      000000000000 0011112356778999999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.1e-43  Score=337.36  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             CCChhHHHHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC--CCC
Q psy5927         134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--HDN  210 (441)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn  210 (441)
                      .+.++.+.+..++|++.+.||+|+||.||+|.+. +..||||++.......       ...+.+.+|++++++++  |||
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~~~~~   89 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-------QTLDSYRNEIAYLNKLQQHSDK   89 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH-------HHHHHHHHHHHHHHHHGGGCTT
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc-------cchHHHHHHHHHHHhccccCCc
Confidence            3445556677889999999999999999999874 5679999997543321       23456678999999997  599


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH  290 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~  290 (441)
                      |+++++++.+.+..++||| +.+++|.+++...   ..+++..+..++.|++.||.|||+.+  |+||||||+|||+++ 
T Consensus        90 iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-  162 (313)
T 3cek_A           90 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-  162 (313)
T ss_dssp             BCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-
T ss_pred             eEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-
Confidence            9999999999999999999 5589999998654   35889999999999999999999999  999999999999975 


Q ss_pred             CCeEEeccCCCccCCCcccccceeccccccCCCcCcccccC-----------CCCCCccceehHHHHHHHHHhCCCCCCC
Q psy5927         291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-----------KRLSTKVDVYGFGIVLFELATGMRAYDD  359 (441)
Q Consensus       291 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DiwSlGvvl~elltG~~p~~~  359 (441)
                      +.+||+|||+++....... ........||+.|+|||.+.+           ..++.++||||||+++|||++|..||..
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             TEEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CeEEEeeccccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            8899999999976432211 112234568999999999875           4688899999999999999999999976


Q ss_pred             cchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         360 TRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       360 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .......+.....   .        ......+...+..+.+|+.+||+.||++||++.++++
T Consensus       242 ~~~~~~~~~~~~~---~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          242 IINQISKLHAIID---P--------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CCSHHHHHHHHHC---T--------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHHHh---c--------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            5432222222111   0        0111122233567899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.9e-42  Score=329.06  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=192.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++.+.||+|+||.||+|.+  .+..||||++....          ...+.+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----------EKLSTILSEVMLLASLNHQYVVRYYAAWLE   73 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----------HHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence            356899999999999999999998  46789999986421          233466789999999999999999998865


Q ss_pred             -------------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee
Q psy5927         221 -------------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL  287 (441)
Q Consensus       221 -------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl  287 (441)
                                   .+..|+||||+++|+|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||+
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~  149 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI  149 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEE
Confidence                         45789999999999999999653  245778899999999999999999999  9999999999999


Q ss_pred             cCCCCeEEeccCCCccCCCccc-----------ccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCC
Q psy5927         288 NHHMDPVIGDFGLTQEGPIEKA-----------THITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMR  355 (441)
Q Consensus       288 ~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~  355 (441)
                      +.++.+||+|||+++.......           .........||+.|+|||.+.+. .++.++|||||||++|||++   
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---  226 (303)
T 1zy4_A          150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---  226 (303)
T ss_dssp             CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---
T ss_pred             cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---
Confidence            9999999999999976432110           01123345689999999999864 68999999999999999998   


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ||............+. ..        ........+...+..+.+++.+||+.||.+||++.++++
T Consensus       227 p~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          227 PFSTGMERVNILKKLR-SV--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CCSSHHHHHHHHHHHH-ST--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCchhHHHHHHhcc-cc--------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            5544322122221111 00        000111233445667899999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.5e-43  Score=338.45  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=179.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHH-HhhcCCCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~  218 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..||||++.......        ...++..|+. +++.++||||+++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--------EQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--------HHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--------HHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            45578999999999999999999985  6789999997543221        2233445555 67778999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEE
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMK--KNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      .+.+..++||||++ |+|.+++...  .....+++..+..++.+++.||.|||+. +  |+||||||+|||++.++.+||
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEE
T ss_pred             EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEE
Confidence            99999999999997 5888777531  2245689999999999999999999998 8  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccc----cCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFL----VGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      +|||+++......    ......||+.|+|||.+    .+..++.++||||||+++|||++|..||.........+    
T Consensus       168 ~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----  239 (327)
T 3aln_A          168 CDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----  239 (327)
T ss_dssp             CCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             ccCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----
Confidence            9999997643221    12233699999999998    45678999999999999999999999997653211111    


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..........+    .......++..+.+|+.+||+.||.+||++.+|++
T Consensus       240 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          240 TQVVKGDPPQL----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCSCCCCC----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCCCCC----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00000000000    01111245678999999999999999999999965

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-42  Score=329.08  Aligned_cols=257  Identities=25%  Similarity=0.347  Sum_probs=204.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||+|++.......       ...+.+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-------KDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-------SCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-------HHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            44578999999999999999999984  6789999987433211       12345678999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC---CCeEEe
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH---MDPVIG  296 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~---~~~kl~  296 (441)
                      +.+..++||||+++++|.+++....   .+++..+..++.+++.||.|||+.+  |+||||||+||+++.+   +.+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEe
Confidence            9999999999999999999886543   4889999999999999999999999  9999999999999764   469999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||++.......    ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...... .....+....  
T Consensus       167 Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~--  238 (287)
T 2wei_A          167 DFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGK--  238 (287)
T ss_dssp             STTGGGTBCCCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCC--
T ss_pred             ccCcceeecCCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCC--
Confidence            999987543221    1223458999999999887 5899999999999999999999999876542 2222211110  


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                        .     ....+....++.++.+++.+||+.||.+||++.++++  .+++
T Consensus       239 --~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          239 --Y-----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             --C-----CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             --C-----CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence              0     0011112345678999999999999999999999987  4444

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.4e-42  Score=339.92  Aligned_cols=264  Identities=21%  Similarity=0.299  Sum_probs=200.6

Q ss_pred             hhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-----------CC
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-----------HD  209 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp  209 (441)
                      ..++|.+.+.||+|+||+||+|.+  .++.||||++....          ...+.+.+|++++.+++           ||
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   86 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMGAN   86 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----------cchhhhhHHHHHHHHhhcccccchhccccc
Confidence            457899999999999999999997  46789999986321          12234557888887775           89


Q ss_pred             CeecccceEEeCC----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCC
Q psy5927         210 NILPLYGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSAN  284 (441)
Q Consensus       210 nIv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~N  284 (441)
                      ||+++++++...+    .+++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +  |+||||||+|
T Consensus        87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~N  162 (373)
T 1q8y_A           87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN  162 (373)
T ss_dssp             TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGG
T ss_pred             hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHH
Confidence            9999999988654    789999999 999999887543 34489999999999999999999998 8  9999999999


Q ss_pred             eeec------CCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCC
Q psy5927         285 ILLN------HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD  358 (441)
Q Consensus       285 iLl~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~  358 (441)
                      ||++      ..+.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||+||..||.
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             eEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9994      4457999999999764321      233468999999999999899999999999999999999999997


Q ss_pred             Ccch-----hHHHHHHHHHhhchhhh---------hhhhc--------------------cCCCchhHHHHHHHHHHHHH
Q psy5927         359 DTRR-----SERHLKSLVEKYSEENM---------YDLVD--------------------KNAQPIELNIAYAFFRIGKQ  404 (441)
Q Consensus       359 ~~~~-----~~~~l~~~~~~~~~~~~---------~~~~~--------------------~~~~~~~~~~~~~l~~li~~  404 (441)
                      ....     ....+..+.........         ..+.+                    ......+..++.++.+|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  316 (373)
T 1q8y_A          237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  316 (373)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence            5432     11222222221110000         00000                    01112446788899999999


Q ss_pred             hcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         405 STKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       405 cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ||+.||.+|||+.++++  .+.+.
T Consensus       317 ~L~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          317 MLQLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             GGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             HhccCccccCCHHHHhhChhhhcc
Confidence            99999999999999997  55543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=336.87  Aligned_cols=261  Identities=18%  Similarity=0.289  Sum_probs=200.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++......       ....+.+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   95 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENVIGLLDVFTPA   95 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence            468999999999999999999984  678999998643221       12345667999999999999999999999876


Q ss_pred             Ce------EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 GK------YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ~~------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +.      +|+||||+. ++|.+++.     ..+++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl  167 (353)
T 3coi_A           96 SSLRNFYDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKI  167 (353)
T ss_dssp             SSGGGCCCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEE
T ss_pred             cccccceeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEE
Confidence            54      499999996 68887652     23889999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+++.....      .....||+.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+..+....
T Consensus       168 ~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~  240 (353)
T 3coi_A          168 LDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT  240 (353)
T ss_dssp             CSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHH
T ss_pred             eecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence            999999753221      233468999999999887 67899999999999999999999999876542 2233322211


Q ss_pred             ch--hh---------hhhhh-------ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         375 SE--EN---------MYDLV-------DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       375 ~~--~~---------~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      ..  ..         ....+       ..........++..+.+|+.+||+.||.+||++.++++  .++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            10  00         00000       00111223456788999999999999999999999986  45443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-41  Score=332.45  Aligned_cols=264  Identities=20%  Similarity=0.311  Sum_probs=201.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCC------ee
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN------IL  212 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv  212 (441)
                      ...++|++.+.||+|+||+||+|.+.   +..||+|+++...          ...+.+.+|+++++.++|++      ++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~~~~~~~~~~~~   85 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----------KYREAARLEINVLKKIKEKDKENKFLCV   85 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----------cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence            44579999999999999999999984   2579999986321          12334557888888887665      89


Q ss_pred             cccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeee-----
Q psy5927         213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILL-----  287 (441)
Q Consensus       213 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl-----  287 (441)
                      .+++++...+..|+||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++  |+||||||+|||+     
T Consensus        86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~  161 (355)
T 2eu9_A           86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEF  161 (355)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCE
T ss_pred             EeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccc
Confidence            9999999999999999999 677777775543 345899999999999999999999999  9999999999999     


Q ss_pred             --------------cCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC
Q psy5927         288 --------------NHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG  353 (441)
Q Consensus       288 --------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG  353 (441)
                                    +.++.+||+|||+++.....      .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                          67889999999999753222      2334699999999999998999999999999999999999


Q ss_pred             CCCCCCcchhHHHHHHHHHhhch--hhhhhh-----------------------hcc------CCCchhHHHHHHHHHHH
Q psy5927         354 MRAYDDTRRSERHLKSLVEKYSE--ENMYDL-----------------------VDK------NAQPIELNIAYAFFRIG  402 (441)
Q Consensus       354 ~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~-----------------------~~~------~~~~~~~~~~~~l~~li  402 (441)
                      ..||....... .+..+......  ..+...                       ...      .........+..+.+|+
T Consensus       236 ~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (355)
T 2eu9_A          236 FTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM  314 (355)
T ss_dssp             SCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred             CCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence            99998765422 22221111100  000000                       000      00011224466899999


Q ss_pred             HHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         403 KQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       403 ~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      .+||+.||.+|||+.++++  .+.++
T Consensus       315 ~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          315 RRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             HHHhcCChhhCcCHHHHhcChhhcCC
Confidence            9999999999999999985  44443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=349.04  Aligned_cols=253  Identities=21%  Similarity=0.354  Sum_probs=188.9

Q ss_pred             HHhhCCCcCcCccccCCcee-EEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         141 TLATNNWDKLNILGKGGFGT-VYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      .+...+|.+.+.||+|+||+ ||++..+++.||||++......            .+.+|+++|+.+ +||||+++++++
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------------~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------------FADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence            45566799999999999998 5566668899999998642211            123799999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-----CCCe
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-----HMDP  293 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-----~~~~  293 (441)
                      .+....|+|||||. |+|.+++.....  .+....+..++.||+.||+|||+++  |+||||||+|||++.     ...+
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~  162 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKA  162 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCE
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeE
Confidence            99999999999995 799999865432  2444556789999999999999999  999999999999953     3457


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCccccc---CCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLV---GKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKS  369 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~  369 (441)
                      ||+|||+++................||+.|+|||++.   +..++.++|||||||++|||+| |..||.......  ...
T Consensus       163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~~  240 (432)
T 3p23_A          163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANI  240 (432)
T ss_dssp             EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HHH
T ss_pred             EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HHH
Confidence            8999999986543332223334567999999999997   3567889999999999999999 999996543311  111


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .....         ...........+..+.+|+.+||+.||.+||++.+|++
T Consensus       241 ~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          241 LLGAC---------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HTTCC---------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccC---------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11000         01111122345667889999999999999999999983

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-43  Score=338.08  Aligned_cols=258  Identities=21%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC----CCCCeecc
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC----RHDNILPL  214 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~hpnIv~l  214 (441)
                      ....++|++.+.||+|+||.||+|.+  .+..||||++..........   ......+.+|+.++.++    +||||+++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP---LSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc---chhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            45678899999999999999999988  45689999987543221110   01122334688888888    89999999


Q ss_pred             cceEEeCCeEEEEEEe-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCC
Q psy5927         215 YGICFETGKYCLVYRY-MPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-HHMD  292 (441)
Q Consensus       215 ~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~  292 (441)
                      ++++.+.+..++|||| +.+++|.+++....   .+++..+..++.|++.||+|||+.+  |+||||||+|||++ .++.
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTE
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCe
Confidence            9999999999999999 78999999986543   4899999999999999999999999  99999999999999 8899


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      +||+|||+++......     .....||..|+|||++.+..+ +.++||||||+++|||++|..||.....       ..
T Consensus       179 ~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~  246 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------IL  246 (312)
T ss_dssp             EEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HH
T ss_pred             EEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hh
Confidence            9999999997643322     234568999999999877665 4589999999999999999999975422       00


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESP  431 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~  431 (441)
                      .             .....+..++..+.+|+.+||+.||++||++.++++  .++....+.+
T Consensus       247 ~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~  295 (312)
T 2iwi_A          247 E-------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP  295 (312)
T ss_dssp             H-------------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred             h-------------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence            0             011123345677899999999999999999999998  5554444433

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-42  Score=336.16  Aligned_cols=258  Identities=19%  Similarity=0.262  Sum_probs=175.6

Q ss_pred             HhhCCCcCcC-ccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         142 LATNNWDKLN-ILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~-~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ...++|.+.+ .||+|+||+||+|.+.  +..||||++....  .        ...   .....+..++||||+++++++
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~--------~~~---e~~~~~~~~~h~~i~~~~~~~   91 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--K--------ARQ---EVDHHWQASGGPHIVCILDVY   91 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--H--------HHH---HHHHHHHHTTSTTBCCEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--H--------HHH---HHHHHHHhcCCCChHHHHHHH
Confidence            3457899865 6999999999999986  6789999986321  0        011   122235667999999999998


Q ss_pred             Ee----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---CC
Q psy5927         219 FE----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---HM  291 (441)
Q Consensus       219 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~~  291 (441)
                      ..    ...+++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++
T Consensus        92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~  168 (336)
T 3fhr_A           92 ENMHHGKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDA  168 (336)
T ss_dssp             EEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTC
T ss_pred             hhccCCCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCc
Confidence            76    456899999999999999987543 346899999999999999999999999  999999999999986   45


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      .+||+|||+++.....     ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus       169 ~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~  242 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-SPGMK  242 (336)
T ss_dssp             CEEECCCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             eEEEeccccceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-hhhHH
Confidence            5999999999754322     22345689999999999888899999999999999999999999976543211 10101


Q ss_pred             HhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       372 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      .......     .....+....++..+.+|+.+||+.||.+||++.++++  .+...
T Consensus       243 ~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          243 RRIRLGQ-----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             Hhhhccc-----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            0000000     00011112345678999999999999999999999998  55543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.8e-43  Score=339.46  Aligned_cols=249  Identities=19%  Similarity=0.298  Sum_probs=198.6

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC--CCCeeccc
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--HDNILPLY  215 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~  215 (441)
                      .....++|++.+.||+|+||.||+|.+  .+..||||++...........   .....+.+|+.+++.++  ||||++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh---hhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            345567899999999999999999998  467899999975432210000   01122347889999986  59999999


Q ss_pred             ceEEeCCeEEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCCe
Q psy5927         216 GICFETGKYCLVYRYMPN-GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-HHMDP  293 (441)
Q Consensus       216 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~~  293 (441)
                      +++.+.+..++||||+.+ ++|.+++...   ..+++..+..++.|++.||+|||+.+  |+||||||+|||++ .++.+
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCE
Confidence            999999999999999976 8999998653   34889999999999999999999999  99999999999999 78999


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      ||+|||+++.....     ......||+.|+|||++.+..+ +.++||||||+++|||++|..||.....       ...
T Consensus       190 kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~  257 (320)
T 3a99_A          190 KLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIR  257 (320)
T ss_dssp             EECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHH
T ss_pred             EEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhc
Confidence            99999999764332     1233469999999999987665 6889999999999999999999976422       000


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      .             ....+..++.++.+|+.+||+.||++||++.+|++
T Consensus       258 ~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 G-------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             C-------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0             01122335667899999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=328.17  Aligned_cols=254  Identities=21%  Similarity=0.300  Sum_probs=183.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ...++|++.+.||+|+||.||+|.+.  +..||||++........       ..+.+..+..+++.++||||+++++++.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-------NKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-------HHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-------HHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            44578999999999999999999984  67899999975432211       1222334555678889999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR-EPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      +.+..++||||+ ++.+.......  ...+++..+..++.+++.||.|||+. +  |+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEEC
Confidence            999999999999 56665544322  34588999999999999999999995 8  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      |++.......    ......||+.|+|||.+.     +..++.++||||||+++|||++|..||.........+......
T Consensus       170 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (318)
T 2dyl_A          170 GISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE  245 (318)
T ss_dssp             TTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS
T ss_pred             CCchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc
Confidence            9987543221    123346899999999984     4568899999999999999999999998754433333332221


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..          ...+....++.++.+|+.+||+.||.+||++.++++
T Consensus       246 ~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          246 EP----------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC----------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            10          011111235667899999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.3e-42  Score=344.17  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=184.7

Q ss_pred             CCCcCcCccccCCceeEEEE-EECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKG-VWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  222 (441)
                      +.|...+.||+|+||+||.+ ...+..||||++....            .+.+.+|++++..+ +||||+++++++.+.+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   82 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------------CDIALMEIKLLTESDDHPNVIRYYCSETTDR   82 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            44556788999999999654 4467899999986421            12345899999876 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCC----CCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC--------
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPS----LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH--------  290 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~----l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~--------  290 (441)
                      .+|+|||||+ |+|.+++........    ..+..+..++.||+.||+|||+++  |+||||||+|||++.+        
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCT
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccc
Confidence            9999999995 799999865433211    123345789999999999999999  9999999999999754        


Q ss_pred             -----CCeEEeccCCCccCCCcccc-cceeccccccCCCcCcccccC-------CCCCCccceehHHHHHHHHHh-CCCC
Q psy5927         291 -----MDPVIGDFGLTQEGPIEKAT-HITLKRVNGTRPYLPHEFLVG-------KRLSTKVDVYGFGIVLFELAT-GMRA  356 (441)
Q Consensus       291 -----~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DiwSlGvvl~ellt-G~~p  356 (441)
                           +.+||+|||+++........ ........||+.|+|||++.+       ..++.++|||||||++|||+| |..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 47999999999865432211 112334579999999999976       568999999999999999999 9999


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      |........   .+......      ...........++.++.+|+.+||+.||.+||++.+|++
T Consensus       240 f~~~~~~~~---~i~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          240 FGDKYSRES---NIIRGIFS------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TCSTTTHHH---HHHHTCCC------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhHH---HHhcCCCC------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            976543221   11111100      000011123467889999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.1e-42  Score=356.26  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=198.1

Q ss_pred             hCCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      .++|++.+.||+|+||.||+|.+  .+..||||++......        ...+.+.+|++++++++||||+++++++.. 
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--------~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~   84 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--------KNRERWCLEIQIMKKLNHPNVVSAREVPDGL   84 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--------HHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--------HHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence            37899999999999999999997  4578999998643221        234566789999999999999999998755 


Q ss_pred             -----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCC---
Q psy5927         221 -----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMD---  292 (441)
Q Consensus       221 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~---  292 (441)
                           .+..|+||||++||+|.+++........+++..+..++.+++.||+|||+.|  |+||||||+|||++.++.   
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCE
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCcee
Confidence                 6778999999999999999987666567899999999999999999999999  999999999999997765   


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      +||+|||+++......    ......||+.|+|||.+.+..++.++|||||||++|||++|..||...............
T Consensus       163 vKL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~  238 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE  238 (676)
T ss_dssp             EEECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred             EEEccccccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence            8999999998643322    123457999999999999999999999999999999999999999765331111000000


Q ss_pred             hhch-----hhhh---hh--hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q psy5927         373 KYSE-----ENMY---DL--VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ  418 (441)
Q Consensus       373 ~~~~-----~~~~---~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  418 (441)
                      ....     ....   .+  ..+........++..+.+|+.+||..||++||++.+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000     0000   00  001112234557889999999999999999999977

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-40  Score=315.69  Aligned_cols=236  Identities=10%  Similarity=0.096  Sum_probs=186.1

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|++.+.||+|+||.||+|.+.  +..||||++.......      ....+.+.+|+.++..++||||+++++++.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP------DDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            34578999999999999999999996  6789999997543321      123456779999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      +.+..|+||||++|++|.+++..    . .....+..++.|++.||+|||++|  |+||||||+|||++.++.+||+++|
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc
Confidence            99999999999999999998842    1 345578889999999999999999  9999999999999999999998554


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                                             |++       .++.++|||||||++|||+||..||.........          ...
T Consensus       175 -----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~----------~~~  214 (286)
T 3uqc_A          175 -----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL----------APA  214 (286)
T ss_dssp             -----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS----------EEC
T ss_pred             -----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh----------HHH
Confidence                                   333       3688999999999999999999999865431100          000


Q ss_pred             hhhhccC---CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         380 YDLVDKN---AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       380 ~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                      .......   .......++..+.+|+.+||+.||++| |+.++++.|+.+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            0000000   011223467789999999999999999 99999999988665443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-40  Score=350.25  Aligned_cols=240  Identities=18%  Similarity=0.262  Sum_probs=192.0

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      ...++|++.+.||+|+||.||+|.+.   ++.||||++......        .....+.+|++++++++||||+++++++
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~  148 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--------EAQAMAMAERQFLAEVVHPSIVQIFNFV  148 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--------HHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--------HHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence            44589999999999999999999984   578999988643221        2234567899999999999999999999


Q ss_pred             EeCCe-----EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         219 FETGK-----YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       219 ~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                      ...+.     .|+||||++|++|.+++..     .+++..++.++.||+.||.|||++|  ||||||||+|||++.+ .+
T Consensus       149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~  220 (681)
T 2pzi_A          149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QL  220 (681)
T ss_dssp             EEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CE
T ss_pred             eecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cE
Confidence            87665     7999999999999887632     5899999999999999999999999  9999999999999985 89


Q ss_pred             EEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHh
Q psy5927         294 VIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK  373 (441)
Q Consensus       294 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~  373 (441)
                      ||+|||+++.....       ....||+.|+|||++.+. ++.++|||||||++|||++|.+||.......         
T Consensus       221 kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------  283 (681)
T 2pzi_A          221 KLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------  283 (681)
T ss_dssp             EECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------
T ss_pred             EEEecccchhcccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---------
Confidence            99999999764322       344699999999999774 5889999999999999999999986532110         


Q ss_pred             hchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhc
Q psy5927         374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-MTQVYNMLSG  425 (441)
Q Consensus       374 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~L~~  425 (441)
                           .      .........+..+.+|+.+||+.||.+||+ ++++...|..
T Consensus       284 -----~------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 -----L------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -----C------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----c------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                 0      001112234567899999999999999995 5556555543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.7e-39  Score=311.30  Aligned_cols=232  Identities=18%  Similarity=0.286  Sum_probs=180.6

Q ss_pred             hCCCcCc-CccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHh-hcCCCCCeecccceEE
Q psy5927         144 TNNWDKL-NILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL-NSCRHDNILPLYGICF  219 (441)
Q Consensus       144 ~~~~~~~-~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~  219 (441)
                      .++|.+. +.||+|+||.||+|.+.  +..||+|+++..              ....+|+.++ +..+||||+++++++.
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~~~~   81 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE   81 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHhhhh
Confidence            4667777 78999999999999984  568999998631              1234677777 5669999999999988


Q ss_pred             e----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---CCC
Q psy5927         220 E----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---HMD  292 (441)
Q Consensus       220 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~~~  292 (441)
                      .    ...+++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+  |+||||||+|||++.   ++.
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           82 NLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             EEETTEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCC
T ss_pred             hhcCCCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCc
Confidence            7    678899999999999999987643 345899999999999999999999999  999999999999998   789


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      +||+|||++....                         +..++.++|||||||++|||+||..||........ .     
T Consensus       159 ~kl~Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~-----  207 (299)
T 3m2w_A          159 LKLTDFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-S-----  207 (299)
T ss_dssp             EEECCCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------
T ss_pred             EEEeccccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-h-----
Confidence            9999999885421                         23578899999999999999999999976543110 0     


Q ss_pred             hhchhhhhhhhccCCCch----hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         373 KYSEENMYDLVDKNAQPI----ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                          ......+.......    ...++.++.+|+.+||+.||.+||++.++++  .+.+..
T Consensus       208 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          208 ----PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             ----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             ----HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                00000011111111    1346778999999999999999999999987  455443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.6e-41  Score=326.53  Aligned_cols=252  Identities=15%  Similarity=0.157  Sum_probs=185.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---------C----
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---------H----  208 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h----  208 (441)
                      +..++|++.+.||+|+||+||+|.++++.||||++......... .......+.+.+|+.+++.++         |    
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVN-GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBT-TBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccc-cccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            44578999999999999999999999999999999865421000 000112234557777777765         5    


Q ss_pred             -------------CCeecccceEEe-------------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q psy5927         209 -------------DNILPLYGICFE-------------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS  262 (441)
Q Consensus       209 -------------pnIv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~  262 (441)
                                   |||+++++++.+             .+.+|+|||||++|++.+.+..    ..+++..+..++.||+
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHH
Confidence                         455555555443             7889999999999987776632    3488999999999999


Q ss_pred             HHHHHHH-cCCCCeeecCCCCCCeeecCCC--------------------CeEEeccCCCccCCCcccccceeccccccC
Q psy5927         263 LGLQFLH-SREPPLIHGDIKSANILLNHHM--------------------DPVIGDFGLTQEGPIEKATHITLKRVNGTR  321 (441)
Q Consensus       263 ~al~~LH-~~~~~iiHrDikp~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~  321 (441)
                      .||+||| +++  |+||||||+|||++.++                    .+||+|||+|+....        ....||+
T Consensus       172 ~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCD  241 (336)
T ss_dssp             HHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCC
T ss_pred             HHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEee
Confidence            9999999 899  99999999999999987                    899999999975321        1236999


Q ss_pred             CCcCcccccCCCCCCccceehHHHH-HHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHH
Q psy5927         322 PYLPHEFLVGKRLSTKVDVYGFGIV-LFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFR  400 (441)
Q Consensus       322 ~y~aPE~~~~~~~s~~~DiwSlGvv-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  400 (441)
                      .|+|||++.+.. +.++||||||++ .+++++|..||............+....      .............++.++.+
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------TFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------CCSSCCCSHHHHHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------ccCcccchhhhhhcCHHHHH
Confidence            999999999865 899999998777 7788999999854211000111111100      01111223445678999999


Q ss_pred             HHHHhcCCCCCCCCCHHHHH
Q psy5927         401 IGKQSTKQNPKERPEMTQVY  420 (441)
Q Consensus       401 li~~cl~~dp~~RPs~~evl  420 (441)
                      |+.+||+.|     |+.+++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     898887

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.4e-40  Score=329.19  Aligned_cols=244  Identities=14%  Similarity=0.081  Sum_probs=181.4

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC-CCeecccce--
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH-DNILPLYGI--  217 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~--  217 (441)
                      .+.+|...+.||+|+||+||+|.+.  ++.||||++........      ...+.+.+|+.++..++| +|+..+..+  
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~------~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~  149 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR  149 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH------HHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence            3456788899999999999999986  77899999874332221      123456689999999977 332221111  


Q ss_pred             -------------------EEe-----CCeEEEEEEecCCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy5927         218 -------------------CFE-----TGKYCLVYRYMPNGSLEDRLLMK----KNTPSLLWTQRLHIAKGTSLGLQFLH  269 (441)
Q Consensus       218 -------------------~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~al~~LH  269 (441)
                                         +..     ...++++|+++ +++|.+++...    .....+++..++.++.|++.||+|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  228 (413)
T 3dzo_A          150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH  228 (413)
T ss_dssp             BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                               111     23467888876 79999988422    22345778899999999999999999


Q ss_pred             cCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccc----------cCCCCCCccc
Q psy5927         270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFL----------VGKRLSTKVD  339 (441)
Q Consensus       270 ~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~D  339 (441)
                      +++  ||||||||+|||++.++.+||+|||+++.....      ....+| +.|+|||++          .+..++.++|
T Consensus       229 ~~~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D  299 (413)
T 3dzo_A          229 HYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD  299 (413)
T ss_dssp             HTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred             hCC--cccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence            999  999999999999999999999999998753221      344568 999999999          5566889999


Q ss_pred             eehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q psy5927         340 VYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV  419 (441)
Q Consensus       340 iwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  419 (441)
                      ||||||++|||+||+.||.......             .....+.. .    ..++..+.+|+.+||+.||++||++.++
T Consensus       300 vwSlGvil~elltg~~Pf~~~~~~~-------------~~~~~~~~-~----~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          300 TWTLGLAIYWIWCADLPNTDDAALG-------------GSEWIFRS-C----KNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHHHHHHHHSSCCCCTTGGGS-------------CSGGGGSS-C----CCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchhh-------------hHHHHHhh-c----ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999999999997654311             01111111 1    1345779999999999999999997666


Q ss_pred             H
Q psy5927         420 Y  420 (441)
Q Consensus       420 l  420 (441)
                      +
T Consensus       362 l  362 (413)
T 3dzo_A          362 M  362 (413)
T ss_dssp             T
T ss_pred             H
Confidence            4

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.8e-33  Score=290.57  Aligned_cols=193  Identities=13%  Similarity=0.035  Sum_probs=131.5

Q ss_pred             ccccCCceeEEEEEE--CCeeEEEEEeeeccchhHH-HhhhHHHHHHHHHHHHHhhcC-CCCCeecccceEEeCCeEEEE
Q psy5927         152 ILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAV-ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       152 ~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      .++.|++|.+..++.  -+..+|||.+......... ..-.....+++.+|+++|+++ .|+||+++++++.+++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            456677776665543  5678999999755322110 111234556788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||++|++|.++|...   ++++..   .|+.||+.||+|||++|  ||||||||+||||+.+|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999999643   345543   58899999999999999  999999999999999999999999999864332


Q ss_pred             ccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCC
Q psy5927         308 KATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA  356 (441)
Q Consensus       308 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p  356 (441)
                      .   ......+||+.|||||++.+ .+..++|+||+|++++++.+|..+
T Consensus       393 ~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2   22345679999999999987 577889999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.1e-30  Score=269.55  Aligned_cols=195  Identities=17%  Similarity=0.209  Sum_probs=151.9

Q ss_pred             cCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEEE
Q psy5927         148 DKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  227 (441)
                      ...+.||+|+||.||+|...+..+++|+......... ........+.+.+|++++++++||||+++..++.+.+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDE-RLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCH-HHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccch-hhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467999999999999988889999998764322111 111223456678999999999999999777777788888999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCc
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIE  307 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~  307 (441)
                      |||++|++|.+++..           +..++.|++.||+|||+++  |+||||||+|||++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999998853           4689999999999999999  999999999999999  9999999999875443


Q ss_pred             ccccc----eeccccccCCCcCcccccC--CCCCCccceehHHHHHHHHHhCCCCCC
Q psy5927         308 KATHI----TLKRVNGTRPYLPHEFLVG--KRLSTKVDVYGFGIVLFELATGMRAYD  358 (441)
Q Consensus       308 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~s~~~DiwSlGvvl~elltG~~p~~  358 (441)
                      .....    ......||+.|||||++.+  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            22110    1245679999999999987  568888999999999999888887774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.7e-25  Score=212.17  Aligned_cols=157  Identities=14%  Similarity=0.082  Sum_probs=119.9

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHH-H--------hhhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAV-E--------TLNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~-~--------~~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      .....|.+.+.||+|+||.||+|.+ .+..||||.++........ .        .........+.+|++++++++  | 
T Consensus        87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-  163 (282)
T 1zar_A           87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-  163 (282)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred             hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence            3455677889999999999999999 4678999998643221100 0        000023456779999999998  5 


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      +++.+++.. +..|+||||++||+|.+ +..         .....++.|++.||.|||+.|  |+||||||+|||++ ++
T Consensus       164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TT
T ss_pred             CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CC
Confidence            777776544 56699999999999988 411         124579999999999999999  99999999999999 99


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccC
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG  331 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  331 (441)
                      .+||+|||+++.                +..|+|||++.+
T Consensus       230 ~vkl~DFG~a~~----------------~~~~~a~e~l~r  253 (282)
T 1zar_A          230 GIWIIDFPQSVE----------------VGEEGWREILER  253 (282)
T ss_dssp             EEEECCCTTCEE----------------TTSTTHHHHHHH
T ss_pred             cEEEEECCCCeE----------------CCCCCHHHHHHH
Confidence            999999999852                445789998754

>3mop_K IRAK-2, interleukin-1 receptor-associated kinase-like 2; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens}

Probab=99.84  E-value=4.8e-22  Score=156.05  Aligned_cols=59  Identities=27%  Similarity=0.323  Sum_probs=56.0

Q ss_pred             CCC-ChHHHHHHHHHHH-hCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhccCc
Q psy5927           1 MNF-TSRQLFQMEQAIL-RRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYV   59 (441)
Q Consensus         1 ~~~-~~~~~~~~~~~~~-~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~~~   59 (441)
                      |.| |++++|+||+.++ +|+|||+||||+||++||||+|||++|.+++|||||++|++|.
T Consensus        33 ~i~~d~~~iR~~e~~~~~~G~SpT~eLL~~Wg~~N~TV~eL~~lL~~l~l~rA~~li~~~~   93 (111)
T 3mop_K           33 YVITDLTQLRKIKSMEWVQGVSITRELLWWWGMRQATVQQLVDLLCRLELYRAAQIILNWK   93 (111)
T ss_dssp             TTTCCHHHHHHHHHGGGSTTCCHHHHHHHHHHTTTCBSHHHHHTTTTTSCHHHHTTTTSCC
T ss_pred             HhhccHHHHHHHHHHHhhcCCCcHHHHHHHHHhcCCcHHHHHHHHHHcccHhHHHHHhccC
Confidence            345 9999999999997 9999999999999999999999999999999999999999985

>1d2z_A Death domain of pelle; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 PDB: 1ik7_A 1ygo_A

Probab=99.84  E-value=1.7e-21  Score=153.24  Aligned_cols=66  Identities=32%  Similarity=0.498  Sum_probs=64.0

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHh-hcCCCCHHHHHHHHHhcChhhHHHhhccCccCCccccC
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKW-GAQNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCI   67 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w-~~~n~tv~~l~~~l~~~~~~~a~~~~~~~~~~~~~~~~   67 (441)
                      |||+- +++.||++.++|+|||+||||+| |++||||+|||++|.++++|+||++|+++|+++||+++
T Consensus        42 m~~~~-ev~~ir~~~~~~~SPT~~LL~~W~g~~n~TV~~L~~lL~k~~l~~a~~~L~~~Vd~~~~~~i  108 (108)
T 1d2z_A           42 KLYPD-QVEQISSQKQRGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHKYI  108 (108)
T ss_dssp             TCCHH-HHHHHHHHHHTTCCHHHHHHHHHHHHHCCBHHHHHHHHHHTTCHHHHHHTGGGSCGGGGGGC
T ss_pred             cCCch-HHHHHHHHHhhCCChHHHHHHHhcCCCCCcHHHHHHHHHHcchHHHHHHHHHHhhHHHhhhC
Confidence            89999 99999999999999999999999 99999999999999999999999999999999999864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=9.8e-21  Score=177.07  Aligned_cols=145  Identities=15%  Similarity=0.115  Sum_probs=104.9

Q ss_pred             CcCcCccccCCceeEEEEEE--CCee--EEEEEeeeccchhHH--Hh-------------hhHHHHHHHHHHHHHhhcCC
Q psy5927         147 WDKLNILGKGGFGTVYKGVW--EKTT--IAVKKLEVHRNDRAV--ET-------------LNQCQREQSLRELKYLNSCR  207 (441)
Q Consensus       147 ~~~~~~LG~G~fg~Vy~~~~--~~~~--vavK~~~~~~~~~~~--~~-------------~~~~~~~~~~~E~~~l~~l~  207 (441)
                      |++.+.||+|+||.||+|.+  .+..  ||||+++........  ..             ........+.+|+++|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67789999999999999998  6788  999997643211000  00             00112235668999999998


Q ss_pred             CCCeecccceEEeCCeEEEEEEecCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeeecCCC
Q psy5927         208 HDNILPLYGICFETGKYCLVYRYMPN-G----SLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLH-SREPPLIHGDIK  281 (441)
Q Consensus       208 hpnIv~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~iiHrDik  281 (441)
                      |++|.-..-+..  +..+|||||+.+ |    +|.+....      .++..+..++.|++.||.||| +.|  |||||||
T Consensus       129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCS
T ss_pred             hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCC
Confidence            876422221111  356899999942 3    77765432      223456789999999999999 988  9999999


Q ss_pred             CCCeeecCCCCeEEeccCCCcc
Q psy5927         282 SANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       282 p~NiLl~~~~~~kl~DFGla~~  303 (441)
                      |+|||++.  .++|+|||+|..
T Consensus       199 p~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEE
T ss_pred             HHHEEEcC--cEEEEECccccc
Confidence            99999998  999999999965

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=7e-19  Score=171.71  Aligned_cols=145  Identities=14%  Similarity=0.136  Sum_probs=98.7

Q ss_pred             CCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchh-------------HHHhhhHHHHHHHHHHHHHhhcCCCCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDR-------------AVETLNQCQREQSLRELKYLNSCRHDNI  211 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~~~~~~~~~E~~~l~~l~hpnI  211 (441)
                      -|.+...||.|+||.||+|.+ +++.||||+++......             ..........-....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            388999999999999999997 46789999876432110             0000000111122356666666654443


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      .-..-+..  ...+|||||++|++|.+...       .  .....++.|++.+|.|||+.|  ||||||||.|||+++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCCC
Confidence            22211111  22379999999988865321       1  124568899999999999999  99999999999999887


Q ss_pred             C----------eEEeccCCCcc
Q psy5927         292 D----------PVIGDFGLTQE  303 (441)
Q Consensus       292 ~----------~kl~DFGla~~  303 (441)
                      .          +.|+||+-+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence            4          89999997754

>2a9i_A IRAK-4, interleukin-1 receptor-associated kinase-4; hexahelical bundle, transferase; 1.70A {Mus musculus} PDB: 3mop_G

Probab=99.72  E-value=3.3e-18  Score=136.15  Aligned_cols=58  Identities=28%  Similarity=0.398  Sum_probs=55.9

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhccC
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPY   58 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~~   58 (441)
                      |+|++.|+++||++.++|+|||++||++||++||||++|+++|.+++|||||++|++.
T Consensus        46 ~ky~~~~i~~~e~~~~~~~SPT~~LL~~Wg~~~~TV~~Ll~lL~~~~l~~Aa~~L~~~  103 (113)
T 2a9i_A           46 DRYNQFHIRRFEALLQTGLSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLPD  103 (113)
T ss_dssp             BSSCHHHHHHHHHTTTTTCCHHHHHHHHHGGGTCBHHHHHHHHHHTTCHHHHHHHCGG
T ss_pred             CCCCHHHHHHHHHhhccCCCHHHHHHHHHccCCCcHHHHHHHHHHcccHHHHHHhchh
Confidence            5799999999999999999999999999999999999999999999999999999883

>1wh4_A IRAK4, interleukin-1 receptor-associated kinase 4; death domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: a.77.1.2

Probab=99.64  E-value=2.2e-16  Score=128.20  Aligned_cols=56  Identities=29%  Similarity=0.452  Sum_probs=54.4

Q ss_pred             CChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhccC
Q psy5927           3 FTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPY   58 (441)
Q Consensus         3 ~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~~   58 (441)
                      |++.||++||++.++|+|||++||++||++||||++|+++|.++++|+||++|++.
T Consensus        55 y~~~ei~~ie~~~~~~~SPT~~LL~~Wg~~~~TV~~Ll~lL~~~~~~~Aa~~L~~~  110 (127)
T 1wh4_A           55 YNQFHIRRFEALLQTGKSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLPD  110 (127)
T ss_dssp             SCHHHHHHHHHHHTTTSCHHHHHHHHHHHHCCBHHHHHHHHHHTTCHHHHHHHCTT
T ss_pred             cCHHHHHHHHHhhccCCCHHHHHHHHHhccCCcHHHHHHHHHHcccHHHHHHHHHh
Confidence            89999999999999999999999999999999999999999999999999999974

>1d2z_B Death domain of tube; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2

Probab=99.53  E-value=8.5e-15  Score=119.24  Aligned_cols=57  Identities=21%  Similarity=0.411  Sum_probs=54.3

Q ss_pred             CCCChHHHHHHHHHHHh---CCCchHHHHHHhhc-----CCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILR---RESPTEELLSKWGA-----QNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~---~~s~t~~ll~~w~~-----~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |.|+++|+++||++++|   |+|||++||.+|||     .||||++||++|.+++|||||+++.+
T Consensus        64 ~kY~~~~i~~ie~~~~r~~~~~Spt~~lLdeWGTsG~~~~rpTV~~L~~LL~kaeL~~AAd~va~  128 (153)
T 1d2z_B           64 FKYTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVAL  128 (153)
T ss_dssp             BSSCHHHHHHHHHHHHHSCTTCCHHHHHHHHHHTCSSSTTSCBHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             cCcCHHHHHHHHHHHhhccCCCCHHHHHHHHhccCCcccCCCcHHHHHHHHHHhhHHHHHHHHHH
Confidence            46999999999999987   99999999999999     99999999999999999999999876

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=5.9e-13  Score=124.09  Aligned_cols=145  Identities=14%  Similarity=0.043  Sum_probs=111.2

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICF  219 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  219 (441)
                      ......|.+...+|.|+++.||+....+..+++|+........         ...+.+|+++++.+. +.++.++++++.
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---------~~~~~~E~~~l~~l~~~~~vP~v~~~~~   80 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---------TYDVEREKDMMLWLEGKLPVPKVLHFER   80 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---------TTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---------HHHHHHHHHHHHHHhcCCCCCeEEEEEe
Confidence            3445678888899999999999998778899999986421111         112447888888774 677888999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE---------------------------  272 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~---------------------------  272 (441)
                      +.+..|+||||++|.+|.+.+.        +......++.+++.+|..||+..                           
T Consensus        81 ~~~~~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T 3tm0_A           81 HDGWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             cCCceEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence            8899999999999999987531        11223467889999999999810                           


Q ss_pred             ------------------------------CCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         273 ------------------------------PPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       273 ------------------------------~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                                                    ..++|+|++|.|||++.+..+.|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                          238999999999999876666799999774

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=5.3e-11  Score=116.17  Aligned_cols=143  Identities=15%  Similarity=0.258  Sum_probs=105.4

Q ss_pred             CcCccccCCceeEEEEEECCeeEEEEEee--eccchhHHHhhhHHHHHHHHHHHHHhhcCC--CCCeecccceEEeC---
Q psy5927         149 KLNILGKGGFGTVYKGVWEKTTIAVKKLE--VHRNDRAVETLNQCQREQSLRELKYLNSCR--HDNILPLYGICFET---  221 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---  221 (441)
                      .++.|+.|.++.||+....+..+++|+..  ......        ....+.+|..+++.+.  +..+.+++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~--------~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLP--------SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCC--------cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            35789999999999998877788888765  221100        1123457888888886  45577888887766   


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR------------------------------  271 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------------------------------  271 (441)
                      +..|+||||++|.++.+.     ....++...+..++.+++.+|..||+.                              
T Consensus       114 g~~~~vme~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             SSCEEEEECCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence            458999999999887541     123467788889999999999999972                              


Q ss_pred             --------------------------CCCeeecCCCCCCeeecCCCC--eEEeccCCCccC
Q psy5927         272 --------------------------EPPLIHGDIKSANILLNHHMD--PVIGDFGLTQEG  304 (441)
Q Consensus       272 --------------------------~~~iiHrDikp~NiLl~~~~~--~kl~DFGla~~~  304 (441)
                                                ...++|||++|.|||++.++.  +.|+||+.+..+
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                      134999999999999997753  589999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=8.3e-11  Score=108.90  Aligned_cols=135  Identities=16%  Similarity=0.076  Sum_probs=93.6

Q ss_pred             CCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCC--eecccceEEeCC
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN--ILPLYGICFETG  222 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~  222 (441)
                      +|.+....+.|..+.||+.... +..+++|......            ...+.+|+.+++.+.+.+  +.++++++.+++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~   88 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG   88 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence            4444333345666999998764 4579999865321            012346788887775434  455888888778


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE------------------------------  272 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------------------------------  272 (441)
                      ..++||||++|.+|.  ..   .   ..   ...++.+++..|..||+..                              
T Consensus        89 ~~~~v~e~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             CEEEEEECCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCEEEEEecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            899999999998883  21   1   11   2356677777788887642                              


Q ss_pred             --------------------------CCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         273 --------------------------PPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       273 --------------------------~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                                                ..++|+|++|.|||++.++.+.|+|||.+..
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      1299999999999998876677999998743

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.01  E-value=1.6e-10  Score=109.99  Aligned_cols=183  Identities=20%  Similarity=0.157  Sum_probs=116.2

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCC--eecccceEEeCC---e
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDN--ILPLYGICFETG---K  223 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--Iv~l~~~~~~~~---~  223 (441)
                      ++.++.|.+..||+..   ..+++|+....           .....+.+|.++|+.+. +..  +..++......+   .
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~-----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~   90 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHS-----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM   90 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSH-----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCc-----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence            4668999999999864   56888875421           11234557888887773 322  233443332222   3


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE-------------------------------  272 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-------------------------------  272 (441)
                      .|+||++++|.+|.+...     ..++..++..++.+++..+..||+..                               
T Consensus        91 ~~~vm~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (304)
T 3sg8_A           91 SFAGFTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL  165 (304)
T ss_dssp             SCEEEECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred             ceEEEcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence            478999999988875332     22566677778888888888888511                               


Q ss_pred             -------------------------CCeeecCCCCCCeeecC--CCCeEEeccCCCccCCCcccccceeccccccCCC--
Q psy5927         273 -------------------------PPLIHGDIKSANILLNH--HMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY--  323 (441)
Q Consensus       273 -------------------------~~iiHrDikp~NiLl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y--  323 (441)
                                               ..++|+|++|.||+++.  ...+.|+||+.+..+.......       ....+  
T Consensus       166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-------~~~~~~~  238 (304)
T 3sg8_A          166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-------SLMEDDE  238 (304)
T ss_dssp             CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-------TTCCTTT
T ss_pred             CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-------HHHhhcc
Confidence                                     23899999999999998  5567899999886542211100       00011  


Q ss_pred             -cCcccccC-----C---------CCCCccceehHHHHHHHHHhCCCCCC
Q psy5927         324 -LPHEFLVG-----K---------RLSTKVDVYGFGIVLFELATGMRAYD  358 (441)
Q Consensus       324 -~aPE~~~~-----~---------~~s~~~DiwSlGvvl~elltG~~p~~  358 (441)
                       ..|+....     +         ....-.+.|++|.++|.+.+|..+|.
T Consensus       239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence             22222110     0         01122588999999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=7.2e-07  Score=84.78  Aligned_cols=136  Identities=20%  Similarity=0.127  Sum_probs=87.7

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC---CeecccceEE-eCCeEE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD---NILPLYGICF-ETGKYC  225 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~  225 (441)
                      ++.++.|....||+.   +..+++|+-..   .        .....+.+|.++|..+.+.   .+.+++.++. ..+..+
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~~---~--------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~   89 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPKS---Q--------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPF   89 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEESS---H--------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEE
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecCC---c--------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceE
Confidence            456788888899987   56788887421   1        1123456899999888642   2445555553 345678


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q psy5927         226 LVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR----------------------------------  271 (441)
Q Consensus       226 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~----------------------------------  271 (441)
                      +||+|++|.+|.+...     ..++...+..++.++...|..||+.                                  
T Consensus        90 ~v~e~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           90 VGYRKVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEEECCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             EEEeccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            9999999988865321     0123333334444444444444431                                  


Q ss_pred             ------------------------CCCeeecCCCCCCeeecC---CCCe-EEeccCCCccC
Q psy5927         272 ------------------------EPPLIHGDIKSANILLNH---HMDP-VIGDFGLTQEG  304 (441)
Q Consensus       272 ------------------------~~~iiHrDikp~NiLl~~---~~~~-kl~DFGla~~~  304 (441)
                                              ...++|+|++|.|||++.   ++.+ .|+||+.+..+
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                    123799999999999987   4554 79999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=9.9e-07  Score=81.94  Aligned_cols=133  Identities=17%  Similarity=0.071  Sum_probs=90.4

Q ss_pred             ccccCCce-eEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeCCeEEEE
Q psy5927         152 ILGKGGFG-TVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       152 ~LG~G~fg-~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv  227 (441)
                      .+..|..| .||+....  +..+.+|+-...            ....+.+|...|+.+. +--+.++++++.+.+..++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            44555554 68986653  456888876421            1123446777777763 33366788888899999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q psy5927         228 YRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE-----------------------------------  272 (441)
Q Consensus       228 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----------------------------------  272 (441)
                      ||+++|.++.+.....       ......+..+++..|.-||+..                                   
T Consensus        99 me~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER  171 (272)
T ss_dssp             EECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred             EEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence            9999998887754321       1223345566666666666421                                   


Q ss_pred             ---------------------CCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         273 ---------------------PPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       273 ---------------------~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                                           ..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                 0179999999999999887778999998753

>1wmg_A Netrin receptor UNC5H2; six helix bundle, death domain, apoptosis, structural genomi NPPSFA; 2.10A {Mus musculus} SCOP: a.77.1.2

Probab=98.48  E-value=1.2e-07  Score=74.35  Aligned_cols=53  Identities=19%  Similarity=0.297  Sum_probs=48.2

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhc---CCCCHHHHHHHHHhcChhhHHHhhccC
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGA---QNHTVLELFKHLYAMRHYQAMLILKPY   58 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~---~n~tv~~l~~~l~~~~~~~a~~~~~~~   58 (441)
                      |||+. +|+.||+    +.|||+.||..|+.   .|+||++|+.+|.+|+...|+++|..+
T Consensus        41 Lg~~~-~i~~~~~----~~SPt~~LL~~W~~~~~~~~tv~~L~~~L~~mgR~Da~~~L~~~   96 (103)
T 1wmg_A           41 LSMDR-YLNYFAT----KASPTGVILDLWEARQQDDGDLNSLASALEEMGKSEMLVAMATD   96 (103)
T ss_dssp             TTCGG-GHHHHHT----SSCHHHHHHHHHHHHCCSTTTHHHHHHHHHHTTCHHHHHHHHHC
T ss_pred             cCChH-HHHHHHc----CCCHHHHHHHHHHHhcCCCCcHHHHHHHHHHcCCHHHHHHHHcc
Confidence            78998 9999874    68999999999986   579999999999999999999999863

>2g7r_A Mucosa-associated lymphoid tissue lymphoma transl protein 1; death domain, chromosomal translocation, hydrolase; 2.70A {Homo sapiens}

Probab=98.41  E-value=1.7e-07  Score=72.40  Aligned_cols=44  Identities=34%  Similarity=0.435  Sum_probs=41.5

Q ss_pred             HHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927          14 AILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus        14 ~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      ..+++.||+..||+.|+.+|+||+||++.|++|++-+|++.|+|
T Consensus        72 vle~~gSPSr~LL~~~~~~g~Tl~~L~~~Lq~mg~~EAi~~L~~  115 (117)
T 2g7r_A           72 VLEPEGSPSLCLLKLMGEKGCTVTELSDFLQAMEHTEVLQLLSP  115 (117)
T ss_dssp             GGSTTCCHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             hhccCCChHHHHHHHHHHcCCcHHHHHHHHHHhccHHHHHHhcC
Confidence            34688999999999999999999999999999999999999987

>3mop_A Myeloid differentiation primary response protein; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens}

Probab=98.31  E-value=2.5e-07  Score=72.93  Aligned_cols=57  Identities=28%  Similarity=0.466  Sum_probs=50.6

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhh-cCCCCHHHHHHHHHhcChhhHHHhhccCccC
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWG-AQNHTVLELFKHLYAMRHYQAMLILKPYVES   61 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~-~~n~tv~~l~~~l~~~~~~~a~~~~~~~~~~   61 (441)
                      |||+..+|+.||+    .+|||.+||.+|+ +.|+||++|+..|.+++=..++..+.++...
T Consensus        36 Lg~~~~~I~~fe~----~~sPT~~lL~~W~~r~~aTVg~L~~~L~~i~R~Dv~~~l~~~~e~   93 (110)
T 3mop_A           36 MDFEYLEIRQLET----QADPTGRLLDAWQGRPGASVGRLLELLTKLGRDDVLLELGPSIEE   93 (110)
T ss_dssp             TTCCHHHHHHHTS----SSSHHHHHHHHHHSSSSCSHHHHHHHHHHHTCHHHHTTSHHHHHH
T ss_pred             cCCCHHHHHHHhC----CCCcHHHHHHHHhcCCCCcHHHHHHHHHHcCCHHHHHHHHHHHHH
Confidence            7999999999974    6999999999995 7899999999999999999999888775544

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.26  E-value=7.6e-06  Score=78.42  Aligned_cols=143  Identities=17%  Similarity=0.197  Sum_probs=78.7

Q ss_pred             CccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc--CCCCCeeccc-c--eEEeCCeEE
Q psy5927         151 NILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS--CRHDNILPLY-G--ICFETGKYC  225 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~-~--~~~~~~~~~  225 (441)
                      +.|+.|..+.||+....+..+++|+.....  ..        .......++.|..  +..|.++... |  +....+..+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~~--~~--------~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRPE--KK--------ALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSCH--HH--------HHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCCH--HH--------HHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            456667789999998877779999886411  00        1111122223332  3345554421 1  223567889


Q ss_pred             EEEEecCCCCHH--------------HHHhhcCC-C--C--------CCCHHHH--------------------------
Q psy5927         226 LVYRYMPNGSLE--------------DRLLMKKN-T--P--------SLLWTQR--------------------------  254 (441)
Q Consensus       226 lv~e~~~~gsL~--------------~~l~~~~~-~--~--------~l~~~~~--------------------------  254 (441)
                      ++|+|++|.++.              ..++.... .  +        ...|...                          
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986542              11221111 0  0        0123211                          


Q ss_pred             -----HHHHHHHHHHHHHHHc-----------CCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         255 -----LHIAKGTSLGLQFLHS-----------REPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       255 -----~~i~~~i~~al~~LH~-----------~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                           ..+...+..++++|+.           ....++|||+++.|||++.++.+.|+||+.+..
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                 0111223345666652           123499999999999998888999999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=2.4e-06  Score=82.82  Aligned_cols=82  Identities=5%  Similarity=-0.074  Sum_probs=49.4

Q ss_pred             cCcc-ccCCceeEEEEEEC--------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-C--CCeecccce
Q psy5927         150 LNIL-GKGGFGTVYKGVWE--------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-H--DNILPLYGI  217 (441)
Q Consensus       150 ~~~L-G~G~fg~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~  217 (441)
                      .+.| +.|....+|+....        +..+++|+..........      ....+.+|+.+++.+. +  -.+.+++.+
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~------~~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF------PTYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS------SCCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC------chhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3567 78888999987764        567888875432100000      0012235666666663 2  245567776


Q ss_pred             EEeC---CeEEEEEEecCCCCHH
Q psy5927         218 CFET---GKYCLVYRYMPNGSLE  237 (441)
Q Consensus       218 ~~~~---~~~~lv~e~~~~gsL~  237 (441)
                      +.+.   +..++||||++|.++.
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBCCC
T ss_pred             ccCCCccCCceEEEEecCCCChh
Confidence            6554   3568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.90  E-value=3.2e-05  Score=76.05  Aligned_cols=81  Identities=10%  Similarity=0.029  Sum_probs=46.0

Q ss_pred             cCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC--CCee-cccceEEeCCeE
Q psy5927         150 LNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH--DNIL-PLYGICFETGKY  224 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv-~l~~~~~~~~~~  224 (441)
                      .+.||.|.++.||++..  .+..++||.............  ....+....|.++++.+..  |..+ +++.+  +.+..
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~--~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW--PLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------C--CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCC--cCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence            46799999999999964  456799997653211000000  0011233467777776632  3333 44433  45556


Q ss_pred             EEEEEecCCC
Q psy5927         225 CLVYRYMPNG  234 (441)
Q Consensus       225 ~lv~e~~~~g  234 (441)
                      ++||||+++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.86  E-value=5.8e-05  Score=71.62  Aligned_cols=137  Identities=18%  Similarity=0.157  Sum_probs=88.0

Q ss_pred             cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC---CCCeecccceEEeCCeEEE
Q psy5927         150 LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR---HDNILPLYGICFETGKYCL  226 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l  226 (441)
                      .+.|+.|.+..+|+....+..+++|+....            ....+..|...|+.+.   ...+.++++++...+..++
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~l  108 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFL  108 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEE
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEE
Confidence            467899999999998877778888886521            1223446777777663   3567788888877788999


Q ss_pred             EEEecCCCCHH--------H---HHhhcCCCC-------------------CCCHHHHH---HHH---------------
Q psy5927         227 VYRYMPNGSLE--------D---RLLMKKNTP-------------------SLLWTQRL---HIA---------------  258 (441)
Q Consensus       227 v~e~~~~gsL~--------~---~l~~~~~~~-------------------~l~~~~~~---~i~---------------  258 (441)
                      ||||++|.++.        .   .|+.....+                   .-+|....   .+.               
T Consensus       109 vme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~  188 (312)
T 3jr1_A          109 LLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGN  188 (312)
T ss_dssp             EEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSC
T ss_pred             EEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHH
Confidence            99999987642        1   222221100                   12344221   010               


Q ss_pred             -HHHHHH-HHHHH--cCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         259 -KGTSLG-LQFLH--SREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       259 -~~i~~a-l~~LH--~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                       ..++.. ...|.  ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus       189 ~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          189 IDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             111111 22342  2234599999999999999888 8999984

>1ngr_A P75 low affinity neurotrophin receptor; intracellular domain, death domain; NMR {Rattus norvegicus} SCOP: a.77.1.2

Probab=97.80  E-value=4e-05  Score=57.51  Aligned_cols=53  Identities=21%  Similarity=0.397  Sum_probs=47.6

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcC-CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~-n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |||+..+|+.|+.    ..|||..||..|..+ ++||+.|+..|.+++-..+++.|.+
T Consensus        31 Lg~~~~~I~~~~~----~~~pt~~lL~~W~~r~~atv~~L~~aL~~igR~Dv~~~L~~   84 (85)
T 1ngr_A           31 LGYQPEHIDSFTH----EACPVRALLASWGAQDSATLDALLAALRRIQRADIVESLCS   84 (85)
T ss_dssp             TTCCHHHHHHHHH----SSCHHHHHHHHGGGSTTCBHHHHHHHHHHTTCHHHHHHHHC
T ss_pred             cCCCHHHHHHHHc----CCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCcHHHHHHHcC
Confidence            7999999999985    479999999999875 5999999999999999999988764

>2dbf_A Nuclear factor NF-kappa-B P105 subunit; apoptosis, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.65  E-value=3.8e-05  Score=59.21  Aligned_cols=52  Identities=17%  Similarity=0.254  Sum_probs=44.0

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |||+-. +..||    +..|||..||..|...++||++|.+.|+.|+.-.|+.+|.+
T Consensus        40 Lg~~~l-i~~f~----~~~SPt~~LL~~we~~~~tv~~L~~~L~~mgr~dav~~L~~   91 (100)
T 2dbf_A           40 LGLGIL-NNAFR----LSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQA   91 (100)
T ss_dssp             HTCGGG-HHHHH----HSSCHHHHHHHHHHHTCCCHHHHHHHHHHHTCSHHHHHHHH
T ss_pred             HCcHHH-HHHHh----cCCChHHHHHHHHHhCCCCHHHHHHHHHHhCcHHHHHHHHH
Confidence            355553 44444    56799999999999999999999999999999999999876

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=0.00012  Score=72.52  Aligned_cols=77  Identities=16%  Similarity=0.163  Sum_probs=46.2

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCC---CCCCccceehHHHHHHHH
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFEL  350 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlGvvl~el  350 (441)
                      .++|||++|.|||++.++ ++|+||+.+..+...-........  -...|++|+.....   .-....++.++...+|+.
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            399999999999998876 999999998764322111111100  12345565544311   111234455777777777


Q ss_pred             HhC
Q psy5927         351 ATG  353 (441)
Q Consensus       351 ltG  353 (441)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.51  E-value=0.00034  Score=66.34  Aligned_cols=158  Identities=14%  Similarity=0.140  Sum_probs=83.5

Q ss_pred             CChhHHHHhhCCCcC-----cCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC---
Q psy5927         135 IPYQELTLATNNWDK-----LNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC---  206 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~-----~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---  206 (441)
                      ++..++......|.+     .+.|+.|....+|+....+..+++|+.......           +.+..|+.++..+   
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~-----------~~l~~e~~~l~~L~~~   75 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK-----------NDLPFFLGLMQHLAAK   75 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---C-----------CHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCH-----------HHHHHHHHHHHHHHHC
Confidence            344445444455654     345777888999998877668889887642110           0112344444443   


Q ss_pred             --CCCCeeccc-c--eEEeCCeEEEEEEecCCCCHHH--------------HHhhcC-C--CC---CC---CHHHHHH--
Q psy5927         207 --RHDNILPLY-G--ICFETGKYCLVYRYMPNGSLED--------------RLLMKK-N--TP---SL---LWTQRLH--  256 (441)
Q Consensus       207 --~hpnIv~l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-~--~~---~l---~~~~~~~--  256 (441)
                        .-|.++... |  +....+..+++|+|++|.++..              .++... .  .+   ..   .|.....  
T Consensus        76 g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~  155 (322)
T 2ppq_A           76 GLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS  155 (322)
T ss_dssp             TCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred             CCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence              234433221 1  1223467899999999865311              122111 1  00   01   1222100  


Q ss_pred             ----------HHHHHHHHHHHHHcC-----CCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         257 ----------IAKGTSLGLQFLHSR-----EPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       257 ----------i~~~i~~al~~LH~~-----~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                                +...+...+++++..     ...++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                      011134455555521     12499999999999999876668999997754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.28  E-value=0.00034  Score=65.86  Aligned_cols=30  Identities=20%  Similarity=0.127  Sum_probs=25.6

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      .++|+|+.+.||+ ..++.+.|+||..+..+
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            3899999999999 66778899999988653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.25  E-value=0.0013  Score=61.28  Aligned_cols=79  Identities=13%  Similarity=0.042  Sum_probs=49.9

Q ss_pred             CCCcCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCC---CeecccceEEe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHD---NILPLYGICFE  220 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~  220 (441)
                      ....-++.+|.|..+.||+.+. +++.+.+|+-.......         ...+..|...|+.+.-.   .+.+++++  +
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---------DGLFRAEALGLDWLGRSFGSPVPQVAGW--D   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---------TTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---------hhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence            3455568899999999999987 46789998754222110         11234687777776321   23344443  2


Q ss_pred             CCeEEEEEEecCCCCH
Q psy5927         221 TGKYCLVYRYMPNGSL  236 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL  236 (441)
                        ..++||||++++..
T Consensus        84 --~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 --DRTLAMEWVDERPP   97 (288)
T ss_dssp             --TTEEEEECCCCCCC
T ss_pred             --CceEEEEeecccCC
Confidence              23789999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.23  E-value=0.002  Score=57.03  Aligned_cols=100  Identities=14%  Similarity=0.101  Sum_probs=65.9

Q ss_pred             CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccc
Q psy5927         233 NGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI  312 (441)
Q Consensus       233 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~  312 (441)
                      ..||.+.|...+  .++++.+++.++.|.+.+|.-+-.... -..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        32 ~vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           32 ALSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc----------
Confidence            357999887654  579999999999999999877622111 11333457899999999998864 2110          


Q ss_pred             eeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh
Q psy5927         313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT  352 (441)
Q Consensus       313 ~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt  352 (441)
                           .....+.|||... ...+.+.-|||||+++|..+-
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                 0233466888764 245678899999999999987

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.20  E-value=0.00071  Score=64.54  Aligned_cols=32  Identities=22%  Similarity=0.269  Sum_probs=27.5

Q ss_pred             CeeecCCCCCCeeecCC----CCeEEeccCCCccCC
Q psy5927         274 PLIHGDIKSANILLNHH----MDPVIGDFGLTQEGP  305 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~----~~~kl~DFGla~~~~  305 (441)
                      .++|||+.+.|||++.+    +.+.|+||+.+..+.
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            49999999999999875    678999999887643

>2ib1_A Death domain containing membrane protein nradd; apoptosis, NOGO, FADD; NMR {Mus musculus}

Probab=97.03  E-value=0.00044  Score=52.45  Aligned_cols=53  Identities=23%  Similarity=0.347  Sum_probs=47.4

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |||+..+|+.|+.    ..+||..+|..|-++   ++||+.|+..|.+++--.+++.+.+
T Consensus        28 Lg~~~~~I~~i~~----~~~~~~~lL~~W~~r~g~~ATv~~L~~aL~~i~R~Di~~~L~~   83 (91)
T 2ib1_A           28 LGYQAEAVETMAC----DQMPAYTLLRNWAAQEGNRATLRVLEDALAAIGREDVVQVLSS   83 (91)
T ss_dssp             HTCCHHHHHHHTT----SSCHHHHHHHHTTSSSSSTTSTTHHHHHHHTTTCHHHHHHHTC
T ss_pred             cCCCHHHHHHHHh----cCcHHHHHHHHHHhccCCCCcHHHHHHHHHHcCHHHHHHHHhc
Confidence            5899999999984    568999999999754   5999999999999999999998876

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.97  E-value=0.0072  Score=57.17  Aligned_cols=29  Identities=31%  Similarity=0.551  Sum_probs=25.1

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      .++|||+++.|||++ + .+.|+||+.+..+
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            389999999999999 4 8999999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.86  E-value=0.0017  Score=64.46  Aligned_cols=72  Identities=14%  Similarity=0.211  Sum_probs=43.6

Q ss_pred             cCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCe-ecccceEE
Q psy5927         150 LNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI-LPLYGICF  219 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~  219 (441)
                      ++.|+.|....||+....         +..+.+|+....  ..         .+.+..|..++..+...++ .++++.+.
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---------~~~li~E~~~l~~L~~~g~~P~l~~~~~  146 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---------ESHLVAESVIFTLLSERHLGPKLYGIFS  146 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---------HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---------HHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence            467888888999998864         356778776321  10         0122357777666632233 45665543


Q ss_pred             eCCeEEEEEEecCCCCH
Q psy5927         220 ETGKYCLVYRYMPNGSL  236 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL  236 (441)
                        +  .+|+||++|.+|
T Consensus       147 --~--g~v~e~l~G~~l  159 (429)
T 1nw1_A          147 --G--GRLEEYIPSRPL  159 (429)
T ss_dssp             --T--EEEECCCCEEEC
T ss_pred             --C--CEEEEEeCCccc
Confidence              2  289999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.81  E-value=0.0024  Score=62.08  Aligned_cols=140  Identities=16%  Similarity=0.149  Sum_probs=75.5

Q ss_pred             cCccccCCceeEEEEEEC---------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEE
Q psy5927         150 LNILGKGGFGTVYKGVWE---------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICF  219 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  219 (441)
                      ++.|..|-...+|+....         +..+.+++.....  .        ......+|.++++.+. +.-..++++++.
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~--------~~~~~~rE~~vl~~L~~~gv~P~ll~~~~  124 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--Q--------GVDSLVLESVMFAILAERSLGPQLYGVFP  124 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C--------CHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--c--------hHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence            356777888889998763         2567777742110  0        1122336777777663 222345665553


Q ss_pred             eCCeEEEEEEecCCCCHHH--------------H---HhhcCC--CCCC--CHHHHHHHHHHHHH---------------
Q psy5927         220 ETGKYCLVYRYMPNGSLED--------------R---LLMKKN--TPSL--LWTQRLHIAKGTSL---------------  263 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~--------------~---l~~~~~--~~~l--~~~~~~~i~~~i~~---------------  263 (441)
                      +    .+||||++|.+|..              .   |+....  ....  .|.+...+..++..               
T Consensus       125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~  200 (379)
T 3feg_A          125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY  200 (379)
T ss_dssp             T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred             C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence            3    28999999865531              1   111110  1112  23444444433321               


Q ss_pred             ----HHHHH----HcC--CCCeeecCCCCCCeeecCC----CCeEEeccCCCcc
Q psy5927         264 ----GLQFL----HSR--EPPLIHGDIKSANILLNHH----MDPVIGDFGLTQE  303 (441)
Q Consensus       264 ----al~~L----H~~--~~~iiHrDikp~NiLl~~~----~~~kl~DFGla~~  303 (441)
                          .+..|    ...  ...++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                22333    221  1249999999999999876    7899999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.68  E-value=0.0049  Score=61.55  Aligned_cols=73  Identities=16%  Similarity=0.119  Sum_probs=44.5

Q ss_pred             cCccccCCceeEEEEEECC--eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCe-ecccceEEeCCeEEE
Q psy5927         150 LNILGKGGFGTVYKGVWEK--TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI-LPLYGICFETGKYCL  226 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~l  226 (441)
                      ++.|+.|-...+|+....+  ..+.+|+...... .   .++      ..+|..++..+...++ .++++++.  +  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~---~id------R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E---IIN------REREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S---CSC------HHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h---hcC------HHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            4578888889999998876  7788887642211 0   111      1267777777754444 45666552  2  25


Q ss_pred             EEEecCCCCH
Q psy5927         227 VYRYMPNGSL  236 (441)
Q Consensus       227 v~e~~~~gsL  236 (441)
                      ||||++|.+|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987554

>2d96_A Nuclear factor NF-kappa-B P100 subunit; six helix bundle, processing, proteasome, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=96.54  E-value=0.0026  Score=49.41  Aligned_cols=44  Identities=18%  Similarity=0.264  Sum_probs=40.4

Q ss_pred             HHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927          14 AILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus        14 ~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +.+...|||.-||..|...++||.+|.+.|+.|++-.|+.+|.+
T Consensus        48 ~f~~~~SPt~~LL~l~E~~ggtl~~L~~aL~~MG~~eav~~L~~   91 (109)
T 2d96_A           48 TYRQTTSPSGSLLRSYELAGGDLAGLLEALSDMGLEEGVRLLRG   91 (109)
T ss_dssp             HHHTSSCHHHHHHHHHHHTTCCHHHHHHHHHHHTCHHHHHHHHC
T ss_pred             HHhCCCChHHHHHHHHHhcCCCHHHHHHHHHHhccHHHHHHhcc
Confidence            34567899999999999999999999999999999999999976

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.29  E-value=0.035  Score=52.98  Aligned_cols=30  Identities=27%  Similarity=0.327  Sum_probs=27.1

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            499999999999999888899999987765

>3g5b_A Netrin receptor UNC5B; ZU5, death domain, UPA, apoptosis, developmental protein, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; 2.00A {Rattus norvegicus}

Probab=96.24  E-value=0.0029  Score=61.28  Aligned_cols=44  Identities=20%  Similarity=0.335  Sum_probs=39.5

Q ss_pred             HHHhCCCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927          14 AILRRESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus        14 ~~~~~~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +..++.|||+.||+.|..+   ++||++|.++|.+|+...|+.+|..
T Consensus       355 ~f~~~~sPT~~LL~~We~~~~~~~tl~~L~~~L~emgR~D~~~~l~~  401 (405)
T 3g5b_A          355 YFATKASPTGVILDLWEARQQDDGDLNSLASALEEMGKSEMLVAMTT  401 (405)
T ss_dssp             HHHTSSCHHHHHHHHHHHHHTTTCCHHHHHHHHHHTTCCHHHHHHHC
T ss_pred             HHhcCCCcHHHHHHHHHhhCCCCCCHHHHHHHHHHhCCHHHHHhhcc
Confidence            4567899999999999755   8999999999999999999998865

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.23  E-value=0.0067  Score=58.60  Aligned_cols=29  Identities=21%  Similarity=0.288  Sum_probs=24.5

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++|+|+.+.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            499999999999998655 89999998764

>1wxp_A THO complex subunit 1; death domain, structural genomics, nuclear matrix, riken structural genomics/proteomics initiative, RSGI, transport protein; NMR {Homo sapiens}

Probab=94.94  E-value=0.0093  Score=46.93  Aligned_cols=57  Identities=18%  Similarity=0.171  Sum_probs=47.1

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||+..+|..||.....-+....++|..|-++   ++||+.|++.|.+.++-..++.|..
T Consensus        39 Lg~~~~~I~~ie~~~~~~~eq~~~mL~~W~~r~G~~AT~~~L~~AL~~~~~~dvae~l~~   98 (110)
T 1wxp_A           39 LEMKDSEIRQIECDSEDMKMRAKQLLVAWQDQEGVHATPENLINALNKSGLSDLAESLTN   98 (110)
T ss_dssp             TTCCHHHHHHHHHHCSSHHHHHHHHHHHHHHHHGGGCCHHHHHHHHHHTTCHHHHHHHHC
T ss_pred             hCCCHHHHHHHHHcCCCHHHHHHHHHHHHHHhhCcCcHHHHHHHHHHHcCcHHHHHHHHH
Confidence            68999999999933222245679999999754   5999999999999999999988876

>2of5_H Leucine-rich repeat and death domain-containing protein; death domain complex, apoptosis; 3.20A {Homo sapiens}

Probab=94.08  E-value=0.032  Score=44.42  Aligned_cols=57  Identities=11%  Similarity=0.193  Sum_probs=47.2

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhhcC----CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWGAQ----NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~~----n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||+..+|..||..-... +.+..++|..|-++    ++||+.|++-|.+.+.-..++.+..
T Consensus        34 Lg~s~~~I~~I~~~~~~~l~eq~~~mL~~W~~~~g~~~Atv~~L~~aL~~~~r~diae~l~~   95 (118)
T 2of5_H           34 LGVSYREVQRIRHEFRDDLDEQIRHMLFSWAERQAGQPGAVGLLVQALEQSDRQDVAEEVRA   95 (118)
T ss_dssp             TTCCHHHHHHHHHHTTTCHHHHHHHHHHHHHHTTSSCSSHHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHhccCCCCcHHHHHHHHHHHcCcHHHHHHHHH
Confidence            689999999999654333 45799999999643    5999999999999999999877655

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.64  E-value=0.16  Score=49.97  Aligned_cols=29  Identities=17%  Similarity=0.322  Sum_probs=26.0

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 8888999999998864

>3oq9_A Tumor necrosis factor receptor superfamily member; apoptosis, DISC, FAS; 6.80A {Mus musculus}

Probab=92.21  E-value=0.079  Score=39.34  Aligned_cols=56  Identities=13%  Similarity=0.140  Sum_probs=46.0

Q ss_pred             CCCChHHHHHHHHHH-HhCCCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           1 MNFTSRQLFQMEQAI-LRRESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~-~~~~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      +|++..+|..||.-= +...-...++|..|-++   .+|+..|++-|.++++-..++.|.
T Consensus        22 LGlse~~Id~I~~~~~~d~~Eq~~qmL~~W~~~~g~~a~~~~Li~~Lr~~~l~~~Ad~I~   81 (86)
T 3oq9_A           22 NNIKEGKIDEIMHDSIQDTAEQKVQLLLCWYQSHGKSDAYQDLIKGLKKAECRRTLDKFQ   81 (86)
T ss_dssp             TTSCHHHHHHHHHTCTTCCTTHHHHHHHHHHHHSCSSSHHHHHHHHHHHTTCSSHHHHHH
T ss_pred             cCCCHhHHHHHHHhCCCChHHHHHHHHHHHHHHhCcchHHHHHHHHHHHccchhHHHHHH
Confidence            588999999998543 33466789999999854   489999999999999999887664

>2yqf_A Ankyrin-1; death domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2yvi_A

Probab=91.56  E-value=0.075  Score=41.72  Aligned_cols=57  Identities=14%  Similarity=0.262  Sum_probs=45.4

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||+..+|..||.--.+. +....++|..|-++   ++||..|++-|.+.+.-..++.|..
T Consensus        39 Lg~s~~~I~~I~~~~p~~~~eq~~~mL~~W~~~~g~~AT~~~L~~aL~~i~r~diae~l~~   99 (111)
T 2yqf_A           39 LQFSVEDINRIRVENPNSLLEQSVALLNLWVIREGQNANMENLYTALQSIDRGEIVNMLEG   99 (111)
T ss_dssp             TTCCHHHHHHHHHHSCSCHHHHHHHHHHHHHHHHTTSCCHHHHHHHHHHTTCCHHHHHHSC
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHHhhCCCchHHHHHHHHHHcCcHHHHHHHHH
Confidence            689999999999322110 23389999999754   4899999999999999999988865

>1ich_A TNF-1, tumor necrosis factor receptor-1; death domain, apoptosis; NMR {Homo sapiens} SCOP: a.77.1.2

Probab=89.27  E-value=0.47  Score=36.89  Aligned_cols=55  Identities=13%  Similarity=0.199  Sum_probs=42.0

Q ss_pred             CCCChHHHHHHHHHHHhCCCc---hHHHHHHhhcC----CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESP---TEELLSKWGAQ----NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~---t~~ll~~w~~~----n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +|+...+|..||.-  .+...   .-++|..|-++    ++||+.|++-|.++++-..++.|..
T Consensus        35 LGLse~~Id~Ie~~--~~r~l~Eq~yqmLr~W~~~~G~~~Atv~~L~~aLr~~~l~~~ae~Ie~   96 (112)
T 1ich_A           35 LGLSDHEIDRLELQ--NGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIEE   96 (112)
T ss_dssp             HTCCHHHHHHHHHH--CCSCHHHHHHHHHHHHHHHSCCSSCHHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHH--CcCChHHHHHHHHHHHHHhcCCCCCcHHHHHHHHHHhccHHHHHHHHH
Confidence            47888899888832  22231   33499999744    4799999999999999999987754

>3ezq_B Protein FADD; apoptosis, DISC, FAS, membrane,receptor, transmembrane; 2.73A {Homo sapiens} PDB: 1e3y_A 1e41_A 3oq9_H

Probab=87.94  E-value=0.43  Score=37.96  Aligned_cols=57  Identities=18%  Similarity=0.248  Sum_probs=45.7

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhhc---CCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWGA---QNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~---~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||+..+|..|+.--.+. +....++|..|-+   +++||+.|++-|.+.++-..++.|..
T Consensus        27 LGlse~dId~Ie~~~p~dl~eq~~~mL~~W~~r~G~~ATv~~L~~AL~~i~~~diAe~Ie~   87 (122)
T 3ezq_B           27 LKVSDTKIDSIEDRYPRNLTERVRESLRIWKNTEKENATVAHLVGALRSCQMNLVADLVQE   87 (122)
T ss_dssp             TTCCHHHHHHHHHHCSSCHHHHHHHHHHHHHHHCTTTCCHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             hCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHHhhCCCchHHHHHHHHHHCCCHHHHHHHHH
Confidence            589999999998532111 2347899999974   68999999999999999999988754

>1fad_A Protein (FADD protein); apoptosis, death domain; NMR {Mus musculus} SCOP: a.77.1.2

Probab=87.31  E-value=0.15  Score=39.03  Aligned_cols=56  Identities=18%  Similarity=0.234  Sum_probs=43.7

Q ss_pred             CCCChHHHHHHHHHHH-hCCCchHHHHHHhhc---CCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           1 MNFTSRQLFQMEQAIL-RRESPTEELLSKWGA---QNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~-~~~s~t~~ll~~w~~---~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      +||+..+|..||.--. .-+....++|..|-+   .++|+..|++-|.+.++-..++.|.
T Consensus        35 Lg~~~~~I~~I~~~~~~d~~eq~~~mL~~W~~~~g~~At~~~L~~AL~~~~~~~iae~i~   94 (99)
T 1fad_A           35 LKVSEAKMDGIEEKYPRSLSERVRESLKVWKNAEKKNASVAGLVKALRTCRLNLVADLVE   94 (99)
T ss_dssp             TTCCHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHGGGGSHHHHHHHHHHHTCHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHhccCCCCcHHHHHHHHHHCCcHHHHHHHH
Confidence            5899999999994331 113458899999964   4699999999999999887776653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.80  E-value=0.1  Score=52.06  Aligned_cols=62  Identities=6%  Similarity=0.004  Sum_probs=18.3

Q ss_pred             cCcCccccCCceeEEEEEECC--eeEEE------EEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         148 DKLNILGKGGFGTVYKGVWEK--TTIAV------KKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      .+.+.||   ||.||+|.+.+  ..|||      |..+...       ........+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-------~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-------VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccc-------ccccccccccccccccccccccccCCCcceEE
Confidence            3456776   99999999864  57888      5543211       12233345668888899999999999988754

>2o71_A Death domain-containing protein cradd; raidd, apoptosis; 2.00A {Homo sapiens}

Probab=85.67  E-value=0.34  Score=38.11  Aligned_cols=52  Identities=13%  Similarity=0.288  Sum_probs=39.8

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhHH
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQAM   52 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a~   52 (441)
                      +||+..+|..|+.--.++ +....++|..|-++   ++||+.|++-|.+.++-...
T Consensus        45 LGlse~dId~I~~~~p~dl~eq~~qmL~~W~~r~G~~AT~~~L~~AL~~~~l~~~v  100 (115)
T 2o71_A           45 LGLSQTDIYRCKANHPHNVQSQVVEAFIRWRQRFGKQATFQSLHNGLRAVEVDPSL  100 (115)
T ss_dssp             TTCCHHHHHHHHHHCTTCHHHHHHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTHH
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHCcCcHHHHHHHHHHHcCCCHHH
Confidence            589999999999543222 24578999999644   49999999999998875544

>2of5_A Death domain-containing protein cradd; death domain complex, apoptosis; 3.20A {Homo sapiens}

Probab=85.47  E-value=0.32  Score=38.23  Aligned_cols=51  Identities=14%  Similarity=0.275  Sum_probs=38.6

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhhcC---CCCHHHHHHHHHhcChhhH
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWGAQ---NHTVLELFKHLYAMRHYQA   51 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~~---n~tv~~l~~~l~~~~~~~a   51 (441)
                      +||+..+|..|+.--.++ +....++|..|-++   ++||+.|++-|.+.++-..
T Consensus        45 LGlse~dId~I~~~~p~~l~eq~~qmL~~W~~r~G~~AT~~~L~~AL~~~~l~~~   99 (114)
T 2of5_A           45 LGLSQTDIYRCKANHPHNVQSQVVEAFIRWRQRFGKQATFQSLHNGLRAVEVDPS   99 (114)
T ss_dssp             TTCCHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTH
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHCcCcHHHHHHHHHHHcCCCHH
Confidence            589999999998533211 24478999999644   4999999999999886433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.32  E-value=2.4  Score=37.23  Aligned_cols=115  Identities=12%  Similarity=0.091  Sum_probs=74.1

Q ss_pred             CCCCeecccceEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCeeecCCCCCCe
Q psy5927         207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ-FLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       207 ~hpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~-~LH~~~~~iiHrDikp~Ni  285 (441)
                      .||++  -..+-.+++.+.+.|+.-+++-=+..+.      .++...++.++..++.... ++++    -+|--|.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceE
Confidence            57777  2333456677777777654433233332      2667888999988887666 4443    57788999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCC
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYD  358 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~  358 (441)
                      +++.++.++|.-.|+-.                    -++|.-     .+..-=+-.+=+++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~--------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKE--------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETT--------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcc--------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999998887542                    233332     1111122356677788888777664

>3ezq_A Tumor necrosis factor receptor superfamily member; apoptosis, DISC, FAS, membrane,receptor, transmembrane; 2.73A {Homo sapiens} SCOP: a.77.1.2 PDB: 1ddf_A

Probab=82.18  E-value=0.35  Score=37.84  Aligned_cols=57  Identities=11%  Similarity=0.122  Sum_probs=45.0

Q ss_pred             CCCChHHHHHHHHHH-HhCCCchHHHHHHhhcCC---CCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAI-LRRESPTEELLSKWGAQN---HTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~-~~~~s~t~~ll~~w~~~n---~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +|++..+|..|+.-= +...-...++|..|-+++   ++|.+|++-|.+.++-..++.|..
T Consensus        30 LGlse~~Id~I~~d~~~d~~Eq~~qlLr~W~~~~G~~aa~~~Li~aLr~~~l~~~Ad~Iq~   90 (115)
T 3ezq_A           30 NGVNEAKIDEIKNDNVQDTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKIQT   90 (115)
T ss_dssp             TTCCHHHHHHHHHHCSSCHHHHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCHhhHHHHHHcCCCChHHHHHHHHHHHHHHhCcccHHHHHHHHHHHccchhHHHHHHH
Confidence            588889999888542 222334789999998665   589999999999999999987754

>2gf5_A FADD protein; death domain, death effector domain, apoptosis, death- inducing signaling complex; NMR {Homo sapiens} SCOP: a.77.1.2 a.77.1.4

Probab=80.65  E-value=0.73  Score=39.80  Aligned_cols=57  Identities=16%  Similarity=0.208  Sum_probs=45.1

Q ss_pred             CCCChHHHHHHHHHH-HhCCCchHHHHHHhhc---CCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAI-LRRESPTEELLSKWGA---QNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~-~~~~s~t~~ll~~w~~---~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||+..+|..|+.-- ..-+....++|..|-+   +++||+.|++-|.+.+.-..++.+..
T Consensus       119 Lgl~~~~I~~I~~~~~~d~~eq~~~mL~~W~~r~g~~At~~~L~~AL~~~~~~diae~l~~  179 (191)
T 2gf5_A          119 LKVSDTKIDSIEDRYPRNLTERVRESLRIWKNTEKENATVAHLVGALRSCQMNLVADLVQE  179 (191)
T ss_dssp             TTCCHHHHHHHHHHSSSCSHHHHHHHHHHHHHHTTTTCCHHHHHHHHHHHTCHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHhCCCCHHHHHHHHHHHHHHhhCCCcHHHHHHHHHHHcCcHHHHHHHHH
Confidence            589999999999633 2224558899999974   46999999999999998888876643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	441
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-51
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-50
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-48
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-33
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-22
d1ik7a_	52	a.77.1.2 (A:) Pelle death domain {Drosophila melan	5e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16
d1wh4a_	127	a.77.1.2 (A:) Interleukin-1 receptor-associated ki	4e-13
d1d2za_	102	a.77.1.2 (A:) Pelle death domain {Drosophila melan	1e-11

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 9e-60
 Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 25/282 (8%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
                   +G G FGTVYKG W    +AVK L V             Q +    E+  L 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQ-------QLQAFKNEVGVLR 59

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH NIL   G      +  +V ++    SL   L + +        + + IA+ T+ G
Sbjct: 60  KTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFE--MIKLIDIARQTAQG 116

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           + +LH++   +IH D+KS NI L+  +   IGDFGL         +H   ++++G+  ++
Sbjct: 117 MDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-QFEQLSGSILWM 173

Query: 325 PHEFLVGKR---LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
             E +  +     S + DVY FGIVL+EL TG   Y +    ++ +  +   Y       
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY------- 226

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            +  +   +  N   A  R+  +  K+   ERP   Q+   +
Sbjct: 227 -LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-54
 Identities = 60/284 (21%), Positives = 114/284 (40%), Gaps = 25/284 (8%)

Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSL 197
           + L  ++++K++ LG G  G V+K   + +   +A K + +         +    R Q +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--------IKPAIRNQII 52

Query: 198 RELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
           REL+ L+ C    I+  YG  +  G+  +   +M  GSL+  L   K    +       +
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKV 109

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
           +     GL +L  +   ++H D+K +NIL+N   +  + DFG++ +     A        
Sbjct: 110 SIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---- 164

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE------RHLKSLV 371
            GTR Y+  E L G   S + D++  G+ L E+A G          E        ++   
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 372 EKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE 415
            +            ++  ++     A F +      + P + P 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-53
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 36/290 (12%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQR 193
           +P + L L       +  LG G FG V+ G +   T +AVK L+                
Sbjct: 10  VPRETLKL-------VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------- 52

Query: 194 EQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQ 253
           +  L E   +   +H  ++ LY +  +     ++  YM NGSL D L        L   +
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINK 110

Query: 254 RLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHIT 313
            L +A   + G+ F+  R    IH D+++ANIL++  +   I DFGL +   IE   +  
Sbjct: 111 LLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTA 166

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
            +       +   E +     + K DV+ FGI+L E+ T  R       +   +++L   
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

Query: 374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           Y                  N     +++ +   K+ P++RP    + ++L
Sbjct: 227 YRM------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 65/281 (23%), Positives = 107/281 (38%), Gaps = 35/281 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
                L  +GKG FG V  G +    +AVK ++           N    +  L E   + 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----------NDATAQAFLAEASVMT 55

Query: 205 SCRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
             RH N++ L G+  E  G   +V  YM  GSL D  L  +    L     L  +     
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            +++L       +H D+ + N+L++      + DFGLT+E    + T            +
Sbjct: 115 AMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKW 166

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
              E L  K+ STK DV+ FGI+L+E+ +  R                 +   +++   V
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------------PRIPLKDVVPRV 213

Query: 384 DKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           +K  +         A + + K     +   RP   Q+   L
Sbjct: 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 1e-51
 Identities = 57/305 (18%), Positives = 133/305 (43%), Gaps = 44/305 (14%)

Query: 137 YQELTLATNNWDK---------LNILGKGGFGTVYKGVWEKTT-----IAVKKLEVHRND 182
           +++   A   + K           ++G G FG V  G  +        +A+K L+    +
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 183 RAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLM 242
           +        QR   L E   +    H N++ L G+  ++    ++  +M NGSL+    +
Sbjct: 69  K--------QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FL 118

Query: 243 KKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ 302
           ++N       Q + + +G + G+++L   +   +H D+ + NIL+N ++   + DFGL++
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 303 EGPIEKATHITLKRVN--GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDD 359
               + +       +       +   E +  ++ ++  DV+ +GIV++E+ + G R Y D
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236

Query: 360 TRRSERHLKSLVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
                          + +++ + ++++ + P  ++   A  ++     +++   RP+  Q
Sbjct: 237 --------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 419 VYNML 423
           + N L
Sbjct: 283 IVNTL 287

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 54/281 (19%), Positives = 111/281 (39%), Gaps = 29/281 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +    +  +G G FG V+ G W     +A+K +                 E  + E + +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----------EDFIEEAEVM 54

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H  ++ LYG+C E    CLV+ +M +G L D   ++           L +      
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCE 112

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ +L   E  +IH D+ + N L+  +    + DFG+T+    ++ T            +
Sbjct: 113 GMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKW 168

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
              E     R S+K DV+ FG++++E+ +  +   + R +   ++ +   +         
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------- 221

Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                      +   ++I     K+ P++RP  +++   L+
Sbjct: 222 -----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-50
 Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 32/279 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            +++    LGKG FG VY    +++   +A+K L   + ++           Q  RE++ 
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVEI 59

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
            +  RH NIL LYG   +  +  L+  Y P G++   L   +        +        +
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELA 116

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
             L + HS+   +IH DIK  N+LL    +  I DFG +   P  + T +      GT  
Sbjct: 117 NALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLD 169

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
           YLP E + G+    KVD++  G++ +E   G   ++                + +  Y  
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQETYKR 215

Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
           + +        +      +  +  K NP +RP + +V  
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-50
 Identities = 53/284 (18%), Positives = 104/284 (36%), Gaps = 31/284 (10%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           +++ L  +G G +G   K   +     +  K+L+         ++ + +++  + E+  L
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-------GSMTEAEKQMLVSEVNLL 57

Query: 204 NSCRHDNILPLYGICFET--GKYCLVYRYMPNGSLEDRLL-MKKNTPSLLWTQRLHIAKG 260
              +H NI+  Y    +       +V  Y   G L   +    K    L     L +   
Sbjct: 58  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117

Query: 261 TSLGLQFLHSR---EPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
            +L L+  H R      ++H D+K AN+ L+   +  +GDFGL +   I        K  
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSFAKAF 174

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
            GT  Y+  E +     + K D++  G +L+EL   M  +    +             +E
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------KE 221

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
               + +   + I    +     I  +        RP + ++  
Sbjct: 222 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-50
 Identities = 57/290 (19%), Positives = 126/290 (43%), Gaps = 30/290 (10%)

Query: 142 LATNNWDKLNILGKGGFGTVYKGVWEKTT------IAVKKLEVHRNDRAVETLNQCQREQ 195
           +  +   +  ++G G FG VYKG+ + ++      +A+K L+    ++        QR  
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--------QRVD 55

Query: 196 SLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRL 255
            L E   +    H NI+ L G+  +     ++  YM NG+L+    +++        Q +
Sbjct: 56  FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLV 113

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
            + +G + G+++L +     +H D+ + NIL+N ++   + DFGL++    +     T  
Sbjct: 114 GMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
                  +   E +  ++ ++  DV+ FGIV++E+ T          +   +K++ + + 
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231

Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG 425
                        P  ++   A +++  Q  +Q    RP+   + ++L  
Sbjct: 232 L------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (431), Expect = 2e-50
 Identities = 65/295 (22%), Positives = 126/295 (42%), Gaps = 32/295 (10%)

Query: 133 PHIP-YQELTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLN 189
           P  P Y +  +   +    + LG G +G VY+GVW+K   T+AVK L+           +
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----------ED 53

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
             + E+ L+E   +   +H N++ L G+C     + ++  +M  G+L D  L + N   +
Sbjct: 54  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEV 112

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                L++A   S  +++L  +    IH D+ + N L+  +    + DFGL++    +  
Sbjct: 113 SAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS 369
           T            +   E L   + S K DV+ FG++L+E+AT   +             
Sbjct: 171 TAHA--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------- 220

Query: 370 LVEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                    +Y+L++K+ +           + + +   + NP +RP   +++   
Sbjct: 221 -----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 53/281 (18%), Positives = 114/281 (40%), Gaps = 31/281 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
            +   L  LG G FG V  G W  +  +A+K ++                ++ + E K +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK----------EGSMSEDEFIEEAKVM 53

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
            +  H+ ++ LYG+C +     ++  YM NG L + L   ++       Q L + K    
Sbjct: 54  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCE 111

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            +++L S+    +H D+ + N L+N      + DFGL++    ++ T            +
Sbjct: 112 AMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRW 167

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
            P E L+  + S+K D++ FG++++E+ +  +                E+++     + +
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-------------YERFTNSETAEHI 214

Query: 384 DKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
            +  +       +   + I      +   ERP    + + +
Sbjct: 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-50
 Identities = 53/293 (18%), Positives = 120/293 (40%), Gaps = 34/293 (11%)

Query: 138 QELTLATNNWDKLNI-LGKGGFGTVYKGVW----EKTTIAVKKLEVHRNDRAVETLNQCQ 192
           ++L L  +N    +I LG G FG+V +GV+    ++  +A+K L+        +   +  
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK--------QGTEKAD 52

Query: 193 REQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWT 252
            E+ +RE + ++   +  I+ L G+C +     LV      G L   L+ K+    +  +
Sbjct: 53  TEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVS 109

Query: 253 QRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHI 312
               +    S+G+++L  +    +H D+ + N+LL +     I DFGL++    + + + 
Sbjct: 110 NVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167

Query: 313 TLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLKSLV 371
                     +   E +  ++ S++ DV+ +G+ ++E L+ G + Y              
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK------------ 215

Query: 372 EKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                  +   +++  +           + +         ++RP+   V   +
Sbjct: 216 --MKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 7e-50
 Identities = 67/297 (22%), Positives = 106/297 (35%), Gaps = 39/297 (13%)

Query: 153 LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL 212
           +GKG FG V++G W    +AVK            +  + +      E+      RH+NIL
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIF----------SSREERSWFREAEIYQTVMLRHENIL 60

Query: 213 PLYGICFETG----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFL 268
                  +      +  LV  Y  +GSL D L    N  ++     + +A  T+ GL  L
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116

Query: 269 HS------REPPLIHGDIKSANILLNHHMDPVIGDFGL-TQEGPIEKATHITLKRVNGTR 321
           H        +P + H D+KS NIL+  +    I D GL  +         I      GT+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 322 PYLPHEFLVGK------RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV-EKY 374
            Y+  E L             + D+Y  G+V +E+A            +     LV    
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 375 SEENMYDLVDKNAQPIEL-------NIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           S E M  +V +      +              +I ++    N   R    ++   LS
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 7e-50
 Identities = 64/284 (22%), Positives = 111/284 (39%), Gaps = 27/284 (9%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT-----IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
            +   L  LG G FG V +G W+  +     +AVK L+                +  +RE
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIRE 61

Query: 200 LKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           +  ++S  H N++ LYG+   T    +V    P GSL DR  ++K+    L       A 
Sbjct: 62  VNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDR--LRKHQGHFLLGTLSRYAV 118

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNG 319
             + G+ +L S+    IH D+ + N+LL       IGDFGL +  P     ++  +    
Sbjct: 119 QVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 320 TRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM 379
              +   E L  +  S   D + FG+ L+E+ T  +         + L  + +       
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------- 229

Query: 380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
               +    P   +     + +  Q     P++RP    + + L
Sbjct: 230 ----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-49
 Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 31/294 (10%)

Query: 132 TPHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-IAVKKLEVHRNDRAVETLNQ 190
           T  +      +   +      LG+G FG V+ G W  TT +A+K L+             
Sbjct: 4   TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----------PGT 53

Query: 191 CQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLL 250
              E  L+E + +   RH+ ++ LY +        +V  YM  GSL    L  +    L 
Sbjct: 54  MSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSL-LDFLKGETGKYLR 111

Query: 251 WTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKAT 310
             Q + +A   + G+ ++       +H D+++ANIL+  ++   + DFGL +   IE   
Sbjct: 112 LPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNE 167

Query: 311 HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSL 370
           +   +       +   E  +  R + K DV+ FGI+L EL T  R               
Sbjct: 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP----------- 216

Query: 371 VEKYSEENMYDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                   + D V++  + P       +   +  Q  ++ P+ERP    +   L
Sbjct: 217 --GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 1e-49
 Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 39/296 (13%)

Query: 134 HIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETLN 189
           ++  + LTL      +   LG G FGTV KG ++      T+AVK L+   ND A     
Sbjct: 2   YLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----- 50

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
              +++ L E   +    +  I+ + GIC E   + LV      G L   L   +    +
Sbjct: 51  --LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HV 104

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                + +    S+G+++L       +H D+ + N+LL       I DFGL++    ++ 
Sbjct: 105 KDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFE-LATGMRAYDDTRRSERHLK 368
            +           +   E +   + S+K DV+ FG++++E  + G + Y           
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG--------- 213

Query: 369 SLVEKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
                     +  +++K  +           + +       + + RP    V   L
Sbjct: 214 -----MKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 7e-49
 Identities = 65/280 (23%), Positives = 104/280 (37%), Gaps = 28/280 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            +WD +  LG+G +G V   V   T   +AVK +++ R     E +         +E+  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI--------KKEICI 56

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
                H+N++  YG   E     L   Y   G L DR+   +    +             
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLM 113

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            G+ +LH     + H DIK  N+LL+   +  I DFGL             L ++ GT P
Sbjct: 114 AGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER-LLNKMCGTLP 170

Query: 323 YLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
           Y+  E L  +      VDV+  GIVL  +  G   +D    S +      EK +  N + 
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            +D                +  +   +NP  R  +  +  
Sbjct: 231 KIDSAPL-----------ALLHKILVENPSARITIPDIKK 259

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 9e-49
 Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 34/278 (12%)

Query: 151 NILGKGGFGTVYKGVWEKTT--IAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH 208
             +G+G F TVYKG+  +TT  +A  +L+  +       L + +R++   E + L   +H
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-------LTKSERQRFKEEAEMLKGLQH 67

Query: 209 DNILPLYGICFETGK----YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
            NI+  Y     T K      LV   M +G+L+  L   K    +         +    G
Sbjct: 68  PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKG 124

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPV-IGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           LQFLH+R PP+IH D+K  NI +      V IGD GL        A  +      GT  +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI-----GTPEF 179

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           +  E    K     VDVY FG+ + E+AT    Y + + + +  + +       +   + 
Sbjct: 180 MAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238

Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
               +            I +   +QN  ER  +  + N
Sbjct: 239 IPEVK-----------EIIEGCIRQNKDERYSIKDLLN 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-48
 Identities = 65/310 (20%), Positives = 114/310 (36%), Gaps = 51/310 (16%)

Query: 133 PHIPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT----TIAVKKLEVHRNDRAVETL 188
           P + + ++          +++G+G FG V K   +K       A+K+++        E  
Sbjct: 5   PVLDWNDIKF-------QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--------EYA 49

Query: 189 NQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMK---- 243
           ++        EL+ L     H NI+ L G C   G   L   Y P+G+L D L       
Sbjct: 50  SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 109

Query: 244 ---------KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPV 294
                        +L   Q LH A   + G+ +L       IH D+ + NIL+  +    
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAK 167

Query: 295 IGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM 354
           I DFGL++   +                ++  E L     +T  DV+ +G++L+E+ +  
Sbjct: 168 IADFGLSRGQEVYVKKT----MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223

Query: 355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
                        + L + Y                 LN     + + +Q  ++ P ERP
Sbjct: 224 GTPYCGMTCAELYEKLPQGYRL------------EKPLNCDDEVYDLMRQCWREKPYERP 271

Query: 415 EMTQVYNMLS 424
              Q+   L+
Sbjct: 272 SFAQILVSLN 281

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (417), Expect = 3e-48
 Identities = 64/315 (20%), Positives = 116/315 (36%), Gaps = 51/315 (16%)

Query: 137 YQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVETLN 189
              L    NN + +  +G+G FG V++            T +AVK L+   +        
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD------ 58

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRL--------- 240
              +    RE   +    + NI+ L G+C      CL++ YM  G L + L         
Sbjct: 59  --MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116

Query: 241 ------------LMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN 288
                       +     P L   ++L IA+  + G+ +L       +H D+ + N L+ 
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVG 174

Query: 289 HHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLF 348
            +M   I DFGL++                    ++P E +   R +T+ DV+ +G+VL+
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKAD-GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233

Query: 349 ELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQ 408
           E+ +                       EE +Y + D N      N     + + +    +
Sbjct: 234 EIFSYGLQPYYGMA------------HEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281

Query: 409 NPKERPEMTQVYNML 423
            P +RP    ++ +L
Sbjct: 282 LPADRPSFCSIHRIL 296

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-48
 Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 31/281 (11%)

Query: 151 NILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS 205
            ++G+G FG VY G       +K   AVK L            +  +  Q L E   +  
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--------RITDIGEVSQFLTEGIIMKD 84

Query: 206 CRHDNILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             H N+L L GIC  + G   +V  YM +G L +   ++  T +      +      + G
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE-GPIEKATHITLKRVNGTRPY 323
           ++FL       +H D+ + N +L+      + DFGL ++    E  +            +
Sbjct: 143 MKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           +  E L  ++ +TK DV+ FG++L+EL T          +      L++           
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------- 253

Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
                          + +  +      + RP  +++ + +S
Sbjct: 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 1e-47
 Identities = 67/321 (20%), Positives = 116/321 (36%), Gaps = 52/321 (16%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVET 187
            P   L+           LG G FG V +             T+AVK L+   +      
Sbjct: 20  FPRNRLSF-------GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------ 66

Query: 188 LNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNT 246
               +RE  + ELK L+    H NI+ L G C   G   ++  Y   G L + L  K+++
Sbjct: 67  --LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124

Query: 247 P---------------SLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM 291
                           +L     L  +   + G+ FL S+    IH D+ + NILL H  
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGR 182

Query: 292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
              I DFGL ++     + ++          ++  E +     + + DV+ +GI L+EL 
Sbjct: 183 ITKICDFGLARDIK-NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

Query: 352 TGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPK 411
           +   +       +     +++           +        +     + I K     +P 
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIK-----------EGFRMLSPEHAPAEMYDIMKTCWDADPL 290

Query: 412 ERPEMTQVYNMLSGSGGESPN 432
           +RP   Q+  ++     ES N
Sbjct: 291 KRPTFKQIVQLIEKQISESTN 311

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 4e-47
 Identities = 61/307 (19%), Positives = 113/307 (36%), Gaps = 50/307 (16%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKTT-------IAVKKLEVHRNDRAVETLNQCQREQSL 197
            N +   +LG G FG V        +       +AVK L+        E  +  +RE  +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--------EKADSSEREALM 88

Query: 198 RELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPS-------- 248
            ELK +     H+NI+ L G C  +G   L++ Y   G L + L  K+   S        
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 249 ------------LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG 296
                       L +   L  A   + G++FL  +    +H D+ + N+L+ H     I 
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHGKVVKIC 206

Query: 297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRA 356
           DFGL ++     + ++          ++  E L     + K DV+ +GI+L+E+ +    
Sbjct: 207 DFGLARDIM-SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

Query: 357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEM 416
                  + +   L++           +              + I +     + ++RP  
Sbjct: 266 PYPGIPVDANFYKLIQ-----------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314

Query: 417 TQVYNML 423
             + + L
Sbjct: 315 PNLTSFL 321

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-47
 Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 34/285 (11%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + W+ +  LG G FG VYK   ++T    A K ++    +         + E  + E+ 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---------ELEDYMVEID 61

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L SC H NI+ L    +      ++  +   G+++   +M +    L  +Q   + K T
Sbjct: 62  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA--VMLELERPLTESQIQVVCKQT 119

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              L +LH     +IH D+K+ NIL     D  + DFG++ +      T        GT 
Sbjct: 120 LDALNYLHDN--KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT---RTIQRRDSFIGTP 174

Query: 322 PYLPHEFLVG-----KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE 376
            ++  E ++      +    K DV+  GI L E+A     + +       LK    +   
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                    N +              K+  ++N   R   +Q+  
Sbjct: 235 LAQPSRWSSNFK-----------DFLKKCLEKNVDARWTTSQLLQ 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 9e-47
 Identities = 56/280 (20%), Positives = 97/280 (34%), Gaps = 35/280 (12%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN 204
           +  L  +G G FG VY     +    +A+KK+            +  + +  ++E+++L 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQ 70

Query: 205 SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             RH N +   G         LV  Y    + +   + KK    L   +   +  G   G
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQG 127

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           L +LHS    +IH D+K+ NILL+      +GDFG                   GT  ++
Sbjct: 128 LAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANSFVGTPYWM 178

Query: 325 PHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
             E ++     +   KVDV+  GI   ELA       +             +        
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----- 233

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                      + +  F        ++ P++RP    +  
Sbjct: 234 -------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 3e-46
 Identities = 53/278 (19%), Positives = 103/278 (37%), Gaps = 31/278 (11%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              + +   +G+G  GTVY  +   T   +A++++ + +           ++E  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEIL 69

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            +   ++ NI+          +  +V  Y+  GSL D +            Q   + +  
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCREC 125

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
              L+FLHS    +IH DIKS NILL       + DFG   +   E++   T   + GT 
Sbjct: 126 LQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTP 180

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
            ++  E +  K    KVD++  GI+  E+  G   Y +                E    +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
            +    +               +    + ++R    ++
Sbjct: 241 KLSAIFR-----------DFLNRCLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 55/295 (18%), Positives = 114/295 (38%), Gaps = 39/295 (13%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKTT-----IAVKKLEVHRNDRAVETLN 189
           I  + + L          +G+G FG V++G++         +A+K  +   +D       
Sbjct: 4   IQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS------ 50

Query: 190 QCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSL 249
              RE+ L+E   +    H +I+ L G+  E     ++      G L     ++    SL
Sbjct: 51  --VREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYSL 105

Query: 250 LWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKA 309
                +  A   S  L +L       +H DI + N+L++ +    +GDFGL++   +E +
Sbjct: 106 DLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDS 161

Query: 310 THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKS 369
           T+    +      ++  E +  +R ++  DV+ FG+ ++E+           ++   +  
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221

Query: 370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
           +                  P+  N     + +  +    +P  RP  T++   LS
Sbjct: 222 IENGERL------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-45
 Identities = 62/286 (21%), Positives = 118/286 (41%), Gaps = 36/286 (12%)

Query: 147 WDKLNILGKGGFGTVYKGVWEKT------TIAVKKLEVHRNDRAVETLNQCQREQSLREL 200
           + K+ +LG G FGTVYKG+W          +A+K+L    + +A + +        L E 
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--------LDEA 62

Query: 201 KYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKG 260
             + S  + ++  L GIC  T    L+ + MP G L D +   K+         L+    
Sbjct: 63  YVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQ 119

Query: 261 TSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGT 320
            + G+ +L  R   L+H D+ + N+L+       I DFGL +    E+  +   +     
Sbjct: 120 IAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVP 176

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM 379
             ++  E ++ +  + + DV+ +G+ ++EL T G + YD                    +
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEI 222

Query: 380 YDLVDKNAQ-PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
             +++K  + P         + I  +    +   RP+  ++    S
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 5e-43
 Identities = 56/305 (18%), Positives = 118/305 (38%), Gaps = 44/305 (14%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVW-------EKTTIAVKKLEVHRNDRAVET 187
           +  +++T+          LG+G FG VY+GV         +T +A+K +         E 
Sbjct: 17  VAREKITM-------SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EA 61

Query: 188 LNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK--- 244
            +  +R + L E   +      +++ L G+  +     ++   M  G L+  L   +   
Sbjct: 62  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM 121

Query: 245 ----NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL 300
                      ++ + +A   + G+ +L++     +H D+ + N ++       IGDFG+
Sbjct: 122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGM 179

Query: 301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT 360
           T++           K +     ++  E L     +T  DV+ FG+VL+E+AT        
Sbjct: 180 TRDIYETDYYRKGGKGL-LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ- 237

Query: 361 RRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVY 420
                         +E+ +  +++        N     F + +   + NPK RP   ++ 
Sbjct: 238 -----------GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286

Query: 421 NMLSG 425
           + +  
Sbjct: 287 SSIKE 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-42
 Identities = 55/278 (19%), Positives = 92/278 (33%), Gaps = 28/278 (10%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++    ILG+G F TV       T    A+K LE          + + +     RE   +
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVM 62

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
           +   H   + LY    +  K      Y  NG L   +       S   T           
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVS 119

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
            L++LH     +IH D+K  NILLN  M   I DFG  +    E           GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NSFVGTAQY 176

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
           +  E L  K      D++  G ++++L  G+  +                 +E  ++  +
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------------NEYLIFQKI 222

Query: 384 DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            K               + ++    +  +R    ++  
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 28/285 (9%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N++   ILG+G    V + + + T    AVK ++V           Q  RE +L+E+  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 204 NSCR-HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
                H NI+ L         + LV+  M  G L D L       +L   +   I +   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
             +  LH     ++H D+K  NILL+  M+  + DFG +     +      L+ V GT  
Sbjct: 121 EVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSC----QLDPGEKLREVCGTPS 174

Query: 323 YLPHEFLVGKRL------STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE 376
           YL  E +             +VD++  G++++ L  G   +   ++       +   Y  
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY-- 232

Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                   +   P   + +     +  +     P++R    +   
Sbjct: 233 --------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  147 bits (373), Expect = 3e-41
 Identities = 48/281 (17%), Positives = 103/281 (36%), Gaps = 31/281 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           +++D    LG G FG V++     T    A K +            ++  +E   +E++ 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---------HESDKETVRKEIQT 76

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           ++  RH  ++ L+    +  +  ++Y +M  G L +++  + N   +   + +   +   
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVC 134

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVI--GDFGLTQEGPIEKATHITLKRVNGT 320
            GL  +H      +H D+K  NI+        +   DFGLT           ++K   GT
Sbjct: 135 KGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLT----AHLDPKQSVKVTTGT 188

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
             +   E   GK +    D++  G++ + L +G+  +      E         ++ +   
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--- 245

Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                        I+       ++    +P  R  + Q   
Sbjct: 246 -------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-41
 Identities = 57/314 (18%), Positives = 110/314 (35%), Gaps = 55/314 (17%)

Query: 135 IPYQELTLATNNWDKLNILGKGGFGTVYKGVWEKT---------TIAVKKLEVHRNDRAV 185
           +P   L L          LG+G FG V                  +AVK L+    ++  
Sbjct: 10  LPRDRLVL-------GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-- 60

Query: 186 ETLNQCQREQSLRELKYLNSC-RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK 244
                      + E++ +    +H NI+ L G C + G   ++  Y   G+L + L  ++
Sbjct: 61  ------DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARR 114

Query: 245 NTPS-------------LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM 291
                            L     +  A   + G+++L S+    IH D+ + N+L+    
Sbjct: 115 PPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDN 172

Query: 292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELA 351
              I DFGL ++       +           ++  E L  +  + + DV+ FG++L+E+ 
Sbjct: 173 VMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 231

Query: 352 TGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQP-IELNIAYAFFRIGKQSTKQNP 410
           T   +                    E ++ L+ +  +     N     + + +      P
Sbjct: 232 TLGGSPYPGV-------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 278

Query: 411 KERPEMTQVYNMLS 424
            +RP   Q+   L 
Sbjct: 279 SQRPTFKQLVEDLD 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 48/276 (17%), Positives = 97/276 (35%), Gaps = 32/276 (11%)

Query: 150 LNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR 207
              LG+G FG V++ V   +  T   K ++V   D+              +E+  LN  R
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----------VLVKKEISILNIAR 59

Query: 208 HDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQF 267
           H NIL L+       +  +++ ++    + +R+    +   L   + +         LQF
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQF 117

Query: 268 LHSREPPLIHGDIKSANILLNHHMDPV--IGDFGLTQEGPIEKATHITLKRVNGTRPYLP 325
           LHS    + H DI+  NI+          I +FG  ++        +          Y  
Sbjct: 118 LHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEYYA 171

Query: 326 HEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK 385
            E      +ST  D++  G +++ L +G+  +      +     +  +Y+ +        
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------- 223

Query: 386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
             +     I+        +   +  K R   ++   
Sbjct: 224 --EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (365), Expect = 8e-41
 Identities = 52/277 (18%), Positives = 97/277 (35%), Gaps = 27/277 (9%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
           ++ ++   ILG GG   V+     +    +AVK L            +     +  RE +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR------DPSFYLRFRREAQ 59

Query: 202 YLNSCRHDNILPLYGICFETGK----YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
              +  H  I+ +Y              +V  Y+   +L D +        +   + + +
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEV 116

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
                  L F H     +IH D+K ANI+++      + DFG+ +       +      V
Sbjct: 117 IADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 318 NGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
            GT  YL  E   G  +  + DVY  G VL+E+ TG   +          + + E     
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
           +               ++     +  ++  +NP+ R 
Sbjct: 235 S----------ARHEGLSADLDAVVLKALAKNPENRY 261

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 4e-40
 Identities = 59/314 (18%), Positives = 114/314 (36%), Gaps = 46/314 (14%)

Query: 135 IPYQ--ELTLATNNWDKLNILGKGGFGTVYKGVWEKT-------TIAVKKLEVHRNDRAV 185
           +PY   +     +       LG+G FG V +             T+AVK L+        
Sbjct: 1   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-------- 52

Query: 186 ETLNQCQREQSLRELKYLNSCRHD-NILPLYGICFETG-KYCLVYRYMPNGSLEDRLLMK 243
           E     +    + ELK L    H  N++ L G C + G    ++  +   G+L   L  K
Sbjct: 53  EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 112

Query: 244 KNTPS-------------LLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH 290
           +N                L     +  +   + G++FL SR    IH D+ + NILL+  
Sbjct: 113 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK 170

Query: 291 MDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFEL 350
               I DFGL ++   +   ++          ++  E +  +  + + DV+ FG++L+E+
Sbjct: 171 NVVKICDFGLARDIY-KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229

Query: 351 ATGMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNP 410
            +   +     + +      +++ +     D                 ++         P
Sbjct: 230 FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP-----------EMYQTMLDCWHGEP 278

Query: 411 KERPEMTQVYNMLS 424
            +RP  +++   L 
Sbjct: 279 SQRPTFSELVEHLG 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (364), Expect = 6e-40
 Identities = 57/278 (20%), Positives = 99/278 (35%), Gaps = 29/278 (10%)

Query: 140 LTLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSL 197
           LT+  N++    I+G+GGFG VY      T    A+K L      R      +       
Sbjct: 1   LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNER 55

Query: 198 RELKYLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
             L  +++     I+ +        K   +   M  G L   L                 
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFY 112

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRV 317
           A    LGL+ +H+R   +++ D+K ANILL+ H    I D GL  +   +K         
Sbjct: 113 AAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----S 165

Query: 318 NGTRPYLPHEFLV-GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE 376
            GT  Y+  E L  G    +  D +  G +LF+L  G   +   +  ++H          
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------- 215

Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
             +  +    A  +  + +     + +   +++   R 
Sbjct: 216 -EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 252

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  143 bits (361), Expect = 1e-39
 Identities = 45/281 (16%), Positives = 100/281 (35%), Gaps = 31/281 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + +D L  LG G FG V++ V + T      K +                +     E+  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---------DKYTVKNEISI 79

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           +N   H  ++ L+    +  +  L+  ++  G L DR+        +   + ++  +   
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQAC 137

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDP--VIGDFGLTQEGPIEKATHITLKRVNGT 320
            GL+ +H     ++H DIK  NI+          I DFGL  +   ++   +T      T
Sbjct: 138 EGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT----TAT 191

Query: 321 RPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
             +   E +  + +    D++  G++ + L +G+  +      E         +  +   
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--- 248

Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                  +    +++       K   ++ P++R  +     
Sbjct: 249 -------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 61/299 (20%), Positives = 111/299 (37%), Gaps = 35/299 (11%)

Query: 143 ATNNWDKLNILGKGGFGTVYKGVWEKTT---IAVKKLEVHRNDRAVETLNQCQREQSLRE 199
           A   ++ +  +G+G +G V+K    K     +A+K++ V   +  +       RE  +  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIRE--VAV 60

Query: 200 LKYLNSCRHDNILPLYGICFET-----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           L++L +  H N++ L+ +C  +      K  LV+ ++         L K   P +     
Sbjct: 61  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETI 118

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
             +      GL FLHS    ++H D+K  NIL+       + DFGL +         + L
Sbjct: 119 KDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYS----FQMAL 172

Query: 315 KRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY 374
             V  T  Y   E L+    +T VD++  G +  E+      +  +   +  L  +++  
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVI 231

Query: 375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTK--------------QNPKERPEMTQV 419
                 D     A P +   + +   I K  T                NP +R      
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 56/283 (19%), Positives = 110/283 (38%), Gaps = 32/283 (11%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
            + +D  ++LG G F  V     ++T   +A+K +     +         +      E+ 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--------KEGSMENEIA 59

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L+  +H NI+ L  I    G   L+ + +  G L DR++ K             +    
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQV 116

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMD---PVIGDFGLTQEGPIEKATHITLKRVN 318
              +++LH  +  ++H D+K  N+L     +    +I DFGL++     +     L    
Sbjct: 117 LDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK----MEDPGSVLSTAC 170

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN 378
           GT  Y+  E L  K  S  VD +  G++ + L  G   + D   ++   + L  +Y    
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY---- 226

Query: 379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                 +   P   +I+ +     +   +++P++R    Q   
Sbjct: 227 ------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-38
 Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 31/277 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            ++    +LGKG FG V+   ++KT    A+K L+          L     E ++ E + 
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV------VLMDDDVECTMVEKRV 55

Query: 203 LN-SCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
           L+ +  H  +  ++           V  Y+  G L   +   ++      ++    A   
Sbjct: 56  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEI 112

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
            LGLQFLHS+   +++ D+K  NILL+      I DFG+ +E  +  A   T     GT 
Sbjct: 113 ILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---GTP 167

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
            Y+  E L+G++ +  VD + FG++L+E+  G   +                  EE ++ 
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------------DEEELFH 213

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQ 418
            +  +       +      +  +   + P++R  +  
Sbjct: 214 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (339), Expect = 8e-37
 Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 24/248 (9%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            ++  L  LG G FG V+           A+K L+     R        Q E +  E   
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------LKQVEHTNDERLM 57

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L+   H  I+ ++G   +  +  ++  Y+  G L   L   +  P          A    
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVC 114

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           L L++LH     +I+ D+K  NILL+ +    I DFG        K        + GT  
Sbjct: 115 LALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFA------KYVPDVTYTLCGTPD 166

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS-----EE 377
           Y+  E +  K  +  +D + FGI+++E+  G   + D+   + + K L  +        E
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

Query: 378 NMYDLVDK 385
           ++ DL+ +
Sbjct: 227 DVKDLLSR 234

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 9e-37
 Identities = 54/288 (18%), Positives = 94/288 (32%), Gaps = 30/288 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           N +     +G G FG +Y G        +A+K   V             +  Q   E K 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----------KHPQLHIESKI 55

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
               +    +P    C   G Y ++   +   SLED  L    +        L +A    
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMI 113

Query: 263 LGLQFLHSREPPLIHGDIKSANIL---LNHHMDPVIGDFG----LTQEGPIEKATHITLK 315
             ++++HS+    IH D+K  N L           I DFG           +   +   K
Sbjct: 114 SRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
            + GT  Y      +G   S + D+   G VL     G   +   + + +  K   E+ S
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--YERIS 229

Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNML 423
           E+ M   ++   +         F             ++P+ + +  + 
Sbjct: 230 EKKMSTPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 29/291 (9%)

Query: 149 KLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC 206
           KL+ LG+G F TVYK   + T   +A+KK+++     A + +       +LRE+K L   
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI----NRTALREIKLLQEL 57

Query: 207 RHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQ 266
            H NI+ L           LV+ +M        +++K N+  L  +        T  GL+
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLE 114

Query: 267 FLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPH 326
           +LH     ++H D+K  N+LL+ +    + DFGL +      + +        TR Y   
Sbjct: 115 YLHQH--WILHRDLKPNNLLLDENGVLKLADFGLAKS---FGSPNRAYTHQVVTRWYRAP 169

Query: 327 EFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSE---RHLKSLVEKYSEENMYDL 382
           E L G R+    VD++  G +L EL   +         +   R  ++L     E+     
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQ-----------NPKERPEMTQVYNM 422
              +    +         I   +              NP  R   TQ   M
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 5e-36
 Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 42/307 (13%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + ++KL  +G+G FG V+K    KT   +A+KK+ +                 +LRE+K 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-------FPITALREIKI 62

Query: 203 LNSCRHDNILPLYGICFET--------GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQR 254
           L   +H+N++ L  IC           G   LV+ +  +       L+         ++ 
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEI 119

Query: 255 LHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITL 314
             + +    GL ++H     ++H D+K+AN+L+       + DFGL +   + K +    
Sbjct: 120 KRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177

Query: 315 KR-VNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE 372
                 T  Y P E L+G+R     +D++G G ++ E+ T            +       
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 373 KYS-EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQ-----------------NPKERP 414
             S    ++  VD      +L +     R  K   K                  +P +R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 415 EMTQVYN 421
           +     N
Sbjct: 298 DSDDALN 304

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 9e-36
 Identities = 57/283 (20%), Positives = 100/283 (35%), Gaps = 28/283 (9%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + +D    LG G F  V K   + T    A K +   +  R   +     RE   RE+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFI---KKRRTKSSRRGVSREDIEREVSI 66

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L   +H N++ L+ +        L+   +  G L D         SL   +     K   
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFD---FLAEKESLTEEEATEFLKQIL 123

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDP----VIGDFGLTQEGPIEKATHITLKRVN 318
            G+ +LHS    + H D+K  NI+L     P     I DFGL  +             + 
Sbjct: 124 NGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIF 177

Query: 319 GTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN 378
           GT  ++  E +  + L  + D++  G++ + L +G   +    + E         Y  E+
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237

Query: 379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
                         N +       ++   ++PK+R  +     
Sbjct: 238 ----------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 53/281 (18%), Positives = 99/281 (35%), Gaps = 34/281 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + +    +LG GGFG+VY G+       +A+K +E  R     E  N  +    +  LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           ++S     ++ L         + L+             + ++   +L             
Sbjct: 64  VSSG-FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVL 120

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             ++  H+    ++H DIK  NIL++ +  +  + DFG          T        GTR
Sbjct: 121 EAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-----GTR 173

Query: 322 PYLPHEFLVGKRLSTK-VDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY 380
            Y P E++   R   +   V+  GI+L+++  G   ++      R      ++ S E   
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE-CQ 232

Query: 381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
            L+                          P +RP   ++ N
Sbjct: 233 HLIRWCLAL-------------------RPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-35
 Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 30/272 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           N++D L +LGKG FG V     + T    A+K L      R    + + +   ++ E + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL------RKEVIIAKDEVAHTVTESRV 58

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L + RH  +  L        + C V  Y   G L   L            +         
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIV 115

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
             L++LH     +++ DIK  N++L+      I DFGL +EG  + AT   +K   GT  
Sbjct: 116 SALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPE 170

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
           YL  E L        VD +G G+V++E+  G   + +                 E +++L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------------DHERLFEL 216

Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
           +          ++     +     K++PK+R 
Sbjct: 217 ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  128 bits (323), Expect = 9e-35
 Identities = 47/291 (16%), Positives = 93/291 (31%), Gaps = 32/291 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
            ++     +G+G FG +++G        +A+K      +        Q + E   R  K 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP------QLRDE--YRTYKL 56

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L  C     +  Y    E     LV   +     +   L+               AK   
Sbjct: 57  LAGCTGIPNV--YYFGQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQML 111

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG-----DFGLTQ----EGPIEKATHIT 313
             +Q +H +   L++ DIK  N L+              DFG+ +        +   +  
Sbjct: 112 ARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169

Query: 314 LKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEK 373
            K ++GT  Y+     +G+  S + D+   G V      G   +   + +    K   E+
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YER 227

Query: 374 YSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS 424
             E+     + +    +       F++    +        P+   +  + S
Sbjct: 228 IGEKKQSTPLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-34
 Identities = 48/280 (17%), Positives = 102/280 (36%), Gaps = 37/280 (13%)

Query: 152 ILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK-YLNSCRH 208
           +LG G  G V +   ++T    A+K L+                 ++ RE++ +  + + 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ--------------DCPKARREVELHWRASQC 64

Query: 209 DNILPLYGIC----FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
            +I+ +  +            +V   +  G L  R+  + +       +   I K     
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 123

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDP---VIGDFGLTQEGPIEKATHITLKRVNGTR 321
           +Q+LHS    + H D+K  N+L           + DFG  +E      +H +L     T 
Sbjct: 124 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----SHNSLTTPCYTP 177

Query: 322 PYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD 381
            Y+  E L  ++     D++  G++++ L  G   +         +   ++       Y+
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS--NHGLAISPGMKTRIRMGQYE 235

Query: 382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN 421
             +    P    ++     + +   K  P +R  +T+  N
Sbjct: 236 FPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 60/296 (20%), Positives = 115/296 (38%), Gaps = 30/296 (10%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L+ +G+G +G V           +A+KK+    +            +++LRE+K
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--------YCQRTLREIK 58

Query: 202 YLNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGT 261
            L   RH+NI+ +  I        +   Y+    +   L     T  L      +     
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQI 118

Query: 262 SLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTR 321
             GL+++HS    ++H D+K +N+LLN   D  I DFGL +    +      L     TR
Sbjct: 119 LRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 322 PYLPHEFLVGKRLST-KVDVYGFGIVLFELATGMRAYDDTRRSE--RHLKSLVEKYSEEN 378
            Y   E ++  +  T  +D++  G +L E+ +    +      +   H+  ++   S+E+
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 379 MYDLVDKNAQPIEL---------------NIAYAFFRIGKQSTKQNPKERPEMTQV 419
           +  +++  A+   L               N       +  +    NP +R E+ Q 
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 48/272 (17%), Positives = 98/272 (36%), Gaps = 33/272 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           + +D++  LG G FG V     +++    A+K L+  +       +   Q E +L E + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRI 94

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L +     ++ L     +     +V  Y+  G +   L                 A    
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIV 151

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
           L  ++LHS    LI+ D+K  N+L++      + DFG  +       T      + GT  
Sbjct: 152 LTFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPE 203

Query: 323 YLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL 382
            L  E ++ K  +  VD +  G++++E+A G   +                     +Y+ 
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------------QPIQIYEK 249

Query: 383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
           +         + +     + +   + +  +R 
Sbjct: 250 IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  126 bits (318), Expect = 4e-34
 Identities = 54/292 (18%), Positives = 105/292 (35%), Gaps = 32/292 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
             +  L  +G+G +G VYK       T A+KK+ + + D  +          ++RE+  L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-------PSTTIREISIL 54

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
              +H NI+ LY +     +  LV+ ++     +   + +     L              
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLN 111

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           G+ + H R   ++H D+K  N+L+N   +  I DFGL +   I    +     +      
Sbjct: 112 GIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYR 167

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDLV 383
            P   +  K+ ST +D++  G +  E+  G   +     ++  L  +       N  +  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWP 226

Query: 384 DKNAQPIELNIAYAFFRIGKQST----------------KQNPKERPEMTQV 419
           +    P        +  +  +S                 K +P +R    Q 
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 5e-33
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 15/216 (6%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           N+ K+  +G+G +G VYK   + T   +A+KK+ +                 ++RE+  L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-------VPSTAIREISLL 55

Query: 204 NSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSL 263
               H NI+ L  +     K  LV+ ++       + +       +              
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQ 113

Query: 264 GLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPY 323
           GL F HS    ++H D+K  N+L+N      + DFGL +   +   T+     V      
Sbjct: 114 GLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYR 169

Query: 324 LPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
            P   L  K  ST VD++  G +  E+ T    +  
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 4e-32
 Identities = 49/298 (16%), Positives = 94/298 (31%), Gaps = 42/298 (14%)

Query: 146 NWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL 203
           ++    ++G G FG VY+     +   +A+KK+     D+              REL+ +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDK----------RFKNRELQIM 67

Query: 204 NSCRHDNILPLYGICFETGK------YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHI 257
               H NI+ L    + +G+        LV  Y+P           +   +L        
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 258 AKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGDFGLTQEGPIEKATHITLKR 316
                  L ++HS    + H DIK  N+LL+       + DFG  ++          +  
Sbjct: 128 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSY 182

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDT--------------RR 362
           +       P         ++ +DV+  G VL EL  G   +                   
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 363 SERHLKSLVEKYSEENMYDLVDKN-AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
           +   ++ +   Y+E     +      +            +  +  +  P  R    + 
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (300), Expect = 2e-31
 Identities = 64/294 (21%), Positives = 113/294 (38%), Gaps = 34/294 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             ++KL  +G+G +GTV+K    +T   +A+K++ +  +D  V          +LRE+  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-------PSSALREICL 54

Query: 203 LNSCRHDNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTS 262
           L   +H NI+ L+ +     K  LV+ +      +       +                 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLL 111

Query: 263 LGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRP 322
            GL F HSR   ++H D+K  N+L+N + +  + +FGL +   I    +        T  
Sbjct: 112 KGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLW 166

Query: 323 YLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE------KYS 375
           Y P + L G +  ST +D++  G +  ELA   R        +  LK +        +  
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQST----------KQNPKERPEMTQV 419
             +M  L D    P+          + K +           K NP +R    + 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 9e-29
 Identities = 56/300 (18%), Positives = 113/300 (37%), Gaps = 44/300 (14%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             +  L  +G G +G V   V  +T   +A+KKL                 +++ REL+ 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-------FAKRAYRELRL 70

Query: 203 LNSCRHDNILPLYGICFETGK------YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
           L   RH+N++ L  +            + LV  +M  G+   +L+  +    L   +   
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQF 125

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           +      GL+++H+      H D+K  N+ +N   +  I DFGL ++   E   ++    
Sbjct: 126 LVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV--- 180

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSE------------ 364
                   P   L   R +  VD++  G ++ E+ TG   +  +   +            
Sbjct: 181 --TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 365 -----RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQV 419
                + L+S   K   + + +L  K+   I  N +     + ++    + ++R    + 
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  110 bits (275), Expect = 1e-27
 Identities = 46/278 (16%), Positives = 107/278 (38%), Gaps = 31/278 (11%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
           +++  +  LG+G +  V++ +       + VK             L   ++++  RE+K 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------------LKPVKKKKIKREIKI 82

Query: 203 LNSCR-HDNILPLYGICFETGKY--CLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAK 259
           L + R   NI+ L  I  +       LV+ ++ N   +          +L          
Sbjct: 83  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMY 136

Query: 260 GTSLGLQFLHSREPPLIHGDIKSANILLNH-HMDPVIGDFGLTQEGPIEKATHITLKRVN 318
                L + HS    ++H D+K  N++++H H    + D+GL +     +  ++ +    
Sbjct: 137 EILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---- 190

Query: 319 GTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE 377
            +R +   E LV  ++    +D++  G +L  +      +     +   L  + +    E
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250

Query: 378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE 415
           ++YD +DK    ++        R  ++  ++      +
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 9e-27
 Identities = 59/278 (21%), Positives = 105/278 (37%), Gaps = 30/278 (10%)

Query: 145 NNWDKLNILGKGGFGTVYKGV-----WEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRE 199
            N++ L +LG G +G V+              A+K L      +A         E +  E
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL-----KKATIVQKAKTTEHTRTE 78

Query: 200 LKYLNSCRH-DNILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIA 258
            + L   R    ++ L+       K  L+  Y+  G L   L            +     
Sbjct: 79  RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYV 135

Query: 259 KGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVN 318
               L L+ LH     +I+ DIK  NILL+ +   V+ DFGL++E   ++          
Sbjct: 136 GEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER--AYDFC 191

Query: 319 GTRPYLPHEFLVGKR--LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE 376
           GT  Y+  + + G        VD +  G++++EL TG   +              EK S+
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG----------EKNSQ 241

Query: 377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP 414
             +   + K+  P    ++     + ++   ++PK+R 
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 2e-25
 Identities = 59/300 (19%), Positives = 111/300 (37%), Gaps = 42/300 (14%)

Query: 144 TNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELK 201
              +  L+ +G G +G+V      KT   +AVKKL                 +++ REL+
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-------HAKRTYRELR 69

Query: 202 YLNSCRHDNILPLYGIC-----FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
            L   +H+N++ L  +       E      +  ++    L + +  +K    L       
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQF 125

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           +      GL+++HS    +IH D+K +N+ +N   +  I DFGL +    E   ++    
Sbjct: 126 LIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---- 179

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLK-------- 368
                   P   L     +  VD++  G ++ EL TG   +  T   ++           
Sbjct: 180 -ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 369 --SLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQST-------KQNPKERPEMTQV 419
              L++K S E+  + +    Q  ++N A  F      +          +  +R    Q 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 47/223 (21%), Positives = 78/223 (34%), Gaps = 27/223 (12%)

Query: 145 NNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKY 202
             +  L  +G G  G V           +A+KKL            NQ   +++ REL  
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELVL 69

Query: 203 LNSCRHDNILPLYGICF------ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLH 256
           +    H NI+ L  +        E     LV   M     +   +           +  +
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSY 123

Query: 257 IAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKR 316
           +      G++ LHS     IH D+K +NI++       I DFGL +       T   +  
Sbjct: 124 LLYQMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTP 177

Query: 317 VNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDD 359
              TR Y   E ++G      VD++  G ++ E+      +  
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 94.7 bits (234), Expect = 5e-22
 Identities = 53/298 (17%), Positives = 92/298 (30%), Gaps = 7/298 (2%)

Query: 141 TLATNNWDKLNILGKGGFGTVYKGVWEKT--TIAVKKLEVHR-NDRAVETLNQCQREQSL 197
                 +  +  LG G F TV+          +A+K +   +    A E   +  +  + 
Sbjct: 9   PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVND 68

Query: 198 RELKYLNSCRHDNILPLYGICFETGKYCLVYRYM--PNGSLEDRLLMKKNTPSLLWTQRL 255
            +    +S   ++IL L       G   +    +    G     L+ K     +      
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 256 HIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLK 315
            I+K   LGL ++H R   +IH DIK  N+L+     P         +            
Sbjct: 129 QISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 316 RVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS 375
               TR Y   E L+G       D++    ++FEL TG   ++                 
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESPNA 433
            E + +L     +  +    + F   G        K  P    +      S  E+   
Sbjct: 248 IELLGELPSYLLRNGKYTRTF-FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

>d1ik7a_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]} Length = 52

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

 Score = 75.2 bits (185), Expect = 5e-18
 Identities = 20/52 (38%), Positives = 27/52 (51%), Gaps = 1/52 (1%)

Query: 17 RRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCI 67
          R  S + E L+ WG Q NHTV  LF     ++ + AM ++K YV    H  I
Sbjct: 1  RGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHKYI 52

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 2e-16
 Identities = 28/197 (14%), Positives = 56/197 (28%), Gaps = 25/197 (12%)

Query: 151 NILGKGGFGTVYKGVWEK-TTIAVKKLEVHR-NDRAVETLNQCQREQSLRELKYLNSCRH 208
            ++G+G    V+    EK     VK  +V   + + V+                      
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 209 DNILPLYGIC----FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLG 264
             +  L G+     +      ++   +            K    +       +       
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELI----------DAKELYRVRVENPDEVLDMILEE 115

Query: 265 LQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYL 324
           +   + R   ++HGD+   N+L+       I DF  + E   E    I  + V     Y 
Sbjct: 116 VAKFYHR--GIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 325 PHEFLVGKRLSTKVDVY 341
                  +   T+ D+ 
Sbjct: 173 ------SRTYRTEKDIN 183

>d1wh4a_ a.77.1.2 (A:) Interleukin-1 receptor-associated kinase 4, IRAK4 {Mouse (Mus musculus) [TaxId: 10090]} Length = 127

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Interleukin-1 receptor-associated kinase 4, IRAK4
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 63.8 bits (155), Expect = 4e-13
 Identities = 17/68 (25%), Positives = 28/68 (41%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVE 60
             +    + + E  +   +SPT ELL  WG  N TV +L   L  +  +    +L P   
Sbjct: 53  DRYNQFHIRRFEALLQTGKSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLPDAV 112

Query: 61  SKYHTCIP 68
            +    +P
Sbjct: 113 PQTVKSLP 120

>d1d2za_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]} Length = 102

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

 Score = 58.8 bits (142), Expect = 1e-11
 Identities = 22/68 (32%), Positives = 32/68 (47%), Gaps = 1/68 (1%)

Query: 1   MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYV 59
           +     Q+ Q+     R  S + E L+ WG Q NHTV  LF     ++ + AM ++K YV
Sbjct: 35  VKLYPDQVEQISSQKQRGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYV 94

Query: 60  ESKYHTCI 67
               H  I
Sbjct: 95  SEDLHKYI 102

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	441
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1ik7a_	52	Pelle death domain {Drosophila melanogaster [TaxId	99.74
d1wh4a_	127	Interleukin-1 receptor-associated kinase 4, IRAK4	99.7
d1d2za_	102	Pelle death domain {Drosophila melanogaster [TaxId	99.46
d1d2zb_	150	Tube death domain {Drosophila melanogaster [TaxId:	99.41
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d1ngra_	85	p75 low affinity neurotrophin receptor {Rat (Rattu	98.05
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.84
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.52
d1wmga_	90	Netrin receptor UNC5B {Mouse (Mus musculus) [TaxId	97.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.66
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.47
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.83
d1icha_	87	Tumor necrosis factor receptor-1 death domain {Hum	89.91
d2gf5a1	103	FADD (Mort1) {Human (Homo sapiens) [TaxId: 9606]}	89.84
d1fada_	95	FADD (Mort1) {Mouse (Mus musculus) [TaxId: 10090]}	82.31

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=429.77  Aligned_cols=269  Identities=28%  Similarity=0.433  Sum_probs=211.6

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ++..++|++.++||+|+||+||+|++++ .||||+++......       ...+.+.+|+++|++++|||||++++++.+
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~   75 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP-------QQLQAFKNEVGVLRKTRHVNILLFMGYSTA   75 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT-------THHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH-------HHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence            3456789999999999999999998765 59999997544322       234567799999999999999999998754


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       +.+++|||||++|+|.+++....  ..+++..+..|+.||+.||+|||+++  ||||||||+||||+.++.+||+|||+
T Consensus        76 -~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          76 -PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             -SSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             -cEEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccc
Confidence             56899999999999999986433  45899999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCC---CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGK---RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+...... .........||+.|||||++.+.   .|+.++|||||||++|||+||..||.+...............   
T Consensus       151 a~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---  226 (276)
T d1uwha_         151 ATVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY---  226 (276)
T ss_dssp             SCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS---
T ss_pred             eeeccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC---
Confidence            97643322 22234556799999999999753   588999999999999999999999987654222222221111   


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                           ..+.....+.+++.++.+|+.+||+.||++|||+.+|++.|+.+....|
T Consensus       227 -----~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         227 -----LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             -----CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -----CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence                 1111223344567889999999999999999999999999998776543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=418.53  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=207.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  ++.||+|++.......      ....+.+.+|+++++.++|||||++++++.+.
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~   78 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   78 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC------hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence            367999999999999999999985  5679999987432111      12345667899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+|||||++|+|.+++....   .+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a  153 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWS  153 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred             CEEEEEEeecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeeccccee
Confidence            99999999999999999986543   4899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +......     .....||+.|||||++.+..++.++|||||||++|||+||..||...... ..+..+.          
T Consensus       154 ~~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~----------  217 (263)
T d2j4za1         154 VHAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRIS----------  217 (263)
T ss_dssp             SCCCCCC-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHH----------
T ss_pred             eecCCCc-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHH----------
Confidence            7643322     23457999999999999999999999999999999999999999765432 2222111          


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         ......+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       218 ---~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         218 ---RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               1112234456788999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-56  Score=425.20  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=216.9

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ++++..++|++.++||+|+||+||+|.+.  ++.||||+++....          ..+++.+|+++|++++|||||++++
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----------~~~~~~~E~~il~~l~HpnIv~~~~   80 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQLLG   80 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----------hHHHHHHHHHHHHhCCCCCEecCCc
Confidence            34566778999999999999999999985  56899999864321          2345779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      +|.+++.+++|||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++  ||||||||+||||++++.+||+
T Consensus        81 ~~~~~~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~  157 (287)
T d1opja_          81 VCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVA  157 (287)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred             cEeeCCeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEc
Confidence            9999999999999999999999886543 456999999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+|+.......  .......||+.|||||++.+..++.++|||||||++|||++|..||.......... ..+..   
T Consensus       158 DFG~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-~~i~~---  231 (287)
T d1opja_         158 DFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEK---  231 (287)
T ss_dssp             CCCCTTTCCSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHT---
T ss_pred             cccceeecCCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-HHHhc---
Confidence            9999986543322  22334458999999999999999999999999999999999766654433322222 21111   


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                              ....+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+..++
T Consensus       232 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         232 --------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             --------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence                    1122334456788999999999999999999999999999886654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-56  Score=418.70  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=205.3

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++++.||+|+||+||+|.+.  +..||||++......        ...+.+.+|+++|++++|||||++++++.+.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--------hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            468999999999999999999985  568999999754321        1223567999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+|||||+||+|.+++..   ...+++..+..++.|++.||+|||++|  ||||||||+|||+++++.+||+|||+|
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceeEEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhh
Confidence            999999999999999998843   345999999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +....... .......+||+.|||||++.+..+ +.++|||||||++|||+||.+||.................      
T Consensus       151 ~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~------  223 (271)
T d1nvra_         151 TVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------  223 (271)
T ss_dssp             EECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC------
T ss_pred             eeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Confidence            86432221 122345679999999999988776 6789999999999999999999977654333332222110      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           ........++.++.+|+.+||+.||++|||++|+++
T Consensus       224 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 -----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 011112345678899999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-55  Score=415.56  Aligned_cols=248  Identities=21%  Similarity=0.336  Sum_probs=207.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++.++||+|+||+||+|.+.  ++.||||+++.....         ..+.+.+|+++++.++|||||++++++.+.+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---------HHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            47999999999999999999974  678999998754321         2345679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+|||||+||+|.+++...    .+++..+..++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhhe
Confidence            999999999999999977532    4899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ......   ......+||+.|||||++.+..++.++|||||||++|||+||..||.+..... .+.......        
T Consensus       165 ~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~--------  232 (293)
T d1yhwa1         165 QITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNG--------  232 (293)
T ss_dssp             ECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHC--------
T ss_pred             eecccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCC--------
Confidence            643322   22345579999999999999999999999999999999999999997765422 222221111        


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ......+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       233 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 --TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             --SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              1112234556788999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.7e-56  Score=422.85  Aligned_cols=259  Identities=21%  Similarity=0.351  Sum_probs=200.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEECCe-----eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEKT-----TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .++|++.++||+|+||+||+|.+..+     .||||.+......        ...+.+.+|+++|++++|||||+++|++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g~~   96 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--------KQRRDFLSEASIMGQFDHPNVIHLEGVV   96 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--------HHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            35688889999999999999998432     4788877543222        2345678999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .+.+.+++|||||++|+|.+++...  .+.+++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+||
T Consensus        97 ~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_          97 TKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCc
Confidence            9999999999999999999987543  346999999999999999999999998  999999999999999999999999


Q ss_pred             CCCccCCCccccc--ceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         299 GLTQEGPIEKATH--ITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       299 Gla~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |+++.........  .......||+.|||||.+.+..++.++|||||||++|||+| |.+||.+.... ..+..+.    
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~~~i~----  247 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIE----  247 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHH----
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-HHHHHHH----
Confidence            9998644322211  11223457899999999999999999999999999999998 89999876542 2222111    


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                              .....+.+.+++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       248 --------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         248 --------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             --------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                    11122344567788999999999999999999999999998753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-56  Score=415.41  Aligned_cols=255  Identities=21%  Similarity=0.375  Sum_probs=200.6

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .++|++.+.||+|+||+||+|.+. +..||||+++....          ..+.+.+|++++++++|||||+++|+|.+.+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   73 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----------cHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence            467999999999999999999985 46799999874322          1235679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++|||||++|+|.+++...  ...+++..+..++.|++.||+|||+++  |+||||||+|||+++++.+||+|||+++
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             ceEEEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchhe
Confidence            999999999999999988543  345889999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC-CCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG-MRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      .......  .......||..|||||++.+..++.++|||||||++|||+|| .+||..... ...+..+...        
T Consensus       150 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~--------  218 (263)
T d1sm2a_         150 FVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG--------  218 (263)
T ss_dssp             -----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHT--------
T ss_pred             eccCCCc--eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhc--------
Confidence            6433222  122335689999999999999999999999999999999995 555554432 3333322221        


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                          .....+..++.++.+|+.+||+.||++|||+++|++.|+++.
T Consensus       219 ----~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         219 ----FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                111223445678999999999999999999999999998763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=417.32  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE--  220 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  220 (441)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++.......       ...+.+.+|++++++++|||||++++++.+  
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   76 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-------AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   76 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-------HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-------HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence            67999999999999999999985  5689999997543322       234567799999999999999999999865  


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC---CCeeecCCCCCCeeecCCCCeEEe
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKK-NTPSLLWTQRLHIAKGTSLGLQFLHSRE---PPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~---~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      .+.+|+|||||+||+|.+++.... ....+++..++.++.|++.||+|||+.+   .+||||||||+|||++.++.+||+
T Consensus        77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            466899999999999999886432 3456999999999999999999999854   349999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+|+......   .......||+.|||||++.+..++.++|||||||++|||+||.+||...... .....+.     
T Consensus       157 DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i~-----  227 (269)
T d2java1         157 DFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKIR-----  227 (269)
T ss_dssp             CHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH-----
T ss_pred             eccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHHH-----
Confidence            999998643221   1234567999999999999999999999999999999999999999875442 1111111     


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             .......+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       228 -------~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 -------EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   11122344556788999999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=417.60  Aligned_cols=258  Identities=19%  Similarity=0.350  Sum_probs=210.2

Q ss_pred             hhCCCcCcC-ccccCCceeEEEEEEC----CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLN-ILGKGGFGTVYKGVWE----KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~-~LG~G~fg~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..++|.+.+ +||+|+||+||+|.+.    +..||||+++....        ....+.+.+|+++|++++|||||+++|+
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~   77 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVRLIGV   77 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--------HHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence            345677777 4999999999999874    33699999874332        1234567899999999999999999998


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+ +.+|+|||||++|+|.+++...  ...+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus        78 ~~~-~~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~D  152 (285)
T d1u59a_          78 CQA-EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISD  152 (285)
T ss_dssp             EES-SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECC
T ss_pred             ecc-CeEEEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeecc
Confidence            864 5689999999999999987533  346899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++................||+.|||||++.+..++.++|||||||++|||+| |..||.+.... ..... +.    
T Consensus       153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~-i~----  226 (285)
T d1u59a_         153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAF-IE----  226 (285)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHH-HH----
T ss_pred             chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHH-HH----
Confidence            9999875444333333445568999999999998899999999999999999998 99999876542 22211 11    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                             .....+.+..++.++.+|+.+||+.||++|||+.+|.+.|+..
T Consensus       227 -------~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         227 -------QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------cCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                   1122234556778999999999999999999999999988753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-56  Score=419.18  Aligned_cols=269  Identities=21%  Similarity=0.255  Sum_probs=213.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++++.||+|+||+||+|.+.  +..||||++......      .....+.+.+|++++++++||||+++++++.+.+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII------KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc------CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            67999999999999999999985  568999998742211      1123456779999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+|||||+||+|.+++....   .+++..+..++.|++.||+|||+++  ||||||||+|||+++++.+||+|||+|+
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEEccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccce
Confidence            9999999999999999886543   4899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ....... .......+||+.|||||++.+..++.++|||||||++|||+||..||....... ....+.           
T Consensus       157 ~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~-----------  223 (288)
T d1uu3a_         157 VLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII-----------  223 (288)
T ss_dssp             ECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-----------
T ss_pred             ecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHH-----------
Confidence            6433221 222345679999999999999999999999999999999999999998764322 111111           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------HHhcCC-CCCCCCCCCCCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--------MLSGSG-GESPNATGPTLP  439 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--------~L~~~~-~~~~~~~~p~~~  439 (441)
                        ......+..++.++.+|+.+||+.||++|||++|+++        .++++. .......+|++|
T Consensus       224 --~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~  287 (288)
T d1uu3a_         224 --KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT  287 (288)
T ss_dssp             --TTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred             --cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence              1112234456778999999999999999999998632        244432 333445677776

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=416.28  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=203.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      ..+.|++.++||+|+||+||+|.++.      ..||||+++.....        .....+.+|++++++++|||||+++|
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~~E~~il~~l~H~nIv~~~g   76 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--------KQRVDFLGEAGIMGQFSHHNIIRLEG   76 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--------HHHHHHHHHHHHHHhcCCCCEeeeeE
Confidence            34678889999999999999999753      25999998643322        23445779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++.+.+..++|||||.+|+|.+.+...  ...+++..+..++.|++.||+|||+++  ||||||||+||||+.++.+||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          77 VISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEc
Confidence            999999999999999999999877543  356999999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++................||+.|||||++.+..++.++|||||||++|||+||..|+.........+..+.     
T Consensus       153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-----  227 (283)
T d1mqba_         153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-----  227 (283)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-----
T ss_pred             ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-----
Confidence            999998654333222233445689999999999999999999999999999999996555543332222222211     


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                             +....+.+.+++..+.+|+.+||+.||++||++.+|++.|+.+.
T Consensus       228 -------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         228 -------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             -------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence                   11223344556778999999999999999999999999997654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=415.69  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      ++..++|++.++||+|+||+||+|.++ ++.||||+++....          ..+.+.+|++++++++|||||+++|++.
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----------SPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----------CHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            455678999999999999999999996 46799999864322          1235779999999999999999999875


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccC
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFG  299 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFG  299 (441)
                      + +.+++|||||++|+|.+++.... ...+++..++.|+.||+.||+|||+++  |+||||||+||||++++.+||+|||
T Consensus        79 ~-~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          79 Q-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeecccc
Confidence            4 56789999999999999775433 235899999999999999999999998  9999999999999999999999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +|+.......  .......||+.|||||++.+..++.++|||||||++|||+||..|+.........+..+..       
T Consensus       155 la~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-------  225 (272)
T d1qpca_         155 LARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------  225 (272)
T ss_dssp             TCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------
T ss_pred             ceEEccCCcc--ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------
Confidence            9986543221  2233456899999999999889999999999999999999965554433322222222211       


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                           ......+..++.++.+|+.+||+.||++|||+++|++.|+..
T Consensus       226 -----~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         226 -----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                 112233445677899999999999999999999999988764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-55  Score=411.54  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=200.5

Q ss_pred             CccccCCceeEEEEEECC----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         151 NILGKGGFGTVYKGVWEK----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       151 ~~LG~G~fg~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      ++||+|+||+||+|.+..    +.||||+++....+       ....+.+.+|+++|++++|||||+++|+|. .+..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-------HHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEE
Confidence            479999999999998732    46999998643222       123456789999999999999999999985 456789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      |||||++|+|.+++...   ..+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+++....
T Consensus        85 vmE~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccc
Confidence            99999999999988643   34899999999999999999999999  99999999999999999999999999986544


Q ss_pred             cccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhhhhcc
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDK  385 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  385 (441)
                      ............||+.|||||.+.+..++.++|||||||++|||+| |..||.+.... . +...+.           ..
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~-~~~~i~-----------~~  226 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-E-VTAMLE-----------KG  226 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-H-HHHHHH-----------TT
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-H-HHHHHH-----------cC
Confidence            3333333345579999999999999899999999999999999998 89999876542 1 111111           11


Q ss_pred             CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Q psy5927         386 NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSG  425 (441)
Q Consensus       386 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  425 (441)
                      ...+.+..++.++.+|+.+||+.||++|||+.+|.+.|+.
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            1233445677889999999999999999999999988865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=406.51  Aligned_cols=247  Identities=26%  Similarity=0.371  Sum_probs=199.3

Q ss_pred             cCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe----C
Q psy5927         148 DKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE----T  221 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~  221 (441)
                      +..++||+|+||+||+|.+.  +..||+|++......       ....+.+.+|+++|++++|||||++++++.+    .
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            56678999999999999986  457999998754322       2234567799999999999999999999865    3


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec-CCCCeEEeccCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN-HHMDPVIGDFGL  300 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~-~~~~~kl~DFGl  300 (441)
                      ..+|+|||||++|+|.+++...   ..+++..+..++.||+.||+|||+++.+||||||||+|||++ .++.+||+|||+
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             CEEEEEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            5689999999999999998654   348899999999999999999999887799999999999996 579999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      |+.....     .....+||+.|||||++.+ .++.++|||||||++|||+||..||.+..........+....      
T Consensus       162 a~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~------  229 (270)
T d1t4ha_         162 ATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------  229 (270)
T ss_dssp             GGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC------
T ss_pred             ceeccCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC------
Confidence            9753322     2234579999999999976 699999999999999999999999976554232222221111      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .....+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                 111223345567899999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=410.63  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=205.5

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      +.|++++.||+|+||+||+|.+.  +..||||++......         ..+.+.+|+++|++++|||||++++++.+.+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---------ELEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---------GGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---------HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            46899999999999999999985  567999998754322         1234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+|||||+||+|.+++....  .++++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999999876433  45899999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCccccc-----CCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLV-----GKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ....   .........||+.|||||++.     +..|+.++|||||||++|||+||..||.+..... .+..+....   
T Consensus       159 ~~~~---~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~---  231 (288)
T d2jfla1         159 KNTR---TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSE---  231 (288)
T ss_dssp             ECHH---HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSC---
T ss_pred             ccCC---CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCC---
Confidence            5321   112234567999999999984     4568999999999999999999999998765432 222222110   


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                             ......+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       232 -------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 -------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   1122234567788999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=422.45  Aligned_cols=266  Identities=23%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEE
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICF  219 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  219 (441)
                      +..++|+++++||+|+||+||+|.+.  +..||+|+++.....        ...+++.+|+++|+.++|||||+++++|.
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   74 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAFY   74 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--------THHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            45689999999999999999999985  578999998754322        12346679999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         220 ETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      +.+.+|+|||||+||+|.+++....   .+++..+..++.|++.||+|||+ ++  ||||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeC
Confidence            9999999999999999999986543   48999999999999999999997 58  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch--
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE--  376 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--  376 (441)
                      |+|+....     ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...................  
T Consensus       150 Gla~~~~~-----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  224 (322)
T d1s9ja_         150 GVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  224 (322)
T ss_dssp             CCCHHHHH-----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred             CCccccCC-----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence            99975321     12345689999999999999999999999999999999999999997654322211100000000  


Q ss_pred             -----------------------hhhhh----hhccCCCch-hHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         377 -----------------------ENMYD----LVDKNAQPI-ELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       377 -----------------------~~~~~----~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                                             .....    ......... ...++.++.+|+.+||..||++|||++|+++  .|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                                   00000    000000000 1124567899999999999999999999987  4543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=422.30  Aligned_cols=260  Identities=23%  Similarity=0.388  Sum_probs=209.5

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCe-------eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeec
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKT-------TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILP  213 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  213 (441)
                      +..++|++.++||+|+||+||+|++.+.       .||||.+......        .....+.+|+.++.++ +|||||+
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~HpnIv~  105 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--------SEREALMSELKMMTQLGSHENIVN  105 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--------HHHHHHHHHHHHHHHhcCCCcEeE
Confidence            4457899999999999999999997432       5888887643221        2234567899999988 8999999


Q ss_pred             ccceEEeCCeEEEEEEecCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q psy5927         214 LYGICFETGKYCLVYRYMPNGSLEDRLLMKKN--------------------TPSLLWTQRLHIAKGTSLGLQFLHSREP  273 (441)
Q Consensus       214 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~  273 (441)
                      +++++.+.+.+|+|||||++|+|.++|..+..                    ...+++..++.|+.||+.||+|||+++ 
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-  184 (325)
T d1rjba_         106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-  184 (325)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             EEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            99999999999999999999999999975432                    245899999999999999999999999 


Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-  352 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-  352 (441)
                       ||||||||+|||++.++.+||+|||+|+...... .........||+.|||||.+.+..++.++|||||||++|||+| 
T Consensus       185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             -eeeccCchhccccccCCeEEEeeccccccccCCC-ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence             9999999999999999999999999997643222 2222345568999999999999999999999999999999998 


Q ss_pred             CCCCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Q psy5927         353 GMRAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLS  424 (441)
Q Consensus       353 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  424 (441)
                      |.+||.+...... +...+..           ....+.+..++.++.+|+.+||+.||++|||++||++.|.
T Consensus       263 g~~Pf~~~~~~~~-~~~~~~~-----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         263 GVNPYPGIPVDAN-FYKLIQN-----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SCCSSTTCCCSHH-HHHHHHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCCHHHH-HHHHHhc-----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            8999987654332 2222211           1112334556788999999999999999999999999985

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=401.00  Aligned_cols=254  Identities=22%  Similarity=0.372  Sum_probs=211.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      .++|++.++||+|+||+||+|+++ +..||||+++.....          .+.+.+|++++++++||||++++|+|.+.+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----------HHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----------HHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            468999999999999999999995 458999999754322          235679999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+  |+||||||+|||+++++.+||+|||+++
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             ceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999999999999875443  45889999999999999999999998  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      ........  ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+.          
T Consensus       149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~~~i~----------  215 (258)
T d1k2pa_         149 YVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIA----------  215 (258)
T ss_dssp             BCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHH----------
T ss_pred             eccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-HHHHHHH----------
Confidence            64332221  2234568999999999999999999999999999999998 89999876542 2222111          


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                        .......+..++.++.+|+.+||+.||++|||+++|++.|..+
T Consensus       216 --~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         216 --QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              1112233445667899999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-54  Score=412.03  Aligned_cols=251  Identities=21%  Similarity=0.317  Sum_probs=193.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .+.|++.+.||+|+||+||+|.+.  +..||||++.......        ....+.+|+++|+.++|||||++++++.++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   79 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--------KEGSMENEIAVLHKIKHPNIVALDDIYESG   79 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            467999999999999999999985  5679999997543221        123456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec---CCCCeEEecc
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIGDF  298 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~---~~~~~kl~DF  298 (441)
                      +.+|+|||||+||+|.+++...   ..+++..+..++.||+.||+|||+++  ||||||||+|||+.   +++.+||+||
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             CEEEEEEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEecc
Confidence            9999999999999999999643   45999999999999999999999999  99999999999994   5789999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEEN  378 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~  378 (441)
                      |+|+......    .....+||+.|||||++.+..|+.++|||||||++|||+||.+||.+..... ....+....    
T Consensus       155 G~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~----  225 (307)
T d1a06a_         155 GLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAE----  225 (307)
T ss_dssp             ----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTC----
T ss_pred             ceeEEccCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccC----
Confidence            9997643221    2344679999999999999999999999999999999999999998765422 222211100    


Q ss_pred             hhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 MYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .....+....++.++.+|+.+||+.||++|||+.|+++
T Consensus       226 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 -----YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -----CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                 00111233456778999999999999999999999988

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=413.25  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=209.3

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      ..++|++++.||+|+||+||+|.+.  +..||||+++.....      .....+++.+|+++|+.++||||+++++++.+
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc------CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            4578999999999999999999984  578999999743211      11234567799999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                      .+.+|+|||||+||+|.+++....   .+++..++.++.||+.||+|||++|  ||||||||+|||++.+|.+||+|||+
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ccccccceeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeeccc
Confidence            999999999999999999886544   4888999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      |+......   ......+||+.|||||++.+..|+.++|||||||++|||++|.+||....... ......         
T Consensus       152 a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~---------  218 (337)
T d1o6la_         152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELIL---------  218 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH---------
T ss_pred             ccccccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHh---------
Confidence            98643322   22345689999999999999999999999999999999999999998765422 221111         


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                          ......+..++.++.+|+.+||+.||.+||+     +.++++
T Consensus       219 ----~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 ----MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----cCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                1112334556778999999999999999995     788875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.3e-53  Score=412.26  Aligned_cols=258  Identities=18%  Similarity=0.300  Sum_probs=210.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||++.....         ...+.+.+|+++|++++|||||++++++.+.
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   95 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---------SDKETVRKEIQTMSVLRHPTLVNLHDAFEDD   95 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---------HHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---------hhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            468999999999999999999985  67899999864321         1234567999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec--CCCCeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN--HHMDPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~--~~~~~kl~DFG  299 (441)
                      +.+|+|||||+||+|.+++...  ...+++..+..|+.||+.||+|||++|  ||||||||+|||++  .++.+||+|||
T Consensus        96 ~~~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2          96 NEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             TEEEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             CEEEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecc
Confidence            9999999999999999988533  345999999999999999999999999  99999999999995  46889999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +|+......    ......||+.|||||++.+..++.++|||||||++|||+||..||.+... ...+..+.....    
T Consensus       172 ~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~----  242 (350)
T d1koaa2         172 LTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDW----  242 (350)
T ss_dssp             TCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC----
T ss_pred             hheeccccc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----
Confidence            998643322    22345799999999999999999999999999999999999999986644 223332221110    


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcCCC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGSGG  428 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~~~  428 (441)
                           .........++.++.+|+.+||+.||++|||+.|+++.  |+....
T Consensus       243 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         243 -----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             -----CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                 01112234567789999999999999999999999983  554433

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-54  Score=409.43  Aligned_cols=246  Identities=23%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      .|+.++.||+|+||+||+|.+.  +..||||++.......      ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence            4999999999999999999984  5679999987543322      1234567799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +|+|||||++|+|..++...   .++++..+..++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+|+.
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccc
Confidence            99999999999997665433   45899999999999999999999999  99999999999999999999999999976


Q ss_pred             CCCcccccceeccccccCCCcCcccccC---CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVG---KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ...       .....||+.|||||++.+   ..|+.++|||||||++|||++|..||.+..... .+.......      
T Consensus       165 ~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~------  230 (309)
T d1u5ra_         165 MAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE------  230 (309)
T ss_dssp             SSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC------
T ss_pred             cCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCC------
Confidence            432       233569999999999864   458999999999999999999999998765422 222221110      


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .....+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       231 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 -----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -----CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                 011122345678999999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-54  Score=405.30  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=207.3

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE  220 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  220 (441)
                      +..++|++.+.||+|+||+||+|.+++ ..||||+++.....          .+.+.+|+.++++++|||||+++|++.+
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----------~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----------HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            445789999999999999999999965 57999998743321          2356799999999999999999999855


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       +.+++|||||++|+|.+++.... ...++|.+++.|+.||+.||+|||+.+  |+||||||+||||+.++.+||+|||+
T Consensus        84 -~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          84 -EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             -CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccch
Confidence             56789999999999998886543 235999999999999999999999999  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      ++.......  .......||+.|+|||++.++.++.++|||||||++|||+||..|+.........+..+..        
T Consensus       160 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~--------  229 (285)
T d1fmka3         160 ARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------  229 (285)
T ss_dssp             TC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------
T ss_pred             hhhccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------
Confidence            986432221  1223356899999999999999999999999999999999976665444332323222211        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                          ....+.+..++.++.+|+.+||+.||++||++++|++.|+..-...+
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         230 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ----cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                11223445677889999999999999999999999999998776654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=404.48  Aligned_cols=256  Identities=22%  Similarity=0.288  Sum_probs=208.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++++.||+|+||+||+|.+.  ++.||||+++........   .....+.+.+|+++|++++|||||++++++.+.
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR---RGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS---SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh---hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            467999999999999999999985  568999999754432211   112345677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC----CeEEec
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM----DPVIGD  297 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~----~~kl~D  297 (441)
                      +.+|+|||||+||+|.+++....   .+++..++.++.|++.||+|||+++  ||||||||+|||++.++    .+||+|
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             CEEEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecc
Confidence            99999999999999999986543   5899999999999999999999999  99999999999998877    499999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||+|+......    ......||+.|+|||++.+..++.++|||||||++|||+||..||.+....+ .+..+... .  
T Consensus       161 fG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~-~--  232 (293)
T d1jksa_         161 FGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAV-N--  232 (293)
T ss_dssp             CTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTT-C--
T ss_pred             hhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhc-C--
Confidence            99997643322    2334569999999999999899999999999999999999999998765422 22221110 0  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                            .......+..++..+.+|+.+||+.||++|||++++++
T Consensus       233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00011223456778999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-54  Score=409.38  Aligned_cols=266  Identities=24%  Similarity=0.385  Sum_probs=215.4

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCC
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDN  210 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  210 (441)
                      .+++...++|++++.||+|+||+||+|++.+       +.||||+++.....        ...+.+.+|+++|++++|||
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~E~~il~~l~h~n   77 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--------DMQADFQREAALMAEFDNPN   77 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--------HHHHHHHHHHHHHHTCCCTT
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--------HHHHHHHHHHHHHHhcCCCC
Confidence            3455667899999999999999999999753       57999998743221        23456789999999999999


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN---------------------TPSLLWTQRLHIAKGTSLGLQFLH  269 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~al~~LH  269 (441)
                      |++++++|.+.+..++||||+++|+|.+++.....                     ...+++..++.|+.|++.||+|||
T Consensus        78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH  157 (301)
T d1lufa_          78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS  157 (301)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence            99999999999999999999999999999864321                     234889999999999999999999


Q ss_pred             cCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHH
Q psy5927         270 SREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFE  349 (441)
Q Consensus       270 ~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~e  349 (441)
                      +++  ||||||||+|||+|.++.+||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++||
T Consensus       158 ~~~--ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e  234 (301)
T d1lufa_         158 ERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  234 (301)
T ss_dssp             HTT--CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             cCC--eEeeEEcccceEECCCCcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence            999  9999999999999999999999999997533222 1222345678999999999999999999999999999999


Q ss_pred             HHhCC-CCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         350 LATGM-RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       350 lltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                      |++|. +||.+... .+....+.            +....+.+..++.++.+|+.+||+.||++||||.+|++.|+++-
T Consensus       235 ll~~~~~p~~~~~~-~e~~~~v~------------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         235 IFSYGLQPYYGMAH-EEVIYYVR------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHTTTCCTTTTSCH-HHHHHHHH------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHccCCCCCCCCCH-HHHHHHHH------------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            99985 67776644 22222211            12223344566778999999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.3e-53  Score=400.28  Aligned_cols=263  Identities=20%  Similarity=0.257  Sum_probs=204.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  ++.||||+++......      ....+.+.+|+++++.++|||||++++++...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~   79 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC------HHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence            478999999999999999999984  6789999997543221      23345677999999999999999999998765


Q ss_pred             C----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         222 G----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       222 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +    .+|+|||||+||+|.+++....   .+++..+..++.||+.||+|||++|  ||||||||+|||++.++..+|+|
T Consensus        80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          80 TPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             CSSSEEEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECC
T ss_pred             cCCCceEEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeeh
Confidence            4    3899999999999999886543   4899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      ||++................+||+.|||||++.+..++.++|||||||++|||+||.+||........ +...+....  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~--  231 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDP--  231 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC--
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCC--
Confidence            99987654443333445566899999999999999999999999999999999999999987654222 222211100  


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-EMTQVYNMLSGSG  427 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~  427 (441)
                       .      ........++.++.+|+.+||+.||.+|| |++++++.|.++.
T Consensus       232 -~------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 -I------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -C------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -C------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence             0      00112234567899999999999999999 8999999887654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=402.92  Aligned_cols=257  Identities=20%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccc
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYG  216 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  216 (441)
                      +..++|++.+.||+|+||+||+|.+..     ..||||.++....        ....+.+.+|++++++++|||||++++
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~   75 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIVKLIG   75 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            445689999999999999999999743     2477777653221        233456779999999999999999999


Q ss_pred             eEEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         217 ICFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       217 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                      ++. .+.+|+|||||++|+|.+++...  ...+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+
T Consensus        76 ~~~-~~~~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~  150 (273)
T d1mp8a_          76 VIT-ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLG  150 (273)
T ss_dssp             EEC-SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEe-cCeEEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEc
Confidence            986 46789999999999999987543  345899999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+|+......  ........||+.|+|||.+.+..++.++|||||||++|||+| |.+||......+ ....+.    
T Consensus       151 DfG~a~~~~~~~--~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-~~~~i~----  223 (273)
T d1mp8a_         151 DFGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIE----  223 (273)
T ss_dssp             C---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HHHHHH----
T ss_pred             cchhheeccCCc--ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-HHHHHH----
Confidence            999998643322  222344568999999999999899999999999999999998 899998765422 221111    


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                              .....+.+.+++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       224 --------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         224 --------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                    1122344556788999999999999999999999999998765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=401.93  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=203.4

Q ss_pred             HhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         142 LATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       142 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +..++|++++.||+|+||.||+|.++++.||||+++...           ..+.+.+|++++++++||||++++|+|.+.
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            445678999999999999999999999999999996422           124567999999999999999999998654


Q ss_pred             -CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCC
Q psy5927         222 -GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGL  300 (441)
Q Consensus       222 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGl  300 (441)
                       +.+++||||+++|+|.++|..+. ...+++..++.|+.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeeccccc
Confidence             56899999999999999986543 234889999999999999999999998  99999999999999999999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      ++.....      .....+|..|+|||++.+..++.++|||||||++|||+| |.+||....... ....+         
T Consensus       150 s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-~~~~i---------  213 (262)
T d1byga_         150 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV---------  213 (262)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHH---------
T ss_pred             ceecCCC------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-HHHHH---------
Confidence            9864322      223358999999999998899999999999999999998 788887654322 22111         


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                         ......+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       214 ---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         214 ---EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ---TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               11122334555678899999999999999999999999999865

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-52  Score=409.08  Aligned_cols=254  Identities=19%  Similarity=0.289  Sum_probs=208.2

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++++.||+|+||+||+|.+.  +..||||+++....         ...+.+.+|+++|++++|||||++++++.+.+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---------LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---------HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            57999999999999999999984  67899999875321         12335668999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec--CCCCeEEeccCC
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN--HHMDPVIGDFGL  300 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~--~~~~~kl~DFGl  300 (441)
                      .+|+|||||+||+|.+++..  ...++++..+..|+.||+.||+|||++|  ||||||||+||||+  .++.+||+|||+
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeeccc
Confidence            99999999999999987743  3345999999999999999999999999  99999999999998  678999999999


Q ss_pred             CccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         301 TQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       301 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      |+......    ......||+.|||||++.+..++.++|||||||++|||+||..||.+..... .+..+.....     
T Consensus       176 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~-----  245 (352)
T d1koba_         176 ATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDW-----  245 (352)
T ss_dssp             CEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCC-----
T ss_pred             ceecCCCC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC-----
Confidence            98654322    2334569999999999999999999999999999999999999998765422 2222211100     


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                          .........++.++.+|+.+||+.||++|||+.|+++  .|++
T Consensus       246 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         246 ----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             ----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                0011223456778999999999999999999999987  3544

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.9e-53  Score=403.93  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=206.4

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++++.||+|+||+||+|++.  +..||||+++.....      .....+.+.+|+.+++.++|||||++++++.+.
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   76 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV------RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA   76 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc------CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence            368999999999999999999985  678999998743211      112345677999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+|||||+||+|.+++....   .+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             CeeeeEeeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccc
Confidence            99999999999999999886543   4778889999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +.....      ....+||+.|||||++.+..|+.++|||||||++|||+||..||.+..... ....+..         
T Consensus       152 ~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~---------  215 (316)
T d1fota_         152 KYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILN---------  215 (316)
T ss_dssp             EECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHH---------
T ss_pred             eEeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHc---------
Confidence            864322      234679999999999999999999999999999999999999998765422 2222111         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                          .....+..++.++.+++.+||..||.+|+     +++++++
T Consensus       216 ----~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         216 ----AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                11223445677899999999999999996     8999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=402.40  Aligned_cols=261  Identities=25%  Similarity=0.399  Sum_probs=201.8

Q ss_pred             hhCCCcCcCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      ..++|++.+.||+|+||+||+|+++.     ..||||+++.......      ...+.+.+|+++|++++|||||+++|+
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~~~g~   79 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP------EAMDDFIREVNAMHSLDHRNLIRLYGV   79 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH------HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34679999999999999999998732     2589998864332211      234567899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      |.+ +..++|||||++|+|.+++..+.  ..+++..++.++.|++.||+|||+++  |+||||||+|||++.++.+||+|
T Consensus        80 ~~~-~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~D  154 (273)
T d1u46a_          80 VLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGD  154 (273)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECC
T ss_pred             Eee-cchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeecc
Confidence            965 56789999999999999886543  35899999999999999999999998  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+++................||..|+|||.+.+..++.++|||||||++|||+| |..||.+....+ ....+...   
T Consensus       155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-~~~~i~~~---  230 (273)
T d1u46a_         155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-ILHKIDKE---  230 (273)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHTS---
T ss_pred             chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-HHHHHHhC---
Confidence            9999875444333333445568889999999999999999999999999999998 899998765422 22222110   


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                              ....+.+..++.++.+|+.+||+.||++|||+.+|++.|.++
T Consensus       231 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                    111233445677899999999999999999999999999865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.9e-52  Score=392.94  Aligned_cols=258  Identities=23%  Similarity=0.310  Sum_probs=209.9

Q ss_pred             CCCcCcCccccCCceeEEEEEE--CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVW--EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~  221 (441)
                      ++|++.+.||+|+||+||+|++  +++.||||++.............+...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999998  46789999997654332211112334567789999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|||||||+||+|.+++..+   .++++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999999654   35899999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC------CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG------KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      +......    ......||+.|+|||.+.+      ..++.++||||+||++|||+||..||.+..... ....+.....
T Consensus       158 ~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~  232 (277)
T d1phka_         158 CQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNY  232 (277)
T ss_dssp             EECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC
T ss_pred             eEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCC
Confidence            8643322    2234579999999999864      346889999999999999999999998765422 2222221100


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                               ....+...+++.++.+|+.+||+.||++|||+.||++
T Consensus       233 ---------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         233 ---------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ---------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                     0112233467789999999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=401.17  Aligned_cols=266  Identities=22%  Similarity=0.323  Sum_probs=203.5

Q ss_pred             hHHHHhhCCCcCcCccccCCceeEEEEEECC-------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCC
Q psy5927         138 QELTLATNNWDKLNILGKGGFGTVYKGVWEK-------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHD  209 (441)
Q Consensus       138 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  209 (441)
                      .++++..++|++.++||+|+||.||+|.+.+       +.||||+++.....        ...+.+.+|..++.++ +|+
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--------~~~~~~~~e~~~l~~~~~h~   77 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------SEHRALMSELKILIHIGHHL   77 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--------HHHHHHHHHHHHHHHHCCCT
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--------HHHHHHHHHHHHHHhhcCCC
Confidence            4455666889999999999999999999732       46999998643221        2334566788877776 789


Q ss_pred             CeecccceEEeC-CeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy5927         210 NILPLYGICFET-GKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPL  275 (441)
Q Consensus       210 nIv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~i  275 (441)
                      ||+.+++++.+. ..+++|||||++|+|.+++.....             ...+++..+..++.||+.||+|||+++  |
T Consensus        78 ~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--i  155 (299)
T d1ywna1          78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--C  155 (299)
T ss_dssp             TBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             eEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--C
Confidence            999999988764 468999999999999999975432             345899999999999999999999999  9


Q ss_pred             eecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhC-C
Q psy5927         276 IHGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATG-M  354 (441)
Q Consensus       276 iHrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG-~  354 (441)
                      |||||||+||||++++.+||+|||+|+...... .........||+.|||||.+.+..++.++|||||||++|||+|| .
T Consensus       156 vHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~  234 (299)
T d1ywna1         156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  234 (299)
T ss_dssp             CCSCCCGGGEEECGGGCEEECC------CCSCT-TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCcCCccceeECCCCcEEEccCcchhhccccc-cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence            999999999999999999999999998643322 12223456799999999999999999999999999999999996 5


Q ss_pred             CCCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         355 RAYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       355 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      +||............+....            ....+..++.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       235 ~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         235 SPYPGVKIDEEFCRRLKEGT------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CSSTTCCCSHHHHHHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHhcCC------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            67876654333332222111            1223344667899999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5e-52  Score=406.19  Aligned_cols=254  Identities=21%  Similarity=0.280  Sum_probs=202.7

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||++.........   ..........|+++++.++|||||++++++.+.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~---~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLSLVSTGDCPFIVCMSYAFHTP   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHT---CHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhh---HHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence            478999999999999999999985  568999998643221110   111222233567888889999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+|||||+||+|.+++....   .+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeecee
Confidence            99999999999999999986543   4788999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMY  380 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~  380 (441)
                      +......     ....+||+.|||||++.+ ..|+.++|||||||++|||+||..||.........  .+..        
T Consensus       155 ~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~--------  219 (364)
T d1omwa3         155 CDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDR--------  219 (364)
T ss_dssp             EECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHH--------
T ss_pred             eecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH--------
Confidence            8643322     234579999999999864 56899999999999999999999999765432211  1111        


Q ss_pred             hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q psy5927         381 DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN  421 (441)
Q Consensus       381 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~  421 (441)
                       .........+..++.++.+|+.+||+.||++||+     ++++++
T Consensus       220 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 -MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -HSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -hcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             1111222334456778999999999999999999     688875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=403.07  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=203.3

Q ss_pred             CCCcCcCccccCCceeEEEEEECCe------eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceE
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKT------TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGIC  218 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  218 (441)
                      .+|+++++||+|+||+||+|.+..+      .||+|+++.....        ...+.+.+|++++++++|||||+++|+|
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g~~   80 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--------KANKEILDEAYVMASVDNPHVCRLLGIC   80 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            5799999999999999999998533      4888887632211        2345677999999999999999999998


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEecc
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDF  298 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DF  298 (441)
                      .++ ..+++++|+.+|+|.+.+...  ...+++..++.++.||+.||+|||+++  ||||||||+|||++.++.+||+||
T Consensus        81 ~~~-~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DF  155 (317)
T d1xkka_          81 LTS-TVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDF  155 (317)
T ss_dssp             ESS-SEEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCC
T ss_pred             ecC-CeeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeecc
Confidence            764 567889999999999987654  456899999999999999999999998  999999999999999999999999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+|+....... ........||+.|||||.+.++.++.++|||||||++|||+| |.+||.+.....  +...+..    
T Consensus       156 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~----  228 (317)
T d1xkka_         156 GLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK----  228 (317)
T ss_dssp             SHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHH----
T ss_pred             ccceecccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc----
Confidence            99986543222 222334568999999999999999999999999999999999 899998765422  1111111    


Q ss_pred             hhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Q psy5927         378 NMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSG  427 (441)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  427 (441)
                             ....+.+..++.++.+|+.+||+.||++|||+.+|++.|..+.
T Consensus       229 -------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 -------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                   1122344566788999999999999999999999999887653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-52  Score=405.39  Aligned_cols=246  Identities=20%  Similarity=0.288  Sum_probs=206.6

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++++.||+|+||+||+|.+.  +..||||++......      .....+.+.+|+++|+.++|||||++++++.+..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV------KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH------HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc------CHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            68999999999999999999985  678999998642211      1123456779999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+++||||+.+|+|.+++....   .+++..+..++.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|+
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ccccccccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeee
Confidence            9999999999999999986543   4899999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      .....      .....||+.|||||++.+..++.++|||||||++|||+||.+||.+... ......+..          
T Consensus       190 ~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~----------  252 (350)
T d1rdqe_         190 RVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVS----------  252 (350)
T ss_dssp             ECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH----------
T ss_pred             ecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-HHHHHHHhc----------
Confidence            64322      2345799999999999999999999999999999999999999987643 222222211          


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERP-----EMTQVYN  421 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~  421 (441)
                         .....+..++.++.+|+.+||..||.+|+     +++++++
T Consensus       253 ---~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         253 ---GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               11123345677899999999999999994     8999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=401.72  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=206.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEECC--e--eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCeecccceE
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWEK--T--TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNILPLYGIC  218 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  218 (441)
                      -++|++.++||+|+||+||+|.+++  .  .||||+++.....        ...+.+.+|+++|+++ +|||||+++|+|
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--------HHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            3688899999999999999999854  2  4677776532221        2234577999999998 799999999999


Q ss_pred             EeCCeEEEEEEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         219 FETGKYCLVYRYMPNGSLEDRLLMK-------------KNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       219 ~~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      .+.+.+++||||+++|+|.++|...             .....+++..+..++.||+.||.|||+++  ||||||||+||
T Consensus        81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NI  158 (309)
T d1fvra_          81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI  158 (309)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred             ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceE
Confidence            9999999999999999999998654             22456999999999999999999999998  99999999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCC-CCCCCcchhH
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM-RAYDDTRRSE  364 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~-~p~~~~~~~~  364 (441)
                      |++.++.+||+|||+++......    ......||..|+|||.+.+..++.++|||||||++|||++|. +||..... .
T Consensus       159 L~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-~  233 (309)
T d1fvra_         159 LVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-A  233 (309)
T ss_dssp             EECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-H
T ss_pred             EEcCCCceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-H
Confidence            99999999999999997543221    122346899999999999999999999999999999999975 56765543 2


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGES  430 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  430 (441)
                      .....+            ......+.+..++.++.+|+.+||+.||++|||+.+|++.|+++..+.
T Consensus       234 ~~~~~i------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         234 ELYEKL------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HHHHHG------------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHH------------HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            222111            111223344567789999999999999999999999999887765443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=395.32  Aligned_cols=250  Identities=19%  Similarity=0.252  Sum_probs=204.9

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||+++....          ....+.+|+++|+.++|||||++++++.+.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----------DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----------HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----------cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            468999999999999999999985  56899999975421          123456899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC--CCeEEeccC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH--MDPVIGDFG  299 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~--~~~kl~DFG  299 (441)
                      +.+|+|||||+||+|.+++...  ...+++.++..++.||+.||+|||++|  |+||||||+|||++.+  +.+||+|||
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccc
Confidence            9999999999999999988533  345899999999999999999999999  9999999999999854  579999999


Q ss_pred             CCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhh
Q psy5927         300 LTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENM  379 (441)
Q Consensus       300 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~  379 (441)
                      +++......    ......||+.|+|||.+.+..++.++|||||||++|||++|..||...... ..+..+.....    
T Consensus       150 ~~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~----  220 (321)
T d1tkia_         150 QARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEY----  220 (321)
T ss_dssp             TCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC----
T ss_pred             hhhccccCC----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCC----
Confidence            998643322    233456899999999999999999999999999999999999999876542 22222221100    


Q ss_pred             hhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         380 YDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                           .........++.++.+|+.+||..||++|||+.|+++
T Consensus       221 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         221 -----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0001112245678899999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=399.60  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhh-cCCCCCeecccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLN-SCRHDNILPLYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~  221 (441)
                      ++|++++.||+|+||+||+|.+.  ++.||||+++.....      .....+.+..|..++. .++|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~------~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH------HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc------ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            68999999999999999999994  678999999742211      1123345567777765 68999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCC
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLT  301 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla  301 (441)
                      +.+|+|||||++|+|.+++....   .+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceeEEEeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchh
Confidence            99999999999999999986543   4788999999999999999999999  999999999999999999999999999


Q ss_pred             ccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhh
Q psy5927         302 QEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYD  381 (441)
Q Consensus       302 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~  381 (441)
                      +......   .......||+.|+|||++.+..++.++|||||||++|||+||..||.+.... .....+..         
T Consensus       151 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~~---------  217 (320)
T d1xjda_         151 KENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIRM---------  217 (320)
T ss_dssp             BCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH---------
T ss_pred             hhccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHc---------
Confidence            8643322   2234457999999999999999999999999999999999999999876542 22222111         


Q ss_pred             hhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q psy5927         382 LVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMT-QVYN  421 (441)
Q Consensus       382 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~  421 (441)
                          .....+..++.++.+|+.+||..||.+||++. +|++
T Consensus       218 ----~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         218 ----DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                11223445677899999999999999999995 6753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=396.16  Aligned_cols=276  Identities=25%  Similarity=0.305  Sum_probs=205.5

Q ss_pred             CcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCeEEE
Q psy5927         149 KLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGKYCL  226 (441)
Q Consensus       149 ~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  226 (441)
                      .+++||+|+||+||+|.+.  ++.||||+++........    ....+.+.+|+++|++++|||||++++++.+.+.+|+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~i   77 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK----DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   77 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhh----HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceee
Confidence            4678999999999999984  567999998754322111    1123456799999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         227 VYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       227 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      |||||.++++..+..   ....+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus        78 vmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          78 VFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             EEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             hhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCC
Confidence            999998887765442   3345888899999999999999999999  99999999999999999999999999976433


Q ss_pred             cccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc---hhhhhhh
Q psy5927         307 EKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS---EENMYDL  382 (441)
Q Consensus       307 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~~~~~  382 (441)
                      ...   .....+||+.|+|||++.+ ..++.++|||||||++|||+||.+||...... ..+..+.+...   .+.....
T Consensus       153 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         153 PNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             CCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSST
T ss_pred             Ccc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccch
Confidence            221   2234579999999999875 45799999999999999999999999876552 33333333221   1100000


Q ss_pred             hc------c-C--CC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCCCCCCCC
Q psy5927         383 VD------K-N--AQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESPNATGPT  437 (441)
Q Consensus       383 ~~------~-~--~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~~~~~p~  437 (441)
                      ..      . .  ..   .....++.++.+|+.+||+.||++|||++|+++  .|++.....+.++.|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~  297 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR  297 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence            00      0 0  00   111234678999999999999999999999997  6776655555555553

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=397.35  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=209.0

Q ss_pred             HHhhCCCcCcCccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCC
Q psy5927         141 TLATNNWDKLNILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDN  210 (441)
Q Consensus       141 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  210 (441)
                      .+..++|++++.||+|+||.||+|+..+         +.||||+++.....        .....+.+|...+.++ +|||
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~~e~~~l~~~~~Hpn   80 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--------KDLSDLISEMEMMKMIGKHKN   80 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--------HHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--------HHHHHHHHHHHHHHHhcCCCe
Confidence            3556789999999999999999998633         36899998753322        2345667888888888 8999


Q ss_pred             eecccceEEeCCeEEEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeee
Q psy5927         211 ILPLYGICFETGKYCLVYRYMPNGSLEDRLLMKKN-------------TPSLLWTQRLHIAKGTSLGLQFLHSREPPLIH  277 (441)
Q Consensus       211 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiH  277 (441)
                      ||+++++|.+++..++|||||++|+|.+++..+..             ...+++..++.++.||+.||+|||+++  |||
T Consensus        81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivH  158 (299)
T d1fgka_          81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH  158 (299)
T ss_dssp             BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEe
Confidence            99999999999999999999999999999975542             245899999999999999999999999  999


Q ss_pred             cCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCCC
Q psy5927         278 GDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMRA  356 (441)
Q Consensus       278 rDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~p  356 (441)
                      |||||+|||++.++.+||+|||+++...... .........||+.|+|||.+.++.|+.++|||||||++|||+| |.+|
T Consensus       159 rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p  237 (299)
T d1fgka_         159 RDLAARNVLVTEDNVMKIADFGLARDIHHID-YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  237 (299)
T ss_dssp             SCCSGGGEEECTTCCEEECSTTCCCCGGGCC-TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             eeecccceeecCCCCeEeccchhhccccccc-cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence            9999999999999999999999998643322 1222345678999999999999999999999999999999998 7889


Q ss_pred             CCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         357 YDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       357 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      |.+.....  +...+.           +......+..++.++.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       238 ~~~~~~~~--~~~~i~-----------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         238 YPGVPVEE--LFKLLK-----------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             STTCCHHH--HHHHHH-----------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCHHH--HHHHHH-----------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            97665421  112111           1112233445677899999999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=398.13  Aligned_cols=269  Identities=25%  Similarity=0.338  Sum_probs=216.5

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC-CCCCe
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC-RHDNI  211 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  211 (441)
                      +++..++|++.++||+|+||.||+|++.       ++.||||+++.....        .....+.+|+.+++.+ +||||
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~E~~~~~~l~~HpnI   89 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--------TEREALMSELKVLSYLGNHMNI   89 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--------HHHHHHHHHHHHHHhccCCCCE
Confidence            4456688999999999999999999863       247999999754321        2344677999999999 69999


Q ss_pred             ecccceEEeCCeEEEEEEecCCCCHHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCee
Q psy5927         212 LPLYGICFETGKYCLVYRYMPNGSLEDRLLMKK---------------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLI  276 (441)
Q Consensus       212 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~ii  276 (441)
                      |+++++|.+.+.+++|||||++|+|.+++....               ....+++..+..++.||+.||+|||+++  ||
T Consensus        90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--iv  167 (311)
T d1t46a_          90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CI  167 (311)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            999999999999999999999999999997543               2345899999999999999999999999  99


Q ss_pred             ecCCCCCCeeecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHh-CCC
Q psy5927         277 HGDIKSANILLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELAT-GMR  355 (441)
Q Consensus       277 HrDikp~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~ellt-G~~  355 (441)
                      ||||||+|||++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++|||||||++|||+| |.+
T Consensus       168 HrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p  246 (311)
T d1t46a_         168 HRDLAARNILLTHGRITKICDFGLARDIKNDS-NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (311)
T ss_dssp             CSCCSGGGEEEETTTEEEECCCGGGSCTTSCT-TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecccccccccccccCcccccccchheeccCCC-cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence            99999999999999999999999998654332 2233445679999999999998899999999999999999999 566


Q ss_pred             CCCCcchhHHHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q psy5927         356 AYDDTRRSERHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGESP  431 (441)
Q Consensus       356 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  431 (441)
                      ||........ +..++..-           .....+..++.++.+|+.+||+.||++|||+.+|++.|++...++.
T Consensus       247 ~~~~~~~~~~-~~~~i~~~-----------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~  310 (311)
T d1t46a_         247 PYPGMPVDSK-FYKMIKEG-----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (311)
T ss_dssp             SSTTCCSSHH-HHHHHHHT-----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CCCCCCHHHH-HHHHHhcC-----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence            6655544332 22222111           1112233456789999999999999999999999999987655543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=392.69  Aligned_cols=256  Identities=22%  Similarity=0.320  Sum_probs=202.9

Q ss_pred             cCccccCCceeEEEEEECC-----eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-CCe
Q psy5927         150 LNILGKGGFGTVYKGVWEK-----TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-TGK  223 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~  223 (441)
                      .++||+|+||+||+|.+.+     ..||||+++....        ....+.+.+|+++|++++||||++++|++.+ .+.
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~  103 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  103 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC--------HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCc
Confidence            4789999999999999843     2489999864322        2334667899999999999999999999876 468


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      +++|||||++|+|.+++...  ...+++..++.++.|++.||.|||+.+  |+||||||+|||+++++.+||+|||+++.
T Consensus       104 ~~lv~E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD  179 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred             eEEEEEEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhh
Confidence            99999999999999988543  345778899999999999999999998  99999999999999999999999999986


Q ss_pred             CCCccc-ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchhhhhhh
Q psy5927         304 GPIEKA-THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEENMYDL  382 (441)
Q Consensus       304 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~  382 (441)
                      ...... .........||+.|+|||.+.+..++.++||||||+++|||+||..||............+.           
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~-----------  248 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-----------  248 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH-----------
T ss_pred             ccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------
Confidence            543322 11222335689999999999988999999999999999999998777765433222222211           


Q ss_pred             hccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC
Q psy5927         383 VDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGGE  429 (441)
Q Consensus       383 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  429 (441)
                       .......+..++.++.+|+.+||+.||++||++.||++.|+++...
T Consensus       249 -~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         249 -QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence             1112223445677899999999999999999999999999877544

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=395.63  Aligned_cols=265  Identities=21%  Similarity=0.320  Sum_probs=215.7

Q ss_pred             HHHhhCCCcCcCccccCCceeEEEEEEC-------CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCee
Q psy5927         140 LTLATNNWDKLNILGKGGFGTVYKGVWE-------KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNIL  212 (441)
Q Consensus       140 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  212 (441)
                      +++..++|++.++||+|+||+||+|.+.       ++.||||+++.....        .....+.+|++++++++|||||
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv   86 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--------RERIEFLNEASVMKEFNCHHVV   86 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--------HHHHHHHHHHHHGGGCCCTTBC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--------HHHHHHHHHHHHHHHcCCCCEe
Confidence            3455678999999999999999999874       357999998643221        2334677999999999999999


Q ss_pred             cccceEEeCCeEEEEEEecCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCe
Q psy5927         213 PLYGICFETGKYCLVYRYMPNGSLEDRLLMKK-------NTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANI  285 (441)
Q Consensus       213 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~Ni  285 (441)
                      +++++|...+..++|||||++|+|.+++....       ....+++..+..++.+++.||.|||+++  |+||||||+||
T Consensus        87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~Ni  164 (308)
T d1p4oa_          87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNC  164 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGE
T ss_pred             eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCce
Confidence            99999999999999999999999999886432       2345789999999999999999999998  99999999999


Q ss_pred             eecCCCCeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCC-CCCCCcchhH
Q psy5927         286 LLNHHMDPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGM-RAYDDTRRSE  364 (441)
Q Consensus       286 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~-~p~~~~~~~~  364 (441)
                      |++.++.+||+|||+++...... .........||+.|+|||.+.+..++.++|||||||++|||+||. +||.+... .
T Consensus       165 Lld~~~~~Kl~DFGla~~~~~~~-~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~  242 (308)
T d1p4oa_         165 MVAEDFTVKIGDFGMTRDIYETD-YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-E  242 (308)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGG-CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-H
T ss_pred             eecCCceEEEeecccceeccCCc-ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-H
Confidence            99999999999999998643322 222234456899999999999999999999999999999999984 77766544 2


Q ss_pred             HHHHHHHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         365 RHLKSLVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       365 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                      ..+..+            .+....+.+..++..+.+|+.+||+.||++|||+.+|++.|++...
T Consensus       243 ~~~~~i------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         243 QVLRFV------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHHH------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHH------------HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            222222            1222333445667889999999999999999999999999987643

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=395.70  Aligned_cols=251  Identities=18%  Similarity=0.262  Sum_probs=197.5

Q ss_pred             hCCCcCcC-ccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhc-CCCCCeecccceEE
Q psy5927         144 TNNWDKLN-ILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNS-CRHDNILPLYGICF  219 (441)
Q Consensus       144 ~~~~~~~~-~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~  219 (441)
                      .++|++.. .||+|+||+||+|.+.  +..||||+++..              ..+.+|++++.+ .+|||||+++++|.
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            46899875 5999999999999984  568999998631              123478888655 58999999999987


Q ss_pred             e----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC---CCC
Q psy5927         220 E----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH---HMD  292 (441)
Q Consensus       220 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~---~~~  292 (441)
                      +    ...+|+|||||+||+|.+++..+. ...+++.++..|+.||+.||+|||++|  |+||||||+|||++.   .+.
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~  152 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI  152 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCC
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccc
Confidence            5    467899999999999999996543 346999999999999999999999999  999999999999986   567


Q ss_pred             eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHH
Q psy5927         293 PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVE  372 (441)
Q Consensus       293 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~  372 (441)
                      +||+|||+|+......    .....+||+.|||||++.+..|+.++|||||||++|||+||.+||.+..... ....+..
T Consensus       153 ~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~  227 (335)
T d2ozaa1         153 LKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKT  227 (335)
T ss_dssp             EEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred             ccccccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHH
Confidence            9999999998644322    2334579999999999999999999999999999999999999997654311 1111111


Q ss_pred             hhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         373 KYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ......    . ....+....++.++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~i~~~~----~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 RIRMGQ----Y-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCCSCS----S-SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCC----C-CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            110000    0 0011223467788999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=389.96  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=198.8

Q ss_pred             CCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC--
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG--  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--  222 (441)
                      ++|.+.++||+|+||+||+|++++..||||+++....   .       ......|+..+..++|||||++++++.+.+  
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~-------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~   72 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---R-------SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---H-------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---h-------HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence            4677889999999999999999999999999863211   1       111124666667889999999999998654  


Q ss_pred             --eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeeecCCCCCCeeecCCCCeE
Q psy5927         223 --KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSR------EPPLIHGDIKSANILLNHHMDPV  294 (441)
Q Consensus       223 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~------~~~iiHrDikp~NiLl~~~~~~k  294 (441)
                        .+|+|||||++|+|.++|...    .++|..++.++.+++.||+|||+.      .++||||||||+||||+.++.+|
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          73 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence              689999999999999999643    489999999999999999999973      12399999999999999999999


Q ss_pred             EeccCCCccCCCcc-cccceeccccccCCCcCcccccCC------CCCCccceehHHHHHHHHHhCCCCCCCcchhH---
Q psy5927         295 IGDFGLTQEGPIEK-ATHITLKRVNGTRPYLPHEFLVGK------RLSTKVDVYGFGIVLFELATGMRAYDDTRRSE---  364 (441)
Q Consensus       295 l~DFGla~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~---  364 (441)
                      |+|||+++...... ..........||+.|||||++.+.      .++.++|||||||+||||+||..||.......   
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~  228 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence            99999997643322 122234456799999999998764      26778999999999999999998874322110   


Q ss_pred             -------HHHHHHHHhhchhhhhhhhccCC--CchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Q psy5927         365 -------RHLKSLVEKYSEENMYDLVDKNA--QPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGSGG  428 (441)
Q Consensus       365 -------~~l~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  428 (441)
                             ............    ...++..  ..........+.+|+.+||+.||++|||+.||++.|+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         229 YDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                   001111110000    0111111  11234566789999999999999999999999999987654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=383.94  Aligned_cols=268  Identities=22%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|++++.||+|+||+||+|.+.  ++.||||+++.....       ....+++.+|+++|++++|||||++++++.+.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-------EGVPSTAIREISLLKELNHPNIVKLLDVIHTEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-------hHHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence            68999999999999999999985  678999999643221       122346779999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      .+|+||||+.+ ++.+.+... ....+++..+..++.|++.||+|||++|  ||||||||+|||++.++.+||+|||+|+
T Consensus        75 ~~~iv~e~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          75 KLYLVFEFLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             EEEEEEECCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             ceeEEEeecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcce
Confidence            99999999964 555545433 3456999999999999999999999999  9999999999999999999999999997


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCC-CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc--hhh-
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS--EEN-  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--~~~-  378 (441)
                      ......   .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||....... .+........  .+. 
T Consensus       151 ~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         151 AFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             HHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred             eccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCCchhh
Confidence            643222   1233446999999999877655 5889999999999999999999998765533 3322222211  000 


Q ss_pred             ---hhhhhc------c-CCC---chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         379 ---MYDLVD------K-NAQ---PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       379 ---~~~~~~------~-~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                         .....+      . ...   .....++.++.+|+.+||..||++|||+.|+++  .|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence               000000      0 000   112244678899999999999999999999998  476553

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=387.03  Aligned_cols=249  Identities=19%  Similarity=0.300  Sum_probs=198.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC--CCCeecccceEE
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--HDNILPLYGICF  219 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~  219 (441)
                      .++|++.+.||+|+||+||+|.+.  +..||||++...........   ....++.+|+.+|++++  |||||++++++.
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~---~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh---hHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence            368999999999999999999985  57899999875432211000   01112347999999886  999999999999


Q ss_pred             eCCeEEEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCC-CCeEEec
Q psy5927         220 ETGKYCLVYRYMPN-GSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHH-MDPVIGD  297 (441)
Q Consensus       220 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~-~~~kl~D  297 (441)
                      +.+..++||||+.+ +++.+++...   ..+++..+..++.|++.||+|||+++  ||||||||+|||++.+ +.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          80 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECC
T ss_pred             eCCeEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECc
Confidence            99999999999976 6787777543   34899999999999999999999999  9999999999999854 7899999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCC-CCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRL-STKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      ||+|+.....     ......||+.|+|||++.+..+ +.++|||||||++|||+||..||.....       ...    
T Consensus       155 FG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~----  218 (273)
T d1xwsa_         155 FGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIR----  218 (273)
T ss_dssp             CTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHH----
T ss_pred             cccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------Hhh----
Confidence            9999764332     2334579999999999987665 6779999999999999999999976421       110    


Q ss_pred             hhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhc
Q psy5927         377 ENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSG  425 (441)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~  425 (441)
                               .....+..++.++.+|+.+||+.||++|||++|+++  .|++
T Consensus       219 ---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         219 ---------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             ---------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ---------cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                     011223345678999999999999999999999987  4543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=377.81  Aligned_cols=268  Identities=20%  Similarity=0.285  Sum_probs=202.2

Q ss_pred             hhCCCcCcCccccCCceeEEEEEEC---CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHh---hcCCCCCeecccc
Q psy5927         143 ATNNWDKLNILGKGGFGTVYKGVWE---KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYL---NSCRHDNILPLYG  216 (441)
Q Consensus       143 ~~~~~~~~~~LG~G~fg~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~l~~  216 (441)
                      ..++|+++++||+|+||+||+|.+.   ++.||||+++........       ...+.+|+++|   +.++||||+++++
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------PLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------BCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-------HHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            3478999999999999999999984   346899999764432211       11223555555   4458999999999


Q ss_pred             eEEe-----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC
Q psy5927         217 ICFE-----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM  291 (441)
Q Consensus       217 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~  291 (441)
                      +|..     ...++++|||+.++++.....  .....+++..+..++.|++.||+|||+++  ||||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTC
T ss_pred             eecccccccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCC
Confidence            9853     346899999998877754432  34456899999999999999999999999  99999999999999999


Q ss_pred             CeEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         292 DPVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       292 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      .+||+|||+++......    ......||+.|+|||++.+..|+.++||||+||++|||+||.+||..... ...+..+.
T Consensus       154 ~~kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~  228 (305)
T d1blxa_         154 QIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKIL  228 (305)
T ss_dssp             CEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHH
T ss_pred             Ceeecchhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHH
Confidence            99999999987643322    23456799999999999999999999999999999999999999987654 33333333


Q ss_pred             Hhhch---hhhh--------hhhcc---CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcC
Q psy5927         372 EKYSE---ENMY--------DLVDK---NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       372 ~~~~~---~~~~--------~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~  426 (441)
                      .....   ....        .....   ........++..+.+|+.+||+.||++|||+.|+++  .|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            32211   0000        00000   111223345678899999999999999999999987  35544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-49  Score=376.19  Aligned_cols=261  Identities=21%  Similarity=0.343  Sum_probs=200.3

Q ss_pred             CCCcCcCccccCCceeEEEEEEC-CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE-KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETGK  223 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  223 (441)
                      ++|+++++||+|+||+||+|.++ +..||||+++......       ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-------GIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-------CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-------HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            68999999999999999999985 5789999997543221       123466799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         224 YCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       224 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                      .+++|||+.++.+..+..   ....+++..+..++.||+.||+|||+.+  ||||||||+|||++.++.+||+|||++..
T Consensus        75 ~~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             EEEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             eeEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEeccccccee
Confidence            999999997776665542   2355999999999999999999999999  99999999999999999999999999875


Q ss_pred             CCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hh-
Q psy5927         304 GPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---EN-  378 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~-  378 (441)
                      ......   ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+ .+.........   .. 
T Consensus       150 ~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  225 (286)
T d1ob3a_         150 FGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNW  225 (286)
T ss_dssp             HCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTS
T ss_pred             cccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCChhhc
Confidence            332211   22334689999999998764 56899999999999999999999998765432 33332221110   00 


Q ss_pred             --hhhhhc-------cC---CCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 --MYDLVD-------KN---AQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 --~~~~~~-------~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                        ......       ..   .......++.++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000       00   01122345678899999999999999999999984

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-48  Score=374.34  Aligned_cols=269  Identities=24%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      +++|+++++||+|+||+||+|.++  ++.||||++......        ...+.+.+|+++|+.++||||+++++++...
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~   78 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--------TYCQRTLREIKILLRFRHENIIGINDIIRAP   78 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--------HHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--------HHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence            357999999999999999999985  678999999753321        2344677999999999999999999998654


Q ss_pred             C----eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         222 G----KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       222 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      .    ..+++++|+.+|+|.+++...    .+++..+..++.|++.||+|||++|  ||||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          79 TIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             STTTCCCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             cccccceEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcc
Confidence            3    234445566799999998543    4899999999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc-
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS-  375 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-  375 (441)
                      ||+++...............+||+.|+|||.+.. ..++.++||||+||++|||++|..||.................. 
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            9999865444333333455679999999999855 46789999999999999999999999876543322221111110 


Q ss_pred             -hhhh--------h----hhhccCCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HhcC
Q psy5927         376 -EENM--------Y----DLVDKNAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYNM--LSGS  426 (441)
Q Consensus       376 -~~~~--------~----~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~  426 (441)
                       ....        .    ........+   ....++.++.+|+.+||..||++|||++++++.  |+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence             0000        0    000011111   122345678999999999999999999999973  5433

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=376.17  Aligned_cols=270  Identities=20%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|+++++||+|+||+||+|.+.  ++.||||+++.....       ....+.+.+|+++|+.++|||||+++++|...
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-------ELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-------HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-------hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            578999999999999999999985  678999999743222       23345677999999999999999999999765


Q ss_pred             C------eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEE
Q psy5927         222 G------KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVI  295 (441)
Q Consensus       222 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl  295 (441)
                      +      .+|+||||| +++|...+..    ..+++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred             ccccccceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccc
Confidence            4      579999999 6778776542    34899999999999999999999999  999999999999999999999


Q ss_pred             eccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         296 GDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       296 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      +|||+|+.....      .....||+.|+|||.+.+. .++.++||||+||++|||++|.+||....... .+.......
T Consensus       163 ~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~  235 (346)
T d1cm8a_         163 LDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVT  235 (346)
T ss_dssp             CCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred             ccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhcc
Confidence            999999764322      2345699999999998764 56899999999999999999999998765422 222222111


Q ss_pred             ch--hh------------hhh-hhcc---CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCCCCCCCC
Q psy5927         375 SE--EN------------MYD-LVDK---NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGGESPNAT  434 (441)
Q Consensus       375 ~~--~~------------~~~-~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~~~~~~~  434 (441)
                      ..  ..            ... +...   ........++..+.+|+.+||..||++|||+.|+++  .|+++......+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~  315 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ  315 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccccc
Confidence            00  00            000 0000   011122345677899999999999999999999998  4776654433333

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=378.76  Aligned_cols=262  Identities=19%  Similarity=0.267  Sum_probs=198.4

Q ss_pred             CCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC--
Q psy5927         146 NWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET--  221 (441)
Q Consensus       146 ~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--  221 (441)
                      +|+..++||+|+||+||+|++.  ++.||||+++.....             ..+|+++|++++||||++++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------------~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------------CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------------HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            5888899999999999999995  567999998753211             12799999999999999999998543  


Q ss_pred             ----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEe
Q psy5927         222 ----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIG  296 (441)
Q Consensus       222 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~  296 (441)
                          .++|+|||||+++.+............+++..+..++.||+.||+|||++|  |+||||||+|||++.++ .+||+
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEEC
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEe
Confidence                357999999976655444433344567999999999999999999999999  99999999999999775 89999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccC-CCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVG-KRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||+++.......    .....||+.|+|||.+.+ ..++.++||||+||++|||++|.+||....... .+..+.....
T Consensus       166 DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g  240 (350)
T d1q5ka_         166 DFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLG  240 (350)
T ss_dssp             CCTTCEECCTTSC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHC
T ss_pred             cccchhhccCCcc----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            9999976433221    234569999999998875 468999999999999999999999998765432 3333222211


Q ss_pred             ---hhhhhhh----hcc-----CCC----chhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCC
Q psy5927         376 ---EENMYDL----VDK-----NAQ----PIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSG  427 (441)
Q Consensus       376 ---~~~~~~~----~~~-----~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~  427 (441)
                         .+.....    .+.     ...    .....++.++.+|+.+||..||++|||+.|+++  .|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence               0101000    000     000    112245678899999999999999999999986  455543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=369.26  Aligned_cols=265  Identities=21%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe-
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE-  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  220 (441)
                      .++|+++++||+|+||+||+|.+.  ++.||||++.......       .....+.+|+++|+.++||||+++++++.. 
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-------GFPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-------HHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            378999999999999999999984  5789999986543221       223456799999999999999999998854 


Q ss_pred             -------CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCe
Q psy5927         221 -------TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDP  293 (441)
Q Consensus       221 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~  293 (441)
                             .+..|+|||||.++.+....   .....++...+..++.|++.||+|||+++  |+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCE
T ss_pred             cccccccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcE
Confidence                   34689999999877665433   23445888999999999999999999999  9999999999999999999


Q ss_pred             EEeccCCCccCCCccc-ccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHH
Q psy5927         294 VIGDFGLTQEGPIEKA-THITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLV  371 (441)
Q Consensus       294 kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~  371 (441)
                      ||+|||+++....... ........+||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+..+.
T Consensus       157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~  235 (318)
T d3blha1         157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALIS  235 (318)
T ss_dssp             EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHH
T ss_pred             EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHH
Confidence            9999999975433221 11223345799999999998765 689999999999999999999999987654 22322222


Q ss_pred             Hhhc---hhhhhhh-----------hccCCCchhH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         372 EKYS---EENMYDL-----------VDKNAQPIEL-----NIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       372 ~~~~---~~~~~~~-----------~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ....   .......           ..........     ..+..+.+|+.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            2111   1100000           0000111111     12446789999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=361.93  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=206.7

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeCC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFETG  222 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  222 (441)
                      ++|+++++||+|+||+||+|++.  ++.||||+++......       ....++.+|+.+|+.++||||+++++++.+..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------GVPSSALREICLLKELKHKNIVRLHDVLHSDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-------THHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-------HHHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence            58999999999999999999984  5679999997544322       23456779999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEeccCCCc
Q psy5927         223 KYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGDFGLTQ  302 (441)
Q Consensus       223 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~DFGla~  302 (441)
                      ..++|++++.+++|..++..   ...+++..+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~  149 (292)
T d1unla_          75 KLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ceeEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhh
Confidence            99999999999998877643   345789999999999999999999999  9999999999999999999999999998


Q ss_pred             cCCCcccccceeccccccCCCcCcccccCCC-CCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch---hh
Q psy5927         303 EGPIEKATHITLKRVNGTRPYLPHEFLVGKR-LSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE---EN  378 (441)
Q Consensus       303 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~  378 (441)
                      .......   ......++..|+|||.+.+.. ++.++|||||||++|||++|..||.........+..+......   ..
T Consensus       150 ~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         150 AFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             ECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence            6543222   122335788899999987754 6899999999999999999999976554434444443332211   00


Q ss_pred             ---hhhhh----------ccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         379 ---MYDLV----------DKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       379 ---~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                         .....          ..........++..+.+|+.+||+.||++|||++||++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00000          01122233455678899999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-47  Score=362.63  Aligned_cols=260  Identities=20%  Similarity=0.229  Sum_probs=196.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeec-ccceEEeC
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILP-LYGICFET  221 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~  221 (441)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++......           +++..|+++++.++|+|++. +.+++.+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----------PQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----------CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----------HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            57999999999999999999985  678999988753221           13458999999998776554 55556778


Q ss_pred             CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeec---CCCCeEEecc
Q psy5927         222 GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLN---HHMDPVIGDF  298 (441)
Q Consensus       222 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~---~~~~~kl~DF  298 (441)
                      +..++||||+ +++|.+.+...  ...+++..+..++.|++.||+|||+++  ||||||||+|||++   .+..+||+||
T Consensus        76 ~~~~ivme~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          76 DYNVMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CEEEEEEEEc-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeecc
Confidence            8899999999 67777766433  345899999999999999999999999  99999999999875   4567999999


Q ss_pred             CCCccCCCcccc----cceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhh
Q psy5927         299 GLTQEGPIEKAT----HITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKY  374 (441)
Q Consensus       299 Gla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~  374 (441)
                      |+|+........    ........||+.|||||.+.+..++.++|||||||++|||+||..||...............  
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~--  228 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI--  228 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH--
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh--
Confidence            999865332211    12234567999999999999999999999999999999999999999765442221111100  


Q ss_pred             chhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         375 SEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      ....    ...........++.++.+++.+||+.||.+||++.++.+.|+..
T Consensus       229 ~~~~----~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         229 SEKK----MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHH----HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hccc----CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0000    00001112234567899999999999999999999988877654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.2e-47  Score=360.99  Aligned_cols=259  Identities=18%  Similarity=0.211  Sum_probs=203.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC-CCeecccceEEe
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH-DNILPLYGICFE  220 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~  220 (441)
                      .++|++.++||+|+||+||+|++.  ++.||||++......           ..+.+|++.++.++| +||+.+++++.+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----------HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            578999999999999999999984  678999988643221           123467888888864 899999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecC-----CCCeEE
Q psy5927         221 TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNH-----HMDPVI  295 (441)
Q Consensus       221 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~-----~~~~kl  295 (441)
                      +...++||||+ +++|.+++....  ..+++..+..++.|++.||+|||++|  ||||||||+|||++.     ++.+||
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             CCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEE
Confidence            99999999999 799999875433  45889999999999999999999999  999999999999974     578999


Q ss_pred             eccCCCccCCCccc----ccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHH--HHH
Q psy5927         296 GDFGLTQEGPIEKA----THITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERH--LKS  369 (441)
Q Consensus       296 ~DFGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~--l~~  369 (441)
                      +|||+|+.......    .........||+.|||||++.+..++.++|||||||++|||+||..||.........  ...
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            99999986432211    112234567999999999999999999999999999999999999999764432211  111


Q ss_pred             HHHhhchhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Q psy5927         370 LVEKYSEENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYNMLSGS  426 (441)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  426 (441)
                      +......        .........++.++.+++..|++.+|++||+++.+.+.|+++
T Consensus       228 i~~~~~~--------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         228 IGEKKQS--------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHHHH--------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHhccCC--------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1111000        001112234567899999999999999999999888877654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=375.12  Aligned_cols=260  Identities=21%  Similarity=0.302  Sum_probs=203.5

Q ss_pred             hCCCcCcCccccCCceeEEEEEE-----CCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCC-CCeecccce
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVW-----EKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRH-DNILPLYGI  217 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~  217 (441)
                      .++|++++.||+|+||+||+|..     .++.||||+++........     ...+.+.+|++++++++| |||++++++
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~-----~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch-----HHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            47899999999999999999987     2467999998654321110     012234589999999966 899999999


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      +.+...++++|||+.+|+|.+++.....   ++...+..++.|++.||+|||+++  ||||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESC
T ss_pred             eccCCceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEee
Confidence            9999999999999999999999865543   677889999999999999999999  99999999999999999999999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCC--CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK--RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      ||+++........  ......||+.|+|||.+.+.  .++.++|||||||+||||+||..||.......... .+.....
T Consensus       173 FG~a~~~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~  249 (322)
T d1vzoa_         173 FGLSKEFVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRIL  249 (322)
T ss_dssp             SSEEEECCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHH
T ss_pred             ccchhhhcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcc
Confidence            9999765433222  23345799999999999764  46889999999999999999999997654322111 1111100


Q ss_pred             hhhhhhhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH--HHhc
Q psy5927         376 EENMYDLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPE-----MTQVYN--MLSG  425 (441)
Q Consensus       376 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~--~L~~  425 (441)
                               ....+.+..++.++.+|+.+||+.||++|||     ++|+++  .+++
T Consensus       250 ---------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         250 ---------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             ---------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ---------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence                     1112334467789999999999999999994     788886  3444

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=365.49  Aligned_cols=257  Identities=19%  Similarity=0.255  Sum_probs=192.8

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEe--
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFE--  220 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--  220 (441)
                      ++|+++++||+|+||+||+|.+.  +..||||++......       ......+.+|+.++++++|||||+++++|..  
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-------HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            68999999999999999999985  678999999754322       2234567799999999999999999999863  


Q ss_pred             ----CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         221 ----TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       221 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                          ...+|+|||||.++.+ +.+.     ..+++..+..++.|++.||+|||+.|  |+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             STTTCCEEEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEEC
T ss_pred             ccccCceeEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeee
Confidence                3688999999965544 4442     24889999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhch
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSE  376 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~  376 (441)
                      |||+++......    .....+||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ....+......
T Consensus       162 df~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~  236 (355)
T d2b1pa1         162 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGT  236 (355)
T ss_dssp             CCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred             chhhhhcccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccC
Confidence            999987643322    2344569999999999999999999999999999999999999997665422 22222211100


Q ss_pred             ----------hhhh-------------------hhhccCCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         377 ----------ENMY-------------------DLVDKNAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       377 ----------~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                                ....                   ..............+.++.+|+.+||..||++|||++||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                      0000                   01111122234557888999999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.2e-47  Score=367.04  Aligned_cols=253  Identities=17%  Similarity=0.257  Sum_probs=196.7

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccceEEe-
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGICFE-  220 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~-  220 (441)
                      ++|+++++||+|+||+||+|++.  ++.||||+++...            .+++.+|+++|+.++ ||||+++++++.. 
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            68999999999999999999984  6789999986422            234568999999995 9999999999874 


Q ss_pred             -CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCC-CeEEecc
Q psy5927         221 -TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHM-DPVIGDF  298 (441)
Q Consensus       221 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~-~~kl~DF  298 (441)
                       ...+++|||||.+++|....      ..+++..+..++.||+.||+|||++|  ||||||||+|||++.++ .+||+||
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCG
T ss_pred             CCCceeEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeeccc
Confidence             35699999999999997643      24899999999999999999999999  99999999999998765 5899999


Q ss_pred             CCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhchh
Q psy5927         299 GLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYSEE  377 (441)
Q Consensus       299 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~  377 (441)
                      |+|+.......    .....||+.|+|||.+.+. .++.++||||+||++|||++|..||............+.......
T Consensus       175 G~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~  250 (328)
T d3bqca1         175 GLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  250 (328)
T ss_dssp             GGCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             ccceeccCCCc----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence            99976433222    3345689999999998775 479999999999999999999999976554333222222111100


Q ss_pred             hh---------------hhhhcc---------CCCchhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q psy5927         378 NM---------------YDLVDK---------NAQPIELNIAYAFFRIGKQSTKQNPKERPEMTQVYN  421 (441)
Q Consensus       378 ~~---------------~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  421 (441)
                      ..               ......         ........++.++.+|+.+||..||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00               000000         011122345678899999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=363.75  Aligned_cols=265  Identities=19%  Similarity=0.288  Sum_probs=200.0

Q ss_pred             hCCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCeecccceEEeC
Q psy5927         144 TNNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNILPLYGICFET  221 (441)
Q Consensus       144 ~~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  221 (441)
                      .++|+++++||+|+||+||+|.+.  ++.||||++.....+.       ...+++.+|+++|++++|||||++++++...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-------IHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-------HHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            578999999999999999999984  6789999987543221       2344667999999999999999999998632


Q ss_pred             -----CeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEe
Q psy5927         222 -----GKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIG  296 (441)
Q Consensus       222 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~  296 (441)
                           ...+++|+|+.+|+|.+++..    ..+++..+..++.||+.||+|||++|  |+||||||+|||++.++.+|++
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cccccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccccccccc
Confidence                 344667778889999998843    34999999999999999999999999  9999999999999999999999


Q ss_pred             ccCCCccCCCcccccceeccccccCCCcCcccccCC-CCCCccceehHHHHHHHHHhCCCCCCCcchhHHHHHHHHHhhc
Q psy5927         297 DFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGK-RLSTKVDVYGFGIVLFELATGMRAYDDTRRSERHLKSLVEKYS  375 (441)
Q Consensus       297 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DiwSlGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~  375 (441)
                      |||++......      .....||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+..... ....+.....
T Consensus       164 dfg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~  236 (348)
T d2gfsa1         164 DFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG  236 (348)
T ss_dssp             CC----CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             ccchhcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            99998754322      2345689999999987765 46899999999999999999999998765422 2222222111


Q ss_pred             h--hh---------hhhhh----ccCCCc---hhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhcCCC
Q psy5927         376 E--EN---------MYDLV----DKNAQP---IELNIAYAFFRIGKQSTKQNPKERPEMTQVYN--MLSGSGG  428 (441)
Q Consensus       376 ~--~~---------~~~~~----~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~--~L~~~~~  428 (441)
                      .  ..         .....    ......   ....++.++.+|+.+||..||++|||+.|+++  .|++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence            0  00         00000    000111   11234677899999999999999999999998  6765543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-40  Score=326.26  Aligned_cols=264  Identities=21%  Similarity=0.254  Sum_probs=193.1

Q ss_pred             CCCcCcCccccCCceeEEEEEEC--CeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-----------CCCe
Q psy5927         145 NNWDKLNILGKGGFGTVYKGVWE--KTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-----------HDNI  211 (441)
Q Consensus       145 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI  211 (441)
                      ++|+++++||+|+||+||+|++.  ++.||||+++...          ...+.+.+|+++++.+.           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----------cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            46999999999999999999984  6789999997432          11233456777776664           5889


Q ss_pred             ecccceEEe--CCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCeeecCCCCCCeeec
Q psy5927         212 LPLYGICFE--TGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHS-REPPLIHGDIKSANILLN  288 (441)
Q Consensus       212 v~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~iiHrDikp~NiLl~  288 (441)
                      +++++++..  ....+++|+++..+..............+++..+..++.|++.||+|||+ .|  |+||||||+|||++
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~  160 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME  160 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeee
Confidence            999998764  35677778777666555545555566678999999999999999999997 88  99999999999998


Q ss_pred             CCCC------eEEeccCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHHHHHHhCCCCCCCcch
Q psy5927         289 HHMD------PVIGDFGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVLFELATGMRAYDDTRR  362 (441)
Q Consensus       289 ~~~~------~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl~elltG~~p~~~~~~  362 (441)
                      .++.      ++++|||.+......      .....||+.|+|||++.+..++.++|+||+||+++||++|+.||.....
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             ccCcccccceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            7654      899999998754322      2345699999999999999999999999999999999999999965432


Q ss_pred             h-----HHHHHHHHHhhch---hh------hhhhhc--------------------cCCCchhHHHHHHHHHHHHHhcCC
Q psy5927         363 S-----ERHLKSLVEKYSE---EN------MYDLVD--------------------KNAQPIELNIAYAFFRIGKQSTKQ  408 (441)
Q Consensus       363 ~-----~~~l~~~~~~~~~---~~------~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~  408 (441)
                      .     ...+.........   ..      .....+                    ..........+.++.+|+.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            1     1111111111100   00      000000                    001122356788899999999999


Q ss_pred             CCCCCCCHHHHHH--HHhcC
Q psy5927         409 NPKERPEMTQVYN--MLSGS  426 (441)
Q Consensus       409 dp~~RPs~~evl~--~L~~~  426 (441)
                      ||.+|||++|+++  .|+..
T Consensus       315 dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         315 DPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             STTTCBCHHHHHTCGGGTTC
T ss_pred             ChhHCcCHHHHhcCcccCCC
Confidence            9999999999997  46544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3e-26  Score=202.59  Aligned_cols=177  Identities=15%  Similarity=0.093  Sum_probs=120.5

Q ss_pred             cCcCccccCCceeEEEEEE-CCeeEEEEEeeeccchh---------HHHhhhHHHHHHHHHHHHHhhcCCCCCeecccce
Q psy5927         148 DKLNILGKGGFGTVYKGVW-EKTTIAVKKLEVHRNDR---------AVETLNQCQREQSLRELKYLNSCRHDNILPLYGI  217 (441)
Q Consensus       148 ~~~~~LG~G~fg~Vy~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  217 (441)
                      .+.++||+|+||+||+|.+ ++..||||+++......         ...............|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4578999999999999997 56889999876322110         0001111223344578899999999999988764


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeeecCCCCCCeeecCCCCeEEec
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSREPPLIHGDIKSANILLNHHMDPVIGD  297 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~iiHrDikp~NiLl~~~~~~kl~D  297 (441)
                      .  .  .+++|||+++..+.+          ++......++.|++.||+|||++|  |+||||||+|||+++++ ++|+|
T Consensus        83 ~--~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          83 E--G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             E--T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETTE-EEECC
T ss_pred             c--C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCCC-EEEEE
Confidence            2  2  379999998766533          233445678999999999999999  99999999999999765 89999


Q ss_pred             cCCCccCCCcccccceeccccccCCCcCcccccCCCCCCccceehHHHHH
Q psy5927         298 FGLTQEGPIEKATHITLKRVNGTRPYLPHEFLVGKRLSTKVDVYGFGIVL  347 (441)
Q Consensus       298 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DiwSlGvvl  347 (441)
                      ||+|.....+..... ..+-+.   . -.+.+ ...|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~-l~rd~~---~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREI-LERDVR---N-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHH-HHHHHH---H-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHHH-HHHHHH---H-HHHHH-cCCCCCcccHHHHHHHH
Confidence            999976433322111 000000   0 01222 34788999999986543

>d1ik7a_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.74  E-value=2e-20  Score=118.97  Aligned_cols=51  Identities=37%  Similarity=0.625  Sum_probs=48.7

Q ss_pred             hCCCchHHHHHHhhc-CCCCHHHHHHHHHhcChhhHHHhhccCccCCccccC
Q psy5927          17 RRESPTEELLSKWGA-QNHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCI   67 (441)
Q Consensus        17 ~~~s~t~~ll~~w~~-~n~tv~~l~~~l~~~~~~~a~~~~~~~~~~~~~~~~   67 (441)
                      ||+|||+|||..||. .||||.|||.+|.+|+||+||.+|+++|++++|+++
T Consensus         1 rg~SPt~elL~~Wg~q~NHTi~eLF~ll~~mk~~~aM~iiK~~V~~~~H~lI   52 (52)
T d1ik7a_           1 RGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHKYI   52 (52)
T ss_dssp             CTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHGGGC
T ss_pred             CCCCcHHHHHHHhCCcccccHHHHHHHHHHHHHHHHHHHHHHHcCHhhhhcC
Confidence            699999999999998 599999999999999999999999999999999874

>d1wh4a_ a.77.1.2 (A:) Interleukin-1 receptor-associated kinase 4, IRAK4 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Interleukin-1 receptor-associated kinase 4, IRAK4
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.70  E-value=7.6e-18  Score=135.81  Aligned_cols=62  Identities=26%  Similarity=0.394  Sum_probs=58.1

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcCCCCHHHHHHHHHhcChhhHHHhhccCccCC
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQNHTVLELFKHLYAMRHYQAMLILKPYVESK   62 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~n~tv~~l~~~l~~~~~~~a~~~~~~~~~~~   62 (441)
                      |+|++.||++||++.++|+|||++||++||++||||++|+++|.+|++|+||++|++.+.+.
T Consensus        53 ~~ys~~~i~~~e~~~~~~~Spt~~LL~~Wg~~~~TV~~L~~~L~~~~~~~A~~~l~~~~~~~  114 (127)
T d1wh4a_          53 DRYNQFHIRRFEALLQTGKSPTCELLFDWGTTNCTVGDLVDLLVQIELFAPATLLLPDAVPQ  114 (127)
T ss_dssp             BSSCHHHHHHHHHHHTTTSCHHHHHHHHHHHHCCBHHHHHHHHHHTTCHHHHHHHCTTSSSS
T ss_pred             cccCHHHHHHHHHHhcCCCCHHHHHHHHHHHcCCcHHHHHHHHHHcCCHHHHHHHccccccc
Confidence            47999999999999999999999999999999999999999999999999999999865443

>d1d2za_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.46  E-value=3.2e-14  Score=110.57  Aligned_cols=67  Identities=33%  Similarity=0.523  Sum_probs=63.9

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcC-CCCHHHHHHHHHhcChhhHHHhhccCccCCccccC
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILKPYVESKYHTCI   67 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~-n~tv~~l~~~l~~~~~~~a~~~~~~~~~~~~~~~~   67 (441)
                      |||+..+|+.||.+.+++.|||++||+.||++ |+||++|++.|.++++++|+++|+.++++.+|+++
T Consensus        35 Lg~~~~~I~~i~~~~~~~~Spt~~lL~~W~~~~~~Tv~~L~~~L~~~~~~da~~~i~~~~~~~~~~~~  102 (102)
T d1d2za_          35 VKLYPDQVEQISSQKQRGRSASNEFLNIWGGQYNHTVQTLFALFKKLKLHNAMRLIKDYVSEDLHKYI  102 (102)
T ss_dssp             TTCCHHHHHHHHHHHHTTCCHHHHHHHHHHHHHCCBHHHHHHHHHHTTCHHHHHHTGGGSCGGGGGGC
T ss_pred             hCCCHHHHHHHHhcccCCCChHHHHHHHHHhcCCCcHHHHHHHHHHcChHHHHHHHHHHHHHHHHhhC
Confidence            69999999999999999999999999999975 99999999999999999999999999999999864

>d1d2zb_ a.77.1.2 (B:) Tube death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tube death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.41  E-value=1.2e-13  Score=108.85  Aligned_cols=55  Identities=20%  Similarity=0.369  Sum_probs=52.1

Q ss_pred             CChHHHHHHHHHHH---hCCCchHHHHHHhhcC-----CCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           3 FTSRQLFQMEQAIL---RRESPTEELLSKWGAQ-----NHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         3 ~~~~~~~~~~~~~~---~~~s~t~~ll~~w~~~-----n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |++.|+++||++++   +|+|||++||.+|||.     ||||++|+++|.+.++|||++.+..
T Consensus        66 Y~~~hi~~ie~~a~~~~~~~S~t~~lL~eWgTSGk~~~rpTvg~Ll~LLvk~el~~AAd~va~  128 (150)
T d1d2zb_          66 YTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVAL  128 (150)
T ss_dssp             SCHHHHHHHHHHHHHSCTTCCHHHHHHHHHHTCSSSTTSCBHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHhhccCCCChHHHHHHHhcccCcccCCCCHHHHHHHHHHcchHHHHHHHHH
Confidence            89999999999887   5999999999999986     9999999999999999999998865

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=3e-08  Score=89.67  Aligned_cols=148  Identities=15%  Similarity=0.077  Sum_probs=99.1

Q ss_pred             HHHHhhCCCcCcCccccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC-CCCeecccce
Q psy5927         139 ELTLATNNWDKLNILGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR-HDNILPLYGI  217 (441)
Q Consensus       139 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  217 (441)
                      ++......|+..+..+.++.+.||+...++..+.+|+.........         ..+.+|...+..+. +--+.+++.+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~---------~~~~~E~~~l~~l~~~vpvP~vl~~   78 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---------YDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST---------TCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch---------hhHHHHHHHHHHHhccCCCCcEEEE
Confidence            4555567787777666566679999888888888888753322111         12336666666553 3335567777


Q ss_pred             EEeCCeEEEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------
Q psy5927         218 CFETGKYCLVYRYMPNGSLEDRLLMKKNTPSLLWTQRLHIAKGTSLGLQFLHSRE-------------------------  272 (441)
Q Consensus       218 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-------------------------  272 (441)
                      +.+++..++||++++|.++.+.....        .....++.+++..+..||+..                         
T Consensus        79 ~~~~~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T d1j7la_          79 ERHDGWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             EecCCceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence            88889999999999998886543110        112334555556666666421                         


Q ss_pred             --------------------------------CCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         273 --------------------------------PPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       273 --------------------------------~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                                                      ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                            0179999999999999877677999997753

>d1ngra_ a.77.1.2 (A:) p75 low affinity neurotrophin receptor {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: p75 low affinity neurotrophin receptor
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.05  E-value=3.7e-06  Score=61.54  Aligned_cols=52  Identities=21%  Similarity=0.402  Sum_probs=46.8

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhcC-CCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGAQ-NHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~-n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      +||++.+|+.|+.    ..|||+++|..|.++ ++||++|++.|..++...+++.|.
T Consensus        31 LGl~~~~I~~i~~----~~spt~~lL~~W~~~~~~tl~~L~~~L~~~~r~Dv~~~l~   83 (85)
T d1ngra_          31 LGYQPEHIDSFTH----EACPVRALLASWGAQDSATLDALLAALRRIQRADIVESLC   83 (85)
T ss_dssp             TTCCHHHHHHHHH----SSCHHHHHHHHGGGSTTCBHHHHHHHHHHTTCHHHHHHHH
T ss_pred             cCCCHHHHHHHHc----CCChHHHHHHHHHHcCCCcHHHHHHHHHHcCcHHHHHHHh
Confidence            6899999999874    689999999999965 689999999999999999998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.84  E-value=1.2e-05  Score=71.37  Aligned_cols=74  Identities=15%  Similarity=0.042  Sum_probs=46.1

Q ss_pred             ccccCC-ceeEEEEEECCe-eEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCC--CCCeecccceEEeCCeEEEE
Q psy5927         152 ILGKGG-FGTVYKGVWEKT-TIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCR--HDNILPLYGICFETGKYCLV  227 (441)
Q Consensus       152 ~LG~G~-fg~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv  227 (441)
                      .+..|. -+.||+...++. .+.+|........            .+..|...++.+.  .-.+.++++++.+++..++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh------------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            444454 368999887544 5677765432211            1224555555442  23356677777888899999


Q ss_pred             EEecCCCCHH
Q psy5927         228 YRYMPNGSLE  237 (441)
Q Consensus       228 ~e~~~~gsL~  237 (441)
                      |++++|.++.
T Consensus        85 ~~~i~G~~~~   94 (255)
T d1nd4a_          85 LGEVPGQDLL   94 (255)
T ss_dssp             EECCSSEETT
T ss_pred             EEeeeccccc
Confidence            9999886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.52  E-value=8.9e-05  Score=70.43  Aligned_cols=32  Identities=34%  Similarity=0.567  Sum_probs=27.1

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccCCC
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEGPI  306 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~~~  306 (441)
                      .++|||+.|.|||+++++ ++|+||..+..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~~  255 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYGPI  255 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEECT
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccCCH
Confidence            399999999999998764 89999998876543

>d1wmga_ a.77.1.2 (A:) Netrin receptor UNC5B {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Netrin receptor UNC5B
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.47  E-value=6.4e-05  Score=55.39  Aligned_cols=52  Identities=19%  Similarity=0.312  Sum_probs=42.8

Q ss_pred             CCCChHHHHHHHHHHHhCCCchHHHHHHhhc---CCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRRESPTEELLSKWGA---QNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~---~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      |||+. ++..|    .+..|||++||..|..   .++||++|.+.|.+++-..++.+|..
T Consensus        34 Lg~~~-~i~~~----~~~~sPt~~lL~~w~~~~~~~~tv~~L~~~L~~i~R~Dvv~~L~~   88 (90)
T d1wmga_          34 LSMDR-YLNYF----ATKASPTGVILDLWEARQQDDGDLNSLASALEEMGKSEMLVAMAT   88 (90)
T ss_dssp             TTCGG-GHHHH----HTSSCHHHHHHHHHHHHCCSTTTHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             hCCcH-HHHHH----HhCCCchhhHHHHHHHHhCCCCcHHHHHHHHHHcCcHHHHHHHhh
Confidence            57864 56555    4679999999999973   46799999999999999999988753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.66  E-value=0.0048  Score=55.91  Aligned_cols=158  Identities=12%  Similarity=0.047  Sum_probs=81.2

Q ss_pred             CChhHHHHhhCCCcCcCc-----cccCCceeEEEEEECCeeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcC---
Q psy5927         135 IPYQELTLATNNWDKLNI-----LGKGGFGTVYKGVWEKTTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSC---  206 (441)
Q Consensus       135 ~~~~~~~~~~~~~~~~~~-----LG~G~fg~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---  206 (441)
                      .+..++.....+|.+++.     |..|---+.|+...++..+++|+..........           ..|++++..+   
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l-----------~~~~~~l~~L~~~   71 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDL-----------PFFLGLMQHLAAK   71 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHH-----------HHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHH-----------HHHHHHHHhhhhc
Confidence            455677777788887554     345555788998888888999988643221111           1233333333   


Q ss_pred             --CCCCeecccc---eEEeCCeEEEEEEecCCCCHHH--------------HHhhcCC-------CCCCC----------
Q psy5927         207 --RHDNILPLYG---ICFETGKYCLVYRYMPNGSLED--------------RLLMKKN-------TPSLL----------  250 (441)
Q Consensus       207 --~hpnIv~l~~---~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~-------~~~l~----------  250 (441)
                        ..|..+...+   +..-.+....++.+..+.....              .++....       .....          
T Consensus        72 g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (316)
T d2ppqa1          72 GLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS  151 (316)
T ss_dssp             TCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred             cccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHH
Confidence              2333332211   1233456677788877644311              0100000       00000          


Q ss_pred             -------HHHHHHHHHHHHHHHHHHHcC--CCCeeecCCCCCCeeecCCCCeEEeccCCCcc
Q psy5927         251 -------WTQRLHIAKGTSLGLQFLHSR--EPPLIHGDIKSANILLNHHMDPVIGDFGLTQE  303 (441)
Q Consensus       251 -------~~~~~~i~~~i~~al~~LH~~--~~~iiHrDikp~NiLl~~~~~~kl~DFGla~~  303 (441)
                             .......+......+.-.+..  ..++||+|+.+.||+++.+...-|.||+.+..
T Consensus       152 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         152 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence                   000111122222222222221  12499999999999999988778999998753

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.47  E-value=0.012  Score=53.42  Aligned_cols=29  Identities=31%  Similarity=0.534  Sum_probs=23.9

Q ss_pred             CeeecCCCCCCeeecCCCCeEEeccCCCccC
Q psy5927         274 PLIHGDIKSANILLNHHMDPVIGDFGLTQEG  304 (441)
Q Consensus       274 ~iiHrDikp~NiLl~~~~~~kl~DFGla~~~  304 (441)
                      .+||+|+.+.|||++++  ..++||+-+..+
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcccC
Confidence            48999999999999743  568999988653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.83  E-value=0.0083  Score=56.28  Aligned_cols=72  Identities=13%  Similarity=0.194  Sum_probs=41.9

Q ss_pred             cCccccCCceeEEEEEECC---------eeEEEEEeeeccchhHHHhhhHHHHHHHHHHHHHhhcCCCCCe-ecccceEE
Q psy5927         150 LNILGKGGFGTVYKGVWEK---------TTIAVKKLEVHRNDRAVETLNQCQREQSLRELKYLNSCRHDNI-LPLYGICF  219 (441)
Q Consensus       150 ~~~LG~G~fg~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~  219 (441)
                      ++.|+.|-.-.+|+....+         ..+.+++.- . .....         ...+|..+++.+.-.++ .++++++.
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~i---------dr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETES---------HLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHH---------HHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhh---------HHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            3678888888999988643         234444432 1 11111         11256777766632233 46676654


Q ss_pred             eCCeEEEEEEecCCCCH
Q psy5927         220 ETGKYCLVYRYMPNGSL  236 (441)
Q Consensus       220 ~~~~~~lv~e~~~~gsL  236 (441)
                      +    .+|+||++|.+|
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            2    589999987544

>d1icha_ a.77.1.2 (A:) Tumor necrosis factor receptor-1 death domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tumor necrosis factor receptor-1 death domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.91  E-value=0.072  Score=37.92  Aligned_cols=56  Identities=14%  Similarity=0.191  Sum_probs=44.0

Q ss_pred             CCCChHHHHHHHHHHHh-CCCchHHHHHHhh----cCCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           1 MNFTSRQLFQMEQAILR-RESPTEELLSKWG----AQNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~-~~s~t~~ll~~w~----~~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      +||+..+|..|+..-.. -+....++|..|-    ..++||+.|..-|.+.++-..++.|.
T Consensus        23 LGls~~~i~~I~~~~~~~~~eq~~~mL~~W~~~~g~~~at~~~L~~aL~~~~~~~~Ae~i~   83 (87)
T d1icha_          23 LGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMDLLGCLEDIE   83 (87)
T ss_dssp             HTCCHHHHHHHHHHCCSCHHHHHHHHHHHHHHHSCCSSCHHHHHHHHHHHTTCHHHHHHHH
T ss_pred             hCcCHHHHHHHHHHCCCCHHHHHHHHHHHHHHhhCCCchHHHHHHHHHHHCCCHHHHHHHH
Confidence            48999999999754321 1245888999994    45689999999999999999887764

>d2gf5a1 a.77.1.2 (A:89-191) FADD (Mort1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: FADD (Mort1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.84  E-value=0.092  Score=38.63  Aligned_cols=57  Identities=18%  Similarity=0.248  Sum_probs=45.1

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhhc---CCCCHHHHHHHHHhcChhhHHHhhcc
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWGA---QNHTVLELFKHLYAMRHYQAMLILKP   57 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~---~n~tv~~l~~~l~~~~~~~a~~~~~~   57 (441)
                      +||++.+|..|+..-... +....++|..|-+   .++|+..|++-|.+.++...++.|..
T Consensus        31 Lgl~~~~I~~I~~~~~~~~~e~~~~mL~~W~~~~g~~at~~~L~~aL~~~~~~dlad~i~~   91 (103)
T d2gf5a1          31 LKVSDTKIDSIEDRYPRNLTERVRESLRIWKNTEKENATVAHLVGALRSCQMNLVADLVQE   91 (103)
T ss_dssp             TTCCHHHHHHHHHHSSSCSHHHHHHHHHHHHHHTTTTCCHHHHHHHHHHHTCHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHcCCCHHHHHHHHHHHHHHHcCCCcHHHHHHHHHHHCCcHHHHHHHHH
Confidence            589999999998543221 3447789999985   46999999999999999998887754

>d1fada_ a.77.1.2 (A:) FADD (Mort1) {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: FADD (Mort1)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=82.31  E-value=0.4  Score=34.36  Aligned_cols=56  Identities=20%  Similarity=0.274  Sum_probs=43.7

Q ss_pred             CCCChHHHHHHHHHHHhC-CCchHHHHHHhh---cCCCCHHHHHHHHHhcChhhHHHhhc
Q psy5927           1 MNFTSRQLFQMEQAILRR-ESPTEELLSKWG---AQNHTVLELFKHLYAMRHYQAMLILK   56 (441)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~---~~n~tv~~l~~~l~~~~~~~a~~~~~   56 (441)
                      +||+..+|..|+.--... +....++|..|-   ..++|+..|.+-|.+.++-..++.|.
T Consensus        31 Lgls~~~I~~I~~~~~~~~~e~~~~mL~~W~~~~g~~at~~~L~~aL~~~~~~d~ae~i~   90 (95)
T d1fada_          31 LKVSEAKMDGIEEKYPRSLSERVRESLKVWKNAEKKNASVAGLVKALRTCRLNLVADLVE   90 (95)
T ss_dssp             TTCCHHHHHHHHHHCSSCHHHHHHHHHHHHHHHHGGGGSHHHHHHHHHHHTCHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHCCCCHHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHcCcHHHHHHHH
Confidence            689999999998542221 234778999995   24789999999999999988887764